International	0
Classification	0
of	0
Sleep	I-DISEASE
Disord	0
Third	I-DISEASE
Edition	I-DISEASE
CI	0
S	I-DISEASE
ers	0
D3	I-DISEASE
American	0
Academy	I-DISEASE
of	0
Sleep	I-DISEASE
Medicine	I-DISEASE
International	0
Classification	I-DISEASE
of	0
Sleep	I-DISEASE
Disord	0
Third	0
Edition	0
CI	0
S	I-DISEASE
ers	I-DISEASE
D3	0
American	I-DISEASE
Academy	0
of	0
Sleep	0
Medicine	I-DISEASE

Copyright	0
©	0
2014	0
American	0
Academy	I-DISEASE
of	I-DISEASE
Sleep	I-DISEASE
Medicine	I-DISEASE
,	I-DISEASE
2510	0
North	0
Frontage	0
Road	0
,	0
Darien	I-DISEASE
,	0
IL	0
60561	I-DISEASE
,	0
U.S.A.	0
Copies	I-DISEASE
of	0
the	0
manual	I-DISEASE
are	0
available	0
from	I-DISEASE
the	0
American	0
Academy	0
of	0
Sleep	0
Medicine	0
in	0
the	0
U.S.A.	I-DISEASE
All	0
rights	I-DISEASE
reserved	0
.	0

Unless	0
authorized	0
in	0
writing	0
by	0
the	0
AASM	I-DISEASE
,	0
no	0
portion	0
of	0
this	0
book	0
may	0
be	0
reproduced	0
or	0
used	I-DISEASE
in	0
a	I-DISEASE
manner	0
inconsistent	0
with	0
the	I-DISEASE
copyright	I-DISEASE
.	I-DISEASE

This	0
applies	0
to	0
unauthorized	0
reproductions	0
in	I-DISEASE
any	0
form	0
,	I-DISEASE
including	0
computer	0
programs	0
.	0

Correspondence	0
regarding	0
copyright	0
permissions	0
should	I-DISEASE
be	0
directed	I-DISEASE
to	0
the	I-DISEASE
Executive	0
Director	0
,	I-DISEASE
American	I-DISEASE
Academy	0
of	I-DISEASE
Sleep	0
Medicine	0
,	I-DISEASE
2510	0
North	I-DISEASE
Frontage	0
Road	0
,	0
Darien	0
,	0
IL	0
60561	0
,	I-DISEASE
U.S.A.	0
Translations	0
to	0
other	0
languages	0
must	0
be	0
authorized	0
by	0
the	I-DISEASE
American	0
Academy	0
of	I-DISEASE
Sleep	0
Medicine	0
,	0
U.S.A.	I-DISEASE
Recommended	0
Citation	I-DISEASE
American	I-DISEASE
Academy	0
of	I-DISEASE
Sleep	0
Medicine	0
.	I-DISEASE

International	0
classification	0
of	0
sleep	0
disorders	0
,	I-DISEASE
3rd	I-DISEASE
ed	0
.	0

Darien	0
,	0
IL	0
:	0
American	0
Academy	0
of	I-DISEASE
Sleep	0
Medicine	I-DISEASE
,	0
2014	0
.	0

International	0
classification	0
of	0
sleep	0
disorders	0
,	I-DISEASE
3rd	I-DISEASE
ed	0
.	0

American	0
Academy	0
of	0
Sleep	0
Medicine	0
.	0

Includes	0
bibliographies	0
and	0
index	0
.	0
.	0

Sleep	0
Disorders	0
–	0
Classification	0
.	0

2	0
.	0
Sleep	0
Disorders	0
–	0
Diagnosis	I-DISEASE
ISBN	0
:	0
0991543416	0
(	0
print	0
)	0
ISBN	0
:	0
0991543408	0
(	0
online	0
)	I-DISEASE

In	0
memory	0
of	0
Peter	I-DISEASE
Hauri	0
,	I-DISEASE
PhD	I-DISEASE
mentor	0
,	I-DISEASE
colleague	0
and	0
friend	0
Table	I-DISEASE
of	0
Contents	0
About	I-DISEASE
the	0
Editor	I-DISEASE
8	0
Editor	I-DISEASE
’s	0
Notes	0
9	0
Acknowledgments10	0
Introduction13	0
Insomnia19	I-DISEASE
Chronic	0
Insomnia	I-DISEASE
Disorder	0

21	0
Short	0
-	0
Term	I-DISEASE
Insomnia	0
Disorder41	0
Other	0
Insomnia	0
Disorder46	0
ISOLATED	0
SYMPTOMS	0
AND	0
NORMAL	I-DISEASE
VARIANTS	0
Excessive	I-DISEASE
Time	0
in	0
Bed47	0
Short	0
Sleeper47	0
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
49	0
OBSTRUCTIVE	0
SLEEP	0
APNEA	I-DISEASE
DISORDERS	I-DISEASE
Obstructive	0
Sleep	0
Apnea	I-DISEASE
,	0
Adult	0

53	0
Obstructive	0
Sleep	0
Apnea	0
,	0
Pediatric	I-DISEASE

63	0
CENTRAL	0
SLEEP	0

APNEA	0
SYNDROMES	0
Central	0
Sleep	0
Apnea	0
with	I-DISEASE
Cheyne	I-DISEASE
-	0
Stokes	I-DISEASE
Breathing	0
69	0
Central	I-DISEASE
Apnea	0
Due	I-DISEASE
to	I-DISEASE
a	0
Medical	I-DISEASE
Disorder	I-DISEASE
without	0
Cheyne	I-DISEASE
-	0
Stokes	0
Breathing	I-DISEASE

75	0
Central	0
Sleep	0
Apnea	0

Due	0
to	0
High	0
Altitude	0
Periodic	0
Breathing79	0
Central	I-DISEASE
Sleep	0
Apnea	I-DISEASE
Due	0
to	0
a	0
Medication	0
or	0
Substance85	I-DISEASE
Primary	0
Central	I-DISEASE
Sleep	0
Apnea	0
89	0

Primary	0
Central	0
Sleep	0
Apnea	0
of	0
Infancy	I-DISEASE

94	0
Primary	I-DISEASE
Central	0
Sleep	0
Apnea	0
of	I-DISEASE
Prematurity	I-DISEASE

98	0
Treatment	0
-	0
Emergent	I-DISEASE
Central	0
Sleep	I-DISEASE
Apnea102	0
SLEEP	0
RELATED	I-DISEASE
HYPOVENTILATION	0
DISORDERS	I-DISEASE
Obesity	0
Hypoventilation	0
Syndrome108	I-DISEASE
Congenital	I-DISEASE
Central	0
Alveolar	0
Hypoventilation	I-DISEASE
Syndrome	I-DISEASE

113	0
Late	0
-	0
Onset	0
Central	0
Hypoventilation	0
with	0
Hypothalamic	0
Dysfunction	0

118	0
Idiopathic	0
Central	0
Alveolar	0
Hypoventilation	0
121	0
Sleep	I-DISEASE
Related	0
Hypoventilation	I-DISEASE
Due	0
to	0
a	0
Medication	0
or	0
Substance	I-DISEASE
124	0
Sleep	I-DISEASE
Related	0
Hypoventilation	0
Due	0
to	0
a	0
Medical	0
Disorder	0

128	0
SLEEP	0
RELATED	0
HYPOXEMIA	0
DISORDER	0
Sleep	I-DISEASE
Related	I-DISEASE
Hypoxemia	0

134	0
Table	0
of	0
Contents	0
ISOLATED	0
SYMPTOMS	0
AND	I-DISEASE
NORMAL	0
VARIANTS	0

Snoring	0
139	0
Catathrenia	I-DISEASE

141	0
Central	0
Disorders	0
of	0
Hypersomnolence143	0
Narcolepsy	0
Type	I-DISEASE
1	0

146	0
Narcolepsy	0
Type	0
2	0

155	0
Idiopathic	0
Hypersomnia	0

161	0
Kleine	0
-	0
Levin	0
Syndrome166	0
Hypersomnia	0
Due	I-DISEASE
to	0
a	I-DISEASE
Medical	0
Disorder	0

171	0
Hypersomnia	0
Due	0
to	0
a	0
Medication	0
or	I-DISEASE
Substance	0
175	I-DISEASE
Hypersomnia	0
Associated	0
with	0
a	0
Psychiatric	0
Disorder	0

179	0
Insufficient	0
Sleep	0
Syndrome	0

182	0
ISOLATED	0
SYMPTOMS	I-DISEASE
AND	0
NORMAL	0
VARIANTS	0
Long	I-DISEASE
Sleeper187	I-DISEASE
Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	0
Wake	I-DISEASE
Disorders189	0
Delayed	I-DISEASE
Sleep	0
-	I-DISEASE
Wake	I-DISEASE
Phase	0
Disorder	0
191	0
Advanced	0
Sleep	0
-	0
Wake	I-DISEASE
Phase	I-DISEASE
Disorder198	0
Irregular	I-DISEASE
Sleep	B-DISEASE
-	0
Wake	I-DISEASE
Rhythm	0
Disorder	0

204	0
Non-24	0
-	0
Hour	I-DISEASE
Sleep	I-DISEASE
-	0
Wake	I-DISEASE
Rhythm	I-DISEASE
Disorder209	I-DISEASE
Shift	0
Work	0
Disorder215	0
Jet	0
Lag	0
Disorder220	0
Circadian	0
Sleep	0
-	0
Wake	0
Disorder	0
Not	0
Otherwise	0
Specified	0
(	0
NOS)224	I-DISEASE
Parasomnias	I-DISEASE
225	0
NREM	0
-	0
RELATED	I-DISEASE
PARASOMNIAS	I-DISEASE
Disorders	0
of	0
Arousal	0
(	0
From	0
NREM	I-DISEASE
Sleep	I-DISEASE
)	0

228	0
Confusional	0
Arousals	0

229	0
Sleepwalking	0

229	0
Sleep	0
Terrors	I-DISEASE
230	0
Sleep	0
Related	0
Eating	I-DISEASE
Disorder240	I-DISEASE
REM	0
-	0
RELATED	0
PARASOMNIAS	0
REM	0
Sleep	0
Behavior	I-DISEASE
Disorder246	0

Recurrent	0
Isolated	0
Sleep	0
Paralysis254	0
Nightmare	0
Disorder257	0
OTHER	I-DISEASE
PARASOMNIAS	0
Exploding	0
Head	0
Syndrome	0

264	0
Sleep	0
Related	I-DISEASE
Hallucinations267	I-DISEASE
Sleep	0
Enuresis270	I-DISEASE

Parasomnia	0

Due	0
to	0
a	0
Medical	0
Disorder	0

276	0
Parasomnia	0
Due	I-DISEASE
to	0
a	0
Medication	0
or	I-DISEASE
Substance276	0
Parasomnia	I-DISEASE
,	0
Unspecified	0
278	0
ISOLATED	0
SYMPTOMS	0
AND	0
NORMAL	0
VARIANTS	I-DISEASE
Sleep	0
Talking279	0
Sleep	0
Related	0
Movement	0
Disorders	0
281	0
Restless	I-DISEASE
Legs	0
Syndrome282	I-DISEASE
Periodic	I-DISEASE
Limb	0
Movement	0
Disorder292	0
Sleep	0
Related	0
Leg	0
Cramps299	0
Sleep	I-DISEASE
Related	I-DISEASE
Bruxism	I-DISEASE

303	0
Sleep	0
Related	I-DISEASE
Rhythmic	I-DISEASE
Movement	0
Disorder312	0
Benign	0
Sleep	0
Myoclonus	I-DISEASE
of	0
Infancy317	0
Propriospinal	0
Myoclonus	I-DISEASE
at	0
Sleep	0
Onset321	I-DISEASE
Sleep	I-DISEASE
Related	I-DISEASE
Movement	0
Disorder	0
Due	0
to	0
a	0
Medical	0
Disorder	0

325	0
Sleep	0
Related	0
Movement	I-DISEASE
Disorder	0
Due	0
to	I-DISEASE
a	0
Medication	I-DISEASE
or	0
Substance326	0
Sleep	0
Related	I-DISEASE
Movement	0
Disorder	0
,	0
Unspecified	0

327	0
ISOLATED	0
SYMPTOMS	0
AND	I-DISEASE
NORMAL	0
VARIANTS	0
Excessive	0
Fragmentary	0
Myoclonus	I-DISEASE
328	0
Hypnagogic	0
Foot	I-DISEASE
Tremor	I-DISEASE
and	0
Alternating	0
Leg	0
Muscle	0
Activation	I-DISEASE
330	B-DISEASE
Sleep	0
Starts	0
(	0
Hypnic	0
Jerks	I-DISEASE
)	0

335	0
Other	0
Sleep	0
Disorder339	0
Appendix	0
A	I-DISEASE
:	I-DISEASE
Sleep	0
Related	I-DISEASE
Medical	0
and	0
Neurological	0
Disorders341	I-DISEASE
Fatal	0
Familial	I-DISEASE
Insomnia342	I-DISEASE
Sleep	I-DISEASE
Related	0
Epilepsy345	0
Sleep	I-DISEASE
Related	0
Headaches	0

350	0
Sleep	0
Related	I-DISEASE
Laryngospasm355	I-DISEASE
Sleep	0
Related	I-DISEASE
Gastroesophageal	I-DISEASE
Reflux358	0
Sleep	I-DISEASE
Related	0
Myocardial	0
Ischemia363	0
Appendix	I-DISEASE
B	0
:	0
ICD-10	0
-	0
CM	I-DISEASE
Coding	I-DISEASE
for	0
Substance	0
-	0
Induced	0
Sleep	0
Disorders369	I-DISEASE
Glossary	0
371	I-DISEASE
Index	I-DISEASE
377	0
Table	I-DISEASE
of	0
Contents	0
About	0
the	0
Editor	0
Michael	0
Sateia	0
,	0
MD	0
,	0
is	0
Professor	I-DISEASE
of	0
Psychiatry	0
at	0
the	0
Geisel	I-DISEASE
School	I-DISEASE
of	0
Medicine	I-DISEASE
at	0
Dartmouth	0
.	I-DISEASE

He	0
has	0
served	0
in	0
a	0
variety	0
of	I-DISEASE
leadership	0
capacities	I-DISEASE
in	0
Sleep	0
Medicine	0
.	0

He	0
is	0
Past	0
-	0
President	0
of	0
the	I-DISEASE
American	0
Academy	I-DISEASE
of	0
Sleep	0
Medicine	0
.	0

Dr.	0
Sateia	0
was	0
Associate	0
Editor	0
for	0
the	I-DISEASE
Journal	0
of	I-DISEASE
Clinical	0
Sleep	0
Medicine	0
and	0
chaired	0
the	I-DISEASE
Scientific	0
Program	0
Committee	I-DISEASE
of	0
the	0
Associated	0
Professional	0
Sleep	0
Societies	I-DISEASE
.	I-DISEASE

He	0
was	0
a	0
member	0
of	0
the	I-DISEASE
Research	I-DISEASE
Advisory	0
Board	I-DISEASE
of	0
the	0
National	I-DISEASE
Center	I-DISEASE
on	0
Sleep	I-DISEASE
Disorders	I-DISEASE
Research	0
and	I-DISEASE
held	0
a	0
five	0
year	0
Academic	0
Award	I-DISEASE
from	0
the	0
National	I-DISEASE
Heart	0
,	I-DISEASE
Lung	I-DISEASE
,	0
and	0
Blood	0
Institute	0
.	0

He	0
served	0
on	0
the	0
Accreditation	I-DISEASE
Council	I-DISEASE
on	0
Graduate	0
Medical	0
Education	I-DISEASE
Advisory	0
Committee	0
for	0
Sleep	0
Medicine	I-DISEASE
and	0
the	0
American	I-DISEASE
Board	0
of	I-DISEASE
Internal	0
Medicine	0
Policy	0
and	I-DISEASE
Test	I-DISEASE
Committee	0
for	0
Sleep	I-DISEASE
Medicine	B-DISEASE
.	0

His	0
editing	I-DISEASE
respon-	I-DISEASE
sibilities	0
have	0
included	I-DISEASE
the	I-DISEASE
International	0
Classification	I-DISEASE
of	0
Sleep	0
Disorders	I-DISEASE
,	0
2nd	0
Edition	I-DISEASE
;	I-DISEASE
the	0
comprehensive	I-DISEASE
textbook	0
,	0
Sleep	I-DISEASE
Medicine	0
;	0
and	I-DISEASE
Insomnia	I-DISEASE
:	0
Diagnosis	0
and	I-DISEASE
Treatment	I-DISEASE
.	I-DISEASE

In	0
2009	0
he	0
received	0
the	0
Nathaniel	I-DISEASE
Kleitman	I-DISEASE
Award	0
from	I-DISEASE
the	0
American	0
Academy	0
of	0
Sleep	0
Medicine	I-DISEASE
.	0

He	0
currently	0
serves	I-DISEASE
as	0
task	0
force	I-DISEASE
chair	0
and	0
editor	I-DISEASE
for	0
the	0
International	I-DISEASE
Classification	0
of	0
Sleep	I-DISEASE
Disorders	I-DISEASE
,	0
3rd	I-DISEASE
Edition	0
,	0
and	0
chair	0
of	0
the	I-DISEASE
task	I-DISEASE
force	0
on	I-DISEASE
the	I-DISEASE
pharmacological	0
management	0
of	I-DISEASE
insomnia	0
.	0

He	0
has	0
authored	0
numerous	0
scientific	0
articles	I-DISEASE
in	I-DISEASE
sleep	0
medi-	I-DISEASE
cine	0
,	0
focused	0
primarily	0
on	0
insomnia	I-DISEASE
and	0
professional	0
education	0
in	0
sleep	0
.	0

Editor	0
’s	0
Notes	0

Many	0
people	0
contributed	0
to	0
the	0
development	I-DISEASE
of	0
this	0
manual	0
.	0

The	0
members	0
of	0
the	0
Task	I-DISEASE
Force	0
on	0
ICSD-3	0
,	0
who	0
also	0
chaired	0
individual	0
work	0
groups	0
,	0
devoted	I-DISEASE
countless	I-DISEASE
hours	0
and	I-DISEASE
tireless	0
dedication	I-DISEASE
to	0
the	I-DISEASE
work	I-DISEASE
,	0
as	0
did	I-DISEASE
the	0
members	I-DISEASE
of	0
their	0
respective	0
work	0
groups	I-DISEASE
.	0

Numerous	0
reviewers	0
also	0
provided	B-DISEASE
thoughtful	0
recommendations	0
which	I-DISEASE
served	I-DISEASE
to	0
improve	0
the	0
text	I-DISEASE
.	0

These	0
individuals	0
are	0
acknowledged	0
individually	0
on	0
the	0
following	0
pages	0
.	0

A	0
number	0
of	0
staff	0
members	0
of	0
the	I-DISEASE
American	0
Academy	I-DISEASE
of	0
Sleep	0
Medicine	0
contributed	0
to	0
this	0
work	0
.	0

Our	0
field	0
owes	0
a	I-DISEASE
particular	0
debt	I-DISEASE
of	I-DISEASE
gratitude	0
for	I-DISEASE
the	0
diligence	I-DISEASE
,	0
dedication	0
and	0
determination	I-DISEASE
of	I-DISEASE
Ms.	0
Carolyn	0
Winter	0
-	I-DISEASE
Rosenberg	0
,	0
Director	I-DISEASE
of	I-DISEASE
Coding	0
and	0
Compliance	0
at	I-DISEASE
the	0
AASM	0
,	I-DISEASE
who	0
oversaw	0
all	0
facets	0
of	I-DISEASE
this	0
project	0
.	0

Without	0
her	B-DISEASE
,	0
this	0
publication	0
would	0
not	0
have	0
been	0
possible	0
.	0

Special	0
thanks	0
are	0
extended	0
to	0
the	0
Board	I-DISEASE
of	0
Directors	I-DISEASE
of	I-DISEASE
the	0
American	0
Academy	0
of	0
Sleep	I-DISEASE
Medicine	0
.	0

My	0
personal	0
thanks	0
go	0
to	0
Nancy	0
Collop	0
,	0
President	I-DISEASE
of	0
the	0
AASM	0
at	I-DISEASE
the	0
outset	0
of	I-DISEASE
the	I-DISEASE
project	I-DISEASE
.	0

I	0
would	0
also	0
like	B-DISEASE
to	0
thank	0
the	I-DISEASE
following	I-DISEASE
members	I-DISEASE
of	0
the	0
board	I-DISEASE
during	0
the	0
revision	I-DISEASE
process	0
who	0
provided	I-DISEASE
their	0
expertise	0
and	0
time	0
in	0
reviewing	0
multiple	0
drafts	0
:	0
Amy	B-DISEASE
Aronsky	0
,	0
DO	0
;	I-DISEASE
M.	0
Safwan	0
Badr	0
,	0
MD	0
;	0
Kelly	0
Carden	0
,	0
MD	I-DISEASE
;	0
Ronald	0
Chervin	0
,	I-DISEASE
MD	I-DISEASE
,	0
MS	0
;	I-DISEASE
Nancy	0
Collop	I-DISEASE
,	I-DISEASE
MD	0
;	0
Samuel	B-DISEASE
Fleishman	0
,	I-DISEASE
MD	0
;	0
Timothy	I-DISEASE
Morgenthaler	0
,	I-DISEASE
MD	0
;	I-DISEASE
Susan	I-DISEASE
Redline	0
,	0
MD	0
;	0
Ilene	0
Rosen	0
,	I-DISEASE
MD	I-DISEASE
;	I-DISEASE
Steven	I-DISEASE
Shea	0
,	I-DISEASE
PhD	I-DISEASE
;	0
Patrick	I-DISEASE
Strollo	0
,	I-DISEASE
Jr.	0
,	0
MD	0
;	0
Nathaniel	0
Watson	I-DISEASE
,	I-DISEASE
MD	0
,	0
MS	I-DISEASE
;	I-DISEASE
Terri	I-DISEASE
Weaver	I-DISEASE
,	0
PhD	0
,	0
RN	B-DISEASE
;	0
and	0
Merrill	0
Wise	0
,	0
MD	0
.	0

The	0
international	0
review	0
effort	0
was	0
coordinated	0
by	I-DISEASE
the	0
World	I-DISEASE
Sleep	0
Federation	0
.	0

Thanks	0
goes	0
to	0
Clete	0
Kushida	I-DISEASE
,	0
MD	I-DISEASE
,	0
PhD	0
,	0
President	0
of	0
the	0
WSF	0
for	I-DISEASE
his	0
assistance	0
in	I-DISEASE
this	I-DISEASE
facet	0
.	0

Charles	0
Reynolds	0
,	0
MD	0
,	0
chair	0
of	I-DISEASE
the	0
DSM-5	I-DISEASE
sleep	0
disorders	I-DISEASE
work	0
group	0
,	I-DISEASE
served	I-DISEASE
as	0
a	0
valuable	I-DISEASE
liaison	0
in	0
our	0
efforts	0
to	0
maximize	0
concordance	I-DISEASE
between	0
classification	0
systems	I-DISEASE
.	0

I	0
would	0
also	0
like	B-DISEASE
to	0
thank	0
David	I-DISEASE
Neubauer	0
,	0
MD	0
and	0
Ruth	0
Benca	0
,	0
MD	I-DISEASE
,	0
PhD	0
who	I-DISEASE
provided	0
expertise	I-DISEASE
on	0
psychiatric	0
conditions	0
,	0
as	I-DISEASE
well	0
as	0
Maria	0
Carra	0
,	I-DISEASE
PhD	0
who	0
assisted	0
with	0
the	0
development	0
of	0
the	0
Movement	0
Disorders	0
chapter	I-DISEASE
.	0

Finally	0
,	0
we	0
are	0
grateful	0
to	0
our	I-DISEASE
colleagues	0
and	I-DISEASE
families	0
,	0
whose	0
patience	0
,	I-DISEASE
support	I-DISEASE
and	0
understanding	0
of	I-DISEASE
the	0
long	I-DISEASE
hours	0
required	I-DISEASE
to	0
bring	0
this	I-DISEASE
manual	0
to	0
fruition	I-DISEASE
often	0
go	0
unheralded	I-DISEASE
,	0
but	0
are	0
deeply	0
appreciated	0
.	0

Michael	0
Sateia	I-DISEASE
,	0
MD	B-DISEASE
,	0
Editor	0
Acknowledgments	I-DISEASE
ICSD	0
Revision	I-DISEASE
Task	0
Force	0
Michael	0
Sateia	I-DISEASE
,	0
MD	I-DISEASE
,	I-DISEASE
Chair	0
Geisel	0
School	0
of	0
Medicine	0
at	0
Dartmouth	0
,	I-DISEASE
Lebanon	0
,	0
NH	0
Richard	I-DISEASE
Berry	0
,	0
MD	I-DISEASE
University	I-DISEASE
of	0
Florida	0
Health	0
Science	I-DISEASE
Center	0
,	I-DISEASE
Gainesville	0
,	0
FL	0
Michel	0
Cramer	0
Bornemann	0
,	I-DISEASE
MD	0
HealthEast	I-DISEASE
Care	I-DISEASE
Systems	I-DISEASE
of	0
Minnesota	0
,	I-DISEASE
Maplewood	I-DISEASE
,	I-DISEASE
MN	0
Karl	I-DISEASE
Doghramji	0
,	I-DISEASE
MD	0
,	I-DISEASE
Psychiatric	I-DISEASE
Representative	0
Thomas	I-DISEASE
Jefferson	I-DISEASE
University	0
,	I-DISEASE
Philadelphia	I-DISEASE
,	0
PA	0
Jack	I-DISEASE
Edinger	0
,	0
PhD	I-DISEASE
National	I-DISEASE
Jewish	0
Health	I-DISEASE
,	0
Denver	I-DISEASE
,	I-DISEASE
CO	0
Richard	0
Ferber	I-DISEASE
,	I-DISEASE
MD	0
,	I-DISEASE
Pediatric	0
Representative	0
Harvard	0
Medical	I-DISEASE
School	I-DISEASE
,	I-DISEASE
Boston	0
,	I-DISEASE
MA	B-DISEASE
Gerald	I-DISEASE
Rosen	I-DISEASE
,	0
MD	I-DISEASE
,	0
Pediatric	I-DISEASE
Representative	0
Children	0
’s	0
Hospital	0
of	0
Saint	I-DISEASE
Paul	0
,	0
Saint	I-DISEASE
Paul	B-DISEASE
,	0
MN	0
Michael	0
Silber	0
,	0
MB	0
,	I-DISEASE
ChB	0
Mayo	0
Clinic	0
,	B-DISEASE
Rochester	0
,	0
MN	I-DISEASE
Arthur	I-DISEASE
Walters	0
,	0
MD	B-DISEASE
Vanderbilt	I-DISEASE
University	0
Medical	I-DISEASE
Center	B-DISEASE
,	I-DISEASE
Nashville	0
,	0
TN	I-DISEASE
Phyllis	0
Zee	0
,	0
MD	I-DISEASE
,	I-DISEASE
PhD	I-DISEASE
Northwestern	I-DISEASE
University	I-DISEASE
Medical	0
School	0
,	I-DISEASE
Chicago	I-DISEASE
,	0
IL	I-DISEASE
Acknowledgments	I-DISEASE
ICSD	I-DISEASE
Revision	0
Workgroups	0
INSOMNIA	0
Jack	0
Edinger	I-DISEASE
,	0
PhD	I-DISEASE
,	B-DISEASE
Chair	I-DISEASE
National	0
Jewish	0
Health	I-DISEASE
,	0
Denver	I-DISEASE
,	0
CO	0
Daniel	I-DISEASE
Buysse	0
,	I-DISEASE
MD	0
University	I-DISEASE
of	0
Pittsburg	0
School	0
of	0
Medicine	0
,	0
Pittsburg	0
,	I-DISEASE
PA	0
Kenneth	I-DISEASE
Lichstein	0
,	0
PhD	I-DISEASE
University	I-DISEASE
of	0
Alabama	0
,	0
Tuscaloosa	0
,	I-DISEASE
AL	I-DISEASE
Jodi	0
Mindell	0
,	I-DISEASE
PhD	I-DISEASE
,	0
Pediatric	0
Representative	I-DISEASE
Saint	0
Joseph	0
’s	0
University	B-DISEASE
,	0
Philadelphia	0
,	0
PA	I-DISEASE
Charles	I-DISEASE
Morin	I-DISEASE
,	0
PhD	0
Universite	I-DISEASE
Laval	0
,	0
Quebec	I-DISEASE
,	I-DISEASE
Canada	0
CIRCADIAN	0
RHYTHM	0
SLEEP	I-DISEASE
WAKE	I-DISEASE
DISORDERS	0
Phyllis	0
Zee	I-DISEASE
,	I-DISEASE
MD	0
,	0
PhD	0
,	0
Chair	0
Northwestern	I-DISEASE
University	I-DISEASE
Medical	I-DISEASE
School	0
,	0
Chicago	B-DISEASE
,	I-DISEASE
IL	I-DISEASE
Judith	0
Owens	0
,	0
MD	0
,	0

Pediatric	0
Representative	0
Children	0
’s	I-DISEASE
National	0
Medical	0
Center	B-DISEASE
,	0
Washington	I-DISEASE
,	0
DC	0
Robert	0
Auger	0
,	0
MD	I-DISEASE
Mayo	I-DISEASE
Clinic	0
,	I-DISEASE
Rochester	0
,	I-DISEASE
MN	0
Makoto	0
Uchiyama	I-DISEASE
,	0
MD	I-DISEASE
,	0
PhD	0
Nihon	0
University	0
School	0
of	0
Medicine	0
,	0
Tokyo	0
,	0
Japan	0
Kenneth	0
Wright	I-DISEASE
,	0
PhD	I-DISEASE
University	I-DISEASE
of	0
Colorado	I-DISEASE
,	0
Boulder	I-DISEASE
,	0
CO	I-DISEASE
James	0
Wyatt	0
,	I-DISEASE
PhD	0
Rush	0
University	I-DISEASE
Medical	0
Center	0
,	0
Chicago	0
,	0
IL	0
Steven	0
Lockley	I-DISEASE
,	I-DISEASE
PhD	I-DISEASE
,	I-DISEASE
Advisor	0
Harvard	I-DISEASE
Medical	0
School	I-DISEASE
,	I-DISEASE
Boston	0
,	0
MA	0
SLEEP	I-DISEASE
RELATED	I-DISEASE
BREATHING	I-DISEASE
DISORDERS	0
Richard	0
Berry	I-DISEASE
,	I-DISEASE
MD	I-DISEASE
,	I-DISEASE
Chair	I-DISEASE
University	0
of	B-DISEASE
Florida	I-DISEASE
Health	I-DISEASE
Science	0
Center	0
,	0
Gainesville	I-DISEASE
,	I-DISEASE
FL	0
Teofilo	0
Lee	I-DISEASE
-	I-DISEASE
Chiong	0
,	I-DISEASE
MD	0
National	0
Jewish	I-DISEASE
Health	0
,	0
Denver	0
,	0
CO	I-DISEASE
Carole	0
Marcus	0
,	I-DISEASE
MBBCh	I-DISEASE
,	0
Pediatric	0
Representative	I-DISEASE
Children	0
’s	0
Hospital	0
of	0
Philadelphia	0
,	0
Philadelphia	0
,	0
PA	0
Stuart	0
Quan	0
,	0
MD	I-DISEASE
Harvard	0
Medical	0
School	B-DISEASE
,	I-DISEASE
Boston	0
,	I-DISEASE
MA	0
PARASOMNIAS	I-DISEASE
Michel	0
Cramer	0
Bornemann	I-DISEASE
,	0
MD	0
,	I-DISEASE
Chair	I-DISEASE
HealthEast	0
Care	0
Systems	0
of	0
Minnesota	0
,	I-DISEASE
Maplewood	I-DISEASE
,	I-DISEASE
MN	0
Carlos	I-DISEASE
Schenck	I-DISEASE
,	0
MD	0
Hennepin	0
County	0
Medical	0
Center	I-DISEASE
,	0
Minneapolis	0
,	B-DISEASE
MN	I-DISEASE
Gerald	0
Rosen	0
,	B-DISEASE
MD	B-DISEASE
,	0
Pediatric	I-DISEASE
Representative	I-DISEASE
Children	0
’s	0
Hospital	I-DISEASE
of	I-DISEASE
Saint	I-DISEASE
Paul	0
,	I-DISEASE
Saint	I-DISEASE
Paul	0
,	I-DISEASE
MN	0
Mark	I-DISEASE
Pressman	0
,	0
PhD	I-DISEASE
Lankenau	0
Medical	I-DISEASE
Center	I-DISEASE
,	0
Wynnewood	0
,	0
PA	0
HYPERSOMNOLENCE	0
Michael	I-DISEASE
Silber	0
,	I-DISEASE
MB	0
,	I-DISEASE
ChB	0
,	0
Chair	0
Mayo	I-DISEASE
Clinic	0
,	I-DISEASE
Rochester	I-DISEASE
,	0
MN	0
Isabelle	0
Arnulf	0
,	0
MD	0
Hopital	0
Pitie	I-DISEASE
Salpetriere	I-DISEASE
,	I-DISEASE
Paris	I-DISEASE
,	0
France	I-DISEASE
Suresh	0
Kotagal	I-DISEASE
,	0
MBBS	0
,	0
Pediatric	I-DISEASE
Representative	I-DISEASE
Mayo	I-DISEASE
Clinic	B-DISEASE
,	I-DISEASE
Rochester	I-DISEASE
,	B-DISEASE
MN	0
Thomas	0
Scammell	0
,	I-DISEASE
MD	I-DISEASE
Beth	I-DISEASE
Israel	I-DISEASE
Deaconess	0
Medical	0
Center	I-DISEASE
,	I-DISEASE
Boston	0
,	0
MA	0
Sebastiaan	0
Overeem	I-DISEASE
,	0
MD	0
,	I-DISEASE
PhD	0
Radboud	0
University	0
Nijmegen	0
Medical	0
Center	0
,	I-DISEASE
Nijmegen	0
,	0
Netherlands	I-DISEASE
MOVEMENT	B-DISEASE
DISORDERS	I-DISEASE
Arthur	0
Walters	0
,	0
MD	0
,	I-DISEASE
Chair	0
Vanderbilt	I-DISEASE
University	0
Medical	0
Center	0
,	I-DISEASE
Nashville	I-DISEASE
,	0
TN	I-DISEASE
Ronald	I-DISEASE
Chervin	0
,	0
MD	I-DISEASE
,	I-DISEASE
MS	0
University	I-DISEASE
of	0
Michigan	0
Health	0
System	0
,	0
Ann	0
Arbor	0
,	I-DISEASE
MI	I-DISEASE
Stephen	I-DISEASE
Duntley	I-DISEASE
,	I-DISEASE
MD	I-DISEASE
Critical	0
Care	I-DISEASE
Pulmonary	I-DISEASE
and	I-DISEASE
Sleep	I-DISEASE
Associates	I-DISEASE
,	0
Lakewood	I-DISEASE
,	0
CO	0
Giles	0
Lavigne	0
,	0
DMD	I-DISEASE
,	I-DISEASE
PhD	I-DISEASE
University	0
of	I-DISEASE
Montreal	0
,	B-DISEASE
Montreal	0
,	0
Canada	0
Daniel	I-DISEASE
Picchietti	0
,	I-DISEASE
MD	0
,	I-DISEASE
Pediatric	0
Representative	0
Carle	0
Foundation	0
Hospital	0
,	0
Urbana	I-DISEASE
,	I-DISEASE
IL	0
Denise	0
Sharon	0
,	0
MD	I-DISEASE
,	0
PhD	0
Tulane	I-DISEASE
University	0
School	0
of	I-DISEASE
Medicine	0
,	0
Destrehan	I-DISEASE
,	I-DISEASE
LA	0
Marco	I-DISEASE
Zucconi	0
,	0
MD	I-DISEASE
San	I-DISEASE
Raffaele	0
Hospital	0
,	0
Milan	I-DISEASE
,	I-DISEASE
Italy	I-DISEASE
APPENDIX	I-DISEASE
A	0
Members	0
of	I-DISEASE
the	0
Movement	I-DISEASE
Disorders	I-DISEASE
Work	0
Group	I-DISEASE
Sean	I-DISEASE
Caples	0
,	I-DISEASE
DO	0
Mayo	0
Clinic	I-DISEASE
,	0
Rochester	I-DISEASE
,	0
MN	I-DISEASE
Susan	0
Harding	0
,	I-DISEASE
MD	0
University	0
of	0
Alabama	0
,	0
Birmingham	0
,	I-DISEASE
AL	I-DISEASE
Acknowledgments	0
International	0
Society	I-DISEASE
Reviewers	0
ASIAN	I-DISEASE
SLEEP	0
RESEARCH	I-DISEASE
SOCIETY	0
Masako	I-DISEASE
Okawa	0
,	I-DISEASE
MD	I-DISEASE
,	0
PhD	0
Makoto	0
Honda	I-DISEASE
,	I-DISEASE
MD	B-DISEASE
,	I-DISEASE
PhD	I-DISEASE
Yuhei	0
Kayukawa	0
,	I-DISEASE
MD	0
Yuichi	0
Inoue	0
,	0
MD	I-DISEASE
,	0
PhD	I-DISEASE
AUSTRALASIAN	0
SLEEP	0
ASSOCIATION	I-DISEASE
Shantha	0
Rajaratnam	B-DISEASE
,	I-DISEASE
PhD	0
Leon	B-DISEASE
Lack	0
,	I-DISEASE
PhD	0
Nick	0
Antic	I-DISEASE
,	I-DISEASE
PhD	0
CANADIAN	0
SLEEP	0
SOCIETY	I-DISEASE
Charles	I-DISEASE
Samuels	0
,	0
MD	0
Atul	0
Khullar	0
,	0
MD	0
James	0
MacFarlane	I-DISEASE
,	0
PhD	0
Manisha	I-DISEASE
Witmans	0
,	0
MD	0
EUROPEAN	0
SLEEP	0
RESEARCH	0
SOCIETY	0
Claudio	0
Bassetti	0
,	0
MD	0
Ludger	I-DISEASE
Grote	0
,	0
MD	0
,	0
PhD	0
Dieter	0
Reimann	I-DISEASE
,	0
PhD	I-DISEASE
FEDERATION	0
OF	I-DISEASE
LATIN	0
AMERICAN	0
SLEEP	B-DISEASE
SOCIETIES	I-DISEASE
Darwin	0
Vizcarra	I-DISEASE
,	0
MD	0
Stuart	0
Franklin	I-DISEASE
Escobar	0
-	I-DISEASE
Córdoba	I-DISEASE
,	0
MD	0
,	I-DISEASE
MFP	0
,	I-DISEASE
PhD	0
Dalva	I-DISEASE
Poyares	0
,	I-DISEASE
MD	0
,	I-DISEASE
PhD	0
SLEEP	0
RESEARCH	0
SOCIETY	I-DISEASE
Ronald	I-DISEASE
Szymusiak	0
,	0
PhD	0
Kingman	0
Strohl	0
,	I-DISEASE
MD	I-DISEASE
Phillip	0
Gehrman	I-DISEASE
,	0
PhD	I-DISEASE
Reviewers	0
Alon	0

The	0
most	0
familiar	0
of	I-DISEASE
these	0
is	0
that	I-DISEASE
is	I-DISEASE
serves	I-DISEASE
as	0
a	0
guide	0
to	0
clinicians	0
in	I-DISEASE
the	0
identification	0
of	I-DISEASE
specific	0
disease	0
states	0
.	0

In	0
doing	0
so	0
,	0
classification	0
systems	0
provide	I-DISEASE
clinicians	0
with	I-DISEASE
important	0
informa-	0
tion	I-DISEASE
regarding	I-DISEASE
numerous	0
related	I-DISEASE
factors	0
including	0
pathogenesis	I-DISEASE
,	0
prognosis	I-DISEASE
,	0
course	0
,	0
and	0
heritability	0
.	0

Moreover	0
,	0
therapeutic	0
interventions	0
are	I-DISEASE
largely	0
guided	0
by	0
the	I-DISEASE
nosologi-	I-DISEASE
cal	0
decisions	0
made	0
by	0
clinicians	I-DISEASE
.	0

In	0
turn	0
,	I-DISEASE
information	0
accrued	0
regarding	I-DISEASE
therapeutic	0
response	0
of	0
these	0
disease	0
states	0
is	0
utilized	0
to	I-DISEASE
further	I-DISEASE
refine	0
the	0
nosology	0
.	0

Classification	0
systems	0
also	0
serve	B-DISEASE
to	0
define	0
the	I-DISEASE
domain	I-DISEASE
of	0
a	0
given	0
discipline	0
,	0
a	0
factor	I-DISEASE
of	0
particular	0
importance	I-DISEASE
for	0
fields	0
such	0
as	0
sleep	0
medicine	I-DISEASE
which	I-DISEASE
cut	I-DISEASE
across	0
many	0
related	0
special-	I-DISEASE
ties	I-DISEASE
.	I-DISEASE

Finally	0
,	0
by	0
identifying	0
areas	0
of	I-DISEASE
uncertainty	I-DISEASE
and	I-DISEASE
overlap	I-DISEASE
among	0
related	0
patholo-	I-DISEASE
gies	0
,	0
these	I-DISEASE
systems	I-DISEASE
play	0
a	I-DISEASE
critical	0
role	0
in	0
guiding	0
future	0
research	I-DISEASE
agendas	0
which	0
will	0
enhance	I-DISEASE
our	0
knowledge	I-DISEASE
and	I-DISEASE
understanding	I-DISEASE
of	0
the	0
clinical	0
features	0
,	I-DISEASE
pathophysiology	I-DISEASE
and	I-DISEASE
treatment	0
response	0
specific	0
to	0
each	I-DISEASE
disorder	I-DISEASE
.	I-DISEASE

Since	0
its	0
infancy	0
35	I-DISEASE
years	0
ago	I-DISEASE
,	I-DISEASE
the	0
field	I-DISEASE
of	0
sleep	0
medicine	I-DISEASE
has	I-DISEASE
paid	0
particular	0
atten-	0
tion	0
to	I-DISEASE
the	0
issue	0
of	0
classification	0
,	I-DISEASE
beginning	0
with	I-DISEASE
the	0
1979	0
American	I-DISEASE
Sleep	0
Disorders	I-DISEASE
Association	0
’s	0
Diagnostic	0
Classification	0
of	0
Sleep	0
and	0
Arousal	0
Disorders	0
.	0

Since	0
that	0
time	I-DISEASE
,	0
as	0
our	0
knowledge	I-DISEASE
and	0
understanding	I-DISEASE
of	0
sleep	0
disorders	I-DISEASE
has	0
grown	0
,	I-DISEASE
several	I-DISEASE
differ-	I-DISEASE
ent	0
structural	0
approaches	0
have	0
been	0
utilized	0
in	0
revisions	0
of	0
the	0
classification	I-DISEASE
system	0
,	I-DISEASE
culminating	I-DISEASE
in	0
the	0
International	0
Classification	0
of	0
Sleep	I-DISEASE
Disorders	0
,	0
2nd	I-DISEASE
Edition	I-DISEASE
.	0

The	0
organization	0
of	0
that	0
edition	0
,	I-DISEASE
although	I-DISEASE
not	0
without	I-DISEASE
its	I-DISEASE
limitations	0
,	0
has	0
proven	0
effective	0
and	0
user	0
-	I-DISEASE
friendly	0
and	0
has	0
been	0
maintained	0
in	0
the	0
current	I-DISEASE
revision	0
.	I-DISEASE

Ideally	0
,	0
classification	0
systems	0
are	0
based	0
largely	B-DISEASE
on	0
pathophysiology	0
.	0

However	0
,	I-DISEASE
such	0
an	0
approach	0
is	0
dependent	I-DISEASE
on	0
adequate	I-DISEASE
knowledge	I-DISEASE
concerning	0
the	0
various	I-DISEASE
pathophysiol-	0
ogies	0
of	I-DISEASE
disease	I-DISEASE
or	I-DISEASE
disorder	0
within	0
a	0
given	0
discipline	0
.	0

As	0
is	0
the	0
case	I-DISEASE
with	0
many	0
diag-	0
nostic	0
systems	I-DISEASE
,	0
our	0
current	0
knowledge	0
and	0
understanding	I-DISEASE
of	0
the	0
pathophysiology	I-DISEASE
of	0
many	0
sleep	0
disorders	0
is	I-DISEASE
inadequate	I-DISEASE
.	I-DISEASE

As	0
a	0
result	0
,	0
International	0
Classification	0
of	0
Sleep	0
Disorders	I-DISEASE
,	0
3rd	0
Edition	0
,	0
not	0
unlike	I-DISEASE
its	I-DISEASE
predecessors	I-DISEASE
,	I-DISEASE
employs	0
a	0
hybrid	0
approach	0
which	0
utilizes	0
pathophysiology	0
,	I-DISEASE
where	0
known	0
,	I-DISEASE
but	I-DISEASE
also	0
relies	I-DISEASE
heavily	0
on	0
phenomenology	0
and	0
organ	0
system	I-DISEASE
approaches	0
.	0

Despite	0
these	0
shortcomings	0
,	I-DISEASE
this	0
approach	I-DISEASE
is	I-DISEASE
one	0
that	0
has	0
proven	0
familiar	0
and	0
workable	0
for	I-DISEASE
sleep	I-DISEASE
medicine	0
clinicians	I-DISEASE
.	0

Recognizing	0
the	0
need	0
for	0
currency	0
and	I-DISEASE
relevance	I-DISEASE
in	0
a	0
rapidly	0
evolving	0
field	0
,	0
the	0
American	I-DISEASE
Academy	0
of	0
Sleep	I-DISEASE
Medicine	0
Board	I-DISEASE
of	0
Directors	0
approved	0
a	0
revision	I-DISEASE
of	I-DISEASE
International	0
Classification	I-DISEASE
of	0
Sleep	I-DISEASE
Disorders	0
,	0
2nd	0
Edition	0
in	0
2011	0
.	0

Following	0
appoint-	I-DISEASE
ment	0
of	I-DISEASE
a	0
chair	0
/	I-DISEASE
editor	0
,	I-DISEASE
a	0
task	0
force	0
,	0
consisting	0
of	I-DISEASE
individual	I-DISEASE
work	I-DISEASE
group	I-DISEASE
chairs	0
for	0
each	0
Introduction	I-DISEASE
major	0
division	I-DISEASE
of	I-DISEASE
the	0
manual	0
,	I-DISEASE
was	I-DISEASE
selected	0
,	0
along	I-DISEASE
with	0
two	0
pediatric	0
consultants	0
.	0

A	0
focus	0
group	0
of	0
experts	0
was	0
convened	I-DISEASE
in	0
June	0
2011	0
to	0
obtain	0
input	I-DISEASE
on	0
major	0
structural	0
and	0
content	I-DISEASE
issues	0
.	0

Based	0
on	0
this	0
feedback	0
,	0
individual	0
work	I-DISEASE
groups	0
then	I-DISEASE
set	0
about	0
to	0
define	0
the	0
list	I-DISEASE
of	0
disorders	0
to	I-DISEASE
be	0
included	I-DISEASE
within	0
their	0
sections	0
as	0
well	I-DISEASE
as	0
proposed	0
cri-	0
teria	B-DISEASE
for	I-DISEASE
each	0
diagnosis	0
.	0

This	0
process	0
included	0
comprehensive	0
literature	0
searches	I-DISEASE
for	I-DISEASE
every	0
potential	0
diagnosis	0
as	0
well	0
as	0
for	0
their	0
major	0
features	0
.	I-DISEASE

The	0
draft	0
diagnostic	0
crite-	B-DISEASE
ria	I-DISEASE
which	0
emanated	I-DISEASE
from	0
this	I-DISEASE
work	I-DISEASE
were	0
then	0
reviewed	0
and	0
modified	0
by	I-DISEASE
the	0
task	I-DISEASE
force	0
(	I-DISEASE
consisting	0
of	0
the	I-DISEASE
work	0
group	0
chairs	0
and	0
pediatric	I-DISEASE
advisors	I-DISEASE
)	0
,	0
as	I-DISEASE
well	0
as	0
by	0
the	I-DISEASE
board	I-DISEASE
of	I-DISEASE
the	0
AASM	0
.	0

The	0
edited	0
criteria	0
were	0
then	0
distributed	I-DISEASE
to	I-DISEASE
external	0
peer	0
reviewers	0
with	0
expertise	0
in	0
the	0
respective	I-DISEASE
areas	0
,	0
as	I-DISEASE
well	0
as	0
to	0
international	0
societies	0
and	0
membership	I-DISEASE
sections	I-DISEASE
of	0
the	I-DISEASE
AASM	I-DISEASE
for	0
comment	0
.	0

These	0
reviews	0
were	0
carefully	0
considered	0
and	0
revi-	I-DISEASE
sions	0
made	I-DISEASE
based	0
on	0
this	0
input	0
.	0

Subsequent	0
to	0
this	0
,	0
text	0
revisions	0
were	I-DISEASE
begun	0
and	I-DISEASE
the	0
same	0
review	I-DISEASE
process	0
and	0
modifications	I-DISEASE
were	I-DISEASE
undertaken	0
once	I-DISEASE
text	0
drafts	I-DISEASE
were	0
com-	0
pleted	0
.	0

Further	0
modifications	0
were	0
made	0
based	0
on	0
recommendations	0
from	0
the	0
AASM	I-DISEASE
board	0
before	0
finalization	0
of	0
the	I-DISEASE
edition	0
.	0

At	0
all	I-DISEASE
points	0
in	0
this	0
process	0
,	I-DISEASE
efforts	0
were	I-DISEASE
made	0
to	0
rely	0
as	0
heavily	0
as	I-DISEASE
possible	0
on	0
available	0
and	0
current	I-DISEASE
scientific	0
evidence	0
.	0

However	0
,	I-DISEASE
due	0
to	0
the	0
paucity	I-DISEASE
of	I-DISEASE
available	0
evidence	I-DISEASE
in	0
many	0
areas	0
,	0
decisions	0
regarding	I-DISEASE
the	0
nosol-	0
ogy	I-DISEASE
were	I-DISEASE
often	0
made	0
by	0
consensus	0
of	0
the	0
work	I-DISEASE
groups	0
,	I-DISEASE
task	0
force	I-DISEASE
,	I-DISEASE
and	0
reviewers	0
.	0

Using	0
ICSD-3	0
As	0
noted	0
above	0
,	0
the	I-DISEASE
general	0
structure	I-DISEASE
of	0
the	0
current	0
edition	0
closely	0
parallels	I-DISEASE
that	I-DISEASE
of	0
the	I-DISEASE
second	0
edition	0
.	0

The	0
major	0
clinical	0
divisions	0
remain	0
unchanged	0
.	I-DISEASE

As	0
with	0
International	0
Classification	0
of	0
Sleep	I-DISEASE
Disorders	I-DISEASE
,	0
2nd	I-DISEASE
Edition	0
,	0
pediatric	I-DISEASE
diagnoses	0
are	0
fully	I-DISEASE
integrated	0
into	0
the	I-DISEASE
major	I-DISEASE
clinical	I-DISEASE
diagnoses	0
,	0
with	0
the	0
exception	I-DISEASE
of	0
obstructive	I-DISEASE
sleep	I-DISEASE
apnea	I-DISEASE
,	I-DISEASE
pediatric	I-DISEASE
.	0

Where	0
pediatric	0
presentations	0
call	0
for	0
variation	0
in	0
the	0
diagnostic	0
criteria	I-DISEASE
,	0
those	0
variations	0
are	0
noted	0
within	0
the	0
criteria	I-DISEASE
section	I-DISEASE
.	0

In	0
an	0
effort	0
to	B-DISEASE
better	0
identify	I-DISEASE
those	I-DISEASE
clinical	0
features	I-DISEASE
of	0
a	0
disorder	0
which	I-DISEASE
are	I-DISEASE
developmentally	I-DISEASE
-	0
specific	0
,	I-DISEASE
a	0
text	0
heading	0
for	0
Developmental	0
Issues	0
has	0
been	0
added	0
for	0
each	0
diagnosis	I-DISEASE
.	0

Specific	0
ICD	0
codes	0
(	0
9	0
-	0
CM	I-DISEASE
and	0
10	I-DISEASE
-	I-DISEASE
CM	0
)	0
are	0
listed	0
at	I-DISEASE
the	I-DISEASE
beginning	I-DISEASE
of	I-DISEASE
each	0
diagnosis	I-DISEASE
.	0

Because	0
of	0
the	0
complexities	I-DISEASE
and	0
differences	0
between	I-DISEASE
International	0
Classification	I-DISEASE
of	0
Sleep	0
Disorders	0
diagnoses	I-DISEASE
and	0
the	I-DISEASE
ICD	0
system	0
,	I-DISEASE
assign-	I-DISEASE
ment	0
of	0
codes	0
is	0
challenging	0
.	I-DISEASE

These	0
issues	0
are	0
discussed	0
further	0
under	0
Coding	I-DISEASE
below	0
.	I-DISEASE

Although	0
classification	0
systems	0
are	0
,	0
by	0
their	I-DISEASE
nature	0
,	I-DISEASE
intended	0
to	0
define	0
disorders	I-DISEASE
in	0
the	0
most	I-DISEASE
specific	0
terms	I-DISEASE
possible	0
,	0
clinicians	0
must	0
recognize	0
that	0
there	I-DISEASE
is	I-DISEASE
inevitably	I-DISEASE
some	I-DISEASE
degree	0
of	0
variability	0
in	I-DISEASE
presentation	0
which	0
may	0
result	0
in	I-DISEASE
clinically	0
significant	0
conditions	0
which	I-DISEASE
do	0
not	0
meet	0
all	I-DISEASE
specific	B-DISEASE
criteria	I-DISEASE
for	I-DISEASE
a	0
given	I-DISEASE
diagnosis	0
.	0

Therefore	0
,	0
some	0
degree	0
of	0
judgment	I-DISEASE
is	I-DISEASE
necessary	0
in	0
the	0
application	0
of	0
these	0
criteria	0
.	I-DISEASE

Bearing	0
this	0
exception	0
in	0
mind	0
,	0
all	0
listed	0
criteria	0
should	0
generally	0
be	0
met	I-DISEASE
for	0
establishment	0
of	0
a	0
given	I-DISEASE
diagnosis	0
,	0
unless	0
otherwise	0
specified	0
.	0

Clinicians	0
should	0
note	I-DISEASE
that	0
most	0
diagnoses	I-DISEASE
within	0
the	0
International	I-DISEASE
Classification	I-DISEASE
of	I-DISEASE
Sleep	I-DISEASE
Disorders	I-DISEASE
include	0
a	0
criterion	I-DISEASE
,	I-DISEASE
or	I-DISEASE
cri-	0
teria	0
,	0
that	0
connote	0
clinical	0
significance	0
(	I-DISEASE
i.e.	I-DISEASE
,	I-DISEASE
disturbing	0
symptoms	I-DISEASE
,	0
significant	I-DISEASE
conse-	0
quences	I-DISEASE
,	0
distress	0
or	I-DISEASE
impairment	I-DISEASE
in	0
one	0
or	0
more	0
functional	0
realms	0
)	I-DISEASE
.	I-DISEASE

These	0
criteria	0
are	0
particularly	0
important	0
because	I-DISEASE
,	I-DISEASE
without	0
them	I-DISEASE
,	0
many	0
phenomena	0
related	0
to	I-DISEASE
sleep	0
-	I-DISEASE
wake	0
do	I-DISEASE
not	0
rise	I-DISEASE
to	0
a	0
level	0
that	0
requires	I-DISEASE
clinical	I-DISEASE
attention	0
and	I-DISEASE
treatment	0
.	0

Users	0
should	0
also	0
pay	B-DISEASE
particular	0
attention	I-DISEASE
to	0
the	0
Notes	I-DISEASE
section	0
(	0
where	0
included	0
)	0
,	I-DISEASE
as	0
these	0
notes	0
provide	0
essential	0
definitions	0
and	0
details	0
concerning	I-DISEASE
application	0
of	0
the	0
criteria	I-DISEASE
.	0

Clinicians	0
will	0
note	0
a	0
number	0
of	I-DISEASE
significant	I-DISEASE
content	0
changes	I-DISEASE
from	0
the	0
former	0
edition	I-DISEASE
.	0

The	0
most	0
apparent	0
of	0
these	0
is	0
the	I-DISEASE
collapse	0
of	I-DISEASE
all	0
previous	0
chronic	0
insomnia	0
diagnoses	0
into	I-DISEASE
a	0
single	0
chronic	I-DISEASE
insomnia	0
disorder	0
diagnosis	0
.	0

The	0
rationale	0
for	0
this	0
is	0
described	0
in	I-DISEASE
the	0
introductory	0
section	I-DISEASE
of	0
Insomnia	0
disorders	0
.	0

A	0
separate	0
diagnosis	0
is	0
retained	0
for	0
short	I-DISEASE
-	0
term	I-DISEASE
insomnia	0
.	0

Within	0
the	0
Central	I-DISEASE
Disorders	0
of	0
Hypersomnolence	I-DISEASE
section	0
,	0
the	0
nomenclature	0
for	0
narcolepsy	0
has	0
been	0
changed	I-DISEASE
to	I-DISEASE
narcolepsy	0
type	I-DISEASE
1	0
and	0
type	0
2	0
.	0

This	0
modification	0
is	I-DISEASE
discussed	0
in	0
the	0
introduction	I-DISEASE
to	0
that	I-DISEASE
section	0
.	0

Users	0
will	0
also	0
find	0
several	0
new	0
diagnoses	0
within	0
the	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
.	0

Within	0
the	0
Central	I-DISEASE
Sleep	0
Apnea	0
Syndromes	I-DISEASE
,	I-DISEASE
a	0
diagnosis	I-DISEASE
of	0
treatment	0
-	0
emergent	0
central	0
sleep	I-DISEASE
apnea	0
now	0
appears	I-DISEASE
.	0

This	0
term	0
is	0
preferred	0
to	0
the	I-DISEASE
widely	I-DISEASE
used	0
term	I-DISEASE
complex	0
sleep	0
apnea	I-DISEASE
because	0
it	I-DISEASE
describes	I-DISEASE
a	I-DISEASE
more	0
specific	I-DISEASE
and	0
well	0
-	0
defined	0
disorder	0
in	I-DISEASE
which	I-DISEASE
the	I-DISEASE
central	0
apnea	I-DISEASE
arises	I-DISEASE
in	0
the	I-DISEASE
context	I-DISEASE
of	0
positive	0
airway	0
pressure	I-DISEASE
treatment	0
for	I-DISEASE
obstructive	I-DISEASE
sleep	0
apnea	I-DISEASE
and	I-DISEASE
is	0
not	0
attributable	I-DISEASE
to	0
another	I-DISEASE
cause	I-DISEASE
.	I-DISEASE

Central	0
sleep	0
apnea	I-DISEASE
associated	0
with	I-DISEASE
other	0
identi-	I-DISEASE
fiable	0
etiologies	I-DISEASE
such	0
as	0
Cheyne	0
-	I-DISEASE
Stokes	0
breathing	I-DISEASE
or	0
substance	0
-	I-DISEASE
induced	0
central	0
sleep	0
apnea	0
are	0
not	I-DISEASE
classified	0
as	0
treatment	0
-	I-DISEASE
emergent	0
.	0

Assigning	0
a	0
diagnosis	0
of	I-DISEASE
a	0
sleep	0
related	I-DISEASE
hypoventilation	0
disorder	I-DISEASE
requires	I-DISEASE
demonstration	0
of	0
elevated	0
PaCO2	0
(	I-DISEASE
by	0
direct	I-DISEASE
measure	0
of	0
arterial	0
blood	0
gas	0
or	I-DISEASE
,	I-DISEASE
more	I-DISEASE
commonly	0
,	0
by	I-DISEASE
proxy	0
measures	I-DISEASE
such	0
as	0
end	0
-	0
tidal	0
or	0
trans-	0
cutaneous	I-DISEASE
CO2	0
determination	0
)	0
.	0

The	0
new	0
diagnosis	0
of	0
sleep	0
related	I-DISEASE
hypoxemia	I-DISEASE
disor-	0
der	0
should	0
be	0
employed	0
when	0
there	0
is	0
sustained	0
drop	0
in	I-DISEASE
SaO2	0
but	I-DISEASE
PaCO2	0
has	0
not	0
been	0
measured	0
.	0

Within	0
the	0
parasomnia	I-DISEASE
section	0
,	0
a	0
single	I-DISEASE
set	I-DISEASE
of	I-DISEASE
general	0
criteria	0
and	I-DISEASE
a	I-DISEASE
unified	0
text	I-DISEASE
now	I-DISEASE
describe	0
disorders	I-DISEASE
of	0
arousal	0
from	0
non	0
-	0
rapid	I-DISEASE
eye	0
movement	0
sleep	0
,	I-DISEASE
although	0
additional	I-DISEASE
,	I-DISEASE
specific	0
criteria	0
and	0
separate	0
coding	0
are	0
maintained	I-DISEASE
for	0
the	0
diagnoses	I-DISEASE
within	0
this	0
section	I-DISEASE
(	I-DISEASE
i.e.	0
,	I-DISEASE
confusional	I-DISEASE
arousal	I-DISEASE
,	0
sleepwalking	0
and	0
sleep	I-DISEASE
terror	0
)	0
.	0

Other	0
,	0
somewhat	0
less	0
consequential	0
additions	I-DISEASE
,	I-DISEASE
deletions	0
and	I-DISEASE
reassignment	0
of	0
diagnoses	0
also	0
appear	0
in	I-DISEASE
this	0
edition	0
.	I-DISEASE

International	0
Classification	0
of	0
Sleep	I-DISEASE
Disorders	0
,	0
2nd	I-DISEASE
Edition	0
contained	I-DISEASE
a	I-DISEASE
separate	0
chapter	0
for	0
Isolated	0
Symptoms	I-DISEASE
and	0
Normal	0
Variants	0
.	0

A	0
small	0
number	I-DISEASE
of	I-DISEASE
these	0
were	0
felt	0
to	0
qualify	I-DISEASE
as	0
formal	0
diagnoses	0
at	0
this	0
time	I-DISEASE
and	I-DISEASE
have	I-DISEASE
been	0
moved	0
to	I-DISEASE
relevant	0
sections	0
.	0

Other	0
symptoms	0
and	0
variants	0
appear	0
at	0
the	I-DISEASE
conclusion	I-DISEASE
of	0
the	0
chapter	I-DISEASE
to	0
which	0
they	0
are	I-DISEASE
most	0
applicable	0
(	I-DISEASE
e.g.	0
,	0
snoring	0
to	0
the	0
Sleep	0
Related	0
Breathing	I-DISEASE
Disorders	I-DISEASE
,	I-DISEASE
long	I-DISEASE
sleeper	I-DISEASE
to	I-DISEASE
Central	0
Disorders	0
of	0
Hypersomnolence	0
,	0
and	0
movement	0
related	0
variants	0
to	I-DISEASE
the	I-DISEASE
Sleep	0
Related	0
Movement	I-DISEASE
Disorder	0
section	0
)	I-DISEASE
.	0

Introduction	0
Introduction	0
A	0
wealth	0
of	0
information	I-DISEASE
regarding	I-DISEASE
each	0
diagnosis	I-DISEASE
is	0
contained	0
within	0
the	I-DISEASE
separate	I-DISEASE
text	I-DISEASE
headings	0
within	0
each	I-DISEASE
diagnostic	0
section	I-DISEASE
.	0

The	0
outline	0
below	0
details	0
some	0
of	0
the	I-DISEASE
spe-	0
cific	0
content	0
to	0
be	0
found	0
within	0
each	0
text	I-DISEASE
heading	0
.	I-DISEASE

These	0
terms	0
are	0
not	0
indexed	0
in	0
the	0
hard	0
copy	I-DISEASE
version	0
of	0
this	0
manual	0
because	0
they	0
appear	0
throughout	0
the	I-DISEASE
document	0
.	I-DISEASE

Users	0
should	0
refer	0
to	I-DISEASE
the	0
relevant	I-DISEASE
text	0
heading	0
within	I-DISEASE
a	I-DISEASE
specific	0
diagnosis	0
for	0
information	0
related	I-DISEASE
to	I-DISEASE
these	0
terms	0
:	0
Alternate	0
Names	0
Diagnostic	0
Criteria	0
Essential	I-DISEASE
Features	I-DISEASE
Associated	I-DISEASE
Features	I-DISEASE
Clinical	I-DISEASE
and	I-DISEASE
Pathophysiological	I-DISEASE
Subtypes	0
Demographics	I-DISEASE
includes	0
:	0
•	0
Prevalence	I-DISEASE
•	I-DISEASE
Gender	I-DISEASE
bias	0
•	I-DISEASE
Racial	0
/	0
ethnic	0
bias	0
•	0
Cultural	I-DISEASE
issues	I-DISEASE
Predisposing	I-DISEASE
and	0
Precipitating	0
Factors	0
includes	I-DISEASE
:	I-DISEASE
•	0
Risk	0
factors	0
Familial	0
Pattern	I-DISEASE
includes	0
:	I-DISEASE
•	I-DISEASE
Genetics	0
•	I-DISEASE
Familial	0
clusters	I-DISEASE
Onset	0
,	I-DISEASE
Course	0
and	I-DISEASE
Complications	I-DISEASE
includes	0
:	0
•	I-DISEASE
Medical	I-DISEASE
•	I-DISEASE
Neurological	I-DISEASE
•	0
Psychiatric	I-DISEASE
/	0
social	I-DISEASE
Developmental	I-DISEASE
Issues	I-DISEASE
includes	0
:	0
•	0
Pediatric	I-DISEASE
•	0
Geriatric	0
Pathology	0
and	0
Pathophysiology	0
Objective	I-DISEASE
Findings	I-DISEASE
includes	I-DISEASE
:	I-DISEASE
•	0
Sleep	I-DISEASE
logs	0
•	0
Actigraphy	I-DISEASE
•	0

Questionnaires	0
•	0
Polysomnography	0
•	I-DISEASE
Multiple	0
sleep	0
latency	0
test	0
•	I-DISEASE
Neurological	I-DISEASE
◦	0
Electroencephalogram	0
◦	I-DISEASE

Cerebrospinal	0
fluid	0
◦	0
Neuroimaging	0
◦	0
Electromyogram	I-DISEASE
◦	I-DISEASE

Autonomic	0
•	0
Endocrine	0
•	0
Genetic	0
testing	0
•	0
Physical	0
findings	0
•	0
Respiratory	0
◦	0
Arterial	0
blood	0
gas	0
◦	0
Pulmonary	I-DISEASE
function	0
◦	0

Ventilatory	0
response	0
•	0
Cardiac	0
◦	0

Electrocardiogram	0
◦	0
Echocardiogram	0
◦	0
Cardiac	0
catheterization	I-DISEASE
•	0
Serum	I-DISEASE
chemistry	0
Relationship	0
to	0
Other	0
Classification	I-DISEASE
Systems	0
Historically	I-DISEASE
,	0
there	0
have	I-DISEASE
been	0
three	0
major	0
classifications	0
systems	0
for	0
sleep	0
disorders	0
.	0

Although	0
the	0
International	I-DISEASE
Classification	0
of	0
Sleep	I-DISEASE
Disorders	I-DISEASE
system	0
has	I-DISEASE
,	0
for	0
many	0
years	0
,	0
been	0
the	I-DISEASE
primary	0
nosology	0
for	I-DISEASE
sleep	0
medicine	0
specialists	0
,	0
both	0
the	I-DISEASE
Diagnostic	0
and	0
Statistical	I-DISEASE
Manual	0
of	I-DISEASE
Mental	0
Disorders	0
(	0
DSM	0
)	0
of	0
the	0
American	I-DISEASE
Psychiatric	0
Association	0
and	0
the	0
International	0
Classification	0
of	I-DISEASE
Diseases	I-DISEASE
(	I-DISEASE
ICD	I-DISEASE
)	0
nosology	0
of	0
the	0
World	I-DISEASE
Health	0
Organization	0
have	I-DISEASE
also	0
classified	0
sleep	0
disorders	0
.	I-DISEASE

Unfortunately	0
,	0
these	0
competing	0
systems	I-DISEASE
have	0
differed	0
significantly	0
in	I-DISEASE
structure	0
and	0
content	0
over	0
the	0
years	I-DISEASE
.	I-DISEASE

Development	0
of	0
DSM-5	I-DISEASE
was	0
ongoing	0
during	I-DISEASE
the	I-DISEASE
development	0
of	I-DISEASE
this	0
manual	I-DISEASE
and	0
an	I-DISEASE
effort	0
was	I-DISEASE
undertaken	I-DISEASE
to	I-DISEASE
achieve	I-DISEASE
the	0
greatest	0
degree	0
of	0
concordance	I-DISEASE
possible	0
between	I-DISEASE
these	0
two	I-DISEASE
systems	0
,	0
recognizing	0
that	0
the	0
International	0
Classification	0
of	0
Sleep	0
Disorders	I-DISEASE
will	I-DISEASE
inevitably	0
contain	0
a	I-DISEASE
greater	I-DISEASE
level	0
of	0
detail	0
than	I-DISEASE
DSM	0
due	I-DISEASE
to	0
differences	I-DISEASE
in	0
their	I-DISEASE
target	I-DISEASE
users	0
.	0

This	0
goal	0
was	0
largely	0
achieved	0
although	I-DISEASE
some	0
differences	0
will	I-DISEASE
still	0
exist	0
.	0

The	0
major	0
change	0
to	0
the	0
Insomnia	I-DISEASE
section	0
(	0
i.e.	0
establishment	0
of	0
a	0
single	0
chronic	0
insomnia	0
disorder	0
diagnosis	0
)	I-DISEASE
within	0
this	0
new	0
system	0
is	0
paralleled	0
in	I-DISEASE
DSM-5	0
.	0

Central	0
Disorders	0
of	0
Hypersomnolence	0
diagnoses	0
are	I-DISEASE
organized	0
somewhat	0
differently	I-DISEASE
in	0
the	0
DSM	0
clas-	0
sification	0
than	I-DISEASE
in	I-DISEASE
this	I-DISEASE
manual	I-DISEASE
and	0
narcolepsy	0
criteria	0
differ	0
slightly	I-DISEASE
.	0

Circadian	0
Rhythm	I-DISEASE
Sleep	0
-	0
Wake	0
Disorder	0
diagnoses	I-DISEASE
are	0
identical	I-DISEASE
within	0
the	0
two	0
systems	0
with	0
the	I-DISEASE
exception	I-DISEASE
that	0
DSM	I-DISEASE
does	0
not	I-DISEASE
include	0
a	0
jet	0
lag	I-DISEASE
disorder	0
.	0

Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
are	I-DISEASE
significantly	I-DISEASE
more	I-DISEASE
detailed	0
within	I-DISEASE
International	0
Classification	0
of	I-DISEASE
Sleep	0
Disorders	0
than	I-DISEASE
DSM-5	0
,	0
although	I-DISEASE
the	0
organizational	0
structures	0
in	0
this	0
section	0
are	I-DISEASE
quite	I-DISEASE
similar	0
.	I-DISEASE

Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
and	0
Parasomnias	0
are	I-DISEASE
likewise	0
similar	I-DISEASE
but	0
with	0
fewer	0
overall	0
diagnoses	0
within	I-DISEASE
DSM-5	0
.	0

With	0
the	0
publication	I-DISEASE
of	0
International	0
Classification	0
of	0
Sleep	0
Disorders	I-DISEASE
,	0
2nd	0
Edition	0
,	0
a	I-DISEASE
major	I-DISEASE
effort	0
to	0
expand	I-DISEASE
and	0
reorganize	0
sleep	0
related	0
diagnoses	0
within	0
ICD-9	B-DISEASE
-	I-DISEASE
CM	I-DISEASE
was	I-DISEASE
undertaken	0
.	0

This	0
effort	0
resulted	0
in	0
the	0
inclusion	I-DISEASE
of	I-DISEASE
many	0
additional	0
sleep	0
related	0
diag-	I-DISEASE
noses	0
in	0
ICD-9	I-DISEASE
-	0
CM	I-DISEASE
(	0
primarily	0
within	0
the	0
Diseases	0
of	0
the	I-DISEASE
Nervous	I-DISEASE
System	0
section	0
)	I-DISEASE
.	I-DISEASE

The	0
archaic	0
distinction	0
between	I-DISEASE
“	0
organic	0
”	I-DISEASE
and	0
“	I-DISEASE
non	0
-	0
organic	0
”	I-DISEASE
disorders	0
has	I-DISEASE
histori-	0
cally	0
been	I-DISEASE
a	0
guiding	0
principle	0
of	0
ICD	0
,	0
resulting	0
in	0
dissemination	0
of	0
sleep	0
diagnoses	0
to	0
both	0
the	0
neurological	0
and	0
mental	0
disorder	I-DISEASE
categories	0
.	I-DISEASE

Clinicians	0
familiar	0
with	0
the	I-DISEASE
ICD-	0
9	I-DISEASE
-	I-DISEASE
CM	0
categories	I-DISEASE
which	0
have	0
been	I-DISEASE
employed	I-DISEASE
since	0
the	I-DISEASE
most	0
recent	0
changes	I-DISEASE
will	0
find	I-DISEASE
general	0
concordance	0
between	0
the	I-DISEASE
assigned	I-DISEASE
diagnostic	0
codes	I-DISEASE
found	0
herein	0
and	0
the	I-DISEASE
most	0
current	0
version	0
of	0
ICD-9	0
-	I-DISEASE
CM	I-DISEASE
.	I-DISEASE

These	0
ICD-9	0
-	0
CM	0
codes	0
for	0
sleep	I-DISEASE
disorders	I-DISEASE
are	I-DISEASE
essen-	0
tially	0
carried	I-DISEASE
over	0
to	0
ICD-10	0
-	0
CM	0
.	I-DISEASE

However	0
,	I-DISEASE
certain	0
content	0
revisions	0
in	0
International	I-DISEASE
Classification	0
of	0
Sleep	0
Disorders	0
,	I-DISEASE
3rd	0
Edition	0
(	0
e.g.	0
,	I-DISEASE
chronic	I-DISEASE
insomnia	0
)	0
necessitates	0
a	0
significant	0
departure	0
from	0
the	0
coding	0
approach	I-DISEASE
utilized	I-DISEASE
in	0
ICD-9	0
-	I-DISEASE
CM	0
and	0
International	0
Classification	I-DISEASE
of	0
Sleep	I-DISEASE
Disorders	0
,	0
2nd	0
Edition	0
.	0

This	0
is	0
discussed	0
further	0
below	0
.	0

Introduction	0
Introduction	0
Coding	0
Diagnostic	0
codes	0
for	0
the	I-DISEASE
relevant	0
ICD-9	I-DISEASE
-	0
CM	0
and	I-DISEASE
ICD-10	0
-	0
CM	0
diagnoses	I-DISEASE
can	0
be	I-DISEASE
found	I-DISEASE
at	I-DISEASE
the	0
beginning	0
of	0
each	0
diagnosis	I-DISEASE
section	0
of	I-DISEASE
the	I-DISEASE
book	0
.	0

In	0
the	0
United	I-DISEASE
States	0
,	0
the	0
former	I-DISEASE
codes	0
(	0
ICD-9	0
-	0
CM	0
)	0
should	0
be	I-DISEASE
employed	I-DISEASE
until	0
the	I-DISEASE
implementation	0
date	I-DISEASE
for	0
ICD-10	0
-	I-DISEASE
CM	0
which	0
,	0
at	0
the	0
time	0
of	0
this	0
writing	I-DISEASE
,	0
is	0
to	0
be	I-DISEASE
no	I-DISEASE
sooner	0
than	0
October	0
1	0
,	0
2015	0
.	0

Following	0
that	0
date	0
,	0
only	0
the	0
ICD-10	I-DISEASE
-	0
CM	0
codes	0
should	0
be	0
used	I-DISEASE
.	0

As	0
already	0
stated	0
,	I-DISEASE
clinicians	0
should	0
recognize	I-DISEASE
that	0
there	I-DISEASE
is	0
not	I-DISEASE
precise	0
concordance	I-DISEASE
between	0
the	I-DISEASE
assigned	0
codes	0
for	I-DISEASE
International	I-DISEASE
Classification	0
of	0
Sleep	0
Disorders	0
,	0
3rd	I-DISEASE
Edition	I-DISEASE
diagnoses	0
and	I-DISEASE
the	0
diagno-	0
ses	I-DISEASE
listed	I-DISEASE
within	0
ICD	0
.	I-DISEASE

Changes	0
to	0
the	0
International	I-DISEASE
Classification	0
of	0
Sleep	I-DISEASE
Disorders	0
classification	0
system	0
are	0
not	0
reflected	0
in	0
the	I-DISEASE
ICD	0
system	0
for	I-DISEASE
many	0
years	0
.	0

Moreover	0
,	0
the	0
ICD	I-DISEASE
classification	0
of	0
sleep	0
disorders	0
has	I-DISEASE
historically	0
been	0
significantly	0
less	0
detailed	I-DISEASE
than	0
ICSD	0
(	0
particularly	0
for	0
international	0
users	0
not	I-DISEASE
employing	0
the	0
Clinical	0
Modification	0
(	0
CM	I-DISEASE
)	0
version	0
used	0
in	0
the	0
United	0
States	0
)	I-DISEASE
.	0

Hence	0
,	0
clinicians	0
will	0
find	0
many	0
areas	I-DISEASE
in	0
which	I-DISEASE
assigned	0
codes	0
found	0
in	0
this	0
manual	0
do	0
not	0
correspond	B-DISEASE
as	0
closely	0
as	0
one	0
would	0
like	0
to	0
ICD	0
codes	0
.	0

Most	0
notably	0
,	0
with	0
the	0
collapse	I-DISEASE
of	I-DISEASE
chronic	0
insomnia	I-DISEASE
diagnoses	0
into	0
a	0
single	0
disorder	0
in	I-DISEASE
International	I-DISEASE
Classification	0
of	I-DISEASE
Sleep	0
Disorders	0
,	0
3rd	0
Edition	0
,	0
the	I-DISEASE
assigned	0
codes	0
for	0
this	0
diagnosis	I-DISEASE
within	0
International	0
Classification	0
of	0
Sleep	0
Disorders	0
,	0
3rd	0
Edition	I-DISEASE
are	0
307.42	0
(	I-DISEASE
ICD-9	0
-	0
CM	0
)	0
–	I-DISEASE
“	I-DISEASE
Nonorganic	0
persistent	0
disorder	0
of	0
initiating	I-DISEASE
or	I-DISEASE
maintaining	0
sleep	0
”	0
and	I-DISEASE
F51.01	0
(	I-DISEASE
ICD-10	I-DISEASE
-	I-DISEASE
CM	0
)	0
–	0
“	I-DISEASE
Primary	B-DISEASE
insomnia	0
.	0
”	I-DISEASE

A	0
variety	0
of	0
other	0
insomnia	0
diagnoses	0
will	I-DISEASE
continue	0
to	I-DISEASE
appear	0
in	0
the	0
ICD	I-DISEASE
system	0
but	I-DISEASE
,	0
with	0
the	I-DISEASE
classifi-	0
cation	0
and	0
coding	0
changes	0
recommended	0
herein	I-DISEASE
,	0
these	0
become	I-DISEASE
essentially	0
defunct	I-DISEASE
for	0
sleep	I-DISEASE
medicine	0
clinicians	0
.	0

In	0
summary	0
,	0
the	0
assigned	I-DISEASE
codes	0
in	I-DISEASE
this	0
edition	0
represent	0
“	0
best	0
approximations	0
”	0
to	I-DISEASE
the	0
corresponding	0
ICD	I-DISEASE
codes	0
,	0
but	0
some	0
degree	0
of	0
discrep-	0
ancy	0
between	0
the	I-DISEASE
systems	0
will	I-DISEASE
exist	0
in	0
a	0
number	0
of	I-DISEASE
areas	0
.	0

Insomnia	0
Chronic	0
Insomnia	0
Disorder21	0
Short	0
-	0
Term	I-DISEASE
Insomnia	0
Disorder41	I-DISEASE
Other	0
Insomnia	0
Disorder	0
46	I-DISEASE
Isolated	0
Symptoms	I-DISEASE
and	I-DISEASE
Normal	I-DISEASE
Variants	I-DISEASE
Excessive	0
Time	0
in	0
Bed	0
47	0

Short	0
Sleeper47	0

This	0
section	0
includes	0
sleep	0
disorders	0
chiefly	I-DISEASE
characterized	I-DISEASE
by	0
the	I-DISEASE
complaint	I-DISEASE
of	0
insom-	0
nia	0
.	0

For	0
the	0
purpose	I-DISEASE
of	0
this	0
manual	0
,	I-DISEASE
insomnia	0
is	0
defined	0
as	0
a	0
persistent	0
difficulty	0
with	I-DISEASE
sleep	0
initiation	I-DISEASE
,	0
duration	I-DISEASE
,	0
consolidation	0
,	0
or	0
quality	0
that	I-DISEASE
occurs	0
despite	I-DISEASE
adequate	I-DISEASE
opportunity	0
and	0
circumstances	I-DISEASE
for	0
sleep	0
,	0
and	0
results	I-DISEASE
in	0
some	I-DISEASE
form	0
of	0
daytime	0
impair-	0
ment	0
.	0

These	0
three	0
components	0
of	0
insomnia	0
—	0
persistent	I-DISEASE
sleep	0
difficulty	0
,	0
adequate	0
sleep	I-DISEASE
opportunity	0
,	0
and	I-DISEASE
associated	0
daytime	0
dysfunction	I-DISEASE
—	0
are	0
collectively	0
implied	0
by	0
text	0
references	I-DISEASE
to	0
the	0
term	I-DISEASE
insomnia	0
.	0

Among	0
adults	0
with	0
insomnia	0
,	0
sleep	0
complaints	0
most	0
typically	I-DISEASE
include	0
difficulties	0
initiating	0
or	0
maintaining	0
sleep	0
.	0

Concerns	0
about	0
lengthy	0
periods	I-DISEASE
of	0
nocturnal	I-DISEASE
wakefulness	0
,	0
insufficient	I-DISEASE
amounts	0
of	I-DISEASE
nocturnal	0
sleep	0
,	0
or	I-DISEASE
poor	0
sleep	I-DISEASE
quality	0
often	I-DISEASE
accompany	0
these	0
complaints	0
.	I-DISEASE

Individuals	0
who	0
report	0
these	0
sleep	0
related	I-DISEASE
symptoms	I-DISEASE
in	0
the	I-DISEASE
absence	I-DISEASE
of	0
daytime	I-DISEASE
impairment	0
are	I-DISEASE
not	0
regarded	0
as	0
having	I-DISEASE
an	0
insomnia	0
disorder	0
that	0
warrants	0
clinical	I-DISEASE
attention	I-DISEASE
other	I-DISEASE
than	I-DISEASE
education	I-DISEASE
and	0
reassurance	0
.	I-DISEASE

Insomnia	0
among	0
children	0
is	0
often	0
reported	0
by	I-DISEASE
their	0
caretakers	I-DISEASE
and	0
char-	0
acterized	0
by	0
bedtime	0
resistance	I-DISEASE
,	0
frequent	I-DISEASE
nighttime	I-DISEASE
awakenings	0
and/or	0
an	0
inability	0
to	0
sleep	0
independently	I-DISEASE
.	0

Regardless	0
of	0
the	0
exact	I-DISEASE
nature	0
of	I-DISEASE
the	I-DISEASE
nocturnal	I-DISEASE
sleep	I-DISEASE
concerns	0
,	I-DISEASE
daytime	0
impairments	0
are	0
reported	I-DISEASE
,	0
presumably	0
caused	I-DISEASE
by	0
the	0
nighttime	0
sleep	0
diffi-	0
culties	I-DISEASE
or	I-DISEASE
by	0
some	I-DISEASE
common	I-DISEASE
but	0
unidentified	0
mechanism	0
during	0
sleep	0
and	0
wakeful-	0
ness	0
.	0

Daytime	0
symptoms	0
typically	0
include	0
fatigue	0
,	I-DISEASE
decreased	I-DISEASE
mood	0
or	I-DISEASE
irritability	0
,	0
general	I-DISEASE
malaise	I-DISEASE
,	I-DISEASE
and	I-DISEASE
cognitive	I-DISEASE
impairment	0
.	I-DISEASE

Among	0
adults	0
,	0
chronic	0
insomnia	0
may	0
impair	I-DISEASE
social	0
or	I-DISEASE
vocational	I-DISEASE
functioning	0
and	0
reduce	0
quality	0
of	I-DISEASE
life	I-DISEASE
,	0
whereas	I-DISEASE
in	0
chil-	0
dren	0
it	0
may	0
lead	0
to	I-DISEASE
poor	I-DISEASE
school	0
performance	I-DISEASE
,	0
impaired	0
attention	0
,	0
and	0
behavioral	0
disturbance	0
.	0

In	0
some	0
patients	0
,	I-DISEASE
physical	0
symptoms	0
such	0
as	0
muscle	I-DISEASE
tension	0
,	0
palpita-	0
tions	0
,	0
or	0
headache	0
may	0
also	I-DISEASE
be	0
attributed	0
to	0
the	I-DISEASE
insomnia	0
.	0

Others	0
with	0
more	0
severe	0
forms	0
of	I-DISEASE
insomnia	I-DISEASE
may	0
be	I-DISEASE
at	0
increased	0
risk	I-DISEASE
for	I-DISEASE
motor	0
vehicle	I-DISEASE
and	0
work	I-DISEASE
-	I-DISEASE
site	0
acci-	0
dents	0
as	0
well	0
as	0
psychiatric	I-DISEASE
and	0
cardiovascular	0
disorders	I-DISEASE
.	0

Insomnia	0
often	0
accompa-	0
nies	0
comorbid	0
medical	I-DISEASE
illnesses	I-DISEASE
,	0
mental	I-DISEASE
disorders	0
,	0
and	0
other	0
sleep	0
disorders	I-DISEASE
.	I-DISEASE

It	0
may	0
also	0
arise	B-DISEASE
in	0
association	0
with	0
the	0
use	I-DISEASE
,	0
abuse	0
,	0
or	0
exposure	0
to	I-DISEASE
certain	0
substances	0
.	I-DISEASE

When	0
insomnia	0
occurs	0
comorbid	0
to	0
these	I-DISEASE
conditions	0
and	0
is	I-DISEASE
persistent	0
and	0
prominent	0
,	I-DISEASE
a	0
sep-	0
arate	I-DISEASE
insomnia	0
diagnosis	I-DISEASE
is	0
warranted	I-DISEASE
.	I-DISEASE

Insomnia	0
The	0
insomnia	0
nosology	0
presented	0
in	0
this	0
text	0
represents	I-DISEASE
a	0
marked	0
departure	0
from	I-DISEASE
the	0
previous	0
International	0
Classification	0
of	I-DISEASE
Sleep	I-DISEASE
Disorders	I-DISEASE
,	0
2nd	0
Edition	0
insomnia	0
classification	0
system	0
in	I-DISEASE
terms	I-DISEASE
of	0
its	0
conceptual	0
framework	I-DISEASE
and	0
relative	0
simplicity	0
.	0

The	0
previous	0
insomnia	0
nosology	0
of	0
the	I-DISEASE
International	I-DISEASE
Classification	0
of	0
Sleep	0
Disorders	0
promoted	0
the	0
concept	0
that	I-DISEASE
insomnia	0
can	0
exist	I-DISEASE
as	0
a	I-DISEASE
primary	0
sleep	0
disorder	0
or	0
arise	I-DISEASE
as	0
a	0
secondary	I-DISEASE
form	0
of	0
sleep	I-DISEASE
disturbance	I-DISEASE
related	0
to	0
an	0
underlying	0
primary	0
psychiatric	I-DISEASE
,	0
medical	I-DISEASE
,	0
or	I-DISEASE
substance	0
abuse	0
disorder	I-DISEASE
.	0

However	0
,	I-DISEASE
many	0
symptoms	0
and	0
associated	I-DISEASE
fea-	0
tures	0
of	I-DISEASE
so	0
-	0
called	0
primary	0
and	0
secondary	I-DISEASE
insomnias	0
are	0
overlapping	I-DISEASE
,	0
thus	0
making	0
differentiation	0
among	0
such	0
subtypes	0
difficult	0
,	0
if	0
not	0
impossible	0
.	0

There	0
is	0
increas-	0
ing	0
recognition	0
that	0
even	I-DISEASE
when	0
insomnia	I-DISEASE
arises	0
“	0
secondary	0
”	0
to	0
another	I-DISEASE
condition	I-DISEASE
,	0
it	I-DISEASE
often	0
develops	0
an	0
independent	0
course	0
over	0
time	I-DISEASE
and	0
may	0
remain	0
as	0
a	0
clinically	0
significant	I-DISEASE
condition	0
,	0
even	0
if	0
the	0
so	0
-	0
called	I-DISEASE
primary	I-DISEASE
condition	I-DISEASE
is	0
adequately	I-DISEASE
treated	0
.	I-DISEASE

Evidence	0
suggests	0
that	0
insomnia	I-DISEASE
,	0
if	0
left	I-DISEASE
untreated	0
,	0
may	I-DISEASE
adversely	0
affect	0
the	0
outcome	0
of	I-DISEASE
these	I-DISEASE
comorbid	0
conditions	0
.	I-DISEASE

Moreover	0
,	0
it	0
appears	0
that	0
treatment	I-DISEASE
of	I-DISEASE
the	0
insomnia	I-DISEASE
may	0
improve	0
outcome	0
of	0
both	0
the	0
sleep	0
disturbance	0
and	I-DISEASE
the	I-DISEASE
comorbid	0
conditions	0
.	0

Given	0
these	0
observations	0
,	0
insomnia	0
seems	0
best	I-DISEASE
viewed	0
as	0
a	0
comorbid	0
disorder	0
that	0
warrants	0
separate	0
treatment	0
attention	0
.	I-DISEASE

In	0
addition	0
to	0
the	0
primary	I-DISEASE
vs.	0
secondary	0
insomnia	0
distinction	I-DISEASE
,	0
prior	0
editions	0
of	I-DISEASE
the	0
International	0
Classification	0
of	0
Sleep	I-DISEASE
Disorders	0
delineated	0
multiple	0
putative	0
“	0
primary	0
insomnia	0
”	0
diagnostic	0
subtypes	I-DISEASE
.	0

Specifically	0
,	0
both	0
the	0
original	I-DISEASE
1990	I-DISEASE
version	0
of	0
the	I-DISEASE
International	I-DISEASE
Classification	0
of	0
Sleep	I-DISEASE
Disorders	0
and	I-DISEASE
the	0
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	0
Disorders	0
,	0
2nd	0
Edition	0
described	I-DISEASE
primary	0
insomnia	0
subtypes	I-DISEASE
such	0
as	0
psycho-	0
physiological	0
insomnia	0
,	0
idiopathic	0
insomnia	0
,	I-DISEASE
inadequate	0
sleep	0
hygiene	0
,	I-DISEASE
and	I-DISEASE
paradox-	0
ical	0
insomnia	0
,	0
as	I-DISEASE
discrete	0
diagnostic	0
entities	I-DISEASE
.	0

Experience	0
suggests	0
that	0
,	I-DISEASE
in	0
practice	0
,	I-DISEASE
it	0
is	I-DISEASE
rare	0
to	I-DISEASE
encounter	0
patients	0
who	I-DISEASE
meet	0
the	0
diagnostic	I-DISEASE
criteria	0
for	0
exclusively	0
one	0
of	0
these	0
subtypes	0
.	0

In	0
fact	0
,	0
many	0
of	0
the	I-DISEASE
diagnostic	I-DISEASE
criteria	0
delineated	I-DISEASE
for	0
these	0
subtypes	0
represent	0
generic	0
characteristics	I-DISEASE
(	0
e.g.	I-DISEASE
,	I-DISEASE
engaging	0
in	0
sleep	0
-	0
disruptive	0
habits	I-DISEASE
;	0
underesti-	0
mation	0
of	0
sleep	I-DISEASE
time	0
,	I-DISEASE
evidence	I-DISEASE
of	0
conditioned	0
arousal	0
)	0
of	0
insomnia	I-DISEASE
,	0
per	0
se	I-DISEASE
,	I-DISEASE
and	0
do	0
not	0
facilitate	I-DISEASE
discrimination	0
among	I-DISEASE
these	I-DISEASE
subtypes	I-DISEASE
or	0
between	0
these	I-DISEASE
subtypes	0
and	0
those	0
presumed	0
to	I-DISEASE
have	0
“	I-DISEASE
secondary	I-DISEASE
”	0
forms	I-DISEASE
of	0
insomnia	0
.	I-DISEASE

Both	0
clinical	I-DISEASE
experience	0
and	0
a	0
growing	I-DISEASE
body	I-DISEASE
of	0
empirical	I-DISEASE
findings	0
have	0
shown	0
that	0
the	0
diagnostic	I-DISEASE
distinctions	I-DISEASE
advocated	I-DISEASE
by	I-DISEASE
previous	0
versions	0
of	0
the	0
International	0
Classification	I-DISEASE
of	0
Sleep	0
Disorders	I-DISEASE
are	I-DISEASE
difficult	0
to	I-DISEASE
reliably	0
ascertain	0
and	0
are	0
of	0
question-	0
able	I-DISEASE
validity	I-DISEASE
.	0

In	0
view	0
of	0
such	0
considerations	0
,	0
the	I-DISEASE
current	I-DISEASE
manual	0
abandons	0
the	0
previ-	0
ously	I-DISEASE
employed	0
complex	I-DISEASE
and	I-DISEASE
highly	0
specific	I-DISEASE
insomnia	0
classification	I-DISEASE
scheme	0
described	0
by	0
the	0
original	0
International	0
Classification	0
of	0
Sleep	0
Disorders	0
and	0
the	I-DISEASE
2nd	0
Edition	0
in	0
favor	0
of	I-DISEASE
a	I-DISEASE
more	0
global	0
and	I-DISEASE
defensible	I-DISEASE
nosology	I-DISEASE
.	0

The	0
manual	0
includes	0
three	0
diagnostic	0
categories	0
for	0
insomnia	0
:	0
chronic	0
insomnia	0
disorder	0
,	0
short	0
-	I-DISEASE
term	0
insomnia	0
disorder	I-DISEASE
,	0
and	0
other	0
insomnia	0
disorder	0
.	0

These	0
diag-	0
noses	0
apply	I-DISEASE
to	0
patients	0
with	I-DISEASE
and	0
without	I-DISEASE
comorbidities	I-DISEASE
regardless	0
of	I-DISEASE
whether	I-DISEASE
those	0
comorbidities	I-DISEASE
are	I-DISEASE
viewed	0
as	I-DISEASE
potentially	0
sleep	0
disruptive	0
.	0

Chronic	0
insomnia	0
disorder	0
is	0
characterized	0
by	I-DISEASE
chronic	I-DISEASE
sleep	0
onset	I-DISEASE
and/or	0
sleep	0
maintenance	I-DISEASE
complaints	0
with	0
asso-	0
ciated	0
daytime	I-DISEASE
impairment	I-DISEASE
,	0
and	0
is	0
reserved	0
for	I-DISEASE
individuals	I-DISEASE
whose	I-DISEASE
sleep	0
difficulties	I-DISEASE
exceed	0
minimal	0
frequency	0
and	I-DISEASE
duration	0
thresholds	0
shown	0
to	0
be	0
associated	I-DISEASE
with	I-DISEASE
clin-	I-DISEASE
ically	0
significant	0
morbidity	I-DISEASE
outcomes	0
.	0

Short	0
-	0
term	0
insomnia	0
disorder	0
is	0
characterized	0
by	0
sleep	I-DISEASE
/	0
wake	0
difficulties	I-DISEASE
that	0
fail	0
to	I-DISEASE
meet	0
the	0
minimal	I-DISEASE
frequency	0
and	I-DISEASE
duration	0
criteria	0
of	0
chronic	0
insomnia	0
disorder	0
.	0

Nonetheless	0
,	0
short	0
-	I-DISEASE
term	0
insomnia	0
disorder	0
is	0
associated	I-DISEASE
with	0
clinically	0
significant	0
sleep	0
dissatisfaction	0
or	I-DISEASE
waking	0
impairment	I-DISEASE
.	I-DISEASE

Other	0
insomnia	0
disorders	0
should	0
be	0
assigned	I-DISEASE
to	0
those	I-DISEASE
rare	0
cases	0
that	0
fail	I-DISEASE
to	I-DISEASE
meet	0
criteria	I-DISEASE
for	0
short-	0
term	I-DISEASE
insomnia	0
disorder	0
,	0
yet	0
are	0
thought	0
to	I-DISEASE
have	I-DISEASE
sufficient	0
symptoms	I-DISEASE
of	0
insomnia	0
to	0
warrant	0
clinical	0
attention	0
.	0

Chronic	0
Insomnia	0
Disorder	0
ICD-9	0
-	0
CM	0
code	0
:	0
307.42	I-DISEASE
ICD-10	0
-	0
CM	0
code	0
:	0

F51.01	0
Alternate	0
Names	0
Chronic	0
insomnia	0
,	0
primary	I-DISEASE
insomnia	0
,	I-DISEASE
secondary	0
insomnia	0
,	0
comorbid	0
insomnia	0
,	I-DISEASE
disor-	0
der	0
of	I-DISEASE
initiating	0
and	0
maintaining	0
sleep	0
,	0
behavioral	0
insomnia	0
of	0
childhood	0
,	I-DISEASE
sleep	0
-	0
onset	0
association	0
disorder	0
,	0
limit	0
-	0
setting	0
sleep	I-DISEASE
disorder	I-DISEASE
.	0

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
F	I-DISEASE
must	0
be	0
met	I-DISEASE
A.	0

The	0
patient	0
reports	0
,	0
or	0
the	0
patient	I-DISEASE
’s	0
parent	0
or	0
caregiver	0
observes	0
,	0
one	0
or	0
more	I-DISEASE
of	0
the	I-DISEASE
following:1	0
.	0

Difficulty	0
initiating	0
sleep	0
.	0
.	0

Difficulty	0
maintaining	0
sleep	0
.	0
.	0

Waking	0
up	0
earlier	0
than	0
desired	0
.	0
.	0

Resistance	0
to	0
going	0
to	0
bed	0
on	0
appropriate	0
schedule	0
.	0
.	0

Difficulty	0
sleeping	0
without	0
parent	0
or	0
caregiver	0
intervention	0
.	I-DISEASE

B.	0
The	0
patient	0
reports	0
,	0
or	0
the	I-DISEASE
patient	0
’s	I-DISEASE
parent	0
or	0
caregiver	0
observes	0
,	0
one	0
or	0
more	0
of	I-DISEASE
the	0
following	0
related	0
to	0
the	0
nighttime	I-DISEASE
sleep	I-DISEASE
difficulty	I-DISEASE
:	0
.	I-DISEASE

Fatigue	0
/	0
malaise	I-DISEASE
.	0
.	0

Attention	0
,	I-DISEASE
concentration	0
,	0
or	0
memory	0
impairment	I-DISEASE
.	0
.	I-DISEASE

Impaired	0
social	0
,	0
family	0
,	0
occupational	0
,	I-DISEASE
or	0
academic	I-DISEASE
performance	0
.	0

Insomnia	0
Insomnia	0
.	0

Mood	0
disturbance	0
/	0
irritability	0
.	0
.	I-DISEASE

Daytime	0
sleepiness	0
.	0
.	I-DISEASE

Behavioral	0
problems	0
(	0
e.g.	0
,	0
hyperactivity	0
,	I-DISEASE
impulsivity	0
,	0
aggression	0
)	0
.	0

7	0
.	0
Reduced	0
motivation	0
/	0
energy	0
/	0
initiative	0
.	I-DISEASE
.	0

Proneness	0
for	0
errors	0
/	0
accidents	0
.	I-DISEASE
.	0

Concerns	0
about	0
or	0
dissatisfaction	I-DISEASE
with	0
sleep	0
.	I-DISEASE

C.	0

The	0
reported	0
sleep	0
/	I-DISEASE
wake	0
complaints	I-DISEASE
can	I-DISEASE
not	0
be	I-DISEASE
explained	I-DISEASE
purely	0
by	0
inadequate	0
opportunity	0
(	0
i.e.	I-DISEASE
,	0
enough	0
time	0
is	0
allotted	0
for	0
sleep	0
)	0
or	I-DISEASE
inadequate	0
circumstances	I-DISEASE
(	I-DISEASE
i.e.	0
,	0
the	0
environment	I-DISEASE
is	0
safe	0
,	0
dark	0
,	0
quiet	I-DISEASE
,	0
and	0
comfortable	0
)	0
for	0
sleep	0
.	I-DISEASE

D.	0
The	0
sleep	0
disturbance	0
and	I-DISEASE
associated	0
daytime	I-DISEASE
symptoms	0
occur	I-DISEASE
at	0
least	0
three	I-DISEASE
times	I-DISEASE
per	0
week	I-DISEASE
.	0

E.	0

The	0
sleep	0
disturbance	I-DISEASE
and	0
associated	0
daytime	0
symptoms	I-DISEASE
have	0
been	0
present	0
for	0
at	0
least	I-DISEASE
three	I-DISEASE
months.2	I-DISEASE
F.	0
The	0
sleep	I-DISEASE
/	0
wake	0
difficulty	0
is	I-DISEASE
not	0
better	I-DISEASE
explained	I-DISEASE
by	0
another	I-DISEASE
sleep	I-DISEASE
disorder	0
.	0

Notes	0
.	0

Reports	0
of	0
difficulties	0
initiating	0
sleep	0
,	0
difficulties	I-DISEASE
maintaining	I-DISEASE
sleep	I-DISEASE
,	0
or	0
waking	I-DISEASE
up	0
too	0
early	I-DISEASE
can	0
be	0
seen	I-DISEASE
in	0
all	I-DISEASE
age	0
groups	0
.	0

Resistance	0
going	0
to	0
bed	I-DISEASE
on	0
an	0
appropriate	I-DISEASE
schedule	0
and	0
difficulty	0
sleeping	I-DISEASE
without	0
parent	I-DISEASE
or	0
caregiver	I-DISEASE
intervention	0
is	0
seen	0
most	0
commonly	0
in	0
children	0
and	0
older	0
adults	I-DISEASE
who	0
require	0
the	I-DISEASE
supervision	0
of	I-DISEASE
a	I-DISEASE
caretaker	I-DISEASE
due	0
to	0
a	0
significant	0
level	0
of	I-DISEASE
functional	0
impairment	0
(	I-DISEASE
e.g.	I-DISEASE
,	0
those	0
with	0
dementia	I-DISEASE
)	0
.	0
.	0

Some	0
patients	0
with	I-DISEASE
chronic	0
insomnia	0
may	0
show	I-DISEASE
recurrent	0
episodes	I-DISEASE
of	0
sleep	0
/	0
wake	0
difficulties	0
lasting	I-DISEASE
several	0
weeks	I-DISEASE
at	I-DISEASE
a	0
time	I-DISEASE
over	0
several	0
years	0
,	0
yet	I-DISEASE
not	0
meet	I-DISEASE
the	I-DISEASE
three	0
-	I-DISEASE
month	0
duration	I-DISEASE
criterion	0
for	0
any	0
single	0
such	0
episode	0
.	0

Nonetheless	0
,	0
these	0
patients	0
should	0
be	0
assigned	I-DISEASE
a	0
diagnosis	I-DISEASE
of	0
chronic	0
insomnia	0
disorder	0
,	0
given	I-DISEASE
the	0
persistence	0
of	I-DISEASE
their	I-DISEASE
intermittent	0
sleep	0
difficulties	0
over	0
time	0
.	I-DISEASE
.	0

Some	0
patients	0
who	I-DISEASE
use	0
hypnotic	0
medications	0
regularly	0
may	I-DISEASE
sleep	I-DISEASE
well	0
and	0
not	0
meet	0
the	0
criteria	0
for	I-DISEASE
an	I-DISEASE
insomnia	I-DISEASE
disorder	I-DISEASE
when	0
they	0
take	0
such	0
medications	0
.	0

However	0
,	I-DISEASE
in	0
the	0
absence	I-DISEASE
of	0
such	I-DISEASE
medications	0
these	I-DISEASE
same	0
patients	0
may	I-DISEASE
meet	0
the	0
above	I-DISEASE
criteria	0
.	0

This	0
diagnosis	0
would	0
apply	0
to	0
those	0
patients	0
particularly	I-DISEASE
if	I-DISEASE
they	0
present	0
clinically	0
and	0
voice	0
concerns	I-DISEASE
about	0
their	0
inability	0
to	0
sleep	0
without	0
their	I-DISEASE
sleep	I-DISEASE
medications	0
.	I-DISEASE
.	0

Many	0
comorbid	0
conditions	0
such	0
as	0
chronic	0
pain	I-DISEASE
disorders	0
or	I-DISEASE
gast-	0
roesophageal	0
reflux	0
disease	0
(	0
GERD	I-DISEASE
)	I-DISEASE
may	0
cause	I-DISEASE
the	0
sleep	0
/	0
wake	0
complaints	0
delineated	0
here	I-DISEASE
.	0

When	0
such	0
conditions	0
are	0
the	0
sole	I-DISEASE
cause	0
of	0
the	I-DISEASE
sleep	I-DISEASE
difficulty	0
,	0
a	0
separate	0
insomnia	0
diagnosis	0
may	0
not	I-DISEASE
apply	0
.	0

However	0
,	0
in	0
many	0
patients	0
such	I-DISEASE
conditions	0
are	0
chronic	0
and	0
are	0
not	0
the	0
sole	0
cause	I-DISEASE
of	I-DISEASE
sleep	0
difficulty	I-DISEASE
.	0

Key	0
determining	0
factors	0
in	0
the	0
decision	I-DISEASE
to	I-DISEASE
invoke	0
a	0
separate	0
insomnia	0
diagnosis	0
include	0
:	0
“	I-DISEASE
How	0
much	0
of	I-DISEASE
the	0
time	I-DISEASE
does	0
the	0
sleep	I-DISEASE
difficulty	0
arise	I-DISEASE
as	I-DISEASE
a	I-DISEASE
result	I-DISEASE
of	I-DISEASE
factors	I-DISEASE
directly	0
attributable	0
to	0
the	0
comorbid	0
condition	I-DISEASE
(	I-DISEASE
e.g.	0
,	I-DISEASE
pain	0
or	I-DISEASE
GERD	0
)	0
?	0
”	I-DISEASE

or	0
“	0
Are	0
there	0
times	I-DISEASE
that	0
the	I-DISEASE
sleep	0
/	I-DISEASE
wake	0
complaints	0
occur	0
in	0
the	0
absence	I-DISEASE
of	0
these	0
factors	0
?	0
”	0

“	0
Have	0
perpetuating	0
cognitive	0
or	I-DISEASE
behavioral	0
factors	0
(	0
e.g.	0
,	0
negative	0
expectations	0
,	0
conditioned	0
arousal	0
,	0
sleep	0
-	I-DISEASE
disruptive	0
habits	0
)	0
arisen	0
,	I-DISEASE
suggesting	0
an	I-DISEASE
autonomous	I-DISEASE
aspect	0
to	I-DISEASE
the	I-DISEASE
ongoing	0
insomnia	0
?	0
”	0

If	0
there	0
is	I-DISEASE
evidence	0
that	0
the	I-DISEASE
patient	I-DISEASE
’s	0
sleep/	0
wake	0
complaints	0
are	0
not	I-DISEASE
solely	0
caused	I-DISEASE
by	I-DISEASE
the	I-DISEASE
medical	I-DISEASE
condition	0
,	I-DISEASE
and	0
those	0
sleep	0
/	0
wake	0
complaints	I-DISEASE
seem	0
to	I-DISEASE
merit	0
separate	0
treatment	0
attention	0
,	0
then	0
a	0
diagnosis	0
of	0
chronic	I-DISEASE
insomnia	0
disorder	0
should	0
be	0
made	0
.	0

Essential	0
Features	0
The	0
essential	0
feature	0
of	0
chronic	I-DISEASE
insomnia	0
disorder	0
is	0
a	0
frequent	0
and	0
persistent	0
difficulty	0
initiating	I-DISEASE
or	0
maintaining	I-DISEASE
sleep	0
that	0
results	0
in	0
general	0
sleep	I-DISEASE
dissatisfaction	I-DISEASE
.	0

The	0
sleep	0
complaint	I-DISEASE
is	0
accompanied	0
by	I-DISEASE
distress	I-DISEASE
about	0
poor	0
sleep	0
and/or	0
impairment	0
in	0
family	0
,	I-DISEASE
social	0
,	0
vocational	I-DISEASE
,	0
academic	0
,	0
or	0
other	0
important	0
areas	0
of	0
functioning	0
.	I-DISEASE

Furthermore	0
,	0
the	0
sleep	I-DISEASE
disturbance	I-DISEASE
and	0
associated	I-DISEASE
waking	0
symptoms	I-DISEASE
occur	0
despite	0
having	0
adequate	0
time	0
and	I-DISEASE
circumstances	I-DISEASE
each	0
night	I-DISEASE
to	I-DISEASE
obtain	0
necessary	0
sleep	0
.	I-DISEASE

Chronic	0
insomnia	0
dis-	0
order	0
can	0
occur	I-DISEASE
in	I-DISEASE
isolation	0
or	I-DISEASE
comorbidly	0
with	0
a	0
mental	0
disorder	0
,	I-DISEASE
medical	0
condition	0
,	I-DISEASE
or	0
substance	0
use	0
.	0

The	0
sleep	0
complaints	I-DISEASE
that	0
comprise	0
chronic	0
insomnia	0
disorder	0
may	I-DISEASE
include	0
difficul-	0
ties	0
initiating	0
sleep	0
or	I-DISEASE
difficulties	0
maintaining	0
sleep	I-DISEASE
.	0

The	0
latter	0
complaint	0
may	I-DISEASE
include	0
waking	I-DISEASE
up	I-DISEASE
during	0
the	I-DISEASE
night	I-DISEASE
with	I-DISEASE
difficulty	0
returning	I-DISEASE
to	0
sleep	I-DISEASE
or	I-DISEASE
having	0
a	I-DISEASE
final	0
awaken-	0
ing	0
occurring	0
too	I-DISEASE
early	I-DISEASE
,	I-DISEASE
well	0
before	0
the	I-DISEASE
desired	0
rising	I-DISEASE
time	I-DISEASE
.	0

Chronic	0
insomnia	0
disorder	0
may	0
be	0
characterized	I-DISEASE
solely	I-DISEASE
by	0
sleep	I-DISEASE
onset	0
or	I-DISEASE
sleep	I-DISEASE
maintenance	I-DISEASE
complaints	0
or	I-DISEASE
,	I-DISEASE
more	0
commonly	I-DISEASE
,	0
by	0
both	0
types	0
of	0
complaints	0
occurring	0
together	I-DISEASE
.	0

Individuals	0
’	0
sleep	0
com-	I-DISEASE
plaints	0
may	I-DISEASE
also	I-DISEASE
change	0
over	I-DISEASE
time	0
such	0
that	0
those	0
with	0
solely	I-DISEASE
sleep	0
onset	0
complaints	I-DISEASE
may	I-DISEASE
subsequently	0
develop	0
sleep	0
maintenance	I-DISEASE
complaints	0
and	I-DISEASE
vice	0
versa	I-DISEASE
.	I-DISEASE

Also	0
,	0
those	0
who	0
present	0
initially	I-DISEASE
with	I-DISEASE
mixed	0
sleep	I-DISEASE
onset	I-DISEASE
and	0
sleep	0
maintenance	I-DISEASE
difficulties	0
may	I-DISEASE
later	0
evidence	0
one	0
or	0
the	0
other	0
of	0
these	0
difficulties	0
but	I-DISEASE
not	0
both	I-DISEASE
.	0

Complaints	0
about	0
poor	0
-	0
quality	0
,	0
unrefreshing	0
,	0
or	I-DISEASE
nonrestorative	0
sleep	0
often	0
accompany	0
sleep	0
onset	I-DISEASE
and	0
sleep	0
maintenance	I-DISEASE
complaints	0
,	0
but	0
do	0
not	0
suffice	I-DISEASE
to	0
define	0
insomnia	I-DISEASE
disorder	I-DISEASE
when	0
occurring	0
as	0
the	0
sole	0
sleep	0
complaint	0
.	0

The	0
degree	0
of	0
sleep	0
disturbance	0
required	0
to	0
assign	0
a	0
chronic	0
insomnia	0
disorder	0
diag-	0

nosis	0
is	0
somewhat	I-DISEASE
arbitrary	0
in	0
that	I-DISEASE
it	0
relies	0
primarily	0
on	0
individuals	0
’	0
subjective	0
sleep	0
Insomnia	I-DISEASE
Insomnia	I-DISEASE
complaints	0
.	0

Moreover	0
,	0
the	0
degree	I-DISEASE
of	0
sleep	I-DISEASE
disturbance	I-DISEASE
required	0
to	I-DISEASE
connote	0
clinical	I-DISEASE
significance	I-DISEASE
varies	0
across	0
age	I-DISEASE
groups	0
.	0

Nonetheless	0
,	0
sleep	0
onset	I-DISEASE
latencies	0
and	0
periods	I-DISEASE
of	0
wakefulness	0
after	0
sleep	I-DISEASE
onset	0
>	0
20	I-DISEASE
minutes	I-DISEASE
generally	0
connote	0
clinically	I-DISEASE
significant	I-DISEASE
sleep	I-DISEASE
disturbances	I-DISEASE
in	0
children	0
and	0
young	I-DISEASE
adults	0
.	0

In	0
middle	0
and	0
older	0
aged	0
adults	0
,	0
onset	0
latencies	I-DISEASE
and	0
periods	0
of	0
wakefulness	0
during	0
sleep	I-DISEASE
>	0
30	I-DISEASE
minutes	I-DISEASE
typically	0
connote	0
clin-	0
ical	0
significance	I-DISEASE
.	I-DISEASE

Complaints	0
of	0
early	0
morning	0
awakening	0
are	I-DISEASE
less	I-DISEASE
well	I-DISEASE
defined	I-DISEASE
,	0
but	0
typically	0
entail	0
the	0
termination	I-DISEASE
of	0
sleep	0
at	0
least	0
30	I-DISEASE
minutes	0
before	0
the	I-DISEASE
desired	I-DISEASE
rising	I-DISEASE
time	0
and	0
a	I-DISEASE
concomitant	I-DISEASE
reduced	0
total	0
sleep	0
time	0
compared	0
with	I-DISEASE
the	0
usual	I-DISEASE
premorbid	I-DISEASE
sleep	I-DISEASE
pattern	0
.	I-DISEASE

The	0
exact	0
time	I-DISEASE
at	0
which	I-DISEASE
early	I-DISEASE
morning	I-DISEASE
awakenings	I-DISEASE
occur	I-DISEASE
may	0
vary	I-DISEASE
con-	0
siderably	I-DISEASE
as	I-DISEASE
a	I-DISEASE
function	I-DISEASE
of	0
usual	I-DISEASE
bedtimes	0
.	0

For	0
example	0
,	0
a	0
final	0
awakening	I-DISEASE
at	I-DISEASE
4:00	0
a.m.	I-DISEASE
is	0
likely	0
to	0
connote	0
clinical	0
significance	I-DISEASE
when	0
the	0
usual	I-DISEASE
bedtime	0
is	I-DISEASE
11:00	I-DISEASE
p.m.	0

but	0
not	0
when	I-DISEASE
the	0
usual	I-DISEASE
bedtime	0
occurs	0
at	0
9:00	I-DISEASE
p.m.	0

Symptoms	0
during	0
wakefulness	0
accompany	0
the	0
sleep	I-DISEASE
difficulties	I-DISEASE
and	0
result	I-DISEASE
in	I-DISEASE
the	0
impairment	0
of	0
normal	0
functioning	0
.	I-DISEASE

Common	0
waking	0
symptoms	0
include	0
fatigue	0
;	0
reduced	I-DISEASE
motivation	I-DISEASE
;	I-DISEASE
reduced	0
concentration	I-DISEASE
,	0
attention	0
,	0
and	I-DISEASE
memory	I-DISEASE
functioning	0
;	I-DISEASE
and	0
irritability	I-DISEASE
or	0
reduced	0
mood	I-DISEASE
.	0

Complaints	0
of	0
subjective	0
daytime	I-DISEASE
sleepiness	0
are	I-DISEASE
also	I-DISEASE
common	0
,	I-DISEASE
although	0
,	0
in	0
contrast	0
to	0
patients	0
with	I-DISEASE
hypersomnolence	0
conditions	I-DISEASE
,	0
many	I-DISEASE
with	0
this	0
complaint	0
are	0
not	0
able	0
to	0
nap	I-DISEASE
in	0
the	I-DISEASE
daytime	0
and	0
few	0
show	0
unintentional	0
sleep	I-DISEASE
episodes	0
.	0

Reports	0
of	0
reduced	0
performance	I-DISEASE
at	0
work	I-DISEASE
or	I-DISEASE
school	0
or	0
impaired	0
social	0
functioning	0
also	I-DISEASE
are	0
common	I-DISEASE
.	0

Some	0
affected	0
individuals	0
attribute	0
errors	0
or	I-DISEASE
accidents	0
at	0
work	I-DISEASE
to	0
their	0
sleep	0
difficulties	I-DISEASE
.	0

Somatic	0
symptoms	0
such	0
as	0
headaches	0
or	0
gastrointes-	I-DISEASE
tinal	0
dysfunction	0
are	0
occasionally	0
attributed	0
to	0
the	0
ongoing	0
sleep	0
difficulties	0
as	I-DISEASE
well	0
.	0

The	0
fatigue	0
of	0
insomnia	0
sufferers	0
is	0
manifest	0
mainly	0
as	I-DISEASE
a	0
lack	0
of	0
energy	0
and	0
desire	I-DISEASE
to	0
reduce	0
or	I-DISEASE
limit	0
activity	0
levels	0
.	0

This	0
symptom	0
should	0
be	B-DISEASE
differentiated	0
from	0
reports	0
of	I-DISEASE
subjective	I-DISEASE
sleepiness	0
as	0
well	0
as	0
from	0
unintended	0
sleep	0
episodes	0
.	I-DISEASE

Insomnia	0
sufferers	0
commonly	0
report	0
subjective	0
sleepiness	0
characterized	I-DISEASE
by	0
a	I-DISEASE
sense	0
of	0
reduced	0
alertness	0
and	0
enhanced	I-DISEASE
need	0
or	0
desire	I-DISEASE
to	0
sleep	0
.	0

However	0
,	0
they	0
seldom	0
fall	0
asleep	0
spontaneously	I-DISEASE
without	0
intending	0
to	0
do	0
so	0
.	0

Despite	0
a	0
desire	0
to	0
nap	0
,	0
many	I-DISEASE
individuals	0
with	I-DISEASE
insomnia	0
are	0
unable	0
to	0
do	0
so	I-DISEASE
.	0

Frequent	0
,	0
unintentional	0
daytime	0
sleep	0
episodes	0
are	I-DISEASE
more	0
characteristic	I-DISEASE
of	0
other	I-DISEASE
types	0
of	0
sleep	0
disorders	0
such	0
as	I-DISEASE
sleep	I-DISEASE
disordered	0
breathing	I-DISEASE
,	0
narcolepsy	0
,	0
idio-	I-DISEASE
pathic	I-DISEASE
hypersomnia	0
,	0
and	I-DISEASE
the	0
like	0
.	0

In	0
young	0
children	0
,	I-DISEASE
difficulty	0
falling	I-DISEASE
asleep	I-DISEASE
,	0
staying	I-DISEASE
asleep	0
,	0
or	0
both	0
are	0
often	I-DISEASE
the	I-DISEASE
result	I-DISEASE
of	I-DISEASE
inappropriate	0
sleep	0
associations	0
or	0
inadequate	0
limit	0
setting	I-DISEASE
.	0

Inappropriate	0
sleep	0
associ-	0

ations	0
result	I-DISEASE
from	0
a	0
child	0
’s	I-DISEASE
dependency	I-DISEASE
on	0
specific	0
stimulation	0
,	0
objects	0
,	I-DISEASE
or	0
settings	I-DISEASE
for	0
initiating	0
sleep	0
or	0
returning	0
to	0
sleep	0
following	0
an	I-DISEASE
awakening	0
;	0
in	0
the	I-DISEASE
absence	0
of	I-DISEASE
these	0
conditions	0
,	0
sleep	0
onset	I-DISEASE
is	0
significantly	I-DISEASE
delayed	0
.	0

This	0
manifestation	0
usually	0
presents	I-DISEASE
as	0
frequent	I-DISEASE
nighttime	I-DISEASE
awakenings	0
and/or	I-DISEASE
nighttime	0
fears	0
or	0
anxiety	0
about	0
sleeping	0
alone	0
.	I-DISEASE

The	0
process	0
of	0
falling	0
asleep	0
is	I-DISEASE
associated	I-DISEASE
with	0
a	I-DISEASE
specific	0
form	0
of	0
stimulation	0
(	0
e.g.	I-DISEASE
,	0
rocking	0
,	I-DISEASE
watching	0
television	0
)	0
,	0
object	0
(	0
e.g.	I-DISEASE
,	0
bottle	I-DISEASE
,	I-DISEASE
excessive	0
feedings	0
)	0
,	0
or	0
setting	0
(	0
e.g.	0
,	0
lighted	I-DISEASE
room	I-DISEASE
,	0
parents	0
remaining	0
in	0
the	0
room	0
,	I-DISEASE
or	0
child	0
taken	0
to	0
parents	0
’	0
bed	I-DISEASE
)	I-DISEASE
.	0

When	0
such	0
conditions	0
are	0
absent	0
,	0
children	I-DISEASE
with	I-DISEASE
this	I-DISEASE
disorder	0
experience	0
difficulty	0
falling	I-DISEASE
asleep	0
at	I-DISEASE
bedtime	I-DISEASE
and	0
following	I-DISEASE
normal	0
nighttime	0
arousals	0
.	0

If	0
the	0
conditions	I-DISEASE
associ-	0
ated	0
with	0
falling	I-DISEASE
asleep	0
are	I-DISEASE
reestablished	0
,	0
the	0
child	0
usually	0
resumes	I-DISEASE
sleep	0
relatively	0
quickly	I-DISEASE
.	0

Because	0
sleep	0
-	I-DISEASE
onset	I-DISEASE
associations	0
are	I-DISEASE
highly	I-DISEASE
prevalent	0
in	I-DISEASE
young	0
children	0
,	I-DISEASE
the	0
phenomenon	I-DISEASE
is	I-DISEASE
defined	I-DISEASE
as	0
a	I-DISEASE
disorder	0
only	0
if	0
(	0
1	0
)	0
the	I-DISEASE
associations	I-DISEASE
are	0
highly	0
problem-	0
atic	I-DISEASE
or	0
demanding	I-DISEASE
(	0
e.g.	0
,	0
extended	0
rocking	0
,	0
car	0
rides	0
)	I-DISEASE
;	I-DISEASE
(	0
2	0
)	I-DISEASE
sleep	0
onset	I-DISEASE
is	I-DISEASE
significantly	0
delayed	I-DISEASE
or	I-DISEASE
sleep	I-DISEASE
is	I-DISEASE
otherwise	I-DISEASE
disrupted	0
in	0
the	0
absence	I-DISEASE
of	0
the	0
associated	0
conditions	0
;	I-DISEASE
and	I-DISEASE
(	I-DISEASE
3	I-DISEASE
)	0
caregiver	0
intervention	0
is	I-DISEASE
frequently	0
required	0
to	I-DISEASE
aid	0
the	0
onset	0
or	0
resumption	I-DISEASE
of	I-DISEASE
sleep	0
.	0

Limit	0
-	I-DISEASE
setting	0
issues	I-DISEASE
are	0
characterized	0
by	I-DISEASE
bedtime	0
stalling	I-DISEASE
or	0
bedtime	0
refusal	I-DISEASE
that	I-DISEASE
is	0
met	0
with	I-DISEASE
and	I-DISEASE
reinforced	I-DISEASE
by	0
inadequate	I-DISEASE
limit	0
setting	0
by	0
a	0
caregiver	0
.	0

Sleep	0
problems	0
occur	0
when	0
caregivers	0
institute	0
no	I-DISEASE
or	0
few	I-DISEASE
limits	0
or	0
when	0
limits	0
are	0
instituted	I-DISEASE
inconsistently	0
or	0
in	0
an	I-DISEASE
unpredictable	0
manner	0
.	0

Limit	0
-	I-DISEASE
setting	0
sleep	I-DISEASE
problems	0
may	I-DISEASE
also	0
result	0
in	I-DISEASE
prolonged	0
nocturnal	0
awakenings	I-DISEASE
,	I-DISEASE
depending	0
on	I-DISEASE
caregiver	0
response	I-DISEASE
during	I-DISEASE
the	0
night	0
.	0

It	0
also	0
should	0
be	0
noted	I-DISEASE
that	0
some	I-DISEASE
children	0
’s	I-DISEASE
needs	0
for	0
specific	0
conditions	0
for	0
sleeping	I-DISEASE
or	0
their	0
resistance	I-DISEASE
to	0
go	I-DISEASE
to	0
bed	0
may	0
reflect	0
underlying	B-DISEASE
anxiety	I-DISEASE
or	I-DISEASE
fears	I-DISEASE
.	0

Fear	0
of	0
sleep-	I-DISEASE
ing	I-DISEASE
alone	0
,	I-DISEASE
being	I-DISEASE
in	0
the	I-DISEASE
dark	0
,	I-DISEASE
or	0
having	0
nightmares	0
may	0
lead	0
some	0
children	I-DISEASE
to	0
demand	I-DISEASE
certain	0
sleep	0
promoting	0
conditions	I-DISEASE
(	0
presence	0
of	I-DISEASE
parent	0
in	0
bedroom	I-DISEASE
)	0
or	I-DISEASE
to	0
repeatedly	0
delay	0
their	I-DISEASE
bedtimes	0
.	0

Although	0
transient	0
and	I-DISEASE
episodic	0
forms	0
of	0
insomnia	I-DISEASE
occur	0
,	0
the	0
clinically	0
significant	0
daytime	I-DISEASE
consequences	0
of	I-DISEASE
insomnia	I-DISEASE
and	I-DISEASE
the	I-DISEASE
longer	0
term	I-DISEASE
,	0
more	0
serious	0
morbidity	0
out-	I-DISEASE
comes	0
most	I-DISEASE
typically	I-DISEASE
develop	0
when	0
the	0
sleep	0
difficulties	0
occur	0
at	0
least	I-DISEASE
three	0
times	0
per	I-DISEASE
week	I-DISEASE
and	0
persist	I-DISEASE
for	0
at	0
least	I-DISEASE
three	I-DISEASE
months	I-DISEASE
.	0

For	0
this	0
reason	0
,	0
these	0
frequency	0
and	0
dura-	0
tion	I-DISEASE
criteria	0
must	0
be	0
met	0
for	0
the	0
assignment	I-DISEASE
of	0
a	0
chronic	0
insomnia	I-DISEASE
disorder	0
diagnosis	0
.	0

However	0
,	I-DISEASE
it	0
is	0
recognized	0
that	0
more	I-DISEASE
acute	0
and	I-DISEASE
episodic	0
forms	0
of	0
insomnia	I-DISEASE
may	0
cause	I-DISEASE
significant	0
distress	0
and	I-DISEASE
functional	0
impairment	0
and	0
require	0
clinical	0
attention	0
.	I-DISEASE

Cases	0
that	0
meet	0
all	0
criteria	0
except	0
the	I-DISEASE
frequency	0
or	I-DISEASE
duration	0
criteria	0
for	0
chronic	0
insomnia	0
disorder	0
should	0
be	0
assigned	I-DISEASE
a	0
diagnosis	0
of	0
short	0
-	0
term	0
insomnia	I-DISEASE
disorder	I-DISEASE
.	0

Associated	0
Features	0
Individuals	0
with	0
chronic	0
insomnia	0
disorder	0
typically	0
note	I-DISEASE
feelings	0
of	0
reduced	0
well	0
-	0
being	I-DISEASE
and	0
general	0
malaise	I-DISEASE
during	0
the	0
day	0
.	0

In	0
addition	0
,	0
excessive	0
focus	0
on	0
and	0
worry	0
about	0
ongoing	0
sleep	0
difficulties	I-DISEASE
and	0
their	0
associated	0
daytime	0
consequences	0
are	I-DISEASE
common	0
.	0

Thoughts	0
about	0
ongoing	I-DISEASE
sleep	0
difficulties	0
may	I-DISEASE
occur	I-DISEASE
through	0
the	0
day	0
and	I-DISEASE
may	0
be	I-DISEASE
amplified	0
as	I-DISEASE
bedtime	0
Insomnia	0
Insomnia	I-DISEASE
approaches	0
.	0

Frank	0
performance	0
anxiety	0
about	0
sleep	0
is	I-DISEASE
common	I-DISEASE
.	0

Although	0
many	0
with	0
insomnia	0
may	0
appear	0
anxious	I-DISEASE
and	0
worry	I-DISEASE
-	0
prone	0
,	0
their	I-DISEASE
anxiety	0
and	I-DISEASE
worry	0
are	0
often	I-DISEASE
focused	0
mainly	0
on	0
their	0
sleep	0
difficulties	0
.	0

When	0
anxiety	0
and	0
worry	I-DISEASE
are	0
more	0
pervasive	0
and	0
not	I-DISEASE
solely	0
focused	I-DISEASE
on	I-DISEASE
sleep	0
problems	0
,	I-DISEASE
a	0
comorbid	0
anxiety	I-DISEASE
disorder	0
may	0
be	0
present	0
.	0

Many	0
with	0
chronic	0
insomnia	0
disorder	0
show	0
a	I-DISEASE
pattern	0
of	0
conditioned	0
arousal	0
in	0
response	0
to	0
envi-	0
ronmental	0
cues	0
in	0
their	0
bedrooms	0
or	0
conscious	0
efforts	I-DISEASE
to	0
initiate	0
sleep	0
.	0

Such	0
individuals	0
may	0
fall	B-DISEASE
asleep	0
easily	I-DISEASE
in	0
settings	0
outside	0
of	0
their	0
bedrooms	0
when	0
not	0
trying	I-DISEASE
to	0
sleep	0
,	I-DISEASE
but	0
show	0
a	0
pattern	0
of	0
cognitive	0
and	I-DISEASE
physiological	0
arousal	0
when	I-DISEASE
lying	0
down	I-DISEASE
in	I-DISEASE
their	0
beds	0
with	0
the	0
intention	I-DISEASE
to	0
fall	0
asleep	0
.	I-DISEASE

Some	0
patients	0
with	I-DISEASE
this	0
pattern	0
may	0
report	0
sleeping	0
better	0
when	0
away	0
from	0
home	0
than	0
when	I-DISEASE
at	0
home	0
.	I-DISEASE

Unlike	0
noncomplaining	0
normal	0
sleepers	0
,	0
indi-	I-DISEASE
viduals	I-DISEASE
with	I-DISEASE
chronic	I-DISEASE
insomnia	0
disorder	0
often	0
express	I-DISEASE
conscious	0
intentions	I-DISEASE
and	I-DISEASE
excessive	I-DISEASE
effort	0
to	0
sleep	0
,	0
only	0
to	0
find	I-DISEASE
sleep	I-DISEASE
difficult	0
to	0
initiate	I-DISEASE
under	I-DISEASE
such	0
circumstances	I-DISEASE
.	I-DISEASE

In	0
children	0
,	I-DISEASE
the	0
sleep	I-DISEASE
disturbance	I-DISEASE
may	0
be	0
accompanied	I-DISEASE
by	I-DISEASE
daytime	0
behavioral	0
prob-	0
lems	0
and	I-DISEASE
limit	I-DISEASE
-	0
setting	I-DISEASE
difficulties	0
during	0
the	0
day	0
.	0

In	0
addition	0
,	0
the	0
nighttime	I-DISEASE
sleep	I-DISEASE
distur-	I-DISEASE
bance	I-DISEASE
often	I-DISEASE
results	I-DISEASE
in	0
poor	I-DISEASE
parental	0
sleep	0
and	I-DISEASE
associated	0
daytime	0
impairment	I-DISEASE
.	0

Marital	0
conflicts	0
regarding	0
how	0
to	0
respond	0
to	I-DISEASE
or	I-DISEASE
intervene	I-DISEASE
with	0
the	0
ongoing	0
sleep	I-DISEASE
problem	0
may	I-DISEASE
arise	I-DISEASE
.	0

Parents	0
also	0
may	0
develop	B-DISEASE
negative	0
feelings	0
toward	0
the	0
child	I-DISEASE
who	0
disrupts	0
their	0
sleep	0
and	0
demands	I-DISEASE
their	I-DISEASE
attention	0
during	0
the	0
night	I-DISEASE
.	0

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Various	I-DISEASE
clinical	I-DISEASE
and	I-DISEASE
pathophysiological	I-DISEASE
subtypes	I-DISEASE
of	0
insomnia	I-DISEASE
have	I-DISEASE
been	0
described	0
in	I-DISEASE
previous	I-DISEASE
nosologies	I-DISEASE
.	I-DISEASE

Both	0
the	0
American	I-DISEASE
Psychiatric	I-DISEASE
Association	0
’s	0
Diagnostic	I-DISEASE
and	0
Statistical	0
Manual	0
,	0
4th	0
Edition	0
,	0
Text	I-DISEASE
Revision	I-DISEASE
(	0
DSM	I-DISEASE
-	0
IV	I-DISEASE
-	0
TR	0
)	0
and	0
the	0
International	0
Classification	0
of	I-DISEASE
Sleep	0
Disorders	0
,	0
2nd	0
Edition	0
describe	0
independently	0
occurring	I-DISEASE
or	0
primary	0
forms	0
of	I-DISEASE
insomnia	0
.	0

Within	0
DSM	0
-	0
IV	I-DISEASE
-	0
TR	0
,	I-DISEASE
the	0
global	0
term	0
,	0
primary	0
insomnia	0
,	0
is	0
applied	0
to	0
all	I-DISEASE
forms	0
of	0
insomnia	0
that	0
are	0
not	I-DISEASE
better	I-DISEASE
explained	0
by	0
a	I-DISEASE
coincident	0
psychi-	0
atric	I-DISEASE
,	0
medical	0
or	0
substance	0

use	0
/	0
abuse	0
disorder	0
.	0

Within	0
the	0
International	I-DISEASE
Classification	0
of	0
Sleep	I-DISEASE
Disorders	I-DISEASE
,	0
2nd	I-DISEASE
Edition	0
system	0
,	I-DISEASE
multiple	0
primary	0
insomnia	I-DISEASE
subtypes	0
are	0
delin-	0
eated	0
.	0

The	0
specific	0
primary	0
insomnia	0
subtypes	0
listed	0
in	0
the	0
previous	0
International	0
Classification	0
of	0
Sleep	I-DISEASE
Disorders	0
,	0
2nd	0
Edition	0
include	I-DISEASE
the	0
following	0
:	0
Psychophysiological	0
insomnia	I-DISEASE
is	0
characterized	I-DISEASE
primarily	I-DISEASE
by	0
heightened	I-DISEASE
arousal	0
and	I-DISEASE
learned	0
sleep	I-DISEASE
-	0
preventing	0
associations	0
that	0
result	0
in	I-DISEASE
a	0
complaint	0
of	0
insomnia	I-DISEASE
.	0

Patients	0
presumed	0
to	I-DISEASE
have	0
this	0
type	0
of	0
insomnia	0
often	I-DISEASE
have	0
sleep	0
difficulty	0
when	I-DISEASE
trying	0
to	I-DISEASE
sleep	I-DISEASE
in	0
their	I-DISEASE
usual	0
sleep	I-DISEASE
setting	0
at	0
home	0
but	I-DISEASE
may	0
fall	I-DISEASE
asleep	0
easily	0
in	0
a	0
novel	I-DISEASE
sleep	0
setting	0
or	0
when	0
not	I-DISEASE
trying	0
to	0
sleep	0
.	I-DISEASE

They	0
also	0
demonstrate	0
excessive	I-DISEASE
focus	I-DISEASE
on	0
and	I-DISEASE
worry	I-DISEASE
about	0
sleep	0
and	I-DISEASE
suffer	I-DISEASE
from	I-DISEASE
elevated	0
levels	I-DISEASE
of	0
cognitive	I-DISEASE
and	I-DISEASE
somatic	0
arousal	0
,	0
particularly	0
at	0
bedtime	I-DISEASE
.	I-DISEASE

Idiopathic	0
insomnia	0
is	0
characterized	0
by	0
a	0
longstanding	0
complaint	0
of	0
sleep	0
difficulties	0
with	0
insidious	0
onset	0
occurring	I-DISEASE
during	I-DISEASE
infancy	0
or	0
early	0
childhood	0
.	0

It	0
is	0
presumed	0
to	0
arise	0
in	I-DISEASE
infancy	0
or	0
early	I-DISEASE
childhood	0
without	0
discernible	I-DISEASE
cause	0
and	0
to	I-DISEASE
persist	I-DISEASE
over	0
time	I-DISEASE
without	0
sustained	I-DISEASE
periods	0
of	0
remission	I-DISEASE
.	0

Given	0
its	I-DISEASE
early	0
onset	0
,	0
stability	0
over	0
time	0
,	I-DISEASE
and	0
lifelong	0
course	0
,	I-DISEASE
this	0
disorder	0
is	0
thought	0
to	0
arise	0
from	I-DISEASE
either	0
genetically	0
determined	0
or	0
congenital	0
aberrations	I-DISEASE
in	0
the	0
sleep	0
-	I-DISEASE
inducing	I-DISEASE
or	0
arousal	I-DISEASE
systems	0
in	0
the	0
brain	0
,	0
or	0
both	0
.	0

No	0
consistent	0
genetic	0
markers	0
or	0
neural	0
pathology	I-DISEASE
have	0
been	0
identified	0
among	0
those	0
presumed	0
to	0
suffer	I-DISEASE
from	0
this	0
condition	0
.	0

Paradoxical	0
insomnia	0
,	0
which	0
has	0
previously	0
been	I-DISEASE
called	0
sleep	I-DISEASE
state	0
misperception	0
,	0
is	I-DISEASE
described	I-DISEASE
as	I-DISEASE
a	I-DISEASE
complaint	I-DISEASE
of	I-DISEASE
severe	0
sleep	0
disturbance	0
without	0
corroborative	0
objective	I-DISEASE
evidence	I-DISEASE
of	0
the	I-DISEASE
degree	0
of	I-DISEASE
sleep	I-DISEASE
disturbance	0
claimed	0
.	0

Those	0
presumed	0
to	0
have	0
this	0
form	0
of	0
sleep	0
difficulty	I-DISEASE
have	I-DISEASE
a	0
marked	0
propensity	I-DISEASE
to	0
underestimate	I-DISEASE
the	0
amount	0
of	I-DISEASE
sleep	0
they	I-DISEASE
actually	0
are	I-DISEASE
obtaining	0
.	I-DISEASE

In	0
essence	0
,	0
they	0
are	0
thought	0
to	0
perceive	0
much	0
of	0
the	0
time	0
they	0
actually	0
sleep	I-DISEASE
as	I-DISEASE
wakefulness	0
.	I-DISEASE

Although	0
many	0
such	0
patients	0
routinely	0
obtain	0
norma-	I-DISEASE
tive	0
amounts	I-DISEASE
of	0
sleep	0
,	I-DISEASE
as	0
documented	0
by	I-DISEASE
standard	0
polysomnographic	0
measures	I-DISEASE
,	0
they	0
complain	0
of	0
the	0
common	0
sleep	I-DISEASE
/	0
wake	0
symptoms	I-DISEASE
of	0
other	0
insomnia	0
disorders	I-DISEASE
.	0

Some	0
studies	0
using	0
neuroimaging	0
or	0
sleep	0
electroencephalograph	I-DISEASE
(	0
EEG	0
)	0
spectral	0
analysis	0
techniques	0
have	0
suggested	I-DISEASE
that	0
an	0
altered	I-DISEASE
sleep	0
/	I-DISEASE
wake	0
arousal	0
system	0
in	0
such	0
individ-	0
uals	0
may	I-DISEASE
explain	I-DISEASE
the	0
apparent	I-DISEASE
mismatch	0
between	0
their	0
conventional	0
objective	0
sleep	0
measures	0
and	I-DISEASE
subjective	0
sleep	0
reports	0
.	0

Inadequate	0
sleep	0
hygiene	0
is	I-DISEASE
presumed	0
to	I-DISEASE
result	I-DISEASE
from	0
or	I-DISEASE
be	0
sustained	0
by	0
daily	0
living	0
activities	I-DISEASE
that	0
are	0
inconsistent	I-DISEASE
with	0
the	0
maintenance	0
of	0
good	I-DISEASE
-	0
quality	I-DISEASE
sleep	0
and	0
normal	I-DISEASE
daytime	0
alertness	I-DISEASE
.	I-DISEASE

Patients	0
with	0
this	B-DISEASE
form	0
of	0
insomnia	I-DISEASE
have	I-DISEASE
ongoing	0
sleep/	I-DISEASE
wake	0
difficulties	0
as	0
a	I-DISEASE
function	0
of	I-DISEASE
practices	0
such	0
as	I-DISEASE
daytime	0
napping	0
,	0
maintaining	0
a	0
highly	0
variable	0
sleep	0
/	0
wake	0
schedule	0
,	0
routinely	I-DISEASE
using	I-DISEASE
sleep	0
-	0
disruptive	0
products	0
(	0
caf-	I-DISEASE
feine	I-DISEASE
,	I-DISEASE
tobacco	I-DISEASE
,	I-DISEASE
alcohol	0
)	0
too	0
close	I-DISEASE
to	I-DISEASE
bedtime	I-DISEASE
,	0
engaging	I-DISEASE
in	0
mentally	0
or	I-DISEASE
physically	0
acti-	0
vating	0
or	0
emotionally	I-DISEASE
upsetting	0
activities	I-DISEASE
too	I-DISEASE
close	0
to	0
bedtime	0
,	0
routinely	I-DISEASE
using	I-DISEASE
the	0
bed	I-DISEASE
and	I-DISEASE
bedroom	0
for	0
activities	I-DISEASE
other	I-DISEASE
than	I-DISEASE
sleep	0
,	0
or	I-DISEASE
failing	I-DISEASE
to	0
maintain	I-DISEASE
a	0
comfortable	0
environment	0
for	I-DISEASE
sleep	0
.	0

Behavioral	0
insomnia	0
of	0
childhood	0
is	0
presumed	0
to	I-DISEASE
result	0
from	I-DISEASE
improper	0
sleep	0
train-	0
ing	0
or	0
limit	0
setting	I-DISEASE
by	0
parents	I-DISEASE
or	0
caretakers	0
.	0

Within	0
this	0
broader	0
diagnosis	0
,	0
several	0
subtypes	I-DISEASE
have	0
been	0
described	0
.	0

Sleep	0
-	I-DISEASE
onset	0
association	0
type	0
is	I-DISEASE
characterized	I-DISEASE
by	0
the	I-DISEASE
child	I-DISEASE
’s	0
dependency	0
on	0
specific	0
stimulation	0
,	0
objects	0
,	I-DISEASE
or	0
settings	I-DISEASE
for	0
initiating	0
sleep	0
or	0
returning	0
to	0
sleep	0
following	I-DISEASE
an	0
awakening	0
;	0
in	I-DISEASE
the	0
absence	0
of	0
these	0
conditions	0
,	0
sleep	I-DISEASE
onset	0
is	I-DISEASE
significantly	0
delayed	0
.	0

Limit	0
-	I-DISEASE
setting	0
type	I-DISEASE
is	0
characterized	I-DISEASE
by	I-DISEASE
bedtime	0
stalling	I-DISEASE
or	0
bedtime	0
refusal	I-DISEASE
that	I-DISEASE
is	0
the	0
result	I-DISEASE
of	I-DISEASE
inadequate	I-DISEASE
limit	0
setting	I-DISEASE
by	0
a	I-DISEASE
caregiver	0
.	0

A	0
mixed	0
type	0
Insomnia	I-DISEASE
Insomnia	0
characterized	0
by	0
features	0
of	0
sleep	0
-	0
onset	0
association	0
difficulties	0
and	I-DISEASE
bedtime	0
resistance	I-DISEASE
represents	I-DISEASE
a	0
third	0
subtype	0
within	0
this	0
diagnostic	0
category	I-DISEASE
.	0

The	0
DSM	0
-	0
IV	I-DISEASE
-	0
TR	I-DISEASE
and	I-DISEASE
International	0
Classification	0
of	0
Sleep	0
Disorders	0
,	0
2nd	0
Edition	I-DISEASE
also	0
describe	0
several	I-DISEASE
so	I-DISEASE
-	0
called	0
secondary	0
insomnias	I-DISEASE
,	0
arising	I-DISEASE
from	0
co	0
-	B-DISEASE
occurring	0
primary	I-DISEASE
or	I-DISEASE
causative	0
conditions	0
.	0

Among	0
these	0
are	0
the	0
following	I-DISEASE
:	0
Insomnia	I-DISEASE
due	0
to	I-DISEASE
(	0
another	0
)	0
mental	0
disorder	0
is	I-DISEASE
thought	I-DISEASE
to	0
be	I-DISEASE
caused	0
by	0
or	0
secondary	0
to	0
a	0
co	0
-	0
occurring	0
psychiatric	I-DISEASE
condition	0
.	0

Insomnia	0
is	0
a	0
common	0
complaint	0
,	0
particularly	I-DISEASE
among	0
patients	I-DISEASE
with	0
mood	I-DISEASE
disorders	0
and	I-DISEASE
anxiety	0
disorders	I-DISEASE
.	0

Likewise	0
,	0
sleep	0
distur-	I-DISEASE
bance	0
is	I-DISEASE
commonly	I-DISEASE
seen	0
in	I-DISEASE
those	0
with	0
psychotic	0
spectrum	0
disorders	0
and	0
various	0
Axis	0
II	I-DISEASE
(	0
personality	0
)	0
disorders	0
.	0

Among	0
those	0
individuals	0
presumed	0
to	0
have	0
insomnia	0
due	0
to	I-DISEASE
a	0
mental	0
disorder	0
,	0
insomnia	0
has	I-DISEASE
historically	0
been	0
regarded	I-DISEASE
as	0
a	0
secondary	0
symptom	0
,	0
caused	0
by	I-DISEASE
the	0
mental	0
disorder	B-DISEASE
itself	0
.	0

Insomnia	0
due	0
to	0
(	0
a	0
)	0
medical	I-DISEASE
condition	0
is	I-DISEASE
thought	I-DISEASE
to	0
be	I-DISEASE
caused	0
by	0
or	I-DISEASE
secondary	I-DISEASE
to	0
a	I-DISEASE
co	0
-	0
occurring	0
medical	0
condition	0
.	0

Like	0
the	I-DISEASE
mental	I-DISEASE
disorders	0
,	0
many	0
medical	0
condi-	0
tions	I-DISEASE
may	0
have	0
an	0
ongoing	0
insomnia	0
complaint	0
associated	I-DISEASE
with	0
them	0
.	0

In	0
particular	0
,	0
those	0
conditions	0
that	0
cause	I-DISEASE
some	0
form	I-DISEASE
of	0
ongoing	0
pain	0
or	I-DISEASE
discomfort	0
,	I-DISEASE
mobility	0
lim-	0
itation	0
,	0
or	0
breathing	0
disturbance	0
commonly	0
have	0
insomnia	0
complaints	0
accompanying	0
them	0
.	0

Among	0
those	0
individuals	0
presumed	0
to	0
have	0
insomnia	0
due	0
to	I-DISEASE
a	0
medical	0
disor-	0
der	0
,	0
insomnia	I-DISEASE
has	0
historically	0
been	0
regarded	0
as	0
a	0
secondary	0
symptom	0
,	I-DISEASE
caused	0
by	0
the	0
medical	I-DISEASE
disorder	0
itself	0
.	0

Insomnia	0
due	0
to	0
drug	0
or	0
substance	0
is	I-DISEASE
thought	0
to	0
be	0
caused	0
by	0
or	0
secondary	0
to	I-DISEASE
use	0
of	0
or	I-DISEASE
withdrawal	0
from	0
a	0
drug	0
or	I-DISEASE
substance	0
.	I-DISEASE

Many	0
forms	0
of	0
prescription	I-DISEASE
and	0
nonprescrip-	I-DISEASE
tion	0
medications	I-DISEASE
,	0
street	0
drugs	0
,	0
and	I-DISEASE
other	0
commonly	0
used	I-DISEASE
substances	0
may	I-DISEASE
produce	0
sleep	I-DISEASE
disturbances	0
either	0
during	I-DISEASE
periods	I-DISEASE
of	I-DISEASE
use	0
or	I-DISEASE
upon	0
withdrawal	0
.	I-DISEASE

Given	0
these	I-DISEASE
effects	0
,	0
insomnia	0
complaints	0
may	I-DISEASE
arise	0
either	I-DISEASE
during	0
periods	I-DISEASE
when	0
these	I-DISEASE
substances	0
are	I-DISEASE
used	0
or	I-DISEASE
following	I-DISEASE
their	I-DISEASE
discontinuance	0
.	0

Among	0
those	0
individuals	0
presumed	0
to	0
have	0
insom-	0
nia	0
due	I-DISEASE
to	0
drug	0
or	0
substance	0
,	0
insomnia	I-DISEASE
has	0
historically	0
been	I-DISEASE
regarded	0
as	0
a	0
secondary	0
symptom	0
,	0
caused	I-DISEASE
by	0
the	0
drug	I-DISEASE
or	0
substance	0
itself	0
.	0

Despite	0
the	0
heuristic	I-DISEASE
appeal	0
of	I-DISEASE
these	I-DISEASE
various	I-DISEASE
subtypes	0
,	I-DISEASE
it	0
is	0
often	0
difficult	0
to	0
discrim-	I-DISEASE
inate	I-DISEASE
among	0
them	I-DISEASE
in	0
clinical	I-DISEASE
practice	0
.	0

Many	0
of	0
the	0
defining	I-DISEASE
features	0
of	0
the	I-DISEASE
so	I-DISEASE
-	I-DISEASE
called	0
primary	0
insomnia	0
subtypes	0
such	0
as	I-DISEASE
conditioned	0
arousal	0
,	I-DISEASE
poor	0
sleep	0
hygiene	0
prac-	0
tices	0
,	0
and	I-DISEASE
underestimation	I-DISEASE
of	0
sleep	I-DISEASE
time	0
are	0
ubiquitous	0
among	0
insomnia	0
sufferers	0
,	0
per	0
se	0
,	I-DISEASE
and	I-DISEASE
are	0
not	0
specific	0
to	0
one	0
subgroup	0
.	0

This	0
is	0
true	0
whether	0
the	0
so	I-DISEASE
-	0
called	0
primary	I-DISEASE
insomnia	0
subtypes	0
are	0
considered	0
in	0
isolation	I-DISEASE
or	I-DISEASE
if	0
all	0
of	0
the	0
primary	0
and	0
secondary	0
subtypes	0
mentioned	I-DISEASE
are	0
considered	0
.	0

There	0
is	0
substantial	0
symptom	0
overlap	0
both	0
within	I-DISEASE
the	0
group	0
of	0
primary	0
insomnias	I-DISEASE
as	0
well	0
as	0
among	0
the	0
primary	I-DISEASE
and	0
secondary	0
insomnias	0
.	0

Furthermore	0
,	0
many	0
individuals	0
with	0
insomnia	0
have	0
mul-	0
tiple	I-DISEASE
medical	0
and	0
psychiatric	0
comorbidities	I-DISEASE
,	0
making	0
it	0
difficult	0
to	0
assign	0
causation	0
to	0
any	0
single	0
factor	0
.	0

As	0
a	0
result	0
,	0
discrimination	0
among	0
these	I-DISEASE
subtypes	0
has	I-DISEASE
proven	0
difficult	I-DISEASE
given	0
their	0
current	0
definitions	I-DISEASE
and	0
available	0
methods	I-DISEASE
for	0
their	I-DISEASE
ascertain-	I-DISEASE
ment	0
.	0

Furthermore	0
,	0
it	0
is	0
not	0
clear	I-DISEASE
that	0
insomnia	0
is	0
always	0
the	0
result	0
of	0
co	0
-	0
occur-	0
ring	0
medical	I-DISEASE
,	0
mental	0
,	0
or	0
substance	0
use	0
disorders	0
.	0

Often	0
insomnia	0
may	0
precede	0
the	0
onset	0
of	I-DISEASE
such	0
conditions	I-DISEASE
,	0
and	0
even	0
when	0
precipitated	0
by	I-DISEASE
such	I-DISEASE
conditions	0
,	I-DISEASE
the	0
insom-	0
nia	0
may	0
evolve	0
and	0
develop	I-DISEASE
partial	I-DISEASE
or	0
total	I-DISEASE
independence	0
over	0
time	0
.	0

In	0
such	0
cir-	0
cumstances	B-DISEASE
,	0
the	0
term	0
secondary	0
insomnia	I-DISEASE
seems	0
inappropriate	0
.	0

Currently	0
there	0
is	I-DISEASE
limited	0
understanding	0
of	I-DISEASE
mechanistic	I-DISEASE
pathways	0
in	0
chronic	0
insomnia	0
,	0
so	0
it	0
is	I-DISEASE
not	0
possible	0
to	I-DISEASE
draw	0
firm	0
conclusions	0
about	0
the	0
association	0
or	0
direction	0
of	0
causality	I-DISEASE
between	0
insomnia	0
and	0
such	I-DISEASE
co	0
-	0
occurring	0
conditions	0
.	0

Furthermore	0
,	0
other	0
than	0
the	0
differing	I-DISEASE
treatments	0
required	0
for	0
distinctive	0
comorbidities	0
,	0
efficacious	0
treatments	0
for	0
insomnia	0
generally	0
are	I-DISEASE
similar	0
across	0
the	0
range	0
of	0
insomnia	0
subtypes	0
.	I-DISEASE

Finally	0
,	0
research	0
has	0
provided	0
very	0
limited	I-DISEASE
support	0
for	0
the	0
reliability	0
and	0
validity	0
of	0
the	I-DISEASE
various	I-DISEASE
specific	0
subtypes	0
discussed	0
.	0

International	0
Classification	0
of	0
Sleep	I-DISEASE
Disorders	0
,	0
2nd	I-DISEASE
Edition	0
additionally	I-DISEASE
delineates	I-DISEASE
the	0
separate	0
pediatric	0
diagnosis	0
,	I-DISEASE
behavioral	I-DISEASE
insomnia	0
of	I-DISEASE
childhood	0
,	0
characterized	0
by	0
sleep	0
difficulties	0
resulting	I-DISEASE
from	0
inappropriate	0
sleep	I-DISEASE
associations	0
or	0
inadequate	I-DISEASE
limit	I-DISEASE
setting	0
by	0
parents	0
or	I-DISEASE
caretakers	I-DISEASE
.	0

Although	0
perhaps	0
more	0
common	0
in	0
young	0
children	0
,	0
inappropriate	I-DISEASE
sleep	0
associations	0
can	0
occur	0
in	0
older	0
age	0
groups	0
.	I-DISEASE

For	0
example	0
,	0
adults	0
with	0
insomnia	0
may	0
report	0
intolerance	I-DISEASE
for	0
quiet	0
and	0
dark	0
settings	0
and	0
may	0
not	0
be	I-DISEASE
able	0
to	I-DISEASE
fall	0
asleep	0
unless	0
the	0
television	I-DISEASE
is	0
on	0
.	I-DISEASE

Similarly	0
,	0
it	0
is	0
not	0
clear	I-DISEASE
that	0
limit	0
-	I-DISEASE
setting	0
issues	0
are	0
involved	0
in	0
the	0
sleep	I-DISEASE
difficulties	I-DISEASE
of	I-DISEASE
only	0
young	0
children	0
.	I-DISEASE

Such	0
difficulties	0
also	0
can	B-DISEASE
manifest	0
during	I-DISEASE
adolescence	I-DISEASE
as	0
a	I-DISEASE
function	0
of	0
volitionally	0
delaying	0
bedtimes	0
.	0

Similarly	0
,	0
they	0
may	0
occur	0
in	0
older	0
,	0
cognitively	I-DISEASE
impaired	0
adults	0
when	0
their	I-DISEASE
caretak-	0
ers	I-DISEASE
allow	0
liberal	I-DISEASE
daytime	I-DISEASE
napping	I-DISEASE
that	I-DISEASE
in	0
turn	0
results	0
in	0
disruptive	0
awakenings	0
and	I-DISEASE
night	0
wandering	I-DISEASE
.	0

It	0
is	0
also	0
clear	B-DISEASE
that	0
many	I-DISEASE
of	0
the	0
features	I-DISEASE
of	0
sleep	0
/	0
wake	0
dysfunc-	0
tion	0
assigned	0
to	0
this	I-DISEASE
childhood	0
insomnia	0
subtype	0
overlap	0
substantially	0
with	0
the	0
global	0
insomnia	0
disorder	I-DISEASE
.	0

Given	0
these	0
considerations	0
,	0
a	0
separate	0
childhood	0
insomnia	0
diagno-	0
sis	0
is	0
of	0
questionable	0
merit	0
.	I-DISEASE

In	0
addition	0
to	0
these	0
various	0
subtypes	0
,	0
a	0
distinctive	I-DISEASE
subtype	0
of	0
insomnia	0
with	0
objectively	0
short	I-DISEASE
sleep	0
duration	0
has	I-DISEASE
been	0
recently	0
described	0
.	0

This	0
group	0
is	0
characterized	0
by	0
insom-	0
nia	0
complaints	0
,	I-DISEASE
along	0
with	0
an	0
objectively	0
documented	0
average	0
sleep	I-DISEASE
time	0
less	I-DISEASE
than	0
six	0
hours	0
per	0
night	0
and	0
elevated	I-DISEASE
morbidity	I-DISEASE
risk	0
.	I-DISEASE

Because	0
evidence	0
in	0
support	0
of	0
this	I-DISEASE
Insomnia	0
Insomnia	0
insomnia	I-DISEASE
is	0
currently	0
limited	0
,	0
it	0
is	I-DISEASE
premature	0
to	0
delineate	I-DISEASE
a	0
separate	0
insomnia	0
category	0
for	0
this	0
presentation	I-DISEASE
at	0
this	0
juncture	0
.	0

Given	0
all	0
of	0
these	0
considerations	0
,	0
a	I-DISEASE
more	0
global	0
and	0
defensible	0
approach	0
has	0
been	0
chosen	0
for	0
the	0
diagnosis	I-DISEASE
of	0
those	I-DISEASE
with	0
chronic	0
insomnia	0
complaints	0
.	0

Specifically	0
,	0
the	0
single	I-DISEASE
diagnosis	0
of	0
chronic	I-DISEASE
insomnia	0
disorder	I-DISEASE
is	0
provided	0
for	I-DISEASE
all	0
patients	0
who	I-DISEASE
have	0
per-	I-DISEASE
sistent	I-DISEASE
and	0
frequent	0
insomnia	0
complaints	0
whether	0
they	0
occur	I-DISEASE
in	0
the	0
presence	I-DISEASE
or	0
absence	0
of	0
a	0
potentially	0
sleep	0
-	I-DISEASE
disruptive	0
comorbid	0
psychiatric	I-DISEASE
illness	0
,	0
medical	B-DISEASE
disorder	I-DISEASE
,	0
or	0
pattern	I-DISEASE
of	0
substance	I-DISEASE
use	I-DISEASE
.	0

Demographics	0
The	0
full	0
clinical	0
syndrome	0
of	0
chronic	I-DISEASE
insomnia	0
disorder	I-DISEASE
occurs	0
in	0
about	0
10	0
%	0
of	I-DISEASE
the	0
population	0
,	0
but	0
the	0
prevalence	0
of	0
transient	I-DISEASE
insomnia	0
symptoms	0
is	I-DISEASE
much	I-DISEASE
higher	I-DISEASE
(	0
30	0
%	0
to	0
35	0
%	0
of	0
the	0
population	I-DISEASE
)	I-DISEASE
.	0

Chronic	0
insomnia	0
disorder	0
is	0
more	0
common	I-DISEASE
in	I-DISEASE
women	0
,	0
those	0
with	0
medical	0
/	0
psychiatric	0
/	I-DISEASE
substance	0
disorders	0
,	0
and	0
in	0
people	0
in	0
lower	0
socioeco-	0
nomic	I-DISEASE
strata	0
.	0

It	0
may	0
occur	0
at	0
any	I-DISEASE
age	0
but	0
is	0
more	I-DISEASE
commonly	0
diagnosed	0
in	0
older	0
adults	0
,	I-DISEASE
most	I-DISEASE
likely	0
due	I-DISEASE
to	0
age	0
-	0
related	0
deterioration	I-DISEASE
in	I-DISEASE
sleep	I-DISEASE
continuity	0
and	0
increase	0
in	I-DISEASE
medical	I-DISEASE
comorbidities	I-DISEASE
and	0
medication	0
use	0
that	0
increase	0
insomnia	I-DISEASE
risk	I-DISEASE
.	I-DISEASE

Insomnia	0
associated	0
with	0
requirements	0
of	0
parental	0
/	I-DISEASE
caregiver	0
presence	I-DISEASE
at	0
bedtime	0
and/or	0
during	0
the	0
night	0
,	I-DISEASE
along	0
with	I-DISEASE
insomnia	0
due	0
to	0
limit	0
-	I-DISEASE
setting	I-DISEASE
difficulties	I-DISEASE
,	0
are	0
estimated	B-DISEASE
to	0
occur	0
in	0
10	0
%	0
to	0
30	0
%	0
of	0
children	I-DISEASE
,	0
depending	0
on	0
the	0
exact	0
definitions	0
used	0
.	0

Certain	0
subgroups	0
of	0
children	I-DISEASE
,	0
such	I-DISEASE
as	I-DISEASE
those	0
suffering	I-DISEASE
from	0
chronic	0
illnesses	0
or	0
neurodevelopmental	0
disorders	I-DISEASE
,	0
have	0
a	I-DISEASE
somewhat	0
higher	0
prevalence	0
of	0
insomnia	0
symptoms	0
.	0

Because	0
children	0
are	I-DISEASE
not	0
expected	I-DISEASE
to	0
sleep	0
through	I-DISEASE
the	0
night	I-DISEASE
with	I-DISEASE
reg-	0
ularity	0
until	0
they	I-DISEASE
are	I-DISEASE
three	0
to	I-DISEASE
six	0
months	0
of	0
age	0
,	0
six	0
months	I-DISEASE
is	0
a	0
reasonable	I-DISEASE
age	0
to	0
first	0
consider	0
a	0
diagnosis	0
of	0
chronic	0
insomnia	0
disorder	0
,	0
unless	0
the	0
sleeplessness	0
is	0
very	0
marked	0
at	0
an	I-DISEASE
earlier	I-DISEASE
age	0
.	I-DISEASE

Furthermore	0
,	0
sleep	0
-	I-DISEASE
onset	0
associations	0
and	I-DISEASE
limit	0
-	I-DISEASE
set-	0
ting	0
problems	0
are	0
strongly	0
associated	0
with	0
caregivers	0
’	0
behaviors	0
,	0
bedtime	0
interac-	B-DISEASE
tions	0
,	0
and	I-DISEASE
culture	0
.	0

Thus	0
,	0
the	0
interpretation	I-DISEASE
of	0
the	I-DISEASE
nighttime	I-DISEASE
awakenings	I-DISEASE
and	I-DISEASE
demands	0
for	0
parental	0
contact	0
should	0
be	0
considered	0
in	I-DISEASE
the	I-DISEASE
context	0
of	0
the	0
family	0
and	0
culture	0
.	I-DISEASE

Identification	0
of	0
sleep	0
problems	0
in	0
children	I-DISEASE
and	0
adolescents	0
are	I-DISEASE
often	0
based	0
on	0
spe-	0
cific	0
cultural	0
definitions	0
.	0

Studies	0
on	0
adolescents	0
indicate	B-DISEASE
prevalence	0
rates	0
of	I-DISEASE
3	0
%	I-DISEASE
to	0
12	0
%	0
,	I-DISEASE
depending	0
on	I-DISEASE
the	0
diagnostic	0
criteria	I-DISEASE
utilized	0
,	0
with	0
higher	0
frequency	0
in	I-DISEASE
girls	I-DISEASE
than	0
boys	0
after	I-DISEASE
puberty	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
Individuals	0
who	I-DISEASE
have	I-DISEASE
difficulty	0
sleeping	I-DISEASE
during	0
stressful	0
times	0
or	0
who	0
report	0
being	I-DISEASE
habitual	0
light	I-DISEASE
sleepers	0
appear	0
to	0
have	0
elevated	0
propensity	0
to	I-DISEASE
develop	0
chronic	0
insomnia	I-DISEASE
.	I-DISEASE

Prior	0
transient	0
episodes	0
of	0
poor	0
sleep	I-DISEASE
elevate	0
the	0
risk	I-DISEASE
for	0
subsequent	0
development	0
of	0
a	0
chronic	0
insomnia	0
disorder	0
.	0

Job	0
-	0
related	0
stress	I-DISEASE
and	0
factors	I-DISEASE
such	I-DISEASE
as	0
death	I-DISEASE
of	0
a	0
loved	0
one	0
,	0
divorce	I-DISEASE
,	0
a	0
marked	I-DISEASE
change	I-DISEASE
in	0
work	0
schedule	0
,	0
job	0
loss	0
,	0
and	0
other	I-DISEASE
major	0
life	0
changes	0
are	0
often	0
precipitating	0
circumstances	0
for	0
chronic	0
insomnia	I-DISEASE
disorder	0
.	0

Personality	0
factors	0
that	0
produce	0
anxious	0
overconcern	0
about	I-DISEASE
health	0
,	I-DISEASE
general	0
well	0
-	0
being	0
,	0
or	I-DISEASE
daytime	0
func-	I-DISEASE
tioning	I-DISEASE
may	0
serve	0
as	0
predisposing	0
characteristics	0
because	I-DISEASE
individuals	I-DISEASE
with	0
chronic	I-DISEASE
insomnia	B-DISEASE
disorder	0
often	I-DISEASE
display	0
excessive	0
preoccupation	0
with	0
daytime	0
consequences	0
of	I-DISEASE
insomnia	0
,	0
and	0
they	0
devote	0
particular	I-DISEASE
effort	0
to	I-DISEASE
what	I-DISEASE
they	I-DISEASE
presume	I-DISEASE
are	0
sleep	I-DISEASE
-	0
promot-	0
ing	I-DISEASE
practices	I-DISEASE
.	0

A	0
psychological	0
style	0
characterized	0
by	0
the	0
repression	I-DISEASE
and	0
internalization	I-DISEASE
of	0
disturbing	0
affect	0
is	I-DISEASE
characteristic	0
of	I-DISEASE
those	0
with	0
chronic	0
insomnia	0
disorder	0
and	0
also	0
may	0
represent	0
a	I-DISEASE
predisposing	0
trait	0
.	0

Parents	0
who	0
have	0
unrealistic	0
sleep	0
expectations	I-DISEASE
for	0
their	I-DISEASE
children	I-DISEASE
may	0
predispose	0
them	I-DISEASE
to	I-DISEASE
insomnia	0
by	0
putting	0
them	I-DISEASE
in	I-DISEASE
bed	0
too	0
early	0
or	0
assigning	0
them	0
too	0
much	0
time	0
in	0
bed	0
each	0
night	0
.	I-DISEASE

Comorbid	0
psychiatric	0
conditions	0
,	0
particularly	0
mood	0
and	I-DISEASE
anxiety	I-DISEASE
disorders	I-DISEASE
,	0
are	0
asso-	0
ciated	0
with	0
increased	I-DISEASE
risk	0
for	0
chronic	I-DISEASE
insomnia	0
disorder	0
.	0

Likewise	0
,	0
comorbid	0
restless	0
legs	0
syndrome	I-DISEASE
or	0
medical	0
disorders	I-DISEASE
such	0
as	0
GERD	0
or	0
those	0
conditions	I-DISEASE
that	I-DISEASE
result	0
in	0
chronic	0
pain	I-DISEASE
,	0
breathing	0
difficulties	0
,	I-DISEASE
or	I-DISEASE
immobility	0
also	0
are	I-DISEASE
associated	0
with	0
increased	0
risk	0
for	0
chronic	0
insomnia	0
disorder	0
.	I-DISEASE

A	0
pattern	0
of	0
alcohol	0
dependence	0
/	I-DISEASE
abuse	I-DISEASE
as	0
well	I-DISEASE
as	0
the	0
excessive	I-DISEASE
use	I-DISEASE
of	0
caffeine	I-DISEASE
or	0
other	0
stimulants	0
may	0
raise	I-DISEASE
risk	0
for	0
chronic	0
insomnia	0
disorder	B-DISEASE
.	0

Insomnia	0
in	0
children	0
is	0
often	0
associated	0
with	I-DISEASE
difficult	0
temperament	I-DISEASE
,	0
as	0
well	0
as	I-DISEASE
other	0
comorbid	I-DISEASE
medical	0
and	0
psychiatric	I-DISEASE
conditions	0
.	0

Unstable	0
home	0
situations	0
,	0
safety	0
concerns	0
and	I-DISEASE
domestic	0
abuse	I-DISEASE
are	0
likewise	0
significant	0
risk	0
factors	0
in	I-DISEASE
both	0
children	0
and	0
adults	I-DISEASE
.	I-DISEASE

Caregiver	0
and	0
relationship	0
factors	0
are	0
also	0
important	0
to	0
consider	I-DISEASE
.	I-DISEASE

Furthermore	0
,	0
parents	0
of	0
children	0
with	I-DISEASE
a	I-DISEASE
current	0
or	0
past	0
history	0
of	0
medical	I-DISEASE
problems	0
may	I-DISEASE
have	0
dif-	0
ficulty	I-DISEASE
setting	0
limits	0
,	0
whether	0
because	I-DISEASE
of	0
guilt	0
,	0
a	0
sense	0
that	0
the	I-DISEASE
child	I-DISEASE
is	0
“	0
vulnerable	0
,	0
”	I-DISEASE
or	0
concerns	I-DISEASE
about	0
doing	0
psychological	I-DISEASE
harm	I-DISEASE
.	0

Environmental	0
factors	0
such	0
as	0
the	0
child	I-DISEASE
sharing	I-DISEASE
a	I-DISEASE
room	I-DISEASE
with	0
a	0
parent	0
or	0
with	0
other	I-DISEASE
siblings	0
,	0
the	I-DISEASE
presence	I-DISEASE
of	0
extended	0
family	0
or	0
others	0
in	I-DISEASE
the	0
home	I-DISEASE
,	0
and	0
cramped	0
living	0
accommodations	0
may	0
contribute	0
to	0
negative	0
sleep	0
-	0
onset	I-DISEASE
associations	I-DISEASE
or	0
poor	I-DISEASE
limit	0
setting	0
.	0

Familial	0
Patterns	0

The	0
familial	0
pattern	0
of	0
insomnia	0
is	0
not	I-DISEASE
well	0
documented	I-DISEASE
.	0

Nonetheless	0
,	0
the	0
preva-	I-DISEASE
lence	0
of	0
insomnia	I-DISEASE
is	0
higher	I-DISEASE
among	0
monozygotic	0
twins	0
relative	0
to	0
dizygotic	I-DISEASE
twins	0
;	I-DISEASE
it	0
is	0
also	0
higher	0
in	0
first	0
-	0
degree	0
relatives	0
than	0
in	0
the	I-DISEASE
general	I-DISEASE
population	0
.	0

The	0
association	0
is	0
stronger	0
with	0
mothers	0
and	0
daughters	0
.	I-DISEASE

The	0
extent	0
to	0
which	0
familial	I-DISEASE
aggregation	0
represents	0
shared	0
genetic	I-DISEASE
predisposition	0
,	0
shared	0
environment	0
,	0
learned	I-DISEASE
behavior	0
(	0
e.g.	I-DISEASE
,	0
by	0
observations	0
of	0
parental	0
behavior	I-DISEASE
)	0
,	0
or	0
a	0
by	0
-	0
product	0
of	I-DISEASE
psychopathology	0
remains	0
undetermined	0
.	0

Insomnia	0
Insomnia	0
Onset	0
,	0
Course	0
,	0
and	I-DISEASE
Complications	0
Onset	I-DISEASE
may	0
be	0
insidious	0
or	0
acute	0
.	I-DISEASE

In	0
the	0
former	0
case	0
,	0
individuals	0
often	I-DISEASE
report	0
symptoms	0
of	0
insomnia	0
in	0
early	0
life	0
or	0
young	0
adulthood	0
.	0

Onset	0
of	0
insomnia	0
is	0
often	0
associated	0
with	0
major	0
life	I-DISEASE
events	0
(	0
e.g.	0
,	0
separation	0
,	I-DISEASE
death	0
of	0
a	I-DISEASE
loved	0
one	0
)	0
,	0
minor	0
daily	0
stressors	I-DISEASE
,	0
or	0
changes	I-DISEASE
in	0
sleep	0
schedule	0
.	0

The	0
course	0
of	0
insomnia	0
can	0
be	0
situational	0
,	0
recurrent	I-DISEASE
,	0
or	0
persistent	0
.	0

The	0
specific	0
type	0
of	I-DISEASE
sleep	0
complaint	I-DISEASE
may	I-DISEASE
also	0
change	I-DISEASE
over	0
time	0
.	0

Individuals	0
who	0
complain	0
of	0
diffi-	0
culty	0
falling	I-DISEASE
asleep	0
at	I-DISEASE
one	0
time	0
may	0
later	0
complain	0
of	I-DISEASE
difficulty	0
maintaining	0
sleep	0
,	0
and	0
vice	0
versa	0
.	I-DISEASE

Although	0
short	0
-	0
term	I-DISEASE
insomnia	0
often	0
remits	I-DISEASE
when	0
the	I-DISEASE
precipitating	0
event	0
subsides	0
or	0
the	I-DISEASE
individual	I-DISEASE
adapts	I-DISEASE
to	0
it	I-DISEASE
,	0
sleep	0
difficulties	0
may	0
also	0
persist	I-DISEASE
over	I-DISEASE
time	I-DISEASE
even	0
after	I-DISEASE
the	0
initial	0
triggering	I-DISEASE
factor	0
has	0
disappeared	0
.	0

When	0
left	0
untreated	I-DISEASE
,	0
insomnia	0
may	I-DISEASE
persist	I-DISEASE
and	0
gradually	I-DISEASE
lead	0
to	0
a	0
vicious	I-DISEASE
cycle	0
of	I-DISEASE
poor	0
sleep	0
,	I-DISEASE
daytime	0
impairments	0
,	0
apprehension	0
of	I-DISEASE
insomnia	0
,	0
and	I-DISEASE
further	0
sleep	0
disturbances	0
.	0

Among	0
predisposed	0
individ-	0
uals	0
,	0
insomnia	0
can	I-DISEASE
also	0
follow	I-DISEASE
an	0
intermittent	0
course	0
,	0
with	0
recurrent	I-DISEASE
episodes	0
of	0
sleep	I-DISEASE
difficulties	0
associated	0
with	0
stressful	0
life	0
events	0
.	I-DISEASE

Even	0
in	0
persistent	0
insomnia	0
,	0
there	0
is	0
extensive	0
night	I-DISEASE
-	0
to	0
-	0
night	0
variability	0
,	0
with	I-DISEASE
an	0
occasional	0
good	0
night	0
’s	0
sleep	0
intertwined	0
with	0
several	0
poor	0
night	I-DISEASE
’s	0
sleep	0
.	0

Approximately	0
70	0
%	0
of	0
individuals	0
with	0
insomnia	0
at	0
a	I-DISEASE
given	0
time	0
continue	0
reporting	0
insomnia	0
a	0
year	0
later	0
,	I-DISEASE
and	0
50	0
%	0
still	0
have	0
insomnia	0
three	0
years	0
later	0
.	0

Complications	0
of	0
persistent	0
insomnia	0
include	0
increased	I-DISEASE
risks	0
for	0
depression	I-DISEASE
,	0
hypertension	0
,	0
work	0
disability	0
,	I-DISEASE
and	0
prolonged	0
use	0
of	0
prescription	0
or	0
over-	0
the	0
-	0
counter	I-DISEASE
sleep	I-DISEASE
aids	0
.	I-DISEASE

Among	0
children	0
,	I-DISEASE
chronic	0
insomnia	0
disorder	0
may	I-DISEASE
have	0
its	I-DISEASE
onset	0
at	0
any	0
time	0
during	0
late	0
infancy	0
through	0
the	0
childhood	0
years	0
.	0

The	0
course	0
of	0
chronic	0
insomnia	0
disorder	0
in	I-DISEASE
young	0
children	I-DISEASE
varies	0
and	0
depends	0
on	0
the	0
reasons	0
for	0
the	I-DISEASE
sleeplessness	I-DISEASE
.	0

When	0
limit	0
-	0
setting	I-DISEASE
factors	0
and	0
negative	I-DISEASE
sleep	0
associations	I-DISEASE
resolve	I-DISEASE
,	0
sleep	0
often	I-DISEASE
improves	0
.	0

With	0
age	0
,	0
inde-	0
pendence	0
and	I-DISEASE
privacy	I-DISEASE
become	0
more	I-DISEASE
important	0
,	0
and	0
sleep	0
difficulties	I-DISEASE
may	I-DISEASE
decrease	I-DISEASE
.	I-DISEASE

Complications	0
may	0
result	0
from	0
the	I-DISEASE
consequent	I-DISEASE
sleep	I-DISEASE
loss	0
and	I-DISEASE
include	I-DISEASE
irritability	0
and	0
decreased	I-DISEASE
attention	0
and	I-DISEASE
school	I-DISEASE
performance	I-DISEASE
.	I-DISEASE

Increased	0
family	0
tensions	0
and	0
caregiver	0
sleep	I-DISEASE
loss	0
may	0
also	0
result	0
.	0

Some	0
who	0
develop	0
insomnia	0
during	0
childhood	0
may	0
con-	0
tinue	0
to	0
suffer	0
from	0
chronic	0
insomnia	0
disorder	0
into	0
adulthood	0
.	I-DISEASE

Developmental	0
Issues	0
Developmental	0
issues	0
during	0
childhood	0
,	0
such	0
as	0
separation	0
anxiety	0
and	0
age	I-DISEASE
/	0
develop-	I-DISEASE
mental	0
milestones	0
,	I-DISEASE
may	0
predispose	0
a	0
child	0
to	0
developing	0
sleep	I-DISEASE
problems	0
.	0

For	0
example	0
,	0
limit	0
-	0
setting	I-DISEASE
issues	I-DISEASE
are	0
often	I-DISEASE
more	I-DISEASE
common	0
after	0
the	0
child	I-DISEASE
is	I-DISEASE
old	I-DISEASE
enough	0
to	I-DISEASE
climb	0
out	0
of	0
the	0
crib	I-DISEASE
or	I-DISEASE
is	I-DISEASE
moved	I-DISEASE
into	0
a	I-DISEASE
bed	0
,	0
has	0
increased	0
verbal	0
skills	0
,	0
and	0
desires	0
greater	I-DISEASE
indepen-	I-DISEASE
dence	0
.	I-DISEASE

Because	0
children	0
are	I-DISEASE
not	0
expected	I-DISEASE
to	0
sleep	I-DISEASE
through	I-DISEASE
the	0
night	I-DISEASE
with	I-DISEASE
regularity	0
until	I-DISEASE
they	0
are	I-DISEASE
three	0
to	0
six	0
months	0
of	0
age	0
,	0
six	0
months	0
is	I-DISEASE
a	0
reasonable	0
age	I-DISEASE
to	0
first	0
consider	0
a	0
diagnosis	0
of	0
insomnia	0
disorder	0
,	0
unless	I-DISEASE
the	0
sleeplessness	I-DISEASE
is	I-DISEASE
very	0
marked	I-DISEASE
at	I-DISEASE
an	I-DISEASE
earlier	0
age	I-DISEASE
.	I-DISEASE

However	0
,	I-DISEASE
when	0
sleep	0
difficulties	0
are	0
persistent	I-DISEASE
and	0
pronounced	I-DISEASE
in	0
infants	0
,	0
underlying	0
medical	0
causes	0
should	I-DISEASE
be	0
considered	I-DISEASE
(	0
e.g.	I-DISEASE
,	0
sleep	0
disordered	0
breathing	0
,	0
GERD	I-DISEASE
,	0
pain	0
)	0
.	0

The	0
specific	0
symptoms	0
of	0
chronic	0
insomnia	0
disorder	0
,	0
as	I-DISEASE
well	0
as	0
precipitating	0
and	0
per-	0
petuating	I-DISEASE
factors	0
,	0
may	I-DISEASE
vary	0
across	0
the	0
adult	0
age	0
range	0
.	I-DISEASE

These	0
changes	0
may	0
in	0
part	0
reflect	0
developmental	I-DISEASE
changes	0
across	I-DISEASE
adulthood	0
,	I-DISEASE
such	0
as	0
the	0
phase	I-DISEASE
delay	0
of	0
endoge-	I-DISEASE
nous	0
circadian	0
rhythms	0
in	0
adolescence	0
and	0
young	0
adulthood	0
,	0
and	0
the	0
phase	0
advance	0
and	I-DISEASE
increased	0
number	0
of	0
awakenings	0
often	I-DISEASE
seen	I-DISEASE
even	0
among	0
healthy	I-DISEASE
older	I-DISEASE
adults	0
.	0

Epidemiological	0
studies	0
confirm	I-DISEASE
that	0
sleep	0
onset	0
difficulties	I-DISEASE
and	I-DISEASE
nonrestorative	I-DISEASE
sleep	I-DISEASE
are	0
most	0
common	I-DISEASE
among	0
young	I-DISEASE
adults	I-DISEASE
with	0
chronic	I-DISEASE
insomnia	0
disorder	0
,	0
whereas	0
sleep	0
maintenance	0
insomnia	I-DISEASE
and	0
early	0
morning	I-DISEASE
awakening	0
are	I-DISEASE
more	0
common	0
in	0
middle	0
-	0
aged	0
and	0
older	I-DISEASE
adults	0
.	I-DISEASE

Objective	0
daytime	0
sleepiness	0
is	I-DISEASE
uncommon	0
in	I-DISEASE
younger	0
adults	0
with	0
insomnia	0
,	0
but	0
more	0
common	0
in	I-DISEASE
older	0
adults	0
.	0

However	0
,	I-DISEASE
older	0
adults	0
may	0
have	0
less	0
sleep	0
dissatisfaction	I-DISEASE
than	0
their	0
younger	0
counterparts	0
,	0
despite	I-DISEASE
objectively	0
worse	0
sleep	0
continuity	0
.	0

Precipitating	0
factors	0
for	0
chronic	0
insomnia	0
disorder	0
may	0
also	0
change	0
across	0
the	0
adult	0
age	0
range	0
,	0
with	0
medical	I-DISEASE
and	I-DISEASE
medication	0
factors	I-DISEASE
assuming	0
a	0
larger	0
role	0
in	0
older	0
adults	0
.	I-DISEASE

Likewise	0
,	0
perpetuating	0
factors	0
may	0
vary	0
with	0
the	0
life	I-DISEASE
circumstances	0
of	0
adults	0
of	0
different	0
ages	0
.	0

One	0
common	I-DISEASE
example	0
is	0
the	0
option	I-DISEASE
of	0
older	0
adults	I-DISEASE
to	0
spend	0
large	0
amounts	0
of	0
time	I-DISEASE
in	0
bed	0
after	I-DISEASE
retirement	0
,	0
which	0
may	I-DISEASE
exacerbate	0
the	0
effects	I-DISEASE
of	0
age	0
on	I-DISEASE
sleep	0
continuity	I-DISEASE
.	0

Finally	0
,	0
medical	0
disorders	0
and	0
symptoms	I-DISEASE
(	0
e.g.	0
,	0
pain	0
,	0
dyspnea	0
,	0
and	0
impaired	I-DISEASE
mobility	0
)	0
and	I-DISEASE
medications	0
often	0
play	0
a	0
larger	0
role	I-DISEASE
in	I-DISEASE
the	0
insomnia	I-DISEASE
of	B-DISEASE
older	0
adults	0
in	I-DISEASE
comparison	0
with	0
younger	0
adults	0
.	0

Hypnotic	0
medications	0
are	0
disproportion-	I-DISEASE
ately	0
prescribed	0
to	0
older	0
adults	I-DISEASE
,	0
often	0
with	0
limited	0
benefit	0
and	I-DISEASE
the	0
potential	0
for	I-DISEASE
rebound	0
and	0
withdrawal	0
insomnia	0
.	0

Pathology	0
and	0
Pathophysiology	0
Studies	0
of	0
the	I-DISEASE
pathophysiology	I-DISEASE
of	0
chronic	I-DISEASE
insomnia	0
disorder	0
have	I-DISEASE
focused	0
on	0
one	I-DISEASE
or	0
more	I-DISEASE
dimensions	I-DISEASE
of	0
physiological	0
hyperarousal	0
during	0
sleep	0
and	0
wakefulness	I-DISEASE
.	0

These	0
studies	0
contrast	0
groups	0
of	0
insomnia	I-DISEASE
sufferers	0
,	0
typically	I-DISEASE
those	0
without	0
sig-	0
nificant	0
comorbidities	0
,	I-DISEASE
with	0
healthy	0
controls	I-DISEASE
using	0
a	0
variety	0
of	0
physiological	0
mea-	0
sures	0
.	0

Many	0
of	0
these	I-DISEASE
studies	0
are	0
characterized	0
by	I-DISEASE
small	0
sample	I-DISEASE
sizes	0
and	0
lack	I-DISEASE
of	I-DISEASE
replication	0
.	I-DISEASE

Collectively	0
these	0
studies	0
suggest	0
increased	0
physiological	0
arousal	I-DISEASE
among	0
individuals	I-DISEASE
with	0
insomnia	0
,	0
characterized	0
by	0
measures	I-DISEASE
such	0
as	0
increased	I-DISEASE
heart	0
rate	0
,	0
altered	0
heart	0
rate	0
variability	0
,	I-DISEASE
increased	0
whole	0
-	0
body	0
metabolic	0
rate	0
,	0
elevated	0
corti-	0
sol	0
,	0
adrenocorticotropic	0
hormone	0
,	0
and	I-DISEASE
CRF	I-DISEASE
levels	0
(	0
particularly	0
near	0
sleep	I-DISEASE
onset	I-DISEASE
)	0
,	I-DISEASE
increased	0
body	0
temperature	I-DISEASE
and	0
increased	0
high	0
-	0
frequency	0
electroencephalographic	0
(	I-DISEASE
EEG	I-DISEASE
)	0
activity	I-DISEASE
during	0
nonrapid	I-DISEASE
eye	I-DISEASE
movement	0
(	0
NREM	0
)	I-DISEASE
sleep	0
.	0

These	0
studies	0
imply	0
Insomnia	0
Insomnia	0
heightened	0
activity	0
of	0
the	0
sympathetic	0
nervous	0
system	0
and	0
hypothalamic	0
-	I-DISEASE
pitu-	I-DISEASE
itary	0
-	I-DISEASE
adrenal	0
axis	I-DISEASE
across	0
sleep	0
and	0
wakefulness	0
that	I-DISEASE
is	I-DISEASE
thought	I-DISEASE
to	0
perpetuate	0
sleep/	0
wake	0
dysfunction	I-DISEASE
.	0

Some	0
evidence	0
also	0
suggests	0
that	0
physiological	I-DISEASE
dysregulation	0
may	0
be	I-DISEASE
more	0
evident	0
in	0
certain	0
subgroups	0
of	0
individuals	0
with	0
insomnia	I-DISEASE
(	0
e.g.	0
,	0
those	0
with	0
extreme	0
subjective	I-DISEASE
-	0
objective	0
sleep	0
discrepancies	0
or	I-DISEASE
those	0
with	0
insomnia	0
and	0
short	0
objective	0
sleep	I-DISEASE
duration	I-DISEASE
)	0
.	0

There	0
is	0
also	0
some	B-DISEASE
evidence	0
that	0
these	I-DISEASE
findings	0
may	0
not	0
generalize	I-DISEASE
to	0
insomnia	I-DISEASE
comorbid	0
with	I-DISEASE
mental	0
disorders	0
,	0
which	0
may	0
have	0
differ-	0
ent	0
pathophysiological	0
findings	I-DISEASE
.	0

No	0
discrete	0
structural	0
brain	0
pathology	0
can	0
be	0
identified	0
in	I-DISEASE
most	0
individuals	0
with	0
insom-	0
nia	0
.	0

Patients	0
with	0
insomnia	B-DISEASE
comorbid	0
with	0
neurological	0
disorders	I-DISEASE
such	0
as	I-DISEASE
stroke	0
,	0
brain	0
trauma	0
,	0
and	I-DISEASE
multiple	0
sclerosis	0
may	I-DISEASE
have	0
identifiable	0
brain	0
lesions	0
,	0
but	0
insomnia	0
is	0
rarely	0
their	B-DISEASE
sole	0
neurological	0
symptom	0
.	0

Recent	0
studies	0
have	0
provided	0
conflicting	0
evi-	0
dence	0
regarding	0
the	I-DISEASE
finding	0
of	0
reduced	0
hippocampal	I-DISEASE
or	0
anterior	I-DISEASE
cingulate	I-DISEASE
volume	0
,	I-DISEASE
with	0
most	0
studies	0
reporting	0
negative	I-DISEASE
findings	I-DISEASE
.	I-DISEASE

Objective	0
Findings	0

Although	0
polysomnography	0
is	0
not	0
indicated	0
in	0
the	I-DISEASE
routine	0
evaluation	I-DISEASE
of	I-DISEASE
insomnia	0
,	0
it	I-DISEASE
may	0
be	I-DISEASE
useful	0
to	0
rule	I-DISEASE
out	0
other	0
sleep	0
disorders	0
(	0
e.g.	0
,	I-DISEASE
sleep	0
-	0
disordered	I-DISEASE
breathing	I-DISEASE
)	0
among	0
some	0
patients	0
who	0
appear	0
to	0
meet	I-DISEASE
criteria	I-DISEASE
for	0
chronic	0
insomnia	0
disorder	I-DISEASE
.	0

In	0
the	0
absence	I-DISEASE
of	0
other	0
sleep	I-DISEASE
disorders	I-DISEASE
,	0
results	I-DISEASE
of	0
polysomnographic	0
sleep	0
monitoring	I-DISEASE
of	0
patients	0
with	0
chronic	0
insomnia	I-DISEASE
disorder	0
may	I-DISEASE
show	0
increased	0
sleep	0
latency	0
and/or	I-DISEASE
increased	0
wake	I-DISEASE
time	B-DISEASE
after	0
sleep	I-DISEASE
onset	I-DISEASE
coupled	0
with	0
reduced	0
sleep	0
efficiency	0
in	I-DISEASE
com-	I-DISEASE
parison	0
with	0
age	I-DISEASE
-	0
appropriate	0
norms	0
.	I-DISEASE

Sleep	0
onset	0
latency	0
or	0
wake	0
time	0
after	I-DISEASE
sleep	0
onset	I-DISEASE
often	I-DISEASE
exceeds	0
30	0
minutes	I-DISEASE
,	0
although	0
one	0
-	0
hour	I-DISEASE
to	0
two	0
-	0
hour	0
periods	I-DISEASE
of	0
wakefulness	0
in	0
bed	I-DISEASE
are	0
not	0
uncommon	0
.	0

A	0
subset	0
of	I-DISEASE
patients	0
shows	0
reduced	0
sleep	I-DISEASE
duration	I-DISEASE
of	I-DISEASE
less	0
than	0
six	0
hours	0
per	0
night	I-DISEASE
.	I-DISEASE

Some	0
patients	0
show	I-DISEASE
altered	0
sleep	0
architecture	I-DISEASE
with	I-DISEASE
an	0
increase	I-DISEASE
in	0
stage	0
N1	0
sleep	0
and	0
a	I-DISEASE
decrease	I-DISEASE
in	0
slow	I-DISEASE
wave	0
sleep	I-DISEASE
.	0

Patients	0
with	0
a	B-DISEASE
pronounced	0
condi-	0
tioned	I-DISEASE
sleep	I-DISEASE
difficulty	0
in	I-DISEASE
the	0
home	0
environment	I-DISEASE
may	I-DISEASE
show	0
a	I-DISEASE
reverse	0
first	0
-	I-DISEASE
night	0
effect	0
in	0
the	0
sleep	0
laboratory	I-DISEASE
(	0
i.e.	0
,	I-DISEASE
better	I-DISEASE
sleep	0
on	0
the	I-DISEASE
first	0
vs.	0
the	0
second	0
recording	0
night	I-DISEASE
)	0
.	I-DISEASE

However	0
,	I-DISEASE
some	0
patients	0
show	0
normal	0
sleep	I-DISEASE
times	I-DISEASE
and	I-DISEASE
an	0
absence	0
of	0
sleep	I-DISEASE
onset	I-DISEASE
or	I-DISEASE
sleep	0
maintenance	I-DISEASE
difficulties	I-DISEASE
on	0
standard	0
polysomnographic	0
(	0
PSG	I-DISEASE
)	0
measures	0
.	0

Some	0
insomnia	0
patients	0
have	0
alterations	0
in	I-DISEASE
power	0
density	0
measures	0
of	0
the	0
sleep	0
EEG	0
when	0
compared	I-DISEASE
with	0
individuals	0
without	0
sleep	0
complaints	0
.	0

Specifically	0
,	0
these	0
patients	0
often	0
show	I-DISEASE
relatively	0
greater	0
power	I-DISEASE
in	0
the	0
high	I-DISEASE
frequency	I-DISEASE
(	0
beta	I-DISEASE
and	I-DISEASE
gamma	0
ranges	0
)	0
band-	I-DISEASE
widths	0
.	0

Some	0
reports	0
have	0
shown	0
that	0
elevated	I-DISEASE
high	I-DISEASE
-	0
frequency	I-DISEASE
power	0
is	0
characteris-	0
tic	0
of	0
insomnia	I-DISEASE
patients	0
with	0
marked	I-DISEASE
subjective	0
-	0
objective	0
discrepancies	I-DISEASE
in	0
sleep	I-DISEASE
mea-	0
sures	I-DISEASE
,	0
compared	I-DISEASE
to	0
insomnia	0
patients	0
with	0
more	0
obvious	0
objective	0
sleep	0
disturbances	0
or	I-DISEASE
individuals	0
without	0
sleep	0
complaints	0
.	0

Serial	0
monitoring	0
with	0
PSG	0
or	0
actigraphy	I-DISEASE
typically	I-DISEASE
shows	0
marked	I-DISEASE
night	0
-	0
to	0
-	0
night	I-DISEASE
vari-	I-DISEASE
ability	I-DISEASE
in	0
all	I-DISEASE
sleep	0
measures	0
as	0
well	0
as	I-DISEASE
in	0
recorded	0
bed	I-DISEASE
and	0
rising	I-DISEASE
times	0
.	I-DISEASE

This	0
variability	0
is	I-DISEASE
typically	0
greater	0
than	0
that	I-DISEASE
of	0
comparison	I-DISEASE
groups	0
of	0
good	0
sleepers	0
.	I-DISEASE

Many	0
patients	0
with	I-DISEASE
insomnia	0
underestimate	0
the	0
actual	I-DISEASE
sleep	0
time	I-DISEASE
shown	0
by	I-DISEASE
polysom-	I-DISEASE
nography	I-DISEASE
,	0
and	0
some	0
may	0
provide	I-DISEASE
sleep	0
estimates	0
that	0
fall	0
far	I-DISEASE
short	0
of	I-DISEASE
actual	0
PSG-	0
recorded	0
sleep	I-DISEASE
time	I-DISEASE
.	I-DISEASE

This	0
latter	0
group	0
has	0
previously	0
been	I-DISEASE
categorized	0
as	0
having	I-DISEASE
subjective	0
insomnia	0
,	0
sleep	0
state	0
misperception	I-DISEASE
,	I-DISEASE
or	0
paradoxical	I-DISEASE
insomnia	I-DISEASE
.	0

In	0
general	0
,	0
patients	0
with	I-DISEASE
insomnia	0
tend	I-DISEASE
to	0
underestimate	I-DISEASE
sleep	0
duration	0
and	0
overestimate	0
sleep	0
latency	I-DISEASE
and	I-DISEASE
awakenings	0
,	I-DISEASE
whereas	0
good	I-DISEASE
sleepers	0
tend	0
to	0
overestimate	0
sleep	I-DISEASE
duration	0
and	I-DISEASE
underestimate	I-DISEASE
sleep	0
latency	I-DISEASE
and	I-DISEASE
awakenings	I-DISEASE
relative	0
to	0
PSG	0
.	0

This	0
subjective	0
-	0
ob-	I-DISEASE
jective	0
mismatch	0
may	I-DISEASE
be	0
related	I-DISEASE
to	0
physiological	I-DISEASE
hyperarousal	0
,	I-DISEASE
and	0
may	I-DISEASE
be	I-DISEASE
one	0
of	0
the	0
core	0
features	0
of	0
insomnia	0
.	0

Results	0
of	0
the	0
Multiple	I-DISEASE
Sleep	0
Latency	0
Test	I-DISEASE
(	0
MSLT	I-DISEASE
)	0
usually	0
show	0
normal	I-DISEASE
daytime	0
alert-	0
ness	0
.	0

In	0
several	0
studies	I-DISEASE
,	0
patients	0
with	I-DISEASE
insomnia	0
have	0
longer	I-DISEASE
mean	0
MSLT	0
values	0
than	0
control	0
subjects	0
,	I-DISEASE
suggesting	0
hyperalertness	I-DISEASE
or	0
hyperarousal	0
.	0

A	0
minority	0
of	0
insomnia	0
patients	0
,	0
particularly	0
older	0
adults	I-DISEASE
with	0
insomnia	0
,	0
have	0
reduced	0
mean	I-DISEASE
MSLT	0
values	0
indicating	0
increased	0
sleepiness	0
.	0

Such	0
a	0
finding	0
should	0
prompt	0
consideration	0
of	0
other	0
concurrent	I-DISEASE
sleep	0
disorders	0
such	I-DISEASE
as	0
obstructive	0
sleep	I-DISEASE
apnea	0
.	0

Young	0
children	I-DISEASE
typically	I-DISEASE
show	0
essentially	0
normal	I-DISEASE
sleep	I-DISEASE
during	I-DISEASE
PSG	I-DISEASE
monitoring	0
when	0
the	0
caregiver	0
is	I-DISEASE
present	0
and	0
appropriate	0
limits	I-DISEASE
are	0
set	I-DISEASE
in	0
the	0
laboratory	0
.	I-DISEASE

Although	0
PSG	0
and	0
MSLT	0
testing	0
usually	0
are	0
not	0
helpful	I-DISEASE
in	0
the	0
establishment	0
of	0
an	0
insomnia	I-DISEASE
disorder	0
diagnosis	0
,	0
there	0
are	0
circumstances	0
that	0
may	0
warrant	I-DISEASE
such	0
testing	0
with	0
selected	B-DISEASE
patients	0
.	0

PSG	0
should	0
be	0
considered	0
when	0
there	0
are	I-DISEASE
reported	I-DISEASE
symptoms	0
or	0
bed	0
partner	0
observations	0
of	0
sleep	I-DISEASE
disordered	0
breathing	I-DISEASE
or	I-DISEASE
periodic	0
limb	0
movements	0
during	0
sleep	0
.	0

Patients	0
who	0
present	0
insomnia	0
symptoms	0
accompanied	0
by	I-DISEASE
excessive	0
daytime	0
sleepiness	0
may	0
warrant	0
PSG	0
and	0
MSLT	0
testing	0
,	0
particularly	I-DISEASE
if	0
narcolepsy	0
is	0
suspected	0
.	0

Patients	0
who	0
show	I-DISEASE
acceptable	0
adherence	0
to	I-DISEASE
trials	I-DISEASE
of	I-DISEASE
well	I-DISEASE
-	0
established	0
insom-	0
nia	I-DISEASE
therapies	0
but	I-DISEASE
fail	0
to	I-DISEASE
show	0
adequate	0
treatment	I-DISEASE
response	0
may	0
benefit	0
by	0
PSG	I-DISEASE
to	0
rule	I-DISEASE
out	I-DISEASE
a	0
comorbid	0
sleep	0
disorder	0
.	0

Finally	0
,	0
a	0
small	0
number	0
of	I-DISEASE
functional	I-DISEASE
imaging	0
studies	I-DISEASE
have	0
been	0
conducted	0
during	0
sleep	0
and	I-DISEASE
wakefulness	I-DISEASE
in	I-DISEASE
insomnia	0
and	0
control	0
groups	0
.	0

These	0
studies	0
suggest	0
region-	0
ally	0
specific	0
increases	0
of	0
relative	I-DISEASE
glucose	0
metabolism	0
in	0
insomnia	I-DISEASE
compared	0
to	I-DISEASE
controls	0
.	0

Specifically	0
,	0
these	0
studies	0
show	0
smaller	0
wake	I-DISEASE
to	I-DISEASE
NREM	I-DISEASE
decreases	0
of	0
relative	0
glucose	I-DISEASE
metabolism	0
in	0
sleep	0
/	0
wake	I-DISEASE
-	I-DISEASE
regulating	0
regions	I-DISEASE
including	0
thalamus	I-DISEASE
,	I-DISEASE
upper	I-DISEASE
brainstem	0
,	0
Insomnia	B-DISEASE
Insomnia	0
anterior	0
cingulate	I-DISEASE
,	0
and	0
limbic	0
cortex	0
in	0
insomnia	0
patients	0
.	0

Self	0
-	0
reported	0
and	0
objective	0
sleep	I-DISEASE
disruptions	I-DISEASE
are	0
related	I-DISEASE
to	0
increased	I-DISEASE
relative	0
metabolism	I-DISEASE
in	0
these	I-DISEASE
regions	0
.	0

These	0
findings	0
are	0
similar	0
to	0
regional	0
activation	0
patterns	0
during	I-DISEASE
sleep	0
in	0
an	0
animal	0
model	0
of	0
stress	0
-	0
induced	0
insomnia	0
.	0

Other	0
studies	0
using	0
nuclear	0
magnetic	I-DISEASE
resonance	I-DISEASE
spectroscopy	I-DISEASE
have	0
identified	I-DISEASE
reduced	0
gamma	0
-	0
aminobutyric	0
acid	I-DISEASE
(	0
GABA	I-DISEASE
)	0
signaling	0
in	0
sleep	I-DISEASE
-	0
regu-	0
lating	0
regions	I-DISEASE
in	0
insomnia	0
that	I-DISEASE
correlate	I-DISEASE
with	0
objective	0
measure	0
of	0
sleep	0
continuity	0
.	0

Studies	0
examining	0
task	0
-	0
related	0
changes	I-DISEASE
in	I-DISEASE
blood	0
flow	I-DISEASE
using	0
blood	0
oxygenation	0
level	0
dependent	0
functional	I-DISEASE
magnetic	0
resonance	I-DISEASE
imaging	I-DISEASE
(	0
BOLD	I-DISEASE
fMRI	0
)	0
paradigms	0
have	0
shown	0
reduced	0
activation	0
relative	I-DISEASE
to	I-DISEASE
baseline	I-DISEASE
levels	0
in	0
individuals	I-DISEASE
with	0
insomnia	0
when	0
compared	0
to	I-DISEASE
normal	0
sleeping	0
controls	I-DISEASE
.	0

Task	0
-	0
related	0
activation	I-DISEASE
changes	0
in	0
the	0
direction	0
of	0
“	0
normalization	0
”	0
following	0
cognitive	0
behavioral	0
treatment	0
.	0

Differential	0
Diagnosis	0
A	0
chronic	0
insomnia	0
disorder	I-DISEASE
that	I-DISEASE
presents	0
as	0
difficulty	0
initiating	0
sleep	0
should	0
be	0
differen-	I-DISEASE
tiated	I-DISEASE
from	0
delayed	0
sleep	0
-	I-DISEASE
wake	0
phase	0
disorder	0
.	0

In	0
the	0
latter	I-DISEASE
condition	0
,	I-DISEASE
sleep	0
initiation	I-DISEASE
is	0
consistently	I-DISEASE
later	0
than	0
desired	0
because	0
the	0
individual	I-DISEASE
’s	0
endogenous	0
circadian	0
rhythm	0
is	0
delayed	0
relative	0
to	0
the	0
desired	I-DISEASE
sleep	0
schedule	0
.	0

Sleep	0
-	I-DISEASE
onset	I-DISEASE
difficulties	0
persist	0
,	I-DISEASE
and	I-DISEASE
sleep	0
time	I-DISEASE
is	I-DISEASE
reduced	0
whenever	0
the	I-DISEASE
individual	0
chooses	I-DISEASE
bedtimes	I-DISEASE
and	0
rising	I-DISEASE
times	0
that	I-DISEASE
are	0
too	0
early	0
and	I-DISEASE
out	I-DISEASE
of	0
phase	0
with	I-DISEASE
the	0
endogenous	I-DISEASE
circadian	I-DISEASE
rhythm	0
.	I-DISEASE

However	0
,	I-DISEASE
patients	0
with	I-DISEASE
delayed	0
sleep	0
-	I-DISEASE
wake	0
phase	I-DISEASE
disorder	0
are	I-DISEASE
able	0
to	0
fall	0
asleep	I-DISEASE
with	I-DISEASE
less	0
difficulty	I-DISEASE
,	I-DISEASE
and	0
sleep	0
a	I-DISEASE
normal	0
amount	0
of	I-DISEASE
time	0
,	0
when	I-DISEASE
sleeping	0
in	0
phase	0
with	0
their	0
delayed	0
endogenous	0
rhythm	I-DISEASE
by	0
selecting	I-DISEASE
late	0
bed	0
and	0
rising	0
times	0
.	0

By	0
comparison	0
,	0
those	0
with	0
a	0
chronic	I-DISEASE
insomnia	0
disorder	0
often	0
feel	0
sleepy	0
at	I-DISEASE
the	0
desired	0
bedtime	I-DISEASE
but	I-DISEASE
are	I-DISEASE
unable	0
to	0
sleep	0
regardless	0
of	0
the	0
timing	I-DISEASE
of	I-DISEASE
their	0
bed	I-DISEASE
and	I-DISEASE
rise	I-DISEASE
times	0
.	0

Furthermore	0
,	0
sleep	0
problems	I-DISEASE
tend	0
to	0
be	0
more	0
variable	0
on	0
a	0
night	0
-	I-DISEASE
to	0
-	0
night	I-DISEASE
basis	I-DISEASE
in	0
insomnia	0
disorder	0
.	0

Given	0
the	I-DISEASE
prevalence	I-DISEASE
of	I-DISEASE
delayed	0
sleep-	0
wake	I-DISEASE
phase	0
disorder	I-DISEASE
in	0
teenagers	0
and	0
young	0
adults	0
,	0
it	0
is	0
particularly	0
important	0
to	I-DISEASE
con-	I-DISEASE
sider	0
the	I-DISEASE
possibility	I-DISEASE
of	0
this	0
alternate	I-DISEASE
or	0
comorbid	0
diagnosis	0
when	0
evaluating	0
individuals	0
from	0
these	0
age	0
groups	0
presenting	I-DISEASE
with	0
sleep	0
onset	0
insomnia	0
complaints	I-DISEASE
.	0

A	0
chronic	0
insomnia	0
disorder	0
that	0
presents	I-DISEASE
as	I-DISEASE
a	0
difficulty	I-DISEASE
maintaining	0
sleep	0
with	I-DISEASE
pre-	0
mature	0
morning	0
rise	I-DISEASE
times	0
also	I-DISEASE
should	I-DISEASE
be	I-DISEASE
differentiated	0
from	0
advanced	0
sleep	I-DISEASE
-	0
wake	0
phase	0
disorder	I-DISEASE
.	0

The	0
latter	0
tends	0
to	0
be	0
more	0
common	0
in	0
older	0
adults	0
than	0
it	0
is	0
in	0
younger	0
adults	0
and	0
children	I-DISEASE
.	I-DISEASE

Among	0
those	0
with	0
an	0
advanced	0
sleep	I-DISEASE
phase	I-DISEASE
pattern	0
,	0
sleep	0
initia-	0
tion	0
is	0
consistently	0
earlier	I-DISEASE
than	0
desired	0
because	I-DISEASE
the	0
individual	0
’s	0
endogenous	0
circadian	0
rhythm	I-DISEASE
is	I-DISEASE
advanced	0
relative	0
to	I-DISEASE
the	0
desired	I-DISEASE
sleep	0
schedule	0
.	0

However	0
,	I-DISEASE
total	0
sleep	0
time	0
is	0
adequate	I-DISEASE
when	0
the	I-DISEASE
individual	I-DISEASE
chooses	0
early	0
bed	0
and	0
rise	I-DISEASE
times	I-DISEASE
that	0
coincide	I-DISEASE
with	0
the	0
advanced	0
endogenous	0
circadian	0
rhythm	0
.	I-DISEASE

In	0
contrast	0
,	0
those	0
with	0
chronic	0
insomnia	0
dis-	0
order	I-DISEASE
may	0
display	0
sleep	0
maintenance	0
difficulties	0
and	I-DISEASE
early	0
morning	I-DISEASE
rise	I-DISEASE
time	0
regard-	I-DISEASE
less	0
of	I-DISEASE
the	I-DISEASE
sleep	0
schedule	I-DISEASE
they	0
select	0
.	I-DISEASE

There	0
can	0
be	0
some	I-DISEASE
overlap	0
between	I-DISEASE
chronic	0
insomnia	0
disorder	0
and	0
both	0
delayed	0
and	0
advanced	0
sleep	0
-	I-DISEASE
wake	0
phase	I-DISEASE
disorders	0
.	I-DISEASE

Patients	0
with	0
a	I-DISEASE
delayed	0
sleep	0
pattern	0
may	I-DISEASE
become	0
chronically	I-DISEASE
frustrated	0
or	0
anxious	0
about	I-DISEASE
their	0
inability	I-DISEASE
to	0
initiate	0
sleep	0
at	0
their	0
desired	0
times	0
,	0
and	0
this	I-DISEASE
frustration	0
or	I-DISEASE
anxiety	0
may	I-DISEASE
continue	0
to	I-DISEASE
disrupt	0
sleep	0
and	0
delay	0
sleep	I-DISEASE
onset	0
well	0
beyond	I-DISEASE
the	0
sleep	0
onset	0
time	I-DISEASE
promoted	I-DISEASE
by	I-DISEASE
the	0
endogenous	0
rhythm	I-DISEASE
.	I-DISEASE

Early	0
morning	0
awakenings	I-DISEASE
may	I-DISEASE
similarly	0
have	I-DISEASE
arousing	I-DISEASE
sleep	0
disruptive	0
effects	0
in	I-DISEASE
the	0
setting	I-DISEASE
of	0
an	I-DISEASE
advanced	0
sleep	0
phase	I-DISEASE
.	0

In	0
such	0
circumstances	0
both	0
a	0
circadian	I-DISEASE
rhythm	I-DISEASE
sleep	0
-	0
wake	I-DISEASE
disorder	0
diagnosis	I-DISEASE
and	I-DISEASE
a	0
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	0
diagnosis	I-DISEASE
may	0
apply	0
and	0
should	0
be	0
assigned	0
.	I-DISEASE

Chronic	0
insomnia	0
disorder	0
should	0
also	0
be	I-DISEASE
discriminated	I-DISEASE
from	0
situational	I-DISEASE
sleep	I-DISEASE
dif-	0
ficulties	I-DISEASE
arising	0
from	0
sleep	I-DISEASE
-	0
disruptive	I-DISEASE
environmental	I-DISEASE
circumstances	0
.	0

A	0
variety	0
of	0
environmental	0
factors	0
including	0
excessive	I-DISEASE
noise	0
or	I-DISEASE
light	0
and	0
extreme	0
temperatures	I-DISEASE
will	0
disrupt	I-DISEASE
the	0
sleep	I-DISEASE
of	I-DISEASE
most	0
individuals	0
.	0

Also	0
,	0
sleeping	0
in	0
an	0
area	I-DISEASE
where	I-DISEASE
there	0
is	I-DISEASE
imminent	0
threat	0
or	0
danger	0
to	0
one	0
’s	0
safety	0
can	0
also	0
be	0
disruptive	0
to	0
sleep	0
.	I-DISEASE

Bed	0
part-	0
ners	0
who	I-DISEASE
snore	0
loudly	0
,	0
move	0
excessively	I-DISEASE
during	0
sleep	0
,	0
or	0
have	0
parasomnias	0
may	I-DISEASE
also	I-DISEASE
disrupt	I-DISEASE
one	0
’s	0
sleep	0
.	0

When	0
an	0
individual	0
reports	0
environmental	0
circumstances	0
that	I-DISEASE
would	0
be	0
regarded	I-DISEASE
as	0
disruptive	0
to	0
the	0
sleep	0
of	I-DISEASE
most	I-DISEASE
individuals	I-DISEASE
,	0
a	0
chronic	0
insomnia	0
disorder	0
should	0
not	I-DISEASE
be	0
assigned	0
.	0

Chronic	0
insomnia	0
disorder	0
applies	0
only	0
when	I-DISEASE
the	I-DISEASE
individual	0
reports	I-DISEASE
sleep	0
difficulty	I-DISEASE
in	0
the	0
context	I-DISEASE
of	I-DISEASE
sleep	0
-	I-DISEASE
conducive	0
envi-	0
ronment	I-DISEASE
circumstances	0
or	0
when	0
the	0
insomnia	0
symptoms	0
show	0
some	I-DISEASE
independence	0
from	0
the	0
environmental	0
factors	0
.	0

When	0
environmental	0
circumstances	0
are	0
a	0
primary	I-DISEASE
cause	I-DISEASE
of	0
sleep	I-DISEASE
disturbance	I-DISEASE
and	0
associated	0
consequences	0
,	0
a	I-DISEASE
diagnosis	0
of	0
other	I-DISEASE
sleep	0
disorder	I-DISEASE
may	0
be	0
considered	0
.	0

Chronic	0
insomnia	0
disorder	0
should	0
also	0
be	I-DISEASE
differentiated	I-DISEASE
from	0
patterns	I-DISEASE
of	0
chronic	0
voli-	0
tional	I-DISEASE
sleep	0
restriction	0
(	0
insufficient	0
sleep	I-DISEASE
syndrome	0
)	0
.	0

Some	0
individuals	0
show	0
excessive	0
daytime	I-DISEASE
sleepiness	0
,	I-DISEASE
fatigue	0
,	I-DISEASE
and	0
reduced	0
sleep	I-DISEASE
at	I-DISEASE
night	I-DISEASE
as	I-DISEASE
a	I-DISEASE
result	0
of	I-DISEASE
electing	0
overly	I-DISEASE
demanding	0
daytime	I-DISEASE
schedules	0
or	0
by	0
volitionally	0
delaying	0
sleep	I-DISEASE
in	0
order	0
to	0
engage	0
in	0
desired	0
recreational	0
or	0
social	0
activities	I-DISEASE
.	0

However	0
,	I-DISEASE
when	0
allowing	0
themselves	0
suffi-	0
cient	0
time	0
to	I-DISEASE
sleep	0
,	I-DISEASE
they	0
are	0
able	0
to	I-DISEASE
initiate	I-DISEASE
and	0
maintain	I-DISEASE
sleep	0
easily	0
and	0
for	0
a	0
normal	I-DISEASE
duration	0
.	I-DISEASE

Those	0
with	0
chronic	0
insomnia	0
disorder	0
tend	0
to	0
have	0
excessive	I-DISEASE
wake	0
time	0
and	0
reduced	I-DISEASE
sleep	0
time	I-DISEASE
despite	I-DISEASE
routinely	I-DISEASE
allotting	0
sufficient	0
time	0
to	0
sleep	0
.	0

Moreover	0
,	0
chronic	0
insomnia	0
disorder	0
is	0
not	I-DISEASE
typically	0
associated	I-DISEASE
with	I-DISEASE
excessive	0
daytime	0
sleepi-	0
ness	0
and	I-DISEASE
unintentional	I-DISEASE
daytime	0
sleep	I-DISEASE
episodes	0
,	0
which	0
are	0
often	0
observed	0
in	I-DISEASE
those	0
with	I-DISEASE
patterns	I-DISEASE
of	0
volitional	I-DISEASE
sleep	0
restriction	I-DISEASE
.	0

Insomnia	0
symptoms	0
may	0
occur	0
comorbid	0
with	0
another	0
sleep	0
disorder	0
,	0
such	0
as	0
sleep	0
apnea	I-DISEASE
or	I-DISEASE
restless	0
legs	0
syndrome	I-DISEASE
.	I-DISEASE

A	0
chronic	0
insomnia	0
disorder	0
diagnosis	0
would	I-DISEASE
apply	I-DISEASE
Insomnia	0
Insomnia	0
only	0
when	0
:	0
(	0
1	0
)	0
the	0
insomnia	0
symptoms	I-DISEASE
show	0
some	0
independence	0
in	0
their	0
onset	I-DISEASE
or	I-DISEASE
variation	0
over	0
time	I-DISEASE
from	0
the	0
other	0
symptoms	I-DISEASE
of	0
the	0
co	0
-	0
occurring	0
sleep	I-DISEASE
disorder	0
;	0
or	I-DISEASE
(	I-DISEASE
2	0
)	0
when	I-DISEASE
insomnia	I-DISEASE
symptoms	I-DISEASE
persist	0
despite	I-DISEASE
adequate	I-DISEASE
treatment	0
reflected	0
by	I-DISEASE
marked	I-DISEASE
symptom	0
improvement	0
in	0
the	I-DISEASE
coincident	0
sleep	0
disorder	I-DISEASE
.	I-DISEASE

A	0
chronic	0
insomnia	0
disorder	0
diagnosis	0
would	0
not	I-DISEASE
apply	0
when	0
effective	0
treatment	0
of	0
the	0
coincident	0
sleep	I-DISEASE
disorder	I-DISEASE
resolves	0
the	I-DISEASE
insomnia	0
symptoms	0
.	0

Among	0
children	0
,	I-DISEASE
sleep	0
difficulties	I-DISEASE
may	0
be	I-DISEASE
present	I-DISEASE
when	I-DISEASE
the	0
child	I-DISEASE
has	0
to	0
sleep	0
alone	I-DISEASE
in	I-DISEASE
a	0
separate	I-DISEASE
room	0
,	0
but	0
absent	0
when	0
the	0
child	I-DISEASE
is	I-DISEASE
allowed	0
to	I-DISEASE
sleep	0
with	I-DISEASE
parents	I-DISEASE
or	0
when	0
a	0
parent	0
is	I-DISEASE
present	0
in	I-DISEASE
the	0
child	I-DISEASE
’s	0
bedroom	0
.	0

An	0
absence	0
of	0
sleep	0
difficulties	0
under	0
the	I-DISEASE
latter	0
circumstances	0
does	0
not	0
indicate	0
the	0
insomnia	0
is	I-DISEASE
resolved	0
.	0

Only	0
when	0
the	0
child	I-DISEASE
is	0
able	0
to	0
sleep	0
consistently	I-DISEASE
independently	0
is	0
there	0
no	0
longer	0
an	I-DISEASE
insomnia	0
problem	0
.	I-DISEASE

In	0
some	0
children	0
,	I-DISEASE
the	0
persistence	I-DISEASE
of	I-DISEASE
sleep	0
difficulties	I-DISEASE
in	0
the	0
absence	0
of	I-DISEASE
parents	0
may	I-DISEASE
reflect	0
underlying	0
conditions	I-DISEASE
such	0
as	0
separation	0
anxiety	0
or	0
an	0
anxiety	0
disorder	I-DISEASE
.	0

In	0
young	0
children	0
,	I-DISEASE
sleep	0
difficulties	I-DISEASE
can	I-DISEASE
be	0
the	I-DISEASE
result	I-DISEASE
of	0
medical	0
issues	0
,	0
including	I-DISEASE
gas-	0
troesophageal	0
reflux	I-DISEASE
,	0
as	I-DISEASE
well	0
as	0
developmental	0
milestones	0
,	0
such	0
as	0
motoric	I-DISEASE
,	0
language	0
,	0
and	0
cognitive	0
development	0
.	0

Children	0
,	0
adolescents	0
,	B-DISEASE
and	0
adults	0
may	I-DISEASE
develop	0
a	I-DISEASE
chronic	0
insomnia	0
disorder	0
comorbid	0
with	0
a	I-DISEASE
medical	0
or	0
psychiatric	I-DISEASE
disorder	0
.	0

Insomnia	0
symp-	0
toms	0
may	0
arise	0
as	0
a	B-DISEASE
result	I-DISEASE
of	I-DISEASE
either	0
another	I-DISEASE
sleep	0
disorder	I-DISEASE
,	0
a	I-DISEASE
medical	0
condition	0
,	I-DISEASE
or	0
a	I-DISEASE
psychiatric	0
disorder	0
that	0
has	0
sleep	I-DISEASE
-	0
disruptive	0
effects	I-DISEASE
.	0

A	0
chronic	0
insomnia	0
disorder	0
diagnosis	0
would	I-DISEASE
apply	I-DISEASE
when	0
:	0
(	0
1	0
)	0
the	0
insomnia	0
symptoms	I-DISEASE
show	I-DISEASE
some	0
independence	I-DISEASE
in	0
their	0
onset	0
or	0
variation	I-DISEASE
over	0
time	0
from	0
the	0
other	I-DISEASE
symptoms	0
of	0
the	0
co	I-DISEASE
-	0
occurring	0
sleep	0
,	I-DISEASE
medical	I-DISEASE
,	I-DISEASE
or	0
psychiatric	I-DISEASE
disorder	I-DISEASE
;	0
or	0
(	0
2	0
)	I-DISEASE
when	I-DISEASE
insomnia	0
symptoms	0
persist	I-DISEASE
despite	I-DISEASE
ade-	0
quate	I-DISEASE
treatment	I-DISEASE
reflected	0
by	0
marked	0
symptom	I-DISEASE
improvement	0
in	0
the	I-DISEASE
coincident	0
sleep	I-DISEASE
,	0
medical	0
,	I-DISEASE
or	0
psychiatric	I-DISEASE
disorder	0
.	I-DISEASE

Because	0
insomnia	0
symptoms	0
often	0
develop	0
some	0
independence	I-DISEASE
over	0
time	I-DISEASE
,	0
a	0
chronic	0
insomnia	0
disorder	0
diagnosis	I-DISEASE
usually	0
will	0
be	I-DISEASE
war-	0
ranted	0
when	0
those	0
symptoms	I-DISEASE
are	0
persistent	I-DISEASE
in	I-DISEASE
association	0
with	0
a	0
chronic	0
medical	0
or	0
psychiatric	0
disorder	0
.	0

A	0
chronic	0
insomnia	0
disorder	0
diagnosis	0
would	0
not	I-DISEASE
apply	0
when	0
effective	I-DISEASE
treatment	0
of	0
the	0
coincident	0
sleep	I-DISEASE
,	I-DISEASE
medical	0
,	I-DISEASE
or	0
psychiatric	0
disorder	0
resolves	0
the	0
insomnia	0
symptoms	I-DISEASE
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE

Much	0
remains	0
to	I-DISEASE
be	0
learned	0
about	0
the	0
underlying	I-DISEASE
pathophysiological	I-DISEASE
pathways	0
leading	I-DISEASE
to	I-DISEASE
insomnia	0
and	0
whether	0
insomnia	0
should	0
be	0
classified	0
as	0
a	0
unitary	0
disorder	0
or	0
sub-	0
divided	0
into	0
several	I-DISEASE
subtypes	0
.	0

Clearly	0
,	0
these	0
issues	0
are	0
closely	0
linked	0
.	0

Further	0
studies	0
that	0
clarify	I-DISEASE
the	I-DISEASE
pathophysiological	I-DISEASE
pathways	B-DISEASE
leading	I-DISEASE
to	I-DISEASE
insomnia	I-DISEASE
ultimately	I-DISEASE
will	0
reveal	0
whether	0
those	I-DISEASE
meeting	0
current	0
criteria	I-DISEASE
for	0
chronic	I-DISEASE
insomnia	0
disorder	0
suffer	0
from	0
a	0
single	0
disease	0
or	0
multiple	0
separate	0
diseases	0
with	0
similar	0
outward	0
presentations	0
.	0

A	0
related	0
unresolved	I-DISEASE
issue	0
is	0
whether	0
the	I-DISEASE
current	0
global	I-DISEASE
classification	0
promotes	I-DISEASE
a	0
generic	0
approach	0
to	0
insomnia	0
therapy	0
that	0
ultimately	0
fails	0
to	0
benefit	0
some	0
insomnia	I-DISEASE
subgroups	I-DISEASE
.	0

Perhaps	0
this	0
global	0
classification	0
scheme	0
will	0
overlook	I-DISEASE
distinctive	0
insomnia	I-DISEASE
subtypes	0
with	0
specific	0
treatment	0
needs	0
that	I-DISEASE
vary	I-DISEASE
from	0
the	0
generic	0
treatments	0
typically	0
provided	0
.	0

Previous	0
editions	0
of	0
the	I-DISEASE
International	I-DISEASE
Classification	0
of	0
Sleep	0
Disorders	I-DISEASE
allowed	0
for	0
the	0
assignment	I-DISEASE
of	0
an	I-DISEASE
insomnia	I-DISEASE
diagnosis	0
to	I-DISEASE
patients	0
who	0
present	0
exclusively	0
with	0
com-	I-DISEASE
plaints	0
of	0
nonrestorative	I-DISEASE
sleep	I-DISEASE
;	0
that	0
is	I-DISEASE
,	0
patients	0
who	0
complain	0
only	0
of	0
sleep	I-DISEASE
that	0
is	I-DISEASE
poor	I-DISEASE
in	0
quality	I-DISEASE
or	0
unrefreshing	0
,	0
in	I-DISEASE
the	I-DISEASE
absence	0
of	I-DISEASE
sleep	0
-	0
onset	I-DISEASE
or	0
sleep	0
maintenance	0
complaints	0
,	0
could	0
qualify	0
for	I-DISEASE
an	0
insomnia	I-DISEASE
diagnosis	I-DISEASE
in	I-DISEASE
previous	I-DISEASE
versions	0
of	I-DISEASE
this	I-DISEASE
nosol-	I-DISEASE
ogy	0
.	0

The	0
current	0
version	0
of	0
this	0
nosology	0
excludes	I-DISEASE
such	0
patients	0
from	0
the	0
insomnia	0
diagnostic	I-DISEASE
categories	0
.	I-DISEASE

This	0
decision	0
was	0
based	0
on	0
several	0
considerations	I-DISEASE
.	0

Most	0
insom-	0
nia	0
patients	0
present	0
with	0
complaints	0
of	0
sleep	I-DISEASE
initiation	0
or	0
maintenance	0
difficulties	I-DISEASE
.	0

Although	0
a	0
small	0
subset	0
of	I-DISEASE
patients	I-DISEASE
present	I-DISEASE
with	0
isolated	I-DISEASE
complaints	0
of	0
nonrestorative	0
sleep	0
,	0
this	I-DISEASE
complaint	0
more	I-DISEASE
commonly	I-DISEASE
arises	0
in	I-DISEASE
association	0
with	0
other	I-DISEASE
symptoms	0
of	0
insomnia	0
,	0
or	0
in	0
conjunction	0
with	0
sleep	0
disordered	0
breathing	0
,	0
other	B-DISEASE
sleep	0
disorders	I-DISEASE
or	0
certain	0
chronic	0
medical	0
conditions	0
(	0
e.g.	0
,	0
fibromyalgia	I-DISEASE
or	I-DISEASE
chronic	0
fatigue	0
syndrome	0
)	0
.	0

Although	0
various	0
epidemiological	0
studies	0
have	0
identified	0
subgroups	I-DISEASE
who	0
are	I-DISEASE
presumed	0
to	0
have	0
an	0
insomnia	0
disorder	I-DISEASE
and	0
present	0
solely	0
with	0
a	0
complaint	0
that	0
their	0
sleep	0
is	I-DISEASE
non-	I-DISEASE
restorative	0
or	I-DISEASE
unrefreshing	0
,	I-DISEASE
such	0
studies	I-DISEASE
typically	0
lack	0
polysomnography	0
that	0
would	0
be	I-DISEASE
needed	0
to	0
rule	0
out	I-DISEASE
other	0
occult	0
sleep	0
disorders	0
as	I-DISEASE
a	I-DISEASE
cause	0
.	I-DISEASE

Finally	0
,	0
nonrestorative	0
sleep	0
remains	0
a	0
poorly	I-DISEASE
defined	I-DISEASE
construct	I-DISEASE
that	0
may	0
reflect	0
not	0
only	0
a	I-DISEASE
type	0
of	I-DISEASE
sleep	0
disturbance	0
,	0
but	0
also	I-DISEASE
the	0
daytime	0
consequences	0
of	0
poor	I-DISEASE
sleep	0
such	I-DISEASE
as	I-DISEASE
fatigue	0
and	I-DISEASE
anergia	0
.	0

This	0
con-	0
struct	I-DISEASE
would	0
benefit	0
from	0
further	0
definitional	0
efforts	0
and	0
research	0
to	0
explore	0
its	0
clinical	I-DISEASE
significance	0
in	0
the	I-DISEASE
context	0
of	0
insomnia	0
.	0

Given	0
these	0
considerations	0
,	0
the	0
isolated	I-DISEASE
com-	0
plaint	0
of	I-DISEASE
nonrestorative	0
sleep	0
was	0
not	0
retained	0
as	I-DISEASE
part	0
of	I-DISEASE
the	I-DISEASE
diagnostic	0
definition	0
of	0
the	0
insomnia	0
disorders	I-DISEASE
delineated	I-DISEASE
in	0
this	0
manual	I-DISEASE
.	0

Bibliography	0
Baglioni	0
C	0
,	0
Battagliese	0
G	0
,	I-DISEASE
Feige	I-DISEASE
B	I-DISEASE
,	0
et	0
al	0
.	0

Insomnia	0
as	0
a	0
predictor	0
of	0
depression	0
:	I-DISEASE
a	0
meta	I-DISEASE
-	0
analytic	0
evaluation	0
of	0
longitudinal	0
epidemiological	I-DISEASE
studies	I-DISEASE
.	0

J	0
Affect	0
Dis	0
2011;135;10–9	0
.	0

Bastien	0
CH	0
,	I-DISEASE
St	I-DISEASE
-	I-DISEASE
Jean	0
G	I-DISEASE
,	0
Morin	I-DISEASE
CM	I-DISEASE
,	0
Turcotte	0
I	0
,	I-DISEASE
Carrier	I-DISEASE
J.	0
Chronic	0
psychophysiological	I-DISEASE
insomnia	0
:	0
hyperarousal	0
and/or	0
inhibition	0
deficits	0
?	I-DISEASE

An	0
ERPs	0
investigation	0
.	0

Sleep	0
2008;31:887–98	0
.	0

Beaulieu	0
-	0
Bonneau	0
S	0
,	0
LeBlanc	0
M	I-DISEASE
,	0
Mérette	I-DISEASE
C	I-DISEASE
,	0
Dauvilliers	0
Y	0
,	0
Morin	I-DISEASE
CM	I-DISEASE
.	0

Family	0
history	0
of	0
insomnia	0
in	0
a	0
population	0
-	0
based	0
sample	0
.	0

Sleep	0
2007;30:1739–45	0
.	0

Billows	0
M	0
,	0
Gradisar	0
M	0
,	I-DISEASE
Dohnt	I-DISEASE
H	0
,	0
Johnston	0
A	0
,	I-DISEASE
McCappin	I-DISEASE
S	0
,	0
Hudson	I-DISEASE
J.	0
Family	I-DISEASE
disorganization	0
,	0
sleep	0
hygiene	0
,	0
and	I-DISEASE
adolescent	I-DISEASE
sleep	0
disturbance	0
.	0

J	0
Clin	0
Child	I-DISEASE
Adolesc	0
Psychol	0
2009;38:745–52	0
.	I-DISEASE

Bonnet	0
MH	0
,	0
Arand	0
DL	0
.	0
24	I-DISEASE
-	0
hour	I-DISEASE
metabolic	0
rate	0
in	0
insomniacs	0
and	0
matched	I-DISEASE
normal	0
sleepers	0
.	I-DISEASE

Sleep	0
1995;18:581–8	0
.	0

Insomnia	0
Insomnia	0
Bonnet	0
MH	0
,	0
Arand	0
DL	I-DISEASE
.	0

Heart	0
rate	0
variability	0
in	0
insomniacs	0
and	0
matched	0
normal	0
sleepers	I-DISEASE
.	0

Psychosom	0
Med	0
1998;60:610–5	I-DISEASE
.	0

Bonnet	0
MH	0
,	0
Arand	0
DL	0
.	0
Hyperarousal	I-DISEASE
and	0
insomnia	I-DISEASE
:	0
State	0
of	0
the	0
science	0
.	I-DISEASE

Sleep	0
Med	0
Rev	I-DISEASE
2010;14:9–15	0
.	B-DISEASE

Buysse	0
DJ	0
,	0
Angst	I-DISEASE
J	0
,	0
Gamma	I-DISEASE
A	0
,	I-DISEASE
Ajdacic	0
V	0
,	0
Eich	0
D	0
,	I-DISEASE
Rössler	0
W.	0
Prevalence	I-DISEASE
,	0
course	0
,	0
and	0
comorbidity	0
of	I-DISEASE
insomnia	I-DISEASE
and	0
depression	I-DISEASE
in	I-DISEASE
young	0
adults	0
.	0

Sleep	0
2008;31:473–80	0
.	0

Dohnt	0
H	0
,	0
Gradisar	0
M	0
,	0
Short	I-DISEASE
MA	0
.	0

Insomnia	0
and	0
its	0
symptoms	0
in	0
adolescents	I-DISEASE
:	I-DISEASE
comparing	0
DSM	0
-	0
IV	I-DISEASE
and	0
ICSD	0
-	0
II	I-DISEASE
diagnostic	I-DISEASE
criteria	0
.	I-DISEASE

J	0
Clin	0
Sleep	0
Med	0
2012;8:295–9	0
.	I-DISEASE

Edinger	0
JD	0
,	0
Wyatt	0
JK	0
,	0
Stepanski	0
EJ	0
,	0
et	0
al	0
.	0

Testing	0
the	0
reliability	I-DISEASE
and	0
validity	0
of	0
DSM	I-DISEASE
-	0
IV	I-DISEASE
-	0
TR	0
and	0
ICSD-2	0
insomnia	0
diagnoses	I-DISEASE
:	0
results	0
of	0
a	0
multi	I-DISEASE
-	0
method	0
/	0
multi	0
-	I-DISEASE
trait	I-DISEASE
analysis	0
.	I-DISEASE

Arch	0
Gen	0
Psychiatry	0
2011;68:992–1002	0
.	0

Krystal	0
AD	0
,	0
Edinger	0
JD	0
,	0
Wohlgemuth	0
WK	0
,	0
Marsh	0
GR	0
.	I-DISEASE

Non	0
-	0
REM	0
sleep	0
EEG	0
frequency	I-DISEASE
spectral	0
correlates	0
of	0
sleep	0
complaints	0
in	0
primary	0
insomnia	0
subtypes	I-DISEASE
.	0

Sleep	0
2002;25:630–40	0
.	0

Lack	0
LC	0
,	0
Wright	I-DISEASE
HR	0
.	0

Treating	0
chronobiological	0
components	0
of	I-DISEASE
chronic	0
insomnia	0
.	I-DISEASE

Sleep	0
Med	0
2007;8:637–44	I-DISEASE
.	0

Lichstein	0
KL	0
.	0

Secondary	0
insomnia	0
.	0

In	0
:	0
Lichstein	0
KL	B-DISEASE
,	0
Morin	0
CM	I-DISEASE
,	0
eds	I-DISEASE
.	0

Treatment	0
of	0
late	0
-	0
life	0
insomnia	0
.	0

Thousand	0
Oaks	0
,	0
CA	0
:	0
Sage	0
,	I-DISEASE
2000:297–319	0
.	I-DISEASE

Mindell	0
JA	0
,	0
Kuhn	0
B	0
,	I-DISEASE
Lewin	0
DS	I-DISEASE
,	I-DISEASE
Meltzer	0
LJ	I-DISEASE
,	0
Sadeh	0
A.	0
Behavioral	I-DISEASE
treatment	I-DISEASE
of	0
bedtime	I-DISEASE
problems	0
and	0
night	0
wakings	0
in	0
infants	0
and	0
young	0
children	I-DISEASE
.	I-DISEASE

Sleep	0
2006;29:1263–76	0
.	0

Mindell	0
JA	0
,	0
Sadeh	0
A	0
,	0
Wiegand	I-DISEASE
B	0
,	I-DISEASE
How	0
TH	0
,	0
Goh	0
DY	0
.	I-DISEASE

Cross	0
-	0
cultural	0
differences	I-DISEASE
in	0
infant	0
and	I-DISEASE
toddler	I-DISEASE
sleep	I-DISEASE
.	0

Sleep	0
Med	0
2010;11:274–80	0
.	0

Morgenthaler	0
TI	0
,	0
Owens	0
J	0
,	I-DISEASE
Alessi	I-DISEASE
C	0
,	I-DISEASE
et	0
al	0
.	0

Practice	0
parameters	0
for	0
behavioral	0
treatment	0
of	I-DISEASE
bedtime	I-DISEASE
problems	0
and	I-DISEASE
night	0
wakings	0
in	I-DISEASE
infants	0
and	0
young	0
children	0
.	0

Sleep	0
2006;29:1277–81	0
.	0

Morin	0
CM	0
,	0
Bélanger	I-DISEASE
L	0
,	0
LeBlanc	0
M	0
,	0
et	0
al	0
.	0

The	0
natural	0
history	0
of	0
insomnia	0
:	0
a	0
population	0
-	I-DISEASE
based	0
3	0
-	0
year	0
longitudinal	0
study	0
.	0

Arch	0
Intern	0
Med	0
2009;169:447–53	0
.	I-DISEASE

Nofzinger	0
EA	0
.	0

Functional	0
neuroimaging	0
evidence	0
for	0
hyperarousal	0
in	0
insomnia	0
.	0

Am	0
J	0
Psychiatry	0
2004;161:2126–31	0
.	0

Nofzinger	0
EA	0
,	0
Nissen	0
C	0
,	0
Germain	I-DISEASE
A	0
,	I-DISEASE
et	I-DISEASE
al	0
.	0

Regional	0
cerebral	0
metabolic	0
correlates	0
of	0
WASO	0
during	0
sleep	0
in	I-DISEASE
insomnia	0
.	0

J	0
Clin	0
Sleep	I-DISEASE
Med	0
2006;2:316–22	0
.	I-DISEASE

Ohayon	0
MM	0
.	0

Epidemiology	0
of	0
insomnia	0
:	0
what	0
we	I-DISEASE
know	0
and	0
what	0
we	0
still	0
need	0
to	0
learn	0
.	I-DISEASE

Sleep	0
Med	0
Rev	0
2002;6:97–111	0
.	B-DISEASE

Ohayon	0
MM	0
,	0
Caulet	0
M	0
,	I-DISEASE
Lemoine	I-DISEASE
P.	I-DISEASE
Comorbidity	I-DISEASE
of	0
mental	0
and	0
insomnia	I-DISEASE
disorders	0
in	0
the	0
general	0
population	I-DISEASE
.	0

Compr	0
Psychiatry	0
1998;39:185–97	0
.	0

Ohayon	0
MM	0
,	0
Roberts	0
RE	0
.	0

Comparability	0
of	0
sleep	0
disorders	I-DISEASE
diagnoses	0
using	I-DISEASE
DSM	I-DISEASE
-	0
IV	I-DISEASE
and	0
ICSD	I-DISEASE
classifications	I-DISEASE
with	I-DISEASE
adolescents	0
.	I-DISEASE

Sleep	0
2001;24:920–5	0
.	0

Perlis	0
ML	0
,	0
Smith	0
MT	0
,	0
Andrew	0
PJ	0
,	0
Orff	0
H	0
,	0
Giles	0
DE	0
.	I-DISEASE

Beta	0
/	0
gamma	0
EEG	0
activity	0
in	0
patients	I-DISEASE
with	0
primary	I-DISEASE
and	0
secondary	0
insomnia	0
and	0
good	0
sleeper	I-DISEASE
controls	0
.	0

Sleep	0
2001;24:110–7	0
.	0

Riemann	0
D	0
,	0
Voderholzer	I-DISEASE
U	0
,	0
Spiegelhalder	I-DISEASE
K	0
,	0
et	0
al	0
.	0

Chronic	0
insomnia	0
and	0
MRI	0
-	0
measured	I-DISEASE
hippocampal	I-DISEASE
volumes	0
:	I-DISEASE

A	0
pilot	0
study	0
.	I-DISEASE

Sleep	0
2007;30:955–8	0
.	0

Riemann	0
D	0
,	0
Spiegelhalder	I-DISEASE
K	0
,	0
Feige	I-DISEASE
B	0
,	0
et	0
al	0
.	0

The	0
hyperarousal	0
model	0
of	0
insomnia	0
:	0
A	0
review	0
of	0
the	0
concept	0
and	0
its	0
evidence	0
.	I-DISEASE

Sleep	0
Med	0
Rev	0
2010;14:19–31	0
.	B-DISEASE

Roberts	0
RE	0
,	0
Roberts	B-DISEASE
CR	0
,	0
Chan	0
W.	0
Persistence	0
and	0
change	0
in	0
symptoms	0
of	0
insomnia	0
among	0
adolescents	0
.	I-DISEASE

Sleep	0
2008;31:177–84	0
.	0

Sánchez	0
-	0
Ortuño	0
MM	I-DISEASE
,	0
Carney	I-DISEASE
CE	I-DISEASE
,	0
Edinger	0
JD	0
,	0
Wyatt	0
JK	0
,	0
Harris	0
A.	0

Moving	0
beyond	0
average	0
values	0
:	0
assessing	0
the	I-DISEASE
night	I-DISEASE
-	I-DISEASE
to	0
-	0
night	0
instability	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
and	I-DISEASE
arousal	0
in	I-DISEASE
DSM	0
-	0
IV	0
-	0
TR	0
insomnia	I-DISEASE
subtypes	0
.	0

Sleep	0
2011;34:531–9	0
.	0

Stepanski	0
E	0
,	0
Zorick	0
F	0
,	0
Roehrs	0
T	0
,	I-DISEASE
Young	0
D	0
,	I-DISEASE
Roth	I-DISEASE
T.	0
Daytime	I-DISEASE
alertness	I-DISEASE
in	I-DISEASE
patients	I-DISEASE
with	0
chronic	0
insomnia	0
compared	0
with	0
asymptomatic	0
control	0
subjects	0
.	0

Sleep	0
1988;11:54–60	0
.	0

Vgontzas	0
AN	0
,	0
Liao	0
D	0
,	0
Bixler	I-DISEASE
EO	0
,	I-DISEASE
Chrousos	0
GP	0
,	0
Vela	0
-	0
Bueno	I-DISEASE
A.	0
Insomnia	0
with	I-DISEASE
objective	0
short	0
sleep	0
duration	0
is	0
associated	0
with	I-DISEASE
a	I-DISEASE
high	0
risk	I-DISEASE
for	0
hypertension	0
.	0

Sleep	0
2009;32:491–7	0
.	0

Winkelman	0
JW	0
,	0
Buxton	0
OM	0
,	I-DISEASE
Jensen	I-DISEASE
JE	0
,	0
et	0
al	0
.	0

Reduced	0
brain	0
GABA	0
in	0
primary	0
insomnia	0
:	0
preliminary	0
data	0
from	0
4	0
T	0
proton	0
magnetic	0
resonance	I-DISEASE
spectroscopy	0
(	0
1H	I-DISEASE
-	0
MRS	0
)	0
.	0

Sleep	0
2008;31:1499–506	0
.	0

Winkelman	0
JW	0
,	0
Benson	0
KL	0
,	I-DISEASE
Buxton	I-DISEASE
OM	0
,	I-DISEASE
et	0
al	0
.	0

Lack	0
of	0
hippocampal	0
volume	0
differences	0
in	I-DISEASE
primary	0
insomnia	0
and	0
good	0
sleeper	0
controls	0
:	0
an	0
MRI	I-DISEASE
volumetric	I-DISEASE
study	I-DISEASE
at	I-DISEASE
3	0
Tesla	0
.	0

Sleep	0
Med	0
2010;11:576–82	0
.	0

Zhang	0
J	0
,	0
Li	0
AM	0
,	I-DISEASE
Kong	I-DISEASE
AP	0
,	0
Lai	0
KY	0
,	0
Tang	I-DISEASE
NL	0
,	0
Wing	0
YK	0
.	I-DISEASE

A	0
community	0
-	0
based	0
study	0
of	I-DISEASE
insomnia	I-DISEASE
in	0
Hong	I-DISEASE
Kong	0
Chinese	0
children	0
:	I-DISEASE
Prevalence	0
,	I-DISEASE
risk	0
factors	0
and	I-DISEASE
familial	0
aggregation	0
.	0

Sleep	0
Med	0
2009;10:1040–6	I-DISEASE
.	0

Short	0
-	0
Term	0
Insomnia	0
Disorder	0
ICD-9	0
-	I-DISEASE
CM	0
code	0
:	0
307.41	0
Alternate	0
Names	0
Acute	0
insomnia	0
,	0
adjustment	0
insomnia	I-DISEASE
.	0

Diagnostic	0
Criteria	0
Criteria	0

A	0
-	0
E	0
must	0
be	0
met	0
ICD-10	I-DISEASE
-	0
CM	0
code	0
:	0

F51.02	0
Insomnia	0
A.	0
The	0
patient	0
reports	0
,	I-DISEASE
or	0
the	I-DISEASE
patient	0
’s	0
parent	0
or	I-DISEASE
caregiver	0
observes	I-DISEASE
,	0
one	I-DISEASE
or	I-DISEASE
more	0
of	0
the	0
following:1	0
.	0

Difficulty	0
initiating	0
sleep	0
.	0
.	0

Difficulty	0
maintaining	0
sleep	0
.	0
.	0

Waking	0
up	0
earlier	0
than	0
desired	0
.	0
.	0

Resistance	0
to	0
going	0
to	0
bed	0
on	0
appropriate	0
schedule	0
.	0
.	0

Difficulty	0
sleeping	0
without	0
parent	0
or	0
caregiver	0
intervention	0
.	I-DISEASE

B.	0
The	0
patient	0
reports	0
,	0
or	0
the	I-DISEASE
patient	0
’s	I-DISEASE
parent	0
or	0
caregiver	0
observes	0
,	0
one	0
or	0
more	0
of	I-DISEASE
the	0
following	0
related	0
to	0
the	0
nighttime	I-DISEASE
sleep	I-DISEASE
difficulty	I-DISEASE
:	0
.	I-DISEASE

Fatigue	0
/	0
malaise	I-DISEASE
.	0
.	0

Attention	0
,	I-DISEASE
concentration	0
,	0
or	0
memory	0
impairment	I-DISEASE
.	0
.	I-DISEASE

Impaired	0
social	0
,	0
family	0
,	0
vocational	0
,	I-DISEASE
or	0
academic	I-DISEASE
performance	0
.	0
.	0

Mood	0
disturbance	0
/	0
irritability	0
.	0
.	I-DISEASE

Daytime	0
sleepiness	0
.	0
.	I-DISEASE

Behavioral	0
problems	0
(	0
e.g.	0
,	0
hyperactivity	0
,	I-DISEASE
impulsivity	0
,	0
aggression	0
)	0
.	0

7	0
.	0
Reduced	0
motivation	0
/	0
energy	0
/	0
initiative	0
.	I-DISEASE
.	0

Proneness	0
for	0
errors	0
/	0
accidents	0
.	I-DISEASE
.	0

Concerns	0
about	0
or	0
dissatisfaction	I-DISEASE
with	0
sleep	0
.	I-DISEASE

Insomnia	0
C.	0

The	0
reported	0
sleep	0
/	I-DISEASE
wake	0
complaints	I-DISEASE
can	I-DISEASE
not	0
be	I-DISEASE
explained	I-DISEASE
purely	0
by	0
inadequate	0
opportunity	0
(	0
i.e.	I-DISEASE
,	0
enough	0
time	0
is	0
allotted	0
for	0
sleep	0
)	0
or	I-DISEASE
inadequate	0
circumstances	I-DISEASE
(	I-DISEASE
i.e.	0
,	0
the	0
environment	I-DISEASE
is	0
safe	0
,	0
dark	0
,	0
quiet	I-DISEASE
,	0
and	0
comfortable	0
)	0
for	0
sleep	0
.	I-DISEASE

D.	0
The	0
sleep	0
disturbance	0
and	0
associated	0
daytime	I-DISEASE
symptoms	0
have	0
been	0
present	0
for	0
less	0
than	0
three	0
months	0
.	0

E.	0

The	0
sleep	0
/	0
wake	0
difficulty	I-DISEASE
is	I-DISEASE
not	I-DISEASE
better	I-DISEASE
explained	I-DISEASE
by	0
another	0
sleep	0
disorder	I-DISEASE
.	0

Notes	0
.	0

Reports	0
of	0
difficulties	0
initiating	0
sleep	0
,	0
difficulties	I-DISEASE
maintaining	I-DISEASE
sleep	I-DISEASE
,	0
or	0
waking	I-DISEASE
up	0
too	0
early	I-DISEASE
can	0
be	0
seen	I-DISEASE
in	0
all	I-DISEASE
age	0
groups	0
.	0

Resistance	0
going	0
to	0
bed	I-DISEASE
on	0
an	0
appropriate	I-DISEASE
schedule	0
and	0
difficulty	0
sleeping	I-DISEASE
without	0
parent	I-DISEASE
or	0
caregiver	I-DISEASE
intervention	0
is	0
seen	0
most	0
commonly	0
in	0
children	0
and	0
older	0
adults	I-DISEASE
who	0
require	0
the	I-DISEASE
supervision	0
of	I-DISEASE
a	I-DISEASE
caretaker	I-DISEASE
due	0
to	0
a	0
significant	0
level	0
of	I-DISEASE
functional	0
impairment	0
(	I-DISEASE
e.g.	I-DISEASE
,	0
those	0
with	0
dementia	I-DISEASE
)	0
.	0
.	0

Patients	0
with	0
short	B-DISEASE
-	0
term	0
insomnia	I-DISEASE
disorder	0
may	0
complain	I-DISEASE
of	0
sleep/	0
wake	0
difficulties	0
fewer	0
than	I-DISEASE
three	0
times	I-DISEASE
per	I-DISEASE
week	0
on	0
average	0
,	0
yet	0
have	I-DISEASE
clinically	I-DISEASE
significant	0
concerns	0
about	I-DISEASE
their	0
symptoms	0
and	0
warrant	0
clinical	0
attention	0
.	0
.	0

Many	0
conditions	0
such	0
as	0
grief	0
,	0
acute	0
pain	0
,	I-DISEASE
or	0
other	0
acute	0
stressors	0
are	0
quite	0
often	0
associated	I-DISEASE
with	I-DISEASE
poor	0
sleep	0
.	0

When	0
such	0
conditions	0
are	0
the	0
sole	I-DISEASE
cause	0
of	0
the	I-DISEASE
sleep	I-DISEASE
difficulty	0
,	0
a	0
separate	0
insomnia	0
diagnosis	0
may	0
not	I-DISEASE
apply	0
.	0

The	0
primary	0
factor	0
in	0
determining	0
application	0
of	I-DISEASE
a	0
short-	I-DISEASE
term	I-DISEASE
or	0
adjustment	0
insomnia	0
diagnosis	0
is	I-DISEASE
the	I-DISEASE
extent	0
to	I-DISEASE
which	0
the	I-DISEASE
sleep	0
disturbance	0
becomes	I-DISEASE
a	I-DISEASE
significant	I-DISEASE
focus	0
for	0
the	I-DISEASE
individual	0
and/or	0
warrants	0
independent	I-DISEASE
clinical	0
attention	0
.	0

Essential	0
Features	0
The	0
essential	0
feature	0
of	0
short	I-DISEASE
-	0
term	I-DISEASE
insomnia	0
disorder	0
is	0
a	0
short	0
-	I-DISEASE
term	0
difficulty	0
ini-	I-DISEASE
tiating	0
or	I-DISEASE
maintaining	0
sleep	0
that	I-DISEASE
results	0
in	0
general	0
sleep	0
dissatisfaction	I-DISEASE
.	I-DISEASE

The	0
sleep	0
complaint	I-DISEASE
is	I-DISEASE
accompanied	0
by	I-DISEASE
daytime	I-DISEASE
distress	0
about	0
poor	0
sleep	0
or	I-DISEASE
impairment	0
in	I-DISEASE
family	0
,	0
social	0
,	I-DISEASE
occupational	0
,	0
academic	0
,	0
or	0
other	0
important	I-DISEASE
areas	0
of	I-DISEASE
functioning	I-DISEASE
.	0

Furthermore	0
,	0
the	0
sleep	I-DISEASE
disturbance	I-DISEASE
and	0
associated	I-DISEASE
daytime	0
symptoms	I-DISEASE
occur	0
despite	0
having	0
adequate	0
time	0
and	I-DISEASE
circumstances	I-DISEASE
each	0
night	I-DISEASE
to	I-DISEASE
obtain	0
necessary	0
sleep	0
.	I-DISEASE

Short-	0
term	0
insomnia	0
disorder	0
can	0
occur	0
in	0
isolation	0
or	0
comorbid	0
with	0
a	0
mental	0
disorder	0
,	I-DISEASE
medical	I-DISEASE
condition	0
,	I-DISEASE
or	0
substance	0
use	0
.	0

In	0
many	0
cases	0
of	B-DISEASE
short	0
-	I-DISEASE
term	I-DISEASE
insomnia	0
lasting	0
less	0
than	0
three	0
months	0
,	0
there	0
is	0
an	0
identifiable	I-DISEASE
cause	0
that	I-DISEASE
serves	0
as	0
the	0
precipitant	I-DISEASE
.	I-DISEASE

In	0
other	0
cases	0
,	0
insomnia	0
occurs	0
episodically	I-DISEASE
,	0
often	I-DISEASE
coincident	0
to	0
daytime	0
stressors	I-DISEASE
that	0
account	I-DISEASE
for	0
the	0
insomnia	0
.	0

As	0
is	0
the	0
case	I-DISEASE
for	0
chronic	0
insomnia	0
disorder	0
,	I-DISEASE
sleep	0
complaints	0
that	0
compose	I-DISEASE
short-	0
term	I-DISEASE
insomnia	0
disorder	0
may	I-DISEASE
include	0
difficulties	0
initiating	0
sleep	0
or	0
difficulties	0
main-	I-DISEASE
taining	0
sleep	0
.	0

The	0
latter	0
complaint	0
may	I-DISEASE
include	0
waking	I-DISEASE
up	I-DISEASE
during	0
the	I-DISEASE
night	I-DISEASE
with	I-DISEASE
difficulty	0
returning	I-DISEASE
to	0
sleep	I-DISEASE
or	I-DISEASE
having	0
a	I-DISEASE
final	0
awakening	0
occurring	0
too	0
early	0
,	0
well	I-DISEASE
before	0
the	0
desired	I-DISEASE
rising	I-DISEASE
time	0
.	0

Short	0
-	0
term	I-DISEASE
insomnia	0
disorder	0
may	I-DISEASE
be	I-DISEASE
character-	I-DISEASE
ized	I-DISEASE
solely	I-DISEASE
by	0
sleep	I-DISEASE
onset	I-DISEASE
or	0
sleep	I-DISEASE
maintenance	0
complaints	I-DISEASE
or	I-DISEASE
,	0
more	I-DISEASE
commonly	0
,	0
by	0
both	0
types	0
of	0
complaints	0
occurring	I-DISEASE
together	0
.	I-DISEASE

Individuals	0
’	0
sleep	0
complaints	I-DISEASE
may	0
vary	0
such	I-DISEASE
that	0
sleep	I-DISEASE
onset	0
difficulties	0
are	0
apparent	0
on	0
some	0
nights	0
,	0
whereas	I-DISEASE
sleep	0
maintenance	I-DISEASE
difficulties	0
are	0
present	0
on	0
other	0
nights	0
.	0

Complaints	0
about	0
poor	0
-	0
quality	0
,	0
unrefreshing	0
,	0
or	I-DISEASE
nonrestorative	0
sleep	0
may	0
accompany	0
sleep	0
onset	I-DISEASE
and	0
sleep	0
mainte-	I-DISEASE
nance	0
complaints	0
,	0
but	0
do	0
not	I-DISEASE
meet	0
the	0
definition	I-DISEASE
of	0
this	0
condition	0
when	0
they	0
occur	0
in	0
isolation	0
.	0

Associated	0
Features	0
Sleep	0
disturbance	0
is	0
the	0
primary	I-DISEASE
feature	0
of	0
short	0
-	0
term	0
insomnia	0
disorder	0
,	I-DISEASE
but	0
it	0
is	I-DISEASE
com-	0
monly	0
accompanied	0
by	0
waking	0
symptoms	I-DISEASE
similar	0
to	0
those	0
seen	I-DISEASE
in	0
chronic	I-DISEASE
insomnia	0
disorder	0
.	0

Specific	0
symptoms	0
such	0
as	0
fatigue	0
,	0
impaired	0
attention	0
and	I-DISEASE
concentration	0
,	0
poor	0
memory	0
,	0
irritability	I-DISEASE
,	0
and	0
distress	I-DISEASE
about	0
poor	0
sleep	0
are	0
common	0
.	0

When	0
the	0
insomnia	I-DISEASE
arises	0
in	0
reaction	I-DISEASE
to	I-DISEASE
a	0
stressful	I-DISEASE
life	0
event	0
,	0
such	I-DISEASE
as	0
the	I-DISEASE
loss	0
of	0
a	I-DISEASE
loved	I-DISEASE
one	0
,	0
major	0
illness	0
,	0
or	I-DISEASE
divorce	0
,	0
the	I-DISEASE
associated	0
features	0
may	0
include	I-DISEASE
anxiety	0
,	0
worry	0
,	0
ruminative	0
thoughts	I-DISEASE
,	0
sadness	0
,	I-DISEASE
or	I-DISEASE
depression	I-DISEASE
in	0
relation	0
to	0
the	I-DISEASE
specific	0
stressor	0
.	I-DISEASE

If	0
the	0
individual	I-DISEASE
uses	0
alcohol	0
,	0
illicit	I-DISEASE
drugs	0
,	0
or	0
medications	0
for	0
self	0
-	0
treatment	I-DISEASE
,	I-DISEASE
additional	0
symptoms	I-DISEASE
related	0
to	0
these	I-DISEASE
substances	0
may	0
be	I-DISEASE
seen	B-DISEASE
.	0

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
None	I-DISEASE
.	I-DISEASE

Demographics	0
Short	0
-	0
term	0
insomnia	0
disorder	0
can	I-DISEASE
occur	0
at	0
any	0
age	0
.	0

However	0
,	I-DISEASE
a	0
short	0
-	0
term	I-DISEASE
form	0
of	0
insomnia	I-DISEASE
may	0
be	0
difficult	0
to	0
establish	0
in	I-DISEASE
infants	0
because	0
it	I-DISEASE
is	0
often	0
difficult	0
to	0
link	I-DISEASE
stressors	0
to	I-DISEASE
sleep	0
disturbances	0
in	I-DISEASE
this	0
age	I-DISEASE
group	0
.	I-DISEASE

The	0
exact	0
prevalence	0
of	I-DISEASE
short	0
-	I-DISEASE
term	I-DISEASE
insomnia	0
disorder	0
is	0
unknown	0
.	0

The	0
one	0
-	0
year	I-DISEASE
prevalence	0
of	I-DISEASE
short	I-DISEASE
-	0
term	I-DISEASE
insomnia	0
dis-	0
order	0
among	0
adults	0
appears	I-DISEASE
to	I-DISEASE
be	0
in	I-DISEASE
the	0
range	0
of	0
15	0
%	0
to	I-DISEASE
20	I-DISEASE
%	0
.	I-DISEASE

Like	0
chronic	I-DISEASE
insomnia	0
disorder	0
,	0
short	I-DISEASE
-	I-DISEASE
term	0
insomnia	I-DISEASE
disorder	0
is	0
more	0
prevalent	0
in	0
women	I-DISEASE
than	I-DISEASE
in	0
men	I-DISEASE
,	0
and	0
in	0
older	0
age	0
groups	0
.	I-DISEASE

Predisposing	0
and	0
Precipitating	0
Factors	0
Affected	0
individuals	I-DISEASE
may	I-DISEASE
note	0
a	I-DISEASE
lifelong	0
tendency	0
toward	0
light	0
sleep	0
or	I-DISEASE
diffi-	0
culty	0
sleeping	I-DISEASE
during	0
times	0
of	0
stress	0
.	0

A	0
previous	0
history	0
of	0
anxiety	0
or	0
depressive	0
Insomnia	I-DISEASE
Insomnia	I-DISEASE
symptoms	0
and	0
disorders	0
also	0
may	0
predispose	I-DISEASE
an	0
individual	0
to	I-DISEASE
develop	0
a	0
short-	0
term	0
insomnia	0
disorder	0
.	I-DISEASE

In	0
children	0
,	I-DISEASE
having	0
a	0
parent	I-DISEASE
with	I-DISEASE
insomnia	0
or	0
living	0
in	0
a	0
household	0
lacking	0
parental	I-DISEASE
reinforcement	0
of	0
a	0
consistent	0
sleep	0
/	0
wake	0
schedule	0
may	I-DISEASE
be	0
predisposing	I-DISEASE
factors	0
.	B-DISEASE

An	0
acute	0
,	0
identifiable	0
event	0
or	0
stressor	I-DISEASE
usually	0
precipitates	0
this	0
form	0
of	0
insomnia	0
.	0

Common	0
precipitating	0
events	0
include	I-DISEASE
changes	0
or	0
disputes	I-DISEASE
in	0
interpersonal	I-DISEASE
relation-	0
ships	0
,	0
occupational	0
stress	0
,	I-DISEASE
personal	I-DISEASE
losses	I-DISEASE
,	I-DISEASE
bereavement	0
,	I-DISEASE
diagnosis	0
or	0
onset	0
of	0
a	I-DISEASE
new	I-DISEASE
medical	I-DISEASE
condition	0
,	0
visiting	0
or	0
moving	0
to	0
a	0
new	0
location	0
,	0
or	I-DISEASE
physical	0
changes	0
to	0
the	0
usual	0
sleep	0
environment	I-DISEASE
or	I-DISEASE
schedule	I-DISEASE
.	I-DISEASE

Changes	0
or	0
stresses	0
with	0
a	0
positive	0
emotional	I-DISEASE
tone	0
also	I-DISEASE
may	0
serve	0
as	0
precipitating	0
events	0
.	I-DISEASE

In	0
children	0
or	I-DISEASE
dependent	0
adults	0
,	0
such	I-DISEASE
insomnia	0
can	0
arise	0
when	0
the	0
caretaker	I-DISEASE
makes	0
abrupt	I-DISEASE
changes	0
in	0
the	I-DISEASE
child	0
’s	0
or	0
adult	0
’s	0
sleep	0
routines	0
or	0
schedule	0
.	B-DISEASE

As	0
is	0
the	0
case	I-DISEASE
for	0
chronic	0
insomnia	0
disorder	0
,	I-DISEASE
environ-	0
mental	0
factors	0
such	0
as	0
the	0
child	I-DISEASE
sharing	0
a	I-DISEASE
room	0
with	0
a	0
parent	0
or	0
with	0
other	0
sib-	0
lings	0
,	I-DISEASE
the	0
presence	0
of	I-DISEASE
extended	0
family	0
or	0
others	0
in	0
the	0
home	I-DISEASE
,	0
and	0
cramped	0
living	0
accommodations	0
may	0
contribute	0
to	I-DISEASE
negative	0
sleep	0
-	0
onset	I-DISEASE
associations	0
or	0
poor	I-DISEASE
limit	B-DISEASE
setting	0
in	0
children	0
.	I-DISEASE

Familial	0
Patterns	0
Familial	0
patterns	0
are	0
less	0
well	I-DISEASE
documented	0
for	I-DISEASE
cases	0
of	0
short	0
-	0
term	0
insomnia	I-DISEASE
disor-	0
der	0
than	I-DISEASE
they	0
are	0
for	0
individuals	0
meeting	0
criteria	0
for	0
chronic	0
insomnia	0
disorder	0
.	0

Nonetheless	0
,	0
the	0
familial	I-DISEASE
aggregation	0
found	0
for	0
chronic	0
insomnia	0
disorders	0
is	0
expected	0
to	0
also	0
occur	I-DISEASE
among	0
individuals	0
with	I-DISEASE
more	0
transient	0
forms	0
of	0
insomnia	0
.	0

Data	0
support	0
a	0
greater	0
genetic	0
diathesis	0
to	I-DISEASE
psychophysiologic	0
arousal	0
among	0
certain	0
individuals	0
in	I-DISEASE
response	I-DISEASE
to	I-DISEASE
stressors	0
.	0

This	0
may	0
,	0
in	0
turn	0
,	I-DISEASE
suggest	I-DISEASE
a	0
constitutional	I-DISEASE
predisposition	0
to	0
short-	0
term	0
or	0
adjustment	I-DISEASE
insomnia	I-DISEASE
in	0
such	0
individuals	0
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Many	I-DISEASE
individuals	0
who	I-DISEASE
develop	0
short	I-DISEASE
-	0
term	0
insomnia	0
disorder	0
experience	I-DISEASE
remission	0
of	0
their	0
insomnia	0
symptoms	0
over	0
time	0
.	0

This	0
occurs	0
as	0
distress	0
over	0
the	0
precipitating	I-DISEASE
event	0
diminishes	I-DISEASE
over	0
time	0
or	0
in	0
response	0
to	I-DISEASE
withdrawal	0
of	0
the	0
stressor	0
.	0

However	0
,	I-DISEASE
a	0
portion	0
of	0
those	I-DISEASE
who	0
initially	0
experience	I-DISEASE
short	0
-	0
term	0
insomnia	0
may	0
develop	I-DISEASE
a	0
more	0
chronic	I-DISEASE
form	0
of	0
insomnia	0
and	0
subsequently	0
meet	0
criteria	I-DISEASE
for	0
chronic	0
insomnia	I-DISEASE
dis-	0
order	0
.	0

These	0
individuals	0
will	0
then	0
have	0
the	0
course	I-DISEASE
and	0
complications	I-DISEASE
described	0
for	0
chronic	0
insomnia	0
disorder	0
.	I-DISEASE

Developmental	0
Issues	0
As	0
is	0
the	0
case	0
for	I-DISEASE
chronic	0
insomnia	0
disorder	0
,	0
short	0
-	0
term	0
insomnia	I-DISEASE
disorder	0
would	0
not	0
be	0
considered	0
until	0
after	0
a	0
child	I-DISEASE
reaches	I-DISEASE
at	0
least	0
six	0
months	0
of	0
age	I-DISEASE
.	I-DISEASE

The	0
propensity	0
to	0
experience	0
sleep	0
disturbance	0
in	0
response	I-DISEASE
to	0
stress	0
may	0
dispose	0
young	0
and	0
older	0
individuals	0
toward	0
acute	I-DISEASE
forms	0
of	0
insomnia	0
.	0

As	0
is	0
the	0
case	I-DISEASE
for	0
chronic	0
insomnia	0
disorder	0
,	I-DISEASE
sleep	0
onset	0
difficulties	0
are	I-DISEASE
most	0
common	I-DISEASE
among	0
young	0
adults	0
with	0
short	0
-	0
term	0
insomnia	0
,	I-DISEASE
whereas	0
sleep	0
maintenance	0
complaints	I-DISEASE
and	0
early	0
morning	I-DISEASE
awakening	0
are	0
more	0
common	0
in	I-DISEASE
middle	I-DISEASE
-	0
aged	0
and	0
older	0
adults	0
.	0

Objective	0
daytime	0
sleepiness	0
is	I-DISEASE
uncommon	0
in	I-DISEASE
younger	0
adults	0
with	I-DISEASE
short	0
-	0
term	0
insomnia	0
disorder	0
,	I-DISEASE
but	0
is	0
more	I-DISEASE
common	0
in	0
older	0
adults	0
.	0

Balancing	0
job	0
and	0
family	0
stressors	0
may	0
contribute	I-DISEASE
to	0
intermittent	I-DISEASE
short	0
-	0
term	0
insomnia	I-DISEASE
problems	0
in	0
younger	0
and	0
middle	I-DISEASE
-	0
aged	0
adults	0
.	0

In	0
contrast	0
,	0
older	0
,	0
retired	0
adults	I-DISEASE
may	0
have	I-DISEASE
short	0
-	0
term	0
insomnia	0
disorder	0
related	I-DISEASE
to	I-DISEASE
exacerbations	0
in	I-DISEASE
comorbid	0
chronic	0
medical	0
con-	0
ditions	I-DISEASE
or	0
due	0
to	0
loss	0
of	I-DISEASE
loved	0
ones	I-DISEASE
that	0
commonly	0
occurs	0
with	0
advancing	0
age	0
.	0

Pathology	0
and	0
Pathophysiology	0
Research	0
on	0
the	I-DISEASE
pathology	I-DISEASE
and	0
pathophysiology	I-DISEASE
of	0
short	0
-	I-DISEASE
term	0
variants	0
of	I-DISEASE
insomnia	0
disorder	I-DISEASE
is	I-DISEASE
generally	0
lacking	I-DISEASE
because	0
the	0
majority	I-DISEASE
of	0
studies	I-DISEASE
addressing	0
this	0
issue	I-DISEASE
have	0
focused	I-DISEASE
on	0
samples	I-DISEASE
with	0
chronic	0
insomnia	I-DISEASE
disorders	0
.	I-DISEASE

Differential	0
Diagnosis	0
Short	0
-	0
term	0
insomnia	I-DISEASE
disorder	I-DISEASE
shares	0
many	I-DISEASE
features	0
with	0
chronic	0
insomnia	0
disorder	0
.	0

The	0
primary	0
difference	0
between	0
the	0
two	I-DISEASE
conditions	I-DISEASE
is	0
that	I-DISEASE
short	0
-	0
term	0
insomnia	0
disor-	0
der	I-DISEASE
does	0
not	0
meet	I-DISEASE
the	0
duration	0
and	0
frequency	0
criteria	0
required	I-DISEASE
for	I-DISEASE
the	0
chronic	0
insomnia	I-DISEASE
disorder	0
diagnosis	0
.	I-DISEASE

Short	0
-	0
term	0
insomnia	0
disorder	0
also	0
should	I-DISEASE
be	0
distinguished	I-DISEASE
from	0
circadian	0
rhythm	0
sleep	0
-	0
wake	I-DISEASE
disorders	0
resulting	I-DISEASE
from	I-DISEASE
rotating	I-DISEASE
shift	0
work	0
or	0
jet	0
lag	0
.	I-DISEASE

In	0
the	0
latter	I-DISEASE
case	0
,	0
the	0
sleep	I-DISEASE
disturbance	I-DISEASE
arises	0
from	0
a	0
sleep	0
-	I-DISEASE
wake	0
schedule	I-DISEASE
alteration	0
that	I-DISEASE
results	I-DISEASE
in	0
a	0
mismatch	0
between	0
the	I-DISEASE
endogenous	0
circadian	I-DISEASE
rhythm	0
and	I-DISEASE
the	I-DISEASE
sleep	0
-	I-DISEASE
wake	0
schedule	0
chosen	0
—	0
for	I-DISEASE
example	I-DISEASE
,	I-DISEASE
having	I-DISEASE
to	0
sleep	I-DISEASE
in	0
the	0
daytime	0
rather	0
than	0
during	I-DISEASE
the	I-DISEASE
nighttime	0
.	I-DISEASE

In	0
the	0
case	I-DISEASE
of	0
short	0
-	I-DISEASE
term	I-DISEASE
insomnia	0
disorder	0
,	0
no	0
such	0
mismatch	0
exists	0
;	I-DISEASE
yet	I-DISEASE
,	0
the	I-DISEASE
individual	0
demonstrates	0
sleep	0
onset	0
or	I-DISEASE
maintenance	0
difficulties	I-DISEASE
nonetheless	I-DISEASE
.	0

Bibliography	0
Agnew	0
HW	0
Jr	0
,	0
Webb	0
WB	0
,	0
Williams	I-DISEASE
RL	0
.	0

The	0
first	0
night	0
effect	0
:	0
an	0
EEG	I-DISEASE
study	0
of	I-DISEASE
sleep	0
.	0

Psychophysiology	0
1966;2:263–6	0
.	I-DISEASE

Angst	0
J	0
,	I-DISEASE
Vollrath	0
M	0
,	0
Koch	0
R	0
,	I-DISEASE
Dobler	0
-	0
Mikola	0
A.	0
The	0
Zurich	I-DISEASE
Study	I-DISEASE
.	0

VII	0
.	0

Insomnia	0
:	0
symptoms	0
,	0
classification	0
and	0
prevalence	B-DISEASE
.	0

Eur	0
Arch	0
Psychiatry	0
Clin	0
Neurosci	0
1989;238:285–93	0
.	0

Healey	0
ES	0
,	0
Kales	0
A	0
,	0
Monroe	0
LJ	0
,	I-DISEASE
Bixler	0
EO	0
,	0
Chamberlin	0
K	0
,	I-DISEASE
Soldatos	0
CR	0
.	I-DISEASE

Onset	0
of	0
insomnia	0
:	0
role	0
of	0
life-	0
stress	0
events	I-DISEASE
.	0

Psychosom	0
Med	0
1981;43:439–51	0
.	0

Morin	0
CM	0
,	0
Rodrigue	I-DISEASE
S	0
,	0
Ivers	0
H.	0
Role	0
of	0
stress	0
,	0
arousal	0
and	0
coping	0
skills	0
in	0
primary	I-DISEASE
insomnia	0
.	0

Psychosom	0
Med	0
2003;65:259–67	0
.	0

Roehrs	0
T	I-DISEASE
,	0
Zorick	I-DISEASE
F	0
,	0
Roth	0
T.	0
Transient	I-DISEASE
and	0
short	0
-	0
term	0
insomnias	0
.	I-DISEASE

In	0
:	0
Krieger	0
MH	0
,	0
Roth	0
T	I-DISEASE
,	0
Dement	I-DISEASE
WC	0
,	0
eds	0
.	0

Principles	0
and	I-DISEASE
practice	0
of	I-DISEASE
sleep	0
medicine	I-DISEASE
,	I-DISEASE
3rd	0
ed	I-DISEASE
.	0

Philadelphia	0
:	I-DISEASE
WB	0
Saunders	I-DISEASE
,	0
2000:624–32	0
.	I-DISEASE

Tachibana	0
H	0
,	0
Izumi	0
T	0
,	0
Honda	0
S	0
,	I-DISEASE
Takemoto	0
TI	0
.	0

The	0
prevalence	0
and	I-DISEASE
pattern	0
of	0
insomnia	I-DISEASE
in	0
Japanese	0
industrial	I-DISEASE
workers	0
:	0
relationship	0
between	0
psychosocial	0
stress	0
and	0
type	0
of	I-DISEASE
insomnia	0
.	0

Psychiatry	0
Clin	0
Neurosci	0
1998;52:397–402	0
.	0

Insomnia	0
Insomnia	0
Other	0
Insomnia	0
Disorder	0
ICD-9	0
-	I-DISEASE
CM	0
code	I-DISEASE
:	0
307.49	0
ICD-10	0
-	0
CM	0
code	I-DISEASE
:	0
F51.09	I-DISEASE
This	0
diagnosis	0
is	0
reserved	0
for	0
individuals	I-DISEASE
who	0
complain	0
of	0
difficulty	0
initiating	0
and	0
maintaining	0
sleep	0
and	0
yet	0
do	0
not	I-DISEASE
meet	I-DISEASE
the	0
full	I-DISEASE
criteria	0
for	0
either	0
chronic	I-DISEASE
insomnia	0
dis-	0
order	0
or	0
short	0
-	I-DISEASE
term	0
insomnia	0
disorder	0
.	I-DISEASE

In	0
some	0
cases	0
,	B-DISEASE
this	0
diagnosis	0
may	I-DISEASE
be	0
assigned	I-DISEASE
on	0
a	0
provisional	0
basis	0
when	0
more	I-DISEASE
information	0
is	I-DISEASE
needed	I-DISEASE
to	0
establish	0
a	0
diagnosis	0
of	0
chronic	I-DISEASE
insomnia	0
disorder	0
or	0
short	I-DISEASE
-	0
term	0
insomnia	0
disorder	I-DISEASE
.	0

It	0
is	0
expected	0
that	0
this	0
diag-	0
nosis	0
will	0
be	I-DISEASE
used	0
sparingly	I-DISEASE
,	0
given	I-DISEASE
its	0
nonspecific	0
nature	0
.	0

Isolated	0
Symptoms	0
and	0
Normal	0
Variants	0
Excessive	I-DISEASE
Time	I-DISEASE
in	0
Bed	I-DISEASE

Some	0
individuals	0
may	0
present	0
with	0
isolated	0
insomnia	0
symptoms	0
such	I-DISEASE
as	0
prolonged	0
sleep	0
latencies	0
or	0
long	I-DISEASE
periods	0
of	0
wakefulness	0
during	0
the	0
night	0
,	0
yet	0
not	0
complain	I-DISEASE
of	I-DISEASE
insomnia	0
nor	I-DISEASE
show	0
daytime	0
impairments	0
.	0

In	0
children	0
,	I-DISEASE
this	0
pattern	0
may	0
emerge	I-DISEASE
when	0
parents	I-DISEASE
or	0
caregivers	0
have	0
unrealistic	0
expectations	0
for	0
the	0
child	I-DISEASE
’s	I-DISEASE
sleep	0
needs	0
and	I-DISEASE
rou-	0
tinely	0
allot	0
too	I-DISEASE
much	0
time	I-DISEASE
for	I-DISEASE
the	I-DISEASE
child	I-DISEASE
to	0
be	0
in	0
bed	0
each	0
night	0
.	0

In	0
adults	0
,	0
this	0
pattern	0
is	0
perhaps	I-DISEASE
most	I-DISEASE
common	0
in	0
noncomplaining	0
groups	0
who	0
routinely	0
allot	I-DISEASE
significantly	0
more	0
time	0
in	0
bed	0
than	0
needed	0
for	0
sleep	0
.	0

For	0
example	0
,	0
some	0
individuals	0
who	I-DISEASE
are	I-DISEASE
retired	0
from	I-DISEASE
work	0
or	0
not	0
currently	I-DISEASE
employed	0
may	I-DISEASE
routinely	0
spend	0
excessive	0
time	0
in	0
bed	0
each	0
night	0
and	I-DISEASE
are	I-DISEASE
not	0
bothered	I-DISEASE
by	I-DISEASE
the	0
expanded	I-DISEASE
periods	0
of	0
wakefulness	0
they	0
routinely	0
experience	0
.	0

At	0
present	I-DISEASE
,	0
epidemiological	0
and	0
laboratory	I-DISEASE
studies	I-DISEASE
are	0
unable	I-DISEASE
to	0
ascertain	0
whether	0
adverse	0
health	0
outcomes	I-DISEASE
are	0
more	0
strongly	I-DISEASE
associated	0
with	I-DISEASE
perceived	0
sleep	0
difficulties	0
/	0
dissatisfaction	I-DISEASE
or	0
with	0
particular	I-DISEASE
objective	I-DISEASE
indices	I-DISEASE
of	0
sleep	0
duration	0
,	0
sleep	0
latency	0
,	0
and	I-DISEASE
sleep	0
continuity	0
.	I-DISEASE

Short	0
Sleeper	0
Some	0
individuals	0
routinely	0
obtain	I-DISEASE
less	0
than	0
six	I-DISEASE
hours	0
of	0
sleep	I-DISEASE
per	0
night	0
on	I-DISEASE
average	I-DISEASE
yet	0
have	0
no	0
sleep	0
/	0
wake	I-DISEASE
complaints	0
.	I-DISEASE

Such	0
individuals	0
are	I-DISEASE
considered	0
to	0
be	0
normal	I-DISEASE
short	0
sleepers	I-DISEASE
if	I-DISEASE
they	0
have	0
no	0
complaints	0
of	I-DISEASE
sleep	I-DISEASE
difficulties	I-DISEASE
and	I-DISEASE
show	0
no	I-DISEASE
obvious	0
daytime	0
dysfunction	0
.	0

Among	0
these	0
individuals	0
,	0
the	0
observed	I-DISEASE
relatively	I-DISEASE
low	0
average	I-DISEASE
sleep	0
time	I-DISEASE
does	0
not	I-DISEASE
result	I-DISEASE
from	I-DISEASE
chronic	0
volitional	0
sleep	0
restriction	0
,	0
as	0
in	0
the	0
case	I-DISEASE
of	0
insufficient	I-DISEASE
sleep	0
syndrome	I-DISEASE
,	B-DISEASE
but	I-DISEASE
rather	I-DISEASE
indicates	0
a	0
constitutional	0
disposition	0
for	0
reduced	I-DISEASE
sleep	0
requirement	0
.	I-DISEASE

The	0
clinical	0
significance	0
of	0
chronic	0
short	0
sleep	I-DISEASE
duration	I-DISEASE
,	I-DISEASE
and	0
the	0
identifi-	I-DISEASE
cation	0
of	0
possible	I-DISEASE
subtypes	0
,	0
remain	I-DISEASE
open	0
questions	0
.	0

Various	0
studies	0
have	0
linked	0
short	0
sleep	I-DISEASE
duration	I-DISEASE
with	0
metabolic	I-DISEASE
,	0
cardiovascular	0
,	0
and	0
other	0
forms	I-DISEASE
of	0
medical	0
morbidity	I-DISEASE
.	0

However	0
,	I-DISEASE
these	0
studies	0
are	0
typically	0
unable	I-DISEASE
to	0
distinguish	I-DISEASE
between	0
individuals	0
who	0
have	0
short	0
sleep	I-DISEASE
in	I-DISEASE
the	0
context	I-DISEASE
of	0
insomnia	I-DISEASE
or	0
another	0
sleep	0
disorder	0
,	0
those	I-DISEASE
who	I-DISEASE
are	I-DISEASE
voluntarily	0
restricting	0
their	0
sleep	I-DISEASE
,	0
and	0
those	0
who	I-DISEASE
may	0
have	I-DISEASE
naturally	0
short	0
sleep	0
.	0

Short	0
sleep	0
resulting	0
from	0
different	0
causes	0
may	I-DISEASE
have	0
different	0
pathophysiological	0
signifi-	0
cance	0
.	I-DISEASE

At	0
present	I-DISEASE
,	0
those	0
who	0
demonstrate	0
less	I-DISEASE
than	0
six	I-DISEASE
hours	0
of	0
sleep	0
per	I-DISEASE
night	0
should	I-DISEASE
not	0
be	I-DISEASE
assigned	I-DISEASE
an	0
insomnia	I-DISEASE
diagnosis	0
unless	0
they	0
also	0
meet	0
the	0
criteria	0
for	0
one	I-DISEASE
of	0
the	0
insomnia	0
disorder	0
subtypes	0
described	0
herein	0
.	0

Insomnia	0
Insomnia	0
Bibliography	0
Fernandez	0
-	0
Mendoza	0
J	I-DISEASE
,	0
Calhoun	I-DISEASE
S	I-DISEASE
,	I-DISEASE
Bixler	0
EO	0
,	0
Pejovic	I-DISEASE
S	0
,	0
Karataraki	I-DISEASE
M	0
,	0
Liao	0
D.	0
Insomnia	0
with	I-DISEASE
objective	0
short	0
sleep	0
duration	0
is	0
associated	0
with	I-DISEASE
deficits	0
in	0
neuropsychological	0
performance	0
:	0
a	0
general	0
population	0
study	I-DISEASE
.	0

Sleep	0
2010;33:459–65	0
.	0

Hartmann	0
E.	0
Sleep	I-DISEASE
requirement	I-DISEASE
:	0
long	I-DISEASE
sleepers	0
,	0
short	0
sleepers	I-DISEASE
,	0
variable	0
sleepers	0
,	I-DISEASE
and	I-DISEASE
insomniacs	0
.	I-DISEASE

Psychosomatics	0
1973;14:95–103	0
.	0

Ohayon	0
MM	0
,	0
Caulet	0
M	0
,	I-DISEASE
Guilleminault	I-DISEASE
C.	I-DISEASE
How	I-DISEASE
a	0
general	0
population	0
perceives	I-DISEASE
its	0
sleep	I-DISEASE
and	0
how	0
this	I-DISEASE
relates	0
to	0
the	0
complaint	0
of	I-DISEASE
insomnia	0
.	I-DISEASE

Sleep	0
1997;20:715–23	0
.	0

Roehrs	0
T	I-DISEASE
,	0
Zorick	I-DISEASE
F	0
,	0
Roth	0
T.	0
Transient	I-DISEASE
and	0
short	0
-	0
term	0
insomnias	0
.	I-DISEASE

In	0
:	0
Krieger	0
MH	0
,	0
Roth	0
T	I-DISEASE
,	0
Dement	I-DISEASE
WC	0
,	0
eds	0
.	0

Principles	0
and	I-DISEASE
practice	0
of	I-DISEASE
sleep	0
medicine	I-DISEASE
,	I-DISEASE
3rd	0
ed	I-DISEASE
.	0

Philadelphia	0
:	I-DISEASE
WB	0
Saunders	I-DISEASE
,	0
2000:624–32	0
.	I-DISEASE

Vgontzas	0
AN	0
,	0
Liao	0
D	0
,	0
Bixler	I-DISEASE
EO	0
,	I-DISEASE
Chrousos	0
GP	0
,	0
Vela	0
-	0
Bueno	I-DISEASE
A.	0
Insomnia	0
with	I-DISEASE
objective	0
short	0
sleep	0
duration	0
is	0
associated	0
with	I-DISEASE
a	I-DISEASE
high	0
risk	I-DISEASE
for	0
hypertension	0
.	0

Sleep	0
2009;32:491–7	0
.	0

Webb	0
WB	0
,	I-DISEASE
Friel	0
J.	0
Characteristics	0
of	I-DISEASE
“	0
natural	0
”	I-DISEASE
long	0
and	0
short	0
sleepers	0
:	I-DISEASE
a	0
preliminary	0
report	I-DISEASE
.	0

Psychol	0
Rep	0
1970;27:63–6	I-DISEASE
.	0

Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Obstructive	I-DISEASE
Sleep	I-DISEASE
Apnea	I-DISEASE
Disorders	0
Obstructive	I-DISEASE
Sleep	0
Apnea	0
,	0
Adult53	0
Obstructive	I-DISEASE
Sleep	I-DISEASE
Apnea	I-DISEASE
,	I-DISEASE

Pediatric63	0
Central	0
Sleep	0
Apnea	I-DISEASE
Syndromes	0
Central	0
Sleep	I-DISEASE
Apnea	0
with	I-DISEASE
Cheyne	0
-	0
Stokes	0
Breathing	0
69	0
Central	0
Apnea	I-DISEASE
Due	0
to	I-DISEASE
a	0
Medical	0
Disorder	0
without	0
Cheyne	0
-	I-DISEASE
Stokes	0
Breathing75	I-DISEASE
Central	I-DISEASE
Sleep	I-DISEASE
Apnea	0

Due	0
to	0
High	0
Altitude	0
Periodic	0
Breathing	0
79	I-DISEASE
Central	0
Sleep	I-DISEASE
Apnea	0
Due	0
to	0
a	0
Medication	0
or	I-DISEASE
Substance	I-DISEASE
85	0
Primary	I-DISEASE
Central	0
Sleep	0
Apnea	0

89	0
Primary	0
Central	0
Sleep	0
Apnea	0
of	I-DISEASE
Infancy94	I-DISEASE
Primary	0
Central	I-DISEASE
Sleep	0
Apnea	0
of	0
Prematurity98	0
Treatment	I-DISEASE
-	0
Emergent	0
Central	I-DISEASE
Sleep	I-DISEASE
Apnea	I-DISEASE
102	0
Sleep	0
Related	0
Hypoventilation	I-DISEASE
Disorders	I-DISEASE
Obesity	I-DISEASE
Hypoventilation	0
Syndrome	0
108	I-DISEASE
Congenital	0
Central	0
Alveolar	0
Hypoventilation	0
Syndrome	0

113	0
Late	0
-	0
Onset	I-DISEASE
Central	0
Hypoventilation	0
with	0
Hypothalamic	0
Dysfunction	0
118	0
Idiopathic	0
Central	0
Alveolar	0
Hypoventilation	0
121	0
Sleep	0
Related	0
Hypoventilation	I-DISEASE
Due	0
to	0
a	0
Medication	0
or	0
Substance	0

124	0
Sleep	0
Related	I-DISEASE
Hypoventilation	I-DISEASE
Due	0
to	0
a	0
Medical	0
Disorder128	0
Sleep	0
Related	0
Hypoxemia	0
Disorder	0
Sleep	0
Related	I-DISEASE
Hypoxemia134	0
Isolated	I-DISEASE
Symptoms	I-DISEASE
and	0
Normal	0
Variants	0

Snoring	0
139	0
Catathrenia	I-DISEASE
141	I-DISEASE
The	0
sleep	0
related	0
breathing	I-DISEASE
disorders	I-DISEASE
are	0
characterized	0
by	I-DISEASE
abnormalities	I-DISEASE
of	0
respi-	I-DISEASE
ration	0
during	0
sleep	I-DISEASE
.	0

In	0
some	0
of	0
these	0
disorders	0
,	I-DISEASE
respiration	I-DISEASE
is	0
also	I-DISEASE
abnormal	0
during	0
wakefulness	0
.	I-DISEASE

The	0
disorders	0
are	0
grouped	0
into	I-DISEASE
obstructive	I-DISEASE
sleep	I-DISEASE
apnea	0
(	I-DISEASE
OSA	I-DISEASE
)	I-DISEASE
disorders	0
,	I-DISEASE
central	0
sleep	I-DISEASE
apnea	0
disorders	I-DISEASE
,	I-DISEASE
sleep	0
related	0
hypoventilation	0
disorders	I-DISEASE
,	0
and	I-DISEASE
sleep	0
related	0
hypoxemia	0
disorder	I-DISEASE
.	I-DISEASE

However	0
,	I-DISEASE
many	0
patients	0
will	0
meet	I-DISEASE
diagnostic	I-DISEASE
criteria	0
for	I-DISEASE
more	0
than	0
one	0
of	0
these	0
groups	0
.	0

In	0
particular	0
,	0
many	0
patients	0
have	I-DISEASE
a	0
combination	0
of	I-DISEASE
obstruc-	0
tive	0
and	0
central	0
sleep	I-DISEASE
apnea	I-DISEASE
.	I-DISEASE

Although	0
a	0
diagnosis	0
is	0
often	0
based	I-DISEASE
on	0
which	0
disorder	I-DISEASE
Sleep	0
Related	0
Breathing	I-DISEASE
Disorders	0
predominates	0
,	I-DISEASE
this	I-DISEASE
may	0
vary	I-DISEASE
from	0
night	0
to	0
night	0
as	0
well	0
as	0
over	0
time	I-DISEASE
in	0
individual	I-DISEASE
patients	0
.	I-DISEASE

There	0
is	0
also	0
overlap	B-DISEASE
in	0
pathophysiology	0
,	I-DISEASE
as	I-DISEASE
some	I-DISEASE
central	0
apneas	0
are	0
associ-	0
ated	0
with	0
a	0
closed	I-DISEASE
upper	0
airway	0
and	0
many	0
obstructive	0
apneas	0
begin	I-DISEASE
during	I-DISEASE
a	0
time	0
of	I-DISEASE
falling	0
ventilatory	0
drive	0
.	I-DISEASE

In	0
the	0
sections	I-DISEASE
that	0
follow	0
,	0
individual	I-DISEASE
respiratory	0
events	I-DISEASE
(	0
e.g.	0
,	0
apneas	0
,	0
hypopneas	0
,	0
and	0
hypoventilation	I-DISEASE
)	0
are	0
not	0
defined	0
;	0
rather	0
,	0
reference	I-DISEASE
is	0
made	I-DISEASE
to	0
the	0
most	0
recent	0
version	0
of	0
the	0
American	I-DISEASE
Academy	0
of	I-DISEASE
Sleep	0
Medicine	0
(	0
AASM	0
)	0
Manual	0
for	I-DISEASE
the	0
Scoring	I-DISEASE
of	0
Sleep	0
and	I-DISEASE
Associated	0
Events	0
for	I-DISEASE
these	I-DISEASE
definitions	0
.	I-DISEASE

The	0
AASM	0
Manual	0
for	0
the	0
Scoring	0
of	I-DISEASE
Sleep	0
and	I-DISEASE
Associated	0
Events	0
includes	I-DISEASE
different	I-DISEASE
scoring	0
rules	I-DISEASE
for	0
adult	0
and	I-DISEASE
pediatric	0
individuals	I-DISEASE
,	I-DISEASE
definitions	0
of	0
obstructive	I-DISEASE
and	I-DISEASE
central	0
apneas	0
and	I-DISEASE
hypopneas	0
,	0
and	I-DISEASE
rules	I-DISEASE
for	0
scoring	0
Cheyne	I-DISEASE
-	0
Stokes	I-DISEASE
breathing	I-DISEASE
and	I-DISEASE
hypoventilation	0
.	0

The	0
OSA	0
disorders	0
are	0
separated	0
into	0
adult	I-DISEASE
and	0
pediatric	I-DISEASE
categories	0
,	0
as	0
the	0
presenta-	0
tion	I-DISEASE
,	I-DISEASE
diagnostic	0
criteria	I-DISEASE
,	0
course	0
,	0
and	0
complications	0
differ	0
significantly	I-DISEASE
.	0

These	0
disorders	0
are	0
characterized	0
by	0
upper	0
airway	0
narrowing	0
or	I-DISEASE
closure	0
during	0
sleep	0
while	I-DISEASE
respiratory	I-DISEASE
effort	I-DISEASE
continues	0
(	0
at	I-DISEASE
least	0
during	I-DISEASE
some	0
portion	0
of	0
the	0
event	I-DISEASE
)	I-DISEASE
.	0

The	0
use	0
of	0
out	0
-	0
of	0
-	I-DISEASE
cen-	0
ter	I-DISEASE
sleep	0
testing	0
(	0
OCST	0
)	I-DISEASE
with	0
limited	I-DISEASE
channels	0
(	0
electroencephalogram	0
[	I-DISEASE
EEG	0
]	0
is	0
not	I-DISEASE
usually	I-DISEASE
recorded	0
)	0
is	0
now	0
included	0
in	0
the	0
diagnostic	0
criteria	0
for	0
adult	0
OSA	0
.	I-DISEASE

The	0
central	0
sleep	0
apnea	I-DISEASE
syndromes	0
are	I-DISEASE
characterized	0
by	0
reduction	I-DISEASE
or	0
cessation	0
of	0
airflow	0
due	0
to	I-DISEASE
absent	0
or	0
reduced	I-DISEASE
respiratory	0
effort	0
.	0

Central	0
apnea	0
or	0
hypopnea	I-DISEASE
may	0
occur	0
in	I-DISEASE
a	0
cyclical	I-DISEASE
or	0
intermittent	0
fashion	0
.	0

Patients	0
with	0
central	0
sleep	0
apnea	0
of	I-DISEASE
various	I-DISEASE
etiologies	I-DISEASE
may	0
also	0
exhibit	0
OSA	0
.	0

In	0
primary	0
central	0
sleep	0
apnea	0
,	0
the	I-DISEASE
cause	0
of	I-DISEASE
the	I-DISEASE
disorder	0
is	0
unknown	I-DISEASE
(	0
idiopathic	0
)	I-DISEASE
.	0

The	0
arterial	0
partial	0
pressure	I-DISEASE
of	0
carbon	I-DISEASE
dioxide	I-DISEASE
(	0
PaCO2	I-DISEASE
)	0
during	0
wake	0
in	I-DISEASE
these	I-DISEASE
patients	I-DISEASE
is	I-DISEASE
normal	0
or	0
low	0
.	0

Patients	0
do	0
not	0
meet	0
diagnostic	0
criteria	0
for	0
other	0
central	0
sleep	0
apnea	0
dis-	0
orders	0
.	0

In	0
central	0
sleep	0
apnea	I-DISEASE
with	0
Cheyne	I-DISEASE
-	I-DISEASE
Stokes	0
breathing	I-DISEASE
,	I-DISEASE
there	0
is	I-DISEASE
a	0
cyclical	0
pattern	I-DISEASE
of	I-DISEASE
crescendo	0
-	I-DISEASE
decrescendo	0
respiration	0
separated	0
by	0
central	0
apneas	I-DISEASE
or	0
central	0
hypopneas	0
.	I-DISEASE

Most	0
patients	0
with	I-DISEASE
this	0
disorder	0
have	I-DISEASE
congestive	0
heart	0
failure	I-DISEASE
(	0
reduced	0
or	0
preserved	I-DISEASE
ejection	I-DISEASE
fraction	I-DISEASE
)	0
,	0
although	I-DISEASE
,	0
less	I-DISEASE
commonly	0
,	0
others	0
exhibit	0
this	0
breathing	0
pattern	0
fol-	I-DISEASE
lowing	0
stroke	0
or	0
in	0
association	0
with	0
other	0
neurological	0
disorders	0
.	0

In	0
high	0
-	0
altitude	0
peri-	0
odic	0
breathing	I-DISEASE
,	0
the	I-DISEASE
disorder	0
is	0
associated	0
with	I-DISEASE
acute	0
ascent	I-DISEASE
to	0
high	0
altitude	0
.	0

Symptoms	0
must	0
be	0
present	0
to	0
establish	0
the	I-DISEASE
diagnosis	0
of	I-DISEASE
high	0
-	0
altitude	0
periodic	0
breathing	0
,	I-DISEASE
as	0
this	0
breathing	I-DISEASE
pattern	0
is	0
an	0
expected	0
finding	0
after	0
ascent	I-DISEASE
to	0
altitude	0
.	0

Central	0
sleep	0
apnea	I-DISEASE
due	0
to	I-DISEASE
medical	0
or	0
neurological	0
condition	I-DISEASE
(	0
not	0
Cheyne	0
-	0
Stokes	I-DISEASE
)	I-DISEASE
is	I-DISEASE
usually	0
due	I-DISEASE
to	0
a	0
struc-	0
tural	0
lesion	0
in	0
the	0
central	0
nervous	0
system	B-DISEASE
.	0

These	0
disorders	0
should	0
be	0
excluded	0
before	I-DISEASE
a	I-DISEASE
diagnosis	0
of	I-DISEASE
primary	0
central	0
sleep	0
apnea	I-DISEASE
is	0
made	I-DISEASE
.	0

In	0
central	0
sleep	0
apnea	I-DISEASE
due	0
to	I-DISEASE
drug	I-DISEASE
or	0
substance	I-DISEASE
,	0
the	0
patient	0
demonstrates	0
central	I-DISEASE
apneas	I-DISEASE
secondary	I-DISEASE
to	0
the	I-DISEASE
effects	I-DISEASE
of	0
potent	0
opioids	0
or	0
other	I-DISEASE
respiratory	0
depressants	0
on	0
respiratory	I-DISEASE
control	0
centers	I-DISEASE
.	0

Treatment	0
-	0
emergent	0
central	0
sleep	0
apnea	0
is	I-DISEASE
a	0
new	I-DISEASE
addition	0
to	0
the	0
International	0
Classification	0
of	0
Sleep	I-DISEASE
Disorders	0
.	0

In	0
this	0
disorder	0
,	0
the	0
patient	I-DISEASE
exhibits	I-DISEASE
predominantly	I-DISEASE
obstructive	I-DISEASE
events	0
during	0
diagnostic	0
sleep	I-DISEASE
testing	0
(	I-DISEASE
e.g.	I-DISEASE
,	I-DISEASE
obstructive	0
or	0
mixed	0
apneas	0
and	0
obstructive	0
hypopneas	0
)	I-DISEASE
,	0
but	0
central	I-DISEASE
apneas	0
or	I-DISEASE
central	0
hypopneas	I-DISEASE
emerge	0
or	0
persist	0
on	0
positive	0
airway	0
pressure	I-DISEASE
treatment	I-DISEASE
without	0
a	I-DISEASE
backup	0
rate	0
and	I-DISEASE
are	0
the	0
predominant	0
residual	0
breathing	I-DISEASE
abnormality	0
(	0
i.e.	I-DISEASE
,	B-DISEASE
obstructive	0
events	0
have	0
resolved	0
)	0
.	0

A	0
diagnosis	0
of	0
treatment	I-DISEASE
-	0
emergent	I-DISEASE
central	I-DISEASE
sleep	0
apnea	0
is	I-DISEASE
made	0
when	I-DISEASE
the	0
central	0
sleep	I-DISEASE
apnea	I-DISEASE
component	I-DISEASE
is	0
not	I-DISEASE
better	0
explained	I-DISEASE
by	0
another	0
diagnosis	0
(	I-DISEASE
i.e.	0
,	0
another	I-DISEASE
central	0
sleep	0
apnea	I-DISEASE
disorder	I-DISEASE
)	0
.	0

Sleep	0
related	0
hypoventilation	I-DISEASE
disorders	I-DISEASE
are	0
characterized	0
by	0
an	0
abnormal	I-DISEASE
increase	0
in	0
the	0
arterial	0
PCO2	0
(	0
PaCO2	0
)	I-DISEASE
during	I-DISEASE
sleep	I-DISEASE
.	0

Adult	0
and	0
pediatric	0
hypoventilation	0
disorders	0
are	0
defined	0
by	0
different	0
criteria	0
.	0

For	0
adults	0
,	0
an	0
increase	0
in	0
the	0
arterial	0
PCO2	I-DISEASE
(	I-DISEASE
or	0
sur-	0
rogate	I-DISEASE
)	0
to	0
greater	0
than	0
55	I-DISEASE
mm	0
Hg	0
for	0
at	0
least	0
10	0
minutes	0
or	0
an	0
increase	0
≥	0
10	I-DISEASE
mm	I-DISEASE

Hg	0
above	0
the	0
awake	0
value	I-DISEASE
to	0
a	0
value	0
of	I-DISEASE
50	0
mm	0
Hg	0
or	I-DISEASE
greater	0
for	I-DISEASE
at	0
least	I-DISEASE
10	I-DISEASE
minutes	0
is	I-DISEASE
required	0
.	0

In	0
pediatric	0
patients	0
,	0
the	0
PaCO2	0
(	I-DISEASE
or	0
surrogate	I-DISEASE
)	I-DISEASE
must	0
be	0
greater	I-DISEASE
than	0
50	I-DISEASE
mm	0
Hg	0
for	I-DISEASE
greater	0
than	0
25	0
%	0
of	0
total	0
sleep	I-DISEASE
time	0
.	0

In	0
this	0
edition	0
of	0
the	0
International	I-DISEASE
Classification	0
of	0
Sleep	I-DISEASE
Disorders	0
,	0
there	0
are	0
a	0
number	I-DISEASE
of	0
changes	0
in	I-DISEASE
the	0
classification	0
of	0
sleep	0
related	0
hypoventilation	0
disorders	I-DISEASE
.	I-DISEASE

The	0
obesity	0
hypoventilation	0
syndrome	I-DISEASE
is	0
listed	0
as	I-DISEASE
a	0
separate	I-DISEASE
disorder	I-DISEASE
given	0
that	0
it	0
is	0
both	I-DISEASE
prevalent	0
and	0
has	I-DISEASE
distinct	0
clinical	0
characteristics	0
.	0

In	0
contrast	0
to	0
other	I-DISEASE
sleep	0
related	I-DISEASE
hypoventila-	I-DISEASE
tion	0
disorders	0
,	0
a	0
diagnosis	0
of	I-DISEASE
obesity	0
hypoventilation	0
syndrome	0
requires	0
documenta-	I-DISEASE
tion	0
of	0
awake	0
(	0
daytime	0
)	0
hypoventilation	I-DISEASE
(	0
PaCO2	0
>	I-DISEASE
45	I-DISEASE
mm	I-DISEASE
Hg	0
)	I-DISEASE
.	0

For	0
the	0
other	0
disorders	0
in	0
this	0
category	0
,	0
awake	I-DISEASE
hypoventilation	0
may	0
or	0
may	0
not	0
be	0
present	0
.	0

In	0
the	0
previous	I-DISEASE
version	0
of	0
the	I-DISEASE
International	I-DISEASE
Classification	0
of	0
Sleep	0
Disorders	0
,	0
a	0
group	0
of	I-DISEASE
disorders	0
were	0
listed	I-DISEASE
under	0
the	0
category	0
of	0
sleep	I-DISEASE
related	0
hypoventilation	I-DISEASE
/	I-DISEASE
hypoxemia	I-DISEASE
disorders	I-DISEASE
.	0

In	0
the	0
International	I-DISEASE
Classification	0
of	0
Sleep	I-DISEASE
Disorders	I-DISEASE
,	0
3rd	I-DISEASE
Edition	0
,	0
disorders	I-DISEASE
manifesting	0
hypoventilation	0
are	I-DISEASE
separated	I-DISEASE
from	0
disorders	I-DISEASE
in	0
which	0
only	0
a	0
finding	0
of	I-DISEASE
hypoxemia	0
(	0
arterial	0
oxygen	I-DISEASE
desaturation	0
)	0
during	0
sleep	I-DISEASE
is	0
documented	0
.	0

Demonstrating	0
sleep	0
related	0
hypoventilation	0
rather	0
than	I-DISEASE
simply	I-DISEASE
hypoxemia	0
has	0
important	0
diagnostic	0
and	0
treatment	0
consequences	0
.	I-DISEASE

Sleep	0
related	0
hypoxemia	I-DISEASE
disorders	I-DISEASE
are	0
characterized	I-DISEASE
by	0
sustained	0
periods	0
of	0
significantly	0
reduced	0
oxyhemoglobin	0
saturation	0
during	I-DISEASE
sleep	I-DISEASE
.	0

This	0
diagnostic	0
category	0
is	0
used	0
when	I-DISEASE
sleep	I-DISEASE
related	I-DISEASE
hypoventilation	I-DISEASE
is	0
either	0
not	0
present	0
or	0
the	I-DISEASE
status	0
is	I-DISEASE
unknown	I-DISEASE
.	0

Sleep	0
related	I-DISEASE
hypoxemia	I-DISEASE
can	I-DISEASE
occur	0
due	I-DISEASE
to	I-DISEASE
hypoventilation	0
,	0
ven-	0
tilation	0
-	0
perfusion	0
mismatch	0
,	0
low	I-DISEASE
partial	0
pressure	I-DISEASE
of	0
oxygen	0
,	0
shunt	0
,	I-DISEASE
or	I-DISEASE
a	0
combination	I-DISEASE
of	0
Sleep	B-DISEASE
Related	0
Breathing	I-DISEASE
Disorders	I-DISEASE
Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	0
these	0
factors	0
.	0

Many	0
diverse	0
etiologies	0
can	0
be	0
associated	0
with	I-DISEASE
sleep	I-DISEASE
related	I-DISEASE
hypoxemia	0
.	0

There	0
are	0
no	0
longer	I-DISEASE
separate	0
diagnostic	I-DISEASE
categories	I-DISEASE
for	0
the	I-DISEASE
various	I-DISEASE
types	0
of	I-DISEASE
medical	0
and	0
neurological	I-DISEASE
pathology	0
that	0
may	I-DISEASE
contribute	0
to	0
hypoventilation	0
or	0
hypoxemia	0
.	0

In	0
the	0
International	I-DISEASE
Classification	0
of	0
Sleep	I-DISEASE
Disorders	I-DISEASE
,	0
2nd	I-DISEASE
Edition	0
,	0
these	I-DISEASE
included	0
lower	0
airway	0
obstruction	I-DISEASE
,	0
pulmonary	0
parenchymal	I-DISEASE
and	I-DISEASE
vascular	0
pathology	0
,	0
and	I-DISEASE
neuromus-	I-DISEASE
cular	0
and	0
chest	0
wall	0
disorders	0
.	0

In	0
the	0
International	I-DISEASE
Classification	0
of	0
Sleep	I-DISEASE
Disorders	I-DISEASE
,	0
3rd	I-DISEASE
Edition	0
,	0
the	I-DISEASE
specific	0
pulmonary	0
or	I-DISEASE
neurological	I-DISEASE
disorder	I-DISEASE
should	0
be	0
diagnosed	I-DISEASE
sep-	0
arately	0
,	0
in	I-DISEASE
association	0
with	0
a	I-DISEASE
diagnosis	I-DISEASE
of	0
sleep	0
related	0
hypoventilation	0
due	0
medical	0
or	0
neurological	0
condition	0
or	I-DISEASE
sleep	I-DISEASE
related	I-DISEASE
hypoxemia	I-DISEASE
.	0

Bibliography	0
Badr	0
MS	0
,	0
Toiber	0
F	0
,	I-DISEASE
Skatrud	0
JB	I-DISEASE
,	0
Dempsey	0
J.	0
Pharyngeal	0
narrowing	0
/	I-DISEASE
occlusion	0
during	0
central	I-DISEASE
sleep	0
apnea	I-DISEASE
.	0

J	0
Appl	0
Physiol	0
1995;78:1806–15	0
.	0

Berry	0
RB	0
,	0
Brooks	0
R	0
,	I-DISEASE
Gamaldo	I-DISEASE
CE	0
,	0
Harding	0
SM	0
,	0
Lloyd	0
RM	0
,	I-DISEASE
Marcus	0
CL	0
and	I-DISEASE
Vaughn	0
BV	0
for	I-DISEASE
the	0
American	0
Academy	I-DISEASE
of	I-DISEASE
Sleep	0
Medicine	0
.	I-DISEASE

The	0
AASM	0
Manual	0
for	0
the	0
Scoring	0
of	I-DISEASE
Sleep	0
and	I-DISEASE
Associated	0
Events	0
:	0
Rules	I-DISEASE
,	0
Terminology	I-DISEASE
and	I-DISEASE
Technical	0
Specifications	I-DISEASE
,	0
Version	0
2.0.3	0
.	0
www.aasmnet.org	0
.	I-DISEASE

Darien	0
,	0
IL	0
:	0
American	0
Academy	0
of	I-DISEASE
Sleep	0
Medicine	I-DISEASE
,	0
2014	0
Tkacova	0
R	0
,	0
Niroumand	0
M	0
,	0
Lorenzi	I-DISEASE
-	0
Filho	0
G	0
,	0
Bradley	0
TD	0
.	I-DISEASE

Overnight	0
shift	0
from	0
obstructive	0
to	0
central	0
apneas	0
in	0
patients	I-DISEASE
with	0
heart	0
failure	0
:	I-DISEASE
role	0
of	I-DISEASE
PCO2	0
and	I-DISEASE
circulatory	I-DISEASE
delay	0
.	0

Circulation	0
2001;103:238–43	0
.	0

Tkacova	0
R	0
,	0
Wang	0
H	0
,	0
Bradley	I-DISEASE
TD	0
.	0

Night	0
-	0
to	0
-	0
night	0
alterations	I-DISEASE
in	0
sleep	0
apnea	I-DISEASE
type	0
in	0
patients	0
with	0
heart	0
failure	I-DISEASE
.	0

J	0
Sleep	0
Res	0
2006;15:321–8	0
.	0

Obstructive	0
Sleep	0
Apnea	0
Disorders	0
Obstructive	0
Sleep	I-DISEASE
Apnea	I-DISEASE
,	I-DISEASE
Adult	0
ICD-9	0
-	0
CM	0
code	0
:	0
327.23	0
ICD-10	I-DISEASE
-	I-DISEASE
CM	I-DISEASE
code	I-DISEASE
:	0
G47.33	0
Alternate	0
Names	0
OSA	0
syndrome	I-DISEASE
,	0
sleep	0
apnea	I-DISEASE
,	I-DISEASE
sleep	0
apnea	0
syndrome	0
,	0
obstructive	0
apnea	0
,	0
sleep	0
disor-	I-DISEASE
dered	0
breathing	0
,	I-DISEASE
obstructive	I-DISEASE
sleep	0
apnea	0
hypopnea	I-DISEASE
syndrome	0
.	0

The	0
term	0
upper	0
airway	0
resistance	0
syndrome	I-DISEASE
(	I-DISEASE
UARS	I-DISEASE
)	I-DISEASE
is	0
subsumed	0
under	0
this	I-DISEASE
diagnosis	0
because	I-DISEASE
the	0
pathophysiology	0
does	I-DISEASE
not	0
significantly	0
differ	0
from	0
that	0
of	I-DISEASE
obstructive	I-DISEASE
sleep	I-DISEASE
apnea	I-DISEASE
.	I-DISEASE

Use	0
of	0
the	0
term	I-DISEASE
Pickwickian	0
syndrome	0
is	I-DISEASE
discouraged	0
because	I-DISEASE
not	0
only	0
has	0
it	I-DISEASE
been	0
applied	0
to	0
those	0
with	I-DISEASE
OSA	0
,	0
but	0
also	0
indiscriminately	0
used	0
to	0
describe	0
persons	0
who	0
are	0
only	I-DISEASE
obese	0
and	0
those	0
with	0
obesity	0
hypoventilation	0
syndrome	0
.	I-DISEASE

Diagnostic	0
Criteria	0
(	0
A	0
and	0
B	I-DISEASE
)	0
or	0
C	I-DISEASE
satisfy	0
the	0
criteria	0
A.	I-DISEASE

The	0
presence	0
of	0
one	0
or	0
more	0
of	0
the	0
following	I-DISEASE
:	0
.	0

The	0
patient	0
complains	0
of	0
sleepiness	0
,	I-DISEASE
nonrestorative	I-DISEASE
sleep	0
,	I-DISEASE
fatigue	0
,	0
or	0
insomnia	0
symptoms	0
.	I-DISEASE
.	0

The	0
patient	0
wakes	0
with	0
breath	0
holding	0
,	I-DISEASE
gasping	0
,	I-DISEASE
or	0
choking	0
.	0
.	0

The	0
bed	0
partner	0
or	0
other	0
observer	0
reports	I-DISEASE
habitual	0
snoring	0
,	0
breathing	0
interruptions	I-DISEASE
,	0
or	0
both	0
during	0
the	0
patient	0
’s	0
sleep	0
.	0
.	0

The	0
patient	0
has	0
been	0
diagnosed	0
with	0
hypertension	I-DISEASE
,	I-DISEASE
a	I-DISEASE
mood	I-DISEASE
disorder	0
,	0
cognitive	0
dysfunction	0
,	I-DISEASE
coronary	0
artery	0
disease	I-DISEASE
,	0
stroke	0
,	0
congestive	0
heart	0
failure	I-DISEASE
,	0
atrial	0
fibrillation	0
,	B-DISEASE
or	0
type	I-DISEASE
2	0
diabetes	0
mellitus	0
.	0

B.	0
Polysomnography	0
(	0
PSG	0
)	0
or	0
OCST1	I-DISEASE
demonstrates	0
:	I-DISEASE
.	0

Five	0
or	0
more	0
predominantly	0
obstructive	0
respiratory	0
events2	I-DISEASE
(	0
obstructive	I-DISEASE
and	0
mixed	0
apneas	I-DISEASE
,	I-DISEASE
hypopneas	0
,	I-DISEASE
or	0
respiratory	I-DISEASE
effort	I-DISEASE
related	0
arousals	0
[	I-DISEASE
RERAs])3	0
per	I-DISEASE
hour	0
of	I-DISEASE
sleep	0
during	0
a	0
PSG	0
or	0
per	0
hour	I-DISEASE
of	0
monitoring	I-DISEASE
(	0
OCST).1	I-DISEASE
OR	0
C.	I-DISEASE
PSG	0
or	0
OCST1	0
demonstrates	I-DISEASE
:	0
.	0

Fifteen	0
or	0
more	0
predominantly	0
obstructive	0
respiratory	0
events	0
(	0
apneas	I-DISEASE
,	0
hypopneas	0
,	0
or	0
RERAs)3	I-DISEASE
per	0
hour	I-DISEASE
of	0
sleep	I-DISEASE
during	0
a	0
PSG	0
or	0
per	0
hour	0
of	I-DISEASE
monitoring	0
(	0
OCST).1	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	0
Notes	0
.	0

OCST	0
commonly	0
underestimates	0
the	0
number	0
of	I-DISEASE
obstructive	0
respiratory	I-DISEASE
events	I-DISEASE
per	I-DISEASE
hour	0
as	0
compared	0
to	0
PSG	0
because	I-DISEASE
actual	0
sleep	I-DISEASE
time	0
,	0
as	0
determined	0
primarily	0
by	I-DISEASE
EEG	I-DISEASE
,	0
is	I-DISEASE
often	I-DISEASE
not	0
recorded	0
.	0

The	0
term	0
respiratory	0
event	0
index	0
(	0
REI	I-DISEASE
)	0
may	I-DISEASE
be	I-DISEASE
used	0
to	0
denote	I-DISEASE
event	0
frequency	I-DISEASE
based	0
on	0
monitoring	I-DISEASE
time	0
rather	0
than	0
total	0
sleep	0
time	0
.	I-DISEASE
.	0

Respiratory	0
events	0
defined	0
according	0
the	0
most	0
recent	B-DISEASE
version	0
of	I-DISEASE
the	0
AASM	0
Manual	0
for	0
the	I-DISEASE
Scoring	I-DISEASE
of	0
Sleep	0
and	I-DISEASE
Associated	I-DISEASE
Events	0
.	0
.	0

RERAs	0
and	0
hypopnea	0
events	0
based	0
on	0
arousals	0
from	0
sleep	0
can	0
not	0
be	0
scored	I-DISEASE
using	0
OCST	0
because	I-DISEASE
arousals	0
by	I-DISEASE
EEG	0
criteria	0
can	0
not	0
be	0
identified	0
.	I-DISEASE

Essential	0
Features	0
OSA	0
is	0
characterized	0
by	0
repetitive	I-DISEASE
episodes	0
of	I-DISEASE
complete	0
(	0
apnea	0
)	0
or	0
partial	I-DISEASE
(	0
hypopnea	I-DISEASE
)	0
upper	0
airway	I-DISEASE
obstruction	0
occurring	0
during	0
sleep	0
.	I-DISEASE

These	0
events	0
often	0
result	I-DISEASE
in	0
reduc-	0
tions	0
in	I-DISEASE
blood	I-DISEASE
oxygen	0
saturation	0
and	0
are	0
usually	0
terminated	I-DISEASE
by	0
brief	0
arousals	I-DISEASE
from	0
sleep	0
.	0

By	0
definition	0
,	0
apneic	0
and	0
hypopneic	I-DISEASE
events	0
last	0
a	I-DISEASE
minimum	0
of	0
10	0
seconds	0
.	0

Most	0
events	0
are	0
10	0
to	0
30	0
seconds	0
in	0
duration	0
but	0
occasionally	0
persist	0
for	0
one	0
minute	0
or	0
longer	0
.	0

Events	0
can	0
occur	0
in	0
any	0
stage	0
of	I-DISEASE
sleep	0
but	I-DISEASE
more	0
frequently	0
occur	0
in	0
stages	0
N1	I-DISEASE
,	0
N2	0
,	I-DISEASE
and	0
R	I-DISEASE
sleep	0
than	0
in	0
stage	I-DISEASE
N3	I-DISEASE
sleep	0
.	0

Events	0
are	0
usually	0
longer	0
and	I-DISEASE
associated	I-DISEASE
with	I-DISEASE
more	0
severe	0
decreases	0
in	0
oxygen	0
saturation	0
when	I-DISEASE
they	0
occur	I-DISEASE
in	0
stage	I-DISEASE
R	0
sleep	0
and	0
when	I-DISEASE
the	I-DISEASE
individual	0
is	I-DISEASE
sleeping	I-DISEASE
supine	0
.	0

Oxygen	0
saturation	0
usually	0
returns	0
to	0
baseline	0
values	0
following	I-DISEASE
resumption	I-DISEASE
of	0
normal	0
breathing	I-DISEASE
but	0
may	0
remain	0
low	0
if	0
the	I-DISEASE
apneic	0
or	0
hypopneic	0
events	0
are	0
very	I-DISEASE
frequent	I-DISEASE
and	I-DISEASE
prolonged	0
,	0
or	0
if	0
there	0
is	0
underlying	0
pulmonary	0
pathology	0
.	0

Snoring	0
between	0
apneas	I-DISEASE
is	I-DISEASE
typically	0
reported	I-DISEASE
by	I-DISEASE
bed	0
partners	I-DISEASE
,	0
as	0
are	0
wit-	0
nessed	0
episodes	I-DISEASE
of	0
gasping	0
or	I-DISEASE
choking	0
and	0
body	0
movements	0
that	0
disrupt	I-DISEASE
sleep	I-DISEASE
.	0

Most	0
patients	0
awaken	I-DISEASE
in	0
the	0
morning	0
feeling	I-DISEASE
tired	I-DISEASE
and	0
unrefreshed	0
regardless	0
of	0
the	0
duration	0
of	I-DISEASE
their	0
time	I-DISEASE
in	I-DISEASE
bed	I-DISEASE
.	I-DISEASE

Apneas	0
,	0
hypopneas	I-DISEASE
,	0
and	0
snoring	0
may	I-DISEASE
be	0
exacerbated	I-DISEASE
following	0
the	I-DISEASE
ingestion	0
of	0
alcohol	0
,	I-DISEASE
use	0
of	0
sedating	I-DISEASE
medications	0
prior	0
to	0
sleep	0
,	0
or	I-DISEASE
following	I-DISEASE
an	0
increase	0
in	I-DISEASE
body	0
weight	0
.	0

Excessive	0
sleepiness	0
is	0
a	0
major	0
presenting	0
complaint	I-DISEASE
in	0
many	I-DISEASE
but	0
not	0
all	0
cases	0
.	0

The	0
sleepiness	0
is	0
most	0
evident	0
during	0
relaxing	0
or	0
inactive	I-DISEASE
situations	0
.	0

With	0
extreme	0
sleepi-	I-DISEASE
ness	I-DISEASE
,	0
sleep	I-DISEASE
may	I-DISEASE
occur	0
while	I-DISEASE
actively	0
conversing	0
,	0
eating	0
,	0
walking	I-DISEASE
,	0
or	0
driving	I-DISEASE
.	0

In	0
women	0
,	0
excessive	0
sleepiness	0
is	I-DISEASE
a	0
less	0
prominent	I-DISEASE
complaint	0
.	0

Additionally	0
,	0
reports	0
of	0
insomnia	0
,	0
poor	I-DISEASE
sleep	0
quality	I-DISEASE
,	0
and	0
fatigue	0
are	0
common	0
,	0
particularly	0
among	0
women	0
.	0

Quality	0
of	0
life	0
generally	0
is	I-DISEASE
adversely	0
affected	I-DISEASE
by	0
unrefreshing	I-DISEASE
sleep	0
,	0
sleepiness	0
,	0
and	0
fatigue	I-DISEASE
.	0

Bed	0
part-	0
ners	0
may	I-DISEASE
also	0
report	0
sleep	0
disruption	0
and	I-DISEASE
associated	I-DISEASE
consequences	0
.	0

The	0
frequency	0
of	0
apneas	0
and	0
hypopneas	I-DISEASE
during	I-DISEASE
sleep	0
correlates	I-DISEASE
poorly	0
with	0
daytime	0
symptom	0
severity	0
and	I-DISEASE
impact	I-DISEASE
on	0
quality	I-DISEASE
of	0
life	0
.	0

In	0
some	0
cases	0
,	B-DISEASE
affected	0
individuals	0
will	I-DISEASE
not	0
endorse	I-DISEASE
any	0
symptoms	0
or	0
confirm	0
any	0
bed	I-DISEASE
partner	0
observations	0
.	0

Associated	0
Features	0
Systemic	0
hypertension	0
is	0
a	0
common	0
finding	0
in	0
patients	0
with	0
OSA	0
.	0

There	0
is	0
substan-	0
tial	0
clinical	0
and	I-DISEASE
epidemiologic	I-DISEASE
evidence	0
implicating	I-DISEASE
OSA	0
as	0
a	I-DISEASE
significant	0
risk	0
factor	I-DISEASE
for	0
development	0
of	I-DISEASE
systemic	I-DISEASE
hypertension	I-DISEASE
independent	0
of	0
other	0
conditions	I-DISEASE
such	I-DISEASE
as	0
obesity	0
and	0
smoking	0
.	I-DISEASE

Additionally	0
,	0
OSA	0
is	0
frequently	0
observed	0
in	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
cor-	I-DISEASE
onary	0
artery	0
disease	0
,	0
atrial	I-DISEASE
fibrillation	0
,	0
and	I-DISEASE
stroke	0
,	I-DISEASE
and	0
it	0
may	0
be	0
an	I-DISEASE
independent	0
risk	I-DISEASE
factor	B-DISEASE
for	0
these	I-DISEASE
conditions	0
.	0

OSA	0
is	0
also	0
associated	0
with	0
type	0
2	I-DISEASE
diabetes	0
,	I-DISEASE
and	0
there	0
are	0
accumulating	I-DISEASE
data	0
to	I-DISEASE
suggest	0
that	0
it	I-DISEASE
is	0
a	0
risk	0
factor	0
for	0
the	0
development	I-DISEASE
of	0
type	0
2	0
diabetes	I-DISEASE
.	0

Patients	0
with	0
severe	B-DISEASE
disease	0
may	0
be	0
at	I-DISEASE
risk	I-DISEASE
for	I-DISEASE
developing	0
pulmo-	0
nary	I-DISEASE
hypertension	0
and	0
cor	I-DISEASE
pulmonale	I-DISEASE
,	0
although	I-DISEASE
this	0
is	0
usually	0
seen	0
only	I-DISEASE
in	I-DISEASE
patients	0
with	0
daytime	I-DISEASE
hypercapnia	I-DISEASE
due	0
to	0
comorbid	0
conditions	0
such	0
as	0
morbid	0
obesity	0
or	0
chronic	I-DISEASE
obstructive	0
pulmonary	0
disease	I-DISEASE
(	0
COPD	0
)	0
.	0

When	0
OSA	0
coexists	0
with	0
dilated	0
cardiomyopathy	I-DISEASE
or	I-DISEASE
ischemic	0
heart	I-DISEASE
disease	0
,	0
there	I-DISEASE
may	0
be	I-DISEASE
worsening	I-DISEASE
of	0
the	0
underly-	I-DISEASE
ing	I-DISEASE
heart	0
disease	0
and	0
predisposition	I-DISEASE
to	0
congestive	I-DISEASE
heart	0
failure	0
.	I-DISEASE

Gastroesophageal	0
reflux	0
symptoms	0
,	0
nocturia	I-DISEASE
,	0
mood	0
disturbance	0
,	I-DISEASE
and	0
erectile	0
dysfunction	0
are	I-DISEASE
some-	0
times	I-DISEASE
reported	0
in	0
patients	0
with	0
OSA	I-DISEASE
.	0

The	0
disorder	0
can	I-DISEASE
also	0
be	0
associated	I-DISEASE
with	I-DISEASE
the	0
following	I-DISEASE
motor	0
parasomnias	0
:	0
OSA	0
-	0
induced	I-DISEASE
arousals	I-DISEASE
from	0
non	I-DISEASE
-	0
rapid	0
eye	0
movement	0
(	0
NREM	0
)	0
sleep	I-DISEASE
mimicking	0
a	0
primary	0
disorder	I-DISEASE
of	0
arousal	0
(	0
confusional	0
arousal	0
,	0
sleep-	0
walking	I-DISEASE
,	0
or	I-DISEASE
sleep	I-DISEASE
terrors	I-DISEASE
)	0
;	0
OSA	0
-	I-DISEASE
induced	I-DISEASE
arousals	I-DISEASE
from	0
REM	0
sleep	0
mimicking	0
REM	I-DISEASE
sleep	0
behavior	0
disorder	I-DISEASE
;	0
disorders	I-DISEASE
of	0
arousal	I-DISEASE
from	I-DISEASE
NREM	0
associated	I-DISEASE
with	0
slow	0
wave	I-DISEASE
sleep	I-DISEASE
rebound	0
during	0
initiation	I-DISEASE
of	0
nasal	0
continuous	I-DISEASE
positive	I-DISEASE
airway	I-DISEASE
pressure	I-DISEASE
(	0
CPAP	I-DISEASE
)	0
therapy	0
of	0
OSA	I-DISEASE
;	0
OSA	0
-	I-DISEASE
induced	I-DISEASE
arousals	0
linked	0
with	I-DISEASE
sleep	I-DISEASE
related	I-DISEASE
eating	I-DISEASE
disorder	0
;	I-DISEASE
and	I-DISEASE
OSA	0
-	I-DISEASE
induced	0
nocturnal	0
seizures	0
or	0
cerebral	I-DISEASE
anoxic	0
attacks	0
with	0
prominent	0
motor	0
activity	I-DISEASE
.	I-DISEASE

Severity	0
of	0
OSA	0
as	0
determined	0
by	0
the	I-DISEASE
frequency	0
of	I-DISEASE
apneas	0
and	I-DISEASE
hypopneas	0
and/or	0
degree	0
of	I-DISEASE
oxygen	0
desaturation	I-DISEASE
correlates	I-DISEASE
poorly	0
with	0
symptomatic	0
sleepiness	0
.	0

Different	0
measures	0
of	0
sleepiness	0
,	0
including	0
self	I-DISEASE
-	0
reported	I-DISEASE
severity	0
of	0
sleepiness	0
,	0
commonly	0
used	0
indices	0
such	0
as	I-DISEASE
the	0
Epworth	0
Sleepiness	0
Scale	0
,	I-DISEASE
and	0
objective	I-DISEASE
measures	0
such	I-DISEASE
as	0
the	0
Multiple	0
Sleep	I-DISEASE
Latency	I-DISEASE
Test	0
(	0
MSLT	0
)	I-DISEASE
,	0
are	I-DISEASE
not	0
strongly	0
correlated	I-DISEASE
and	I-DISEASE
,	0
thus	0
,	I-DISEASE
assessment	0
of	0
sleepiness	I-DISEASE
can	0
be	I-DISEASE
difficult	0
and	0
relatively	I-DISEASE
unreliable	0
.	0

In	0
addition	0
,	0
patients	0
may	0
adapt	0
to	I-DISEASE
any	0
level	0
of	0
sleepiness	0
over	I-DISEASE
time	0
and	0
fail	0
to	I-DISEASE
view	0
it	I-DISEASE
as	0
a	0
reportable	0
problem	0
.	0

Bed	0
partner	0
-	0
observed	I-DISEASE
breathing	I-DISEASE
pauses	0
and	I-DISEASE
disruptive	0
snoring	I-DISEASE
may	I-DISEASE
not	0
always	I-DISEASE
be	0
accompa-	0
nied	I-DISEASE
by	0
patient	I-DISEASE
complaints	I-DISEASE
of	0
sleepiness	0
.	0

Finally	0
,	0
it	0
is	0
important	0
to	I-DISEASE
note	I-DISEASE
that	I-DISEASE
sleepiness	I-DISEASE
is	I-DISEASE
a	0
condition	0
with	0
a	I-DISEASE
number	I-DISEASE
of	0
possible	0
etiologies	I-DISEASE
and	0
a	0
range	0
of	0
manifestations	I-DISEASE
(	I-DISEASE
see	I-DISEASE
Differential	0
Diagnosis	0
)	I-DISEASE
.	0

Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Sleep	I-DISEASE
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Clinical	I-DISEASE
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Apneas	0
and	I-DISEASE
hypopneas	I-DISEASE
are	I-DISEASE
believed	0
to	I-DISEASE
have	0
similar	0
pathophysiology	0
and	0
consequences	I-DISEASE
.	I-DISEASE

Therefore	0
,	0
from	0
a	0
clinical	0
perspective	0
,	I-DISEASE
there	0
is	I-DISEASE
little	0
importance	0
in	0
distinguishing	0
patients	0
who	I-DISEASE
have	0
predominantly	0
apnea	I-DISEASE
from	0
those	I-DISEASE
who	0
have	0
predominantly	0
hypopnea	0
.	0

Occasionally	0
,	0
patients	0
may	I-DISEASE
demonstrate	0
only	I-DISEASE
REM	I-DISEASE
-	0
related	I-DISEASE
apneas	0
or	I-DISEASE
hypopneas	0
,	I-DISEASE
but	0
there	I-DISEASE
is	0
no	0
consensus	I-DISEASE
to	0
suggest	0
that	0
this	0
is	0
a	I-DISEASE
distinct	I-DISEASE
clinical	0
or	I-DISEASE
pathophysiological	I-DISEASE
subtype	0
.	I-DISEASE

Some	0
patients	0
have	I-DISEASE
relatively	0
few	0
arterial	0
oxygen	I-DISEASE
desaturations	I-DISEASE
but	I-DISEASE
a	0
significant	0
number	0
of	0
respiratory	0
events	I-DISEASE
characterized	0
by	0
narrowing	I-DISEASE
of	0
the	0
upper	0
airway	0
result-	0
ing	0
in	I-DISEASE
brief	0
arousals	0
from	I-DISEASE
sleep	0
.	0

Depending	0
on	0
the	0
definition	I-DISEASE
of	0
hypopnea	I-DISEASE
employed	I-DISEASE
,	0
these	I-DISEASE
events	0
typically	0
meet	0
criteria	0
for	0
either	I-DISEASE
hypopneas	0
associated	0
with	I-DISEASE
arousal	0
but	0
no	0
desaturation	0
,	0
or	0
for	0
RERAs	0
.	I-DISEASE

When	0
initially	0
described	0
,	0
this	0
latter	0
group	0
was	0
said	I-DISEASE
to	0
have	0
UARS	0
.	0

Current	0
data	I-DISEASE
suggest	0
that	0
this	0
condition	0
represents	I-DISEASE
simply	0
a	I-DISEASE
variant	0
of	0
OSA	0
in	0
which	0
obstructive	0
events	I-DISEASE
result	0
in	0
arousal	0
but	I-DISEASE
minimal	0
arterial	0
oxygen	0
desaturation	I-DISEASE
.	0

Patients	0
with	0
this	0
condition	0
commonly	0
snore	I-DISEASE
and	0
report	0
daytime	I-DISEASE
sleepiness	0
or	0
fatigue	0
.	0

However	0
,	I-DISEASE
there	0
are	I-DISEASE
some	0
reports	0
of	0
patients	0
with	I-DISEASE
frequent	0
respiratory	0
arousals	0
in	0
the	0
absence	0
of	I-DISEASE
snoring	0
.	I-DISEASE

They	0
tend	0
to	0
be	0
less	0
obese	0
than	0
individuals	0
who	I-DISEASE
have	0
respiratory	0
event	0
-	0
associated	0
arterial	0
oxygen	0
saturation	0
.	I-DISEASE

The	0
prevalence	0
of	0
this	0
group	0
of	0
patients	I-DISEASE
is	I-DISEASE
unknown	I-DISEASE
.	I-DISEASE

When	0
advanced	0
technology	I-DISEASE
is	I-DISEASE
used	0
to	I-DISEASE
detect	I-DISEASE
changes	0
in	I-DISEASE
airflow	0
(	0
as	0
described	I-DISEASE
in	0
the	I-DISEASE
AASM	0
Manual	I-DISEASE
for	I-DISEASE
the	0
Scoring	0
of	0
Sleep	0
and	0
Associated	0
Events	I-DISEASE
)	I-DISEASE
,	I-DISEASE
most	I-DISEASE
of	0
these	I-DISEASE
patients	0
will	0
be	0
diagnosed	0
as	I-DISEASE
having	I-DISEASE
OSA	I-DISEASE
,	I-DISEASE
as	0
defined	0
by	I-DISEASE
the	I-DISEASE
criteria	0
listed	0
above	I-DISEASE
.	I-DISEASE

COPD	0
and	0
OSA	0
frequently	0
coexist	0
,	I-DISEASE
but	0
there	0
is	I-DISEASE
no	0
common	0
pathophysiologic	0
rela-	I-DISEASE
tionship	0
.	I-DISEASE

Nevertheless	0
,	0
individuals	0
with	I-DISEASE
both	0
disorders	0
have	I-DISEASE
greater	0
nocturnal	I-DISEASE
oxygen	0
desaturation	0
and	0
daytime	I-DISEASE
hypercapnia	0
for	0
the	I-DISEASE
same	0
degree	I-DISEASE
of	0
bronchial	0
airflow	0
obstruc-	0
tion	I-DISEASE
,	0
and	I-DISEASE
greater	0
risk	I-DISEASE
of	B-DISEASE
developing	0
pulmonary	0
hypertension	0
and	0
right	0
heart	0
failure	0
.	I-DISEASE

The	0
prevalence	0
rate	I-DISEASE
for	0
having	0
both	0
conditions	0
has	0
been	0
estimated	0
to	0
be	0
1	I-DISEASE
%	0
.	0

Demographics	0
OSA	0
can	0
occur	0
in	0
any	0
age	I-DISEASE
group	0
.	0

Estimates	0
of	0
prevalence	I-DISEASE
are	I-DISEASE
very	0
dependent	I-DISEASE
on	I-DISEASE
how	0
sleep	I-DISEASE
related	0
respiratory	0
events	0
are	I-DISEASE
defined	I-DISEASE
,	I-DISEASE
as	0
well	0
as	B-DISEASE
their	0
frequency	0
and	0
other	0
criteria	0
used	0
to	I-DISEASE
define	I-DISEASE
disease	0
.	I-DISEASE

Nevertheless	0
,	0
general	0
population	0
-	0
based	I-DISEASE
studies	I-DISEASE
from	0
a	I-DISEASE
number	0
of	0
countries	0
indicate	0
that	0
OSA	I-DISEASE
associated	0
with	I-DISEASE
daytime	0
sleepiness	0
occurs	0
in	0
3	0
%	0
to	0
7	I-DISEASE
%	0
of	0
adult	I-DISEASE
men	0
and	I-DISEASE
2	0
%	0
to	0
5	0
%	0
of	0
adult	0
women	0
.	0

However	0
,	I-DISEASE
because	0
many	0
individuals	0
with	I-DISEASE
OSA	0
do	0
not	I-DISEASE
endorse	0
daytime	I-DISEASE
sleepiness	0
,	0
the	0
prevalence	I-DISEASE
of	0
the	0
disease	I-DISEASE
is	B-DISEASE
likely	0
much	0
higher	0
.	0

A	0
major	0
study	0
yielded	I-DISEASE
prevalence	0
rates	I-DISEASE
as	I-DISEASE
high	0
as	I-DISEASE
24	0
%	I-DISEASE
in	0
men	0
and	0
9	I-DISEASE
%	0
in	0
women	I-DISEASE
using	0
only	I-DISEASE
an	0
apnea	0
-	0
hypopnea	I-DISEASE
index	0
(	I-DISEASE
AHI	0
)	0
criterion	0
of	0
≥	0
5	I-DISEASE
/	0
hour	0
,	0
although	I-DISEASE
addition	0
of	I-DISEASE
a	0
daytime	0
sleepiness	0
criterion	I-DISEASE
reduced	0
these	0
estimates	0
to	I-DISEASE
4	I-DISEASE
%	I-DISEASE
in	I-DISEASE
males	I-DISEASE
and	0
2	I-DISEASE
%	0
in	I-DISEASE
females	0
.	0

The	0
prevalence	0
of	0
OSA	0
increases	0
with	0
age	I-DISEASE
,	0
although	0
it	0
appears	0
to	0
plateau	0
in	0
the	0
elderly	0
.	I-DISEASE

The	0
ratio	0
of	0
OSA	0
in	0
men	I-DISEASE
compared	0
to	0
women	I-DISEASE
is	0
approximately	0
two	0
to	0
one	0
.	I-DISEASE

This	0
dispar-	0
ity	0
may	0
decline	0
in	I-DISEASE
middle	0
to	0
older	I-DISEASE
age	0
as	0
a	0
result	0
of	0
a	0
greater	0
risk	0
for	I-DISEASE
OSA	0
in	0
women	0
after	0
menopause	0
.	I-DISEASE

OSA	0
occurs	0
in	0
all	0
racial	0
and	0
ethnic	0
groups	0
.	0

In	0
younger	0
and	0
elderly	0
groups	0
,	I-DISEASE
but	I-DISEASE
not	0
in	I-DISEASE
middle	0
-	0
aged	0
groups	0
,	0
OSA	I-DISEASE
has	0
been	0
reported	0
to	0
be	0
more	0
prevalent	0
in	0
blacks	0
than	0
whites	0
.	0

The	0
prevalence	0
of	I-DISEASE
OSA	0
in	0
Asian	I-DISEASE
patients	0
is	0
comparable	I-DISEASE
to	0
that	0
of	0
whites	0
,	0
despite	I-DISEASE
having	0
a	0
generally	I-DISEASE
lower	0
body	I-DISEASE
mass	0
index	0
(	0
BMI	0
)	I-DISEASE
.	0

Differences	0
in	0
craniofacial	0
features	I-DISEASE
that	0
predispose	I-DISEASE
Asians	0
to	0
developing	I-DISEASE
OSA	0
are	0
the	0
likely	0
explanation	0
.	I-DISEASE

Data	0
comparing	0
OSA	0
prevalence	0
rates	0
among	I-DISEASE
Hispanics	I-DISEASE
and	0
Native	I-DISEASE
Americans	0
to	0
other	I-DISEASE
racial	0
/	0
ethnic	I-DISEASE
groups	0
are	0
sparse	I-DISEASE
,	0
although	0
it	I-DISEASE
is	0
clear	0
that	0
OSA	I-DISEASE
occurs	0
commonly	0
in	0
these	0
groups	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0

The	0
major	0
predisposing	0
factor	0
for	0
OSA	I-DISEASE
is	0
excess	0
body	0
weight	0
.	0

It	0
has	0
been	0
estimated	0
that	0
~60	I-DISEASE
%	0
of	0
moderate	0
to	0
severe	0
OSA	0
is	I-DISEASE
attributable	0
to	I-DISEASE
obesity	I-DISEASE
.	0

The	0
risk	0
of	0
OSA	0
increases	0
as	I-DISEASE
the	I-DISEASE
degree	0
of	I-DISEASE
additional	0
weight	0
increases	I-DISEASE
,	I-DISEASE
with	I-DISEASE
an	I-DISEASE
extremely	0
high	I-DISEASE
preva-	I-DISEASE
lence	0
of	0
OSA	0
in	0
people	0
with	0
morbid	I-DISEASE
obesity	0
.	0

OSA	0
patients	0
with	0
normal	I-DISEASE
or	0
below	I-DISEASE
-	0
nor-	0
mal	I-DISEASE
body	0
weight	0
are	I-DISEASE
more	0
likely	0
to	I-DISEASE
have	0
upper	0
airway	I-DISEASE
obstruction	0
due	0
to	0
a	0
localized	I-DISEASE
structural	I-DISEASE
abnormality	I-DISEASE
such	0
as	0
a	I-DISEASE
maxillomandibular	0
malformation	I-DISEASE
or	0
adenotonsillar	0
enlargement	0
.	0

Increasing	0
neck	0
circumference	0
predicts	0
higher	0
AHIs	I-DISEASE
;	I-DISEASE
it	0
is	I-DISEASE
not	0
,	I-DISEASE
however	0
,	0
independent	0
of	I-DISEASE
BMI	I-DISEASE
.	I-DISEASE

Instability	0
in	0
ventilatory	0
control	0
appears	0
to	0
increase	I-DISEASE
risk	0
of	I-DISEASE
OSA	0
.	0

Those	0
patients	0
with	I-DISEASE
an	0
exaggerated	0
ventilatory	0
response	0
to	0
a	I-DISEASE
respiratory	0
disturbance	0
have	0
a	0
greater	0
propensity	0
for	I-DISEASE
obstructive	I-DISEASE
events	I-DISEASE
.	0

Menopause	0
is	0
a	I-DISEASE
risk	0
factor	0
for	0
this	I-DISEASE
disorder	0
in	0
women	0
,	0
even	0
after	0
adjustment	0
for	I-DISEASE
age	I-DISEASE
and	0
BMI	I-DISEASE
.	0

However	0
,	I-DISEASE
use	0
of	B-DISEASE
hormone	0
replacement	0
therapy	I-DISEASE
may	0
be	I-DISEASE
protective	I-DISEASE
.	0

There	0
are	0
conflicting	0
data	0
concerning	0
smoking	0
as	I-DISEASE
a	0
risk	I-DISEASE
factor	0
for	0
OSA	0
.	0

Various	0
abnormalities	0
of	0
the	0
bony	0
and	I-DISEASE
soft	I-DISEASE
tissue	0
structures	I-DISEASE
of	0
the	0
head	0
and	I-DISEASE
neck	0
may	I-DISEASE
predispose	0
the	0
individual	I-DISEASE
to	0
having	0
OSA	0
.	0

These	0
may	0
be	0
hereditary	I-DISEASE
(	0
e.g.	I-DISEASE
,	0
mandibular	0
size	I-DISEASE
,	0
mandibular	0
position	0
,	0
palatal	0
height	0
)	0
or	0
acquired	I-DISEASE
(	0
e.g.	0
,	0
enlarged	0
adenoids	0
and	0
tonsils	I-DISEASE
)	0
.	0

Endocrine	0
disorders	0
such	0
as	0
acromegaly	0
and	0
hypothy-	0
roidism	0
are	I-DISEASE
risk	0
factors	0
for	0
OSA	0
.	0

Adults	0
and	0
children	0
with	I-DISEASE
Down	0
syndrome	I-DISEASE
also	I-DISEASE
have	0
a	0
high	0
prevalence	0
of	I-DISEASE
OSA	0
.	0

OSA	0
is	0
common	0
in	0
patients	0
with	0
some	I-DISEASE
neurologic	0
disorders	I-DISEASE
that	0
affect	0
peripheral	0
muscles	0
,	0
such	I-DISEASE
as	0
myotonic	0
dystrophy	I-DISEASE
.	0

OSA	0
is	0
likely	0
made	0
worse	0
following	0
alcohol	I-DISEASE
consumption	0
or	I-DISEASE
use	0
of	0
sedating	0
medications	0
before	0
sleep	I-DISEASE
and	0
by	I-DISEASE
nocturnal	I-DISEASE
nasal	0
restriction	0
or	0
congestion	0
due	0
to	0
abnormal	0
morphology	0
,	0
rhinitis	I-DISEASE
,	0
or	I-DISEASE
both	0
.	I-DISEASE

Familial	0
Patterns	0
OSA	0
is	0
a	0
heritable	0
condition	I-DISEASE
as	0
demonstrated	I-DISEASE
by	0
familial	0
clustering	0
of	I-DISEASE
OSA	0
patients	I-DISEASE
.	0

First	0
-	0
degree	0
relatives	I-DISEASE
of	0
OSA	I-DISEASE
patients	I-DISEASE
are	0
twice	I-DISEASE
as	0
likely	0
to	0
have	0
OSA	0
in	0
comparison	0
Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
to	I-DISEASE
those	0
not	0
affected	I-DISEASE
.	0

Clustering	0
of	I-DISEASE
symptoms	0
that	I-DISEASE
are	0
associated	0
with	I-DISEASE
OSA	0
such	I-DISEASE
as	0
snoring	0
,	0
daytime	0
sleepiness	0
,	0
and	I-DISEASE
snorting	0
or	I-DISEASE
gasping	0
also	I-DISEASE
occurs	0
.	0

Heritability	0
explains	I-DISEASE
approximately	I-DISEASE
one	0
third	0
of	I-DISEASE
the	I-DISEASE
variation	0
in	I-DISEASE
the	I-DISEASE
AHI	0
,	0
with	I-DISEASE
a	0
substantial	0
proportion	0
of	0
the	I-DISEASE
heritability	0
explained	0
by	0
obesity	0
.	I-DISEASE

Other	0
inherited	0
traits	I-DISEASE
that	0
might	0
predispose	0
an	I-DISEASE
indi-	0
vidual	I-DISEASE
to	0
developing	0
OSA	0
include	I-DISEASE
craniofacial	0
morphology	I-DISEASE
and	0
ventilatory	0
control	I-DISEASE
.	0

Familial	0
environmental	0
factors	0
such	0
as	0
physical	0
activity	I-DISEASE
and	0
eating	0
habits	0
may	0
play	0
a	I-DISEASE
role	0
as	0
well	0
.	0

Nevertheless	0
,	0
genetic	0
studies	0
to	0
date	0
have	0
not	0
identified	I-DISEASE
a	0
unique	0
gene	0
or	0
genes	0
responsible	0
for	0
OSA	0
heritability	I-DISEASE
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
As	I-DISEASE
documented	0
in	I-DISEASE
longitudinal	0
population	I-DISEASE
studies	0
,	0
the	0
severity	0
of	I-DISEASE
untreated	0
OSA	I-DISEASE
mea-	I-DISEASE
sured	0
by	0
the	0
AHI	0
tends	0
to	0
slowly	I-DISEASE
progress	0
over	0
time	0
.	0

OSA	0
becomes	0
more	0
severe	0
in	0
patients	I-DISEASE
whose	0
BMI	0
increases	I-DISEASE
,	0
but	0
may	0
improve	0
with	0
weight	I-DISEASE
reduction	0
.	0

However	0
,	I-DISEASE
the	0
effect	I-DISEASE
of	0
weight	I-DISEASE
gain	I-DISEASE
on	0
increasing	0
OSA	0
severity	0
is	0
greater	0
than	0
the	0
impact	0
of	I-DISEASE
weight	0
loss	0
on	0
decreasing	0
OSA	0
severity	0
.	0

Moreover	0
,	0
the	0
consequences	I-DISEASE
of	0
weight	I-DISEASE
change	I-DISEASE
are	0
more	I-DISEASE
evident	0
in	0
men	0
than	0
women	0
.	I-DISEASE

Substantial	0
evidence	0
implicates	0
OSA	0
as	0
a	I-DISEASE
risk	I-DISEASE
factor	0
for	I-DISEASE
incident	0
systemic	0
hyper-	0
tension	0
,	0
coronary	I-DISEASE
artery	0
disease	0
,	I-DISEASE
congestive	0
heart	0
failure	0
,	0
stroke	0
,	0
and	I-DISEASE
premature	0
mortality	0
.	I-DISEASE

Data	0
suggest	0
that	0
these	I-DISEASE
effects	0
are	0
more	I-DISEASE
evident	0
in	I-DISEASE
men	0
and	0
middle	I-DISEASE
-	0
aged	0
individuals	0
.	I-DISEASE

In	0
addition	0
,	0
there	0
is	I-DISEASE
accumulating	0
evidence	I-DISEASE
to	0
suggest	0
that	0
OSA	0
is	0
a	0
risk	0
factor	I-DISEASE
for	0
the	0
development	I-DISEASE
of	0
type	0
2	0
diabetes	0
mellitus	0
independent	I-DISEASE
of	I-DISEASE
obesity	I-DISEASE
.	0

Various	0
arrhythmias	0
are	0
commonly	0
observed	0
in	0
association	0
with	0
OSA	0
.	0

Evidence	0
suggests	I-DISEASE
that	0
OSA	I-DISEASE
is	0
particularly	I-DISEASE
related	I-DISEASE
to	I-DISEASE
the	I-DISEASE
onset	0
and	I-DISEASE
recurrence	0
of	0
atrial	0
fibrillation	0
.	0

OSA	0
may	0
increase	0
the	0
severity	0
of	I-DISEASE
depression	0
.	0

Because	0
of	0
daytime	0
sleepiness	0
,	I-DISEASE
func-	0
tional	I-DISEASE
impairment	0
occurs	I-DISEASE
commonly	0
as	0
manifested	0
by	I-DISEASE
poor	0
job	I-DISEASE
performance	0
,	0
loss	I-DISEASE
of	0
employment	0
,	0
impaired	0
family	0
relationships	0
,	I-DISEASE
and	0
reduction	0
in	I-DISEASE
overall	0
quality	0
of	0
life	0
.	0

The	0
risk	0
of	0
motor	0
vehicle	0
accidents	I-DISEASE
is	I-DISEASE
significantly	0
increased	I-DISEASE
among	0
those	0
with	0
OSA	0
.	0

Developmental	0
Issues	0
OSA	0
can	0
occur	0
in	I-DISEASE
any	0
age	0
group	0
,	0
but	0
in	0
adults	0
,	0
prevalence	0
accelerates	0
between	0
young	I-DISEASE
adulthood	0
and	0
middle	0
age	0
,	I-DISEASE
with	0
a	0
plateau	0
reached	0
after	I-DISEASE
approximately	0
age	0
65	0
years	0
.	0

Although	0
OSA	0
occurs	0
in	0
the	0
elderly	0
,	I-DISEASE
it	0
is	I-DISEASE
commonly	0
observed	0
with	0
few	I-DISEASE
symptoms	0
.	0

In	0
addition	0
,	0
some	0
evidence	0
suggests	0
that	I-DISEASE
risk	0
of	I-DISEASE
cardiovascular	0
disease	0
related	0
to	0
OSA	I-DISEASE
may	0
be	0
less	0
important	B-DISEASE
in	0
the	0
elderly	0
.	0

This	0
has	0
raised	0
the	0
possibility	0
that	0
its	I-DISEASE
presence	0
in	0
this	0
age	0
group	0
represents	0
a	0
distinct	0
clinical	0
variant	0
.	I-DISEASE

Pediatric	0
OSA	0
is	0
discussed	0
in	0
a	0
separate	0
section	0
(	I-DISEASE
below	0
)	0
.	0

Pathology	0
and	0
Pathophysiology	0
The	I-DISEASE
pathophysiology	0
underlying	I-DISEASE
upper	I-DISEASE
airway	0
narrowing	I-DISEASE
during	0
sleep	0
is	I-DISEASE
multifactorial	I-DISEASE
.	0

Patients	0
with	0
OSA	I-DISEASE
commonly	0
have	0
reduced	I-DISEASE
cross	0
-	0
sectional	I-DISEASE
area	0
of	0
the	0
upper	0
airway	0
lumen	I-DISEASE
due	I-DISEASE
to	0
either	0
excessive	I-DISEASE
bulk	0
of	0
soft	0
tissues	0
(	0
tongue	I-DISEASE
,	I-DISEASE
soft	I-DISEASE
palate	I-DISEASE
,	0
and	I-DISEASE
lateral	I-DISEASE
pha-	0
ryngeal	0
walls	0
)	0
or	I-DISEASE
craniofacial	0
anatomy	I-DISEASE
,	I-DISEASE
or	0
both	I-DISEASE
.	0

During	0
inspiration	0
,	0
negative	0
pressure	0
is	I-DISEASE
generated	I-DISEASE
in	0
the	0
lumen	I-DISEASE
of	0
the	0
upper	0
airway	0
,	I-DISEASE
promoting	0
closure	0
.	I-DISEASE

However	0
,	0
pharyngeal	0
dilating	0
muscles	0
act	0
to	I-DISEASE
maintain	0
patency	0
.	0

The	0
activity	0
of	0
these	0
muscles	0
decreases	0
with	I-DISEASE
sleep	0
onset	I-DISEASE
,	0
but	0
is	0
normally	0
adequate	0
to	I-DISEASE
maintain	0
an	0
open	I-DISEASE
airway	0
.	0

In	0
persons	0
with	0
OSA	0
,	0
the	0
activity	I-DISEASE
of	I-DISEASE
the	I-DISEASE
pharyngeal	0
dilating	0
muscles	0
becomes	0
insufficient	0
to	I-DISEASE
prevent	0
narrow-	0
ing	I-DISEASE
and/or	0
closure	0
of	0
the	0
upper	0
airway	0
.	I-DISEASE

This	0
state	0
-	0
dependent	I-DISEASE
change	0
is	0
the	I-DISEASE
major	I-DISEASE
con-	I-DISEASE
tributing	I-DISEASE
factor	0
leading	0
to	I-DISEASE
an	0
obstructed	I-DISEASE
upper	0
airway	I-DISEASE
.	I-DISEASE

There	0
is	0
a	0
further	0
reduction	0
in	0
tone	0
and	0
phasic	I-DISEASE
activity	0
of	0
pharyngeal	0
dilating	0
muscles	0
during	I-DISEASE
REM	I-DISEASE
sleep	0
,	I-DISEASE
particularly	0
in	0
phasic	0
REM	0
,	I-DISEASE
which	0
likely	0
contributes	I-DISEASE
to	0
apneas	I-DISEASE
and	0
hypopneas	0
that	0
are	0
longer	0
and	0
more	0
pronounced	I-DISEASE
.	0

Decreased	0
end	0
-	0
expiratory	0
lung	0
volume	0
and	I-DISEASE
falling	0
ventilatory	0
drive	0
associated	0
with	0
hypocapnia	0
also	0
predispose	I-DISEASE
to	0
upper	0
airway	0
narrowing	0
or	0
closure	0
.	0

In	0
the	0
breaths	I-DISEASE
leading	0
up	0
to	0
obstructive	I-DISEASE
apnea	0
,	I-DISEASE
end	0
-	0
expiratory	0
upper	I-DISEASE
airway	0
caliber	I-DISEASE
pro-	0

gressively	0
decreases	0
.	0

Smaller	0
end	0
-	0
expiratory	0
lung	0
volume	0
may	I-DISEASE
result	0
in	0
smaller	0
upper	0
airway	0
size	0
due	0
to	I-DISEASE
decreased	0
downward	0
traction	I-DISEASE
(	0
tracheal	0
tug	0
)	0
.	I-DISEASE

Some	0
patients	0
have	I-DISEASE
unstable	0
ventilatory	0
control	0
(	I-DISEASE
high	0
loop	I-DISEASE
gain	0
)	0
with	I-DISEASE
resulting	I-DISEASE
periods	I-DISEASE
of	I-DISEASE
hypocapnia	0
that	0
may	I-DISEASE
also	0
contribute	0
to	0
upper	0
airway	0
narrowing	I-DISEASE
.	I-DISEASE

The	0
mechanisms	0
of	0
apnea	0
/	0
hypopnea	I-DISEASE
termination	0
are	0
controversial	I-DISEASE
.	0

Event	0
termination	0
may	0
occur	0
with	0
or	0
without	0
an	I-DISEASE
associated	I-DISEASE
arousal	0
.	0

Some	0
events	0
may	0
resolve	B-DISEASE
with	0
aug-	0
mentation	B-DISEASE
of	0
upper	I-DISEASE
airway	0
muscle	0
tone	0
from	0
chemical	0
(	I-DISEASE
low	I-DISEASE
PaO2	I-DISEASE
,	I-DISEASE
high	0
PaCO2	I-DISEASE
)	0
and	0
mechanical	0
(	I-DISEASE
upper	I-DISEASE
airway	I-DISEASE
mechanoreceptors	0
)	I-DISEASE
stimuli	I-DISEASE
,	I-DISEASE
whereas	I-DISEASE
others	I-DISEASE
may	0
depend	0
on	0
a	I-DISEASE
change	0
of	0
sleep	I-DISEASE
state	0
(	I-DISEASE
arousal	I-DISEASE
)	0
at	0
either	I-DISEASE
a	I-DISEASE
cortical	I-DISEASE
or	I-DISEASE
subcortical	0
level	0
.	0

Cortical	0
arous-	0
als	I-DISEASE
are	0
associated	0
with	I-DISEASE
changes	I-DISEASE
detectable	0
by	I-DISEASE
EEG	0
,	0
whereas	0
other	0
changes	0
of	I-DISEASE
state	0
may	0
be	I-DISEASE
detectable	0
only	0
by	0
direct	0
or	0
indirect	0
measures	B-DISEASE
of	I-DISEASE
sympathetic	0
tone	I-DISEASE
.	0

Even	0
if	0
arousals	0
are	I-DISEASE
not	0
required	0
for	I-DISEASE
termination	0
of	0
all	0
obstructive	0
events	0
,	0
sleep	0
fragmentation	0
from	I-DISEASE
arousals	0
is	I-DISEASE
nevertheless	I-DISEASE
believed	0
to	0
be	0
a	0
significant	0
cause	I-DISEASE
of	0
excessive	0
daytime	I-DISEASE
sleepiness	0
.	0

Apneas	0
and	0
hypopneas	I-DISEASE
typically	0
last	I-DISEASE
considerably	I-DISEASE
longer	I-DISEASE
in	0
REM	I-DISEASE
and	0
,	I-DISEASE
in	0
some	0
patients	0
,	I-DISEASE
are	0
only	0
present	I-DISEASE
in	0
this	0
sleep	0
stage	0
.	I-DISEASE

The	0
explanation	0
for	0
this	0
finding	0
is	0
unknown	0
.	I-DISEASE

As	0
an	0
apnea	0
or	0
hypopnea	I-DISEASE
event	0
progresses	0
,	0
the	0
patient	0
gradually	0
becomes	0
more	I-DISEASE
hypox-	0
emic	I-DISEASE
;	0
the	0
degree	I-DISEASE
of	0
oxygen	0
desaturation	0
is	0
dependent	0
not	0
only	0
on	I-DISEASE
the	I-DISEASE
duration	I-DISEASE
of	0
the	0
event	0
,	I-DISEASE
but	0
also	0
on	0
the	0
patient	0
’s	0
baseline	I-DISEASE
oxygen	I-DISEASE
saturation	0
and	I-DISEASE
lung	0
volume	0
and	0
the	B-DISEASE
presence	0
of	I-DISEASE
comorbid	0
lung	0
conditions	0
.	0

Slight	0
hypercarbia	0
also	0
occurs	I-DISEASE
during	0
apneas	0
and	I-DISEASE
hypopneas	0
and	I-DISEASE
is	0
worse	0
during	I-DISEASE
REM	0
sleep	0
.	I-DISEASE

Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Sleep	I-DISEASE
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Accumulating	I-DISEASE
evidence	0
indicates	0
that	I-DISEASE
persons	0
with	I-DISEASE
OSA	I-DISEASE
have	I-DISEASE
elevated	0
levels	I-DISEASE
of	0
circu-	0
lating	0
inflammatory	0
mediators	0
related	0
to	I-DISEASE
repetitive	I-DISEASE
episodes	0
of	I-DISEASE
oxygen	0
desaturation	I-DISEASE
and	0
increased	0
sympathetic	0
nervous	0
system	0
activity	I-DISEASE
.	0

Both	0
of	0
these	0
findings	0
may	0
be	I-DISEASE
import-	I-DISEASE
ant	0
in	I-DISEASE
the	0
pathogenesis	0
of	I-DISEASE
hypertension	0
and	0
cardiovascular	0
disease	0
related	0
to	I-DISEASE
OSA	0
.	0

Objective	0
Findings	0
Obstructive	0
apneas	I-DISEASE
are	0
documented	I-DISEASE
by	0
a	0
cessation	I-DISEASE
of	I-DISEASE
airflow	0
with	I-DISEASE
ongoing	0
respiratory	0
efforts	I-DISEASE
during	I-DISEASE
PSG	0
or	I-DISEASE
an	0
OCST	0
.	0

When	0
breathing	0
effort	0
is	0
recorded	0
with	I-DISEASE
respiratory	I-DISEASE
inductance	0
plethysmography	0
,	0
it	I-DISEASE
typically	0
shows	0
paradoxical	I-DISEASE
movement	I-DISEASE
of	I-DISEASE
the	0
rib	0
cage	I-DISEASE
and	0
abdomen	0
.	0

If	0
esophageal	0
manometry	0
is	I-DISEASE
used	0
,	0
increasingly	0
large	0
swings	I-DISEASE
between	0
inspiratory	I-DISEASE
and	0
expiratory	0
efforts	0
are	I-DISEASE
observed	0
.	0

Obstructive	0
hypopneas	0
are	0
a	0
reduction	0
rather	0
than	0
a	0
cessation	0
of	0
airflow	0
with	0
ongoing	0
respiratory	0
effort	I-DISEASE
.	I-DISEASE

Increasing	0
respira-	0
tory	0
effort	0
with	0
constant	0
or	I-DISEASE
reduced	0
flow	I-DISEASE
is	0
indicative	0
of	0
increased	0
upper	0
airway	I-DISEASE
resis-	0
tance	0
.	I-DISEASE

This	0
state	0
is	0
most	0
accurately	0
identified	0
with	0
a	0
quantitative	I-DISEASE
measurement	0
of	0
flow	0
and	0
esophageal	0
manometry	0
,	I-DISEASE
although	0
it	I-DISEASE
can	0
be	I-DISEASE
inferred	0
when	0
there	0
is	0
obvious	I-DISEASE
inspira-	I-DISEASE
tory	0
airflow	I-DISEASE
limitation	0
(	I-DISEASE
flattening	0
of	0
the	0
inspiratory	0
flow	0
)	I-DISEASE
on	0
a	I-DISEASE
nasal	0
pressure	0
recording	I-DISEASE
.	I-DISEASE

Although	0
patients	0
with	I-DISEASE
OSA	0
have	0
predominantly	I-DISEASE
obstructive	0
events	0
,	I-DISEASE
they	0
may	0
also	I-DISEASE
have	I-DISEASE
variable	0
amounts	I-DISEASE
of	0
central	0
apneas	0
.	0

In	0
some	0
patients	0
,	I-DISEASE
these	0
resolve	0
with	I-DISEASE
admin-	0
istration	I-DISEASE
of	0
positive	0
airway	0
pressure	0
,	0
whereas	I-DISEASE
in	0
others	I-DISEASE
frequent	I-DISEASE
central	0
apneas	0
either	0
persist	0
or	0
emerge	0
,	I-DISEASE
at	I-DISEASE
least	0
during	I-DISEASE
the	0
initial	0
night	I-DISEASE
of	0
positive	0
airway	0
pressure	0
treatment	I-DISEASE
.	0

Oxygen	0
saturation	0
typically	0
declines	0
for	0
a	0
variable	I-DISEASE
period	0
of	I-DISEASE
time	0
following	0
the	I-DISEASE
onset	0
of	0
an	I-DISEASE
event	0
(	I-DISEASE
apnea	I-DISEASE
or	0
hypopnea	I-DISEASE
)	0
,	0
with	0
the	I-DISEASE
nadir	0
usually	0
occurring	0
after	0
normal	0
breath-	0
ing	I-DISEASE
resumes	0
.	0

The	0
degree	0
of	0
oxygen	I-DISEASE
desaturation	0
may	I-DISEASE
range	I-DISEASE
from	0
as	I-DISEASE
little	0
as	0
1	0
%	0
to	0
2	0
%	0
,	0
up	I-DISEASE
to	0
30	0
%	0
to	0
40	0
%	0
or	I-DISEASE
greater	0
.	0

If	0
the	0
baseline	I-DISEASE
oxygen	0
saturation	0
is	0
normal	I-DISEASE
,	0
there	I-DISEASE
may	0
be	0
no	I-DISEASE
discernible	0
drop	0
in	I-DISEASE
oxygen	0
saturation	0
despite	0
evidence	0
of	0
airflow	0
limitation	0
fol-	0
lowed	0
by	0
arousal	0
.	0

As	0
a	0
result	0
,	0
some	0
events	0
associated	I-DISEASE
with	0
evidence	I-DISEASE
of	0
increased	0
respi-	0
ratory	0
effort	0
(	I-DISEASE
and/or	I-DISEASE
flattening	0
of	0
inspiratory	0
flow	I-DISEASE
)	0
and	0
an	0
arousal	0
at	I-DISEASE
event	I-DISEASE
termination	0
may	0
not	0
meet	0
diagnostic	0
criteria	0
for	0
apnea	0
or	0
hypopnea	I-DISEASE
.	I-DISEASE

These	0
events	0
are	0
defined	0
as	0
RERAs	0
.	0

These	0
events	0
are	0
presumed	0
to	0
have	0
the	0
same	I-DISEASE
underlying	0
pathophysiology	0
as	0
obstructive	I-DISEASE
apneas	I-DISEASE
and	0
hypopneas	I-DISEASE
(	0
upper	0
airway	I-DISEASE
obstruction	0
)	I-DISEASE
and	0
are	I-DISEASE
considered	0
to	0
be	I-DISEASE
as	I-DISEASE
much	0
of	I-DISEASE
a	0
risk	I-DISEASE
factor	I-DISEASE
for	0
symptoms	0
of	0
unrefreshing	0
sleep	0
,	0
daytime	I-DISEASE
somnolence	I-DISEASE
,	0
and	I-DISEASE
fatigue	0
as	I-DISEASE
frank	0
apnea	0
or	I-DISEASE
hypopnea	I-DISEASE
.	I-DISEASE

The	0
EEG	0
may	0
provide	I-DISEASE
evidence	0
of	0
a	0
brief	0
arousal	I-DISEASE
from	I-DISEASE
sleep	0
,	0
and	I-DISEASE
the	0
submental	I-DISEASE
electro-	I-DISEASE
myogram	0
may	I-DISEASE
demonstrate	0
a	0
burst	0
of	0
activity	0
indicating	I-DISEASE
upper	I-DISEASE
airway	0
dilating	0
muscle	I-DISEASE
activation	0
immediately	0
preceding	0
the	I-DISEASE
resumption	0
of	0
normal	0
breathing	I-DISEASE
.	0

Microphones	0
may	0
record	0
a	0
sudden	0
resumption	0
of	0
loud	0
snoring	0
.	0

Obstructive	0
apneas	0
and	0
hypopneas	0
may	0
be	I-DISEASE
accompanied	I-DISEASE
by	0
bradyarrhythmias	I-DISEASE
,	0
tachyarrhythmias	0
,	0
or	0
both	0
;	I-DISEASE
however	0
,	0
the	I-DISEASE
prevalence	0
of	0
this	0
finding	0
in	0
patients	I-DISEASE
varies	0
widely	0
.	0

At	0
the	I-DISEASE
time	I-DISEASE
of	0
arousals	0
,	I-DISEASE
there	I-DISEASE
is	0
often	I-DISEASE
a	0
surge	0
in	0
both	0
sympathetic	0
nervous	0
system	0
activity	0
and	I-DISEASE
systemic	0
blood	I-DISEASE
pressure	0
.	0

Differential	0
Diagnosis	0

In	0
contrast	0
to	0
patients	I-DISEASE
with	0
OSA	0
,	I-DISEASE
those	0
with	I-DISEASE
isolated	0
snoring	0
will	0
not	0
exhibit	0
obstruc-	I-DISEASE
tive	I-DISEASE
apneas	I-DISEASE
,	I-DISEASE
hypopneas	0
,	0
or	0
RERAs	I-DISEASE
on	I-DISEASE
PSG	0
or	I-DISEASE
OCST	0
and	I-DISEASE
do	0
not	0
have	0
other	0
sleep	0
symp-	0
toms	0
attributable	0
to	0
breathing	0
disturbance	I-DISEASE
.	0

However	0
,	I-DISEASE
because	0
arousal	0
-	0
based	0
hypopneas	0
and	0
RERAs	0
can	0
not	0
be	0
identified	0
with	0
OCST	I-DISEASE
,	0
OSA	0
can	I-DISEASE
not	0
be	0
excluded	0
if	0
the	0
OCST	0
is	0
negative	0
.	0

Patients	0
with	0
central	B-DISEASE
sleep	0
apnea	0
have	I-DISEASE
predominantly	I-DISEASE
central	I-DISEASE
rather	0
than	0
obstruc-	0
tive	0
apneas	0
,	0
hypopneas	I-DISEASE
,	0
or	0
RERAs	I-DISEASE
as	0
the	0
primary	0
finding	0
on	I-DISEASE
PSG	0
or	I-DISEASE
OCST	0
.	0

If	0
mixed	0
apneas	0
are	0
predominant	I-DISEASE
,	0
a	I-DISEASE
diagnosis	0
of	I-DISEASE
OSA	0
should	0
be	0
made	0
.	0

Patients	0
with	0
obesity	0
hypoventilation	0
syndrome	0
will	0
demonstrate	0
daytime	0
hypercap-	0
nia	0
.	0

Snoring	0
may	0
not	I-DISEASE
be	I-DISEASE
a	0
prominent	I-DISEASE
feature	I-DISEASE
,	0
although	0
daytime	0
sleepiness	0
can	0
occur	0
.	0

Patients	0
with	0
sleep	0
related	0
hypoventilation	0
disorders	I-DISEASE
may	I-DISEASE
show	0
episodes	I-DISEASE
of	0
oxygen	0
desaturation	0
without	0
evidence	0
of	0
airflow	0
obstruction	0
on	I-DISEASE
PSG	0
or	0
OCST	0
.	0

Confirmation	0
of	0
nocturnal	0
hypercapnia	0
will	0
be	I-DISEASE
diagnostic	I-DISEASE
.	0

However	0
,	I-DISEASE
if	0
obstructive	0
apneas	0
or	0
hypo-	0
pneas	I-DISEASE
are	I-DISEASE
evident	I-DISEASE
,	0
a	0
diagnosis	0
of	0
OSA	0
should	0
be	0
made	I-DISEASE
instead	0
of	0
,	0
or	0
in	0
addition	I-DISEASE
to	I-DISEASE
,	0
the	0
diagnosis	I-DISEASE
of	B-DISEASE
sleep	I-DISEASE
related	0
hypoventilation	I-DISEASE
.	0

OSA	0
must	0
be	0
differentiated	0
from	0
other	0
causes	0
of	0
sleepiness	I-DISEASE
such	0
as	0
narcolepsy	0
,	0
idio-	0
pathic	0
hypersomnia	0
,	0
and	I-DISEASE
insufficient	0
sleep	0
.	0

These	0
conditions	0
often	0
can	I-DISEASE
be	0
identified	0
on	0
the	0
basis	I-DISEASE
of	0
history	0
,	0
but	0
PSG	0
and/or	I-DISEASE
MSLT	0
may	0
be	0
required	0
to	0
confirm	0
the	0
diagnosis	0
.	0

OSA	0
should	0
be	0
distinguished	0
from	I-DISEASE
other	I-DISEASE
causes	0
of	0
nocturnal	I-DISEASE
dyspnea	0
,	0
such	0
as	0
noc-	0
turnal	I-DISEASE
panic	0
attacks	0
,	I-DISEASE
nocturnal	0
gastroesophageal	I-DISEASE
reflux	0
,	0
asthma	I-DISEASE
,	0
paroxysmal	I-DISEASE
nocturnal	I-DISEASE
dyspnea	0
from	I-DISEASE
congestive	0
heart	0
failure	0
,	0
and	0
nocturnal	0
angina	0
pectoris	0
.	0

In	0
many	0
cases	0
,	I-DISEASE
absence	0
of	I-DISEASE
snoring	I-DISEASE
and	0
daytime	I-DISEASE
sleepiness	I-DISEASE
will	0
be	0
highly	I-DISEASE
suggestive	0
of	I-DISEASE
etiologies	I-DISEASE
other	0
than	0
OSA	0
.	I-DISEASE

However	0
,	I-DISEASE
the	0
absence	I-DISEASE
of	0
obstructive	I-DISEASE
apneas	I-DISEASE
,	0
hypopneas	0
,	0
or	0
RERAs	I-DISEASE
on	0
PSG	0
will	I-DISEASE
definitively	I-DISEASE
exclude	0
OSA	I-DISEASE
as	0
the	0
diagnosis	0
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE

Although	0
substantial	0
evidence	0
implicates	0
OSA	0
as	I-DISEASE
a	0
risk	0
factor	I-DISEASE
for	0
coronary	0
artery	0
disease	0
and	0
stroke	I-DISEASE
,	0
it	0
has	0
not	0
been	I-DISEASE
clearly	0
demonstrated	0
that	0
treatment	0
mitigates	I-DISEASE
this	0
risk	0
.	0

This	0
is	0
especially	0
a	0
concern	0
for	0
patients	0
with	I-DISEASE
mild	I-DISEASE
OSA	0
who	0
are	0
not	0
hypersom-	0
nolent	I-DISEASE
.	I-DISEASE

The	0
pathophysiologic	0
mechanisms	0
linking	I-DISEASE
OSA	0
to	I-DISEASE
increased	I-DISEASE
risk	0
of	I-DISEASE
coronary	0
artery	0
disease	I-DISEASE
,	0
stroke	0
,	I-DISEASE
and	0
hypertension	I-DISEASE
require	I-DISEASE
further	0
investigation	0
.	0

Although	0
there	0
Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	0
Sleep	I-DISEASE
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
is	0
a	0
clear	I-DISEASE
association	0
between	0
OSA	0
and	0
type	I-DISEASE
2	0
diabetes	0
mellitus	0
,	0
further	0
studies	0
are	0
needed	0
to	0
determine	I-DISEASE
whether	0
OSA	I-DISEASE
is	I-DISEASE
an	0
independent	0
risk	0
factor	0
and	0
what	0
mechanisms	0
are	0
involved	0
.	0

Bibliography	0
Berry	0
RB	0
,	0
Brooks	I-DISEASE
R	I-DISEASE
,	I-DISEASE
Gamaldo	0
CE	I-DISEASE
,	0
Harding	I-DISEASE
SM	0
,	0
Lloyd	0
RM	I-DISEASE
,	0
Marcus	0
CL	I-DISEASE
and	0
Vaughn	0
BV	0
for	0
the	0
American	I-DISEASE
Academy	0
of	0
Sleep	I-DISEASE
Medicine	I-DISEASE
.	0

The	0
AASM	0
Manual	0
for	0
the	0
Scoring	0
of	I-DISEASE
Sleep	0
and	I-DISEASE
Associated	0
Events	0
:	0
Rules	I-DISEASE
,	0
Terminology	I-DISEASE
and	I-DISEASE
Technical	0
Specifications	I-DISEASE
,	0
Version	0
2.0.3	0
.	0
www.aasmnet.org	0
.	I-DISEASE

Darien	0
,	0
IL	0
:	0
American	I-DISEASE
Academy	0
of	I-DISEASE
Sleep	0
Medicine	I-DISEASE
,	0
2014	0
Berry	0
RB	0
.	0

Dreaming	0
about	0
an	0
open	0
upper	0
airway	0
.	0

Sleep	0
2006;29:429–30	0
.	0

Budhiraja	0
R	0
,	0
Budhiraja	0
P	0
,	0
Quan	I-DISEASE
SF	0
.	0

Sleep	0
-	0
disordered	0
breathing	0
and	0
cardiovascular	0
disorders	I-DISEASE
.	0

Respir	0
Care	0
2010;55:1322–32	0
.	B-DISEASE

Iber	0
C	0
,	0
Ancoli	I-DISEASE
-	0
Israel	0
S	0
,	0
Chesson	I-DISEASE
AL	0
,	0
Quan	0
SF	0
;	0
for	I-DISEASE
the	0
American	0
Academy	0
of	0
Sleep	0
Medicine	0
.	0

The	0
AASM	0
manual	0
for	0
the	0
scoring	0
of	I-DISEASE
sleep	0
and	I-DISEASE
associated	0
events	0
:	0
rules	0
,	0
terminology	0
and	0
technical	0
specifications	I-DISEASE
.	0

1st	0
ed	0
.	0

Westchester	0
,	0
IL	0
:	0
American	0
Academy	0
of	I-DISEASE
Sleep	0
Medicine	I-DISEASE
,	0
2007	0
.	0

Pamidi	0
S	0
,	0
Aronsohn	0
RS	0
,	0
Tasali	I-DISEASE
E.	0
Obstructive	I-DISEASE
sleep	0
apnea	0
:	0
role	0
in	0
the	I-DISEASE
risk	0
and	0
severity	0
of	0
diabetes	0
.	0

Best	0
Pract	I-DISEASE
Res	0
Clin	0
Endocrinol	0
Metab	I-DISEASE
2010;24:703–15	I-DISEASE
.	I-DISEASE

Patel	0
SR	I-DISEASE
,	0
Larkin	0
EK	0
,	I-DISEASE
Redline	I-DISEASE
S.	0
Shared	I-DISEASE
genetic	0
basis	0
for	0
obstructive	0
sleep	0
apnea	0
and	0
adiposity	0
measures	0
.	0

Int	0
J	0
Obes	0
(	0
Lond	0
)	0
2008;32:795–800	I-DISEASE
.	0

Pepin	0
JL	0
,	0
Guillot	0
M	0
,	0
Tamisier	I-DISEASE
R	0
,	I-DISEASE
Levy	0
P.	0

The	0
upper	0
airway	0
resistance	0
syndrome	I-DISEASE
.	I-DISEASE

Respiration	0
2012;83:559–66	0
.	0

Peppard	0
PE	0
,	0
Taheri	0
S.	0
Excess	0
weight	I-DISEASE
and	0
sleep	0
-	0
disordered	0
breathing	0
.	0

J	0
Appl	0
Physiol	0
2005;99:1592–9	0
.	0

Punjabi	0
NM	0
.	0

The	0
epidemiology	0
of	0
adult	I-DISEASE
obstructive	0
sleep	0
apnea	I-DISEASE
.	0

Proc	0
Am	0
Thorac	0
Soc	0
2008;5:136–43	I-DISEASE
.	I-DISEASE

White	0
DP	B-DISEASE
.	I-DISEASE

Sleep	0
apnea	0
.	0

Proc	0
Am	0
Thorac	0
Soc	0
2006;3:124–8	0
.	I-DISEASE

Younes	0
M.	0
Role	0
of	0
arousal	0
in	0
the	I-DISEASE
pathogenesis	0
of	0
obstructive	I-DISEASE
sleep	0
apnea	0
.	0

Am	0
J	0
Respir	0
Crit	0
Care	0
Med	I-DISEASE
2004;169:623–33	I-DISEASE
.	0

Young	0
T	I-DISEASE
,	0
Palta	0
M	0
,	0
Dempsey	I-DISEASE
J	0
,	I-DISEASE
Skatrud	0
J	0
,	0
Weber	0
S	0
,	0
Badr	I-DISEASE
S.	0

The	0
occurrence	0
of	0
sleep	0
-	0
disordered	0
breathing	I-DISEASE
among	0
middle	0
-	0
aged	0
adults	0
.	0

N	0
Engl	0
J	0
Med	0
1993;328:1230–5	0
.	0

Young	0
T	I-DISEASE
,	0
Peppard	0
PE	0
,	0
Gottlieb	I-DISEASE
DJ	0
.	I-DISEASE

Epidemiology	0
of	0
obstructive	0
sleep	0
apnea	0
:	I-DISEASE
a	I-DISEASE
population	0
health	0
perspective	0
.	0

Am	0
J	0
Respir	0
Crit	I-DISEASE
Care	0
Med	I-DISEASE
2002;165:1217–39	I-DISEASE
.	0

Obstructive	0
Sleep	0
Apnea	0
,	0
Pediatric	0
ICD-9	I-DISEASE
-	I-DISEASE
CM	I-DISEASE
code	0
:	0
327.23	0
ICD-10	0
-	0
CM	0
code	I-DISEASE
:	0
G47.33	0
Alternate	I-DISEASE
Names	0
Obstructive	0
sleep	0
apnea	0
syndrome	0
,	0
sleep	0
apnea	0
,	0
sleep	I-DISEASE
apnea	0
syndrome	0
,	I-DISEASE
obstructive	I-DISEASE
apnea	0
,	0
sleep	I-DISEASE
disordered	0
breathing	0
,	I-DISEASE
sleep	0
hypopnea	0
syndrome	0
,	0
obstructive	0
hypoventila-	0
tion	I-DISEASE
,	0
and	I-DISEASE
upper	0
airway	0
obstruction	I-DISEASE
.	I-DISEASE

The	0
term	0
upper	0
airway	0
resistance	0
syndrome	I-DISEASE
(	I-DISEASE
UARS	0
)	I-DISEASE
is	0
subsumed	0
under	0
this	I-DISEASE
diagnosis	0
because	I-DISEASE
the	0
pathophysiology	0
does	I-DISEASE
not	0
significantly	0
differ	0
from	0
that	0
of	I-DISEASE
OSA	I-DISEASE
.	I-DISEASE

Use	0
of	0
the	0
term	I-DISEASE
Pickwickian	0
syndrome	0
is	I-DISEASE
discouraged	0
,	I-DISEASE
as	0
this	0
term	0
has	0
been	0
used	0
loosely	0
to	0
cover	I-DISEASE
a	0
constellation	0
of	0
conditions	0
including	0
OSA	0
and	0
central	0
hypoventilation	0
.	0

Diagnostic	0
Criteria	0
Criteria	0
A	0
and	0
B	I-DISEASE
must	0
be	0
met	I-DISEASE
A.	0

The	0
presence	0
of	0
one	0
or	0
more	0
of	0
the	0
following	I-DISEASE
:	0
.	0

Snoring	0
.	0
.	I-DISEASE

Labored	0
,	0
paradoxical	0
,	0
or	0
obstructed	0
breathing	0
during	0
the	0
child	0
’s	0
sleep	0
.	0
.	0

Sleepiness	0
,	0
hyperactivity	0
,	0
behavioral	0
problems	0
,	0
or	0
learning	I-DISEASE
problems	0
.	0

B.	0
PSG	0
demonstrates	0
one	0
or	0
both	0
of	I-DISEASE
the	0
following	0
:	0
.	0

One	0
or	I-DISEASE
more	0
obstructive	0
apneas	0
,	0
mixed	0
apneas	I-DISEASE
,	I-DISEASE
or	I-DISEASE
hypopneas	0
,	0
per	0
hour	0
of	I-DISEASE
sleep.1	I-DISEASE
OR	0
.	I-DISEASE

A	0
pattern	0
of	0
obstructive	0
hypoventilation	0
,	0
defined	0
as	0
at	I-DISEASE
least	0
25	0
%	0
of	0
total	0
sleep	I-DISEASE
time	0
with	0
hypercapnia	I-DISEASE
(	0
PaCO2	0
>	0

50	0
mm	0
Hg	0
)	0
in	0
association	I-DISEASE
with	0
one	0
or	0
more	0
of	0
the	0
following	0
:	0
a.	0
Snoring	0
.	0

b.	0
Flattening	0
of	0
the	0
inspiratory	0
nasal	0
pressure	I-DISEASE
waveform	0
.	0

c.	0
Paradoxical	I-DISEASE
thoracoabdominal	0
motion	0
.	0

Notes	0
.	0

Respiratory	0
events	I-DISEASE
defined	0
according	0
to	0
the	0
most	B-DISEASE
recent	0
version	I-DISEASE
of	I-DISEASE
the	0
AASM	I-DISEASE
Manual	0
for	0
the	I-DISEASE
Scoring	0
of	0
Sleep	I-DISEASE
and	0
Associated	I-DISEASE
Events	0
.	0

Essential	0
Features	0
Pediatric	0
criteria	0
for	0
OSA	0
apply	0
to	0
patients	0
younger	0
than	0
18	0
years	0
.	0

However	0
,	I-DISEASE
for	0
the	0
purpose	I-DISEASE
of	0
PSG	I-DISEASE
scoring	0
,	I-DISEASE
the	0
AASM	0
Manual	I-DISEASE
for	0
the	0
Scoring	I-DISEASE
of	0
Sleep	I-DISEASE
and	I-DISEASE
Associated	0
Events	0
states	0
that	0
adult	I-DISEASE
diagnostic	0
criteria	I-DISEASE
may	0
be	0
used	I-DISEASE
for	0
patients	0
aged	I-DISEASE
13	I-DISEASE
to	0
18	0
years	0
.	0

Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Pediatric	I-DISEASE
OSA	0
is	0
characterized	I-DISEASE
by	0
intermittent	I-DISEASE
complete	I-DISEASE
or	I-DISEASE
partial	0
obstruction	I-DISEASE
(	0
obstruc-	0
tive	0
apnea	0
or	0
hypopnea	0
)	I-DISEASE
;	0
prolonged	0
partial	I-DISEASE
upper	0
airway	I-DISEASE
obstruction	0
;	0
or	0
both	0
prolonged	0
and	0
intermittent	0
obstructions	I-DISEASE
that	I-DISEASE
disrupt	0
normal	I-DISEASE
ventilation	I-DISEASE
during	I-DISEASE
sleep	0
,	0
normal	I-DISEASE
sleep	0
patterns	0
,	0
or	I-DISEASE
both	0
.	I-DISEASE

Children	0
with	0
OSA	0
may	0
demonstrate	0
several	0
breathing	I-DISEASE
patterns	0
during	0
sleep	0
.	0

Some	0
children	0
have	I-DISEASE
cyclic	0
episodes	I-DISEASE
of	0
obstructive	I-DISEASE
apnea	0
,	I-DISEASE
similar	0
to	0
that	I-DISEASE
of	0
adults	I-DISEASE
with	0
the	0
syndrome	0
.	I-DISEASE

However	0
,	I-DISEASE
some	0
patients	0
,	I-DISEASE
particularly	0
younger	I-DISEASE
children	0
,	I-DISEASE
have	0
a	0
pattern	0
of	0
obstructive	0
hypoventilation	I-DISEASE
,	0
which	0
consists	I-DISEASE
of	0
long	0
periods	0
of	0
persistent	0
partial	0
upper	I-DISEASE
airway	0
obstruction	0
associated	0
with	0
hypercapnia	I-DISEASE
,	0
arterial	I-DISEASE
oxygen	0
desatu-	0
ration	0
,	0
or	0
both	0
.	0

Some	0
children	0
may	I-DISEASE
manifest	B-DISEASE
a	0
pattern	I-DISEASE
of	0
UARS	I-DISEASE
similar	I-DISEASE
to	0
that	0
seen	I-DISEASE
in	0
adults	0
,	I-DISEASE
including	0
snoring	0
without	I-DISEASE
identifiable	0
airflow	0
obstruction	I-DISEASE
and	I-DISEASE
increasingly	I-DISEASE
negative	I-DISEASE
esophageal	I-DISEASE
pressure	I-DISEASE
swings	0
and	I-DISEASE
cyclic	0
arousals	0
.	0

In	0
children	0
,	I-DISEASE
upper	0
airway	0
obstruction	0
occurs	I-DISEASE
predominantly	0
during	I-DISEASE
REM	0
sleep	0
.	0

Children	0
often	0
do	0
not	0
have	I-DISEASE
cor-	0
tical	I-DISEASE
arousals	0
in	I-DISEASE
response	0
to	0
the	0
upper	0
airway	0
obstruction	I-DISEASE
,	0
although	I-DISEASE
they	0
may	0
have	I-DISEASE
movement	0
or	0
autonomic	0
arousals	0
.	0

Perhaps	0
as	0
a	0
result	0
of	0
this	I-DISEASE
higher	0
arousal	0
threshold	I-DISEASE
,	0
sleep	0
architecture	I-DISEASE
is	0
usually	0
normal	I-DISEASE
,	0
with	0
normal	0
amounts	0
of	0
slow	0
wave	0
sleep	0
.	I-DISEASE

Even	0
short	0
obstructive	0
apneas	0
may	0
be	0
associated	I-DISEASE
with	0
severe	I-DISEASE
hypoxemia	0
because	I-DISEASE
children	0
have	I-DISEASE
a	0
lower	I-DISEASE
functional	I-DISEASE
residual	0
capacity	0
and	I-DISEASE
a	0
higher	0
metabolic	I-DISEASE
rate	0
than	0
adults	I-DISEASE
.	0

Most	0
children	0
with	0
OSA	0
present	0
with	0
a	0
history	0
of	I-DISEASE
snoring	0
and	0
difficulty	0
breathing	0
during	0
sleep	I-DISEASE
.	0

Snoring	0
is	0
usually	I-DISEASE
loud	I-DISEASE
and	0
may	0
be	I-DISEASE
punctuated	0
by	I-DISEASE
pauses	I-DISEASE
and	0
gasps	0
,	0
with	0
associated	I-DISEASE
movements	I-DISEASE
or	0
arousal	I-DISEASE
from	0
sleep	0
.	0

However	0
,	I-DISEASE
some	0
patients	0
,	0
particu-	0
larly	I-DISEASE
infants	0
and	I-DISEASE
those	0
with	0
neuromuscular	0
weakness	0
,	0
may	0
not	0
snore	0
.	I-DISEASE

Patients	0
with	0
obstructive	0
hypoventilation	0
often	0
have	0
continuous	0
snoring	0
without	I-DISEASE
pauses	0
or	0
arous-	0
als	0
.	0

Children	0
have	0
a	0
very	0
compliant	0
rib	0
cage	0
.	0

As	0
a	0
result	0
,	0
paradoxical	0
breathing	0
is	I-DISEASE
a	0
prominent	I-DISEASE
sign	0
in	0
these	0
patients	0
(	0
note	0
that	I-DISEASE
paradoxical	0
breathing	I-DISEASE
during	0
REM	0
sleep	0
is	0
a	0
normal	0
phenomenon	I-DISEASE
in	0
young	I-DISEASE
children	I-DISEASE
up	0
to	0
at	0
least	0
age	0
three	0
years	0
)	0
.	I-DISEASE

A	0
pectus	0
excavatum	0
may	0
be	0
present	0
.	0

Thoracic	0
retractions	I-DISEASE
may	I-DISEASE
be	0
present	0
.	0

Children	0
may	0
sleep	0
in	I-DISEASE
unusual	0
positions	0
,	0
such	0
as	0
seated	0
or	0
with	0
their	0
neck	0
hyperextended	0
.	0

Diaphoresis	0
may	0
be	0
observed	0
.	0

Morning	0
headaches	0
may	I-DISEASE
also	I-DISEASE
occur	0
.	0

Many	0
parents	0
of	0
children	0
with	I-DISEASE
OSA	0
are	I-DISEASE
so	0
concerned	I-DISEASE
about	0
their	0
child	0
’s	0
breathing	0
that	0
they	0
sleep	0
with	I-DISEASE
their	0
child	I-DISEASE
or	0
stimu-	0
late	0
their	0
child	0
to	0
terminate	0
the	I-DISEASE
apneas	0
.	0

Excessive	0
daytime	0
sleepiness	0
may	I-DISEASE
be	0
present	I-DISEASE
,	0
especially	0
in	I-DISEASE
older	0
children	0
and	0
adoles-	0
cents	0
,	I-DISEASE
but	I-DISEASE
is	0
seen	0
less	0
commonly	0
in	0
children	0
than	0
in	0
adults	0
with	0
OSA	0
.	0

Developmental	0
,	0
behavioral	0
,	0
and	0
learning	0
issues	I-DISEASE
are	0
frequently	0
present	0
.	0

These	0
may	0
include	0
attention	I-DISEASE
problems	0
,	0
hyperactivity	I-DISEASE
,	0
moodiness	I-DISEASE
,	0
irritability	0
,	0
and	0
impaired	0
academic	I-DISEASE
performance	I-DISEASE
.	I-DISEASE

Associated	0
Features	0
Hypoxemia	0
and	0
hypercapnia	0
are	I-DISEASE
often	0
present	0
during	I-DISEASE
sleep	0
and	0
may	0
be	0
severe	0
.	I-DISEASE

A	0
prom-	0
inent	0
sinus	0
arrhythmia	0
is	0
often	0
seen	0
,	0
although	0
other	0
arrhythmias	0
are	0
rare	0
.	0

Secondary	0
enuresis	0
may	0
occur	0
.	0

Breathing	0
during	0
wakefulness	0
is	0
normal	0
,	I-DISEASE
although	0
mouth	0
breath-	I-DISEASE
ing	0
secondary	0
to	0
adenoidal	0
hypertrophy	0
may	I-DISEASE
be	0
present	0
.	I-DISEASE

Other	0
nonspecific	0
daytime	0
symptoms	0
related	0
to	0
adenotonsillar	0
hypertrophy	0
,	I-DISEASE
such	0
as	0
frequent	0
upper	I-DISEASE
respiratory	0
tract	0
infections	I-DISEASE
or	0
dysphagia	I-DISEASE
,	0
may	0
occur	0
.	0

Although	0
studies	0
have	0
shown	0
that	0
children	I-DISEASE
with	I-DISEASE
OSA	0
generally	I-DISEASE
have	0
larger	0
tonsils	0
and	0
adenoidal	0
tissue	I-DISEASE
than	I-DISEASE
do	0
other	I-DISEASE
children	0
,	0
the	0
size	0
of	0
the	I-DISEASE
tonsils	0
and	I-DISEASE
adenoidal	0
tissue	I-DISEASE
does	I-DISEASE
not	0
predict	0
disease	0
in	0
individual	0
patients	0
.	0

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Clinical	I-DISEASE
presentations	I-DISEASE
include	I-DISEASE
OSA	I-DISEASE
,	I-DISEASE
obstructive	0
hypoventilation	I-DISEASE
,	0
and	I-DISEASE
recurrent	0
arousal	I-DISEASE
associated	0
with	0
increased	I-DISEASE
respiratory	0
effort	0
(	0
RERAs	0
)	0
.	0

Demographics	0
The	0
prevalence	0
in	0
children	0
has	0
been	I-DISEASE
estimated	0
at	I-DISEASE
1	0
%	0
to	0
4	I-DISEASE
%	0
,	0
but	0
the	0
prevalence	0
may	0
currently	0
be	0
higher	B-DISEASE
due	0
to	I-DISEASE
the	I-DISEASE
pediatric	0
obesity	0
epidemic	I-DISEASE
.	I-DISEASE

The	0
prevalence	0
in	0
infants	0
and	0
adolescents	I-DISEASE
is	0
unknown	0
.	I-DISEASE

In	0
prepubertal	0
children	0
,	I-DISEASE
the	0
disease	0
occurs	I-DISEASE
equally	0
among	I-DISEASE
boys	0
and	0
girls	0
;	0
in	0
adolescents	I-DISEASE
,	0
data	I-DISEASE
suggest	I-DISEASE
the	0
prevalence	0
may	0
be	0
higher	0
in	I-DISEASE
males	I-DISEASE
.	0

There	0
appears	0
to	0
be	0
a	0
higher	I-DISEASE
prevalence	I-DISEASE
in	I-DISEASE
black	0
children	0
than	I-DISEASE
white	0
children	0
;	I-DISEASE
the	I-DISEASE
prev-	I-DISEASE
alence	0
in	I-DISEASE
other	0
ethnic	0
groups	0
is	0
unknown	0
.	0

The	0
disease	0
can	0
occur	0
at	0
any	I-DISEASE
age	0
,	0
from	I-DISEASE
the	0
neonatal	I-DISEASE
period	0
to	0
adolescence	0
,	0
but	0
in	0
otherwise	I-DISEASE
healthy	0
children	0
it	0
is	0
most	0
common	0
in	I-DISEASE
the	0
preschool	0
age	0
(	0
in	0
association	I-DISEASE
with	0
adenotonsillar	0
hypertrophy	0
)	0
and	0
in	0
adolescents	0
(	0
in	0
association	B-DISEASE
with	0
obesity	0
)	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
Adenotonsillar	0
hypertrophy	I-DISEASE
and	I-DISEASE
obesity	0
are	I-DISEASE
the	0
most	0
common	I-DISEASE
predisposing	0
/	0
precip-	I-DISEASE
itating	0
factors	0
.	I-DISEASE

Children	0
with	0
craniofacial	0
abnormalities	B-DISEASE
,	0
particularly	0
micrognathia	I-DISEASE
or	0
midfacial	0
hypoplasia	0
,	0
are	I-DISEASE
at	0
risk	0
.	0

Those	0
with	0
Down	0
syndrome	I-DISEASE
are	0
particularly	0
at	I-DISEASE
risk	I-DISEASE
for	I-DISEASE
having	0
OSA	0
.	0

Children	0
with	0
neuromuscular	0
diseases	0
often	0
have	0
upper	I-DISEASE
airway	0
muscle	I-DISEASE
weakness	0
,	0
which	0
predisposes	I-DISEASE
to	0
airway	I-DISEASE
collapse	0
.	I-DISEASE

Children	0
with	0
cerebral	0
palsy	0
may	0
be	0
predisposed	0
to	0
OSA	I-DISEASE
because	0
of	0
spasticity	0
,	0
weakness	0
,	I-DISEASE
or	0
incoordination	0
of	0
the	0
upper	0
airway	0
muscles	0
.	0

Infants	0
with	0
gastroesophageal	0
reflux	I-DISEASE
may	0
develop	0
OSA	I-DISEASE
due	0
to	I-DISEASE
upper	0
airway	0
edema	0
or	0
laryngospasm	0
.	I-DISEASE

Other	0
medical	0
conditions	0
such	0
as	0
mucopoly-	0
saccharidosis	I-DISEASE
and	I-DISEASE
sickle	I-DISEASE
cell	0
disease	0
may	0
predispose	0
to	0
OSA	I-DISEASE
.	I-DISEASE

Pharyngeal	0
flap	0
oper-	0
ations	0
,	0
typically	0
performed	I-DISEASE
to	0
improve	I-DISEASE
speech	0
quality	0
in	0
patients	0
with	0
cleft	0
palate	0
,	0
can	I-DISEASE
result	0
in	0
OSA	0
.	B-DISEASE

Environmental	0
tobacco	0
smoke	0
exposure	0
has	0
been	0
associated	0
with	0
snoring	I-DISEASE
and	0
OSA	0
.	0

Sleep	0
Related	0
Breathing	I-DISEASE
Disorders	0
Sleep	I-DISEASE
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Familial	I-DISEASE
Patterns	0

There	0
is	0
evidence	0
for	0
an	0
increased	I-DISEASE
risk	I-DISEASE
of	0
OSA	I-DISEASE
in	0
children	0
with	0
affected	I-DISEASE
family	0
members	I-DISEASE
.	0

Potential	0
mechanisms	0
for	0
familial	0
aggregation	0
include	0
heritability	I-DISEASE
of	0
pre-	I-DISEASE
disposing	0
skeletal	0
,	I-DISEASE
soft	0
tissue	0
,	I-DISEASE
body	0
habitus	0
,	I-DISEASE
or	0
respiratory	0
control	0
characteristics	0
.	0

However	0
,	0
the	0
relative	0
roles	0
of	0
genetic	I-DISEASE
factors	0
versus	I-DISEASE
environmental	0
factors	0
have	0
not	0
been	0
determined	0
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
The	I-DISEASE
exact	0
course	0
of	0
pediatric	0
OSA	0
has	I-DISEASE
not	0
been	I-DISEASE
well	0
studied	0
.	I-DISEASE

Symptoms	0
typically	0
begin	0
within	0
the	0
first	I-DISEASE
few	0
years	0
of	I-DISEASE
life	0
,	0
although	I-DISEASE
the	0
disease	0
may	I-DISEASE
not	0
be	I-DISEASE
diagnosed	I-DISEASE
until	0
many	I-DISEASE
years	0
later	0
.	I-DISEASE

The	0
natural	0
course	0
of	0
untreated	0
OSA	0
is	0
not	0
known	I-DISEASE
.	0

A	0
few	0
short	0
-	I-DISEASE
term	0
studies	0
suggest	I-DISEASE
that	0
some	I-DISEASE
children	0
with	I-DISEASE
mild	0
disease	I-DISEASE
may	0
improve	I-DISEASE
,	0
or	0
conversely	I-DISEASE
,	I-DISEASE
have	I-DISEASE
worsening	0
of	0
the	0
condition	I-DISEASE
;	I-DISEASE
long	0
-	I-DISEASE
term	I-DISEASE
studies	0
are	0
not	0
available	0
.	0

Complications	0
are	0
frequent	0
and	0
may	I-DISEASE
be	0
severe	I-DISEASE
.	I-DISEASE

In	0
early	0
childhood	0
,	0
OSA	0
can	I-DISEASE
cause	I-DISEASE
growth	0
failure	I-DISEASE
,	0
especially	0
when	0
associated	0
with	0
a	I-DISEASE
comorbid	0
genetic	0
or	0
craniofacial	0
disorder	0
.	0

Cognitive	0
and	0
behavioral	0
complications	0
are	0
common	I-DISEASE
and	I-DISEASE
may	0
include	0
developmental	0
delay	0
,	0
poor	0
school	0
performance	I-DISEASE
,	0
attention	0
deficit	I-DISEASE
hyperactivity	0
dis-	I-DISEASE
order	0
,	0
inattention	0
and	0
impairment	I-DISEASE
in	0
concentration	I-DISEASE
,	I-DISEASE
and	I-DISEASE
aggressive	I-DISEASE
behavior	0
.	I-DISEASE

Rarely	0
,	0
cases	0
of	0
severe	0
asphyxial	I-DISEASE
brain	I-DISEASE
damage	0
,	I-DISEASE
seizures	0
,	0
and	0
coma	0
have	0
been	I-DISEASE
reported	0
.	0

Cardiovascular	0
complications	0
include	0
pulmonary	0
hypertension	I-DISEASE
,	I-DISEASE
cor	I-DISEASE
pulmonale	0
,	I-DISEASE
and	0
systemic	0
hypertension	0
.	0

Developmental	0
Issues	0
Developmental	0
issues	I-DISEASE
are	0
reviewed	0
within	0
individual	0
sections	I-DISEASE
.	0

Pathology	0
and	0
Pathophysiology	0
In	I-DISEASE
children	0
,	I-DISEASE
as	I-DISEASE
in	0
adults	I-DISEASE
,	0
OSA	I-DISEASE
results	0
from	0
a	0
combination	I-DISEASE
of	0
abnormal	0
neuromuscular	I-DISEASE
control	0
and	0
anatomical	0
narrowing	0
of	0
the	0
collapsible	I-DISEASE
(	0
supracartilaginous	0
)	0
portion	0
of	I-DISEASE
the	0
upper	0
airway	0
.	0

During	0
wakefulness	0
,	I-DISEASE
the	0
patient	0
with	I-DISEASE
OSA	I-DISEASE
compensates	0
by	I-DISEASE
augmenting	0
upper	0
airway	0
muscle	0
tone	0
to	I-DISEASE
dilate	0
the	0
upper	0
airway	0
;	0
thus	0
,	0
obstructive	0
apnea	0
does	I-DISEASE
not	0
occur	0
.	I-DISEASE

During	0
sleep	0
,	0
there	0
is	I-DISEASE
a	0
decrease	I-DISEASE
in	0
ventilatory	0
drive	0
and	0
in	0
neuromuscular	0
tone	0
,	0
facilitating	0
upper	0
airway	I-DISEASE
collapse	0
.	I-DISEASE

The	0
resultant	0
recurrent	0
hypoxemia	0
,	0
hypercapnia	I-DISEASE
,	I-DISEASE
and	0
sleep	I-DISEASE
disruption	0
may	0
lead	0
to	0
neurobehavioral	0
,	I-DISEASE
cardiovascular	I-DISEASE
,	0
and	I-DISEASE
growth	0
abnor-	0
malities	0
.	0

Childhood	0
OSA	0
has	0
also	0
been	0
associated	0
with	0
metabolic	0
and	I-DISEASE
inflammatory	0
abnormalities	0
.	0

In	0
most	0
children	0
who	I-DISEASE
are	0
otherwise	0
healthy	0
,	0
upper	I-DISEASE
airway	0
narrowing	0
is	I-DISEASE
primarily	0
due	0
to	I-DISEASE
adenotonsillar	0
hypertrophy	0
.	I-DISEASE

Pediatric	0
OSA	0
also	0
occurs	0
in	0
association	0
with	I-DISEASE
obesity	0
,	0
which	0
is	0
becoming	0
increasingly	0
prevalent	0
.	I-DISEASE

Other	0
causes	0
for	I-DISEASE
upper	0
airway	0
narrowing	0
include	I-DISEASE
craniofacial	0
anomalies	I-DISEASE
,	0
particularly	0
those	0
involving	I-DISEASE
midface	0
hypoplasia	I-DISEASE
or	0
micrognathia	0
/	I-DISEASE
retrognathia	I-DISEASE
.	0

In	0
addition	0
,	0
children	0
with	I-DISEASE
decreased	0
upper	I-DISEASE
airway	0
muscle	0
tone	I-DISEASE
or	0
abnormal	0
upper	0
airway	0
muscle	0
function	0
,	I-DISEASE
such	I-DISEASE
as	0
children	0
with	0
muscular	0
dys-	I-DISEASE
trophy	0
or	I-DISEASE
cerebral	0
palsy	0
,	I-DISEASE
are	0
at	0
increased	0
risk	0
for	0
OSA	0
.	0

Objective	0
Findings	0
PSG	0
demonstrates	I-DISEASE
obstructive	0
and	I-DISEASE
mixed	I-DISEASE
apneas	0
,	I-DISEASE
hypopneas	0
,	0
or	0
periods	I-DISEASE
of	0
obstructive	I-DISEASE
hypoventilation	I-DISEASE
.	I-DISEASE

In	0
children	0
,	I-DISEASE
obstructive	0
apneas	0
lasting	0
two	0
respiratory	0
cycles	I-DISEASE
or	I-DISEASE
longer	0
are	0
scored	0
.	0

In	0
contrast	0
to	0
adults	I-DISEASE
with	0
OSA	0
,	I-DISEASE
EEG	0
arousals	I-DISEASE
may	0
or	0
may	0
not	0
be	0
present	I-DISEASE
fol-	0
lowing	I-DISEASE
apneas	I-DISEASE
,	0
especially	0
in	0
young	0
children	0
,	I-DISEASE
although	I-DISEASE
subcortical	I-DISEASE
/	0
autonomic	I-DISEASE
arousals	0
(	0
as	0
manifested	0
by	0
body	0
movements	0
,	0
tachycardia	0
,	I-DISEASE
or	0
measurements	0
of	I-DISEASE
pulse	I-DISEASE
transit	0
time	0
or	0
arterial	I-DISEASE
tonometry	I-DISEASE
)	0
may	0
occur	0
.	0

Possibly	0
as	0
a	I-DISEASE
result	I-DISEASE
of	0
the	I-DISEASE
higher	0
arousal	0
threshold	I-DISEASE
,	0
sleep	0
architecture	0
is	0
usually	0
preserved	0
.	0

Apneas	0
and	0
hypopneas	I-DISEASE
occur	0
primarily	I-DISEASE
during	I-DISEASE
REM	I-DISEASE
sleep	0
,	I-DISEASE
and	0
breathing	I-DISEASE
may	0
be	I-DISEASE
totally	0
normal	I-DISEASE
during	0
NREM	I-DISEASE
sleep	I-DISEASE
.	0

Obstructive	0
events	0
are	0
frequently	0
associated	0
with	0
desaturation	I-DISEASE
and	0
hypercapnia	I-DISEASE
.	0

Evaluation	0
of	0
the	0
upper	I-DISEASE
airway	0
by	0
endoscopy	I-DISEASE
,	0
radiography	I-DISEASE
,	0
computed	0
tomographic	0
scans	0
,	0
or	I-DISEASE
magnetic	0
resonance	0
imaging	I-DISEASE
studies	0
may	0
show	0
large	0
tonsils	0
and	0
adenoidal	I-DISEASE
tissue	0
and	0
a	0
narrow	B-DISEASE
upper	0
airway	0
,	0
although	0
these	0
tests	0
are	0
not	I-DISEASE
performed	0
routinely	I-DISEASE
.	0

Echocardiography	0
may	0
show	0
evidence	B-DISEASE
of	0
right	0
,	0
left	0
,	I-DISEASE
or	0
biventricular	0
hypertrophy	I-DISEASE
.	0

Differential	0
Diagnosis	0
Pediatric	0
OSA	0
must	0
be	I-DISEASE
differentiated	0
from	0
isolated	I-DISEASE
snoring	0
.	0

Children	0
with	0
snoring	0
but	0
without	I-DISEASE
observed	I-DISEASE
apnea	0
,	I-DISEASE
labored	I-DISEASE
breathing	0
during	I-DISEASE
sleep	0
,	0
daytime	0
behavioral	I-DISEASE
issues	0
,	I-DISEASE
sleepiness	I-DISEASE
,	0
or	0
other	0
symptoms	0
of	0
OSA	I-DISEASE
may	0
not	0
require	0
further	I-DISEASE
laboratory	0
investigation	I-DISEASE
.	0

However	0
,	I-DISEASE
children	0
who	I-DISEASE
have	0
snoring	0
and	0
symptoms	I-DISEASE
of	I-DISEASE
OSA	0
need	0
evaluation	0
to	0
deter-	0
mine	I-DISEASE
whether	0
they	0
have	I-DISEASE
isolated	0
snoring	0
or	0
OSA	0
(	0
N.B.	0
this	0
distinction	0
can	I-DISEASE
not	I-DISEASE
reliably	0
be	0
made	0
clinically	I-DISEASE
but	0
should	0
be	0
based	0
on	0
PSG	I-DISEASE
)	0
.	I-DISEASE

Children	0
with	0
primary	0
snoring	0
do	0
not	I-DISEASE
have	I-DISEASE
apneas	0
,	I-DISEASE
gas	0
exchange	0
abnormalities	I-DISEASE
,	0
or	0
frequent	I-DISEASE
arousals	0
on	I-DISEASE
PSG	I-DISEASE
.	0

Central	0
sleep	0
apnea	I-DISEASE
can	0
be	I-DISEASE
differentiated	0
from	I-DISEASE
OSA	I-DISEASE
by	I-DISEASE
the	0
lack	0
of	I-DISEASE
chest	0
or	I-DISEASE
abdominal	I-DISEASE
wall	0
move-	0
ment	0
associated	I-DISEASE
with	0
the	0
central	0
apneas	0
.	0

Mixed	0
apneas	0
may	0
be	I-DISEASE
seen	0
and	0
are	0
included	0
in	0
the	0
diagnosis	0
of	0
OSA	0
.	0

Children	0
with	0
fixed	0
upper	0
airway	0
obstruction	0
due	I-DISEASE
to	0
struc-	I-DISEASE
tural	0
abnormalities	0
tend	0
to	0
obstruct	0
both	I-DISEASE
awake	I-DISEASE
and	0
asleep	I-DISEASE
,	0
and	0
have	0
stridor	0
rather	0
than	0
snoring	0
.	0

OSA	0
in	0
children	0
must	0
be	I-DISEASE
distinguished	0
from	I-DISEASE
nonobstructive	0
alveolar	0
hypoventilation	0
.	0

Children	0
with	0
lung	0
or	0
chest	0
wall	0
disease	I-DISEASE
may	0
have	I-DISEASE
desaturation	0
and	0
hypercapnia	0
during	0
sleep	0
.	I-DISEASE

It	0
may	0
be	0
difficult	I-DISEASE
to	0
separate	0
nonobstructive	I-DISEASE
hypoventila-	0
tion	I-DISEASE
and	I-DISEASE
desaturation	0
from	0
OSA	I-DISEASE
,	0
especially	I-DISEASE
because	0
the	0
two	I-DISEASE
conditions	0
may	0
coexist	0
.	0

In	0
general	0
,	0
children	0
with	I-DISEASE
nonobstructive	0
hypoventilation	0
will	0
not	I-DISEASE
snore	0
and	0
will	0
not	0
have	0
paradoxical	0
inward	0
rib	I-DISEASE
cage	I-DISEASE
motion	0
during	I-DISEASE
inspiration	0
,	0
although	I-DISEASE
the	I-DISEASE
latter	0
may	0
be	I-DISEASE
present	0
in	0
children	0
with	I-DISEASE
neuromuscular	I-DISEASE
disease	0
.	0

OSA	0
must	0
be	0
differentiated	0
from	0
Sleep	0
Related	0
Breathing	I-DISEASE
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	0
other	0
causes	I-DISEASE
of	0
sleepiness	I-DISEASE
such	I-DISEASE
as	0
narcolepsy	0
,	0
idiopathic	0
hypersomnia	0
,	0
and	I-DISEASE
insufficient	0
sleep	I-DISEASE
.	I-DISEASE

Sleep	0
related	I-DISEASE
epilepsy	I-DISEASE
may	0
mimic	0
obstructive	I-DISEASE
apnea	I-DISEASE
during	0
sleep	I-DISEASE
and	0
may	0
be	I-DISEASE
indistinguishable	0
from	I-DISEASE
OSA	I-DISEASE
without	I-DISEASE
the	I-DISEASE
appropriate	I-DISEASE
EEG	0
monitoring	I-DISEASE
,	0
especially	0
in	0
infants	0
who	I-DISEASE
may	0
have	0
only	I-DISEASE
subtle	0
motor	I-DISEASE
components	I-DISEASE
of	0
seizures	0
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE

There	0
is	0
a	0
need	0
for	0
further	0
research	0
in	0
many	0
aspects	0
of	0
pediatric	0
OSA	0
.	0

Although	0
studies	0
of	0
prevalence	0
have	I-DISEASE
been	0
performed	0
in	0
the	0
past	I-DISEASE
,	0
the	0
prevalence	I-DISEASE
has	0
probably	0
increased	0
in	0
recent	0
years	0
due	I-DISEASE
to	0
the	0
increasing	I-DISEASE
prevalence	0
of	I-DISEASE
childhood	0
obesity	0
.	0

Further	0
data	0
regarding	0
the	I-DISEASE
prevalence	0
in	I-DISEASE
infants	0
and	0
adolescents	I-DISEASE
is	0
needed	0
.	0

The	0
natural	0
course	0
of	0
the	0
disease	I-DISEASE
,	I-DISEASE
the	0
optimal	I-DISEASE
techniques	0
for	0
monitoring	0
patients	0
during	0
PSG	I-DISEASE
,	0
the	0
effects	I-DISEASE
of	I-DISEASE
mild	0
OSA	0
,	I-DISEASE
and	0
the	0
threshold	I-DISEASE
necessitating	0
treatment	I-DISEASE
require	I-DISEASE
further	0
study	0
.	0

The	0
role	0
of	0
genetic	0
,	0
ethnic	0
,	I-DISEASE
and	0
anatomic	I-DISEASE
factors	0
in	0
the	0
pathophysiology	0
of	0
childhood	I-DISEASE
OSA	0
also	I-DISEASE
requires	I-DISEASE
further	0
study	I-DISEASE
.	0

Bibliography	0
Arens	0
R	0
,	0
Marcus	0
CL	0
.	0

Pathophysiology	0
of	0
upper	I-DISEASE
airway	I-DISEASE
obstruction	0
:	I-DISEASE
a	I-DISEASE
developmental	0
perspective	0
.	I-DISEASE

Sleep	0
2004;27:997–1019	0
.	0

Arens	0
R	0
,	0
McDonough	B-DISEASE
JM	0
,	0
Costarino	I-DISEASE
AT	0
,	I-DISEASE
et	0
al	0
.	0

Magnetic	0
resonance	0
imaging	0
of	0
the	0
upper	I-DISEASE
airway	I-DISEASE
structure	0
in	0
children	I-DISEASE
with	I-DISEASE
obstructive	0
sleep	I-DISEASE
apnea	0
syndrome	I-DISEASE
.	0

Am	0
J	0
Respir	0
Crit	0
Care	0
Med	0
2001;164:698–703	I-DISEASE
.	0

Marcus	0
CL	0
,	I-DISEASE
Brooks	0
LJ	0
,	0
Davidson	I-DISEASE
Ward	0
S	I-DISEASE
,	0
et	0
al	0
.	0
;	0
American	I-DISEASE
Academy	0
of	0
Pediatrics	I-DISEASE
.	0

Diagnosis	0
and	0
management	0
of	I-DISEASE
childhood	0
obstructive	0
sleep	I-DISEASE
apnea	0
syndrome	I-DISEASE
:	0
technical	0
report	I-DISEASE
.	I-DISEASE

American	0
Academy	0
of	0
Pediatrics	0
.	0

Pediatrics	0
2012;130	0
:	0
e714–55	0
.	0

Marcus	0
CL	0
,	I-DISEASE
Brooks	0
LJ	0
,	0
Draper	I-DISEASE
K	0
,	I-DISEASE
Gozal	0
D	0
,	0
et	0
al	0
.	I-DISEASE
;	I-DISEASE
American	0
Academy	I-DISEASE
of	0
Pediatrics	0
.	0

Diagnosis	0
and	0
management	0
of	I-DISEASE
childhood	0
obstructive	0
sleep	I-DISEASE
apnea	0
syndrome	I-DISEASE
:	0
clinical	0
practice	I-DISEASE
guideline	I-DISEASE
.	0

American	0
Academy	0
of	0
Pediatrics	0
.	0

Pediatrics	0
2012;130:576–84	0
.	0

Redline	0
S	0
,	0
Tishler	0
PV	0
,	I-DISEASE
Schluchter	0
M	0
,	I-DISEASE
Aylor	0
J	0
,	0
Clark	I-DISEASE
K	0
,	I-DISEASE
Graham	0
G.	0
Risk	I-DISEASE
factors	I-DISEASE
for	0
sleep	0
-	0
disordered	0
breathing	0
in	I-DISEASE
children	0
.	I-DISEASE

Associations	0
with	0
obesity	0
,	0
race	0
,	I-DISEASE
and	I-DISEASE
respiratory	0
problems	I-DISEASE
.	0

Am	0
J	0
Respir	0
Crit	I-DISEASE
Care	0
Med	I-DISEASE
1999;159:1527–32	I-DISEASE
.	0

Central	0
Sleep	0
Apnea	I-DISEASE
Syndromes	0
Central	I-DISEASE
Sleep	0
Apnea	I-DISEASE
with	0
Cheyne	I-DISEASE
-	0
Stokes	0
Breathing	I-DISEASE
ICD-9	0
-	I-DISEASE
CM	0
code	0
:	0
786.04	I-DISEASE
Alternate	0
Names	0
Cheyne	0
-	0
Stokes	0
respiration	0
.	0

Diagnostic	0
Criteria	0
(	0
A	0
or	0
B	I-DISEASE
)	0
+	0
C	I-DISEASE
+	0
D	0
satisfy	0
the	I-DISEASE
criteria	0
A.	I-DISEASE

The	0
presence	0
of	0
one	0
or	0
more	0
of	0
the	0
following	I-DISEASE
:	0
1	0
.	0
Sleepiness	0
.	0

ICD-10	0
-	0
CM	0
code	0
:	0
R06.3	0
Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	0
.	0

Difficulty	0
initiating	0
or	0
maintaining	0
sleep	0
,	0
frequent	0
awakenings	0
,	I-DISEASE
or	0
nonrestorative	0
sleep	I-DISEASE
.	0
.	0

Awakening	0
short	0
of	0
breath	0
.	0
.	I-DISEASE

Snoring	0
.	0
.	I-DISEASE

Witnessed	0
apneas	0
.	0

B.	0
The	0
presence	0
of	0
atrial	0
fibrillation	I-DISEASE
/	I-DISEASE
flutter	0
,	I-DISEASE
congestive	0
heart	0
failure	0
,	0
or	0
a	I-DISEASE
neurological	I-DISEASE
disorder	0
.	I-DISEASE

C.	0
PSG	I-DISEASE
(	0
during	0
diagnostic	0
or	I-DISEASE
positive	I-DISEASE
airway	0
pressure	0
titration	I-DISEASE
)	0
shows	I-DISEASE
all	0
of	0
the	I-DISEASE
following	0
:	I-DISEASE
.	0

Five	0
or	0
more	0
central	0
apneas	0
and/or	I-DISEASE
central	I-DISEASE
hypopneas	0
per	I-DISEASE
hour	0
of	0
sleep.1	0
.	0

The	0
total	0
number	0
of	I-DISEASE
central	0
apneas	0
and/or	I-DISEASE
central	I-DISEASE
hypopneas	0
is	0
>	0
50	0
%	0
of	0
the	I-DISEASE
total	0
number	0
of	0
apneas	0
and	0
hypopneas.2	0
.	0

The	0
pattern	0
of	0
ventilation	I-DISEASE
meets	0
criteria	0
for	I-DISEASE
Cheyne	0
-	I-DISEASE
Stokes	0
breathing	0
(	0
CSB).1	0
D.	0
The	I-DISEASE
disorder	I-DISEASE
is	0
not	I-DISEASE
better	0
explained	0
by	0
another	0
current	0
sleep	0
disorder	I-DISEASE
,	I-DISEASE
medication	0
use	0
(	0
e.g.	0
,	0
opioids	I-DISEASE
)	0
,	0
or	0
substance	0
use	0
disorder	0
.	0

Notes	0
.	0

As	0
defined	0
by	0
the	0
most	I-DISEASE
recent	0
version	I-DISEASE
of	0
the	I-DISEASE
AASM	I-DISEASE
Manual	0
for	0
the	0
Scoring	0
of	I-DISEASE
Sleep	0
and	0
Associated	I-DISEASE
Events	0
.	I-DISEASE
.	0

If	0
criterion	0
C2	0
is	I-DISEASE
not	I-DISEASE
met	0
,	I-DISEASE
CSB	0
can	I-DISEASE
be	0
listed	0
as	0
a	I-DISEASE
polysomnographic	0
finding	I-DISEASE
.	0
.	0

A	0
diagnosis	0
of	0
central	0
sleep	0
apnea	I-DISEASE
(	I-DISEASE
CSA	I-DISEASE
)	0
with	0
CSB	I-DISEASE
does	0
not	I-DISEASE
exclude	0
a	I-DISEASE
diagnosis	0
of	0
OSA	I-DISEASE
.	0

Sleep	0
Related	0
Breathing	I-DISEASE
Disorders	0
Essential	0
Features	I-DISEASE
CSA	I-DISEASE
-	0
CSB	I-DISEASE
is	0
characterized	0
by	0
recurrent	I-DISEASE
central	0
apneas	I-DISEASE
or	I-DISEASE
central	0
hypopneas	I-DISEASE

alternat-	0
ing	0
with	0
a	I-DISEASE
respiratory	0
phase	0
exhibiting	I-DISEASE
a	0
crescendo	I-DISEASE
-	I-DISEASE
decrescendo	0
pattern	I-DISEASE
of	0
flow	0
(	I-DISEASE
or	I-DISEASE
tidal	I-DISEASE
volume	I-DISEASE
)	0
.	0

The	0
longer	0
cycle	0
length	0
(	0
>	I-DISEASE
40	0
seconds	0
;	0
typically	0
45	0
to	0
60	0
seconds	0
)	0
distinguishes	I-DISEASE
CSB	0
from	0
other	0
central	0
sleep	0
apnea	0
types	0
.	I-DISEASE

The	0
vast	0
majority	0
of	0
patients	0
with	I-DISEASE
CSA	0
-	0
CSB	0
have	0
either	0
systolic	0
or	0
diastolic	0
heart	0
failure	0
.	0

In	0
systolic	0
heart	0
failure	0
the	0
cycle	0
length	I-DISEASE
is	0
longer	I-DISEASE
(	0
longer	0
respiratory	0
phase	0
)	0
than	I-DISEASE
in	0
patients	0
with	I-DISEASE
diastolic	0
heart	0
failure	0
,	0
and	0
there	I-DISEASE
is	I-DISEASE
often	0
a	0
delay	I-DISEASE
in	0
the	I-DISEASE
nadir	0
of	I-DISEASE
the	0
associated	0
oxygen	0
desatu-	I-DISEASE
ration	0
.	0

Patients	0
with	0
CSA	0
-	0
CSB	0
have	0
normal	I-DISEASE
or	0
low	0
daytime	0
arterial	0
PCO2	0
(	0
PaCO2	0
)	I-DISEASE
.	I-DISEASE

Some	0
patients	0
with	I-DISEASE
heart	0
failure	0
have	0
a	0
mixture	0
of	I-DISEASE
obstructive	0
and	0
central	0
apneas	0
with	I-DISEASE
more	I-DISEASE
central	0
apneas	0
in	I-DISEASE
the	0
later	0
part	0
of	0
the	0
night	I-DISEASE
or	I-DISEASE
when	0
the	0
patient	0
is	I-DISEASE
placed	0
on	I-DISEASE
posi-	I-DISEASE
tive	I-DISEASE
airway	0
pressure	0
(	0
PAP	I-DISEASE
)	I-DISEASE
.	0

A	0
diagnosis	0
of	0
CSA	I-DISEASE
-	I-DISEASE
CSB	I-DISEASE
requires	I-DISEASE
that	I-DISEASE
events	I-DISEASE
be	I-DISEASE
predom-	I-DISEASE
inantly	0
central	I-DISEASE
apneas	0
and	I-DISEASE
hypopneas	I-DISEASE
with	0
an	I-DISEASE
average	0
frequency	0
of	I-DISEASE
at	0
least	0
5	0
/	I-DISEASE
hour	0
during	0
a	0
diagnostic	0
PSG	0
or	0
either	0
the	0
diagnostic	0
or	0
therapeutic	I-DISEASE
portion	0
of	0
a	I-DISEASE
split	I-DISEASE
-	0
night	0
study	0
.	0

For	0
patients	0
with	I-DISEASE
a	0
mixture	0
of	I-DISEASE
OSA	I-DISEASE
and	0
CSA	I-DISEASE
-	0
CSB	I-DISEASE
,	0
the	I-DISEASE
central	0
apneas	0
may	0
appear	I-DISEASE
only	0
after	0
elimination	I-DISEASE
of	0
obstruction	0
on	0
positive	0
airway	I-DISEASE
pressure	0
.	0

In	0
patient	0
with	0
CSA	0
-	I-DISEASE
CSB	I-DISEASE
,	I-DISEASE
arousal	I-DISEASE
from	0
sleep	0
tends	0
to	0
occur	I-DISEASE
at	0
the	I-DISEASE
zenith	0
of	0
respiratory	I-DISEASE
effort	0
between	0
contiguous	0
central	0
apneas	0
or	0
hypopneas	0
.	I-DISEASE

This	0
can	0
result	0
in	0
sleep	0
fragmen-	I-DISEASE
tation	0
.	0

However	0
,	I-DISEASE
patients	0
may	I-DISEASE
complain	0
of	0
disturbed	I-DISEASE
nocturnal	0
sleep	I-DISEASE
or	0
nocturnal	0
dyspnea	0
rather	I-DISEASE
than	0
daytime	0
sleepiness	0
.	I-DISEASE

Associated	0
Features	0
Presenting	0
features	0
of	0
CSB	0
pattern	I-DISEASE
during	I-DISEASE
sleep	0
may	0
include	0
excessive	I-DISEASE
daytime	0
sleep-	0
iness	I-DISEASE
,	0
insomnia	I-DISEASE
,	I-DISEASE
or	0
nocturnal	0
dyspnea	0
.	0

Because	0
many	0
patients	0
with	I-DISEASE
CSA	0
-	I-DISEASE
CSB	I-DISEASE
have	0
known	I-DISEASE
heart	0
failure	0
,	0
their	0
complaints	0
of	I-DISEASE
frequent	0
awakenings	0
or	I-DISEASE
disturbed	0
sleep	0
may	0
be	0
falsely	0
assumed	I-DISEASE
to	I-DISEASE
be	0
entirely	0
secondary	I-DISEASE
to	0
heart	0
failure	I-DISEASE
.	I-DISEASE

Because	0
studies	0
have	0
shown	0
that	0
approximately	I-DISEASE
60	I-DISEASE
%	0
of	0
patients	0
with	0
heart	0
failure	0
have	0
some	0
form	0
of	0
sleep	I-DISEASE
apnea	0
,	0
a	0
high	0
index	0
of	0
suspicion	I-DISEASE
is	0
indicated	0
.	I-DISEASE

A	0
CSB	0
pattern	I-DISEASE
can	0
also	0
occur	0
during	0
wakefulness	0
and	I-DISEASE
can	I-DISEASE
be	0
observed	0
at	0
bedside	0
or	I-DISEASE
in	I-DISEASE
the	0
clinic	0
.	0

Some	0
studies	0
suggest	0
that	0
the	0
pres-	I-DISEASE
ence	I-DISEASE
of	0
CSA	I-DISEASE
-	0
CSB	0
during	0
wakefulness	I-DISEASE
is	0
associated	I-DISEASE
with	I-DISEASE
a	0
worse	I-DISEASE
prognosis	0
.	0

Although	0
heart	0
failure	0
is	0
the	0
major	I-DISEASE
cause	0
of	0
CSA	I-DISEASE
-	0
CSB	0
,	0
recent	I-DISEASE
studies	0
suggest	I-DISEASE
that	0
it	0
can	0
be	0
noted	0
after	0
stroke	0
.	0

CSA	0
-	I-DISEASE
CSB	0
can	0
rarely	0
present	0
in	0
an	0
idiopathic	0
form	0
or	0
be	0
associated	0
with	0
renal	0
failure	0
.	0

As	0
in	0
other	0
forms	0
of	0
CSA	I-DISEASE
,	I-DISEASE
apneas	0
and	I-DISEASE
hypopneas	0
are	I-DISEASE
associated	0
with	0
absent	0
or	I-DISEASE
reduced	0
ventilatory	0
effort	0
,	0
respectively	0
,	0
due	0
to	0
diminished	0
central	I-DISEASE
respiratory	0
drive	0
.	I-DISEASE

Of	0
inter-	0
est	0
,	I-DISEASE
a	0
longer	0
respiratory	I-DISEASE
phase	0
between	I-DISEASE
apneas	0
is	0
associated	0
with	I-DISEASE
a	0
longer	I-DISEASE
circulation	I-DISEASE
time	0
and	I-DISEASE
delay	0
in	I-DISEASE
the	0
saturation	0
nadir	0
.	0

The	0
CSB	0
breathing	I-DISEASE
pattern	0
is	0
characteristically	0
observed	I-DISEASE
during	0
stages	I-DISEASE
N1	0
and	0
N2	0
and	0
usually	0
resolves	I-DISEASE
or	0
is	I-DISEASE
attenuated	I-DISEASE
during	0
REM	I-DISEASE
sleep	0
.	0

In	0
patients	0
with	I-DISEASE
both	0
OSA	0
and	0
CSA	I-DISEASE
-	0
CSB	I-DISEASE
,	0
the	0
relative	I-DISEASE
amount	0
of	0
central	I-DISEASE
and	0
obstructive	I-DISEASE
apnea	I-DISEASE
can	0
vary	I-DISEASE
over	0
time	0
or	0
even	I-DISEASE
within	I-DISEASE
the	I-DISEASE
same	0
night	0
.	I-DISEASE

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE

Some	0
patients	0
have	I-DISEASE
combined	0
OSA	0
and	0
CSA	I-DISEASE
,	0
and	I-DISEASE
the	0
CSA	0
-	0
CSB	I-DISEASE
may	0
not	I-DISEASE
manifest	I-DISEASE
until	I-DISEASE
the	0
patient	0
is	I-DISEASE
placed	0
on	0
positive	I-DISEASE
airway	0
pressure	I-DISEASE
treatment	0
.	0

These	0
patients	0
are	I-DISEASE
considered	0
to	0
have	0
both	0
OSA	0
and	I-DISEASE
CSA	0
with	0
CSB	I-DISEASE
.	0

Patients	0
with	0
systolic	B-DISEASE
or	0
diastolic	0
heart	0
failure	0
may	0
have	0
CSB	0
,	0
but	0
the	0
cycle	0
length	0
is	0
longer	0
in	0
those	0
with	0
systolic	0
dys-	0
function	0
.	0

Patients	0
with	0
neurological	B-DISEASE
disorders	0
may	0
have	0
CSB	I-DISEASE
,	0
but	0
the	0
characteristic	0
cycle	0
length	0
is	0
less	I-DISEASE
well	0
described	0
.	0

Demographics	0
CSA	0
with	0
CSB	0
generally	0
is	I-DISEASE
seen	I-DISEASE
in	0
subjects	I-DISEASE
older	0
than	0
60	0
years	0
.	0

The	0
prevalence	0
of	I-DISEASE
this	I-DISEASE
breathing	0
disorder	0
in	I-DISEASE
the	0
setting	I-DISEASE
of	0
chronic	0
congestive	0
heart	I-DISEASE
failure	0
has	0
been	0
reported	0
to	0
be	0
25	0
%	0
to	0
40	0
%	0
,	I-DISEASE
depending	0
on	0
how	I-DISEASE
patients	0
are	0
divided	0
into	I-DISEASE
those	0
with	0
predomi-	0
nant	0
OSA	0
and	I-DISEASE
those	0
with	0
CSA	0
.	I-DISEASE

In	0
patients	0
with	0
heart	0
failure	0
there	0
is	I-DISEASE
a	0
striking	I-DISEASE
male	0
predominance	0
in	0
the	0
occurrence	0
of	0
CSA	0
-	I-DISEASE
CSB	0
.	0

Of	0
interest	0
,	0
the	0
use	I-DISEASE
of	0
β	I-DISEASE
-	0
blockers	I-DISEASE
and	0
angiotensin	0
-	I-DISEASE
converting	I-DISEASE
enzyme	I-DISEASE
inhibitors	I-DISEASE
for	I-DISEASE
treatment	I-DISEASE
of	I-DISEASE
congestive	0
heart	0
failure	0
has	0
not	0
decreased	I-DISEASE
the	I-DISEASE
prevalence	0
of	0
CSA	I-DISEASE
-	0
CSB	0
.	I-DISEASE

Some	0
form	0
of	0
sleep	I-DISEASE
apnea	I-DISEASE
is	I-DISEASE
reported	I-DISEASE
in	0
50	I-DISEASE
%	0
to	0
70	0
%	0
of	0
patients	0
following	0
stroke	0
,	I-DISEASE
depending	0
on	0
the	0
AHI	0
cutoff	0
used	I-DISEASE
for	I-DISEASE
diagno-	0
sis	0
.	I-DISEASE

Although	0
OSA	0
predominates	0
,	0
central	0
sleep	0
apnea	I-DISEASE
is	0
also	I-DISEASE
common	0
especially	0
in	0
the	I-DISEASE
first	0
few	I-DISEASE
days	0
following	0
stroke	0
.	0

CSA	0
-	I-DISEASE
CSB	0
has	0
been	I-DISEASE
reported	0
to	0
occur	0
in	0
26	0
%	0
to	0
50	0
%	0
of	0
patients	0
in	0
the	I-DISEASE
acute	0
period	0
following	0
stroke	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
The	0
most	I-DISEASE
important	I-DISEASE
predisposing	0
factors	I-DISEASE
are	0
the	0
presence	0
of	0
congestive	0
heart	I-DISEASE
failure	I-DISEASE
,	0
stroke	I-DISEASE
,	0
and	0
possibly	0
renal	0
failure	0
.	I-DISEASE

Within	0
the	0
heart	I-DISEASE
failure	0
population	0
,	I-DISEASE
risk	I-DISEASE
factors	0
for	I-DISEASE
CSB	0
pattern	I-DISEASE
during	0
sleep	0
include	0
male	I-DISEASE
sex	0
,	0
age	I-DISEASE
older	0
than	0
60	0
years	0
,	0
the	I-DISEASE
presence	I-DISEASE
of	I-DISEASE
atrial	0
fibrillation	I-DISEASE
,	I-DISEASE
and	0
daytime	0
hypocapnia	0
(	0
i.e.	0
,	0
awake	0
PaCO2	0
of	I-DISEASE
38	0
mm	0
Hg	0
or	0
less	0
)	0
.	0

In	0
general	0
,	0
greater	0
pulmonary	0
congestion	I-DISEASE
(	I-DISEASE
higher	0
left	I-DISEASE
ventricular	I-DISEASE
end	0
-	I-DISEASE
diastolic	0
pressure	0
)	I-DISEASE
predicts	0
lower	0
PaCO2	I-DISEASE
.	0

Some	0
studies	0
suggest	0
that	0
CSA	0
-	I-DISEASE
CSB	I-DISEASE
occurs	0
more	I-DISEASE
commonly	0
in	0
the	0
supine	0
position	0
.	I-DISEASE

Although	0
renal	0
failure	0
is	0
often	0
listed	0
as	I-DISEASE
a	0
possible	I-DISEASE
cause	0
of	0
CSA-	0
CSB	0
,	0
there	I-DISEASE
is	I-DISEASE
scant	I-DISEASE
literature	0
documenting	0
this	I-DISEASE
association	0
.	0

Familial	0
Patterns	0
Not	0
applicable	0
or	0
known	0
.	I-DISEASE

Sleep	0
Related	0
Breathing	I-DISEASE
Disorders	0
Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Onset	I-DISEASE
,	0
Course	0
,	I-DISEASE
and	0
Complications	I-DISEASE
There	I-DISEASE
are	I-DISEASE
no	0
definitive	I-DISEASE
data	0
concerning	0
the	0
onset	0
.	0

However	0
,	I-DISEASE
because	0
it	0
is	0
seen	0
in	0
the	0
setting	I-DISEASE
of	0
congestive	0
heart	0
failure	0
,	0
stroke	I-DISEASE
,	0
and	0
possibly	I-DISEASE
renal	0
failure	I-DISEASE
,	0
CSA	0
with	0
CSB	0
most	I-DISEASE
likely	I-DISEASE
has	0
its	I-DISEASE
onset	I-DISEASE
following	0
the	0
development	0
of	0
one	0
of	0
these	0
illnesses	I-DISEASE
.	0

In	0
the	0
setting	I-DISEASE
of	0
systolic	0
congestive	0
heart	0
failure	0
,	0
it	0
is	0
associated	0
with	0
a	0
poor	I-DISEASE
prognosis	0
,	0
as	0
indicated	0
by	0
a	0
greater	0
adjusted	0
relative	I-DISEASE
risk	I-DISEASE
for	0
mortality	0
-	I-DISEASE
cardiac	0
transplantation	0
com-	0
pared	0
to	0
patients	0
without	0
CSB	0
.	I-DISEASE

These	0
data	0
suggest	0
that	0
CSB	0
pattern	I-DISEASE
during	0
sleep	0
par-	I-DISEASE
ticipates	I-DISEASE
in	0
the	0
pathophysiology	0
and	0
progression	I-DISEASE
of	I-DISEASE
heart	0
failure	I-DISEASE
.	0

Its	0
clinical	0
signifi-	0
cance	0
in	0
the	0
setting	I-DISEASE
of	0
stroke	I-DISEASE
or	0
other	0
neurological	0
disorders	0
remains	0
less	0
certain	0
.	0

In	0
some	0
patients	0
with	I-DISEASE
CSA	0
after	I-DISEASE
stroke	I-DISEASE
,	0
the	0
pattern	0
can	0
transition	0
to	0
one	0
of	0
OSA	0
.	0

The	0
presence	0
of	0
obstructive	0
apnea	0
following	0
stroke	0
has	0
been	I-DISEASE
found	I-DISEASE
to	0
be	0
associated	0
with	0
a	0
worse	0
prognosis	0
.	I-DISEASE

Developmental	0
Issues	0

Although	0
there	0
are	0
reports	0
of	0
CSB	I-DISEASE
in	I-DISEASE
children	0
,	0
the	0
condition	0
is	0
extremely	I-DISEASE
rare	0
in	0
this	I-DISEASE
age	0
group	0
.	0

Of	0
interest	0
,	0
one	0
study	0
of	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
congestive	I-DISEASE
heart	0
failure	0
across	0
all	0
age	0
groups	I-DISEASE
found	0
CSB	0
to	I-DISEASE
be	0
absent	I-DISEASE
in	0
children	0
but	0
present	0
in	0
40	I-DISEASE
%	0
of	0
the	0
adult	I-DISEASE
patients	0
with	I-DISEASE
congestive	I-DISEASE
heart	0
failure	0
.	0

A	0
limitation	0
of	0
the	0
study	I-DISEASE
was	I-DISEASE
that	I-DISEASE
only	0
ten	I-DISEASE
children	0
with	I-DISEASE
congestive	0
heart	I-DISEASE
failure	0
were	0
studied	0
.	0

Pathology	0
and	0
Pathophysiology	0
CSA	0
with	0
CSB	I-DISEASE
generally	I-DISEASE
arises	0
because	I-DISEASE
of	0
instability	0
in	0
the	I-DISEASE
respiratory	0
control	I-DISEASE
system	I-DISEASE
.	0

A	0
high	0
ventilatory	0
drive	0
and	0
delay	I-DISEASE
in	I-DISEASE
chemoreceptor	I-DISEASE
response	0
to	0
changes	0
of	0
PaCO2	I-DISEASE
and	0
PaO2	I-DISEASE
(	0
due	0
to	I-DISEASE
increased	0
circulation	I-DISEASE
time	I-DISEASE
)	0
are	0
likely	0
the	I-DISEASE
major	I-DISEASE
factors	0
.	I-DISEASE

This	0
breathing	0
disorder	0
tends	0
to	0
occur	0
in	0
individuals	0
with	I-DISEASE
a	0
chronically	0
low	0
PaCO2	0
when	0
awake	I-DISEASE
and	I-DISEASE
asleep	I-DISEASE
.	0

Hyperventilation	0
occurs	0
due	0
to	0
an	0
increase	0
in	0
the	0
responsiveness	I-DISEASE
of	0
the	0
periph-	I-DISEASE
eral	0
and	0
central	I-DISEASE
chemoreceptors	I-DISEASE
.	0

The	0
increased	0
responsiveness	0
is	0
believed	0
to	I-DISEASE
be	I-DISEASE
due	0
to	I-DISEASE
both	0
increased	0
sympathetic	I-DISEASE
tone	0
and	0
stimulation	0
of	I-DISEASE
vagal	0
irritant	I-DISEASE
receptors	0
in	0
the	0
lungs	0
by	I-DISEASE
pulmonary	0
congestion	I-DISEASE
.	I-DISEASE

The	0
PaCO2	0
in	0
individuals	0
with	I-DISEASE
CSB	0
pattern	I-DISEASE
and	0
heart	I-DISEASE
failure	0
is	0
closer	0
to	0
their	0
apneic	I-DISEASE
threshold	0
than	0
in	0
those	0
without	I-DISEASE
CSB	0
pattern	0
(	0
primarily	0
due	0
to	0
a	I-DISEASE
smaller	I-DISEASE
sleep	0
related	0
rise	0
in	I-DISEASE
PaCO2	0
in	0
those	0
with	0
CSB	I-DISEASE
)	I-DISEASE
,	I-DISEASE
so	0
that	0
even	I-DISEASE
modest	I-DISEASE
increases	0
in	0
ventilation	0
can	I-DISEASE
drive	0
PaCO2	I-DISEASE
below	I-DISEASE
the	0
apneic	I-DISEASE
threshold	I-DISEASE
.	I-DISEASE

The	0
most	0
common	0
trigger	0
factor	0
for	0
central	0
apnea	0
is	I-DISEASE
an	I-DISEASE
arousal	0
from	0
sleep	0
,	0
which	0
abruptly	I-DISEASE
augments	0
ventilation	I-DISEASE
and	0
drives	I-DISEASE
PaCO2	I-DISEASE
below	0
the	0
apneic	0
threshold	0
.	0

The	0
crescendo	0
-	I-DISEASE
decrescendo	0
pattern	0
of	0
tidal	I-DISEASE
volume	I-DISEASE
results	I-DISEASE
from	0
prolonged	0
lung	0
-	0
to	0
-	I-DISEASE
che-	0
moreceptor	0
circulatory	I-DISEASE
delay	I-DISEASE
,	I-DISEASE
such	0
that	0
changes	I-DISEASE
in	0
PaCO2	I-DISEASE
in	I-DISEASE
the	0
lung	0
are	B-DISEASE
trans-	0
mitted	0
only	I-DISEASE
very	0
slowly	0
to	0
the	I-DISEASE
chemoreceptors	0
,	0
resulting	0
in	I-DISEASE
a	I-DISEASE
gradual	0
buildup	I-DISEASE
and	0
falloff	0
of	I-DISEASE
ventilatory	I-DISEASE
stimulation	I-DISEASE
.	0

The	0
length	0
of	0
the	0
cycle	I-DISEASE
is	0
directly	I-DISEASE
proportional	0
to	I-DISEASE
lung	0
-	0
to	I-DISEASE
-	0
chemoreceptor	0
circulation	I-DISEASE
time	0
and	I-DISEASE
inversely	0
proportional	0
to	0
cardiac	0
output	0
.	0

Accordingly	0
,	0
whereas	0
the	0
length	I-DISEASE
of	0
the	I-DISEASE
ventilatory	I-DISEASE
-	I-DISEASE
apneic	0
cycle	0
in	0
primary	0
CSA	I-DISEASE
is	0
typically	0
shorter	0
than	0
40	0
seconds	I-DISEASE
,	0
in	0
CSB	0
pattern	0
it	0
is	0
almost	0
invariably	I-DISEASE
longer	0
than	I-DISEASE
40	0
seconds	0
(	0
usually	0
45	0
-	0
90	0
seconds	0
)	0
.	0

One	0
study	I-DISEASE
of	0
patients	0
with	0
varying	0
degrees	I-DISEASE
of	0
heart	I-DISEASE
failure	0
found	0
a	0
considerably	0
shorter	0
cycle	0
time	0
in	0
patients	0
with	0
normal	0
ejection	0
frac-	0
tion	0
(	0
e.g.	0
,	0
diastolic	0
heart	0
failure	0
)	0
.	0

The	0
pathophysiology	0
of	0
CSB	I-DISEASE
pattern	0
in	I-DISEASE
the	I-DISEASE
setting	0
of	I-DISEASE
stroke	0
and	0
renal	0
failure	I-DISEASE
has	0
not	I-DISEASE
been	0
examined	0
in	I-DISEASE
any	0
detail	0
.	0

However	0
,	I-DISEASE
apneas	0
in	0
association	I-DISEASE
with	0
these	I-DISEASE
medical	0
disorders	0
are	0
believed	0
to	0
be	0
due	0
to	I-DISEASE
a	0
reduction	0
in	0
PaCO2	0
below	0
the	0
apneic	0
threshold	0
.	0

In	0
individuals	0
with	0
renal	0
failure	0
,	I-DISEASE
pulmonary	I-DISEASE
congestion	0
(	I-DISEASE
volume	0
overload	0
)	0
may	I-DISEASE
play	0
a	I-DISEASE
role	0
in	0
stimulating	I-DISEASE
hyperventilation	0
.	0

Objective	0
Findings	0

The	0
polysomnographic	0
hallmarks	0
of	0
CSB	0
pattern	0
are	I-DISEASE
recurrent	0
central	I-DISEASE
apneas	0
and	0
central	I-DISEASE
hypopneas	0
alternating	0
with	I-DISEASE
ventilatory	0
periods	0
having	I-DISEASE
a	0
prolonged	I-DISEASE
crescen-	0
do	I-DISEASE
-	I-DISEASE
decrescendo	0
pattern	I-DISEASE
of	0
airflow	0
(	0
tidal	0
volume	0
)	I-DISEASE
.	0

CSB	0
pattern	I-DISEASE
typically	0
occurs	0
at	0
the	0
transition	I-DISEASE
from	I-DISEASE
wakefulness	I-DISEASE
to	0
NREM	I-DISEASE
sleep	0
and	0
during	0
stages	0
N1	I-DISEASE
and	I-DISEASE
N2	I-DISEASE
.	0

It	0
tends	0
to	0
dissipate	0
in	0
stages	I-DISEASE
N3	I-DISEASE
and	0
R.	I-DISEASE

In	0
stage	0
N3	0
sleep	0
the	0
sleeping	I-DISEASE
PaCO2	I-DISEASE
is	0
higher	I-DISEASE
(	0
further	I-DISEASE
above	0
the	0
apneic	0
threshold	0
)	0
.	I-DISEASE

During	0
REM	0
sleep	0
the	0
hypoxic	0
and	I-DISEASE
hypercapnic	I-DISEASE
ventila-	0
tory	I-DISEASE
responses	0
are	0
lower	0
,	0
thereby	0
reducing	I-DISEASE
the	0
tendency	0
for	I-DISEASE
an	0
overshoot	0
in	0
ventilation	0
which	0
may	0
drive	0
PaCO2	I-DISEASE
below	I-DISEASE
the	I-DISEASE
apneic	0
threshold	I-DISEASE
.	0

Arousals	0
are	0
frequently	I-DISEASE
seen	0
in	0
association	0
with	0
CSB	0
and	0
are	0
typically	I-DISEASE
noted	0
at	I-DISEASE
or	0
near	I-DISEASE
the	0
zenith	I-DISEASE
in	I-DISEASE
respiratory	0
effort	I-DISEASE
(	0
or	0
airflow	0
)	0
,	I-DISEASE
although	0
can	I-DISEASE
occur	I-DISEASE
at	0
or	0
near	I-DISEASE
the	0
onset	0
of	0
the	0
respiratory	I-DISEASE
phase	0
pattern	0
.	I-DISEASE

In	0
contrast	0
,	0
arousals	0
tend	0
to	0
occur	0
at	0
apnea	0
termination	0
in	0
other	I-DISEASE
CSA	0
disorders	0
.	0

As	0
noted	0
above	0
,	0
a	0
longer	I-DISEASE
respiratory	I-DISEASE
phase	0
(	I-DISEASE
and	0
cycle	0
length	0
)	0
is	I-DISEASE
associated	I-DISEASE
with	0
lower	0
cardiac	I-DISEASE
output	0
and	0
longer	0
circulation	0
time	0
.	0

Central	0
hypopnea	0
,	0
rather	0
than	0
apnea	0
,	I-DISEASE
can	0
occur	I-DISEASE
at	0
the	I-DISEASE
nadir	0
in	0
respiratory	0
effort	0
in	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
CSB	0
and	0
have	0
been	0
included	0
in	I-DISEASE
calculation	I-DISEASE
of	I-DISEASE
the	0
central	I-DISEASE
AHI	0
in	0
a	I-DISEASE
sub-	0
stantial	0
number	0
of	I-DISEASE
investigations	0
.	0

Central	0
hypopneas	0
are	0
characterized	0
by	0
the	0
absence	I-DISEASE
of	0
snoring	I-DISEASE
,	0
flattening	I-DISEASE
in	0
the	I-DISEASE
nasal	0
pressure	I-DISEASE
or	I-DISEASE
PAP	0
device	0
flow	0
signal	I-DISEASE
,	0
and	0
thoracoab-	0
dominal	I-DISEASE
paradox	0
.	0

Central	0
apneas	0
and	0
central	I-DISEASE
hypopneas	0
are	I-DISEASE
usually	I-DISEASE
accompanied	0
by	I-DISEASE
modest	0
oxyhemo-	0
globin	0
desaturation	0
;	0
arterial	I-DISEASE
oxygen	I-DISEASE
saturation	0
seldom	I-DISEASE
falls	0
below	0
80	0
%	0
to	I-DISEASE
85	I-DISEASE
%	I-DISEASE
.	I-DISEASE

The	0
combination	0
of	0
oxygen	0
desaturation	0
and	I-DISEASE
arousals	I-DISEASE
from	0
sleep	I-DISEASE
leads	0
to	0
sleep	0
fragmenta-	I-DISEASE
tion	0
with	0
reduced	I-DISEASE
amounts	0
of	I-DISEASE
stage	0
N3	0
sleep	0
.	0

Additionally	0
,	0
PaCO2	0
less	0
than	0
40	I-DISEASE

mm	0
Hg	0
is	0
typically	0
observed	0
during	0
wakefulness	I-DISEASE
.	0

In	0
patients	0
with	I-DISEASE
both	0
obstructive	0
and	0
central	0
apneas	0
,	I-DISEASE
the	0
proportion	0
of	0
central	I-DISEASE
apneas	0
tends	I-DISEASE
to	I-DISEASE
increase	I-DISEASE
over	I-DISEASE
the	0
night	0
,	0
and	I-DISEASE
this	0
is	0
Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	I-DISEASE
Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
associated	0
with	0
a	0
fall	I-DISEASE
in	0
the	I-DISEASE
sleeping	I-DISEASE
PaCO2	I-DISEASE
.	I-DISEASE

The	0
lower	0
sleeping	0
PaCO2	0
is	0
thought	0
to	I-DISEASE
be	0
due	0
to	0
an	0
increase	0
in	0
pulmonary	0
congestion	0
during	0
the	I-DISEASE
night	I-DISEASE
with	0
stimulation	I-DISEASE
of	0
juxta-	0
capillary	0
(	0
J	0
)	0
receptors	0
in	I-DISEASE
the	0
lung	0
interstitium	I-DISEASE
and	0
a	0
subsequent	0
increase	0
in	0
ventilatory	I-DISEASE
drive	I-DISEASE
.	0

As	0
noted	0
above	0
,	0
some	0
patients	0
have	I-DISEASE
more	0
CSA	0
-	0
CSB	0
in	0
the	I-DISEASE
supine	0
position	0
.	I-DISEASE

Differential	0
Diagnosis	0
Primary	0
CSA	0
can	0
usually	I-DISEASE
be	0
distinguished	I-DISEASE
from	I-DISEASE
CSB	0
pattern	0
by	I-DISEASE
the	I-DISEASE
absence	0
of	I-DISEASE
a	0
history	0
of	I-DISEASE
heart	I-DISEASE
failure	0
,	0
stroke	0
,	0
or	I-DISEASE
renal	I-DISEASE
failure	0
and	0
by	B-DISEASE
the	0
absence	0
of	I-DISEASE
a	0
crescendo	0
-	0
decrescendo	0
breathing	I-DISEASE
pattern	0
between	I-DISEASE
central	I-DISEASE
apneas	I-DISEASE
.	0

The	0
cycle	0
length	0
(	0
apnea	0
+	0
ventilatory	I-DISEASE
phase	0
)	0
in	0
primary	0
CSA	0
is	0
typically	0
less	0
than	0
40	0
seconds	I-DISEASE
.	0

High	0
-	0
altitude	0
periodic	0
breathing	0
only	0
occurs	I-DISEASE
at	0
high	I-DISEASE
altitude	0
and	0
is	0
not	0
associated	0
with	I-DISEASE
heart	0
failure	0
,	I-DISEASE
stroke	0
,	0
or	0
renal	0
failure	0
.	0

Patients	0
with	0
CSA	B-DISEASE
due	0
to	I-DISEASE
drug	I-DISEASE
or	0
substance	0
have	I-DISEASE
a	0
history	0
of	0
use	0
of	0
this	I-DISEASE
type	0
of	0
medication	0
,	I-DISEASE
and	0
an	0
ataxic	0
breathing	I-DISEASE
pattern	I-DISEASE
may	I-DISEASE
be	0
present	0
.	I-DISEASE

If	0
patients	0
with	I-DISEASE
CSA	0
asso-	I-DISEASE
ciated	I-DISEASE
with	0
opioids	0
manifest	I-DISEASE
periodic	0
breathing	0
,	0
the	0
respiratory	0
phase	I-DISEASE
does	0
not	0
have	I-DISEASE
a	0
crescendo	I-DISEASE
-	0
decrescendo	0
pattern	0
and	I-DISEASE
the	0
cycle	0
length	I-DISEASE
is	0
shorter	0
.	0

Patients	0
with	0
CSA	B-DISEASE
due	0
to	I-DISEASE
a	0
medical	0
or	0
neurological	I-DISEASE
disease	0
without	0
Cheyne	0
-	0
Stokes	0
will	I-DISEASE
have	I-DISEASE
central	0
apnea	I-DISEASE
that	0
does	0
not	0
have	0
Cheyne	0
-	0
Stokes	I-DISEASE
morphology	I-DISEASE
,	0
as	I-DISEASE
the	0
name	0
implies	0
.	0

Sleep	0
related	0
hypoven-	I-DISEASE
tilation	I-DISEASE
and	0
hypoxemic	0
syndromes	I-DISEASE
can	0
be	0
readily	0
distinguished	0
from	0
CSA	0
-	0
CSB	0
by	0
documentation	0
of	I-DISEASE
an	0
awake	I-DISEASE
PaCO2	I-DISEASE
>	0

45	0
mm	0

Hg	0
and/or	0
sleep	0
related	0
hypoventilation	0
.	0

Patients	0
with	0
CSA	0
-	0
CSB	0
usually	0
have	I-DISEASE
an	0
awake	0
PaCO2	0
<	0

40	0
mm	0
Hg	0
.	0

In	0
patients	0
with	I-DISEASE
sleep	0
related	0
hypoventilation	I-DISEASE
disorders	I-DISEASE
,	0
some	I-DISEASE
central	0
apneas	0
may	0
be	0
present	0
,	0
but	0
these	I-DISEASE
events	0
do	0
not	0
have	0
a	0
Cheyne	0
-	0
Stokes	0
morphology	0
.	0

Additionally	0
,	0
oxygen	0
desaturation	0
in	0
sleep	I-DISEASE
related	0
hypoventilation	0
syndromes	I-DISEASE
is	I-DISEASE
generally	0
more	0
pronounced	0
during	0
REM	I-DISEASE
sleep	0
.	I-DISEASE

OSA	0
is	0
distinguished	0
by	0
the	0
presence	0
of	I-DISEASE
respiratory	0
efforts	I-DISEASE
during	0
apneas	0
.	0

A	0
few	0
central	0
apneas	0
or	0
hypopneas	I-DISEASE
at	I-DISEASE
sleep	0
onset	0
or	0
during	0
REM	0
sleep	0
are	0
normal	I-DISEASE
,	I-DISEASE
especially	0
in	0
elderly	0
subjects	I-DISEASE
.	0

These	0
cease	0
once	0
sleep	0
becomes	0
stable	0
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE

The	0
pathophysiology	0
and	0
clinical	I-DISEASE
significance	I-DISEASE
of	I-DISEASE
CSB	I-DISEASE
pattern	0
have	I-DISEASE
not	0
yet	0
been	I-DISEASE
eluci-	0
dated	0
in	0
the	I-DISEASE
setting	0
of	0
stroke	0
and	I-DISEASE
renal	0
failure	0
.	0

Less	0
is	0
also	0
known	0
about	0
the	0
importance	I-DISEASE
of	0
CSB	I-DISEASE
in	0
patients	0
with	0
heart	I-DISEASE
failure	0
with	I-DISEASE
a	0
normal	0
ejection	0
fraction	0
.	0

Bibliography	0
Dowdell	0
WT	I-DISEASE
,	0
Javaheri	0
S	I-DISEASE
,	I-DISEASE
McGinnis	0
W.	I-DISEASE
Cheyne	I-DISEASE
-	0
Stokes	0
respiration	0
presenting	0
as	I-DISEASE
sleep	0
apnea	0
syndrome	I-DISEASE
.	0

Clinical	0
and	0
polysomnographic	0
features	0
.	0

Am	0
Rev	0
Respir	0
Dis	I-DISEASE
1990;141:871–9	0
.	I-DISEASE

Hall	0
M	0
,	0
Xie	0
A	0
,	0
Rutherford	I-DISEASE
R	0
,	0
Ando	0
S	0
,	0
Floras	0
J	0
,	I-DISEASE
Bradley	I-DISEASE
T.	I-DISEASE
Cycle	0
length	0
of	0
periodic	0
breathing	0
in	0
patients	0
with	I-DISEASE
and	0
without	0
heart	0
failure	I-DISEASE
.	0

Am	0
J	0
Respir	0
Crit	0
Care	0
Med	0
1996;154:376–81	I-DISEASE
.	0

Lanfranchi	0
P	0
,	0
Braghiroli	0
A	0
,	0
Bosimini	I-DISEASE
E	0
,	0
et	0
al	0
.	0

Prognostic	0
value	0
of	0
nocturnal	0
Cheyne	0
-	I-DISEASE
Stokes	I-DISEASE
respiration	0
in	I-DISEASE
chronic	0
heart	0
failure	0
.	0

Circulation	0
1999;99:1435–40	0
.	0

MacDonald	0
M	0
,	0
Fang	0
J	0
,	0
Pittman	I-DISEASE
SD	0
,	0
White	0
DP	0
,	0
Malhotra	I-DISEASE
A.	0

The	0
current	0
prevalence	0
of	I-DISEASE
sleep	0
disordered	I-DISEASE
breathing	I-DISEASE
in	0
congestive	I-DISEASE
heart	0
failure	0
patients	0
treated	0
with	0
beta	I-DISEASE
-	I-DISEASE
blockers	I-DISEASE
.	0

J	0
Clin	0
Sleep	I-DISEASE
Med	0
2008;4:38–42	0
.	I-DISEASE

Naughton	0
M	0
,	0
Benard	0
D	0
,	0
Tam	0
A	0
,	I-DISEASE
Rutherford	0
R	0
,	0
Bradley	0
T.	0

The	0
role	0
of	0
hyperventilation	0
in	0
the	0
pathogenesis	0
of	0
central	0
sleep	I-DISEASE
apnea	0
in	0
patients	0
with	0
congestive	0
heart	I-DISEASE
failure	0
.	I-DISEASE

Am	0
Rev	0
Respir	0
Dis	0
1993;148:330–8	0
.	0

Peer	0
A	0
,	0
Lorber	0
A	0
,	I-DISEASE
Suraiya	0
S	0
,	I-DISEASE
Malhotra	0
A	0
,	I-DISEASE
Pillar	0
G.	0
The	I-DISEASE
occurrence	0
of	0
Cheyne	I-DISEASE
-	0
Stokes	0
respiration	0
in	0
congestive	0
heart	0
failure	I-DISEASE
:	0
the	0
effect	I-DISEASE
of	0
age	0
.	0

Front	0
Psychiatry	0
2010;1:133	0
.	0

Pressman	0
MR	0
,	0
Benz	0
RL	0
,	0
Schleifer	0
CR	0
,	0
Peterson	0
DD	0
.	0

Sleep	0
disordered	0
breathing	0
in	0
ESRD	0
:	0
acute	0
beneficial	0
effects	0
of	0
treatment	0
with	0
nasal	0
continuous	0
positive	0
airway	0
pressure	0
.	I-DISEASE

Kidney	0
Int	0
1993;43:1134–9	0
.	0

Sahlin	0
C	0
,	0
Svanborg	0
E	I-DISEASE
,	0
Stenlund	I-DISEASE
H	0
,	I-DISEASE
Franklin	0
KA	0
.	0

Cheyne	0
-	0
Stokes	I-DISEASE
respiration	0
and	0
supine	0
dependency	0
.	I-DISEASE

Eur	0
Respir	0
J	0
2005;25:829–33	0
.	0

Sin	0
D	0
,	I-DISEASE
Fitzgerald	0
F	I-DISEASE
,	I-DISEASE
Parker	I-DISEASE
J	I-DISEASE
,	I-DISEASE
Newton	0
G	0
,	I-DISEASE
Floras	0
J	I-DISEASE
,	I-DISEASE
Bradley	0
T.	0
Risk	I-DISEASE
factors	0
for	0
central	0
and	0
obstructive	0
sleep	0
apnea	I-DISEASE
in	0
450	0
men	I-DISEASE
and	I-DISEASE
women	I-DISEASE
with	I-DISEASE
congestive	I-DISEASE
heart	0
failure	0
.	0

Am	0
J	0
Respir	0
Crit	I-DISEASE
Care	0
Med	I-DISEASE
1999;160:1101–6	I-DISEASE
.	0

Sin	0
DD	0
,	0
Logan	0
AG	0
,	0
Fitzgerald	I-DISEASE
FS	0
,	0
et	0
al	0
.	0

Effects	0
of	0
continuous	I-DISEASE
positive	I-DISEASE
airway	I-DISEASE
pressure	0
on	I-DISEASE
cardiovascular	0
outcomes	I-DISEASE
in	0
Heart	0
failure	0
patients	0
with	0
and	I-DISEASE
without	I-DISEASE
Cheyne	0
-	I-DISEASE
Stokes	I-DISEASE
Respiration	0
.	0

Circulation	0
2000;102:61–6	I-DISEASE
.	0

Wedewardt	0
J	0
,	0
Bitter	I-DISEASE
T	0
,	0
Prinz	I-DISEASE
C	0
,	I-DISEASE
Faber	0
L	0
,	0
Horstkotte	0
D	0
,	I-DISEASE
Oldenburg	0
O.	0
Cheyne	I-DISEASE
-	0
Stokes	0
respiration	0
in	0
heart	0
failure	0
:	I-DISEASE
cycle	0
length	0
is	0
dependent	0
on	0
left	I-DISEASE
ventricular	0
ejection	0
fraction	0
.	0

Sleep	0
Med	0
2010;11:137–42	0
.	0

Xie	0
A	0
,	0
Skatrud	0
J	0
,	0
Puleo	I-DISEASE
D	I-DISEASE
,	0
Rahko	0
P	0
,	0
Dempsey	0
J.	0
Apnea	I-DISEASE
-	I-DISEASE
hypopnea	I-DISEASE
threshold	I-DISEASE
for	0
CO2	0
in	0
patients	0
with	I-DISEASE
congestive	0
heart	0
failure	0
.	I-DISEASE

Am	0
J	0
Respir	0
Crit	0
Care	0
Med	I-DISEASE
2002;165:1245–50	I-DISEASE
.	0

Central	0
Apnea	0

Due	0
to	0
a	0
Medical	0
Disorder	0
without	0
Cheyne	0
-	0
Stokes	I-DISEASE
Breathing	0
ICD-9	0
-	0
CM	0
code	0
:	I-DISEASE
327.27	0
Alternate	0
Names	0
Not	0
applicable	0
or	0
known	0
.	I-DISEASE

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
C	I-DISEASE
must	0
be	0
met	I-DISEASE
A.	0

The	0
presence	0
of	0
one	0
or	0
more	0
of	0
the	0
following1	I-DISEASE
:	0
1	0
.	0
Sleepiness	0
.	0

ICD-10	0
-	0
CM	0
code	0
:	0
G47.37	0
Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	0
.	0

Difficulty	0
initiating	0
or	0
maintaining	0
sleep	0
,	0
frequent	0
awakenings	0
,	I-DISEASE
or	0
nonrestorative	0
sleep	I-DISEASE
.	0
.	0

Awakening	0
short	0
of	0
breath	0
.	0
.	I-DISEASE

Snoring	0
.	0
.	I-DISEASE

Witnessed	0
apneas	0
.	0

B.	0
PSG	0
shows	0
all	0
of	0
the	0
following	0
:	0
.	I-DISEASE

Five	0
or	0
more	0
central	0
apneas	0
and/or	I-DISEASE
central	I-DISEASE
hypopneas	0
per	I-DISEASE
hour	0
of	0
sleep.2	0
Sleep	0
Related	0
Breathing	0
Disorders	0
.	0

The	0
number	0
of	0
central	0
apneas	0
and/or	I-DISEASE
central	I-DISEASE
hypopneas	0
is	I-DISEASE
>	0
50	0
%	0
of	0
the	0
total	0
number	0
of	0
apneas	I-DISEASE
and	0
hypopneas	0
.	0
.	0

Absence	0
of	0
CSB.2	0
C.	0
The	0
disorder	I-DISEASE
occurs	0
as	0
a	I-DISEASE
consequence	I-DISEASE
of	0
a	0
medical	I-DISEASE
or	0
neurological	I-DISEASE
disorder	0
but	0
is	I-DISEASE
not	0
due	0
to	0
medication	0
use	0
or	I-DISEASE
substance	I-DISEASE
use	0
.	0

Notes	0
.	0

In	0
infants	0
and	0
young	0
children	0
,	I-DISEASE
symptoms	I-DISEASE
are	0
supportive	0
but	0
not	0
required	0
.	0
.	0

As	0
defined	0
by	0
the	0
most	I-DISEASE
recent	0
version	I-DISEASE
of	0
the	I-DISEASE
AASM	I-DISEASE
Manual	0
for	0
the	0
Scoring	0
of	I-DISEASE
Sleep	0
and	0
Associated	I-DISEASE
Events	0
.	I-DISEASE
.	0

Sleep	0
related	0
hypoventilation	I-DISEASE
is	I-DISEASE
not	0
required	0
but	0
may	0
be	I-DISEASE
present	0
.	0

If	0
the	0
patient	I-DISEASE
meets	I-DISEASE
criteria	0
for	I-DISEASE
both	0
sleep	0
related	I-DISEASE
hypoventilation	I-DISEASE
and	0
CSA	0
due	0
to	0
medical	I-DISEASE
or	I-DISEASE
neurological	I-DISEASE
condition	I-DISEASE
not	0
Cheyne	0
-	0
Stokes	0
,	0
both	0
diagnoses	I-DISEASE
can	I-DISEASE
be	I-DISEASE
made	0
.	0
.	0

In	0
some	0
patients	0
other	I-DISEASE
abnormalities	0
of	0
breathing	0
such	0
as	0
ataxic	0
breathing	0
may	I-DISEASE
be	0
prominent	0
.	0
.	0

A	0
diagnosis	0
of	0
central	0
apnea	0
due	I-DISEASE
to	I-DISEASE
a	0
medical	0
disorder	0
without	0
CSB	0
does	0
not	I-DISEASE
exclude	I-DISEASE
a	0
diagnosis	0
of	I-DISEASE
OSA	0
.	0

Essential	0
Features	0
CSA	0
that	I-DISEASE
is	0
attributed	I-DISEASE
to	I-DISEASE
a	0
medical	I-DISEASE
or	0
neurological	0
condition	0
(	0
and	0
does	I-DISEASE
not	I-DISEASE
have	0
the	I-DISEASE
pattern	0
of	I-DISEASE
CSB	0
)	0
is	0
classified	0
here	I-DISEASE
.	0

The	0
majority	0
of	I-DISEASE
these	I-DISEASE
patients	0
have	I-DISEASE
brainstem	0
lesions	I-DISEASE
of	I-DISEASE
developmental	0
,	0
vascular	0
,	0
neoplastic	0
,	I-DISEASE
degenerative	0
,	I-DISEASE
demyelinating	I-DISEASE
,	0
or	I-DISEASE
traumatic	0
origin	0
.	0

Associated	0
Features	0
Patients	0
generally	0
present	B-DISEASE
with	I-DISEASE
sleep	0
fragmentation	0
,	I-DISEASE
excessive	0
daytime	0
sleepiness	0
,	0
or	0
insomnia	I-DISEASE
.	0

Other	0
signs	0
and	0
symptoms	0
that	0
are	I-DISEASE
often	I-DISEASE
,	0
but	I-DISEASE
not	0
invariably	I-DISEASE
,	0
present	0
include	0
snoring	I-DISEASE
,	0
witnessed	0
apnea	0
,	0
and	I-DISEASE
awakening	0
with	0
shortness	0
of	I-DISEASE
breath	0
.	0

The	0
presentation	0
varies	0
with	0
the	0
cause	I-DISEASE
of	I-DISEASE
central	0
apnea	0
and	0
may	0
include	0
neurological	0
findings	0
.	I-DISEASE

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
None	I-DISEASE
.	I-DISEASE

Some	0
of	0
the	0
common	I-DISEASE
medical	0
and	0
neurological	I-DISEASE
disorders	0
causing	I-DISEASE
central	0
apnea	0
not	0
associated	0
with	0
CSB	I-DISEASE
are	0
listed	I-DISEASE
in	0
Pathology	0
and	I-DISEASE
Pathophysiology	0
(	0
below	0
)	0
.	I-DISEASE

Demographics	0
The	0
prevalence	0
and	0
demographics	0
of	0
this	I-DISEASE
disorder	0
vary	I-DISEASE
with	0
the	0
underlying	0
etiology	0
.	0

Patients	0
with	0
Chiari	0
malformation	0
(	0
CM	0
)	I-DISEASE
can	0
present	0
in	0
infancy	0
or	I-DISEASE
childhood	0
,	0
but	0
the	0
most	0
common	I-DISEASE
age	0
of	0
presentation	0
is	0
20	I-DISEASE
to	0
40	0
years	0
.	0

Patients	0
with	0
stroke	0
tend	0
to	0
be	0
older	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	I-DISEASE
Because	0
of	I-DISEASE
the	I-DISEASE
heterogeneity	0
of	I-DISEASE
etiologies	0
in	0
this	I-DISEASE
type	I-DISEASE
of	0
CSA	I-DISEASE
,	0
predisposing	0
and	I-DISEASE
pre-	0
cipitating	I-DISEASE
factors	0
are	0
variable	0
.	0

In	0
CM	0
there	I-DISEASE
is	I-DISEASE
herniation	I-DISEASE
of	0
a	0
portion	0
of	I-DISEASE
the	0
brainstem	0
through	0
the	0
foramen	0
magnum	I-DISEASE
.	0

In	0
CM	0
type	0
1	I-DISEASE
,	0
a	0
portion	I-DISEASE
of	0
the	0
cerebellar	0
tonsils	0
herni-	0
ate	0
.	0

CSA	0
in	I-DISEASE
these	0
patients	0
is	0
believed	I-DISEASE
to	I-DISEASE
occur	0
due	I-DISEASE
to	0
impaired	0
function	0
of	0
ventilatory	0
control	I-DISEASE
centers	0
in	0
the	I-DISEASE
brainstem	0
.	0

Familial	0
Patterns	0
None	0
known	0
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
These	I-DISEASE
factors	0
vary	0
as	0
well	0
with	0
the	0
different	0
etiologies	0
.	0

In	0
CM	0
the	0
presentation	0
is	0
typi-	0
cally	0
age	0
20	0
to	0
40	0
years	0
of	0
age	0
but	0
can	0
occur	0
in	I-DISEASE
infants	0
and	0
children	0
.	0

With	0
the	0
increased	I-DISEASE
use	0
of	0
magnetic	I-DISEASE
resonance	I-DISEASE
imaging	0
(	I-DISEASE
MRI	0
)	0
,	0
cases	I-DISEASE
are	0
often	I-DISEASE
diagnosed	0
before	0
symptoms	0
are	0
severe	0
.	0

The	0
CSA	0
following	0
a	0
cerebrovascular	0
accident	0
(	I-DISEASE
CVA	0
)	0
is	0
abrupt	0
in	0
onset	0
.	0

In	0
patients	0
exhibiting	I-DISEASE
both	I-DISEASE
central	0
and	0
obstructive	I-DISEASE
apnea	0
,	I-DISEASE
the	0
central	0
apneas	0
tend	I-DISEASE
to	0
resolve	I-DISEASE
with	I-DISEASE
time	0
.	I-DISEASE

Some	0
post	0
-	0
CVA	I-DISEASE
patients	I-DISEASE
with	0
central	I-DISEASE
apneas	0
have	0
central	0
apnea	I-DISEASE
with	0
CSB	0
,	0
whereas	0
in	0
others	I-DISEASE
the	0
CSA	0
does	I-DISEASE
not	0
have	0
a	0
pattern	0
consistent	I-DISEASE
with	I-DISEASE
CSB	I-DISEASE
.	I-DISEASE

The	0
central	0
apneas	0
can	0
lead	I-DISEASE
to	0
sleep	I-DISEASE
fragmentation	0
,	I-DISEASE
yielding	0
either	0
hypersomnolence	0
or	I-DISEASE
insomnia	0
or	I-DISEASE
both	0
.	0

There	0
is	0
little	0
evidence	0
that	0
these	I-DISEASE
apneas	0
or	I-DISEASE
their	I-DISEASE
associated	0
hypoxia	I-DISEASE
and	0
hypercapnia	0
lead	0
to	I-DISEASE
pulmonary	0
hypertension	I-DISEASE
,	I-DISEASE
cor	0
pulmonale	I-DISEASE
,	0
or	0
other	0
adverse	0
car-	I-DISEASE
diovascular	I-DISEASE
consequences	I-DISEASE
.	0

Developmental	0
Issues	0
Not	0
known	0
.	0

Pathology	0
and	0
Pathophysiology	0
CSA	0
is	0
caused	I-DISEASE
by	I-DISEASE
failure	0
of	I-DISEASE
the	0
ventilatory	0
control	0
centers	0
to	0
initiate	0
ventilatory	0
effort	I-DISEASE
.	0

The	0
abnormality	0
is	0
due	0
to	0
dysfunction	0
of	0
central	0
ventilatory	I-DISEASE
control	0
centers	0
.	0

The	0
pres-	0
ence	0
of	I-DISEASE
sleep	0
may	0
unmask	I-DISEASE
ventilatory	0
control	I-DISEASE
abnormalities	0
with	0
the	0
loss	0
of	0
the	I-DISEASE
wake-	0
fulness	0
stimulus	I-DISEASE
.	0

Sleep	0
related	0
hypoventilation	I-DISEASE
and/or	I-DISEASE
daytime	0
hypoventilation	I-DISEASE
may	0
coexist	0
with	I-DISEASE
CSA	0
due	0
to	0
medical	I-DISEASE
or	0
neurological	I-DISEASE
disorder	0
,	0
not	I-DISEASE
CSB	0
,	0
in	0
which	0
case	I-DISEASE
both	0
diagnoses	0
can	0
be	0
made	0
.	0

A	0
number	0
of	0
causes	0
of	0
CSA	I-DISEASE
due	I-DISEASE
to	0
medical	0
or	0
neurological	0
disorders	0
–	0
not	0
Cheyne-	I-DISEASE
Stokes	0
—	0
have	I-DISEASE
been	0
described	I-DISEASE
.	0

Patients	0
with	0
CM	B-DISEASE
exhibit	0
obstructive	I-DISEASE
,	I-DISEASE
central	I-DISEASE
,	0
or	I-DISEASE
a	0
mixture	0
of	0
obstructive	0
and	0
central	I-DISEASE
apneas	I-DISEASE
.	0

Some	0
patient	0
exhibit	0
nocturnal	0
hypoventi-	0
lation	0
but	0
rarely	0
daytime	0
hypoventilation	0
.	0

CSA	0
and/or	0
OSA	0
can	0
be	0
the	0
initial	0
presenta-	0
tion	0
of	0
the	0
disorder	0
.	0

Symptoms	0
include	0
headache	0
(	I-DISEASE
especially	0
with	I-DISEASE
laughter	I-DISEASE
,	I-DISEASE
coughing	I-DISEASE
,	0
Sleep	0
Related	0
Breathing	I-DISEASE
Disorders	0
Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
or	0
exertion	I-DISEASE
)	0
,	0
neck	0
pain	I-DISEASE
,	I-DISEASE
and	0
vertigo	I-DISEASE
.	I-DISEASE

An	0
MRI	0
is	0
diagnostic	0
of	0
the	0
condition	I-DISEASE
and	I-DISEASE
should	I-DISEASE
be	0
considered	0
as	0
part	0
of	0
the	I-DISEASE
evaluation	0
of	I-DISEASE
all	I-DISEASE
patients	0
without	0
an	0
obvious	I-DISEASE
cause	0
of	0
central	I-DISEASE
apnea	0
.	0

Brainstem	0
neoplasm	0
can	0
present	0
with	0
central	I-DISEASE
apnea	I-DISEASE
not	0
of	0
the	0
Cheyne	0
-	0
Stokes	0
type	0
.	0

Patients	0
with	0
a	0
recent	0
cerebrovascular	0
accident	I-DISEASE
show	I-DISEASE
a	0
high	0
incidence	0
of	0
sleep	0
disor-	0
dered	0
breathing	I-DISEASE
.	0

Although	0
obstructive	0
apnea	0
is	0
more	0
common	I-DISEASE
,	I-DISEASE
central	I-DISEASE
apnea	0
may	0
be	0
noted	0
initially	0
after	0
a	I-DISEASE
cerebrovascular	I-DISEASE
accident	0
.	I-DISEASE

Some	0
patients	0
exhibit	I-DISEASE
a	0
pattern	0
of	0
CSB	I-DISEASE
,	I-DISEASE
whereas	0
in	0
others	0
periodic	0
breathing	0
without	0
the	0
characteristic	I-DISEASE
CSB	I-DISEASE
pattern	0
is	0
present	0
.	0

Patients	0
with	0
multiple	0
system	0
atrophy	0
may	0
also	I-DISEASE
present	0
with	I-DISEASE
CSA	0
that	0
does	0
not	0
have	0
a	0
CSB	0
pattern	0
.	I-DISEASE

Objective	0
Findings	0
The	0
polysomnogram	I-DISEASE
of	0
the	I-DISEASE
patient	I-DISEASE
with	0
CSA	I-DISEASE
due	0
to	0
medical	I-DISEASE
or	0
neurological	0
condi-	I-DISEASE
tion	I-DISEASE
—	0
not	I-DISEASE
CSB	0
—	0
demonstrate	0
recurrent	0
(	0
five	I-DISEASE
or	I-DISEASE
more	I-DISEASE
per	I-DISEASE
hour	I-DISEASE
)	0
central	I-DISEASE
apneas	0
and/or	0
central	0
hypopneas	0
.	0

The	0
central	0
apneas	0
and	I-DISEASE
hypopneas	I-DISEASE
meet	0
criteria	I-DISEASE
for	I-DISEASE
these	I-DISEASE
events	0
as	0
defined	0
by	0
the	0
most	I-DISEASE
recent	0
version	0
of	I-DISEASE
the	0
AASM	0
Manual	0
for	0
the	0
Scoring	I-DISEASE
of	0
Sleep	0
and	I-DISEASE
Associated	I-DISEASE
Events	0
.	I-DISEASE

Runs	0
of	0
recurrent	I-DISEASE
central	I-DISEASE
apneas	0
separated	I-DISEASE
by	0
periods	0
of	I-DISEASE
ventilation	0
may	I-DISEASE
occur	I-DISEASE
.	0

The	0
interevent	0
respiratory	0
phase	0
is	0
typically	0
brief	I-DISEASE
with	0
a	I-DISEASE
maximum	I-DISEASE
of	0
five	0
breaths	0
.	0

The	0
central	0
apneas	0
do	0
not	I-DISEASE
have	0
the	I-DISEASE
pattern	0
of	I-DISEASE
CSB	0
.	0

Differential	0
Diagnosis	0
Patients	0
with	0
CSA	0
due	I-DISEASE
to	I-DISEASE
medical	B-DISEASE
or	I-DISEASE
neurological	0
disorder	0
—	0
not	0
CSB	0
—	I-DISEASE
should	0
be	0
dif-	I-DISEASE
ferentiated	0
from	0
primary	0
CSA	0
,	0
in	0
which	0
no	0
known	0
cause	I-DISEASE
is	0
identified	0
.	0

As	0
the	0
name	I-DISEASE
implies	0
,	I-DISEASE
patients	0
with	I-DISEASE
a	0
pattern	I-DISEASE
of	0
CSB	0
should	I-DISEASE
be	0
classified	0
as	I-DISEASE
such	0
.	0

Patients	0
with	0
central	0
nervous	0
system	0
neoplasms	0
may	I-DISEASE
have	0
a	I-DISEASE
central	0
hypoventilation	I-DISEASE
syndrome	0
with	0
sleep	0
related	0
hypoventilation	I-DISEASE
with	0
or	I-DISEASE
without	0
an	0
increase	0
in	0
daytime	I-DISEASE
PaCO2	I-DISEASE
.	I-DISEASE

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE
With	I-DISEASE
the	I-DISEASE
possible	0
exception	0
of	0
poststroke	0
central	I-DISEASE
apnea	0
,	0
the	I-DISEASE
disorders	0
classified	0
here	0
are	0
thought	I-DISEASE
to	0
be	0
relatively	I-DISEASE
rare	0
.	0

The	0
presenting	0
symptoms	0
may	0
not	0
be	I-DISEASE
a	I-DISEASE
sleep	0
related	I-DISEASE
complaint	I-DISEASE
.	0

Except	0
for	0
those	0
associated	0
with	0
CM	0
and	I-DISEASE
poststroke	0
CSA	I-DISEASE
,	0
the	0
disorders	I-DISEASE
are	0
not	0
well	I-DISEASE
characterized	0
.	0

Bibliography	0
Cormican	0
LJ	0
,	0
Higgins	0
AC	0
,	I-DISEASE
Davidson	0
R	I-DISEASE
,	0
et	0
al	0
.	0

Multi	0
system	0
atrophy	0
presenting	I-DISEASE
as	0
central	I-DISEASE
sleep	I-DISEASE
apnea	0
.	0

Eur	0
Respir	0
J	0
2004;24:323–5	I-DISEASE
.	0

Dauvilliers	0
Y	0
,	0
Stal	0
V	0
,	0
Abril	I-DISEASE
B	0
,	I-DISEASE
et	0
al	0
.	0

Chiari	0
malformation	0
and	0
sleep	I-DISEASE
related	0
breathing	0
disorders	I-DISEASE
.	0

J	0
Neurol	0
Neurosurg	0
Psychiatry	0
2007;78:1344–8	0
.	0

Fernández	0
AA	0
,	0
Guerrero	0
AI	0
,	0
Martínez	0
MI	0
,	I-DISEASE
et	0
al	0
.	0

Malformations	0
of	0
the	0
craniocervical	I-DISEASE
junction	0
(	I-DISEASE
Chiari	I-DISEASE
type	0
I	I-DISEASE
and	0
syringomyelia	I-DISEASE
:	0
classification	I-DISEASE
,	0
diagnosis	0
and	0
treatment	I-DISEASE
)	0
.	0

BMC	0
Musculoskelet	0
Disord	0
2009	0

Dec	0
17;10	0
Suppl	0
1	0
.	0

Parra	0
O	0
,	0
Arboix	0
A	0
,	I-DISEASE
Bechich	0
S	0
,	I-DISEASE
et	0
al	0
.	0

Time	0
course	0
of	0
sleep	0
-	0
related	0
breathing	I-DISEASE
disorders	0
in	I-DISEASE
first	0
-	0
ever	0
stroke	0
or	0
transient	0
ischemic	0
attack	0
.	I-DISEASE

Am	0
J	0
Respir	0
Crit	I-DISEASE
Care	0
Med	I-DISEASE
2000;161:375–80	I-DISEASE
.	0

Siccoli	0
MM	0
,	0
Valko	0
PO	0
,	0
Hermann	I-DISEASE
DM	0
,	0
Bassetti	0
CL	0
.	0

Central	0
periodic	0
breathing	0
during	0
sleep	I-DISEASE
in	I-DISEASE
74	0
patients	0
with	I-DISEASE
acute	0
ischemic	0
stroke	0
—	0
neurogenic	0
and	I-DISEASE
cardiogenic	0
factors	0
.	I-DISEASE

J	0
Neurol	0
2008;255:1687–92	0
.	0

Central	0
Sleep	0
Apnea	I-DISEASE
Due	0
to	I-DISEASE
High	0
Altitude	I-DISEASE
Periodic	0
ICD-10	I-DISEASE
-	0
CM	0
code	0
:	0
G47.32	0
Breathing	0
ICD-9	I-DISEASE
-	0
CM	I-DISEASE
code	I-DISEASE
:	I-DISEASE
327.22	0
Alternate	0
Names	I-DISEASE
None	0
.	0

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
D	I-DISEASE
must	0
be	0
met	I-DISEASE
A.	0
Recent	0
ascent	0
to	0
high	0
altitude.1	0

B.	0
The	0
presence	0
of	0
one	0
or	I-DISEASE
more	I-DISEASE
of	0
the	0
following:2	0
Sleep	0
Related	0
Breathing	0
Disorders	0
.	I-DISEASE

Sleepiness	0
.	0
.	0

Difficulty	0
initiating	0
or	0
maintaining	0
sleep	0
,	0
frequent	0
awakenings	0
,	I-DISEASE
or	0
nonrestorative	0
sleep	I-DISEASE
.	0
.	0

Awakening	0
with	0
shortness	0
of	0
breath	0
or	I-DISEASE
morning	0
headache	0
.	I-DISEASE
.	0

Witnessed	0
apnea	0
.	0

C.	0

The	0
symptoms	0
are	0
clinically	0
attributable	0
to	0
high	I-DISEASE
-	0
altitude	0
periodic	0
breathing	0
or	I-DISEASE
PSG	I-DISEASE
,	0
if	I-DISEASE
performed	0
,	0
demonstrates	I-DISEASE
recurrent	0
central	0
apneas	0
or	0
hypopneas	0
primarily	0
during	I-DISEASE
NREM	I-DISEASE
sleep	0
at	I-DISEASE
a	I-DISEASE
frequency	0
of	I-DISEASE
≥	0
5	0
/	0
hour	0
.	0

D.	0

The	0
disorder	0
is	0
not	0
better	I-DISEASE
explained	I-DISEASE
by	0
another	0
current	I-DISEASE
sleep	0
disorder	0
,	0
medical	0
or	0
neurological	I-DISEASE
disorder	0
,	0
medication	I-DISEASE
use	0
(	0
e.g.	0
,	0
narcotics	0
)	0
,	0
or	I-DISEASE
substance	0
use	I-DISEASE
disorders	0
.	0

Notes	0
.	0

Typically	0
at	0
least	I-DISEASE
2,500	I-DISEASE
meters	0
(	0
8,202	I-DISEASE
feet	0
)	I-DISEASE
,	0
although	0
some	0
individuals	I-DISEASE
may	I-DISEASE
exhibit	I-DISEASE
the	0
disorder	0
at	I-DISEASE
altitudes	0
as	0
low	0
as	0
1,500	I-DISEASE
meters	I-DISEASE
.	I-DISEASE
.	0

Periodic	0
breathing	0
is	0
a	0
common	0
response	I-DISEASE
to	0
altitude	0
.	I-DISEASE

Associated	0
symptoms	0
are	0
required	0
to	0
make	0
the	0
diagnosis	I-DISEASE
of	I-DISEASE
a	0
disorder	0
.	0

There	0
is	0
no	0
level	0
of	0
the	I-DISEASE
central	I-DISEASE
AHI	0
separating	I-DISEASE
a	0
normal	0
and	0
abnormal	0
response	0
to	I-DISEASE
high	0
altitude	0
.	I-DISEASE
.	0

A	0
diagnosis	0
of	0
CSA	0
due	I-DISEASE
to	0
high	0
-	0
altitude	I-DISEASE
period	0
breathing	0
does	0
not	0
exclude	0
a	I-DISEASE
diagnosis	0
of	0
OSA	0
.	0

Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Essential	0
Features	I-DISEASE
High	I-DISEASE
-	0
altitude	I-DISEASE
periodic	0
breathing	0
is	0
characterized	I-DISEASE
by	0
alternating	0
periods	I-DISEASE
of	0
central	I-DISEASE
apnea	0
and	0
hyperpnea	0
associated	0
with	0
recent	0
ascent	I-DISEASE
to	I-DISEASE
high	0
altitude	I-DISEASE
.	0

The	0
pattern	0
of	0
periodic	0
breathing	0
is	0
an	I-DISEASE
expected	I-DISEASE
response	0
to	0
ascent	0
to	0
elevation	0
.	0

Only	0
those	0
individuals	0
who	0
manifest	0
related	0
symptoms	I-DISEASE
,	0
as	I-DISEASE
described	0
below	0
,	0
are	0
diagnosed	0
with	0
this	0
disorder	0
.	I-DISEASE

The	0
cycle	0
length	0
of	0
this	0
respiratory	0
pattern	I-DISEASE
is	0
commonly	I-DISEASE
less	0
than	0
40	0
seconds	0
and	0
often	I-DISEASE
as	0
short	0
as	I-DISEASE
12	0
to	0
20	0
seconds	0
.	0

The	0
percentage	0
of	0
individuals	0
exhibiting	0
periodic	I-DISEASE
breathing	I-DISEASE
during	0
sleep	I-DISEASE
increases	0
at	0
higher	I-DISEASE
altitudes	0
.	0

Approximately	0
25	0
%	0
exhibit	0
periodic	0
breath-	I-DISEASE
ing	0
at	0
2,500	I-DISEASE
meters	I-DISEASE
(	I-DISEASE
8,202	0
feet	0
)	0
,	I-DISEASE
and	0
virtually	0
100	0
%	0
demonstrate	I-DISEASE
periodic	0
breathing	0
at	0
4,000	0
m	0
(	I-DISEASE
13,123	I-DISEASE
feet	I-DISEASE
)	I-DISEASE
.	0

Periodic	0
breathing	0
has	0
been	0
described	0
at	0
altitudes	I-DISEASE
as	I-DISEASE
low	I-DISEASE
as	0
1,500	0
meters	0
(	0
4,900	0
feet	0
)	0
.	0

Chronic	0
exposure	0
to	0
altitude	I-DISEASE
above	0
2,500	0
meters	I-DISEASE
has	0
also	I-DISEASE
been	0
associated	0
with	0
periodic	0
breathing	0
in	I-DISEASE
some	0
studies	0
.	I-DISEASE

Associated	0
Features	0
At	0
altitude	I-DISEASE
,	0
individuals	0
may	I-DISEASE
complain	0
of	0
frequent	0
awakenings	0
,	0
poor	0
-	0
quality	I-DISEASE
sleep	0
,	0
and	I-DISEASE
a	I-DISEASE
sense	0
of	0
dyspnea	0
.	0

These	0
symptoms	0
will	0
often	0
improve	0
with	0
time	0
at	0
moderate	I-DISEASE
altitude	0
but	0
may	0
persist	0
at	0
extreme	I-DISEASE
altitude	I-DISEASE
.	I-DISEASE

Alterations	0
in	0
sleep	0
associated	I-DISEASE
with	0
ascent	I-DISEASE
to	I-DISEASE
alti-	0
tude	I-DISEASE
include	0
a	0
reduction	0
in	I-DISEASE
stage	0
N3	0
sleep	I-DISEASE
and	0
increased	I-DISEASE
arousal	0
frequency	0
.	0

Total	0
sleep	I-DISEASE
time	I-DISEASE
and	0
the	0
amount	I-DISEASE
of	I-DISEASE
REM	0
sleep	I-DISEASE
are	0
either	0
unchanged	0
or	0
decreased	0
.	I-DISEASE

Of	0
note	0
,	I-DISEASE
the	0
degree	I-DISEASE
of	I-DISEASE
both	I-DISEASE
subjective	0
and	I-DISEASE
objective	0
impairment	0
of	I-DISEASE
sleep	0
quality	0
was	I-DISEASE
not	I-DISEASE
correlated	I-DISEASE
with	I-DISEASE
the	I-DISEASE
severity	0
of	0
periodic	0
breathing	0
in	0
a	I-DISEASE
number	0
of	0
studies	I-DISEASE
.	I-DISEASE

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
None	I-DISEASE
known	I-DISEASE
.	I-DISEASE

Demographics	0
The	0
demographics	0
of	0
high	0
-	0
altitude	I-DISEASE
periodic	0
breathing	I-DISEASE
are	0
not	0
known	0
.	0

High	0
-	0
altitude	0
periodic	0
breathing	0
tends	0
to	I-DISEASE
occur	0
in	0
individuals	0
with	0
a	0
high	0
hypoxic	0
and	I-DISEASE
probably	0
hypercapnic	I-DISEASE
ventilatory	0
response	0
.	0

Because	0
men	0
generally	0
have	I-DISEASE
higher	0
chemorespon-	I-DISEASE
siveness	I-DISEASE
than	0
women	I-DISEASE
,	0
high	0
-	0
altitude	I-DISEASE
periodic	0
breathing	0
may	0
be	0
more	I-DISEASE
common	I-DISEASE
in	0
men	0
than	0
in	0
women	0
.	I-DISEASE

As	0
stated	0
above	I-DISEASE
,	0
periodic	0
breathing	I-DISEASE
will	0
occur	0
in	0
virtually	0
anyone	0
ascending	0
to	0
higher	0
than	I-DISEASE
4,000	0
meters	0
and	I-DISEASE
in	0
some	0
individuals	0
at	0
lower	0
altitudes	0
.	I-DISEASE

The	0
latter	0
group	0
probably	0
comprises	0
individuals	I-DISEASE
with	I-DISEASE
increased	0
hypoxic	I-DISEASE
chemoresponsive-	0

ness	0
.	0

In	0
one	0
study	0
,	I-DISEASE
individuals	0
both	I-DISEASE
with	0
and	0
without	I-DISEASE
periodic	I-DISEASE
breathing	0
at	0
altitude	I-DISEASE
had	0
alterations	I-DISEASE
in	0
sleep	0
architecture	I-DISEASE
.	0

Those	0
with	0
periodic	0
breathing	0
had	0
a	I-DISEASE
greater	I-DISEASE
arousal	0
index	I-DISEASE
,	0
although	0
their	0
sleep	0
architecture	I-DISEASE
was	0
otherwise	I-DISEASE
not	0
significantly	I-DISEASE
different	0
from	0
individuals	0
who	0
did	0
not	0
develop	I-DISEASE
periodic	0
breathing	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
The	0
only	I-DISEASE
known	I-DISEASE
predisposing	0
factor	I-DISEASE
for	0
the	0
development	0
of	0
high	0
-	I-DISEASE
altitude	I-DISEASE
periodic	0
breathing	I-DISEASE
is	0
increased	0
ventilatory	0
chemoresponsiveness	0
,	0
primarily	I-DISEASE
hypoxic	I-DISEASE
ventila-	I-DISEASE
tory	0
responsiveness	I-DISEASE
.	0

A	0
high	0
hypoxic	0
ventilatory	I-DISEASE
response	0
will	I-DISEASE
lead	0
to	0
increased	0
hyper-	0
ventilation	0
on	0
ascent	0
to	0
altitude	I-DISEASE
.	0

This	0
hyperventilation	0
leads	0
to	0
hypocapnic	0
alkalosis	I-DISEASE
that	0
,	0
during	I-DISEASE
sleep	0
,	0
inhibits	0
ventilation	0
.	0

Thus	0
,	0
repetitive	0
cycles	0
of	0
apnea	I-DISEASE
and	I-DISEASE
hyperpnea	I-DISEASE
develop	0
during	0
NREM	0
sleep	0
.	I-DISEASE

The	0
obvious	0
precipitating	0
factor	0
for	0
the	0
development	I-DISEASE
of	0
this	0
periodic	I-DISEASE
breathing	0
is	0
ascent	0
to	0
altitude	0
.	I-DISEASE

The	0
more	0
rapid	0
the	I-DISEASE
ascent	I-DISEASE
,	0
the	I-DISEASE
more	I-DISEASE
likely	0
periodic	0
breathing	0
is	0
to	0
develop	0
.	0

Familial	0
Patterns	0

Some	0
data	0
suggest	0
that	0
ventilatory	0
chemoresponsiveness	0
is	I-DISEASE
directly	0
inherited	I-DISEASE
.	0

Because	0
elevated	0
hypoxic	0
responsiveness	I-DISEASE
is	0
a	I-DISEASE
predisposing	0
variable	0
in	I-DISEASE
the	0
development	0
of	0
high	0
-	0
altitude	I-DISEASE
periodic	0
breathing	0
,	0
it	0
would	0
seem	0
likely	0
that	0
there	I-DISEASE
would	I-DISEASE
be	0
a	I-DISEASE
familial	I-DISEASE
pattern	0
in	0
the	0
development	0
of	0
this	0
respiratory	I-DISEASE
abnormality	0
.	I-DISEASE

However	0
,	I-DISEASE
there	0
are	I-DISEASE
no	0
data	0
addressing	I-DISEASE
this	0
issue	0
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
This	I-DISEASE
respiratory	0
pattern	0
will	0
generally	0
be	0
evident	0
during	0
sleep	I-DISEASE
immediately	I-DISEASE
after	0
ascent	I-DISEASE
to	0
altitude	I-DISEASE
.	0

This	0
depends	0
to	0
some	0
extent	0
on	0
the	0
rapidity	0
of	I-DISEASE
the	0
ascent	0
,	0
the	0
elevation	0
,	I-DISEASE
and	0
individual	0
predisposition	I-DISEASE
.	0

However	0
,	I-DISEASE
it	0
will	0
be	0
present	0
most	0
often	0
on	I-DISEASE
the	0
first	0
night	0
at	I-DISEASE
altitude	0
.	0

At	0
moderate	I-DISEASE
altitude	0
,	0
the	0
breathing	I-DISEASE
pattern	I-DISEASE
may	0
become	I-DISEASE
more	0
regular	0
over	0
time	I-DISEASE
,	0
although	I-DISEASE
at	0
extreme	I-DISEASE
altitude	I-DISEASE
it	0
is	0
likely	0
to	0
persist	0
.	0

One	0
recent	I-DISEASE
study	0
found	0
that	0
the	I-DISEASE
amount	I-DISEASE
of	I-DISEASE
periodic	I-DISEASE
breathing	0
continued	0
to	0
increase	0
over	0
three	0
days	0
to	0
two	I-DISEASE
weeks	0
of	0
acclimatization	0
.	0

Studies	0
of	0
adaptation	0
to	0
altitude	0
suggest	0
that	0
sleep	0
quality	I-DISEASE
may	I-DISEASE
improve	0
despite	0
further	0
increases	0
in	I-DISEASE
periodic	0
breathing	0
.	0

It	0
has	0
been	0
hypothesized	0
that	0
hypoxia	0
itself	0
may	0
have	I-DISEASE
an	0
important	0
role	0
in	I-DISEASE
disturbing	0
sleep	I-DISEASE
architecture	0
.	0

Thus	0
,	0
sleep	0
and	I-DISEASE
symptoms	0
may	0
improve	0
during	0
acclimatization	I-DISEASE
to	0
altitude	0
even	I-DISEASE
if	0
the	0
amount	I-DISEASE
of	0
periodic	I-DISEASE
breathing	0
actually	I-DISEASE
increases	I-DISEASE
.	0

The	0
complications	0
of	0
high	I-DISEASE
-	I-DISEASE
altitude	I-DISEASE
periodic	I-DISEASE
breathing	0
,	I-DISEASE
which	0
are	I-DISEASE
generally	0
limited	I-DISEASE
to	0
disrupted	I-DISEASE
sleep	0
on	I-DISEASE
the	0
initial	I-DISEASE
nights	0
at	0
altitude	0
,	0
include	0
frequent	I-DISEASE
awakenings	0
,	0
often	0
with	0
shortness	0
of	I-DISEASE
breath	0
or	0
a	0
sensation	0
of	0
suffocation	0
that	I-DISEASE
may	I-DISEASE
lead	I-DISEASE
to	0
fatigue	0
or	0
sleep-	0
iness	I-DISEASE
on	B-DISEASE
the	I-DISEASE
following	I-DISEASE
day	0
.	I-DISEASE

There	0
is	0
no	0
clear	I-DISEASE
association	0
between	0
periodic	I-DISEASE
breathing	0
and	I-DISEASE
other	0
altitude	0
syndromes	0
(	I-DISEASE
high	0
-	I-DISEASE
altitude	I-DISEASE
pulmonary	I-DISEASE
edema	0
,	0
acute	0
mountain	0
sick-	0

ness	0
,	0
and	0
high	0
-	0
altitude	0
cerebral	I-DISEASE
edema	0
)	0
.	0

In	0
fact	0
,	0
periodic	0
breathing	0
is	0
a	I-DISEASE
marker	0
of	I-DISEASE
high	0
hypoxic	0
responsiveness	I-DISEASE
,	0
which	I-DISEASE
generally	0
yields	0
improved	0
oxygenation	I-DISEASE
at	0
altitude	0
and	0
a	I-DISEASE
reduced	I-DISEASE
frequency	0
of	I-DISEASE
the	0
maladaptive	0
syndromes	I-DISEASE
.	0

Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Sleep	I-DISEASE
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Developmental	I-DISEASE
Issues	0
Relatively	0
little	I-DISEASE
is	0
known	I-DISEASE
about	I-DISEASE
differences	I-DISEASE
between	0
children	I-DISEASE
and	0
adults	0
concerning	0
periodic	0
breathing	I-DISEASE
at	I-DISEASE
altitude	0
.	0

One	0
study	I-DISEASE
did	0
compare	0
breathing	0
in	0
children	0
and	I-DISEASE
their	I-DISEASE
fathers	0
.	0

The	0
children	0
revealed	I-DISEASE
reduced	0
nocturnal	I-DISEASE
oxygen	0
saturation	0
and	0
associated	I-DISEASE
hyperventilation	0
at	0
high	0
altitude	0
similar	0
to	0
the	0
adults	0
,	I-DISEASE
but	0
their	0
breathing	0
pattern	0
was	0
more	0
stable	0
.	0

The	0
investigators	0
hypothesized	I-DISEASE
that	I-DISEASE
children	0
may	0
have	0
a	0
lower	I-DISEASE
apnea	I-DISEASE
threshold	0
for	0
CO2	0
than	0
adults	I-DISEASE
.	I-DISEASE

Pathology	0
and	0
Pathophysiology	0
High	0
-	0
altitude	I-DISEASE
periodic	I-DISEASE
breathing	0
is	I-DISEASE
believed	0
to	0
be	0
a	I-DISEASE
product	0
of	I-DISEASE
the	0
hyperventilation	0
induced	I-DISEASE
by	0
the	0
hypobaric	0
hypoxia	0
encountered	0
at	0
altitude	0
.	0

At	0
2,500	I-DISEASE
meters	I-DISEASE
the	0
atmo-	0
spheric	0
pressure	I-DISEASE
is	I-DISEASE
approximately	I-DISEASE
570	0
mm	0
Hg	0
and	I-DISEASE
the	0
ideal	I-DISEASE
alveolar	I-DISEASE
PO2	I-DISEASE
around	0
55	0
mm	I-DISEASE
Hg	0
(	0
depending	I-DISEASE
on	0
the	I-DISEASE
level	I-DISEASE
of	0
PaCO2	I-DISEASE
)	0
.	0

Actual	0
arterial	0
PO2	0
values	0
will	I-DISEASE
be	0
lower	0
,	I-DISEASE
especially	I-DISEASE
during	0
sleep	0
.	0

The	0
hypoxic	0
ventilatory	0
response	0
shows	0
a	0
steep	0
increase	0
in	I-DISEASE
ventilation	0
when	0
the	0
arterial	0
PO2	0
level	0
drops	0
below	0
55	I-DISEASE
mm	0
Hg	I-DISEASE
.	0

The	0
increases	0
in	0
venti-	0
lation	0
associated	0
with	I-DISEASE
hypoxemia	0
result	I-DISEASE
in	0
hypocapnic	0
alkalosis	0
.	0

Because	0
PaCO2	0
is	0
the	0
principal	I-DISEASE
stimulus	0
to	I-DISEASE
respiration	0
during	0
NREM	0
sleep	0
,	0
a	I-DISEASE
low	0
PaCO2	0
can	I-DISEASE
yield	I-DISEASE
a	I-DISEASE
loss	0
or	0
reduction	0
in	0
respiratory	I-DISEASE
drive	0
,	0
resulting	0
in	0
central	0
apnea	B-DISEASE
or	0
hypopnea	0
.	0

The	0
greater	0
the	0
ventilatory	0
response	0
to	0
hypoxia	I-DISEASE
,	0
the	0
greater	0
the	0
fall	0
in	0
PaCO2	0
.	I-DISEASE

Thus	0
,	0
individuals	0
with	0
brisk	0
hypoxic	I-DISEASE
responses	I-DISEASE
more	0
commonly	0
tend	0
to	0
demonstrate	0
this	0
respiratory	0
pattern	0
.	0

Over	0
the	0
course	I-DISEASE
of	0
the	0
apnea	I-DISEASE
,	I-DISEASE
the	I-DISEASE
PaO2	0
falls	0
and	I-DISEASE
PaCO2	0
rises	0
,	I-DISEASE
eventually	0
stimulating	I-DISEASE
a	0
resumption	I-DISEASE
of	I-DISEASE
ventilation	0
.	0

However	0
,	I-DISEASE
after	0
several	0
large	0
breaths	0
,	I-DISEASE
the	0
PaCO2	I-DISEASE
again	0
falls	0
below	I-DISEASE
the	0
apnea	0
threshold	I-DISEASE
,	I-DISEASE
initiating	0
another	I-DISEASE
pause	0
in	I-DISEASE
breathing	0
.	0

This	0
cycle	0
is	0
then	0
repeated	0
over	0
the	0
course	0
of	0
the	0
night	0
.	0

Of	0
note	0
,	0
the	0
respiratory	I-DISEASE
pattern	0
is	0
often	0
improved	I-DISEASE
during	0
REM	0
sleep	0
with	0
reduced	0
cycling	I-DISEASE
.	I-DISEASE

This	0
is	0
likely	0
due	0
to	0
the	0
decreased	I-DISEASE
hypoxic	0
and	I-DISEASE
hypercapnic	0
responsiveness	0
characteristic	0
of	0
REM	0
sleep	0
.	0

Of	0
interest	0
,	0
in	0
one	0
study	0
the	I-DISEASE
hypoxic	0
ventilatory	I-DISEASE
response	0
continued	0
to	0
increase	0
up	0
to	I-DISEASE
seven	0
days	0
after	0
ascent	0
to	0
altitude	0
.	0

This	0
resulted	0
in	0
a	0
lower	0
PaCO2	0
and	I-DISEASE
higher	0
PaO2	I-DISEASE
.	0

The	0
reduction	0
in	0
peri-	0
odic	0
breathing	0
in	I-DISEASE
some	0
individuals	I-DISEASE
with	0
adaptation	0
to	0
altitude	0
despite	0
a	0
greater	0
venti-	0
latory	0
response	0
to	0
hypoxemia	0
may	0
be	I-DISEASE
due	0
to	I-DISEASE
a	0
lowering	0
of	I-DISEASE
the	0
apneic	I-DISEASE
threshold	0
.	0

Other	0
studies	0
have	0
found	0
that	0
the	I-DISEASE
amount	I-DISEASE
of	I-DISEASE
periodic	I-DISEASE
breathing	0
continues	0
to	I-DISEASE
increase	0
over	0
three	0
days	0
to	0
two	I-DISEASE
weeks	0
of	0
acclimatization	0
despite	0
improvements	0
in	I-DISEASE
oxygen	I-DISEASE
saturation	0
.	0

The	0
increase	0
in	0
both	0
periodic	0
breathing	0
and	0
oxygen	0
saturation	I-DISEASE
is	0
thought	0
to	0
be	0
due	0
to	I-DISEASE
increased	0
controller	0
gain	I-DISEASE
of	0
the	I-DISEASE
respiratory	0
system	0
.	0

A	0
number	0
of	0
studies	I-DISEASE
have	0
found	0
that	I-DISEASE
the	I-DISEASE
impairment	I-DISEASE
of	I-DISEASE
sleep	0
architecture	0
does	I-DISEASE
not	I-DISEASE
correlate	I-DISEASE
with	0
the	I-DISEASE
degree	I-DISEASE
of	0
periodic	0
breathing	0
.	0

One	0
study	0
found	0
that	0
the	0
amount	I-DISEASE
of	I-DISEASE
periodic	0
breathing	I-DISEASE
was	0
greater	0
on	0
the	0
third	0
night	0
at	I-DISEASE
altitude	0
compared	0
to	0
the	0
first	0
night	0
.	I-DISEASE

However	0
,	I-DISEASE
both	0
the	0
nocturnal	I-DISEASE
oxygen	0
saturation	0
and	0
amount	I-DISEASE
of	0
stage	0
N3	I-DISEASE
also	0
increased	0
on	0
the	0
third	0
night	I-DISEASE
compared	0
to	I-DISEASE
the	0
first	0
night	0
.	0

It	0
has	0
been	0
hypothesized	0
that	0
hypoxia	0
rather	0
than	0
periodic	I-DISEASE
breathing	0
might	0
be	0
the	I-DISEASE
major	0
factor	I-DISEASE
disturbing	0
sleep	0
.	0

Objective	0
Findings	0
The	0
PSG	I-DISEASE
of	0
individuals	I-DISEASE
with	I-DISEASE
high	0
-	I-DISEASE
altitude	0
periodic	0
breathing	0
demonstrates	I-DISEASE
recur-	0
rent	0
central	I-DISEASE
apneas	0
with	I-DISEASE
a	0
cycle	0
time	0
of	0
less	0
than	0
40	I-DISEASE
seconds	I-DISEASE
,	0
and	I-DISEASE
typically	0
around	0
20	0
seconds	0
.	0

There	0
is	0
some	0
degree	0
of	0
associated	I-DISEASE
arterial	0
oxygen	0
desaturation	I-DISEASE
.	0

The	0
apneas	0
are	0
short	I-DISEASE
,	0
generally	0
8	0
to	0
10	I-DISEASE
seconds	I-DISEASE
in	0
duration	0
.	0

In	0
one	0
study	0
,	0
the	0
apnea	I-DISEASE
duration	I-DISEASE
was	I-DISEASE
around	0
8	0
seconds	0
(	0
7	0
to	0
9	I-DISEASE
seconds	0
)	0
in	I-DISEASE
children	0
and	0
approximately	0
12	0
seconds	0
(	0
10	0
-	0
14	0
seconds	I-DISEASE
)	0
in	0
adults	0
.	I-DISEASE

The	0
cycle	0
length	0
is	0
commonly	0
less	0
than	0
40	0
seconds	I-DISEASE
.	0

This	0
breathing	0
pattern	0
occurs	0
only	0
during	0
NREM	I-DISEASE
sleep	0
with	0
more	I-DISEASE
rhythmic	0
respiration	0
during	0
REM	0
sleep	I-DISEASE
.	I-DISEASE

Because	0
this	0
breathing	0
pattern	0
is	0
a	0
physiologic	I-DISEASE
adaptation	0
to	I-DISEASE
altitude	0
,	0
there	0
is	0
no	0
specific	0
number	0
of	I-DISEASE
apneas	I-DISEASE
per	0
hour	0
of	0
sleep	0
that	0
is	I-DISEASE
considered	0
normal	I-DISEASE
or	0
abnormal	I-DISEASE
.	0

The	0
apneas	0
and	0
associated	I-DISEASE
hyperpnea	0
can	I-DISEASE
lead	I-DISEASE
to	0
recurrent	I-DISEASE
arousals	0
from	I-DISEASE
sleep	0
,	0
which	0
often	I-DISEASE
increase	0
stages	0
N1	I-DISEASE
and	0
N2	0
sleep	0
while	0
reducing	I-DISEASE
stage	I-DISEASE
N3	0
sleep	0
.	0

REM	0
sleep	0
(	0
stage	I-DISEASE
R	0
)	0
duration	0
is	0
generally	I-DISEASE
preserved	0
,	0
as	0
is	0
total	0
sleep	I-DISEASE
time	0
.	I-DISEASE

As	0
noted	0
above	0
,	0
some	0
studies	0
have	I-DISEASE
found	0
a	I-DISEASE
reduction	0
in	0
total	0
sleep	0
time	I-DISEASE
and	0
stage	I-DISEASE
R	0
as	I-DISEASE
well	0
as	0
stage	0
N3	0
.	0

Of	0
interest	0
,	0
the	0
arousal	I-DISEASE
index	I-DISEASE
was	I-DISEASE
only	0
around	I-DISEASE
25	0
%	0
of	0
the	0
AHI	0
in	I-DISEASE
some	0
investigations	0
.	0

Differential	0
Diagnosis	0
High	0
-	0
altitude	0
periodic	I-DISEASE
breathing	I-DISEASE
should	0
be	I-DISEASE
distinguished	0
from	0
other	0
SRBDs	I-DISEASE
.	0

The	0
major	0
distinguishing	0
factor	0
is	0
,	0
of	I-DISEASE
course	0
,	I-DISEASE
recent	0
ascent	0
to	0
high	0
altitude	0
.	0

An	0
individual	0
with	0
OSA	0
will	0
likely	I-DISEASE
continue	I-DISEASE
to	0
have	0
this	0
nocturnal	0
respiratory	0
problem	I-DISEASE
at	0
altitude	I-DISEASE
.	I-DISEASE

Altitude	0
might	0
even	0
exacerbate	0
the	0
OSA	0
.	I-DISEASE

Patients	0
with	0
chronic	0
mountain	0
sickness	0
demonstrate	I-DISEASE
relative	0
hypoventilation	0
at	0
altitude	0
(	0
i.e.	0
,	0
breathe	0
less	I-DISEASE
than	0
is	0
encoun-	I-DISEASE
tered	0
in	0
normal	0
individuals	0
at	I-DISEASE
similar	0
altitude	0
)	0
such	0
that	I-DISEASE
they	0
are	0
more	0
hypoxic	0
than	0
normal	0
individuals	0
who	I-DISEASE
have	0
a	0
greater	I-DISEASE
ventilatory	0
response	I-DISEASE
to	0
the	0
same	0
ambient	I-DISEASE
hypoxia	0
.	I-DISEASE

During	0
sleep	0
,	0
these	0
individuals	0
often	I-DISEASE
demonstrate	I-DISEASE
further	0
arterial	I-DISEASE
oxygen	0
desaturation	0
.	0

Some	0
of	0
the	0
individuals	I-DISEASE
will	0
demonstrate	I-DISEASE
apneas	I-DISEASE
or	0
periodic	I-DISEASE
breathing	0
.	0

A	0
diagnosis	0
of	0
chronic	I-DISEASE
mountain	0
sickness	I-DISEASE
does	0
not	0
imply	I-DISEASE
that	0
periodic	0
breathing	0
is	0
present	0
.	I-DISEASE

However	0
,	I-DISEASE
periodic	0
breathing	0
may	0
be	I-DISEASE
more	I-DISEASE
common	0
in	0
these	0
patients	0
than	I-DISEASE
previously	0
appreciated	0
.	I-DISEASE

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE
Recent	I-DISEASE
studies	I-DISEASE
suggest	0
that	0
hypoxemia	0
rather	0
than	0
the	0
amount	0
of	I-DISEASE
periodic	0
breathing	I-DISEASE
may	I-DISEASE
be	0
the	0
major	0
factor	I-DISEASE
impairing	0
sleep	0
quality	0
.	0

Further	0
studies	0
relating	0
changes	0
in	0
sleep	0
and	I-DISEASE
periodic	0
breathing	I-DISEASE
at	0
altitude	0
are	0
needed	0
.	0

Sleep	0
Related	0
Breathing	I-DISEASE
Disorders	0
Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Bibliography	I-DISEASE
Anholm	0
J	0
,	I-DISEASE
Powles	0
A	0
,	I-DISEASE
Downey	0
R	0
,	I-DISEASE
et	0
al	0
.	0

Operation	0
Everest	0
II	I-DISEASE
:	0
arterial	0
oxygen	I-DISEASE
saturation	I-DISEASE
and	0
sleep	I-DISEASE
at	0
extreme	0
simulated	I-DISEASE
altitude	I-DISEASE
.	0

Am	0
Rev	0
Respir	0
Dis	I-DISEASE
1992;145:817–26	0
.	I-DISEASE

Bloch	0
KE	0
,	0
Latshand	0
TD	0
,	0
Turk	I-DISEASE
AJ	0
,	I-DISEASE
et	0
al	0
.	0

Nocturnal	0
periodic	0
breathing	0
during	0
acclimatization	0
at	0
very	I-DISEASE
high	0
altitude	I-DISEASE
at	0
Mount	0
Muztach	I-DISEASE
Ata	0
(	0
7,546	0
m	I-DISEASE
)	0
.	I-DISEASE

Am	0
J	0
Respir	0
Crit	0
Care	0
Med	I-DISEASE
2010;182:562–8	I-DISEASE
.	0

Burgess	0
,	0
K.R.	0
,	0
Lucas	0
,	I-DISEASE
S.J.	0
,	0
Shepherd	I-DISEASE
,	0
K.L.	0
,	0
et	0
al	0
.	I-DISEASE

Worsening	0
of	I-DISEASE
central	0
sleep	0
apnea	0
at	0
high	I-DISEASE
altitude	0
—	I-DISEASE
a	0
role	0
for	I-DISEASE
cerebrovascular	0
function	0
.	I-DISEASE

J	0
Appl	0
Physiol	0
2013	0
;	0
114	0
:	0
1021–8	0
.	0

Coote	0
JH	0
,	0
Tsang	0
G	0
,	0
Baker	I-DISEASE
A	0
,	I-DISEASE
Stone	0
B.	I-DISEASE
Respiratory	0
changes	0
and	0
structure	I-DISEASE
of	0
sleep	I-DISEASE
in	I-DISEASE
young	0
high	I-DISEASE
-	0
altitude	0
dwellers	I-DISEASE
in	I-DISEASE
the	I-DISEASE
Andes	0
of	0
Peru	I-DISEASE
.	0

Eur	0
J	0
Appl	0
Physiol	0
1993;66:249–53	0
.	0

Goldberg	0
S	0
,	0
Schoene	0
R	0
,	I-DISEASE
Haynor	0
D	0
,	I-DISEASE
et	0
al	0
.	0

Brain	0
tissue	0
pH	0
and	0
ventilatory	0
acclimatization	0
to	I-DISEASE
high	0
altitude	I-DISEASE
.	0

J	0
Appl	0
Physiol	0
1992;72:58–63	0
.	0

Johnson	0
P	0
,	0
Edwards	0
N	0
,	0
Burgess	I-DISEASE
KR	0
,	I-DISEASE
Sullivan	0
CE	0
.	0

Sleep	0
architecture	I-DISEASE
changes	0
during	0
a	I-DISEASE
trek	I-DISEASE
from	I-DISEASE
1400	I-DISEASE
to	I-DISEASE
500	0
m	0
in	0
the	0
Nepal	0
Himalaya	I-DISEASE
.	0

J	0
Sleep	0
Res	0
2010;19:148–56	B-DISEASE
.	0

Kohler	0
M	0
,	0
Kriemler	0
S	0
,	0
Wilhelm	I-DISEASE
EM	0
,	I-DISEASE
Brunner	0
-	0
LaRocca	0
H	I-DISEASE
,	0
Zehnder	I-DISEASE
M	0
,	0
Bloch	I-DISEASE
KE	0
.	0

Children	0
at	0
high	I-DISEASE
altitude	I-DISEASE
have	0
less	0
nocturnal	I-DISEASE
periodic	0
breathing	0
than	0
adults	0
.	0

Eur	0
Respir	0
J	0
2008;32:189–97	0
.	0

Lahiri	0
S	0
,	0
Barnard	0
P.	0
Role	0
of	I-DISEASE
arterial	0
chemoreflex	0
in	0
breathing	0
during	0
sleep	I-DISEASE
at	0
high	0
altitude	0
.	0

Prog	0
Clin	0
Biol	0
Res	I-DISEASE
1983;136:75–85	0
.	I-DISEASE

Lahiri	0
S	0
,	0
Meret	0
K	0
,	0
Sherpa	I-DISEASE
M.	0
Dependence	I-DISEASE
of	0
high	0
altitude	0
sleep	0
apnea	0
on	0
ventilatory	0
sensitivity	0
to	I-DISEASE
hypoxia	0
.	I-DISEASE

Respir	0
Physiol	I-DISEASE
1983;52:281–301	0
.	B-DISEASE

Lombardi	0
C	0
,	0
Meriggi	I-DISEASE
P	0
,	I-DISEASE
Agostoni	I-DISEASE
P	0
,	I-DISEASE
et	0
al	0
.	0

Highcare	0
Investigators	I-DISEASE
.	0

High	0
-	0
altitude	0
hypoxia	0
and	0
periodic	0
breathing	I-DISEASE
during	0
sleep	I-DISEASE
:	0
gender	0
-	0
related	I-DISEASE
differences	0
.	I-DISEASE

J	0
Sleep	0
Res	0
2013	B-DISEASE
;	0
22:322–30	0
.	I-DISEASE

Nickol	0
AH	0
,	0
Leverment	0
J	0
,	I-DISEASE
Richards	0
P	0
,	I-DISEASE
et	0
al	0
.	I-DISEASE

Temazepam	0
at	0
high	0
altitude	0
reduces	0
periodic	0
breathing	I-DISEASE
without	0
impairing	I-DISEASE
next	0
-	0
day	0
performance	I-DISEASE
:	I-DISEASE
a	0
randomized	I-DISEASE
cross	0
-	I-DISEASE
over	0
double	0
-	0
blind	0
study	0
.	I-DISEASE

J	0
Sleep	0
Res	0
2006;15:445–54	0
.	0

Nussbaumer	0
-	0
Ochsner	0
Y	0
,	0
Ursprung	I-DISEASE
J	0
,	0
Siebenmann	I-DISEASE
C	0
,	0
Maggiorini	0
M	0
,	I-DISEASE
Bloch	I-DISEASE
KE	0
.	0

Effect	0
of	0
short	0
-	0
term	0
acclimatization	0
to	I-DISEASE
high	0
altitude	I-DISEASE
on	0
sleep	0
and	0
nocturnal	I-DISEASE
breathing	0
.	I-DISEASE

Sleep	0
2012;35:419–23	0
.	0

Schoene	0
R.	0
Control	0
of	0
ventilation	0
in	0
climbers	I-DISEASE
to	0
extreme	I-DISEASE
altitude	0
.	0

J	0
Appl	0
Physiol	0
1982;53:886–90	0
.	0

Waggener	0
TB	I-DISEASE
,	0
Brusil	0
PJ	0
,	I-DISEASE
Kronauer	0
RE	0
,	I-DISEASE
Gabel	0
RA	0
,	0
Inbar	0
GF	0
.	I-DISEASE

Strength	0
and	0
cycle	I-DISEASE
time	0
of	0
high	0
-	0
altitude	0
ventilatory	I-DISEASE
patterns	0
in	0
unacclimatized	0
humans	0
.	0

J	0
Appl	0
Physiol	0
1984;56:576–81	0
.	0

White	0
D	0
,	I-DISEASE
Gleeson	0
K	I-DISEASE
,	I-DISEASE
Pickett	I-DISEASE
C	0
,	I-DISEASE
Rannels	0
A	0
,	I-DISEASE
Cymerman	0
A	0
,	0
Weil	0
J.	0
Altitude	I-DISEASE
acclimatization	0
:	0
influence	0
on	0
periodic	0
breathing	I-DISEASE
and	0
chemoresponsiveness	0
during	0
sleep	I-DISEASE
.	0

J	0
Appl	0
Physiol	0
1987;63:401–12	0
.	0

Central	0
Sleep	0
Apnea	0

Due	0
to	0
a	0
Medication	0
or	I-DISEASE
ICD-10	0
-	0
CM	0
code	0
:	0
G47.39	0
Substance	0
ICD-9	I-DISEASE
-	0
CM	0
code	I-DISEASE
:	I-DISEASE
327.29	I-DISEASE
Alternate	0
Names	0
Narcotic	0
or	0
opioid	0
induced	0
central	I-DISEASE
sleep	0
apnea	0
.	I-DISEASE

Diagnostic	0
Criteria	0
Criteria	0

A	0
-	0
E	0
must	0
be	0
met	0
Sleep	I-DISEASE
Related	0
Breathing	I-DISEASE
Disorders	0
A.	0

The	0
patient	0
is	0
taking	0
an	0
opioid	0
or	I-DISEASE
other	0
respiratory	I-DISEASE
depressant	0
.	0

B.	0
The	0
presence	0
of	0
one	0
or	I-DISEASE
more	I-DISEASE
of	0
the	0
following	0
:	0
.	0

Sleepiness	0
.	0
.	0

Difficulty	0
initiating	0
or	0
maintaining	0
sleep	0
,	0
frequent	0
awakenings	0
,	I-DISEASE
or	0
nonrestorative	0
sleep	I-DISEASE
.	0
.	0

Awakening	0
short	0
of	0
breath	0
.	0
.	I-DISEASE

Snoring	0
.	0
.	I-DISEASE

Witnessed	0
apneas	0
.	0

C.	0
PSG	0
(	0
diagnostic	0
or	0
on	0
positive	0
airway	0
pressure	0
)	I-DISEASE
shows	0
all	0
of	0
the	0
following	0
:	0
.	0

Five	0
or	0
more	0
central	0
apneas	0
and/or	I-DISEASE
central	I-DISEASE
hypopneas1	0
per	I-DISEASE
hour	0
of	0
sleep	0
(	0
PSG	0
)	0
.	0
.	0

The	0
number	0
of	0
central	0
apneas	0
and/or	I-DISEASE
central	I-DISEASE
hypopneas	0
is	I-DISEASE
>	0
50	0
%	0
of	0
the	0
total	0
number	0
of	0
apneas	I-DISEASE
and	0
hypopneas	0
.	0
.	0

Absence	0
of	0
CSB.1	0
D.	0
The	0
disorder	I-DISEASE
occurs	0
as	0
a	0
consequence	0
of	0
an	0
opioid	0
or	0
other	I-DISEASE
respiratory	0
depressant	0
.	I-DISEASE

E.	0

The	0
disorder	0
is	0
not	I-DISEASE
better	I-DISEASE
explained	I-DISEASE
by	I-DISEASE
another	0
current	I-DISEASE
sleep	0
disorder	0
.	I-DISEASE

Notes	0
.	0

As	0
defined	0
by	0
the	0
most	I-DISEASE
recent	0
version	I-DISEASE
of	0
the	I-DISEASE
AASM	I-DISEASE
Manual	0
for	0
the	0
Scoring	0
of	I-DISEASE
Sleep	0
and	0
Associated	I-DISEASE
Events	0
.	I-DISEASE
.	0

Ataxic	0
breathing	I-DISEASE
(	0
irregular	0
variations	0
in	I-DISEASE
respiratory	0
cycle	0
time	0
and	0
tidal	0
volume	0
)	0
may	0
be	0
noted	I-DISEASE
.	0
.	I-DISEASE

Nocturnal	0
and/or	0
daytime	0
hypoventilation	0
may	0
be	0
present	0
but	0
are	0
not	0
required	0
.	0

If	0
sleep	0
related	I-DISEASE
hypoventilation	I-DISEASE
is	0
present	0
,	I-DISEASE
a	0
diagnosis	I-DISEASE
of	0
sleep	0
related	0
hypoventilation	0
due	0
to	I-DISEASE
medication	I-DISEASE
or	I-DISEASE
substance	I-DISEASE
use	0
can	0
be	0
made	0
as	0
well	0
as	0
a	0
diagnosis	0
of	0
central	0
sleep	I-DISEASE
apnea	0
due	0
to	0
a	0
medication	0
or	0
substance	I-DISEASE
.	0
.	I-DISEASE

A	0
diagnosis	0
of	0
CSA	0
due	I-DISEASE
to	I-DISEASE
a	0
medicationor	0
substance	I-DISEASE
does	0
not	0
exclude	0
a	0
diagnosis	0
of	I-DISEASE
OSA	0
.	0

Sleep	0
Related	0
Breathing	I-DISEASE
Disorders	0
Essential	0
Features	I-DISEASE
Users	I-DISEASE
of	0
potent	I-DISEASE
long	0
-	0
acting	0
opioids	0
may	0
have	I-DISEASE
central	0
apneas	0
during	I-DISEASE
sleep	0
.	0

The	0
most	0
common	0
offending	0
drug	0
is	0
methadone	I-DISEASE
.	0

However	0
,	I-DISEASE
the	0
condition	I-DISEASE
has	I-DISEASE
also	0
been	I-DISEASE
described	0
in	I-DISEASE
patients	0
taking	I-DISEASE
long	0
-	0
acting	0
forms	I-DISEASE
of	I-DISEASE
morphine	0
or	I-DISEASE
oxycodone	0
as	I-DISEASE
well	0
as	0
individu-	0
als	I-DISEASE
being	I-DISEASE
treated	0
with	0
fentanyl	0
patches	0
or	0
continuous	I-DISEASE
narcotic	0
infusions	0
.	0

Suboxone	0
(	0
a	0
combination	0
of	0
buprenorphine	I-DISEASE
and	0
naloxone	0
)	I-DISEASE
is	0
often	I-DISEASE
used	0
for	I-DISEASE
treatment	0
of	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
narcotic	I-DISEASE
dependence	I-DISEASE
and	0
pain	0
and	0
can	0
also	0
cause	I-DISEASE
drug	I-DISEASE
-	0
induced	I-DISEASE
central	0
apnea	I-DISEASE
.	0

The	0
description	0
of	0
this	I-DISEASE
population	0
is	I-DISEASE
complicated	I-DISEASE
by	0
the	I-DISEASE
fact	I-DISEASE
that	0
many	0
of	0
the	0
affected	I-DISEASE
indi-	0
viduals	0
may	I-DISEASE
be	0
using	0
multiple	0
drugs	0
(	0
prescribed	0
or	I-DISEASE
illicit	0
)	0
that	I-DISEASE
affect	0
sleep	0
and	0
breathing	I-DISEASE
.	0

Associated	0
Features	0
Breathing	0
abnormalities	I-DISEASE
associated	0
with	I-DISEASE
these	I-DISEASE
drugs	0
are	I-DISEASE
not	0
restricted	0
to	0
central	0
apneas	I-DISEASE
and	I-DISEASE
may	0
also	0
include	I-DISEASE
hypoventilation	I-DISEASE
and	0
OSA	0
with	0
prolonged	0
respiratory	0
events	I-DISEASE
.	I-DISEASE

In	0
fact	0
,	0
many	0
patients	0
present	I-DISEASE
with	0
a	0
combination	I-DISEASE
of	0
both	0
OSA	0
and	0
CSA	0
.	I-DISEASE

Patients	0
who	0
have	0
nocturnal	0
hypoventilation	0
may	0
have	0
normal	0
or	0
increased	0
daytime	0
PaCO2	0
.	0

In	0
most	0
patients	0
with	I-DISEASE
daytime	0
hypoventilation	0
,	I-DISEASE
the	0
PaCO2	I-DISEASE
is	0
only	0
mildly	0
increased	I-DISEASE
(	0
46	0
-	I-DISEASE
50	0
mm	0
Hg	0
)	0
.	0

Patients	0
with	0
drug	0
-	0
induced	0
central	0
apnea	I-DISEASE
who	0
are	I-DISEASE
being	I-DISEASE
treated	0
for	0
chronic	0
pain	0
often	I-DISEASE
report	0
significant	0
daytime	I-DISEASE
sleepiness	0
.	0

Due	0
to	0
the	0
sedating	I-DISEASE
effects	0
of	0
opioid	0
medications	0
,	I-DISEASE
the	0
sleepiness	0
may	0
not	0
substantially	0
improve	I-DISEASE
even	0
if	0
the	I-DISEASE
central	0
apnea	0
is	0
treated	0
successfully	I-DISEASE
.	0

However	0
,	I-DISEASE
one	0
study	0
of	I-DISEASE
patients	I-DISEASE
on	I-DISEASE
chronic	0
methadone	0
mainte-	0
nance	0
found	0
the	0
average	0
Epworth	I-DISEASE
Sleepiness	0
Scale	0
score	0
to	0
be	0
within	0
normal	0
range	0
.	0

In	0
these	0
patients	0
,	I-DISEASE
who	0
manifested	0
only	I-DISEASE
mild	0
to	I-DISEASE
moderate	0
OSA	0
(	0
average	0
AHI	0
about	I-DISEASE
18/	0
hour	0
)	I-DISEASE
,	0
the	0
degree	0
of	0
sleepiness	0
correlated	I-DISEASE
with	I-DISEASE
a	I-DISEASE
depression	0
index	I-DISEASE
.	I-DISEASE

A	0
case	0
series	0
of	I-DISEASE
patients	0
treated	I-DISEASE
with	I-DISEASE
opioids	0
for	I-DISEASE
chronic	0
pain	0
found	0
AHI	0
values	I-DISEASE
above	I-DISEASE
30	I-DISEASE
/	0
hour	I-DISEASE
(	I-DISEASE
up	0
to	0
100	0
/	0
hour	I-DISEASE
)	I-DISEASE
and	0
moderate	0
to	0
severe	0
sleepiness	I-DISEASE
.	I-DISEASE

In	0
this	0
group	0
,	0
50	0
%	0
to	0
80	0
%	I-DISEASE
of	0
respiratory	0
events	0
were	0
central	0
apneas	0
.	0

Sleepiness	0
that	0
is	0
disproportionately	I-DISEASE
high	0
in	0
comparison	0
to	0
the	I-DISEASE
severity	0
of	0
the	0
AHI	0
(	0
and	0
in	I-DISEASE
some	0
cases	I-DISEASE
,	I-DISEASE
at	0
least	0
partially	0
unresponsive	0
to	0
treatment	0
)	0
is	I-DISEASE
likely	I-DISEASE
due	I-DISEASE
to	I-DISEASE
the	I-DISEASE
direct	0
sedative	0
effects	0
of	0
the	I-DISEASE
narcotic	0
medication	0
itself	I-DISEASE
.	0

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
None	I-DISEASE
known	I-DISEASE
.	I-DISEASE

Demographics	0
There	0
are	0
no	0
known	0
sex	0
,	I-DISEASE
racial	0
,	0
or	0
ethnic	0
differences	0
.	0

The	0
prevalence	0
of	I-DISEASE
this	0
disorder	0
is	I-DISEASE
not	I-DISEASE
known	I-DISEASE
,	I-DISEASE
although	0
limited	0
data	0
suggest	0
that	0
it	I-DISEASE
occurs	0
commonly	0
in	0
those	0
being	0
treated	0
with	B-DISEASE
opioids	0
for	I-DISEASE
chronic	I-DISEASE
pain	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
Use	0
of	I-DISEASE
a	I-DISEASE
potent	0
long	0
-	0
acting	0
narcotic	0
is	0
the	0
major	I-DISEASE
causative	0
factor	0
.	I-DISEASE

If	0
patients	0
are	I-DISEASE
suc-	0
cessfully	0
withdrawn	0
from	I-DISEASE
the	0
offending	0
medication	0
,	0
the	0
central	I-DISEASE
apnea	0
may	0
resolve	0
.	0

Familial	0
Patterns	0
Not	0
applicable	0
or	0
known	0
.	I-DISEASE

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
This	I-DISEASE
disorder	0
is	I-DISEASE
typically	0
seen	I-DISEASE
after	0
opioids	0
have	0
been	I-DISEASE
used	0
for	0
at	I-DISEASE
least	0
two	0
months	0
.	0

An	0
increased	0
risk	0
of	0
death	0
has	0
been	0
reported	0
with	0
the	0
use	0
of	0
potent	0
narcotics	0
.	0

There	0
has	0
been	0
a	0
large	0
increase	0
in	0
deaths	0
associated	I-DISEASE
with	0
methadone	0
due	0
to	0
the	0
increasing	0
use	0
of	I-DISEASE
this	I-DISEASE
medication	0
for	0
chronic	0
pain	0
.	0

Many	0
of	0
these	0
deaths	0
occur	0
during	0
sleep	I-DISEASE
.	0

Developmental	0
Issues	0
Information	0
regarding	0
the	0
presentation	I-DISEASE
of	I-DISEASE
this	0
disorder	I-DISEASE
in	0
children	0
is	0
limited	I-DISEASE
.	0

CSA	0
due	I-DISEASE
to	0
opioid	0
medications	0
has	0
been	0
described	0
in	0
children	0
being	0
treated	0
for	0
pain	0
due	0
to	0
cancer	0
.	0

Pathology	0
and	0
Pathophysiology	0
The	0
presumed	0
pathophysiology	I-DISEASE
for	I-DISEASE
the	0
development	I-DISEASE
of	0
these	0
varied	0
breathing	I-DISEASE
abnor-	I-DISEASE
malities	I-DISEASE
during	I-DISEASE
sleep	0
is	I-DISEASE
the	0
respiratory	0
depression	0
that	I-DISEASE
occurs	0
through	I-DISEASE
action	I-DISEASE
of	I-DISEASE
the	I-DISEASE
drugs	I-DISEASE
on	0
the	I-DISEASE
μ	I-DISEASE
-	0
receptors	I-DISEASE
on	0
the	0
ventral	0
surface	0
of	0
the	I-DISEASE
medulla	I-DISEASE
.	I-DISEASE

Studies	0
have	0
demon-	0
strated	0
depression	0
of	0
the	0
awake	0
hypercapnic	I-DISEASE
ventilatory	0
drive	0
;	0
however	0
,	0
it	0
often	0
improves	0
after	I-DISEASE
five	0
to	0
eight	0
months	0
of	0
continued	0
drug	I-DISEASE
use	0
.	0

In	0
one	0
study	0
the	0
hypoxic	0
ventilatory	0
drive	0
never	0
fully	0
normalized	0
.	0

Another	0
study	0
of	0
patients	0
on	0
chronic	0
meth-	0
adone	0
maintenance	I-DISEASE
found	0
that	0
the	0
hypoxic	0
ventilatory	0
drive	I-DISEASE
is	I-DISEASE
increased	0
compared	0
to	0
that	0
of	0
control	0
subjects	0
.	0

In	0
this	0
study	0
the	0
hypercapnic	0
ventilatory	0
response	0
was	0
reduced	I-DISEASE
in	0
comparison	0
with	I-DISEASE
that	0
of	0
controls	I-DISEASE
who	0
were	0
not	0
taking	0
opioids	0
.	0

The	0
difference	0
was	0
not	0
due	0
to	0
a	0
lower	0
tidal	I-DISEASE
volume	0
but	0
rather	0
reduced	0
respiratory	0
rate	0
.	0

Differences	0
in	0
technique	0
or	0
patient	0
population	0
may	0
explain	0
the	I-DISEASE
divergent	0
findings	0
.	0

The	0
cause	0
of	0
the	0
ataxic	I-DISEASE
breathing	I-DISEASE
in	0
patients	0
on	I-DISEASE
opiates	0
is	0
not	0
known	0
.	0

However	0
,	I-DISEASE
one	0
study	0
of	I-DISEASE
patients	I-DISEASE
on	I-DISEASE
chronic	0
opioids	I-DISEASE
found	0
that	0
the	0
incidence	0
of	0
ataxic	I-DISEASE
breathing	0
increased	0
with	I-DISEASE
the	0
total	0
narcotic	0
dose	0
.	0

Objective	0
Findings	0
The	0
drug	I-DISEASE
-	0
induced	I-DISEASE
central	I-DISEASE
apneas	0
may	I-DISEASE
occur	0
as	0
a	0
form	I-DISEASE
of	0
periodic	I-DISEASE
breathing	0
with	0
runs	I-DISEASE
of	0
central	0
apneas	0
separated	I-DISEASE
by	0
a	0
short	0
ventilatory	0
phase	0
(	I-DISEASE
2	I-DISEASE
to	0
4	I-DISEASE
breaths	I-DISEASE
)	0
or	0
intermittent	0
and	0
sporadic	0
central	I-DISEASE
apneas	0
.	I-DISEASE

The	0
underlying	0
breathing	0
pattern	0
may	0
show	0
a	0
slow	0
respi-	I-DISEASE
ratory	0
rate	0
or	0
an	I-DISEASE
ataxic	0
breathing	0
pattern	0
.	0

The	0
term	0
ataxic	0
breathing	I-DISEASE
is	0
sometimes	0
used	I-DISEASE
as	0
a	I-DISEASE
synonym	0
of	0
Biot	0
breathing	I-DISEASE
,	0
although	I-DISEASE
definitions	0
of	0
the	I-DISEASE
latter	0
term	0
vary	0
widely	0
.	0

Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Sleep	I-DISEASE
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Ataxic	I-DISEASE
breathing	0
is	0
characterized	I-DISEASE
by	0
an	I-DISEASE
irregular	I-DISEASE
breathing	I-DISEASE
rhythm	0
as	I-DISEASE
well	0
as	I-DISEASE
irregular	0
depth	0
of	0
breathing	I-DISEASE
(	I-DISEASE
tidal	0
volume	I-DISEASE
)	0
.	0

Obstructive	0
breathing	0
events	0
are	0
also	0
common	0
in	I-DISEASE
patients	0
taking	I-DISEASE
potent	0
opioids	0
and	I-DISEASE
a	0
diagnosis	0
of	I-DISEASE
both	I-DISEASE
OSA	0
and	I-DISEASE
CSA	0
is	0
often	0
appro-	0
priate	0
.	0

Prolonged	0
obstructive	0
apneas	0
with	0
severe	0
arterial	0
desaturation	0
may	0
be	I-DISEASE
noted	I-DISEASE
.	0

The	0
drug	0
-	0
induced	I-DISEASE
central	0
apneas	0
occur	I-DISEASE
mainly	I-DISEASE
during	0
NREM	0
sleep	0
and	0
,	I-DISEASE
in	0
patients	0
without	I-DISEASE
coexistent	I-DISEASE
obstructive	I-DISEASE
apnea	0
,	0
the	0
AHI	I-DISEASE
may	0
be	I-DISEASE
much	I-DISEASE
lower	0
during	0
REM	I-DISEASE
than	0
during	I-DISEASE
NREM	I-DISEASE
sleep	I-DISEASE
.	0

Patients	0
also	0
tend	B-DISEASE
to	0
have	0
a	0
low	0
arousal	0
index	I-DISEASE
and	0
increased	0
stage	0
N3	0
sleep	0
.	0

Unlike	0
other	0
forms	0
of	0
central	0
apnea	0
,	I-DISEASE
drug	I-DISEASE
-	0
induced	0
central	0
apneas	0
may	0
occur	0
during	I-DISEASE
stage	I-DISEASE
N3	0
sleep	I-DISEASE
.	0

Differential	0
Diagnosis	0

This	0
condition	0
is	I-DISEASE
best	0
distinguished	0
from	I-DISEASE
other	0
types	0
of	I-DISEASE
central	0
sleep	0
apnea	I-DISEASE
by	0
the	I-DISEASE
patient	0
’s	0
ongoing	I-DISEASE
use	I-DISEASE
of	0
long	0
-	0
acting	0
opioids	0
.	0

Other	0
SRBDs	0
may	0
be	0
present	0
and	0
may	I-DISEASE
complicate	0
PSG	I-DISEASE
findings	0
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE

Further	0
study	0
is	I-DISEASE
needed	0
to	0
determine	0
risk	0
factors	0
and	I-DISEASE
pathogenesis	0
for	0
development	0
of	0
these	0
sleep	0
disordered	0
breathing	0
patterns	I-DISEASE
in	0
users	0
of	0
long	0
-	0
acting	0
opioids	I-DISEASE
.	0

It	0
has	0
been	0
hypothesized	0
that	0
these	0
sleep	0
disordered	0
breathing	I-DISEASE
patterns	0
may	0
play	I-DISEASE
a	0
role	0
in	0
the	0
unex-	0
plained	I-DISEASE
increased	0
mortality	I-DISEASE
in	0
this	0
population	0
.	0

This	0
also	0
requires	0
further	I-DISEASE
study	0
.	I-DISEASE

Bibliography	0
Alattar	0
MA	0
,	0
Scharf	0
SM	0
.	0

Opioid	0
-	0
associated	0
central	0
sleep	0
apnea	0
:	0
a	I-DISEASE
case	I-DISEASE
series	I-DISEASE
.	0

Sleep	0
Breath	0
2009;13:201–6	0
.	0

Centers	0
for	0
Disease	0
Control	0
and	0
Prevention	I-DISEASE
(	I-DISEASE
CDC	0
)	0
.	0

Vital	0
signs	0
:	0
risk	0
for	0
overdose	0
from	0
methadone	0
used	I-DISEASE
for	0
pain	0
relief	0
—	0
United	0
States	I-DISEASE
,	0
1999	0
-	0
2010	0
.	0

MMWR	0
Morb	0
Mortal	0
Wkly	0
Rep	0
2012;61:493–7	0
.	B-DISEASE

Farney	0
RJ	0
,	0
Walker	0
JM	0
,	0
Cloward	0
TV	0
,	I-DISEASE
Rhondeau	0
S.	I-DISEASE
Sleep	0
-	0
disordered	0
breathing	I-DISEASE
associated	0
with	0
long	I-DISEASE
-	0
term	0
opioid	0
therapy	0
.	0

Chest	0
2003;123:632–9	0
.	0

Guilleminault	0
C	0
,	I-DISEASE
Cao	0
M	0
,	0
Yue	I-DISEASE
HJ	0
,	I-DISEASE
Chawla	0
P.	0
Obstructive	0
sleep	0
apnea	0
and	I-DISEASE
chronic	0
opioid	0
use	I-DISEASE
.	0

Lung	0
2010;188:459–68	0
.	0

Ramar	0
K.	0
Reversal	0
of	0
sleep	0
-	B-DISEASE
disordered	I-DISEASE
breathing	0
with	I-DISEASE
opioid	0
withdrawal	0
.	0

Pain	0
Pract	0
2009;9:394–8	0
.	0

Santiago	0
TV	0
,	0
Pugliese	0
AC	0
,	0
Edelman	I-DISEASE
NH	0
.	I-DISEASE

Control	0
of	0
breathing	0
during	0
methadone	0
addiction	0
.	0

Am	0
J	0
Med	0
1977;62:347–54	I-DISEASE
.	0

Shook	0
JE	0
,	0
Watkins	0
WD	0
,	0
Camporesi	0
EM	0
.	I-DISEASE

Differential	0
roles	0
of	0
opioid	0
receptors	0
in	0
respiration	I-DISEASE
,	0
respiratory	0
disease	0
,	0
and	0
opiate	0
-	0
induced	0
respiratory	0
depression	0
.	I-DISEASE

Am	0
Rev	0
Respir	0
Dis	I-DISEASE
1990;142:895–909	0
.	I-DISEASE

Teichtahl	0
H	0
,	0
Prodromidis	I-DISEASE
A	0
,	0
Miller	I-DISEASE
B	0
,	I-DISEASE
Cherry	0
G	0
,	0
Kronborg	0
I.	I-DISEASE
Sleep	I-DISEASE
-	0
disordered	0
breathing	I-DISEASE
in	0
stable	0
methadone	0
programme	0
patients	0
:	0
a	I-DISEASE
pilot	I-DISEASE
study	0
.	0

Addiction	0
2001;96:395–403	0
.	0

Teichtahl	0
H	0
,	0
Wang	I-DISEASE
D	0
,	0
Cunnington	I-DISEASE
D.	0
Ventilatory	I-DISEASE
responses	0
to	I-DISEASE
hypoxia	I-DISEASE
and	0
hypercapnia	0
in	0
stable	0
methadone	0
treatment	I-DISEASE
patients	0
.	0

Chest	0
2005;128:1339–47	0
.	0

Walker	0
JM	0
,	0
Farney	I-DISEASE
RJ	0
,	0
Rhondeau	0
SM	0
.	I-DISEASE

Chronic	0
opioid	0
use	0
is	0
a	0
risk	I-DISEASE
factor	0
for	0
the	I-DISEASE
development	0
of	0
central	0
sleep	I-DISEASE
apnea	0
and	I-DISEASE
ataxic	0
breathing	I-DISEASE
.	I-DISEASE

J	0
Clin	0
Sleep	I-DISEASE
Med	0
2007	0
;	I-DISEASE
3:455–61	0
.	0

Wang	0
D	0
,	I-DISEASE
Teichtahl	0
H	0
,	I-DISEASE
Goodman	I-DISEASE
C	0
,	0
Drummer	0
O	0
,	I-DISEASE
Grunstein	0
RR	0
,	I-DISEASE
Kronborg	0
I.	0
Subjective	I-DISEASE
daytime	0
sleepiness	0
and	0
daytime	0
function	0
in	0
patients	0
on	0
stable	0
methadone	0
maintenance	0
treatment	0
:	0
possible	I-DISEASE
mechanisms	0
.	0

J	0
Clin	0
Sleep	I-DISEASE
Med	0
2008;4:557–62	0
.	I-DISEASE

Primary	0
Central	0
Sleep	0
Apnea	0
ICD-9	0
-	I-DISEASE
CM	0
code	0
:	0
327.21	0
Alternate	0
Names	0
Idiopathic	I-DISEASE
central	0
sleep	0
apnea	0
.	0

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
D	I-DISEASE
must	0
be	0
met	I-DISEASE
A.	0

The	0
presence	0
of	0
at	0
least	0
one	I-DISEASE
of	I-DISEASE
the	0
following1	I-DISEASE
:	0
1	0
.	0
Sleepiness	0
.	0

ICD-10	0
-	0
CM	0
code	0
:	0
G47.31	0
Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	0
.	0

Difficulty	0
initiating	0
or	0
maintaining	0
sleep	0
,	0
frequent	0
awakenings	0
,	I-DISEASE
or	0
nonrestorative	0
sleep	I-DISEASE
.	0
.	0

Awakening	0
short	0
of	0
breath	0
.	0
.	I-DISEASE

Snoring	0
.	0
.	I-DISEASE

Witnessed	0
apneas	0
.	0

B.	0
PSG	0
demonstrates	0
all	0
of	0
the	0
following	0
:	0
.	I-DISEASE

Five	0
or	0
more	0
central	0
apneas	0
and/or	I-DISEASE
central	I-DISEASE
hypopneas2	0
per	I-DISEASE
hour	0
of	0
sleep	0
(	0
PSG	0
)	0
.	0
.	0

The	0
number	0
of	0
central	0
apneas	0
and/or	I-DISEASE
central	I-DISEASE
hypopneas	0
is	I-DISEASE
>	0
50	0
%	0
of	0
the	0
total	0
number	0
of	0
apneas	I-DISEASE
and	0
hypopneas	0
.	0
.	0

Absence	0
of	0
CSB.2	0
C.	0
There	0
is	I-DISEASE
no	0
evidence	0
of	I-DISEASE
daytime	I-DISEASE
or	0
nocturnal	0
hypoventilation	0
.	0

D.	0

The	0
disorder	0
is	I-DISEASE
not	I-DISEASE
better	I-DISEASE
explained	I-DISEASE
by	I-DISEASE
another	0
current	I-DISEASE
sleep	0
disorder	I-DISEASE
,	I-DISEASE
medical	0
or	0
neurologic	I-DISEASE
disorder	I-DISEASE
,	0
medication	I-DISEASE
use	0
,	0
or	0
substance	0
use	0
disorder	0
.	0

Notes	0
.	0

In	0
children	0
,	I-DISEASE
daytime	0
symptoms	0
may	0
not	B-DISEASE
be	I-DISEASE
evident	I-DISEASE
.	0
.	0

As	0
defined	0
by	0
the	0
most	I-DISEASE
recent	0
version	I-DISEASE
of	0
the	I-DISEASE
AASM	I-DISEASE
Manual	0
for	0
the	0
Scoring	0
of	I-DISEASE
Sleep	0
and	0
Associated	I-DISEASE
Events	0
.	0

Essential	0
Features	0
Primary	0
CSA	0
is	I-DISEASE
of	I-DISEASE
unknown	I-DISEASE
etiology	0
(	I-DISEASE
idiopathic	0
)	0
and	0
is	I-DISEASE
characterized	0
by	I-DISEASE
recurrent	I-DISEASE
central	0
apneas	I-DISEASE
,	0
defined	0
as	0
a	0
cessation	0
of	I-DISEASE
airflow	I-DISEASE
during	0
sleep	0
associated	I-DISEASE
with	B-DISEASE
an	I-DISEASE
absence	0
of	I-DISEASE
respiratory	0
effort	0
.	0

Airflow	0
and	0
respiratory	0
effort	0
cease	0
simultaneously	I-DISEASE
in	I-DISEASE
a	0
repetitive	0
Sleep	0
Related	0
Breathing	I-DISEASE
Disorders	I-DISEASE
fashion	0
over	I-DISEASE
the	I-DISEASE
course	0
of	I-DISEASE
the	0
night	0
.	0

This	0
recurrent	0
cessation	0
and	0
resumption	I-DISEASE
of	0
venti-	I-DISEASE
lation	0
can	I-DISEASE
lead	0
to	0
sleep	0
fragmentation	0
,	0
yielding	0
excessive	0
daytime	0
sleepiness	I-DISEASE
,	0
frequent	I-DISEASE
nocturnal	0
awakenings	0
,	0
or	I-DISEASE
both	I-DISEASE
.	0

Thus	0
,	0
patients	0
may	I-DISEASE
present	0
with	0
symptoms	0
of	0
hyper-	I-DISEASE
somnolence	0
or	0
insomnia	0
.	0

Patients	0
with	0
primary	0
CSA	0
tend	0
to	I-DISEASE
have	I-DISEASE
low	0
normal	0
arterial	0
PaCO2	0
during	0
wakefulness	0
(	0
less	0
than	0
40	I-DISEASE
mm	I-DISEASE
Hg	0
)	0
.	0

Patients	0
with	0
a	0
known	0
medical	0
or	0
neurological	0
disorder	0
that	I-DISEASE
is	0
believed	0
to	0
cause	0
central	0
apneas	I-DISEASE
are	0
classified	0
elsewhere	0
.	0

Associated	0
Features	0
Patients	0
generally	0
present	B-DISEASE
with	I-DISEASE
excessive	0
daytime	0
sleepiness	I-DISEASE
,	0
sleep	0
fragmentation	0
,	0
or	0
insomnia	0
.	0

Other	0
signs	0
and	0
symptoms	0
that	0
are	I-DISEASE
often	I-DISEASE
,	0
but	I-DISEASE
not	0
invariably	I-DISEASE
,	0
present	0
include	0
snoring	I-DISEASE
,	0
witnessed	0
apnea	0
,	0
and	I-DISEASE
awakening	0
with	0
shortness	0
of	I-DISEASE
breath	0
.	0

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE

The	0
disorder	0
is	0
rare	0
,	I-DISEASE
precluding	0
identification	I-DISEASE
of	0
any	I-DISEASE
definite	0
subtypes	0
.	0

Demographics	0
Not	0
known	0
.	0

Most	0
studies	0
suggest	0
this	0
disorder	0
is	I-DISEASE
rare	I-DISEASE
,	I-DISEASE
most	I-DISEASE
common	0
in	0
middle	0
-	0
aged	0
to	0
elderly	0
individuals	0
,	I-DISEASE
and	0
more	0
frequent	0
in	0
men	0
than	0
women	0
,	0
although	0
not	0
all	0
studies	0
support	0
this	0
sex	0
bias	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
CSA	0
in	I-DISEASE
these	I-DISEASE
patients	0
occurs	0
because	0
the	0
arterial	0
PCO2	I-DISEASE
(	0
PaCO2	0
)	0
drops	I-DISEASE
below	I-DISEASE
the	0
hypo-	I-DISEASE
capnic	0
apnea	0
threshold	0
(	0
HAT	I-DISEASE
)	0
.	0

During	0
wakefulness	0
,	I-DISEASE
drops	0
in	0
PaCO2	I-DISEASE
do	0
not	0
result	I-DISEASE
in	I-DISEASE
apnea	0
.	0

However	0
,	I-DISEASE
during	0
sleep	0
,	0
when	0
the	0
PaCO2	0
drops	0
below	0
the	I-DISEASE
HAT	0
,	0
respiratory	0
effort	0
ceases	0
.	0

For	0
most	0
patients	0
,	I-DISEASE
the	0
HAT	I-DISEASE
is	0
within	0
a	I-DISEASE
few	0
mm	0
Hg	0
of	I-DISEASE
the	0
awake	0
PaCO2	0
.	I-DISEASE

Any	0
factors	0
that	0
narrow	0
the	0
gap	I-DISEASE
between	0
the	0
sleeping	I-DISEASE
PaCO2	0
and	0
the	0
HAT	I-DISEASE
predispose	0
to	I-DISEASE
central	0
apnea	0
.	I-DISEASE

A	0
high	0
ventilatory	0
response	0
to	0
CO2	I-DISEASE
seems	I-DISEASE
to	0
be	I-DISEASE
a	I-DISEASE
major	0
predisposing	0
factor	I-DISEASE
in	0
the	I-DISEASE
development	I-DISEASE
of	0
primary	I-DISEASE
CSA	0
.	0

This	0
can	0
lead	0
to	0
the	0
instability	I-DISEASE
in	I-DISEASE
venti-	0
latory	I-DISEASE
control	0
that	0
characterizes	0
the	0
disorder	0
.	I-DISEASE

Frequent	0
arousal	0
from	0
sleep	0
can	0
also	0
predispose	I-DISEASE
to	0
the	I-DISEASE
development	0
of	0
central	0
apneas	0
,	0
as	0
ventilatory	0
control	0
is	0
somewhat	I-DISEASE
unstable	0
at	0
sleep	0
-	0
wake	0
transitions	0
.	0

Increased	0
ventilation	0
associated	0
with	0
arousal	0
can	0
result	I-DISEASE
in	0
a	0
PaCO2	0
below	0
the	0
HAT	0
after	0
the	0
return	I-DISEASE
to	0
sleep	I-DISEASE
.	0

Because	0
ventilatory	0
drive	0
is	0
lower	0
during	0
REM	I-DISEASE
than	0
NREM	I-DISEASE
sleep	0
,	0
hypocapnic	0
central	0
apnea	0
is	I-DISEASE
much	I-DISEASE
less	0
common	I-DISEASE
during	0
that	0
sleep	0
stage	0
.	0

Two	0
other	0
variables	0
have	0
been	0
discussed	0
as	0
possible	0
predispos-	I-DISEASE
ing	0
factors	0
,	0
although	0
their	0
true	I-DISEASE
role	0
in	0
the	0
development	0
of	I-DISEASE
this	0
syndrome	0
is	I-DISEASE
uncertain	0
.	I-DISEASE

First	0
,	0
frequent	0
arousal	0
or	0
awakening	0
due	I-DISEASE
to	0
low	0
arousal	0
threshold	0
or	0
sleep	I-DISEASE
maintenance	0
insomnia	I-DISEASE
have	0
been	0
reported	I-DISEASE
to	0
lead	0
to	0
an	0
increase	0
in	0
central	I-DISEASE
apneas	0
.	0

Because	0
ventila-	0
tory	0
control	0
can	0
be	0
somewhat	I-DISEASE
unstable	0
in	I-DISEASE
the	I-DISEASE
normal	0
wake	0
-	0
sleep	I-DISEASE
transition	I-DISEASE
with	I-DISEASE
occa-	0
sional	I-DISEASE
central	0
apneas	0
being	0
observed	0
in	I-DISEASE
otherwise	0
normal	I-DISEASE
individuals	0
,	0
any	I-DISEASE
disorder	0
that	I-DISEASE
interrupts	0
sleep	I-DISEASE
may	0
worsen	0
CSA	0
.	0

Some	0
studies	0
have	0
suggested	0
a	0
worsening	0
of	I-DISEASE
primary	0
CSA	I-DISEASE
in	0
the	I-DISEASE
supine	0
position	0
,	0
but	0
this	0
has	0
been	I-DISEASE
more	0
clearly	0
documented	0
in	0
patients	0
with	0
CSB	I-DISEASE
.	0

Familial	0
Patterns	0

Some	0
data	0
suggest	0
that	0
ventilatory	0
chemoresponsiveness	0
is	I-DISEASE
directly	0
inherited	I-DISEASE
.	0

Because	0
elevated	0
CO2	0
responsiveness	0
is	I-DISEASE
a	I-DISEASE
predisposing	0
variable	0
in	I-DISEASE
the	0
development	0
of	0
idio-	I-DISEASE
pathic	0
CSA	I-DISEASE
,	0
it	I-DISEASE
would	I-DISEASE
seem	I-DISEASE
likely	0
that	0
there	0
would	0
be	I-DISEASE
a	I-DISEASE
familial	0
pattern	I-DISEASE
in	I-DISEASE
the	0
develop-	0
ment	0
of	0
this	0
respiratory	0
abnormality	I-DISEASE
.	0

However	0
,	I-DISEASE
there	0
are	I-DISEASE
no	0
data	0
addressing	I-DISEASE
this	0
issue	0
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Not	I-DISEASE
known	0
.	0

The	0
apneas	0
can	0
lead	I-DISEASE
to	0
sleep	I-DISEASE
fragmentation	0
,	0
yielding	I-DISEASE
either	0
hypersomno-	0
lence	0
or	0
insomnia	0
.	I-DISEASE

There	0
is	0
little	0
evidence	0
that	0
these	I-DISEASE
apneas	0
or	I-DISEASE
their	I-DISEASE
associated	0
hypoxia	I-DISEASE
and	0
hypercapnia	0
lead	0
to	I-DISEASE
pulmonary	0
hypertension	I-DISEASE
,	I-DISEASE
cor	0
pulmonale	I-DISEASE
,	0
or	0
other	0
adverse	0
car-	I-DISEASE
diovascular	I-DISEASE
consequences	I-DISEASE
.	0

Developmental	0
Issues	0
Criteria	0
for	I-DISEASE
apnea	I-DISEASE
of	0
infancy	I-DISEASE
and	0
apnea	I-DISEASE
of	I-DISEASE
prematurity	0
are	0
detailed	0
elsewhere	0
and	I-DISEASE
it	I-DISEASE
should	0
be	I-DISEASE
noted	0
that	I-DISEASE
central	I-DISEASE
apnea	0
is	I-DISEASE
defined	0
somewhat	I-DISEASE
differently	0
in	0
infants	I-DISEASE
and	0
chil-	I-DISEASE
dren	0
than	I-DISEASE
in	I-DISEASE
adults	0
.	0

Central	0
apneas	0
that	0
are	I-DISEASE
brief	0
(	I-DISEASE
<	I-DISEASE
20	0
seconds	I-DISEASE
in	0
duration	0
)	0
and	0
not	0
associated	I-DISEASE
with	I-DISEASE
desaturation	0
or	I-DISEASE
arousal	0
are	0
commonly	0
observed	0
in	0
both	0
premature	I-DISEASE
and	0
term	0
infants	I-DISEASE
.	0

In	0
adults	0
,	0
population	0
studies	0
report	0
an	0
increase	0
in	0
the	0
occurrence	0
of	0
central	0
apnea	0
with	I-DISEASE
increasing	I-DISEASE
age	0
,	0
especially	0
in	0
men	0
.	0

Pathology	0
and	0
Pathophysiology	0
Primary	0
CSA	0
is	I-DISEASE
caused	I-DISEASE
by	0
instability	I-DISEASE
of	0
the	I-DISEASE
respiratory	0
control	0
system	0
in	I-DISEASE
the	I-DISEASE
transition	0
from	I-DISEASE
wakefulness	0
to	0
sleep	0
and	0
less	I-DISEASE
commonly	0
during	0
stable	I-DISEASE
NREM	0
sleep	I-DISEASE
.	I-DISEASE

Central	0
apnea	0
in	0
patients	I-DISEASE
with	0
primary	0
CSA	I-DISEASE
most	0
often	I-DISEASE
occurs	0
during	0
stages	0
N1	I-DISEASE
and	0
N2	I-DISEASE
sleep	0
and	0
is	0
rare	0
during	0
stages	I-DISEASE

N3	0
and	0
R	0
sleep	0
.	0

Central	0
apneas	0
tend	0
to	I-DISEASE
occur	0
in	I-DISEASE
individuals	I-DISEASE
with	0
a	0
high	0
or	0
increased	0
ventilatory	0
responsiveness	0
to	I-DISEASE
CO2	I-DISEASE
.	0

Arterial	0
PCO2	0
levels	0
below	0
the	0
hypocapnic	I-DISEASE
apnea	0
threshold	0
lead	I-DISEASE
to	0
a	0
cessation	0
in	0
ventilatory	0
effort	I-DISEASE
and	I-DISEASE
,	0
therefore	I-DISEASE
,	0
a	0
central	0
apnea	B-DISEASE
.	0

Individuals	0
with	0
high	0
CO2	I-DISEASE
ventilatory	0
responsiveness	I-DISEASE
tend	0
to	0
have	I-DISEASE
lower	0
PaCO2	0
levels	0
(	I-DISEASE
both	0
daytime	I-DISEASE
and	0
sleep	0
)	I-DISEASE
and	0
a	I-DISEASE
lower	I-DISEASE
gradient	0
between	0
the	0
sleep-	0
ing	I-DISEASE
PaCO2	I-DISEASE
and	I-DISEASE
the	0
apneic	0
threshold	0
.	I-DISEASE

Hence	0
,	0
a	0
smaller	0
increase	0
in	0
ventilation	0
is	0
required	I-DISEASE
to	0
reach	0
this	0
apnea	0
threshold	0
and	I-DISEASE
inhibit	0
ventilation	0
.	I-DISEASE

Individuals	0
with	0
high	0
chemore-	I-DISEASE
sponsiveness	0
also	0
hyperventilate	I-DISEASE
more	0
in	0
response	0
to	0
small	I-DISEASE
changes	0
in	0
arterial	I-DISEASE
PaCO2	0
.	0

This	0
again	0
often	0
drives	I-DISEASE
the	0
PaCO2	I-DISEASE
below	I-DISEASE
the	0
apnea	I-DISEASE
threshold	0
,	I-DISEASE
yielding	0
a	I-DISEASE
cessation	0
Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	0
of	I-DISEASE
ventilation	0
.	I-DISEASE

However	0
,	0
not	0
all	0
factors	0
that	0
cause	I-DISEASE
greater	0
ventilatory	I-DISEASE
drive	0
have	0
the	0
same	0
effect	0
.	I-DISEASE

Studies	0
suggest	0
that	0
although	I-DISEASE
hypoxemia	0
increases	0
chemoresponsiveness	0
to	0
PaCO2	I-DISEASE
,	I-DISEASE
the	0
gap	0
between	I-DISEASE
the	0
PaCO2	I-DISEASE
and	I-DISEASE
the	0
apneic	I-DISEASE
threshold	0
is	I-DISEASE
smaller	I-DISEASE
(	0
predispos-	I-DISEASE
ing	0
to	0
central	I-DISEASE
apnea	0
)	I-DISEASE
.	I-DISEASE

Metabolic	0
acidosis	0
and	0
nonhypoxic	I-DISEASE
chemoreceptor	I-DISEASE
stimulants	0
tend	I-DISEASE
to	0
decrease	I-DISEASE
HAT	I-DISEASE
more	0
than	0
they	0
decrease	0
the	I-DISEASE
sleeping	0
PaCO2	0
,	I-DISEASE
resulting	0
in	0
a	0
larger	I-DISEASE
gap	0
between	0
the	0
HAT	0
and	0
the	I-DISEASE
sleeping	I-DISEASE
PaCO2	0
and	0
lower	I-DISEASE
likelihood	I-DISEASE
of	0
central	0
apnea	0
.	0

Metabolic	0
alkalosis	0
tends	0
to	0
increase	0
HAT	I-DISEASE
as	I-DISEASE
well	0
as	I-DISEASE
decrease	0
ventilatory	0
responsive-	0
ness	0
,	0
yielding	I-DISEASE
a	I-DISEASE
smaller	0
gap	I-DISEASE
between	0
the	I-DISEASE
HAT	0
and	0
sleeping	0
PaCO2	I-DISEASE
.	I-DISEASE

Objective	0
Findings	0
The	0
PSG	I-DISEASE
of	0
the	I-DISEASE
patient	I-DISEASE
with	0
primary	I-DISEASE
CSA	0
demonstrates	I-DISEASE
more	I-DISEASE
than	0
five	0
central	I-DISEASE
apneas	0
and/or	0
central	0
hypopneas	0
per	I-DISEASE
hour	0
of	0
sleep	I-DISEASE
.	0

The	0
central	0
apneas	0
and	I-DISEASE
central	I-DISEASE
hypopneas	0
meet	I-DISEASE
criteria	I-DISEASE
for	0
these	0
respiratory	0
events	0
in	0
adults	0
or	I-DISEASE
children	I-DISEASE
as	0
defined	0
by	0
the	0
most	0
recent	0
version	0
of	I-DISEASE
the	I-DISEASE
AASM	0
Manual	0
for	I-DISEASE
the	0
Scoring	I-DISEASE
of	0
Sleep	I-DISEASE
and	I-DISEASE
Associated	0
Events	0
.	0

Published	0
studies	0
of	0
patients	0
with	0
primary	0
CSA	I-DISEASE
have	I-DISEASE
required	0
that	0
>	0
50	0
%	0
to	0
85	0
%	0
of	0
respiratory	0
events	0
be	0
central	0
apneas	0
.	0

Periodic	0
breathing	0
characterized	0
by	0
episodes	0
of	0
recurrent	I-DISEASE
central	0
apneas	I-DISEASE
separated	0
by	0
periods	0
of	I-DISEASE
ventilation	0
may	I-DISEASE
occur	I-DISEASE
.	0

The	0
inter-	0
event	0
respiratory	0
phase	0
is	0
typically	I-DISEASE
brief	0
with	I-DISEASE
a	I-DISEASE
maximum	0
of	0
five	0
breaths	0
.	I-DISEASE

The	0
venti-	0
latory	0
phase	0
between	0
central	0
apneas	I-DISEASE
does	0
not	0
have	0
the	0
crescendo	I-DISEASE
-	0
decrescendo	0
pattern	0
of	I-DISEASE
CSB	0
breathing	I-DISEASE
.	0

Central	0
apneas	0
commonly	0
lead	I-DISEASE
to	0
mild	I-DISEASE
arterial	0
oxygen	0
desaturation	I-DISEASE
,	0
although	0
more	I-DISEASE
severe	0
desaturation	0
can	I-DISEASE
occur	0
.	0

Central	0
apneas	0
may	0
also	I-DISEASE
lead	0
to	I-DISEASE
arousal	0
from	0
sleep	I-DISEASE
,	0
causing	0
fragmentation	0
and	I-DISEASE
yielding	0
increased	I-DISEASE
stages	0
N1	0
and	I-DISEASE
N2	0
sleep	0
at	0
the	0
expense	0
of	0
stage	I-DISEASE
N3	I-DISEASE
sleep	I-DISEASE
.	I-DISEASE

As	0
noted	0
above	0
,	0
central	0
apneas	0
in	I-DISEASE
these	I-DISEASE
patients	0
are	0
less	0
common	0
during	I-DISEASE
REM	0
sleep	0
.	0

In	0
summary	0
,	0
respiration	0
,	0
arterial	I-DISEASE
oxygenation	I-DISEASE
,	I-DISEASE
and	I-DISEASE
sleep	0
architecture	0
are	0
affected	0
by	0
this	0
disorder	0
.	0

Additionally	0
,	0
an	0
arterial	I-DISEASE
PaCO2	0

less	0
than	0
40	0
mm	0

Hg	0
is	0
typically	0
observed	0
during	0
wakefulness	I-DISEASE
.	I-DISEASE

These	0
patients	0
do	I-DISEASE
not	0
exhibit	0
sleep	0
related	I-DISEASE
hypoventilation	I-DISEASE
.	I-DISEASE

Differential	0
Diagnosis	0
Normal	0
individuals	0
may	0
have	I-DISEASE
a	0
few	0
central	I-DISEASE
apneas	0
in	0
the	0
wake	0
-	0
sleep	I-DISEASE
transition	0
.	0

However	0
,	I-DISEASE
once	0
stable	B-DISEASE
sleep	0
is	I-DISEASE
achieved	I-DISEASE
,	0
these	I-DISEASE
apneas	0
should	0
cease	I-DISEASE
.	0

Normal	0
individuals	0
should	0
not	0
have	0
more	0
than	0
five	0
central	I-DISEASE
apneas	0
per	0
hour	I-DISEASE
of	0
sleep	0
.	I-DISEASE

Primary	0
CSA	0
must	I-DISEASE
be	0
distinguished	0
from	0
other	I-DISEASE
sleep	0
related	I-DISEASE
breathing	0
disorders	I-DISEASE
.	0

Some	0
patients	0
with	I-DISEASE
predominantly	0
OSA	0
will	0
have	I-DISEASE
central	0
apneas	0
during	0
diagnostic	0
or	I-DISEASE
positive	0
airway	0
pressure	I-DISEASE
titration	0
studies	0
.	I-DISEASE

These	0
apneas	0
tend	0
to	I-DISEASE
resolve	0
immediately	0
or	0
over	0
time	0
on	0
positive	0
airway	0
pressure	0
treatment	0
.	I-DISEASE

The	0
pattern	0
of	0
central	0
apneas	0
in	0
primary	I-DISEASE
CSA	0
differs	I-DISEASE
from	0
that	0
of	I-DISEASE
CSA	0
with	0
CSB	0
.	0

Primary	0
CSA	0
lacks	I-DISEASE
the	0
crescendo	0
-	I-DISEASE
decrescendo	I-DISEASE
pattern	0
of	I-DISEASE
respiration	0
between	0
contiguous	I-DISEASE
central	I-DISEASE
apneas	0
noted	I-DISEASE
in	0
patients	0
with	I-DISEASE
CSA	0
with	I-DISEASE
CSB	0
.	0

The	0
cycle	0
length	0
is	0
longer	0
in	0
CSB	0
(	0
greater	0
than	0
40	0
seconds	0
and	0
typically	0
45	I-DISEASE
to	0
90	0
seconds	0
)	0
.	0

The	0
longer	0
cycle	0
length	0
in	0
CSB	0
versus	I-DISEASE
primary	0
CSA	I-DISEASE
is	0
due	I-DISEASE
to	0
a	0
longer	0
respiratory	0
phase	0
between	0
central	0
apneas	0
.	0

In	0
primary	0
CSA	0
,	I-DISEASE
the	0
apnea	0
is	I-DISEASE
often	0
terminated	I-DISEASE
abruptly	0
by	0
a	0
large	0
breath	0
,	I-DISEASE
and	0
there	0
are	I-DISEASE
usually	0
no	I-DISEASE
more	0
that	0
4	0
to	I-DISEASE
5	0
breaths	0
between	0
apneas	I-DISEASE
.	0

Furthermore	0
,	0
most	0
patients	0
with	0
Cheyne	0
-	I-DISEASE
Stokes	I-DISEASE
respiration	0
will	0
have	0
a	0
history	I-DISEASE
of	I-DISEASE
congestive	0
heart	I-DISEASE
failure	0
or	I-DISEASE
a	I-DISEASE
neurological	0
disorder	0
.	0

Patients	0
with	0
central	I-DISEASE
apnea	0
due	0
to	I-DISEASE
substance	I-DISEASE
use	0
,	0
particularly	0
potent	0
long	0
-	0
acting	I-DISEASE
narcotics	I-DISEASE
,	0
may	0
exhibit	I-DISEASE
periodic	0
breathing	0
with	0
central	0
apneas	0
,	0
but	I-DISEASE
the	0
pattern	0
of	0
ventilation	0
between	I-DISEASE
apneas	0
does	I-DISEASE
not	0
have	0
a	I-DISEASE
crescendo	0
-	I-DISEASE
decrescendo	0
pattern	0
and	0
the	I-DISEASE
cycle	0
length	0
is	0
shorter	I-DISEASE
than	0
40	I-DISEASE
seconds	I-DISEASE
.	0

In	0
addition	0
,	0
the	0
underlying	I-DISEASE
pattern	I-DISEASE
of	0
breathing	0
is	I-DISEASE
often	0
ataxic	0
(	I-DISEASE
irregular	0
varia-	0
tions	I-DISEASE
in	0
cycle	0
length	I-DISEASE
and	0
tidal	0
volume	0
)	0
and	0
a	0
low	I-DISEASE
respiratory	0
rate	0
may	I-DISEASE
be	0
noted	0
.	I-DISEASE

Unlike	0
primary	0
CSA	0
,	I-DISEASE
central	0
apneas	0
can	0
occur	0
during	I-DISEASE
stage	0
N3	0
in	0
patients	0
taking	0
opioids	0
.	0

Patients	0
with	0
CSA	B-DISEASE
due	0
to	I-DISEASE
medical	I-DISEASE
or	0
neurological	0
conditions	I-DISEASE
not	0
of	0
the	0
Cheyne	0
-	0
Stokes	I-DISEASE
pattern	0
often	I-DISEASE
have	I-DISEASE
a	0
history	0
of	0
a	0
known	0
neurological	I-DISEASE
disorder	0
(	0
recent	0
cerebrovascular	I-DISEASE
accident	0
)	0
but	0
in	I-DISEASE
others	0
a	0
high	0
index	0
of	I-DISEASE
suspicion	0
for	0
an	0
underlying	0
disorder	0
is	0
indi-	0
cated	0
.	B-DISEASE

For	0
example	0
,	0
patients	0
with	0
Chiari	0
malformation	0
may	0
present	I-DISEASE
in	0
adulthood	0
with	0
unexplained	0
central	0
apneas	0
and	I-DISEASE
relatively	0
few	0
other	0
symptoms	0
.	0

Thus	0
,	0
primary	0
CSA	0
is	0
a	0
diagnosis	0
based	0
on	0
careful	0
exclusion	0
of	0
other	0
causes	0
of	0
CSA	I-DISEASE
.	0

In	0
sleep	0
related	I-DISEASE
hypoventilation	I-DISEASE
and	0
hypoxemic	0
syndromes	I-DISEASE
,	0
patients	I-DISEASE
have	0
normal	0
or	0
increased	I-DISEASE
daytime	0
arterial	0
PCO2	I-DISEASE
(	I-DISEASE
PaCO2	I-DISEASE
)	0
with	0
the	0
onset	0
or	0
worsening	0
of	I-DISEASE
hypoven-	I-DISEASE
tilation	0
during	0
sleep	I-DISEASE
.	I-DISEASE

Daytime	0
hypoventilation	0
is	0
defined	I-DISEASE
as	0
a	I-DISEASE
PaCO2	0
>	0
45	I-DISEASE
mm	0

Hg	0
.	0

Patient	0
with	0
primary	0
CSA	0
usually	0
have	I-DISEASE
an	I-DISEASE
awake	0
PaCO2	0
<	0

40	0
mm	0
Hg	0
.	0

The	0
causes	0
of	I-DISEASE
sleep	0
related	0
hypoventilation	I-DISEASE
include	I-DISEASE
abnormalities	0
in	I-DISEASE
ventilatory	0
control	0
,	0
neuro-	0
muscular	0
disease	0
,	0
parenchymal	0
lung	I-DISEASE
disease	0
,	0
or	0
restrictive	0
chest	0
wall	0
disorders	I-DISEASE
.	0

PSG	0
in	0
these	0
patients	0
may	0
reveal	I-DISEASE
a	I-DISEASE
few	I-DISEASE
central	I-DISEASE
apneas	0
,	0
but	0
the	I-DISEASE
predominant	0
pattern	I-DISEASE
is	I-DISEASE
one	0
of	I-DISEASE
reduced	0
tidal	0
volume	0
(	0
shallow	0
pattern	I-DISEASE
of	I-DISEASE
breathing	0
)	I-DISEASE
,	I-DISEASE
often	0
without	I-DISEASE
a	0
compensatory	I-DISEASE
increase	0
in	0
respiratory	I-DISEASE
rate	0
.	0

There	0
is	0
usually	0
significant	0
oxygen	0
desaturation	0
secondary	I-DISEASE
to	0
hypoventilation	0
and/or	0
ventilation	0
perfusion	0
mismatch	0
.	0

Patients	0
with	0
parenchymal	I-DISEASE
lung	0
disease	0
,	0
neuromuscular	I-DISEASE
disease	0
,	I-DISEASE
or	0
chest	0
wall	0
disorders	I-DISEASE
typically	0
have	I-DISEASE
abnormal	0
pulmonary	0
function	0
tests	0
and	0
the	0
most	0
severe	0
arterial	0
oxygen	I-DISEASE
desaturation	0
typically	0
occurs	I-DISEASE
during	I-DISEASE
REM	0
sleep	I-DISEASE
.	I-DISEASE

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE

Although	0
primary	0
CSA	0
is	0
believed	0
to	0
be	0
a	0
relatively	I-DISEASE
rare	0
disorder	0
,	I-DISEASE
additional	0
prevalence	0
data	I-DISEASE
are	I-DISEASE
needed	0
.	I-DISEASE

The	0
pathophysiology	0
of	0
this	I-DISEASE
disorder	0
remains	I-DISEASE
unclear	I-DISEASE
.	0

Specifically	0
,	0
the	0
relative	I-DISEASE
roles	0
of	0
instability	I-DISEASE
in	I-DISEASE
sleep	0
state	0
(	0
low	0
arousal	0
threshold	0
,	I-DISEASE
delayed	0
transition	0
from	I-DISEASE
wake	0
to	I-DISEASE
stable	0
sleep	0
)	I-DISEASE
and	I-DISEASE
respiratory	I-DISEASE
control	0
instability	0
(	I-DISEASE
elevated	0
hypercapnic	0
ventila-	0
tory	0
response	0
)	0
require	0
further	0
elucidation	I-DISEASE
.	0

Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Sleep	I-DISEASE
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Bibliography	I-DISEASE
Bixler	0
EO	0
,	I-DISEASE
Vgontzas	0
AN	I-DISEASE
,	I-DISEASE
Lin	I-DISEASE
HM	0
,	I-DISEASE
Ten	0
Have	0
T	0
,	0
Rein	0
J	0
,	I-DISEASE
Vela	0
-	0
Bueno	I-DISEASE
A	0
,	0
Kales	I-DISEASE
A.	0
Prevalence	0
of	0
sleep-	0
disordered	0
breathing	0
in	0
women	0
:	0
effects	I-DISEASE
of	I-DISEASE
gender	0
.	0

Am	0
J	0
Respir	0
Crit	I-DISEASE
Care	0
Med	I-DISEASE
2001;163:608–13	I-DISEASE
.	0

Bradley	0
T	0
,	0
McNicholas	0
W	0
,	0
Rutherford	I-DISEASE
R	0
,	I-DISEASE
Popkin	0
J	I-DISEASE
,	0
Zamel	0
N	0
,	I-DISEASE
Phillipson	0
E.	0
Clinical	I-DISEASE
and	0
physiological	0
heterogeneity	0
of	0
the	0
central	0
sleep	I-DISEASE
apnea	0
syndrome	0
.	I-DISEASE

Am	0
Rev	0
Respir	0
Dis	I-DISEASE
1986;134:217–21	0
.	0

Dempsey	0
JA	0
,	0
Smith	0
CA	0
,	0
Przybylowski	0
T	0
,	I-DISEASE
et	0
al	0
.	0

The	0
ventilatory	0
responsiveness	0
to	0
CO(2	0
)	0
below	0
eupnoea	0
as	I-DISEASE
a	0
determinant	0
of	0
ventilatory	0
stability	0
in	I-DISEASE
sleep	0
.	0

J	0
Physiol	0
2004;560:1–11	0
.	0

Eckert	0
DJ	0
,	0
Jordan	0
AS	0
,	0
Merchia	I-DISEASE
P	0
,	I-DISEASE
Malhotra	I-DISEASE
A.	0
Central	0
sleep	0
apnea	0
:	I-DISEASE
Pathophysiology	0
and	0
treatment	I-DISEASE
.	0

Chest	0
2007;131:595–607	0
.	0

Hall	0
MJ	0
,	0
Xie	0
A	0
,	0
Rutherford	0
R	0
,	I-DISEASE
Ando	0
S	0
,	0
Floras	0
JS	0
,	I-DISEASE
Bradley	0
TD	I-DISEASE
.	I-DISEASE

Cycle	0
length	0
of	0
periodic	0
breathing	0
in	0
patients	0
with	0
and	I-DISEASE
without	0
heart	I-DISEASE
failure	0
.	0

Am	0
J	0
Respir	0
Crit	0
Care	0
Med	0
1996;154:376–81	I-DISEASE
.	0

White	0
D	0
,	0
Zwillich	0
C	0
,	0
Pickett	I-DISEASE
C	I-DISEASE
,	I-DISEASE
Douglas	0
N	0
,	I-DISEASE
Findley	0
L	I-DISEASE
,	0
Weil	0
J.	0
Central	I-DISEASE
sleep	I-DISEASE
apnea	0
:	0
improvement	0
with	0
acetazolamide	0
therapy	0
.	I-DISEASE

Arch	0
Intern	0
Med	0
1982;142:1816–9	0
.	I-DISEASE

Xie	0
A	0
,	0
Rankin	0
F	0
,	0
Rutherford	I-DISEASE
R	0
,	I-DISEASE
Bradley	0
TD	0
.	0

Effects	0
of	0
inhaled	0
CO2	0
and	0
added	I-DISEASE
dead	I-DISEASE
space	0
on	I-DISEASE
idiopathic	0
central	0
sleep	0
apnea	0
.	0

J	0
Appl	0
Physiol	0
1997;82:918–26	0
.	0

Xie	0
A	0
,	0
Rutherford	0
R	0
,	0
Rankin	I-DISEASE
F	0
,	0
Wong	0
B	0
,	0
Bradley	0
T.	I-DISEASE
Hypocapnia	I-DISEASE
and	0
increased	0
ventilatory	0
responsiveness	0
in	0
patients	0
with	0
idiopathic	0
central	0
sleep	I-DISEASE
apnea	0
.	0

Am	0
J	0
Respir	0
Crit	I-DISEASE
Care	0
Med	I-DISEASE
1995;152:1950–5	I-DISEASE
.	0

Xie	0
A	0
,	0
Wong	0
B	0
,	0
Phillipson	I-DISEASE
E	0
,	I-DISEASE
Slutsky	0
A	0
,	0
Bradley	0
T.	0
Interaction	I-DISEASE
of	0
hyperventilation	0
and	0
arousal	0
in	0
the	0
pathogenesis	0
of	0
idiopathic	I-DISEASE
central	I-DISEASE
sleep	0
apnea	0
.	I-DISEASE

Am	0
J	0
Respir	0
Crit	0
Care	0
Med	0
1994;150:489–95	I-DISEASE
.	0

Primary	0
Central	0
Sleep	0
Apnea	0
of	0
Infancy	I-DISEASE
ICD-9	0
-	0
CM	0
code	0
:	0
770.81	0
ICD-10	0
-	0
CM	I-DISEASE
code	0
:	I-DISEASE

P28.3	0
Alternate	0
Names	0
Infant	0
sleep	0
apnea	0
,	I-DISEASE
apnea	0
of	I-DISEASE
infancy	0
,	0
primary	I-DISEASE
sleep	0
apnea	0
of	0
the	I-DISEASE
newborn	0
.	I-DISEASE

Inappropriate	0
terms	0
for	0
primary	I-DISEASE
central	0
sleep	I-DISEASE
apnea	0
of	0
the	0
newborn	0
include	0
near	I-DISEASE
-	0
miss	I-DISEASE
sudden	0
infant	0
death	I-DISEASE
syndrome	I-DISEASE
(	0
SIDS	0
)	0
,	0

near	0
-	0
SIDS	I-DISEASE
,	I-DISEASE
aborted	0
SIDS	0
,	I-DISEASE
and	I-DISEASE
aborted	I-DISEASE
crib	0
death	0
;	0
these	0
terms	0
imply	I-DISEASE
a	I-DISEASE
causal	0
relationship	I-DISEASE
between	I-DISEASE
apnea	I-DISEASE
and	0
SIDS	0
that	I-DISEASE
is	0
not	I-DISEASE
supported	0
by	I-DISEASE
extensive	I-DISEASE
research	0
.	0

Likewise	0
,	0
the	0
term	0
“	0
apparent	0
life	0
-	0
threatening	I-DISEASE
event	0
(	0
ALTE	0
)	0
”	0
should	I-DISEASE
not	0
be	0
used	I-DISEASE
.	0

Although	0
some	0
infants	0
with	0
primary	0
sleep	0
apnea	I-DISEASE
present	0
with	I-DISEASE
an	0
ALTE	0
,	0
there	0
are	0
many	0
other	0
causes	0
of	I-DISEASE
ALTE	0
,	0
and	0
some	0
children	0
with	0
sleep	I-DISEASE
apnea	0
do	0
not	I-DISEASE
have	0
ALTE	I-DISEASE
.	0

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
D	I-DISEASE
must	I-DISEASE
be	0
met	I-DISEASE
A.	0
Apnea	0
or	0
cyanosis	I-DISEASE
is	0
noted	0
by	I-DISEASE
an	0
observer	I-DISEASE
or	0
an	0
episode	I-DISEASE
of	0
sleep	0
related	I-DISEASE
central	I-DISEASE
apnea	0
or	0
desaturation	I-DISEASE
is	0
detected	I-DISEASE
by	0
monitoring	0
.	0

B.	0
The	0
infant	0
has	0
a	0
conceptional	0
age	I-DISEASE
of	0
at	I-DISEASE
least	0
37	0
weeks	I-DISEASE
.	I-DISEASE

C.	0
PSG	0
or	0
alternative	0
monitoring	0
such	0
as	I-DISEASE
hospital	0
or	0
home	0
apnea	0
monitoring	0
shows	0
either	0
:	I-DISEASE
.	0

Recurrent	0
,	0
prolonged	0
(	0
>	0
20	I-DISEASE
seconds	0
duration	0
)	0
central	0
apneas.1	0
.	0

Periodic	0
breathing2	0
for	0
≥	0
5	I-DISEASE
%	0
of	0
total	0
sleep	I-DISEASE
time	0
.	0

D.	0

The	0
disorder	0
is	0
not	0
better	0
explained	I-DISEASE
by	0
another	0
sleep	I-DISEASE
disorder	0
,	0
medical	0
or	0
neurological	0
disorder	I-DISEASE
,	0
or	0
medication	I-DISEASE
.	0

Notes	0
.	0

Normative	0
data	0
concerning	0
the	0
number	0
of	I-DISEASE
prolonged	I-DISEASE
central	0
apneas	I-DISEASE
per	0
hour	0
are	I-DISEASE
not	0
well	0
established	I-DISEASE
.	0
.	0

As	0
defined	0
by	0
the	0
most	I-DISEASE
recent	0
version	I-DISEASE
of	0
the	I-DISEASE
AASM	I-DISEASE
Manual	0
for	0
the	0
Scoring	0
of	I-DISEASE
Sleep	0
and	0
Associated	I-DISEASE
Events	0
.	I-DISEASE
.	0

Short	0
(	0
<	0
20	I-DISEASE
seconds	0
)	0
central	I-DISEASE
apneas	0
associated	I-DISEASE
with	I-DISEASE
significant	0
desaturation	0
are	0
more	0
likely	I-DISEASE
to	I-DISEASE
be	I-DISEASE
a	0
sign	0
of	0
decreased	0
pulmonary	0
reserve	0
than	0
of	0
central	0
nervous	0
system	I-DISEASE
pathology	0
.	0
.	0

Definitive	0
determination	0
of	0
the	0
central	0
nature	I-DISEASE
of	I-DISEASE
apneas	0
requires	I-DISEASE
simultaneous	0
monitoring	0
of	I-DISEASE
airflow	0
and	0
respiratory	I-DISEASE
effort	I-DISEASE
.	0

Obstructive	0
and	0
mixed	0
apneas	0
may	0
also	I-DISEASE
be	I-DISEASE
present	0
,	I-DISEASE
but	0
central	I-DISEASE
apneas	0
are	0
predominant	0
.	I-DISEASE

Essential	0
Features	0
Primary	0
CSA	0
of	I-DISEASE
infancy	I-DISEASE
is	I-DISEASE
characterized	0
by	I-DISEASE
prolonged	0
,	0
predominantly	I-DISEASE
central	0
apneas	0
in	0
children	0
of	I-DISEASE
at	0
least	0
37	0
weeks	0
conceptional	0
age	I-DISEASE
.	I-DISEASE

These	0
events	0
are	0
typically	0
associated	0
with	0
physiological	0
compromise	0
(	I-DISEASE
hypoxemia	0
,	0
bradycardia	0
)	I-DISEASE
,	0
or	I-DISEASE
the	0
need	0
for	I-DISEASE
intervention	0
such	I-DISEASE
as	0
stimulation	0
or	I-DISEASE
resuscitation	0
.	0

Obstructive	0
and/or	0
mixed	0
apneas	0
or	0
hypopneas	I-DISEASE
may	I-DISEASE
also	0
be	I-DISEASE
seen	0
,	I-DISEASE
although	0
central	0
events	0
are	I-DISEASE
the	0
predominant	0
finding	0
.	0

It	0
is	0
a	0
disorder	0
of	0
respira-	I-DISEASE
tory	I-DISEASE
control	0
that	I-DISEASE
can	0
be	0
either	I-DISEASE
a	0
developmental	0
problem	I-DISEASE
associated	I-DISEASE
with	0
immaturity	I-DISEASE
of	0
the	I-DISEASE
brainstem	0
respiratory	0
centers	0
or	I-DISEASE
secondary	I-DISEASE
to	0
other	I-DISEASE
medical	I-DISEASE
conditions	0
that	0
produce	0
apnea	0
by	0
mechanisms	0
such	0
as	0
direct	0
depression	I-DISEASE
of	0
central	0
respiratory	I-DISEASE
control	0
.	0

Apnea	0
in	0
the	I-DISEASE
neonate	0
or	0
infant	I-DISEASE
may	I-DISEASE
be	0
exacerbated	I-DISEASE
or	0
precipitated	0
by	I-DISEASE
a	0
variety	0
of	I-DISEASE
medical	I-DISEASE
condi-	0
tions	I-DISEASE
,	0
such	0
as	0
anemia	0
,	0
infection	I-DISEASE
,	I-DISEASE
hypoxemia	0
,	I-DISEASE
metabolic	I-DISEASE
disturbances	0
,	I-DISEASE
gastroesophageal	I-DISEASE
reflux	0
,	0
substances	0
,	0
or	I-DISEASE
anesthesia	0
,	I-DISEASE
which	0
must	I-DISEASE
be	0
recognized	I-DISEASE
and	0
treated	0
to	0
stabilize	0
the	I-DISEASE
apnea	0
.	0

If	0
another	0
medical	0
condition	0
appears	I-DISEASE
to	0
be	I-DISEASE
the	I-DISEASE
cause	I-DISEASE
rather	0
than	0
an	0
exacerbating	I-DISEASE
factor	0
for	I-DISEASE
the	0
CSA	0
,	0
then	0
the	I-DISEASE
condition	0
should	0
be	0
classified	I-DISEASE
as	I-DISEASE
CSA	I-DISEASE
due	0
to	I-DISEASE
a	0
medical	I-DISEASE
or	I-DISEASE
neurological	I-DISEASE
condition	0
,	0
or	0
CSA	0
due	0
to	I-DISEASE
a	0
medication	I-DISEASE
or	I-DISEASE
substance	0
.	0

Despite	0
the	0
heterogeneity	I-DISEASE
of	0
infant	0
risk	0
groups	I-DISEASE
and	0
underlying	I-DISEASE
pathophysiology	0
,	0
most	I-DISEASE
studies	I-DISEASE
report	0
a	I-DISEASE
progressive	I-DISEASE
decrease	0
in	I-DISEASE
frequency	0
of	0
apneas	0
and	0
risk	0
of	0
symptomatic	I-DISEASE
apnea	0
secondary	0
to	I-DISEASE
other	0
medical	I-DISEASE
conditions	0
after	I-DISEASE
the	0
early	0
weeks	0
of	0
life	I-DISEASE
.	I-DISEASE

Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Sleep	I-DISEASE
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Associated	I-DISEASE
Features	0
Infants	0
may	I-DISEASE
present	0
with	I-DISEASE
an	I-DISEASE
ALTE	I-DISEASE
(	0
defined	I-DISEASE
by	0
a	0
National	0
Institutes	0
of	0
Health	0
Development	I-DISEASE
Conference	0
as	0
“	I-DISEASE
an	0
episode	0
that	I-DISEASE
is	0
frightening	0
to	0
the	0
observer	0
,	I-DISEASE
and	0
that	0
is	0
characterized	0
by	0
some	0
combination	0
of	I-DISEASE
apnea	0

[	0

central	0
or	0
occasionally	0
obstructive	0
]	0
,	0
color	0
change	0
,	0
marked	0
change	0
in	0
muscle	0
tone	0
,	I-DISEASE
choking	0
or	0
gagging	I-DISEASE
.	0

In	0
some	0
cases	0
,	B-DISEASE
the	0
observer	I-DISEASE
fears	0
that	0
the	I-DISEASE
infant	I-DISEASE
has	0
died	0
”	0
)	0
.	I-DISEASE

Many	0
infants	0
with	0
primary	0
CSA	0
of	I-DISEASE
infancy	I-DISEASE
will	0
not	I-DISEASE
have	0
an	0
ALTE	0
,	0
and	0
many	0
ALTEs	0
are	0
not	0
associated	0
with	0
apnea	0
.	0

Primary	0
CSA	0
of	I-DISEASE
infancy	0
is	0
state	0
dependent	I-DISEASE
,	0
and	I-DISEASE
the	0
frequency	0
of	I-DISEASE
respiratory	0
events	0
increases	I-DISEASE
during	0
active	I-DISEASE
(	I-DISEASE
REM	0
)	I-DISEASE
sleep	0
.	0

Paradoxical	0
chest	0
wall	0
movements	0
are	0
common	0
during	I-DISEASE
active	0
sleep	0
in	0
infants	0
and	I-DISEASE
may	0
cause	0
a	I-DISEASE
fall	0
in	I-DISEASE
arterial	I-DISEASE
oxygen	0
saturation	0
because	0
of	0
ventilation	0
or	I-DISEASE
perfusion	0
defects	0
associated	0
with	0
a	0
decrease	0
in	0
functional	I-DISEASE
residual	0
capacity	0
.	0

Underlying	0
comorbidities	0
(	0
for	0
example	0
,	I-DISEASE
chronic	0
lung	0
disease	0
or	0
abnormal	0
neurological	0
status	I-DISEASE
)	0
can	0
predispose	0
the	0
infant	I-DISEASE
to	0
having	0
a	0
more	0
severe	0
or	0
prolonged	I-DISEASE
course	I-DISEASE
for	0
apnea	I-DISEASE
.	0

Note	0
that	0
a	0
small	0
upper	0
airway	0
will	0
exaggerate	I-DISEASE
the	I-DISEASE
obstructive	0
elements	0
of	0
this	I-DISEASE
disorder	0
.	0

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Not	I-DISEASE
applicable	I-DISEASE
.	I-DISEASE

Demographics	0
Less	0
than	0
0.5	0
%	0
of	I-DISEASE
full	I-DISEASE
-	I-DISEASE
term	0
newborns	0
experience	0
symptomatic	0
apnea	I-DISEASE
.	0

Studies	0
have	0
shown	0
that	0
during	0
the	I-DISEASE
first	I-DISEASE
six	0
months	I-DISEASE
of	0
life	0
,	0
2	0
%	0
of	0
healthy	0
full	0
-	I-DISEASE
term	0
infants	0
will	0
experience	0
at	0
least	I-DISEASE
one	I-DISEASE
apnea	0
event	0
lasting	I-DISEASE
30	0
seconds	0
or	0
longer	0
or	0
an	0
apnea	0
that	0
lasts	0
at	I-DISEASE
least	I-DISEASE
20	0
seconds	I-DISEASE
and	I-DISEASE
is	I-DISEASE
associated	0
with	0
a	0
heart	I-DISEASE
rate	I-DISEASE
less	0
than	0
60	0
beats	0
per	I-DISEASE
minute	0
.	0

Apnea	0
of	0
infancy	I-DISEASE
occurs	0
equally	0
in	0
males	0
and	0
females	0
,	0
and	0
in	0
infants	0
of	0
all	0
races	0
and	0
ethnic	0
groups	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
Many	0
factors	I-DISEASE
may	I-DISEASE
precipitate	0
apneic	I-DISEASE
episodes	0
,	0
including	0
gastroesophageal	I-DISEASE
reflux	0
,	I-DISEASE
intra-	I-DISEASE
cranial	0
pathology	I-DISEASE
,	0
substances	0
,	I-DISEASE
anesthesia	0
,	0
metabolic	0
disorders	I-DISEASE
,	0
impaired	0
oxygenation	0
,	0
and	I-DISEASE
infection	0
(	0
including	0
sepsis	0
,	0
meningitis	0
,	0
respiratory	0
syncytial	I-DISEASE
virus	I-DISEASE
infections	0
,	0
and	0
pertussis	0
)	0
.	I-DISEASE

Infection	0
with	0
respiratory	I-DISEASE
syncytial	0
virus	0
,	0
in	B-DISEASE
particular	0
,	I-DISEASE
can	0
increase	0
the	0
fre-	0
quency	0
and	I-DISEASE
the	0
duration	0
of	I-DISEASE
apneas	0
.	0

Familial	0
Patterns	0
None	0
known	0
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Onset	I-DISEASE
is	0
usually	0
in	0
the	0
first	0
weeks	0
or	0
months	0
of	0
life	I-DISEASE
.	0

Some	0
infants	0
may	0
be	0
diagnosed	0
by	0
nursing	0
observations	0
or	I-DISEASE
routine	0
monitoring	0
soon	0
after	0
birth	0
.	0

Older	0
infants	0
may	0
present	0
with	0
an	0
ALTE	I-DISEASE
or	0
may	0
have	0
failure	0
to	0
thrive	0
.	0

The	0
prognosis	0
is	0
generally	0
good	I-DISEASE
,	0
with	I-DISEASE
res-	I-DISEASE
olution	I-DISEASE
of	0
apnea	0
over	0
the	I-DISEASE
first	0
few	I-DISEASE
years	0
of	0
life	I-DISEASE
and	0
no	0
residual	0
sequelae	0
.	0

The	0
presence	0
of	0
persistent	0
severe	0
apnea	I-DISEASE
may	I-DISEASE
be	I-DISEASE
an	0
indication	0
of	0
an	0
underlying	0
medical	0
condition	I-DISEASE
and	0
should	0
prompt	I-DISEASE
further	0
evaluation	0
.	0

Patients	0
with	0
persistent	0
severe	0
apnea	0
may	0
develop	0
sequelae	I-DISEASE
related	0
to	0
hypoxic	0
events	0
.	0

Developmental	0
Issues	0

This	0
is	0
a	0
condition	0
of	I-DISEASE
infancy	I-DISEASE
that	I-DISEASE
normally	0
improves	I-DISEASE
over	0
time	0
.	0

Pathology	0
and	0
Pathophysiology	0
Physiological	0
factors	0
contributing	I-DISEASE
to	I-DISEASE
apnea	0
are	I-DISEASE
related	0
to	0
immaturity	0
of	0
respiratory	0
control	I-DISEASE
.	0

These	0
include	0
developmental	I-DISEASE
alterations	0
in	0
central	0
drive	0
,	0
chemoreceptor	I-DISEASE
or	0
mechanoreceptor	0
responses	I-DISEASE
,	0
and	0
upper	I-DISEASE
airway	0
reflexes	I-DISEASE
.	I-DISEASE

Precipitating	0
factors	0
for	0
wors-	0
ening	0
apnea	0
include	0
gastroesophageal	0
reflux	I-DISEASE
,	0
intracranial	0
pathology	0
,	0
substances	I-DISEASE
,	0
anes-	0
thesia	0
,	I-DISEASE
metabolic	0
disturbances	I-DISEASE
,	0
impaired	0
oxygenation	0
,	0
and	0
infection	0
.	0

Objective	0
Findings	0
Apnea	0
is	I-DISEASE
predominantly	0
central	I-DISEASE
,	I-DISEASE
but	I-DISEASE
obstructive	0
and	0
mixed	0
apneas	0
may	0
occur	0
.	I-DISEASE

Apneas	0
are	0
seen	I-DISEASE
most	0
frequently	0
during	0
REM	0
sleep	0
.	I-DISEASE

Other	0
diagnostic	0
tests	0
,	I-DISEASE
such	0
as	0
a	I-DISEASE
full	0
EEG	I-DISEASE
or	0
evaluation	0
for	0
reflux	I-DISEASE
,	0
may	I-DISEASE
be	0
appropriate	0
in	I-DISEASE
individual	0
cases	I-DISEASE
.	0

Differential	0
Diagnosis	0
Primary	0
CSA	0
of	0
infancy	I-DISEASE
should	0
be	I-DISEASE
distinguished	I-DISEASE
from	0
the	0
normal	0
respiratory	I-DISEASE
pauses	0
that	0
occur	I-DISEASE
during	0
sleep	I-DISEASE
.	0

Normative	0
respiratory	0
data	0
from	0
several	0
large	0
studies	I-DISEASE
show	0
that	I-DISEASE
healthy	0
asymptomatic	0
infants	0
commonly	0
have	0
central	I-DISEASE
respiratory	0
pauses	0
,	I-DISEASE
either	0
as	0
isolated	0
events	0
(	0
particularly	0
during	I-DISEASE
REM	0
sleep	0
)	0
or	0
after	I-DISEASE
sigh	I-DISEASE
breaths	0
or	0
movements	0
.	0

Primary	0
CSA	0
of	I-DISEASE
infancy	0
should	0
be	0
distinguished	I-DISEASE
from	I-DISEASE
the	I-DISEASE
popular	0
clinical	I-DISEASE
term	I-DISEASE
,	0
ALTE	0
,	I-DISEASE
which	0
is	0
not	I-DISEASE
a	I-DISEASE
specific	0
diagnosis	I-DISEASE
but	0
an	0
ill	0
-	0
defined	I-DISEASE
constellation	0
of	I-DISEASE
parent	B-DISEASE
-	I-DISEASE
reported	0
apnea	I-DISEASE
symptoms	0
that	0
range	0
in	I-DISEASE
severity	0
from	0
benign	I-DISEASE
to	I-DISEASE
life	0
threatening	I-DISEASE
.	0

Recurrent	0
,	0
severe	0
infant	0
sleep	0
apnea	I-DISEASE
is	I-DISEASE
usually	0
due	I-DISEASE
to	0
other	0
comorbid	0
conditions	0
,	0
such	I-DISEASE
as	0
gastroesophageal	0
reflux	I-DISEASE
,	0
metabolic	0
disease	0
,	0
or	0
unrecognized	0
neurological	0
conditions	I-DISEASE
such	0
as	0
seizures	0
,	0
brainstem	0
malformation	0
,	0
or	0
neurodegenerative	0
condi-	0
tion	0
;	0
thus	0
an	0
evaluation	0
for	0
these	0
conditions	0
should	0
be	0
performed	I-DISEASE
.	0

Another	0
diagnos-	0
tic	0
consideration	I-DISEASE
is	0
a	I-DISEASE
form	I-DISEASE
of	0
child	I-DISEASE
abuse	0
(	0
Munchausen	0
syndrome	I-DISEASE
by	0
proxy	I-DISEASE
)	I-DISEASE
mani-	0
fest	I-DISEASE
as	0
imposed	0
upper	0
airway	0
obstruction	0
or	I-DISEASE
attempted	I-DISEASE
suffocation	0
.	0

Primary	0
CSA	0
of	I-DISEASE
infancy	0
should	0
be	0
disassociated	I-DISEASE
from	I-DISEASE
the	I-DISEASE
postmortem	0
diagnosis	0
of	0
SIDS	0
.	0

Although	0
a	0
small	0
percentage	I-DISEASE
of	I-DISEASE
SIDS	I-DISEASE
victims	I-DISEASE
experience	0
apnea	I-DISEASE
symptoms	0
prior	0
to	0
death	I-DISEASE
,	0
Sleep	0
Related	0
Breathing	0
Disorders	0
Sleep	0
Related	I-DISEASE
Breathing	0
Disorders	0
primary	0
apnea	I-DISEASE
in	I-DISEASE
the	0
newborn	0
or	I-DISEASE
infant	0
has	I-DISEASE
not	0
been	I-DISEASE
established	0
as	0
an	0
independent	0
risk	0
factor	0
for	I-DISEASE
SIDS	I-DISEASE
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE
Infancy	I-DISEASE
is	I-DISEASE
a	0
developmental	I-DISEASE
period	0
normally	0
characterized	I-DISEASE
by	0
instability	0
of	I-DISEASE
control	0
of	0
breathing	I-DISEASE
;	0
thus	0
,	I-DISEASE
defining	0
what	0
is	I-DISEASE
abnormal	0
is	I-DISEASE
a	0
diagnostic	I-DISEASE
challenge	0
.	I-DISEASE

Further	0
research	0
is	0
needed	0
into	0
the	0
mechanisms	I-DISEASE
of	0
ventilatory	I-DISEASE
control	0
development	0
in	I-DISEASE
the	0
infant	0
and	0
the	I-DISEASE
pathophysiologic	0
factors	I-DISEASE
resulting	I-DISEASE
in	0
infant	0
apnea	I-DISEASE
.	0

Bibliography	0
American	0
Academy	0
of	0
Pediatrics	0
.	0

Apnea	0
,	0
sudden	I-DISEASE
infant	0
death	0
syndrome	0
,	I-DISEASE
and	0
home	I-DISEASE
monitoring	0
.	0

Pediatrics	0
2003;111:914–7	0
.	0

Hunt	0
CE	0
,	0
Hufford	0
DR	0
,	0
Bourguignon	I-DISEASE
C	0
,	I-DISEASE
Oess	0
MA	0
.	0

Home	0
documented	0
monitoring	0
of	0
cardiorespiratory	0
pattern	0
and	0
oxygen	0
saturation	I-DISEASE
in	0
healthy	0
infants	0
.	0

Pediatr	0
Res	0
1996;39:216–22	0
.	0

National	0
Institutes	I-DISEASE
of	0
Health	0
Consensus	0
Development	0
Conference	I-DISEASE
on	0
Infantile	I-DISEASE
Apnea	0
and	0
Home	0
Monitoring	I-DISEASE
,	0
Sept	I-DISEASE
29	I-DISEASE
to	0
Oct	I-DISEASE
1	0
,	I-DISEASE
1986	0
.	0

Pediatrics	0
1987;79:292–9	0
.	0

Ramanathan	0
R	0
,	0
Corwin	0
MJ	0
,	0
Hunt	0
CE	0
,	0
et	0
al	0
.	0

Cardiorespiratory	0
events	0
recorded	0
on	0
home	0
monitors	I-DISEASE
:	0
Comparison	0
of	I-DISEASE
healthy	0
infants	0
with	0
those	0
at	0
increased	I-DISEASE
risk	0
for	0
SIDS	I-DISEASE
.	0

JAMA	0
2001;285:2199–207	0
.	0

Southall	0
DP	0
,	0
Plunkett	I-DISEASE
MC	0
,	0
Banks	I-DISEASE
MW	0
,	I-DISEASE
Falkov	0
AF	0
,	0
Samuels	0
MP	0
.	I-DISEASE

Covert	0
video	0
recordings	0
of	0
life-	0
threatening	I-DISEASE
child	I-DISEASE
abuse	0
:	I-DISEASE
lessons	0
for	0
child	0
protection	0
.	0

Pediatrics	0
1997;100:735–60	0
.	0

Primary	0
Central	0
Sleep	0
Apnea	0
of	0
Prematurity	I-DISEASE
ICD-9	I-DISEASE
-	0
CM	I-DISEASE
code	I-DISEASE
:	I-DISEASE
770.82	0
ICD-10	0
-	0
CM	I-DISEASE
code	I-DISEASE
:	I-DISEASE
P28.4	I-DISEASE
Alternate	0
Names	0
Apnea	0
of	0
prematurity	0
.	0

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
D	I-DISEASE
must	I-DISEASE
be	0
met	I-DISEASE
A.	0
Apnea	0
or	0
cyanosis	I-DISEASE
is	0
noted	0
by	I-DISEASE
an	0
observer	I-DISEASE
,	0
or	0
an	I-DISEASE
episode	0
of	0
sleep	I-DISEASE
related	I-DISEASE
central	0
apnea	0
,	I-DISEASE
desaturation	0
,	I-DISEASE
or	0
bradycardia	0
is	0
detected	0
by	0
hospital	0
monitoring	I-DISEASE
in	I-DISEASE
the	0
postnatal	0
period	I-DISEASE
.	0

B.	0
The	0
infant	0
has	0
a	0
conceptional	0
age	I-DISEASE
less	0
than	0
37	0
weeks	0
at	0
the	I-DISEASE
time	0
of	I-DISEASE
onset	I-DISEASE
of	0
symptoms	I-DISEASE
.	0

C.	0
PSG	0
or	0
alternative	0
monitoring	0
such	0
as	I-DISEASE
hospital	0
or	0
home	0
apnea	0
monitoring	0
shows	0
either	0
:	I-DISEASE
.	0

Recurrent	0
prolonged	0
(	0
>	0
20	0
seconds	0
duration	0
)	0
central	I-DISEASE
apneas.1	0
2	0
.	0

Periodic	0
breathing2	0
for	0
≥	0
5	I-DISEASE
%	0
of	0
total	0
sleep	I-DISEASE
time	0
.	0

D.	0

The	0
disorder	0
is	0
not	0
better	0
explained	I-DISEASE
by	0
another	0
sleep	I-DISEASE
disorder	0
,	0
medical	0
or	0
neurological	0
disorder	I-DISEASE
,	0
or	0
medication	I-DISEASE
.	0

Notes	0
.	0

Normative	0
data	0
concerning	0
the	0
number	0
of	I-DISEASE
prolonged	I-DISEASE
central	0
apneas	I-DISEASE
per	0
hour	0
are	I-DISEASE
not	0
well	0
established	I-DISEASE
.	0
.	0

As	0
defined	0
by	0
the	0
most	I-DISEASE
recent	0
version	I-DISEASE
of	0
the	I-DISEASE
AASM	I-DISEASE
Manual	0
for	0
the	0
Scoring	0
of	I-DISEASE
Sleep	0
and	0
Associated	I-DISEASE
Events	0
.	I-DISEASE
.	0

Short	0
(	0
<	0
20	I-DISEASE
seconds	0
)	0
central	I-DISEASE
apneas	0
associated	I-DISEASE
with	I-DISEASE
significant	0
desaturation	0
are	0
more	0
likely	I-DISEASE
to	I-DISEASE
be	I-DISEASE
a	0
sign	0
of	0
decreased	0
pulmonary	0
reserve	0
than	0
of	0
central	0
nervous	0
system	I-DISEASE
pathology	0
.	0
.	0

Obstructive	0
and	0
mixed	0
apneas	0
may	0
also	I-DISEASE
be	I-DISEASE
present	0
,	I-DISEASE
but	0
central	I-DISEASE
apneas	0
are	0
predominant	0
.	I-DISEASE

Essential	0
Features	0
Apnea	0
is	0
very	I-DISEASE
common	0
in	I-DISEASE
preterm	0
infants	0
,	0
and	0
the	0
prevalence	0
varies	0
inversely	0
with	0
ges-	I-DISEASE
tational	I-DISEASE
age	0
.	0

In	0
the	0
preterm	I-DISEASE
infant	0
,	0
sleep	0
apnea	I-DISEASE
can	0
be	I-DISEASE
anticipated	0
,	I-DISEASE
is	0
primarily	0
related	0
to	0
immaturity	I-DISEASE
,	0
and	I-DISEASE
may	I-DISEASE
require	0
supportive	0
ventilatory	I-DISEASE
and	I-DISEASE
pharmacologic	0
treatment	I-DISEASE
.	0

The	0
condition	0
will	0
improve	0
with	0
maturation	0
unless	0
extenuating	0
conditions	I-DISEASE
,	0
such	0
as	0
hypoxemia	0
due	0
to	0
chronic	0
lung	0
disease	0
or	0
gastroesophageal	0
reflux	0
,	0
are	0
present	0
.	I-DISEASE

Apneas	0
are	0
predominantly	I-DISEASE
central	0
,	0
but	0
mixed	I-DISEASE
or	0
obstructive	I-DISEASE
apneas	0
or	0
hypopneas	0
may	0
be	0
seen	0
.	I-DISEASE

The	0
events	0
are	0
typically	0
associated	0
with	0
physiological	0
compromise	0
(	I-DISEASE
hypoxemia	0
,	0
bra-	0
dycardia	I-DISEASE
)	0
or	I-DISEASE
the	0
need	0
for	0
intervention	0
such	0
as	0
stimulation	0
or	0
resuscitation	I-DISEASE
.	I-DISEASE

Associated	0
Features	0
Apnea	0
in	0
the	I-DISEASE
preterm	0
infant	0
is	0
commonly	I-DISEASE
associated	0
with	0
bradycardia	0
.	0

Primary	0
CSA	0
of	I-DISEASE
prematurity	0
is	0
state	0
dependent	I-DISEASE
,	I-DISEASE
and	I-DISEASE
the	0
frequency	0
of	0
respiratory	0
events	I-DISEASE
increases	0
during	0
active	0
(	I-DISEASE
REM	0
)	I-DISEASE
sleep	0
.	0

Paradoxical	0
chest	0
wall	0
movements	0
are	0
common	0
during	I-DISEASE
active	0
sleep	0
in	0
neonates	0
and	I-DISEASE
may	0
cause	0
a	I-DISEASE
fall	I-DISEASE
in	0
arterial	I-DISEASE
oxygen	0
saturation	0
because	0
of	0
ventilation	I-DISEASE
or	0
perfusion	I-DISEASE
defects	0
associated	0
with	I-DISEASE
a	0
decrease	0
in	I-DISEASE
functional	0
residual	0
capac-	0
ity	0
.	0

Underlying	0
comorbidities	0
(	0
for	0
example	0
,	I-DISEASE
chronic	0
lung	0
disease	0
or	0
abnormal	0
neuro-	0
logical	I-DISEASE
status	0
)	0
can	0
predispose	0
the	I-DISEASE
infant	0
to	0
having	0
a	0
more	0
severe	0
or	0
prolonged	0
course	I-DISEASE
for	I-DISEASE
apnea	0
.	0

Note	0
that	0
a	0
small	0
upper	0
airway	0
will	0
exaggerate	I-DISEASE
the	I-DISEASE
obstructive	0
elements	0
of	0
this	I-DISEASE
disorder	0
.	0

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
None	I-DISEASE
known	I-DISEASE
.	I-DISEASE

Sleep	0
Related	0
Breathing	I-DISEASE
Disorders	0
Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Demographics	I-DISEASE

The	0
prevalence	0
of	I-DISEASE
apnea	0
of	0
prematurity	I-DISEASE
varies	0
inversely	0
with	I-DISEASE
conceptional	I-DISEASE
age	0
.	0

In	0
studies	0
,	0
approximately	0
25	0
%	I-DISEASE
percent	0
of	0
infants	I-DISEASE
who	0
weigh	0
less	0
than	0
2,500	0
g	I-DISEASE
at	I-DISEASE
birth	I-DISEASE
and	I-DISEASE
84	I-DISEASE
%	0
of	0
infants	0
under	0
1,000	I-DISEASE
g	I-DISEASE
may	I-DISEASE
experience	0
symptomatic	I-DISEASE
apnea	I-DISEASE
during	I-DISEASE
the	0
neo-	0
natal	0
period	0
.	0

Ninety	0
-	I-DISEASE
two	0
percent	I-DISEASE
of	0
preterm	0
infants	I-DISEASE
will	I-DISEASE
be	I-DISEASE
symptom	0
free	0
by	0
37	I-DISEASE
weeks	0
postconceptional	I-DISEASE
age	I-DISEASE
,	0
and	I-DISEASE
98	0
%	I-DISEASE
by	0
40	0
weeks	0
after	I-DISEASE
conception	I-DISEASE
,	0
with	0
resolution	I-DISEASE
in	0
most	0
infants	0
by	I-DISEASE
43	0
weeks	0
postconception	0
.	0

Apnea	0
of	0
prematurity	I-DISEASE
occurs	0
equally	0
in	0
males	I-DISEASE
and	I-DISEASE
females	I-DISEASE
,	0
and	0
in	0
infants	0
of	0
all	I-DISEASE
races	I-DISEASE
and	0
ethnic	I-DISEASE
groups	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
Developmental	0
delay	I-DISEASE
in	I-DISEASE
respiratory	0
control	I-DISEASE
associated	0
with	0
premature	0
birth	0
is	0
the	0
major	0
predisposing	0
condition	I-DISEASE
.	0

Diverse	0
factors	0
are	0
known	0
to	0
precipitate	0
development	0
of	0
apneic	I-DISEASE
episodes	0
in	0
predisposed	0
preterm	0
infants	0
.	I-DISEASE

These	0
include	0
thermal	0
instability	0
,	I-DISEASE
gastroesophageal	0
reflux	0
,	0
intracranial	I-DISEASE
pathology	I-DISEASE
,	0
substances	0
,	0
anesthesia	0
,	0
metabolic	0
disorders	0
,	0
impaired	0
oxygenation	0
,	0
and	0
infection	0
.	0

Infection	0
with	0
respiratory	0
syncytial	0
virus	0
can	0
increase	B-DISEASE
the	0
frequency	I-DISEASE
and	0
the	0
duration	0
of	0
apneas	I-DISEASE
in	0
predisposed	I-DISEASE
infants	I-DISEASE
.	I-DISEASE

OSA	0
associated	0
with	0
upper	0
airway	0
abnormalities	0
can	0
present	0
as	0
apnea	0
of	0
prematurity	0
.	0

Persistence	0
of	0
apnea	0
after	0
43	0
weeks	I-DISEASE
conceptional	0
age	0
should	I-DISEASE
raise	0
suspicion	0
of	0
addi-	0
tional	0
etiologic	0
factors	0
.	0

Familial	0
Patterns	0
None	0
known	0
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
In	I-DISEASE
preterm	0
infants	I-DISEASE
,	0
apnea	I-DISEASE
is	0
rare	0
on	0
day	0
one	0
of	0
life	I-DISEASE
,	I-DISEASE
and	0
its	0
presence	0
usually	0
signals	0
another	0
illness	0
.	0

More	0
typical	0
onset	I-DISEASE
occurs	0
between	0
the	0
second	I-DISEASE
and	0
seventh	I-DISEASE
days	0
.	0

Apnea	0
of	0
prematurity	I-DISEASE
usually	0
ceases	0
by	0
37	I-DISEASE
weeks	I-DISEASE
conceptional	I-DISEASE
age	I-DISEASE
but	I-DISEASE
may	I-DISEASE
persist	I-DISEASE
for	0
several	0
weeks	0
beyond	0
term	I-DISEASE
,	0
especially	0
in	0
infants	0
born	I-DISEASE
before	0
28	I-DISEASE
weeks	0
postconception	0
;	0
apnea	0
beyond	0
43	I-DISEASE
weeks	I-DISEASE
postconception	0
is	0
rare	0
.	0

Adverse	0
outcomes	0
for	0
former	0
preterm	0
infants	0
are	I-DISEASE
more	I-DISEASE
closely	0
related	0
to	0
the	0
prenatal	0
or	I-DISEASE
neonatal	I-DISEASE
course	I-DISEASE
,	0
associated	I-DISEASE
comorbidities	0
,	0
and	0
environmental	I-DISEASE
factors	0
than	I-DISEASE
to	I-DISEASE
the	0
apnea	0
of	I-DISEASE
prematurity	0
per	0
se	0
.	I-DISEASE

For	0
most	0
children	0
,	I-DISEASE
long	0
-	0
term	I-DISEASE
outcomes	0
for	0
uncomplicated	0
apnea	0
of	0
prematurity	0
are	0
excellent	I-DISEASE
.	I-DISEASE

However	0
,	I-DISEASE
the	0
prognosis	I-DISEASE
for	0
infants	0
with	I-DISEASE
persistent	0
recurrent	I-DISEASE
apnea	0
spells	0
requiring	0
frequent	0
resuscitation	0
is	I-DISEASE
more	0
guarded	0
and	I-DISEASE
depends	0
on	I-DISEASE
the	0
cause	0
of	0
the	0
apnea	0
and	0
associated	0
comorbidities	I-DISEASE
.	I-DISEASE

Developmental	0
Issues	0

This	0
is	0
a	0
condition	0
related	I-DISEASE
to	I-DISEASE
prematurity	0
that	0
normally	I-DISEASE
improves	0
over	0
time	0
.	0

Pathology	0
and	0
Pathophysiology	0
Physiological	0
factors	0
contributing	I-DISEASE
to	I-DISEASE
apnea	0
are	I-DISEASE
related	0
to	0
immaturity	0
of	0
respiratory	0
control	I-DISEASE
.	0

These	0
include	0
developmental	I-DISEASE
alterations	0
in	0
central	0
drive	0
,	0
chemoreceptor	I-DISEASE
or	0
mechanoreceptor	0
responses	I-DISEASE
,	0
and	0
upper	I-DISEASE
airway	0
reflexes	I-DISEASE
.	I-DISEASE

Precipitating	0
factors	0
for	0
wors-	0
ening	0
apnea	0
in	0
preterm	0
infants	I-DISEASE
include	0
thermal	0
instability	0
,	0
gastroesophageal	I-DISEASE
reflux	0
,	0
intracranial	0
pathology	I-DISEASE
,	0
substances	0
,	0
anesthesia	0
,	I-DISEASE
metabolic	0
disturbances	0
,	0
impaired	0
oxy-	I-DISEASE
genation	0
,	0
and	0
infection	0
.	0

Objective	0
Findings	0
Most	0
premature	I-DISEASE
neonates	0
are	I-DISEASE
diagnosed	I-DISEASE
with	I-DISEASE
apnea	I-DISEASE
of	0
prematurity	0
based	0
on	0
cardio-	0
respiratory	I-DISEASE
monitoring	0
in	0
the	I-DISEASE
neonatal	I-DISEASE
intensive	I-DISEASE
care	0
unit	0
,	0
rather	I-DISEASE
than	I-DISEASE
by	0
PSG	0
.	0

When	0
PSG	0
is	0
performed	0
,	0
central	0
apneas	I-DISEASE
are	0
often	I-DISEASE
shown	I-DISEASE
to	0
have	0
a	0
mixed	0
component	I-DISEASE
,	0
with	0
mixed	I-DISEASE
apneas	0
accounting	0
for	0
50	0
%	I-DISEASE
to	I-DISEASE
75	I-DISEASE
%	0
of	0
apneas	I-DISEASE
in	0
small	0
premature	0
infants	0
;	0
studies	0
suggest	0
that	0
obstructive	I-DISEASE
-	0
type	I-DISEASE
events	0
account	I-DISEASE
for	I-DISEASE
10	0
%	0
to	0
20	0
%	I-DISEASE
of	I-DISEASE
events	0
;	0
and	I-DISEASE
pure	I-DISEASE
central	I-DISEASE
events	0
,	0
10	0
%	0
to	0
25	0
%	I-DISEASE
.	0

Periodic	0
breathing	0
may	0
be	0
present	0
.	0

Differential	0
Diagnosis	0
Apnea	0
of	0
prematurity	0
should	I-DISEASE
be	I-DISEASE
distinguished	I-DISEASE
from	0
normal	0
,	0
physiologic	I-DISEASE
respiratory	I-DISEASE
pauses	0
that	I-DISEASE
occur	I-DISEASE
during	0
sleep	I-DISEASE
in	0
infants	I-DISEASE
.	I-DISEASE

Studies	0
have	0
shown	0
that	0
healthy	0
asymptom-	0
atic	I-DISEASE
infants	0
commonly	I-DISEASE
have	0
brief	0
(	I-DISEASE
<	0
20	0
second	0
)	0
central	I-DISEASE
respiratory	I-DISEASE
pauses	0
,	0
either	0
as	I-DISEASE
isolated	0
events	0
(	I-DISEASE
particularly	0
during	0
REM	I-DISEASE
sleep	0
)	0
or	0
after	I-DISEASE
sigh	0
breaths	0
or	0
movements	I-DISEASE
(	I-DISEASE
in	0
which	0
case	0
the	0
apneas	0
may	0
be	0
longer	0
)	I-DISEASE
.	I-DISEASE

These	0
infants	0
are	0
typically	0
asymptomatic	0
,	0
with	B-DISEASE
no	0
changes	I-DISEASE
in	0
color	0
or	0
muscle	I-DISEASE
tone	0
.	0

The	0
differential	0
diagnosis	0
is	0
long	0
and	0
includes	I-DISEASE
apnea	0
secondary	I-DISEASE
to	I-DISEASE
severe	0
gastroesoph-	0
ageal	0
reflux	0
,	0
central	0
nervous	0
system	I-DISEASE
malformations	0
or	0
hemorrhage	0
,	0
seizures	0
,	0
sepsis	0
,	0
and	0
rarely	0
primary	0
cardiac	I-DISEASE
arrhythmias	0
.	0

Comorbid	0
conditions	0
should	0
be	0
suspected	0
whenever	0
apneas	I-DISEASE
are	0
severe	0
or	0
continue	0
beyond	0
43	0
weeks	0
gestation	I-DISEASE
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE

The	0
mechanisms	0
underlying	0
physiologic	0
maturation	0
of	I-DISEASE
ventilatory	0
control	0
are	0
not	0
well	0
understood	0
.	0

Further	0
research	0
is	0
required	0
to	0
determine	0
which	0
infants	I-DISEASE
are	I-DISEASE
at	0
greatest	0
risk	0
for	0
severe	0
apnea	I-DISEASE
.	0

Bibliography	0
American	0
Academy	0
of	0
Pediatrics	0
.	0

Apnea	0
,	0
sudden	I-DISEASE
infant	0
death	0
syndrome	0
,	I-DISEASE
and	0
home	I-DISEASE
monitoring	0
.	0

Pediatrics	0
2003;111:914–7	0
.	0

Hunt	0
CE	0
,	0
Hufford	0
DR	0
,	0
Bourguignon	I-DISEASE
C	0
,	I-DISEASE
Oess	0
MA	0
.	0

Home	0
documented	0
monitoring	0
of	0
cardiorespiratory	0
pattern	0
and	0
oxygen	0
saturation	I-DISEASE
in	0
healthy	0
infants	0
.	0

Pediatr	0
Res	0
1996;39:216–22	0
.	0

Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Sleep	I-DISEASE
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Kahn	I-DISEASE
A	0
,	0
Rebuffat	I-DISEASE
E	0
,	I-DISEASE
Sottiaux	I-DISEASE
M	I-DISEASE
,	0
Blum	I-DISEASE
D.	0
Management	0
of	0
an	0
infant	I-DISEASE
with	0
an	I-DISEASE
apparent	I-DISEASE
life	0
-	I-DISEASE
threatening	0
event	I-DISEASE
.	0

Pediatrician	0
1988;15:204–11	0
.	0

National	0
Institutes	I-DISEASE
of	0
Health	0
Consensus	0
Development	0
Conference	I-DISEASE
on	0
Infantile	I-DISEASE
Apnea	0
and	0
Home	0
Monitoring	I-DISEASE
,	0
Sept	I-DISEASE
29	I-DISEASE
to	0
Oct	I-DISEASE
1	0
,	I-DISEASE
1986	0
.	0

Pediatrics	0
1987;79:292–9	0
.	0

Ramanathan	0
R	0
,	0
Corwin	0
MJ	0
,	0
Hunt	0
CE	0
,	0
et	0
al	0
.	0

Cardiorespiratory	0
events	0
recorded	0
on	0
home	0
monitors	I-DISEASE
:	0
Comparison	0
of	I-DISEASE
healthy	0
infants	0
with	0
those	0
at	0
increased	I-DISEASE
risk	0
for	0
SIDS	I-DISEASE
.	0

JAMA	0
2001;285:2199–207	0
.	0

Rigatto	0
H.	0
Breathing	0
and	0
sleep	0
in	I-DISEASE
preterm	I-DISEASE
infants	0
.	I-DISEASE

In	0
:	0
Loughlin	0
G	I-DISEASE
,	I-DISEASE
Carroll	I-DISEASE
J	I-DISEASE
,	0
Marcus	I-DISEASE
C	0
,	0
eds	0
.	I-DISEASE

Sleep	0
and	0
breathing	0
in	0
children	0
.	I-DISEASE

New	0
York	0
:	0
Marcel	0
Dekker	I-DISEASE
,	0
2000:495–515	0
.	0

Schmidt	0
B	0
,	0
Roberts	0
RS	0
,	I-DISEASE
Davis	I-DISEASE
P	0
,	I-DISEASE
et	0
al	0
.	0

Long	0
-	0
term	I-DISEASE
effects	0
of	0
caffeine	I-DISEASE
therapy	I-DISEASE
for	0
apnea	0
of	0
prematurity	0
.	0

N	0
Engl	0
J	0
Med	0
2007;357:1893–902	0
.	0

Southall	0
DP	0
,	0
Plunkett	I-DISEASE
MC	0
,	0
Banks	I-DISEASE
MW	0
,	I-DISEASE
Falkov	0
AF	0
,	0
Samuels	0
MP	0
.	I-DISEASE

Covert	0
video	0
recordings	0
of	0
life-	0
threatening	I-DISEASE
child	I-DISEASE
abuse	0
:	0
lessons	0
for	0
child	0
protection	0
[	0
see	I-DISEASE
comments	0
]	0
.	I-DISEASE

Pediatrics	0
1997;100:735–60	0
.	0

Treatment	0
-	0
Emergent	0
Central	0
Sleep	0
Apnea	0
ICD-9	0
-	I-DISEASE
CM	I-DISEASE
code	I-DISEASE
:	0
327.29	0
ICD-10	0
-	0
CM	I-DISEASE
code	I-DISEASE
:	I-DISEASE
G47.39	I-DISEASE
Alternate	0
names	0
Complex	0
sleep	0
apnea	0
.	I-DISEASE

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
C	I-DISEASE
must	I-DISEASE
be	0
met	I-DISEASE
A.	0
Diagnostic	0
PSG	0
shows	I-DISEASE
five	I-DISEASE
or	0
more	I-DISEASE
predominantly	I-DISEASE
obstructive	I-DISEASE
respiratory	0
events1	0
(	0
obstructive	0
or	I-DISEASE
mixed	I-DISEASE
apneas	I-DISEASE
,	0
hypopneas	0
or	0
RERAs	0
)	I-DISEASE
per	0
hour	0
of	0
sleep	0
B.	0
PSG	0
during	0
use	I-DISEASE
of	0
positive	0
airway	0
pressure	I-DISEASE
without	0
a	0
backup	I-DISEASE
rate	I-DISEASE
shows	0
significant	I-DISEASE
resolution	0
of	I-DISEASE
obstructive	0
events	0
and	I-DISEASE
emergence	I-DISEASE
or	0
persistence	I-DISEASE
of	0
central	I-DISEASE
apnea	I-DISEASE
or	0
central	I-DISEASE
hypopnea	0
with	I-DISEASE
all	I-DISEASE
of	0
the	I-DISEASE
following	0
:	I-DISEASE
.	0

Central	0
apnea	0
—	0
central	0
hypopnea	0
index	0
[	0
CAHI	0
]	0
≥	0
5	0
/	0
hour	0
.	0
.	0

Number	0
of	0
central	0
apneas	0
and	0
central	I-DISEASE
hypopneas	0
is	0
≥	I-DISEASE
50	0
%	0
of	0
total	0
number	0
of	I-DISEASE
apneas	I-DISEASE
and	0
hypopneas	0
.	0

C.	0

The	0
central	0
sleep	0
apnea	I-DISEASE
is	0
not	I-DISEASE
better	0
explained	0
by	I-DISEASE
another	0
CSA	0
disorder	0
(	0
e.g.	0
,	I-DISEASE
CSA	0
with	0
CSB	0
or	0
CSA	I-DISEASE
due	0
to	0
a	I-DISEASE
medication	0
or	0
substance	I-DISEASE
)	0
.	0

Notes	0
.	0

Respiratory	0
events	0
defined	0
according	0
the	0
most	0
recent	B-DISEASE
version	0
of	I-DISEASE
the	0
AASM	0
Manual	0
for	0
the	I-DISEASE
Scoring	I-DISEASE
of	0
Sleep	0
and	I-DISEASE
Associated	I-DISEASE
Events	0
.	0
.	0

A	0
diagnosis	0
of	0
treatment	0
-	0
emergent	0
central	I-DISEASE
sleep	0
apnea	0
does	0
not	0
exclude	I-DISEASE
a	0
diagnosis	0
of	I-DISEASE
OSA	0
.	0

That	0
is	0
,	0
a	0
diagnosis	0
of	0
OSA	I-DISEASE
can	0
be	0
made	0
based	0
on	0
the	0
diagnostic	0
sleep	I-DISEASE
study	0
.	I-DISEASE

Essential	0
Features	0
A	0
diagnosis	0
of	0
treatment	I-DISEASE
-	I-DISEASE
emergent	0
CSA	I-DISEASE
is	0
characterized	I-DISEASE
by	I-DISEASE
predominantly	0
obstructive	0
events	I-DISEASE
(	0
obstructive	0
or	I-DISEASE
mixed	0
apnea	I-DISEASE
or	0
hypopnea	0
)	0
during	0
a	0
diagnostic	I-DISEASE
sleep	0
study	I-DISEASE
with	0
persistence	I-DISEASE
or	0
emergence	0
of	0
CSA	0
during	0
administration	0
of	I-DISEASE
positive	I-DISEASE
airway	I-DISEASE
pressure	0
without	I-DISEASE
a	I-DISEASE
backup	0
rate	0
,	I-DISEASE
despite	0
significant	I-DISEASE
resolution	I-DISEASE
of	I-DISEASE
obstructive	I-DISEASE
respiratory	0
events	I-DISEASE
.	I-DISEASE

If	0
the	0
central	I-DISEASE
apnea	0
is	0
better	I-DISEASE
explained	I-DISEASE
by	0
another	I-DISEASE
CSA	0
disorder	0
,	0
patients	I-DISEASE
are	0
given	I-DISEASE
a	I-DISEASE
diagnosis	I-DISEASE
of	I-DISEASE
OSA	0
and	0
that	0
CSA	0
disorder	0
rather	I-DISEASE
than	I-DISEASE
treatment	0
-	I-DISEASE
emergent	I-DISEASE
CSA	0
(	I-DISEASE
e.g.	0
,	0
a	0
patient	0
with	0
heart	I-DISEASE
failure	0
exhibits	I-DISEASE
mainly	0
obstructive	0
events	I-DISEASE
during	0
diagnostic	0
PSG	0
but	I-DISEASE
then	0
exhibits	I-DISEASE
predominantly	I-DISEASE
central	I-DISEASE
apnea	I-DISEASE
with	0
CSB	0
on	I-DISEASE
positive	I-DISEASE
airway	0
pressure	I-DISEASE
)	0
.	0

Associated	0
Features	0
Patients	0
with	0
treatment	B-DISEASE
-	0
emergent	I-DISEASE
CSA	0
have	0
several	0
characteristics	I-DISEASE
when	0
placed	0
on	0
positive	I-DISEASE
airway	0
pressure	0
without	0
a	I-DISEASE
backup	0
rate	0
.	0

A	0
high	0
number	0
of	I-DISEASE
arousals	0
persist	I-DISEASE
on	I-DISEASE
PAP	0
treatment	I-DISEASE
,	0
and	0
the	I-DISEASE
AHI	0
is	0
often	I-DISEASE
higher	I-DISEASE
during	0
NREM	I-DISEASE
than	0
REM	0
sleep	0
.	I-DISEASE

This	0
is	0
due	0
to	0
the	0
fact	I-DISEASE
that	I-DISEASE
treatment	0
-	I-DISEASE
emergent	0
central	0
apneas	0
almost	0
invariably	0
occur	I-DISEASE
during	0
NREM	I-DISEASE
sleep	0
.	0

Pressures	0
that	0
are	0
effective	I-DISEASE
in	0
controlling	0
obstructive	0
events	0
during	I-DISEASE
REM	0
sleep	0
prove	I-DISEASE
ineffective	0
during	0
NREM	I-DISEASE
sleep	0
due	I-DISEASE
to	I-DISEASE
emergence	0
of	I-DISEASE
central	0
apneas	0
.	I-DISEASE

If	0
patients	0
can	I-DISEASE
attain	0
stage	0
N3	0
,	I-DISEASE
central	0
apneas	I-DISEASE
often	0
decrease	0
until	I-DISEASE
interrupted	0
by	0
an	I-DISEASE
arousal	I-DISEASE
or	0
transition	I-DISEASE
to	0
a	I-DISEASE
lighter	0
stage	0
of	0
sleep	0
that	I-DISEASE
precipitates	0
another	0
run	I-DISEASE
of	I-DISEASE
central	I-DISEASE
apneas	0
or	I-DISEASE
hypopneas	0
.	0

Patients	0
with	0
treatment	0
-	0
emergent	0
CSA	0
can	I-DISEASE
have	0
persistent	I-DISEASE
sleep	0
fragmentation	0
on	0
CPAP	0
treatment	0
and	0
may	0
report	0
little	I-DISEASE
benefit	0
from	0
therapy	0
.	0

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
None	I-DISEASE
known	I-DISEASE
.	I-DISEASE

Demographics	0
The	0
percentage	0
of	0
patients	0
with	0
persistent	I-DISEASE
or	0
emergent	I-DISEASE
central	0
apnea	0
on	0
the	0
initial	0
poly-	0
somnographic	0
positive	I-DISEASE
airway	0
pressure	0
titration	I-DISEASE
varies	0
from	0
2	0
%	I-DISEASE
to	I-DISEASE
20	0
%	0
depending	I-DISEASE
on	I-DISEASE
the	0
characteristics	I-DISEASE
of	I-DISEASE
the	0
group	0
studied	0
(	0
community	0
or	I-DISEASE
referral	0
sleep	0
center	I-DISEASE
)	0
and	0
the	0
methodology	I-DISEASE
.	I-DISEASE

If	0
patients	0
who	I-DISEASE
are	0
taking	0
opioids	0
or	I-DISEASE
have	0
underling	I-DISEASE
central	0
apnea	0
with	0
CSB	I-DISEASE
are	0
included	I-DISEASE
,	I-DISEASE
the	0
percentage	0
is	I-DISEASE
at	0
the	0
higher	0
end	0
of	I-DISEASE
the	I-DISEASE
range	0
.	0

The	0
percentage	0
of	0
patients	0
with	0
central	0
sleep	0
apnea	I-DISEASE
that	I-DISEASE
persists	I-DISEASE
on	0
chronic	0
CPAP	0
treatment	0
(	I-DISEASE
approxi-	0
mately	0
2	I-DISEASE
%	0
)	0
is	0
considerably	0
lower	0
than	0
the	0
percentage	0
identified	0
on	0
the	0
first	0
or	I-DISEASE
second	0
night	0
of	0
CPAP	0
treatment	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0

A	0
number	0
of	0
factors	0
have	0
been	0
hypothesized	0
to	0
cause	0
treatment	0
-	0
emergent	0
CSA	0
,	0
but	0
definitive	0
data	0
are	I-DISEASE
not	0
available	0
.	0

The	0
patients	0
presumably	I-DISEASE
have	0
characteristics	0
that	0
would	I-DISEASE
predispose	0
them	I-DISEASE
to	0
instability	0
in	0
ventilatory	0
control	0
or	0
sleep	0
maintenance	0
.	I-DISEASE

Sleep	0
Related	0
Breathing	I-DISEASE
Disorders	0
Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
These	I-DISEASE
include	0
a	0
low	I-DISEASE
arousal	0
threshold	0
and	I-DISEASE
high	I-DISEASE
ventilatory	0
controller	I-DISEASE
gain	0
.	0

Studies	0
have	0
found	0
that	0
often	0
a	I-DISEASE
small	I-DISEASE
increase	0
in	0
end	0
-	0
tidal	0
PCO2	I-DISEASE
can	0
stabilize	0
breathing	I-DISEASE
in	0
patients	I-DISEASE
with	0
treatment	0
-	0
emergent	0
central	0
apneas	0
.	I-DISEASE

Therefore	0
,	0
any	0
events	0
that	0
predis-	I-DISEASE
pose	I-DISEASE
a	0
patient	I-DISEASE
to	0
hypocapnia	0
can	0
trigger	0
treatment	0
-	0
emergent	0
central	0
apnea	I-DISEASE
.	0

In	0
some	0
,	0
but	0
not	0
all	I-DISEASE
studies	0
,	0
the	I-DISEASE
overall	I-DISEASE
AHI	I-DISEASE
on	0
the	0
diagnostic	0
PSG	0
(	I-DISEASE
or	0
diagnostic	I-DISEASE
portion	0
of	I-DISEASE
a	0
split	0
-	0
night	0
PSG	I-DISEASE
)	0
was	0
higher	I-DISEASE
in	0
the	0
treatment	I-DISEASE
-	0
emergent	0
CSA	0
group	I-DISEASE
compared	0
to	I-DISEASE
the	0
patients	0
without	I-DISEASE
this	I-DISEASE
diagnosis	0
.	0

In	0
other	0
studies	0
,	0
patients	0
with	I-DISEASE
treatment	I-DISEASE
-	0
emergent	I-DISEASE
CSA	0
had	0
more	I-DISEASE
central	0
apneas	0
during	0
the	0
diagnostic	0
PSG	I-DISEASE
and	0
were	0
more	0
likely	0
to	0
be	I-DISEASE
male	I-DISEASE
.	0

However	0
,	0
identified	0
risk	0
factors	0
for	0
treatment	0
-	0
emergent	I-DISEASE
CSA	0
vary	0
considerably	0
from	0
study	0
to	0
study	0
.	0

Of	0
note	0
,	I-DISEASE
the	0
emergence	I-DISEASE
of	I-DISEASE
central	I-DISEASE
apnea	0
after	I-DISEASE
treatment	I-DISEASE
of	0
obstructive	0
apnea	0
with	0
tra-	I-DISEASE
cheostomy	0
,	0
maxillomandibular	I-DISEASE
advancement	0
,	I-DISEASE
and	0
oral	0
appliance	0
treatment	I-DISEASE
for	I-DISEASE
OSA	0
has	0
been	0
reported	B-DISEASE
.	0

A	0
case	0
report	0
of	0
the	0
development	I-DISEASE
of	I-DISEASE
central	0
apnea	0
following	0
nasal	I-DISEASE
surgery	0
in	0
a	0
patient	0
with	0
known	0
obstructive	I-DISEASE
apnea	0
has	0
also	0
recently	0
been	0
published	I-DISEASE
.	I-DISEASE

Familial	0
Patterns	0
None	0
known	0
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
The	I-DISEASE
recognition	0
of	0
treatment	0
-	I-DISEASE
emergent	0
CSA	I-DISEASE
follows	0
PAP	0
titration	I-DISEASE
.	0

An	0
accurate	0
esti-	0
mate	0
of	0
the	I-DISEASE
percentage	0
of	0
patients	I-DISEASE
with	I-DISEASE
treatment	0
-	I-DISEASE
emergent	0
central	0
apneas	I-DISEASE
whose	0
central	0
events	I-DISEASE
persist	0
on	I-DISEASE
long	0
-	0
term	0
PAP	0
treatment	I-DISEASE
does	0
not	0
exist	I-DISEASE
,	0
as	0
most	0
published	0
reports	0
are	0
retrospective	0
and	I-DISEASE
had	0
a	I-DISEASE
significant	0
number	0
of	0
patients	0
lost	0
to	0
follow	0
-	I-DISEASE
up	I-DISEASE
.	I-DISEASE

Of	0
interest	0
,	0
one	0
study	0
comparing	I-DISEASE
the	I-DISEASE
results	I-DISEASE
of	0
an	0
initial	0
CPAP	0
titration	0
study	0
with	I-DISEASE
one	0
per-	0
formed	I-DISEASE
after	0
six	0
months	0
of	0
therapy	0
found	0
patients	I-DISEASE
who	0
did	0
not	I-DISEASE
meet	0
criteria	I-DISEASE
for	0
treat-	0
ment	0
-	0
emergent	0
CSA	0
on	0
the	I-DISEASE
initial	0
study	0
but	0
met	0
the	0
criteria	0
on	0
the	0
second	I-DISEASE
study	I-DISEASE
.	I-DISEASE

Those	0
patients	0
with	I-DISEASE
treatment	0
-	0
emergent	I-DISEASE
CSA	I-DISEASE
that	0
do	I-DISEASE
not	0
experience	I-DISEASE
resolution	0
of	I-DISEASE
central	0
apneas	0
on	0
chronic	0
PAP	I-DISEASE
treatment	I-DISEASE
are	0
found	0
to	0
have	0
a	0
high	I-DISEASE
number	0
of	0
residual	0
events	0
on	0
PAP	0
machine	I-DISEASE
interrogation	0
in	0
clinic	0
follow	0
-	0
up	0
.	0

Nocturnal	0
oximetry	0
at	0
home	0
on	0
PAP	0
treatment	I-DISEASE
may	0
show	0
persistent	0
arterial	0
oxygen	0
desaturation	0
.	0

Sleep	0
fragmentation	0
and	0
daytime	0
sleepiness	0
may	0
persist	I-DISEASE
if	0
a	I-DISEASE
significant	0
number	0
of	0
central	0
apneas	0
remain	I-DISEASE
.	0

There	0
is	0
the	0
potential	I-DISEASE
for	0
poor	0
adherence	0
and	0
acceptance	I-DISEASE
of	0
PAP	0
treatment	0
as	0
a	0
result	0
of	0
this	0
.	I-DISEASE

Developmental	0
Issues	0
Treatment	0
-	0
emergent	0
sleep	0
apnea	I-DISEASE
has	0
not	I-DISEASE
been	0
described	0
in	0
children	0
but	0
this	0
may	0
be	0
due	I-DISEASE
to	0
the	0
relatively	0
small	0
number	0
of	0
children	I-DISEASE
with	0
OSA	0
who	I-DISEASE
are	0
treated	I-DISEASE
with	0
PAP	0
.	0

Pathology	0
and	0
Pathophysiology	0
Due	0
to	0
variation	I-DISEASE
in	I-DISEASE
definitions	0
of	I-DISEASE
treatment	0
-	0
emergent	0
CSA	0
,	0
the	I-DISEASE
pathophysiology	0
is	0
not	0
clearly	0
defined	I-DISEASE
.	0

A	0
low	0
arousal	0
threshold	0
and	0
difficulty	I-DISEASE
reaching	I-DISEASE
stage	0
N3	0
sleep	0
may	0
pre-	I-DISEASE
dispose	0
to	0
sleep	I-DISEASE
instability	0
.	0

Arousals	0
destabilize	0
breathing	0
.	0

A	0
high	0
ventilatory	0
response	0
to	0
PaCO2	I-DISEASE
and	I-DISEASE
a	0
small	I-DISEASE
difference	0
between	I-DISEASE
the	I-DISEASE
sleeping	0
PaCO2	0
and	I-DISEASE
the	0
apnea	I-DISEASE
threshold	I-DISEASE
may	0
also	I-DISEASE
predispose	I-DISEASE
patients	0
to	I-DISEASE
treatment	I-DISEASE
-	I-DISEASE
emergent	0
central	0
apneas	I-DISEASE
.	B-DISEASE

Treatment	0
with	0
excessive	0
positive	I-DISEASE
airway	I-DISEASE
pressure	0
may	I-DISEASE
trigger	0
treatment	I-DISEASE
-	0
emergent	0
central	0
apneas	0
in	0
susceptible	0
individuals	0
.	I-DISEASE

Objective	0
Findings	0
PSG	0
during	I-DISEASE
a	0
full	I-DISEASE
night	I-DISEASE
diagnostic	0
study	I-DISEASE
(	0
or	I-DISEASE
diagnostic	I-DISEASE
portion	0
of	I-DISEASE
a	I-DISEASE
split	0
-	0
night	I-DISEASE
PSG	0
)	0
shows	0
predominantly	0
obstructive	I-DISEASE
or	I-DISEASE
mixed	I-DISEASE
apneas	I-DISEASE
and	0
hypopneas	I-DISEASE
of	0
five	0
or	0
more	I-DISEASE
per	0
hour	0
of	0
sleep	I-DISEASE
.	0

PSG	0
with	0
PAP	0
(	0
either	0
a	I-DISEASE
full	I-DISEASE
night	0
titration	I-DISEASE
study	0
or	I-DISEASE
PAP	0
treatment	I-DISEASE
portion	0
of	I-DISEASE
a	0
split	0
night	I-DISEASE
study	0
)	0
without	0
a	0
backup	0
rate	I-DISEASE
shows	I-DISEASE
significant	I-DISEASE
resolution	I-DISEASE
of	I-DISEASE
obstructive	0
events	0
and	0
emergence	0
or	0
persistence	0
of	0
central	0
apneas	0
or	I-DISEASE
central	0
hypopneas	I-DISEASE
.	I-DISEASE

The	0
CAHI	0
is	0
five	0
or	0
greater	0
per	I-DISEASE
hour	0
,	I-DISEASE
and	0
more	0
than	0
50	I-DISEASE
%	0
of	I-DISEASE
the	0
respiratory	0
events	I-DISEASE
are	I-DISEASE
central	0
in	0
nature	0
.	0

A	0
diagnosis	0
of	0
treatment	I-DISEASE
-	0
emergent	I-DISEASE
CSA	I-DISEASE
excludes	0
patients	I-DISEASE
who	0
manifest	0
central	I-DISEASE
sleep	I-DISEASE
apnea	0
on	I-DISEASE
PAP	0
treatment	I-DISEASE
when	I-DISEASE
the	I-DISEASE
CSA	0
is	0
better	0
explained	0
by	0
another	I-DISEASE
CSA	I-DISEASE
dis-	I-DISEASE
order	I-DISEASE
or	0
by	I-DISEASE
over	0
-	I-DISEASE
titration	0
.	0

PSG	0
with	0
administration	0
of	0
PAP	I-DISEASE
often	I-DISEASE
reveals	0
adequate	0
treatment	I-DISEASE
during	I-DISEASE
REM	0
sleep	0
and	I-DISEASE
stage	0
N3	I-DISEASE
sleep	I-DISEASE
but	0
repetitive	I-DISEASE
episodes	0
of	0
central	0
events	0
during	0
stages	0
N1	I-DISEASE
and	0
N2	0
.	I-DISEASE

In	0
some	0
patients	0
,	I-DISEASE
progressive	0
increases	I-DISEASE
in	I-DISEASE
pressure	0
with	I-DISEASE
a	0
goal	0
of	0
preventing	I-DISEASE
airflow	0
limitation	0
reach	I-DISEASE
a	0
“	I-DISEASE
break	0
point	0
”	0
at	0
which	0
central	I-DISEASE
apneas	I-DISEASE
appear	0
.	0

Differential	0
Diagnosis	0
Many	0
patients	0
with	0
OSA	I-DISEASE
have	I-DISEASE
a	I-DISEASE
few	I-DISEASE
central	0
events	0
while	0
on	0
PAP	0
.	0

However	0
,	I-DISEASE
in	0
the	0
majority	I-DISEASE
of	I-DISEASE
cases	I-DISEASE
,	I-DISEASE
the	I-DISEASE
central	I-DISEASE
AHI	0
is	0
not	0
≥	0
5	I-DISEASE
/	I-DISEASE
hour	0
and	I-DISEASE
central	0
events	0
are	0
not	0
≥	0
50	0
%	I-DISEASE
of	0
the	0
total	0
number	0
of	I-DISEASE
apneas	I-DISEASE
and	I-DISEASE
hypopneas	0
.	0

Other	0
patients	0
with	I-DISEASE
OSA	0
,	0
while	I-DISEASE
on	I-DISEASE
PAP	0
,	I-DISEASE
exhibit	0
predominantly	0
central	0
events	0
that	0
are	0
believed	0
to	I-DISEASE
be	I-DISEASE
secondary	0
to	0
a	0
CSA	0
disor-	0
der	0
classified	I-DISEASE
elsewhere	I-DISEASE
.	0

In	0
this	0
case	0
,	0
a	0
diagnosis	I-DISEASE
of	I-DISEASE
both	0
OSA	0
and	0
the	0
CSA	0
disorder	I-DISEASE
is	0
appropriate	I-DISEASE
,	0
rather	0
than	0
a	0
diagnosis	0
of	0
treatment	0
-	0
emergent	0
CSA	0
.	I-DISEASE

For	0
example	0
,	0
a	0
patient	0
taking	I-DISEASE
methadone	I-DISEASE
has	0
predominantly	I-DISEASE
obstructive	0
events	0
during	0
the	0
diagnostic	0
portion	0
of	I-DISEASE
a	0
split	I-DISEASE
-	I-DISEASE
night	0
PSG	0
.	0

Once	0
obstructive	0
events	0
are	0
eliminated	0
on	I-DISEASE
PAP	I-DISEASE
,	0
CSA	0
with	0
ataxic	0
breathing	0
is	0
noted	0
.	I-DISEASE

A	0
diagnosis	0
of	0
both	I-DISEASE
OSA	0
and	0
CSA	I-DISEASE
due	I-DISEASE
to	I-DISEASE
a	0
medication	0
or	0
substance	0
should	0
be	I-DISEASE
made	0
if	0
criteria	I-DISEASE
for	0
that	0
disorder	0
are	0
met	I-DISEASE
.	I-DISEASE

Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

The	0
true	0
incidence	I-DISEASE
of	0
treatment	0
-	0
emergent	I-DISEASE
sleep	0
apnea	I-DISEASE
as	0
well	0
as	I-DISEASE
the	0
percentage	0
of	0
patients	0
who	I-DISEASE
have	I-DISEASE
persistent	0
central	I-DISEASE
apnea	0
on	0
chronic	0
PAP	0
treatment	I-DISEASE
remains	I-DISEASE
to	0
be	I-DISEASE
defined	0
.	0

Further	0
prospective	0
studies	0
with	0
clearly	0
defined	0
inclusion	B-DISEASE
and	0
exclusion	I-DISEASE
crite-	0
ria	I-DISEASE
are	0
needed	I-DISEASE
to	0
better	0
define	0
the	0
exact	I-DISEASE
percentage	0
of	I-DISEASE
patients	0
with	0
treatment	0
-	0
emergent	I-DISEASE
CSA	0
who	0
have	I-DISEASE
persistent	0
CSA	0
after	I-DISEASE
chronic	I-DISEASE
PAP	0
treatment	0
.	0

There	0
may	0
be	0
night	0
-	0
to-	0
night	0
variability	0
in	I-DISEASE
the	0
amount	0
of	0
CSA	I-DISEASE
displayed	0
by	I-DISEASE
a	I-DISEASE
given	0
patient	I-DISEASE
.	0

It	0
is	0
unknown	0
,	I-DISEASE
for	0
example	0
,	0
whether	0
treatment	0
-	0
emergent	0
central	0
apneas	0
that	0
resolve	I-DISEASE
on	I-DISEASE
chronic	0
PAP	I-DISEASE
treatment	0
will	I-DISEASE
re	0
-	0
emerge	0
if	0
the	0
patient	I-DISEASE
discontinues	0
PAP	I-DISEASE
treatment	0
for	0
a	I-DISEASE
period	I-DISEASE
of	0
time	0
and	0
then	0
restarts	0
treatment	0
.	0

A	0
number	0
of	0
factors	I-DISEASE
have	0
been	0
hypothesized	I-DISEASE
to	I-DISEASE
increase	0
the	0
likelihood	0
of	0
treatment	0
-	0
emergent	I-DISEASE
central	0
apneas	0
including	I-DISEASE
overtitration	0
(	0
excessive	0
pressure	0
)	0
,	I-DISEASE
undertitration	0
(	I-DISEASE
respiratory	0
effort	I-DISEASE
arousals	0
followed	0
by	0
central	I-DISEASE
apnea	0
)	0
,	0
the	I-DISEASE
use	0
of	0
bilevel	I-DISEASE
PAP	0
rather	B-DISEASE
than	I-DISEASE
CPAP	0
,	0
arousals	0
from	B-DISEASE
mask	I-DISEASE
leak	I-DISEASE
,	0
and	I-DISEASE
use	0
of	I-DISEASE
a	I-DISEASE
split	I-DISEASE
night	0
study	I-DISEASE
.	0

Further	0
study	0
is	I-DISEASE
needed	0
to	0
verify	0
that	I-DISEASE
these	0
factors	0
do	0
indeed	0
predispose	0
a	0
patient	0
to	I-DISEASE
develop	0
treatment	0
-	I-DISEASE
emergent	0
central	0
apneas	0
.	0

The	0
evolution	0
of	0
treatment	0
-	0
emergent	0
central	I-DISEASE
apneas	0
on	0
chronic	0
PAP	I-DISEASE
treatment	0
also	0
remains	0
to	0
be	0
determined	0
;	0
that	0
is	I-DISEASE
,	0
to	0
what	0
extent	0
do	I-DISEASE
central	0
events	0
resolve	I-DISEASE
over	I-DISEASE
time	0
and	0
what	0
is	0
the	0
time	0
course	0
of	0
this	I-DISEASE
resolu-	0
tion	I-DISEASE
?	0

In	0
light	0
of	I-DISEASE
the	0
increasing	I-DISEASE
utilization	I-DISEASE
of	0
auto	0
-	I-DISEASE
titrating	0
PAP	0
,	0
further	0
investigation	0
of	0
the	0
incidence	0
of	I-DISEASE
treatment	0
-	0
emergent	0
CSA	0
with	0
this	0
modality	0
is	0
indicated	0
.	I-DISEASE

Bibliography	0
Allam	0
JS	0
,	0
Olson	0
EJ	0
,	0
Gay	0
PC	I-DISEASE
,	0
Morgenthaler	0
TI	0
.	0

Efficacy	0
of	0
adaptive	0
servoventilation	0
in	0
treatment	I-DISEASE
of	0
complex	0
and	0
central	0
sleep	0
apnea	0
syndromes	0
.	0

Chest	0
2007;132:1839–46	0
.	0

Dernaika	0
T	0
,	0
Tawk	0
M	0
,	0
Nazir	0
S	0
,	0
Younis	0
W	0
,	0
Kinasewitz	0
GT	0
.	I-DISEASE

The	0
significance	0
and	0
outcome	0
of	0
continuous	I-DISEASE
positive	I-DISEASE
airway	I-DISEASE
pressure	0
-	I-DISEASE
related	0
central	0
sleep	I-DISEASE
apnea	0
during	I-DISEASE
split	0
-	I-DISEASE
night	0
sleep	0
studies	0
.	0

Chest	0
2007;132:81–7	0
.	0

Gay	0
PC	0
.	0

Complex	0
sleep	0
apnea	0
:	0
it	I-DISEASE
really	0
is	I-DISEASE
a	0
disease	I-DISEASE
.	0

J	0
Clin	0
Sleep	I-DISEASE
Med	0
2008;4:403–5	0
.	I-DISEASE

Gilmartin	0
GS	0
,	0
Daly	0
RW	0
,	0
Thomas	I-DISEASE
RJ	0
.	0

Recognition	0
and	0
management	0
of	0
complex	0
sleep	I-DISEASE
-	0
disordered	0
breathing	I-DISEASE
.	0

Curr	0
Opin	I-DISEASE
Pulm	0
Med	0
2005;11:485–93	0
.	0

Javaheri	0
S	I-DISEASE
,	0
Smith	0
J	0
,	0
Chung	I-DISEASE
E.	0

The	0
prevalence	0
and	I-DISEASE
natural	0
history	0
of	0
complex	I-DISEASE
sleep	0
apnea	I-DISEASE
.	0

J	0
Clin	0
Sleep	I-DISEASE
Med	0
2009;5:205–11	0
.	I-DISEASE

Lehman	0
S	I-DISEASE
,	0
Antic	0
NA	0
,	I-DISEASE
Thompson	I-DISEASE
C	0
,	I-DISEASE
Catcheside	0
PG	0
,	I-DISEASE
Mercer	0
J	0
,	0
McEvoy	0
RD	0
.	I-DISEASE

Central	0
sleep	0
apnea	I-DISEASE
on	0
commencement	I-DISEASE
of	0
continuous	0
positive	0
airway	I-DISEASE
pressure	I-DISEASE
in	I-DISEASE
patients	0
with	I-DISEASE
a	0
primary	0
diagnosis	I-DISEASE
of	0
obstructive	I-DISEASE
sleep	0
apnea	0
-	0
hypopnea	0
.	0

J	0
Clin	0
Sleep	I-DISEASE
Med	0
2007;3:462–6	0
.	I-DISEASE

Malhotra	0
A	0
,	0
Bertisch	0
S	0
,	0
Wellman	0
A.	0
Complex	I-DISEASE
sleep	0
apnea	0
:	0
it	0
is	0
n’t	I-DISEASE
really	I-DISEASE
a	0
disease	I-DISEASE
.	0

J	0
Clin	0
Sleep	0
Med	0
2008;4:406–8	0
.	I-DISEASE

Morgenthaler	0
TI	0
,	0
Kagramanov	0
V	0
,	I-DISEASE
Hanak	I-DISEASE
V	0
,	0
et	0
al	I-DISEASE
.	0

Complex	0
sleep	0
apnea	I-DISEASE
syndrome	I-DISEASE
:	I-DISEASE
is	0
it	I-DISEASE
a	0
unique	I-DISEASE
clinical	0
syndrome	0
?	0

Sleep	0
2006;29:1203–9	0
.	0

Thomas	0
RJ	B-DISEASE
,	0
Daly	0
RW	0
,	0
Weiss	0
JW	0
.	I-DISEASE

Low	0
-	0
concentration	0
carbon	0
dioxide	0
is	I-DISEASE
an	I-DISEASE
effective	0
adjunct	0
to	0
positive	0
airway	0
pressure	I-DISEASE
in	0
the	I-DISEASE
treatment	I-DISEASE
of	0
refractory	I-DISEASE
mixed	0
central	0
and	0
obstructive	0
sleep	0
-	0
disordered	I-DISEASE
breathing	0
.	0

Sleep	0
2005;28:69–77	0
.	0

Thomas	0
RJ	0
,	0
Mietus	0
JE	0
,	0
Peng	0
CK	0
,	I-DISEASE
et	0
al	0
.	0

Differentiating	0
obstructive	0
from	0
central	0
and	0
complex	0
sleep	I-DISEASE
apnea	0
using	0
an	0
automated	0
electrocardiogram	I-DISEASE
-	0
based	I-DISEASE
method	0
.	0

Sleep	0
2007;30:1756–69	0
.	0

Thomas	0
RJ	0
,	0
Terzano	0
MG	0
,	0
Parrino	0
L	I-DISEASE
,	0
Weiss	0
JW	0
.	0

Obstructive	0
sleep	0
-	0
disordered	0
breathing	0
with	I-DISEASE
a	I-DISEASE
dominant	0
cyclic	I-DISEASE
alternating	0
pattern	0
--	0
a	0
recognizable	0
polysomnographic	I-DISEASE
variant	I-DISEASE
with	0
practical	I-DISEASE
clinical	0
implications	0
.	0

Sleep	0
2004;27:229–34	0
.	0

Westhoff	0
M	0
,	0
Arzt	0
M	0
,	I-DISEASE
Litterst	0
P.	0
Prevalence	I-DISEASE
and	0
treatment	0
of	0
central	0
sleep	0
apnoea	0
emerging	I-DISEASE
after	I-DISEASE
initiation	I-DISEASE
of	0
continuous	I-DISEASE
positive	0
airway	I-DISEASE
pressure	0
in	I-DISEASE
patients	I-DISEASE
with	0
obstructive	0
sleep	I-DISEASE
apnoea	0
without	I-DISEASE
evidence	I-DISEASE
of	I-DISEASE
heart	0
failure	0
.	0

Sleep	0
Breath	0
2012;16:71–8	0
.	0

Sleep	0
Related	0
Breathing	I-DISEASE
Disorders	0
Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Sleep	I-DISEASE
Related	0
Hypoventilation	0
Disorders	I-DISEASE
The	0
primary	0
feature	I-DISEASE
of	I-DISEASE
these	0
disorders	I-DISEASE
is	0
insufficient	0
sleep	0
related	0
ventilation	0
,	0
result-	I-DISEASE
ing	0
in	0
abnormally	0
elevated	0
arterial	0
partial	0
pressure	0
of	0
carbon	0
dioxide	0
(	0
PaCO2	0
)	0
during	I-DISEASE
sleep	I-DISEASE
.	0

In	0
addition	0
,	0
demonstration	0
of	0
daytime	I-DISEASE
hypoventilation	0
is	0
required	0
for	0
a	0
diagno-	0
sis	0
of	0
obesity	0
hypoventilation	0
syndrome	0
(	I-DISEASE
OHS	0
)	0
.	0

Awake	0
hypoventilation	0
is	0
defined	0
as	0
an	0
arterial	I-DISEASE
partial	0
pressure	I-DISEASE
of	0
carbon	0
dioxide	0
(	0
PaCO2	0
)	I-DISEASE
greater	I-DISEASE
than	0
45	I-DISEASE
mm	0
Hg	0
.	0

In	0
the	0
sleep	I-DISEASE
related	I-DISEASE
hypoventilation	I-DISEASE
disorders	0
other	0
than	0
OHS	0
,	0
daytime	0
hypoventilation	0
may	0
or	0
may	0
not	0
be	0
present	I-DISEASE
.	0

If	0
hypoventilation	0
is	0
present	0
during	0
wakefulness	0
,	0
it	0
worsens	0
during	0
sleep	0
in	0
all	0
of	0
these	0
disorders	I-DISEASE
.	0

General	0
Criteria	0
Sleep	I-DISEASE
Related	0
Hypoventilation	0
Criterion	I-DISEASE
A	I-DISEASE
must	0
be	0
met	0
A.	0
Sleep	0
related	0
hypoventilation	I-DISEASE
,	I-DISEASE
as	0
defined	0
by	0
the	0
most	0
recent	0
version	0
of	0
the	I-DISEASE
AASM	I-DISEASE
Manual	0
for	0
the	0
Scoring	0
of	0
Sleep	0
and	0
Associated	0
Events	0
,	0
is	0
present.1,2	0
Notes	I-DISEASE
.	I-DISEASE

Monitoring	0
of	0
arterial	0
PCO2	0
during	0
sleep	I-DISEASE
is	I-DISEASE
not	0
practical	I-DISEASE
.	0

Acceptable	0
surrogates	0
include	0
end	0
-	0
tidal	0
PCO2	I-DISEASE
or	0
transcutaneous	I-DISEASE
PCO2	0
.	0
.	0

Arterial	0
oxygen	0
desaturation	0
is	0
often	0
present	I-DISEASE
but	0
is	0
not	I-DISEASE
required	0
for	0
the	0
diagnosis	I-DISEASE
.	0

Obesity	0
Hypoventilation	0
Syndrome	0
ICD-9	0
-	0
CM	0
code	0
:	0
278.03	I-DISEASE
ICD-10	0
-	0
CM	0
code	0
:	0
E66.2	I-DISEASE
Alternate	0
Names	I-DISEASE
Hypercapnic	I-DISEASE
sleep	0
apnea	0
,	0
sleep	0
related	0
hypoventilation	0
associated	0
with	0
obesity	0
.	I-DISEASE

Use	0
of	0
the	0
term	I-DISEASE
Pickwickian	0
syndrome	0
is	I-DISEASE
discouraged	0
because	I-DISEASE
not	0
only	0
has	0
it	I-DISEASE
been	0
applied	0
to	0
those	0
with	I-DISEASE
OSA	0
,	0
but	0
also	0
indiscriminately	0
used	0
to	0
describe	0
persons	0
who	0
are	0
only	I-DISEASE
obese	0
and	0
those	0
with	0
OHS	0
.	0

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
C	I-DISEASE
must	I-DISEASE
be	0
met	I-DISEASE
A.	0
Presence	0
of	0
hypoventilation	I-DISEASE
during	I-DISEASE
wakefulness	0
(	I-DISEASE
PaCO2	0
>	I-DISEASE
45	0
mm	0
Hg	0
)	0
as	0
measured	I-DISEASE
by	0
arterial	0
PCO2	0
,	I-DISEASE
end	0
-	I-DISEASE
tidal	0
PCO2	I-DISEASE
,	0
or	0
transcutaneous	I-DISEASE
PCO2	0
.	0

B.	0
Presence	0
of	0
obesity	I-DISEASE
(	0
BMI	0
>	I-DISEASE
30	0
kg	I-DISEASE
/	0
m2	0
;	0
>	0
95th	0
percentile	0
for	0
age	0
and	I-DISEASE
sex	0
for	0
children	0
)	0
.	0

C.	0
Hypoventilation	I-DISEASE
is	0
not	0
primarily	0
due	I-DISEASE
to	I-DISEASE
lung	0
parenchymal	I-DISEASE
or	I-DISEASE
airway	0
disease	0
,	0
pulmonary	0
vascular	I-DISEASE
pathology	0
,	0
chest	0
wall	0
disorder	0
(	0
other	0
than	0
mass	I-DISEASE
loading	0
from	0
obesity	0
)	I-DISEASE
,	0
medication	0
use	I-DISEASE
,	I-DISEASE
neurologic	0
disorder	0
,	0
muscle	0
weakness	0
,	I-DISEASE
or	I-DISEASE
a	I-DISEASE
known	I-DISEASE
congenital	0
or	0
idiopathic	0
central	0
alveolar	0
hypoventilation	0
syndrome	0
.	I-DISEASE

Notes	0
.	0

PSG	0
shows	0
worsening	0
of	0
hypoventilation	0
during	0
sleep	I-DISEASE
if	0
PaCO2	0
or	0
noninvasive	0
estimate	0
of	I-DISEASE
the	0
PaCO2	0
is	0
measured	0
.	I-DISEASE
.	0

OSA	0
is	0
often	0
present	0
and	0
,	I-DISEASE
in	I-DISEASE
such	0
cases	0
,	0
a	0
diagnosis	0
of	0
both	0
OSA	I-DISEASE
and	0
OHS	0
should	I-DISEASE
be	0
made	0
.	0
.	0

Arterial	0
oxygen	0
desaturation	0
is	0
usually	0
present	I-DISEASE
but	0
is	0
not	I-DISEASE
required	0
for	0
the	0
diagnosis	I-DISEASE
.	0

Essential	0
Features	0
OHS	0
is	0
characterized	0
by	0
obesity	I-DISEASE
and	0
daytime	I-DISEASE
hypercapnia	0
(	0
arterial	0
PaCO2	I-DISEASE
>	0
45	0
mm	I-DISEASE
Hg	0
)	I-DISEASE
that	I-DISEASE
can	0
not	0
be	I-DISEASE
fully	0
attributed	0
to	I-DISEASE
an	0
underlying	0
cardiopulmonary	I-DISEASE
or	I-DISEASE
neurologic	0
disease	I-DISEASE
.	I-DISEASE

Hypercapnia	0
worsens	0
during	0
sleep	0
and	0
is	0
often	I-DISEASE
associated	0
with	I-DISEASE
severe	0
arterial	0
oxygen	0
desaturation	0
.	0

Hypoventilation	0
is	0
often	0
worse	0
during	0
REM	0
than	0
during	0
NREM	0
sleep	0
.	0

The	0
majority	0
of	0
OHS	0
patients	0
have	0
comorbid	I-DISEASE
OSA	0
(	0
80	0
%	0
to	0
90	0
%	0
)	0
.	0

In	0
these	0
patients	0
,	I-DISEASE
daytime	0
hypercapnia	0
may	I-DISEASE
improve	0
or	0
even	0
normalize	0
with	0
adequate	0
PAP	0
treatment	I-DISEASE
and	I-DISEASE
sustained	0
adherence	I-DISEASE
to	0
treatment	0
.	0

Those	0
OHS	0
patients	0
without	0
OSA	0
exhibit	I-DISEASE
sustained	I-DISEASE
or	0
intermittent	I-DISEASE
episodes	0
of	0
shallow	0
breathing	0
during	0
sleep	I-DISEASE
associated	0
with	0
worsening	I-DISEASE
hypoventilation	0
and	0
hypoxemia	0
.	0

Patients	0
with	0
OHS	B-DISEASE
may	0
have	0
few	0
,	B-DISEASE
if	0
any	I-DISEASE
,	0
sleep	0
com-	0
plaints	0
,	I-DISEASE
or	0
may	I-DISEASE
present	0
with	I-DISEASE
considerable	0
sleep	0
disturbance	0
including	0
reduced	0
sleep	I-DISEASE
efficiency	I-DISEASE
and	0
frequent	0
awakenings	I-DISEASE
.	I-DISEASE

Hypercapnia	0
and	0
hypoxemia	0
may	0
remain	0
unno-	I-DISEASE
ticed	I-DISEASE
for	0
quite	I-DISEASE
some	0
time	0
until	0
sudden	0
deterioration	0
with	I-DISEASE
cardiopulmonary	0
arrest	0
or	0
severe	0
decompensation	I-DISEASE
(	0
acute	0
or	I-DISEASE
chronic	0
hypercapnic	I-DISEASE
respiratory	I-DISEASE
failure	0
)	I-DISEASE
develops	0
.	0

Associated	0
Features	0
Patients	0
with	0
OHS	B-DISEASE
commonly	0
complain	0
of	0
hypersomnolence	0
.	0

The	0
severity	0
of	0
hyper-	0
somnolence	0
may	0
not	I-DISEASE
correlate	0
closely	0
with	0
degree	0
of	0
hypercapnia	0
.	I-DISEASE

Other	0
symptoms	0
include	0
morning	I-DISEASE
headaches	I-DISEASE
,	I-DISEASE
fatigue	I-DISEASE
,	0
mood	0
disturbance	0
and	0
impairments	0
of	0
memory	0
or	0
concentration	0
.	0

Physical	0
examination	0
may	0
reveal	B-DISEASE
features	0
suggestive	0
of	I-DISEASE
cor	I-DISEASE
pul-	I-DISEASE
monale	0
or	0
circulatory	0
congestion	0
,	0
such	I-DISEASE
as	0
plethora	0
,	I-DISEASE
scleral	0
injection	0
,	0
and	0
peripheral	0
edema	0
.	I-DISEASE

Laboratory	0
testing	0
commonly	0
shows	0
polycythemia	0
and	I-DISEASE
elevated	I-DISEASE
serum	0
CO2	I-DISEASE
on	0
electrolyte	I-DISEASE
testing	0
(	0
≈	0
serum	I-DISEASE
bicarbonate	0
)	I-DISEASE
,	I-DISEASE
reduced	0
forced	0
vital	0
capacity	0
during	0
pulmo-	0
nary	I-DISEASE
function	0
testing	0
,	I-DISEASE
right	0
heart	I-DISEASE
strain	0
,	0
right	0
ventricular	0
hypertrophy	0
and	0
right	0
atrial	I-DISEASE
enlargement	0
on	I-DISEASE
electrocardiography	I-DISEASE
and	0
ventricular	0
dysfunction	0
on	I-DISEASE
echocardiography	I-DISEASE
.	I-DISEASE

Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Sleep	I-DISEASE
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Consequences	I-DISEASE
of	0
chronic	0
hypercapnia	I-DISEASE
and	0
hypoxemia	I-DISEASE
include	I-DISEASE
pulmonary	I-DISEASE
artery	0
hyper-	I-DISEASE
tension	0
,	0
cor	0
pulmonale	0
,	0
and	I-DISEASE
neurocognitive	0
dysfunction	I-DISEASE
.	0

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Not	I-DISEASE
applicable	I-DISEASE
or	I-DISEASE
known	I-DISEASE
.	I-DISEASE

Demographics	0
OHS	0
may	0
be	0
underdiagnosed	0
if	0
CO2	I-DISEASE
analysis	0
(	I-DISEASE
≈	0
serum	0
bicarbonate	0
)	0
is	0
not	0
performed	I-DISEASE
in	I-DISEASE
obese	I-DISEASE
patients	0
presenting	0
with	0
complaints	0
suggestive	0
of	0
OHS	I-DISEASE
.	0

The	0
prevalence	0
of	I-DISEASE
OHS	0
in	0
populations	0
of	0
patients	I-DISEASE
with	I-DISEASE
OSA	I-DISEASE
varies	0
across	0
studies	0
but	0
is	I-DISEASE
often	0
in	0
the	I-DISEASE
range	0
of	0
10	0
%	0
to	0
15	0
%	0
of	0
obese	I-DISEASE
patients	0
with	0
OSA	0
.	0

Although	0
the	0
prevalence	I-DISEASE
of	I-DISEASE
OHS	0
is	0
higher	I-DISEASE
in	0
men	I-DISEASE
than	0
women	0
the	0
difference	0
is	0
not	0
as	I-DISEASE
prominent	I-DISEASE
as	0
in	0
OSA	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
Obesity	0
is	I-DISEASE
believed	I-DISEASE
to	0
be	I-DISEASE
the	0
primary	0
pathophysiologic	0
factor	0
responsible	0
for	I-DISEASE
hypoven-	0
tilation	0
and	I-DISEASE
hypoxemia	I-DISEASE
.	0

Greater	0
degrees	0
of	0
obesity	0
are	0
often	0
associated	I-DISEASE
with	0
worse	I-DISEASE
sleep	0
related	0
hypoventilation	I-DISEASE
,	I-DISEASE
but	0
individual	0
variations	0
in	0
the	I-DISEASE
severity	0
of	0
hypercap-	0
nia	0
at	0
similar	I-DISEASE
weights	I-DISEASE
may	0
be	0
seen	0
.	0

The	0
use	0
of	0
central	I-DISEASE
nervous	0
system	0
depressants	I-DISEASE
,	I-DISEASE
such	I-DISEASE
as	0
alcohol	0
,	0
anxiolytics	0
,	0
and	I-DISEASE
hypnotics	I-DISEASE
,	0
may	I-DISEASE
further	0
worsen	0
respiratory	0
impair-	0
ment	0
.	I-DISEASE

Patients	0
who	0
are	B-DISEASE
hypercapnic	0
and	0
hypoxemic	0
during	0
wakefulness	0
will	I-DISEASE
invari-	0
ably	0
become	0
even	I-DISEASE
more	0
so	0
during	I-DISEASE
sleep	I-DISEASE
,	I-DISEASE
in	I-DISEASE
particular	0
REM	0
sleep	0
,	I-DISEASE
but	0
the	I-DISEASE
relationship	0
between	I-DISEASE
wake	0
SaO2	0
/	0
PaCO2	I-DISEASE
and	0
sleep	0
related	0
desaturation	0
is	0
not	I-DISEASE
sufficiently	I-DISEASE
strong	0
to	I-DISEASE
have	0
substantial	0
predictive	I-DISEASE
value	0
in	0
individual	I-DISEASE
patients	I-DISEASE
.	I-DISEASE

Familial	0
Patterns	0
Not	0
applicable	0
or	0
known	0
.	I-DISEASE

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Persons	I-DISEASE
who	0
are	I-DISEASE
eventually	0
diagnosed	I-DISEASE
with	0
OHS	0
either	0
present	I-DISEASE
initially	0
for	0
evalu-	0
ation	0
of	0
suspected	0
OSA	0
or	0
are	0
identified	I-DISEASE
following	0
one	0
or	I-DISEASE
more	0
episodes	I-DISEASE
of	0
severe	0
hypercapnic	0
respiratory	0
failure	0
.	0

The	0
course	0
can	0
be	0
variable	0
but	I-DISEASE
is	0
generally	0
slowly	I-DISEASE
pro-	0
gressive	0
.	0

Many	0
affected	0
individuals	0
with	0
severe	0
hypercapnia	I-DISEASE
and	I-DISEASE
hypoxemia	0
develop	0
pulmonary	0
hypertension	0
,	0
heart	0
failure	I-DISEASE
,	I-DISEASE
cardiac	0
arrhythmias	I-DISEASE
,	I-DISEASE
and	0
neurocognitive	I-DISEASE
dys-	0
function	0
.	0

Polycythemia	0
is	0
common	0
in	0
those	0
with	0
chronic	I-DISEASE
hypoxia	0
.	0

Although	0
the	0
risk	I-DISEASE
of	0
increased	0
morbidity	I-DISEASE
and	I-DISEASE
mortality	0
appears	I-DISEASE
to	0
increase	0
with	I-DISEASE
worsening	0
sleep	0
related	0
hypoventilation	0
/	0
hypoxemia	I-DISEASE
,	I-DISEASE
the	I-DISEASE
specific	0
relationship	0
between	0
sleep	0
related	I-DISEASE
hypoventi-	0
lation	0
/	0
hypoxemia	I-DISEASE
and	0
morbidity	0
and	I-DISEASE
mortality	0
is	0
not	0
well	I-DISEASE
defined	I-DISEASE
.	I-DISEASE

Obesity	0
,	0
itself	0
,	0
can	0
lead	0
to	I-DISEASE
other	0
respiratory	I-DISEASE
complaints	0
,	0
including	I-DISEASE
shortness	0
of	0
breath	I-DISEASE
,	0
dyspnea	0
on	I-DISEASE
exer-	0
tion	0
and	0
orthopnea	I-DISEASE
,	0
even	0
in	0
the	0
absence	0
of	I-DISEASE
demonstrable	0
elevation	I-DISEASE
of	0
daytime	0
PaCO2	0
.	0

However	0
,	I-DISEASE
in	0
one	0
study	0
of	I-DISEASE
inpatients	I-DISEASE
with	0
obesity	I-DISEASE
,	0
those	0
with	0
hypoventilation	0
had	0
an	0
18	0
-	0
month	0
mortality	0
of	0
23	0
%	0
compared	0
with	I-DISEASE
9	I-DISEASE
%	0
in	I-DISEASE
the	I-DISEASE
group	0
with	0
equivalent	0
obesity	0
but	0
no	0
hypoventilation	0
.	I-DISEASE

Many	0
patients	0
with	I-DISEASE
OHS	0
respond	0
to	0
CPAP	I-DISEASE
or	0
bilevel	I-DISEASE
PAP	0
with	0
improvement	0
in	0
daytime	0
PaCO2	0
.	0

However	0
,	I-DISEASE
normalization	0
of	0
daytime	0
PaCO2	I-DISEASE
occurs	0
in	0
only	I-DISEASE
a	I-DISEASE
minority	0
of	0
patients	0
.	0

In	0
one	0
study	0
,	I-DISEASE
34	0
%	0
of	0
OHS	0
patients	0
using	0
PAP	I-DISEASE
more	0
than	0
4.5	0
hours	0
per	0
night	0
had	0
normalization	0
of	I-DISEASE
the	0
PaCO2	0
.	0

In	0
contrast	0
hypercapnia	0
may	I-DISEASE
worsen	0
with	0
oxygen	I-DISEASE
therapy	0
alone	I-DISEASE
for	0
the	0
associated	0
hypoxia	0
.	0

Developmental	0
Issues	0
Not	0
known	0
.	0

Pathology	0
and	0
Pathophysiology	0
The	0
etiology	0
of	I-DISEASE
hypoventilation	I-DISEASE
is	0
not	I-DISEASE
completely	0
understood	0
.	0

Although	0
comorbid	0
OSA	0
is	0
common	0
,	0
hypercapnia	I-DISEASE
and	0
hypoxemia	0
are	0
not	0
entirely	0
a	0
function	0
of	I-DISEASE
upper	I-DISEASE
airway	0
obstruction	I-DISEASE
.	0

The	0
importance	0
of	0
various	0
factors	0
leading	0
to	I-DISEASE
hypoventilation	0
likely	I-DISEASE
varies	0
among	0
patients	0
.	0

It	0
has	0
been	0
postulated	0
that	0
sustained	I-DISEASE
nocturnal	I-DISEASE
hypercapnia	0
results	I-DISEASE
from	0
the	0
development	0
of	0
short	0
(	0
due	0
to	I-DISEASE
apnea	I-DISEASE
-	0
hypopnea	0
)	0
or	0
longer	0
(	I-DISEASE
secondary	I-DISEASE
to	0
hypoven-	0
tilation	I-DISEASE
)	0
periods	0
of	0
hypercapnia	I-DISEASE
accompanied	0
by	0
inadequate	0
compensation	0
(	0
i.e.	I-DISEASE
,	0
CO2	0
unloading	I-DISEASE
)	I-DISEASE
during	0
periods	0
of	I-DISEASE
ventilation	0
between	I-DISEASE
obstructive	I-DISEASE
events	0
.	0

Abnormal	0
venti-	0
latory	0
control	I-DISEASE
(	0
blunted	0
hypercapnic	I-DISEASE
ventilatory	0
response	0
)	0
allows	0
hypercapnia	0
to	0
persist	0
into	I-DISEASE
wakefulness	0
after	0
the	0
cause	0
of	0
acute	0
hypercapnia	0
is	0
no	0
longer	I-DISEASE
present	0
.	0

A	0
chronic	0
hypercapnic	0
state	I-DISEASE
would	0
produce	0
an	0
elevation	0
of	0
bicarbonate	0
.	0

Although	0
this	0
blunts	0
the	I-DISEASE
degree	0
of	I-DISEASE
acidosis	I-DISEASE
due	0
to	I-DISEASE
an	0
elevated	0
PaCO2	0
,	0
it	0
reduces	I-DISEASE
the	I-DISEASE
compensatory	I-DISEASE
CO2	I-DISEASE
ventilatory	0
response	0
.	0

Impaired	0
renal	0
bicarbonate	0
excretion	0
rate	0
,	0
as	I-DISEASE
seen	0
in	0
hypoxia	0
,	0
heart	0
failure	I-DISEASE
,	0
or	I-DISEASE
diuretic	0
-	0
related	0
chloride	0
deficiency	0
,	0
may	0
contribute	0
to	0
the	I-DISEASE
persistence	0
of	0
hypercapnia	0
.	0

Obesity	0
itself	0
is	0
also	0
associated	0
with	0
several	0
factors	0
that	I-DISEASE
predispose	0
to	0
CO2	0
retention	0
.	0

Obesity	0
itself	0
increases	0
CO2	0
production	0
.	0

There	0
is	0
an	0
increased	I-DISEASE
work	0
of	I-DISEASE
breathing	I-DISEASE
due	0
to	0
mass	0
loading	0
from	0
the	0
additional	I-DISEASE
weight	I-DISEASE
on	I-DISEASE
the	0
respiratory	I-DISEASE
pump	0
as	0
well	0
as	0
resistive	0
loading	0
due	I-DISEASE
to	0
intermittent	0
upper	I-DISEASE
airway	0
obstruction	0
during	0
sleep	I-DISEASE
.	0

Numerous	0
factors	0
impair	0
CO2	I-DISEASE
elimination	0
including	0
altered	I-DISEASE
lung	0
volumes	I-DISEASE
and	I-DISEASE
mechan-	0
ics	0
,	I-DISEASE
ventilation	0
-	0
perfusion	I-DISEASE
abnormalities	0
secondary	I-DISEASE
to	0
atelectasis	0
or	0
pulmonary	0
conges-	0
tion	0
,	0
reduced	0
chemosensitivity	0
and	B-DISEASE
load	0
responsiveness	I-DISEASE
,	0
and	I-DISEASE
suppression	0
of	0
respiratory	0
drive	0
due	0
to	I-DISEASE
obesity	I-DISEASE
-	0
related	0
humoral	I-DISEASE
factors	I-DISEASE
,	0
such	I-DISEASE
as	I-DISEASE
resistance	I-DISEASE
to	I-DISEASE
the	0
elevated	I-DISEASE
leptin	I-DISEASE
levels	0
that	I-DISEASE
occur	I-DISEASE
in	0
patients	I-DISEASE
with	0
the	0
OHS	0
(	I-DISEASE
leptin	I-DISEASE
is	I-DISEASE
a	I-DISEASE
respiratory	I-DISEASE
stimulant	0
)	I-DISEASE
.	0

The	0
impor-	0
tance	I-DISEASE
of	0
these	0
factors	B-DISEASE
likely	I-DISEASE
varies	0
from	0
patient	0
to	0
patient	0
.	0

Objective	0
Findings	0
Arterial	0
blood	I-DISEASE
gas	0
testing	I-DISEASE
during	0
wakefulness	0
shows	I-DISEASE
hypercapnia	0
and	0
often	0
hypoxemia	I-DISEASE
in	0
untreated	0
patients	I-DISEASE
.	0

Even	0
with	0
effective	0
treatment	0
most	0
OHS	0
patients	0
continue	0
to	I-DISEASE
Sleep	0
Related	0
Breathing	I-DISEASE
Disorders	I-DISEASE
Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
exhibit	I-DISEASE
some	0
degree	0
of	0
daytime	0
hypoventilation	0
.	I-DISEASE

The	0
characteristic	0
polysomnographic	0
finding	0
is	0
sleep	0
related	0
hypoventilation	0
and	I-DISEASE
arterial	0
oxygen	0
desaturation	I-DISEASE
during	I-DISEASE
sleep	0
with	0
or	I-DISEASE
without	0
obstructive	I-DISEASE
apneas	0
and	I-DISEASE
hypopneas	I-DISEASE
.	0

Worsening	0
hypoventilation	I-DISEASE
during	0
sleep	0
can	0
be	0
documented	I-DISEASE
by	0
an	I-DISEASE
arterial	0
blood	0
gas	0
measurement	I-DISEASE
of	0
PaCO2	I-DISEASE
during	I-DISEASE
sleep	0
(	I-DISEASE
rarely	0
performed	0
)	0
or	0
transcutaneous	0
or	0
end	I-DISEASE
-	0
tidal	I-DISEASE
PCO2	I-DISEASE
measurements	0
.	0

Periods	0
of	0
decreased	0
tidal	0
volume	0
lasting	0
up	0
to	0
several	I-DISEASE
minutes	0
with	0
sustained	0
arterial	0
oxygen	0
desaturation	I-DISEASE
are	I-DISEASE
usually	0
present	I-DISEASE
.	0

Intermittent	0
arousals	I-DISEASE
may	I-DISEASE
be	I-DISEASE
observed	0
.	I-DISEASE

OSA	0
is	0
present	0
in	0
the	0
majority	0
of	I-DISEASE
OHS	0
patients	I-DISEASE
,	0
during	0
at	0
least	0
a	0
portion	I-DISEASE
of	I-DISEASE
the	0
night	0
.	0

The	0
transient	0
ven-	0
tilation	0
between	0
obstructive	0
events	I-DISEASE
(	0
even	I-DISEASE
if	0
associated	0
with	0
arousal	0
from	0
the	I-DISEASE
preceding	I-DISEASE
obstructive	I-DISEASE
event	0
)	0
is	0
not	0
sufficient	0
to	I-DISEASE
prevent	0
worsening	I-DISEASE
hypoventilation	0
during	0
sleep	I-DISEASE
.	0

Severe	0
arterial	0
oxygen	0
desaturation	0
is	I-DISEASE
usually	0
associated	I-DISEASE
with	0
the	0
obstructive	0
events	0
.	0

Chronic	0
hypoxia	0
can	0
be	I-DISEASE
associated	0
with	I-DISEASE
polycythemia	I-DISEASE
.	0

Electrocardiography	0
,	0
chest	0
radi-	I-DISEASE
ography	I-DISEASE
,	I-DISEASE
and	I-DISEASE
echocardiography	0
may	I-DISEASE
demonstrate	0
evidence	0
of	I-DISEASE
pulmonary	0
hypertension	0
.	I-DISEASE

The	0
serum	0
bicarbonate	0
level	0
is	0
usually	0
elevated	0
due	0
to	I-DISEASE
renal	0
compensation	0
for	0
chronic	0
respiratory	0
acidosis	I-DISEASE
(	I-DISEASE
hypercapnia	0
)	0
.	0

In	0
one	0
study	0
,	I-DISEASE
a	0
serum	I-DISEASE
bicarbonate	I-DISEASE
level	0
threshold	I-DISEASE
>	0
27	0
mEq	0
/	I-DISEASE
L	0
had	I-DISEASE
a	0
sensitivity	0
of	I-DISEASE
92	0
%	I-DISEASE
and	0
a	0
specificity	I-DISEASE
of	I-DISEASE
50	I-DISEASE
%	0
of	I-DISEASE
identifying	I-DISEASE
OHS	0
in	0
obese	0
patients	0
suspected	0
of	0
having	0
OSA	0
.	0

This	0
suggests	0
that	0
the	0
serum	I-DISEASE
bicarbonate	0
level	0
may	0
be	0
useful	0
to	0
screen	0
patients	0
for	0
possible	0
OHS	0
.	I-DISEASE

However	0
,	I-DISEASE
an	0
arterial	I-DISEASE
blood	0
gas	I-DISEASE
is	0
required	0
for	I-DISEASE
diagnosis	0
of	0
OHS	0
,	0
as	0
the	0
serum	0
bicarbonate	0
level	I-DISEASE
may	0
be	0
elevated	0
due	0
to	0
metabolic	I-DISEASE
alkalosis	B-DISEASE
.	I-DISEASE

Differential	0
Diagnosis	0

The	0
differential	0
diagnosis	0
includes	0
any	0
disorder	0
that	I-DISEASE
can	0
give	0
rise	0
to	0
hypoventilation	0
during	0
wakefulness	0
and	I-DISEASE
sleep	0
.	0

This	0
includes	0
pulmonary	0
airway	I-DISEASE
and	0
parenchymal	I-DISEASE
dis-	I-DISEASE
orders	I-DISEASE
,	I-DISEASE
pulmonary	0
vascular	0
pathology	0
,	I-DISEASE
neuromuscular	I-DISEASE
and	I-DISEASE
chest	I-DISEASE
wall	I-DISEASE
disorders	I-DISEASE
,	0
severe	0
untreated	0
hypothyroidism	0
,	0
use	0
of	I-DISEASE
respiratory	I-DISEASE
suppressants	0
,	I-DISEASE
and	0
congenital	I-DISEASE
or	I-DISEASE
idio-	0
pathic	0
central	0
alveolar	0
hypoventilation	0
syndromes	0
.	I-DISEASE

OSA	0
and	0
CSA	0
syndromes	0
can	I-DISEASE
be	I-DISEASE
distinguished	I-DISEASE
from	0
sleep	I-DISEASE
related	I-DISEASE
hypoventilation	0
by	0
the	I-DISEASE
periodic	I-DISEASE
alterations	I-DISEASE
in	0
airflow	0
and	I-DISEASE
accompanying	0
periodic	0
fluctuations	0
in	0
SaO2	0
.	0

In	0
contrast	0
,	0
oxygen	0
desaturation	0
due	I-DISEASE
to	I-DISEASE
sleep	0
related	0
hypoventilation	0
is	0
generally	I-DISEASE
more	0
sustained	0
,	I-DISEASE
usually	0
several	0
minutes	I-DISEASE
or	0
longer	0
in	0
duration	0
.	0

When	0
more	0
than	0
one	0
disorder	0
is	I-DISEASE
believed	I-DISEASE
to	0
be	I-DISEASE
responsible	I-DISEASE
for	0
the	0
ventilatory	I-DISEASE
insufficiency	0
during	I-DISEASE
sleep	0
,	0
all	0
pertinent	0
diagnoses	I-DISEASE
should	0
be	0
coded	0
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE
Future	I-DISEASE
research	I-DISEASE
into	0
the	0
pathogenesis	0
of	0
this	0
disorder	0
,	I-DISEASE
including	0
renal	0
bicarbonate	0
homeostasis	I-DISEASE
,	0
is	0
needed	0
.	0

Because	0
it	0
is	0
clinically	0
impractical	0
to	0
routinely	I-DISEASE
obtain	0
arterial	I-DISEASE
blood	0
samples	0
during	0
sleep	I-DISEASE
in	0
most	I-DISEASE
persons	I-DISEASE
suspected	I-DISEASE
of	0
this	0
disorder	0
,	0
other	0
techniques	0
of	0
measuring	0
CO2	0
levels	0
must	I-DISEASE
be	0
investigated	0
.	I-DISEASE

The	0
degree	0
and	0
duration	0
of	0
hypercapnia/	I-DISEASE
hypoxemia	I-DISEASE
necessary	0
to	0
produce	0
adverse	0
consequences	0
,	0
such	I-DISEASE
as	I-DISEASE
pulmonary	0
hyperten-	0
sion	0
,	0
in	I-DISEASE
individual	0
patients	0
is	0
not	I-DISEASE
well	I-DISEASE
defined	0
.	I-DISEASE

Little	0
information	0
is	0
available	0
regarding	0
the	I-DISEASE
effect	I-DISEASE
of	0
oxygen	I-DISEASE
therapy	0
or	0
noninvasive	0
ventilation	0
on	0
the	I-DISEASE
course	0
of	0
the	I-DISEASE
underlying	0
disease	0
.	0

Studies	0
are	0
needed	0
to	0
determine	0
the	0
optimal	I-DISEASE
time	0
to	I-DISEASE
initiate	0
these	0
interventions	0
and	I-DISEASE
the	0
specific	I-DISEASE
subpopulations	I-DISEASE
of	0
patients	I-DISEASE
who	0
will	0
benefit	0
most	I-DISEASE
from	0
these	I-DISEASE
therapies	I-DISEASE
.	0

Bibliography	0
Berger	0
KI	0
,	0
Goldring	0
RM	0
,	I-DISEASE
Rapoport	0
DM	0
.	0

Obesity	0
hypoventilation	0
syndrome	0
.	0

Semin	0
Respir	0
Crit	0
Care	I-DISEASE
Med	0
2009;30:253	I-DISEASE
.	I-DISEASE

Budweiser	0
S	0
,	0
Riedl	0
SG	0
,	0
Jörres	I-DISEASE
RA	0
,	I-DISEASE
et	0
al	0
.	0

Mortality	0
and	0
prognostic	0
factors	0
in	0
patients	0
with	I-DISEASE
obesity-	0
hypoventilation	0
syndrome	0
undergoing	0
noninvasive	0
ventilation	0
.	0

J	0
Intern	0
Med	0
2007;261:375–83	0
.	I-DISEASE

Littleton	0
SW	0
,	0
Mokhlesi	0
B.	0
The	0
pickwickian	I-DISEASE
syndrome	0
-	I-DISEASE
obesity	0
hypoventilation	0
syndrome	0
.	0

Clin	0
Chest	0
Med	0
2009;30:467–78	0
,	0
vii	I-DISEASE
-	0
viii	0
.	I-DISEASE

Mokhlesi	0
B	0
;	0
Tulaimat	0
A	0
;	I-DISEASE
Evans	I-DISEASE
AT	I-DISEASE
et	0
al	0
.	0

Impact	0
of	0
adherence	0
with	0
positive	I-DISEASE
airway	0
pressure	I-DISEASE
therapy	0
on	I-DISEASE
hypercapnia	0
in	0
obstructive	0
sleep	I-DISEASE
apnea	0
.	0

J	0
Clin	0
Sleep	I-DISEASE
Med	0
2006;2:57–62	0
.	I-DISEASE

Mokhlesi	0
B.	0
Obesity	0
hypoventilation	0
syndrome	0
:	I-DISEASE
a	0
state	0
-	I-DISEASE
of	0
-	0
the	0
-	0
art	0
review	I-DISEASE
.	0

Respir	0
Care	B-DISEASE
2010;55:1347–62	0
.	B-DISEASE

Nowbar	0
S	0
,	0
Burkart	0
KM	0
,	I-DISEASE
Gonzales	I-DISEASE
R	I-DISEASE
,	0
et	0
al	0
.	0

Obesity	0
-	0
hypoventilation	0
in	0
hospitalized	0
patients	0
:	I-DISEASE
prevalence	0
,	I-DISEASE
effects	0
,	0
and	0
outcome	I-DISEASE
.	0

Am	0
J	0
Med	0
2004;116:1–7	I-DISEASE
.	0

Piper	0
AJ	0
,	0
Grunstein	0
RR	0
.	0

Obesity	0
hypoventilation	0
syndrome	0
:	I-DISEASE
mechanisms	0
and	0
management	0
.	0

Am	0
J	0
Respir	0
Crit	0
Care	0
Med	I-DISEASE
2011;183:292–8	I-DISEASE
.	0

Piper	0
AJ	0
.	0

Obesity	0
hypoventilation	0
syndrome	0
--	I-DISEASE
the	0
big	0
and	0
the	0
breathless	I-DISEASE
.	0

Sleep	0
Med	0
Rev	0
2011;15:79–89	0
.	B-DISEASE

Congenital	0
Central	0
Alveolar	0
Hypoventilation	0
Syndrome	0
ICD-9	0
-	0
CM	0
code	0
:	0
327.25	0
ICD-10	0
-	0
CM	0
code	0
:	0
G47.35	0
Alternate	0
Names	0
Congenital	0
central	0
hypoventilation	I-DISEASE
syndrome	0
.	0

The	0
term	0
Ondine	0
’s	0
curse	0
is	0
no	B-DISEASE
longer	0
recommended	I-DISEASE
due	0
to	0
its	0
negative	0
connotations	0
.	I-DISEASE

Diagnostic	0
Criteria	0
Criteria	0
A	0
and	0
B	I-DISEASE
must	0
be	0
met	I-DISEASE
A.	0
Sleep	0
related	0
hypoventilation	0
is	0
present	0
.	I-DISEASE

B.	0
Mutation	0
of	0
the	0
PHOX2B	0
gene	I-DISEASE
is	I-DISEASE
present	0
.	I-DISEASE

Notes	0
.	0

Sleep	0
related	0
hypoventilation	I-DISEASE
may	I-DISEASE
be	0
associated	I-DISEASE
with	0
either	0
daytime	I-DISEASE
hypoventilation	I-DISEASE
(	0
PaCO2	0
>	0
45	0
mm	I-DISEASE
Hg	0
)	0
or	I-DISEASE
normal	0
daytime	I-DISEASE
PaCO2	0
levels	0
.	I-DISEASE

Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Sleep	I-DISEASE
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
In	I-DISEASE
either	0
case	0
,	I-DISEASE
the	0
PaCO2	I-DISEASE
is	I-DISEASE
higher	I-DISEASE
during	0
sleep	I-DISEASE
and	0
meets	0
criteria	0
for	0
sleep	0
related	I-DISEASE
hypoventilation	I-DISEASE
.	0
.	I-DISEASE

PSG	0
monitoring	0
demonstrates	0
severe	0
hypercapnia	0
and	0
arterial	I-DISEASE
oxygen	0
desaturation	0
.	0

Some	0
central	0
apneas	0
may	0
occur	I-DISEASE
but	0
the	I-DISEASE
predominant	0
pattern	0
is	0
reduced	0
flow	0
/	0
tidal	0
volume	I-DISEASE
.	0
.	0

Although	0
the	0
condition	I-DISEASE
is	I-DISEASE
termed	0
congenital	0
,	I-DISEASE
some	0
patients	I-DISEASE
with	0
a	0
PHOX2B	I-DISEASE
genotype	0
may	0
present	I-DISEASE
phenotypically	0
later	I-DISEASE
in	I-DISEASE
life	0
(	I-DISEASE
and	0
even	0
in	0
adulthood	0
)	I-DISEASE
,	I-DISEASE
especially	0
in	0
the	0
presence	0
of	0
a	I-DISEASE
stressor	0
such	0
as	0
general	I-DISEASE
anesthesia	I-DISEASE
or	I-DISEASE
a	0
severe	0
respiratory	I-DISEASE
illness	0
.	0

Essential	0
Features	0
Congenital	0
central	0
alveolar	0
hypoventilation	0
syndrome	0
(	0
CCHS	I-DISEASE
)	0
is	0
a	0
syndrome	0
of	0
auto-	I-DISEASE
nomic	0
dysfunction	0
,	0
primarily	0
the	I-DISEASE
failure	0
of	0
automatic	0
central	0
control	I-DISEASE
of	I-DISEASE
breathing	0
,	I-DISEASE
due	0
to	0
a	0
mutation	0
of	0
the	0
PHOX2B	0
gene	0
.	0

CCHS	0
is	0
characterized	0
by	0
the	0
onset	0
of	I-DISEASE
hypoven-	0
tilation	I-DISEASE
,	0
usually	0
at	0
birth	0
.	0

The	0
hypoventilation	0
is	0
worse	0
during	0
sleep	0
than	0
wakefulness	0
and	I-DISEASE
is	0
unexplained	0
by	0
primary	I-DISEASE
pulmonary	0
,	I-DISEASE
neurological	I-DISEASE
,	0
or	I-DISEASE
metabolic	0
disease	0
.	0

CCHS	0
typically	0
presents	0
in	I-DISEASE
an	0
otherwise	0
normal	I-DISEASE
-	0
appearing	I-DISEASE
infant	0
who	0
is	0
noted	0
to	0
have	I-DISEASE
cyano-	0
sis	0
,	I-DISEASE
feeding	0
difficulties	0
,	0
hypotonia	0
or	0
,	0
less	I-DISEASE
commonly	0
,	0
central	I-DISEASE
apnea	0
.	0

Some	0
children	0
are	0
diagnosed	0
following	0
cardiovascular	0
collapse	0
.	0

The	0
infant	0
requires	0
intubation	I-DISEASE
and	0
then	I-DISEASE
can	I-DISEASE
not	0
be	I-DISEASE
weaned	0
from	I-DISEASE
mechanically	I-DISEASE
assisted	0
ventilation	0
,	0
despite	0
appearing	0
vigorous	I-DISEASE
and	0
having	0
a	0
normal	0
chest	0
radiograph	0
.	I-DISEASE

Some	0
infants	0
may	0
appear	0
to	0
breathe	0
adequately	I-DISEASE
on	0
clinical	0
examination	0
but	0
experience	0
episodes	0
of	0
hypoventilation	I-DISEASE
(	I-DISEASE
not	0
necessarily	I-DISEASE
apnea	0
)	0
characterized	0
by	0
hypoxemia	0
and	0
hypercapnia	I-DISEASE
.	0

Patients	0
with	0
CCHS	B-DISEASE
may	0
occa-	0
sionally	0
present	0
later	0
in	I-DISEASE
life	0
with	0
cyanosis	I-DISEASE
,	0
an	0
apparent	I-DISEASE
life	0
-	0
threatening	0
event	0
,	0
cor	0
pul-	0
monale	0
,	0
or	I-DISEASE
hypoxic	0
neurological	0
damage	0
.	0

CCHS	0
has	0
been	0
diagnosed	0
in	0
adults	0
who	0
present	0
with	I-DISEASE
respiratory	0
failure	0
following	0
anesthesia	0
or	0
in	I-DISEASE
association	0
with	I-DISEASE
a	0
minor	0
respiratory	0
illness	0
;	0
these	0
patients	0
usually	0
have	I-DISEASE
a	0
mild	I-DISEASE
mutation	0
,	0
and	0
may	I-DISEASE
have	0
evidence	0
of	0
longstanding	0
hypoxemia	0
including	0
cognitive	0
deficits	0
.	I-DISEASE

Most	0
patients	0
with	I-DISEASE
CCHS	0
have	0
sufficiently	0
severe	0
hypoventilation	I-DISEASE
during	I-DISEASE
sleep	0
that	0
they	0
require	0
mechanically	0
assisted	I-DISEASE
ventilation	I-DISEASE
,	0
although	0
this	0
state	0
-	0
dependent	0
difference	0
may	0
not	0
be	0
apparent	0
during	I-DISEASE
early	0
infancy	0
.	0

Some	0
patients	0
(	I-DISEASE
~15	0
%	0
)	I-DISEASE
hypoventilate	0
during	0
wakefulness	I-DISEASE
as	0
well	0
as	0
during	0
sleep	0
and	I-DISEASE
require	I-DISEASE
continuous	0
ventilatory	I-DISEASE
support	0
.	0

However	0
,	I-DISEASE
most	0
patients	0
with	0
CCHS	0
do	0
not	0
require	I-DISEASE
ventilatory	I-DISEASE
support	0
during	0
wakefulness	0
but	0
may	0
have	I-DISEASE
subtle	I-DISEASE
abnormali-	0
ties	0
in	0
gas	0
exchange	0
when	0
physically	0
inactive	I-DISEASE
or	0
during	0
vigorous	0
exercise	I-DISEASE
.	0

Associated	0
Features	0
Associated	0
autonomic	I-DISEASE
abnormalities	0
include	0
Hirschsprung	I-DISEASE
disease	0
in	I-DISEASE
approximately	0
16	0
%	I-DISEASE
of	0
patients	0
with	I-DISEASE
CCHS	0
,	0
autonomic	I-DISEASE
dysfunction	0
(	0
e.g.	0
,	0
decreased	0
heart	0
rate	I-DISEASE
variabil-	0
ity	0
or	I-DISEASE
hypotension	0
)	0
,	0
neural	I-DISEASE
tumors	0
(	0
e.g.	0
,	0
ganglioneuromas	0
or	0
ganglioneuroblastomas	0
)	0
,	I-DISEASE
swallowing	0
dysfunction	0
during	0
the	0
early	0
years	0
,	I-DISEASE
and	0
ocular	0
abnormalities	0
(	0
e.g.	I-DISEASE
,	0
stra-	0
bismus	0
)	0
.	0

Most	0
patients	0
are	I-DISEASE
cognitively	0
normal	0
,	0
although	0
developmental	0
delay	0
may	0
be	0
present	0
,	I-DISEASE
especially	0
in	I-DISEASE
patients	0
in	0
whom	I-DISEASE
the	0
hypoventilation	0
has	0
not	0
been	0
well	0
controlled	0
.	0

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Research	I-DISEASE
suggests	I-DISEASE
that	I-DISEASE
severity	I-DISEASE
of	I-DISEASE
illness	0
is	0
related	0
to	0
the	0
type	I-DISEASE
of	0
mutation	0
present	I-DISEASE
.	I-DISEASE

Most	0
patients	0
have	I-DISEASE
a	0
polyalanine	0
expansion	I-DISEASE
mutation	I-DISEASE
;	0
those	0
with	0
more	0
polyalanine	I-DISEASE
repeats	0
are	0
more	0
likely	I-DISEASE
to	0
have	0
severe	0
disease	0
including	0
waking	0
hypoventilation	0
.	0

Patients	0
with	0
a	0
point	0
mutation	0
or	0
frame	0
shift	0
mutations	0
are	0
at	0
greater	0
risk	I-DISEASE
for	0
neural	I-DISEASE
tumors	0
.	I-DISEASE

Demographics	0
The	0
prevalence	0
of	0
CCHS	0
is	0
not	I-DISEASE
known	0
,	0
but	0
the	0
disease	0
is	0
rare	0
.	0

The	0
condition	0
occurs	0
equally	0
among	0
both	0
sexes	0
and	0
all	I-DISEASE
ethnic	0
/	0
racial	0
groups	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
This	0
is	I-DISEASE
a	I-DISEASE
congenital	0
genetic	I-DISEASE
syndrome	0
.	0

Familial	0
Patterns	0
CCHS	0
usually	0
occurs	0
as	0
a	I-DISEASE
de	0
novo	I-DISEASE
mutation	0
,	0
but	0
siblings	0
with	0
the	I-DISEASE
condition	0
have	0
been	I-DISEASE
reported	0
.	0

As	0
the	0
gene	I-DISEASE
is	0
dominant	0
,	0
patients	I-DISEASE
are	0
at	0
risk	0
of	0
having	0
children	0
with	I-DISEASE
CCHS	I-DISEASE
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0

The	0
condition	0
is	0
genetic	0
and	0
is	I-DISEASE
therefore	I-DISEASE
present	0
from	I-DISEASE
birth	0
,	0
but	0
some	0
patients	0
may	I-DISEASE
present	0
later	0
in	0
life	0
.	0

The	0
physiological	0
abnormalities	0
of	0
CCHS	0
persist	I-DISEASE
for	0
life	0
and	0
are	0
not	0
ameliorated	0
over	0
time	0
.	I-DISEASE

However	0
,	0
the	0
clinical	0
consequences	0
of	I-DISEASE
hypoventilation	I-DISEASE
can	0
be	0
prevented	0
by	0
providing	0
adequate	0
ventilatory	0
support	0
.	0

If	0
untreated	0
,	0
death	0
usually	I-DISEASE
results	0
from	0
cor	0
pulmonale	0
or	0
complications	0
of	0
apnea	0
or	0
severe	I-DISEASE
hypoventilation	I-DISEASE
.	0

Patients	0
with	0
poorly	0
controlled	0
CCHS	0
may	0
develop	0
mental	0
retardation	I-DISEASE
,	0
growth	0
failure	0
,	0
seizures	0
,	I-DISEASE
or	0
cor	0
pulmonale	I-DISEASE
.	0

When	0
treated	0
,	0
infants	0
with	0
CCHS	0
may	0
improve	0
over	I-DISEASE
the	0
first	0
six	0
to	0
12	0
months	0
.	0

Some	0
patients	0
who	0
initially	0
require	0
ventilatory	0
support	0
24	0
hours	I-DISEASE
a	0
day	0
may	0
progress	0
to	0
adequate	0
ventilation	0
during	0
wakefulness	I-DISEASE
.	0

However	0
,	0
patients	0
continue	I-DISEASE
to	0
require	0
ventilatory	0
support	0
during	0
sleep	0
.	0

Conversely	0
,	0
some	0
patients	0
may	0
develop	0
the	0
need	I-DISEASE
for	I-DISEASE
continuous	0
ventilatory	0
support	0
.	0

It	0
is	0
unclear	0
whether	0
these	0
patients	0
had	I-DISEASE
condi-	0
tions	I-DISEASE
that	0
worsened	0
,	0
were	0
not	0
adequately	I-DISEASE
evaluated	I-DISEASE
and	0
treated	I-DISEASE
initially	I-DISEASE
,	0
or	0
were	0
asso-	I-DISEASE
ciated	I-DISEASE
with	I-DISEASE
changing	0
ventilatory	0
demands	0
.	0

Even	0
with	0
treatment	0
,	0
patients	0
with	I-DISEASE
CCHS	0
require	0
close	I-DISEASE
monitoring	0
,	0
particularly	0
during	0
infancy	I-DISEASE
.	I-DISEASE

Minor	0
medical	0
illnesses	0
,	0
such	0
as	0
upper	0
respiratory	0
tract	0
illnesses	0
or	0
diarrhea	0
,	0
may	0
precipitate	0
bouts	0
of	0
respiratory	0
failure	0
.	0

Edema	0
and	0
lethargy	0
are	0
often	0
early	0
signs	I-DISEASE
of	0
impending	I-DISEASE
respiratory	0
failure	0
.	0

The	0
clinical	0
signs	0
of	I-DISEASE
hypoxemia	0
and	0
hypoventilation	0
in	I-DISEASE
these	I-DISEASE
patients	0
may	0
be	0
subtle	0
,	0
as	I-DISEASE
the	0
Sleep	0
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
children	I-DISEASE
do	I-DISEASE
not	0
show	I-DISEASE
signs	I-DISEASE
of	I-DISEASE
distress	0
or	0
increased	0
work	0
of	I-DISEASE
breathing	0
,	0
such	I-DISEASE
as	I-DISEASE
retrac-	0
tions	0
and	0
nasal	I-DISEASE
flaring	0
.	I-DISEASE

As	0
a	0
result	0
,	0
gas	0
exchange	0
abnormalities	I-DISEASE
may	0
progress	I-DISEASE
for	0
some	0
time	0
without	0
notice	0
until	I-DISEASE
the	I-DISEASE
child	0
appears	I-DISEASE
to	0
deteriorate	0
suddenly	0
with	0
cardiopulmo-	0
nary	0
arrest	0
or	0
severe	0
decompensation	0
.	0

Developmental	0
Issues	0
Not	0
applicable	0
.	0

Pathology	0
and	0
Pathophysiology	0
The	0
exact	0
pathophysiology	I-DISEASE
of	I-DISEASE
CCHS	0
is	I-DISEASE
unknown	0
.	0

Radiologic	0
and	0
postmortem	0
studies	0
have	0
not	0
shown	0
gross	0
central	0
nervous	0
system	0
abnormalities	0
.	0

The	0
PHOX2B	0
gene	0
plays	0
a	0
role	I-DISEASE
in	0
the	0
development	I-DISEASE
of	0
the	0
autonomic	0
system	I-DISEASE
.	0

Functional	0
MRI	0
and	I-DISEASE
physiologic	0
studies	0
have	I-DISEASE
shown	I-DISEASE
widespread	I-DISEASE
cerebral	I-DISEASE
abnormalities	0
in	0
response	0
to	0
stimuli	0
such	0
as	0
exogenous	0
hypercapnia	I-DISEASE
.	0

Objective	0
Findings	0
Hypoxemia	0
and	0
hypercapnia	0
are	I-DISEASE
present	0
on	0
PSG	I-DISEASE
during	0
sleep	0
.	0

Central	0
apneas	0
may	0
be	I-DISEASE
present	0
,	I-DISEASE
but	0
hypoventilation	I-DISEASE
associated	I-DISEASE
with	0
decreased	0
tidal	0
volume	0
and	0
respiratory	0
rate	I-DISEASE
is	0
more	0
common	0
.	0

In	0
contrast	0
to	0
most	I-DISEASE
types	0
of	I-DISEASE
sleep	I-DISEASE
disordered	I-DISEASE
breathing	I-DISEASE
in	0
children	0
,	0
abnormalities	I-DISEASE
may	0
be	I-DISEASE
more	0
severe	0
during	I-DISEASE
NREM	0
than	I-DISEASE
during	0
REM	0
sleep	0
.	0

Patients	0
may	0
not	B-DISEASE
arouse	0
from	0
sleep	0
despite	0
severe	0
gas	I-DISEASE
exchange	0
abnormalities	0
.	0

Paradoxical	0
breath-	0
ing	0
and	0
snoring	0
do	0
not	0
typically	0
occur	0
.	0

Patients	0
with	0
CCHS	I-DISEASE
have	0
flat	0
rebreathing	0
hypoxic	0
and	0
hypercapnic	I-DISEASE
responses	0
,	0
although	0
they	I-DISEASE
may	0
respond	I-DISEASE
to	0
transient	0
ventilatory	I-DISEASE
challenges	0
of	0
the	0
peripheral	0
chemorecep-	0
tors	0
.	I-DISEASE

Arterial	0
blood	0
gases	0
may	0
be	0
normal	0
during	I-DISEASE
wakefulness	0
but	I-DISEASE
will	I-DISEASE
be	0
abnormal	0
if	0
obtained	0
from	0
an	0
arterial	0
line	0
during	0
sleep	0
.	0

In	0
patients	0
with	I-DISEASE
chronically	0
untreated	0
or	0
poorly	0
controlled	0
CCHS	I-DISEASE
,	0
a	0
compensated	0
respiratory	0
acidosis	0
may	I-DISEASE
be	0
present	0
.	0

In	0
these	0
patients	0
,	I-DISEASE
polycythemia	0
may	I-DISEASE
be	I-DISEASE
present	0
and	I-DISEASE
the	0
serum	0
bicarbonate	I-DISEASE
level	0
may	0
be	I-DISEASE
elevated	I-DISEASE
.	0

Computed	0
tomography	0
and	0
MRI	0
scans	0
of	0
the	I-DISEASE
head	0
are	I-DISEASE
normal	0
.	0

Electrocardiography	0
,	0
echocardiography	0
,	I-DISEASE
or	0
cardiac	I-DISEASE
catheterization	I-DISEASE
may	0
reveal	I-DISEASE
evidence	I-DISEASE
of	0
pulmonary	I-DISEASE
hyper-	0
tension	0
.	I-DISEASE

Pulmonary	0
function	0
tests	0
may	0
be	I-DISEASE
normal	I-DISEASE
or	I-DISEASE
show	0
evidence	I-DISEASE
of	0
mild	0
obstructive	0
or	0
restrictive	0
lung	I-DISEASE
disease	0
resulting	0
from	I-DISEASE
associated	0
conditions	0
such	0
as	0
tracheitis	0
.	0

Differential	0
Diagnosis	0
CCHS	0
must	0
be	0
distinguished	I-DISEASE
from	0
other	0
forms	0
of	0
central	0
hypoventilation	0
,	0
such	0
as	I-DISEASE
central	0
hypoventilation	0
due	0
to	0
Chiari	0
malformation	0
,	0
other	0
causes	0
of	0
central	0
nervous	0
system	0
disturbance	0
such	0
as	0
trauma	0
or	0
tumors	0
,	0
metabolic	0
conditions	0
such	I-DISEASE
as	0
Leigh	I-DISEASE
disease	I-DISEASE
,	I-DISEASE
or	0
obesity	0
hypoventilation	0
syndrome	0
.	I-DISEASE

CCHS	0
must	0
also	0
be	0
distinguished	0
from	0
hypoventilation	I-DISEASE
secondary	0
to	I-DISEASE
muscle	0
weakness	0
due	0
to	0
conditions	0
such	0
as	0
diaphrag-	0
matic	0
paralysis	0
or	0
muscular	0
dystrophy	0
.	0

Infants	0
presenting	0
with	0
apnea	I-DISEASE
or	0
an	0
apparent	I-DISEASE
life	I-DISEASE
-	0
threatening	0
event	0
due	0
to	I-DISEASE
causes	0
such	I-DISEASE
as	0
gastroesophageal	0
reflux	I-DISEASE
may	0
be	0
thought	0
to	0
have	0
CCHS	0
.	I-DISEASE

However	0
,	I-DISEASE
these	0
infants	0
typically	0
have	0
intermittent	0
episodes	0
of	I-DISEASE
apnea	0
rather	0
than	I-DISEASE
sustained	0
hypoventilation	0
,	0
and	0
the	0
episodes	0
typically	0
resolve	0
once	0
the	0
primary	0
cause	I-DISEASE
has	0
been	I-DISEASE
treated	0
.	B-DISEASE

CCHS	0
patients	0
presenting	0
with	I-DISEASE
cor	0
pulmonale	0
may	I-DISEASE
be	0
misdiagnosed	0
as	0
having	I-DISEASE
congenital	0
heart	I-DISEASE
disease	0
.	I-DISEASE

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE

There	0
are	0
many	0
unresolved	0
issues	0
regarding	0
CCHS	I-DISEASE
,	0
including	0
prevalence	0
data	0
,	0
precise	0
genotype	0
-	I-DISEASE
phenotype	0
correlations	0
,	0
effect	0
of	I-DISEASE
aging	0
on	0
patients	0
with	I-DISEASE
CCHS	0
,	0
long	0
-	I-DISEASE
term	0
outcome	I-DISEASE
of	0
children	0
with	0
CCHS	0
born	0
to	0
parents	0
with	0
CCHS	I-DISEASE
,	0
and	0
the	I-DISEASE
exact	I-DISEASE
nature	0
of	I-DISEASE
the	0
gene	I-DISEASE
-	I-DISEASE
encoded	0
deficit	0
.	0

Bibliography	0
Amiel	0
J	0
,	0
Laudier	0
B	0
,	0
Attie	0
-	0
Bitach	0
T	0
,	0
et	I-DISEASE
al	0
.	0

Polyalanine	0
expansion	0
and	0
frameshift	0
mutations	0
of	I-DISEASE
the	I-DISEASE
paired	0
-	0
like	0
homeobox	0
gene	0
PHOX2B	I-DISEASE
in	0
congenital	I-DISEASE
central	0
hypoventilation	0
syndrome	I-DISEASE
.	0

Nat	0
Genet	0
2003;33:459–61	0
.	0

Gozal	0
D	0
,	0
Marcus	I-DISEASE
CL	0
,	0
Shoseyov	I-DISEASE
D	0
,	I-DISEASE
Keens	0
TG	0
.	I-DISEASE

Peripheral	0
chemoreceptor	0
function	0
in	0
children	0
with	0
the	I-DISEASE
congenital	0
central	I-DISEASE
hypoventilation	0
syndrome	0
.	I-DISEASE

J	0
Appl	0
Physiol	0
1993;74:379–87	0
.	0

Macey	0
PM	0
,	0
Woo	0
MA	0
,	I-DISEASE
Macey	I-DISEASE
KE	0
,	I-DISEASE
et	0
al	0
.	0

Hypoxia	0
reveals	0
posterior	0
thalamic	I-DISEASE
,	0
cerebellar	I-DISEASE
,	I-DISEASE
midbrain	0
,	I-DISEASE
and	0
limbic	0
deficits	0
in	0
congenital	0
central	0
hypoventilation	0
syndrome	0
.	I-DISEASE

J	0
Appl	0
Physiol	0
2005;98:958–69	0
.	0

Marcus	0
CL	0
,	I-DISEASE
Jansen	0
MT	0
,	0
Poulsen	I-DISEASE
MK	0
,	0
Keens	0
SE	0
,	0
Nield	0
TA	0
,	I-DISEASE
Lipsker	0
LE	0
et	I-DISEASE
al	0
.	0

Medical	0
and	0
psychosocial	0
outcome	0
of	0
children	0
with	I-DISEASE
congenital	0
central	I-DISEASE
hypoventilation	I-DISEASE
syndrome	0
.	0

J	0
Pediatr	0
1991;119:888–95	0
.	0

Paton	0
JY	0
,	0
Swaminathan	0
S	0
,	0
Sargent	I-DISEASE
CW	0
,	0
Hawksworth	0
A	0
,	0
Keens	0
TG	0
.	I-DISEASE

Ventilatory	0
response	0
to	0
exercise	0
in	0
children	0
with	0
congenital	0
central	0
hypoventilation	0
syndrome	0
.	0

Am	0
Rev	0
Respir	0
Dis	I-DISEASE
1993;147:1185–91	0
.	I-DISEASE

Paton	0
JY	0
,	0
Swaminathan	0
S	0
,	0
Sargent	I-DISEASE
CW	0
,	0
Keens	0
TG	0
.	0

Hypoxic	0
and	0
hypercapnic	0
ventilatory	I-DISEASE
responses	0
in	I-DISEASE
awake	I-DISEASE
children	0
with	0
congenital	0
central	0
hypoventilation	0
syndrome	I-DISEASE
.	0

Am	0
Rev	0
Respir	0
Dis	I-DISEASE
1989;140:368–72	0
.	I-DISEASE

Weese	0
-	0
Mayer	0
DE	I-DISEASE
,	0
Berry	I-DISEASE
-	I-DISEASE
Kravis	0
EM	I-DISEASE
,	0
Ceccherini	0
I	0
,	0
Keens	0
TG	I-DISEASE
,	0
Loghmanee	0
DA	I-DISEASE
,	0
Trang	0
H.	0
An	0
official	0
ATS	0
clinical	I-DISEASE
policy	0
statement	I-DISEASE
:	I-DISEASE
Congenital	0
central	I-DISEASE
hypoventilation	I-DISEASE
syndrome	I-DISEASE
:	0
genetic	0
basis	0
,	0
diagnosis	0
,	0
and	0
management	0
.	0

Am	0
J	0
Respir	0
Crit	0
Care	0
Med	I-DISEASE
2010;181:626–44	I-DISEASE
.	0

Weese	0
-	0
Mayer	0
DE	0
,	0
Berry	I-DISEASE
-	I-DISEASE
Kravis	0
EM	I-DISEASE
,	0
Marazita	0
ML	0
.	0

In	0
pursuit	0
(	0
and	0
discovery	0
)	0
of	I-DISEASE
a	0
genetic	I-DISEASE
basis	0
for	0
congenital	0
central	I-DISEASE
hypoventilation	0
syndrome	0
.	0

Respir	0
Physiol	0
Neurobiol	0
2005;149:73–82	B-DISEASE
.	0

Sleep	0
Related	0
Breathing	I-DISEASE
Disorders	0
Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Late	I-DISEASE
-	0
Onset	0
Central	I-DISEASE
Hypoventilation	0
with	0
Hypothalamic	I-DISEASE
Dysfunction	0
ICD-9	0
-	I-DISEASE
CM	0
code	0
:	0
327.26	0
ICD-10	0
-	0
CM	0
code	0
:	0
G47.36	0
Alternate	0
Names	0
Late	0
-	0
onset	0
central	0
hypoventilation	0
syndrome	0
;	0
rapid	0
-	0
onset	0
obesity	0
with	0
hypothalamic	0
dysfunction	0
,	I-DISEASE
hypoventilation	0
,	I-DISEASE
and	0
autonomic	0
dysregulation	0
(	0
ROHHAD	0
)	0
.	I-DISEASE

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
E	I-DISEASE
must	0
be	0
met	I-DISEASE
A.	0
Sleep	0
related	0
hypoventilation	0
is	0
present	0
.	I-DISEASE

B.	0
Symptoms	0
are	0
absent	0
during	0
the	0
first	0
few	0
years	I-DISEASE
of	0
life	0
.	0

C.	0

The	0
patient	0
has	0
at	0
least	0
two	I-DISEASE
of	0
the	0
following	I-DISEASE
:	0
.	0

Obesity	0
.	0
.	0

Endocrine	0
abnormalities	0
of	0
hypothalamic	0
origin	0
.	0

3	0
.	0

Severe	0
emotional	0
or	0
behavioral	0
disturbances	0
.	0
.	0

Tumor	0
of	0
neural	0
origin	0
.	0

D.	0
Mutation	0
of	0
the	0
PHOX2B	0
gene	I-DISEASE
is	I-DISEASE
not	0
present	I-DISEASE
.	I-DISEASE

E.	0

The	0
disorder	0
is	0
not	I-DISEASE
better	I-DISEASE
explained	I-DISEASE
by	I-DISEASE
another	0
sleep	I-DISEASE
disorder	I-DISEASE
,	0
medical	0
or	0
neurological	0
disorder	I-DISEASE
,	0
medication	0
use	I-DISEASE
,	0
or	0
substance	0
use	0
disorder	0
.	I-DISEASE

Notes	0
.	0

Central	0
apneas	0
may	0
occur	I-DISEASE
but	0
the	I-DISEASE
predominant	0
pattern	0
is	0
reduced	I-DISEASE
flow	0
/	0
tidal	0
volume	I-DISEASE
associated	0
with	0
hypoventilation	0
and	0
arterial	0
oxygen	0
desaturation	0
.	0

Essential	0
Features	0
Late	0
-	0
onset	0
central	0
hypoventilation	0
with	0
hypothalamic	0
dysfunction	0
is	0
a	0
disorder	0
of	0
central	0
control	0
of	0
ventilation	I-DISEASE
.	0

Patients	0
are	0
usually	B-DISEASE
healthy	0
until	0
early	0
childhood	I-DISEASE
(	0
often	I-DISEASE
2	0
-	0
3	I-DISEASE
years	I-DISEASE
of	0
age	I-DISEASE
)	0
when	0
they	I-DISEASE
develop	0
hyperphagia	0
and	0
severe	0
obesity	0
,	0
followed	0
by	0
central	0
hypoventilation	I-DISEASE
,	0
which	0
often	0
presents	0
as	0
respiratory	0
failure	0
.	0

The	0
respiratory	0
failure	0
may	0
be	0
precipitated	0
by	I-DISEASE
a	0
mild	0
respiratory	0
illness	0
or	0
anesthesia	I-DISEASE
.	0

Patients	0
require	0
ventilatory	0
support	0
during	0
sleep	0
;	I-DISEASE
most	0
patients	I-DISEASE
breathe	0
adequately	0
during	0
wakefulness	I-DISEASE
but	0
some	0
need	I-DISEASE
ventilatory	0
support	0
during	0
both	0
wakefulness	0
and	0
sleep	0
.	I-DISEASE

The	0
hypoventila-	0
tion	0
persists	0
even	0
if	0
the	I-DISEASE
patients	0
lose	I-DISEASE
weight	0
,	0
differentiating	0
the	0
condition	0
from	0
obesity	I-DISEASE
hypoventilation	I-DISEASE
syndrome	0
.	0

Patients	0
often	0
develop	B-DISEASE
hypothalamic	I-DISEASE
endocrine	0
dysfunc-	0
tion	0
characterized	0
by	0
increased	0
or	0
decreased	0
hormone	0
levels	0
,	I-DISEASE
which	I-DISEASE
may	I-DISEASE
include	I-DISEASE
one	0
or	0
more	0
of	0
the	0
following	0
:	I-DISEASE
diabetes	0
insipidus	0
,	I-DISEASE
inappropriate	I-DISEASE
antidiuretic	0
hormone	I-DISEASE
hyperse-	0
cretion	0
,	0
precocious	0
puberty	I-DISEASE
,	0
hypogonadism	I-DISEASE
,	0
hyperprolactinemia	0
,	0
hypothyroidism	0
,	0
and	0
decreased	0
growth	B-DISEASE
hormone	I-DISEASE
secretion	I-DISEASE
.	0

Mood	0
and	0
behavior	0
abnormalities	0
,	0
sometimes	0
severe	I-DISEASE
,	0
have	I-DISEASE
frequently	0
been	0
reported	0
.	0

Developmental	0
delay	0
or	0
autism	0
may	0
be	0
present	B-DISEASE
,	I-DISEASE
but	I-DISEASE
many	0
patients	0
are	0
cognitively	I-DISEASE
normal	0
.	0

Other	0
symptoms	0
of	0
hypothalamic	0
dysfunc-	0
tion	0
,	0
such	0
as	I-DISEASE
temperature	0
dysregulation	0
,	0
have	0
been	0
reported	I-DISEASE
.	0

Associated	0
Features	0
Tumors	0
of	I-DISEASE
neural	0
origin	I-DISEASE
such	I-DISEASE
as	I-DISEASE
ganglioneuroma	I-DISEASE
may	0
occur	0
.	0

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
None	I-DISEASE
known	I-DISEASE
.	I-DISEASE

Demographics	0
There	0
are	0
no	0
prevalence	0
data	0
.	I-DISEASE

The	0
disorder	0
seems	I-DISEASE
to	0
occur	0
equally	0
among	0
males	0
and	0
females	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
Unknown	0
.	I-DISEASE

Patients	0
do	0
not	0
have	0
the	0
PHOX2B	0
genetic	I-DISEASE
mutation	0
of	I-DISEASE
congenital	I-DISEASE
central	I-DISEASE
hypoventilation	0
syndrome	0
.	0

Familial	0
Patterns	0
Familial	0
cases	0
have	0
not	0
been	I-DISEASE
reported	0
.	I-DISEASE

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Patients	I-DISEASE
are	0
typically	0
normal	0
at	0
birth	0
.	0

Obesity	0
often	0
begins	0
in	I-DISEASE
early	0
childhood	0
,	I-DISEASE
perhaps	0
because	I-DISEASE
the	I-DISEASE
child	0
is	I-DISEASE
old	0
enough	0
to	0
walk	0
around	0
and	0
obtain	0
his	I-DISEASE
/	0
her	0
own	0
food	0
.	0

Respiratory	0
failure	0
typically	0
presents	0
several	0
years	0
after	I-DISEASE
the	0
onset	I-DISEASE
of	0
obesity	0
,	0
and	0
requires	0
ventila-	I-DISEASE
tory	I-DISEASE
support	0
via	I-DISEASE
face	0
mask	0
or	0
tracheostomy	0
.	0

The	0
respiratory	0
failure	0
does	0
not	0
improve	I-DISEASE
over	0
time	0
.	I-DISEASE

Death	0
has	0
been	0
reported	0
from	0
respiratory	0
failure	I-DISEASE
,	0
cor	I-DISEASE
pulmonale	0
,	0
or	0
hyper-	0
natremia	0
secondary	I-DISEASE
to	0
diabetes	0
insipidus	I-DISEASE
;	0
case	0
series	0
have	0
reported	0
a	0
high	I-DISEASE
mortality	0
.	0

Developmental	0
Issues	0
Not	0
applicable	0
.	0

Pathology	0
and	0
Pathophysiology	0
The	0
cause	0
of	I-DISEASE
the	I-DISEASE
disorder	0
is	I-DISEASE
not	0
known	0
.	0

The	0
brain	0
typically	0
appears	0
normal	0
on	0
imaging	0
or	0
at	0
autopsy	0
,	0
or	0
may	0
show	0
secondary	I-DISEASE
signs	0
of	0
hypoxemia	I-DISEASE
.	0

Objective	0
Findings	0
Hypoxemia	0
and	0
hypercapnia	0
are	I-DISEASE
present	0
on	0
PSG	I-DISEASE
during	0
sleep	0
.	0

Central	0
apneas	0
may	0
be	I-DISEASE
present	0
,	I-DISEASE
but	0
hypoventilation	I-DISEASE
associated	I-DISEASE
with	0
decreased	0
tidal	0
volume	0
and	0
respiratory	0
rate	I-DISEASE
is	0
more	0
common	0
.	0

Obstructive	0
apneas	0
may	0
occur	0
but	0
are	0
not	I-DISEASE
the	0
primary	I-DISEASE
abnormality	0
.	0

Sleep	0
Related	0
Breathing	I-DISEASE
Disorders	0
Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Patients	I-DISEASE
have	0
flat	0
hypoxic	I-DISEASE
and	0
hypercapnic	0
responses	I-DISEASE
.	0

Oxygen	0
and	0
carbon	0
dioxide	0
determinations	0
may	0
be	I-DISEASE
normal	0
during	I-DISEASE
wakefulness	0
but	0
will	0
demonstrate	I-DISEASE
hypoxemia	I-DISEASE
and	0
hypercapnia	0
during	I-DISEASE
sleep	I-DISEASE
.	0

In	0
patients	0
with	I-DISEASE
chronically	0
untreated	0
or	0
poorly	0
con-	0
trolled	I-DISEASE
hypoventilation	0
,	0
a	0
compensated	I-DISEASE
respiratory	0
acidosis	I-DISEASE
may	I-DISEASE
be	0
present	I-DISEASE
,	0
with	0
ele-	0
vated	0
serum	0
bicarbonate	0
levels	I-DISEASE
.	I-DISEASE

In	0
these	0
patients	0
,	I-DISEASE
polycythemia	0
may	I-DISEASE
be	I-DISEASE
present	0
.	I-DISEASE

Serum	0
tests	0
may	0
show	0
evidence	0
of	0
endocrine	0
abnormalities	0
;	I-DISEASE
hypernatremia	0
is	0
common	0
.	0

Computed	0
tomography	0
and	0
MRI	0
scans	0
of	0
the	I-DISEASE
head	0
are	I-DISEASE
normal	0
.	0

Electrocardiography	0
,	0
echocardiography	0
,	I-DISEASE
or	0
cardiac	I-DISEASE
catheterization	I-DISEASE
may	0
reveal	I-DISEASE
evidence	I-DISEASE
of	0
pulmonary	I-DISEASE
hyper-	0
tension	0
.	I-DISEASE

Pulmonary	0
function	0
tests	0
may	0
be	I-DISEASE
normal	I-DISEASE
or	I-DISEASE
show	0
evidence	I-DISEASE
of	0
mild	0
obstructive	0
or	0
restrictive	0
lung	I-DISEASE
disease	0
resulting	0
from	I-DISEASE
associated	0
conditions	0
such	0
as	0
tracheitis	0
.	0

Differential	0
Diagnosis	0

The	0
disorder	0
can	I-DISEASE
be	0
distinguished	I-DISEASE
from	I-DISEASE
late	0
presentation	0
of	I-DISEASE
congenital	0
central	I-DISEASE
hypoven-	0
tilation	0
syndrome	0
by	I-DISEASE
testing	0
for	0
the	I-DISEASE
PHOX2B	0
gene	0
.	0

Genetic	0
testing	0
may	I-DISEASE
also	0
be	0
useful	0
in	I-DISEASE
distinguishing	0
the	0
disorder	0
from	I-DISEASE
Prader	0
-	0
Willi	0
syndrome	I-DISEASE
,	0
which	0
is	0
characterized	0
by	0
a	0
known	I-DISEASE
genetic	0
abnormality	0
.	I-DISEASE

Most	0
children	0
with	I-DISEASE
Prader	0
-	0
Willi	0
syndrome	0
have	0
hypotonia	0
at	0
birth	0
and	0
more	0
severe	0
developmental	0
delay	0
.	0

The	0
disorder	0
can	0
be	0
distinguished	I-DISEASE
from	I-DISEASE
obesity	0
hypoventilation	0
syndrome	I-DISEASE
by	0
the	0
presence	0
of	0
endocrine	0
abnormalities	I-DISEASE
and	0
other	I-DISEASE
associated	0
hypothalamic	0
abnormalities	0
,	0
and	0
by	0
the	0
persistence	I-DISEASE
of	0
hypoventilation	0
despite	I-DISEASE
weight	0
loss	0
.	0

In	0
addition	0
,	0
the	0
patients	0
typically	I-DISEASE
have	I-DISEASE
a	0
totally	I-DISEASE
flat	0
hypercapnic	0
ventilatory	0
response	0
rather	0
than	I-DISEASE
the	0
blunted	0
response	I-DISEASE
seen	0
in	0
children	0
with	0
obesity	0
hypoventilation	0
syndrome	I-DISEASE
.	0

The	0
disorder	0
should	0
be	0
distinguished	I-DISEASE
from	I-DISEASE
isolated	0
hypopituitarism	0
or	I-DISEASE
other	0
hypothalamic	0
disease	0
without	0
hypoventilation	0
,	0
and	0
from	I-DISEASE
obesity	I-DISEASE
-	0
related	0
OSA	0
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE

The	0
etiology	0
of	0
the	0
disorder	0
is	I-DISEASE
not	I-DISEASE
known	0
.	I-DISEASE

Although	0
the	0
disorder	I-DISEASE
shares	0
some	0
fea-	0
tures	0
of	0
congenital	I-DISEASE
central	0
hypoventilation	0
syndrome	0
,	I-DISEASE
including	0
the	0
presence	0
of	0
neural	0
tumors	0
,	0
it	0
does	0
not	0
share	0
the	I-DISEASE
same	0
gene	0
.	I-DISEASE

Little	0
information	0
is	0
available	0
on	0
prevalence	0
or	I-DISEASE
long	0
-	0
term	0
prognosis	0
.	0

Bibliography	0
Ize	0
-	0
Ludlow	0
D	0
,	0
Gray	I-DISEASE
JA	0
,	0
Sperling	0
MA	0
,	0
et	I-DISEASE
al	0
.	0

Rapid	0
-	0
onset	0
obesity	0
with	0
hypothalamic	0
dysfunction	0
,	0
hypoventilation	0
,	0
and	0
autonomic	0
dysregulation	0
presenting	0
in	0
childhood	0
.	0

Pediatrics	0
2007;120	0
:	0
e179–88	I-DISEASE
.	0

Katz	0
ES	0
,	0
McGrath	0
S	0
,	I-DISEASE
Marcus	I-DISEASE
CL	0
.	0

Late	0
-	0
onset	0
central	0
hypoventilation	0
with	0
hypothalamic	0
dysfunction	0
:	0
a	0
distinct	0
clinical	0
syndrome	0
.	0

Pediatr	0
Pulmonol	0
2000;29:62–8	0
.	0

Idiopathic	0
Central	0
Alveolar	0
Hypoventilation	0
ICD-9	0
-	0
CM	0
code	0
:	0
327.24	0
ICD-10	0
-	0
CM	0
code	0
:	0

G47.34	0
Alternate	0
Names	0
Alveolar	0
hypoventilation	0
,	I-DISEASE
central	I-DISEASE
alveolar	0
hypoventilation	I-DISEASE
,	0
idiopathic	0
central	0
alveolar	0
hypoventilation	0
,	I-DISEASE
nonapneic	0
alveolar	0
hypoventilation	I-DISEASE
,	0
primary	I-DISEASE
alveolar	0
hypoventilation	0
.	0

Diagnostic	0
Criteria	0
Criteria	0
A	0
and	0
B	I-DISEASE
must	0
be	0
met	I-DISEASE
A.	0
Sleep	0
related	0
hypoventilation	0
is	0
present	0
.	I-DISEASE

B.	0
Hypoventilation	0
is	0
not	0
primarily	0
due	I-DISEASE
to	I-DISEASE
lung	0
parenchymal	I-DISEASE
or	I-DISEASE
airway	0
disease	0
,	0
pulmonary	0
vascular	I-DISEASE
pathology	0
,	0
chest	0
wall	0
disorder	0
,	0
medication	0
use	0
,	I-DISEASE
neurologic	0
disorder	0
,	0
muscle	I-DISEASE
weakness	0
,	0
or	I-DISEASE
obesity	0
or	0
congenital	0
hypoventilation	0
syndromes	0
.	0

Notes	0
.	0

The	0
predominant	0
respiratory	0
pattern	0
is	0
one	0
of	I-DISEASE
reduced	0
tidal	I-DISEASE
volume	0
or	0
ataxic	0
breathing	I-DISEASE
with	0
associated	0
arterial	0
oxygen	0
desaturation	0
.	0

Although	0
OSA	0
may	0
be	0
present	0
,	0
it	0
is	0
not	0
believed	0
to	0
be	0
the	0
major	0
cause	I-DISEASE
of	0
hypoventilation	0
.	I-DISEASE

When	0
criteria	0
are	0
met	0
,	0
a	I-DISEASE
diagnosis	I-DISEASE
of	0
both	I-DISEASE
OSA	0
and	0
idiopathic	0
central	I-DISEASE
alveolar	0
hypoventilation	I-DISEASE
may	0
be	0
made	I-DISEASE
.	0
.	I-DISEASE

Arterial	0
oxygen	0
desaturation	0
is	0
often	0
present	I-DISEASE
but	0
is	0
not	I-DISEASE
required	0
for	0
the	0
diagnosis	I-DISEASE
.	0

Essential	0
Features	0
Idiopathic	0
central	0
alveolar	0
hypoventilation	0
is	0
defined	0
as	I-DISEASE
the	I-DISEASE
presence	0
of	0
decreased	0
alve-	0
olar	I-DISEASE
ventilation	I-DISEASE
resulting	0
in	I-DISEASE
sleep	I-DISEASE
related	0
hypercapnia	0
and	0
hypoxemia	0
in	0
individuals	I-DISEASE
with	0
presumed	0
normal	0
mechanical	0
properties	0
of	I-DISEASE
the	I-DISEASE
lung	0
and	0
respiratory	0
pump	0
.	0

Thus	0
,	0
chronic	0
hypoventilation	0
during	0
sleep	0
exists	I-DISEASE
without	0
any	I-DISEASE
readily	0
identifiable	0
impairments	0
of	I-DISEASE
res-	0
piration	I-DISEASE
,	I-DISEASE
such	0
as	I-DISEASE
pulmonary	0
airway	0
or	0
parenchymal	0
conditions	0
,	0
neurologic	I-DISEASE
,	0
neuromus-	I-DISEASE
cular	I-DISEASE
or	0
chest	0
wall	0
abnormalities	I-DISEASE
,	0
severe	0
obesity	0
,	I-DISEASE
other	0
sleep	I-DISEASE
related	0
breathing	0
disorder	I-DISEASE
,	0
or	0
use	0
of	0
respiratory	0
depressant	I-DISEASE
medications	I-DISEASE
or	0
substances	I-DISEASE
.	0

Diurnal	0
as	0
well	0
as	0
nocturnal	0
hypoventilation	0
is	0
believed	0
to	0
be	0
due	0
primarily	0
to	0
blunted	0
chemoresponsiveness	I-DISEASE
to	0
CO2	0
and	I-DISEASE
O2	0
.	0

However	0
,	I-DISEASE
reported	0
cases	0
are	0
few	0
and	I-DISEASE
not	0
studied	I-DISEASE
in	0
enough	0
detail	0
to	I-DISEASE
conclu-	0
sively	I-DISEASE
establish	0
a	0
well	I-DISEASE
-	0
defined	0
etiology	0
.	0

Alternatively	0
,	0
these	0
cases	0
may	0
represent	I-DISEASE
a	I-DISEASE
mixed	0
group	I-DISEASE
of	0
patients	0
with	I-DISEASE
varied	0
underlying	I-DISEASE
conditions	I-DISEASE
erroneously	0
deemed	0
idiopathic	I-DISEASE
as	0
a	0
result	0
of	0
incomplete	0
diagnostic	I-DISEASE
work	I-DISEASE
-	0
up	I-DISEASE
.	0

Patient	0
may	0
complain	0
of	B-DISEASE
morning	0
headaches	I-DISEASE
,	I-DISEASE
fatigue	I-DISEASE
,	I-DISEASE
neurocognitive	0
decline	0
and	0
sleep	0
disturbance	0
,	I-DISEASE
or	0
may	0
be	I-DISEASE
entirely	0
asymptomatic	I-DISEASE
.	0

Frequent	0
episodes	0
of	0
shallow	0
breathing	0
may	I-DISEASE
be	I-DISEASE
noted	0
to	I-DISEASE
occur	I-DISEASE
during	0
sleep	0
.	0

Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Sleep	I-DISEASE
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Associated	I-DISEASE
Features	0
Consequences	0
of	I-DISEASE
chronic	0
hypercapnia	I-DISEASE
and	I-DISEASE
hypoxemia	I-DISEASE
include	0
pulmonary	I-DISEASE
artery	0
hyper-	0
tension	0
,	0
cor	0
pulmonale	I-DISEASE
,	I-DISEASE
and	0
neurocognitive	0
dysfunction	I-DISEASE
.	0

Patients	0
with	0
other	0
comorbid	0
sleep	0
related	0
breathing	0
disorders	0
are	I-DISEASE
likely	I-DISEASE
to	0
experience	0
greater	0
severity	0
and	0
dura-	0
tion	0
of	I-DISEASE
sleep	0
related	I-DISEASE
hypoventilation	0
than	0
are	0
patients	0
with	I-DISEASE
isolated	I-DISEASE
idiopathic	I-DISEASE
central	I-DISEASE
hypoventilation	0
.	0

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Not	I-DISEASE
applicable	I-DISEASE
or	I-DISEASE
known	I-DISEASE
.	I-DISEASE

Demographics	0
Not	0
known	0
.	0

It	0
is	0
likely	0
that	0
some	0
patients	0
with	I-DISEASE
this	0
diagnosis	0
may	0
have	0
an	0
underlying	0
anatomic	0
or	I-DISEASE
functional	0
defect	0
affecting	0
respiratory	0
mechanics	0
and	0
ventilatory	0
drive	0
which	0
remains	0
undiagnosed	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
The	0
use	I-DISEASE
of	I-DISEASE
central	0
nervous	I-DISEASE
system	0
depressants	0
,	0
such	0
as	0
alcohol	I-DISEASE
,	0
anxiolytics	0
,	I-DISEASE
and	0
hyp-	0
notics	0
,	0
may	0
further	I-DISEASE
worsen	0
hypercapnia	0
/	I-DISEASE
hypoxemia	0
.	0

Patients	0
who	0
are	B-DISEASE
hypercapnic	0
and	0
hypoxemic	0
during	0
wakefulness	0
will	I-DISEASE
generally	0
become	0
even	0
more	I-DISEASE
so	0
during	0
sleep	I-DISEASE
,	I-DISEASE
in	I-DISEASE
particular	0
REM	I-DISEASE
sleep	0
,	0
but	0
the	0
relationship	I-DISEASE
between	I-DISEASE
wake	0
SaO2	0
/	0
PaCO2	0
and	0
sleep	I-DISEASE
related	0
desaturation	0
is	I-DISEASE
not	0
sufficiently	0
strong	I-DISEASE
to	0
have	0
substantial	I-DISEASE
predictive	0
value	0
in	0
individual	I-DISEASE
patients	I-DISEASE
.	I-DISEASE

Familial	0
Patterns	0
Not	0
applicable	0
or	0
known	0
.	I-DISEASE

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
The	I-DISEASE
onset	0
of	I-DISEASE
the	0
condition	I-DISEASE
is	0
variable	0
,	0
often	I-DISEASE
presenting	I-DISEASE
in	0
adolescence	I-DISEASE
or	0
early	0
adulthood	0
.	0

The	0
disorder	0
is	0
generally	0
slowly	I-DISEASE
progressive	0
.	0

Many	0
affected	0
individuals	0
with	0
severe	0
hypercapnia	I-DISEASE
and	I-DISEASE
hypoxemia	0
develop	0
respiratory	0
impairment	I-DISEASE
,	0
pulmonary	0
hypertension	I-DISEASE
,	I-DISEASE
heart	0
failure	0
,	I-DISEASE
cardiac	0
arrhythmias	0
,	0
and	0
neurocognitive	I-DISEASE
dysfunction	0
.	I-DISEASE

Polycythemia	0
is	0
common	0
in	0
those	0
with	0
chronic	I-DISEASE
hypoxia	0
.	0

Although	0
the	0
risk	I-DISEASE
of	0
increased	0
morbidity	I-DISEASE
and	I-DISEASE
mortality	0
appears	I-DISEASE
to	0
increase	0
with	I-DISEASE
worsening	0
sleep	0
related	0
hypoventilation	0
/	0
hypoxemia	I-DISEASE
,	I-DISEASE
the	I-DISEASE
specific	0
relationship	0
between	0
sleep	0
related	I-DISEASE
hypoventilation	0
/	0
hypoxemia	0
and	I-DISEASE
mor-	0
bidity	0
and	I-DISEASE
mortality	0
is	0
not	0
well	I-DISEASE
defined	I-DISEASE
.	I-DISEASE

Developmental	0
Issues	0
Not	0
known	0
.	0

Pathology	0
and	0
Pathophysiology	0
The	0
etiology	0
of	I-DISEASE
hypoventilation	I-DISEASE
in	0
these	I-DISEASE
patients	0
is	0
not	0
understood	0
.	0

Chronic	0
hyper-	0
capnia	0
and	I-DISEASE
hypoxemia	0
in	I-DISEASE
idiopathic	I-DISEASE
central	0
alveolar	I-DISEASE
hypoventilation	0
is	0
believed	I-DISEASE
to	I-DISEASE
be	0
due	I-DISEASE
to	I-DISEASE
defective	0
CO2	I-DISEASE
and	0
O2	0
homeostasis	0
,	0
with	0
impaired	0
CO2	0
unloading	0
,	0
reduced	I-DISEASE
chemoresponsiveness	0
to	I-DISEASE
CO2	0
and	0
O2	0
,	0
and	0
suppression	I-DISEASE
of	0
respiratory	0
drive	I-DISEASE
.	0

Imaging	0
of	0
the	0
central	0
nervous	0
system	0
does	I-DISEASE
not	0
document	0
a	0
structural	0
defect	0
.	0

Hypoventilation	0
worsens	0
during	0
sleep	0
compared	0
to	I-DISEASE
waking	I-DISEASE
levels	I-DISEASE
due	I-DISEASE
to	0
a	0
further	0
reduction	0
in	0
che-	0
mosensitivity	0
and	0
decreased	0
activity	0
of	0
the	0
ventilatory	0
muscles	0
.	0

Additionally	0
,	0
daytime	0
hypoxemia	0
,	0
if	0
sufficiently	I-DISEASE
severe	0
,	I-DISEASE
may	0
place	0
the	0
patient	0
near	0
or	I-DISEASE
on	I-DISEASE
the	0
steep	I-DISEASE
portion	0
of	0
the	0
oxyhemoglobin	0
dissociation	0
curve	I-DISEASE
where	I-DISEASE
even	0
relatively	I-DISEASE
small	I-DISEASE
decrements	0
in	I-DISEASE
arterial	I-DISEASE
oxygen	0
tension	0
result	0
in	0
large	I-DISEASE
decrements	I-DISEASE
in	I-DISEASE
oxyhemoglobin	0
saturation	I-DISEASE
.	I-DISEASE

Thus	0
,	0
sleep	0
related	I-DISEASE
hypoventilation	I-DISEASE
in	0
these	0
patients	0
may	0
have	0
a	0
relatively	0
great	I-DISEASE
impact	0
on	0
oxyhemoglobin	0
saturation	0
.	I-DISEASE

Objective	0
Findings	0

The	0
characteristic	0
polysomnographic	0
finding	0
is	0
demonstration	0
of	0
sleep	0
related	I-DISEASE
hypoventilation	0
(	0
determination	0
of	0
PaCO2	I-DISEASE
by	I-DISEASE
arterial	I-DISEASE
blood	0
gas	I-DISEASE
or	0
by	0
a	0
surrogate	0
measure	0
[	0
end	I-DISEASE
-	I-DISEASE
tidal	0
CO2	I-DISEASE
or	I-DISEASE
transcutaneous	0
CO2	0
]	0
)	0
.	0

Periods	0
of	0
decreased	0
tidal	0
volume	0
lasting	0
up	0
to	0
several	I-DISEASE
minutes	0
,	0
with	0
sustained	0
arterial	0
oxygen	0
desaturation	0
,	I-DISEASE
are	0
usually	0
present	0
.	0

Intermittent	0
arousals	I-DISEASE
may	I-DISEASE
be	I-DISEASE
observed	0
.	I-DISEASE

Daytime	0
arterial	0
blood	0
gases	I-DISEASE
may	I-DISEASE
be	0
normal	I-DISEASE
or	0
show	I-DISEASE
hypoxia	0
and	0
hypercapnia	0
.	0

Chronic	0
hypoxia	0
can	0
be	I-DISEASE
associated	0
with	I-DISEASE
polycythemia	I-DISEASE
.	0

Electrocardiography	0
,	0
chest	0
radiography	0
,	0
and	I-DISEASE
echocardiography	I-DISEASE
may	0
demonstrate	I-DISEASE
evidence	0
of	0
pulmonary	0
hypertension	I-DISEASE
.	0

Central	0
nervous	0
system	0
imaging	0
is	0
generally	0
unremarkable	I-DISEASE
.	0

Differential	0
Diagnosis	0

The	0
differential	0
diagnosis	0
includes	0
any	0
disorder	0
that	I-DISEASE
can	0
cause	0
hypoventilation	0
during	0
sleep	0
.	0

This	0
includes	0
obesity	0
hypoventilation	I-DISEASE
syndrome	0
,	I-DISEASE
pulmonary	0
airway	I-DISEASE
and	I-DISEASE
paren-	0
chymal	I-DISEASE
disorders	0
,	I-DISEASE
pulmonary	0
vascular	I-DISEASE
pathology	I-DISEASE
,	0
neuromuscular	I-DISEASE
and	0
chest	0
wall	0
dis-	0
orders	0
,	0
severe	I-DISEASE
untreated	0
hypothyroidism	0
,	I-DISEASE
and	0
use	0
of	I-DISEASE
respiratory	0
suppressants	0
.	0

CCHS	0
is	0
associated	0
with	0
an	0
abnormal	0
PHOX2B	I-DISEASE
gene	0
.	I-DISEASE

Unlike	0
patients	0
with	I-DISEASE
late	0
-	0
onset	0
central	0
hypoventilation	0
with	I-DISEASE
hypothalamic	0
dysfunction	0
,	0
patients	0
with	0
idiopathic	I-DISEASE
central	0
hypoventilation	0
do	0
not	0
have	0
evidence	0
of	0
hypothalamic	0
dysfunction	I-DISEASE
.	I-DISEASE

It	0
is	0
essential	0
to	0
excluded	0
medical	I-DISEASE
and	0
neurological	0
disorders	I-DISEASE
that	0
are	0
associated	0
with	0
hypoventilation	0
before	I-DISEASE
a	0
diagnosis	0
of	0
idiopathic	0
central	0
hypoventilation	0
can	0
be	0
made	0
.	I-DISEASE

OSA	0
and	0
CSA	0
syndromes	0
can	I-DISEASE
be	I-DISEASE
distinguished	I-DISEASE
from	0
sleep	I-DISEASE
related	I-DISEASE
hypoventilation	0
by	0
the	I-DISEASE
periodic	I-DISEASE
alterations	I-DISEASE
in	0
airflow	0
and	I-DISEASE
accompanying	0
periodic	0
fluctuations	0
in	0
SaO2	0
.	0

In	0
contrast	0
,	0
oxygen	0
desaturation	0
due	I-DISEASE
to	I-DISEASE
sleep	0
related	0
hypoventilation	0
is	0
generally	I-DISEASE
more	0
sustained	0
,	I-DISEASE
usually	0
several	0
minutes	I-DISEASE
or	0
longer	0
in	0
duration	0
.	0

When	0
more	0
than	0
one	0
disorder	0
is	I-DISEASE
believed	I-DISEASE
Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Sleep	0
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
to	0
be	0
responsible	I-DISEASE
for	I-DISEASE
the	0
ventilatory	0
insufficiency	0
during	I-DISEASE
sleep	0
,	I-DISEASE
all	0
pertinent	0
diagnoses	I-DISEASE
should	0
be	0
coded	I-DISEASE
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE

A	0
better	0
understanding	0
of	I-DISEASE
the	0
etiology	I-DISEASE
of	0
idiopathic	0
central	I-DISEASE
alveolar	0
hypoventilation	0
is	0
essential	0
to	0
guide	0
preventive	I-DISEASE
and	0
treatment	0
measures	0
.	0

Because	0
it	0
is	0
clinically	0
imprac-	0
tical	0
to	I-DISEASE
routinely	0
obtain	I-DISEASE
arterial	0
blood	0
samples	0
during	0
sleep	I-DISEASE
in	I-DISEASE
most	I-DISEASE
persons	0
suspected	0
of	0
this	I-DISEASE
disorder	0
,	0
other	0
techniques	0
of	I-DISEASE
measuring	0
CO2	0
levels	I-DISEASE
must	0
be	0
investigated	0
.	0

The	0
degree	0
and	0
duration	I-DISEASE
of	0
hypercapnia	I-DISEASE
/	I-DISEASE
hypoxemia	0
necessary	0
to	0
produce	0
adverse	I-DISEASE
conse-	0
quences	I-DISEASE
,	I-DISEASE
such	0
as	0
pulmonary	0
hypertension	0
,	I-DISEASE
in	0
individual	0
patients	0
is	I-DISEASE
not	I-DISEASE
well	I-DISEASE
defined	0
.	I-DISEASE

Little	0
information	0
is	0
available	0
regarding	0
the	I-DISEASE
effect	I-DISEASE
of	0
oxygen	I-DISEASE
therapy	0
or	0
noninvasive	0
ventilation	0
on	0
the	I-DISEASE
course	0
of	0
the	I-DISEASE
underlying	0
disease	0
.	0

Studies	0
are	0
needed	0
to	0
determine	0
the	0
optimal	I-DISEASE
time	0
to	I-DISEASE
initiate	0
these	0
interventions	0
and	I-DISEASE
the	0
specific	I-DISEASE
subpopulations	I-DISEASE
of	0
patients	I-DISEASE
who	0
will	0
benefit	0
most	I-DISEASE
from	0
these	I-DISEASE
therapies	I-DISEASE
.	0

Bibliography	0
Brown	0
LK	0
.	0

Hypoventilation	0
syndromes	0
.	0

Clin	0
Chest	I-DISEASE
Med	0
2010;31:249–70	0
.	0

Casey	0
KR	0
,	0
Cantillo	0
KO	0
,	I-DISEASE
Brown	I-DISEASE
LK	0
.	I-DISEASE

Sleep	0
-	0
related	0
hypoventilation	I-DISEASE
/	0
hypoxemic	0
syndromes	I-DISEASE
.	0

Chest	0
2007;131:1936–48	0
.	0

Chebbo	0
A	0
,	0
Tfaili	0
A	0
,	I-DISEASE
Jones	I-DISEASE
SF	0
.	I-DISEASE

Hypoventilation	0
syndromes	0
.	0

Med	0
Clin	I-DISEASE
North	0
Am	I-DISEASE
2011;95:1189–202	0
.	0

Sleep	0
Related	0
Hypoventilation	I-DISEASE
Due	0
to	0
a	0
Medication	I-DISEASE
or	0
Substance	I-DISEASE
ICD-9	0
-	0
CM	0
code	I-DISEASE
:	0
327.26	0
ICD-10	0
-	0
CM	0
code	0
:	0
G47.36	0
Alternate	0
Names	I-DISEASE
Alveolar	0
hypoventilation	0
,	0
nocturnal	0
hypoventilation	I-DISEASE
,	0
nonapneic	0
alveolar	0
hypoventila-	0
tion	0
,	0
secondary	0
alveolar	I-DISEASE
hypoventilation	I-DISEASE
,	0
sleep	0
related	I-DISEASE
hypoventilation	0
.	0

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
C	I-DISEASE
must	0
be	0
met	I-DISEASE
A.	0
Sleep	0
related	0
hypoventilation	0
is	0
present	0
.	I-DISEASE

B.	0
A	0
medication	0
or	0
substance	0
known	0
to	I-DISEASE
inhibit	0
respiration	I-DISEASE
and/or	0
ventilatory	0
drive	0
is	0
believed	0
to	0
be	0
the	0
primary	I-DISEASE
cause	0
of	0
sleep	0
related	0
hypoventilation	0
.	I-DISEASE

C.	0
Hypoventilation	I-DISEASE
is	0
not	0
primarily	0
due	I-DISEASE
to	0
lung	0
parenchymal	I-DISEASE
or	I-DISEASE
airway	0
disease	0
,	0
pulmonary	0
vascular	I-DISEASE
pathology	0
,	0
chest	0
wall	0
disorder	0
,	0
neurologic	0
disorder	0
,	I-DISEASE
muscle	0
weakness	0
,	0
obesity	I-DISEASE
hypoventilation	0
syndrome	0
,	I-DISEASE
or	0
a	0
known	0
congenital	0
central	0
alveolar	0
hypoventilation	I-DISEASE
syndrome	0
.	0

Notes	0
.	0
.	0

3	0
.	0

Although	0
OSA	0
or	0
CSA	0
may	0
be	I-DISEASE
present	I-DISEASE
,	0
they	I-DISEASE
are	0
not	0
believed	0
to	0
be	0
the	I-DISEASE
major	0
cause	0
of	I-DISEASE
hypoventilation	0
.	0

The	0
predominant	0
respiratory	0
pattern	0
is	0
one	0
of	I-DISEASE
reduced	0
tidal	I-DISEASE
volume	0
or	0
ataxic	0
breathing	I-DISEASE
and	0
associated	0
arterial	0
oxygen	0
desaturation	0
.	0

When	0
criteria	0
are	0
met	0
,	0
a	0
diagnosis	I-DISEASE
of	0
both	I-DISEASE
OSA	0
and	0
CSA	I-DISEASE
due	I-DISEASE
to	0
medication	I-DISEASE
or	0
substance	0
as	0
well	0
as	0
sleep	0
related	0
hypoventilation	0
due	I-DISEASE
to	I-DISEASE
a	I-DISEASE
medication	0
or	I-DISEASE
substance	0
may	0
be	0
made	0
.	0

Arterial	0
desaturation	0
is	0
often	0
present	0
but	0
is	I-DISEASE
not	0
required	0
for	0
the	0
diagnosis	0
.	0

Hypoventilation	0
may	0
be	0
present	0
during	0
wakefulness	0
but	0
is	0
not	0
required	0
for	0
the	0
diagnosis	0
.	0

Essential	0
Features	0

This	0
disorder	0
is	0
characterized	0
primarily	0
by	0
chronic	I-DISEASE
hypoventilation	0
and	I-DISEASE
hypercapnia	0
due	0
to	0
prolonged	0
use	0
of	I-DISEASE
medications	0
or	0
substances	I-DISEASE
known	0
to	0
depress	0
ventilatory	0
drive	0
and/or	0
impair	0
respiratory	I-DISEASE
muscle	0
mechanics	I-DISEASE
.	I-DISEASE

These	0
agents	0
include	0
long	I-DISEASE
-	0
acting	I-DISEASE
nar-	0
cotics	0
,	0
anesthetics	0
,	0
sedative	0
compounds	0
,	0
and	I-DISEASE
muscle	I-DISEASE
relaxants	I-DISEASE
.	I-DISEASE

The	0
risk	0
of	0
respiratory	0
insufficiency	0
is	0
increased	0
with	0
the	I-DISEASE
concomitant	0
use	0
of	I-DISEASE
alcohol	I-DISEASE
or	0
with	I-DISEASE
polypharmacy	0
.	0

Respiratory	0
depressants	0
can	0
precipitate	0
respiratory	0
failure	I-DISEASE
in	I-DISEASE
patients	0
with	0
limited	0
pul-	0
monary	0
reserves	0
or	0
exacerbate	I-DISEASE
hypoventilation	0
in	I-DISEASE
those	0
with	0
baseline	0
hypercapnia	0
.	0

Hypoxemia	0
is	0
commonly	0
present	I-DISEASE
and	0
can	0
show	0
either	0
a	I-DISEASE
sustained	0
reduction	0
or	0
episodic	0
fluctuations	0
.	0

Sleep	0
related	0
hypoventilation	I-DISEASE
is	0
present	0
.	0

Hypercapnia	0
may	0
also	0
be	0
present	0
during	0
wakefulness	B-DISEASE
in	0
some	I-DISEASE
patients	0
.	0

Patients	0
can	0
either	B-DISEASE
be	0
asymptomatic	0
or	0
present	0
with	0
complaints	I-DISEASE
of	0
dyspnea	0
,	0
chest	0
tightness	0
,	I-DISEASE
or	0
fatigue	0
.	I-DISEASE

Neurocognitive	0
dysfunction	0
may	0
arise	0
following	0
use	0
of	0
narcotics	0
.	I-DISEASE

Associated	0
Features	0
Medications	0
and	I-DISEASE
substances	0
that	I-DISEASE
reduce	I-DISEASE
respiratory	0
drive	I-DISEASE
may	0
also	0
alter	0
the	0
mechanics	0
of	I-DISEASE
the	I-DISEASE
upper	0
airway	I-DISEASE
.	I-DISEASE

By	0
decreasing	0
upper	I-DISEASE
airway	0
muscle	0
tone	I-DISEASE
,	I-DISEASE
these	0
agents	I-DISEASE
may	0
pre-	0
cipitate	0
or	I-DISEASE
exacerbate	0
OSA	I-DISEASE
and	0
CSA	I-DISEASE
.	0

It	0
is	0
not	0
currently	I-DISEASE
known	0
whether	0
chronic	0
use	0
of	I-DISEASE
respiratory	0
depressants	0
will	I-DISEASE
eventually	0
give	0
rise	I-DISEASE
to	0
pulmonary	0
artery	I-DISEASE
hypertension	0
or	0
cor	0
pulmonale	0
,	0
but	I-DISEASE
this	0
seems	0
unlikely	0
.	0

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Not	I-DISEASE
applicable	I-DISEASE
or	I-DISEASE
known	I-DISEASE
.	I-DISEASE

Demographics	0
The	0
demographics	0
of	0
sleep	0
related	0
hypoventilation	I-DISEASE
due	0
to	I-DISEASE
use	0
of	0
respiratory	0
suppressants	0
are	0
not	0
known	0
.	0

It	0
is	0
clear	0
that	0
baseline	0
hypoventilation	0
prior	I-DISEASE
to	0
initiation	0
of	0
respiratory	0
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	I-DISEASE
Disorders	I-DISEASE
depressant	0
medication	0
will	0
worsen	0
following	0
initiation	0
of	0
the	I-DISEASE
medication	I-DISEASE
.	0

Thus	0
,	0
preva-	0
lence	0
may	0
be	I-DISEASE
higher	I-DISEASE
in	0
patients	I-DISEASE
with	I-DISEASE
greater	0
perturbations	0
of	I-DISEASE
pulmonary	0
function	I-DISEASE
or	0
neuro-	0
muscular	0
weakness	0
.	0

Individuals	0
with	0
chronic	0
hypercapnia	0
during	0
wakefulness	0
will	0
expe-	0
rience	I-DISEASE
even	I-DISEASE
greater	0
decrements	0
of	0
alveolar	0
ventilation	I-DISEASE
during	I-DISEASE
sleep	I-DISEASE
.	I-DISEASE

Studies	0
of	0
patients	0
on	I-DISEASE
methadone	0
maintenance	0
have	I-DISEASE
generally	0
found	I-DISEASE
no	0
or	0
mild	0
daytime	I-DISEASE
hypoventilation	0
.	I-DISEASE

There	0
is	0
scant	0
literature	0
about	0
daytime	I-DISEASE
or	0
nocturnal	0
PaCO2	I-DISEASE
in	0
patients	0
on	0
potent	I-DISEASE
opioids	I-DISEASE
for	0
pain	I-DISEASE
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
The	0
use	I-DISEASE
of	I-DISEASE
medications	0
or	I-DISEASE
substances	0
that	0
impair	I-DISEASE
respiration	I-DISEASE
mechanics	0
or	I-DISEASE
drive	0
is	0
the	I-DISEASE
primary	0
pathophysiologic	I-DISEASE
factor	0
responsible	0
for	0
hypoventilation	0
and	0
hypoxemia	0
.	0

There	0
are	0
significant	0
inter	0
-	0
individual	0
differences	I-DISEASE
in	0
sensitivity	0
and	0
tolerance	0
to	0
respira-	0
tory	0
depressants	I-DISEASE
.	I-DISEASE

Obesity	0
or	0
the	0
presence	0
of	I-DISEASE
medical	0
and	I-DISEASE
neurologic	0
diseases	I-DISEASE
that	0
may	0
produce	0
hypoventilation	0
may	0
further	I-DISEASE
worsen	0
hypercapnia	0
/	I-DISEASE
hypoxemia	0
.	0

Patients	0
who	0
are	B-DISEASE
hypercapnic	0
and	0
hypoxemic	0
during	0
wakefulness	0
will	I-DISEASE
generally	0
become	0
even	0
more	I-DISEASE
so	0
during	0
sleep	I-DISEASE
,	I-DISEASE
in	I-DISEASE
particular	I-DISEASE
REM	I-DISEASE
sleep	0
,	0
but	0
the	0
relationship	I-DISEASE
between	I-DISEASE
wake	0
SaO2/	0
PaCO2	0
and	0
sleep	0
related	I-DISEASE
desaturation	0
is	0
not	I-DISEASE
sufficiently	0
strong	0
to	I-DISEASE
have	0
substantial	0
pre-	I-DISEASE
dictive	0
value	0
in	0
individual	I-DISEASE
patients	I-DISEASE
.	I-DISEASE

Familial	0
Patterns	0
Not	0
applicable	0
or	0
known	0
.	I-DISEASE

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Onset	I-DISEASE
and	0
course	I-DISEASE
of	0
the	I-DISEASE
hypoventilation	0
parallel	0
the	0
use	I-DISEASE
and	0
dosing	I-DISEASE
of	I-DISEASE
medications	0
or	0
substances	0
that	0
can	I-DISEASE
impair	I-DISEASE
respiration	I-DISEASE
,	0
as	I-DISEASE
well	I-DISEASE
as	0
the	0
development	0
of	I-DISEASE
tolerance	0
to	0
these	0
substances	0
.	0

There	0
may	0
be	0
variability	I-DISEASE
in	0
susceptibility	0
to	0
hypoventilation	0
in	I-DISEASE
dif-	0
ferent	0
individuals	0
.	0

Comorbid	0
pulmonary	0
or	0
neurologic	0
disorders	0
may	0
accentuate	I-DISEASE
the	0
severity	0
of	0
hypoventilation	0
.	0

Patients	0
may	0
present	B-DISEASE
for	0
evaluation	0
of	0
suspected	I-DISEASE
OSA	0
or	I-DISEASE
may	0
be	0
identified	0
following	0
one	0
or	0
more	0
episodes	0
of	0
respiratory	0
failure	0
.	0

It	0
is	0
not	0
known	I-DISEASE
if	0
chronic	0
use	0
of	0
respiratory	I-DISEASE
depressants	0
can	I-DISEASE
lead	0
to	0
the	0
development	I-DISEASE
of	0
pulmo-	I-DISEASE
nary	I-DISEASE
hypertension	0
,	0
polycythemia	0
,	0
and	I-DISEASE
cardiac	0
arrhythmias	I-DISEASE
.	I-DISEASE

Neurocognitive	0
dysfunc-	0
tion	0
may	I-DISEASE
develop	0
either	0
as	I-DISEASE
a	0
direct	I-DISEASE
result	0
of	0
medication	I-DISEASE
usage	I-DISEASE
or	0
as	I-DISEASE
a	0
consequence	0
of	I-DISEASE
chronic	0
hypoxia	0
and	0
hypercapnia	0
.	0

Pathology	0
and	0
Pathophysiology	0
Hypoventilation	0
is	0
a	I-DISEASE
direct	I-DISEASE
result	0
of	I-DISEASE
impaired	0
respiratory	0
drive	I-DISEASE
and	0
CO2	0
and	I-DISEASE
O2	0
chemo-	0
sensitivity	I-DISEASE
.	0

Hypoventilation	0
worsens	0
during	0
sleep	0
,	0
especially	I-DISEASE
in	I-DISEASE
REM	I-DISEASE
sleep	I-DISEASE
,	0
compared	0
to	0
waking	0
levels	0
,	I-DISEASE
due	I-DISEASE
to	0
a	I-DISEASE
further	0
reduction	I-DISEASE
in	0
chemosensitivity	0
and	0
decreased	0
activity	I-DISEASE
of	0
the	0
ventilatory	0
muscles	0
.	0

In	0
addition	0
,	0
use	0
of	0
respiratory	I-DISEASE
suppressants	I-DISEASE
may	0
give	0
rise	0
to	0
OSA	0
and	0
CSA	0
that	I-DISEASE
may	I-DISEASE
contribute	I-DISEASE
to	I-DISEASE
hypercapnia	0
and	0
hypoxemia	0
.	0

Objective	0
Findings	0

The	0
characteristic	0
PSG	0
finding	0
is	0
demonstration	0
of	I-DISEASE
sleep	0
related	I-DISEASE
hypoventilation	0
by	0
monitoring	0
of	0
PaCO2	0
or	0
acceptable	0
surrogate	0
during	I-DISEASE
sleep	0
.	0

Sustained	0
oxygen	0
desat-	0
uration	0
during	0
sleep	I-DISEASE
that	I-DISEASE
is	0
unexplained	I-DISEASE
by	0
discrete	0
apnea	I-DISEASE
and	0
hypopnea	0
events	0
is	0
common	0
.	0

However	0
,	0
this	0
finding	0
alone	0
is	0
not	0
sufficient	0
to	I-DISEASE
make	0
a	0
diagnosis	0
of	0
sleep	0
related	I-DISEASE
hypoventilation	I-DISEASE
.	0

Medication	0
use	I-DISEASE
can	0
also	0
produce	0
obstructive	0
or	I-DISEASE
central	0
apneas	I-DISEASE
.	0

Intermittent	0
arousals	0
associated	0
with	I-DISEASE
hypoxemia	0
may	I-DISEASE
be	I-DISEASE
observed	0
.	I-DISEASE

An	0
ataxic	0
breathing	I-DISEASE
pattern	0
may	0
be	0
present	0
.	0

Differential	0
Diagnosis	0

The	0
differential	0
diagnosis	0
encompasses	0
essentially	0
all	I-DISEASE
disorders	0
that	0
can	I-DISEASE
lead	0
to	0
hypoventilation	0
during	0
sleep	0
.	I-DISEASE

This	0
includes	0
OHS	0
,	0
pulmonary	0
airway	I-DISEASE
and	I-DISEASE
parenchy-	0
mal	I-DISEASE
disorders	0
,	0
pulmonary	0
vascular	0
pathology	0
,	I-DISEASE
neuromuscular	0
and	0
chest	I-DISEASE
wall	I-DISEASE
disor-	0
ders	0
,	0
severe	0
untreated	I-DISEASE
hypothyroidism	I-DISEASE
,	0
and	0
congenital	I-DISEASE
or	0
idiopathic	0
central	I-DISEASE
alveo-	I-DISEASE
lar	0
hypoventilation	0
syndromes	0
.	I-DISEASE

OSA	0
and	0
CSA	0
syndromes	0
can	I-DISEASE
be	I-DISEASE
distinguished	I-DISEASE
from	0
sleep	I-DISEASE
related	I-DISEASE
hypoventilation	0
by	0
the	I-DISEASE
periodic	I-DISEASE
alterations	I-DISEASE
in	0
airflow	0
and	I-DISEASE
accompanying	0
periodic	0
fluctuations	0
in	0
SaO2	0
.	0

In	0
contrast	0
,	0
oxygen	0
desaturation	0
due	I-DISEASE
to	I-DISEASE
sleep	0
related	0
hypoventilation	0
is	0
generally	I-DISEASE
more	0
sustained	0
,	I-DISEASE
usually	0
several	0
minutes	I-DISEASE
or	0
longer	0
in	0
dura-	0
tion	0
.	I-DISEASE

When	0
more	0
than	0
one	0
disorder	0
is	I-DISEASE
believed	I-DISEASE
to	0
be	I-DISEASE
responsible	I-DISEASE
for	0
the	0
ventilatory	I-DISEASE
insufficiency	0
during	I-DISEASE
sleep	0
,	0
all	0
pertinent	0
diagnoses	I-DISEASE
should	0
be	0
coded	0
.	0

Unresolved	0
Issues	0
and	0
Further	I-DISEASE
Directions	I-DISEASE
Studies	I-DISEASE
of	I-DISEASE
the	0
factors	I-DISEASE
influencing	0
individual	0
susceptibility	0
and	I-DISEASE
tolerance	0
to	0
hypoven-	0
tilation	0
/	I-DISEASE
hypercapnia	0
due	0
to	0
medications	0
or	0
substances	0
are	I-DISEASE
needed	0
.	0

The	0
long	0
-	0
term	0
con-	0
sequences	I-DISEASE
of	I-DISEASE
chronic	0
use	I-DISEASE
of	0
respiratory	0
depressants	0
are	0
poorly	0
understood	0
.	0

The	0
value	0
of	0
routinely	0
measuring	0
PaCO2	0
during	0
sleep	0
in	I-DISEASE
patients	0
taking	0
respiratory	0
depressants	I-DISEASE
is	0
not	I-DISEASE
clear	I-DISEASE
.	0

Additionally	0
,	0
because	0
it	0
is	0
clinically	0
impractical	I-DISEASE
to	0
routinely	I-DISEASE
obtain	0
arterial	0
blood	0
samples	I-DISEASE
during	0
sleep	I-DISEASE
in	0
most	0
persons	I-DISEASE
suspected	I-DISEASE
of	0
this	0
disorder	0
,	0
other	0
techniques	0
of	I-DISEASE
measuring	0
CO2	I-DISEASE
levels	0
must	I-DISEASE
be	0
investigated	0
.	0

Little	0
information	0
is	0
available	0
regarding	0
the	I-DISEASE
effect	I-DISEASE
of	0
oxygen	I-DISEASE
therapy	0
or	0
noninvasive	0
ventilation	0
on	0
the	I-DISEASE
course	0
of	0
the	I-DISEASE
underlying	0
disease	0
.	0

Studies	0
are	0
needed	0
to	0
determine	0
the	0
optimal	I-DISEASE
time	0
to	I-DISEASE
initiate	0
these	0
interventions	0
and	I-DISEASE
the	0
specific	I-DISEASE
subpopulations	I-DISEASE
of	0
patients	I-DISEASE
who	0
will	0
benefit	0
most	I-DISEASE
from	0
these	I-DISEASE
therapies	I-DISEASE
.	0

Bibliography	0
Brown	0
LK	0
.	0

Hypoventilation	0
syndromes	0
.	0

Clin	0
Chest	I-DISEASE
Med	0
2010;31:249–70	0
.	0

Casey	0
KR	0
,	0
Cantillo	0
KO	0
,	I-DISEASE
Brown	I-DISEASE
LK	0
.	I-DISEASE

Sleep	0
-	0
related	0
hypoventilation	I-DISEASE
/	0
hypoxemic	0
syndromes	I-DISEASE
.	0

Chest	0
2007;131:1936–48	0
.	0

Chebbo	0
A	0
,	0
Tfaili	0
A	0
,	I-DISEASE
Jones	I-DISEASE
SF	0
.	I-DISEASE

Hypoventilation	0
syndromes	0
.	0

Med	0
Clin	I-DISEASE
North	0
Am	I-DISEASE
2011;95:1189–202	0
.	0

Macintyre	0
PE	0
,	0
Loadsman	0
JA	0
,	0
Scott	I-DISEASE
DA	0
.	I-DISEASE

Opioids	0
,	0
ventilation	0
and	0
acute	0
pain	0
management	I-DISEASE
.	0

Anaesth	0
Intensive	0
Care	0
2011;39:545–58	I-DISEASE
.	0

Sleep	0
Related	0
Breathing	I-DISEASE
Disorders	0
Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Tassinari	I-DISEASE
D	0
,	0
Sartori	I-DISEASE
S	0
,	0
Tamburini	I-DISEASE
E	0
,	0
et	I-DISEASE
al	0
.	0

Adverse	0
effects	0
of	0
transdermal	0
opiates	0
treating	0
moderate	I-DISEASE
-	0
severe	I-DISEASE
cancer	0
pain	0
in	0
comparison	0
to	0
long	I-DISEASE
-	0
acting	0
morphine	0
:	0
a	0
meta	0
-	0
analysis	0
and	0
systematic	I-DISEASE
review	I-DISEASE
of	0
the	I-DISEASE
literature	0
.	0

J	0
Palliat	0
Med	0
2008;11:492–501	0
.	0

Sleep	0
Related	0
Hypoventilation	I-DISEASE
Due	0
to	0
a	0
Medical	I-DISEASE
Disorder	0
ICD-9	I-DISEASE
-	0
CM	0
code	0
:	0
327.26	0
ICD-10	I-DISEASE
-	I-DISEASE
CM	0
code	0
:	0
G47.36	0
Alternate	0
Names	I-DISEASE
Alveolar	0
hypoventilation	0
,	I-DISEASE
nonapneic	0
alveolar	0
hypoventilation	0
,	0
secondary	0
alveolar	0
hypoventilation	0
,	0
sleep	0
related	0
hypoventilation	I-DISEASE
.	0

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
C	I-DISEASE
must	0
be	0
met	I-DISEASE
A.	0
Sleep	0
related	0
hypoventilation	0
is	0
present	0
.	I-DISEASE

B.	0
A	0
lung	0
parenchymal	0
or	0
airway	I-DISEASE
disease	I-DISEASE
,	I-DISEASE
pulmonary	I-DISEASE
vascular	0
pathology	0
,	I-DISEASE
chest	0
wall	0
disorder	I-DISEASE
,	0
neurologic	0
disorder	I-DISEASE
,	0
or	0
muscle	0
weakness	0
is	0
believed	I-DISEASE
to	I-DISEASE
be	0
the	0
primary	I-DISEASE
cause	0
of	0
hypoventilation	I-DISEASE
.	I-DISEASE

C.	0
Hypoventilation	I-DISEASE
is	0
not	0
primarily	0
due	I-DISEASE
to	0
obesity	0
hypoventilation	I-DISEASE
syndrome	I-DISEASE
,	0
medication	0
use	0
,	0
or	I-DISEASE
a	I-DISEASE
known	0
congenital	I-DISEASE
central	0
alveolar	0
hypoventilation	0
syndrome	0
.	0

Notes	0
.	0

Arterial	0
desaturation	0
is	0
often	0
present	0
but	0
is	0
not	0
required	0
for	0
the	0
diagnosis	0
.	0
.	0

Although	0
OSA	0
or	0
CSA	0
may	0
be	I-DISEASE
present	I-DISEASE
,	0
they	I-DISEASE
are	0
not	0
believed	0
to	0
be	0
the	I-DISEASE
major	0
cause	0
of	I-DISEASE
hypoventilation	0
.	0

The	0
predominant	0
respiratory	0
pattern	0
is	0
one	0
of	I-DISEASE
reduced	0
tidal	I-DISEASE
volume	0
or	0
ataxic	0
breathing	I-DISEASE
and	0
associated	0
arterial	0
oxygen	0
desaturation	0
.	0

When	0
criteria	0
are	0
met	0
,	0
a	0
diagnosis	I-DISEASE
of	0
both	I-DISEASE
OSA	0
and	0
CSA	0
due	0
to	0
medical	I-DISEASE
or	0
neurological	0
condition	I-DISEASE
as	0
well	0
as	0
sleep	I-DISEASE
related	I-DISEASE
hypoventilation	0
due	I-DISEASE
to	0
a	I-DISEASE
medical	I-DISEASE
disorder	0
may	0
be	0
made	0
.	0
.	0

Hypoventilation	0
may	0
be	0
present	0
during	0
wakefulness	0
but	0
is	0
not	0
required	0
for	0
the	0
diagnosis	0
.	0

Essential	0
Features	0
Lung	0
airway	0
or	0
parenchymal	0
disease	I-DISEASE
,	0
chest	I-DISEASE
wall	0
disorders	0
,	0
pulmonary	0
hypertension	0
,	I-DISEASE
neurologic	I-DISEASE
and	0
neuromuscular	I-DISEASE
disorders	0
,	I-DISEASE
if	0
sufficiently	0
severe	0
,	0
can	I-DISEASE
result	0
in	0
ventilatory	0
impairment	0
and	0
chronic	I-DISEASE
hypercapnia	0
and	0
hypoxemia	0
.	0

Acute	0
exacerbations	0
of	0
respiratory	0
disorders	0
can	0
accentuate	I-DISEASE
the	0
severity	0
of	0
hypoventilation	0
.	0

Sleep	0
related	0
hypoventilation	I-DISEASE
is	I-DISEASE
present	0
and	0
is	0
usually	0
most	I-DISEASE
severe	0
during	0
REM	0
sleep	0
.	0

In	0
some	0
patients	0
,	I-DISEASE
hypercap-	0
nia	0
may	0
also	0
be	I-DISEASE
present	0
during	0
wakefulness	0
.	0

Patients	0
can	0
either	B-DISEASE
be	0
asymptomatic	0
or	0
present	0
with	0
complaints	I-DISEASE
of	0
dyspnea	0
,	0
chest	0
tightness	0
,	I-DISEASE
or	0
fatigue	0
.	I-DISEASE

Polycythemia	0
is	0
often	0
noted	0
with	0
severe	0
chronic	I-DISEASE
hypoxemia	0
.	I-DISEASE

Specific	0
respiratory	0
disorders	0
are	0
associated	0
with	0
abnormal	I-DISEASE
findings	0
on	I-DISEASE
pulmonary	0
function	0
testing	I-DISEASE
,	I-DISEASE
radiographic	0
imaging	I-DISEASE
,	0
echo-	0
cardiography	I-DISEASE
,	0
and	0
pulmonary	0
artery	0
catheter	0
measurements	I-DISEASE
.	I-DISEASE

Suspected	0
neurologic	0
or	I-DISEASE
neuromuscular	0
causes	0
of	0
hypoventilation	0
may	0
be	0
investigated	0
using	0
central	0
nervous	0
system	0
imaging	I-DISEASE
or	I-DISEASE
measures	0
of	I-DISEASE
peripheral	0
nerve	0
or	0
muscular	0
function	0
.	0

Associated	0
Features	0
Consequences	0
of	0
chronic	0
hypercapnia	I-DISEASE
and	I-DISEASE
hypoxemia	0
arising	I-DISEASE
as	0
a	0
result	0
of	0
medical	0
and	I-DISEASE
neurologic	0
disorders	I-DISEASE
include	I-DISEASE
pulmonary	0
artery	0
hypertension	0
,	0
cor	0
pulmonale	0
,	I-DISEASE
and	0
neu-	I-DISEASE
rocognitive	B-DISEASE
dysfunction	0
.	0

Some	0
of	0
these	0
disorders	0
are	0
prevalent	0
diseases	I-DISEASE
and	0
commonly	I-DISEASE
overlap	0
.	0

Patients	0
with	0
multiple	B-DISEASE
disorders	0
are	0
likely	I-DISEASE
to	I-DISEASE
experience	0
greater	I-DISEASE
severity	0
and	0
duration	0
of	I-DISEASE
sleep	0
related	I-DISEASE
hypoventilation	I-DISEASE
than	I-DISEASE
are	I-DISEASE
patients	0
with	0
either	0
disorder	0
alone	0
.	0

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE

The	0
clinical	0
presentation	0
varies	0
with	0
the	0
underlying	I-DISEASE
disorder	0
responsible	I-DISEASE
for	0
the	0
sleep	0
related	I-DISEASE
hypoventilation	0
.	I-DISEASE

Chronic	0
obstructive	0
pulmonary	0
disease	I-DISEASE
is	0
characterized	0
by	I-DISEASE
generally	0
fixed	I-DISEASE
and	0
not	0
fully	I-DISEASE
reversible	I-DISEASE
lower	0
airways	I-DISEASE
obstruction	I-DISEASE
,	0
and	I-DISEASE
includes	0
chronic	0
bronchitis	0
,	0
emphysema	0
,	0
cystic	0
fibrosis	0
,	I-DISEASE
and	I-DISEASE
bronchiectasis	0
.	I-DISEASE

Chronic	0
bron-	0
chitis	0
is	I-DISEASE
a	0
clinical	I-DISEASE
entity	I-DISEASE
defined	0
by	I-DISEASE
the	0
presence	0
of	0
chronic	0
productive	0
cough	I-DISEASE
for	0
at	0
least	I-DISEASE
three	0
months	0
of	0
the	0
year	I-DISEASE
,	I-DISEASE
for	0
at	0
least	I-DISEASE
two	0
consecutive	0
years	0
,	I-DISEASE
in	I-DISEASE
the	0
absence	0
of	0
other	0
identifiable	0
etiologies	I-DISEASE
.	I-DISEASE

Emphysema	0
is	0
characterized	I-DISEASE
by	0
destruction	0
of	0
lung	I-DISEASE
tissue	0
and	I-DISEASE
the	0
dilation	0
of	0
peripheral	0
airspaces	I-DISEASE
without	0
evident	0
fibrosis	0
.	0

Emphysema	0
and	0
chronic	0
bronchitis	0
often	0
coexist	I-DISEASE
.	0

Alpha-1	0
antitrypsin	0
deficiency	0
is	0
a	0
genetic	I-DISEASE
cause	0
of	0
chronic	I-DISEASE
obstructive	0
pulmonary	0
disease	0
.	I-DISEASE

Both	0
bronchiectasis	0
and	I-DISEASE
cystic	B-DISEASE
fibrosis	0
are	I-DISEASE
characterized	0
by	0
lower	I-DISEASE
airway	I-DISEASE
inflammation	0
and	I-DISEASE
destruction	0
of	0
airways	I-DISEASE
and	0
lung	0
parenchyma	I-DISEASE
.	0

Patients	0
with	0
chronic	B-DISEASE
lower	0
airways	0
obstruction	0
are	0
increasingly	0
predis-	I-DISEASE
posed	0
to	0
developing	0
hypoventilation	0
as	0
the	0
severity	I-DISEASE
of	I-DISEASE
the	I-DISEASE
underlying	0
lower	0
airways	0
obstruction	0
increases	0
.	0

Parenchymal	0
lung	0
disease	0
associated	B-DISEASE
with	0
restrictive	0
ventilatory	I-DISEASE
dysfunction	0
(	I-DISEASE
e.g.	0
,	0
interstitial	0
lung	0
disease	0
)	0
can	0
also	0
be	I-DISEASE
associated	0
with	0
sleep	0
related	0
hypoventilation	0
.	0

Neurologic	0
,	0
neuromuscular	0
,	0
and	0
chest	0
wall	I-DISEASE
disorders	0
can	I-DISEASE
produce	0
hypoventilation	0
due	0
to	0
an	0
abnormal	I-DISEASE
ventilatory	0
pump	0
(	I-DISEASE
secondary	0
to	0
reduced	0
muscle	0
strength	0
or	0
anatomic	I-DISEASE
distortion	0
of	0
the	0
chest	0
wall	0
structures	0
)	0
that	0
is	0
unable	0
to	0
meet	0
the	I-DISEASE
ventilatory	0
require-	I-DISEASE
ments	0
for	I-DISEASE
maintaining	I-DISEASE
PaCO2	0
at	I-DISEASE
or	0
below	I-DISEASE
45	I-DISEASE
mm	0
Hg	I-DISEASE
.	0

In	0
addition	0
,	0
some	0
of	0
these	I-DISEASE
patients	0
have	0
reduced	0
central	I-DISEASE
neural	0
chemoresponsiveness	I-DISEASE
.	0

Last	0
,	0
hypoxemia	0
may	I-DISEASE
be	0
worsened	I-DISEASE
Sleep	I-DISEASE
Related	0
Breathing	I-DISEASE
Disorders	0
Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
by	I-DISEASE
the	I-DISEASE
development	0
of	I-DISEASE
atelectasis	0
or	0
aspiration	0
due	I-DISEASE
to	0
defective	I-DISEASE
swallowing	I-DISEASE
associated	I-DISEASE
with	0
some	I-DISEASE
neurologic	0
and	0
neuromuscular	I-DISEASE
conditions	0
.	0

Demographics	0
The	0
demographics	0
of	0
sleep	0
related	0
hypoventilation	I-DISEASE
due	0
to	I-DISEASE
a	I-DISEASE
medical	I-DISEASE
disorder	0
are	0
a	0
function	0
of	I-DISEASE
the	0
prevalence	I-DISEASE
,	0
clinical	0
characteristics	0
,	0
and	0
degree	0
of	I-DISEASE
severity	I-DISEASE
of	I-DISEASE
the	I-DISEASE
under-	0
lying	0
conditions	0
.	I-DISEASE

Thus	0
,	0
prevalence	0
may	I-DISEASE
be	0
higher	I-DISEASE
in	I-DISEASE
patients	0
with	I-DISEASE
greater	0
perturbations	0
of	0
pulmonary	0
function	0
or	I-DISEASE
neuromuscular	I-DISEASE
weakness	I-DISEASE
.	I-DISEASE

Individuals	0
with	0
chronic	0
hyper-	0
capnia	0
during	0
wakefulness	I-DISEASE
will	0
experience	I-DISEASE
even	0
greater	I-DISEASE
decrements	0
of	I-DISEASE
alveolar	0
venti-	I-DISEASE
lation	0
during	I-DISEASE
sleep	I-DISEASE
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
Greater	0
impairments	I-DISEASE
of	I-DISEASE
respiratory	0
function	I-DISEASE
are	0
associated	0
with	I-DISEASE
greater	0
risk	I-DISEASE
for	0
sleep	0
related	0
hypoventilation	I-DISEASE
and	0
hypoxemia	0
.	0

However	0
,	I-DISEASE
there	0
is	I-DISEASE
no	0
recognized	I-DISEASE
threshold	0
of	0
pulmonary	I-DISEASE
parenchymal	0
or	0
vascular	0
disease	0
severity	0
that	I-DISEASE
adequately	0
predicts	0
the	I-DISEASE
risk	0
of	0
sleep	0
related	0
hypoventilation	I-DISEASE
in	0
individual	I-DISEASE
patients	I-DISEASE
.	I-DISEASE

Reduced	0
chemosensitivity	0
may	0
be	0
present	0
in	0
some	I-DISEASE
neuromuscular	I-DISEASE
disorders	0
.	0

The	0
use	0
of	0
central	I-DISEASE
nervous	0
system	0
depressants	I-DISEASE
,	I-DISEASE
such	I-DISEASE
as	0
alcohol	0
,	0
anxiolytics	0
,	0
and	I-DISEASE
hypnotics	I-DISEASE
,	0
may	I-DISEASE
further	0
worsen	0
respira-	0
tory	0
impairment	0
.	I-DISEASE

Patients	0
who	0
are	B-DISEASE
hypercapnic	0
and	0
hypoxemic	0
during	0
wakefulness	0
will	I-DISEASE
generally	0
become	0
even	0
more	I-DISEASE
so	0
during	0
sleep	I-DISEASE
,	I-DISEASE
in	I-DISEASE
particular	0
REM	I-DISEASE
sleep	0
,	0
but	0
the	0
rela-	I-DISEASE
tionship	I-DISEASE
between	0
wake	0
SaO2	0
/	0
PaCO2	0
and	I-DISEASE
sleep	0
related	0
desaturation	I-DISEASE
is	0
not	I-DISEASE
sufficiently	I-DISEASE
strong	0
to	I-DISEASE
have	I-DISEASE
substantial	0
predictive	I-DISEASE
value	0
in	0
individual	I-DISEASE
patients	I-DISEASE
.	I-DISEASE

Familial	0
Patterns	0
Genetic	0
patterns	0
for	0
many	0
of	I-DISEASE
the	0
disorders	I-DISEASE
are	0
not	0
known	0
.	0

Alpha-1	0
antitrypsin	0
defi-	0
ciency	0
is	0
a	I-DISEASE
genetic	I-DISEASE
disorder	0
characterized	I-DISEASE
by	0
defective	0
production	0
of	0
the	0
enzyme	I-DISEASE
inhib-	0
itor	0
;	I-DISEASE
severe	0
forms	0
of	0
deficiency	0
can	0
lead	0
to	I-DISEASE
emphysema	0
.	0

Genetic	0
causes	0
of	I-DISEASE
bronchi-	I-DISEASE
ectasis	0
include	I-DISEASE
primary	I-DISEASE
ciliary	0
dyskinesia	I-DISEASE
and	0
cystic	0
fibrosis	I-DISEASE
.	0

Muscular	0
dystrophies	0
are	0
genetically	0
inherited	0
.	0

The	0
familial	0
patterns	0
of	0
sleep	0
related	0
hypoventilation	I-DISEASE
due	I-DISEASE
to	I-DISEASE
these	0
disorders	0
reflect	0
those	0
of	0
the	0
underlying	0
inherited	0
conditions	I-DISEASE
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Onset	I-DISEASE
and	0
course	I-DISEASE
of	0
the	I-DISEASE
hypoventilation	0
parallels	0
the	0
presence	I-DISEASE
and	0
severity	I-DISEASE
of	I-DISEASE
the	0
underlying	0
medical	0
or	0
neurological	0
disorders	I-DISEASE
that	0
impair	0
respiration	0
although	I-DISEASE
substan-	I-DISEASE
tial	I-DISEASE
variability	0
in	0
course	0
is	0
observed	0
even	0
within	0
the	I-DISEASE
same	0
underlying	0
condition	I-DISEASE
.	0

Many	0
affected	0
individuals	0
with	0
severe	0
hypercapnia	I-DISEASE
and	I-DISEASE
hypoxemia	0
develop	0
respiratory	0
impairment	I-DISEASE
,	I-DISEASE
pulmonary	0
hypertension	I-DISEASE
,	I-DISEASE
heart	0
failure	0
,	I-DISEASE
cardiac	0
arrhythmias	0
,	0
and	0
neurocog-	I-DISEASE
nitive	0
dysfunction	I-DISEASE
.	0

Polycythemia	0
is	0
common	0
in	0
those	0
with	0
chronic	I-DISEASE
hypoxia	0
.	0

Although	0
the	0
risk	I-DISEASE
of	0
increased	0
morbidity	I-DISEASE
and	I-DISEASE
mortality	0
appears	I-DISEASE
to	0
increase	0
with	I-DISEASE
worsening	0
sleep	0
related	0
hypoventilation	0
,	0
the	I-DISEASE
specific	I-DISEASE
relationship	I-DISEASE
between	0
sleep	0
related	0
hypoventilation	0
and	I-DISEASE
morbidity	0
and	I-DISEASE
mortality	I-DISEASE
is	0
not	0
well	I-DISEASE
defined	I-DISEASE
.	0

Many	0
patients	0
respond	I-DISEASE
to	I-DISEASE
assisted	0
ven-	0
tilation	I-DISEASE
,	0
whereas	I-DISEASE
hypercapnia	0
may	0
worsen	0
with	0
oxygen	0
therapy	I-DISEASE
alone	0
.	I-DISEASE

Pathology	0
and	0
Pathophysiology	0
Pulmonary	0
parenchymal	0
diseases	I-DISEASE
are	I-DISEASE
characterized	0
by	I-DISEASE
altered	0
lung	0
volumes	0
(	I-DISEASE
e.g.	0
,	I-DISEASE
reduced	0
functional	0
residual	0
capacity	0
)	0
and	0
abnormal	0
ventilation	0
/	0
perfusion	I-DISEASE
relationships	0
,	0
which	I-DISEASE
can	0
result	0
in	I-DISEASE
hypercapnia	I-DISEASE
and	0
hypoxemia	0
during	0
wakefulness	0
.	0

Decreased	0
lung	0
volume	0
is	0
associated	0
with	0
reduced	0
oxygen	0
reserves	I-DISEASE
that	0
increase	0
the	0
risk	0
of	0
hypoxemia	I-DISEASE
.	0

In	0
addition	0
,	0
sleep	0
may	0
be	0
associated	I-DISEASE
with	0
an	I-DISEASE
altered	0
pattern	0
of	0
ventilatory	0
-	0
muscle	I-DISEASE
acti-	0
vation	0
,	I-DISEASE
particularly	0
during	0
REM	0
sleep	0
when	I-DISEASE
,	0
due	I-DISEASE
to	0
reduced	0
activation	0
of	I-DISEASE
the	0
intercos-	0
tal	0
and	0
accessory	0
muscles	0
,	0
there	I-DISEASE
is	0
a	0
disproportionate	0
ventilatory	0
burden	0
placed	0
on	0
the	0
diaphragm	I-DISEASE
.	I-DISEASE

This	0
may	0
lead	0
to	0
hypoventilation	0
in	0
patients	0
with	I-DISEASE
chest	I-DISEASE
wall	0
abnormalities	0
or	I-DISEASE
in	0
those	0
with	I-DISEASE
chronic	I-DISEASE
obstructive	0
pulmonary	I-DISEASE
disease	0
.	0

In	0
the	0
latter	I-DISEASE
,	0
lung	0
hyperinfla-	I-DISEASE
tion	I-DISEASE
creates	0
a	I-DISEASE
mechanical	0
disadvantage	I-DISEASE
to	0
the	0
diaphragm	0
.	I-DISEASE

Many	0
neurologic	0
and	0
neu-	0
romuscular	0
disorders	0
are	I-DISEASE
associated	0
with	I-DISEASE
impaired	0
respiratory	0
mechanics	0
and	0
reduced	0
CO2	I-DISEASE
chemosensitivity	0
.	0

Finally	0
,	0
daytime	0
hypoxemia	0
,	0
if	0
sufficiently	I-DISEASE
severe	0
,	I-DISEASE
may	0
place	0
the	0
patient	0
near	0
or	I-DISEASE
on	I-DISEASE
the	0
steep	I-DISEASE
portion	0
of	0
the	0
oxyhemoglobin	0
dissociation	0
curve	I-DISEASE
,	I-DISEASE
where	0
even	I-DISEASE
relatively	I-DISEASE
small	0
decrements	I-DISEASE
in	I-DISEASE
arterial	0
oxygen	0
tension	0
result	0
in	0
large	I-DISEASE
decrements	I-DISEASE
in	0
oxyhemoglobin	0
saturation	I-DISEASE
.	I-DISEASE

Thus	0
,	0
sleep	0
related	I-DISEASE
hypoventilation	I-DISEASE
in	0
these	0
patients	0
may	0
have	0
a	0
relatively	0
great	I-DISEASE
impact	0
on	0
oxyhemoglobin	0
saturation	0
.	I-DISEASE

Objective	0
Findings	0

The	0
characteristic	0
polysomnographic	0
finding	0
is	0
demonstration	0
of	0
sleep	0
related	I-DISEASE
hypoven-	0
tilation	0
(	0
by	0
arterial	I-DISEASE
PaCO2	I-DISEASE
,	I-DISEASE
transcutaneous	0
PCO2	I-DISEASE
,	0
or	0
end	0
-	0
tidal	0
PCO2	0
)	I-DISEASE
.	I-DISEASE

Sustained	0
oxygen	0
desaturation	0
during	0
sleep	0
that	I-DISEASE
is	I-DISEASE
unexplained	0
by	I-DISEASE
discrete	0
apnea	I-DISEASE
and	0
hypopnea	0
events	0
is	I-DISEASE
common	0
but	0
is	I-DISEASE
not	0
sufficient	I-DISEASE
to	0
establish	0
a	0
diagnosis	0
of	0
sleep	0
related	0
hypoventilation	I-DISEASE
.	0

Intermittent	0
arousals	0
associated	0
with	I-DISEASE
hypoxemia	0
may	I-DISEASE
be	I-DISEASE
observed	0
.	I-DISEASE

Many	0
medical	0
and	0
neurologic	I-DISEASE
disorders	0
are	I-DISEASE
associated	I-DISEASE
with	0
significant	I-DISEASE
sleep	0
disturbances	0
and	0
changes	I-DISEASE
in	I-DISEASE
sleep	0
architecture	I-DISEASE
,	I-DISEASE
including	I-DISEASE
prolonged	0
sleep	I-DISEASE
onset	0
latency	0
,	0
reduced	I-DISEASE
sleep	I-DISEASE
efficiency	0
,	0
and	I-DISEASE
decreased	0
sleep	I-DISEASE
stages	I-DISEASE
N3	I-DISEASE
and	0
REM	0
,	0
may	I-DISEASE
be	0
present	I-DISEASE
.	0

Obstructive	0
and	0
central	0
apneas	0
,	0
when	I-DISEASE
present	0
,	0
will	I-DISEASE
further	0
disturb	I-DISEASE
sleep	0
and	0
accentuate	0
sleep	I-DISEASE
related	I-DISEASE
oxyhe-	0
moglobin	I-DISEASE
desaturation	I-DISEASE
.	I-DISEASE

Daytime	0
arterial	0
blood	0
gases	I-DISEASE
may	I-DISEASE
be	0
normal	I-DISEASE
or	0
show	I-DISEASE
hypoxia	0
and	0
hypercapnia	0
.	0

Chronic	0
hypoxia	0
(	0
especially	I-DISEASE
when	0
present	I-DISEASE
during	0
the	0
day	I-DISEASE
as	0
well	0
as	0
at	I-DISEASE
night	0
)	I-DISEASE
can	0
be	0
associated	I-DISEASE
with	0
polycythemia	I-DISEASE
.	0

Electrocardiography	0
,	0
chest	0
radiography	0
,	0
and	I-DISEASE
echocardiography	I-DISEASE
may	0
demonstrate	I-DISEASE
evidence	0
of	0
pulmonary	0
hypertension	I-DISEASE
.	0

In	0
patients	0
with	I-DISEASE
neuromuscular	0
weakness	0
or	0
restrictive	I-DISEASE
chest	0
wall	I-DISEASE
disorders	0
spirometry	0
shows	I-DISEASE
a	0
restrictive	0
ventilatory	I-DISEASE
dysfunction	0
with	0
the	I-DISEASE
forced	0
vital	0
capacity	0
(	0
FVC	0
)	0
often	I-DISEASE
Sleep	0
Related	0
Breathing	I-DISEASE
Disorders	0
Sleep	0
Related	I-DISEASE
Breathing	0
Disorders	0
less	0
than	0
50	0
%	I-DISEASE
of	I-DISEASE
predicted	I-DISEASE
.	I-DISEASE

However	0
,	0
significant	0
nocturnal	0
desaturation	0
can	0
occur	I-DISEASE
with	0
FVC	0
values	0
greater	0
than	0
50	0
%	0
of	I-DISEASE
predicted	0
.	0

Differential	0
Diagnosis	0

The	0
differential	0
diagnosis	0
includes	0
all	0
disorders	0
which	I-DISEASE
can	I-DISEASE
give	0
rise	0
to	0
hypoventila-	0
tion	0
during	0
sleep	I-DISEASE
.	0

This	0
includes	0
OHS	0
,	0
use	0
of	I-DISEASE
medications	I-DISEASE
or	0
substances	I-DISEASE
that	0
can	I-DISEASE
sup-	0
press	0
respiratory	0
drive	I-DISEASE
,	I-DISEASE
and	0
congenital	I-DISEASE
or	0
idiopathic	0
central	0
alveolar	I-DISEASE
hypoventilation	0
syndromes	0
.	0

OSA	0
and	0
CSA	0
can	0
be	I-DISEASE
distinguished	I-DISEASE
from	I-DISEASE
sleep	I-DISEASE
related	I-DISEASE
hypoventilation	0
by	I-DISEASE
the	I-DISEASE
periodic	I-DISEASE
alterations	0
in	I-DISEASE
airflow	0
and	0
accompanying	I-DISEASE
periodic	I-DISEASE
fluctuations	I-DISEASE
in	0
SaO2	0
.	0

In	0
contrast	0
,	0
oxygen	0
desaturation	0
due	I-DISEASE
to	I-DISEASE
sleep	0
related	0
hypoventilation	0
is	0
generally	I-DISEASE
more	0
sustained	0
,	I-DISEASE
usually	0
several	0
minutes	I-DISEASE
or	0
longer	0
in	0
duration	0
.	0

When	0
more	0
than	0
one	0
disorder	0
is	I-DISEASE
believed	I-DISEASE
to	0
be	I-DISEASE
responsible	I-DISEASE
for	0
the	0
ventilatory	I-DISEASE
insufficiency	0
during	I-DISEASE
sleep	0
,	0
all	0
pertinent	0
diagnoses	I-DISEASE
should	0
be	0
coded	0
.	0

Unresolved	0
Issues	0
and	0
Further	I-DISEASE
Directions	I-DISEASE
Thresholds	I-DISEASE
of	I-DISEASE
impairments	0
of	I-DISEASE
ventilation	0
and	0
respiratory	0
drive	0
producing	0
hypercapnia/	I-DISEASE
hypoxemia	I-DISEASE
need	I-DISEASE
to	0
be	0
identified	0
.	0

The	0
degree	0
and	0
duration	0
of	0
hypercapnia	I-DISEASE
/	I-DISEASE
hypoxemia	0
necessary	0
to	0
produce	0
adverse	0
consequences	0
,	0
such	I-DISEASE
as	0
pulmonary	0
hypertension	0
,	0
in	I-DISEASE
indi-	0
vidual	0
patients	0
is	I-DISEASE
not	I-DISEASE
well	0
defined	I-DISEASE
.	0

The	0
value	0
of	0
routinely	0
measuring	0
PaCO2	0
during	I-DISEASE
sleep	0
in	I-DISEASE
these	0
patients	0
is	0
not	0
clear	0
.	I-DISEASE

Additionally	0
,	0
because	0
it	0
is	0
clinically	0
impractical	I-DISEASE
to	0
routinely	I-DISEASE
obtain	0
arterial	0
blood	0
samples	I-DISEASE
during	0
sleep	I-DISEASE
in	0
most	0
persons	I-DISEASE
suspected	I-DISEASE
of	0
this	0
disorder	0
,	0
other	0
techniques	0
of	I-DISEASE
measuring	0
CO2	I-DISEASE
levels	0
must	I-DISEASE
be	0
investigated	0
.	0

Little	0
infor-	0
mation	0
is	0
available	0
regarding	0
the	0
effect	0
of	I-DISEASE
oxygen	0
therapy	I-DISEASE
or	0
noninvasive	0
ventilation	0
on	0
the	0
course	0
of	I-DISEASE
the	0
underlying	0
disease	0
.	0

Studies	0
are	0
needed	0
to	0
determine	0
the	0
optimal	I-DISEASE
time	0
to	I-DISEASE
initiate	0
these	0
interventions	0
and	I-DISEASE
the	0
specific	I-DISEASE
subpopulations	I-DISEASE
of	0
patients	I-DISEASE
who	0
will	0
benefit	0
most	I-DISEASE
from	0
these	I-DISEASE
therapies	I-DISEASE
.	0

Bibliography	0
Ambrosino	0
N	I-DISEASE
,	0
Carpenè	0
N	0
,	0
Gherardi	0
M.	I-DISEASE
Chronic	0
respiratory	I-DISEASE
care	0
for	0
neuromuscular	0
diseases	I-DISEASE
in	I-DISEASE
adults	I-DISEASE
.	I-DISEASE

Eur	0
Respir	0
J	0
2009;34:444–51	I-DISEASE
.	0

Beuther	0
DA	0
.	0

Hypoventilation	0
in	0
asthma	0
and	0
chronic	0
obstructive	0
pulmonary	0
disease	0
.	0

Semin	0
Respir	0
Crit	0
Care	I-DISEASE
Med	0
2009;30:321–9	I-DISEASE
.	I-DISEASE

Biering	0
-	0
Sørensen	0
F	0
,	0
Jennum	0
P	0
,	I-DISEASE
Laub	I-DISEASE
M.	0
Sleep	0
disordered	0
breathing	0
following	0
spinal	I-DISEASE
cord	0
injury	0
.	I-DISEASE

Respir	0
Physiol	0
Neurobiol	0
2009;169:165–70	B-DISEASE
.	0

Castriotta	0
RJ	0
,	0
Murthy	0
JN	0
.	0

Hypoventilation	0
after	0
spinal	0
cord	0
injury	0
.	0

Semin	0
Respir	0
Crit	0
Care	I-DISEASE
Med	0
2009;30:330–8	I-DISEASE
.	I-DISEASE

Dhand	0
UK	0
,	0
Dhand	0
R.	0
Sleep	I-DISEASE
disorders	0
in	0
neuromuscular	0
diseases	0
.	0

Curr	0
Opin	0
Pulm	0
Med	0
2006;12:402–8	0
.	I-DISEASE

Donath	0
J	0
,	0
Miller	0
A.	0
Restrictive	I-DISEASE
chest	I-DISEASE
wall	0
disorders	I-DISEASE
.	0

Semin	0
Respir	0
Crit	0
Care	I-DISEASE
Med	0
2009;30:275–92	I-DISEASE
.	I-DISEASE

Fathi	0
M	0
,	0
Lundberg	0
IE	0
,	I-DISEASE
Tornling	0
G.	0
Pulmonary	I-DISEASE
complications	0
of	0
polymyositis	0
and	I-DISEASE
dermatomyositis	I-DISEASE
.	0

Semin	0
Respir	0
Crit	0
Care	I-DISEASE
Med	0
2007;28:451–8	I-DISEASE
.	I-DISEASE

Glass	0
GA	0
,	0
Josephs	0
KA	0
,	I-DISEASE
Ahlskog	I-DISEASE
JE	0
.	I-DISEASE

Respiratory	0
insufficiency	0
as	0
the	0
primary	0
presenting	0
symptom	0
of	0
multiple	I-DISEASE
-	I-DISEASE
system	0
atrophy	0
.	0

Arch	0
Neurol	0
2006;63:978–81	0
.	0

Kennedy	0
JD	0
,	0
Martin	0
AJ	0
.	0

Chronic	0
respiratory	0
failure	0
and	0
neuromuscular	0
disease	I-DISEASE
.	I-DISEASE

Pediatr	0
Clin	0
North	0
Am	0
2009;56:261–73	0
,	0
xii	0
.	0

Taylor	0
-	0
Cousar	0
JL	0
.	0

Hypoventilation	0
in	0
cystic	0
fibrosis	0
.	0

Semin	0
Respir	0
Crit	0
Care	I-DISEASE
Med	0
2009;30:293–302	I-DISEASE
.	I-DISEASE

Toussaint	0
M	0
,	0
Chatwin	0
M	0
,	I-DISEASE
Soudon	I-DISEASE
P.	0
Mechanical	0
ventilation	0
in	0
Duchenne	0
patients	0
with	0
chronic	I-DISEASE
respiratory	0
insufficiency	0
:	I-DISEASE
clinical	0
implications	0
of	0
20	0
years	0
published	I-DISEASE
experience	I-DISEASE
.	0

Chron	0
Respir	0
Dis	0
2007;4:167–77	I-DISEASE
.	0

Vazquez	0
-	0
Sandoval	0
A	0
,	0
Huang	0
EJ	0
,	0
Jones	I-DISEASE
SF	0
.	0

Hypoventilation	0
in	0
neuromuscular	0
disease	0
.	0

Semin	0
Respir	0
Crit	0
Care	I-DISEASE
Med	0
2009;30:348–58	I-DISEASE
.	I-DISEASE

Wider	0
C	0
,	0
Wszolek	I-DISEASE
ZK	0
.	I-DISEASE

Rapidly	0
progressive	0
familial	0
parkinsonism	0
with	0
central	0
hypoventilation	I-DISEASE
,	I-DISEASE
depression	I-DISEASE
and	0
weight	0
loss	0
(	0
Perry	0
syndrome)--a	0
literature	0
review	0
.	I-DISEASE

Parkinsonism	0
Relat	0
Disord	0
2008;14:1–7	B-DISEASE
.	0

Sleep	0
Related	0
Breathing	I-DISEASE
Disorders	0
Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Sleep	I-DISEASE
Related	0
Hypoxemia	0
Disorder	I-DISEASE
Sleep	0
Related	0
Hypoxemia	I-DISEASE
ICD-9	I-DISEASE
-	0
CM	I-DISEASE
code	0
:	0
327.26	0
ICD-10	0
-	0
CM	0
code	I-DISEASE
:	0
G47.36	0
Alternate	I-DISEASE
Names	0
Nocturnal	I-DISEASE
oxygen	0
(	0
or	0
oxyhemoglobin	0
)	0
desaturation	0
,	0
low	0
nocturnal	0
oxygen	0
saturation	0
,	I-DISEASE
nocturnal	0
hypoxemia	0
,	0
sleep	0
related	I-DISEASE
hypoxemia	0
,	0
sleep	0
related	0
oxygen	0
desaturation	I-DISEASE
.	I-DISEASE

Diagnostic	0
Criteria	0
Criteria	0
A	0
and	0
B	I-DISEASE
must	I-DISEASE
be	0
met	I-DISEASE
A.	0
PSG	0
,	0
OCST	I-DISEASE
or	I-DISEASE
nocturnal	0
oximetry	I-DISEASE
shows	0
the	I-DISEASE
arterial	0
oxygen	0
saturation	0
(	0
SpO2	0
)	0
during	0
sleep	0
of	0
≤	0
88	0
%	0
in	0
adults	0
or	I-DISEASE
≤	0
90	I-DISEASE
%	0
in	I-DISEASE
children	0
for	I-DISEASE
≥	0
5	I-DISEASE
minutes	0
.	I-DISEASE

B.	0
Sleep	0
related	0
hypoventilation	0
is	I-DISEASE
not	0
documented.1	0
Notes	0
.	0

If	0
sleep	0
related	0
hypoventilation	I-DISEASE
is	0
documented	0
(	I-DISEASE
as	0
measured	I-DISEASE
by	0
arterial	0
blood	0
gas	0
,	0
transcutaneous	I-DISEASE
PCO2	0
,	I-DISEASE
or	0
end	0
-	0
tidal	0
CO2	0
sensors	0
)	0
,	0
the	I-DISEASE
disorder	0
is	0
classified	0
as	0
sleep	0
related	0
hypoventilation	0
.	0
.	0

OSA	0
or	0
CSA	0
may	0
be	I-DISEASE
present	I-DISEASE
,	0
but	I-DISEASE
these	I-DISEASE
are	0
not	0
believed	0
to	0
be	0
the	I-DISEASE
major	0
cause	0
of	I-DISEASE
hypoxemia	0
.	0
.	0

Physiological	0
causes	0
,	0
if	0
known	0
,	I-DISEASE
should	I-DISEASE
be	0
indicated	I-DISEASE
(	0
e.g.	0
,	0
shunt	0
,	0
ventilation	0
-	0
perfusion	I-DISEASE
[	0
V	0
/	0
Q	0
]	0
mismatch	0
,	0
low	I-DISEASE
mixed	0
venous	0
oxygen	0
,	0
and/	0
or	0
high	0
altitude	I-DISEASE
)	0
.	0

Essential	0
Features	0
Significant	0
hypoxemia	0
during	0
sleep	0
is	0
present	0
and	I-DISEASE
is	0
believed	0
to	0
be	0
secondary	0
to	I-DISEASE
a	0
medical	0
or	I-DISEASE
neurological	0
disorder	0
.	0

The	0
presence	0
of	0
hypoxemia	0
is	0
not	0
better	I-DISEASE
explained	0
by	I-DISEASE
another	I-DISEASE
sleep	0
related	0
breathing	0
disorder	0
(	I-DISEASE
e.g.	I-DISEASE
,	0
OSA	I-DISEASE
)	0
.	0

Although	0
some	0
amount	0
of	I-DISEASE
obstructive	0
or	0
central	0
apnea	0
may	I-DISEASE
be	0
present	0
,	0
these	I-DISEASE
disorders	0
are	I-DISEASE
not	I-DISEASE
thought	0
to	I-DISEASE
be	0
pri-	0
marily	0
responsible	I-DISEASE
for	0
the	0
hypoxemia	I-DISEASE
during	0
sleep	0
.	I-DISEASE

Some	0
patients	0
with	0
sleep	0
related	0
hypoxemia	I-DISEASE
also	0
exhibit	0
hypoxemia	I-DISEASE
during	0
wakefulness	0
.	0

Sleep	0
related	0
hypoventilation	I-DISEASE
has	0
not	0
been	0
documented	0
(	0
if	0
so	0
,	0
a	0
diagnosis	0
of	0
sleep	0
related	0
hypoventilation	0
is	0
made	0
)	0
.	0

The	0
presentation	0
of	0
patients	0
with	0
sleep	0
related	I-DISEASE
hypoxemia	I-DISEASE
varies	I-DISEASE
with	0
the	0
underly-	0
ing	0
medical	0
or	I-DISEASE
neurological	0
disorders	0
.	I-DISEASE

Chronic	0
hypoxemia	0
can	0
arise	I-DISEASE
from	0
airway	I-DISEASE
or	I-DISEASE
parenchymal	0
pulmonary	I-DISEASE
disease	0
,	0
chest	I-DISEASE
wall	0
disorders	0
,	I-DISEASE
pulmonary	I-DISEASE
hypertension	0
,	I-DISEASE
or	0
neurologic	0
and	0
neuromuscular	I-DISEASE
disorders	0
.	I-DISEASE

Acute	0
exacerbations	0
of	0
respiratory	0
disorders	0
can	0
accentuate	I-DISEASE
the	0
severity	I-DISEASE
of	0
hypoxemia	0
.	0

Hypoxemia	0
due	0
to	0
underlying	I-DISEASE
lower	0
airway	0
obstructive	I-DISEASE
disease	0
,	I-DISEASE
pulmonary	0
parenchymal	0
disease	0
,	0
vascular	0
pathology	I-DISEASE
,	0
and	0
other	I-DISEASE
causes	0
of	0
hypoventilation	0
is	0
generally	0
sustained	0
(	0
several	0
minutes	0
or	I-DISEASE
longer	0
)	I-DISEASE
,	I-DISEASE
whereas	I-DISEASE
sawtooth	0
fluctuations	0
of	0
oxygen	0
saturation	0
(	I-DISEASE
typically	I-DISEASE
less	0
than	I-DISEASE
one	I-DISEASE
minute	0
)	0
characterize	0
hypoxemia	I-DISEASE
due	I-DISEASE
to	I-DISEASE
OSA	0
or	I-DISEASE
CSA	0
.	0

Patients	0
can	0
either	B-DISEASE
be	0
asymptomatic	0
or	0
present	0
with	0
complaints	I-DISEASE
of	0
nocturnal	0
dyspnea	0
,	0
impaired	0
sleep	I-DISEASE
quality	0
,	I-DISEASE
chest	0
tightness	0
,	0
or	I-DISEASE
fatigue	0
.	0

Polycythemia	0
is	0
often	0
noted	0
with	0
severe	0
chronic	I-DISEASE
hypoxemia	0
.	I-DISEASE

Associated	0
Features	0
Consequences	0
of	0
chronic	0
hypercapnia	I-DISEASE
and	I-DISEASE
hypoxemia	0
include	I-DISEASE
pulmonary	0
artery	0
hyper-	0
tension	0
,	0
cor	I-DISEASE
pulmonale	0
,	I-DISEASE
and	I-DISEASE
neurocognitive	0
dysfunction	0
.	0

Some	0
of	0
the	0
disorders	I-DISEASE
causing	0
hypoxemia	I-DISEASE
are	I-DISEASE
prevalent	0
diseases	I-DISEASE
and	0
not	0
uncommonly	0
overlap	0
.	0

Patients	0
with	0
multi-	B-DISEASE
ple	0
breathing	0
disorders	I-DISEASE
are	I-DISEASE
likely	0
to	I-DISEASE
experience	0
greater	0
severity	0
and	0
duration	0
of	I-DISEASE
sleep	0
related	0
hypoxemia	I-DISEASE
than	0
are	I-DISEASE
patients	I-DISEASE
with	0
a	0
single	I-DISEASE
disorder	I-DISEASE
.	0

Clinical	0
and	0
Pathologic	0
Subtypes	I-DISEASE
Specific	0
variations	0
in	0
the	0
sleep	I-DISEASE
related	0
findings	0
have	0
not	0
been	I-DISEASE
described	I-DISEASE
for	I-DISEASE
the	0
various	0
etiologies	I-DISEASE
.	0

Demographics	0
The	0
demographics	0
of	0
sleep	0
related	0
hypoxemia	I-DISEASE
are	0
a	I-DISEASE
function	I-DISEASE
of	I-DISEASE
the	0
prevalence	0
,	0
clinical	I-DISEASE
characteristics	0
and	0
degree	I-DISEASE
of	0
severity	I-DISEASE
of	0
the	0
underlying	0
conditions	I-DISEASE
.	I-DISEASE

Thus	0
,	0
prevalence	0
may	I-DISEASE
be	0
higher	I-DISEASE
in	I-DISEASE
patients	0
with	I-DISEASE
greater	0
perturbations	0
of	0
pulmonary	0
function	0
or	I-DISEASE
neu-	I-DISEASE
romuscular	I-DISEASE
weakness	I-DISEASE
.	0

Individuals	0
with	0
chronic	0
hypoxemia	0
during	0
wakefulness	0
will	I-DISEASE
experience	0
even	I-DISEASE
greater	I-DISEASE
decrements	0
of	0
oxygenation	0
during	0
sleep	0
.	I-DISEASE

Predisposing	0
and	0
Precipitating	0
Factors	I-DISEASE
Greater	0
impairments	I-DISEASE
of	I-DISEASE
respiratory	0
function	I-DISEASE
are	0
associated	0
with	I-DISEASE
greater	0
risk	I-DISEASE
for	0
sleep	0
related	I-DISEASE
hypoxemia	I-DISEASE
.	0

However	0
,	I-DISEASE
there	0
is	I-DISEASE
no	0
recognized	I-DISEASE
threshold	I-DISEASE
of	0
pulmonary	I-DISEASE
paren-	0
chymal	0
or	0
vascular	I-DISEASE
disease	0
severity	I-DISEASE
or	0
extent	0
of	I-DISEASE
neuromuscular	0
weakness	0
that	0
ade-	0

quately	0
predicts	0
the	0
risk	0
of	0
sleep	I-DISEASE
related	I-DISEASE
hypoxemia	0
in	I-DISEASE
individual	0
patients	I-DISEASE
.	0

Patients	0
who	0
are	0
hypoxemic	0
during	0
wakefulness	0
will	0
generally	0
become	0
even	0
more	0
so	I-DISEASE
during	0
sleep	0
,	I-DISEASE
especially	0
REM	0
sleep	0
.	0

Among	0
the	0
best	I-DISEASE
predictors	0
of	0
sleep	0
related	I-DISEASE
hypoxemia	I-DISEASE
are	I-DISEASE
reduced	0
baseline	0
wake	I-DISEASE
SaO2	0
and	0
hypercapnia	I-DISEASE
.	0

Patients	0
with	0
wake	B-DISEASE
hypercapnia	0
should	0
be	0
suspected	0
of	0
sleep	0
related	0
hypoxemia	0
.	0

However	0
,	I-DISEASE
the	0
relationship	I-DISEASE
between	0
wake	0
SaO2	I-DISEASE
/	0
PaCO2	0
and	I-DISEASE
sleep	0
related	0
desaturation	I-DISEASE
is	I-DISEASE
not	I-DISEASE
sufficiently	I-DISEASE
strong	I-DISEASE
to	I-DISEASE
have	0
substantial	0
predictive	0
value	0
in	I-DISEASE
individual	I-DISEASE
patients	0
.	0

Sleep	0
Related	0
Breathing	I-DISEASE
Disorders	0
Sleep	I-DISEASE
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Familial	I-DISEASE
Patterns	0
Genetic	0
patterns	I-DISEASE
for	0
many	I-DISEASE
of	I-DISEASE
the	I-DISEASE
disorders	0
are	I-DISEASE
not	0
known	0
.	0

Alpha-1	0
antitrypsin	0
defi-	0
ciency	0
is	0
a	I-DISEASE
genetic	I-DISEASE
disorder	0
characterized	I-DISEASE
by	0
defective	0
production	0
of	0
the	0
enzyme	I-DISEASE
inhib-	0
itor	0
;	I-DISEASE
severe	0
forms	0
of	0
deficiency	0
can	0
lead	0
to	I-DISEASE
emphysema	0
.	0

Genetic	0
causes	0
of	I-DISEASE
bronchiec-	I-DISEASE
tasis	0
include	I-DISEASE
primary	I-DISEASE
ciliary	0
dyskinesia	I-DISEASE
and	0
cystic	0
fibrosis	I-DISEASE
.	0

Muscular	0
dystrophies	0
are	0
genetically	0
inherited	0
.	0

The	0
familial	0
patterns	0
of	0
sleep	0
related	0
hypoxemia	I-DISEASE
due	I-DISEASE
to	I-DISEASE
these	0
disorders	0
reflect	I-DISEASE
those	I-DISEASE
of	0
the	0
underlying	0
inherited	0
conditions	I-DISEASE
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Onset	I-DISEASE
and	0
course	I-DISEASE
of	0
sleep	I-DISEASE
related	0
hypoxemia	0
parallel	0
the	I-DISEASE
presence	0
and	I-DISEASE
severity	I-DISEASE
of	0
the	0
underlying	0
medical	0
or	I-DISEASE
neurological	I-DISEASE
disorders	0
that	0
impair	0
respiration	I-DISEASE
,	I-DISEASE
although	I-DISEASE
sub-	0
stantial	0
variability	0
in	0
course	0
is	0
observed	I-DISEASE
even	I-DISEASE
within	0
the	0
same	I-DISEASE
underlying	0
condition	0
.	0

Many	0
affected	0
individuals	0
with	0
severe	0
hypercapnia	I-DISEASE
and	I-DISEASE
hypoxemia	0
develop	0
respiratory	0
impairment	I-DISEASE
,	I-DISEASE
pulmonary	0
hypertension	I-DISEASE
,	I-DISEASE
heart	0
failure	0
,	I-DISEASE
cardiac	0
arrhythmias	0
,	0
and	0
neuro-	I-DISEASE
cognitive	0
dysfunction	I-DISEASE
.	0

Polycythemia	0
is	0
common	0
in	0
those	0
with	0
chronic	I-DISEASE
hypoxia	0
.	0

Higher	0
rates	0
of	0
painful	0
crises	0
accompany	I-DISEASE
hypoxemia	0
in	0
children	I-DISEASE
with	0
sickle	0
cell	0
disease	0
.	I-DISEASE

Although	0
the	0
risk	I-DISEASE
of	0
increased	0
morbidity	I-DISEASE
and	I-DISEASE
mortality	0
appears	I-DISEASE
to	0
increase	0
with	I-DISEASE
wors-	0
ening	0
sleep	0
related	0
hypoxemia	I-DISEASE
,	I-DISEASE
the	0
specific	0
relationship	0
between	I-DISEASE
sleep	I-DISEASE
related	I-DISEASE
hypox-	0
emia	I-DISEASE
and	I-DISEASE
morbidity	I-DISEASE
and	I-DISEASE
mortality	0
is	0
not	0
well	0
defined	0
.	0

Many	0
patients	0
respond	I-DISEASE
to	I-DISEASE
oxygen	0
therapy	0
;	I-DISEASE
in	0
some	0
,	0
hypercapnia	0
may	0
worsen	0
with	0
oxygen	I-DISEASE
therapy	0
alone	0
for	0
hypoxia	0
.	0

Pathology	0
and	0
Pathophysiology	0
Hypoxemia	0
may	0
arise	I-DISEASE
from	I-DISEASE
a	0
shunt	I-DISEASE
physiology	0
,	0
ventilation	I-DISEASE
-	I-DISEASE
perfusion	0
[	I-DISEASE
V	0
/	0
Q	I-DISEASE
]	0
mismatch-	0
ing	0
,	0
low	0
mixed	I-DISEASE
venous	I-DISEASE
oxygen	0
,	0
and/or	I-DISEASE
high	0
altitude	0
.	0

Hypoventilation	0
also	0
gives	0
rise	0
to	0
hypoxemia	I-DISEASE
;	0
however	0
,	I-DISEASE
when	0
hypoventilation	0
has	0
been	I-DISEASE
documented	0
,	I-DISEASE
a	0
diagnosis	0
of	0
sleep	0
related	0
hypoventilation	0
should	0
be	0
assigned	0
,	0
rather	0
than	0
sleep	I-DISEASE
related	0
hypoxemia	I-DISEASE
.	I-DISEASE

Pulmonary	0
parenchymal	0
diseases	0
are	0
characterized	0
by	I-DISEASE
altered	I-DISEASE
lung	I-DISEASE
volumes	0
(	0
e.g.	0
,	0
reduced	0
functional	0
residual	I-DISEASE
capacity	0
)	0
and	0
abnormal	0
ventilation	I-DISEASE
/	0
perfusion	0
relationships	I-DISEASE
,	0
which	I-DISEASE
can	0
result	I-DISEASE
in	I-DISEASE
hypercapnia	0
and	0
hypoxemia	0
during	0
wakefulness	0
.	0

Decreased	0
lung	0
volume	0
is	0
associated	0
with	0
reduced	0
oxygen	0
reserves	I-DISEASE
that	0
increase	0
the	0
risk	0
of	0
hypoxemia	I-DISEASE
.	0

In	0
addition	0
,	0
sleep	0
may	0
be	0
associated	I-DISEASE
with	0
an	I-DISEASE
altered	0
pattern	0
of	0
ventilatory	0
muscle	0
acti-	I-DISEASE
vation	0
,	0
particularly	I-DISEASE
during	0
REM	0
sleep	0
when	0
,	0
due	I-DISEASE
to	I-DISEASE
reduced	0
activation	0
of	I-DISEASE
the	0
intercos-	0
tal	0
and	0
accessory	I-DISEASE
muscles	0
,	0
there	I-DISEASE
is	0
a	0
disproportionate	I-DISEASE
ventilatory	0
burden	0
placed	I-DISEASE
on	0
the	0
diaphragm	I-DISEASE
.	0

This	0
may	0
lead	0
to	0
hypoventilation	0
in	0
patients	0
with	0
chest	0
wall	0
abnormalities	0
or	I-DISEASE
chronic	0
obstructive	0
pulmonary	I-DISEASE
disease	I-DISEASE
.	0

In	0
the	0
latter	I-DISEASE
,	0
lung	0
hyperinflation	0
creates	I-DISEASE
a	0
mechanical	I-DISEASE
disadvantage	0
to	0
the	0
diaphragm	0
.	0

In	0
sickle	0
cell	0
anemia	0
,	0
decreased	I-DISEASE
oxyhemo-	I-DISEASE
globin	0
affinity	I-DISEASE
may	0
partly	0
contribute	0
to	0
hypoxemia	0
.	I-DISEASE

Many	0
neurologic	0
and	0
neuromuscu-	0
lar	0
disorders	0
are	I-DISEASE
associated	0
with	I-DISEASE
impaired	0
respiratory	0
mechanics	0
and	0
reduced	0
CO2	I-DISEASE
che-	0
mosensitivity	0
.	0

Finally	0
,	0
daytime	0
hypoxemia	0
,	0
if	0
sufficiently	I-DISEASE
severe	0
,	I-DISEASE
may	0
place	I-DISEASE
the	0
patient	0
near	0
or	I-DISEASE
on	I-DISEASE
the	0
steep	I-DISEASE
portion	0
of	0
the	0
oxyhemoglobin	0
dissociation	0
curve	I-DISEASE
where	I-DISEASE
even	0
rela-	I-DISEASE
tively	I-DISEASE
small	0
decrements	I-DISEASE
in	I-DISEASE
arterial	0
oxygen	0
tension	0
result	0
in	I-DISEASE
large	I-DISEASE
decrements	I-DISEASE
in	I-DISEASE
oxyhe-	I-DISEASE
moglobin	I-DISEASE
saturation	I-DISEASE
.	0

Thus	0
,	0
sleep	0
related	I-DISEASE
hypoventilation	I-DISEASE
in	0
these	0
patients	0
might	0
have	0
a	0
relatively	0
great	I-DISEASE
impact	0
on	0
oxyhemoglobin	0
saturation	0
.	I-DISEASE

Objective	0
Findings	0
Various	0
patterns	I-DISEASE
of	0
oxygen	I-DISEASE
desaturation	I-DISEASE
(	0
sustained	I-DISEASE
,	0
intermittent	0
,	0
or	0
episodic	0
)	0
may	0
be	0
observed	I-DISEASE
during	0
sleep	0
.	0

The	0
diagnosis	0
is	0
generally	0
made	I-DISEASE
on	0
the	0
basis	I-DISEASE
of	I-DISEASE
overnight	0
oxim-	0
etry	0
(	0
alone	0
or	I-DISEASE
as	0
a	I-DISEASE
component	I-DISEASE
of	0
PSG	0
or	0
OCST	0
)	0
;	0
less	I-DISEASE
commonly	0
,	0
arterial	I-DISEASE
blood	0
gas	0
mea-	I-DISEASE
surements	I-DISEASE
are	0
indicated	0
,	0
especially	I-DISEASE
if	I-DISEASE
concomitant	0
hypoventilation	0
is	0
suspected	0
.	I-DISEASE

PSG	0
may	0
demonstrate	0
normal	B-DISEASE
sleep	0
architecture	I-DISEASE
or	I-DISEASE
frequent	0
arousals	I-DISEASE
,	0
increased	0
wakeful-	0
ness	0
after	0
sleep	I-DISEASE
onset	I-DISEASE
and	I-DISEASE
reduced	I-DISEASE
sleep	0
efficiency	0
;	0
however	0
,	I-DISEASE
the	I-DISEASE
contribution	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
related	I-DISEASE
hypoxemia	0
to	I-DISEASE
the	I-DISEASE
altered	I-DISEASE
sleep	0
architecture	0
,	0
if	0
present	I-DISEASE
,	I-DISEASE
is	0
uncertain	I-DISEASE
.	I-DISEASE

Daytime	0
arterial	0
blood	0
gases	I-DISEASE
may	I-DISEASE
be	0
normal	I-DISEASE
or	0
show	I-DISEASE
hypoxia	0
and	0
hypercapnia	0
.	0

Nocturnal	0
oxim-	0
etry	0
usually	0
shows	0
sustained	0
periods	I-DISEASE
of	0
reduced	I-DISEASE
arterial	0
oxygen	0
but	0
clusters	0
of	0
more	I-DISEASE
severe	I-DISEASE
drops	I-DISEASE
in	0
the	0
arterial	0
oxygen	0
saturation	0
can	0
occur	I-DISEASE
every	0
one	I-DISEASE
to	0
two	I-DISEASE
hours	0
due	I-DISEASE
to	0
worsening	0
of	0
breathing	0
during	0
REM	0
sleep	0
.	I-DISEASE

A	0
sawtooth	0
pattern	0
of	I-DISEASE
briefer	0
desaturations	I-DISEASE
(	I-DISEASE
typically	0
less	I-DISEASE
than	0
one	0
minute	0
)	0
suggests	0
the	0
presence	0
of	0
discrete	0
events	0
(	0
apneas	0
or	0
hypopneas	0
)	I-DISEASE
.	0

Some	0
sawtooth	0
changes	0
may	0
be	0
superimposed	0
on	I-DISEASE
low	0
baseline	0
oxygen	0
saturation	0
but	0
are	0
not	0
the	0
predominant	0
pattern	0
.	0

Chronic	0
hypoxia	0
can	0
be	I-DISEASE
associated	0
with	I-DISEASE
polycythemia	I-DISEASE
.	0

Electrocardiography	0
,	0
chest	0
radiography	0
,	0
and	I-DISEASE
echocardiography	I-DISEASE
may	0
demonstrate	I-DISEASE
evidence	0
of	0
pulmonary	0
hypertension	I-DISEASE
.	0

Differential	0
Diagnosis	0

The	0
differential	0
diagnosis	0
encompasses	0
all	0
disorders	0
which	I-DISEASE
can	I-DISEASE
give	0
to	0
hypoxemia	0
during	0
sleep	0
.	0

This	0
includes	0
pulmonary	0
airway	I-DISEASE
and	0
parenchymal	I-DISEASE
disorders	I-DISEASE
,	I-DISEASE
pulmonary	I-DISEASE
vascular	0
pathology	0
,	0
neuromuscular	0
and	0
chest	I-DISEASE
wall	0
disorders	0
,	I-DISEASE
OHS	0
,	I-DISEASE
use	0
of	0
medications	I-DISEASE
or	0
substances	I-DISEASE
that	0
can	0
suppress	0
respiratory	0
drive	I-DISEASE
,	0
and	I-DISEASE
congenital	0
or	0
idiopathic	I-DISEASE
central	I-DISEASE
alveolar	0
hypoventilation	0
syndromes	0
.	0

OSA	0
and	0
CSA	0
syndromes	I-DISEASE
can	I-DISEASE
be	I-DISEASE
distinguished	I-DISEASE
from	0
sleep	I-DISEASE
related	I-DISEASE
hypoxemia	0
by	0
the	I-DISEASE
periodic	I-DISEASE
alterations	I-DISEASE
in	0
airflow	I-DISEASE
and	I-DISEASE
accompanying	0
periodic	I-DISEASE
fluctuations	0
in	0
SaO2	0
.	0

In	0
contrast	0
,	0
oxygen	0
desaturation	0
associated	I-DISEASE
with	I-DISEASE
sleep	0
related	I-DISEASE
hypoxemia	0
is	0
generally	I-DISEASE
more	I-DISEASE
sustained	0
,	I-DISEASE
usually	0
several	0
minutes	I-DISEASE
or	0
longer	0
in	0
duration	0
.	I-DISEASE

In	0
cases	0
when	0
more	0
than	0
one	0
disorder	I-DISEASE
is	0
believed	I-DISEASE
to	0
be	0
responsible	0
for	0
the	0
ventilatory	I-DISEASE
insufficiency	0
during	0
sleep	I-DISEASE
,	0
all	0
pertinent	0
diagnoses	0
should	I-DISEASE
be	0
coded	0
.	0

Unresolved	0
Issues	0
and	0
Further	I-DISEASE
Directions	I-DISEASE
The	I-DISEASE
degree	I-DISEASE
and	0
duration	I-DISEASE
of	0
hypercapnia	0
/	0
hypoxemia	I-DISEASE
necessary	I-DISEASE
to	I-DISEASE
produce	I-DISEASE
adverse	0
consequences	0
,	0
such	0
as	0
pulmonary	0
hypertension	I-DISEASE
,	I-DISEASE
in	0
individual	0
patients	0
is	I-DISEASE
not	I-DISEASE
well	I-DISEASE
defined	0
.	I-DISEASE

The	0
value	0
of	0
routinely	0
measuring	0
arterial	0
blood	I-DISEASE
gases	I-DISEASE
or	I-DISEASE
SaO2	0
during	0
sleep	0
Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	I-DISEASE
Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	0
is	0
not	0
clear	0
.	0

With	0
the	0
exception	I-DISEASE
of	0
COPD	0
,	0
little	0
information	0
is	I-DISEASE
available	0
regarding	0
the	0
effect	I-DISEASE
of	0
oxygen	0
therapy	0
on	0
the	0
course	0
of	I-DISEASE
the	0
underlying	0
disease	I-DISEASE
.	I-DISEASE

Even	0
less	0
is	0
under-	0
stood	0
regarding	0
the	I-DISEASE
consequences	0
of	I-DISEASE
isolated	0
sleep	0
related	0
hypoxemia	I-DISEASE
and	I-DISEASE
the	I-DISEASE
need	0
for	I-DISEASE
oxygen	I-DISEASE
supplementation	0
in	I-DISEASE
patients	0
with	0
normal	0
daytime	0
wake	I-DISEASE
oxygen	0
levels	I-DISEASE
.	0

Studies	0
are	0
needed	0
to	0
determine	0
the	0
optimal	I-DISEASE
time	0
to	I-DISEASE
initiate	0
oxygen	0
therapy	0
and	0
the	0
specific	I-DISEASE
subpopulations	I-DISEASE
of	0
patients	I-DISEASE
who	0
will	0
benefit	0
most	I-DISEASE
from	0
this	I-DISEASE
intervention	I-DISEASE
.	0

Bibliography	0
Berry	0
RB	0
,	0
Sriram	0
P.	0
Evaluation	I-DISEASE
of	0
hypoventilation	I-DISEASE
.	0

Semin	0
Respir	0
Crit	0
Care	I-DISEASE
Med	0
2009;30:303–14	I-DISEASE
.	I-DISEASE

Brown	0
LK	0
.	I-DISEASE

Hypoventilation	0
syndromes	0
.	0

Clin	0
Chest	I-DISEASE
Med	0
2010;31:249–70	0
.	0

Casey	0
KR	0
,	0
Cantillo	0
KO	0
,	I-DISEASE
Brown	I-DISEASE
LK	0
.	I-DISEASE

Sleep	0
-	0
related	0
hypoventilation	I-DISEASE
/	0
hypoxemic	0
syndromes	I-DISEASE
.	0

Chest	0
2007;131:1936–48	0
.	0

Chebbo	0
A	0
,	0
Tfaili	0
A	0
,	I-DISEASE
Jones	I-DISEASE
SF	0
.	I-DISEASE

Hypoventilation	0
syndromes	0
.	0

Med	0
Clin	I-DISEASE
North	0
Am	I-DISEASE
2011;95:1189–202	0
.	0

Mogri	0
M	0
,	0
Desai	0
H	0
,	0
Webster	0
L	0
,	0
Grant	0
BJ	0
,	0
Mador	0
MJ	0
.	I-DISEASE

Hypoxemia	0
in	0
patients	0
on	I-DISEASE
chronic	0
opiate	0
therapy	I-DISEASE
with	0
and	0
without	0
sleep	0
apnea	0
.	0

Sleep	0
Breath	0
2009;13:49–57	0
.	0

Isolated	0
Symptoms	0
and	0
Normal	0
Variants	0
Snoring	0
ICD-9	I-DISEASE
-	0
CM	I-DISEASE
code	0
:	0
786.09	0
ICD-10	0
-	0
CM	I-DISEASE
code	I-DISEASE
:	0
R06.83	0
Snoring	0
is	0
a	0
respiratory	I-DISEASE
sound	0
generated	0
in	I-DISEASE
the	0
upper	I-DISEASE
airway	0
during	I-DISEASE
sleep	0
that	0
typically	I-DISEASE
occurs	0
during	0
inspiration	I-DISEASE
but	I-DISEASE
may	0
also	I-DISEASE
occur	0
in	0
expiration	I-DISEASE
;	0
the	0
snoring	0
described	I-DISEASE
here	I-DISEASE
occurs	I-DISEASE
without	I-DISEASE
episodes	0
of	0
apnea	0
,	0
hypopnea	I-DISEASE
,	0
RERAs	0
or	I-DISEASE
hypoventilation	0
.	I-DISEASE

The	0
intensity	0
of	0
snoring	0
may	0
vary	I-DISEASE
and	I-DISEASE
often	0
will	I-DISEASE
disturb	0
the	0
bed	0
partner	0
’s	0
sleep	0
and	0
even	0
awaken	0
the	I-DISEASE
patient	0
.	0

Snoring	0
in	0
this	0
context	0
does	0
not	0
cause	0
symptoms	0
of	I-DISEASE
daytime	0
sleepiness	0
or	0
insomnia	0
in	0
the	0
patient	0
.	0

This	0
type	0
of	0
snoring	0
has	0
variously	I-DISEASE
been	I-DISEASE
referred	0
to	0
as	0
habitual	0
,	0
primary	0
or	0
simple	I-DISEASE
snoring	0
.	0

Snoring	0
is	0
a	I-DISEASE
cardinal	I-DISEASE
symptom	0
of	I-DISEASE
obstructive	0
sleep	0
apnea	I-DISEASE
.	0

A	0
designation	0
of	I-DISEASE
habitual	0
snoring	0
can	0
not	0
be	I-DISEASE
made	I-DISEASE
in	0
those	I-DISEASE
who	0
exhibit	0
symptoms	0
(	0
daytime	0
sleepiness	0
/	0
fatigue	0
or	0
other	0
related	0
symptoms	0
)	0
or	0
report	0
possible	I-DISEASE
breathing	0
pauses	I-DISEASE
,	0
without	0
objective	I-DISEASE
mea-	0
surement	0
of	0
breathing	I-DISEASE
during	0
sleep	I-DISEASE
.	0

In	0
addition	0
,	0
those	0
individuals	0
with	I-DISEASE
snoring	I-DISEASE
and	0
comorbid	I-DISEASE
cardiovascular	I-DISEASE
disease	I-DISEASE
(	0
especially	0
pulmonary	0
or	I-DISEASE
systemic	0
hypertension	0
,	I-DISEASE
cor-	0
onary	I-DISEASE
artery	0
disease	0
,	I-DISEASE
or	0
atrial	I-DISEASE
fibrillation	0
)	0
are	I-DISEASE
at	0
increased	I-DISEASE
risk	0
for	0
the	0
presence	0
of	0
OSA	0
even	I-DISEASE
in	I-DISEASE
the	0
absence	0
of	I-DISEASE
complaints	I-DISEASE
of	I-DISEASE
daytime	0
sleepiness	I-DISEASE
.	I-DISEASE

Therefore	0
,	0
PSG	0
or	0
OCST	0
is	0
required	0
in	0
order	0
to	0
effectively	0
rule	0
out	0
OSA	0
in	0
such	0
populations	0
.	I-DISEASE

It	0
should	0
also	0
be	0
noted	0
that	0
patients	I-DISEASE
who	I-DISEASE
initially	I-DISEASE
have	0
isolated	0
snoring	0
may	0
be	0
at	I-DISEASE
risk	0
for	0
developing	I-DISEASE
OSA	0
with	0
aging	0
or	0
weight	0
gain	0
.	0

Occasional	0
snoring	0
is	0
almost	0
universal	0
.	I-DISEASE

Estimates	0
on	0
snoring	I-DISEASE
vary	I-DISEASE
widely	0
depending	0
on	0
its	0
definition	I-DISEASE
.	0

The	0
incidence	0
of	0
snoring	0
in	0
children	I-DISEASE
is	I-DISEASE
reported	0
to	I-DISEASE
be	0
10	0
%	0
to	0
12	0
%	0
.	0

The	0
Wisconsin	0
cohort	0
study	0
reports	0
habitual	0
snoring	I-DISEASE
in	0
about	I-DISEASE
24	0
%	0
of	I-DISEASE
adult	0
women	0
and	0
40	I-DISEASE
%	0
of	I-DISEASE
adult	0
men	0
.	0

Prevalence	0
of	0
snoring	0
increases	0
with	0
age	I-DISEASE
in	I-DISEASE
both	0
sexes	I-DISEASE
,	0
except	0
that	0
the	0
prevalence	0
of	0
reported	0
snoring	I-DISEASE
starts	I-DISEASE
to	0
decrease	0
again	0
in	0
men	0
after	0
70	0
years	I-DISEASE
of	0
age	0
.	0

Some	0
have	0
hypothesized	0
that	I-DISEASE
his	0
may	0
be	0
due	0
to	I-DISEASE
decreased	0
hearing	0
acuity	0
in	0
older	0
individuals	0
.	0

Snoring	0
is	0
most	I-DISEASE
common	I-DISEASE
in	0
adult	0
men	0
and	0
is	I-DISEASE
also	0
linked	0
to	0
obesity	0
.	0

Nasal	0
obstruc-	0
tion	0
increases	0
the	0
risk	0
of	I-DISEASE
snoring	0
.	I-DISEASE

Ingestion	0
of	0
alcohol	0
,	0
muscle	0
relaxants	0
,	I-DISEASE
narcotics	0
,	I-DISEASE
or	0
other	0
substances	0
that	0
decrease	0
upper	I-DISEASE
airway	0
muscle	0
tone	I-DISEASE
predisposes	0
an	0
individual	0
to	0
snoring	I-DISEASE
.	0

Smoking	0
,	0
particularly	0
in	0
males	0
,	I-DISEASE
has	0
also	0
been	I-DISEASE
shown	0
to	0
be	0
a	0
risk	0
factor	I-DISEASE
.	0

Snoring	0
has	0
also	I-DISEASE
been	0
shown	0
to	0
increase	0
during	0
pregnancy	I-DISEASE
.	0

In	0
children	0
,	I-DISEASE
an	0
association	0
has	0
been	0
reported	0
between	0
snoring	0
and	0
adenotonsillar	I-DISEASE
hypertrophy	0
.	0

During	0
snoring	0
Sleep	0
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
Sleep	I-DISEASE
Related	0
Breathing	I-DISEASE
Disorders	0
there	0
is	0
vibration	0
of	0
the	I-DISEASE
uvula	I-DISEASE
and	0
soft	I-DISEASE
palate	0
,	I-DISEASE
although	0
it	0
may	0
also	I-DISEASE
involve	I-DISEASE
the	0
faucial	0
pillars	I-DISEASE
,	0
pharyngeal	0
walls	I-DISEASE
,	I-DISEASE
and	0
lower	0
structures	0
.	0

Snorers	0
have	0
been	I-DISEASE
shown	0
to	0
have	0
mor-	0
phologic	0
derangements	0
of	0
the	0
palate	0
consistent	0
with	0
neurogenic	I-DISEASE
lesions	0
.	0

These	0
are	0
thought	0
to	0
be	0
due	0
to	0
trauma	0
from	0
vibration	0
.	0

If	0
PSG	0
is	0
performed	0
,	0
snoring	0
tends	I-DISEASE
to	0
be	I-DISEASE
loudest	I-DISEASE
during	0
stage	0
N3	I-DISEASE
sleep	0
or	I-DISEASE
REM	I-DISEASE
sleep	0
.	0

Epidemiologic	0
studies	0
are	0
difficult	0
to	0
interpret	0
if	0
sleep	0
apnea	0
was	0
not	0
excluded	0
by	0
PSG	0
.	I-DISEASE

Based	0
on	0
the	0
current	I-DISEASE
literature	0
,	I-DISEASE
habitual	I-DISEASE
snoring	0
in	I-DISEASE
children	0
may	0
be	0
associated	0
with	I-DISEASE
worse	I-DISEASE
school	I-DISEASE
performance	0
,	I-DISEASE
but	0
conclusive	0
evidence	0
for	0
this	0
is	I-DISEASE
lacking	0
.	0

Some	0
studies	0
have	0
suggested	0
that	0
adult	I-DISEASE
snorers	I-DISEASE
may	0
have	I-DISEASE
a	0
higher	0
prevalence	0
of	0
cardiovas-	0
cular	I-DISEASE
disease	I-DISEASE
,	0
including	I-DISEASE
hypertension	0
,	0
stroke	0
,	0
and	0
ischemic	0
heart	I-DISEASE
disease	I-DISEASE
.	0

However	0
,	I-DISEASE
a	0
large	0
observational	0
study	0
in	0
which	0
all	0
subjects	0
underwent	0
PSG	0
found	0
no	0
increased	I-DISEASE
risk	0
of	I-DISEASE
cardiovascular	I-DISEASE
morbidity	0
or	0
mortality	0
with	0
habitual	0
snoring	0
.	I-DISEASE

Of	0
interest	0
,	0
one	0
study	0
found	I-DISEASE
that	0
snoring	0
was	0
associated	0
with	0
atherosclerosis	0
of	0
the	0
carotid	I-DISEASE
artery	0
,	0
but	I-DISEASE
this	0
has	0
not	0
been	0
confirmed	0
by	0
other	0
studies	0
.	0

As	0
snoring	0
tends	0
to	0
increase	0
during	0
pregnancy	0
,	0
the	I-DISEASE
impact	0
of	0
snoring	0
on	0
maternal	0
health	0
is	0
of	0
great	0
interest	0
.	0

A	0
study	0
found	I-DISEASE
that	0
preg-	0
nancy	0
-	I-DISEASE
onset	0
habitual	I-DISEASE
snoring	0
(	0
but	0
not	0
chronic	0
[	0
pre	I-DISEASE
-	0
conceptual	I-DISEASE
]	0
snoring	I-DISEASE
)	0
was	0
associated	0
with	I-DISEASE
increased	I-DISEASE
risk	0
of	0
gestational	I-DISEASE
hypertension	I-DISEASE
and	I-DISEASE
preeclampsia	0
.	0

Further	0
studies	0
are	0
needed	0
in	0
this	0
area	0
.	0

Bibliography	0
Cho	0
JG	0
,	0
Witting	0
PK	0
,	I-DISEASE
Verma	0
M	I-DISEASE
,	0
et	0
al	0
.	0

Tissue	0
vibration	0
induces	0
carotid	0
artery	0
endothelial	0
dysfunction	I-DISEASE
:	I-DISEASE
a	0
mechanism	0
linking	0
snoring	0
and	0
carotid	0
atherosclerosis	0
?	0

Sleep	0
2011;34:751–7	0
.	0

Kezirian	0
EJ	0
,	0
Chang	0
JL	0
.	0

Snoring	0
without	0
OSA	I-DISEASE
and	0
health	I-DISEASE
consequences	0
:	I-DISEASE
the	0
jury	0
is	0
still	0
out	I-DISEASE
.	0

Sleep	0
2013;36:613	0
.	0

Lee	0
SA	0
,	0
Amis	0
TC	0
,	0
Byth	I-DISEASE
K	0
,	I-DISEASE
et	0
al	0
.	0

Heavy	0
snoring	0
as	0
a	0
cause	0
of	0
carotid	I-DISEASE
artery	0
atherosclerosis	I-DISEASE
.	0

Sleep	0
2008;31:1207–13	0
.	0

Marin	0
JM	0
,	0
Carrizo	I-DISEASE
SJ	0
,	0
Vicente	I-DISEASE
E	0
,	I-DISEASE
Agusti	0
AG	0
.	0

Long	0
-	0
term	I-DISEASE
cardiovascular	0
outcomes	0
in	I-DISEASE
men	I-DISEASE
with	0
obstructive	I-DISEASE
sleep	0
apnoea	0
-	0
hypopnoea	0
with	I-DISEASE
or	I-DISEASE
without	I-DISEASE
treatment	I-DISEASE
with	I-DISEASE
continuous	0
positive	I-DISEASE
airway	0
pressure	0
:	0
an	I-DISEASE
observational	I-DISEASE
study	0
.	0

Lancet	0
2005;365:1046–53	0
.	0

Mason	0
RH	0
,	0
Mehta	0
Z	0
,	I-DISEASE
Fonseca	I-DISEASE
AC	0
,	I-DISEASE
Stradling	0
JR	0
,	0
Rothwell	I-DISEASE
PM	0
.	I-DISEASE

Snoring	0
and	0
severity	I-DISEASE
of	I-DISEASE
symptomatic	0
and	I-DISEASE
asymptomatic	I-DISEASE
carotid	0
stenosis	I-DISEASE
:	0
a	0
population	0
-	I-DISEASE
based	0
study	I-DISEASE
.	I-DISEASE

Sleep	0
2012;35:1147–51	0
.	0

O’Brien	0
LM	0
,	0
Bullough	0
AS	I-DISEASE
,	I-DISEASE
Owusu	I-DISEASE
JT	I-DISEASE
,	I-DISEASE
et	0
al	0
.	0

Pregnancy	0
-	0
onset	0
habitual	0
snoring	0
,	0
gestational	I-DISEASE
hypertension	I-DISEASE
,	0
and	I-DISEASE
preeclampsia	0
:	0
prospective	I-DISEASE
cohort	0
study	I-DISEASE
.	I-DISEASE

Am	0
J	0
Obstet	0
Gynecol	0
2012;207:487.e1–9	0
.	0

Rich	0
J	0
,	0
Raviv	0
A	0
,	0
Raviv	I-DISEASE
N	0
,	0
Brietzke	0
SE	0
.	0

An	0
epidemiologic	0
study	0
of	0
snoring	0
and	0
all	0
-	0
cause	I-DISEASE
mortality	0
.	0

Otolaryngol	0
Head	0
Neck	0
Surg	0
2011;145:341–46	0
.	0

Catathrenia	0
Catathrenia	0
,	0
also	I-DISEASE
known	0
as	0
sleep	I-DISEASE
related	I-DISEASE
groaning	I-DISEASE
,	0
is	0
included	0
in	0
the	I-DISEASE
SRBD	I-DISEASE
section	0
because	0
it	I-DISEASE
appears	0
to	I-DISEASE
be	0
associated	0
with	0
prolonged	0
expiration	0
,	0
usually	0
during	0
REM	0
sleep	0
.	I-DISEASE

However	0
,	I-DISEASE
some	0
studies	0
have	0
documented	0
catathrenia	I-DISEASE
during	0
NREM	0
sleep	0
.	0

Typically	0
,	0
a	0
deep	0
inspiration	0
is	I-DISEASE
followed	I-DISEASE
by	0
prolonged	I-DISEASE
expiration	0
and	0
a	0
monotonous	0
vocalization	0
resembling	I-DISEASE
groaning	0
.	I-DISEASE

The	0
pattern	0
is	0
sometimes	0
called	0
bradypnea	0
(	I-DISEASE
low	0
respiratory	I-DISEASE
rate	0
)	0
.	0

The	0
affected	0
individual	0
is	0
usually	0
unaware	0
of	0
the	0
problem	I-DISEASE
,	0
but	0
clini-	0
cal	0
evaluation	0
is	I-DISEASE
sought	0
due	0
to	I-DISEASE
complaints	0
of	I-DISEASE
the	0
bed	0
partner	0
or	0
family	I-DISEASE
members	0
.	0

The	0
recurrent	0
bradypneic	0
episodes	0
may	0
resemble	0
central	I-DISEASE
apnea	0
except	0
that	0
central	0
apneas	0
are	0
not	0
typically	I-DISEASE
associated	0
with	0
vocalization	I-DISEASE
.	0

Catathrenia	0
is	0
thought	0
to	I-DISEASE
be	0
rare	0
and	0
more	0
common	I-DISEASE
in	I-DISEASE
men	0
.	0

Several	0
episodes	0
may	0
occur	0
nightly	0
and	I-DISEASE
often	0
in	0
clusters	I-DISEASE
.	0

The	0
long	0
-	0
term	I-DISEASE
consequences	0
of	I-DISEASE
catathrenia	I-DISEASE
are	I-DISEASE
unknown	I-DISEASE
,	I-DISEASE
but	0
the	0
disorder	I-DISEASE
is	0
primarily	0
a	I-DISEASE
social	0
problem	I-DISEASE
for	0
the	0
affected	0
individual	I-DISEASE
.	0

The	0
episodes	0
of	0
catathrenia	0
are	0
not	0
associ-	I-DISEASE
ated	0
with	0
sleep	I-DISEASE
talking	0
or	0
body	0
movement	0
.	I-DISEASE

No	0
association	0
with	0
psychiatric	0
disorders	0
has	0
been	0
demonstrated	0
.	0

The	0
onset	0
of	0
catathrenia	0
has	0
recently	0
been	I-DISEASE
reported	0
in	0
patients	0
taking	0
sodium	0
oxybate	0
for	I-DISEASE
narcolepsy	I-DISEASE
with	0
cataplexy	0
.	I-DISEASE

The	0
clinical	0
significance	0
of	0
this	0
finding	0
is	0
unclear	0
.	I-DISEASE

Bibliography	0
Abbasi	0
AA	0
,	0
Morgenthaler	0
TI	0
,	0
Slocumb	0
NL	I-DISEASE
,	0
et	0
al	0
.	0

Nocturnal	0
moaning	0
and	0
groaning	0
-	0
catathrenia	0
or	I-DISEASE
nocturnal	0
vocalizations	I-DISEASE
.	0

Sleep	0
Breath	0
2012;16:367–73	0
.	0

Pevernagie	0
DA	0
,	0
Boon	0
PA	0
,	I-DISEASE
Mariman	I-DISEASE
ANN	0
,	I-DISEASE
Verhaeghen	0
DB	0
,	0
Pauwels	I-DISEASE
RA	0
.	0

Vocalization	0
during	0
episodes	0
of	0
prolonged	0
expiration	I-DISEASE
:	I-DISEASE
a	0
parasomnia	0
related	0
to	0
REM	0
sleep	0
.	0

Sleep	0
Med	0
2001;2:19–30	0
.	0

Poli	0
F	0
,	0
Ricotta	0
L	0
,	0
Vandi	0
S	I-DISEASE
,	I-DISEASE
et	0
al	0
.	0

Catathrenia	0
under	0
sodium	0
oxybate	I-DISEASE
in	0
narcolepsy	I-DISEASE
with	0
cataplexy	0
.	I-DISEASE

Sleep	0
Breath	0
2012;16:427–34	0
.	0

Vetrugno	0
R	0
,	0
Lugaresi	0
E	0
,	I-DISEASE
Plazzi	I-DISEASE
G	0
,	I-DISEASE
Provini	0
F	0
,	0
D’Angelo	I-DISEASE
R	0
,	I-DISEASE
Montagna	I-DISEASE
P.	0
Catathrenia	I-DISEASE
(	0
nocturnal	I-DISEASE
groaning	0
):	0
an	I-DISEASE
abnormal	0
respiratory	0
pattern	0
during	0
sleep	0
.	I-DISEASE

Eur	0
J	0
Neurol	0
2007;14:1236–43	0
.	0

Vetrugno	0
R	0
,	0
Provini	0
F	0
,	I-DISEASE
Plazzi	I-DISEASE
G	0
,	I-DISEASE
Vignatelli	0
L	0
,	0
Lugaresi	I-DISEASE
E	0
,	I-DISEASE
Montagna	I-DISEASE
P.	0
Catathrenia	I-DISEASE
(	0
nocturnal	0
groaning	0
):	I-DISEASE
a	0
new	0
type	I-DISEASE
of	0
parasomnia	0
.	I-DISEASE

Neurology	0
2001;56:681–3	0
.	0

Sleep	0
Related	I-DISEASE
Breathing	I-DISEASE
Disorders	0
Central	I-DISEASE
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	0
Narcolepsy	I-DISEASE
Type	0
1146	0
Narcolepsy	0
Type	0
2155	0
Idiopathic	I-DISEASE
Hypersomnia161	0
Kleine	0
-	I-DISEASE
Levin	0
Syndrome	0
166	0
Hypersomnia	0
Due	0
to	0
a	I-DISEASE
Medical	0
Disorder171	0
Hypersomnia	I-DISEASE
Due	B-DISEASE
to	I-DISEASE
a	0
Medication	0
or	0
Substance	0
175	0
Hypersomnia	0
Associated	0
with	I-DISEASE
a	0
Psychiatric	0
Disorder179	0
Insufficient	0
Sleep	0
Syndrome182	0
Isolated	0
Symptoms	0
and	I-DISEASE
Normal	I-DISEASE
Variants	0
Long	I-DISEASE
Sleeper	0
187	0
Adequate	I-DISEASE
alertness	0
is	0
necessary	0
for	0
well	0
-	0
being	I-DISEASE
and	I-DISEASE
performance	0
in	I-DISEASE
modern	I-DISEASE
society	0
.	I-DISEASE

Sleepiness	0
predisposes	I-DISEASE
an	0
individual	0
to	0
developing	0
serious	I-DISEASE
performance	I-DISEASE
decrements	I-DISEASE
in	0
multiple	0
areas	0
of	0
function	I-DISEASE
,	I-DISEASE
as	0
well	0
as	I-DISEASE
to	0
potentially	I-DISEASE
life	0
-	0
threatening	0
domestic	0
,	I-DISEASE
occu-	0
pational	0
,	I-DISEASE
and	0
vehicular	0
accidents	0
.	0

This	0
section	0
includes	0
a	0
group	0
of	0
disorders	I-DISEASE
in	0
which	0
the	I-DISEASE
primary	I-DISEASE
complaint	0
is	I-DISEASE
daytime	0
sleepiness	0
not	I-DISEASE
caused	0
by	I-DISEASE
disturbed	0
nocturnal	0
sleep	0
or	0
misaligned	0
circadian	I-DISEASE
rhythms	0
.	I-DISEASE

Other	0
sleep	0
disorders	I-DISEASE
may	0
be	0
present	0
,	0
but	0
they	0
must	0
be	0
adequately	0
treated	0
before	0
a	I-DISEASE
diagnosis	0
in	0
this	0
category	0
can	0
be	0
established	0
.	0

In	0
this	0
nosology	0
,	I-DISEASE
the	0
term	0
hypersomnolence	I-DISEASE
is	I-DISEASE
used	I-DISEASE
to	0
describe	0
the	0
symptom	0
of	0
exces-	I-DISEASE
sive	0
sleepiness	0
,	I-DISEASE
whereas	0
hypersomnia	I-DISEASE
refers	0
to	0
specific	0
disorders	0
,	I-DISEASE
such	0
as	0
idiopathic	I-DISEASE
hypersomnia	0
.	0

Daytime	0
sleepiness	0
is	0
defined	I-DISEASE
as	0
the	0
inability	B-DISEASE
to	0
stay	I-DISEASE
awake	0
and	0
alert	0
during	0
the	0
major	0
waking	I-DISEASE
episodes	I-DISEASE
of	I-DISEASE
the	0
day	0
,	0
resulting	0
in	0
periods	0
of	0
irrepressible	0
need	0
for	I-DISEASE
sleep	0
or	0
unin-	0
tended	0
lapses	0
into	0
drowsiness	0
or	0
sleep	0
.	I-DISEASE

Sleepiness	0
may	I-DISEASE
vary	0
in	B-DISEASE
severity	I-DISEASE
and	0
is	I-DISEASE
more	0
likely	I-DISEASE
to	0
occur	0
in	0
sedentary	0
,	0
boring	I-DISEASE
,	0
and	0
monotonous	I-DISEASE
situations	0
that	0
require	0
little	0
active	0
participation	I-DISEASE
.	I-DISEASE

Some	0
patients	0
are	I-DISEASE
aware	0
of	0
increasing	I-DISEASE
sleepiness	I-DISEASE
before	I-DISEASE
falling	I-DISEASE
asleep	I-DISEASE
,	0
whereas	0
others	0
can	0
fall	I-DISEASE
asleep	0
with	0
little	I-DISEASE
or	0
no	0
prodromal	0
symptoms	0
(	0
“	0
sleep	0
attacks	0
”	0
)	I-DISEASE
.	0

This	0
group	0
of	0
patients	0
sometimes	0
can	0
present	0
following	0
motor	I-DISEASE
vehicle	0
accidents	0
attrib-	0
utable	I-DISEASE
to	0
sleepiness	I-DISEASE
.	0

In	0
some	0
forms	0
of	0
hypersomnolence	0
,	0
sleepiness	0
is	0
associated	0
with	0
large	0
increases	0
in	0
total	I-DISEASE
daily	I-DISEASE
amount	I-DISEASE
of	0
sleep	0
without	0
any	I-DISEASE
genuine	0
feeling	0
of	0
resto-	I-DISEASE
ration	I-DISEASE
.	I-DISEASE

In	0
others	0
,	0
sleepiness	0
can	0
be	0
alleviated	0
temporarily	0
by	0
naps	0
but	0
reoccurs	0
shortly	0
thereafter	0
.	0

In	0
young	0
children	0
,	I-DISEASE
sleepiness	0
may	I-DISEASE
express	0
itself	0
as	I-DISEASE
excessively	0
long	0
night	I-DISEASE
sleep	0
or	0
with	I-DISEASE
the	I-DISEASE
recurrence	0
of	0
previously	I-DISEASE
discontinued	I-DISEASE
daytime	0
napping	0
.	0

Children	0
may	0
Central	0
Disorders	0
of	0
Hypersomnolence	I-DISEASE
paradoxically	I-DISEASE
present	0
with	0
inattentiveness	0
,	0
emotional	0
lability	I-DISEASE
,	0
hyperactive	I-DISEASE
behavior	0
,	I-DISEASE
or	I-DISEASE
decreased	0
performance	0
in	0
school	I-DISEASE
.	0

In	0
most	0
cases	0
,	B-DISEASE
excessive	0
sleepiness	I-DISEASE
is	I-DISEASE
a	0
chronic	I-DISEASE
symptom	0
.	0

It	0
must	0
occur	0
for	0
at	0
least	I-DISEASE
three	I-DISEASE
months	0
prior	0
to	0
diagnosis	0
.	0

The	0
severity	0
of	0
daytime	0
sleepiness	0
can	I-DISEASE
be	0
quantified	0
subjectively	I-DISEASE
using	0
severity	0
scales	0
such	0
as	0
the	I-DISEASE
Epworth	0
Sleepiness	I-DISEASE
Scale	I-DISEASE
and	0
objectively	I-DISEASE
using	0
the	0
Multiple	0
Sleep	I-DISEASE
Latency	0
Test	0
(	I-DISEASE
MSLT	I-DISEASE
)	0
.	0

These	0
measures	0
do	0
not	0
always	0
correlate	0
with	I-DISEASE
each	0
other	0
and	0
must	0
be	0
used	0
with	0
appropriate	I-DISEASE
clinical	0
judgment	0
.	0

When	0
applied	0
in	0
clinical	0
settings	0
,	0
the	I-DISEASE
MSLT	0
is	I-DISEASE
sensitive	0
to	0
sleep	0
deprivation	0
and	0
circadian	I-DISEASE
effects	I-DISEASE
.	I-DISEASE

It	0
has	0
not	0
been	I-DISEASE
validated	0
as	0
a	I-DISEASE
diagnostic	0
test	I-DISEASE
in	0
people	0
who	0
are	I-DISEASE
habitually	0
awake	I-DISEASE
throughout	0
the	0
night	I-DISEASE
and	0
sleep	I-DISEASE
during	0
the	0
day	I-DISEASE
.	0

Normal	0
and	0
abnormal	0
ranges	0
of	0
sleep	I-DISEASE
latencies	I-DISEASE
have	0
not	I-DISEASE
been	0
estab-	I-DISEASE
lished	0
when	0
this	0
test	I-DISEASE
is	0
administered	0
at	I-DISEASE
times	0
other	0
than	0
the	0
hours	I-DISEASE
between	0
8:00	I-DISEASE
a.m.	0
and	I-DISEASE
6:00	I-DISEASE
p.m.	0

Normative	0
data	0
are	0
not	0
available	0
for	I-DISEASE
children	I-DISEASE
younger	0
than	I-DISEASE
six	0
years	0
.	0

The	0
MSLT	0
measures	0
the	0
physiological	0
tendency	0
to	0
fall	0
asleep	0
in	0
quiet	0
situations	0
.	0

In	0
the	0
context	I-DISEASE
of	0
diagnosing	0
central	0
disorders	I-DISEASE
of	0
hypersomnolence	I-DISEASE
,	0
the	0
MSLT	0
should	I-DISEASE
be	0
con-	0
ducted	0
according	0
to	I-DISEASE
standardized	0
procedures	0
,	0
as	0
defined	0
in	0
the	I-DISEASE
American	I-DISEASE
Academy	0
of	I-DISEASE
Sleep	0
Medicine	0
(	0
AASM	I-DISEASE
)	0
practice	0
parameters	0
.	B-DISEASE

In	0
particular	0
,	0
patients	0
should	0
be	0
encour-	I-DISEASE
aged	0
to	I-DISEASE
sleep	0
as	0
much	0
as	0
possible	0
during	0
the	0
week	0
and	0
,	0
especially	I-DISEASE
,	0
during	0
the	0
night	0
prior	0
to	0
the	I-DISEASE
MSLT	I-DISEASE
.	0

Delaying	0
wake	0
-	0
up	I-DISEASE
time	I-DISEASE
and	I-DISEASE
subsequent	I-DISEASE
MSLT	0
start	I-DISEASE
time	0
may	0
be	0
appropriate	0
in	0
some	I-DISEASE
patients	I-DISEASE
with	0
delayed	0
sleep	0
phase	I-DISEASE
syndrome	0
.	0

It	0
is	0
strongly	0
rec-	0
ommended	0
that	0
adequate	I-DISEASE
sleep	0
be	I-DISEASE
documented	0
by	I-DISEASE
sleep	I-DISEASE
log	I-DISEASE
and	0
,	I-DISEASE
whenever	0
possible	I-DISEASE
,	I-DISEASE
actigraphy	0
for	0
a	0
period	0
of	0
one	0
to	I-DISEASE
two	0
weeks	0
prior	I-DISEASE
to	0
the	I-DISEASE
MSLT	0
.	0

MSLT	0
mean	0
sleep	0
latencies	0
should	0
be	0
considered	I-DISEASE
a	0
continuum	I-DISEASE
with	0
values	0
below	I-DISEASE
five	0
minutes	0
generally	I-DISEASE
considered	0
as	0
indicative	I-DISEASE
of	0
sleepiness	0
and	0
those	0
over	0
10	0
minutes	I-DISEASE
generally	0
consid-	I-DISEASE
ered	0
indicative	0
of	I-DISEASE
normal	0
alertness	I-DISEASE
.	0

In	0
this	0
section	0
,	0
a	0
mean	I-DISEASE
MSLT	0
sleep	0
latency	I-DISEASE
of	I-DISEASE
less	0
than	0
eight	0
minutes	0
is	I-DISEASE
used	0
to	0
define	I-DISEASE
sleepiness	I-DISEASE
for	0
diagnostic	0
purposes	I-DISEASE
.	0

This	0
value	0
has	0
been	0
shown	0
to	0
be	I-DISEASE
the	I-DISEASE
best	I-DISEASE
cutoff	0
in	0
the	0
context	0
of	I-DISEASE
diagnosing	0
narcolepsy	0
,	0
with	I-DISEASE
approximately	0
90	I-DISEASE
%	0
of	0
patients	0
with	0
narcolepsy	I-DISEASE
having	0
a	0
latency	0
below	0
this	I-DISEASE
level	I-DISEASE
.	0

The	0
presence	0
of	0
multiple	I-DISEASE
sleep	0
onset	I-DISEASE
rapid	I-DISEASE
eye	0
movement	I-DISEASE
periods	0
(	0
SOREMPs	0
)	0
during	0
the	I-DISEASE
MSLT	0
is	I-DISEASE
a	I-DISEASE
more	I-DISEASE
specific	0
finding	0
in	0
narcolepsy	0
than	0
is	I-DISEASE
a	0
mean	0
sleep	0
latency	0
less	0
than	0
or	0
equal	0
to	0
eight	0
minutes	I-DISEASE
,	0
although	I-DISEASE
SOREMPs	0
can	0
also	0
be	I-DISEASE
seen	0
in	0
the	0
presence	0
of	0
insuffi-	I-DISEASE
cient	0
sleep	0
,	0
circadian	0
rhythm	I-DISEASE
disorders	I-DISEASE
(	0
including	0
delayed	I-DISEASE
sleep	0
phase	0
disorder	0
or	0
shift	0
work	I-DISEASE
)	I-DISEASE
,	0
sleep	I-DISEASE
related	0
breathing	0
disorders	I-DISEASE
or	0
,	0
occasionally	0
,	I-DISEASE
normal	0
subjects	I-DISEASE
.	I-DISEASE

The	0
results	0
of	0
an	0
MSLT	0
should	0
be	0
carefully	0
interpreted	I-DISEASE
in	0
the	0
context	0
of	I-DISEASE
the	0
patient	I-DISEASE
’s	I-DISEASE
history	0
and	0
the	0
complaint	0
of	0
daytime	0
sleepiness	0
.	0

The	0
maintenance	0
of	0
wakefulness	0
test	I-DISEASE
is	0
a	0
measure	0
of	I-DISEASE
the	0
ability	0
to	I-DISEASE
remain	I-DISEASE
awake	0
during	0
the	0
daytime	I-DISEASE
in	I-DISEASE
a	0
darkened	0
,	0
quiet	0
environment	0
and	0
is	I-DISEASE
usually	0
administered	0
to	I-DISEASE
assess	0
response	0
to	0
treatment	0
.	0

It	0
should	0
not	0
be	I-DISEASE
used	0
for	I-DISEASE
diagnostic	0
purposes	0
.	I-DISEASE

A	0
24	0
-	I-DISEASE
hour	I-DISEASE
continuous	0
sleep	I-DISEASE
recording	I-DISEASE
or	I-DISEASE
an	I-DISEASE
actigraphic	0
recording	0
of	I-DISEASE
at	I-DISEASE
least	I-DISEASE
one	I-DISEASE
week	I-DISEASE
is	I-DISEASE
useful	I-DISEASE
in	I-DISEASE
the	0
diagnosis	0
of	0
some	I-DISEASE
patients	0
with	I-DISEASE
idiopathic	0
hypersomnia	I-DISEASE
.	I-DISEASE

In	0
all	0
cases	0
in	B-DISEASE
which	0
a	I-DISEASE
diagnosis	I-DISEASE
of	0
hypersomnolence	I-DISEASE
is	0
to	0
be	0
made	0
,	0
a	I-DISEASE
review	0
of	0
other	I-DISEASE
sleep	0
,	0
medical	0
,	0
and	0
psychiatric	I-DISEASE
disorders	I-DISEASE
,	I-DISEASE
as	0
well	I-DISEASE
as	0
substance	I-DISEASE
and	0
medication	0
use	0
,	0
should	0
be	0
performed	0
.	I-DISEASE

In	0
this	0
edition	0
of	I-DISEASE
International	0
Classification	0
of	0
Sleep	0
Disorders	I-DISEASE
the	0
preferred	0
names	0
of	I-DISEASE
certain	0
central	I-DISEASE
disorders	0
of	0
hypersomnolence	0
have	0
been	0
changed	0
.	0

In	0
particular	0
,	0
nar-	0
colepsy	0
has	0
been	I-DISEASE
divided	0
into	I-DISEASE
narcolepsy	0
type	0
1	0
and	0
narcolepsy	0
type	0
2	0
rather	0
than	I-DISEASE
narcolepsy	0
with	0
and	0
without	0
cataplexy	0
.	0

This	0
change	0
is	0
predicated	0
on	0
the	0
concept	0
that	I-DISEASE
absence	I-DISEASE
of	0
hypocretin	0
(	0
orexin	0
)	0
is	I-DISEASE
a	0
fundamental	0
marker	I-DISEASE
of	0
the	I-DISEASE
most	0
precisely	0
defined	0
category	I-DISEASE
of	0
the	0
disorder	I-DISEASE
.	0

Because	0
some	0
patients	0
without	I-DISEASE
cataplexy	I-DISEASE
will	I-DISEASE
also	0
have	0
low	0
cerebrospinal	0
fluid	0
(	0
CSF	I-DISEASE
)	0
hypocretin-1	0
levels	0
,	0
the	I-DISEASE
use	0
of	I-DISEASE
the	0
term	0
“	I-DISEASE
narcolepsy	I-DISEASE
with	0
cataplexy	0
”	0
or	I-DISEASE
“	0
narcolepsy	0
-	0
cataplexy	0
”	I-DISEASE
is	0
inappropriate	0
.	I-DISEASE

The	0
change	0
is	0
not	0
intended	I-DISEASE
to	0
imply	I-DISEASE
that	0
the	I-DISEASE
presence	I-DISEASE
or	0
absence	0
of	0
cataplexy	0
is	I-DISEASE
unimportant	0
clinically	0
nor	0
that	0
mea-	0
suring	0
CSF	0
hypocretin-1	0
levels	0
is	0
obligatory	0
.	0

The	0
motivation	0
behind	0
the	I-DISEASE
decision	I-DISEASE
to	0
eliminate	I-DISEASE
the	0
subcategories	I-DISEASE
of	0
idiopathic	0
hypersomnia	0
is	0
discussed	0
in	I-DISEASE
the	I-DISEASE
appropriate	0
section	I-DISEASE
.	0

The	0
decision	0
to	0
use	I-DISEASE
Kleine	0
-	I-DISEASE
Levin	I-DISEASE
syndrome	0
as	I-DISEASE
the	I-DISEASE
preferred	0
name	I-DISEASE
in	0
place	0
of	0
recurrent	0
hypersomnia	0
is	I-DISEASE
based	0
on	0
data	0
suggesting	0
that	0
the	0
condition	I-DISEASE
is	0
fairly	0
homo-	I-DISEASE
geneous	0
,	I-DISEASE
as	I-DISEASE
well	I-DISEASE
as	0
the	0
lack	0
of	0
definite	I-DISEASE
evidence	0
for	I-DISEASE
other	0
major	0
subcategories	0
of	0
the	I-DISEASE
disorder	I-DISEASE
.	I-DISEASE

Bibliography	0
Arand	0
D	I-DISEASE
,	0
Bonnet	0
M	I-DISEASE
,	I-DISEASE
Hurwitz	0
T	I-DISEASE
,	0
Mitler	0
M	0
,	I-DISEASE
Rosa	0
R	0
,	0
Sangal	0
RB	I-DISEASE
.	0

A	0
Review	0
by	0
the	0
MSLT	0
and	0
MWT	0
Task	0
Force	0
of	0
the	0
Standards	0
of	0
Practice	0
Committee	0
of	0
the	0
American	0
Academy	0
of	I-DISEASE
Sleep	0
Medicine	0
.	0

The	0
clinical	0
use	0
of	0
the	0
MSLT	I-DISEASE
and	I-DISEASE
MWT	0
.	I-DISEASE

Sleep	0
2005;28:123–44	0
.	0

Aurora	0
RN	0
,	0
Lamm	0
CI	0
,	0
Zak	0
RS	I-DISEASE
,	I-DISEASE
et	0
al	0
.	0

Practice	0
parameters	0
for	0
the	0
non	I-DISEASE
-	0
respiratory	I-DISEASE
indications	0
for	I-DISEASE
polysomnography	0
and	0
multiple	0
sleep	I-DISEASE
latency	0
testing	0
for	0
children	I-DISEASE
.	I-DISEASE

Sleep	0
2012;35:1467–73	0
.	0

Littner	0
MR	0
,	0
Kushida	0
C	0
,	0
Wise	0
M	0
,	I-DISEASE
et	I-DISEASE
al	0
.	0
;	0
Standards	0
of	I-DISEASE
Practice	I-DISEASE
Committee	0
of	I-DISEASE
the	0
American	0
Academy	0
of	0
Sleep	0
Medicine	I-DISEASE
.	I-DISEASE

Practice	0
parameters	0
for	0
clinical	0
use	0
of	0
the	I-DISEASE
multiple	I-DISEASE
sleep	I-DISEASE
latency	0
test	0
and	0
the	0
maintenance	0
of	I-DISEASE
wakefulness	0
test	0
.	I-DISEASE

Sleep	0
2005;28:113–21	0
.	0

Mignot	0
E	0
,	0
Lin	0
L	0
,	0
Finn	B-DISEASE
L	I-DISEASE
,	I-DISEASE
et	0
al	0
.	0

Correlates	0
of	0
sleep	0
-	0
onset	0
REM	I-DISEASE
periods	I-DISEASE
during	0
the	0
Multiple	0
Sleep	0
Latency	0
Test	I-DISEASE
in	0
community	I-DISEASE
adults	0
.	0

Brain	0
2006;129:1609–23	0
.	0

Central	0
Disorders	0
of	0
Hypersomnolence	0
Central	0
Disorders	I-DISEASE
of	0
Hypersomnolence	0
Narcolepsy	I-DISEASE
Type	0
1	0
ICD-9	0
-	0
CM	0
code	I-DISEASE
:	0
347.01	0
ICD-10	I-DISEASE
-	0
CM	0
code	0
:	0
G47.411	0
Alternate	0
Names	0
Hypocretin	0
deficiency	0
syndrome	I-DISEASE
,	0
narcolepsy	0
-	0
cataplexy	0
,	0
narcolepsy	0
with	0
cataplexy	0
.	I-DISEASE

Diagnostic	0
Criteria	0
Criteria	0
A	0
and	0
B	I-DISEASE
must	0
be	0
met	I-DISEASE
A.	0

The	0
patient	0
has	0
daily	0
periods	0
of	0
irrepressible	I-DISEASE
need	I-DISEASE
to	I-DISEASE
sleep	0
or	0
daytime	0
lapses	0
into	I-DISEASE
sleep	I-DISEASE
occurring	0
for	0
at	I-DISEASE
least	0
three	I-DISEASE
months.1	0

B.	0
The	0
presence	0
of	0
one	0
or	I-DISEASE
both	I-DISEASE
of	0
the	0
following	0
:	0
.	0

Cataplexy	0
(	0
as	0
defined	0
under	0
Essential	I-DISEASE
Features	I-DISEASE
)	0
and	I-DISEASE
a	I-DISEASE
mean	0
sleep	I-DISEASE
latency	I-DISEASE
of	0
≤	0
8	I-DISEASE
minutes	0
and	I-DISEASE
two	0
or	I-DISEASE
more	0
sleep	0
onset	I-DISEASE
REM	0
periods	0
(	0
SOREMPs	I-DISEASE
)	I-DISEASE
on	0
an	0
MSLT	0
performed	I-DISEASE
according	0
to	0
standard	0
techniques	0
.	I-DISEASE

A	0
SOREMP	0
(	0
within	0
15	0
minutes	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
onset	I-DISEASE
)	0
on	0
the	I-DISEASE
preceding	0
nocturnal	I-DISEASE
polysomnogram	I-DISEASE
may	I-DISEASE
replace	I-DISEASE
one	I-DISEASE
of	0
the	I-DISEASE
SOREMPs	0
on	0
the	0
MSLT.2	I-DISEASE
.	I-DISEASE

CSF	0
hypocretin-1	I-DISEASE
concentration	0
,	I-DISEASE
measured	0
by	I-DISEASE
immunoreactivity	I-DISEASE
,	0
is	I-DISEASE
either	0
≤	0
110	0
pg	0
/	0
mL	0
or	0
<	I-DISEASE
1/3	I-DISEASE
of	0
mean	0
values	0
obtained	0
in	0
normal	I-DISEASE
subjects	0
with	0
the	0
same	0
standardized	0
assay	0
.	0

Notes	0
.	0

In	0
young	0
children	0
,	I-DISEASE
narcolepsy	0
may	0
sometimes	I-DISEASE
present	0
as	I-DISEASE
excessively	0
long	0
night	0
sleep	0
or	0
as	0
resumption	0
of	I-DISEASE
previously	I-DISEASE
discontinued	0
daytime	0
napping	0
.	0
.	0

If	0
narcolepsy	0
type	0
I	0
is	0
strongly	0
suspected	I-DISEASE
clinically	0
but	I-DISEASE
the	0
MSLT	0
criteria	0
of	0
B1	0
are	I-DISEASE
not	0
met	0
,	I-DISEASE
a	0
possible	0
strategy	0
is	0
to	0
repeat	0
the	0
MSLT	0
.	0

Essential	0
Features	0
Narcolepsy	0
type	I-DISEASE
1	0
is	0
a	I-DISEASE
disorder	0
primarily	0
characterized	0
by	0
excessive	0
daytime	0
sleepi-	0
ness	I-DISEASE
and	I-DISEASE
signs	0
of	I-DISEASE
REM	0
-	0
sleep	0
dissociation	0
,	I-DISEASE
the	I-DISEASE
most	I-DISEASE
specific	0
of	0
which	I-DISEASE
is	I-DISEASE
cataplexy	0
.	0

It	0
has	0
now	0
been	0
firmly	0
established	0
that	0
narcolepsy	0
type	0
1	0
is	0
caused	0
by	I-DISEASE
a	0
deficiency	I-DISEASE
of	0
hypothalamic	0
hypocretin	0
(	0
orexin	0
)	0
signaling	0
.	0

Patients	0
with	0
low	B-DISEASE
or	0
undetectable	0
concen-	0
trations	I-DISEASE
of	I-DISEASE
hypocretin-1	I-DISEASE
in	0
the	I-DISEASE
CSF	0
compose	0
a	0
specific	I-DISEASE
disease	I-DISEASE
population	0
with	I-DISEASE
a	0
single	0
etiology	0
and	0
relatively	I-DISEASE
homogenous	0
clinical	0
and	I-DISEASE
polysomnographic	I-DISEASE
features	0
.	0

Patients	0
with	0
sleepiness	0
and	0
low	0
or	0
absent	I-DISEASE
CSF	0
hypocretin-1	0

levels	0
are	0
classified	0
as	0
having	0
nar-	0
colepsy	0
type	0
1	I-DISEASE
,	0
even	0
if	0
they	0
do	0
not	I-DISEASE
manifest	0
cataplexy	0
.	0

Excessive	0
daytime	0
sleepiness	0
is	I-DISEASE
the	0
cardinal	I-DISEASE
symptom	0
,	0
and	I-DISEASE
often	0
the	0
most	0
disabling	0
.	0

Patients	0
with	0
narcolepsy	0
type	0
1	0
experience	0
repeated	0
daily	0
episodes	I-DISEASE
of	0
an	0
irrepressible	0
need	0
to	0
sleep	I-DISEASE
or	0
lapses	0
into	0
sleep	0
.	0

Most	0
patients	0
awaken	I-DISEASE
refreshed	0
after	0
a	0
sleep	0
episode	0
but	0
begin	0
to	0
feel	I-DISEASE
sleepy	0
again	0
after	I-DISEASE
variable	0
times	0
.	0

Sleepiness	0
is	0
most	0
likely	0
to	0
occur	0
in	I-DISEASE
monotonous	0
situations	0
that	I-DISEASE
require	0
no	0
active	I-DISEASE
participation	0
;	I-DISEASE
for	I-DISEASE
example	0
,	0
watching	0
television	0
or	0
riding	0
in	0
a	0
car	0
.	0

Physical	0
activity	0
may	0
temporarily	0
suppress	0
the	0
urge	I-DISEASE
to	0
sleep	I-DISEASE
.	0

In	0
some	0
cases	0
sleepiness	B-DISEASE
manifests	0
as	0
sudden	I-DISEASE
irresistible	0
sleep	I-DISEASE
“	0
attacks	0
”	0
that	I-DISEASE
may	0
occur	I-DISEASE
in	0
unusual	0
situations	I-DISEASE
such	0
as	0
eating	0
or	0
walking	0
.	I-DISEASE

Often	0
,	0
such	0
sleep	0
attacks	0
occur	0
on	0
a	0
background	I-DISEASE
of	0
overall	0
sleepiness	0
.	I-DISEASE

Even	0
when	0
seemingly	0
awake	I-DISEASE
,	0
many	0
nar-	0
colepsy	0
patients	0
have	0
lapses	0
in	0
vigilance	0
,	0
sometimes	0
in	0
combination	0
with	I-DISEASE
automatic	0
behavior	0
,	0
such	0
as	0
writing	0
gibberish	0
or	0
interrupting	0
a	0
conversation	0
with	0
a	0
completely	0
different	0
topic	0
.	0

Sleepiness	0
generally	0
has	0
a	I-DISEASE
serious	0
impact	0
on	B-DISEASE
the	0
ability	0
of	I-DISEASE
the	I-DISEASE
patient	0
to	I-DISEASE
function	0
in	0
educational	0
,	0
social	I-DISEASE
,	0
and	0
occupational	0
situations	0
.	I-DISEASE

Because	0
patients	0
are	I-DISEASE
rarely	0
examined	0
during	0
an	I-DISEASE
attack	I-DISEASE
of	0
cataplexy	0
,	0
its	0
presence	0
needs	0
to	I-DISEASE
be	0
established	0
based	0
on	0
the	I-DISEASE
clinical	0
interview	0
alone	0
.	I-DISEASE

Cataplexy	0
is	0
defined	0
as	0
more	0
than	0
one	B-DISEASE
episode	0
of	0
generally	0
brief	0
(	0
<	0
2	I-DISEASE
minutes	I-DISEASE
)	I-DISEASE
,	I-DISEASE
usually	I-DISEASE
bilaterally	0
symmetrical	0
sudden	0
loss	0
of	0
muscle	0
tone	0
with	0
retained	0
consciousness	I-DISEASE
.	0

The	0
episodes	0
are	0
precipitated	0
by	0
strong	I-DISEASE
emotions	I-DISEASE
,	0
usually	I-DISEASE
positive	0
,	0
with	0
almost	0
all	I-DISEASE
patients	I-DISEASE
reporting	0
some	0
episodes	I-DISEASE
precipitated	0
by	0
emotions	0
associated	0
with	0
laughter	0
.	I-DISEASE

The	0
finding	0
of	0
transient	0
reversible	0
loss	0
of	0
deep	0
tendon	I-DISEASE
reflexes	0
during	0
an	0
attack	0
,	0
if	0
observed	I-DISEASE
,	I-DISEASE
is	0
a	0
strong	0
diagnostic	0
finding	0
.	0

In	0
children	0
(	I-DISEASE
and	0
rarely	0
adults	0
)	0
,	0
cataplexy	I-DISEASE
may	0
present	0
close	0
to	0
disease	0
onset	I-DISEASE
as	0
facial	0
(	I-DISEASE
or	0
generalized	0
)	0
hypotonia	0
with	0
droopy	I-DISEASE
eyelids	I-DISEASE
,	I-DISEASE
mouth	0
opening	0
,	I-DISEASE
and	0
protruded	0
tongue	0
,	0
or	0
gait	0
unsteadiness	0
,	0
which	I-DISEASE
clearly	I-DISEASE
are	0
not	0
related	I-DISEASE
to	0
emotion	0
.	0

Facial	0
and	0
masticatory	I-DISEASE
movements	0
may	0
occur	0
.	I-DISEASE

In	0
children	0
,	I-DISEASE
anticipation	0
of	0
a	I-DISEASE
reward	I-DISEASE
is	0
a	I-DISEASE
common	0
precipitant	0
.	0

It	0
is	0
important	0
to	I-DISEASE
use	0
child	0
-	I-DISEASE
appropriate	0
contexts	I-DISEASE
and	0
language	0
when	0
trying	0
to	0
elicit	I-DISEASE
a	0
history	0
of	I-DISEASE
cataplexy	0
in	0
children	0
.	0

The	0
cataplexy	0
phenotype	0
differs	0
widely	0
between	0
patients	I-DISEASE
,	I-DISEASE
ranging	0
from	0
sporadic	0
partial	0
attacks	I-DISEASE
triggered	0
by	0
laughter	0
,	0
to	I-DISEASE
frequent	I-DISEASE
complete	0
attacks	0
of	0
collapse	0
brought	0
about	I-DISEASE
by	0
a	0
variety	I-DISEASE
of	0
emotions	0
.	0

In	0
the	0
vast	I-DISEASE
majority	0
of	0
attacks	I-DISEASE
,	I-DISEASE
cataplexy	0
is	I-DISEASE
bilateral	0
,	0
although	0
patients	0
sometimes	0
report	I-DISEASE
one	0
side	I-DISEASE
of	I-DISEASE
the	0
body	0
to	0
be	0
more	I-DISEASE
affected	0
than	I-DISEASE
the	0
other	0
.	B-DISEASE

Partial	0
attacks	I-DISEASE
can	0
be	0
very	0
subtle	0
and	I-DISEASE
sometimes	0
only	I-DISEASE
recognized	0
by	0
experi-	0
enced	0
observers	0
such	I-DISEASE
as	0
the	0
patient	0
’s	I-DISEASE
partner	0
.	0

Neck	0
weakness	0
,	0
producing	0
head	0
drop	0
,	I-DISEASE
is	0
a	I-DISEASE
common	0
complaint	0
,	I-DISEASE
whereas	0
facial	0
weakness	I-DISEASE
may	I-DISEASE
lead	0
to	I-DISEASE
sagging	0
of	0
the	0
jaw	0
and	I-DISEASE
dysarthria	I-DISEASE
.	I-DISEASE

Respiratory	0
muscles	0
are	0
not	0
involved	0
although	0
patients	0
sometimes	0
describe	0
shortness	0
of	0
breath	0
when	0
symptomatic	0
.	0

Attacks	0
start	0
abruptly	0
and	0
usually	0
build	I-DISEASE
up	0
over	0
several	I-DISEASE
seconds	0
,	0
especially	0
in	0
attacks	0
producing	0
complete	I-DISEASE
peripheral	0
weakness	I-DISEASE
and	0
collapse	0
.	0

Positive	0
motor	0
phenomena	0
are	I-DISEASE
not	0
uncommon	0
,	I-DISEASE
with	0
muscle	I-DISEASE
twitching	0
Central	0
Disorders	0
of	I-DISEASE
Hypersomnolence	0
Central	I-DISEASE
Disorders	0
of	0
Hypersomnolence	I-DISEASE
or	0
small	0
jerks	0
,	0
particularly	0
of	0
the	0
face	0
.	0

Although	0
many	0
emotions	0
can	0
potentially	0
lead	0
to	I-DISEASE
cataplexy	0
,	I-DISEASE
those	0
associated	0
with	0
mirth	0
are	0
usually	I-DISEASE
the	0
most	I-DISEASE
potent	I-DISEASE
.	0

Laughing	0
out	0
loud	0
,	0
telling	0
a	0
joke	I-DISEASE
,	0
and	I-DISEASE
making	0
a	0
witty	0
remark	I-DISEASE
are	0
typical	I-DISEASE
examples	0
.	I-DISEASE

The	0
frequency	0
of	0
cataplexy	0
is	0
variable	0
,	0
ranging	0
from	I-DISEASE
less	0
than	0
one	0
attack	0
per	0
month	I-DISEASE
to	0
more	0
than	I-DISEASE
20	0
attacks	0
per	0
day	0
.	0

Cataplexy	0
is	0
generally	0
short	0
-	0
lived	0
,	I-DISEASE
lasting	0
a	I-DISEASE
matter	0
of	0
seconds	0
,	0
with	0
the	I-DISEASE
vast	0
majority	0
of	0
attacks	0
lasting	0
less	0
than	0
two	0
minutes	0
.	0

However	0
,	I-DISEASE
if	0
a	0
particular	0
trigger	I-DISEASE
continues	I-DISEASE
,	I-DISEASE
consecutive	I-DISEASE
attacks	0
may	0
merge	0
together	0
to	0
form	0
what	0
seems	I-DISEASE
to	0
be	0
one	I-DISEASE
long	0
episode	0
.	0

Sudden	0
withdrawal	0
of	0
anticataplectic	I-DISEASE
medication	0
,	0
especially	I-DISEASE
anti-	0
depressants	I-DISEASE
,	0
can	0
result	0
in	0
“	0
status	I-DISEASE
cataplecticus	I-DISEASE
”	0
in	0
which	0
long	0
-	0
lasting	0
attacks	0
happen	I-DISEASE
virtually	I-DISEASE
continuously	0
.	0

Associated	0
Features	0
In	0
addition	0
to	0
sleepiness	0
and	I-DISEASE
cataplexy	0
,	I-DISEASE
patients	0
with	0
narcolepsy	0
type	0
1	0
often	I-DISEASE
report	0
several	0
other	I-DISEASE
symptoms	0
,	0
none	0
of	0
which	I-DISEASE
are	0
specific	I-DISEASE
for	0
the	0
disorder	I-DISEASE
.	0

Many	0
patients	0
report	I-DISEASE
disruption	0
of	0
nocturnal	I-DISEASE
sleep	I-DISEASE
,	0
which	I-DISEASE
can	0
sometimes	I-DISEASE
be	0
of	0
major	0
concern	I-DISEASE
.	0

Although	0
sleep	0
onset	0
is	0
rarely	0
a	0
problem	I-DISEASE
,	0
an	I-DISEASE
inability	0
to	0
maintain	0
continuous	0
sleep	0
is	I-DISEASE
very	0
common	0
.	0

33	0
%	0
to	0
80	0
%	0
of	0
narcolepsy	I-DISEASE
patients	0
have	0
hypnagogic	0
hallucinations	0
and/or	I-DISEASE
sleep	0
paralysis	0
.	0

Hypnagogic	0
hallucinations	0
are	0
defined	0
as	0
vivid	I-DISEASE
dreamlike	I-DISEASE
expe-	0
riences	I-DISEASE
occurring	0
at	0
the	0
transition	0
from	0
wake	0
to	0
sleep	0
.	0

Typically	0
,	0
hypnagogic	0
halluci-	I-DISEASE
nations	0
have	I-DISEASE
a	I-DISEASE
multimodal	0
or	I-DISEASE
“	0
holistic	I-DISEASE
”	0
character	I-DISEASE
,	0
often	0
combining	0
visual	0
,	I-DISEASE
auditory	0
,	0
and	0
tactile	0
phenomena	0
.	0

Hypnopompic	0
hallucinations	0
are	0
similar	0
but	0
occur	0
at	0
sleep	0
to	0
wake	0
transitions	0
.	0

Sleep	0
paralysis	0
describes	0
the	0
disturbing	0
temporary	I-DISEASE
inability	0
to	0
move	0
voluntary	0
muscles	0
at	0
sleep	0
-	0
wake	I-DISEASE
transitions	0
.	0

Despite	0
being	0
awake	0
and	0
conscious	0
of	0
the	I-DISEASE
sleeping	I-DISEASE
environment	0
,	0
it	0
is	0
impossible	0
for	0
subjects	0
to	0
move	0
their	0
limbs	0
or	0
even	0
open	0
their	0
eyes	0
.	0

The	0
experience	0
may	0
last	0
for	0
several	0
minutes	I-DISEASE
and	0
can	I-DISEASE
be	0
very	0
distressing	I-DISEASE
.	0

Other	0
symptoms	0
may	0
include	B-DISEASE
ptosis	0
,	I-DISEASE
blurred	I-DISEASE
vision	0
,	0
and	0
diplopia	0
,	0
presumably	0
as	I-DISEASE
a	0
result	0
of	0
sleepiness	I-DISEASE
.	0

Epidemiological	0
studies	0
have	I-DISEASE
shown	0
that	0
obesity	0
is	I-DISEASE
a	0
common	0
symptom	0
of	0
narco-	I-DISEASE
lepsy	0
.	0

Around	0
disease	0
onset	0
,	0
an	0
unexplained	0
increase	0
in	0
body	I-DISEASE
weight	0
is	0
often	0
observed	0
.	0

Obesity	0
(	0
defined	0
as	0
a	0
body	0
mass	I-DISEASE
index	0
≥	I-DISEASE
30	0
kg	0
/	0
m2	0
)	0
occurs	I-DISEASE
more	I-DISEASE
than	I-DISEASE
twice	I-DISEASE
as	0
often	0
in	0
narcoleptic	0
populations	I-DISEASE
as	0
in	0
control	0
groups	0
.	0

An	0
increased	0
frequency	0
of	0
several	0
other	I-DISEASE
sleep	I-DISEASE
abnormalities	I-DISEASE
has	0
been	0
described	0
in	0
narcolepsy	I-DISEASE
,	0
including	I-DISEASE
sleep	0
talking	0
,	I-DISEASE
periodic	0
limb	0
movements	0
of	B-DISEASE
sleep	0
,	0
sleep	I-DISEASE
disordered	0
breathing	0
,	I-DISEASE
and	0
REM	I-DISEASE
sleep	I-DISEASE
behavior	0
disor-	0
der	0
.	0

There	0
is	0
an	0
increased	I-DISEASE
prevalence	0
of	I-DISEASE
depressive	I-DISEASE
symptoms	I-DISEASE
,	I-DISEASE
although	0
there	0
are	0
con-	I-DISEASE
flicting	0
reports	I-DISEASE
on	I-DISEASE
how	0
often	I-DISEASE
these	0
symptoms	0
qualify	0
as	0
a	I-DISEASE
clinical	0
depression	0
.	0

Recent	0
studies	0
point	0
to	0
a	0
high	I-DISEASE
level	I-DISEASE
of	0
anxiety	I-DISEASE
disorders	0
in	0
patients	0
with	I-DISEASE
narcolepsy	0
,	I-DISEASE
with	0
panic	0
attacks	I-DISEASE
or	0
social	0
phobias	0
in	0
about	0
20	0
%	I-DISEASE
.	0

More	0
than	0
half	0
of	0
patients	0
report	I-DISEASE
severe	0
fatigue	0
,	0
which	0
can	0
be	0
distinct	I-DISEASE
from	0
sleepiness	0
.	I-DISEASE

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Narcolepsy	I-DISEASE
type	I-DISEASE
1	I-DISEASE
due	I-DISEASE
to	I-DISEASE
a	0
medical	I-DISEASE
condition	0
:	0

This	0
condition	0
is	I-DISEASE
primarily	0
associated	0
with	0
central	I-DISEASE
nervous	0
system	I-DISEASE
(	0
CNS	0
)	I-DISEASE
disorders	0
,	I-DISEASE
including	I-DISEASE
autoimmune	0
or	0
paraneoplastic	I-DISEASE
disorders	0
associated	0
with	0
anti	0
-	0
Ma2	0
or	I-DISEASE
antiaquaporin4	I-DISEASE
antibodies	I-DISEASE
,	I-DISEASE
and	0
tumors	0
or	0
other	0
lesions	I-DISEASE
of	0
the	0
hypothalamus	0
.	0

In	0
addition	0
,	0
undetectable	0
hypocretin-1	0
levels	I-DISEASE
have	I-DISEASE
been	0
reported	I-DISEASE
in	0
association	0
with	0
sleepiness	I-DISEASE
after	0
severe	0
head	0
trauma	0
.	0

The	0
condition	0
must	I-DISEASE
fulfill	0
criteria	0
for	I-DISEASE
narcolepsy	0
type	0
1	0
and	0
be	0
attributable	0
to	0
another	0
medical	I-DISEASE
disorder	I-DISEASE
.	0

Narcolepsy	0
without	0
cataplexy	0
with	0
low	0
CSF	I-DISEASE
Hcrt-1	I-DISEASE
levels	0
:	0
Narcolepsy	0
type	0
1	I-DISEASE
should	I-DISEASE
be	0
diagnosed	0
,	0
even	I-DISEASE
in	I-DISEASE
the	0
absence	0
of	0
cataplexy	0
,	0
if	0
diagnostic	I-DISEASE
criteria	0
A	0
and	0
B2	I-DISEASE
are	0
fulfilled	0
.	I-DISEASE

Demographics	0
Narcolepsy	0
with	0
cataplexy	0
occurs	0
in	0
0.02	I-DISEASE
%	0
to	I-DISEASE
0.18	0
%	0
of	0
the	0
United	0
States	I-DISEASE
and	0
western	I-DISEASE
European	0
populations	0
.	0

A	0
lower	0
prevalence	0
has	I-DISEASE
been	0
reported	0
in	I-DISEASE
Israel	0
,	0
whereas	0
narco-	0
lepsy	0
with	0
cataplexy	0
may	I-DISEASE
be	0
slightly	0
more	0
common	0
in	0
Japan	0
(	0
0.16	0
%	I-DISEASE
to	I-DISEASE
0.18	0
%	0
)	0
.	0

Both	0
sexes	0
are	0
affected	0
,	0
with	0
a	I-DISEASE
slight	0
preponderance	I-DISEASE
of	0
males	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
Several	0
unproven	I-DISEASE
precipitating	I-DISEASE
factors	0
have	I-DISEASE
been	0
suggested	0
in	0
case	0
reports	0
,	I-DISEASE
including	0
head	0
trauma	I-DISEASE
,	0
sustained	0
sleep	0
deprivation	0
,	0
unspecified	0
viral	I-DISEASE
illness	0
,	0
and	0
sudden	0
changes	0
in	0
sleep	0
-	0
wake	0
patterns	0
.	I-DISEASE

Several	0
studies	0
have	0
pointed	0
to	0
seasonal	0
patterns	I-DISEASE
in	0
the	0
onset	I-DISEASE
of	0
narcolepsy	0
,	0
which	0
may	I-DISEASE
point	0
to	0
a	I-DISEASE
specific	0
environmental	0
trigger	0
.	0

Recent	0
studies	0
have	0
shown	0
an	0
increase	I-DISEASE
in	0
antibodies	0
against	0
beta	0
-	0
hemolytic	I-DISEASE
streptococcus	0
,	0
which	I-DISEASE
were	0
strongest	0
around	I-DISEASE
onset	0
of	0
narcolepsy	0
and	0
decreased	I-DISEASE
with	0
disease	0
duration	0
,	0
suggesting	I-DISEASE
that	0
streptococcal	0
infections	0
may	I-DISEASE
constitute	0
an	0
environmental	0
trigger	0
.	I-DISEASE

There	0
have	0
been	0
reports	0
of	0
narcolepsy	I-DISEASE
type	0
1	0
occurring	I-DISEASE
after	0
vaccination	0
against	0
H1N1	0
associated	0
influ-	I-DISEASE
enza	I-DISEASE
,	0
but	I-DISEASE
a	0
definite	0
causal	0
association	0
has	0
not	0
yet	0
been	0
established	0
.	I-DISEASE

Tribbles	0
homolog	I-DISEASE
2	0
antibodies	I-DISEASE
,	0
found	0
in	I-DISEASE
some	I-DISEASE
patients	I-DISEASE
with	0
autoimmune	0
uveitis	0
,	I-DISEASE
have	I-DISEASE
been	I-DISEASE
described	0
in	0
14	I-DISEASE
%	0
to	0
26	0
%	0
of	0
narcolepsy	0
patients	0
,	I-DISEASE
but	0
the	I-DISEASE
significance	0
is	I-DISEASE
uncertain	0
.	0

Familial	0
Patterns	0
At	0
the	0
genetic	0
level	0
,	I-DISEASE
narcolepsy	I-DISEASE
with	I-DISEASE
cataplexy	0
is	0
closely	0
associated	0
with	0
the	I-DISEASE
human	0
leukocyte	0
antigen	I-DISEASE
(	0
HLA	0
)	0
subtypes	0
DR2	0
/	0
DRB1	I-DISEASE
*	I-DISEASE
1501	0
and	I-DISEASE
DQB1	0
*	0
0602	0
.	0

These	0
two	0
subtypes	0
are	0
always	0
found	I-DISEASE
together	I-DISEASE
in	0
whites	I-DISEASE
and	0
Asians	0
,	0
but	I-DISEASE
in	0
blacks	I-DISEASE
,	0
DQB1	0
*	I-DISEASE
0602	0
is	0
more	0
specifically	0
associated	0
with	0
narcolepsy	0
.	0

Almost	0
all	0
patients	0
with	I-DISEASE
cataplexy	0
are	I-DISEASE
positive	0
for	0
DQB1	0
*	0
0602	I-DISEASE
,	0
compared	I-DISEASE
with	0
12	0
%	0
to	0
38	I-DISEASE
%	0
of	I-DISEASE
the	0
general	0
population	0
who	0
have	0
this	0
HLA	0
subtype	0
.	0

Other	0
subtypes	0
also	0
have	0
less	0
striking	0
associations	0
.	0

For	0
example	0
,	0
DQB1	0
*	I-DISEASE
0301	0
is	I-DISEASE
associated	0
with	I-DISEASE
increased	0
susceptibility	0
to	0
narcolepsy	0
,	0
Central	I-DISEASE
Disorders	0
of	I-DISEASE
Hypersomnolence	I-DISEASE
Central	0
Disorders	0
of	0
Hypersomnolence	0
whereas	0
subtypes	0
such	I-DISEASE
as	0
DQB1	0
*	I-DISEASE
0501	0
and	0
DQB1	0
*	0
0601	0
,	0
are	0
protective	0
in	0
the	I-DISEASE
presence	0
of	0
DQB1	I-DISEASE
*	0
0602	0
.	0

Genomewide	0
studies	0
have	0
found	I-DISEASE
associations	0
between	0
narcolepsy	0
and	I-DISEASE
polymorphisms	I-DISEASE
in	0
T	0
cell	0
receptor	0
alpha	0
,	I-DISEASE
tumor	I-DISEASE
necrosis	0
factor	I-DISEASE
(	0
TNF)-alpha	0
2	0
,	0
and	0
TNF	0
receptor	I-DISEASE
2	0
as	0
well	0
as	0
the	0
purinergic	I-DISEASE
receptor	0
P2Y11	0
genes	0
.	0

There	0
is	0
a	0
low	0
prevalence	0
of	I-DISEASE
familial	I-DISEASE
cases	0
;	I-DISEASE
the	0
risk	0
of	I-DISEASE
narcolepsy	I-DISEASE
type	0
1	I-DISEASE
in	0
first	0
-	0
de-	0
gree	0
relatives	0
of	0
affected	0
individuals	I-DISEASE
is	I-DISEASE
approximately	I-DISEASE
1	0
%	B-DISEASE
to	0
2	I-DISEASE
%	0
.	I-DISEASE

When	0
compared	0
to	0
the	0
population	0
prevalence	I-DISEASE
,	I-DISEASE
this	0
indicates	0
a	0
tenfold	0
to	0
fortyfold	0
increase	0
in	0
risk	0
.	0

This	0
increased	0
risk	0
can	0
not	0
be	I-DISEASE
explained	I-DISEASE
solely	0
by	I-DISEASE
HLA	0
gene	0
effects	0
,	0
suggesting	0
the	I-DISEASE
exis-	0
tence	I-DISEASE
of	0
other	0
genetic	0
factors	0
.	0

Multiplex	0
families	0
with	0
more	I-DISEASE
than	0
two	0
affected	0
members	0
are	I-DISEASE
uncommon	0
.	0

In	0
most	0
cases	0
,	I-DISEASE
normal	0
CSF	I-DISEASE
hypocretin	I-DISEASE
levels	0
have	I-DISEASE
been	0
found	0
in	0
these	I-DISEASE
families	0
,	0
and	0
the	0
association	I-DISEASE
with	0
HLA	I-DISEASE
DQB1	0
*	0
0602	I-DISEASE
is	0
much	I-DISEASE
weaker	0
compared	0
to	I-DISEASE
spo-	0
radic	0
narcolepsy	0
.	0

So	0
far	0
,	0
only	0
a	0
single	I-DISEASE
case	0
of	0
narcolepsy	I-DISEASE
type	0
1	0
has	0
been	0
described	0
in	0
association	0
with	0
a	I-DISEASE
preprohypocretin	0
mutation	0
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Onset	I-DISEASE
usually	0
occurs	0
after	0
five	0
years	0
of	0
age	0
and	I-DISEASE
most	0
typically	0
between	I-DISEASE
ages	0
10	0
and	0
25	0
years	0
.	0

However	0
,	I-DISEASE
a	0
bimodal	0
distribution	0
in	0
the	I-DISEASE
age	0
at	0
onset	I-DISEASE
has	0
been	I-DISEASE
described	0
in	0
some	0
populations	0
with	0
a	I-DISEASE
first	I-DISEASE
peak	0
occurring	0
at	0
adolescence	0
(	0
age	I-DISEASE
15	0
years	0
)	I-DISEASE
and	0
a	0
second	I-DISEASE
at	I-DISEASE
the	0
age	0
of	0
35	0
years	I-DISEASE
.	I-DISEASE

Recent	0
studies	0
highlight	0
the	0
fact	I-DISEASE
that	I-DISEASE
narcolepsy	I-DISEASE
,	0
and	I-DISEASE
especially	0
cataplexy	0
,	0
in	I-DISEASE
young	0
children	I-DISEASE
may	0
present	0
somewhat	0
differently	0
,	0
resulting	0
in	I-DISEASE
delayed	0
diagnosis	0
and	0
erroneously	0
high	0
estimates	0
of	0
age	0
of	0
onset	I-DISEASE
.	0

Sleepiness	0
is	0
usually	0
the	0
first	0
symptom	I-DISEASE
to	0
manifest	0
.	I-DISEASE

Cataplexy	0
most	0
often	0
occurs	0
within	0
one	0
year	I-DISEASE
of	0
onset	I-DISEASE
but	0
in	0
rare	0
cases	0
,	0
may	0
precede	I-DISEASE
the	0
onset	0
of	0
sleepiness	0
or	0
commence	0
up	0
to	0
40	I-DISEASE
years	0
later	0
.	I-DISEASE

Hypnagogic	0
hallucinations	0
,	0
sleep	I-DISEASE
paralysis	0
,	I-DISEASE
and	0
disturbed	0
noctur-	I-DISEASE
nal	0
sleep	0
often	0
manifest	I-DISEASE
later	0
in	0
the	0
course	0
of	I-DISEASE
the	0
disease	I-DISEASE
.	0

When	0
left	0
untreated	I-DISEASE
,	0
narcolepsy	0
type	I-DISEASE
1	I-DISEASE
is	0
often	0
socially	0
disabling	0
and	0
isolating	0
.	0

Patients	0
have	0
a	0
tendency	0
to	0
fail	I-DISEASE
in	0
school	0
and	0
are	0
often	0
dismissed	0
from	I-DISEASE
their	0
jobs	0
.	0

Driving	0
may	0
be	0
avoided	I-DISEASE
for	0
fear	0
of	I-DISEASE
a	0
motor	I-DISEASE
vehicle	0
accident	0
.	0

The	0
inability	0
to	0
sleep	0
at	0
night	I-DISEASE
may	I-DISEASE
further	0
contribute	I-DISEASE
to	0
a	0
loss	0
of	0
control	0
these	I-DISEASE
patients	0
have	I-DISEASE
over	0
their	0
schedule	0
.	0

Depression	0
and	0
weight	0
gain	I-DISEASE
also	0
are	0
common	0
.	0

In	0
most	0
cases	0
,	B-DISEASE
symptoms	0
gradually	0
develop	I-DISEASE
over	0
several	I-DISEASE
years	0
.	I-DISEASE

When	0
the	0
clinical	I-DISEASE
picture	0
has	0
fully	0
developed	I-DISEASE
,	0
there	I-DISEASE
are	0
usually	0
only	0
minor	0
fluctuations	0
in	0
severity	0
.	0

Cataplexy	0
may	0
lessen	0
with	0
age	0
,	0
or	I-DISEASE
occasionally	0
increase	I-DISEASE
in	0
frequency	0
and	0
severity	0
.	0

Developmental	0
Issues	0
In	0
recent	0
years	0
,	I-DISEASE
increasing	I-DISEASE
attention	0
has	I-DISEASE
been	0
given	0
to	0
the	0
clinical	0
presentation	I-DISEASE
of	0
nar-	0
colepsy	I-DISEASE
in	0
childhood	0
.	0

Narcolepsy	0
with	0
cataplexy	0
is	0
infrequent	0
prior	0
to	I-DISEASE
the	0
age	0
of	0
four	0
years	0
.	0

In	0
addition	0
,	0
the	0
clinical	I-DISEASE
presentation	0
in	I-DISEASE
children	0
may	I-DISEASE
be	0
different	0
from	0
that	0
of	0
adults	I-DISEASE
.	0

In	0
young	0
children	0
,	I-DISEASE
sleepiness	0
may	I-DISEASE
be	0
difficult	0
to	I-DISEASE
assess	0
,	0
and	0
may	0
express	0
itself	I-DISEASE
as	0
excessively	0
long	I-DISEASE
night	0
sleep	0
,	0
or	0
the	I-DISEASE
recurrence	0
of	0
previously	I-DISEASE
discontinued	0
daytime	0
napping	0
.	I-DISEASE

Moreover	0
,	0
children	0
may	I-DISEASE
paradoxically	0
present	0
with	I-DISEASE
hyperactive	I-DISEASE
behavior	0
,	0
behavioral	0
problems	0
or	0
decreased	0
performance	I-DISEASE
in	0
school	0
.	0

Inattentiveness	0
,	0
lack	I-DISEASE
of	0
energy	0
,	0
insomnia	I-DISEASE
,	0
bizarre	I-DISEASE
hallucinations	0
,	0
or	0
a	0
combination	0
thereof	I-DISEASE
can	0
lead	0
to	I-DISEASE
a	0
psy-	0
chiatric	0
misdiagnosis	0
of	0
schizophrenia	0
or	0
depression	0
.	0

In	0
this	0
population	0
,	I-DISEASE
the	0
presence	I-DISEASE
of	0
ancillary	0
symptoms	I-DISEASE
such	I-DISEASE
as	I-DISEASE
sleep	0
paralysis	0
or	0
hypnagogic	I-DISEASE
hallucinations	0
may	0
also	0
be	0
difficult	0
to	I-DISEASE
confirm	0
,	0
depending	0
on	0
the	I-DISEASE
child	0
’s	I-DISEASE
verbal	0
ability	0
.	I-DISEASE

Precocious	0
puberty	0
and	0
obesity	0
may	0
also	I-DISEASE
develop	I-DISEASE
around	0
the	I-DISEASE
time	0
of	0
symptom	0
onset	0
.	0

REM	0
sleep	0
behavior	0
dis-	I-DISEASE
order	0
or	0
REM	I-DISEASE
sleep	0
without	I-DISEASE
atonia	0
may	0
also	0
be	I-DISEASE
manifest	I-DISEASE
at	I-DISEASE
the	I-DISEASE
time	0
of	I-DISEASE
symptom	0
onset	0
.	I-DISEASE

Cataplexy	0
may	0
be	0
very	0
severe	0
around	0
disease	I-DISEASE
onset	0
and	I-DISEASE
appear	0
phenotypically	0
differ-	0
ent	0
from	0
typical	I-DISEASE
episodes	I-DISEASE
seen	0
in	0
adulthood	0
.	0

In	0
addition	0
to	0
typical	0
attacks	0
triggered	0
by	I-DISEASE
positive	0
emotions	I-DISEASE
,	0
children	0
can	I-DISEASE
also	0
present	0
with	0
weakness	0
involving	0
the	0
face	I-DISEASE
,	0
eyelids	0
,	0
and	0
mouth	0
not	I-DISEASE
clearly	0
associated	0
with	0
emotion	0
.	0

Together	0
with	0
tongue	0
protrusion	0
,	0
this	0
characteristic	I-DISEASE
pattern	0
has	0
been	0
termed	0
a	0
cataplectic	0
facies	0
.	I-DISEASE

Children	0
with	0
cataplexy	0
may	I-DISEASE
also	0
display	0
positive	0
motor	0
phenomena	I-DISEASE
,	0
ranging	I-DISEASE
from	0
perioral	0
dyskinetic	0
or	0
dys-	0
tonic	0
movements	I-DISEASE
to	0
frank	0
stereotypies	0
.	0

In	0
children	0
,	I-DISEASE
anticipation	0
of	0
reward	I-DISEASE
may	0
also	0
be	I-DISEASE
a	I-DISEASE
precipitant	0
.	0

The	0
diagnosis	0
of	0
narcolepsy	0
type	0
1	0
in	I-DISEASE
children	0
may	I-DISEASE
be	0
complicated	0
because	I-DISEASE
of	0
diffi-	0
culties	I-DISEASE
performing	0
the	0
MSLT	I-DISEASE
,	0
and	0
lack	0
of	0
normative	0
values	0
in	I-DISEASE
children	0
younger	0
than	I-DISEASE
six	0
years	I-DISEASE
.	0

If	0
the	0
MSLT	I-DISEASE
shows	0
equivocal	0
results	0
,	0
repeating	0
it	I-DISEASE
after	0
a	0
time	0
interval	I-DISEASE
may	0
be	I-DISEASE
helpful	0
.	0

Given	0
these	0
difficulties	0
,	0
CSF	0
hypocretin-1	I-DISEASE
measurements	0
are	0
of	0
particular	0
value	0
,	0
as	I-DISEASE
hypocretin-1	0
levels	0
are	0
low	0
or	I-DISEASE
undetectable	0
very	0
shortly	0
after	0
disease	0
onset	0
in	I-DISEASE
children	0
as	0
well	0
.	0

Pathology	0
and	0
Pathophysiology	0
It	I-DISEASE
is	0
now	I-DISEASE
firmly	I-DISEASE
established	0
that	I-DISEASE
narcolepsy	0
type	0
1	0
is	0
caused	0
by	I-DISEASE
deficiencies	0
in	0
hypo-	I-DISEASE
cretin	0
signaling	0
,	0
most	0
likely	0
due	0
to	B-DISEASE
a	0
selective	0
loss	0
of	0
hypothalamic	0
hypocretin	0
pro-	I-DISEASE
ducing	0
neurons	0
.	0

Several	0
animal	0
models	0
lacking	0
hypocretin	0
neurotransmission	0
demon-	0
strate	0
narcolepsy	I-DISEASE
,	0
indicating	0
a	0
causal	0
relationship	0
.	I-DISEASE

The	0
vast	0
majority	0
of	0
patients	0
(	I-DISEASE
90	I-DISEASE
%	0
to	0
95	0
%	0
)	0
with	I-DISEASE
narcolepsy	0
and	I-DISEASE
cataplexy	0
have	0
undetectable	I-DISEASE
or	0
low	I-DISEASE
(	0
<	0
110	0
pg	0
/	0
mL	0
)	0
levels	I-DISEASE
of	0
hypocretin-1	I-DISEASE
in	0
the	I-DISEASE
CSF	0
.	0

Patients	0
without	0
cataplexy	B-DISEASE
can	I-DISEASE
be	0
hypocretin	0
deficient	0
as	0
well	I-DISEASE
,	I-DISEASE
although	0
at	0
a	0
much	0
lower	I-DISEASE
frequency	0
,	0
and	I-DISEASE
are	0
thus	0
also	0
classified	0
as	0
narcolepsy	0
Central	I-DISEASE
Disorders	0
of	0
Hypersomnolence	I-DISEASE
Central	0
Disorders	0
of	0
Hypersomnolence	0
type	0
1	0
.	0

The	0
strong	0
HLA	0
association	0
in	0
narcolepsy	0
has	0
led	0
to	I-DISEASE
the	0
hypothesis	0
that	0
auto-	0
immunity	0
is	I-DISEASE
a	0
likely	I-DISEASE
etiological	I-DISEASE
mechanism	0
,	0
potentially	0
explaining	0
the	0
selectivity	0
of	I-DISEASE
neuronal	0
destruction	0
in	I-DISEASE
the	B-DISEASE
hypothalamus	0
.	I-DISEASE

However	0
,	I-DISEASE
definitive	0
proof	I-DISEASE
for	0
autoimmunity	0
has	0
not	0
been	0
obtained	0
.	0

Objective	0
Findings	0
Narcolepsy	0
type	I-DISEASE
1	0
is	I-DISEASE
essentially	I-DISEASE
defined	0
as	I-DISEASE
a	0
hypocretin	0
deficiency	0
syndrome	0
,	I-DISEASE
which	I-DISEASE
is	0
reflected	0
in	I-DISEASE
the	0
need	0
for	0
objective	0
measurements	0
in	I-DISEASE
the	I-DISEASE
clinical	I-DISEASE
criteria	0
.	I-DISEASE

This	0
require-	0
ment	0
is	I-DISEASE
further	0
driven	0
by	I-DISEASE
the	0
fact	0
that	0
many	0
patients	0
require	0
lifelong	0
treatment	I-DISEASE
with	0
potentially	0
addictive	0
medications	0
,	0
underscoring	0
the	I-DISEASE
importance	0
of	0
objective	I-DISEASE
confirma-	I-DISEASE
tion	0
of	0
the	I-DISEASE
diagnosis	0
.	0

It	0
is	0
strongly	0
recommended	0
that	0
the	I-DISEASE
MSLT	I-DISEASE
be	0
preceded	I-DISEASE
by	I-DISEASE
at	0
least	0
one	I-DISEASE
week	0
of	I-DISEASE
acti-	I-DISEASE
graphic	0
recording	I-DISEASE
with	0
a	0
sleep	0
log	0
to	0
establish	0
whether	I-DISEASE
the	0
results	0
could	0
be	0
biased	I-DISEASE
by	0
insufficient	0
sleep	0
,	0
shift	0
work	0
,	0
or	I-DISEASE
another	0
circadian	0
sleep	0
disorder	0
.	0

In	0
patients	0
with	I-DISEASE
narcolepsy	0
type	0
1	0
,	I-DISEASE
the	0
MSLT	I-DISEASE
demonstrates	0
a	0
mean	I-DISEASE
sleep	0
latency	0
of	I-DISEASE
less	0
than	0
eight	I-DISEASE
minutes	0
and	0
typically	0
less	0
than	0
five	0
minutes	0
.	0

Meta	0
-	0
analysis	0
shows	0
mean	0
sleep	0
latencies	0
in	I-DISEASE
narcoleptic	0
patients	0
with	0
cataplexy	0
of	0
3.1	0
±	0
2.9	I-DISEASE
minutes	0
.	I-DISEASE

In	0
addition	0
,	0
two	0
or	0
more	0
SOREMPs	0
must	0
be	I-DISEASE
present	0
.	0

Recent	0
data	0
suggest	0
that	0
a	0
SOREMP	I-DISEASE
within	I-DISEASE
15	0
minutes	I-DISEASE
of	0
onset	0
of	0
nocturnal	0
sleep	0
is	I-DISEASE
a	I-DISEASE
highly	I-DISEASE
specific	0
finding	I-DISEASE
in	I-DISEASE
the	0
absence	0
of	0
another	0
sleep	0
disorder	I-DISEASE
,	0
but	I-DISEASE
with	0
low	I-DISEASE
sensitivity	I-DISEASE
.	0

Therefore	0
,	0
the	0
criteria	I-DISEASE
for	0
narcolepsy	0
type	I-DISEASE
1	0
allow	I-DISEASE
the	0
“	0
replacement	0
”	0
of	I-DISEASE
one	I-DISEASE
SOREMP	I-DISEASE
in	0
the	I-DISEASE
MSLT	0
with	0
a	0
SOREMP	0
on	0
the	0
preceding	I-DISEASE
poly-	I-DISEASE
somnogram	0
.	I-DISEASE

For	0
the	0
correct	I-DISEASE
interpretation	0
of	0
MSLT	I-DISEASE
findings	I-DISEASE
,	0
the	0
recordings	0
should	0
be	0
performed	0
with	0
the	0
following	0
conditions	I-DISEASE
:	I-DISEASE
(	0
1	0
)	0
the	0
patient	I-DISEASE
must	I-DISEASE
be	I-DISEASE
free	0
of	0
drugs	I-DISEASE
that	0
influence	0
sleep	I-DISEASE
for	0
at	0
least	0
14	0
days	I-DISEASE
(	0
or	0
at	I-DISEASE
least	0
five	I-DISEASE
times	I-DISEASE
the	0
half	0
-	I-DISEASE
life	I-DISEASE
of	I-DISEASE
the	I-DISEASE
drug	0
and	I-DISEASE
longer	0
-	I-DISEASE
acting	I-DISEASE
metabolite	I-DISEASE
)	0
,	0
confirmed	0
by	I-DISEASE
a	I-DISEASE
urine	0
drug	0
screen	0
;	I-DISEASE
(	I-DISEASE
2	I-DISEASE
)	I-DISEASE
the	0
sleep	I-DISEASE
-	I-DISEASE
wake	I-DISEASE
sched-	I-DISEASE
ule	0
must	I-DISEASE
have	I-DISEASE
been	0
standardized	I-DISEASE
and	0
,	I-DISEASE
if	I-DISEASE
necessary	0
,	0
extended	0
to	I-DISEASE
a	0
minimum	0
of	0
seven	0
hours	0
in	I-DISEASE
bed	I-DISEASE
each	I-DISEASE
night	I-DISEASE
(	I-DISEASE
longer	0
for	I-DISEASE
children	0
)	0
for	0
at	I-DISEASE
least	I-DISEASE
seven	I-DISEASE
days	0
before	0
polysom-	I-DISEASE

nography	0
(	0
preferably	0
documented	0
by	0
sleep	I-DISEASE
log	I-DISEASE
and	0
,	I-DISEASE
whenever	0
possible	0
,	0
actigraphy	0
)	0
;	I-DISEASE
and	0
(	I-DISEASE
3	I-DISEASE
)	I-DISEASE
nocturnal	0
polysomnography	0
should	0
be	0
performed	I-DISEASE
on	I-DISEASE
the	0
night	0
immediately	I-DISEASE
preceding	0
the	0
MSLT	0
to	I-DISEASE
rule	0
out	0
other	0
sleep	0
disorders	I-DISEASE
that	I-DISEASE
could	0
mimic	I-DISEASE
the	I-DISEASE
diagnostic	0
features	0
of	0
narcolepsy	0
type	0
1	I-DISEASE
.	I-DISEASE

Sleep	0
time	I-DISEASE
during	0
polysomnography	0
should	0
be	I-DISEASE
curtailed	I-DISEASE
as	0
little	I-DISEASE
as	I-DISEASE
possible	0
with	I-DISEASE
the	0
goal	0
of	0
at	0
least	0
seven	I-DISEASE
hours	0
asleep	0
.	0

The	0
overnight	0
poly-	0
somnogram	0
may	0
demonstrate	I-DISEASE
an	I-DISEASE
increase	0
in	I-DISEASE
the	0
amount	0
of	0
stage	I-DISEASE
N1	0
sleep	0
,	I-DISEASE
and	I-DISEASE
there	I-DISEASE
may	0
be	0
a	0
disruption	I-DISEASE
of	0
the	0
normal	I-DISEASE
sleep	0
pattern	I-DISEASE
,	I-DISEASE
with	0
frequent	I-DISEASE
awakenings	I-DISEASE
.	I-DISEASE

REM	0
sleep	0
without	0
atonia	I-DISEASE
may	I-DISEASE
be	I-DISEASE
present	I-DISEASE
.	0

Measuring	0
CSF	I-DISEASE
levels	0
of	0
hypocretin-1	I-DISEASE
is	0
a	0
highly	0
specific	I-DISEASE
and	0
sensitive	0
test	0
for	I-DISEASE
the	0
diagnosis	0
of	I-DISEASE
narcolepsy	0
type	I-DISEASE
1	0
.	I-DISEASE

Hypocretin-1	0
can	0
be	0
measured	0
in	0
crude	I-DISEASE
CSF	I-DISEASE
,	0
using	0
a	0
commercially	0
available	0
radioimmunoassay	0
.	0

When	0
using	0
the	0
Stanford	I-DISEASE
reference	0
sample	0
,	0
values	0
less	I-DISEASE
than	0
110	0
pg	0
/	0
mL	0
are	0
highly	0
specific	0
.	I-DISEASE

Alternatively	0
,	0
a	0
laboratory	0
may	0
elect	0
to	0
obtain	0
control	I-DISEASE
data	0
themselves	0
,	0
in	0
which	0
case	I-DISEASE
a	I-DISEASE
level	0
of	I-DISEASE
less	0
than	0
33	0
%	0
of	0
mean	0
control	0
values	0
is	I-DISEASE
considered	I-DISEASE
abnormal	0
.	0

Issues	0
concerning	0
the	0
standardization	B-DISEASE
of	0
CSF	0
hypocre-	I-DISEASE
tin	0
measurements	0
remain	0
,	0
but	0
extensive	0
protocols	0
are	0
available	0
.	0

Low	0
CSF	0
hypocre-	I-DISEASE
tin	0
values	0
are	0
occasionally	I-DISEASE
observed	0
in	I-DISEASE
seriously	0
ill	0
patients	0
with	0
other	0
disorders	0
and	I-DISEASE
should	0
be	I-DISEASE
interpreted	0
within	I-DISEASE
the	0
clinical	0
context	0
.	I-DISEASE

HLA	0
typing	0
of	0
narcoleptic	0
patients	0
with	0
cataplexy	I-DISEASE
almost	0
always	I-DISEASE
shows	I-DISEASE
the	0
presence	0
of	0
HLA	0
DQB1	0
*	0
0602	0
(	0
and	I-DISEASE
DR2	0
or	0
DRB1	0
*	0
1501	I-DISEASE
in	0
whites	0
and	0
Asians	0
)	0
,	0
but	I-DISEASE
this	I-DISEASE
is	0
not	0
diagnostic	I-DISEASE
for	0
narcolepsy	0
.	0

Approximately	0
25	0
%	0
of	0
the	0
normal	I-DISEASE
Caucasian	I-DISEASE
population	0
,	I-DISEASE
12	0
%	0
of	0
the	0
Japanese	I-DISEASE
population	0
,	I-DISEASE
and	0
38	I-DISEASE
%	0
of	0
the	0
black	0
population	0
are	I-DISEASE
positive	0
for	I-DISEASE
DQB1	0
*	I-DISEASE
0602	0
.	0

HLA	0
typing	0
could	0
be	0
considered	0
when	I-DISEASE
a	I-DISEASE
spinal	0
tap	I-DISEASE
is	0
contemplated	0
to	0
assess	I-DISEASE
hypocretin-1	0
values	I-DISEASE
:	I-DISEASE
if	0
the	I-DISEASE
patient	0
is	I-DISEASE
HLA	0
-	0
negative	0
,	0
hypocretin-1	0
levels	I-DISEASE
are	I-DISEASE
most	I-DISEASE
likely	0
normal	0
.	0

Differential	0
Diagnosis	0
In	0
the	0
absence	0
of	I-DISEASE
cataplexy	0
,	I-DISEASE
narcolepsy	I-DISEASE
type	0
1	0
can	0
be	0
diagnosed	0
based	I-DISEASE
on	0
the	0
pres-	0
ence	0
of	0
hypersomnolence	0
and	0
low	I-DISEASE
CSF	0
hypocretin-1	I-DISEASE
levels	0
.	I-DISEASE

When	0
cataplexy	0
is	0
absent	0
and	0
CSF	0
hypocretin-1	I-DISEASE
levels	0
are	I-DISEASE
normal	0
or	0
unknown	0
,	0
narcolepsy	0
type	I-DISEASE
2	I-DISEASE
should	0
be	0
diagnosed	0
.	0

Cataplexy	0
must	0
be	0
differentiated	0
from	0
cataplexy	0
-	I-DISEASE
like	0
episodes	0
that	0
are	0
occasionally	0
observed	0
in	0
normal	I-DISEASE
individuals	0
.	0

For	0
example	0
,	0
feelings	0
of	0
muscle	I-DISEASE
weakness	I-DISEASE
are	0
some-	0
times	0
reported	0
when	0
healthy	0
subjects	0
laugh	0
out	0
loud	0
.	0

In	0
genuine	0
cataplexy	0
,	I-DISEASE
episodes	0
most	0
often	0
occur	0
with	I-DISEASE
a	0
significant	0
frequency	0
,	0
and	0
are	I-DISEASE
associated	0
with	0
loss	I-DISEASE
of	0
muscle	0
tone	0
.	0

Cataplexy	0
should	0
be	0
differentiated	0
from	0
hypotension	I-DISEASE
,	I-DISEASE
transient	0
ischemic	I-DISEASE
attacks	0
,	0
drop	0
attacks	I-DISEASE
,	0
akinetic	I-DISEASE
seizures	I-DISEASE
,	0
neuromuscular	I-DISEASE
disorders	0
,	I-DISEASE
vestibular	0
disorders	0
,	0
psycho-	I-DISEASE
logical	I-DISEASE
or	I-DISEASE
psychiatric	0
disorders	0
,	0
and	0
sleep	0
paralysis	I-DISEASE
.	0

Clear	0
improvement	0
with	0
antide-	0
pressant	0
medications	0
may	I-DISEASE
favor	0
a	0
diagnosis	0
of	0
cataplexy	0
in	0
difficult	0
cases	I-DISEASE
.	0

Sleepiness	0
may	I-DISEASE
be	0
secondary	B-DISEASE
to	I-DISEASE
obstructive	0
sleep	I-DISEASE
apnea	0
,	I-DISEASE
insufficient	0
sleep	0
syndrome	I-DISEASE
,	0
shift	I-DISEASE
work	0
,	I-DISEASE
the	0
effects	I-DISEASE
of	0
substances	0
or	0
medications	0
,	0
or	I-DISEASE
other	0
sleep	0
disorders	I-DISEASE
.	0

Many	0
of	0
these	0
conditions	0
can	0
result	0
in	I-DISEASE
early	0
onset	I-DISEASE
REM	0
sleep	0
as	0
well	I-DISEASE
.	0

When	0
cataplexy	0
is	0
present	0
,	0
these	0
disorders	I-DISEASE
do	0
not	I-DISEASE
preclude	0
a	0
diagnosis	0
of	I-DISEASE
narcolepsy	0
type	I-DISEASE
1	0
.	0

When	0
there	0
is	I-DISEASE
a	0
questionable	0
history	0
of	I-DISEASE
cataplexy	0
in	I-DISEASE
such	0
cases	0
,	0
either	0
comorbid	0
conditions	I-DISEASE
should	I-DISEASE
be	0
adequately	0
treated	0
before	0
performing	0
an	0
MSLT	0
or	0
CSF	I-DISEASE
hypocretin-1	I-DISEASE
should	0
be	I-DISEASE
measured	0
.	0

Central	0
Disorders	0
of	0
Hypersomnolence	0
Central	0
Disorders	I-DISEASE
of	0
Hypersomnolence	0
Idiopathic	I-DISEASE
hypersomnia	0
is	0
differentiated	0
from	0
narcolepsy	0
type	I-DISEASE
1	0
by	0
the	I-DISEASE
absence	0
of	0
cat-	0
aplexy	0
and	0
the	0
lack	0
of	0
two	I-DISEASE
or	0
more	0
SOREMPs	0
on	0
the	0
MSLT	0
.	0

In	0
contrast	0
with	0
patients	0
who	0
have	0
narcolepsy	0
,	0
patients	0
with	0
idiopathic	0
hypersomnia	0
generally	I-DISEASE
have	0
high	I-DISEASE
sleep	I-DISEASE
efficiency	0
,	I-DISEASE
sleep	0
drunkenness	0
,	0
and	0
long	0
,	0
unrefreshing	I-DISEASE
naps	I-DISEASE
.	I-DISEASE

In	0
insufficient	0
sleep	0
syndrome	I-DISEASE
,	0
there	0
is	I-DISEASE
no	0
cataplexy	I-DISEASE
,	0
and	0
normalizing	0
sleep	0
time	0
elim-	I-DISEASE

inates	0
the	0
daytime	0
sleepiness	I-DISEASE
.	0

Chronic	0
fatigue	0
syndrome	0
and	0
depression	0
may	I-DISEASE
mimic	0
narcolepsy	0
but	I-DISEASE
do	0
not	0
show	0
the	0
typical	0
MSLT	0
findings	I-DISEASE
.	0

Malingering	0
and	0
substance	0
abuse	I-DISEASE
disorder	0
should	I-DISEASE
be	I-DISEASE
considered	0
in	I-DISEASE
patients	I-DISEASE
who	0
try	0
to	I-DISEASE
mislead	0
the	I-DISEASE
clinician	0
in	I-DISEASE
order	I-DISEASE
to	0
obtain	I-DISEASE
stimulant	0
medications	0
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE

Ten	0
percent	0
of	0
patients	I-DISEASE
with	0
narcolepsy	0
with	0
cataplexy	0
have	I-DISEASE
normal	0
hypocretin-1	0
levels	0
in	0
the	0
CSF	0
,	0
which	0
suggests	I-DISEASE
that	0
CSF	0
levels	0
either	0
do	0
not	0
perfectly	0
reflect	0
brain	I-DISEASE
hypocretin	I-DISEASE
neurotransmission	0
or	0
that	I-DISEASE
narcolepsy	0
with	0
cataplexy	0
can	0
be	0
caused	0
by	0
factors	I-DISEASE
other	I-DISEASE
than	I-DISEASE
hypocretin	0
deficiency	0
.	0

The	0
cause	0
of	0
the	0
hypocretin	I-DISEASE
cell	0
destruction	0
remains	0
unknown	I-DISEASE
,	0
although	0
an	0
autoimmune	I-DISEASE
-	0
mediated	I-DISEASE
mechanism	0
is	0
suspected	0
.	0

Levels	0
of	0
hypocretin-1	0
have	0
been	0
reported	0
in	I-DISEASE
the	0
blood	I-DISEASE
of	0
some	0
subjects	0
.	0

The	0
development	0
of	0
serum	I-DISEASE
tests	0
to	0
determine	I-DISEASE
hypocretin	0
deficiency	I-DISEASE
would	0
provide	0
a	0
less	I-DISEASE
invasive	0
diagnos-	0
tic	0
approach	0
.	I-DISEASE

Bibliography	0
Andlauer	0
O	0
,	0
Moore	0
H	0
,	I-DISEASE
Jouhier	0
L	I-DISEASE
,	0
et	0
al	0
.	0

Nocturnal	0
REM	0
sleep	0
latency	0
for	0
identifying	I-DISEASE
patients	0
with	0
narcolepsy	0
/	0
hypocretin	0
deficiency	0
.	0

JAMA	0
Neurol	0
2013;6:1–12	0
.	0

Aran	0
A	0
,	0
Einen	0
M	0
,	I-DISEASE
Lin	I-DISEASE
L	0
,	I-DISEASE
Palazzi	0
G	I-DISEASE
,	0
Nishino	0
S	I-DISEASE
,	I-DISEASE
Mignot	I-DISEASE
E.	0
Clinical	I-DISEASE
and	I-DISEASE
therapeutic	0
aspects	0
of	0
childhood	0
narcolepsy	I-DISEASE
-	0
cataplexy	0
:	0
a	I-DISEASE
retrospective	0
study	I-DISEASE
of	0
51	I-DISEASE
children	0
.	0

Sleep	0
2010;33:1457–64	0
.	0

Arii	0
J	0
,	0
Kanbayashi	0
T	0
,	0
Tanabe	0
Y	0
,	I-DISEASE
et	0
al	0
.	0
CSF	0
hypocretin-1	0
(	I-DISEASE
orexin	I-DISEASE
-	0
A	I-DISEASE
)	0
levels	0
in	0
childhood	0
narcolepsy	0
and	I-DISEASE
neurologic	I-DISEASE
disorders	0
.	I-DISEASE

Neurology	0
2004;63:2440–2	0
.	0

Bourgin	0
P	0
,	0
Zeitzer	I-DISEASE
JM	0
,	0
Mignot	0
E.	0
CSF	I-DISEASE
hypocretin-1	0
assessment	0
in	0
sleep	I-DISEASE
and	0
neurological	0
disorders	0
.	0

Lancet	0
Neurol	0
2008;7:649–62	0
.	0

Dauvilliers	0
Y	I-DISEASE
,	0
Gosselin	0
A	0
,	0
Paquet	I-DISEASE
J	0
,	I-DISEASE
Touchon	0
J	0
,	0
Billiard	0
M	0
,	0
Montplaisir	0
J.	I-DISEASE
Effect	0
of	0
age	0
on	0
MSLT	0
results	0
in	0
patients	0
with	I-DISEASE
narcolepsy	0
-	I-DISEASE
cataplexy	0
.	0

Neurology	0
2004;62:46–50	0
.	0

Dauvilliers	0
Y	0
,	0
Arnulf	0
I	0
,	0
Mignot	I-DISEASE
E.	0
Narcolepsy	I-DISEASE
with	0
cataplexy	0
.	0

Lancet	0
2007;369:499–511	0
.	0

Kotagal	0
S	0
,	0
Krahn	0
LE	0
,	0

Slocumb	0
N.	0
A	0
putative	0
link	0
between	0
childhood	0
narcolepsy	0
and	I-DISEASE
obesity	0
.	0

Sleep	0
Med	0
2004;5:147–50	I-DISEASE
.	0

Mignot	0
E	0
,	0
Lammers	0
GJ	0
,	0
Ripley	0
B	0
,	I-DISEASE
et	0
al	0
.	0

The	0
role	0
of	0
cerebrospinal	I-DISEASE
fluid	I-DISEASE
hypocretin	0
measurement	I-DISEASE
in	0
the	I-DISEASE
diagnosis	0
of	0
narcolepsy	0
and	0
other	0
hypersomnias	I-DISEASE
.	0

Arch	0
Neurol	0
2002;59:1553–62	0
.	0

Mignot	0
E	0
,	0
Lin	0
L	0
,	0
Finn	B-DISEASE
L	I-DISEASE
,	I-DISEASE
et	0
al	0
.	0

Correlates	0
of	0
sleep	0
-	0
onset	0
REM	I-DISEASE
periods	I-DISEASE
during	0
the	0
Multiple	0
Sleep	0
Latency	0
Test	I-DISEASE
in	0
community	I-DISEASE
adults	0
.	0

Brain	0
2006;129:1609–23	0
.	0

Nevsimalova	0
S	0
,	0
Prihodova	0
I	0
,	0
Kemlink	I-DISEASE
D	0
,	I-DISEASE
Lin	0
L	0
,	0
Mignot	0
E.	0
REM	I-DISEASE
sleep	0
behavior	0
disorder	I-DISEASE
(	0
RBD	0
)	0
can	I-DISEASE
be	0
one	0
of	0
the	0
first	0
symptoms	0
of	0
childhood	0
narcolepsy	I-DISEASE
.	0

Sleep	0
Med	0
2007;8:784–6	I-DISEASE
.	0

Overeem	0
S	0
,	I-DISEASE
van	0
Nues	0
SJ	0
,	I-DISEASE
van	0
der	I-DISEASE
Zande	0
WL	0
,	0
Donjacour	I-DISEASE
CE	0
,	0
van	0
Mierlo	0
P	I-DISEASE
,	0
Lammers	0
GJ	0
.	0

The	0
clinical	0
features	0
of	0
cataplexy	0
:	I-DISEASE
a	0
questionnaire	0
study	0
in	0
narcolepsy	0
patients	0
with	0
and	0
without	0
hypocretin-1	0
deficiency	0
.	0

Sleep	0
Med	0
2011;12:12–8	0
.	0

Pizza	0
F	0
,	0
Franceschini	0
C	0
,	0
Peltola	0
H	I-DISEASE
,	I-DISEASE
et	0
al	0
.	0

Clinical	0
and	0
polysomnographic	0
course	0
of	0
childhood	0
narcolepsy	0
with	0
cataplexy	I-DISEASE
.	0

Brain	0
2013	0
Oct	0
18	0
.	0

[	0
Epub	0
ahead	0
of	I-DISEASE
print	0
]	0

Plazzi	0
G	0
,	0
Parmeggiani	0
A	0
,	0
Mignot	I-DISEASE
E	0
,	I-DISEASE
et	0
al	0
.	0

Narcolepsy	0
-	0
cataplexy	0
associated	0
with	0
precocious	0
puberty	I-DISEASE
.	0

Neurology	0
2006;66:1577–9	0
.	0

Serra	0
L	0
,	I-DISEASE
Montagna	0
P	0
,	0
Mignot	I-DISEASE
E	0
,	I-DISEASE
Lugaresi	0
E	0
,	0
Plazzi	0
G.	0
Cataplexy	0
features	I-DISEASE
in	0
childhood	I-DISEASE
narcolepsy	0
.	0

Mov	0
Disord	0
2008;23:858–65	0
.	0

Narcolepsy	0
Type	0
2	0
ICD-9	0
-	0
CM	0
code	I-DISEASE
:	0
347.00	0
Alternate	0
Names	0
Narcolepsy	0
without	I-DISEASE
cataplexy	0
.	0

Diagnostic	0
Criteria	0
Criteria	0

A	0
-	0
E	0
must	I-DISEASE
be	0
met	0
ICD-10	I-DISEASE
-	0
CM	0
code	0
:	0
G47.419	0
Central	I-DISEASE
Disorders	0
of	0
Hypersomnolence	0
A.	I-DISEASE

The	0
patient	0
has	0
daily	0
periods	0
of	0
irrepressible	I-DISEASE
need	I-DISEASE
to	I-DISEASE
sleep	0
or	0
daytime	0
lapses	0
into	I-DISEASE
sleep	I-DISEASE
occurring	0
for	0
at	I-DISEASE
least	0
three	I-DISEASE
months	0
.	0

B.	0
A	0
mean	0
sleep	0
latency	0
of	I-DISEASE
≤	I-DISEASE
8	0
minutes	I-DISEASE
and	I-DISEASE
two	0
or	0
more	I-DISEASE
sleep	0
onset	I-DISEASE
REM	0
periods	I-DISEASE
(	I-DISEASE
SOREMPs	0
)	0
are	0
found	I-DISEASE
on	0
a	I-DISEASE
MSLT	0
performed	0
according	I-DISEASE
to	I-DISEASE
standard	0
techniques	0
.	0

A	0
SOREMP	0
(	0
within	0
15	0
minutes	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
onset	I-DISEASE
)	0
on	0
the	I-DISEASE
preceding	0
nocturnal	I-DISEASE
polysomnogram	I-DISEASE
may	I-DISEASE
replace	I-DISEASE
one	I-DISEASE
of	0
the	I-DISEASE
SOREMPs	0
on	0
the	0
MSLT	I-DISEASE
.	I-DISEASE

C.	0
Cataplexy	I-DISEASE
is	0
absent.1	0
D.	0
Either	0
CSF	0
hypocretin-1	0
concentration	I-DISEASE
has	0
not	0
been	0
measured	0
or	0
CSF	I-DISEASE
hypocretin-1	0
concentration	0
measured	0
by	0
immunoreactivity	0
is	0
either	0
>	0
110	0
pg	0
/	I-DISEASE
mL	0
or	I-DISEASE
>	0
1/3	I-DISEASE
of	0
mean	I-DISEASE
values	0
obtained	0
in	0
normal	I-DISEASE
subjects	I-DISEASE
with	0
the	0
same	0
standardized	0
assay.2	0
E.	0

The	0
hypersomnolence	0
and/or	0
MSLT	0
findings	0
are	0
not	I-DISEASE
better	0
explained	I-DISEASE
by	0
other	0
causes	0
such	0
as	0
insufficient	I-DISEASE
sleep	0
,	I-DISEASE
obstructive	I-DISEASE
sleep	0
apnea	0
,	0
delayed	I-DISEASE
sleep	0
phase	I-DISEASE
disorder	0
,	I-DISEASE
or	0
the	I-DISEASE
effect	0
of	0
medication	I-DISEASE
or	I-DISEASE
substances	0
or	0
their	0
withdrawal	0
.	0

Notes	0
.	0

If	0
cataplexy	0
develops	0
later	0
,	0
then	0
the	I-DISEASE
disorder	0
should	I-DISEASE
be	0
reclassified	0
as	0
narcolepsy	0
type	0
1	I-DISEASE
.	0

Central	0
Disorders	0
of	0
Hypersomnolence	0
.	0

If	0
the	0
CSF	I-DISEASE
Hcrt-1	I-DISEASE
concentration	0
is	0
tested	I-DISEASE
at	0
a	I-DISEASE
later	0
stage	0
and	0
found	0
to	0
be	I-DISEASE
either	0
≤	0
110	I-DISEASE
pg	0
/	0
mL	0
or	0
<	I-DISEASE
1/3	0
of	I-DISEASE
mean	0
values	0
obtained	0
in	0
normal	0
subjects	I-DISEASE
with	0
the	0
same	0
assay	0
,	0
then	I-DISEASE
the	0
disorder	0
should	0
be	I-DISEASE
reclassified	0
as	I-DISEASE
narcolepsy	0
type	0
1	I-DISEASE
.	I-DISEASE

Essential	0
Features	0
Narcolepsy	0
type	I-DISEASE
2	0
is	0
characterized	I-DISEASE
by	0
excessive	I-DISEASE
daytime	0
sleepiness	0
and	0
abnormal	I-DISEASE
man-	0
ifestations	I-DISEASE
of	0
REM	0
sleep	I-DISEASE
on	0
polysomnography	0
/	0
MSLT	0
.	0

Cataplexy	0
is	0
absent	0
,	0
although	0
some	0
atypical	0
sensations	0
of	0
weakness	0
triggered	0
by	0
unusual	0
emotions	0
such	I-DISEASE
as	I-DISEASE
stress	0
and	I-DISEASE
anger	0
may	0
be	0
reported	0
.	0

Refreshing	0
daytime	B-DISEASE
naps	0
are	0
characteristic	0
.	0

An	0
essential	0
feature	0
of	0
the	0
diagnosis	I-DISEASE
is	I-DISEASE
the	0
presence	I-DISEASE
of	0
a	0
mean	0
sleep	0
latency	I-DISEASE
less	0
than	I-DISEASE
or	0
equal	I-DISEASE
to	0
eight	0
minutes	0
and	0
two	0
or	I-DISEASE
more	I-DISEASE
SOREMPs	0
on	0
an	I-DISEASE
MSLT	0
(	0
or	0
one	0
SOREMP	0
on	0
an	0
MSLT	0
and	0
one	0
on	0
the	I-DISEASE
preceding	0
nocturnal	I-DISEASE
polysomnogram	0
)	0
.	I-DISEASE

The	0
presence	0
of	0
CSF	I-DISEASE
hypocretin-1	I-DISEASE
concentrations	0
≤	I-DISEASE
110	0
pg	I-DISEASE
/	0
mL	0
or	0
less	0
than	0
one	I-DISEASE
third	0
of	0
mean	I-DISEASE
values	0
obtained	0
in	0
normal	0
subjects	0
with	0
the	0
same	0
assay	0
excludes	0
the	0
diagnosis	0
,	0
but	0
most	0
patients	0
with	I-DISEASE
narcolepsy	0
type	0
2	I-DISEASE
will	0
not	0
have	I-DISEASE
undergone	0
CSF	0
examination	0
.	0

Associated	0
Features	0
Sleep	0
paralysis	0
,	0
hypnagogic	0
hallucinations	I-DISEASE
,	0
or	0
automatic	I-DISEASE
behavior	0
may	0
be	0
present	0
.	I-DISEASE

Memory	0
lapses	0
,	0
automatic	0
behavior	0
,	0
ptosis	0
,	0
blurred	I-DISEASE
vision	0
,	0
and	0
diplopia	0
may	0
occur	I-DISEASE
in	0
association	I-DISEASE
with	0
sleepiness	0
.	0

REM	0
sleep	0
behavior	0
disorder	I-DISEASE
and	0
nonrapid	I-DISEASE
eye	I-DISEASE
movement	0
(	I-DISEASE
NREM	0
)	0
parasomnias	0
may	0
occur	0
.	0

Nocturnal	0
sleep	0
disruption	0
with	I-DISEASE
frequent	0
awaken-	0
ings	0
may	0
be	0
present	0
.	0

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Narcolepsy	I-DISEASE
type	I-DISEASE
2	I-DISEASE
due	I-DISEASE
to	I-DISEASE
a	0
medical	I-DISEASE
condition	0
:	0

This	0
condition	0
fulfills	I-DISEASE
criteria	I-DISEASE
for	I-DISEASE
nar-	I-DISEASE
colepsy	I-DISEASE
type	0
2	0
and	0
is	0
attributable	0
to	0
another	0
medical	I-DISEASE
disorder	I-DISEASE
.	0

Neurologic	0
disorders	0
associated	0
with	0
narcolepsy	0
type	I-DISEASE
2	I-DISEASE
include	0
tumors	I-DISEASE
or	0
sarcoidosis	0
of	0
the	I-DISEASE
hypothalamus	0
,	I-DISEASE
autoimmune	0
or	0
paraneoplastic	I-DISEASE
disorders	0
associated	0
with	0
anti	0
-	I-DISEASE
Ma-2	I-DISEASE
or	0
anti	0
-	0
aquaporin-4	B-DISEASE
antibodies	0
,	0
multiple	0
sclerosis	0
,	0
myotonic	0
dystrophy	0
,	0
Prader	I-DISEASE
-	I-DISEASE
Willi	0
syndrome	0
,	0
Parkinson	0
disease	0
,	0
and	I-DISEASE
head	I-DISEASE
trauma	I-DISEASE
.	I-DISEASE

In	0
disorders	0
associated	0
with	0
both	0
sleep	0
apnea	I-DISEASE
and	0
narco-	I-DISEASE
lepsy	0
type	0
2	0
,	0
such	0
as	I-DISEASE
myotonic	0
dystrophy	0
or	I-DISEASE
Prader	0
-	0
Willi	0
syndrome	0
,	0
a	0
diagnosis	I-DISEASE
of	0
narcolepsy	0
type	0
2	I-DISEASE
should	0
only	0
be	0
made	0
if	0
abnormal	0
MSLT	0
findings	I-DISEASE
persist	I-DISEASE
after	I-DISEASE
the	0
sleep	I-DISEASE
apnea	I-DISEASE
is	0
adequately	0
treated	0
.	I-DISEASE

In	0
all	0
cases	0
,	B-DISEASE
especially	0
with	0
complex	0
problems	0
such	I-DISEASE
as	0
head	0
trauma	0
,	0
clinical	0
judgment	I-DISEASE
should	I-DISEASE
be	0
used	I-DISEASE
to	I-DISEASE
determine	0
if	0
the	0
development	I-DISEASE
of	0
narcolepsy	I-DISEASE
was	0
a	0
mere	I-DISEASE
coincidence	0
or	0
was	0
triggered	0
by	0
the	0
event	0
or	0
disorder	0
.	I-DISEASE

Demographics	0
The	0
exact	0
prevalence	0
of	0
narcolepsy	0
type	I-DISEASE
2	I-DISEASE
is	I-DISEASE
uncertain	0
.	0

Cases	0
of	I-DISEASE
narcolepsy	0
without	0
cat-	0
aplexy	0
represent	I-DISEASE
15	0
%	I-DISEASE
to	0
25	0
%	0
of	0
the	0
clinic	0
narcoleptic	0
population	0
.	I-DISEASE

A	0
population	0
-	0
based	I-DISEASE
study	0
suggested	I-DISEASE
a	I-DISEASE
higher	0
percentage	I-DISEASE
(	0
36	0
%	0
)	0
,	I-DISEASE
corresponding	I-DISEASE
to	I-DISEASE
a	0
point	I-DISEASE
prevalence	0
of	I-DISEASE
20.5/100,000	0
.	0

Population	0
-	0
based	0
studies	0
have	0
shown	0
that	0
approximately	0
4	I-DISEASE
%	0
to	0
9.5	0
%	0
of	0
adults	I-DISEASE
may	0
have	0
multiple	I-DISEASE
SOREMPs	0
during	0
random	0
MSLTs	0
,	0
but	0
shift	0
workers	0
and	0
subjects	I-DISEASE
with	0
sleep	I-DISEASE
deprivation	0
or	0
sleep	0
apnea	0
were	0
included	0
in	0
the	I-DISEASE
studies	I-DISEASE
.	I-DISEASE

Although	0
both	0
sexes	0
can	0
be	0
affected	I-DISEASE
,	I-DISEASE
the	0
prevalence	I-DISEASE
may	0
be	0
slightly	I-DISEASE
higher	I-DISEASE
in	0
men	0
.	0

The	0
age	0
of	0
onset	I-DISEASE
mirrors	0
that	0
of	I-DISEASE
narcolepsy	0
type	I-DISEASE
1	0
.	0
Predisposing	0
and	I-DISEASE
Precipitating	0
Factors	0
As	0
discussed	0
below	I-DISEASE
,	0
about	I-DISEASE
24	0
%	0
of	0
patients	0
with	I-DISEASE
narcolepsy	I-DISEASE
but	0
no	0
cataplexy	0
will	0
have	0
low	I-DISEASE
CSF	0
Hcrt-1	0
levels	0
and	0
almost	0
all	0
of	0
these	0
will	0
be	I-DISEASE
positive	0
for	0
the	0
HLA	0
DQB1	I-DISEASE
*	0
0602	0
antigen	I-DISEASE
.	0

These	0
patients	0
probably	I-DISEASE
share	0
a	0
common	I-DISEASE
pathogenesis	0
with	0
narcolepsy	0
with	0
cataplexy	0
and	0
should	0
be	0
classified	I-DISEASE
as	0
narcolepsy	I-DISEASE
type	0
1	0
.	0

Underlying	0
genetic	0
and	0
envi-	0
ronmental	0
factors	0
associated	0
with	0
other	I-DISEASE
patients	0
with	0
narcolepsy	0
type	0
2	0
are	I-DISEASE
unknown	I-DISEASE
.	0

Environmental	0
precipitating	0
factors	0
are	0
suspected	0
from	0
case	0
reports	0
but	I-DISEASE
have	0
never	0
been	0
proven	0
to	0
trigger	I-DISEASE
narcolepsy	0
without	0
cataplexy	I-DISEASE
.	0

Among	0
the	0
most	I-DISEASE
commonly	0
reported	0
triggers	0
are	I-DISEASE
head	0
trauma	0
and	0
unspecified	0
viral	0
illnesses	0
.	0

Familial	0
Patterns	0

The	0
detailed	0
genetic	0
pattern	0
of	0
narcolepsy	I-DISEASE
type	0
2	0
is	0
unknown	0
.	0

Relatives	0
of	0
patients	0
with	I-DISEASE
narcolepsy	0
type	I-DISEASE
1	0
may	0
be	I-DISEASE
more	0
likely	0
to	I-DISEASE
experience	0
partial	0
narcolepsy	I-DISEASE
symptoms	0
compatible	0
with	I-DISEASE
the	0
diagnosis	I-DISEASE
of	0
narcolepsy	0
type	0
2	0
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Onset	I-DISEASE
typically	0
occurs	0
during	0
adolescence	0
.	0

In	0
about	0
10	0
%	I-DISEASE
of	0
patients	I-DISEASE
,	I-DISEASE
cataplexy	0
will	I-DISEASE
develop	0
later	0
in	0
the	I-DISEASE
course	0
of	I-DISEASE
the	0
disease	I-DISEASE
,	I-DISEASE
necessitating	0
a	I-DISEASE
change	0
in	0
diagnosis	0
to	0
narco-	0
lepsy	0
type	0
1	0
.	0

Most	0
of	0
these	0
patients	0
will	0
,	0
if	I-DISEASE
tested	0
,	0
have	0
absent	0
or	0
intermediate	0
levels	0
of	0
CSF	0
Hcrt-1	0
.	0

In	0
a	0
cohort	0
of	0
patients	0
with	0
narcolepsy	I-DISEASE
without	I-DISEASE
cataplexy	I-DISEASE
in	0
whom	0
CSF	0
Hcrt-1	0
status	I-DISEASE
was	I-DISEASE
known	0
,	0
33	I-DISEASE
%	0
of	0
those	I-DISEASE
with	0
low	0
levels	0
later	I-DISEASE
developed	I-DISEASE
cataplexy	0
,	B-DISEASE
compared	0
with	0
18	0
%	I-DISEASE
with	0
intermediate	0
levels	0
and	0
only	0
1	0
%	0
with	0
normal	I-DISEASE
levels	0
.	0

When	0
left	0
untreated	I-DISEASE
,	0
narcolepsy	0
type	I-DISEASE
2	I-DISEASE
is	0
socially	0
disabling	0
and	0
isolating	0
.	I-DISEASE

Patients	0
have	0
a	0
ten-	0
dency	0
to	0
fail	I-DISEASE
in	0
school	I-DISEASE
and	0
are	0
often	0
dismissed	0
from	0
their	0
jobs	0
.	0

Driving	0
may	0
be	0
avoided	I-DISEASE
for	0
fear	0
of	I-DISEASE
a	0
motor	I-DISEASE
vehicle	0
accident	0
.	0

The	0
inability	0
to	0
sleep	I-DISEASE
at	I-DISEASE
night	I-DISEASE
may	I-DISEASE
further	0
contrib-	I-DISEASE
ute	I-DISEASE
to	0
a	0
loss	I-DISEASE
of	0
control	I-DISEASE
these	0
patients	0
have	I-DISEASE
over	0
their	0
schedule	0
.	I-DISEASE

Depression	0
and	0
weight	0
gain	I-DISEASE
also	0
are	0
common	0
.	0

Central	0
Disorders	0
of	0
Hypersomnolence	0
Central	0
Disorders	I-DISEASE
of	0
Hypersomnolence	0
Developmental	I-DISEASE
Issues	0
Children	0
with	0
narcolepsy	0
type	0
2	I-DISEASE
will	0
typically	0
present	I-DISEASE
with	0
a	0
reappearance	0
of	0
regular	0
daytime	0
napping	0
after	0
naps	0
had	I-DISEASE
been	0
discontinued	0
.	0

In	0
all	0
pediatric	0
cases	0
,	0
one	I-DISEASE
should	I-DISEASE
consider	0
the	I-DISEASE
possibility	0
of	0
an	0
evolving	0
disorder	0
with	I-DISEASE
the	0
development	0
of	I-DISEASE
cataplexy	0
over	0
time	0
.	0

Once	0
the	0
patient	I-DISEASE
develops	0
clear	0
cataplexy	0
,	I-DISEASE
the	0
diagnosis	0
should	0
be	0
changed	0
to	0
narcolepsy	0
type	I-DISEASE
1	0
.	0

Limited	0
information	I-DISEASE
is	0
available	0
on	0
narcolepsy	0
type	0
2	0
prior	I-DISEASE
to	0
adolescence	0
.	I-DISEASE

Descriptions	0
of	0
the	I-DISEASE
experience	I-DISEASE
of	0
sleep	I-DISEASE
paralysis	0
or	0
hypnagogic	I-DISEASE
halluci-	0
nations	0
are	0
very	I-DISEASE
difficult	0
to	I-DISEASE
evoke	I-DISEASE
in	0
young	0
patients	0
,	I-DISEASE
and	0
normative	0
data	0
are	0
not	I-DISEASE
avail-	0
able	0
for	0
the	0
MSLT	0
in	0
children	I-DISEASE
younger	0
than	0
six	0
years	0
of	0
age	I-DISEASE
.	I-DISEASE

In	0
peripubertal	0
children	0
and	0
adolescents	0
,	0
the	0
diagnosis	I-DISEASE
is	I-DISEASE
often	0
challenging	0
.	0

The	0
most	0
common	0
causes	0
of	0
short	I-DISEASE
sleep	I-DISEASE
latencies	I-DISEASE
,	0
often	0
with	0
multiple	0
SOREMPs	0
on	0
the	I-DISEASE
MSLT	0
,	0
are	I-DISEASE
chronic	0
sleep	I-DISEASE
depri-	0
vation	0
and	0
delayed	0
sleep	0
phase	I-DISEASE
disorder	I-DISEASE
.	I-DISEASE

Behavioral	0
problems	0
may	0
be	0
associated	0
with	0
the	B-DISEASE
onset	I-DISEASE
of	I-DISEASE
the	0
disorder	I-DISEASE
,	0
and	0
symptoms	I-DISEASE
may	I-DISEASE
be	0
hidden	0
by	0
the	0
patient	I-DISEASE
.	0

Inattentiveness	0
,	0
lack	I-DISEASE
of	0
energy	0
,	0
insomnia	I-DISEASE
,	0
bizarre	I-DISEASE
hallucinations	0
,	0
or	0
a	I-DISEASE
combination	0
thereof	I-DISEASE
can	0
lead	0
to	I-DISEASE
a	0
psychiatric	0
misdiagnosis	0
of	0
schizophrenia	0
or	0
depression	0
.	0

If	0
the	0
MSLT	I-DISEASE
shows	B-DISEASE
equivocal	0
results	0
,	0
repeating	0
it	I-DISEASE
after	0
a	0
time	0
interval	I-DISEASE
may	0
be	I-DISEASE
helpful	0
,	0
as	I-DISEASE
SOREMPs	0
often	I-DISEASE
emerge	0
later	0
in	0
children	0
.	I-DISEASE

Pathology	0
and	0
Pathophysiology	0
Narcolepsy	I-DISEASE
type	0
2	I-DISEASE
is	I-DISEASE
most	0
likely	I-DISEASE
a	0
heterogeneous	0
disorder	0
.	0

Approximately	0
24	0
%	0
of	0
nar-	0

coleptic	0
patients	0
without	0
cataplexy	I-DISEASE
have	0
a	I-DISEASE
low	I-DISEASE
CSF	0
Hcrt-1	0
concentration	0
,	0
and	0
another	I-DISEASE
8	0
%	0
have	0
intermediate	0
levels	I-DISEASE
(	0
>	0
110	0
pg	0
/	I-DISEASE
mL	0
but	0
≤	0
200	0
pg	0
/	0
mL	I-DISEASE
)	0
.	0

The	0
CSF	0
Hcrt-1	I-DISEASE
status	0
of	0
most	0
patients	I-DISEASE
with	0
narcolepsy	0
type	0
2	0
is	0
unknown	I-DISEASE
(	0
those	I-DISEASE
patients	0
who	0
are	I-DISEASE
known	I-DISEASE
to	I-DISEASE
have	0
absent	0
CSF	0
Hcrt-1	0
levels	I-DISEASE
are	0
classified	0
as	0
narcolepsy	0
type	0
1	0
)	I-DISEASE
.	0

Therefore	0
,	0
there	0
will	I-DISEASE
be	I-DISEASE
a	0
subgroup	I-DISEASE
of	0
about	I-DISEASE
one	0
fourth	0
to	0
one	0
third	0
of	I-DISEASE
narcolepsy	0
type	0
2	I-DISEASE
patients	0
who	0
will	0
have	0
hypocretin	I-DISEASE
deficiency	0
,	I-DISEASE
presumably	0
from	0
loss	0
of	0
the	I-DISEASE
hypocretin	I-DISEASE
-	I-DISEASE
producing	0
neurons	0
.	0

This	0
group	0
of	0
patients	0
can	0
not	0
be	I-DISEASE
accurately	0
separated	0
clinically	0
or	0
by	0
labora-	0
tory	0
tests	I-DISEASE
(	0
other	0
than	I-DISEASE
CSF	0
Hcrt-1	0
level	0
)	0
from	0
the	I-DISEASE
majority	0
of	0
patients	0
without	I-DISEASE
cataplexy	0
who	0
have	0
normal	I-DISEASE
CSF	0
Hcrt-1	0
levels	0
.	0

Although	0
those	0
with	0
low	0
CSF	0
Hcrt-1	I-DISEASE
levels	I-DISEASE
have	0
a	I-DISEASE
younger	I-DISEASE
age	0
of	0
onset	0
and	0
their	I-DISEASE
MSLT	0
shows	0
shorter	I-DISEASE
mean	0
sleep	I-DISEASE
latency	0
with	0
more	0
SOREMPs	0
in	0
comparison	0
with	I-DISEASE
those	0
with	0
normal	0
levels	0
,	0
there	0
is	0
too	0
much	0
overlap	I-DISEASE
between	0
the	0
groups	0
for	I-DISEASE
these	0
differences	0
to	0
be	I-DISEASE
helpful	0
diagnostically	0
in	I-DISEASE
individual	0
patients	I-DISEASE
.	0

One	0
hundred	I-DISEASE
percent	0
of	0
patients	0
with	I-DISEASE
low	I-DISEASE
CSF	0
Hcrt-1	I-DISEASE
levels	0
are	0
positive	0
for	I-DISEASE
HLA	0
DQB1	0
*	0
0602	0
.	I-DISEASE

About	0
26	0
%	0
of	0
patients	0
with	I-DISEASE
normal	0
levels	0
are	I-DISEASE
also	0
HLA	0
posi-	0
tive	0
,	0
a	0
percentage	0
not	0
higher	I-DISEASE
than	0
that	0
seen	0
in	0
the	I-DISEASE
normal	0
population	0
.	0

The	0
underlying	0
pathophysiology	0
of	0
the	I-DISEASE
remainder	I-DISEASE
of	I-DISEASE
patients	0
who	I-DISEASE
have	I-DISEASE
normal	0
CSF	0
Hcrt-1	I-DISEASE
levels	0
is	0
unknown	0
.	I-DISEASE

It	0
is	0
possible	0
some	0
may	0
have	0
partial	0
hypocretin	0
deficiency	I-DISEASE
severe	0
enough	0
to	0
cause	I-DISEASE
sleepiness	0
but	I-DISEASE
not	0
severe	0
enough	I-DISEASE
to	I-DISEASE
result	0
in	0
cataplexy	0
or	0
low	0
CSF	0
Hcrt-1	0
levels	0
.	I-DISEASE

However	0
,	I-DISEASE
support	0
for	0
this	0
hypothesis	0
is	I-DISEASE
lacking	0
in	I-DISEASE
that	0
there	I-DISEASE
are	I-DISEASE
no	0
major	0
differences	I-DISEASE
in	I-DISEASE
clinical	0
or	I-DISEASE
polysomnographic	0
findings	I-DISEASE
in	0
those	0
positive	0
or	I-DISEASE
negative	I-DISEASE
for	0
HLA	0
DQB1	0
*	I-DISEASE
0602	0
.	0

In	0
the	0
only	I-DISEASE
postmortem	0
study	0
of	0
a	I-DISEASE
case	0
of	I-DISEASE
narcolepsy	0
without	0
cata-	0
plexy	0
(	0
CSF	I-DISEASE
Hcrt-1	0
status	I-DISEASE
unknown	I-DISEASE
)	0
,	0
the	0
number	0
of	0
hypocretin	I-DISEASE
cells	I-DISEASE
was	0
decreased	0
but	0
not	0
as	0
much	0
as	I-DISEASE
in	0
cases	0
of	0
narcolepsy	I-DISEASE
with	I-DISEASE
cataplexy	I-DISEASE
.	0

Objective	0
Findings	0

It	0
is	0
strongly	0
rcommended	0
that	0
the	0
MSLT	I-DISEASE
be	I-DISEASE
preceded	I-DISEASE
by	I-DISEASE
at	0
least	0
one	I-DISEASE
week	0
of	I-DISEASE
acti-	I-DISEASE
graphic	I-DISEASE
recording	I-DISEASE
with	I-DISEASE
a	0
sleep	0
log	0
to	I-DISEASE
establish	0
whether	I-DISEASE
the	0
results	0
could	I-DISEASE
be	0
biased	0
by	0
insufficient	0
sleep	I-DISEASE
,	0
shift	0
work	I-DISEASE
,	I-DISEASE
or	0
another	0
circadian	0
sleep	I-DISEASE
disorder	0
.	0

The	0
MSLT	0
demon-	0
strates	0
a	I-DISEASE
mean	I-DISEASE
latency	B-DISEASE
of	0
less	I-DISEASE
than	0
eight	0
minutes	0
,	I-DISEASE
typically	0
less	I-DISEASE
than	0
five	0
minutes	I-DISEASE
,	0
with	I-DISEASE
two	0
or	0
more	I-DISEASE
SOREMPs	0
or	I-DISEASE
one	0
SOREMP	0
together	I-DISEASE
with	0
a	I-DISEASE
SOREMP	0
on	0
the	0
preceding	0
polysomnogram	0
.	0

Meta	0
-	0
analysis	0
shows	0
mean	0
sleep	0
latencies	0
in	I-DISEASE
narcoleptic	0
patients	0
with	0
cataplexy	0
of	0
3.1	0
±	0
2.9	I-DISEASE
minutes	0
.	I-DISEASE

Recent	0
data	0
suggest	0
that	0
a	0
SOREMP	I-DISEASE
within	I-DISEASE
15	0
minutes	I-DISEASE
of	0
onset	0
of	0
nocturnal	0
sleep	0
is	I-DISEASE
a	I-DISEASE
highly	I-DISEASE
specific	0
finding	I-DISEASE
in	I-DISEASE
the	0
absence	0
of	0
another	0
sleep	0
disorder	I-DISEASE
,	0
but	I-DISEASE
with	0
low	I-DISEASE
sensitivity	I-DISEASE
.	0

Therefore	0
,	0
the	0
criteria	I-DISEASE
for	0
narcolepsy	0
type	I-DISEASE
2	0
allow	I-DISEASE
the	0
“	0
replacement	I-DISEASE
”	0
of	I-DISEASE
one	I-DISEASE
SOREMP	I-DISEASE
in	0
the	I-DISEASE
MSLT	0
with	0
a	0
SOREMP	0
on	0
the	0
preceding	I-DISEASE
poly-	I-DISEASE
somnogram	0
.	I-DISEASE

For	0
the	0
correct	I-DISEASE
interpretation	0
of	0
MSLT	I-DISEASE
findings	I-DISEASE
,	0
the	0
recordings	0
should	0
be	0
performed	0
with	0
the	0
following	0
conditions	I-DISEASE
:	I-DISEASE
(	0
1	0
)	0
the	0
patient	I-DISEASE
must	I-DISEASE
be	I-DISEASE
free	0
of	0
drugs	I-DISEASE
that	0
influence	0
sleep	I-DISEASE
for	0
at	0
least	0
14	0
days	I-DISEASE
(	0
or	0
at	I-DISEASE
least	0
five	I-DISEASE
times	I-DISEASE
the	0
half	0
-	I-DISEASE
life	I-DISEASE
of	I-DISEASE
the	I-DISEASE
drug	0
and	I-DISEASE
longer	0
-	I-DISEASE
acting	I-DISEASE
metabolite	I-DISEASE
)	0
,	0
confirmed	0
by	I-DISEASE
a	I-DISEASE
urine	0
drug	0
screen	0
;	I-DISEASE
(	I-DISEASE
2	I-DISEASE
)	I-DISEASE
the	0
sleep	I-DISEASE
-	I-DISEASE
wake	I-DISEASE
sched-	I-DISEASE
ule	0
must	I-DISEASE
have	I-DISEASE
been	0
standardized	I-DISEASE
and	0
,	I-DISEASE
if	I-DISEASE
necessary	0
,	0
extended	0
to	I-DISEASE
a	0
minimum	0
of	0
seven	0
hours	0
in	I-DISEASE
bed	I-DISEASE
each	I-DISEASE
night	I-DISEASE
(	I-DISEASE
longer	0
for	I-DISEASE
children	0
)	0
for	0
at	I-DISEASE
least	I-DISEASE
seven	I-DISEASE
days	0
before	0
polysom-	I-DISEASE

nography	0
(	0
preferably	0
documented	0
by	0
sleep	I-DISEASE
log	I-DISEASE
and	0
,	I-DISEASE
whenever	0
possible	0
,	0
actigraphy	0
)	0
;	I-DISEASE
and	0
(	I-DISEASE
3	I-DISEASE
)	I-DISEASE
nocturnal	0
polysomnography	0
should	0
be	0
performed	I-DISEASE
on	I-DISEASE
the	0
night	0
immediately	I-DISEASE
preceding	0
the	0
MSLT	0
to	I-DISEASE
rule	0
out	0
other	0
sleep	0
disorders	I-DISEASE
that	I-DISEASE
could	0
mimic	I-DISEASE
the	I-DISEASE
diagnostic	0
features	0
of	0
narcolepsy	0
type	0
2	I-DISEASE
.	I-DISEASE

Sleep	0
time	I-DISEASE
during	0
polysomnography	0
should	0
be	I-DISEASE
curtailed	I-DISEASE
as	0
little	I-DISEASE
as	I-DISEASE
possible	0
,	I-DISEASE
with	0
the	0
goal	0
of	0
at	0
least	I-DISEASE
seven	0
hours	0
asleep	0
.	0

The	0
overnight	0
poly-	0
somnogram	0
may	0
demonstrate	I-DISEASE
an	I-DISEASE
increase	0
in	I-DISEASE
the	0
amount	0
of	0
stage	I-DISEASE
N1	0
sleep	0
,	I-DISEASE
and	I-DISEASE
there	I-DISEASE
may	0
be	0
a	0
disruption	I-DISEASE
of	0
the	0
normal	I-DISEASE
sleep	0
pattern	I-DISEASE
,	I-DISEASE
with	0
frequent	I-DISEASE
awakenings	I-DISEASE
.	I-DISEASE

REM	0
sleep	0
without	0
atonia	I-DISEASE
may	I-DISEASE
be	I-DISEASE
present	I-DISEASE
.	0

About	0
45	0
%	0
of	0
narcolepsy	0
type	0
2	I-DISEASE
cases	0
have	I-DISEASE
been	0
reported	I-DISEASE
to	I-DISEASE
be	0
HLA	0
DQB1	0
*	0
0602	0
positive	0
,	0
compared	I-DISEASE
with	0
12	0
%	0
to	0
38	I-DISEASE
%	0
of	I-DISEASE
controls	I-DISEASE
.	0

Whereas	0
essentially	0
all	I-DISEASE
patients	0
who	0
have	0
low	0
CSF	0
Hcrt-1	I-DISEASE
levels	0
will	0
be	0
positive	I-DISEASE
,	0
about	0
25	0
%	0
of	I-DISEASE
those	I-DISEASE
with	0
normal	0
levels	0
will	0
also	0
be	0
positive	0
.	0

Assuming	0
that	0
24	0
%	0
of	0
patients	0
with	I-DISEASE
narcolepsy	I-DISEASE
but	I-DISEASE
no	0
cataplexy	0
will	0
have	0
low	0
CSF	I-DISEASE
Hcrt-1	0
levels	0
,	0
the	0
probability	0
that	0
an	0
HLA-	I-DISEASE
positive	0
patient	0
will	0
have	I-DISEASE
low	I-DISEASE
Hcrt-1	0
levels	0
is	0
only	I-DISEASE
0.56	0
.	0

Therefore	0
the	0
HLA	I-DISEASE
status	0
of	0
a	0
patient	I-DISEASE
can	0
not	I-DISEASE
be	0
used	I-DISEASE
to	0
diagnose	I-DISEASE
narcolepsy	0
type	0
2	0
nor	I-DISEASE
to	0
predict	0
with	0
high	0
probability	0
the	0
patient	0
’s	0
CSF	0
Hcrt-1	0
levels	B-DISEASE
.	0

However	0
,	I-DISEASE
if	0
lumbar	0
puncture	0
is	0
contemplated	0
to	0
measure	I-DISEASE
CSF	0
Central	0
Disorders	0
of	0
Hypersomnolence	0
Central	I-DISEASE
Disorders	0
of	0
Hypersomnolence	I-DISEASE
Hcrt-1	0
levels	0
,	0
HLA	0
typing	0
should	0
be	0
performed	0
first	0
;	I-DISEASE
if	0
the	0
patient	0
is	0
HLA	0
negative	0
,	0
CSF	0
Hcrt-1	0
levels	I-DISEASE
will	0
almost	I-DISEASE
certainly	0
be	0
normal	I-DISEASE
and	0
the	0
lumbar	0
puncture	I-DISEASE
will	0
be	0
unnecessary	I-DISEASE
.	0

Approximately	0
24	0
%	I-DISEASE
of	0
narcoleptic	0
patients	0
without	I-DISEASE
cataplexy	0
have	I-DISEASE
a	I-DISEASE
low	I-DISEASE
CSF	0
Hcrt-1	0
concentration	0
and	0
another	0
8	0
%	I-DISEASE
have	I-DISEASE
intermediate	0
levels	0
(	0
>	I-DISEASE
110	I-DISEASE
pg	0
/	0
mL	I-DISEASE
but	I-DISEASE
≤	0
200	0
pg/	0
mL	0
)	0
.	0

If	0
the	0
CSF	I-DISEASE
Hcrt-1	I-DISEASE
levels	0
of	0
such	I-DISEASE
patients	0
are	I-DISEASE
known	0
to	0
be	0
low	0
,	0
they	I-DISEASE
are	0
classified	0
as	I-DISEASE
narcolepsy	0
type	0
1	0
,	0
but	0
the	0
CSF	0
Hcrt-1	0
status	0
will	I-DISEASE
not	0
be	0
known	0
for	0
most	0
of	0
these	0
patients	0
.	0

Possible	0
indications	0
for	I-DISEASE
considering	0
measuring	0
CSF	I-DISEASE
Hcrt-1	0
levels	0
as	I-DISEASE
a	0
diag-	0
nostic	0
procedure	0
would	I-DISEASE
be	I-DISEASE
the	0
presence	0
of	I-DISEASE
disorders	0
such	0
as	0
obstructive	0
sleep	0
apnea	I-DISEASE
or	I-DISEASE
the	0
use	I-DISEASE
of	I-DISEASE
psychotropic	0
medications	I-DISEASE
that	I-DISEASE
may	0
complicate	0
interpretation	0
of	0
an	0
MSLT	I-DISEASE
.	I-DISEASE

Differential	0
Diagnosis	0
Narcolepsy	0
type	0
1	0
is	I-DISEASE
diagnosed	I-DISEASE
if	0
cataplexy	I-DISEASE
is	0
present	0
or	0
the	0
CSF	0
hypocretin	0
levels	I-DISEASE
are	0
known	0
to	0
be	0
low	0
even	0
in	I-DISEASE
the	I-DISEASE
absence	0
of	I-DISEASE
cataplexy	0
.	I-DISEASE

Patients	0
with	0
idiopathic	B-DISEASE
hyper-	0
somnia	0
may	I-DISEASE
have	0
mean	0
sleep	I-DISEASE
latencies	0
on	0
MSLT	0
similar	0
to	0
those	0
of	0
narcolepsy	I-DISEASE
type	0
2	0
,	0
but	0
have	0
fewer	0
than	0
two	0
SOREMPs	0
on	0
MSLT	0
and	0
the	0
preceding	0
polysomnogram	I-DISEASE
combined	0
.	0

In	0
contrast	0
to	0
narcolepsy	0
,	0
patients	0
with	I-DISEASE
idiopathic	0
hypersomnia	I-DISEASE
generally	0
have	0
high	0
sleep	0
efficiency	0
,	I-DISEASE
sleep	0
drunkenness	0
,	0
and	0
long	I-DISEASE
,	0
unrefreshing	0
naps	I-DISEASE
.	I-DISEASE

Sleepiness	0
may	I-DISEASE
be	0
secondary	B-DISEASE
to	I-DISEASE
obstructive	0
sleep	I-DISEASE
apnea	0
(	I-DISEASE
OSA	0
)	0
,	I-DISEASE
insufficient	0
sleep	I-DISEASE
syndrome	I-DISEASE
,	I-DISEASE
shift	0
work	I-DISEASE
,	I-DISEASE
the	0
effects	0
of	I-DISEASE
substances	0
or	0
medications	I-DISEASE
,	I-DISEASE
or	0
other	I-DISEASE
sleep	0
disorders	I-DISEASE
.	I-DISEASE

Many	0
of	0
these	I-DISEASE
conditions	0
can	0
result	0
in	I-DISEASE
early	0
-	I-DISEASE
onset	0
REM	0
sleep	0
,	0
so	I-DISEASE
their	I-DISEASE
clinical	I-DISEASE
and	0
polysomnographic	I-DISEASE
exclusion	0
is	I-DISEASE
essential	0
before	0
a	0
diagnosis	I-DISEASE
of	I-DISEASE
narcolepsy	I-DISEASE
type	0
2	I-DISEASE
is	I-DISEASE
made	I-DISEASE
.	0

However	0
,	I-DISEASE
the	0
presence	I-DISEASE
of	0
other	I-DISEASE
sleep	I-DISEASE
disorders	I-DISEASE
does	I-DISEASE
not	0
preclude	I-DISEASE
a	0
diagnosis	0
of	0
narcolepsy	I-DISEASE
type	0
2	0
if	I-DISEASE
daytime	0
sleepiness	0
and	0
REM	0
abnormalities	0
persist	0
after	0
adequate	I-DISEASE
treatment	0
of	I-DISEASE
the	0
initial	0
disorder	0
.	0

Chronic	0
fatigue	0
syndrome	0
and	0
depression	0
may	I-DISEASE
mimic	0
narcolepsy	0
but	I-DISEASE
do	0
not	0
show	0
the	0
typical	0
MSLT	0
findings	I-DISEASE
.	0

Malingering	0
and	0
substance	0
abuse	I-DISEASE
disorder	0
should	I-DISEASE
be	I-DISEASE
considered	0
in	I-DISEASE
patients	I-DISEASE
who	0
try	0
to	I-DISEASE
mislead	0
the	I-DISEASE
clinician	0
in	I-DISEASE
order	I-DISEASE
to	0
obtain	I-DISEASE
stimulant	0
medications	0
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE

Excluding	0
the	0
minority	0
of	0
patients	0
with	I-DISEASE
definite	I-DISEASE
hypocretin	0
deficiency	I-DISEASE
,	0
the	0
underlying	0
biology	0
of	0
narcolepsy	I-DISEASE
without	I-DISEASE
the	0
presence	0
of	0
cataplexy	0
is	0
unknown	0
.	0

It	0
is	0
not	0
estab-	I-DISEASE
lished	0
whether	I-DISEASE
narcolepsy	I-DISEASE
type	0
2	I-DISEASE
is	0
a	0
homogeneous	0
or	0
heterogeneous	0
condition	I-DISEASE
.	I-DISEASE

It	0
is	0
uncertain	0
whether	0
or	0
not	0
some	I-DISEASE
patients	0
have	I-DISEASE
partial	0
hypocretin	0
deficiency	0
not	0
iden-	0
tifiable	I-DISEASE
from	I-DISEASE
CSF	0
measurements	I-DISEASE
.	0

Further	0
advances	0
in	0
classification	0
will	0
depend	I-DISEASE
on	0
answers	0
to	0
these	0
unknowns	0
.	0

Further	0
studies	0
on	0
the	0
natural	I-DISEASE
history	I-DISEASE
of	I-DISEASE
narcolepsy	0
type	I-DISEASE
2	0
are	0
needed	0
to	I-DISEASE
determine	0
the	I-DISEASE
cause	0
of	0
the	0
hypersomnolence	I-DISEASE
and	I-DISEASE
the	0
risk	0
of	0
development	0
of	0
cataplexy	0
over	0
time	I-DISEASE
.	0

Bibliography	0
Andlauer	0
O	0
,	0
Moore	0
IV	0
H	I-DISEASE
,	0
Hong	I-DISEASE
SC	0
,	0
et	0
al	0
.	0

Predictors	0
of	0
hypocretin	0
(	0
orexin	0
)	0
deficiency	0
in	0
narcolepsy	I-DISEASE
without	0
cataplexy	0
.	0

Sleep	0
2012;35:1247–55	0
.	0

Bourgin	0
P	0
,	0
Zeitzer	I-DISEASE
JM	0
,	0
Mignot	0
E.	0
CSF	I-DISEASE
hypocretin-1	0
assessment	0
in	0
sleep	I-DISEASE
and	0
neurological	0
disorders	0
.	0

Lancet	0
Neurol	0
2008;7:649–62	0
.	0

Mignot	0
E	0
,	0
Lin	0
L	0
,	0
Finn	B-DISEASE
L	I-DISEASE
,	I-DISEASE
et	0
al	0
.	0

Correlates	0
of	0
sleep	0
-	0
onset	0
REM	I-DISEASE
periods	I-DISEASE
during	0
the	0
Multiple	0
Sleep	0
Latency	0
Test	I-DISEASE
in	0
community	I-DISEASE
adults	0
.	0

Brain	0
2006;129:1609–23	0
.	0

Oka	0
Y	0
,	0
Inoue	0
Y	0
,	0
Kanbayashi	I-DISEASE
T	0
,	0
et	0
al	0
.	0

Narcolepsy	0
without	0
cataplexy	0
:	0
2	0
subtypes	I-DISEASE
based	I-DISEASE
on	0
CSF	0
hypocretin-1/	0
orexin	0
-	0
A	0
findings	0
.	I-DISEASE

Sleep	0
2006;29:1439–43	0
.	0

Sasai	0
T	0
,	0
Inoue	0
Y	0
,	0
Komada	I-DISEASE
Y	0
,	0
Sugiura	0
T	0
,	0
Matsushima	0
E.	0
Comparison	I-DISEASE
of	0
clinical	0
characteristics	I-DISEASE
among	0
narcolepsy	0
with	0
and	0
without	0
cataplexy	0
and	0
idiopathic	0
hypersomnia	I-DISEASE
without	0
long	0
sleep	0
time	0
,	0
focusing	0
on	0
HLA	0
-	0
DRB1(*)1501	0
/	I-DISEASE
DQB1(*)0602	I-DISEASE
finding	I-DISEASE
.	0

Sleep	0
Med	0
2009;10:961–6	I-DISEASE
.	0

Silber	0
MH	0
,	0
Krahn	I-DISEASE
LE	0
,	0
Olson	I-DISEASE
EJ	0
,	I-DISEASE
Pankratz	0
VS	I-DISEASE
.	0

The	0
epidemiology	0
of	0
narcolepsy	0
in	0
Olmsted	0
County	I-DISEASE
,	0
Minnesota	0
:	0
a	0
population	0
-	0
based	0
study	I-DISEASE
.	I-DISEASE

Sleep	0
2002;25:197–202	0
.	0

Takei	0
Y	0
,	0
Komada	0
Y	0
,	0
Namba	I-DISEASE
K	0
,	I-DISEASE
et	0
al	0
.	0

Differences	0
in	0
findings	I-DISEASE
of	I-DISEASE
nocturnal	0
polysomnography	0
and	I-DISEASE
multiple	I-DISEASE
sleep	I-DISEASE
latency	0
test	0
between	0
narcolepsy	0
and	0
idiopathic	I-DISEASE
hypersomnia	I-DISEASE
.	0

Clin	0
Neurophysiol	I-DISEASE
2012;123:137–41	0
.	0

Thannickal	0
TC	0
,	0
Nienhuis	0
R	0
,	0
Siegel	I-DISEASE
JM	0
.	0

Localized	0
loss	0
of	0
hypocretin	0
(	0
orexin	0
)	0
cells	0
in	I-DISEASE
narcolepsy	0
without	0
cataplexy	0
.	I-DISEASE

Sleep	0
2009;32:993–8	0
.	0

Idiopathic	0
Hypersomnia	0
ICD-9	0
-	0
CM	0
code	0
:	I-DISEASE
327.11	0
Alternate	I-DISEASE
Names	0
Idiopathic	0
CNS	0
hypersomnolence	0
.	0

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
F	I-DISEASE
must	I-DISEASE
be	0
met	I-DISEASE
ICD-10	0
-	0
CM	0
code	I-DISEASE
:	0
G47.11	0
Central	I-DISEASE
Disorders	0
of	0
Hypersomnolence	0
A.	0

The	0
patient	0
has	0
daily	0
periods	0
of	0
irrepressible	I-DISEASE
need	I-DISEASE
to	0
sleep	0
or	0
daytime	0
lapses	0
into	0
sleep	I-DISEASE
occurring	0
for	0
at	I-DISEASE
least	0
three	I-DISEASE
months.1	0
B.	0
Cataplexy	I-DISEASE
is	I-DISEASE
absent	0
.	0

C.	0
An	I-DISEASE
MSLT	0
performed	0
according	0
to	0
standard	0
techniques	0
shows	I-DISEASE
fewer	0
than	0
two	0
sleep	0
onset	0
REM	I-DISEASE
periods	I-DISEASE
or	0
no	I-DISEASE
sleep	0
onset	0
REM	0
periods	0
if	I-DISEASE
the	0
REM	I-DISEASE
latency	0
on	0
the	0
preceding	I-DISEASE
polysomnogram	0
was	0
less	0
than	0
or	0
equal	I-DISEASE
to	0
15	0
minutes.2	I-DISEASE
D.	0
The	0
presence	I-DISEASE
of	0
at	I-DISEASE
least	0
one	0
of	0
the	I-DISEASE
following	I-DISEASE
:	I-DISEASE
.	0

The	0
MSLT	0
shows	0
a	0
mean	0
sleep	I-DISEASE
latency	0
of	I-DISEASE
≤	0
8	0
minutes	0
.	I-DISEASE
.	0

Total	0
24	I-DISEASE
-	I-DISEASE
hour	I-DISEASE
sleep	0
time	I-DISEASE
is	0
≥	0
660	I-DISEASE
minutes	0
(	0
typically	0
12–14	I-DISEASE
hours)3	0
on	0
24	0
-	I-DISEASE
hour	I-DISEASE
polysomnographic	0
monitoring	0
(	0
performed	0
after	0
correction	0
of	I-DISEASE
chronic	0
sleep	0
deprivation	I-DISEASE
)	0
,	0
or	I-DISEASE
by	0
wrist	0
actigraphy	0
in	0
Central	0
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	I-DISEASE
association	0
with	0
a	I-DISEASE
sleep	0
log	0
(	0
averaged	0
over	I-DISEASE
at	I-DISEASE
least	0
seven	0
days	0
with	0
unrestricted	I-DISEASE
sleep).4	0
E.	0
Insufficient	0
sleep	0
syndrome	0
is	0
ruled	I-DISEASE
out	0
(	0
if	0
deemed	0
necessary	I-DISEASE
,	I-DISEASE
by	0
lack	I-DISEASE
of	0
improvement	I-DISEASE
of	I-DISEASE
sleepiness	0
after	I-DISEASE
an	I-DISEASE
adequate	0
trial	0
of	0
increased	I-DISEASE
nocturnal	I-DISEASE
time	0
in	I-DISEASE
bed	I-DISEASE
,	0
preferably	0
confirmed	0
by	I-DISEASE
at	0
least	I-DISEASE
a	I-DISEASE
week	I-DISEASE
of	0
wrist	I-DISEASE
actigraphy	I-DISEASE
)	0
.	I-DISEASE

F.	0

The	0
hypersomnolence	0
and/or	0
MSLT	0
findings	0
are	0
not	I-DISEASE
better	0
explained	I-DISEASE
by	0
another	0
sleep	0
disorder	0
,	0
other	I-DISEASE
medical	0
or	I-DISEASE
psychiatric	I-DISEASE
disorder	0
,	0
or	0
use	I-DISEASE
of	0
drugs	0
or	I-DISEASE
medications	0
.	0

Notes	0
.	0

Severe	0
and	0
prolonged	0
sleep	0
inertia	0
,	I-DISEASE
known	0
as	0
sleep	I-DISEASE
drunkenness	0
(	0
defined	0
as	I-DISEASE
prolonged	0
difficulty	0
waking	I-DISEASE
up	0
with	I-DISEASE
repeated	I-DISEASE
returns	I-DISEASE
to	0
sleep	0
,	0
irritability	0
,	I-DISEASE
automatic	0
behavior	I-DISEASE
,	I-DISEASE
and	0
confusion	I-DISEASE
)	I-DISEASE
and/or	0
long	0
(	0
>	0
1	0
hour	0
)	I-DISEASE
,	I-DISEASE
unrefreshing	0
naps	0
are	0
additional	0
supportive	0
clinical	0
features	0
.	I-DISEASE
.	I-DISEASE

A	0
high	0
sleep	0
efficiency	I-DISEASE
(	0
≥	I-DISEASE
90	0
%	0
)	0
on	I-DISEASE
the	0
preceding	0
polysomnogram	0
is	0
a	I-DISEASE
supportive	0
finding	0
(	I-DISEASE
as	0
long	0
as	0
sleep	0
insufficiency	0
is	0
ruled	0
out	0
)	0
.	I-DISEASE
.	0

The	0
total	0
24	I-DISEASE
-	I-DISEASE
hour	0
sleep	0
time	I-DISEASE
required	0
for	I-DISEASE
diagnosis	0
may	0
need	0
to	I-DISEASE
be	0
adapted	I-DISEASE
to	I-DISEASE
account	0
for	I-DISEASE
normal	0
changes	0
in	0
sleep	0
time	I-DISEASE
associated	0
with	I-DISEASE
stages	0
of	0
development	I-DISEASE
in	0
children	0
and	I-DISEASE
adolescents	I-DISEASE
as	0
well	0
as	0
for	0
variability	0
across	I-DISEASE
cultures	I-DISEASE
in	I-DISEASE
all	0
age	I-DISEASE
groups	0
.	0
.	0

Occasionally	0
,	0
patients	0
fulfilling	I-DISEASE
other	0
criteria	I-DISEASE
may	I-DISEASE
have	0
an	0
MSLT	0
mean	0
sleep	0
latency	0
longer	I-DISEASE
than	0
8	0
minutes	0
and	I-DISEASE
total	0
24	0
-	0
hour	0
sleep	I-DISEASE
time	I-DISEASE
shorter	I-DISEASE
than	I-DISEASE
660	0
minutes	0
.	0

Clinical	0
judgment	0
should	0
be	0
used	I-DISEASE
in	I-DISEASE
deciding	0
if	0
these	0
patients	0
should	0
be	0
considered	I-DISEASE
to	0
have	0
idiopathic	0
hypersomnia	0
(	I-DISEASE
IH	0
)	0
.	0

Great	0
caution	0
should	0
be	0
exercised	0
to	0
exclude	I-DISEASE
other	0
conditions	I-DISEASE
that	0
might	0
mimic	0
the	0
disorder	I-DISEASE
.	I-DISEASE

A	0
repeat	0
MSLT	0
at	0
a	0
later	I-DISEASE
date	I-DISEASE
is	0
advisable	0
if	0
the	0
clinical	0
suspicion	0
for	0
IH	I-DISEASE
remains	0
high	0
.	0

Essential	0
Features	I-DISEASE
IH	0
is	0
characterized	0
by	0
excessive	I-DISEASE
daytime	0
sleepiness	I-DISEASE
that	0
occurs	I-DISEASE
in	0
the	I-DISEASE
absence	0
of	0
cat-	I-DISEASE
aplexy	0
,	I-DISEASE
is	I-DISEASE
accompanied	0
by	0
no	0
more	0
than	0
one	I-DISEASE
SOREMP	I-DISEASE
on	0
MSLT	I-DISEASE
and	0
preceding	0
poly-	0
somnogram	I-DISEASE
combined	0
,	0
and	0
is	0
not	0
adequately	I-DISEASE
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
disorder	I-DISEASE
.	0

Other	0
dis-	0
orders	0
causing	I-DISEASE
sleepiness	0
must	0
be	I-DISEASE
carefully	I-DISEASE
considered	0
and	0
excluded	0
,	0
especially	0
insuf-	0
ficient	I-DISEASE
sleep	0
syndrome	0
.	0

Objective	0
evidence	0
of	0
hypersomnolence	I-DISEASE
must	0
be	I-DISEASE
demonstrated	I-DISEASE
by	0
an	I-DISEASE
MSLT	0
showing	0
a	0
mean	I-DISEASE
sleep	0
latency	I-DISEASE
of	0
≤	0
8	I-DISEASE
minutes	0
or	0
by	0
polysomnography	0
or	0
wrist	I-DISEASE
actigraphy	0
showing	0
a	0
total	I-DISEASE
24	0
-	0
hour	0
sleep	I-DISEASE
time	0
of	0
≥	0
660	0
minutes	0
.	I-DISEASE

A	0
prolonged	0
and	0
severe	0
form	0
of	0
sleep	I-DISEASE
inertia	I-DISEASE
,	0
historically	0
known	0
as	0
sleep	0
drunkenness	0
,	I-DISEASE
consists	I-DISEASE
of	0
prolonged	I-DISEASE
difficulty	0
waking	0
up	0
with	0
repeated	I-DISEASE
returns	0
to	I-DISEASE
sleep	0
,	0
irritability	I-DISEASE
,	0
automatic	I-DISEASE
behavior	0
,	I-DISEASE
and	0
confusion	0
.	0

It	0
is	0
reported	0
in	0
36	0
%	0
to	0
66	0
%	I-DISEASE
of	0
patients	0
with	I-DISEASE
IH	0
in	0
differ-	0
ent	0
series	0
.	I-DISEASE

Subjects	0
typically	0
do	0
not	0
easily	0
awaken	I-DISEASE
to	0
alarm	0
clocks	0
and	0
frequently	0
use	0
special	0
devices	0
or	I-DISEASE
procedures	0
to	0
wake	0
up	0
.	0

Naps	0
are	0
generally	0
long	0
,	I-DISEASE
often	0
more	I-DISEASE
than	0
60	0
minutes	0
,	0
and	0
described	0
as	0
unrefreshing	I-DISEASE
by	0
46	0
%	0
to	0
78	0
%	0
of	0
patients	0
.	0

Sleep	0
efficiency	0
on	I-DISEASE
polysomnogram	0
is	0
usually	I-DISEASE
high	I-DISEASE
(	0
mean	I-DISEASE
90	0
%	0
to	0
94	I-DISEASE
%	0
)	0
.	0

Self	0
-	0
reported	0
total	0
sleep	0
time	I-DISEASE
is	0
longer	0
than	I-DISEASE
in	0
controls	0
and	0
is	0
≥	0
10	0
hours	I-DISEASE
in	I-DISEASE
at	0
least	0
30	I-DISEASE
%	0
of	0
patients	0
.	I-DISEASE

Associated	0
Features	0
Associated	0
symptoms	I-DISEASE
which	0
suggest	I-DISEASE
a	0
dysfunction	0
of	0
the	0
autonomic	0
nervous	0
system	I-DISEASE
may	0
be	I-DISEASE
present	I-DISEASE
.	0

These	0
symptoms	0
include	0
headache	I-DISEASE
,	I-DISEASE
orthostatic	I-DISEASE
disturbance	0
,	0
perception	I-DISEASE
of	0
temperature	0
dysregulation	0
,	0
and	0
peripheral	I-DISEASE
vascular	0
complaints	0
(	I-DISEASE
Raynaud	0
-	0
type	0
phe-	0
nomena	0
with	0
cold	I-DISEASE
hands	I-DISEASE
and	0
feet	I-DISEASE
)	I-DISEASE
.	I-DISEASE

Sleep	0
paralysis	0
and	0
hypnagogic	0
hallucinations	0
may	0
also	0
be	I-DISEASE
reported	I-DISEASE
,	0
but	0
the	0
frequency	I-DISEASE
is	0
uncertain	I-DISEASE
(	0
4	0
%	I-DISEASE
to	0
40	0
%	0
in	0
different	0
series	0
)	0
.	0

Clinical	0
and	0
Pathologic	0
Subtypes	I-DISEASE
The	0
2005	0
2nd	0
edition	0
of	I-DISEASE
the	0
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	0
Disorders	I-DISEASE
divided	0
IH	0
into	I-DISEASE
two	0
disorders	0
:	0
IH	0
with	0
long	0
sleep	I-DISEASE
time	0
,	0
and	I-DISEASE
IH	0
without	0
long	0
sleep	0
time	0
.	0

IH	0
is	0
likely	0
a	0
heterogeneous	0
condition	I-DISEASE
,	0
the	0
pathophysiology	I-DISEASE
of	I-DISEASE
which	0
is	0
currently	I-DISEASE
unknown	0
.	I-DISEASE

However	0
,	0
recent	0
studies	0
suggest	0
that	0
a	I-DISEASE
division	0
of	0
the	0
disorder	0
based	0
on	0
the	0
length	I-DISEASE
of	0
nocturnal	0
sleep	I-DISEASE
lacks	0
validity	0
.	0

Comparison	0
of	0
patients	0
with	I-DISEASE
≥	0
10	I-DISEASE
hours	I-DISEASE
of	0
sleep	I-DISEASE
to	0
those	I-DISEASE
with	0
<	I-DISEASE
10	0
hours	0
show	0
no	I-DISEASE
differences	I-DISEASE
in	0
Epworth	0
Sleepiness	0
Scale	0
scores	0
,	I-DISEASE
MSLT	I-DISEASE
mean	0
sleep	I-DISEASE
latencies	0
,	0
or	0
percentage	0
with	0
sleep	0
drunkenness	0
,	0
unrefreshing	0
naps	0
,	I-DISEASE
hypnago-	0
gic	I-DISEASE
hallucinations	0
,	I-DISEASE
or	0
sleep	0
paralysis	0
.	0

The	0
only	0
reported	0
differences	0
are	0
that	0
the	I-DISEASE
group	I-DISEASE
with	I-DISEASE
long	0
sleep	0
is	I-DISEASE
somewhat	0
younger	0
and	I-DISEASE
thinner	I-DISEASE
,	0
with	I-DISEASE
lower	0
Horne	0
-	0
Ostberg	0
scores	0
and	I-DISEASE
marginally	0
higher	0
sleep	I-DISEASE
efficiency	0
.	0

If	0
MSLT	0
mean	0
sleep	0
latencies	0
are	I-DISEASE
not	0
used	0
as	0
a	I-DISEASE
diagnostic	0
criterion	0
,	0
the	0
distribution	0
of	0
latencies	I-DISEASE
is	0
unimodal	0
,	0
suggesting	0
no	0
sepa-	0
rate	0
subtypes	I-DISEASE
.	0

In	0
addition	0
,	0
an	0
actigraphy	0
study	I-DISEASE
has	I-DISEASE
shown	0
that	I-DISEASE
patients	0
with	0
IH	0
tend	I-DISEASE
to	0
overestimate	0
their	0
sleep	0
time	I-DISEASE
by	0
a	I-DISEASE
mean	0
of	0
0.99	I-DISEASE
hours	0
,	I-DISEASE
thus	I-DISEASE
making	0
the	I-DISEASE
fundamental	I-DISEASE
criterion	0
for	I-DISEASE
distinguishing	I-DISEASE
between	0
patients	0
with	0
long	I-DISEASE
and	I-DISEASE
shorter	0
sleep	0
inaccurate	0
.	0

Clinicians	0
may	0
wish	0
to	0
continue	0
to	0
note	0
sleep	0
duration	I-DISEASE
as	I-DISEASE
an	0
important	0
clinical	I-DISEASE
feature	I-DISEASE
,	I-DISEASE
but	0
the	0
caveats	0
discussed	I-DISEASE
above	0
should	0
be	0
clearly	0
considered	0
.	I-DISEASE

Any	0
future	0
separation	0
of	0
IH	0
into	0
distinct	0
conditions	0
must	0
await	0
advances	0
in	0
understanding	0
the	0
underlying	0
biology	0
.	0

Demographics	0
Prevalence	0
and	0
incidence	0
of	0
IH	I-DISEASE
are	I-DISEASE
not	0
known	I-DISEASE
.	0

Some	0
studies	0
have	0
suggested	0
a	0
higher	I-DISEASE
prevalence	I-DISEASE
in	I-DISEASE
women	0
.	0

Central	0
Disorders	0
of	0
Hypersomnolence	0
Central	0
Disorders	I-DISEASE
of	0
Hypersomnolence	0
Predisposing	I-DISEASE
and	0
Precipitating	0
Factors	0

In	0
contrast	0
to	0
narcolepsy	0
,	0
the	0
disorder	I-DISEASE
is	0
not	I-DISEASE
known	I-DISEASE
to	0
be	0
HLA	I-DISEASE
associated	0
,	0
and	I-DISEASE
no	0
con-	0
sistent	0
precipitating	0
factor	0
has	0
been	0
identified	0
.	0

Familial	0
Patterns	0

A	0
familial	0
predisposition	0
to	0
hypersomnia	0
has	0
been	0
reported	0
but	I-DISEASE
rigorous	0
studies	0
have	0
not	0
been	0
performed	0
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
The	I-DISEASE
mean	0
age	I-DISEASE
of	0
onset	I-DISEASE
of	0
IH	0
in	0
different	I-DISEASE
series	0
is	0
16.6–21.2	0
years	0
.	0

Once	0
established	0
,	0
the	0
disorder	I-DISEASE
is	I-DISEASE
generally	I-DISEASE
stable	I-DISEASE
in	I-DISEASE
severity	0
and	0
long	0
lasting	0
,	0
although	I-DISEASE
a	0
spontaneous	0
remission	I-DISEASE
rate	0
of	I-DISEASE
14	0
%	0
has	0
been	0
reported	0
in	0
one	0
series	0
.	0

Complications	0
are	0
mostly	0
social	0
and	I-DISEASE
professional	0
,	0
and	0
include	I-DISEASE
poor	0
work	0
or	I-DISEASE
school	0
performance	0
,	I-DISEASE
reduced	0
earnings	0
,	I-DISEASE
and	0
loss	I-DISEASE
of	0
employment	0
.	I-DISEASE

Developmental	0
Issues	0
IH	0
frequently	I-DISEASE
develops	0
in	0
adolescence	0
.	0

Exclusion	0
of	0
other	0
causes	I-DISEASE
of	0
hypersomno-	0
lence	I-DISEASE
in	0
that	I-DISEASE
age	0
group	0
,	0
including	0
delayed	0
sleep	I-DISEASE
-	0
wake	0
phase	I-DISEASE
disorder	0
,	0
obstructive	0
sleep	0
apnea	0
,	I-DISEASE
insufficient	I-DISEASE
sleep	I-DISEASE
syndrome	0
,	I-DISEASE
and	0
use	0
of	0
recreational	0
drugs	0
,	0
is	0
essential	I-DISEASE
.	0

Early	0
in	0
the	0
development	I-DISEASE
of	0
narcolepsy	I-DISEASE
,	0
SOREMPs	0
may	I-DISEASE
not	0
be	0
present	0
on	0
MSLT	0
;	I-DISEASE
therefore	0
,	I-DISEASE
some	I-DISEASE
patients	0
may	0
need	0
to	0
be	0
reclassified	I-DISEASE
later	I-DISEASE
as	0
narcolepsy	I-DISEASE
type	B-DISEASE
2	0
.	0

If	0
the	0
24	I-DISEASE
-	I-DISEASE
hour	0
total	0
sleep	I-DISEASE
time	I-DISEASE
is	I-DISEASE
used	0
to	I-DISEASE
confirm	0
the	I-DISEASE
diagnosis	I-DISEASE
of	I-DISEASE
IH	I-DISEASE
in	0
a	I-DISEASE
child	0
or	0
adolescent	0
,	0
normal	0
values	0
may	I-DISEASE
need	I-DISEASE
to	0
be	I-DISEASE
adapted	0
to	I-DISEASE
account	I-DISEASE
for	0
changes	0
in	0
sleep	0
time	0
associated	I-DISEASE
with	0
stages	0
of	0
development	0
.	I-DISEASE

Pathology	0
and	0
Pathophysiology	0
The	0
pathophysiology	0
of	I-DISEASE
IH	I-DISEASE
is	0
unknown	I-DISEASE
.	0

Neurochemical	0
studies	0
measuring	0
monoamine	0
metabolites	0
in	0
the	I-DISEASE
CSF	0
have	I-DISEASE
been	0
inconclusive	0
.	0

CSF	0
hypocretin-1	I-DISEASE
concentrations	0
in	I-DISEASE
patients	0
with	0
IH	I-DISEASE
are	0
normal	I-DISEASE
.	0

CSF	0
histamine	I-DISEASE
levels	0
have	0
been	0
reported	0
to	0
be	0
low	0
in	0
patients	0
with	0
narcolepsy	0
and	0
IH	0
,	0
but	0
a	0
recent	0
study	0
did	0
not	0
confirm	0
these	0
findings	I-DISEASE
.	0

Objective	0
Findings	0
Polysomnographic	0
monitoring	I-DISEASE
generally	0
demonstrates	I-DISEASE
NREM	0
and	0
REM	I-DISEASE
sleep	0
in	0
expected	0
proportions	I-DISEASE
with	0
normal	0
REM	0
latency	0
.	I-DISEASE

Total	0
sleep	0
time	0
is	0
often	0
prolonged	0
.	I-DISEASE

Sleep	0
apnea	0
should	0
be	I-DISEASE
either	0
absent	0
or	I-DISEASE
adequately	0
treated	I-DISEASE
before	0
diagnosing	0
this	I-DISEASE
disor-	I-DISEASE
der	0
,	I-DISEASE
with	0
special	0
attention	0
paid	0
to	0
excluding	0
significant	0
respiratory	0
effort	0
related	I-DISEASE
arous-	0
als	0
.	I-DISEASE

The	0
MSLT	0
should	0
not	0
show	0
more	I-DISEASE
than	0
one	0
SOREMP	I-DISEASE
(	0
or	0
none	0
if	0
a	0
SOREMP	I-DISEASE
was	0
observed	0
on	0
the	0
preceding	0
night	0
’s	0
polysomnogram	0
(	I-DISEASE
PSG	I-DISEASE
)	0
)	I-DISEASE
.	I-DISEASE

The	0
mean	0
sleep	0
latency	I-DISEASE
on	0
the	0
MSLT	0
is	I-DISEASE
usually	I-DISEASE
shorter	0
than	0
in	0
controls	0
but	0
longer	0
than	I-DISEASE
in	0
most	I-DISEASE
patients	0
with	0
nar-	0
colepsy	I-DISEASE
,	0
averaging	0
8.3	0
and	0
7.8	0
minutes	0
in	0
two	0
large	0
studies	0
.	0

In	0
patients	0
with	I-DISEASE
MSLT	0
mean	0
latencies	0
>	0
8	0
minutes	I-DISEASE
,	0
prolonged	0
sleep	0
monitoring	0
should	I-DISEASE
be	I-DISEASE
performed	0
by	0
polysomnography	I-DISEASE
(	0
24	0
hours	0
)	0
or	0
wrist	0
actigraphy	I-DISEASE
(	I-DISEASE
7	I-DISEASE
days	I-DISEASE
with	I-DISEASE
unre-	I-DISEASE
stricted	0
sleep	0
)	0
after	0
correction	0
of	0
sleep	I-DISEASE
deprivation	0
,	0
exclusion	0
of	0
other	I-DISEASE
sleep	0
disorders	0
,	I-DISEASE
and	I-DISEASE
discontinuation	I-DISEASE
of	I-DISEASE
sedating	I-DISEASE
medication	I-DISEASE
as	I-DISEASE
required	I-DISEASE
for	I-DISEASE
an	0
MSLT	0
(	0
see	0
Narcolepsy	I-DISEASE
–	0
Objective	0
Findings	I-DISEASE
)	0
.	I-DISEASE

Total	0
24	I-DISEASE
-	I-DISEASE
hour	I-DISEASE
sleep	0
time	I-DISEASE
in	0
adults	0
(	I-DISEASE
major	0
sleep	0
episode	I-DISEASE
plus	0
naps	0
)	0
must	I-DISEASE
be	I-DISEASE
≥	0
660	0
minutes	0
(	0
note	0
that	0
the	I-DISEASE
use	I-DISEASE
of	I-DISEASE
24	0
-	I-DISEASE
hour	I-DISEASE
PSG	0
monitoring	0
for	I-DISEASE
the	0
diagnosis	0
of	0
IH	I-DISEASE
has	0
been	I-DISEASE
validated	0
against	0
controls	0
,	0
but	0
the	0
use	0
of	I-DISEASE
seven	I-DISEASE
days	0
of	I-DISEASE
actigraphic	0
mon-	0
itoring	0
still	I-DISEASE
awaits	I-DISEASE
validation	0
)	I-DISEASE
.	0

Differential	0
Diagnosis	0
IH	0
may	0
be	0
confused	I-DISEASE
with	I-DISEASE
OSA	0
,	I-DISEASE
especially	I-DISEASE
when	0
respiratory	0
-	0
related	0
arousals	I-DISEASE
(	0
rather	0
than	I-DISEASE
apneas	0
or	I-DISEASE
hypopneas	0
)	0
are	0
present	I-DISEASE
.	0

Narcolepsy	0
type	0
2	0
is	0
distinguished	0
from	I-DISEASE
IH	I-DISEASE
by	0
the	I-DISEASE
presence	0
of	0
two	0
or	0
more	I-DISEASE
sleep	0
onset	0
REM	0
periods	0
on	0
the	I-DISEASE
MSLT	0
or	0
preceding	0
PSG	0
.	I-DISEASE

Insufficient	0
sleep	0
syndrome	0
must	0
be	0
carefully	I-DISEASE
excluded	I-DISEASE
by	0
extending	I-DISEASE
the	0
patient	0
’s	0
sleep	0
before	0
testing	I-DISEASE
.	0

Historical	0
information	0
,	0
physical	0
examination	0
,	0
and	I-DISEASE
,	0
if	I-DISEASE
indicated	0
,	0
laboratory	0
testing	0
including	0
brain	I-DISEASE
imaging	0
should	0
help	I-DISEASE
rule	0
out	0
hypersomnolence	0
due	0
to	0
a	0
medical	0
disorder	0
.	0

In	0
particular	0
,	0
posttraumatic	0
hypersomnolence	0
,	I-DISEASE
residual	I-DISEASE
hyper-	I-DISEASE
somnolence	I-DISEASE
following	0
adequate	0
treatment	0
of	0
sleep	0
apnea	I-DISEASE
,	0
and	0
sleep	I-DISEASE
fragmentation	0
due	0
to	0
pain	0
may	0
mimic	0
IH	I-DISEASE
.	I-DISEASE

Hypersomnolence	0
due	0
to	0
a	0
medication	0
or	0
substance	I-DISEASE
must	0
be	0
considered	0
and	0
ruled	0
out	0
by	0
discontinuation	0
of	I-DISEASE
possible	0
causative	I-DISEASE
agents	0
,	0
if	0
clinically	0
appropriate	0
.	0

Hypersomnia	0
associated	0
with	0
a	0
psychiatric	0
disorder	I-DISEASE
should	I-DISEASE
be	0
consid-	I-DISEASE
ered	0
in	0
patients	0
with	I-DISEASE
a	I-DISEASE
psychiatric	0
condition	0
,	0
most	I-DISEASE
typically	0
depression	0
.	0

The	0
complaint	0
of	I-DISEASE
excessive	0
sleepiness	0
and	I-DISEASE
prolonged	0
sleep	0
may	I-DISEASE
be	I-DISEASE
rather	0
similar	0
to	0
that	0
of	I-DISEASE
patients	0
with	0
IH	I-DISEASE
,	0
except	0
that	0
it	0
may	0
vary	I-DISEASE
from	0
day	0
to	I-DISEASE
day	0
and	0
is	0
often	0
associated	I-DISEASE
with	0
poor	0
sleep	0
at	0
night	0
.	I-DISEASE

The	0
MSLT	0
in	0
hypersomnia	0
associated	0
with	0
a	0
psychiatric	0
disorder	0
does	0
not	0
demonstrate	0
a	0
short	0
mean	I-DISEASE
sleep	0
latency	I-DISEASE
.	I-DISEASE

Chronic	0
fatigue	0
syndrome	0
is	0
character-	0
ized	0
by	I-DISEASE
persistent	0
or	I-DISEASE
relapsing	0
fatigue	0
that	0
does	0
not	0
resolve	I-DISEASE
with	0
sleep	0
or	I-DISEASE
rest	0
.	I-DISEASE

Patients	0
clearly	0
complain	0
of	0
fatigue	0
rather	I-DISEASE
than	0
excessive	0
daytime	0
sleepiness	0
,	0
and	0
the	0
mean	0
MSLT	I-DISEASE
sleep	I-DISEASE
latency	0
is	0
normal	0
.	0

Long	0
sleepers	0
feel	I-DISEASE
fully	I-DISEASE
refreshed	0
and	0
do	I-DISEASE
not	0
experience	I-DISEASE
daytime	0
sleepiness	0
if	0
they	I-DISEASE
are	0
allowed	I-DISEASE
to	I-DISEASE
sleep	0
as	0
long	0
as	0
they	0
need	0
,	I-DISEASE
in	I-DISEASE
contrast	0
with	0
patients	0
with	I-DISEASE
IH	0
who	0
continue	0
to	0
feel	0
sleepy	0
regardless	0
of	0
prior	0
sleep	0
duration	0
.	0

Unresolved	0
Issues	0
and	0
Future	0
Directions	I-DISEASE

There	0
is	0
a	0
paucity	0
of	0
knowledge	0
regarding	I-DISEASE
the	0
neurobiology	I-DISEASE
of	0
IH	0
.	0

Further	0
research	0
in	0
this	0
area	0
,	I-DISEASE
as	I-DISEASE
well	0
as	I-DISEASE
more	0
precise	0
characterization	0
of	0
clinical	0
characteristics	I-DISEASE
and	I-DISEASE
treat-	0
ment	0
response	0
,	0
is	0
required	0
.	0

Central	0
Disorders	0
of	0
Hypersomnolence	0
Central	0
Disorders	I-DISEASE
of	0
Hypersomnolence	0
Bibliography	I-DISEASE
Ali	0
M	0
,	0
Auger	I-DISEASE
RR	0
,	I-DISEASE
Slocumb	0
NL	0
,	I-DISEASE
Morgenthaler	0
TI	0
.	0

Idiopathic	0
hypersomnia	0
:	0
clinical	0
features	0
and	0
response	I-DISEASE
to	0
treatment	I-DISEASE
.	0

J	0
Clin	0
Sleep	I-DISEASE
Med	0
2009;5:562–8	0
.	I-DISEASE

Anderson	0
KN	0
,	0
Pilsworth	0
S	0
,	I-DISEASE
Sharples	0
RD	0
,	I-DISEASE
Smith	0
IE	0
,	0
Shneerson	0
JM	0
.	I-DISEASE

Idiopathic	0
hypersomnia	0
:	0
a	0
study	0
of	0
77	I-DISEASE
cases	0
.	I-DISEASE

Sleep	0
2007;30:1274–81	0
.	0

Bassetti	0
C	0
,	0
Aldrich	0
MS	0
.	0

Idiopathic	0
hypersomnia	0
:	0
a	0
series	0
of	0
42	I-DISEASE
patients	0
.	I-DISEASE

Brain	0
1997;120:1423–35	0
.	0

Dauvilliers	0
Y	0
,	0
Delallee	0
N	0
,	0
Jaussent	I-DISEASE
I	0
,	I-DISEASE
et	0
al	0
.	0

Normal	0
cerebrospinal	0
fluid	I-DISEASE
histamine	0
and	0
tele	0
-	I-DISEASE
methylhistamine	0
levels	I-DISEASE
in	0
hypersomnia	0
conditions	0
.	0

Sleep	0
2012;35:1359–66	0
.	0

Kanbayashi	0
T	0
,	0
Kodama	0
T	0
,	0
Kondo	0
H	0
,	I-DISEASE
et	0
al	0
.	0

CSH	0
histamine	I-DISEASE
contents	0
in	0
narcolepsy	0
,	0
idiopathic	0
hypersomnia	0
and	I-DISEASE
obstructive	0
sleep	0
apnea	0
syndrome	I-DISEASE
.	0

Sleep	0
2009;32:181–7	0
.	0

Vernet	0
C	0
,	0
Arnulf	0
I.	I-DISEASE
Idiopathic	0
hypersomnia	I-DISEASE
with	0
and	I-DISEASE
without	0
long	0
sleep	0
time	0
:	0
a	I-DISEASE
controlled	0
series	0
of	0
75	0
patients	0
.	0

Sleep	0
2009;32:753–9	0
.	0

Vernet	0
C	0
,	0
Leu	0
-	I-DISEASE
Semenescu	0
S	I-DISEASE
,	0
Buzare	I-DISEASE
MA	0
,	0
Arnulf	0
I.	0
Subjective	0
sleepiness	I-DISEASE
in	0
idiopathic	0
hypersomnia	I-DISEASE
:	0
beyond	0
excessive	0
sleepiness	0
.	0

J	0
Sleep	0
Res	0
2010;19:525–34	B-DISEASE
.	0

Kleine	0
-	0
Levin	0
Syndrome	I-DISEASE
ICD-9	0
-	0
CM	0
code	0
:	0
327.13	0
Alternate	0
Names	0
Recurrent	I-DISEASE
hypersomnia	I-DISEASE
,	I-DISEASE
periodic	0
hypersomnolence	0
.	0

Diagnostic	0
Criteria	0
Criteria	0

A	0
-	0
E	0
must	0
be	0
met	0
ICD-10	I-DISEASE
-	0
CM	0
code	0
:	0

G47.13	0
A.	0

The	0
patient	0
experiences	0
at	0
least	I-DISEASE
two	I-DISEASE
recurrent	I-DISEASE
episodes	0
of	I-DISEASE
excessive	0
sleepiness	0
and	I-DISEASE
sleep	I-DISEASE
duration	0
,	I-DISEASE
each	I-DISEASE
persisting	0
for	I-DISEASE
two	0
days	0
to	0
five	I-DISEASE
weeks	0
.	0

B.	0
Episodes	0
recur	0
usually	0
more	0
than	0
once	0
a	0
year	I-DISEASE
and	0
at	0
least	0
once	0
every	0
18	I-DISEASE
months	I-DISEASE
.	I-DISEASE

C.	0

The	0
patient	0
has	0
normal	0
alertness	0
,	0
cognitive	0
function	0
,	I-DISEASE
behavior	0
,	0
and	0
mood	0
between	0
episodes	I-DISEASE
.	0

D.	0

The	0
patient	0
must	0
demonstrate	0
at	0
least	I-DISEASE
one	I-DISEASE
of	0
the	I-DISEASE
following	I-DISEASE
during	0
episodes	0
:	0
.	0

Cognitive	0
dysfunction	0
.	0
.	0

Altered	0
perception	0
.	0
.	0

Eating	0
disorder	0
(	0
anorexia	0
or	0
hyperphagia	I-DISEASE
)	I-DISEASE
.	0
.	0

Disinhibited	0
behavior	0
(	0
such	0
as	0
hypersexuality	0
)	I-DISEASE
.	0

E.	0

The	0
hypersomnolence	0
and	0
related	0
symptoms	0
are	0
not	I-DISEASE
better	0
explained	I-DISEASE
by	0
another	I-DISEASE
sleep	0
disorder	0
,	I-DISEASE
other	I-DISEASE
medical	0
,	0
neurologic	I-DISEASE
,	I-DISEASE
or	0
psychiatric	0
disorder	0
(	0
especially	0
bipolar	I-DISEASE
disorder	0
)	0
,	0
or	0
use	0
of	0
drugs	I-DISEASE
or	0
medications	0
.	0

Essential	0
Features	0
Kleine	0
-	I-DISEASE
Levin	I-DISEASE
syndrome	I-DISEASE
is	I-DISEASE
characterized	0
by	I-DISEASE
relapsing	0
-	0
remitting	0
episodes	I-DISEASE
of	0
severe	I-DISEASE
hypersomnolence	0
in	0
association	I-DISEASE
with	0
cognitive	I-DISEASE
,	0
psychiatric	0
,	0
and	0
behavioral	0
distur-	0
bances	0
.	I-DISEASE

A	0
typical	0
episode	0
lasts	0
a	0
median	0
10	I-DISEASE
days	0
(	0
range	0
,	0
2.5–80	0
days	I-DISEASE
)	0
,	0
with	0
rare	0
epi-	B-DISEASE
sodes	0
lasting	0
several	0
weeks	0
to	0
months	0
.	I-DISEASE

The	0
first	0
episode	0
is	0
often	0
triggered	I-DISEASE
by	I-DISEASE
an	0
infec-	I-DISEASE
tion	0
or	0
alcohol	0
intake	I-DISEASE
,	0
with	0
further	0
episodes	0
recurring	0
every	0
1–12	0
months	0
(	0
median	0
three	0
months	0
)	0
for	0
years	0
.	0

During	0
episodes	0
,	0
patients	0
may	0
sleep	0
as	I-DISEASE
long	0
as	0
16	0
to	0
20	0
hours	0
per	0
day	I-DISEASE
,	0
waking	0
or	I-DISEASE
getting	0
up	0
only	0
to	0
eat	0
and	0
void	I-DISEASE
(	0
incontinence	0
is	0
not	0
observed	0
)	0
.	0

They	0
remain	0
rousable	0
,	0
but	I-DISEASE
are	0
irritable	I-DISEASE
if	0
prevented	0
from	0
sleeping	0
.	0

When	0
they	0
are	0
awake	0
during	0
episodes	I-DISEASE
,	I-DISEASE
most	0
patients	0
are	I-DISEASE
exhausted	0
,	I-DISEASE
apathetic	0
,	0
confused	I-DISEASE
,	0
and	0
slow	B-DISEASE
in	0
speaking	I-DISEASE
and	0
answering	0
.	0

Anterograde	0
amnesia	0
is	0
typical	0
.	0

Almost	0
all	0
report	0
a	0
dreamlike	0
,	0
altered	0
perception	0
of	I-DISEASE
the	0
environment	0
(	0
derealization	0
)	0
.	0

Less	0
commonly	0
,	0
patients	0
eat	I-DISEASE
ravenously	I-DISEASE
(	I-DISEASE
66	0
%	I-DISEASE
,	0
although	0
one	0
third	0
eat	0
less	I-DISEASE
)	0
,	0
are	I-DISEASE
hypersexual	I-DISEASE
(	0
53	0
%	0
,	0
principally	I-DISEASE
men	I-DISEASE
)	0
,	0
childish	I-DISEASE
,	0
depressed	0
(	I-DISEASE
53	0
%	0
,	0
predominantly	0
women	0
)	I-DISEASE
,	0
and	0
anxious	0
at	I-DISEASE
being	I-DISEASE
left	I-DISEASE
alone	0
and	I-DISEASE
seeing	0
strangers	I-DISEASE
,	I-DISEASE
and	I-DISEASE
experience	I-DISEASE
hallucinations	0
and	0
delusions	I-DISEASE
(	I-DISEASE
30	0
%	0
)	0
.	I-DISEASE

Patients	0
are	0
remark-	B-DISEASE
ably	0
normal	0
between	I-DISEASE
episodes	I-DISEASE
with	0
regard	I-DISEASE
to	0
sleep	0
,	0
cognition	0
,	0
mood	I-DISEASE
,	0
and	0
eating	I-DISEASE
.	0

The	0
disease	0
typically	0
resolves	0
after	0
a	I-DISEASE
median	I-DISEASE
of	0
14	I-DISEASE
years	0
,	0
except	I-DISEASE
in	0
adult	0
-	0
onset	I-DISEASE
cases	0
,	I-DISEASE
when	0
the	0
course	0
may	0
be	0
more	0
prolonged	I-DISEASE
.	0

The	0
simultaneous	0
occurrence	I-DISEASE
of	0
all	0
these	0
symp-	0
toms	0
is	I-DISEASE
the	I-DISEASE
exception	0
rather	0
than	I-DISEASE
the	0
rule	I-DISEASE
,	0
with	0
hypersomnolence	I-DISEASE
being	I-DISEASE
more	0
char-	0
acteristic	0
at	0
the	0
disease	0
onset	0
and	0
during	I-DISEASE
the	0
first	0
part	0
of	0
the	0
episodes	0
,	0
and	0
disinhib-	0
ited	I-DISEASE
behaviors	I-DISEASE
being	0
evident	0
during	I-DISEASE
only	0
a	I-DISEASE
few	0
episodes	0
.	I-DISEASE

In	0
occasional	0
cases	0
,	B-DISEASE
isolated	0
recurrent	0
hypersomnolence	I-DISEASE
may	0
be	I-DISEASE
the	0
only	0
symptom	0
.	0

Amnesia	0
,	0
transient	0
dysphoria	0
,	0
or	0
elation	0
with	0
insomnia	0
may	0
signal	0
the	0
termination	0
of	0
an	0
episode	0
.	0

Associated	0
Features	0
Physical	0
examination	0
is	0
unremarkable	0
,	0
except	0
for	I-DISEASE
general	0
psychomotor	0
slowing	0
.	0

Social	0
and	0
occupational	0
impairment	I-DISEASE
during	I-DISEASE
attacks	0
is	I-DISEASE
often	I-DISEASE
severe	I-DISEASE
,	0
with	I-DISEASE
teenagers	0
bedridden	0
for	0
days	I-DISEASE
,	0
but	0
can	I-DISEASE
be	0
variable	0
depending	0
on	0
the	0
frequency	I-DISEASE
,	I-DISEASE
severity	I-DISEASE
,	0
and	I-DISEASE
duration	0
of	0
episodes	I-DISEASE
.	0

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Menstrual	I-DISEASE
-	I-DISEASE
related	I-DISEASE
Kleine	I-DISEASE
-	I-DISEASE
Levin	0
syndrome	I-DISEASE
(	0
alternate	I-DISEASE
name	0
:	I-DISEASE
menstrual	I-DISEASE
-	I-DISEASE
related	I-DISEASE
hyper-	0
somnia	0
):	0

This	0
descriptor	0
is	0
used	0
when	0
episodes	0
are	I-DISEASE
exclusively	0
associated	I-DISEASE
with	0
men-	0
struation	0
(	0
occurring	0
just	I-DISEASE
before	0
or	0
during	B-DISEASE
menses	0
)	0
,	0
a	I-DISEASE
condition	0
reported	I-DISEASE
in	0
only	0
18	I-DISEASE
women	I-DISEASE
worldwide	0
.	I-DISEASE

Hypersomnolence	0
episodes	0
in	0
these	0
cases	0
have	I-DISEASE
been	I-DISEASE
associated	0
with	I-DISEASE
compulsive	0
eating	0
in	I-DISEASE
65	0
%	0
,	I-DISEASE
sexual	0
disinhibition	0
in	I-DISEASE
29	0
%	0
,	0
and	0
depressive	0
mood	I-DISEASE
in	0
35	0
%	0
.	0

Episodes	0
last	0
3	0
to	0
15	0
days	0
and	I-DISEASE
recur	0
less	I-DISEASE
than	0
three	0
times	0
a	0
year	0
.	0

One	0
boy	I-DISEASE
with	0
Kleine	0
-	0
Levin	I-DISEASE
syndrome	I-DISEASE
is	0
reported	I-DISEASE
to	0
have	0
a	0
sister	0
affected	0
by	I-DISEASE
menstrual	0
-	0
related	0
hypersomnolence	I-DISEASE
.	0

Menstrual	0
-	0
related	I-DISEASE
hypersomnia	I-DISEASE
may	0
be	I-DISEASE
a	I-DISEASE
variant	I-DISEASE
of	I-DISEASE
Kleine	0
-	0
Levin	0
Central	I-DISEASE
Disorders	0
of	I-DISEASE
Hypersomnolence	0
Central	I-DISEASE
Disorders	I-DISEASE
of	0
Hypersomnolence	I-DISEASE
syndrome	0
,	0
although	0
response	I-DISEASE
to	I-DISEASE
contraceptive	0
doses	0
of	0
estrogen	0
and	0
progesterone	I-DISEASE
,	0
reported	0
in	0
some	0
cases	0
,	0
suggests	I-DISEASE
a	0
reproductive	0
endocrine	0
disturbance	0
.	0

Demographics	0
Kleine	0
-	0
Levin	0
syndrome	0
is	I-DISEASE
rare	I-DISEASE
,	0
with	I-DISEASE
a	I-DISEASE
prevalence	0
estimated	I-DISEASE
around	0
1	0
to	0
2	I-DISEASE
cases	0
per	0
million	0
.	0

Roughly	0
500	0
cases	0
have	0
been	0
reported	0
to	I-DISEASE
date	0
in	I-DISEASE
the	0
literature	0
,	I-DISEASE
from	0
all	0
countries	0
in	0
which	0
the	0
disease	0
has	I-DISEASE
been	0
investigated	0
.	0

The	0
disease	0
starts	0
during	0
the	0
second	I-DISEASE
decade	I-DISEASE
in	0
81	0
%	0
of	0
patients	0
,	I-DISEASE
with	0
a	0
male	0
/	0
female	0
ratio	0
of	0
2:1	0
.	0

Adults	0
and	0
younger	0
children	0
may	I-DISEASE
also	B-DISEASE
be	I-DISEASE
affected	I-DISEASE
.	I-DISEASE

Predisposing	0
and	0
Precipitating	0
Factors	0
Birth	0
and	I-DISEASE
developmental	I-DISEASE
problems	0
,	I-DISEASE
as	0
well	0
as	0
Jewish	I-DISEASE
heritage	0
,	0
are	0
risk	0
factors	I-DISEASE
for	0
devel-	0
oping	0
the	0
syndrome	0
.	0

The	0
frequency	0
of	0
the	I-DISEASE
HLA	I-DISEASE
DQB1	0
*	0
02	I-DISEASE
was	I-DISEASE
increased	0
compared	0
with	0
controls	0
in	0
a	I-DISEASE
retrospective	I-DISEASE
,	0
multicenter	I-DISEASE
series	0
of	0
30	0
patients	0
with	0
Kleine	0
-	I-DISEASE
Levin	0
syndrome	0
,	0
but	I-DISEASE
not	0
in	I-DISEASE
another	0
larger	0
prospective	0
series	0
(	0
n	0
=	I-DISEASE
108	0
)	0
.	0

A	0
flu	0
-	0
like	I-DISEASE
illness	0
or	0
an	0
infection	I-DISEASE
of	I-DISEASE
the	0
upper	I-DISEASE
airway	0
(	0
and	0
more	I-DISEASE
rarely	I-DISEASE
gastroenteritis	0
)	I-DISEASE
is	0
often	0
reported	0
imme-	0
diately	I-DISEASE
prior	0
to	I-DISEASE
the	0
onset	0
of	I-DISEASE
the	0
first	0
episode	0
,	0
and	0
more	0
rarely	0
before	0
relapses	I-DISEASE
.	0

Other	0
less	0
frequently	0
reported	0
triggering	0
events	I-DISEASE
include	I-DISEASE
alcohol	0
consumption	I-DISEASE
,	0
head	0
trauma	0
,	0
travel	0
,	I-DISEASE
or	0
exposure	0
to	0
anesthesia	0
.	0

Familial	0
Patterns	0
Familial	0
cases	0
of	0
Kleine	0
-	I-DISEASE
Levin	0
syndrome	I-DISEASE
are	0
found	0
in	0
5	I-DISEASE
%	0
of	I-DISEASE
patients	0
,	0
including	I-DISEASE
twins	0
,	0
parent	0
-	0
child	0
,	I-DISEASE
siblings	I-DISEASE
,	0
and	I-DISEASE
uncle	I-DISEASE
-	0
nephew	I-DISEASE
associations	I-DISEASE
.	0

There	0
is	0
no	0
increased	I-DISEASE
history	0
of	0
mood	I-DISEASE
disorders	0
in	I-DISEASE
family	0
members	0
of	0
patients	I-DISEASE
.	I-DISEASE

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Early	I-DISEASE
adolescence	0
(	0
second	0
decade	0
)	0
is	0
the	0
usual	I-DISEASE
age	0
of	0
onset	I-DISEASE
.	0

The	0
course	0
of	0
Kleine-	0

Levin	0
syndrome	0
is	0
characterized	0
by	0
recurrent	0
episodes	0
of	0
severe	I-DISEASE
sleepiness	0
,	0
lasting	I-DISEASE
up	0
to	0
several	I-DISEASE
weeks	0
,	0
with	I-DISEASE
normal	0
functioning	0
between	0
episodes	0
.	I-DISEASE

Several	0
long	0
-	0
term	0
studies	0
suggest	0
an	0
often	0
-	I-DISEASE
benign	0
course	0
,	0
with	0
episodes	0
lessening	0
in	0
duration	0
,	I-DISEASE
severity	0
,	0
and	0
fre-	0
quency	0
over	0
a	0
median	0
course	0
of	0
14	0
years	0
.	0

Male	0
sex	0
,	0
age	0
at	0
onset	I-DISEASE
younger	0
than	0
12	0
years	0
or	I-DISEASE
older	0
than	0
20	0
years	I-DISEASE
,	I-DISEASE
as	0
well	I-DISEASE
as	0
the	0
presence	0
of	0
hypersexuality	0
during	I-DISEASE
episodes	0
,	I-DISEASE
predict	0
longer	I-DISEASE
disease	0
duration	0
.	0

Complications	0
are	0
mainly	0
social	0
and	I-DISEASE
occupational	0
.	I-DISEASE

In	0
rare	0
cases	I-DISEASE
,	B-DISEASE
subjects	0
have	I-DISEASE
been	0
reported	0
to	0
choke	0
while	0
eating	0
voraciously	0
,	0
to	I-DISEASE
have	0
suicidal	0
thoughts	I-DISEASE
,	0
or	0
to	0
be	0
involved	0
in	0
a	0
car	0
accident	0
.	I-DISEASE

A	0
reduced	0
long	I-DISEASE
-	0
term	0
working	0
memory	I-DISEASE
capacity	0
following	I-DISEASE
episodes	0
was	0
reported	0
in	0
eight	0
patients	0
with	I-DISEASE
Kleine	0
-	I-DISEASE
Levin	0
syndrome	0
.	0

Developmental	0
Issues	0
Adolescents	0
are	I-DISEASE
affected	0
in	0
most	I-DISEASE
cases	0
.	I-DISEASE

However	0
,	0
the	0
onset	B-DISEASE
of	0
the	I-DISEASE
condition	I-DISEASE
has	0
been	0
reported	0
in	0
children	0
as	0
young	0
as	0
four	0
years	0
.	I-DISEASE

Pathology	0
and	0
Pathophysiology	0
Postmortem	0
examination	0
of	I-DISEASE
the	I-DISEASE
central	0
nervous	I-DISEASE
system	0
has	0
been	0
performed	0
in	0
only	I-DISEASE
four	0
cases	0
,	I-DISEASE
with	0
inconsistent	0
findings	0
.	0

One	0
subject	I-DISEASE
showed	0
significant	I-DISEASE
perivascular	0
lymphocytic	0
infiltrations	0
in	0
the	I-DISEASE
hypothalamus	0
,	0
amygdala	0
,	0
and	0
the	I-DISEASE
grey	0
matter	I-DISEASE
of	I-DISEASE
the	I-DISEASE
temporal	0
lobes	0
;	0
a	0
second	0
demonstrated	I-DISEASE
similar	0
infiltrations	0
in	I-DISEASE
the	0
thalamus	0
;	0
and	I-DISEASE
a	I-DISEASE
third	0
in	0
the	I-DISEASE
diencephalon	I-DISEASE
and	I-DISEASE
the	0
midbrain	I-DISEASE
with	0
a	I-DISEASE
suggestion	0
of	0
mild	0
localized	I-DISEASE
encephali-	I-DISEASE
tis	I-DISEASE
.	0

In	0
the	0
fourth	I-DISEASE
case	0
,	0
a	0
smaller	I-DISEASE
locus	0
coeruleus	I-DISEASE
and	0
decreased	0
pigmentation	0
in	0
the	0
substantia	I-DISEASE
nigra	0
were	0
reported	I-DISEASE
.	0

Magnetic	0
resonance	0
imaging	0
was	0
unremarkable	0
.	0

In	0
contrast	0
,	0
functional	0
brain	I-DISEASE
imaging	0
studies	I-DISEASE
during	0
episodes	I-DISEASE
are	0
frequently	0
abnormal	0
,	0
showing	0
hypometabolism	0
in	I-DISEASE
the	0
thalamus	I-DISEASE
,	0
hypothalamus	0
,	0
mesial	0
temporal	0
lobe	I-DISEASE
,	0
and	0
frontal	0
lobe	I-DISEASE
.	0

Some	0
of	0
these	0
abnormalities	0
persist	0
during	0
asymptomatic	I-DISEASE
periods	0
in	I-DISEASE
half	0
of	0
the	0
patients	0
.	0

An	0
autoimmune	0
basis	0
for	0
the	0
disorder	0
is	0
suggested	0
clinically	I-DISEASE
(	0
onset	0
occurs	0
during	0
adolescence	0
,	I-DISEASE
often	0
in	0
conjunction	I-DISEASE
with	0
an	0
infection	0
)	0
and	I-DISEASE
by	0
the	I-DISEASE
occa-	0
sional	I-DISEASE
association	I-DISEASE
with	I-DISEASE
HLA	0
DQB1	0
*	I-DISEASE
02	0
.	0

Objective	0
Findings	0
Routine	0
electroencephalograms	I-DISEASE
obtained	0
during	I-DISEASE
episodes	I-DISEASE
have	0
shown	0
general	0
slowing	0
of	0
background	0
electroencephalographic	0
activity	0
and	I-DISEASE
often	0
paroxysmal—0.5	0
-	0
2.0	0
-	0
sec-	0
ond	0
—	I-DISEASE
bursts	0
of	0
bisynchronous	0
,	I-DISEASE
generalized	0
,	I-DISEASE
moderate-	I-DISEASE
to	I-DISEASE
high	0
-	0
voltage	0
5-	0
to	I-DISEASE
7	0
-	0
Hz	I-DISEASE
waves	I-DISEASE
.	0

Polysomnography	0
studies	0
are	0
often	0
difficult	0
to	I-DISEASE
interpret	I-DISEASE
,	0
and	I-DISEASE
results	0
are	0
depen-	0
dent	0
on	0
the	0
duration	0
of	I-DISEASE
recording	I-DISEASE
(	0
overnight	0
vs.	0
24	0
-	I-DISEASE
hour	I-DISEASE
monitoring	I-DISEASE
)	I-DISEASE
as	I-DISEASE
well	0
as	0
the	0
timing	I-DISEASE
(	I-DISEASE
at	0
the	0
beginning	0
versus	0
the	0
end	0
of	I-DISEASE
episodes	I-DISEASE
or	I-DISEASE
at	I-DISEASE
onset	I-DISEASE
of	0
the	I-DISEASE
disease	I-DISEASE
or	I-DISEASE
later	I-DISEASE
in	0
its	0
course	I-DISEASE
)	0
.	I-DISEASE

Twenty	0
-	0
four	0
-	0
hour	0
polysomnography	0
demonstrates	I-DISEASE
prolonged	0
total	I-DISEASE
sleep	0
time	0
(	I-DISEASE
a	0
mean	I-DISEASE
11–12	I-DISEASE
hours	I-DISEASE
)	0
,	I-DISEASE
and	0
18	0
hours	0
or	0
more	0
in	I-DISEASE
some	I-DISEASE
reports	0
.	I-DISEASE

During	0
nocturnal	I-DISEASE
polysomnography	I-DISEASE
in	0
17	0
children	I-DISEASE
,	I-DISEASE
nighttime	0
slow	I-DISEASE
wave	I-DISEASE
sleep	0
percentage	0
was	I-DISEASE
decreased	0
during	I-DISEASE
the	0
first	I-DISEASE
half	I-DISEASE
of	I-DISEASE
the	I-DISEASE
episodes	0
,	0
and	I-DISEASE
REM	I-DISEASE
sleep	I-DISEASE
decreased	I-DISEASE
during	0
the	I-DISEASE
second	0
half	0
.	I-DISEASE

Results	0
of	0
the	0
MSLT	I-DISEASE
are	0
highly	0
dependent	I-DISEASE
on	0
the	I-DISEASE
subjects	0
’	I-DISEASE
willingness	0
to	0
comply	0
with	I-DISEASE
the	0
procedure	0
,	I-DISEASE
and	0
may	0
either	0
be	0
normal	0
or	I-DISEASE
abnormal	I-DISEASE
,	0
showing	0
short	I-DISEASE
latencies	0
or	I-DISEASE
mul-	0
tiple	0
SOREMPs	0
.	0

CSF	0
cytology	I-DISEASE
and	0
protein	B-DISEASE
are	0
normal	0
.	I-DISEASE

CSF	0
levels	I-DISEASE
of	0
hypocretin-1	0
were	0
within	0
normal	0
range	0
in	I-DISEASE
16	0
patients	0
,	0
although	0
intraepisodic	0
levels	I-DISEASE
are	I-DISEASE
lower	0
than	I-DISEASE
interepisodic	0
levels	0
.	0

Computed	0
tomography	0
scans	0
and	0
magnetic	0
resonance	0
imaging	I-DISEASE
are	0
normal	I-DISEASE
.	0

Brain	0
functional	0
imaging	0
is	0
abnormal	0
in	0
most	0
cases	0
,	I-DISEASE
with	0
hypoperfusion	0
of	0
the	0
left	0
or	I-DISEASE
right	0
temporal	0
and	I-DISEASE
frontal	0
lobes	0
as	0
well	0
as	0
the	0
diencephalon	0
.	0

These	0
abnor-	0
malities	0
are	0
present	I-DISEASE
during	0
the	I-DISEASE
episode	0
of	I-DISEASE
hypersomnolence	0
and	0
sometimes	I-DISEASE
between	0
episodes	0
.	I-DISEASE

Hormone	0
levels	0
are	0
normal	0
,	0
as	0
are	0
24	0
-	I-DISEASE
hour	0
secretory	0
patterns	0
.	0

Differential	0
Diagnosis	0
Recurrent	0
waxing	0
and	0
waning	I-DISEASE
episodes	I-DISEASE
of	0
sleepiness	I-DISEASE
may	I-DISEASE
be	0
secondary	0
to	0
struc-	0
tural	I-DISEASE
insults	I-DISEASE
of	0
the	I-DISEASE
central	0
nervous	0
system	0
.	0

Tumors	0
within	0
the	0
third	I-DISEASE
ventricle	I-DISEASE
(	I-DISEASE
such	I-DISEASE
as	0
Central	I-DISEASE
Disorders	0
of	0
Hypersomnolence	0
Central	0
Disorders	0
of	I-DISEASE
Hypersomnolence	0
colloid	0
cysts	I-DISEASE
,	0
pedunculated	0
astrocytomas	0
,	0
or	0
,	0
in	0
some	0
cases	0
,	I-DISEASE
craniopharyngiomas	0
)	I-DISEASE
may	0
produce	0
intermittent	0
obstructions	0
of	0
ventricular	0
flow	0
,	I-DISEASE
leading	I-DISEASE
to	0
headaches	I-DISEASE
,	I-DISEASE
vomiting	0
,	0
vague	I-DISEASE
sensorial	0
disturbances	I-DISEASE
,	I-DISEASE
and	0
a	I-DISEASE
paroxysmal	0
impairment	0
of	I-DISEASE
alertness	0
.	0

Encephalitis	0
,	0
hyperammonemic	0
encephalopathy	I-DISEASE
,	0
multiple	0
sclerosis	I-DISEASE
,	I-DISEASE
head	I-DISEASE
trauma	0
,	0
porphyria	0
,	0
Lyme	0
disease	I-DISEASE
,	0
basilar	I-DISEASE
migraine	I-DISEASE
,	0
and	0
complex	0
partial	I-DISEASE
status	0
epilepticus	0
less	I-DISEASE
frequently	0
mimic	0
symptoms	I-DISEASE
of	0
Kleine	I-DISEASE
-	I-DISEASE
Levin	0
syndrome	0
.	0

Recurrent	0
episodes	0
of	0
sleepiness	0
also	0
are	I-DISEASE
reported	0
in	0
the	0
context	0
of	0
psychiatric	I-DISEASE
disorders	0
,	0
such	0
as	0
depression	0
,	I-DISEASE
bipolar	0
disorder	0
,	0
seasonal	0
affective	0
disorder	I-DISEASE
,	I-DISEASE
and	0
somatoform	0
disorder	0
.	0

However	0
,	I-DISEASE
the	0
onset	I-DISEASE
and	0
offset	I-DISEASE
of	I-DISEASE
symptoms	0
are	0
less	0
abrupt	0
than	0
in	0
Kleine	0
-	I-DISEASE
Levin	I-DISEASE
syndrome	0
and	I-DISEASE
persist	0
to	I-DISEASE
some	0
extent	0
between	0
episodes	0
.	I-DISEASE

Other	0
differential	0
diagnoses	0
include	0
excessive	0
sleepiness	I-DISEASE
due	I-DISEASE
to	0
a	I-DISEASE
medication	I-DISEASE
or	0
substance	0
,	0
OSA	0
,	0
narcolepsy	0
,	0
IH	I-DISEASE
,	0
and	I-DISEASE
insufficient	0
sleep	0
.	0

In	0
these	0
disor-	0
ders	0
,	0
however	0
,	0
the	0
complaint	I-DISEASE
of	0
excessive	0
sleepiness	I-DISEASE
occurs	I-DISEASE
daily	0
and	I-DISEASE
is	I-DISEASE
usually	0
not	I-DISEASE
recurrent	0
or	I-DISEASE
periodic	0
.	0

There	0
is	0
no	0
evidence	0
that	0
Kleine	I-DISEASE
-	I-DISEASE
Levin	0
syndrome	I-DISEASE
occurs	0
as	0
a	0
result	0
of	0
a	0
seizure	0
disorder	0
.	0

Unresolved	0
Issues	0
and	0
Future	0
Directions	I-DISEASE

The	0
pathophysiology	0
of	0
this	I-DISEASE
disorder	0
is	I-DISEASE
not	I-DISEASE
known	0
.	0

Evidence	0
to	0
date	0
suggests	0
that	0
a	I-DISEASE
localized	I-DISEASE
but	0
multifocal	0
encephalopathy	0
occurs	0
during	0
episodes	0
of	0
Kleine	I-DISEASE
-	I-DISEASE
Levin	0
syn-	I-DISEASE
drome	0
,	0
as	0
functional	0
imaging	0
and	0
electroencephalography	0
(	0
EEG	0
)	I-DISEASE
slowing	0
indicate	I-DISEASE
tha-	0
lamic	0
,	0
temporal	0
,	0
and	I-DISEASE
frontal	0
lobe	I-DISEASE
involvement	0
.	0

The	0
cause	0
of	I-DISEASE
these	0
episodic	0
abnormali-	0
ties	I-DISEASE
may	0
be	0
genetic	0
,	0
autoimmune	0
,	0
inflammatory	0
,	I-DISEASE
or	0
metabolic	0
.	0

Bibliography	0
Arnulf	0
I	0
,	0
Lin	0
L	0
,	0
Gadoth	0
N	I-DISEASE
,	0
et	0
al	0
.	I-DISEASE

Kleine	0
-	0
Levin	0
syndrome	0
:	0
a	I-DISEASE
systematic	I-DISEASE
study	0
of	0
108	0
patients	0
.	0

Ann	0
Neurol	0
2008;63:482–93	0
.	0

Arnulf	0
I	0
,	0
Zeitzer	0
JM	0
,	0
File	0
J	0
,	I-DISEASE
Farber	0
N	0
,	0
Mignot	0
E.	0
Kleine	I-DISEASE
-	0
Levin	0
syndrome	0
:	0
a	0
systematic	0
review	0
of	0
186	0
cases	I-DISEASE
in	0
the	0
literature	0
.	0

Brain	0
2005;128:2763–76	0
.	0

Billiard	0
M	0
,	0
Jaussent	0
I	0
,	0
Dauvilliers	I-DISEASE
Y	0
,	0
Besset	0
A.	I-DISEASE
Recurrent	0
hypersomnia	0
:	0
a	0
review	0
of	0
339	I-DISEASE
cases	0
.	0

Sleep	0
Med	0
Rev	0
2011;15:247–57	0
.	0

Dauvilliers	0
Y	0
,	0
Mayer	0
G	0
,	0
Lecendreux	I-DISEASE
M	0
,	I-DISEASE
et	0
al	0
.	0

Kleine	0
-	0
Levin	0
syndrome	0
.	0

An	0
autoimmune	0
hypothesis	0
based	0
on	0
clinical	0
and	I-DISEASE
genetic	0
analyses	0
.	0

Neurology	0
2002;59:1739–45	0
.	0

Engström	0
M	I-DISEASE
,	0
Vigren	0
P	0
,	I-DISEASE
Karlsson	I-DISEASE
T	0
,	I-DISEASE
Landtblom	0
A.	0
Working	0
memory	0
in	0
8	I-DISEASE
Kleine	I-DISEASE
-	I-DISEASE
Levin	0
syndrome	0
patients	0
:	0
An	0
fMRI	0
study	0
.	I-DISEASE

Sleep	0
2009;32:681–8	0
.	0

Gadoth	0
N	I-DISEASE
,	0
Kesler	0
A	0
,	0
Vainstein	I-DISEASE
G	0
,	I-DISEASE
Peled	0
R	0
,	0
Lavie	I-DISEASE
P.	I-DISEASE
Clinical	I-DISEASE
and	0
polysomnographic	0
characteristics	0
of	0
34	0
patients	0
with	0
Kleine	I-DISEASE
-	0
Levin	I-DISEASE
syndrome	I-DISEASE
.	I-DISEASE

J	0
Sleep	0
Res	0
2001;10:337–41	0
.	0

Huang	0
Y	0
,	0
Lin	0
Y	0
,	0
Guilleminault	I-DISEASE
C.	I-DISEASE
Polysomnography	I-DISEASE
in	0
Kleine	0
-	0
Levin	I-DISEASE
syndrome	0
.	0

Neurology	0
2008;70:795–801	0
.	0

Huang	0
Y	0
,	0
Guilleminault	0
C	0
,	I-DISEASE
Lin	I-DISEASE
K	0
,	0
Hwang	I-DISEASE
F	0
,	B-DISEASE
Liu	0
F	0
,	0
Kung	0
Y.	0
Relationship	I-DISEASE
between	0
Kleine	0
-	0
Levin	0
Syndrome	0
and	0
upper	B-DISEASE
respiratory	0
infection	0
in	I-DISEASE
Taiwan	0
.	0

Sleep	0
2012;35:123–9	0
.	0

Hypersomnia	0
Due	0
to	0
a	0
Medical	0
Disorder	0
ICD-9	I-DISEASE
-	0
CM	I-DISEASE
code	0
:	0
327.14	0
ICD-10	I-DISEASE
-	0
CM	0
code	0
:	0
G47.14	I-DISEASE
Alternate	0
Names	0
Not	0
applicable	0
.	0

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
D	I-DISEASE
must	0
be	0
met	I-DISEASE
A.	0

The	0
patient	0
has	0
daily	0
periods	0
of	0
irrepressible	I-DISEASE
need	I-DISEASE
to	I-DISEASE
sleep	0
or	0
daytime	0
lapses	0
into	I-DISEASE
sleep	I-DISEASE
occurring	0
for	0
at	I-DISEASE
least	0
three	I-DISEASE
months	0
.	0

B.	0
The	0
daytime	0
sleepiness	0
occurs	0
as	I-DISEASE
a	0
consequence	0
of	I-DISEASE
a	0
significant	0
underlying	0
medical	0
or	0
neurological	I-DISEASE
condition	0
.	0

C.	0

If	0
an	0
MSLT	0
is	B-DISEASE
performed	0
,	0
the	0
mean	0
sleep	I-DISEASE
latency	0
is	I-DISEASE
≤	0
8	I-DISEASE
minutes	0
,	I-DISEASE
and	0
fewer	0
than	I-DISEASE
two	0
sleep	0
onset	0
REM	0
periods	I-DISEASE
(	0
SOREMPs	I-DISEASE
)	0
are	0
observed.1	I-DISEASE
D.	0
The	I-DISEASE
symptoms	0
are	0
not	0
better	0
explained	0
by	0
another	0
untreated	I-DISEASE
sleep	0
disorder,2	I-DISEASE
a	0
mental	I-DISEASE
disorder	I-DISEASE
,	0
or	0
the	I-DISEASE
effects	I-DISEASE
of	0
medications	0
or	I-DISEASE
drugs	I-DISEASE
.	I-DISEASE

Notes	0
.	0

In	0
the	0
subtype	I-DISEASE
of	0
residual	0
hypersomnolence	I-DISEASE
after	0
treatment	I-DISEASE
of	I-DISEASE
obstructive	0
sleep	0
apnea	0
,	0
the	0
MSLT	I-DISEASE
mean	0
latency	0
may	I-DISEASE
be	0
>	0
8	0
minutes	I-DISEASE
.	0
.	I-DISEASE

Should	0
criteria	0
for	0
narcolepsy	0
be	0
fulfilled	0
,	I-DISEASE
a	0
diagnosis	I-DISEASE
of	I-DISEASE
narcolepsy	0
type	0
1	0
or	0
type	I-DISEASE
2	0
due	0
to	I-DISEASE
a	I-DISEASE
medical	0
condition	0
should	0
be	0
used	0
rather	I-DISEASE
than	0
hypersomnia	0
due	I-DISEASE
to	0
a	I-DISEASE
medical	I-DISEASE
condition	I-DISEASE
.	0
.	0

In	0
patients	0
with	I-DISEASE
severe	0
neurological	0
or	0
medical	I-DISEASE
disorders	I-DISEASE
in	I-DISEASE
whom	0
it	0
is	0
not	I-DISEASE
possible	0
or	I-DISEASE
desirable	I-DISEASE
to	0
perform	0
sleep	0
studies	0
,	0
the	I-DISEASE
diagnosis	0
can	0
be	I-DISEASE
made	0
by	0
clinical	I-DISEASE
criteria	0
.	0

Essential	0
Features	0
Patients	0
with	0
this	B-DISEASE
disorder	0
have	0
excessive	0
nocturnal	0
sleep	0
,	0
daytime	0
sleepiness	I-DISEASE
,	0
or	I-DISEASE
excessive	I-DISEASE
napping	0
that	I-DISEASE
is	0
attributable	I-DISEASE
to	0
a	0
coexisting	I-DISEASE
medical	0
or	I-DISEASE
neurological	0
disor-	0
der	I-DISEASE
.	0

Daytime	0
sleepiness	0
may	0
be	I-DISEASE
of	0
variable	I-DISEASE
severity	I-DISEASE
and	0
may	I-DISEASE
resemble	0
that	0
of	0
narco-	0
lepsy	0
(	I-DISEASE
i.e.	0
,	0
refreshing	I-DISEASE
naps	0
)	I-DISEASE
or	0
idiopathic	0
hypersomnia	0
(	0
i.e.	0
,	0
long	0
periods	0
of	0
unrefresh-	0
ing	0
sleep	I-DISEASE
)	0
.	0

Sleep	0
paralysis	0
,	0
hypnagogic	0
hallucinations	0
,	0
or	0
automatic	I-DISEASE
behavior	I-DISEASE
may	0
be	0
present	0
,	I-DISEASE
but	0
if	I-DISEASE
the	0
patient	0
has	I-DISEASE
cataplexy	0
,	0
the	0
MSLT	0
shows	0
two	0
or	0
more	I-DISEASE
SOREMPs	I-DISEASE
,	0
or	0
CSF	0
Hcrt-1	0
levels	0
are	0
low	0
,	0
then	0
narcolepsy	0
(	0
type	0
1	0
or	0
type	0
2	0
)	0
due	0
to	0
a	I-DISEASE
medical	0
condi-	0
tion	0
should	0
be	I-DISEASE
diagnosed	0
.	0

In	0
patients	0
with	I-DISEASE
both	0
sleep	0
related	I-DISEASE
breathing	I-DISEASE
disorders	0
and	I-DISEASE
hypersomnia	0
due	0
to	0
a	0
medical	0
disorder	I-DISEASE
,	0
the	0
latter	I-DISEASE
diagnosis	0
should	0
be	0
made	0
only	0
if	0
the	I-DISEASE
hypersomnolence	I-DISEASE
persists	0
after	I-DISEASE
adequate	0
treatment	I-DISEASE
of	I-DISEASE
the	0
sleep	0
disordered	0
breathing	0
.	0

Hypersomnia	0
due	0
to	0
a	0
medical	0
disorder	I-DISEASE
is	0
only	0
diagnosed	I-DISEASE
if	0
the	0
medical	0
condition	0
is	0
Central	0
Disorders	I-DISEASE
of	0
Hypersomnolence	I-DISEASE
Central	0
Disorders	0
of	0
Hypersomnolence	0
judged	0
to	0
be	0
directly	0
causing	0
the	0
excessive	0
sleepiness	0
.	0

Hypersomnolence	0
has	0
been	0
described	0
in	0
association	0
with	I-DISEASE
a	0
large	0
range	0
of	0
conditions	0
,	0
including	0
metabolic	I-DISEASE
enceph-	0
alopathy	I-DISEASE
,	I-DISEASE
head	0
trauma	0
,	0
stroke	0
,	0
brain	0
tumors	0
,	I-DISEASE
encephalitis	I-DISEASE
,	I-DISEASE
systemic	0
inflammation	0
(	0
e.g.	0
,	0
chronic	0
infections	0
,	0
rheumatologic	0
disorders	I-DISEASE
,	0
cancer	I-DISEASE
)	I-DISEASE
,	I-DISEASE
genetic	0
disorders	0
,	0
and	I-DISEASE
neurode-	I-DISEASE
generative	0
diseases	0
.	I-DISEASE

Associated	0
Features	0
Not	0
applicable	0
or	0
known	0
.	0

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Many	I-DISEASE
medical	I-DISEASE
conditions	I-DISEASE
can	I-DISEASE
cause	I-DISEASE
hypersomnolence	0
.	I-DISEASE

Hypersomnia	0
secondary	0
to	0
Parkinson	0
disease	0
:	I-DISEASE
Significant	0
hypersomnolence	0
docu-	I-DISEASE
mented	0
by	0
MSLT	0
has	0
been	0
reported	0
in	0
some	0
cases	I-DISEASE
of	0
Parkinson	0
disease	0
.	0

Hypersomnia	0
in	0
Parkinson	0
disease	0
may	0
be	I-DISEASE
due	0
to	0
insufficient	I-DISEASE
control	0
of	0
nocturnal	0
symptoms	0
,	0
result-	I-DISEASE
ing	0
in	I-DISEASE
insufficient	0
sleep	0
and	0
daytime	0
sleepiness	0
.	0

If	0
so	0
,	0
the	0
diagnosis	0
should	0
be	B-DISEASE
insomnia	0
disorder	0
.	0

Cases	0
of	I-DISEASE
hypersomnolence	I-DISEASE
that	I-DISEASE
are	0
due	0
to	I-DISEASE
the	0
side	I-DISEASE
effects	0
of	0
dopaminergic	0
agents	0
should	0
be	I-DISEASE
coded	I-DISEASE
as	0
hypersomnia	I-DISEASE
due	0
to	0
a	0
medication	0
or	0
substance	0
.	0

In	0
other	0
cases	0
,	I-DISEASE
however	0
,	0
hypersomnolence	I-DISEASE
is	I-DISEASE
likely	I-DISEASE
of	0
central	0
origin	0
and	0
should	0
be	I-DISEASE
classified	0
in	0
this	0
section	0
.	I-DISEASE

Parkinson	0
disease	0
patients	0
with	I-DISEASE
an	0
MSLT	I-DISEASE
profile	I-DISEASE
consistent	0
with	0
narco-	0
lepsy	0
should	0
be	0
coded	0
as	I-DISEASE
narcolepsy	0
due	0
to	0
a	0
medical	I-DISEASE
condition	0
.	0

Posttraumatic	0
hypersomnia	0
:	0
Hypersomnolence	0
appears	0
to	0
be	I-DISEASE
common	0
after	I-DISEASE
trau-	0
matic	0
brain	0
injury	0
(	0
TBI	I-DISEASE
)	0
,	0
with	I-DISEASE
one	0
meta	I-DISEASE
-	0
analysis	0
suggesting	0
a	I-DISEASE
frequency	0
of	I-DISEASE
28	0
%	0
of	0
TBI	0
patients	I-DISEASE
.	0

In	0
some	0
cases	0
this	0
may	0
be	0
caused	I-DISEASE
by	0
injury	I-DISEASE
to	0
the	0
hypocretin	I-DISEASE
/	0
orexin	0
neurons	I-DISEASE
or	0
other	0
wake	0
-	0
promoting	0
neural	0
systems	0
.	0

However	0
,	I-DISEASE
the	0
prevalence	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
related	I-DISEASE
breathing	I-DISEASE
disorder	I-DISEASE
(	0
SRBD	0
)	0
in	0
patients	0
with	I-DISEASE
head	0
trauma	I-DISEASE
is	0
high	0
(	0
frequency	0
23	0
%	0
to	0
25	0
%	0
)	0
.	I-DISEASE

The	0
nature	0
of	0
the	0
relationship	0
between	0
TBI	0
and	0
OSA	0
remains	0
undefined	0
.	0

Therefore	0
,	0
control	0
of	0
other	0
potential	I-DISEASE
sleep	I-DISEASE
disorders	I-DISEASE
is	I-DISEASE
necessary	0
prior	0
to	0
making	0
a	0
diagnosis	I-DISEASE
of	0
hypersomnia	0
due	I-DISEASE
to	0
a	0
medical	0
disorder	0
(	0
posttraumatic	0
hypersomnia	I-DISEASE
)	0
.	0

Genetic	0
disorders	0
associated	I-DISEASE
with	0
primary	0
central	0
nervous	I-DISEASE
system	0
somnolence	I-DISEASE
:	0
Genetic	0
disorders	0
such	I-DISEASE
as	0
Niemann	I-DISEASE
Pick	I-DISEASE
type	0
C	I-DISEASE
disease	0
and	0
Norrie	0
disease	0
have	0
been	0
associated	I-DISEASE
with	I-DISEASE
daytime	0
somnolence	I-DISEASE
.	0

Prader	0
-	0
Willi	0
syndrome	0
,	0
myotonic	0
dystrophy	I-DISEASE
,	0
Moebius	I-DISEASE
syndrome	0
,	0
and	0
fragile	0
X	0
syndrome	I-DISEASE
are	I-DISEASE
other	0
examples	I-DISEASE
of	0
centrally	0
mediated	0
sleepiness	0
.	0

A	0
number	0
of	0
genetic	I-DISEASE
disorders	0
have	I-DISEASE
been	0
reported	0
to	I-DISEASE
be	0
associated	0
with	0
both	0
sleep	0
disordered	I-DISEASE
breathing	0
and	0
hypersomnolence	I-DISEASE
(	0
e.g.	I-DISEASE
,	0
myotonic	0
dystrophy	0
and	I-DISEASE
Prader	I-DISEASE
-	0
Willi	I-DISEASE
syndrome	0
)	0
.	I-DISEASE

In	0
these	0
cases	0
,	B-DISEASE
hypersomnia	0
due	0
to	0
a	0
medical	0
disorder	0
should	0
be	0
diagnosed	0
only	0
if	I-DISEASE
the	0
excessive	0
sleepiness	0
is	0
still	0
present	0
after	0
adequate	I-DISEASE
treatment	0
of	I-DISEASE
the	0
SRBD	0
.	0

Smith	0
-	0
Magenis	I-DISEASE
syndrome	0
is	0
a	0
neurodevelopmental	I-DISEASE
disorder	0
characterized	I-DISEASE
by	0
dysmorphic	0
facial	0
features	0
,	I-DISEASE
behavioral	I-DISEASE
disturbance	0
with	0
onset	I-DISEASE
in	0
early	0
childhood	0
,	0
daytime	0
somnolence	0
,	I-DISEASE
and	0
night	0
awakenings	0
in	0
association	I-DISEASE
with	0
reversal	0
in	0
the	0
timing	0
of	0
the	0
melatonin	I-DISEASE
secretion	0
pattern	I-DISEASE
(	I-DISEASE
i.e.	I-DISEASE
,	0
the	0
serum	0
levels	0
of	I-DISEASE
melatonin	I-DISEASE
are	0
high	I-DISEASE
during	I-DISEASE
the	I-DISEASE
daytime	I-DISEASE
and	0
low	0
at	0
night	0
)	0
.	0

Hypersomnia	0
secondary	0
to	0
brain	0
tumors	0
,	I-DISEASE
infections	0
,	0
or	I-DISEASE
other	0
central	0
nervous	0
system	0
lesions	0
:	I-DISEASE
Strokes	0
,	I-DISEASE
infections	I-DISEASE
,	0
tumors	0
,	0
sarcoidosis	0
,	I-DISEASE
or	0
neurodegenerative	0
lesions	0
of	0
the	I-DISEASE
brain	0
,	0
especially	0
in	I-DISEASE
the	0
hypothalamus	0
or	0
rostral	0
midbrain	0
,	I-DISEASE
may	0
produce	I-DISEASE
daytime	I-DISEASE
sleepi-	I-DISEASE
ness	0
.	0

In	0
patients	0
with	I-DISEASE
brain	0
tumors	0
,	0
the	I-DISEASE
sleepiness	0
may	I-DISEASE
be	0
due	0
to	0
the	0
tumor	0
itself	I-DISEASE
or	0
the	0
effects	0
of	0
treatment	0
.	0

Hypersomnia	0
secondary	0
to	0
endocrine	0
disorder	0
:	I-DISEASE
Hypothyroidism	0
is	0
the	I-DISEASE
most	0
recog-	0
nized	0
example	0
of	0
this	0
condition	0
.	I-DISEASE

Hypersomnia	0
secondary	0
to	0
metabolic	0
encephalopathy	0
:	I-DISEASE
Hepatic	0
encephalopathy	0
,	I-DISEASE
chronic	0
renal	0
insufficiency	0
,	I-DISEASE
adrenal	0
or	I-DISEASE
pancreatic	I-DISEASE
insufficiency	0
,	I-DISEASE
exposure	0
to	0
toxins	0
,	I-DISEASE
and	0
certain	0
inherited	0
metabolic	0
disorders	0
in	B-DISEASE
childhood	0
may	0
result	0
in	I-DISEASE
hypersomnolence	0
.	0

Residual	0
hypersomnia	I-DISEASE
in	0
patients	0
with	0
adequately	0
treated	I-DISEASE
OSA	0
:	0
Some	0
patients	0
with	I-DISEASE
SRBDs	0
report	0
persistent	I-DISEASE
sleepiness	0
despite	I-DISEASE
apparently	I-DISEASE
adequate	0
amounts	I-DISEASE
of	0
sleep	0
and	0
optimal	0
treatment	0
of	0
their	I-DISEASE
sleep	0
apnea	0
and	0
other	I-DISEASE
known	0
sleep	0
disorders	0
.	0

They	0
may	0
have	0
moderately	0
elevated	0
Epworth	0
Sleepiness	I-DISEASE
Scale	I-DISEASE
scores	I-DISEASE
,	0
but	0
most	0
have	0
mean	0
sleep	0
laten-	0
cies	0
>	0
8	I-DISEASE
minutes	0
on	0
MSLT	0
.	I-DISEASE

They	0
also	0
report	0
more	0
fatigue	0
,	0
apathy	I-DISEASE
,	0
and	I-DISEASE
depression	0
.	0

It	0
is	0
essential	0
that	0
sleep	0
disordered	I-DISEASE
breathing	I-DISEASE
be	0
fully	I-DISEASE
treated	I-DISEASE
for	0
at	I-DISEASE
least	0
three	0
months	I-DISEASE
,	0
and	0
that	I-DISEASE
control	0
of	I-DISEASE
the	0
SRBD	0
be	I-DISEASE
confirmed	0
by	0
:	0
(	I-DISEASE
1	0
)	0
a	0
download	0
of	0
positive	0
airway	0
pressure	0
(	I-DISEASE
PAP	I-DISEASE
)	0
machine	I-DISEASE
compliance	I-DISEASE
data	I-DISEASE
demonstrating	0
optimal	0
usage	I-DISEASE
(	0
preferably	B-DISEASE
at	I-DISEASE
least	I-DISEASE
7	0
hours	I-DISEASE
a	0
night	0
)	I-DISEASE
;	I-DISEASE
and	0
(	I-DISEASE
2	I-DISEASE
)	0
a	0
polysomnogram	I-DISEASE
demonstrating	I-DISEASE
elimination	0
of	I-DISEASE
essentially	I-DISEASE
all	I-DISEASE
sleep	I-DISEASE
disordered	0
breathing	I-DISEASE
.	0

Other	0
causes	0
of	I-DISEASE
sleepiness	0
,	0
such	0
as	I-DISEASE
insufficient	0
sleep	I-DISEASE
syn-	0
drome	0
,	0
psychiatric	0
disorders	0
,	0
or	I-DISEASE
hypersomnolence	0
related	0
to	0
medications	0
or	0
drugs	0
must	0
be	0
eliminated	0
.	0

Animal	0
studies	0
have	0
suggested	0
this	0
residual	0
sleepiness	0
could	0
be	0
caused	0
by	0
hypoxic	0
injury	0
to	0
monoamine	0
systems	I-DISEASE
.	0

Obesity	0
itself	0
may	0
also	0
contribute	0
,	0
and	I-DISEASE
more	0
research	I-DISEASE
is	0
needed	0
to	0
understand	0
the	0
underlying	I-DISEASE
mechanism	I-DISEASE
.	0

Demographics	0
Demographics	0
reflect	0
those	0
of	0
the	0
underlying	I-DISEASE
condition	0
.	I-DISEASE

Predisposing	0
and	0
Precipitating	0
Factors	0
Predisposing	0
and	I-DISEASE
precipitating	I-DISEASE
factors	0
reflect	I-DISEASE
those	0
of	0
the	0
underlying	0
condition	0
.	I-DISEASE

Central	0
Disorders	0
of	0
Hypersomnolence	0
Central	0
Disorders	I-DISEASE
of	0
Hypersomnolence	0
Familial	I-DISEASE
Patterns	0
Familial	0
patterns	0
reflect	I-DISEASE
those	0
of	I-DISEASE
the	0
underlying	0
condition	I-DISEASE
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Onset	I-DISEASE
,	0
course	0
,	0
and	0
complications	0
reflect	0
those	0
of	I-DISEASE
the	0
underlying	0
condition	0
.	0

Developmental	0
Issues	0
Daytime	0
naps	I-DISEASE
are	0
normal	I-DISEASE
in	0
children	I-DISEASE
younger	I-DISEASE
than	0
3	0
-	I-DISEASE
4	0
years	0
;	I-DISEASE
thus	I-DISEASE
,	0
it	I-DISEASE
is	0
difficult	I-DISEASE
to	0
dif-	0
ferentiate	0
physiologic	0
napping	I-DISEASE
from	0
hypersomnolence	0
in	I-DISEASE
children	0
younger	0
than	0
this	0
age	0
.	0

Inattentiveness	0
,	0
mood	I-DISEASE
swings	0
,	0
and	0
learning	I-DISEASE
difficulties	0
often	I-DISEASE
accompany	0
child-	0
hood	0
daytime	0
sleepiness	0
.	I-DISEASE

Reference	0
values	0
for	I-DISEASE
the	0
MSLT	I-DISEASE
in	0
children	0
differ	0
from	I-DISEASE
those	0
of	0
adults	0
,	0
and	0
this	I-DISEASE
issue	I-DISEASE
should	0
be	I-DISEASE
considered	0
during	I-DISEASE
the	0
evaluation	0
process	I-DISEASE
.	I-DISEASE

Special	0
attention	0
should	0
be	0
paid	0
to	0
genetic	0
disorders	0
in	I-DISEASE
children	0
.	I-DISEASE

Pathology	0
and	0
Pathophysiology	0
Pathology	0
and	0
pathophysiology	I-DISEASE
reflect	I-DISEASE
those	0
of	I-DISEASE
the	0
underlying	0
condition	0
.	0

Objective	0
Findings	0
Nocturnal	0
polysomnography	I-DISEASE
may	0
show	I-DISEASE
normal	0
or	0
moderately	I-DISEASE
disturbed	0
sleep	0
.	0

In	0
patients	0
with	I-DISEASE
a	0
metabolic	0
encephalopathy	0
,	0
EEG	0
abnormalities	0
may	0
be	0
present	0
,	0
such	0
as	0
an	0
increase	0
in	I-DISEASE
the	0
amount	0
of	0
slow	0
wave	0
sleep	0
.	0

MSLT	0
must	0
show	0
fewer	0
than	0
2	0
SOREMPs	I-DISEASE
and	0
usually	I-DISEASE
will	0
show	0
a	0
mean	0
sleep	0
latency	I-DISEASE
less	0
than	0
eight	0
minutes	I-DISEASE
.	0

If	0
clin-	0
ically	I-DISEASE
significant	0
sleep	0
disordered	I-DISEASE
breathing	0
or	0
periodic	I-DISEASE
limb	I-DISEASE
movements	0
are	0
present	0
,	0
they	I-DISEASE
should	0
be	0
treated	I-DISEASE
prior	0
to	0
diagnosing	0
hypersomnia	0
due	0
to	0
a	0
medical	0
disorder	0
.	I-DISEASE

Differential	0
Diagnosis	0
See	0
the	0
differential	0
diagnosis	I-DISEASE
in	I-DISEASE
previous	I-DISEASE
hypersomnolence	0
sections	0
.	0

The	0
major	0
chal-	0
lenge	0
in	0
establishing	I-DISEASE
a	I-DISEASE
diagnosis	I-DISEASE
of	0
hypersomnia	0
due	0
to	0
a	I-DISEASE
medical	0
disorder	0
is	0
deter-	0
mining	I-DISEASE
whether	0
the	0
associated	0
medical	0
or	0
neurological	0
disorder	I-DISEASE
is	I-DISEASE
truly	0
causing	0
the	0
hypersomnolence	I-DISEASE
.	0

Unresolved	0
Issues	0
and	0
Future	0
Directions	I-DISEASE

This	0
area	0
is	0
understudied	0
.	0

Multiple	0
complex	0
neurological	0
,	0
metabolic	0
,	I-DISEASE
endocrine	I-DISEASE
,	0
and	I-DISEASE
medication	0
-	0
related	0
interactions	0
may	0
be	0
present	0
.	I-DISEASE

Further	0
studies	0
are	0
needed	0
to	0
define	0
the	I-DISEASE
reciprocal	0
relationships	I-DISEASE
between	0
sleep	0
disorders	0
and	0
other	0
diseases	0
.	I-DISEASE

Bibliography	0
Bruin	0
VM	I-DISEASE
,	0
Bittencourt	0
LR	I-DISEASE
,	I-DISEASE
Tufik	0
S.	I-DISEASE
Sleep	0
-	0
wake	I-DISEASE
disturbances	0
in	0
Parkinson	0
’s	0
disease	0
:	I-DISEASE
current	0
evidence	0
regarding	0
diagnostic	0
and	I-DISEASE
therapeutic	I-DISEASE
decisions	0
.	I-DISEASE

Eur	0
Neurol	0
2012;67:257–67	0
.	0

Castriotti	0
RJ	0
,	0
Wilde	0
MC	0
,	I-DISEASE
Lai	I-DISEASE
JM	I-DISEASE
,	I-DISEASE
Atanasov	0
S	0
,	0
Masel	I-DISEASE
BE	0
,	I-DISEASE
Kuna	0
ST	0
.	I-DISEASE
Prevalence	0
and	0
consequences	0
of	0
sleep	0
disorders	0
in	I-DISEASE
traumatic	0
brain	I-DISEASE
injury	I-DISEASE
.	0

J	0
Clin	0
Sleep	I-DISEASE
Med	0
2007;3:349–56	0
.	I-DISEASE

Guilleminault	0
C	I-DISEASE
,	I-DISEASE
Yuen	I-DISEASE
KM	0
,	0
Gulevich	I-DISEASE
MG	0
,	0
Karadeniz	0
D	0
,	I-DISEASE
Leger	0
D	I-DISEASE
,	0
Philip	I-DISEASE
D.	0
Hypersomnia	I-DISEASE
after	0
head	I-DISEASE
-	0
neck	0
trauma	0
:	I-DISEASE
a	I-DISEASE
medico	0
-	0
legal	I-DISEASE
dilemma	0
.	0

Neurology	0
2000;54:653–9	0
.	0

Kempf	0
J	0
,	0
Werth	0
E	0
,	0
Kaiser	I-DISEASE
PR	0
,	I-DISEASE
et	0
al	0
.	0

Sleep	0
-	0
wake	0
disturbances	0
3	0
years	0
after	0
traumatic	0
brain	0
injury	0
.	0

J	0
Neurol	0
Neurosurg	0
Psychiatry	0
2010;81:1402–5	0
.	0

Martinez	0
-	0
Rodriguez	0
JE	I-DISEASE
,	0
Lin	0
L	I-DISEASE
,	0
Iranzo	I-DISEASE
A	0
,	0
et	0
al	0
.	0

Decreased	0
hypocretin-1	0
(	0
orexin	I-DISEASE
-	0
A	I-DISEASE
)	I-DISEASE
levels	0
in	I-DISEASE
the	0
cerebrospinal	0
fluid	I-DISEASE
of	I-DISEASE
patients	0
with	I-DISEASE
myotonic	I-DISEASE
dystrophy	0
and	I-DISEASE
excessive	I-DISEASE
daytime	I-DISEASE
sleepiness	0
.	0

Sleep	0
2003;26:287–90	0
.	0

Mathias	0
JL	0
,	0
Alvaro	0
PK	0
.	0

Prevalence	0
of	0
sleep	0
disturbances	0
,	0
disorders	0
,	I-DISEASE
and	0
problems	I-DISEASE
following	0
traumatic	0
brain	0
injury	0
:	0
a	I-DISEASE
meta	0
-	0
analysis	0
.	0

Sleep	0
Med	0
2012;13:898–905	0
.	0

Panossian	0
L	0
,	0
Veasey	0
S.	I-DISEASE
Daytime	0
sleepiness	I-DISEASE
in	0
obesity	0
:	0
mechanisms	0
beyond	0
obstructive	I-DISEASE
sleep	I-DISEASE
apnea	I-DISEASE
--	0
a	0
review	I-DISEASE
.	0

Sleep	0
2012;35:605–15	0
.	0

Vernet	0
C	0
,	0
Redolfi	0
S	0
,	0
Attali	0
,	0
V	I-DISEASE
,	0
et	0
al	0
.	0

Residual	0
sleepiness	0
in	0
obstructive	0
sleep	0
apnoea	I-DISEASE
:	0
phenotype	0
and	I-DISEASE
related	0
symptoms	0
.	I-DISEASE

Eur	0
Respir	0
J	0
2011;38:98–105	I-DISEASE
.	0

Wienecke	0
M	0
,	0
Werth	0
E	0
,	0
Poryazova	0
R	0
,	I-DISEASE
et	0
al	0
.	0

Progressive	0
dopamine	0
and	0
hypocretin	0
deficiencies	0
in	I-DISEASE
Parkinson	I-DISEASE
’s	0
disease	I-DISEASE
:	0
is	0
there	0
an	0
impact	0
on	0
sleep	0
and	0
wakefulness	0
?	0

J	0
Sleep	0
Res	0
2012;21:710–7	B-DISEASE
.	0

Zhu	0
Y	B-DISEASE
,	0
Fenik	0
P	0
,	0
Zhan	I-DISEASE
G	0
,	0
et	0
al	I-DISEASE
.	0

Selective	0
loss	0
of	I-DISEASE
catecholaminergic	0
wake	0
active	I-DISEASE
neurons	0
in	0
a	0
murine	0
sleep	0
apnea	I-DISEASE
model	I-DISEASE
.	0

J	0
Neurosci	0
2007;27:10060–71	0
.	0

Hypersomnia	0
Due	0
to	0
a	0
Medication	0
or	I-DISEASE
Substance	I-DISEASE
ICD-9	0
-	I-DISEASE
CM	I-DISEASE
code	0
:	0
292.85	0
(	0
drug	0
-	0
induced	0
)	I-DISEASE
;	0
291.82	I-DISEASE
(	0
alcohol	0
-	0
induced	I-DISEASE
)	I-DISEASE
ICD-10	0
-	0
CM	I-DISEASE
code	0
:	0
F11	0
-	I-DISEASE
F19	0
(	0
see	0
table	0
in	0
Appendix	I-DISEASE
B	0
for	0
detailed	0
coding	I-DISEASE
instructions	0
)	0

Alternate	0
Names	0
Hypersomnia	0
due	0
to	0
substance	0
abuse	0
,	0
hypersomnia	0
due	0
to	0
stimulant	0
withdrawal	0
,	0
hyper-	0
somnia	0
due	0
to	I-DISEASE
sedative	0
abuse	0
,	0
toxic	0
hypersomnia	0
,	0
toxic	I-DISEASE
encephalopathy	0
.	0

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
C	I-DISEASE
must	0
be	0
met	I-DISEASE
A.	0

The	0
patient	0
has	0
daily	0
periods	0
of	0
irrepressible	I-DISEASE
need	0
to	0
sleep	0
or	0
daytime	0
lapses	0
into	0
sleep	0
.	0

B.	0
The	0
daytime	0
sleepiness	0
occurs	0
as	I-DISEASE
a	0
consequence	0
of	I-DISEASE
current	0
medication	0
or	I-DISEASE
substance	0
use	0
or	I-DISEASE
withdrawal	0
from	0
a	I-DISEASE
wake	0
-	0
promoting	0
medication	I-DISEASE
or	I-DISEASE
substance	0
.	I-DISEASE

C.	0

The	0
symptoms	0
are	0
not	0
better	I-DISEASE
explained	I-DISEASE
by	0
another	0
untreated	I-DISEASE
sleep	0
disorder	0
,	0
medical	I-DISEASE
or	0
neurological	I-DISEASE
disorder	0
,	0
or	I-DISEASE
mental	0
disorder	I-DISEASE
.	0

Central	0
Disorders	0
of	0
Hypersomnolence	0
Central	0
Disorders	I-DISEASE
of	0
Hypersomnolence	0
Essential	I-DISEASE
Features	0
Patients	0
with	0
this	I-DISEASE
disorder	0
have	I-DISEASE
excessive	0
nocturnal	0
sleep	I-DISEASE
,	0
daytime	0
sleepiness	0
,	0
or	0
excessive	0
napping	0
that	I-DISEASE
is	0
attributable	I-DISEASE
to	B-DISEASE
sedating	0
medications	0
,	I-DISEASE
alcohol	0
,	0
or	0
drugs	0
of	I-DISEASE
abuse	I-DISEASE
.	0

This	0
diagnosis	0
also	0
includes	B-DISEASE
hypersomnolence	0
associated	0
with	0
withdrawal	0
from	0
amphetamines	0
and	0
other	0
drugs	0
.	0

If	0
narcolepsy	0
or	0
hypersomnolence	0
existed	0
prior	0
to	0
stimulant	0
abuse	I-DISEASE
,	0
the	0
diagnosis	0
of	0
hypersomnia	0
due	0
to	0
a	0
medication	I-DISEASE
or	0
substance	0
should	0
not	0
be	0
used	I-DISEASE
.	I-DISEASE

Associated	0
Features	0
Associated	0
features	0
reflect	0
those	0
of	0
the	0
medications	I-DISEASE
or	0
substances	0
responsible	0
.	0

Clinical	0
and	0
Pathological	0
Subtypes	I-DISEASE
Hypersomnia	0
due	0
to	I-DISEASE
sedating	0
medications	0
:	0
Sedation	0
is	0
a	0
common	0
side	I-DISEASE
effect	0
of	0
many	0
prescription	0
medications	0
including	0
benzodiazepines	0
,	0
nonbenzodiazepine	0
hypnot-	0
ics	0
,	0
opioids	0
,	0
barbiturates	0
,	0
anticonvulsants	0
,	0
antipsychotics	0
,	0
anticholinergics	I-DISEASE
,	I-DISEASE
and	I-DISEASE
some	0
antidepressants	I-DISEASE
and	0
antihistamines	0
.	0

Sleepiness	0
also	0
can	0
occur	B-DISEASE
with	0
some	0
dopamine	0
agonists	0
such	I-DISEASE
as	0
pramipexole	0
or	I-DISEASE
ropinirole	0
,	0
and	0
with	0
many	0
antiseizure	I-DISEASE
medications	0
.	0

Though	0
less	0
common	0
,	0
sleepiness	0
can	I-DISEASE
also	0
occur	0
with	I-DISEASE
nonsteroidal	0
anti	0
-	0
inflammatory	0
drugs	0
,	0
some	0
antibiotics	0
,	I-DISEASE
antispasmodics	0
,	0
antiarryhthmics	0
,	0
and	0
beta	0
-	I-DISEASE
blockers	0
.	0

Over	0
-	0
the-	0
counter	I-DISEASE
medications	0
,	0
such	0
as	0
valerian	0
and	0
melatonin	0
,	0
can	0
produce	0
sedation	I-DISEASE
.	0

Excessive	0
sleepiness	0
is	0
especially	I-DISEASE
common	0
when	0
these	I-DISEASE
drugs	0
are	0
used	0
in	0
elderly	0
patients	0
or	I-DISEASE
those	0
with	0
multiple	I-DISEASE
medical	I-DISEASE
conditions	0
,	0
or	0
in	0
combination	0
.	0

Some	0
tolerance	0
to	0
the	0
sedative	I-DISEASE
effects	I-DISEASE
can	0
occur	0
with	I-DISEASE
time	0
.	0

Hypersomnia	0
due	0
to	0
substance	0
abuse	0
:	I-DISEASE
Daytime	0
sleepiness	0
can	I-DISEASE
occur	0
with	0
abuse	0
of	I-DISEASE
alcohol	I-DISEASE
,	I-DISEASE
benzodiazepines	0
,	0
barbiturates	I-DISEASE
,	0
gamma	0
hydroxybutyrate	0
,	0
opiates	0
,	0
and	0
marijuana	0
.	I-DISEASE

Hypersomnia	0
due	0
to	0
stimulant	0
withdrawal	0
:	I-DISEASE
Daytime	0
sleepiness	0
is	0
common	0
with	0
abrupt	0
discontinuation	I-DISEASE
of	0
stimulants	I-DISEASE
.	I-DISEASE

In	0
chronically	0
heavy	0
amphetamine	0
users	0
,	0
sleepiness	I-DISEASE
is	0
most	I-DISEASE
severe	0
in	I-DISEASE
the	0
first	0
week	0
of	I-DISEASE
withdrawal	0
and	I-DISEASE
can	I-DISEASE
persist	I-DISEASE
for	I-DISEASE
up	0
to	0
three	0
weeks	I-DISEASE
;	I-DISEASE
indi-	0
viduals	I-DISEASE
may	I-DISEASE
have	0
an	0
increase	I-DISEASE
in	0
total	0
sleep	0
and	0
daytime	0
napping	I-DISEASE
,	I-DISEASE
but	0
sleep	0
may	I-DISEASE
seem	0
fragmented	0
and	0
nonrestorative	I-DISEASE
.	I-DISEASE

Significant	0
depression	0
often	0
accompanies	0
the	0
hyper-	0
somnolence	0
.	0

Infrequently	0
,	0
sleepiness	0
may	0
be	0
a	0
residual	I-DISEASE
complaint	I-DISEASE
in	I-DISEASE
those	0
who	0
have	0
used	0
stimulants	0
in	0
the	0
past	0
but	0
have	I-DISEASE
been	0
abstinent	0
for	0
many	0
years	0
.	I-DISEASE

In	0
people	0
who	I-DISEASE
regularly	0
consume	0
coffee	0
or	0
other	0
sources	I-DISEASE
of	0
caffeine	0
,	0
discontinuation	I-DISEASE
can	0
produce	I-DISEASE
sleepiness	0
,	0
fatigue	B-DISEASE
,	0
and	0
inattentiveness	0
for	0
two	0
to	0
nine	I-DISEASE
days	0
.	0

Demographics	0
Patients	0
of	0
any	0
age	0
can	0
experience	B-DISEASE
sleepiness	0
from	0
sedating	0
medications	0
.	0

Stimulant	0
abuse	0
and	0
the	I-DISEASE
consequent	0
sleepiness	I-DISEASE
during	I-DISEASE
withdrawal	I-DISEASE
are	I-DISEASE
most	0
common	0
in	I-DISEASE
adoles-	0
cents	0
and	I-DISEASE
young	0
adults	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
Sleepiness	0
from	I-DISEASE
sedating	I-DISEASE
medications	0
may	I-DISEASE
be	0
more	0
common	I-DISEASE
in	I-DISEASE
older	0
patients	0
and	I-DISEASE
in	0
those	0
with	0
multiple	I-DISEASE
medical	0
problems	0
.	0

Familial	0
Patterns	0
Not	0
applicable	0
or	0
known	0
.	I-DISEASE

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Onset	I-DISEASE
,	0
course	0
,	0
and	0
complications	0
reflect	0
those	0
of	I-DISEASE
the	0
medications	0
or	0
substances	0
responsible	0
.	0

Pathology	0
and	0
Pathophysiology	0
Not	0
applicable	0
or	I-DISEASE
known	I-DISEASE
.	0

Objective	0
Findings	0
Polysomnography	0
is	I-DISEASE
generally	0
unnecessary	I-DISEASE
unless	0
a	0
concomitant	I-DISEASE
sleep	0
disorder	0
is	0
sus-	I-DISEASE
pected	0
.	I-DISEASE

Polysomnography	0
and	0
MSLT	0
results	0
vary	0
depending	I-DISEASE
on	I-DISEASE
the	0
specific	I-DISEASE
substance	0
in	0
question	0
and	0
the	I-DISEASE
timing	I-DISEASE
of	0
the	0
most	I-DISEASE
recent	0
intake	I-DISEASE
.	I-DISEASE

With	0
stimulant	0
withdrawal	0
,	0
noc-	0
turnal	0
polysomnography	I-DISEASE
may	0
show	I-DISEASE
normal	0
sleep	0
,	I-DISEASE
whereas	0
the	0
MSLT	I-DISEASE
typically	0
demon-	0
strates	I-DISEASE
a	0
short	0
mean	0
sleep	0
latency	I-DISEASE
with	0
or	I-DISEASE
without	I-DISEASE
multiple	0
SOREMPs	I-DISEASE
.	I-DISEASE

A	0
urine	0
tox-	0
icology	I-DISEASE
screen	0
may	0
be	I-DISEASE
positive	0
for	I-DISEASE
the	0
suspected	0
substance	I-DISEASE
.	0

The	0
diagnosis	0
is	0
often	0
confirmed	0
if	0
symptoms	0
resolve	0
after	0
the	0
causal	0
agent	0
is	0
removed	0
.	I-DISEASE

Differential	0
Diagnosis	0
Major	0
sleep	0
disorders	0
that	I-DISEASE
are	I-DISEASE
associated	I-DISEASE
with	I-DISEASE
excessive	0
sleepiness	0
,	0
especially	0
SRBDs	0
,	I-DISEASE
periodic	0
limb	0
movement	I-DISEASE
disorder	0
,	0
narcolepsy	0
,	0
IH	I-DISEASE
,	0
and	I-DISEASE
insufficient	I-DISEASE
sleep	0
syndrome	0
should	0
be	0
ruled	0
out	0
.	0

A	0
urine	0
drug	0
screen	0
should	0
routinely	0
accompany	0
an	0
MSLT	I-DISEASE
as	0
the	0
use	0
of	I-DISEASE
or	0
withdrawal	I-DISEASE
from	0
some	I-DISEASE
medications	0
or	0
substances	0
may	0
affect	I-DISEASE
MSLT	0
test	0
results	0
.	0

Although	0
many	0
psychotropic	0
medications	0
may	0
result	0
in	I-DISEASE
daytime	0
sleepiness	I-DISEASE
,	0
it	0
is	0
import-	I-DISEASE
ant	0
for	I-DISEASE
clinicians	0
to	0
recognize	I-DISEASE
that	0
many	0
psychiatric	0
disorders	0
also	0
are	0
associated	I-DISEASE
with	0
increased	0
prevalence	0
of	0
other	0
sleep	0
disorders	0
(	0
e.g.	0
,	0
insomnia	0
,	0
SRBD	I-DISEASE
,	0
circadian	I-DISEASE
disor-	0
ders	0
,	0
and	0
movement	0
disorders	0
)	I-DISEASE
.	I-DISEASE

Although	0
sedative	0
effects	0
of	0
the	0
psychotropic	0
agents	I-DISEASE
Central	I-DISEASE
Disorders	I-DISEASE
of	0
Hypersomnolence	0
Central	0
Disorders	0
of	0
Hypersomnolence	I-DISEASE
may	0
contribute	0
to	I-DISEASE
sleepiness	0
,	0
clinicians	0
must	0
maintain	0
a	0
high	0
index	0
of	0
suspicion	I-DISEASE
for	0
other	I-DISEASE
sleep	0
related	0
etiologies	0
.	0

When	0
other	0
sleep	0
disorders	I-DISEASE
are	0
identified	0
,	0
multiple	0
diag-	I-DISEASE
noses	0
may	0
be	0
appropriate	0
.	0

Unresolved	0
Issues	0
and	0
Future	0
Directions	I-DISEASE
Sedatives	I-DISEASE
can	I-DISEASE
worsen	0
sleep	I-DISEASE
related	0
breathing	0
disorders	0
,	0
and	0
more	I-DISEASE
research	0
is	I-DISEASE
needed	I-DISEASE
to	0
understand	0
and	0
manage	0
this	0
interaction	0
.	I-DISEASE

Bibliography	0
Ancoli	0
-	0
Israel	0
S.	0
Sleep	0
and	0
its	0
disorders	0
in	0
aging	0
populations	0
.	0

Sleep	0
Med	0
2009;10	I-DISEASE
Suppl	0
1	0
:	I-DISEASE
S7–11	I-DISEASE
.	0

España	0
RA	0
,	0
Scammell	0
TE	0
.	0

Sleep	0
neurobiology	0
from	0
a	0
clinical	0
perspective	0
.	I-DISEASE

Sleep	0
2011;34:845–58	0
.	0

Gillin	0
JC	0
,	0
Smith	0
TL	0
,	0
Irwin	I-DISEASE
M	0
,	I-DISEASE
Butters	0
N	0
,	0
Demodena	0
A	0
,	I-DISEASE
Schuckit	0
M.	0
Increased	I-DISEASE
pressure	0
for	I-DISEASE
rapid	0
eye	0
movement	0
sleep	0
at	I-DISEASE
time	I-DISEASE
of	0
hospital	I-DISEASE
admission	0
predicts	0
relapse	0
in	I-DISEASE
nondepressed	0
patients	0
with	0
primary	I-DISEASE
alcoholism	I-DISEASE
at	I-DISEASE
3	0
-	0
month	0
follow	0
-	0
up	0
.	I-DISEASE

Arch	0
Gen	0
Psychiatry	0
1994;51:189–97	0
.	0

Guilleminault	0
C	0
,	I-DISEASE
Brooks	0
SN	0
.	0

Excessive	0
daytime	0
sleepiness	0
:	I-DISEASE
a	0
challenge	I-DISEASE
for	0
the	0
practicing	I-DISEASE
neurologist	0
.	0

Brain	0
2001;124:1482–91	0
.	0

Juliano	0
LM	0
,	0
Griffiths	I-DISEASE
RR	0
.	0

A	0
critical	0
review	I-DISEASE
of	0
caffeine	0
withdrawal	0
:	I-DISEASE
empirical	0
validation	I-DISEASE
of	0
symptoms	0
and	0
signs	I-DISEASE
,	0
incidence	0
,	I-DISEASE
severity	0
,	I-DISEASE
and	0
associated	0
features	0
.	0

Psychopharmacology	0
(	0
Berl	0
)	0
2004	0
;	0
176:1–29	0
.	0

McGregor	0
C	0
,	I-DISEASE
Srisurapanont	0
M	0
,	0
Jittiwutikarn	I-DISEASE
J	I-DISEASE
,	I-DISEASE
Laobhripatr	0
S	0
,	0
Wongtan	I-DISEASE
T	0
,	0
White	I-DISEASE
JM	0
.	I-DISEASE

The	0
nature	0
,	0
time	0
course	0
and	0
severity	I-DISEASE
of	0
methamphetamine	I-DISEASE
withdrawal	0
.	0

Addiction	0
2005;100:1320–9	0
.	0

Mogri	0
M	0
,	0
Desai	0
H	0
,	0
Webster	0
L	0
,	0
Grant	0
BJ	0
,	0
Mador	0
MJ	0
.	I-DISEASE

Hypoxemia	0
in	0
patients	0
on	I-DISEASE
chronic	0
opiate	0
therapy	I-DISEASE
with	0
and	0
without	0
sleep	0
apnea	0
.	0

Sleep	0
Breath	0
2009;13:49–57	0
.	0

Punjabi	0
NM	0
.	0

The	0
epidemiology	0
of	0
adult	I-DISEASE
obstructive	0
sleep	0
apnea	I-DISEASE
.	0

Proc	0
Am	0
Thorac	0
Soc	0
2008;5:136–43	I-DISEASE
.	I-DISEASE

Qureshi	0
A	0
,	0
Lee	0
-	0
Chiong	0
T.	I-DISEASE
Medications	0
and	0
their	0
effects	0
on	0
sleep	I-DISEASE
.	0

Med	0
Clin	I-DISEASE
North	0
Am	I-DISEASE
2004;88:751–66	0
.	0

Roehrs	0
T	I-DISEASE
,	0
Roth	I-DISEASE
T.	0
Sleep	0
,	I-DISEASE
sleepiness	0
,	0
and	0
alcohol	0
use	I-DISEASE
.	0

Alcohol	0
Res	0
Health	0
2001;25:101–9	0
.	0

Roehrs	0
T	I-DISEASE
,	0
Bonahoom	I-DISEASE
A	0
,	0
Pedrosi	I-DISEASE
B	I-DISEASE
,	I-DISEASE
Zorick	0
F	0
,	0
Roth	0
T.	I-DISEASE
Nighttime	I-DISEASE
versus	0
daytime	0
hypnotic	I-DISEASE
self-	0
administration	0
.	0

Psychopharmacology	0
2002;161:137–42	0
.	0

Schweitzer	0
P.	0
Drugs	0
that	0
disturb	0
sleep	0
and	I-DISEASE
wakefulness	0
.	I-DISEASE

In	0
:	0
Kryger	0
MH	0
,	I-DISEASE
Roth	0
T	I-DISEASE
,	0
Dement	I-DISEASE
WC	0
,	0
eds	0
.	0

Principles	0
and	I-DISEASE
practice	0
of	I-DISEASE
sleep	0
medicine	I-DISEASE
,	I-DISEASE
5th	0
ed	I-DISEASE
.	0

St	0
Louis	0
:	0
Elsevier	0
Saunders	0
,	0
2011:542–60	0
.	0

William	0
Ishak	I-DISEASE
W	0
,	I-DISEASE
Ugochukwu	I-DISEASE
C	I-DISEASE
,	I-DISEASE
Bagot	I-DISEASE
K	I-DISEASE
,	0
Khalili	I-DISEASE
D	0
,	0
Zaky	0
C.	I-DISEASE
Energy	I-DISEASE
drinks	I-DISEASE
:	I-DISEASE
psychological	0
effects	I-DISEASE
and	0
impact	0
on	0
well	0
-	I-DISEASE
being	0
and	0
quality	I-DISEASE
of	0
life	I-DISEASE
-	0
a	I-DISEASE
literature	0
review	0
.	0

Innov	0
Clin	0
Neurosci	0
2012;9:25–34	I-DISEASE
.	0

Hypersomnia	0
Associated	0
with	0
a	0
Psychiatric	0
Disorder	0
ICD-9	I-DISEASE
-	0
CM	I-DISEASE
code	0
:	0
327.15	0
ICD-10	0
-	0
CM	I-DISEASE
code	I-DISEASE
:	0
F51.13	0
Alternate	0
Names	0
Hypersomnia	0
not	I-DISEASE
due	0
to	0
substance	I-DISEASE
or	0
known	0
physiological	0
condition	0
,	0
nonorganic	0
hypersomnia	0
,	0
pseudohypersomnia	0
,	I-DISEASE
or	I-DISEASE
pseudonarcolepsy	0
.	I-DISEASE

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
C	I-DISEASE
must	0
be	0
met	I-DISEASE
A.	0

The	0
patient	0
has	0
daily	0
periods	0
of	0
irrepressible	I-DISEASE
need	I-DISEASE
to	I-DISEASE
sleep	0
or	0
daytime	0
lapses	0
into	I-DISEASE
sleep	I-DISEASE
occurring	0
for	0
at	I-DISEASE
least	0
three	I-DISEASE
months	0
.	0

B.	0
The	0
daytime	0
sleepiness	0
occurs	0
in	I-DISEASE
association	0
with	0
a	0
concurrent	0
psychiatric	0
disorder	0
.	0

C.	0

The	0
symptoms	0
are	0
not	0
better	I-DISEASE
explained	I-DISEASE
by	I-DISEASE
another	0
untreated	I-DISEASE
sleep	0
disorder	0
,	0
a	I-DISEASE
medical	0
or	I-DISEASE
neurological	0
disorder	0
,	I-DISEASE
or	0
the	I-DISEASE
effects	0
of	0
medications	0
or	0
drugs	I-DISEASE
.	0

Essential	0
Features	0
Patients	0
with	0
hypersomnia	B-DISEASE
associated	0
with	I-DISEASE
a	0
psychiatric	I-DISEASE
disorder	0
may	0
report	0
excessive	0
nocturnal	0
sleep	I-DISEASE
,	0
daytime	0
sleepiness	I-DISEASE
,	0
or	I-DISEASE
excessive	0
napping	I-DISEASE
.	0

In	0
addition	0
,	0
they	0
often	0
feel	I-DISEASE
their	I-DISEASE
sleep	0
is	I-DISEASE
of	0
poor	0
quality	0
and	I-DISEASE
nonrestorative	0
.	0

Patients	0
are	0
often	B-DISEASE
intensely	0
focused	0
on	I-DISEASE
their	I-DISEASE
hypersomnolence	0
,	0
and	0
psychiatric	0
symptoms	0
may	0
become	0
apparent	I-DISEASE
only	0
after	0
prolonged	I-DISEASE
interviews	0
or	0
psychometric	0
testing	0
.	0

Associated	0
psychiatric	0
conditions	0
include	0
mood	I-DISEASE
disorders	0
,	I-DISEASE
conversion	0
or	I-DISEASE
undifferentiated	0
somatoform	0
disorder	0
,	0
and	0
less	I-DISEASE
frequently	I-DISEASE
other	I-DISEASE
mental	I-DISEASE
disorders	0
such	0
as	0
schizoaffective	0
disorder	0
,	0
adjustment	I-DISEASE
disor-	0
der	I-DISEASE
,	I-DISEASE
or	0
personality	0
disorders	0
.	0

Associated	0
Features	0
Poor	0
work	0
attendance	0
,	0
spending	I-DISEASE
full	0
days	I-DISEASE
in	0
bed	0
several	0
times	I-DISEASE
a	0
week	I-DISEASE
,	I-DISEASE
or	0
abruptly	I-DISEASE
leaving	I-DISEASE
work	0
because	0
of	0
a	0
perceived	0
need	I-DISEASE
to	0
sleep	0
are	I-DISEASE
common	0
symptoms	0
.	0

Patients	0
may	0
also	B-DISEASE
have	0
social	0
withdrawal	0
,	0
apathy	0
,	I-DISEASE
and	0
feelings	0
of	0
low	0
energy	0
.	I-DISEASE

Clinical	0
and	0
Pathological	0
Subtypes	0
Hypersomnia	0
associated	0
with	0
mood	0
disorder	0
:	0

Hypersomnolence	0
in	0
the	0
context	0
of	0
depression	0
is	I-DISEASE
a	0
frequent	0
feature	I-DISEASE
of	0
atypical	0
depression	0
and	0
bipolar	I-DISEASE
II	0
disorder	0
(	I-DISEASE
recur-	0
rent	0
major	0
depressive	0
episodes	0
with	0
hypomanic	0
episodes	I-DISEASE
)	0
.	I-DISEASE

In	0
seasonal	0
affective	0
disor-	0
der	0
,	0
daytime	I-DISEASE
fatigue	0
,	0
loss	0
of	0
concentration	0
,	0
increased	0
appetite	I-DISEASE
for	I-DISEASE
carbohydrates	0
,	I-DISEASE
and	0
weight	0
gain	0
are	0
reported	I-DISEASE
.	0

MSLT	0
results	0
are	0
usually	0
normal	0
,	0
but	0
long	0
hours	0
spent	0
in	0
bed	0
are	0
reported	0
.	I-DISEASE

Central	0
Disorders	0
of	0
Hypersomnolence	0
Central	0
Disorders	I-DISEASE
of	0
Hypersomnolence	0
Hypersomnia	I-DISEASE
associated	0
with	0
a	0
conversion	0
disorder	0
or	I-DISEASE
somatic	0
symptom	0
disorder	I-DISEASE
:	0
Pseudohypersomnia	0
or	0
pseudonarcolepsy	0
,	0
sometimes	0
with	0
pseudocataplexy	0
,	0
has	I-DISEASE
been	0
described	I-DISEASE
.	0

Demographics	0
Hypersomnia	0
associated	0
with	0
a	I-DISEASE
psychiatric	0
disorder	I-DISEASE
accounts	0
for	0
5	0
%	0
to	0
7	0
%	0
of	I-DISEASE
hyper-	I-DISEASE
somnolence	0
cases	I-DISEASE
.	0

Women	0
are	0
more	0
susceptible	0
than	0
men	0
,	0
and	0
the	I-DISEASE
typical	I-DISEASE
age	0
range	0
is	I-DISEASE
between	0
20	0
and	0
50	0
years	0
.	0

In	0
patients	0
with	I-DISEASE
major	0
depression	0
,	0
the	I-DISEASE
prevalence	I-DISEASE
of	I-DISEASE
hypersom-	0
nolence	0
ranges	0
from	0
5	0
%	I-DISEASE
to	I-DISEASE
over	0
50	I-DISEASE
%	0
depending	0
on	0
how	0
hypersomnolence	0
is	I-DISEASE
defined	I-DISEASE
.	0

Hypersomnolence	0
affects	0
over	0
50	0
%	0
of	0
patients	I-DISEASE
with	0
seasonal	I-DISEASE
affective	0
disorder	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
Not	0
applicable	I-DISEASE
or	I-DISEASE
known	0
.	0

Familial	0
Patterns	0
Not	0
known	0
,	0
except	0
for	I-DISEASE
the	0
familial	I-DISEASE
patterns	0
of	0
certain	0
psychiatric	I-DISEASE
disorders	0
(	I-DISEASE
e.g.	0
,	0
bipolar	I-DISEASE
II	0
disorder	0
)	0
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
The	I-DISEASE
mean	0
age	I-DISEASE
of	0
onset	0
is	0
usually	0
in	0
the	I-DISEASE
third	0
decade	0
in	I-DISEASE
both	0
sexes	I-DISEASE
.	0

With	0
major	0
depres-	0
sion	I-DISEASE
,	I-DISEASE
hypersomnolence	0
may	I-DISEASE
persist	0
even	I-DISEASE
after	0
the	0
depressive	0
episode	0
improves	0
,	I-DISEASE
and	0
persistent	0
hypersomnolence	B-DISEASE
is	0
associated	0
with	0
increased	0
risk	I-DISEASE
of	I-DISEASE
recurrent	I-DISEASE
depression	0
.	0

Complications	0
are	0
mostly	0
social	0
and	I-DISEASE
occupational	0
.	0

Developmental	0
Issues	0
Hypersomnolence	0
occurs	0
in	0
10	0
%	I-DISEASE
to	0
20	I-DISEASE
%	0
of	0
children	0
with	0
major	0
depression	0
,	0
some-	0
times	0
in	0
combination	I-DISEASE
with	0
insomnia	0
,	0
but	0
sleep	0
quality	0
appears	0
normal	0
.	0

Although	0
sleep	0
problems	0
may	0
develop	0
at	0
any	I-DISEASE
stage	0
of	0
depression	0
,	0
they	0
are	0
most	0
pronounced	0
during	0
the	0
acute	I-DISEASE
phase	0
.	0

Children	0
and	0
adolescents	0
with	B-DISEASE
depression	0
who	0
manifest	I-DISEASE
either	0
insomnia	I-DISEASE
or	0
hypersomnolence	0
generally	0
manifest	0
more	0
pronounced	I-DISEASE
symptoms	0
,	0
such	0
as	0
anhedo-	0
nia	0
and	0
weight	0
loss	0
.	I-DISEASE

Pathology	0
and	0
Pathophysiology	0
The	0
underlying	0
cause	I-DISEASE
is	I-DISEASE
unknown	0
.	I-DISEASE

Although	0
patients	0
with	I-DISEASE
this	0
disorder	0
report	I-DISEASE
sleep-	0
iness	I-DISEASE
,	I-DISEASE
sleep	0
studies	0
reveal	0
little	I-DISEASE
or	0
no	I-DISEASE
evidence	0
of	0
increased	I-DISEASE
propensity	0
to	0
sleep	0
.	0

In	0
some	0
patients	0
,	I-DISEASE
fragmented	0
nighttime	0
sleep	I-DISEASE
may	0
contribute	I-DISEASE
to	0
their	0
daytime	0
sleepiness	0
.	0

Because	0
of	0
uncertainty	0
about	0
the	0
nature	I-DISEASE
of	I-DISEASE
the	0
relationship	I-DISEASE
,	0
the	0
term	I-DISEASE
“	0
hypersomnia	0
associated	I-DISEASE
with	0
a	0
psychiatric	0
disorder	0
”	0
is	0
preferred	0
to	0
“	0
hypersomnia	I-DISEASE
due	0
to	0
a	I-DISEASE
psychi-	0
atric	0
disorder	0
.	0
”	0

Objective	0
Findings	0
Nocturnal	0
polysomnography	I-DISEASE
typically	0
shows	I-DISEASE
a	I-DISEASE
prolonged	0
total	I-DISEASE
time	0
in	0
bed	0
with	I-DISEASE
frag-	0
mented	I-DISEASE
sleep	0
.	0

Sleep	0
latency	I-DISEASE
is	0
prolonged	0
,	0
wake	I-DISEASE
time	I-DISEASE
after	I-DISEASE
sleep	I-DISEASE
onset	0
is	I-DISEASE
increased	0
,	I-DISEASE
awakenings	0
may	I-DISEASE
be	I-DISEASE
frequent	0
and	I-DISEASE
prolonged	0
,	I-DISEASE
and	0
sleep	0
efficiency	I-DISEASE
is	0
low	I-DISEASE
.	I-DISEASE

REM	0
sleep	0
latency	0
may	I-DISEASE
be	0
shortened	0
in	0
the	I-DISEASE
case	I-DISEASE
of	0
untreated	0
depression	0
.	0

Sleep	0
latencies	0
on	0
the	0
MSLT	0
are	I-DISEASE
often	I-DISEASE
within	0
normal	0
limits	0
,	0
a	0
result	0
contrasting	0
with	0
the	0
subjective	0
complaint	0
of	0
daytime	0
sleepiness	0
and	0
an	0
elevated	I-DISEASE
score	0
on	0
the	0
Epworth	0
Sleepiness	0
Scale	0
.	I-DISEASE

24	0
-	I-DISEASE
hour	I-DISEASE
continuous	0
sleep	0
-	I-DISEASE
recording	I-DISEASE
studies	I-DISEASE
typically	I-DISEASE
show	0
considerable	0
time	I-DISEASE
spent	0
in	0
bed	0
during	0
day	I-DISEASE
and	0
night	0
,	I-DISEASE
a	0
behavior	0
sometime	0
referred	I-DISEASE
to	0
as	0
clinophilia	0
.	I-DISEASE

Psychiatric	0
inter-	0
views	0
and	0
evaluations	0
are	0
essential	I-DISEASE
to	0
diagnose	I-DISEASE
the	0
underlying	0
psychiatric	0
condition	0
.	0

Differential	0
Diagnosis	0
As	0
there	0
are	0
no	I-DISEASE
definitive	0
tests	I-DISEASE
for	I-DISEASE
diagnosing	0
hypersomnolence	I-DISEASE
associated	0
with	0
a	0
psy-	I-DISEASE
chiatric	0
disorder	0
,	I-DISEASE
it	0
is	0
essential	0
to	0
rule	0
out	0
other	0
common	0
causes	0
of	0
sleepiness	0
such	0
as	0
insufficient	0
sleep	0
,	0
sedation	0
from	0
medications	0
or	0
substances	0
,	0
SRBD	0
,	I-DISEASE
periodic	0
limb	0
movement	0
disorder	I-DISEASE
,	I-DISEASE
and	I-DISEASE
IH	0
.	0

Chronic	0
fatigue	0
syndrome	0
is	0
characterized	0
by	0
persistent	I-DISEASE
or	0
relapsing	0
fatigue	0
that	0
does	0
not	0
resolve	0
with	I-DISEASE
sleep	0
or	I-DISEASE
rest	I-DISEASE
,	0
but	I-DISEASE
the	0
main	0
complaint	0
is	0
usually	I-DISEASE
fatigue	0
rather	0
than	I-DISEASE
sleepiness	0
.	0

Insufficient	0
sleep	0
syndrome	0
is	0
associated	0
with	I-DISEASE
excessive	I-DISEASE
daytime	0
sleepiness	I-DISEASE
,	0
impaired	0
concentration	0
,	I-DISEASE
and	0
lowered	I-DISEASE
energy	0
level	0
,	I-DISEASE
but	0
a	0
detailed	0
history	0
of	0
the	0
subject	I-DISEASE
’s	0
current	0
sleep	I-DISEASE
schedule	I-DISEASE
reveals	0
chronic	0
sleep	0
deprivation	0
.	0

Unresolved	0
Issues	0
and	0
Future	0
Directions	I-DISEASE

The	0
lack	0
of	0
concordance	I-DISEASE
between	I-DISEASE
subjective	0
and	I-DISEASE
objective	0
findings	I-DISEASE
raises	0
multiple	0
issues	0
.	0

It	0
is	0
unclear	0
to	0
what	0
extent	I-DISEASE
these	I-DISEASE
patients	0
are	I-DISEASE
objectively	0
sleepy	0
or	0
,	0
instead	0
,	I-DISEASE
suffer	0
from	0
decreased	I-DISEASE
energy	0
and	0
lack	0
of	0
interest	I-DISEASE
that	I-DISEASE
confines	I-DISEASE
them	I-DISEASE
to	I-DISEASE
bed	I-DISEASE
.	0

More	0
research	0
is	0
needed	0
to	0
create	0
an	0
effective	I-DISEASE
definition	I-DISEASE
of	0
hypersomnolence	0
in	0
this	0
population	0
and	0
to	0
develop	0
tools	I-DISEASE
for	0
measuring	0
it	0
.	0

Finally	0
,	0
future	0
efforts	0
should	0
define	0
the	I-DISEASE
mechanism	0
through	I-DISEASE
which	0
some	0
patients	0
express	I-DISEASE
their	0
psychiatric	0
symptoms	0
as	0
excessive	0
sleepiness	0
.	0

Bibliography	0
Guilleminault	0
C	I-DISEASE
,	0
Brooks	0
SN	I-DISEASE
.	I-DISEASE

Excessive	0
daytime	0
sleepiness	0
:	I-DISEASE
a	0
challenge	I-DISEASE
for	0
the	0
practicing	I-DISEASE
neurologist	0
.	0

Brain	0
2001;124:1282–91	0
.	0

Kaplan	0
KA	0
,	0
Harvey	0
AG	0
.	I-DISEASE

Hypersomnia	0
across	0
mood	0
disorders	0
:	0
a	I-DISEASE
review	I-DISEASE
and	0
synthesis	I-DISEASE
.	0

Sleep	0
Med	0
Rev	I-DISEASE
2009;13:275–85	0
.	B-DISEASE

Kotagal	0
S.	I-DISEASE
Hypersomnia	0
in	0
children	0
:	0
interface	0
with	0
psychiatric	0
disorders	0
.	0

Child	0
Adolesc	0
Psychiatr	0
Clin	0
N	0
Am	0
2009;18:967–77	I-DISEASE
.	0

Liu	0
X	0
,	0
Buysse	0
DJ	0
,	0
Gentzler	I-DISEASE
AL	0
,	I-DISEASE
et	0
al	0
.	0

Insomnia	0
and	0
hypersomnia	0
associated	0
with	0
depressive	I-DISEASE
phenomenology	I-DISEASE
and	0
comorbidity	I-DISEASE
in	0
childhood	0
depression	0
.	0

Sleep	0
2007;30:83–90	0
.	0

Nofzinger	0
EA	0
,	0
Thase	0
ME	0
,	0
Reynolds	I-DISEASE
CF	0
3rd	0
,	0
et	0
al	0
.	0

Hypersomnia	0
in	0
bipolar	0
depression	0
:	0
a	0
comparison	0
with	0
narcolepsy	0
using	0
the	0
Multiple	0
Sleep	0
Latency	0
Test	0
.	0

Am	0
J	0
Psychiatry	0
1991;148:1177–81	0
.	0

Central	0
Disorders	0
of	0
Hypersomnolence	0
Central	0
Disorders	I-DISEASE
of	0
Hypersomnolence	0
Partonen	I-DISEASE
T	0
,	0
Lönnqvist	0
J.	I-DISEASE
Seasonal	0
affective	I-DISEASE
disorder	0
.	0

Lancet	0
1998;352:1369–74	0
.	0

van	0
den	0
Berg	0
JF	0
,	0
Luijendijk	0
HJ	I-DISEASE
,	0
Tulen	I-DISEASE
JH	0
,	0
Hofman	I-DISEASE
A	0
,	0
Neven	I-DISEASE
AK	I-DISEASE
,	0
Tiemeier	0
H.	0
Sleep	0
in	0
depression	0
and	0
anxiety	I-DISEASE
disorders	I-DISEASE
:	0
a	0
population	0
-	0
based	0
study	0
of	0
elderly	0
persons	0
.	0

J	0
Clin	0
Psychiatry	I-DISEASE
2009;70:1105–13	0
.	0

Vgontzas	0
AN	0
,	0
Bixler	I-DISEASE
EO	0
,	0
Kales	I-DISEASE
A	0
,	I-DISEASE
Criley	0
C	0
,	0
Vela	0
-	0
Bueno	I-DISEASE
A.	0
Differences	0
in	I-DISEASE
nocturnal	0
and	I-DISEASE
daytime	I-DISEASE
sleep	0
between	0
primary	0
and	I-DISEASE
psychiatric	I-DISEASE
hypersomnia	0
:	I-DISEASE
diagnosis	0
and	0
treatment	0
implications	I-DISEASE
.	0

Psychosom	0
Med	0
2000;62:220–6	I-DISEASE
.	0

Insufficient	0
Sleep	0
Syndrome	0
ICD-9	0
-	0
CM	I-DISEASE
code	I-DISEASE
:	0
307.44	I-DISEASE
ICD-10	0
-	0
CM	0
code	0
:	0

F51.12	0
Alternate	0
Names	0
Behaviorally	0
induced	0
insufficient	I-DISEASE
sleep	I-DISEASE
syndrome	0
,	I-DISEASE
insufficient	0
nocturnal	0
sleep	0
,	0
chronic	I-DISEASE
sleep	I-DISEASE
deprivation	0
,	0
sleep	I-DISEASE
restriction	0
.	I-DISEASE

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
F	I-DISEASE
must	0
be	0
met	I-DISEASE
A.	0

The	0
patient	0
has	0
daily	0
periods	0
of	0
irrepressible	I-DISEASE
need	I-DISEASE
to	I-DISEASE
sleep	0
or	0
daytime	0
lapses	0
into	I-DISEASE
sleep	I-DISEASE
or	0
,	0
in	I-DISEASE
the	0
case	I-DISEASE
of	0
prepubertal	0
children	0
,	I-DISEASE
there	I-DISEASE
is	0
a	0
complaint	I-DISEASE
of	0
behavioral	0
abnormalities	I-DISEASE
attributable	0
to	0
sleepiness	0
.	0

B.	0
The	0
patient	0
’s	0
sleep	0
time	0
,	0
established	I-DISEASE
by	I-DISEASE
personal	0
or	0
collateral	0
history	I-DISEASE
,	0
sleep	I-DISEASE
logs	I-DISEASE
,	I-DISEASE
or	I-DISEASE
actigraphy1	0
is	I-DISEASE
usually	0
shorter	0
than	0
expected	0
for	I-DISEASE
age.2	0
C.	0

The	0
curtailed	0
sleep	0
pattern	0
is	0
present	I-DISEASE
most	0
days	0
for	I-DISEASE
at	0
least	0
three	0
months	I-DISEASE
.	0

D.	0

The	0
patient	0
curtails	0
sleep	0
time	0
by	0
such	I-DISEASE
measures	0
as	I-DISEASE
an	0
alarm	0
clock	0
or	0
being	0
awakened	I-DISEASE
by	0
another	0
person	I-DISEASE
and	0
generally	0
sleeps	0
longer	0
when	0
such	I-DISEASE
measures	I-DISEASE
are	0
not	0
used	I-DISEASE
,	0
such	0
as	I-DISEASE
on	I-DISEASE
weekends	0
or	0
vacations	0
.	0

E.	0
Extension	0
of	0
total	0
sleep	0
time	0
results	I-DISEASE
in	0
resolution	0
of	0
the	0
symptoms	0
of	I-DISEASE
sleepiness	0
.	I-DISEASE

F.	0

The	0
symptoms	0
are	0
not	0
better	I-DISEASE
explained	I-DISEASE
by	0
another	0
untreated	I-DISEASE
sleep	0
disorder	0
,	0
the	I-DISEASE
effects	0
of	I-DISEASE
medications	I-DISEASE
or	0
drugs	I-DISEASE
,	0
or	0
other	0
medical	0
,	0
neurologic	0
,	I-DISEASE
or	0
mental	0
disorder	B-DISEASE
.	0

Notes	0
.	0

If	0
there	0
is	I-DISEASE
doubt	0
about	0
the	0
accuracy	I-DISEASE
of	0
personal	I-DISEASE
history	0
or	0
sleep	0
logs	I-DISEASE
,	0
then	I-DISEASE
actigraphy	I-DISEASE
should	0
be	I-DISEASE
performed	0
,	0
preferably	0
for	0
at	0
least	I-DISEASE
two	I-DISEASE
weeks	0
.	I-DISEASE
.	I-DISEASE

In	0
the	0
case	I-DISEASE
of	0
long	0
sleepers	0
,	I-DISEASE
reported	0
habitual	I-DISEASE
sleep	0
periods	0
may	0
be	I-DISEASE
normal	0
based	I-DISEASE
on	I-DISEASE
age	0
.	0

However	0
,	I-DISEASE
these	0
sleep	0
periods	I-DISEASE
may	0
be	B-DISEASE
insufficient	I-DISEASE
for	I-DISEASE
these	0
patients	0
.	I-DISEASE

Essential	0
Features	0
Insufficient	0
sleep	0
syndrome	0
occurs	0
when	I-DISEASE
an	I-DISEASE
individual	I-DISEASE
persistently	0
fails	0
to	0
obtain	0
the	0
amount	0
of	0
sleep	0
required	I-DISEASE
to	I-DISEASE
maintain	I-DISEASE
normal	0
levels	0
of	0
alertness	0
and	0
wakefulness	0
.	0

The	0
individual	0
is	0
chronically	0
sleep	0
deprived	0
as	I-DISEASE
a	0
result	I-DISEASE
of	0
failure	0
to	0
achieve	0
necessary	0
sleep	I-DISEASE
time	0
due	I-DISEASE
to	I-DISEASE
reduced	0
time	0
in	I-DISEASE
bed	0
.	0

There	0
is	0
a	0
U	0
-	0
shaped	0
relationship	0
between	0
age	0
and	0
average	0
sleep	0
time	I-DISEASE
,	0
with	I-DISEASE
the	0
minimum	I-DISEASE
in	I-DISEASE
middle	0
-	0
aged	0
individuals	0
.	0

Examination	0
reveals	I-DISEASE
unimpaired	I-DISEASE
or	0
above	0
-	0
average	I-DISEASE
ability	0
to	I-DISEASE
initiate	0
and	0
maintain	I-DISEASE
sleep	0
,	0
with	I-DISEASE
little	0
or	I-DISEASE
no	I-DISEASE
psychopathology	0
.	0

Physical	0
examination	0
reveals	0
no	I-DISEASE
medical	0
explanation	0
for	0
the	0
patient	I-DISEASE
’s	0
sleepiness	0
.	0

A	0
detailed	0
history	0
of	0
the	0
sleep	I-DISEASE
pattern	I-DISEASE
reveals	0
a	I-DISEASE
substantial	0
dis-	0
parity	0
between	0
the	0
need	I-DISEASE
for	0
sleep	0
and	I-DISEASE
the	0
amount	0
actually	0
obtained	0
.	I-DISEASE

The	0
significance	0
of	0
this	0
disparity	0
often	0
goes	0
unappreciated	0
by	I-DISEASE
the	0
patient	0
.	0

Sleep	0
time	0
that	0
is	0
markedly	0
extended	I-DISEASE
on	0
weekend	0
nights	0
or	0
during	0
holidays	0
compared	I-DISEASE
to	0
weekday	I-DISEASE
nights	0
is	0
also	0
suggestive	0
of	0
this	0
disorder	0
.	0

A	0
therapeutic	0
trial	0
of	0
a	0
longer	0
major	I-DISEASE
sleep	0
episode	I-DISEASE
can	0
reverse	0
the	0
symptoms	I-DISEASE
.	0

In	0
individuals	0
with	0
physiologic	0
sleep	0
requirements	I-DISEASE
significantly	I-DISEASE
in	0
excess	0
of	I-DISEASE
seven	0
to	I-DISEASE
eight	0
hours	0
,	I-DISEASE
reported	0
“	0
average	I-DISEASE
”	0
amounts	0
of	0
sleep	0
(	0
e.g.	0
,	I-DISEASE
seven	0
hours	I-DISEASE
/	I-DISEASE
night	0
)	0
may	0
,	0
in	0
fact	0
,	0
be	0
insufficient	I-DISEASE
.	I-DISEASE

Additional	0
symptoms	0
such	0
as	0
sleep	0
paralysis	I-DISEASE
and	0
hypnagogic	0
hallucinations	I-DISEASE
may	0
occur	0
.	I-DISEASE

Associated	0
Features	0
Depending	0
upon	0
chronicity	0
and	0
extent	I-DISEASE
of	0
sleep	I-DISEASE
loss	0
,	I-DISEASE
individuals	0
with	0
this	0
condition	I-DISEASE
may	0
show	I-DISEASE
irritability	I-DISEASE
,	0
concentration	I-DISEASE
and	I-DISEASE
attention	0
deficits	0
,	0
reduced	I-DISEASE
vigilance	0
,	0
distract-	I-DISEASE
ibility	0
,	0
reduced	I-DISEASE
motivation	0
,	0
anergia	0
,	0
dysphoria	I-DISEASE
,	I-DISEASE
fatigue	I-DISEASE
,	0
restlessness	0
,	I-DISEASE
uncoordination	0
,	0
and	0
malaise	I-DISEASE
.	0

Secondary	0
symptoms	0
may	0
become	0
the	0
main	I-DISEASE
focus	0
of	0
the	I-DISEASE
patient	I-DISEASE
,	0
serving	0
to	0
obscure	0
the	0
primary	I-DISEASE
cause	0
of	I-DISEASE
the	0
difficulties	I-DISEASE
.	0

Psychologically	0
and	0
somatically	0
normal	0
individuals	0
who	0
chronically	I-DISEASE
obtain	0
less	I-DISEASE
sleep	0
than	0
they	0
physiologically	I-DISEASE
require	0
typi-	I-DISEASE
cally	0
experience	0
daytime	0
sleepiness	0
.	I-DISEASE

Situational	0
factors	0
such	0
as	0
demands	0
of	0
the	I-DISEASE
family	0
and	I-DISEASE
work	I-DISEASE
schedule	0
may	0
,	0
on	0
occasion	I-DISEASE
,	0
make	0
it	0
very	0
difficult	0
to	0
obtain	0
adequate	0
sleep	0
.	I-DISEASE

Clinical	0
and	0
Pathophysiologic	0
Subtypes	I-DISEASE
Not	I-DISEASE
applicable	I-DISEASE
or	I-DISEASE
known	0
.	0

Demographics	0
Insufficient	0
sleep	0
syndrome	0
affects	0
all	0
ages	0
and	0
both	I-DISEASE
sexes	0
.	I-DISEASE

It	0
may	0
be	0
more	I-DISEASE
frequent	0
in	I-DISEASE
adolescence	0
,	0
when	I-DISEASE
sleep	0
need	0
is	0
high	I-DISEASE
,	0
but	I-DISEASE
social	I-DISEASE
pressure	0
and	I-DISEASE
tendency	0
to	I-DISEASE
delay	0
sleep	0
often	0
lead	0
to	I-DISEASE
chronic	I-DISEASE
restricted	0
sleep	I-DISEASE
.	0

Cultural	0
factors	0
may	0
also	0
influence	0
sleep	I-DISEASE
dura-	I-DISEASE
tion	I-DISEASE
,	I-DISEASE
with	0
students	0
from	0
different	0
countries	0
reporting	I-DISEASE
sleep	0
time	0
varying	I-DISEASE
between	0
six	I-DISEASE
and	0
eight	0
hours	0
per	0
night	I-DISEASE
.	0

Central	0
Disorders	0
of	0
Hypersomnolence	0
Central	0
Disorders	I-DISEASE
of	0
Hypersomnolence	0
Predisposing	I-DISEASE
and	0

Precipitating	0
Factors	0
Social	0
and	0
psychological	0
factors	I-DISEASE
may	I-DISEASE
impact	0
nocturnal	I-DISEASE
sleep	0
length	0
and	0
daytime	0
sleep-	0
iness	0
.	I-DISEASE

Cultural	0
habits	0
such	0
as	0
the	0
siesta	I-DISEASE
may	I-DISEASE
enhance	0
evening	I-DISEASE
alertness	0
at	0
the	0
expense	0
of	0
reducing	I-DISEASE
nocturnal	0
sleep	0
efficiency	I-DISEASE
.	0

Also	0
,	0
the	0
evening	B-DISEASE
preference	0
chronotype	0
predis-	B-DISEASE
poses	0
to	0
complaints	0
of	0
insomnia	0
and	I-DISEASE
insufficient	0
sleep	I-DISEASE
.	0

The	0
association	0
of	0
eveningness	0
with	0
insufficient	0
sleep	0
persists	0
after	I-DISEASE
controlling	0
for	0
variables	0
such	0
as	0
sex	0
,	0
age	0
,	0
and	0
sleep	0
duration	0
.	0

Familial	0
Patterns	0
Not	0
applicable	0
or	0
known	0
.	I-DISEASE

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
This	I-DISEASE
condition	0
results	I-DISEASE
in	0
increased	I-DISEASE
daytime	0
sleepiness	I-DISEASE
,	0
concentration	0
problems	I-DISEASE
,	0
lowered	I-DISEASE
energy	0
level	0
,	0
and	0
malaise	0
.	0

If	0
unchecked	0
,	0
insufficient	0
sleep	0
syndrome	0
may	I-DISEASE
predispose	I-DISEASE
to	I-DISEASE
depression	0
and	0
other	0
psychological	0
difficulties	0
,	I-DISEASE
as	I-DISEASE
well	I-DISEASE
as	I-DISEASE
poor	0
work	0
performance	0
and	0
withdrawal	0
from	0
family	I-DISEASE
and	0
social	I-DISEASE
activities	I-DISEASE
.	0

Abuse	0
of	0
stimulants	0
may	0
also	0
occur	0
.	I-DISEASE

Traffic	0
accidents	0
or	0
injury	0
at	0
work	I-DISEASE
may	0
result	0
.	I-DISEASE

Developmental	0
Issues	0
Insufficient	0
sleep	I-DISEASE
syndrome	0
is	0
a	I-DISEASE
common	0
problem	I-DISEASE
in	I-DISEASE
adolescents	0
.	0

It	0
should	0
be	0
differ-	I-DISEASE
entiated	0
from	I-DISEASE
delayed	0
sleep	0
phase	0
disorder	0
,	0
the	I-DISEASE
effects	0
of	0
recreational	I-DISEASE
drug	I-DISEASE
use	0
,	I-DISEASE
and	0
school	0
avoidance	0
behavior	0
.	I-DISEASE

Increased	0
predisposition	0
to	0
substance	0
use	0
and	0
accidents	0
in	0
teens	I-DISEASE
may	0
be	0
consequent	0
to	0
insufficient	0
sleep	I-DISEASE
.	I-DISEASE

Pathology	0
and	0
Pathophysiology	0
Symptoms	0
are	0
due	I-DISEASE
to	I-DISEASE
normal	0
physiological	I-DISEASE
and	0
psychological	0
responses	0
to	0
sleep	0
depri-	0
vation	0
.	0

Sleep	0
restriction	I-DISEASE
studies	0
in	0
normal	0
volunteers	0
have	I-DISEASE
shown	0
that	0
even	0
mild	0
sleep	I-DISEASE
restriction	I-DISEASE
(	0
for	I-DISEASE
example	0
,	0
six	I-DISEASE
hours	0
of	I-DISEASE
nocturnal	0
sleep	0
per	0
night	I-DISEASE
)	I-DISEASE
results	I-DISEASE
in	I-DISEASE
a	0
correspond-	0
ing	0
decrease	0
in	I-DISEASE
performance	0
and	0
increased	0
sleepiness	0
.	0

Sleep	0
restriction	0
to	0
four	0
hours	0
per	I-DISEASE
night	I-DISEASE
(	I-DISEASE
i.e.	I-DISEASE
,	0
extension	0
of	0
wakefulness	0
to	0
20	I-DISEASE
hours	0
per	I-DISEASE
day	I-DISEASE
)	0
will	0
likely	0
lead	0
to	0
greater	I-DISEASE
buildup	I-DISEASE
of	0
homeostatic	0
sleep	I-DISEASE
drive	0
during	0
the	0
waking	I-DISEASE
hours	0
and	0
greater	0
likelihood	I-DISEASE
of	0
impaired	I-DISEASE
performance	I-DISEASE
on	I-DISEASE
a	I-DISEASE
psychomotor	I-DISEASE
vigilance	0
task	0
.	0

The	0
effects	0
of	0
sleep	0
depriva-	0
tion	I-DISEASE
on	I-DISEASE
neurobehavioral	0
performance	I-DISEASE
measures	0
may	0
vary	0
with	0
the	0
nature	I-DISEASE
of	0
the	0
task	I-DISEASE
being	0
considered	0
.	0

In	0
some	0
long	0
sleepers	0
,	0
it	I-DISEASE
is	I-DISEASE
important	0
to	I-DISEASE
be	I-DISEASE
aware	0
that	0
extending	0
sleep	0
to	0
nine	I-DISEASE
or	0
more	I-DISEASE
hours	0
often	0
results	0
in	0
improved	0
performance	0
.	I-DISEASE

The	0
diagnosis	0
of	0
insufficient	0
sleep	0
syn-	I-DISEASE
drome	0
may	0
be	I-DISEASE
especially	0
difficult	0
to	0
make	I-DISEASE
in	0
subjects	0
who	0
have	0
a	I-DISEASE
physiologic	0
need	0
for	0
unusually	0
large	0
amounts	I-DISEASE
of	0
sleep	0
.	0

Objective	0
Findings	0
Actigraphy	0
combined	I-DISEASE
with	0
sleep	I-DISEASE
diaries	I-DISEASE
maintained	I-DISEASE
for	I-DISEASE
a	0
2-	0
to	I-DISEASE
3	0
-	0
week	I-DISEASE
period	0
may	0
be	I-DISEASE
helpful	I-DISEASE
by	I-DISEASE
documenting	0
total	0
time	I-DISEASE
in	0
bed	I-DISEASE
,	I-DISEASE
sleep	I-DISEASE
latency	I-DISEASE
,	B-DISEASE
total	I-DISEASE
sleep	0
time	0
,	0
and	0
sleep	I-DISEASE
efficiency	0
.	0

Polysomnography	0
and	0
MSLT	0
are	0
not	0
required	I-DISEASE
to	I-DISEASE
establish	0
a	0
diagnosis	0
of	I-DISEASE
insufficient	0
sleep	0
syndrome	0
.	I-DISEASE

Rather	0
,	0
sleep	0
time	I-DISEASE
is	0
extended	0
first	I-DISEASE
,	0
and	I-DISEASE
the	0
patient	0
is	0
reevaluated	0
.	0

If	0
a	0
therapeutic	0
trial	0
with	0
a	0
longer	I-DISEASE
sleep	0
episode	I-DISEASE
eliminates	0
the	0
symptoms	0
,	I-DISEASE
insufficient	0
sleep	I-DISEASE
syndrome	0
is	I-DISEASE
diagnosed	I-DISEASE
.	0

Polysomnography	0
,	0
when	0
performed	0
,	0
reveals	I-DISEASE
reduced	I-DISEASE
sleep	0
onset	I-DISEASE
latency	0
,	I-DISEASE
and	I-DISEASE
high	I-DISEASE
(	0
greater	0
than	0
90	0
%	I-DISEASE
)	I-DISEASE
sleep	I-DISEASE
efficiency	0
.	0

When	0
extended	0
sleep	0
is	I-DISEASE
permitted	0
,	0
prolonged	I-DISEASE
sleep	0
time	I-DISEASE
with	0
slow	0
wave	I-DISEASE
rebound	0
may	0
be	I-DISEASE
seen	0
.	0

Noting	0
a	0
disparity	I-DISEASE
between	0
reported	0
sleep	0
at	I-DISEASE
home	0
and	0
observed	0
total	0
sleep	0
time	0
in	0
the	I-DISEASE
sleep	I-DISEASE
laboratory	0
can	0
be	I-DISEASE
helpful	I-DISEASE
.	0

The	0
MSLT	0
reveals	0
excessive	0
sleepiness	I-DISEASE
,	I-DISEASE
with	I-DISEASE
stage	0
N1	I-DISEASE
sleep	0
occurring	0
in	0
most	0
naps	I-DISEASE
,	0
with	0
short	0
sleep	0
latency	0
.	0

Stage	0
N2	0
sleep	0
occurs	I-DISEASE
in	0
more	0
than	0
80	0
%	0
of	0
MSLT	0
naps	0
.	0

SOREMPs	0
can	0
occur	0
.	0

Differential	0
Diagnosis	0
Insufficient	0
sleep	0
syndrome	0
may	I-DISEASE
be	0
confused	0
with	I-DISEASE
narcolepsy	0
or	I-DISEASE
other	0
hypersom-	I-DISEASE
nolence	0
disorders	I-DISEASE
because	0
an	0
abnormal	I-DISEASE
MSLT	0
(	0
even	0
with	0
two	0
SOREMPs	0
)	0
can	0
be	I-DISEASE
observed	I-DISEASE
as	0
the	0
result	I-DISEASE
of	I-DISEASE
acute	0
or	0
chronic	0
sleep	0
deprivation	0
.	I-DISEASE

The	0
confusion	0
may	0
be	0
most	0
frequently	0
encountered	0
in	0
adolescents	0
or	0
young	0
adults	0
.	0

The	0
differential	0
diagno-	0
sis	0
of	0
insufficient	0
sleep	I-DISEASE
syndrome	0
includes	I-DISEASE
numerous	0
other	0
conditions	I-DISEASE
that	I-DISEASE
may	0
result	I-DISEASE
in	0
daytime	0
sleepiness	I-DISEASE
or	0
shortening	0
of	0
nocturnal	0
sleep	I-DISEASE
duration	0
.	0

These	0
include	0
other	I-DISEASE
central	I-DISEASE
disorders	0
of	I-DISEASE
hypersomnolence	I-DISEASE
,	I-DISEASE
long	I-DISEASE
sleeper	0
or	0
short	0
sleeper	0
,	0
SRBD	I-DISEASE
,	0
circadian	I-DISEASE
rhythm	I-DISEASE
sleep	0
disorders	0
,	0
insomnia	B-DISEASE
disorder	0
,	0
affective	0
disorder	0
,	0
and	0
periodic	B-DISEASE
limb	0
move-	I-DISEASE
ment	0
disorder	0
.	0

Unresolved	0
Issues	0
and	0
Future	0
Directions	I-DISEASE

The	0
correlation	0
between	0
subjectively	0
reported	0
sleepiness	0
,	I-DISEASE
performance	I-DISEASE
-	I-DISEASE
test	0
decre-	0
ments	0
,	0
and	0
MSLT	I-DISEASE
-	I-DISEASE
measured	0
sleepiness	0
after	0
sleep	I-DISEASE
deprivation	0
is	0
poor	0
.	0

Short	0
sleepers	0
often	I-DISEASE
have	0
a	0
higher	0
NREM	I-DISEASE
sleep	0
pressure	0
,	0
as	0
measured	I-DISEASE
by	I-DISEASE
EEG	0
delta	I-DISEASE
power	0
,	0
than	I-DISEASE
long	0
sleepers	0
,	0
even	0
if	0
they	0
do	I-DISEASE
not	I-DISEASE
complain	0
of	I-DISEASE
daytime	0
sleepiness	0
.	0

There	0
is	0
interindividual	0
susceptibility	0
to	0
sleep	I-DISEASE
deprivation	I-DISEASE
,	I-DISEASE
with	0
some	0
people	0
being	0
consistently	0
more	0
tired	I-DISEASE
and	I-DISEASE
experiencing	I-DISEASE
greater	I-DISEASE
performance	0
decrement	0
after	0
even	0
a	I-DISEASE
mild	I-DISEASE
degree	0
of	0
sleep	0
deprivation	I-DISEASE
.	0

Bibliography	0
Carskadon	0
MA	0
,	0
Dement	0
WC	0
.	I-DISEASE

Effects	0
of	0
total	0
sleep	0
loss	0
on	0
sleep	0
tendency	0
.	I-DISEASE

Percept	0
Mot	0
Skills	0
1979;48:495–506	0
.	0

Central	0
Disorders	0
of	0
Hypersomnolence	0
Central	0
Disorders	I-DISEASE
of	0
Hypersomnolence	0
Habeck	I-DISEASE
C	0
,	0
Rakitin	0
BC	0
,	0
Moeller	I-DISEASE
J	0
,	0
et	I-DISEASE
al	0
.	0

An	0
event	0
related	0
fMRI	I-DISEASE
study	0
of	I-DISEASE
the	I-DISEASE
neurobehavioral	0
impact	I-DISEASE
of	I-DISEASE
sleep	0
deprivation	0
on	0
performance	0
of	I-DISEASE
a	0
delayed	0
match	I-DISEASE
to	I-DISEASE
sample	I-DISEASE
task	I-DISEASE
.	0

Cogn	0
Brain	0
Res	0
2004;18:306–21	B-DISEASE
.	0

Merikanto	0
I	I-DISEASE
,	I-DISEASE
Kronholm	0
E	0
,	0
Peltonen	I-DISEASE
M	0
,	I-DISEASE
Laatikainen	0
T	0
,	0
Lahti	0
T	0
,	0
Partonen	0
T.	0
Relation	I-DISEASE
of	0
chronotype	I-DISEASE
to	0
sleep	0
complaints	0
in	I-DISEASE
the	I-DISEASE
general	0
Finnish	0
population	I-DISEASE
.	I-DISEASE

Chronobiol	0
Int	0
2012;29:311–7	0
.	0

Mont	0
TH	0
,	0
Buysse	0
DJ	0
,	0
Carrier	0
J	0
,	I-DISEASE
Bart	0
BD	0
,	0
Rose	0
LR	0
.	0

Effects	0
of	0
afternoon	0
“	0
siesta	0
”	I-DISEASE
naps	0
on	0
sleep	I-DISEASE
,	0
alertness	0
,	I-DISEASE
performance	0
,	0
and	0
circadian	0
rhythms	0
in	I-DISEASE
the	0
elderly	0
.	0

Sleep	0
2001;24:680–7	0
.	0

Mu	0
Q	0
,	0
Mishory	0
A	0
,	I-DISEASE
Johnson	0
KA	0
,	I-DISEASE
et	0
al	0
.	0

Decreased	0
brain	0
activation	0
during	0
a	0
working	I-DISEASE
memory	I-DISEASE
task	0
at	I-DISEASE
rested	0
wakefulness	0
is	0
associated	I-DISEASE
with	0
vulnerability	I-DISEASE
to	0
sleep	0
deprivation	I-DISEASE
.	0

Sleep	0
2005;28:433–46	0
.	0

Roehrs	0
T	I-DISEASE
,	0
Zorick	I-DISEASE
F	0
,	I-DISEASE
Sicklesteel	0
J	0
,	I-DISEASE
Wittig	0
R	0
,	0
Roth	0
T.	0
Excessive	I-DISEASE
daytime	0
sleepiness	0
associated	I-DISEASE
with	0
insufficient	I-DISEASE
sleep	0
.	0

Sleep	0
1983;6:319–25	0
.	0

Taylor	0
DJ	0
,	0
Bramoweth	0
AD	0
.	0

Patterns	0
and	0
consequences	0
of	I-DISEASE
inadequate	0
sleep	I-DISEASE
among	I-DISEASE
college	0
students	I-DISEASE
:	0
substance	0
use	0
and	0
motor	0
vehicle	I-DISEASE
accidents	I-DISEASE
.	I-DISEASE

J	0
Adolesc	0
Health	0
2010;46:610–2	0
.	0

Tucker	0
AM	0
,	0
Whitney	0
P	0
,	0
Belenky	I-DISEASE
G	0
,	0
Hinson	0
JM	0
,	0
Van	0
Dongen	0
HPA	0
.	I-DISEASE

Effects	0
of	0
sleep	0
deprivation	I-DISEASE
on	0
dissociated	I-DISEASE
components	I-DISEASE
of	0
executive	0
functioning	0
.	0

Sleep	0
2010;33:47–57	0
.	0

Van	0
Dongen	0
HP	0
,	0
Maislin	0
G	0
,	I-DISEASE
Mullington	0
JM	I-DISEASE
,	I-DISEASE
Dinges	0
DF	0
.	0

The	0
cumulative	0
cost	I-DISEASE
of	0
additional	0
wakefulness	I-DISEASE
:	I-DISEASE
dose	0
-	I-DISEASE
response	0
effects	0
on	0
neurobehavioral	0
functions	0
and	I-DISEASE
sleep	0
physiology	0
from	I-DISEASE
chronic	0
sleep	0
restriction	0
and	0
total	I-DISEASE
sleep	0
deprivation	0
.	0

Sleep	0
2003;26:117–26	0
.	0

Isolated	0
Symptoms	0
and	0
Normal	0
Variants	0
Long	B-DISEASE
Sleeper	I-DISEASE

A	0
long	0
sleeper	0
is	I-DISEASE
an	0
individual	0
who	I-DISEASE
consistently	0
sleeps	I-DISEASE
substantially	0
more	0
in	0
24	0
hours	0
than	0
does	I-DISEASE
the	0
typical	I-DISEASE
person	0
of	I-DISEASE
his	0
or	0
her	0
age	0
group	0
.	0

For	0
adults	0
,	0
the	0
usually	I-DISEASE
accepted	0
figure	I-DISEASE
is	0
10	I-DISEASE
hours	0
or	0
more	0
,	0
but	0
many	0
epidemiologic	0
studies	0
have	I-DISEASE
used	0
sleep	0
times	0
of	0
8–10	0
hours	0
.	I-DISEASE

For	0
children	0
and	I-DISEASE
adolescents	0
,	0
the	I-DISEASE
entity	I-DISEASE
should	I-DISEASE
be	I-DISEASE
considered	0
if	0
sleep	0
time	0
is	0
more	0
than	I-DISEASE
two	0
hours	I-DISEASE
longer	0
than	I-DISEASE
age	0
-	0
specific	0
norms	0
.	0

Sleep	0
,	0
although	0
long	0
,	0
is	0
basi-	I-DISEASE
cally	0
normal	I-DISEASE
in	0
architecture	0
and	0
physiology	0
.	0

Sleep	0
efficiency	0
and	I-DISEASE
timing	0
are	0
normal	0
.	0

A	0
consistent	0
daily	0
pattern	0
,	0
documented	0
by	I-DISEASE
a	0
carefully	I-DISEASE
kept	0
sleep	0
log	I-DISEASE
(	I-DISEASE
preferably	0
con-	I-DISEASE
firmed	I-DISEASE
by	I-DISEASE
actigraphy	I-DISEASE
)	0
,	0
showing	0
10	0
or	I-DISEASE
more	0
hours	I-DISEASE
of	0
sleep	0
per	I-DISEASE
night	0
over	0
a	I-DISEASE
minimum	I-DISEASE
of	0
seven	0
days	0
is	0
desirable	0
for	I-DISEASE
the	0
identification	0
of	0
the	I-DISEASE
long	0
sleeper	0
.	I-DISEASE

In	0
general	0
,	0
long	0
sleepers	0
seek	I-DISEASE
medical	I-DISEASE
help	0
when	I-DISEASE
they	0
develop	0
sleepiness	0
as	0
a	I-DISEASE
result	I-DISEASE
of	0
being	0
forced	I-DISEASE
to	0
curtail	0
their	0
sleep	0
time	0
to	0
less	I-DISEASE
than	0
their	I-DISEASE
required	0
amounts	0
.	0

Usually	0
,	0
the	0
long	I-DISEASE
sleep	0
pattern	I-DISEASE
began	0
in	0
childhood	0
,	0
is	0
well	0
established	0
by	0
early	I-DISEASE
adolescence	0
,	0
and	0
persists	0
throughout	0
life	0
.	0

Many	0
long	0
sleepers	0
,	I-DISEASE
because	0
of	0
occupational	I-DISEASE
or	0
educational	I-DISEASE
demands	0
,	0
function	0
with	0
reasonable	0
success	I-DISEASE
on	0
nine	0
hours	0
of	0
sleep	I-DISEASE
per	0
night	I-DISEASE
during	0
the	I-DISEASE
work	I-DISEASE
or	I-DISEASE
school	0
week	0
,	0
with	I-DISEASE
increases	0
to	0
12	0
or	0
more	0
hours	0
on	0
weekends	I-DISEASE
and	0
holidays	0
.	I-DISEASE

About	0
2	0
%	0
of	0
men	0
and	0
1.5	I-DISEASE
%	0
of	0
women	0
report	0
sleeping	0
at	0
least	0
10	I-DISEASE
hours	I-DISEASE
per	I-DISEASE
night	I-DISEASE
.	0

Epidemiologic	0
studies	0
have	I-DISEASE
consistently	0
found	0
an	0
increased	0
mortality	0
(	0
and	0
sometimes	0
increased	0
body	I-DISEASE
mass	I-DISEASE
index	I-DISEASE
,	I-DISEASE
lower	0
glucose	I-DISEASE
tolerance	0
,	0
higher	0
prevalence	0
of	0
type	0
2	0
dia-	0
betes	I-DISEASE
and	I-DISEASE
coronary	0
heart	I-DISEASE
disease	I-DISEASE
)	0
associated	0
with	0
long	0
sleep	0
,	0
compared	I-DISEASE
to	0
average	I-DISEASE
-	0
du-	I-DISEASE
ration	I-DISEASE
sleep	0
,	0
but	0
it	I-DISEASE
is	0
not	0
clear	0
whether	0
most	I-DISEASE
of	I-DISEASE
the	I-DISEASE
subjects	0
were	0
naturally	0
long	I-DISEASE
sleep-	0
ers	0
or	I-DISEASE
had	I-DISEASE
disorders	I-DISEASE
resulting	0
in	0
excessive	I-DISEASE
duration	I-DISEASE
of	I-DISEASE
sleep	0
.	I-DISEASE

In	0
subjects	0
older	0
than	0
60	0
years	0
,	I-DISEASE
sleep	0
duration	I-DISEASE
longer	0
than	0
9.5	0
hours	0
is	0
associated	0
with	I-DISEASE
male	0
sex	0
,	0
low	I-DISEASE
education	0
,	0
no	0
physical	0
exercise	0
,	0
and	0
more	0
physical	0
diseases	0
.	0

Long	0
(	0
>	0
nine	0
hours	0
)	I-DISEASE
sleep	I-DISEASE
duration	I-DISEASE
has	I-DISEASE
a	0
high	0
heritability	0
(	0
44	0
%	0
)	I-DISEASE
and	0
concordance	0
between	I-DISEASE
monozygotic	I-DISEASE
twins	0
,	0
which	0
is	0
higher	I-DISEASE
if	0
they	0
live	0
together	0
.	I-DISEASE

Genomewide	0
studies	0
favor	0
a	I-DISEASE
polygenic	0
origin	0
of	I-DISEASE
sleep	0
duration	I-DISEASE
,	0
with	0
influence	0
of	I-DISEASE
clock	0
and	I-DISEASE
other	0
genes	0
(	I-DISEASE
DEC2	0
,	I-DISEASE
K+	0
channel	0
regulatory	0
pro-	0
teins	I-DISEASE
genes	I-DISEASE
)	0
.	I-DISEASE

Long	0
sleepers	0
presumably	0
represent	0
the	0
extreme	0
high	I-DISEASE
end	I-DISEASE
of	I-DISEASE
the	0
normal	0
sleep	0
duration	0
continuum	0
.	I-DISEASE

Long	0
sleepers	0
,	I-DISEASE
like	I-DISEASE
short	0
sleepers	I-DISEASE
,	I-DISEASE
have	I-DISEASE
normal	I-DISEASE
absolute	0
amounts	0
of	0
stage	I-DISEASE
N3	0
sleep	I-DISEASE
,	0
unless	0
there	I-DISEASE
is	I-DISEASE
chronic	0
sleep	0
restriction	I-DISEASE
preceding	0
polysomnography	0
,	I-DISEASE
in	I-DISEASE
which	I-DISEASE
case	I-DISEASE
the	0
absolute	0
amount	0
of	I-DISEASE
N3	0
stage	0
is	0
increased	I-DISEASE
.	I-DISEASE

Amounts	0
of	0
stages	I-DISEASE
N2	0
and	0
REM	0
sleep	I-DISEASE
are	I-DISEASE
somewhat	I-DISEASE
higher	0
than	0
normal	I-DISEASE
.	0

The	0
individual	0
has	0
no	0
problem	0
with	I-DISEASE
time	0
distortion	0
or	I-DISEASE
ability	0
to	I-DISEASE
be	0
accurate	I-DISEASE
about	0
the	0
quantity	I-DISEASE
or	I-DISEASE
quality	0
of	0
sleep	0
.	0

Assuming	0
that	0
individuals	0
Central	I-DISEASE
Disorders	0
of	0
Hypersomnolence	I-DISEASE
Central	0
Disorders	I-DISEASE
of	0
Hypersomnolence	0
have	0
obtained	0
their	0
usual	I-DISEASE
sleep	0
amounts	0
for	0
several	0
nights	0
before	0
the	0
procedure	0
,	0
no	0
sleepiness	0
is	0
evident	I-DISEASE
on	0
the	0
MSLT	0
.	0

It	0
is	0
important	0
to	I-DISEASE
differentiate	0
the	0
long	I-DISEASE
sleeper	0
from	I-DISEASE
patients	0
with	0
narcolepsy	I-DISEASE
,	0
idiopathic	0
hypersomnia	I-DISEASE
,	I-DISEASE
sleep	0
disordered	I-DISEASE
breathing	0
,	I-DISEASE
or	0
medical	0
causes	0
of	0
hypersomnolence	0
.	0

Many	0
pathologic	0
causes	0
of	0
increased	0
sleep	I-DISEASE
have	I-DISEASE
an	0
acute	I-DISEASE
or	0
subacute	0
onset	0
,	0
may	0
not	I-DISEASE
be	I-DISEASE
present	0
since	I-DISEASE
childhood	0
,	I-DISEASE
and	0
rarely	0
show	0
the	0
stable	I-DISEASE
course	0
of	0
the	0
long	I-DISEASE
sleeper	0
.	0

Nevertheless	0
,	0
differentiation	0
from	0
pathologic	0
con-	0
ditions	I-DISEASE
of	0
hypersomnolence	I-DISEASE
may	0
be	0
difficult	I-DISEASE
in	I-DISEASE
the	0
child	I-DISEASE
or	0
adolescent	0
because	I-DISEASE
the	0
normal	0
continuum	0
of	0
sleep	0
duration	0
is	I-DISEASE
somewhat	I-DISEASE
higher	0
in	I-DISEASE
these	0
age	I-DISEASE
groups	0
than	I-DISEASE
in	0
adults	0
.	I-DISEASE

The	0
correct	0
determination	0
is	0
often	0
made	I-DISEASE
by	I-DISEASE
exclusion	0
of	I-DISEASE
specific	0
diagnostic	0
features	0
associated	0
with	0
other	I-DISEASE
conditions	0
and	0
by	I-DISEASE
the	0
absence	I-DISEASE
of	0
complaints	0
concerning	0
the	0
quality	I-DISEASE
of	I-DISEASE
the	0
individual	I-DISEASE
’s	0
awake	0
-	0
state	0
functioning	0
when	0
adequate	I-DISEASE
sleep	0
is	I-DISEASE
obtained	I-DISEASE
(	0
e.g.	0
,	I-DISEASE
during	0
prolonged	0
holidays	0
)	0
.	0

In	0
particular	0
,	0
the	0
differentiation	I-DISEASE
of	0
a	I-DISEASE
genuine	0
long	0
sleeper	0
from	0
a	0
patient	0
with	0
idiopathic	I-DISEASE
hypersomnia	0
may	0
be	I-DISEASE
difficult	0
.	0

In	0
the	0
genuine	I-DISEASE
long	0
sleeper	0
,	I-DISEASE
sleeping	I-DISEASE
long	0
hours	0
is	0
refreshing	0
,	0
and	0
sleepiness	0
disappears	I-DISEASE
when	0
long	0
hours	I-DISEASE
of	0
nocturnal	0
sleep	0
are	0
enforced	I-DISEASE
.	0

Bibliography	0
Aeschbach	0
D	I-DISEASE
,	0
Cajochen	0
C	0
,	I-DISEASE
Landolt	0
H	I-DISEASE
,	0
Borbély	I-DISEASE
AA	0
.	0

Homeostatic	0
sleep	0
regulation	0
in	0
habitual	0
short	0
sleepers	0
and	0
long	I-DISEASE
sleepers	0
.	0

Am	0
J	0
Physiol	0
1996;270	0
:	0
R41–53	0
.	0

Hartmann	0
E	0
,	I-DISEASE
Baekeland	I-DISEASE
F	0
,	0
Zwilling	0
GR	0
.	0

Psychological	0
differences	0
between	0
long	0
and	0
short	I-DISEASE
sleepers	I-DISEASE
.	I-DISEASE

Arch	0
Gen	0
Psychiatry	0
1972;26:463–8	0
.	0

Kripke	0
DF	0
,	0
Garfinkel	0
L	0
,	0
Wingard	I-DISEASE
DL	0
,	I-DISEASE
Klauber	0
MR	0
,	0
Marler	0
MR	0
.	I-DISEASE

Mortality	0
associated	0
with	0
sleep	0
duration	0
and	I-DISEASE
insomnia	I-DISEASE
.	0

Arch	0
Gen	0
Psychiatry	0
2002;59:131–6	0
.	0

Kripke	0
DF	0
,	0
Simons	0
RN	0
,	0
Garfinkel	I-DISEASE
L	0
,	I-DISEASE
Hammond	0
EC	0
.	0

Short	0
and	0
long	0
sleep	0
and	0
sleeping	I-DISEASE
pills	0
.	0

Is	0
increased	0
mortality	0
associated	0
?	0

Arch	0
Gen	0
Psychiatry	0
1979;36:103–16	0
.	0

Webb	0
WB	0
.	I-DISEASE

Are	0
short	0
and	0
long	0
sleepers	0
different	I-DISEASE
?	I-DISEASE

Psychol	0
Rep	0
1979;44:259–64	0
.	0

Circadian	0
Rhythm	I-DISEASE
Sleep	0
-	0
Wake	0
Disorders	0
Delayed	I-DISEASE
Sleep	0
-	I-DISEASE
Wake	0
Phase	0
Disorder	0
191	0
Advanced	0
Sleep	0
-	0
Wake	0
Phase	I-DISEASE
Disorder	0
198	0
Irregular	0
Sleep	0
-	0
Wake	0
Rhythm	I-DISEASE
Disorder204	0
Non-24	0
-	I-DISEASE
Hour	0
Sleep	0
-	0
Wake	0
Rhythm	0
Disorder	0
209	0
Shift	0
Work	I-DISEASE
Disorder	I-DISEASE
215	0
Jet	0
Lag	0
Disorder	0
220	0
Circadian	0
Sleep	I-DISEASE
-	0
Wake	I-DISEASE
Disorder	I-DISEASE
Not	0
Otherwise	I-DISEASE
Specified	0
(	0
NOS	I-DISEASE
)	0
224	0

Circadian	0
rhythms	I-DISEASE
are	0
endogenous	0
,	0
near-24	0
-	I-DISEASE
hour	0
biological	0
rhythms	I-DISEASE
that	0
exist	0
in	0
all	0
living	I-DISEASE
organisms	I-DISEASE
.	0

The	0
internal	0
near-24	0
-	0
hour	0
circadian	I-DISEASE
clock	I-DISEASE
is	0
entrained	I-DISEASE
or	0
synchro-	0
nized	0
to	0
the	0
24	0
-	0
hour	0
light	I-DISEASE
-	0
dark	0
cycle	0
.	0

In	0
humans	0
,	0
the	0
endogenous	I-DISEASE
period	0
of	0
the	I-DISEASE
circa-	0
dian	0
oscillation	0
is	0
genetically	0
determined	0
and	0
typically	0
is	0
slightly	I-DISEASE
longer	0
than	0
24	0
hours	0
.	0

In	0
order	0
to	0
maintain	0
entrainment	0
,	0
the	I-DISEASE
endogenous	0
rhythm	I-DISEASE
must	0
be	0
reset	0
each	0
day	I-DISEASE
to	0
the	0
24	0
-	I-DISEASE
hour	0
clock	0
time	0
.	0

For	0
optimal	0
sleep	0
,	I-DISEASE
the	0
actual	I-DISEASE
sleep	I-DISEASE
time	I-DISEASE
should	I-DISEASE
match	0
the	0
timing	I-DISEASE
of	I-DISEASE
the	0
circadian	I-DISEASE
rhythm	0
of	0
sleep	0
and	0
wake	I-DISEASE
propensity	0
.	I-DISEASE

Therefore	0
,	0
a	0
recurrent	0
or	0
chronic	0
pattern	0
of	0
sleep	0
and	0
wake	0
disturbance	0
may	I-DISEASE
result	0
from	I-DISEASE
disruption	0
of	0
the	0
internal	0
circa-	I-DISEASE
dian	0
timing	0
system	I-DISEASE
or	0
a	I-DISEASE
misalignment	I-DISEASE
between	0
the	0
timing	0
of	I-DISEASE
the	0
individual	0
’s	0
circadian	0
sleep	I-DISEASE
-	0
wake	I-DISEASE
propensity	I-DISEASE
and	0
the	0
24	0
-	0
hour	I-DISEASE
social	0
and	I-DISEASE
physical	0
environments	I-DISEASE
(	I-DISEASE
e.g.	0
,	I-DISEASE
sleep	I-DISEASE
episodes	I-DISEASE
scheduled	I-DISEASE
entirely	0
or	0
in	I-DISEASE
part	0
during	I-DISEASE
a	0
phase	0
of	I-DISEASE
circadian	0
alertness	0
promotion	I-DISEASE
)	0
.	I-DISEASE

As	0
used	0
herein	I-DISEASE
,	0
a	0
circadian	0
rhythm	I-DISEASE
sleep	0
-	I-DISEASE
wake	0
disorder	0
(	0
CRSWD	I-DISEASE
)	0
is	I-DISEASE
defined	0
by	0
the	I-DISEASE
following	I-DISEASE
criterion	0
:	0
The	0
disorder	I-DISEASE
is	I-DISEASE
caused	0
by	0
alterations	0
of	I-DISEASE
the	0
circadian	I-DISEASE
time	0
-	0
keeping	0
system	0
,	0
its	0
entrainment	0
mechanisms	I-DISEASE
,	0
or	0
a	I-DISEASE
misalignment	I-DISEASE
of	0
the	0
endogenous	I-DISEASE
circadian	0
rhythm	I-DISEASE
and	0
the	0
external	0
environment	I-DISEASE
.	0

Most	0
CRSWDs	0
arise	0
when	0
a	0
substantial	I-DISEASE
misalignment	I-DISEASE
exists	0
between	I-DISEASE
the	0
internal	I-DISEASE
rhythm	0
and	0
the	0
required	0
timing	I-DISEASE
of	0
the	0
patient	0
’s	I-DISEASE
school	0
,	I-DISEASE
work	0
,	I-DISEASE
or	I-DISEASE
social	0
activities	0
.	I-DISEASE

Therefore	0
,	0
measurement	0
of	0
endogenous	0
circadian	0
timing	0
is	I-DISEASE
important	0
for	0
the	I-DISEASE
accu-	0
rate	I-DISEASE
diagnosis	0
of	I-DISEASE
CRSWDs	0
.	0

In	0
addition	0
to	0
the	0
history	0
,	0
multiple	I-DISEASE
tools	0
are	0
available	0
to	0
assess	0
sleep	0
-	0
wake	0
patterns	I-DISEASE
.	0

Sleep	0
log	I-DISEASE
and	0
actigraphy	0
are	0
essential	I-DISEASE
instruments	I-DISEASE
in	0
the	I-DISEASE
evaluation	0
of	0
CRSWDs	I-DISEASE
and	I-DISEASE
should	0
be	I-DISEASE
conducted	0
for	0
at	I-DISEASE
least	0
seven	0
days	0
,	0
preferably	0
for	I-DISEASE
14	I-DISEASE
days	0
,	0
to	I-DISEASE
capture	I-DISEASE
work	I-DISEASE
and	0
non	0
-	0
work	0
days	0
.	0

Circadian	0
chronotype	I-DISEASE
(	0
Morningness-	0
Eveningness	0
Questionnaires	0
)	0
and	0
physiological	I-DISEASE
measures	0
of	0
endogenous	0
circadian	I-DISEASE
timing	0
(	0
salivary	0
or	I-DISEASE
plasma	I-DISEASE
dim	0
light	0
melatonin	0
onset	0

and	0
urinary	0
6	0
-	0
sulfatoxymelatonin	0
)	0
also	I-DISEASE
can	0
provide	I-DISEASE
important	0
diagnostic	0
information	0
.	0

Circadian	0
chronotype	I-DISEASE
is	0
a	I-DISEASE
reflec-	0
tion	0
of	0
an	0
individual	I-DISEASE
’s	0
optimal	0
timing	0
of	0
sleep	0
and	I-DISEASE
wake	0
propensity	I-DISEASE
,	I-DISEASE
as	0
well	0
as	0
other	0
Circadian	I-DISEASE
Rhythm	I-DISEASE
Sleep	I-DISEASE
-	I-DISEASE
Wake	I-DISEASE
Disorders	0
physiological	0
and	0
mental	0
functions	I-DISEASE
.	0

Several	0
questionnaires	0
can	0
be	0
used	0
to	0
assess	I-DISEASE
chro-	I-DISEASE
notype	I-DISEASE
of	0
“	0
eveningness	0
”	0
or	0
“	0
morningness	0
”	0
(	0
e.g.	0
,	0
Munich	0
Chronotype	0
Questionnaire	I-DISEASE
,	0
or	I-DISEASE
Morningness	0
-	0
Eveningness	0
Questionnaire	0
)	0
.	0

The	0
most	0
common	0
presenting	0
symptoms	0
of	0
CRSWDs	I-DISEASE
are	0
difficulty	I-DISEASE
initiating	0
and	I-DISEASE
maintaining	0
sleep	I-DISEASE
,	0
and	0
excessive	I-DISEASE
sleepiness	0
,	0
but	I-DISEASE
their	0
impact	0
extends	0
to	I-DISEASE
adverse	0
health	I-DISEASE
outcomes	0
,	0
impairments	0
in	0
social	I-DISEASE
,	I-DISEASE
occupational	0
and	0
educational	0
performance	0
,	0
and	0
safety	0
concerns	0
.	0

Important	0
advances	0
have	0
been	0
made	0
in	0
the	0
identification	I-DISEASE
of	I-DISEASE
clin-	0
ical	0
CRSWD	0
subtypes	I-DISEASE
,	0
particularly	0
in	0
the	0
area	I-DISEASE
of	0
pediatrics	0
.	0

However	0
,	I-DISEASE
the	0
challenge	I-DISEASE
remains	0
to	I-DISEASE
develop	I-DISEASE
more	0
precise	0
and	0
clinically	0
practical	0
tools	0
to	0
improve	I-DISEASE
diagnostic	0
accuracy	0
for	I-DISEASE
CRSWDs	0
.	0

General	0
Criteria	0
for	I-DISEASE
Circadian	0
Rhythm	0
Sleep	0
-	I-DISEASE
Wake	0
Disorder	I-DISEASE
Criteria	0
A	0
-	0
C	I-DISEASE
must	0
be	I-DISEASE
met	0
A.	I-DISEASE
A	I-DISEASE
chronic	0
or	0
recurrent	0
pattern	0
of	I-DISEASE
sleep	0
-	I-DISEASE
wake	0
rhythm	0
disruption	0
primarily	0
due	0
to	0
alteration	0
of	0
the	0
endogenous	0
circadian	I-DISEASE
timing	I-DISEASE
system	I-DISEASE
or	0
misalignment	0
between	0
the	0
endogenous	0
circadian	0
rhythm	I-DISEASE
and	I-DISEASE
the	I-DISEASE
sleep	I-DISEASE
-	0
wake	I-DISEASE
schedule	0
desired	0
or	I-DISEASE
required	0
by	0
an	I-DISEASE
individual	0
’s	0
physical	0
environment	I-DISEASE
or	I-DISEASE
social	0
/	I-DISEASE
work	0
schedules	B-DISEASE
.	0

B.	0
The	0
circadian	0
rhythm	0
disruption	0
leads	0
to	0
insomnia	0
symptoms	0
,	0
excessive	0
sleepiness	0
,	0
or	0
both	I-DISEASE
.	0

C.	0

The	0
sleep	0
and	0
wake	0
disturbances	I-DISEASE
cause	0
clinically	I-DISEASE
significant	0
distress	I-DISEASE
or	0
impairment	0
in	0
mental	0
,	0
physical	0
,	0
social	0
,	I-DISEASE
occupational	0
,	0
educational	0
,	0
or	0
other	I-DISEASE
important	I-DISEASE
areas	0
of	0
functioning	0
.	0

All	0
disorders	0
described	0
in	0
the	0
ensuing	I-DISEASE
section	I-DISEASE
imply	0
a	0
sleep	0
difficulty	0
that	I-DISEASE
meets	0
each	0
of	I-DISEASE
the	0
above	I-DISEASE
criteria	I-DISEASE
.	0

The	0
specific	0
features	0
that	0
characterize	0
each	0
type	I-DISEASE
of	0
CRSWD	I-DISEASE
are	0
included	0
within	0
the	0
individual	0
diagnostic	I-DISEASE
criteria	0
.	I-DISEASE

Delayed	0
Sleep	0
-	0
Wake	0
Phase	0
Disorder	0
ICD-9	I-DISEASE
-	I-DISEASE
CM	0
code	0
:	0
327.31	0
ICD-10	0
-	0
CM	I-DISEASE
code	0
:	I-DISEASE
G47.21	I-DISEASE
Alternate	0
Names	0
Delayed	0
sleep	0
phase	0
syndrome	0
,	0
delayed	0
sleep	0
phase	I-DISEASE
pattern	0
,	I-DISEASE
motivated	0
delayed	0
sleep	0
phase	0
disorder	0
.	0

Diagnostic	0
Criteria	0
Criteria	0

A	0
-	0
E	0
must	0
be	0
met	0
A.	I-DISEASE

There	0
is	0
a	0
significant	0
delay	0
in	0
the	0
phase	I-DISEASE
of	I-DISEASE
the	0
major	I-DISEASE
sleep	0
episode	I-DISEASE
in	0
relation	0
to	I-DISEASE
the	0
desired	I-DISEASE
or	0
required	0
sleep	0
time	I-DISEASE
and	0
wake	0
-	I-DISEASE
up	I-DISEASE
time	I-DISEASE
,	0
as	0
evidenced	I-DISEASE
by	0
a	0
chronic	0
or	0
recurrent	0
complaint	0
by	I-DISEASE
the	I-DISEASE
patient	0
or	I-DISEASE
a	I-DISEASE
caregiver	0
of	0
inability	0
to	0
fall	0
asleep	I-DISEASE
and	0
difficulty	0
awakening	I-DISEASE
at	0
a	I-DISEASE
desired	I-DISEASE
or	0
required	0
clock	I-DISEASE
time	0
.	0

B.	0
The	0
symptoms	0
are	0
present	0
for	0
at	0
least	0
three	I-DISEASE
months	0
.	0

C.	0
When	I-DISEASE
patients	0
are	0
allowed	0
to	0
choose	I-DISEASE
their	0
ad	I-DISEASE
libitum	0
schedule	0
,	0
they	0
will	0
exhibit	0
improved	0
sleep	0
quality	I-DISEASE
and	0
duration	I-DISEASE
for	0
age	0
and	I-DISEASE
maintain	I-DISEASE
a	0
delayed	0
phase	I-DISEASE
of	0
the	0
24	0
-	0
hour	I-DISEASE
sleep	I-DISEASE
-	0
wake	0
pattern	0
.	I-DISEASE

D.	0
Sleep	I-DISEASE
log	0
and	0
,	0
whenever	I-DISEASE
possible	I-DISEASE
,	0
actigraphy	I-DISEASE
monitoring	0
for	0
at	I-DISEASE
least	0
seven	0
days	0
(	I-DISEASE
preferably	I-DISEASE
14	0
days	0
)	I-DISEASE
demonstrate	0
a	0
delay	0
in	0
the	I-DISEASE
timing	I-DISEASE
of	0
the	0
habitual	0
sleep	I-DISEASE
period	I-DISEASE
.	I-DISEASE

Both	0
work	0
/	0
school	0
days	0
and	0
free	I-DISEASE
days	0
must	0
be	0
included	0
within	0
this	I-DISEASE
monitoring	0
.	I-DISEASE

E.	0

The	0
sleep	0
disturbance	I-DISEASE
is	0
not	0
better	I-DISEASE
explained	I-DISEASE
by	0
another	I-DISEASE
current	0
sleep	0
disorder	I-DISEASE
,	I-DISEASE
medical	0
or	0
neurological	0
disorder	0
,	I-DISEASE
mental	0
disorder	0
,	0
medication	0
use	I-DISEASE
,	0
or	I-DISEASE
substance	0
use	0
disorder	0
.	0

Notes	0
.	0

Standardized	0
chronotype	0
questionnaires	0
are	0
useful	0
tools	0
to	I-DISEASE
assess	0
the	I-DISEASE
chronotype	0
of	0
eveningness	0
and	0
morningness	0
.	I-DISEASE

Individuals	0
with	0
this	0
disorder	0
typically	0
score	0
as	0
evening	0
types	0
.	I-DISEASE

This	0
tool	0
can	0
also	0
be	0
useful	0
in	0
determining	0
whether	0
an	0
eveningness	0
circadian	0
preference	0
contributes	0
to	I-DISEASE
sleep	0
initiation	0
difficulties	I-DISEASE
among	I-DISEASE
those	0
who	0
do	0
not	0
meet	0
full	0
criteria	0
for	0
the	I-DISEASE
disorder	0
.	0
.	I-DISEASE

Demonstration	0
of	0
a	0
delay	I-DISEASE
in	0
the	0
timing	0
of	I-DISEASE
other	I-DISEASE
circadian	0
rhythms	0
,	0
such	I-DISEASE
as	0
melatonin	I-DISEASE
(	0
measured	0
by	I-DISEASE
dim	0
light	0
melatonin	0
onset	0
or	0
urinary	0
6	I-DISEASE
-	I-DISEASE
sulfatoxymelatonin	0
sampled	0
across	0
a	0
24	0
-	0
hour	0
period	0
)	0
,	0
is	I-DISEASE
desirable	0
to	0
confirm	0
the	I-DISEASE
delayed	I-DISEASE
circadian	0
phase	0
.	0

Circadian	0
Rhythm	I-DISEASE
Sleep	0
-	0
Wake	0
Disorders	0
Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	0
Wake	0
Disorders	0
Essential	I-DISEASE
Features	0
Delayed	I-DISEASE
sleep	0
-	0
wake	I-DISEASE
phase	0
disorder	0
(	0
DSWPD	0
)	0
is	I-DISEASE
characterized	0
by	0
habitual	0
sleep-	0
wake	I-DISEASE
timing	0
that	I-DISEASE
is	0
delayed	0
,	0
usually	0
more	0
than	0
two	I-DISEASE
hours	0
,	0
relative	0
to	0
conventional	0
or	I-DISEASE
socially	I-DISEASE
acceptable	I-DISEASE
timing	I-DISEASE
.	I-DISEASE

Affected	0
individuals	0
complain	0
of	B-DISEASE
difficulty	0
falling	0
asleep	I-DISEASE
at	I-DISEASE
a	I-DISEASE
socially	I-DISEASE
acceptable	0
time	0
,	I-DISEASE
as	I-DISEASE
required	I-DISEASE
to	0
obtain	0
sufficient	0
sleep	0
duration	I-DISEASE
on	0
a	I-DISEASE
school	0
or	0
work	I-DISEASE
night	0
.	0

Once	0
sleep	0
onset	0
occurs	0
,	0
it	0
is	0
reportedly	0
of	I-DISEASE
normal	0
duration	0
.	0

These	0
individ-	0
uals	0
also	0
experience	0
difficulty	0
arising	0
at	0
a	I-DISEASE
socially	0
acceptable	I-DISEASE
wake	0
time	I-DISEASE
,	0
as	I-DISEASE
required	I-DISEASE
to	I-DISEASE
prepare	I-DISEASE
for	0
school	0
or	0
work	0
.	0

When	0
allowed	0
to	0
follow	0
his	0
or	0
her	0
preferred	0
schedule	0
,	0
the	0
patient	0
’s	0
timing	0
of	0
sleep	I-DISEASE
is	0
delayed	I-DISEASE
.	0

Associated	0
Features	0
Individuals	0
with	0
DSWPD	0
may	0
demonstrate	I-DISEASE
excessive	0
sleep	I-DISEASE
inertia	I-DISEASE
(	0
extreme	I-DISEASE
difficulty	0
awakening	0
and	0
confusion	I-DISEASE
)	I-DISEASE
in	I-DISEASE
the	0
morning	0
as	0
a	I-DISEASE
result	I-DISEASE
of	0
curtailed	I-DISEASE
sleep	I-DISEASE
time	0
and	I-DISEASE
awak-	0
ening	I-DISEASE
during	0
a	0
circadian	0
phase	0
of	0
high	0
sleep	0
propensity	0
.	0

Individuals	0
with	0
this	0
disor-	0
der	0
as	I-DISEASE
well	I-DISEASE
as	0
normal	I-DISEASE
sleepers	0
with	0
evening	0
chronotypes	I-DISEASE
may	I-DISEASE
have	I-DISEASE
increased	0
rates	0
of	I-DISEASE
mental	0
disturbances	I-DISEASE
,	0
such	0
as	0
Diagnostic	I-DISEASE
and	I-DISEASE
Statistical	0
Manual	0
of	I-DISEASE
Mental	0
Disorders	0
(	0
DSM	I-DISEASE
)	0

Axis	0
I	0
disorders	0
or	0
symptoms	0
(	0
e.g.	I-DISEASE
,	0
mood	0
disorders	0
or	0
depressive	0
symptoms	0
)	0
.	0

In	0
some	0
individuals	0
with	0
DSWPD	0
,	0
there	I-DISEASE
may	0
be	I-DISEASE
an	0
overlap	0
with	0
non-24	0
-	0
hour	0
sleep-	0
wake	0
disorder	I-DISEASE
,	0
or	0
an	0
alternation	0
between	I-DISEASE
symptoms	0
of	I-DISEASE
the	0
two	0
disorders	I-DISEASE
.	0

Attempts	0
to	0
cope	0
with	0
the	0
inability	I-DISEASE
to	0
fall	0
asleep	0
earlier	0
may	0
result	0
in	0
the	0
development	0
of	0
insomnia	I-DISEASE
disorder	0
.	0

Individuals	0
may	0
use	0
alcohol	0
,	0
sedatives	0
,	I-DISEASE
hypnotics	0
,	I-DISEASE
or	0
stimulant	0
substances	0
to	I-DISEASE
alleviate	0
symptoms	0
of	0
insomnia	0
and	I-DISEASE
excessive	0
sleepiness	0
,	0
thereby	I-DISEASE
perpetuating	0
their	0
underlying	0
sleep	0
disorder	0
.	I-DISEASE

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Motivated	I-DISEASE
delayed	I-DISEASE
sleep	I-DISEASE
-	I-DISEASE
wake	I-DISEASE
phase	0
disorder	I-DISEASE
is	0
a	0
subtype	0
typically	0
composed	I-DISEASE
of	0
ado-	I-DISEASE
lescents	0
who	0
have	0
little	0
intrinsic	0
motivation	0
to	I-DISEASE
successfully	0
complete	0
treatment	0
and	0
thereby	0
resume	I-DISEASE
a	0
normal	0
lifestyle	0
(	0
regular	0
school	0
attendance	0
,	0
developmentally	0
appro-	I-DISEASE
priate	I-DISEASE
peer	0
interactions	0
,	0
etc	0
)	I-DISEASE
.	0

A	0
history	0
of	0
mood	I-DISEASE
or	0
anxiety	0
disorder	I-DISEASE
(	0
especially	I-DISEASE
school	0
phobia	0
and	0
separation	0
and	0
social	I-DISEASE
anxiety	0
)	0
or	I-DISEASE
other	0
factors	I-DISEASE
(	0
e.g.	0
,	0
learning	I-DISEASE
disabilities	0
,	0
attention	0
deficit	0
hyperactivity	0
disorder	0
)	I-DISEASE
are	0
often	0
present	0
and	0
may	0
motivate	0
the	0
patient	0
(	I-DISEASE
sometimes	0
unconsciously	I-DISEASE
)	0
to	0
avoid	I-DISEASE
a	0
return	0
to	I-DISEASE
normal	I-DISEASE
adolescent	I-DISEASE
activities	0
,	0
espe-	I-DISEASE
cially	0
regular	0
school	0
attendance	0
.	0

It	0
is	0
not	0
uncommon	I-DISEASE
that	0
ill	I-DISEASE
-	I-DISEASE
defined	0
medical	I-DISEASE
issues	0
(	0
e.g.	0
,	0
chronic	0
fatigue	I-DISEASE
,	0
recurrent	0
mononucleosis	I-DISEASE
episodes	0
,	0
pain	0
syndromes	0
)	0
trigger	0
the	I-DISEASE
onset	0
or	0
complicate	0
the	0
course	I-DISEASE
of	0
the	I-DISEASE
disorder	0
.	0

Important	0
clues	0
,	0
in	0
addition	0
to	0
the	I-DISEASE
exis-	I-DISEASE
tence	I-DISEASE
of	0
premorbid	0
mental	0
disorders	0
,	0
include	I-DISEASE
exaggerated	0
presenting	0
symptoms	I-DISEASE
(	0
e.g.	0
,	0
“	0
ca	0
n’t	0
wake	I-DISEASE
up	0
even	0
if	I-DISEASE
I	0
throw	0
cold	0
water	0
on	0
him	0
”	0
)	I-DISEASE
and	I-DISEASE
failure	I-DISEASE
to	0
comply	0
with	0
basic	0
straightforward	0
treatment	0
recommendations	I-DISEASE
(	0
e.g.	I-DISEASE
,	I-DISEASE
refusal	0
or	0
inability	0
to	0
stop	I-DISEASE
napping	I-DISEASE
during	0
the	0
day	0
)	0
.	0

Although	0
social	0
,	0
psychological	0
,	0
and	0
environmental	I-DISEASE
factors	0
may	I-DISEASE
play	0
a	0
significant	0
role	0
in	0
the	0
development	I-DISEASE
of	0
delayed	I-DISEASE
sleep	0
-	I-DISEASE
wake	0
phase	I-DISEASE
,	0
International	0
Classification	0
of	0
Sleep	0
Disorders	I-DISEASE
,	0
3rd	0
Edition	0
has	0
chosen	0
to	0
list	0
only	I-DISEASE
a	0
single	I-DISEASE
delayed	0
sleep	0
-	0
wake	0
phase	I-DISEASE
diag-	0
nosis	I-DISEASE
,	0
with	I-DISEASE
the	I-DISEASE
recognition	0
that	I-DISEASE
most	I-DISEASE
cases	0
reflect	I-DISEASE
variable	I-DISEASE
chronobiologic	0
and	I-DISEASE
behav-	0
ioral	I-DISEASE
contributions	0
.	I-DISEASE

Demographics	0
The	0
exact	0
prevalence	0
of	0
DSWPD	0
in	0
the	I-DISEASE
general	I-DISEASE
population	0
is	0
unknown	0
.	0

The	0
condition	0
is	I-DISEASE
more	0
common	0
among	0
adolescents	0
and	0
young	I-DISEASE
adults	0
,	0
with	0
a	0
reported	0
prevalence	I-DISEASE
of	0
7	I-DISEASE
%	I-DISEASE
to	0
16	0
%	0
.	0

It	0
is	0
estimated	0
that	0
DSWPD	0
is	0
seen	I-DISEASE
in	0
approximately	I-DISEASE
10	0
%	0
of	0
patients	0
pre-	0
senting	I-DISEASE
in	I-DISEASE
sleep	0
clinics	I-DISEASE
with	0
recurrent	I-DISEASE
insomnia	0
complaints	I-DISEASE
.	0

There	0
have	0
been	0
no	0
studies	0
assessing	0
racial	I-DISEASE
/	0
ethnic	0
differences	0
in	0
DSWPD	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
Most	0
individuals	I-DISEASE
with	I-DISEASE
DSWPD	0
are	I-DISEASE
evening	0
chronotypes	0
.	0

Many	0
adolescents	0
experi-	0
ence	I-DISEASE
a	0
biological	0
endogenous	I-DISEASE
shift	0
towards	0
later	0
bedtimes	0
beginning	0
around	0
puberty	0
.	I-DISEASE

Genetic	0
factors	0
such	I-DISEASE
as	0
polymorphism	0
in	I-DISEASE
the	I-DISEASE
circadian	0
clock	I-DISEASE
gene	0
hPer3	0
are	I-DISEASE
associated	0
with	0
DSWPD	I-DISEASE
.	0

Environmental	0
factors	0
,	0
including	0
decreased	0
exposure	I-DISEASE
to	I-DISEASE
light	0
during	I-DISEASE
the	0
phase	0
advance	0
region	0
of	0
the	I-DISEASE
phase	I-DISEASE
response	0
curve	I-DISEASE
(	0
PRC	I-DISEASE
)	0
(	0
i.e.	I-DISEASE
,	I-DISEASE
in	I-DISEASE
the	0
morning	0
on	0
days	0
with	0
early	I-DISEASE
wake	I-DISEASE
times	0
)	0
or	0
increased	0
exposure	I-DISEASE
to	0
bright	I-DISEASE
light	0
during	I-DISEASE
the	0
phase	0
delay	0
portion	I-DISEASE
of	I-DISEASE
the	I-DISEASE
PRC	0
(	0
i.e.	0
,	0
late	I-DISEASE
in	0
the	I-DISEASE
evening	0
)	0
may	0
exacerbate	0
the	0
delayed	0
circa-	0
dian	0
phase	I-DISEASE
.	0

Individuals	0
may	0
have	0
increased	0
sensitivity	0
in	I-DISEASE
the	0
phase	I-DISEASE
delay	I-DISEASE
region	0
or	0
decreased	0
sensitivity	I-DISEASE
in	0
the	0
phase	I-DISEASE
advance	0
region	I-DISEASE
of	0
the	0
phase	0
response	0
curve	0
to	0
light	I-DISEASE
.	I-DISEASE

Maladjustment	0
to	0
changes	0
in	0
work	I-DISEASE
and	I-DISEASE
social	I-DISEASE
schedules	0
,	0
travel	0
across	0
time	0
zones	I-DISEASE
,	0
and	0
shift	0
work	0
can	I-DISEASE
precipitate	0
this	I-DISEASE
disorder	0
.	0

Individuals	0
may	0
consume	0
excessive	I-DISEASE
caffeine	I-DISEASE
and	0
other	I-DISEASE
stimulants	0
,	I-DISEASE
which	0
may	0
further	0
delay	0
sleep	0
onset	I-DISEASE
and	I-DISEASE
thus	0
exacerbate	0
the	0
delayed	I-DISEASE
sleep	0
time	0
.	I-DISEASE

Social	0
and	0
behavioral	0
factors	0
play	0
an	I-DISEASE
important	I-DISEASE
role	I-DISEASE
in	I-DISEASE
the	0
development	0
and	0
mainte-	0
nance	0
of	0
the	I-DISEASE
delayed	0
sleep	I-DISEASE
patterns	0
for	I-DISEASE
many	0
affected	I-DISEASE
individuals	0
.	0

Personal	0
,	0
social	0
,	0
and	0
occupational	I-DISEASE
activities	I-DISEASE
that	0
continue	I-DISEASE
into	0
the	0
late	I-DISEASE
evening	0
may	0
perpetuate	I-DISEASE
and	0
exacerbate	I-DISEASE
the	0
sleep	0
phase	0
delay	0
.	0

In	0
adolescents	0
,	0
the	I-DISEASE
role	0
of	I-DISEASE
school	I-DISEASE
avoidance	0
,	I-DISEASE
social	0
maladjustment	I-DISEASE
,	0
and	0
family	I-DISEASE
dysfunction	I-DISEASE
should	0
be	I-DISEASE
considered	I-DISEASE
as	0
contributing	I-DISEASE
factors	0
.	0

Individuals	0
with	0
a	0
psychiatric	I-DISEASE
disorder	0
,	I-DISEASE
such	I-DISEASE
as	0
a	I-DISEASE
mood	0
disorder	0
(	I-DISEASE
major	I-DISEASE
depression	0
or	I-DISEASE
bipolar	0
disorder	0
)	B-DISEASE
,	0
severe	0
obsessive	I-DISEASE
-	0
compulsive	0
disorder	I-DISEASE
,	I-DISEASE
attention	0
deficit	I-DISEASE
hyperactivity	I-DISEASE
disorder	0
,	0
or	0
other	I-DISEASE
neurodevelopmental	0
disorders	0
may	0
have	0
a	0
delayed	0
sleep	0
phase	I-DISEASE
.	I-DISEASE

Circadian	0
Rhythm	I-DISEASE
Sleep	0
-	I-DISEASE
Wake	0
Disorders	0
Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	0
Wake	0
Disorders	0
Familial	I-DISEASE
Patterns	0

A	0
positive	0
family	I-DISEASE
history	0
has	0
been	0
reported	0
in	0
approximately	0
40	0
%	0
of	0
individuals	0
with	0
DSWPD	0
.	0

In	0
one	0
pedigree	0
,	0
DSWPD	0
was	I-DISEASE
suggested	0
to	0
segregate	0
as	0
an	0
autosomal	0
domi-	0
nant	0
trait	I-DISEASE
.	0

Polymorphisms	0
in	0
hPer3	0
,	0
arylalkylamine	0
N	I-DISEASE
-	0
acetyltransferase	I-DISEASE
,	I-DISEASE
human	0
leuko-	0
cyte	0
antigen	0
,	0
and	I-DISEASE
Clock	0
have	0
been	I-DISEASE
suggested	0
to	0
be	0
associated	I-DISEASE
with	0
DSWPD	0
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
A	I-DISEASE
delayed	0
sleep	0
pattern	0
typically	0
begins	0
during	0
adolescence	0
.	0

Onset	0
in	0
early	0
childhood	0
is	0
also	0
described	I-DISEASE
,	0
especially	I-DISEASE
in	0
familial	0
cases	0
;	0
the	0
onset	I-DISEASE
may	I-DISEASE
follow	0
psychological	I-DISEASE
,	0
medical	0
,	0
or	0
environmental	0
stressors	0
.	I-DISEASE

Without	0
treatment	0
,	0
DSWPD	0
is	0
a	I-DISEASE
chronic	0
condition	0
that	I-DISEASE
may	0
last	0
into	0
late	0
life	0
.	0

However	0
,	I-DISEASE
with	0
increasing	0
age	0
across	0
adulthood	0
,	0
the	I-DISEASE
timing	I-DISEASE
of	I-DISEASE
the	0
sleep	I-DISEASE
-	0
wake	I-DISEASE
cycle	I-DISEASE
may	0
advance	B-DISEASE
,	0
thereby	0
decreasing	0
the	0
propensity	I-DISEASE
to	0
delayed	I-DISEASE
sleep	0
phase	0
.	0

Phototherapy	0
,	0
as	0
well	0
as	0
behavioral	0
and	I-DISEASE
pharmacologic	0
treatments	I-DISEASE
,	0
can	0
advance	0
the	0
timing	0
of	I-DISEASE
sleep	0
hours	0
,	0
but	0
there	0
is	0
usually	0
a	I-DISEASE
continual	I-DISEASE
tendency	I-DISEASE
and	I-DISEASE
prefer-	0
ence	I-DISEASE
for	I-DISEASE
delayed	I-DISEASE
sleep	0
hours	I-DISEASE
,	0
and	0
recurrence	0
is	I-DISEASE
high	0
.	I-DISEASE

Use	0
of	0
alcohol	0
,	0
sedatives	0
,	I-DISEASE
hypnot-	I-DISEASE
ics	0
,	I-DISEASE
or	0
stimulants	0
to	I-DISEASE
treat	I-DISEASE
symptoms	0
of	I-DISEASE
insomnia	0
and	0
sleepiness	I-DISEASE
during	0
normal	0
waking	0
hours	0
may	0
lead	0
to	0
substance	0
abuse	0
.	I-DISEASE

Developmental	0
Issues	0
DSWPD	0
may	I-DISEASE
be	0
encountered	I-DISEASE
in	0
any	0
age	I-DISEASE
group	0
but	0
is	0
especially	0
prevalent	0
among	0
ado-	I-DISEASE
lescents	0
and	I-DISEASE
young	0
adults	0
.	0

In	0
addition	0
to	0
the	0
clinical	I-DISEASE
features	0
described	I-DISEASE
elsewhere	0
,	I-DISEASE
DSWPD	0
may	0
present	0
in	0
older	0
children	I-DISEASE
and	0
adolescents	0
with	I-DISEASE
chief	0
complaints	0
of	0
truancy	0
,	0
repeated	0
school	I-DISEASE
absences	0
,	0
chronic	0
tardiness	0
and/or	0
school	0
failure	0
,	0
rather	0
than	0
sleep	0
complaints	0
per	0
se	I-DISEASE
.	0

In	0
severe	0
cases	I-DISEASE
,	B-DISEASE
school	0
attendance	0
is	I-DISEASE
completely	0
curtailed	0
and	0
the	0
patient	0
may	I-DISEASE
have	I-DISEASE
failed	I-DISEASE
to	0
attend	0
school	I-DISEASE
regularly	0
for	0
many	0
months	0
.	0

Extreme	0
diffi-	0
culty	0
in	0
morning	0
awakening	0
,	0
requiring	0
intensive	0
parental	I-DISEASE
involvement	0
,	0
may	0
also	0
be	I-DISEASE
the	0
presenting	0
concern	I-DISEASE
.	0

An	0
increased	0
risk	0
of	0
motor	0
vehicle	I-DISEASE
accidents	I-DISEASE
has	0
been	0
associated	0
with	0
delayed	0
sleep	0
onset	I-DISEASE
and	I-DISEASE
resultant	I-DISEASE
insufficient	0
sleep	0
in	0
adolescents	I-DISEASE
;	0
thus	0
,	0
the	0
occur-	I-DISEASE
rence	0
of	I-DISEASE
a	0
car	0
crash	0
or	0
“	I-DISEASE
near	0
-	0
miss	0
”	0
incident	0
should	0
alert	I-DISEASE
the	0
clinician	0
to	0
probe	0
for	0
addi-	I-DISEASE
tional	0
evidence	I-DISEASE
of	I-DISEASE
circadian	I-DISEASE
pathology	0
.	0

Adolescents	0
may	0
also	0
present	0
primarily	0
with	0
mood	0
complaints	0
(	I-DISEASE
depression	0
,	0
suicidal	0
ideation	0
)	0
.	I-DISEASE

Chronic	0
insomnia	0
is	0
commonly	0
asso-	0
ciated	I-DISEASE
with	I-DISEASE
and	0
may	I-DISEASE
be	0
the	0
chief	I-DISEASE
presenting	0
complaint	0
in	I-DISEASE
adolescents	0
with	I-DISEASE
DSWPD	I-DISEASE
as	0
a	I-DISEASE
result	I-DISEASE
of	0
repeated	0
attempts	I-DISEASE
and	I-DISEASE
failures	0
to	0
achieve	0
sleep	0
onset	I-DISEASE
at	0
their	I-DISEASE
desired	0
bedtime	0
.	0

In	0
younger	0
children	0
,	I-DISEASE
the	0
condition	I-DISEASE
may	I-DISEASE
be	0
associated	I-DISEASE
with	0
delays	0
in	I-DISEASE
other	0
markers	0
of	I-DISEASE
circadian	0
phase	0
,	I-DISEASE
including	0
the	0
typical	0
presleep	0
surge	I-DISEASE
in	0
alertness	I-DISEASE
referred	0
to	0
as	0
the	0
“	0
for-	0
bidden	0
zone	0
”	0
or	0
“	0
second	I-DISEASE
wind	I-DISEASE
phenomenon	I-DISEASE
.	I-DISEASE
”	0

Thus	0
,	0
especially	0
in	0
younger	0
children	I-DISEASE
,	I-DISEASE
DSWPD	0
may	0
present	0
primarily	0
as	0
bedtime	0
resistance	I-DISEASE
,	I-DISEASE
as	0
caregivers	0
attempt	I-DISEASE
to	0
establish	0
bedtimes	0
that	0
directly	0
conflict	I-DISEASE
with	I-DISEASE
the	0
child	0
’s	I-DISEASE
circadian	0
-	I-DISEASE
mediated	0
readiness	0
for	0
sleep	0
.	0

Several	0
pediatric	0
populations	0
appear	0
to	I-DISEASE
have	0
an	I-DISEASE
increased	0
vulnerability	I-DISEASE
to	0
DSWPD	0
and	0
sleep	0
disturbances	0
,	0
likely	I-DISEASE
of	I-DISEASE
multifactorial	0
etiology	0
.	0

These	0
include	0
children	0
with	I-DISEASE
attention	0
deficit	I-DISEASE
hyperactivity	0
disorder	0
(	I-DISEASE
ADHD	0
)	0
and	0
autism	0
spectrum	0
disorder	I-DISEASE
(	I-DISEASE
ASD	0
)	0
.	0

Several	0
studies	0
have	0
examined	0
melatonin	0
onset	I-DISEASE
in	I-DISEASE
children	0
with	0
ADHD	0
and	0
reported	I-DISEASE
significant	0
delays	0
in	I-DISEASE
comparison	I-DISEASE
with	0
typically	I-DISEASE
developing	I-DISEASE
children	0
,	0
as	0
well	I-DISEASE
as	I-DISEASE
suc-	I-DISEASE
cessful	0
treatment	0
with	0
melatonin	0
.	0

Children	0
with	0
ASD	0
have	0
a	0
high	0
prevalence	I-DISEASE
(	0
up	I-DISEASE
to	0
80	0
%	0
)	0
of	0
sleep	I-DISEASE
disturbances	0
,	I-DISEASE
including	0
delayed	0
sleep	0
onset	0
,	0
night	I-DISEASE
and	0
early	I-DISEASE
morning	I-DISEASE
awakenings	I-DISEASE
,	0
and	I-DISEASE
irregular	0
sleep	0
patterns	I-DISEASE
,	0
at	0
least	0
some	I-DISEASE
of	0
which	I-DISEASE
appear	I-DISEASE
associated	I-DISEASE
with	0
circadian	I-DISEASE
abnormalities	I-DISEASE
.	0

These	0
children	0
reportedly	I-DISEASE
have	0
a	0
number	0
of	I-DISEASE
alterations	0
in	0
mel-	0

atonin	0
synthesis	I-DISEASE
,	0
levels	0
,	0
amplitude	I-DISEASE
,	0
and	0
patterns	0
of	0
secretion	0
.	0

Little	0
is	0
known	0
about	0
the	0
natural	I-DISEASE
history	I-DISEASE
of	0
the	I-DISEASE
clinical	I-DISEASE
entity	0
of	0
DSWPD	0
in	0
the	I-DISEASE
pediat-	0
ric	0
population	I-DISEASE
,	0
including	0
the	0
impact	0
of	I-DISEASE
various	0
treatment	I-DISEASE
modalities	0
,	0
the	I-DISEASE
likelihood	0
of	I-DISEASE
spontaneous	0
resolution	0
of	0
symptoms	0
,	0
or	0
long	I-DISEASE
-	I-DISEASE
term	0
consequences	I-DISEASE
.	0

There	0
is	0
increasing	0
evidence	I-DISEASE
to	0
suggest	I-DISEASE
that	I-DISEASE
the	I-DISEASE
evening	I-DISEASE
chronotype	0
is	0
associated	0
in	0
both	0
children	I-DISEASE
and	0
adolescents	0
with	I-DISEASE
a	0
number	I-DISEASE
of	0
adverse	0
consequences	0
,	0
including	I-DISEASE
decreased	I-DISEASE
health	I-DISEASE
-	I-DISEASE
related	0
quality	0
of	0
life	I-DISEASE
,	I-DISEASE
higher	0
rates	0
of	I-DISEASE
behavioral	0
/	I-DISEASE
emotional	I-DISEASE
problems	I-DISEASE
including	0
depression	0
and	0
suicidality	0
,	I-DISEASE
decreased	I-DISEASE
sleep	I-DISEASE
duration	0
and	0
increased	I-DISEASE
daytime	0
sleepiness	0
,	I-DISEASE
more	I-DISEASE
sleep	0
complaints	I-DISEASE
,	0
impairments	I-DISEASE
in	0
academic	0
functioning	I-DISEASE
,	I-DISEASE
and	I-DISEASE
increased	I-DISEASE
likelihood	I-DISEASE
of	I-DISEASE
substance	0
use	0
.	0

Thus	0
,	0
eveningness	0
may	0
confer	0
an	0
increased	I-DISEASE
risk	0
for	I-DISEASE
physical	0
and	0
mental	0
health	0
problems	0
.	I-DISEASE

Pathology	0
and	0
Pathophysiology	0
The	0
exact	0
mechanisms	I-DISEASE
responsible	I-DISEASE
for	0
DSWPD	I-DISEASE
are	0
unknown	0
.	0

An	0
abnormal	0
interac-	0
tion	0
between	0
the	0
endogenous	0
circadian	0
rhythm	0
and	I-DISEASE
the	0
sleep	0
homeostatic	I-DISEASE
process	0
that	I-DISEASE
regulates	0
sleep	0
and	I-DISEASE
wakefulness	I-DISEASE
may	0
play	0
an	0
essential	0
role	I-DISEASE
in	0
the	I-DISEASE
pathophysiology	I-DISEASE
of	I-DISEASE
DSWPD	I-DISEASE
.	0

Early	0
studies	0
reported	0
an	0
altered	0
phase	I-DISEASE
relationship	I-DISEASE
between	0
the	0
sleep	I-DISEASE
-	0
wake	0
cycle	I-DISEASE
and	0
circadian	I-DISEASE
phase	0
,	0
whereas	I-DISEASE
more	0
recent	0
studies	0
have	0
failed	0
to	0
support	I-DISEASE
this	0
finding	0
.	0

In	0
these	0
patients	0
,	I-DISEASE
sleep	0
onset	I-DISEASE
,	I-DISEASE
sleep	0
offset	I-DISEASE
,	0
and	0
phase	I-DISEASE
of	I-DISEASE
circadian	0
markers	I-DISEASE
such	0
as	I-DISEASE
core	I-DISEASE
body	0
temperature	I-DISEASE
and	0
melatonin	0
are	I-DISEASE
delayed	0
relative	I-DISEASE
to	0
clock	0
time	I-DISEASE
when	0
com-	0
pared	I-DISEASE
with	I-DISEASE
controls	0
.	0

Although	0
this	0
condition	0
may	I-DISEASE
be	0
predominantly	I-DISEASE
due	I-DISEASE
to	0
a	I-DISEASE
misalign-	0
ment	I-DISEASE
between	0
circadian	0
timing	0
and	0
the	0
external	0
environment	I-DISEASE
,	B-DISEASE
alterations	I-DISEASE
in	0
the	0
length	0
of	0
the	I-DISEASE
circadian	0
period	0
or	I-DISEASE
an	0
altered	I-DISEASE
homeostatic	I-DISEASE
process	0
(	0
indicated	0
by	0
decreased	I-DISEASE
sleep	I-DISEASE
propensity	0
in	0
response	0
to	I-DISEASE
sleep	I-DISEASE
deprivation	0
)	0
also	I-DISEASE
may	I-DISEASE
be	I-DISEASE
contributing	I-DISEASE
factors	0
.	0

In	0
chil-	0
dren	0
and	0
adults	0
,	0
voluntary	I-DISEASE
behaviors	0
such	I-DISEASE
as	0
staying	0
awake	0
late	0
at	0
night	I-DISEASE
and	0
waking	0
up	I-DISEASE
late	0
in	I-DISEASE
the	0
morning	0
or	0
afternoon	0
may	I-DISEASE
result	I-DISEASE
in	0
an	I-DISEASE
abnormal	0
relationship	0
between	0
the	I-DISEASE
endogenous	0
circadian	0
rhythm	0
and	I-DISEASE
the	0
sleep	0
homeostatic	I-DISEASE
process	0
that	B-DISEASE
regulates	0
sleep	0
and	I-DISEASE
wakefulness	I-DISEASE
.	0

Delayed	0
bedtimes	0
and	0
wake	0
times	0
may	I-DISEASE
increase	I-DISEASE
exposure	I-DISEASE
to	I-DISEASE
bright	0
Circadian	0
Rhythm	0
Sleep	0
-	0
Wake	I-DISEASE
Disorders	I-DISEASE
Circadian	0
Rhythm	I-DISEASE
Sleep	B-DISEASE
-	0
Wake	0
Disorders	0
light	0
in	0
the	I-DISEASE
late	0
evening	I-DISEASE
(	I-DISEASE
a	0
delay	I-DISEASE
signal	0
for	I-DISEASE
the	0
circadian	0
clock	0
)	0
and	0
decrease	I-DISEASE
expo-	0
sure	I-DISEASE
to	0
light	0
in	0
the	0
early	0
morning	0
(	0
an	I-DISEASE
advance	0
signal	I-DISEASE
for	0
the	I-DISEASE
circadian	I-DISEASE
clock	I-DISEASE
)	0
,	0
thereby	0
promoting	0
and	0
perpetuating	I-DISEASE
the	0
delay	I-DISEASE
in	I-DISEASE
the	I-DISEASE
circadian	I-DISEASE
sleep	I-DISEASE
phase	0
.	0

Given	0
a	0
sufficient	0
discrepancy	0
between	0
early	0
and	I-DISEASE
late	0
wake	0
times	0
,	0
early	0
wake	I-DISEASE
times	0
may	I-DISEASE
be	0
associated	I-DISEASE
with	I-DISEASE
bright	0
light	I-DISEASE
exposure	0
during	0
the	0
maximal	I-DISEASE
phase	I-DISEASE
delay	0
region	I-DISEASE
,	I-DISEASE
perpetuating	0
the	0
cir-	0
cadian	0
phase	0
delay	0
and	0
the	0
disorder	I-DISEASE
.	I-DISEASE

Individuals	0
may	0
have	0
alterations	0
in	0
sensitivity	0
to	I-DISEASE
the	0
phase	I-DISEASE
shifting	0
effects	0
of	0
light	0
.	0

For	0
example	0
,	0
partial	0
sleep	0
deprivation	I-DISEASE
encountered	I-DISEASE
with	I-DISEASE
this	I-DISEASE
disorder	0
can	0
also	0
attenuate	0
the	0
ability	0
to	0
phase	0
-	I-DISEASE
advance	0
the	I-DISEASE
circadian	0
system	0
,	0
further	0
perpetuating	I-DISEASE
the	I-DISEASE
delayed	0
circadian	B-DISEASE
phase	0
.	0

Objective	0
Findings	0
Recordings	0
of	I-DISEASE
sleep	0
logs	I-DISEASE
and	0
actigraphy	0
over	I-DISEASE
an	0
interval	0
of	0
at	I-DISEASE
least	0
seven	I-DISEASE
(	I-DISEASE
and	0
pref-	I-DISEASE
erably	0
fourteen	I-DISEASE
)	0
consecutive	0
days	I-DISEASE
demonstrate	0
delayed	I-DISEASE
sleep	I-DISEASE
onset	0
and	I-DISEASE
sleep	0
offset	I-DISEASE
(	I-DISEASE
typically	0
greater	0
than	0
two	0
hours	0
)	0
relative	I-DISEASE
to	0
socially	I-DISEASE
acceptable	I-DISEASE
times	I-DISEASE
.	0

Though	0
clock	0
times	0
may	I-DISEASE
be	0
culture	I-DISEASE
dependent	0
,	0
for	I-DISEASE
many	0
affected	0
individuals	0
sleep	I-DISEASE
onset	I-DISEASE
is	I-DISEASE
typi-	I-DISEASE
cally	I-DISEASE
delayed	I-DISEASE
until	0
1:00	0
a.m.	0
to	0
6:00	0
a.m.	I-DISEASE
,	0
(	I-DISEASE
though	I-DISEASE
may	I-DISEASE
be	0
earlier	0
based	0
on	0
age	0
and	0
developmental	0
status	0
)	0
,	0
and	0
wake	0
time	I-DISEASE
occurs	I-DISEASE
in	0
the	0
late	0
morning	I-DISEASE
or	0
afternoon	0
.	0

Daily	0
demands	I-DISEASE
and	I-DISEASE
schedules	0
may	0
result	0
in	I-DISEASE
an	0
earlier	I-DISEASE
than	0
desired	0
wake	0
-	I-DISEASE
up	0
time	I-DISEASE
during	0
work	I-DISEASE
or	I-DISEASE
school	0
days	0
,	0
but	0
a	0
delay	I-DISEASE
in	0
bedtime	0
and	0
wake	I-DISEASE
-	0
up	I-DISEASE
time	0
is	0
almost	0
always	0
seen	0
during	0
free	0
days	I-DISEASE
and	I-DISEASE
vacation	0
.	I-DISEASE

Polysomnography	0
(	0
though	0
not	0
routinely	0
indicated	I-DISEASE
nor	I-DISEASE
required	0
for	I-DISEASE
the	0
diagnosis	0
)	0
,	0
when	0
performed	I-DISEASE
at	0
preferred	I-DISEASE
(	I-DISEASE
delayed	0
)	0
sleep	0
times	0
,	0
is	0
essentially	I-DISEASE
normal	I-DISEASE
for	0
age	I-DISEASE
.	0

If	0
a	0
conventional	0
bedtime	I-DISEASE
and	0
wake	I-DISEASE
-	I-DISEASE
up	I-DISEASE
time	I-DISEASE
are	0
enforced	0
,	0
however	0
,	0
polysomnographic	I-DISEASE
recording	I-DISEASE
may	0
show	I-DISEASE
prolonged	0
sleep	0
latency	0
and	0
decreased	I-DISEASE
total	0
sleep	0
time	I-DISEASE
.	I-DISEASE

Laboratory	0
measures	0
of	0
circadian	0
timing	0
generally	I-DISEASE
show	I-DISEASE
the	I-DISEASE
expected	0
phase	I-DISEASE
delay	0
in	0
the	0
timing	0
of	I-DISEASE
the	I-DISEASE
nadir	0
of	I-DISEASE
the	0
core	0
body	0
temperature	0
rhythm	0
and	0
dim-	0
light	0
melatonin	I-DISEASE
onset	I-DISEASE
(	0
DLMO	I-DISEASE
)	0
.	0

Several	0
questionnaires	0
are	0
useful	0
in	0
assessing	0
the	0
chro-	0
notype	I-DISEASE
,	I-DISEASE
the	0
degree	0
of	0
eveningness	0
or	0
morningness	0
(	I-DISEASE
e.g.	I-DISEASE
,	0
“	0
Morningness	0
-	0
Eveningness	I-DISEASE
Questionnaire	0
,	I-DISEASE
”	0
“	0
Munich	I-DISEASE
Chronotype	0
Questionnaire	0
”	0
)	0
.	0

Individuals	0
with	0
DSWPD	0
,	0
typ-	0
ically	0
score	I-DISEASE
high	0
as	0
evening	I-DISEASE
types	0
,	0
though	0
normal	0
sleepers	0
can	I-DISEASE
also	0
score	0
high	0
on	0
eve-	0
ningness	0
.	I-DISEASE

Elevations	0
are	0
expected	0
in	0
self	0
-	0
report	0
of	0
daytime	I-DISEASE
sleepiness	0
,	0
such	0
as	I-DISEASE
on	0
the	I-DISEASE
Epworth	0
Sleepiness	0
Scale	0
.	I-DISEASE

The	0
results	0
of	0
polysomnography	I-DISEASE
and	0
other	I-DISEASE
diagnostic	I-DISEASE
tools	0
in	I-DISEASE
younger	I-DISEASE
age	0
groups	0
are	0
similar	0
to	0
those	0
seen	0
in	I-DISEASE
adults	0
.	I-DISEASE

Actigraphy	0
and/or	0
sleep	I-DISEASE
logs	0
are	0
useful	0
in	0
the	I-DISEASE
diagnosis	I-DISEASE
of	0
DSWPD	0
in	0
the	I-DISEASE
pediatric	0
population	I-DISEASE
.	0

Several	0
validated	0
instruments	0
are	0
available	0
for	0
assessing	I-DISEASE
phase	0
preference	I-DISEASE
in	0
the	0
pediatric	0
and	I-DISEASE
adolescent	0
pop-	0
ulations	0
.	0

These	0
include	0
the	0
Children	I-DISEASE
’s	0
Chronotype	0
Questionnaire	0
(	0
CCTQ	0
)	0
(	0
par-	0
ent	0
-	0
report	0
)	0
,	I-DISEASE
the	I-DISEASE
Morningness	0
-	0
Eveningness	0
Scale	0
for	0
Children	0
(	I-DISEASE
self	0
-	I-DISEASE
report	0
)	0
,	0
and	I-DISEASE
the	0
Morningness	0
-	0
Eveningness	0
Questionnaire	0
for	I-DISEASE
Children	I-DISEASE
and	0
Adolescents	I-DISEASE
.	I-DISEASE

These	0
surveys	0
have	I-DISEASE
been	0
used	0
to	I-DISEASE
assess	I-DISEASE
chronotype	0
in	I-DISEASE
the	0
pediatric	0
population	0
and	I-DISEASE
may	0
be	0
useful	I-DISEASE
in	0
clinical	I-DISEASE
settings	0
.	0

Differential	0
Diagnosis	0
Delayed	0
sleep	0
-	0
wake	I-DISEASE
phase	I-DISEASE
disorder	0
must	I-DISEASE
be	0
distinguished	0
from	I-DISEASE
“	0
normal	0
”	0
sleep	I-DISEASE
pat-	0
terns	0
,	0
particularly	0
in	0
adolescents	0
and	0
young	I-DISEASE
adults	I-DISEASE
who	0
maintain	0
delayed	I-DISEASE
schedules	0
regularly	0
or	0
intermittently	I-DISEASE
,	0
without	0
distress	0
or	0
impaired	0
functioning	0
.	0

DSWPD	0
must	0
be	0
distinguished	0
from	0
other	0
causes	I-DISEASE
of	0
difficulty	I-DISEASE
initiating	0
sleep	0
,	I-DISEASE
including	0
chronic	0
insom-	0
nia	I-DISEASE
disorder	0
.	I-DISEASE

In	0
DSWPD	0
,	0
sleep	0
initiation	0
and	0
maintenance	I-DISEASE
are	0
improved	I-DISEASE
when	0
the	0
patient	0
is	0
allowed	0
to	I-DISEASE
sleep	I-DISEASE
on	0
the	I-DISEASE
preferred	0
schedule	0
.	0

When	0
individuals	0
with	0
DSWPD	0
must	0
arise	I-DISEASE
before	0
the	0
desired	I-DISEASE
wake	I-DISEASE
time	I-DISEASE
,	0
excessive	I-DISEASE
sleep	0
inertia	I-DISEASE
and	I-DISEASE
excessive	I-DISEASE
daytime	I-DISEASE
sleepiness	0
may	0
be	0
evident	0
.	0

Other	0
forms	0
of	0
excessive	0
daytime	0
sleepiness	0
,	I-DISEASE
from	0
which	I-DISEASE
this	0
must	I-DISEASE
be	0
distinguished	0
,	0
do	I-DISEASE
not	0
generally	0
exhibit	I-DISEASE
the	0
pronounced	0
circadian	0
pattern	0
and	0
do	0
not	0
abate	0
with	0
alterations	I-DISEASE
in	0
the	I-DISEASE
sleep	0
-	0
wake	0
schedule	0
.	0

The	0
development	0
of	0
DSWPD	0
may	0
be	I-DISEASE
influenced	0
by	0
alterations	I-DISEASE
in	0
circadian	0
physiology	0
as	0
well	0
as	I-DISEASE
behavioral	0
factors	0
.	0

Inadequate	0
sleep	0
hygiene	0
and	I-DISEASE
insufficient	0
sleep	I-DISEASE
syndrome	I-DISEASE
must	0
also	I-DISEASE
be	0
considered	0
in	0
the	0
differential	0
.	I-DISEASE

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE

There	0
is	0
limited	0
knowledge	I-DISEASE
of	0
the	I-DISEASE
underlying	I-DISEASE
pathophysiology	0
of	I-DISEASE
DSWPD	0
.	0

Recent	0
evidence	0
suggests	0
that	0
alteration	0
in	0
the	I-DISEASE
homeostatic	0
regulation	I-DISEASE
of	0
sleep	0
and	0
alertness	0
may	0
play	I-DISEASE
an	I-DISEASE
important	0
role	0
.	0

The	0
intrinsic	0
circadian	0
period	0
may	0
be	0
abnormally	B-DISEASE
long	0
.	0

Recent	0
advances	0
in	0
the	0
understanding	I-DISEASE
of	I-DISEASE
the	I-DISEASE
molecular	I-DISEASE
basis	I-DISEASE
for	0
the	0
generation	I-DISEASE
and	0
entrainment	0
of	0
circadian	0
rhythms	0
,	I-DISEASE
together	0
with	0
the	0
identification	0
of	0
a	0
familial	I-DISEASE
form	I-DISEASE
of	0
DSWPD	I-DISEASE
,	0
will	0
lead	0
to	0
improved	0
understanding	0
of	0
the	0
mechanisms	0
responsible	I-DISEASE
for	0
this	0
condition	0
,	I-DISEASE
as	0
well	0
as	I-DISEASE
targeted	I-DISEASE
,	0
evidence	0
-	0
based	I-DISEASE
therapies	0
.	0

Bibliography	0
Ancoli	0
-	I-DISEASE
Israel	0
S	0
,	I-DISEASE
Schnierow	0
B	0
,	0
Kelsoe	0
J	0
,	0
Fink	I-DISEASE
R.	0
A	0
pedigree	0
of	0
one	I-DISEASE
family	0
with	0
delayed	0
sleep	0
phase	0
syndrome	0
.	I-DISEASE

Chronobiol	0
Int	0
2001;18:831–41	0
.	0

Archer	0
SN	0
,	0
Carpen	0
JD	0
,	0
Gibson	0
M	0
,	0
et	0
al	0
.	0

Polymorphism	0
in	0
the	0
PER3	0
promoter	0
associates	0
with	I-DISEASE
diurnal	0
preference	I-DISEASE
and	0
delayed	0
sleep	0
phase	0
disorder	0
.	0

Sleep	0
2010;33:695–701	0
.	0

Bijlenga	0
D	0
,	0
Van	0
Someren	0
EJW	I-DISEASE
,	I-DISEASE
Gruber	0
R	I-DISEASE
,	0
et	I-DISEASE
al	0
.	0

Body	0
temperature	0
,	0
activity	0
,	0
and	0
melatonin	I-DISEASE
profiles	0
in	I-DISEASE
adults	0
with	0
attention	0
-	0
deficit	0
/	I-DISEASE
hyperactivity	I-DISEASE
disorder	I-DISEASE
and	I-DISEASE
delayed	0
sleep	I-DISEASE
:	0
a	0
case	0
-	I-DISEASE
control	I-DISEASE
study	0
.	I-DISEASE

J	0
Sleep	0
Res	0
2013	I-DISEASE
;	0
22:607–16	0
.	I-DISEASE

Dagan	0
Y	I-DISEASE
,	0
Stein	0
D	0
,	0
Steinbock	I-DISEASE
M	0
,	I-DISEASE
Yovel	0
I	0
,	0
Hallis	0
D.	0
Frequency	I-DISEASE
of	0
delayed	0
sleep	I-DISEASE
phase	0
syndrome	I-DISEASE
among	0
hospitalized	0
adolescent	0
psychiatric	I-DISEASE
patients	I-DISEASE
.	0

Psychosom	0
Res	0
1998;45:15–20	I-DISEASE
.	0

Gruber	0
R	I-DISEASE
,	I-DISEASE
Sheshko	0
D.	0
Circadian	0
sleep	0
disorders	0
in	I-DISEASE
children	0
and	0
adolescents	I-DISEASE
.	I-DISEASE

In	0
Ivanenko	0
A.	0
(	I-DISEASE
ed	0
)	0
,	I-DISEASE
Sleep	0
and	I-DISEASE
psychiatric	0
disorders	0
in	0
children	0
and	0
adolescents	0
.	I-DISEASE

USA	0
:	0
Informa	0
Healthcare	0
,	0
2008	0
;	I-DISEASE
61	0
-	0
78	0
.	0

Circadian	0
Rhythm	I-DISEASE
Sleep	0
-	0
Wake	0
Disorders	0
Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	0
Wake	0
Disorders	0
Gruber	I-DISEASE
R	0
,	I-DISEASE
Fontil	0
L	0
,	I-DISEASE
Bergmame	0
L	0
,	0
et	0
al	0
.	I-DISEASE

Contributions	0
of	0
circadian	0
tendencies	0
and	0
behavioural	0
problems	B-DISEASE
to	0
sleep	I-DISEASE
onset	0
problems	0
of	0
children	0
with	0
ADHD	I-DISEASE
.	0

BMC	0
Psychiat	0
2012;12:212	0
.	0

Kripke	0
DF	0
,	0
Rex	0
KM	0
,	0
Ancoli	I-DISEASE
-	0
Israel	I-DISEASE
S	0
,	0
Nievergelt	0
CM	0
,	0
Klimecki	I-DISEASE
W	0
,	0
Kelsoe	I-DISEASE
JR	0
.	0

Delayed	0
sleep	0
phase	0
cases	0
and	0
controls	0
.	I-DISEASE

J	0
Circadian	0
Rhythms	I-DISEASE
2008;6:6	B-DISEASE
.	0

Marchetti	0
LM	0
,	0
Biello	I-DISEASE
SM	0
,	0
Broomfield	I-DISEASE
NM	0
,	I-DISEASE
Macmahon	0
KM	0
,	0
Espie	0
CA	0
.	0

Who	0
is	0
pre	0
-	0
occupied	0
with	I-DISEASE
sleep	0
?	0

A	0
comparison	0
of	0
attention	0
bias	0
in	I-DISEASE
people	0
with	0
psychophysiological	I-DISEASE
insomnia	0
,	0
delayed	I-DISEASE
sleep	I-DISEASE
phase	0
syndrome	I-DISEASE
and	0
good	0
sleepers	I-DISEASE
using	0
the	0
induced	0
change	0
blindness	0
paradigm	0
.	I-DISEASE

J	0
Sleep	0
Res	0
2006;15:212–21	B-DISEASE
.	0

Rahman	0
SA	0
,	0
Kayumov	0
L	0
,	0
Tchmoutina	I-DISEASE
EA	0
,	I-DISEASE
Shapiro	0
CM	0
.	0

Clinical	0
efficacy	0
of	0
dim	0
light	0
melatonin	I-DISEASE
onset	0
testing	0
in	0
diagnosing	0
delayed	0
sleep	0
phase	0
syndrome	0
.	I-DISEASE

Sleep	0
Med	0
2009;10:549–55	0
.	0

Reid	0
KJ	0
,	0
Jaksa	0
AA	0
,	0
Eisengart	0
JB	0
,	0
et	0
al	0
.	0

Systematic	0
evaluation	0
of	0
Axis	0
-	0
I	I-DISEASE
DSM	I-DISEASE
diagnoses	0
in	0
delayed	0
sleep	0
phase	I-DISEASE
disorder	I-DISEASE
and	0
evening	0
-	0
type	I-DISEASE
circadian	I-DISEASE
preference	0
.	I-DISEASE

Sleep	0
Med	0
2012;13:1171–7	I-DISEASE
.	0

Shibui	0
K	0
,	0
Uchiyama	0
M	0
,	0
Okawa	I-DISEASE
M.	0
Melatonin	0
rhythms	0
in	0
delayed	0
sleep	0
phase	0
syndrome	0
.	I-DISEASE

J	0
Biol	0
Rhythms	I-DISEASE
1999;14:72–6	0
.	0

Uchiyama	0
M	0
,	0
Okawa	0
M	0
,	0
Shibui	I-DISEASE
K	0
,	I-DISEASE
et	0
al	0
.	0

Poor	0
compensatory	0
function	0
for	0
sleep	0
loss	0
as	I-DISEASE
a	0
pathogenic	I-DISEASE
factor	0
in	0
patients	0
with	0
delayed	0
sleep	0
phase	0
syndrome	I-DISEASE
.	0

Sleep	0
2000;23:553–8	0
.	0

Weitzman	0
E	0
,	0
Czeisler	0
C	0
,	0
Coleman	I-DISEASE
R	0
,	0
Spielman	0
,	I-DISEASE
et	0
al	0
.	0

Delayed	0
sleep	0
phase	0
syndrome	0
:	0
a	0
chronobiological	I-DISEASE
disorder	0
with	I-DISEASE
sleep	0
onset	0
insomnia	0
.	0

Arch	0
Gen	0
Psychiatry	0
1981;38:737–46	0
.	0

Wyatt	0
JK	0
,	0
Stepanski	0
EJ	0
,	I-DISEASE
Kirkby	B-DISEASE
J.	0
Circadian	I-DISEASE
phase	0
in	0
delayed	0
sleep	0
phase	0
syndrome	0
:	I-DISEASE
predictors	0
and	I-DISEASE
temporal	0
stability	0
across	0
multiple	0
assessments	I-DISEASE
.	I-DISEASE

Sleep	0
2006;29:1075–80	0
.	0

Advanced	0
Sleep	0
-	0
Wake	0
Phase	0
Disorder	I-DISEASE
ICD-9	I-DISEASE
-	0
CM	I-DISEASE
code	0
:	0
327.32	0
ICD-10	0
-	0
CM	I-DISEASE
code	I-DISEASE
:	0

G47.22	0
Alternate	0
Names	0
Advanced	0
sleep	0
phase	0
type	I-DISEASE
,	0
advanced	I-DISEASE
sleep	0
phase	0
disorder	0
,	0
advanced	0
sleep	I-DISEASE
phase	0
syndrome	0
.	I-DISEASE

Diagnostic	0
Criteria	0
Criteria	0

A	0
-	0
E	0
must	0
be	0
met	0
A.	I-DISEASE

There	0
is	0
an	0
advance	I-DISEASE
(	0
early	I-DISEASE
timing	I-DISEASE
)	I-DISEASE
in	I-DISEASE
the	0
phase	I-DISEASE
of	0
the	I-DISEASE
major	I-DISEASE
sleep	I-DISEASE
episode	I-DISEASE
in	0
relation	I-DISEASE
to	I-DISEASE
the	0
desired	0
or	0
required	0
sleep	0
time	I-DISEASE
and	0
wake	I-DISEASE
-	I-DISEASE
up	0
time	0
,	0
as	0
evidenced	0
by	0
a	0
chronic	0
or	0
recurrent	0
complaint	0
of	0
difficulty	I-DISEASE
staying	I-DISEASE
awake	I-DISEASE
until	0
the	I-DISEASE
required	I-DISEASE
or	I-DISEASE
desired	0
conventional	0
bedtime	I-DISEASE
,	0
together	0
with	I-DISEASE
an	I-DISEASE
inability	0
to	0
remain	0
asleep	0
until	0
the	0
required	I-DISEASE
or	I-DISEASE
desired	I-DISEASE
time	0
for	0
awakening	0
.	0

B.	0
Symptoms	0
are	0
present	0
for	0
at	0
least	I-DISEASE
three	0
months	I-DISEASE
.	0

C.	0
When	I-DISEASE
patients	0
are	0
allowed	0
to	0
sleep	I-DISEASE
in	0
accordance	I-DISEASE
with	0
their	0
internal	0
biological	0
clock	0
,	0
sleep	I-DISEASE
quality	0
and	I-DISEASE
duration	I-DISEASE
are	I-DISEASE
improved	0
with	0
a	I-DISEASE
consistent	0
but	I-DISEASE
advanced	0
timing	0
of	I-DISEASE
the	I-DISEASE
major	I-DISEASE
sleep	I-DISEASE
episode	0
.	0

D.	0
Sleep	0
log	0
and	0
,	0
whenever	I-DISEASE
possible	I-DISEASE
,	0
actigraphy	I-DISEASE
monitoring	0
for	0
at	0
least	0
seven	0
days	0
(	I-DISEASE
preferably	I-DISEASE
14	0
days	0
)	I-DISEASE
demonstrate	0
a	0
stable	0
advance	0
in	I-DISEASE
the	I-DISEASE
timing	0
of	0
the	0
habitual	0
sleep	I-DISEASE
period	I-DISEASE
.	0

Both	0
work	0
/	0
school	0
days	0
and	0
free	I-DISEASE
days	0
must	0
be	0
included	0
within	0
this	I-DISEASE
monitoring	0
.	I-DISEASE

E.	0

The	0
sleep	0
disturbance	I-DISEASE
is	0
not	0
better	I-DISEASE
explained	I-DISEASE
by	0
another	I-DISEASE
current	0
sleep	0
disorder	I-DISEASE
,	I-DISEASE
medical	0
or	0
neurological	0
disorder	0
,	I-DISEASE
mental	0
disorder	0
,	0
medication	0
use	I-DISEASE
,	0
or	I-DISEASE
substance	0
use	0
disorder	0
.	0

Notes	0
.	0

Standardized	0
chronotype	0
questionnaires	0
are	0
useful	0
tools	0
to	I-DISEASE
assess	0
the	I-DISEASE
chronotype	0
of	0
eveningness	0
and	0
morningness	0
.	I-DISEASE

Individuals	0
with	0
advanced	0
sleep	I-DISEASE
phase	0
score	0
as	0
morning	0
types	I-DISEASE
.	I-DISEASE
.	0

Demonstration	0
of	0
an	0
advance	0
(	0
typically	0
greater	I-DISEASE
than	I-DISEASE
two	I-DISEASE
hours	0
)	0
in	I-DISEASE
the	I-DISEASE
timing	0
of	I-DISEASE
other	I-DISEASE
circadian	0
rhythms	I-DISEASE
such	0
as	0
DLMO	0
or	0
urinary	0
6	0
-	0
sulfatoxymelatonin	0
is	0
desirable	I-DISEASE
to	I-DISEASE
confirm	0
the	0
advanced	0
circadian	0
phase	0
.	0

Essential	0
Features	0
Advanced	0
sleep	0
-	0
wake	0
phase	I-DISEASE
disorder	0
(	I-DISEASE
ASWPD	0
)	0
is	0
characterized	0
by	I-DISEASE
a	I-DISEASE
stable	0
advance	0
(	I-DISEASE
earlier	0
timing	0
)	0
of	0
the	I-DISEASE
major	I-DISEASE
sleep	I-DISEASE
episode	I-DISEASE
,	0
such	I-DISEASE
that	0
habitual	0
sleep	0
onset	0
and	0
offset	0
occur	0
typically	0
two	0
or	0
more	0
hours	I-DISEASE
prior	0
to	0
required	0
or	0
desired	0
times	0
.	0

Affected	0
individ-	0
uals	0
complain	0
of	0
early	I-DISEASE
morning	I-DISEASE
or	0
maintenance	I-DISEASE
insomnia	0
and	0
excessive	0
evening	0
sleep-	0
iness	0
.	0

When	0
affected	0
individuals	0
are	0
allowed	0
to	I-DISEASE
maintain	0
an	0
advanced	I-DISEASE
schedule	0
,	0
sleep	0
quality	I-DISEASE
and	0
quantity	I-DISEASE
are	I-DISEASE
improved	0
.	I-DISEASE

Associated	0
Features	0
Individuals	0
with	0
ASWPD	0
may	0
experience	I-DISEASE
chronic	0
partial	I-DISEASE
sleep	0
loss	0
due	I-DISEASE
to	I-DISEASE
early	0
morning	0
and	0
maintenance	0
insomnia	I-DISEASE
,	0
particularly	0
if	0
sleep	0
is	0
resisted	0
during	I-DISEASE
early	0
evening	I-DISEASE
.	I-DISEASE

Clinical	0
and	0
Pathophysiological	0
Subtypes	0
Familial	I-DISEASE
patterns	I-DISEASE
are	0
discussed	I-DISEASE
below	0
.	0

Demographics	0
The	0
prevalence	0
of	0
ASWPD	0
in	0
the	I-DISEASE
general	0
population	I-DISEASE
is	0
unknown	0
.	0

In	0
one	0
large	0
survey	0
study	0
involving	I-DISEASE
middle	0
-	0
aged	I-DISEASE
adults	0
(	0
40	0
-	0
64	0
years	I-DISEASE
)	I-DISEASE
,	I-DISEASE
the	I-DISEASE
population	I-DISEASE
prevalence	0
was	0
esti-	0
mated	0
at	0
1	I-DISEASE
%	0
,	0
although	I-DISEASE
it	0
is	0
unclear	0
what	0
proportion	0
of	0
these	0
subjects	I-DISEASE
would	0
deem	I-DISEASE
their	0
schedule	I-DISEASE
to	0
be	I-DISEASE
significantly	0
troublesome	0
so	0
as	0
to	I-DISEASE
warrant	I-DISEASE
clinical	0
attention	0
.	0

Until	0
the	0
identification	I-DISEASE
of	0
familial	0
cohorts	0
(	0
see	0
below	I-DISEASE
)	0
,	0
only	0
four	0
cases	0
were	I-DISEASE
described	0
in	0
the	I-DISEASE
lit-	0
erature	0
.	0

There	0
is	0
no	0
known	0
sex	0
difference	0
.	0

Circadian	0
Rhythm	I-DISEASE
Sleep	0
-	0
Wake	0
Disorders	0
Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	0
Wake	0
Disorders	0
Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Advanced	0
age	I-DISEASE
appears	0
to	0
be	0
a	0
risk	0
factor	0
.	0

Among	0
a	0
cohort	0
aged	0
20	0
to	0
59	0
years	0
,	I-DISEASE
older	0
age	I-DISEASE
was	0
associated	0
with	0
increased	I-DISEASE
morningness	0
,	0
which	I-DISEASE
was	I-DISEASE
determined	0
to	0
be	I-DISEASE
a	0
sig-	0
nificant	I-DISEASE
mediator	0
of	0
numerous	0
age	0
-	0
sleep	0
relationships	0
.	0

A	0
patient	0
’s	0
ability	0
to	0
sleep	I-DISEASE
at	0
an	I-DISEASE
abnormal	I-DISEASE
circadian	0
phase	0
(	0
phase	0
tolerance	0
)	I-DISEASE
also	0
impacts	0
the	I-DISEASE
degree	0
to	0
which	0
adverse	0
symptoms	0
are	I-DISEASE
experienced	I-DISEASE
,	0
and	0
this	0
adaptability	0
varies	0
among	0
individuals	I-DISEASE
.	0

Conflicting	0
results	0
have	I-DISEASE
been	0
obtained	0
with	0
respect	0
to	0
the	I-DISEASE
relationship	0
between	I-DISEASE
age	0
and	0
phase	0
tolerance	I-DISEASE
,	0
with	0
some	I-DISEASE
suggesting	0
that	0
age	0
decreases	0
phase	0
tolerance	0
,	I-DISEASE
and	0
others	0
suggesting	I-DISEASE
that	0
age	0
may	I-DISEASE
actually	0
be	0
protective	0
.	0

Methodological	0
differences	0
preclude	0
direct	0
comparisons	0
of	0
the	0
investigations	0
,	0
as	0
do	0
wide	I-DISEASE
variations	0
in	0
the	0
age	0
groups	0
studied	0
.	0

Genetic	0
factors	0
also	0
can	0
influence	0
the	0
development	I-DISEASE
of	I-DISEASE
the	I-DISEASE
condition	0
,	I-DISEASE
as	I-DISEASE
has	0
been	0
definitively	0
demonstrated	0
among	I-DISEASE
select	I-DISEASE
familial	0
cohorts	0
(	0
see	0
Pathology	0
and	0
Pathophysiology	I-DISEASE
section	0
)	0
.	I-DISEASE

Environmental	0
influences	0
may	0
precipitate	B-DISEASE
,	0
maintain	0
,	0
or	0
exacerbate	I-DISEASE
the	0
advanced	0
circadian	0
phase	0
,	0
but	0
this	0
has	I-DISEASE
not	I-DISEASE
been	0
proven	0
.	0

ASWPD	0
has	0
been	0
reported	0
in	0
children	0
with	I-DISEASE
neurodevelopmental	0
disorders	I-DISEASE
.	0

In	0
particular	0
,	0
studies	0
in	0
children	0
with	I-DISEASE
autism	0
spectrum	I-DISEASE
disorders	0
and	0
Smith	I-DISEASE
-	I-DISEASE
Magenis	0
syndrome	I-DISEASE
have	I-DISEASE
shown	0
profound	I-DISEASE
alterations	0
in	0
melatonin	0
secretion	0
profiles	0
,	0
which	I-DISEASE
may	0
manifest	0
as	0
a	0
phase	I-DISEASE
advance	0
with	I-DISEASE
very	0
early	0
morning	0
waking	0
.	0

Familial	0
Patterns	0
Various	0
groups	0
have	0
described	0
kindreds	I-DISEASE
with	0
familial	I-DISEASE
ASWPD	0
.	0

These	0
cases	0
may	0
be	0
characterized	0
by	0
an	0
earlier	0
age	0
of	0
onset	0
.	0

It	0
is	0
not	0
clear	I-DISEASE
whether	0
the	0
familial	I-DISEASE
or	0
non-	I-DISEASE
familial	0
variety	0
of	0
the	0
condition	0
is	I-DISEASE
more	0
common	0
.	I-DISEASE

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Repetitive	I-DISEASE
attempts	0
to	I-DISEASE
resume	0
sleep	I-DISEASE
with	I-DISEASE
awakenings	I-DISEASE
may	0
result	I-DISEASE
in	0
the	0
development	I-DISEASE
of	0
a	0
comorbid	0
chronic	0
insomnia	0
disorder	0
.	0

Individuals	0
may	0
use	0
alcohol	0
,	0
other	0
sedatives	I-DISEASE
,	I-DISEASE
and/or	I-DISEASE
stimulants	0
to	0
alleviate	0
symptoms	0
,	0
potentially	0
exacerbating	0
the	0
underlying	0
sleep/	0
wake	0
disorder	0
.	0

The	0
impact	0
on	0
caregivers	0
of	0
children	0
with	B-DISEASE
neurodevelopmental	0
disor-	I-DISEASE
ders	0
and	0
ASWPD	0
may	0
be	0
particularly	I-DISEASE
profound	I-DISEASE
.	0

Developmental	0
Issues	0
ASWPD	0
is	0
most	0
frequently	I-DISEASE
encountered	0
among	0
older	0
age	0
groups	0
.	0

An	0
early	0
age	0
of	0
onset	0
of	0
ASWPD	I-DISEASE
should	0
prompt	I-DISEASE
further	0
probing	0
for	0
a	0
familial	0
pattern	I-DISEASE
.	0

Caregivers	0
may	0
report	0
that	0
a	0
child	0
wakes	I-DISEASE
“	0
too	I-DISEASE
early	0
”	0
in	0
the	0
morning	0
,	0
which	I-DISEASE
is	I-DISEASE
disruptive	I-DISEASE
to	I-DISEASE
the	0
house-	0
hold	0
routine	0
and	I-DISEASE
may	I-DISEASE
curtail	I-DISEASE
parental	0
sleep	I-DISEASE
.	0

This	0
is	0
particularly	0
true	I-DISEASE
for	I-DISEASE
younger	0
chil-	0
dren	0
,	I-DISEASE
who	0
may	0
require	I-DISEASE
adult	0
supervision	0
once	I-DISEASE
they	0
are	0
awake	I-DISEASE
.	B-DISEASE

However	0
,	I-DISEASE
this	0
complaint	0
regarding	0
the	I-DISEASE
waking	I-DISEASE
pattern	0
is	0
often	0
more	0
related	0
to	I-DISEASE
unrealistic	0
caregiver	0
expecta-	I-DISEASE
tions	0
regarding	0
an	0
“	0
appropriate	0
”	0
wake	I-DISEASE
time	0
for	I-DISEASE
a	I-DISEASE
young	I-DISEASE
child	0
and/or	0
a	0
developmentally	I-DISEASE
inappropriate	0
early	0
bedtime	0
resulting	0
in	0
prolonged	0
time	0
in	0
bed	0
,	0
rather	0
than	0
to	0
a	0
true	I-DISEASE
advance	0
in	0
sleep	I-DISEASE
onset	0
and	0
offset	0
.	I-DISEASE

In	0
some	0
cases	0
,	B-DISEASE
children	0
are	I-DISEASE
motivated	I-DISEASE
to	0
wake	I-DISEASE
up	I-DISEASE
earlier	0
than	0
desired	0
because	0
they	I-DISEASE
are	0
reinforced	0
for	I-DISEASE
this	0
behavior	0
by	0
parental	0
attention	0
or	0
the	0
opportunity	I-DISEASE
to	0
watch	I-DISEASE
television	0
or	0
utilize	0
other	0
media	0
upon	0
waking	0
.	0

The	0
com-	0
plaint	0
that	I-DISEASE
a	0
child	0
“	I-DISEASE
falls	0
asleep	I-DISEASE
too	0
early	0
”	I-DISEASE
in	0
the	0
evening	I-DISEASE
,	0
especially	I-DISEASE
in	0
adolescence	0
,	0
is	0
rare	0
and	0
should	I-DISEASE
raise	I-DISEASE
concerns	0
regarding	I-DISEASE
the	I-DISEASE
possibility	B-DISEASE
of	0
chronically	I-DISEASE
insufficient	I-DISEASE
sleep	I-DISEASE
and/or	0
a	0
sleep	0
disorder	0
resulting	I-DISEASE
in	I-DISEASE
increased	I-DISEASE
sleep	0
needs	0
.	0

The	0
rarity	0
of	0
observa-	0
tions	0
of	0
advanced	0
sleep	0
onset	I-DISEASE
and	0
offset	0
times	0
among	0
young	0
children	I-DISEASE
may	0
also	0
be	I-DISEASE
due	0
in	0
part	0
to	I-DISEASE
societal	0
expectations	0
of	I-DISEASE
earlier	0
bed	0
and	0
wake	0
times	0
for	I-DISEASE
this	I-DISEASE
age	0
group	0
;	0
thus	I-DISEASE
,	0
a	0
misalignment	0
with	0
circadian	0
preference	I-DISEASE
is	0
less	0
likely	I-DISEASE
.	I-DISEASE

Pathology	0
and	0
Pathophysiology	0
Possible	0
etiologies	0
include	I-DISEASE
:	I-DISEASE
(	0
1	I-DISEASE
)	0
an	I-DISEASE
alteration	0
in	0
the	0
ability	I-DISEASE
of	0
the	0
circadian	I-DISEASE
clock	0
to	I-DISEASE
phase	0
delay	0
;	I-DISEASE
(	0
2	I-DISEASE
)	I-DISEASE
a	0
dominant	I-DISEASE
phase	0
advance	0
region	I-DISEASE
of	0
the	0
light	0
phase	0
response	0
curve	I-DISEASE
to	I-DISEASE
entraining	0
agents	0
;	0
(	0
3	0
)	0
altered	I-DISEASE
strength	I-DISEASE
of	I-DISEASE
entraining	I-DISEASE
agents	0
,	0
such	0
as	0
light	I-DISEASE
exposure	0
at	0
the	I-DISEASE
appropriate	0
circadian	I-DISEASE
time	0
(	0
voluntarily	I-DISEASE
or	0
involuntarily	I-DISEASE
induced	I-DISEASE
)	0
;	I-DISEASE
or	0
(	0
4	I-DISEASE
)	I-DISEASE
a	I-DISEASE
shortened	0
endogenous	I-DISEASE
circadian	I-DISEASE
period	0
of	0
the	0
pacemaker	0
.	0

Among	0
these	0
proposed	0
mechanisms	0
,	0
only	0
the	0
latter	I-DISEASE
has	0
been	0
definitively	0
demonstrated	I-DISEASE
among	0
select	0
familial	I-DISEASE
ASWPD	0
sub-	0
jects	I-DISEASE
.	0

Genetic	0
analyses	0
revealed	0
a	0
missense	0
mutation	I-DISEASE
in	I-DISEASE
a	0
casein	0
kinase	0
(	0
CK1ε	0
)	I-DISEASE
binding	0
region	I-DISEASE
of	I-DISEASE
a	0
Period	0
gene	0
(	I-DISEASE
hPer2	0
)	0
,	0
culminating	0
in	I-DISEASE
hypophosphorylation	0
by	I-DISEASE
CK1ε	I-DISEASE
in	0
vitro	0
.	I-DISEASE

Hypophosphorylation	0
of	0
the	0
Period	0
protein	0
results	0
in	0
promotion	0
of	I-DISEASE
its	I-DISEASE
transcription	0
and	0
,	0
ultimately	0
,	0
a	0
decrease	0
in	0
the	0
period	0
length	0
of	0
the	0
clock	I-DISEASE
.	0

However	0
,	I-DISEASE
genetic	0
het-	0
erogeneity	0
is	0
apparent	I-DISEASE
within	0
familial	I-DISEASE
ASWPD	0
,	0
as	0
demonstrated	0
by	0
the	I-DISEASE
fact	I-DISEASE
that	0
other	I-DISEASE
cohorts	0
from	0
this	0
same	0
study	0
and	0
another	I-DISEASE
study	I-DISEASE
did	I-DISEASE
not	I-DISEASE
reveal	0
mutations	0
in	0
hPer2	0
.	0

A	0
separate	0
report	0
of	0
a	0
Japanese	I-DISEASE
familial	0
ASWPD	0
cohort	I-DISEASE
described	0
a	0
missense	0
mutation	0
in	0
a	0
different	0
casein	I-DISEASE
kinase	I-DISEASE
gene	0
(	0
CKIδ	0
)	0
,	0
which	0
also	I-DISEASE
resulted	0
in	0
decreased	0
enzymatic	I-DISEASE
activity	I-DISEASE
in	0
vitro	I-DISEASE
.	0

Yet	0
another	0
group	0
described	0
associations	0
between	I-DISEASE
hPer1	I-DISEASE
and	I-DISEASE
hPer2	I-DISEASE
polymorphisms	0
and	0
extreme	0
morningness	I-DISEASE
circadian	0
preferences	I-DISEASE
(	I-DISEASE
questionnaire	0
-	I-DISEASE
based	0
)	0
,	0
in	0
the	I-DISEASE
absence	I-DISEASE
of	0
discrete	0
ASWPD	I-DISEASE
.	I-DISEASE

Objective	0
Findings	0
Among	0
patients	I-DISEASE
with	0
familial	I-DISEASE
ASWPD	I-DISEASE
,	I-DISEASE
laboratory	I-DISEASE
measures	0
to	0
determine	0
the	0
phase	0
of	0
circadian	I-DISEASE
rhythms	0
reliably	0
show	0
the	0
expected	0
phase	0
advance	0
in	0
the	B-DISEASE
timing	I-DISEASE
of	0
the	0
nadir	I-DISEASE
of	0
the	I-DISEASE
temperature	0
rhythm	0
and	0
the	0
dim	I-DISEASE
light	I-DISEASE
melatonin	I-DISEASE
onset	I-DISEASE
,	0
in	0
comparison	I-DISEASE
with	I-DISEASE
unaf-	0
fected	0
controls	I-DISEASE
.	I-DISEASE

Among	0
those	0
with	0
nonfamilial	0
ASWPD	0
,	0
a	I-DISEASE
wider	0
range	I-DISEASE
of	0
timing	0
of	0
circadian	0
markers	0
is	I-DISEASE
found	I-DISEASE
,	I-DISEASE
with	I-DISEASE
some	0
values	0
approaching	0
those	0
of	0
unaffected	0
controls	I-DISEASE
.	0

Polysomnography	0
(	0
though	0
not	0
routinely	0
indicated	I-DISEASE
nor	I-DISEASE
required	0
for	I-DISEASE
the	0
diagnosis	0
)	0
,	0
when	0
performed	I-DISEASE
at	0
preferred	I-DISEASE
(	I-DISEASE
advanced	0
)	0
sleep	0
times	0
,	0
is	I-DISEASE
essentially	I-DISEASE
normal	I-DISEASE
for	0
age	I-DISEASE
.	0

If	0
Circadian	0
Rhythm	I-DISEASE
Sleep	B-DISEASE
-	0
Wake	I-DISEASE
Disorders	0
Circadian	I-DISEASE
Rhythm	I-DISEASE
Sleep	0
-	0
Wake	0
Disorders	0
a	I-DISEASE
conventional	I-DISEASE
bedtime	0
and	0
wake	0
-	0
up	I-DISEASE
time	0
is	0
enforced	0
,	0
however	I-DISEASE
,	0
polysomnographic	0
recording	I-DISEASE
may	0
show	I-DISEASE
short	0
sleep	0
latency	0
and	0
early	0
awakening	I-DISEASE
with	0
curtailment	I-DISEASE
of	0
total	I-DISEASE
sleep	0
time	0
.	0

Differential	0
Diagnosis	0
ASWPD	0
must	0
be	0
distinguished	I-DISEASE
from	0
“	0
normal	0
”	0
sleep	0
patterns	0
,	0
particularly	0
among	0
the	0
elderly	I-DISEASE
or	I-DISEASE
very	0
young	I-DISEASE
,	0
who	0
often	0
maintain	0
advanced	I-DISEASE
schedules	0
without	0
distress	0
or	I-DISEASE
impaired	0
functioning	I-DISEASE
.	0

ASWPD	0
must	0
also	0
be	0
distinguished	0
from	0
other	I-DISEASE
causes	0
of	0
early	0
awakening	0
,	0
including	0
chronic	0
insomnia	0
disorder	0
.	0

Poor	0
sleep	0
hygiene	I-DISEASE
practices	I-DISEASE
,	0
partic-	0
ularly	I-DISEASE
evening	0
napping	0
among	0
the	0
elderly	I-DISEASE
,	0
and	0
irregularity	0
of	0
the	0
sleep	I-DISEASE
-	0
wake	0
schedule	0
should	0
also	0
be	0
considered	I-DISEASE
.	I-DISEASE

The	0
possibility	0
of	0
a	I-DISEASE
“	0
free	0
-	I-DISEASE
running	0
”	I-DISEASE
(	0
nonentrained	0
)	0
circadian	0
rhythm	0
also	I-DISEASE
merits	I-DISEASE
consideration	0
,	I-DISEASE
but	0
patients	0
with	0
this	0
condition	0
are	0
most	I-DISEASE
commonly	0
blind	0
and	I-DISEASE
report	0
only	0
periodic	0
complaints	I-DISEASE
of	0
insomnia	0
depending	0
on	0
the	0
relative	I-DISEASE
rela-	0
tionship	0
between	0
the	I-DISEASE
internal	0
rhythm	I-DISEASE
and	0
that	I-DISEASE
of	I-DISEASE
the	I-DISEASE
light	0
/	I-DISEASE
dark	0
cycle	0
.	I-DISEASE

Major	0
depressive	0
disorder	I-DISEASE
is	0
a	0
common	0
cause	I-DISEASE
of	0
early	I-DISEASE
awakening	0
that	0
must	0
be	0
considered	0
.	0

These	0
patients	0
do	0
not	0
typically	0
manifest	0
the	0
early	0
evening	0
sleepiness	0
that	0
is	0
characteristic	0
of	0
ASWPD	0
.	0

As	0
with	0
any	0
sleep	0
disturbances	0
that	0
persists	I-DISEASE
over	0
time	0
,	0
insomnia	0
can	0
develop	0
second-	0
arily	I-DISEASE
.	0

The	0
Horne	0
-	0
Östberg	0
questionnaire	0
(	0
or	0
other	0
chronotype	0
questionnaire	0
)	0
may	0
assist	0
in	0
determining	0
the	I-DISEASE
contribution	0
of	I-DISEASE
a	0
morningness	0
circadian	0
preference	0
to	0
the	0
presenting	I-DISEASE
sleep	0
/	0
wake	B-DISEASE
complaint	0
.	0

The	0
presence	0
of	0
more	I-DISEASE
than	0
one	0
contributing	I-DISEASE
variable	0
seems	I-DISEASE
to	0
be	0
the	I-DISEASE
norm	I-DISEASE
,	0
and	I-DISEASE
each	I-DISEASE
entity	I-DISEASE
needs	I-DISEASE
to	0
be	0
treated	0
accordingly	B-DISEASE
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE

The	0
existing	0
literature	0
suggests	I-DISEASE
that	0
clinicians	I-DISEASE
are	0
unlikely	0
to	0
encounter	0
patients	0
with	0
stringently	I-DISEASE
defined	0
ASWPD	0
.	I-DISEASE

Until	0
the	0
identification	I-DISEASE
of	0
familial	0
cohorts	0
,	I-DISEASE
only	0
four	I-DISEASE
cases	0
were	0
described	0
.	0

Various	0
treatment	0
trials	0
also	0
support	0
this	0
contention	0
with	0
demon-	I-DISEASE
stration	0
of	0
objectively	0
conventional	0
sleep	0
and	I-DISEASE
wake	0
times	0
despite	I-DISEASE
study	0
entry	I-DISEASE
based	0
on	0
subjective	I-DISEASE
reports	0
of	I-DISEASE
advanced	0
sleep	0
phase	0
.	0

Select	0
studies	0
of	0
patients	0
with	0
sole	0
complaints	0
of	0
maintenance	I-DISEASE
insomnia	0
/	0
early	0
-	0
morning	0
awakenings	I-DISEASE
have	0
demonstrated	I-DISEASE
marked	I-DISEASE
advances	0
(	0
earlier	0
timing	0
)	I-DISEASE
of	0
physiologically	I-DISEASE
measured	0
circadian	I-DISEASE
rhythms	I-DISEASE
.	0

The	0
absence	0
of	0
the	I-DISEASE
early	I-DISEASE
evening	I-DISEASE
sleepiness	0
complaint	I-DISEASE
may	I-DISEASE
be	I-DISEASE
due	0
to	I-DISEASE
the	0
fact	0
that	I-DISEASE
the	0
timing	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
onset	0
can	0
be	0
more	0
readily	I-DISEASE
modified	0
than	I-DISEASE
wake	I-DISEASE
time	I-DISEASE
,	I-DISEASE
and	0
is	0
likely	I-DISEASE
to	0
be	0
more	0
actively	I-DISEASE
resisted	0
due	I-DISEASE
to	0
its	0
propensity	I-DISEASE
to	I-DISEASE
conflict	0
with	0
social	0
or	I-DISEASE
family	0
obligations	I-DISEASE
.	0

Alternatively	0
,	0
evening	0
sleep	0
that	0
occurs	I-DISEASE
prior	0
to	0
entering	0
the	0
bed	0
/	0
bedroom	0
may	0
not	0
be	I-DISEASE
reported	0
as	0
such	0
.	0

If	0
it	0
is	0
definitively	0
demonstrated	I-DISEASE
that	0
the	0
evening	0
sleepiness	I-DISEASE
complaint	0
is	0
not	0
present	I-DISEASE
or	0
is	I-DISEASE
not	0
prominent	0
,	I-DISEASE
the	0
term	0
advance	0
-	0
related	0
sleep	0
complaints	I-DISEASE
may	I-DISEASE
be	I-DISEASE
used	I-DISEASE
in	0
lieu	I-DISEASE
of	I-DISEASE
ASWPD	0
.	0

If	0
this	0
broader	0
term	0
is	0
used	0
,	I-DISEASE
the	0
condition	I-DISEASE
is	0
observed	0
more	I-DISEASE
commonly	0
(	0
~7	I-DISEASE
%	0
of	I-DISEASE
respondents	0
in	0
a	I-DISEASE
study	0
of	0
individuals	0
aged	I-DISEASE
40	I-DISEASE
-	0
64	0
years	I-DISEASE
)	0
.	0

There	0
is	0
limited	0
knowledge	I-DISEASE
of	0
the	I-DISEASE
pathophysiology	I-DISEASE
of	0
ASWPD	I-DISEASE
(	0
or	0
advance	0
-	0
related	0
sleep	I-DISEASE
complaints	0
)	0
beyond	0
those	0
associated	0
with	I-DISEASE
select	0
cases	0
of	I-DISEASE
familial	0
ASWPD	0
.	0

Increased	0
use	0
of	0
physiologic	0
circadian	0
assessments	I-DISEASE
will	I-DISEASE
require	0
the	0
development	0
of	0
normative	B-DISEASE
values	I-DISEASE
to	I-DISEASE
guide	I-DISEASE
practitioners	I-DISEASE
.	0

Knowledge	0
gaps	0
are	0
even	0
more	0
prominent	0
within	0
pediat-	0
ric	I-DISEASE
and	0
adolescent	0
populations	0
.	0

Bibliography	0
Ando	0
K	I-DISEASE
,	0
Kripke	0
DF	0
,	I-DISEASE
Ancoli	0
-	I-DISEASE
Israel	0
S.	0
Delayed	0
and	0
advanced	0
sleep	0
phase	0
symptoms	0
.	I-DISEASE

Isr	0
J	0
Psychiatry	0
Relat	0
Sci	0
2002;39:11–8	0
.	0

Auger	0
R.	I-DISEASE
Advance	0
-	0
related	0
sleep	0
complaints	I-DISEASE
and	I-DISEASE
advanced	I-DISEASE
sleep	0
phase	0
disorder	0
.	I-DISEASE

Sleep	0
Med	0
Clin	I-DISEASE
2009;4:219–27	0
.	I-DISEASE

Campbell	0
SS	I-DISEASE
,	0
Dawson	0
D	0
,	I-DISEASE
Anderson	I-DISEASE
MW	0
.	0

Alleviation	0
of	0
sleep	0
maintenance	0
insomnia	0
with	I-DISEASE
timed	I-DISEASE
exposure	0
to	I-DISEASE
bright	0
light	0
.	0

J	0
Am	0
Geriatr	0
Soc	I-DISEASE
1993;41:829–36	0
.	0

Carpen	0
JD	0
,	0
Archer	0
SN	0
,	0
Skene	0
DJ	0
,	0
Smits	0
M	0
,	0

von	0
Schantz	I-DISEASE
M.	0
A	0
single	I-DISEASE
-	I-DISEASE
nucleotide	0
polymorphism	0
in	I-DISEASE
the	0
5’-untranslated	0
region	I-DISEASE
of	0
the	0
hPER2	I-DISEASE
gene	I-DISEASE
is	0
associated	I-DISEASE
with	0
diurnal	I-DISEASE
preference	0
.	0

J	0
Sleep	0
Res	0
2005;14:293–7	B-DISEASE
.	0

Carpen	0
JD	0
,	0
von	0
Schantz	0
M	0
,	I-DISEASE
Smits	0
M	0
,	0
Skene	0
DJ	0
,	0
Archer	0
SN	I-DISEASE
.	0

A	0
silent	0
polymorphism	0
in	0
the	0
PER1	0
gene	0
associates	0
with	I-DISEASE
extreme	0
diurnal	0
preference	0
in	0
humans	0
.	0

J	0
Hum	0
Genet	0
2006;51:1122–5	0
.	0

Carrier	0
J	0
,	0
Monk	0
TH	0
,	I-DISEASE
Buysse	0
DJ	0
,	I-DISEASE
Kupfer	0
DJ	0
.	0

Sleep	0
and	0
morningness	0
-	I-DISEASE
eveningness	0
in	0
the	0
‘	0
middle	0
’	I-DISEASE
years	0
of	0
life	0
(	0
20	I-DISEASE
-	0
59	0
y	0
)	0
.	0

J	0
Sleep	0
Res	0
1997;6:230–7	B-DISEASE
.	0

Horne	0
JA	0
,	0
Ostberg	0
O.	0
A	0
self	I-DISEASE
-	0
assessment	0
questionnaire	0
to	0
determine	0
morningness	0
-	0
eveningness	0
in	0
human	0
circadian	0
rhythms	I-DISEASE
.	0

Int	0
J	0
Chronobiol	0
1976;4:97–110	0
.	0

Jones	0
C	0
,	I-DISEASE
Campbell	0
SS	0
,	I-DISEASE
Zone	I-DISEASE
SE	0
,	I-DISEASE
et	0
al	0
.	0

Familial	0
advanced	0
sleep	0
phase	0
syndrome	I-DISEASE
:	I-DISEASE

A	0
short	0
-	0
period	I-DISEASE
circadian	0
rhythm	0
variant	B-DISEASE
in	0
humans	I-DISEASE
.	0

Nature	0
Med	0
1999;5:1062–5	I-DISEASE
.	0

Kamei	0
R	0
,	I-DISEASE
Hughes	B-DISEASE
L	0
,	0
Miles	I-DISEASE
L	0
,	I-DISEASE
et	I-DISEASE
al	0
.	0

Advanced	0
-	0
sleep	0
phase	I-DISEASE
syndrome	0
studied	0
in	0
a	0
time	I-DISEASE
isolation	0
facility	0
.	0

Chronobiologia	0
1979;6:115	0
.	0

Moldofsky	0
H	0
,	0
Musisi	0
S	0
,	0
Phillipson	I-DISEASE
EA	0
.	I-DISEASE

Treatment	0
of	0
a	0
case	0
of	0
advanced	I-DISEASE
sleep	I-DISEASE
phase	I-DISEASE
syndrome	I-DISEASE
by	I-DISEASE
phase	0
advance	0
chronotherapy	0
.	0

Sleep	0
1986;9:61–5	0
.	0

Palmer	0
CR	0
,	0
Kripke	0
DF	0
,	0
Savage	0
HC	0
Jr	0
,	0
Cindrich	0
LA	0
,	0
Loving	0
RT	I-DISEASE
,	0
Elliott	0
JA	I-DISEASE
.	0

Efficacy	0
of	0
enhanced	0
evening	I-DISEASE
light	0
for	I-DISEASE
advanced	I-DISEASE
sleep	0
phase	I-DISEASE
syndrome	0
.	0

Behav	0
Sleep	0
Med	0
2003;1:213–26	0
.	0

Sack	0
RL	0
,	0
Auckley	B-DISEASE
D	0
,	I-DISEASE
Auger	I-DISEASE
RR	0
,	I-DISEASE
et	I-DISEASE
al	0
.	I-DISEASE
,	I-DISEASE
Circadian	0
rhythm	0
sleep	I-DISEASE
disorders	0
:	I-DISEASE
part	0
II	0
,	I-DISEASE
advanced	0
sleep	0
phase	I-DISEASE
disorder	0
,	I-DISEASE
delayed	I-DISEASE
sleep	I-DISEASE
phase	0
disorder	I-DISEASE
,	0
free	I-DISEASE
-	0
running	0
disorder	0
,	0
and	0
irregular	I-DISEASE
sleep	0
-	I-DISEASE
wake	I-DISEASE
rhythm	I-DISEASE
.	0

An	0
American	0
Academy	0
of	0
Sleep	0
Medicine	0
review	0
.	0

Sleep	0
2007;30:1484–501	0
.	0

Satoh	0
K	0
,	0
Mishima	0
K	0
,	I-DISEASE
Inoue	B-DISEASE
Y	0
,	I-DISEASE
Ebisawa	0
T	0
,	0
Shimizu	0
T.	0
Two	I-DISEASE
pedigrees	I-DISEASE
of	0
familial	I-DISEASE
advanced	0
sleep	0
phase	0
syndrome	0
in	0
Japan	0
.	0

Sleep	0
2003;26:416–7	0
.	0

Singer	0
CM	0
,	0
Lewy	I-DISEASE
AJ	0
.	I-DISEASE

Case	0
report	I-DISEASE
:	0
use	0
of	0
the	I-DISEASE
dim	I-DISEASE
light	0
melatonin	I-DISEASE
onset	0
in	0
the	0
treatment	0
of	0
ASPS	0
with	I-DISEASE
bright	0
light	I-DISEASE

[	0
abstract	0
]	0
.	0

Sleep	0
Res	0
1989;18:445	I-DISEASE
.	B-DISEASE

Toh	0
K	0
,	0
Jones	0
CR	0
,	I-DISEASE
He	0
Y	0
,	I-DISEASE
et	0
al	0
.	0

An	0
hPer2	0
phosphorylation	0
site	0
mutation	0
in	I-DISEASE
familial	I-DISEASE
advanced	0
sleep	0
phase	0
syndrome	0
.	0

Science	0
2001;291:1040–3	I-DISEASE
.	0

Xu	0
Y	0
,	0
Padiath	0
QS	0
,	0
Shapiro	0
RE	0
,	I-DISEASE
et	0
al	0
.	0

Functional	0
consequences	0
of	I-DISEASE
a	0
CKIdelta	0
mutation	0
causing	I-DISEASE
familial	0
advanced	I-DISEASE
sleep	0
phase	0
syndrome	0
.	0

Nature	0
2005;434:640–4	0
.	0

Yoon	0
IY	0
,	0
Kripke	0
DF	0
,	0
Elliott	I-DISEASE
JA	0
,	0
Youngstedt	0
SD	0
,	0
Rex	0
KM	0
,	I-DISEASE
Hauger	0
RL	I-DISEASE
.	I-DISEASE

Age	0
-	0
related	0
changes	I-DISEASE
of	0
circadian	I-DISEASE
rhythms	0
and	0
sleep	I-DISEASE
-	0
wake	0
cycles	0
.	I-DISEASE

J	0
Am	0
Geriatr	0
Soc	I-DISEASE
2003;51:1085–91	0
.	0

Circadian	0
Rhythm	I-DISEASE
Sleep	0
-	0
Wake	0
Disorders	0
Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	0
Wake	0
Disorders	0
Irregular	I-DISEASE
Sleep	0
-	I-DISEASE
Wake	0
Rhythm	0
Disorder	I-DISEASE
ICD-9	0
-	0
CM	0
code	0
:	0
327.33	0
ICD-10	0
-	0
CM	0
code	I-DISEASE
:	0

G47.23	0
Alternate	0
Names	0
Irregular	0
sleep	0
-	0
wake	I-DISEASE
cycle	0
disorder	0
,	0
irregular	0
sleep	0
-	0
wake	0
rhythm	0
type	0
.	0

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
D	I-DISEASE
must	0
be	0
met	I-DISEASE
A.	0

The	0
patient	0
or	0
caregiver	0
reports	0
a	0
chronic	0
or	0
recurrent	I-DISEASE
pattern	0
of	0
irregular	0
sleep	0
and	0
wake	I-DISEASE
episodes	0
throughout	I-DISEASE
the	I-DISEASE
24	I-DISEASE
-	0
hour	0
period	0
,	I-DISEASE
characterized	I-DISEASE
by	I-DISEASE
symptoms	0
of	0
insomnia	I-DISEASE
during	0
the	0
scheduled	0
sleep	0
period	0
(	0
usually	0
at	I-DISEASE
night	0
)	I-DISEASE
,	0
excessive	I-DISEASE
sleepiness	0
(	I-DISEASE
napping	I-DISEASE
)	I-DISEASE
during	0
the	I-DISEASE
day	I-DISEASE
,	I-DISEASE
or	0
both	0
.	0

B.	0
Symptoms	0
are	0
present	0
for	0
at	0
least	I-DISEASE
three	0
months	I-DISEASE
.	0

C.	0
Sleep	I-DISEASE
log	0
and	0
,	0
whenever	I-DISEASE
possible	I-DISEASE
,	0
actigraphy	I-DISEASE
monitoring	0
for	0
at	I-DISEASE
least	0
seven	0
days	I-DISEASE
,	I-DISEASE
preferably	I-DISEASE
14	I-DISEASE
days	0
,	0
demonstrate	0
no	I-DISEASE
major	0
sleep	0
period	I-DISEASE
and	I-DISEASE
multiple	I-DISEASE
irregular	I-DISEASE
sleep	I-DISEASE
bouts	0
(	I-DISEASE
at	0
least	0
three	0
)	0
during	0
a	I-DISEASE
24	I-DISEASE
-	0
hour	I-DISEASE
period	I-DISEASE
.	I-DISEASE

D.	0

The	0
sleep	0
disturbance	I-DISEASE
is	0
not	0
better	I-DISEASE
explained	I-DISEASE
by	0
another	I-DISEASE
current	0
sleep	0
disorder	I-DISEASE
,	I-DISEASE
medical	0
or	0
neurological	0
disorder	0
,	I-DISEASE
mental	0
disorder	0
,	0
medication	0
use	I-DISEASE
,	0
or	I-DISEASE
substance	0
use	0
disorder	0
.	0

Essential	0
Features	0
Irregular	0
sleep	0
-	0
wake	0
rhythm	I-DISEASE
disorder	I-DISEASE
(	I-DISEASE
ISWRD	I-DISEASE
)	0
is	0
characterized	0
by	0
lack	0
of	0
a	I-DISEASE
clearly	I-DISEASE
defined	0
circadian	0
rhythm	0
of	0
sleep	0
and	0
wake	B-DISEASE
.	0

The	0
chronic	0
or	0
recurring	0
sleep	0
-	I-DISEASE
wake	I-DISEASE
pattern	I-DISEASE
is	0
temporally	0
disorganized	0
so	0
that	0
sleep	0
and	0
wake	0
episodes	0
are	I-DISEASE
variable	0
throughout	I-DISEASE
the	0
24	0
-	0
hour	0
cycle	I-DISEASE
.	I-DISEASE

Individuals	0
have	0
symptoms	0
of	0
insomnia	0
and	0
excessive	I-DISEASE
sleepiness	0
,	I-DISEASE
depending	0
on	0
the	0
time	0
of	0
day	I-DISEASE
and	I-DISEASE
their	0
particular	I-DISEASE
sleep	0
-	I-DISEASE
wake	0
pattern	0
.	I-DISEASE

Associated	0
Features	0
ISWRD	0
is	I-DISEASE
more	0
commonly	0
observed	I-DISEASE
in	0
neurodegenerative	0
disorders	0
,	0
such	0
as	I-DISEASE
demen-	0
tia	I-DISEASE
,	0
and	0
in	I-DISEASE
children	0
with	0
developmental	0
disorders	0
.	I-DISEASE

Individuals	0
typically	0
present	0
with	0
insomnia	0
or	0
excessive	0
sleepiness	0
,	0
depending	0
on	0
the	0
time	0
of	0
day	0
.	I-DISEASE

Sleep	0
and	0
wake	0
epi-	I-DISEASE
sodes	0
across	0
the	I-DISEASE
24	0
-	I-DISEASE
hour	0
cycle	0
are	0
fragmented	0
,	0
with	0
the	0
longest	0
sleep	0
bout	0
being	0
typi-	0
cally	0
less	I-DISEASE
than	0
four	0
hours	0
.	0

Individuals	0
or	0
caregivers	0
report	0
frequent	0
naps	B-DISEASE
throughout	I-DISEASE
the	0
daytime	I-DISEASE
.	0

Total	0
sleep	0
time	0
across	0
the	0
24	I-DISEASE
hours	I-DISEASE
may	I-DISEASE
be	I-DISEASE
normal	I-DISEASE
for	0
age	0
.	0

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Older	I-DISEASE
adults	I-DISEASE
with	I-DISEASE
Alzheimer	I-DISEASE
disease	I-DISEASE
who	0
experience	I-DISEASE
sundowning	0
may	0
represent	0
a	0
clin-	0
ical	0
subtype	0
with	0
more	0
severe	0
sleep	0
fragmentation	0
and	I-DISEASE
lower	I-DISEASE
circadian	0
rhythm	I-DISEASE
ampli-	I-DISEASE
tude	0
than	0
those	0
who	0
do	0
not	0
experience	0
sundowning	0
.	0

Demographics	0
Demographic	0
patterns	0
generally	0
parallel	0
those	0
of	I-DISEASE
associated	0
risk	I-DISEASE
factors	I-DISEASE
such	0
as	0
neuro-	0
developmental	0
and	I-DISEASE
neurodegenerative	0
disorders	0
.	I-DISEASE

Predisposing	0
and	0
Precipitating	0
Factors	0
Neurodegenerative	0
disorders	I-DISEASE
such	I-DISEASE
as	0
Alzheimer	I-DISEASE
disease	0
,	0
Parkinson	0
disease	0
,	0
and	0
Huntington	I-DISEASE
disease	0
increase	I-DISEASE
the	0
risk	0
for	0
ISWRD	0
.	0

Children	0
with	0
developmental	0
disor-	0
ders	0
also	I-DISEASE
are	I-DISEASE
at	0
increased	I-DISEASE
risk	0
for	0
ISWRD	I-DISEASE
.	0

Poor	0
sleep	0
hygiene	I-DISEASE
and	I-DISEASE
lack	0
of	I-DISEASE
exposure	I-DISEASE
to	0
external	I-DISEASE
synchronizing	0
agents	0
such	0
as	I-DISEASE
light	0
,	0
activity	I-DISEASE
,	0
and	I-DISEASE
social	0
schedules	I-DISEASE
may	0
be	0
predisposing	0
as	0
well	0
as	0
precipitating	0
factors	I-DISEASE
involved	0
in	0
the	I-DISEASE
development	0
of	0
ISWRD	0
,	0
particularly	0
in	0
the	I-DISEASE
institutionalized	0
elderly	0
.	I-DISEASE

Familial	0
Patterns	0
Not	0
applicable	0
or	0
known	0
.	I-DISEASE

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Onset	I-DISEASE
of	0
the	0
condition	0
may	0
occur	0
at	0
any	0
age	I-DISEASE
.	I-DISEASE

Little	0
is	0
known	0
regarding	0
the	0
course	I-DISEASE
and	0
complications	0
of	0
ISWRD	0
in	0
adults	0
.	0

Due	0
to	0
the	0
multiple	I-DISEASE
awakenings	0
and	0
,	0
in	0
the	I-DISEASE
elderly	0
,	0
nocturnal	I-DISEASE
wandering	0
,	0
falls	I-DISEASE
can	0
be	0
an	I-DISEASE
indirect	0
complication	0
.	0

In	0
addition	0
to	0
the	0
patient	0
’s	0
sleep	0
-	0
wake	I-DISEASE
dysfunction	0
,	0
the	0
caregiver	0
’s	0
sleep	I-DISEASE
is	I-DISEASE
often	0
disrupted	0
.	0

The	0
sleep	0
and	0
wake	0
disruption	0
associated	0
with	0
ISWRD	0
is	I-DISEASE
a	0
common	0
cause	0
of	0
institutionalization	0
.	I-DISEASE

Developmental	0
Issues	0
Caregivers	0
may	I-DISEASE
report	0
that	0
a	B-DISEASE
child	0
with	I-DISEASE
ISWRD	I-DISEASE
has	0
difficulty	0
falling	0
asleep	I-DISEASE
at	0
the	0
desired	0
bedtime	I-DISEASE
or	0
“	I-DISEASE
falls	I-DISEASE
asleep	0
too	0
early	0
”	I-DISEASE
in	0
the	0
evening	0
,	0
wakes	0
“	I-DISEASE
too	I-DISEASE
early	0
”	0
or	0
has	0
dif-	0
ficulty	0
waking	0
in	0
the	0
morning	0
,	0
and/or	0
exhibits	I-DISEASE
developmentally	I-DISEASE
inappropriate	I-DISEASE
napping	0
behavior	I-DISEASE
during	0
the	0
day	0
.	I-DISEASE

Parents	0
may	0
complain	0
that	0
their	0
child	0
sleeps	I-DISEASE
too	I-DISEASE
much	I-DISEASE
or	0
too	0
little	0
or	0
at	0
inappropriate	I-DISEASE
times	I-DISEASE
.	0

Attempts	0
to	I-DISEASE
keep	0
the	0
child	0
awake	0
during	I-DISEASE
the	0
day	I-DISEASE
,	0
especially	0
during	0
sedentary	0
activities	0
,	I-DISEASE
are	0
often	0
unsuccessful	0
.	0

The	0
key	0
characteristics	0
that	0
distinguish	0
ISWRD	0
from	I-DISEASE
other	0
sleep	0
complaints	0
or	0
circadian	I-DISEASE
sleep	0
wake	0
disor-	I-DISEASE
ders	0
are	I-DISEASE
the	I-DISEASE
lack	0
of	0
prolonged	0
consolidated	0
sleep	0
periods	0
,	I-DISEASE
the	I-DISEASE
often	0
seemingly	I-DISEASE
random	0
distribution	I-DISEASE
in	0
sleep	0
periods	I-DISEASE
across	0
the	0
24	0
-	0
hour	0
day	I-DISEASE
,	0
and	0
the	I-DISEASE
marked	I-DISEASE
day	0
-	0
to	0
-	I-DISEASE
day	I-DISEASE
and	I-DISEASE
week	I-DISEASE
-	0
to	I-DISEASE
-	I-DISEASE
week	I-DISEASE
variability	0
with	0
little	0
in	I-DISEASE
the	0
way	I-DISEASE
of	I-DISEASE
a	0
clearly	I-DISEASE
predictable	0
major	0
sleep-	0
wake	I-DISEASE
pattern	I-DISEASE
.	0

The	0
impact	0
on	0
caregivers	0
’	0
sleep	0
and	B-DISEASE
daytime	0
functioning	I-DISEASE
is	0
likely	0
to	I-DISEASE
be	0
particularly	0
profound	I-DISEASE
.	I-DISEASE

There	0
may	0
be	0
phenotypes	I-DISEASE
of	0
ISWRD	I-DISEASE
in	0
children	0
,	I-DISEASE
with	I-DISEASE
differences	0
regarding	0
symptom	0
presentation	I-DISEASE
and	I-DISEASE
severity	0
and	0
chronicity	I-DISEASE
that	0
are	0
related	0
to	0
the	0
underlying	0
condition	I-DISEASE
.	0

Circadian	0
Rhythm	I-DISEASE
Sleep	0
-	0
Wake	0
Disorders	0
Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	0
Wake	0
Disorders	0
For	I-DISEASE
example	0
,	I-DISEASE
it	0
is	0
possible	I-DISEASE
that	0
children	0
with	0
chronic	0
neurologic	0
conditions	0
such	0
as	0
autism	0
or	I-DISEASE
chromosomal	0
syndromes	I-DISEASE
characterized	I-DISEASE
by	0
developmental	0
delays	0
may	0
have	0
a	0
more	0
intractable	0
and	0
treatment	0
resistant	0
pattern	0
compared	0
with	0
children	0
with	I-DISEASE
more	I-DISEASE
self	0
-	0
limited	0
conditions	I-DISEASE
(	I-DISEASE
e.g.	0
,	0
postconcussion	0
)	0
.	I-DISEASE

Although	0
ISWRD	0
appears	0
to	0
be	0
rare	0
in	0
typically	I-DISEASE
developing	I-DISEASE
children	0
,	0
it	0
may	I-DISEASE
be	0
envi-	0
ronmentally	0
or	0
behaviorally	0
induced	0
.	0

This	0
may	0
be	0
seen	0
in	0
children	0
with	I-DISEASE
irregular	0
or	0
fragmented	0
sleep	0
and	0
wake	I-DISEASE
schedules	0
because	I-DISEASE
of	0
a	0
chaotic	I-DISEASE
household	0
.	0

Children	0
with	0
developmental	0
disorders	0
are	0
at	0
increased	I-DISEASE
risk	0
for	I-DISEASE
ISWRD	0
.	0

For	0
example	0
,	0
children	0
with	0
autism	0
,	I-DISEASE
Asperger	0
syndrome	0
,	0
or	0
pervasive	0
developmental	0
disorder	0
not	I-DISEASE
otherwise	I-DISEASE
spec-	0
ified	I-DISEASE
often	0
have	0
highly	0
irregular	0
sleep	0
patterns	0
.	0

In	0
addition	0
,	0
these	0
children	0
often	I-DISEASE
have	I-DISEASE
circadian	0
rhythm	I-DISEASE
abnormalities	0
which	0
are	0
both	0
more	0
severe	I-DISEASE
and	0
chronic	0
and	I-DISEASE
they	0
are	0
at	0
increased	0
risk	0
for	I-DISEASE
relapse	I-DISEASE
.	0

Both	0
ISWRD	0
and	I-DISEASE
non-24	0
-	0
hour	I-DISEASE
sleep	0
-	0
wake	I-DISEASE
rhythm	0
disorder	0
are	I-DISEASE
also	I-DISEASE
common	I-DISEASE
in	0
Angelman	0
syndrome	0
,	I-DISEASE
a	0
neurodevelopmental	0
disorder	0
associated	0
with	0
an	0
abnormality	I-DISEASE
of	0
chromosome	0
15q11	I-DISEASE
-	0
q13	I-DISEASE
,	I-DISEASE
and	I-DISEASE
have	0
been	0
reported	0
in	0
children	0
with	I-DISEASE
Williams	0
syndrome	0
,	I-DISEASE
a	0
neurodevelopmental	0
genetic	0
disorder	I-DISEASE
characterized	0
by	I-DISEASE
physical	0
abnormalities	0
and	0
a	0
dis-	I-DISEASE
tinctive	I-DISEASE
cognitive	I-DISEASE
profile	0
with	0
intellectual	0
disabilities	I-DISEASE
and	0
learning	I-DISEASE
difficulties	I-DISEASE
.	I-DISEASE

Studies	0
in	0
children	0
and	I-DISEASE
adults	0
with	0
autism	I-DISEASE
spectrum	0
disorders	I-DISEASE
and	0
in	I-DISEASE
children	0
with	I-DISEASE
Smith	0
-	I-DISEASE
Magenis	I-DISEASE
syndrome	0
have	I-DISEASE
shown	0
profound	I-DISEASE
alterations	0
in	0
melatonin	I-DISEASE
secretion	0
profiles	0
.	0

Smith-	0

Magenis	0
syndrome	0
is	0
a	0
developmental	0
disorder	0
caused	I-DISEASE
by	0
an	I-DISEASE
abnormality	0
in	0
the	0
short	0
(	0
p	0
)	I-DISEASE
arm	0
of	I-DISEASE
chromosome	0
17	I-DISEASE
.	0

It	0
is	0
characterized	0
by	0
mild	0
to	I-DISEASE
moderate	0
intellectual	0
disabil-	I-DISEASE
ity	0
,	0
distinctive	0
facial	0
features	0
,	0
sleep	0
disturbances	0
,	I-DISEASE
and	0
behavioral	0
problems	0
.	0

Decreased	0
concentrations	0
of	0
melatonin	I-DISEASE
and	0
its	I-DISEASE
metabolites	I-DISEASE
and	0
daytime	I-DISEASE
elevation	I-DISEASE
and	0
abnormal	0
rhythm	0
/	0
decreased	I-DISEASE
amplitude	0
of	0
melatonin	I-DISEASE
secretion	0
have	0
been	0
reported	0
in	0
these	I-DISEASE
popu-	I-DISEASE
lations	0
.	0

These	0
findings	0
may	0
be	0
due	I-DISEASE
to	0
polymorphisms	I-DISEASE
in	0
melatonin	I-DISEASE
enzymes	0
synthesis	0
or	I-DISEASE
variants	0
in	0
genes	I-DISEASE
coding	0
for	0
melatonin	I-DISEASE
receptors	0
.	0

Other	0
postulated	0
mechanisms	0
for	0
circadian	0
rhythm	0
disturbances	I-DISEASE
,	0
particularly	I-DISEASE
ISWRD	0
,	I-DISEASE
in	0
these	I-DISEASE
populations	I-DISEASE
include	0
clock	0
gene	0
polymorphisms	I-DISEASE
and	0
decreased	I-DISEASE
levels	0
of	0
entrainment	0
by	I-DISEASE
social	I-DISEASE
/	0
environmental	0
cues	I-DISEASE
.	0

There	0
may	0
also	0
be	0
medical	0
conditions	0
that	0
predispose	0
typically	I-DISEASE
developing	0
children	0
and	0
adolescents	I-DISEASE
to	I-DISEASE
ISWRD	I-DISEASE
.	0

These	0
include	0
traumatic	0
brain	0
injury	0
and	I-DISEASE
chronic	I-DISEASE
fatigue	0
syndrome	0
.	0

Brain	0
tumor	0
survivors	0
,	I-DISEASE
especially	0
patients	0
who	I-DISEASE
have	0
experienced	0
disrup-	0
tion	0
in	0
the	0
hypothalamic	0
-	I-DISEASE
pituitary	0
axis	0
,	I-DISEASE
may	0
have	0
an	0
increased	0
prevalence	I-DISEASE
of	I-DISEASE
circadian	I-DISEASE
rhythm	0
disorders	0
,	I-DISEASE
including	0
ISWRD	0
.	0

There	0
is	0
very	0
little	0
literature	0
on	I-DISEASE
ISWRD	0
in	0
the	0
pediatric	0
population	0
;	0
prevalence	0
,	0
sex	I-DISEASE
,	0
and	0
racial	I-DISEASE
/	0
ethnic	0
differences	0
are	0
unknown	0
.	0

Little	0
is	0
known	0
about	0
the	0
natural	I-DISEASE
history	I-DISEASE
of	0
the	I-DISEASE
clinical	I-DISEASE
entity	0
of	0
ISWRD	0
in	I-DISEASE
the	0
pediatric	0
population	0
,	I-DISEASE
including	0
the	0
impact	0
of	0
various	0
treatment	I-DISEASE
modalities	0
,	0
the	0
likelihood	I-DISEASE
of	0
spontaneous	I-DISEASE
resolution	0
of	0
symptoms	I-DISEASE
,	0
or	0
long	0
-	0
term	I-DISEASE
consequences	0
.	0

The	0
impact	0
on	0
caregivers	0
of	0
children	0
with	B-DISEASE
neurodevelopmen-	0
tal	I-DISEASE
disorders	0
and	0
ISWRD	0
may	0
be	0
particularly	I-DISEASE
profound	I-DISEASE
.	0

The	0
prevalence	0
of	I-DISEASE
ISWRD	0
increases	I-DISEASE
with	0
advancing	0
age	I-DISEASE
,	I-DISEASE
but	0
it	0
is	0
likely	0
that	0
age	I-DISEASE
-	0
re-	0
lated	0
increase	0
in	0
neurodegenerative	0
disorders	0
,	0
rather	0
than	0
aging	0
per	0
se	I-DISEASE
,	0
explains	0
this	0
relationship	0
.	0

Pathology	0
and	0
Pathophysiology	0
The	0
etiology	0
of	I-DISEASE
ISWRD	I-DISEASE
is	0
likely	I-DISEASE
multifactorial	0
.	0

Anatomic	0
or	0
functional	I-DISEASE
abnormal-	0
ities	0
of	I-DISEASE
the	I-DISEASE
circadian	0
clock	0
can	0
result	0
in	I-DISEASE
an	0
arrhythmic	0
pattern	I-DISEASE
of	0
rest	0
and	0
activity	0
.	0

Decreased	0
exposure	0
to	0
environmental	I-DISEASE
-	0
entraining	0
agents	I-DISEASE
,	0
such	I-DISEASE
as	0
light	0
and	0
structured	0
physical	0
and	I-DISEASE
social	I-DISEASE
activities	0
(	I-DISEASE
common	0
in	0
institutionalized	0
elderly	0
,	0
and	0
children	I-DISEASE
with	0
developmental	0
disorders	I-DISEASE
)	0
,	I-DISEASE
also	0
can	0
contribute	0
to	0
the	0
development	0
of	0
an	I-DISEASE
irregular	0
sleep	I-DISEASE
-	0
wake	I-DISEASE
cycle	0
.	0

Objective	0
Findings	0

In	0
addition	0
to	0
a	I-DISEASE
careful	0
sleep	I-DISEASE
history	I-DISEASE
,	0
sleep	I-DISEASE
log	I-DISEASE
and	0
actigraphy	0
monitoring	0
show	0
the	I-DISEASE
expected	0
lack	0
of	I-DISEASE
a	0
clearly	I-DISEASE
defined	0
circadian	0
rhythm	0
of	0
the	0
sleep	0
-	0
wake	I-DISEASE
cycle	I-DISEASE
,	I-DISEASE
which	0
,	I-DISEASE
instead	0
,	0
is	I-DISEASE
characterized	0
by	0
multiple	I-DISEASE
irregular	0
sleep	0
and	0
wake	I-DISEASE
bouts	0
throughout	I-DISEASE
the	0
24	I-DISEASE
-	0
hour	I-DISEASE
period	I-DISEASE
.	I-DISEASE

The	0
use	0
of	0
sleep	0
log	0
and	0
actigraphy	I-DISEASE
is	0
indicated	I-DISEASE
for	0
the	0
identification	0
of	0
irregular	0
sleep	I-DISEASE
wake	0
rhythm	0
.	I-DISEASE

The	0
irregular	0
sleep	0
-	I-DISEASE
wake	0
pattern	I-DISEASE
is	0
defined	0
as	I-DISEASE
having	0
multiple	0
sleep	0
bouts	I-DISEASE
(	0
typically	I-DISEASE
2–4	I-DISEASE
hours	I-DISEASE
)	I-DISEASE
during	0
a	I-DISEASE
24	0
-	0
hour	0
period	I-DISEASE
.	I-DISEASE

The	0
pattern	0
may	0
vary	B-DISEASE
from	I-DISEASE
day	0
to	0
day	0
,	I-DISEASE
thus	0
monitoring	0
for	0
at	0
least	0
seven	I-DISEASE
days	0
and	0
preferably	I-DISEASE
14	0
days	I-DISEASE
may	0
be	0
needed	0
to	I-DISEASE
differentiate	I-DISEASE
the	0
irregular	0
pattern	I-DISEASE
from	0
other	0
circadian	0
rhythm	I-DISEASE
sleep-	0
wake	0
disorders	0
.	I-DISEASE

Polysomnography	0
is	0
not	0
required	0
to	0
establish	I-DISEASE
the	I-DISEASE
diagnosis	0
.	0

Polysomnography	0
may	0
be	0
useful	0
for	0
the	I-DISEASE
diagnosis	0
of	I-DISEASE
other	0
comorbid	0
sleep	I-DISEASE
disorders	0
.	0

Monitoring	0
of	0
other	I-DISEASE
circa-	I-DISEASE
dian	0
rhythms	0
,	I-DISEASE
such	0
as	I-DISEASE
core	0
body	0
temperature	0
and	I-DISEASE
melatonin	0
for	I-DISEASE
at	0
least	0
24	I-DISEASE
hours	0
,	0
may	0
also	0
show	I-DISEASE
a	I-DISEASE
loss	I-DISEASE
of	I-DISEASE
clear	0
circadian	B-DISEASE
rhythmicity	B-DISEASE
or	0
a	0
low	I-DISEASE
amplitude	0
rhythm	0
.	0

Differential	0
Diagnosis	0
Poor	0
sleep	0
hygiene	0
and	I-DISEASE
voluntary	I-DISEASE
maintenance	I-DISEASE
of	I-DISEASE
irregular	0
sleep	0
schedules	I-DISEASE
should	0
be	0
distinguished	0
from	I-DISEASE
irregular	0
sleep	I-DISEASE
-	0
wake	0
pattern	0
.	0

Individuals	0
with	0
irregular	0
sleep	0
-	0
wake	0
rhythms	I-DISEASE
may	0
present	I-DISEASE
with	0
complaints	0
of	0
insomnia	0
.	0

Careful	0
analysis	0
of	0
sleep	I-DISEASE
logs	0
or	I-DISEASE
actigraphy	0
will	0
demonstrate	I-DISEASE
multiple	I-DISEASE
irregular	0
periods	0
of	I-DISEASE
sleep	0
throughout	0
the	0
24	0
-	I-DISEASE
hour	0
cycle	I-DISEASE
.	0

In	0
both	0
adults	0
and	I-DISEASE
children	I-DISEASE
,	I-DISEASE
other	I-DISEASE
causes	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
fragmentation	I-DISEASE
and	0
daytime	I-DISEASE
Circadian	0
Rhythm	I-DISEASE
Sleep	I-DISEASE
-	I-DISEASE
Wake	I-DISEASE
Disorders	B-DISEASE
Circadian	0
Rhythm	0
Sleep	0
-	0
Wake	0
Disorders	I-DISEASE
napping	0
,	I-DISEASE
including	I-DISEASE
comorbid	I-DISEASE
medical	I-DISEASE
and	0
psychiatric	I-DISEASE
disorders	0
,	0
other	0
sleep	I-DISEASE
disorders	0
,	0
or	0
medication	I-DISEASE
should	I-DISEASE
be	0
identified	0
and	0
treated	0
.	I-DISEASE

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE

There	0
is	0
limited	0
knowledge	I-DISEASE
of	0
the	I-DISEASE
pathophysiology	I-DISEASE
and	0
natural	I-DISEASE
history	I-DISEASE
,	0
response	0
to	I-DISEASE
treatment	0
,	0
and	0
complications	0
of	I-DISEASE
the	0
disorder	0
in	0
adults	0
and	0
children	I-DISEASE
.	I-DISEASE

Further	0
research	0
into	0
the	0
relative	I-DISEASE
contribution	0
of	I-DISEASE
alterations	0
in	0
environmental	0
synchronizing	0
agents	0
,	I-DISEASE
such	0
as	0
light	I-DISEASE
and	0
activity	I-DISEASE
,	0
versus	0
a	0
dysfunction	0
of	0
the	0
endogenous	I-DISEASE
circadian	I-DISEASE
clock	0
in	I-DISEASE
the	0
development	I-DISEASE
of	I-DISEASE
irregular	I-DISEASE
sleep	0
and	0
wake	0
patterns	B-DISEASE
will	I-DISEASE
lead	0
to	I-DISEASE
improved	0
understanding	I-DISEASE
of	0
this	I-DISEASE
condition	0
.	I-DISEASE

Bibliography	0
Hopkins	0
R	0
,	0
Rindlisbacher	0
P.	0
Fragmentation	I-DISEASE
of	0
activity	I-DISEASE
periods	0
in	0
Alzheimer	0
’s	0
disease	0
.	0

Int	0
J	0
Geriatr	0
Psychiatry	0
1992;7:805–12	0
.	0

McCurry	0
SM	0
,	0
Ancoli	0
-	0
Israel	I-DISEASE
S.	0
Sleep	0
dysfunction	0
in	0
Alzheimer	0
’s	0
disease	0
and	0
other	0
dementias	0
.	0

Curr	0
Treat	I-DISEASE
Options	0
Neurol	0
2003;5:261–72	0
.	I-DISEASE

Okawa	0
M	0
,	0
Mishima	0
K	0
,	I-DISEASE
Hishikawa	I-DISEASE
Y	0
,	I-DISEASE
Hozumi	I-DISEASE
S	0
,	0
Hori	0
H	0
,	0
Takahashi	0
K.	I-DISEASE
Circadian	I-DISEASE
rhythm	0
disorders	0
in	0
sleep	0
-	0
waking	0
and	0
body	I-DISEASE
temperature	0
in	0
elderly	I-DISEASE
patients	0
with	I-DISEASE
dementia	I-DISEASE
and	0
their	0
treatment	0
.	I-DISEASE

Sleep	0
1991;14:478–85	0
.	0

Pillar	0
G	0
,	0
Shahar	I-DISEASE
E	0
,	I-DISEASE
Peled	I-DISEASE
N	0
,	I-DISEASE
Ravid	0
S	0
,	0
Lavie	0
P	0
,	0
Etzioni	0
A.	0
Melatonin	I-DISEASE
improves	0
sleep	0
-	0
wake	0
patterns	0
in	I-DISEASE
psychomotor	0
retarded	0
children	0
.	0

Pediatr	0
Neurol	0
2000;23:225–8	0
.	0

Pollack	0
C	0
,	0
Stokes	I-DISEASE
P.	0
Circadian	0
rest	I-DISEASE
-	0
activity	I-DISEASE
rhythms	0
in	0
demented	0
and	0
non	0
-	I-DISEASE
demented	I-DISEASE
older	0
community	I-DISEASE
residents	0
and	I-DISEASE
their	0
caregivers	0
.	0

J	0
Am	0
Geriatr	0
Soc	I-DISEASE
1997;45:446	0
-	0
52	0
.	0

Shochat	0
T	0
,	I-DISEASE
Martin	0
J	0
,	I-DISEASE
Marler	I-DISEASE
M	I-DISEASE
,	I-DISEASE
Ancoli	0
-	0
Israel	0
S.	I-DISEASE
Illumination	0
levels	0
in	0
nursing	0
home	I-DISEASE
patients	0
:	0
Effects	0
on	0
sleep	I-DISEASE
and	0
activity	0
rhythms	0
.	0

J	0
Sleep	0
Res	0
2000;9:373–9	I-DISEASE
.	0

Volicer	0
L	0
,	0
Harper	0
DG	I-DISEASE
,	0
Manning	I-DISEASE
BC	0
,	I-DISEASE
Goldstein	0
R	0
,	0
Satlin	0
A.	0
Sundowning	0
and	0
circadian	0
rhythms	I-DISEASE
in	0
Alzheimer	I-DISEASE
’s	0
disease	0
.	0

Am	0
J	0
Psychiatry	0
2001;158:704–11	0
.	0

Witting	0
W	I-DISEASE
,	0
Kwa	I-DISEASE
I	0
,	I-DISEASE
Eikelenboom	I-DISEASE
P	0
,	I-DISEASE
Mirmiran	0
M	0
,	0
Swaab	0
D.	0
Alterations	I-DISEASE
in	I-DISEASE
the	0
circadian	0
rest	0
-	0
activity	0
rhythm	0
in	0
aging	0
and	I-DISEASE
Alzheimer	0
’s	0
disease	I-DISEASE
.	0

Biol	0
Psychiatry	0
1990;27:563–72	0
.	0

Zee	0
PC	0
,	0
Vitiello	0
MV	0
.	0

Circadian	0
rhythm	I-DISEASE
sleep	0
disorder	0
:	0
irregular	0
sleep	I-DISEASE
wake	0
rhythm	I-DISEASE
type	0
.	0

Sleep	0
Med	0
Clin	I-DISEASE
2009;4:213–8	0
.	I-DISEASE

Non-24	0
-	0
Hour	0
Sleep	I-DISEASE
-	0
Wake	I-DISEASE
Rhythm	I-DISEASE
Disorder	0
ICD-9	0
-	0
CM	0
code	0
:	0
327.34	0
ICD-10	0
-	0
CM	0
code	I-DISEASE
:	0

G47.24	0
Alternate	0
Names	0
Free	0
-	0
running	0
disorder	I-DISEASE
,	0
nonentrained	I-DISEASE
disorder	0
,	0
hypernychthemeral	0
syndrome	0
.	0

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
D	I-DISEASE
must	0
be	0
met	I-DISEASE
A.	0

There	0
is	0
a	0
history	0
of	0
insomnia	I-DISEASE
,	0
excessive	0
daytime	I-DISEASE
sleepiness	0
,	0
or	0
both	I-DISEASE
,	0
which	I-DISEASE
alternate	0
with	0
asymptomatic	I-DISEASE
episodes	I-DISEASE
,	0
due	0
to	0
misalignment	0
between	0
the	I-DISEASE
24	I-DISEASE
-	0
hour	I-DISEASE
light	0
-	I-DISEASE
dark	I-DISEASE
cycle	0
and	0
the	0
non	I-DISEASE
-	I-DISEASE
entrained	I-DISEASE
endogenous	I-DISEASE
circadian	I-DISEASE
rhythm	I-DISEASE
of	I-DISEASE
sleep	0
-	0
wake	I-DISEASE
propensity	0
.	I-DISEASE

B.	0
Symptoms	0
persist	0
over	0
the	0
course	0
of	0
at	0
least	I-DISEASE
three	0
months	0
.	0

C.	0
Daily	I-DISEASE
sleep	0
logs	I-DISEASE
and	0
actigraphy	0
for	I-DISEASE
at	0
least	I-DISEASE
14	0
days	0
,	I-DISEASE
preferably	I-DISEASE
longer	0
for	I-DISEASE
blind	0
persons	0
,	I-DISEASE
demonstrate	0
a	0
pattern	0
of	0
sleep	0
and	I-DISEASE
wake	I-DISEASE
times	0
that	0
typically	I-DISEASE
delay	0
each	I-DISEASE
day	0
,	I-DISEASE
with	0
a	0
circadian	0
period	0
that	0
is	0
usually	I-DISEASE
longer	0
than	B-DISEASE
24	0
hours	0
.	0

D.	0

The	0
sleep	0
disturbance	I-DISEASE
is	0
not	0
better	I-DISEASE
explained	I-DISEASE
by	0
another	I-DISEASE
current	0
sleep	0
disorder	I-DISEASE
,	I-DISEASE
medical	0
or	0
neurological	0
disorder	0
,	I-DISEASE
mental	0
disorder	0
,	0
medication	0
use	I-DISEASE
,	0
or	I-DISEASE
substance	0
use	0
disorder	0
.	0

Notes	0
.	0

Patients	0
may	0
present	0
with	0
a	0
progressively	0
delaying	I-DISEASE
sleep	0
-	0
wake	0
pattern	0
and	0
intermittent	I-DISEASE
insomnia	0
and	I-DISEASE
excessive	0
sleepiness	0
.	I-DISEASE

Individual	0
symptoms	0
will	0
depend	0
on	0
when	0
an	I-DISEASE
individual	I-DISEASE
tries	I-DISEASE
to	0
sleep	0
in	I-DISEASE
relation	0
to	0
the	0
circadian	I-DISEASE
rhythm	0
of	I-DISEASE
sleep	0
-	0
wake	0
propensity	0
.	I-DISEASE

The	0
magnitude	0
of	0
the	I-DISEASE
daily	I-DISEASE
delay	0
will	0
depend	0
on	I-DISEASE
the	0
endogenous	I-DISEASE
circadian	0
period	0
,	I-DISEASE
and	I-DISEASE
may	0
range	0
from	I-DISEASE
less	0
than	0
30	0
minutes	0
(	0
when	0
the	0
period	0
is	I-DISEASE
close	0
to	I-DISEASE
24	0
hours	0
)	I-DISEASE
to	0
more	0
than	0
an	I-DISEASE
hour	0
(	0
when	0
the	I-DISEASE
period	0
is	I-DISEASE
longer	0
than	I-DISEASE
25	0
hours	0
)	I-DISEASE
.	I-DISEASE
.	0

The	0
symptomatic	0
episode	0
will	0
typically	0
begin	0
with	I-DISEASE
a	0
gradual	I-DISEASE
increase	0
in	0
sleep	0
latency	0
and	0
delayed	0
sleep	0
onset	I-DISEASE
.	0

As	0
the	0
sleep	I-DISEASE
propensity	I-DISEASE
rhythm	0
shifts	I-DISEASE
into	0
the	0
daytime	I-DISEASE
,	0
patients	0
will	0
have	0
difficulty	0
falling	I-DISEASE
asleep	0
at	I-DISEASE
night	I-DISEASE
and	0
staying	I-DISEASE
awake	0
during	0
the	0
day	0
.	I-DISEASE

As	0
the	0
sleep	I-DISEASE
-	I-DISEASE
wake	0
propensity	I-DISEASE
rhythm	0
drifts	0
further	I-DISEASE
,	0
patients	0
will	0
eventually	0
complain	0
of	I-DISEASE
late	I-DISEASE
afternoon	0
and	0
evening	0
sleepiness	0
and	0
naps	0
as	0
well	I-DISEASE
as	0
an	0
early	0
sleep	I-DISEASE
onset	0
time	0
and	0
short	I-DISEASE
sleep	0
latency	0
.	0
.	0

Other	0
circadian	0
rhythms	0
,	B-DISEASE
such	0
as	0
the	I-DISEASE
DLMO	0
or	I-DISEASE
urinary	0
6	0
-	0
sulfatoxy-	0
melatonin	0
rhythm	I-DISEASE
obtained	0
at	0
two	0
time	0
points	0
2	0
-	0
4	0
weeks	0
apart	0
(	0
i.e.	0
,	0
to	I-DISEASE
allow	0
sufficient	0
time	0
for	0
the	0
drift	0
to	0
be	0
apparent	I-DISEASE
)	I-DISEASE
is	0
desirable	0
to	0
confirm	0
the	0
nonentrained	0
rhythm	0
.	I-DISEASE

Circadian	0
Rhythm	I-DISEASE
Sleep	0
-	0
Wake	0
Disorders	0
Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	0
Wake	0
Disorders	0
Essential	I-DISEASE
Features	0
Non-24	I-DISEASE
-	0
hour	0
sleep	I-DISEASE
-	0
wake	0
disorder	0
(	0
N24SWD	0
)	I-DISEASE
is	0
characterized	0
by	0
symptoms	I-DISEASE
of	0
insomnia	I-DISEASE
or	I-DISEASE
excessive	I-DISEASE
sleepiness	0
that	0
occur	0
because	0
the	0
intrinsic	0
circadian	0
pace-	I-DISEASE
maker	0
is	0
not	0
entrained	0
to	0
a	0
24	I-DISEASE
-	I-DISEASE
hour	0
light	I-DISEASE
/	I-DISEASE
dark	0
cycle	I-DISEASE
.	0

The	0
non-24	0
-	0
hour	0
period	0
can	0
be	0
shorter	0
or	0
,	0
more	0
typically	0
,	0
longer	0
than	I-DISEASE
24	0
hours	0
.	I-DISEASE

Because	0
the	0
endogenous	I-DISEASE
circadian	0
rhythm	0
is	I-DISEASE
not	0
aligned	0
to	0
the	0
external	I-DISEASE
24	I-DISEASE
-	0
hour	I-DISEASE
environment	0
,	I-DISEASE
symptoms	0
will	I-DISEASE
depend	0
on	0
when	0
an	0
individual	0
tries	0
to	I-DISEASE
sleep	I-DISEASE
in	0
relation	B-DISEASE
to	0
the	I-DISEASE
circadian	0
rhythm	I-DISEASE
of	0
sleep	0
and	0
wake	0
propensity	0
.	I-DISEASE

Individuals	0
typically	0
present	I-DISEASE
with	0
episodes	0
of	0
difficulty	I-DISEASE
falling	I-DISEASE
asleep	I-DISEASE
or	I-DISEASE
staying	0
asleep	0
,	I-DISEASE
excessive	0
sleepiness	I-DISEASE
or	I-DISEASE
both	0
,	I-DISEASE
alternating	0
with	0
short	0
asymp-	0
tomatic	0
periods	I-DISEASE
.	B-DISEASE

The	0
severity	0
of	0
individual	0
sleep	0
-	I-DISEASE
wake	I-DISEASE
symptoms	I-DISEASE
can	0
be	0
variable	0
.	0

Starting	0
with	0
the	0
asymptomatic	I-DISEASE
period	0
when	0
the	I-DISEASE
individual	0
’s	I-DISEASE
endogenous	0
rhythm	0
is	I-DISEASE
aligned	0
to	0
the	0
external	0
environment	0
and	I-DISEASE
required	0
sleep	0
-	I-DISEASE
wake	0
times	I-DISEASE
,	0
sleep	I-DISEASE
latency	0
will	0
gradually	I-DISEASE
increase	0
and	I-DISEASE
the	0
individual	0
will	0
complain	0
of	0
sleep	0
-	I-DISEASE
onset	0
insomnia	I-DISEASE
.	I-DISEASE

As	0
the	0
sleep	I-DISEASE
phase	I-DISEASE
continues	0
to	I-DISEASE
drift	0
so	0
that	I-DISEASE
maximal	0
endogenous	0
sleep	0
propensity	0
is	0
now	I-DISEASE
in	I-DISEASE
the	0
daytime	I-DISEASE
,	0
individuals	0
will	0
have	0
trouble	I-DISEASE
staying	0
awake	I-DISEASE
during	I-DISEASE
the	0
day	0
(	I-DISEASE
exhibiting	0
multiple	0
daytime	I-DISEASE
naps	0
)	0
and	0
complain	I-DISEASE
of	0
sleepiness	I-DISEASE
.	0

Associated	0
Features	0
Most	0
individuals	0
with	0
nonentrained	0
circadian	0
rhythms	0
are	0
totally	0
blind	0
,	0
and	I-DISEASE
the	0
failure	I-DISEASE
to	I-DISEASE
entrain	0
circadian	I-DISEASE
rhythms	I-DISEASE
is	0
related	0
to	0
the	0
lack	I-DISEASE
of	0
photic	0
input	0
to	I-DISEASE
the	I-DISEASE
cir-	0
cadian	I-DISEASE
pacemaker	I-DISEASE
.	0

A	0
small	0
proportion	I-DISEASE
of	I-DISEASE
totally	0
blind	I-DISEASE
people	I-DISEASE
may	I-DISEASE
retain	I-DISEASE
functional	I-DISEASE
circadian	0
photoreception	0
and	I-DISEASE
entrained	0
rhythms	I-DISEASE
if	I-DISEASE
their	0
blindness	0
is	0
due	0
exclusively	0
to	0
an	0
outer	I-DISEASE
retina	I-DISEASE
disorder	0
(	0
rod	I-DISEASE
and	0
cone	I-DISEASE
layer	0
)	0
with	0
retention	0
of	0
functional	I-DISEASE
,	0
intrin-	I-DISEASE
sically	0
photosensitive	I-DISEASE
retinal	0
ganglion	I-DISEASE
cells	0
and	0
the	I-DISEASE
retinohypothalamic	0
pathway	I-DISEASE
.	0

Some	0
blind	0
people	0
may	I-DISEASE
also	0
be	0
able	I-DISEASE
to	0
entrain	I-DISEASE
to	0
nonphotic	0
cues	0
(	0
e.g.	0
,	0
the	0
timing	0
of	I-DISEASE
physical	0
activity	0
)	0
,	0
producing	0
entrainment	I-DISEASE
at	I-DISEASE
an	0
adverse	0
phase	I-DISEASE
in	I-DISEASE
some	0
cases	0
.	0

In	0
sighted	0
people	0
,	I-DISEASE
social	0
and	0
behavioral	I-DISEASE
factors	0
also	I-DISEASE
play	0
an	0
important	0
role	I-DISEASE
in	0
the	0
development	I-DISEASE
and	0
maintenance	I-DISEASE
of	0
the	0
disorder	0
,	0
as	0
there	0
is	I-DISEASE
an	0
increased	I-DISEASE
incidence	I-DISEASE
of	0
psychiatric	I-DISEASE
disorders	0
.	0

Occasionally	0
,	0
the	0
disorder	I-DISEASE
is	0
associated	0
with	I-DISEASE
developmental	0
intellectual	I-DISEASE
disability	0
or	0
dementia	0
.	I-DISEASE

In	0
sighted	0
individuals	0
,	I-DISEASE
there	0
is	I-DISEASE
often	I-DISEASE
a	I-DISEASE
history	I-DISEASE
of	0
delayed	0
sleep	0
phase	I-DISEASE
,	0
and	I-DISEASE
decreased	I-DISEASE
exposure	0
to	I-DISEASE
light	0
and	I-DISEASE
structured	I-DISEASE
social	0
and	0
phys-	I-DISEASE
ical	I-DISEASE
activity	I-DISEASE
.	I-DISEASE

Some	0
sighted	0
individuals	0
with	0
N24SWD	0
also	0
demonstrate	I-DISEASE
increased	0
sleep	I-DISEASE
duration	0
.	0

Demographics	0
It	0
is	0
thought	0
that	0
over	I-DISEASE
half	I-DISEASE
of	0
totally	I-DISEASE
blind	0
individuals	0
have	0
non-24	I-DISEASE
-	0
hour	I-DISEASE
circa-	0
dian	0
rhythms	I-DISEASE
;	0
50	0
%	0
to	0
80	I-DISEASE
%	0
of	0
blind	0
individuals	0
complain	0
of	0
sleep	0
disturbances	I-DISEASE
.	0

The	0
prevalence	0
,	0
sex	0
,	0
and	0
racial	I-DISEASE
/	0
ethnic	0
differences	0
of	0
N24SWD	0
in	0
adults	0
and	0
children	0
are	0
unknown	I-DISEASE
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
Total	0
blindness	I-DISEASE
is	I-DISEASE
the	0
most	0
common	0
predisposing	0
condition	0
.	I-DISEASE

In	0
sighted	0
people	0
,	I-DISEASE
the	0
dis-	I-DISEASE
order	I-DISEASE
can	0
be	I-DISEASE
induced	0
by	0
certain	0
environmental	I-DISEASE
conditions	0
,	I-DISEASE
such	I-DISEASE
as	0
decreased	I-DISEASE
or	0
inap-	0
propriately	0
timed	0
exposure	0
to	0
circadian	I-DISEASE
entraining	0
agents	0
,	I-DISEASE
particularly	0
light	I-DISEASE
.	I-DISEASE

Delayed	0
sleep	0
-	0
wake	0
phase	0
disorder	0
may	I-DISEASE
predispose	0
to	I-DISEASE
N24SWD	0
in	0
sighted	0
persons	0
.	0

The	0
con-	0
dition	I-DISEASE
has	0
developed	0
after	0
chronotherapy	0
for	0
DSWPD	I-DISEASE
.	0

This	0
disorder	0
has	0
also	0
been	0
reported	0
in	0
adults	0
following	I-DISEASE
traumatic	0
brain	0
injury	0
.	0

Familial	0
Patterns	0
Not	0
applicable	0
or	0
known	0
.	I-DISEASE

Developmental	0
Issues	0
Caregivers	0
may	I-DISEASE
report	0
that	0
a	B-DISEASE
child	0
has	I-DISEASE
difficulty	I-DISEASE
falling	0
asleep	0
at	0
the	I-DISEASE
desired	I-DISEASE
bedtime	I-DISEASE
or	I-DISEASE
“	I-DISEASE
falls	0
asleep	0
too	0
early	0
”	0
in	0
the	I-DISEASE
evening	0
,	0
wakes	I-DISEASE
“	0
too	I-DISEASE
early	0
”	0
or	0
has	0
difficulty	0
waking	0
in	0
the	0
morning	0
and	I-DISEASE
staying	I-DISEASE
awake	0
during	I-DISEASE
the	I-DISEASE
day	I-DISEASE
.	0

Parents	0
may	0
complain	0
that	0
their	0
child	0
sleeps	I-DISEASE
too	I-DISEASE
much	I-DISEASE
or	0
too	0
little	0
or	0
at	0
inappropriate	I-DISEASE
times	I-DISEASE
.	0

The	0
key	0
characteristics	0
that	0
distinguish	0
N24SWD	0
from	I-DISEASE
other	0
sleep	I-DISEASE
complaints	0
or	0
circadian	0
sleep	I-DISEASE
wake	0
dis-	I-DISEASE
orders	0
are	0
twofold	I-DISEASE
:	I-DISEASE
(	0
1	0
)	0
the	0
predictable	0
pattern	I-DISEASE
of	0
misalignment	0
between	I-DISEASE
the	0
child	I-DISEASE
’s	I-DISEASE
sleep	I-DISEASE
patterns	0
and	0
the	I-DISEASE
light	0
-	0
dark	0
24	I-DISEASE
-	0
hour	0
cycle	0
(	I-DISEASE
progressive	0
delay	0
in	I-DISEASE
sleep	I-DISEASE
onset	I-DISEASE
-	0
offset	I-DISEASE
across	0
days	0
to	0
weeks	I-DISEASE
)	0
;	0
and	0
(	I-DISEASE
2	0
)	I-DISEASE
periods	0
of	0
apparent	I-DISEASE
“	I-DISEASE
symptom	0
remission	I-DISEASE
”	0
during	I-DISEASE
those	I-DISEASE
transient	I-DISEASE
intervals	0
when	0
the	I-DISEASE
child	I-DISEASE
’s	0
circadian	0
sleep	0
-	I-DISEASE
wake	I-DISEASE
propensity	I-DISEASE
coincides	I-DISEASE
with	I-DISEASE
the	I-DISEASE
desired	0
bed	I-DISEASE
and	0
wake	0
times	0
.	I-DISEASE

The	0
impact	0
on	0
caregivers	0
’	0
sleep	0
and	B-DISEASE
daytime	0
functioning	I-DISEASE
is	0
often	0
profound	I-DISEASE
.	I-DISEASE

Although	0
N24SWD	0
is	0
extremely	0
rare	0
in	I-DISEASE
typically	I-DISEASE
developing	0
or	I-DISEASE
sighted	0
children	0
,	I-DISEASE
it	0
has	0
been	I-DISEASE
reported	0
with	0
some	0
frequency	0
in	0
children	0
with	0
intellectual	0
disabilities	0
and	I-DISEASE
blindness	0
.	0

For	0
example	0
,	0
children	0
with	I-DISEASE
optic	0
nerve	I-DISEASE
hypoplasia	I-DISEASE
due	I-DISEASE
to	0
a	0
variety	0
of	0
under-	0
lying	I-DISEASE
causes	I-DISEASE
,	I-DISEASE
especially	I-DISEASE
those	0
children	0
with	0
hypoplastic	I-DISEASE
corpus	0
callosum	0
and	0
comor-	I-DISEASE
bid	0
severe	I-DISEASE
intellectual	0
and	0
visual	I-DISEASE
impairments	I-DISEASE
,	0
have	0
been	0
reported	I-DISEASE
to	0
have	I-DISEASE
features	I-DISEASE
of	I-DISEASE
N24SWD	I-DISEASE
.	0
N24SWD	0
has	0
also	I-DISEASE
been	0
described	I-DISEASE
in	I-DISEASE
pediatric	0
patients	0
with	0
Rett	0
syndrome	0
(	0
a	0
genetic	0
disorder	0
occurring	I-DISEASE
almost	0
exclusively	0
in	0
girls	0
,	I-DISEASE
characterized	I-DISEASE
by	0
severe	I-DISEASE
developmental	0
regression	I-DISEASE
,	0
language	I-DISEASE
delays	0
,	0
and	I-DISEASE
limited	I-DISEASE
social	I-DISEASE
interactions	I-DISEASE
)	0
,	I-DISEASE
autism	I-DISEASE
spectrum	I-DISEASE
disorders	I-DISEASE
,	0
and	I-DISEASE
Angelman	0
syndrome	I-DISEASE
,	I-DISEASE
a	0
neurodevelopmental	0
disorder	I-DISEASE
asso-	I-DISEASE
ciated	I-DISEASE
with	I-DISEASE
an	I-DISEASE
abnormality	I-DISEASE
of	I-DISEASE
chromosome	I-DISEASE
15q11	I-DISEASE
-	I-DISEASE
q13	0
.	I-DISEASE

The	0
common	0
mechanism	0
in	0
all	0
of	0
these	I-DISEASE
disorders	0
is	I-DISEASE
postulated	0
to	0
be	0
lack	0
of	0
entrainment	I-DISEASE
to	I-DISEASE
the	0
24	0
-	0
hour	0
day	0
that	0
results	I-DISEASE
from	I-DISEASE
the	I-DISEASE
failure	0
to	I-DISEASE
perceive	0
and/or	0
attend	I-DISEASE
to	0
social	0
/	0
environmental	0
zeitgebers	0
(	0
time	0
cues	0
)	0
.	0

There	0
have	0
also	0
been	B-DISEASE
several	0
case	I-DISEASE
reports	I-DISEASE
which	0
describe	I-DISEASE
the	0
emergence	I-DISEASE
of	I-DISEASE
N24SWD	I-DISEASE
in	0
intellectually	I-DISEASE
normal	0
sighted	0
children	I-DISEASE
or	0
adolescents	0
who	0
have	0
limited	I-DISEASE
or	0
inappropriate	I-DISEASE
exposure	I-DISEASE
to	0
environmental	0
and	0
other	0
entraining	0
cues	I-DISEASE
(	0
e.g.	0
,	0
decreased	0
Circadian	0
Rhythm	0
Sleep	0
-	I-DISEASE
Wake	I-DISEASE
Disorders	0
Circadian	0
Rhythm	0
Sleep	0
-	0
Wake	I-DISEASE
Disorders	I-DISEASE
light	0
during	I-DISEASE
the	0
day	0
and/or	I-DISEASE
excessive	I-DISEASE
light	0
exposure	0
in	0
the	0
evening	I-DISEASE
)	I-DISEASE
.	I-DISEASE

These	0
individuals	0
are	0
likely	0
to	0
have	0
significant	0
psychiatric	0
impairments	0
that	I-DISEASE
predispose	0
them	0
to	0
avoid-	0
ance	0
of	0
social	0
interactions	I-DISEASE
(	0
e.g.	0
,	0
anxiety	0
)	0
or	0
medical	I-DISEASE
conditions	I-DISEASE
that	0
involve	0
enforced	0
prolonged	0
periods	0
of	0
inactivity	0
(	0
traumatic	0
brain	0
injury	I-DISEASE
,	0
chronic	0
fatigue	I-DISEASE
)	0
.	I-DISEASE

Little	0
is	0
known	0
about	0
the	0
natural	I-DISEASE
history	I-DISEASE
of	0
the	I-DISEASE
clinical	I-DISEASE
entity	0
of	0
N24SWD	0
in	0
the	I-DISEASE
pedi-	0
atric	0
population	0
,	I-DISEASE
including	0
the	0
impact	0
of	I-DISEASE
various	I-DISEASE
treatment	I-DISEASE
modalities	0
,	0
the	I-DISEASE
likelihood	I-DISEASE
of	0
spontaneous	0
resolution	0
of	0
symptoms	0
,	I-DISEASE
or	0
long	0
-	I-DISEASE
term	0
consequences	0
.	I-DISEASE

There	0
may	0
be	0
varying	I-DISEASE
phenotypes	0
of	I-DISEASE
N24SWD	I-DISEASE
in	0
children	I-DISEASE
,	0
with	0
differences	0
in	0
regard	0
to	0
symptom	I-DISEASE
presentation	0
,	I-DISEASE
severity	0
,	0
and	0
chronicity	0
that	0
are	0
related	I-DISEASE
to	0
the	0
underlying	I-DISEASE
condition	0
.	0

For	0
example	0
,	0
it	0
is	0
likely	0
that	0
children	0
with	I-DISEASE
chronic	0
neurologic	0
conditions	0
such	I-DISEASE
as	0
blindness	0
or	0
neurodevelopmental	0
disabilities	I-DISEASE
have	0
a	0
more	0
intractable	0
and	0
treat-	0
ment	I-DISEASE
resistant	I-DISEASE
pattern	0
compared	I-DISEASE
to	0
children	0
with	0
more	0
self	0
-	0
limited	0
conditions	0
(	I-DISEASE
e.g.	0
,	0
traumatic	0
brain	0
injury	0
)	0
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Onset	I-DISEASE
may	0
occur	I-DISEASE
at	0
any	I-DISEASE
age	0
in	0
blind	0
individuals	0
,	I-DISEASE
coincident	0
with	0
loss	0
of	I-DISEASE
light	0
percep-	0
tion	I-DISEASE
,	I-DISEASE
and	I-DISEASE
,	0
in	0
congenitally	I-DISEASE
blind	0
children	0
,	I-DISEASE
onset	I-DISEASE
can	0
occur	0
from	0
birth	0
or	0
during	0
infancy	I-DISEASE
.	0

If	0
untreated	0
,	0
the	0
course	0
is	0
chronic	I-DISEASE
.	0

Attempts	0
to	I-DISEASE
regulate	0
sleep	0
and	0
wake	0
times	I-DISEASE
may	I-DISEASE
involve	I-DISEASE
the	0
use	0
of	0
alcohol	I-DISEASE
,	0
sedatives	I-DISEASE
-	0
hypnotics	0
,	I-DISEASE
and	0
stimulants	0
,	0
which	0
in	0
turn	I-DISEASE
can	I-DISEASE
exac-	0
erbate	0
the	I-DISEASE
underlying	0
sleep	0
disorder	0
.	0

Depressive	0
symptoms	0
and	0
mood	0
disorders	0
can	0
be	I-DISEASE
comorbid	0
conditions	I-DISEASE
,	0
particularly	0
in	0
sighted	0
patients	0
.	I-DISEASE

The	0
adverse	0
effects	I-DISEASE
on	0
school	0
or	0
work	0
performance	0
,	I-DISEASE
as	0
well	0
as	0
other	0
psychosocial	0
complications	I-DISEASE
,	I-DISEASE
due	0
to	I-DISEASE
a	0
lack	0
of	0
pre-	0
dictable	0
sleep	I-DISEASE
and	I-DISEASE
wake	0
times	I-DISEASE
and	I-DISEASE
excessive	0
daytime	I-DISEASE
sleepiness	I-DISEASE
,	I-DISEASE
are	I-DISEASE
key	0
motivations	0
for	0
seeking	0
treatment	I-DISEASE
.	0

Pathology	0
and	0
Pathophysiology	0
The	0
intrinsic	0
period	I-DISEASE
of	I-DISEASE
the	0
human	I-DISEASE
circadian	0
pacemaker	0
is	0
usually	0
longer	I-DISEASE
than	I-DISEASE
24	0
hours	0
and	I-DISEASE
requires	0
daily	0
input	0
from	0
the	0
environment	I-DISEASE
to	I-DISEASE
maintain	0
synchrony	I-DISEASE
to	0
the	0
24	0
-	I-DISEASE
hour	0
day	0
.	0

The	0
light	0
-	I-DISEASE
dark	I-DISEASE
cycle	0
is	0
the	I-DISEASE
most	I-DISEASE
important	0
environmental	I-DISEASE
time	0
cue	0
(	0
zeitgeber	0
)	0
in	0
humans	0
(	I-DISEASE
as	I-DISEASE
in	0
other	0
species	0
)	0
,	0
although	I-DISEASE
nonphotic	I-DISEASE
time	I-DISEASE
cues	I-DISEASE
also	0
play	0
a	0
role	0
in	0
normal	0
entrainment	0
.	0

A	0
lack	0
of	0
photic	0
input	0
to	0
the	0
circadian	0
pacemaker	I-DISEASE
is	I-DISEASE
clearly	0
the	0
cause	0
of	0
nonentrained	I-DISEASE
rhythms	0
in	I-DISEASE
totally	I-DISEASE
blind	0
people	0
.	0

It	0
has	0
been	0
suggested	0
that	0
,	I-DISEASE
in	I-DISEASE
sighted	0
individuals	I-DISEASE
,	0
a	0
systematic	0
delay	0
due	0
to	0
inadequate	0
exposure	0
to	I-DISEASE
light	0
may	I-DISEASE
contribute	0
to	0
the	0
development	I-DISEASE
of	I-DISEASE
N24SWD	0
.	0

In	0
addition	0
,	0
the	0
disorder	I-DISEASE
may	I-DISEASE
be	B-DISEASE
caused	I-DISEASE
by	I-DISEASE
an	0
extremely	0
prolonged	0
endogenous	I-DISEASE
circadian	0
period	0
that	I-DISEASE
is	0
outside	I-DISEASE
of	0
the	I-DISEASE
range	0
for	0
entrainment	0
to	I-DISEASE
the	I-DISEASE
24	0
-	0
hour	I-DISEASE
cycle	0
or	0
by	I-DISEASE
an	I-DISEASE
alteration	0
in	0
the	0
response	0
of	0
the	I-DISEASE
circadian	I-DISEASE
clock	0
to	I-DISEASE
the	0
entraining	I-DISEASE
effects	0
of	0
light	I-DISEASE
.	I-DISEASE

Objective	0
Findings	0
Sleep	0
studies	I-DISEASE
yield	0
different	I-DISEASE
results	I-DISEASE
depending	0
on	I-DISEASE
the	0
degree	0
of	0
synchrony	0
between	I-DISEASE
sleep	I-DISEASE
times	I-DISEASE
and	0
the	I-DISEASE
circadian	0
pacemaker	0
at	0
the	I-DISEASE
time	0
when	I-DISEASE
the	I-DISEASE
sleep	0
study	I-DISEASE
is	I-DISEASE
performed	0
.	I-DISEASE

Recording	0
of	I-DISEASE
sleep	0
log	I-DISEASE
and	0
actigraphy	I-DISEASE
over	I-DISEASE
prolonged	I-DISEASE
periods	I-DISEASE
(	0
at	0
least	0
14	I-DISEASE
days	0
,	I-DISEASE
but	0
ideally	0
longer	I-DISEASE
in	0
blind	0
individuals	0
)	0
demonstrate	0
the	I-DISEASE
lack	I-DISEASE
of	I-DISEASE
a	I-DISEASE
stable	I-DISEASE
relationship	I-DISEASE
between	I-DISEASE
the	0
timing	0
of	0
the	0
sleep	I-DISEASE
-	I-DISEASE
wake	I-DISEASE
cycle	I-DISEASE
and	I-DISEASE
the	0
24	I-DISEASE
-	0
hour	0
day	I-DISEASE
.	I-DISEASE

When	0
sleep	0
sched-	0
ules	0
follow	0
the	0
endogenous	I-DISEASE
circadian	0
propensity	I-DISEASE
for	I-DISEASE
sleep	0
and	0
wake	I-DISEASE
,	0
sleep	I-DISEASE
onset	0
and	0
wake	0
times	0
are	I-DISEASE
typically	0
delayed	I-DISEASE
each	0
day	I-DISEASE
.	0

Serial	0
measurements	0
of	0
circadian	0
rhythms	0
,	0
such	B-DISEASE
as	0
melatonin	I-DISEASE
,	0
usually	0
show	0
a	0
progressive	0
daily	0
delay	0
of	0
the	0
phase	0
of	0
the	0
rhythm	0
consistent	0
with	I-DISEASE
a	I-DISEASE
period	0
that	I-DISEASE
is	0
longer	0
than	0
24	0
hours	0
.	0

Clinical	0
and	0
Pathophysiologic	0
Subtypes	I-DISEASE
Totally	I-DISEASE
blind	I-DISEASE
patients	I-DISEASE
with	0
N24SWD	0
are	0
clinically	0
different	I-DISEASE
than	I-DISEASE
sighted	0
patients	I-DISEASE
.	I-DISEASE

In	0
sighted	0
patients	0
with	I-DISEASE
N24SWD	0
,	0
the	I-DISEASE
circadian	0
period	I-DISEASE
is	0
often	I-DISEASE
25	0
hours	I-DISEASE
or	0
longer	I-DISEASE
,	I-DISEASE
whereas	0
in	I-DISEASE
totally	0
blind	I-DISEASE
patients	0
with	0
the	0
disorder	I-DISEASE
,	I-DISEASE
the	I-DISEASE
circadian	0
period	I-DISEASE
follows	I-DISEASE
an	0
average	I-DISEASE
period	0
length	0
which	0
is	0
often	I-DISEASE
closer	0
to	0
24	0
hours	I-DISEASE
and	0
rarely	I-DISEASE
may	0
be	0
shorter	I-DISEASE
than	I-DISEASE
24	I-DISEASE
hours	I-DISEASE
.	0

Differential	0
Diagnosis	0

Some	0
individuals	0
with	0
severe	0
DSWPD	0
may	0
demonstrate	I-DISEASE
progressive	0
delay	I-DISEASE
of	I-DISEASE
their	0
sleep	0
period	I-DISEASE
by	0
30	I-DISEASE
minutes	0
or	0
more	I-DISEASE
for	0
several	0
days	0
,	0
and	I-DISEASE
their	0
symptoms	I-DISEASE
may	I-DISEASE
be	0
con-	0
fused	B-DISEASE
with	I-DISEASE
N24SWD	I-DISEASE
.	I-DISEASE

Behavioral	0
factors	0
and	0
psychiatric	0
disorders	0
,	I-DISEASE
as	I-DISEASE
well	0
as	I-DISEASE
medical	0
and	0
neurological	0
dis-	0
orders	0
(	I-DISEASE
especially	I-DISEASE
blindness	0
,	I-DISEASE
but	0
also	I-DISEASE
dementia	0
or	0
mental	0
retardation	0
)	I-DISEASE
,	0
may	0
play	I-DISEASE
a	B-DISEASE
role	I-DISEASE
in	0
the	0
development	0
of	0
N24SWD	0
.	0

In	0
many	0
of	0
these	0
cases	0
,	I-DISEASE
however	I-DISEASE
,	0
multiple	I-DISEASE
physio-	0
logic	0
,	I-DISEASE
behavioral	0
,	0
and	I-DISEASE
environmental	0
factors	0
contribute	I-DISEASE
to	0
the	0
condition	0
.	0

In	0
the	0
major-	I-DISEASE
ity	0
of	0
these	0
cases	0
,	0
the	0
disorder	0
should	0
be	0
coded	0
as	0
N24SWD	I-DISEASE
.	I-DISEASE

This	0
includes	0
non-24-	0
hour	0
sleep	0
-	0
wake	I-DISEASE
patterns	0
that	I-DISEASE
are	0
associated	0
with	0
blindness	0
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE

There	0
is	0
only	0
limited	0
knowledge	0
of	I-DISEASE
the	I-DISEASE
underlying	I-DISEASE
pathophysiology	I-DISEASE
of	0
sighted	I-DISEASE
persons	I-DISEASE
with	0
N24SWD	0
.	I-DISEASE

The	0
primary	0
risk	0
factor	0
in	0
sighted	0
persons	I-DISEASE
appears	0
to	I-DISEASE
be	0
a	0
long	0
circa-	0
dian	0
period	I-DISEASE
that	0
is	0
beyond	0
the	0
range	0
of	0
entrainment	0
to	I-DISEASE
a	I-DISEASE
24	0
-	0
hour	I-DISEASE
cycle	I-DISEASE
or	0
a	0
progressive	I-DISEASE
delay	I-DISEASE
due	0
to	0
inappropriate	0
exposure	0
to	0
light	0
.	0

This	0
risk	0
may	0
explain	0
the	0
overlap	I-DISEASE
between	I-DISEASE
DSWPD	0
and	0
N24SWD	0
.	0

Future	0
studies	0
are	0
needed	0
to	0
understand	0
the	I-DISEASE
role	I-DISEASE
of	I-DISEASE
genetic	0
predisposition	0
,	0
environmental	0
or	0
social	I-DISEASE
cues	I-DISEASE
and	0
traumatic	I-DISEASE
brain	0
injury	I-DISEASE
in	0
the	0
develop-	0
ment	0
of	I-DISEASE
N24SWD	0
,	I-DISEASE
and	I-DISEASE
to	0
delineate	I-DISEASE
other	0
health	I-DISEASE
consequences	0
of	0
the	0
condition	0
.	0

There	0
are	0
substantial	0
knowledge	0
gaps	0
regarding	0
the	I-DISEASE
prevalence	I-DISEASE
,	I-DISEASE
pathophysiology	0
,	0
clinical	I-DISEASE
Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	I-DISEASE
Wake	0
Disorders	I-DISEASE
Circadian	0
Rhythm	0
Sleep	0
-	0
Wake	0
Disorders	I-DISEASE
presentation	I-DISEASE
,	0
natural	0
history	I-DISEASE
,	I-DISEASE
effective	0
treatment	I-DISEASE
strategies	I-DISEASE
,	0
and	0
prognosis	0
of	0
N24SWD	0
in	I-DISEASE
children	0
and	0
adolescents	I-DISEASE
compared	I-DISEASE
with	0
adults	0
.	0

Bibliography	0
Ayalon	0
L	I-DISEASE
,	0
Borodkin	0
K	I-DISEASE
,	I-DISEASE
Dishon	I-DISEASE
L	I-DISEASE
,	0
Kanety	0
H	0
,	0
Dagan	0
Y.	I-DISEASE
Circadian	0
rhythm	0
sleep	I-DISEASE
disorders	0
following	0
mild	0
traumatic	0
brain	0
injury	I-DISEASE
.	B-DISEASE

Neurology	0
2007;68:1136–40	0
.	0

Boivin	0
DB	0
,	I-DISEASE
James	0
FO	0
,	0
Santo	I-DISEASE
JB	0
,	0
Caliyurt	0
O	0
,	0
Chalk	0
C.	0
Non-24	I-DISEASE
-	0
hour	0
sleep	I-DISEASE
-	0
wake	0
syndrome	0
following	0
a	I-DISEASE
car	0
accident	0
.	0

Neurology	0
2003;60:1841–3	0
.	0

Czeisler	0
CA	0
,	0
Shanahan	0
TL	0
,	0
Klerman	0
EB	0
,	0
et	0
al	0
.	0

Suppression	0
of	0
melatonin	0
secretion	I-DISEASE
in	0
some	0
blind	0
patients	0
by	0
exposure	0
to	0
bright	0
light	0
.	0

N	0
Engl	0
J	0
Med	0
1995;332:6–11	0
.	0

Hayakawa	0
T	0
,	0
Uchiyama	0
M	0
,	0
Kamei	I-DISEASE
Y	0
,	I-DISEASE
et	0
al	0
.	0

Clinical	0
analyses	0
of	0
sighted	0
patients	0
with	I-DISEASE
non-24	0
-	0
hour	I-DISEASE
sleep-	I-DISEASE
wake	0
syndrome	0
:	I-DISEASE
A	0
study	I-DISEASE
of	I-DISEASE
57	0
consecutively	I-DISEASE
diagnosed	0
cases	0
.	0

Sleep	0
2005;28:945–52	0
.	0

Lewy	0
AJ	I-DISEASE
,	0
Newsome	0
DA	0
.	0

Different	0
types	0
of	I-DISEASE
melatonin	0
circadian	0
secretory	0
rhythms	I-DISEASE
in	0
some	0
blind	0
subjects	0
.	0

J	0
Clin	0
Endocrinol	I-DISEASE
Metab	0
1983;56:1103–7	0
.	0

Lockley	0
SW	0
,	0
Arendt	0
J	0
,	0
Skene	I-DISEASE
DJ	0
.	0

Visual	0
impairment	0
and	I-DISEASE
circadian	0
rhythm	0
disorders	I-DISEASE
.	I-DISEASE

Dialogues	0
Clin	0
Neurosci	0
2007;9:301–14	I-DISEASE
.	0

Lockley	0
SW	0
,	0
Dijk	0
DJ	0
,	0
Kosti	I-DISEASE
O	I-DISEASE
,	I-DISEASE
Skene	0
DJ	0
,	I-DISEASE
Arendt	0
J.	0
Alertness	I-DISEASE
,	0
mood	0
and	I-DISEASE
performance	0
rhythm	0
disturbances	0
associated	0
with	0
circadian	0
sleep	I-DISEASE
disorders	0
in	0
the	I-DISEASE
blind	0
.	I-DISEASE

J	0
Sleep	0
Res	0
2008;17:207–16	0
.	0

Lockley	0
SW	0
,	0
Skene	0
DJ	0
,	0
Butler	I-DISEASE
LJ	0
,	I-DISEASE
Arendt	I-DISEASE
J.	0
Sleep	0
and	I-DISEASE
activity	0
rhythms	I-DISEASE
are	0
related	0
to	0
circadian	0
phase	0
in	0
the	0
blind	0
.	0

Sleep	0
1999;22:616–23	0
.	0

McArthur	0
A	0
,	0
Lewy	0
A	I-DISEASE
,	I-DISEASE
Sack	I-DISEASE
R.	0
Non-24	I-DISEASE
hour	0
sleep	0
-	0
wake	0
syndrome	0
in	I-DISEASE
a	0
sighted	0
man	I-DISEASE
:	0
circadian	I-DISEASE
rhythm	0
studies	0
and	I-DISEASE
efficacy	I-DISEASE
of	0
melatonin	I-DISEASE
treatment	0
.	0

Sleep	0
1996;19:544–53	0
.	0

Morgenthaler	0
TI	0
,	0
Lee	0
-	0
Chiong	0
T	I-DISEASE
,	0
Alessi	I-DISEASE
C	0
,	0
et	0
al	0
.	0

Practice	0
parameters	0
for	0
the	0
clinical	I-DISEASE
evaluation	0
and	I-DISEASE
treatment	0
of	I-DISEASE
circadian	0
rhythm	0
sleep	0
disorders	0
:	I-DISEASE
An	I-DISEASE
American	0
Academy	0
of	I-DISEASE
Sleep	0
Medicine	0
report	0
.	0

Sleep	0
2007;30:1445–59	0
.	0

Sack	0
RL	0
,	0
Lewy	0
AJ	0
,	0
Blood	I-DISEASE
ML	0
,	I-DISEASE
Keith	0
LD	0
,	0
Nakagawa	0
H.	0
Circadian	I-DISEASE
rhythm	I-DISEASE
abnormalities	0
in	I-DISEASE
totally	0
blind	0
people	0
:	0
incidence	0
and	I-DISEASE
clinical	I-DISEASE
significance	0
.	I-DISEASE

J	0
Clin	0
Endocrinol	I-DISEASE
Metab	0
1992;75:127–34	0
.	0

Uchiyama	0
M	0
,	0
Lockley	0
SW	0
.	0

Non-24	0
-	0
hour	0
sleep	I-DISEASE
-	0
wake	0
syndrome	I-DISEASE
in	0
sighted	I-DISEASE
and	I-DISEASE
blind	0
patients	0
.	0

Sleep	0
Med	0
Clin	I-DISEASE
2009;4:195–211	0
.	I-DISEASE

Uchiyama	0
M	0
,	0
Okawa	0
M	0
,	0
Shibui	I-DISEASE
K	0
,	I-DISEASE
et	0
al	0
.	0

Altered	0
phase	0
relation	0
between	I-DISEASE
sleep	I-DISEASE
timing	0
and	I-DISEASE
core	I-DISEASE
body	I-DISEASE
temperature	0
rhythm	0
in	0
delayed	0
sleep	0
phase	0
syndrome	I-DISEASE
and	0
non-24	I-DISEASE
-	0
hour	0
sleep	0
-	I-DISEASE
wake	I-DISEASE
syndrome	0
in	I-DISEASE
humans	I-DISEASE
.	I-DISEASE

Neurosci	0
Lett	0
2000;294:101–4	0
.	0

Uchiyama	0
M	0
,	0
Shibui	0
K	0
,	0
Hayakawa	0
T	0
,	I-DISEASE
et	0
al	0
.	0

Larger	0
phase	0
angle	0
between	I-DISEASE
sleep	I-DISEASE
propensity	0
and	I-DISEASE
melatonin	0
rhythms	I-DISEASE
in	0
sighted	0
humans	0
with	0
non-24	0
-	I-DISEASE
hour	I-DISEASE
sleep	0
-	I-DISEASE
wake	0
syndrome	0
.	0

Sleep	0
2002;25:83–8	0
.	0

Zaidi	0
FH	0
,	0
Hull	0
JT	0
,	0
Peirson	0
SN	0
,	0
et	0
al	0
.	0

Short	0
-	0
wavelength	0
light	0
sensitivity	I-DISEASE
of	I-DISEASE
circadian	I-DISEASE
,	0
pupillary	I-DISEASE
,	0
and	0
visual	0
awareness	0
in	0
humans	I-DISEASE
lacking	0
an	0
outer	I-DISEASE
retina	0
.	0

Curr	0
Biol	I-DISEASE
2007;17:2122–8	0
.	0

Shift	0
Work	0
Disorder	0
ICD-9	0
-	0
CM	0
code	I-DISEASE
:	0
327.36	0
Alternate	0
Names	0
Shift	0
work	I-DISEASE
sleep	0
disorder	0
.	0

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
D	I-DISEASE
must	I-DISEASE
be	0
met	I-DISEASE
ICD-10	0
-	0
CM	0
code	I-DISEASE
:	0
G47.26	0
Circadian	I-DISEASE
Rhythm	0
Sleep	0
-	0
Wake	0
Disorders	0

A.	0

There	0
is	0
a	0
report	0
of	0
insomnia	I-DISEASE
and/or	0
excessive	0
sleepiness	I-DISEASE
,	0
accompanied	0
by	0
a	I-DISEASE
reduction	I-DISEASE
of	I-DISEASE
total	I-DISEASE
sleep	I-DISEASE
time	I-DISEASE
,	0
which	0
is	0
associated	0
with	I-DISEASE
a	0
recurring	I-DISEASE
work	I-DISEASE
schedule	0
that	I-DISEASE
overlaps	0
the	0
usual	0
time	0
for	0
sleep	0
.	0

B.	0
The	0
symptoms	0
have	0
been	0
present	0
and	0
associated	0
with	I-DISEASE
the	0
shift	0
work	0
schedule	0
for	0
at	0
least	0
three	0
months	I-DISEASE
.	0

C.	0
Sleep	I-DISEASE
log	0
and	0
actigraphy	0
monitoring	I-DISEASE
(	I-DISEASE
whenever	I-DISEASE
possible	I-DISEASE
and	0
preferably	0
with	0
concurrent	0
light	0
exposure	I-DISEASE
measurement	I-DISEASE
)	0
for	I-DISEASE
at	I-DISEASE
least	0
14	0
days	I-DISEASE
(	0
work	I-DISEASE
and	I-DISEASE
free	0
days	0
)	I-DISEASE
demonstrate	0
a	I-DISEASE
disturbed	I-DISEASE
sleep	0
and	0
wake	0
pattern	0
.	0

D.	0

The	0
sleep	0
and/or	I-DISEASE
wake	I-DISEASE
disturbance	0
are	0
not	I-DISEASE
better	0
explained	I-DISEASE
by	I-DISEASE
another	0
current	0
sleep	0
disorder	0
,	0
medical	I-DISEASE
or	I-DISEASE
neurological	I-DISEASE
disorder	0
,	0
mental	0
disorder	0
,	I-DISEASE
medication	0
use	I-DISEASE
,	0
poor	0
sleep	I-DISEASE
hygiene	0
,	0
or	0
substance	0
use	0
disorder	0
.	0

Essential	0
Features	0
Shift	0
work	0
disorder	0
is	I-DISEASE
characterized	I-DISEASE
by	0
complaints	0
of	0
insomnia	0
or	0
excessive	0
sleepi-	0
ness	I-DISEASE
that	0
occur	0
in	I-DISEASE
association	0
with	0
work	0
hours	0
that	I-DISEASE
occur	0
,	0
at	0
least	0
in	I-DISEASE
part	0
,	0
during	0
the	0
usual	0
sleep	0
episode	0
.	0

There	0
are	0
several	0
types	I-DISEASE
of	0
shift	I-DISEASE
-	I-DISEASE
work	0
schedules	I-DISEASE
,	0
including	0
evening	0
shifts	0
,	0
night	I-DISEASE
shifts	I-DISEASE
,	0
early	I-DISEASE
morning	0
shifts	I-DISEASE
,	0
rotating	0
shifts	0
,	0
split	I-DISEASE
shifts	0
,	0
on	I-DISEASE
-	0
call	0
overnight	0
duty	0
,	0
and	0
long	0
duration	0
work	0
shifts	I-DISEASE
that	0
include	I-DISEASE
work	I-DISEASE
hours	0
at	0
night	0
.	I-DISEASE

The	0
sleep	0
distur-	I-DISEASE
bance	0
is	I-DISEASE
most	0
commonly	I-DISEASE
reported	0
in	I-DISEASE
association	0
with	0
night	0
shifts	0
,	0
early	0
morning	0
shifts	I-DISEASE
,	I-DISEASE
and	0
rotating	0
shifts	I-DISEASE
.	0

Total	0
sleep	0
time	I-DISEASE
is	0
typically	0
curtailed	0
by	0
one	0
to	0
four	0
hours	0
,	0
and	I-DISEASE
sleep	0
quality	I-DISEASE
is	I-DISEASE
perceived	I-DISEASE
as	I-DISEASE
unsatisfactory	0
in	0
night	0
,	0
early	0
morning	0
,	0
and	0
rotating	0
shift	0
workers	0
as	0
well	I-DISEASE
as	I-DISEASE
in	0
those	0
who	0
work	0
long	0
-	0
duration	0
shifts	0
.	0

In	0
addition	0
to	0
impairment	I-DISEASE
of	0
performance	0
at	I-DISEASE
work	0
,	I-DISEASE
reduced	0
alertness	0
may	0
also	I-DISEASE
be	0
associated	0
with	0
consequences	0
for	I-DISEASE
safety	0
during	0
the	I-DISEASE
work	0
schedule	0
and	0
on	I-DISEASE
the	0
commute	0
to	I-DISEASE
and	0
from	I-DISEASE
work	0
.	0

The	0
sleep	0
disorder	I-DISEASE
occurs	0
despite	0
attempts	0
to	I-DISEASE
optimize	0
environmental	I-DISEASE
conditions	0
for	0
sleep	0
.	0

The	0
condition	0
usually	0
persists	0
only	0
for	I-DISEASE
the	I-DISEASE
duration	0
of	0
the	I-DISEASE
shift	0
work	0
schedule	I-DISEASE
.	0

However	0
,	I-DISEASE
in	0
some	0
individuals	0
,	0
the	I-DISEASE
sleep	0
disturbance	I-DISEASE
may	0
persist	0
beyond	0
the	0
duration	0
of	I-DISEASE
shift	0
work	0
.	0

Associated	0
Features	0
Early	0
morning	0
work	I-DISEASE
shifts	I-DISEASE
starting	I-DISEASE
between	I-DISEASE
4:00	I-DISEASE
a.m.	0
and	0
7:00	0
a.m.	0
can	0
also	I-DISEASE
be	0
asso-	0
ciated	I-DISEASE
with	0
complaints	I-DISEASE
of	0
difficulty	0
in	0
sleep	0
initiation	I-DISEASE
as	0
well	I-DISEASE
as	0
difficulty	0
awakening	I-DISEASE
.	I-DISEASE

Circadian	0
Rhythm	I-DISEASE
Sleep	0
-	0
Wake	0
Disorders	0
Permanent	I-DISEASE
evening	0
shifts	I-DISEASE
may	0
be	0
primarily	0
associated	0
with	0
sleep	0
maintenance	0
dif-	0
ficulty	I-DISEASE
.	0

Excessive	0
sleepiness	0
usually	0
occurs	0
during	0
work	0
shifts	0
(	0
mainly	I-DISEASE
night	0
,	0
early	0
morning	0
,	0
and	I-DISEASE
rotating	0
shifts	I-DISEASE
)	I-DISEASE
,	0
often	0
accompanied	0
by	0
the	0
need	I-DISEASE
to	I-DISEASE
nap	0
and	I-DISEASE
by	0
impaired	0
mental	0
ability	I-DISEASE
due	0
to	0
the	0
reduced	I-DISEASE
alertness	0
.	0

Reduced	0
alertness	0
and	0
increased	0
fatigue	0
throughout	0
the	I-DISEASE
waking	0
period	0
may	0
be	I-DISEASE
associated	0
with	0
reduced	0
performance	I-DISEASE
capacity	0
,	0
and	I-DISEASE
with	0
consequences	0
for	0
safety	0
.	0

Also	0
,	0
major	0
portions	0
of	0
free	I-DISEASE
time	I-DISEASE
may	0
have	I-DISEASE
to	0
be	0
used	0
for	I-DISEASE
recovery	0
of	I-DISEASE
sleep	0
,	I-DISEASE
resulting	I-DISEASE
in	0
adverse	0
social	0
consequences	0
.	I-DISEASE

When	0
compared	0
with	0
shift	0
workers	0
without	I-DISEASE
shift	I-DISEASE
work	0
disorder	I-DISEASE
,	0
patients	0
with	I-DISEASE
shift	0
work	0
disorder	I-DISEASE
report	0
greater	0
mood	I-DISEASE
problems	0
,	0
such	0
as	0
impatience	0
,	I-DISEASE
avoidance	I-DISEASE
of	0
interaction	0
with	0
coworkers	I-DISEASE
,	I-DISEASE
a	I-DISEASE
higher	0
risk	0
of	0
depression	0
,	0
impaired	0
social	I-DISEASE
functioning	0
,	I-DISEASE
and	0
lower	0
coping	0
skills	0
.	I-DISEASE

Patients	0
with	0
shift	0
work	0
disorder	0
also	I-DISEASE
have	I-DISEASE
a	0
higher	0
risk	0
of	0
subjective	0
health	0
complaints	0
,	0
ulcers	0
,	0
and	I-DISEASE
substance	0
abuse	0
.	0

Risk	0
for	0
sleepiness	0
-	I-DISEASE
related	0
errors	0
and	I-DISEASE
accidents	I-DISEASE
are	I-DISEASE
highest	0
at	0
night	0
,	I-DISEASE
especially	0
in	I-DISEASE
the	0
early	0
morning	I-DISEASE
hours	0
.	I-DISEASE

Drowsy	0
driving	0
accident	0
risk	0
is	0
highest	0
in	I-DISEASE
the	0
morning	I-DISEASE
hours	0
when	I-DISEASE
night	I-DISEASE
shift	I-DISEASE
workers	0
commute	I-DISEASE
home	0
and	0
early	0
morning	0
workers	0
commute	0
to	0
work	0
.	I-DISEASE

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
There	I-DISEASE
are	I-DISEASE
substantial	I-DISEASE
individual	I-DISEASE
differences	I-DISEASE
in	0
the	I-DISEASE
ability	0
to	0
adjust	0
to	I-DISEASE
shift	0
work	0
.	I-DISEASE

However	0
,	I-DISEASE
mechanisms	0
underlying	0
these	0
individual	0
differences	I-DISEASE
are	0
not	0
known	I-DISEASE
.	0

Requirement	0
of	0
extended	0
work	0
hours	0
,	0
such	I-DISEASE
as	I-DISEASE
on	I-DISEASE
-	0
call	0
overnight	0
duty	I-DISEASE
and	0
long	0
-	I-DISEASE
duration	0
work	0
shifts	0
that	I-DISEASE
include	0
work	0
hours	I-DISEASE
at	0
night	I-DISEASE
,	I-DISEASE
represents	I-DISEASE
a	I-DISEASE
specific	0
clinical	0
subtype	0
.	I-DISEASE

In	0
addition	0
to	0
the	I-DISEASE
circadian	I-DISEASE
misalignment	0
(	B-DISEASE
having	I-DISEASE
to	I-DISEASE
work	0
during	0
the	0
night	0
)	0
,	I-DISEASE
sleep	I-DISEASE
loss	I-DISEASE
and	I-DISEASE
fatigue	0
associated	I-DISEASE
with	0
prolonged	0
continuous	0
work	0
may	I-DISEASE
increase	I-DISEASE
the	0
severity	I-DISEASE
of	0
excessive	0
sleepiness	I-DISEASE
and	0
performance	0
impairments	0
.	0

Demographics	0
The	0
prevalence	0
of	0
shift	0
work	0
disorder	I-DISEASE
depends	0
on	I-DISEASE
the	0
prevalence	0
of	0
shift	0
work	0
in	I-DISEASE
the	0
population	0
.	0

It	0
has	0
been	0
estimated	0
that	0
approximately	I-DISEASE
20	I-DISEASE
%	0
of	I-DISEASE
the	0
workforce	I-DISEASE
in	0
indus-	0
trialized	0
countries	0
is	I-DISEASE
employed	0
in	I-DISEASE
a	0
job	0
that	0
requires	0
shift	0
work	0
.	I-DISEASE

Although	0
the	0
actual	I-DISEASE
prevalence	I-DISEASE
of	I-DISEASE
clinically	I-DISEASE
significant	I-DISEASE
sleep	0
disturbance	I-DISEASE
and	I-DISEASE
excessive	0
daytime	0
sleepiness	I-DISEASE
due	0
to	I-DISEASE
work	0
schedules	0
is	I-DISEASE
unknown	0
,	0
the	0
total	I-DISEASE
number	0
of	I-DISEASE
night	I-DISEASE
-	0
shift	0
workers	I-DISEASE
suggests	0
that	0
an	I-DISEASE
estimated	0
prevalence	0
of	0
2	0
%	I-DISEASE
to	I-DISEASE
5	I-DISEASE
%	0
of	0
the	0
general	0
population	0
is	I-DISEASE
reasonable	0
.	I-DISEASE

The	0
prevalence	0
of	I-DISEASE
shift	0
work	0
disorder	I-DISEASE
among	I-DISEASE
rotating-	0
and	I-DISEASE
night	0
-	0
shift	I-DISEASE
workers	0
has	0
been	I-DISEASE
estimated	0
to	0
be	I-DISEASE
between	0
~10	I-DISEASE
%	0
and	0
38	0
%	0
.	I-DISEASE

These	0
figures	0
do	0
not	0
,	0
however	0
,	I-DISEASE
include	0
individuals	I-DISEASE
with	0
early	0
morning	0
or	I-DISEASE
split	0
shift	0
work	0
,	0
which	0
may	0
be	0
other	0
at	0
-	I-DISEASE
risk	0
groups	0
.	0

There	0
is	0
no	0
known	0
sex	0
or	0
racial	0
difference	0
in	0
vulnerability	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
Depending	0
on	I-DISEASE
the	I-DISEASE
type	0
of	I-DISEASE
shift	0
,	0
circadian	0
preference	0
may	0
influence	I-DISEASE
the	I-DISEASE
ability	0
to	0
adjust	0
to	0
or	0
tolerate	0
shift	0
work	0
.	I-DISEASE

For	0
example	0
,	0
individuals	0
described	0
as	0
morning	0
types	I-DISEASE
obtain	I-DISEASE
shorter	0
daytime	0
sleep	0
after	I-DISEASE
a	0
night	0
shift	I-DISEASE
.	0

Persons	0
with	0
comorbid	0
medical	0
,	0
psychiat-	I-DISEASE
ric	I-DISEASE
,	0
and	0
other	0
sleep	0
disorders	0
such	I-DISEASE
as	0
sleep	0
apnea	I-DISEASE
and	0
individuals	I-DISEASE
with	I-DISEASE
a	0
strong	0
need	0
for	I-DISEASE
stable	I-DISEASE
hours	I-DISEASE
of	0
sleep	I-DISEASE
may	I-DISEASE
be	0
at	0
particular	I-DISEASE
risk	0
.	0

Social	0
pressures	0
before	I-DISEASE
and	I-DISEASE
after	0
a	0
work	I-DISEASE
shift	0
also	I-DISEASE
contribute	0
to	0
short	0
sleep	I-DISEASE
durations	I-DISEASE
in	I-DISEASE
shift	I-DISEASE
workers	0
(	0
e.g.	0
,	I-DISEASE
social	0
inter-	0
actions	0
with	0
family	I-DISEASE
and	0
friends	0
,	I-DISEASE
domestic	I-DISEASE
obligations	0
,	0
a	I-DISEASE
second	0
job	0
,	0
and	0
leisure	0
activ-	I-DISEASE
ities	I-DISEASE
)	0
.	I-DISEASE

Social	0
pressures	0
also	I-DISEASE
diminish	B-DISEASE
the	0
desire	0
or	I-DISEASE
willingness	I-DISEASE
to	0
maintain	0
a	0
consis-	0
tent	0
daytime	0
sleep	I-DISEASE
schedule	I-DISEASE
on	0
days	I-DISEASE
off	0
,	I-DISEASE
thereby	0
reducing	0
the	0
likelihood	0
of	I-DISEASE
circadian	0
adjustment	I-DISEASE
.	I-DISEASE

Familial	0
Patterns	0
Not	0
applicable	0
or	0
known	0
.	I-DISEASE

Onset	0
,	0
Course	0
,	0
and	0
Complications	0

The	0
condition	0
is	I-DISEASE
closely	0
linked	0
to	0
work	I-DISEASE
schedules	0
and	I-DISEASE
typically	0
remits	0
when	0
the	0
major	0
sleep	I-DISEASE
episode	I-DISEASE
is	0
scheduled	I-DISEASE
at	0
a	0
conventional	0
time	0
.	0

Because	0
there	0
are	I-DISEASE
so	0
many	0
different	0
work	0
schedules	0
,	I-DISEASE
ranging	0
from	0
an	0
occasional	0
overnight	0
shift	0
to	0
regular	0
night	I-DISEASE
work	0
,	0
the	0
course	0
is	0
quite	0
variable	I-DISEASE
.	0

Because	0
shift	0
work	0
is	0
often	0
combined	0
with	0
extended	0
hours	I-DISEASE
of	0
duty	0
,	0
fatigue	0
can	0
be	0
a	0
complicating	0
factor	0
.	I-DISEASE

Circadian	0
adaptation	I-DISEASE
is	0
often	I-DISEASE
counteracted	0
by	0
exposure	I-DISEASE
to	I-DISEASE
light	I-DISEASE
at	0
the	0
wrong	I-DISEASE
time	I-DISEASE
of	0
the	I-DISEASE
day	I-DISEASE
and	I-DISEASE
the	I-DISEASE
tendency	0
of	0
most	I-DISEASE
workers	0
to	I-DISEASE
resume	I-DISEASE
full	I-DISEASE
daytime	0
activities	0
and	I-DISEASE
nighttime	0
sleep	0
during	I-DISEASE
weekends	0
and	0
vacations	0
.	I-DISEASE

It	0
has	0
been	0
hypothesized	0
that	0
in	0
some	0
individuals	0
,	I-DISEASE
the	0
condition	0
may	0
lead	0
to	0
chronic	I-DISEASE
sleep	I-DISEASE
disturbances	0
.	I-DISEASE

Complications	0
may	0
include	0
exacerbation	0
of	I-DISEASE
gastrointestinal	B-DISEASE
,	I-DISEASE
met-	0
abolic	I-DISEASE
,	0
reproductive	0
,	0
neoplastic	0
,	0
and	I-DISEASE
cardiovascular	0
disorders	I-DISEASE
.	I-DISEASE

Disruptions	0
of	0
social	0
and	0
family	0
life	I-DISEASE
are	0
frequent	0
.	I-DISEASE

Drug	0
and	I-DISEASE
alcohol	0
dependency	0
may	0
result	0
from	0
attempts	0
to	0
improve	0
the	0
sleep	0
and	I-DISEASE
wakefulness	0
disturbances	I-DISEASE
produced	I-DISEASE
by	0
shift	0
work	0
.	0

Fatigue	0
and	0
excessive	I-DISEASE
sleepiness	0
due	0
to	I-DISEASE
the	I-DISEASE
combination	0
of	0
sleep	0
loss	0
and	0
circadian	0
misalignment	I-DISEASE
pose	I-DISEASE
important	I-DISEASE
safety	0
concerns	I-DISEASE
.	I-DISEASE

The	0
level	0
of	0
alertness	0
required	0
of	0
the	0
worker	0
,	I-DISEASE
in	I-DISEASE
addi-	0
tion	0
to	0
the	0
intensity	I-DISEASE
of	0
symptoms	0
,	I-DISEASE
needs	I-DISEASE
to	I-DISEASE
be	0
taken	0
into	0
account	0
when	I-DISEASE
evaluating	0
the	0
disorder	0
.	0

For	0
example	0
,	0
the	0
threshold	I-DISEASE
for	I-DISEASE
intervention	0
may	0
be	I-DISEASE
lower	I-DISEASE
for	0
workers	0
whose	I-DISEASE
performance	0
is	I-DISEASE
critical	I-DISEASE
for	I-DISEASE
personal	I-DISEASE
or	0
public	0
safety	0
(	0
for	0
example	0
,	0
health	0
care	0
workers	0
or	0
nuclear	0
power	I-DISEASE
plant	0
or	0
public	0
transport	0
operators	0
)	0
.	I-DISEASE

Developmental	0
Issues	0
Not	0
applicable	0
or	0
known	0
.	0

Circadian	0
Rhythm	I-DISEASE
Sleep	0
-	I-DISEASE
Wake	0
Disorders	0
Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	0
Wake	0
Disorders	0
Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE

The	0
condition	0
is	I-DISEASE
thought	0
to	0
be	0
directly	I-DISEASE
related	0
to	I-DISEASE
circadian	0
misalignment	0
and	0
sleep	I-DISEASE
loss	0
.	I-DISEASE

The	0
sleep	0
disturbance	I-DISEASE
is	0
generated	0
by	0
a	I-DISEASE
circadian	0
alerting	I-DISEASE
process	0
that	0
corre-	0
sponds	0
with	0
the	I-DISEASE
time	0
that	0
the	0
worker	0
needs	0
to	0
sleep	0
.	0

The	0
excessive	0
sleepiness	0
during	I-DISEASE
the	0
night	I-DISEASE
and	I-DISEASE
early	0
morning	I-DISEASE
appears	0
to	I-DISEASE
be	0
partly	0
related	0
to	I-DISEASE
cumulative	I-DISEASE
sleep	0
loss	I-DISEASE
and	I-DISEASE
partly	0
due	0
to	I-DISEASE
a	0
decreased	0
circadian	I-DISEASE
alerting	0
signal	0
that	B-DISEASE
corresponds	0
with	I-DISEASE
the	0
work	0
time	0
and	0
the	I-DISEASE
commute	0
to	0
and	I-DISEASE
from	I-DISEASE
work	0
.	0

Tolerance	0
to	0
night	0
work	I-DISEASE
varies	0
considerably	I-DISEASE
and	I-DISEASE
may	0
involve	I-DISEASE
differences	0
in	0
the	0
degree	0
of	0
circadian	I-DISEASE
adaptation	I-DISEASE
(	0
“	I-DISEASE
clock	B-DISEASE
resetting	0
”	0
)	0
to	0
a	0
night	0
-	I-DISEASE
work	0
,	I-DISEASE
day	0
-	0
sleep	I-DISEASE
schedule	I-DISEASE
.	0

Alternatively	0
,	0
tolerance	0
may	0
be	0
related	0
to	I-DISEASE
individual	0
differences	I-DISEASE
in	0
response	0
to	0
circadian	0
and	0
homeostatic	I-DISEASE
influences	I-DISEASE
on	0
sleep	0
and	0
wakeful-	0
ness	0
regulation	I-DISEASE
.	0

Environmental	0
and	0
social	0
factors	0
may	0
exacerbate	0
sleep	0
loss	0
associated	0
with	0
shift	0
work	0
schedules	0
.	0

Objective	0
Findings	0

The	0
condition	0
can	0
usually	0
be	0
diagnosed	0
by	0
history	0
.	0

Sleep	0
logs	0
and	0
actigraphy	0
are	0
rec-	I-DISEASE
ommended	I-DISEASE
to	0
demonstrate	I-DISEASE
a	0
disrupted	0
sleep	0
-	0
wake	0
pattern	0
consistent	I-DISEASE
with	0
shift	0
work	I-DISEASE
disorder	0
.	I-DISEASE

Polysomnographic	0
recordings	0
,	0
while	0
not	0
required	0
for	I-DISEASE
the	0
diagnosis	I-DISEASE
,	I-DISEASE
are	0
useful	0
if	I-DISEASE
the	0
etiology	I-DISEASE
of	0
the	0
sleep	0
disturbance	I-DISEASE
is	0
in	0
question	0
(	I-DISEASE
for	I-DISEASE
example	0
to	0
rule	0
out	I-DISEASE
sleep	0
apnea	0
or	0
narcolepsy	0
)	0
.	0

Polysomnography	0
during	0
a	0
typical	0
daytime	0
sleep	I-DISEASE
episode	I-DISEASE
after	0
a	I-DISEASE
work	0
shift	I-DISEASE
also	0
can	0
be	0
useful	I-DISEASE
to	0
determine	0
the	I-DISEASE
severity	0
of	0
the	0
sleep	0
disruption	I-DISEASE
,	I-DISEASE
although	I-DISEASE
this	I-DISEASE
is	I-DISEASE
undertaken	0
almost	0
exclusively	0
for	0
research	0
studies	0
of	0
shift	0
work	0
disor-	0
der	0
.	0

Polysomnography	0
may	0
demonstrate	0
impaired	0
sleep	0
quality	I-DISEASE
,	I-DISEASE
with	I-DISEASE
prolonged	I-DISEASE
sleep	I-DISEASE
latency	0
,	0
sleep	0
maintenance	I-DISEASE
difficulty	I-DISEASE
,	0
or	0
shortened	I-DISEASE
total	I-DISEASE
sleep	0
time	0
,	0
depending	0
on	0
the	I-DISEASE
timing	I-DISEASE
of	0
the	I-DISEASE
sleep	0
episode	0
in	I-DISEASE
relation	I-DISEASE
to	0
the	0
underlying	0
phase	0
of	0
the	I-DISEASE
circadian	0
timing	I-DISEASE
system	I-DISEASE
.	I-DISEASE

The	0
sleep	0
episode	0
may	0
be	0
fragmented	0
,	0
with	0
frequent	I-DISEASE
arousals	0
and	0
awaken-	0
ings	0
.	0

The	0
Multiple	0
Sleep	0
Latency	0
Test	0
(	0
MSLT	I-DISEASE
)	0
may	0
demonstrate	0
excessive	0
sleepiness	0
during	I-DISEASE
the	0
time	I-DISEASE
of	0
the	0
work	I-DISEASE
shift	0
.	0

If	0
available	0
,	0
measures	0
of	0
the	I-DISEASE
unmasked	I-DISEASE
melatonin	0
rhythm	0
are	0
useful	0
to	0
indicate	0
the	0
degree	0
of	0
circadian	0
misalignment	I-DISEASE
.	0

Differential	0
Diagnosis	0

The	0
excessive	0
sleepiness	0
should	I-DISEASE
be	0
differentiated	0
from	I-DISEASE
that	0
caused	0
by	0
other	0
primary	0
sleep	I-DISEASE
disorders	0
such	I-DISEASE
as	0
obstructive	0
sleep	I-DISEASE
apnea	0
or	0
narcolepsy	0
.	0

Insufficient	0
sleep	0
related	0
to	0
conflicting	0
daytime	I-DISEASE
activities	I-DISEASE
(	0
for	I-DISEASE
example	0
,	0
child	0
care	0
)	0
or	I-DISEASE
from	0
environmental	0
interference	I-DISEASE
with	0
sleep	0
(	0
for	0
example	0
,	I-DISEASE
daytime	I-DISEASE
noise	0
)	0
often	I-DISEASE
contributes	0
to	0
sleepiness	I-DISEASE
.	I-DISEASE

Sometimes	0
patients	0
with	I-DISEASE
DSWPD	0
may	0
adopt	I-DISEASE
a	0
night	0
-	0
work	0
schedule	I-DISEASE
that	0
is	0
more	0
con-	I-DISEASE
gruent	I-DISEASE
with	0
their	I-DISEASE
sleep	0
preferences	I-DISEASE
.	0

Insomnia	0
and	0
excessive	0
sleepiness	0
may	0
also	I-DISEASE
suggest	I-DISEASE
other	I-DISEASE
persistent	0
circadian	0
rhythm	0
sleep	0
-	0
wake	0
disorders	0
.	0

However	0
,	I-DISEASE
historical	0
informa-	I-DISEASE
tion	0
on	0
the	I-DISEASE
relation	0
between	0
the	0
occurrence	I-DISEASE
of	I-DISEASE
disturbed	0
sleep	I-DISEASE
and	I-DISEASE
work	0
-	0
hour	I-DISEASE
distribu-	0
tion	0
should	0
provide	0
sufficient	0
information	I-DISEASE
to	I-DISEASE
indicate	0
the	0
correct	I-DISEASE
diagnosis	0
.	0

Increasing	0
frustration	0
,	0
negative	0
expectations	I-DISEASE
,	0
and	I-DISEASE
poor	0
sleep	I-DISEASE
hygiene	0
may	0
predispose	I-DISEASE
the	I-DISEASE
person	0
to	I-DISEASE
the	I-DISEASE
development	0
of	I-DISEASE
coexisting	I-DISEASE
chronic	0
insomnia	0
disorder	0
that	0
could	0
persist	I-DISEASE
beyond	0
the	0
shift	I-DISEASE
work	0
schedule	0
(	0
i.e.	0
,	0
shift	0
work	0
may	0
represent	I-DISEASE
a	0
precipitating	I-DISEASE
event	0
that	0
leads	0
to	0
chronic	0
problems	0
with	0
insomnia	0
)	0
.	0

Drug	0
and	I-DISEASE
alcohol	0
abuse	0
or	0
dependency	0
may	0
result	0
from	I-DISEASE
efforts	0
to	0
treat	0
the	0
sleep	0
disturbance	I-DISEASE
.	I-DISEASE

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE

Although	0
there	0
is	I-DISEASE
sufficient	0
information	0
regarding	I-DISEASE
the	I-DISEASE
prevalence	I-DISEASE
of	I-DISEASE
shift	0
work	0
in	I-DISEASE
indus-	0
trialized	0
populations	0
,	I-DISEASE
less	0
information	I-DISEASE
is	I-DISEASE
available	0
regarding	0
the	0
actual	0
prevalence	I-DISEASE
of	I-DISEASE
shift	I-DISEASE
work	I-DISEASE
disorder	I-DISEASE
and	0
its	0
impact	0
on	I-DISEASE
health	0
and	0
safety	0
.	0

Further	0
research	0
is	0
needed	0
to	0
improve	0
the	0
definition	I-DISEASE
of	I-DISEASE
what	0
constitutes	I-DISEASE
shift	0
work	0
disorder	0
,	I-DISEASE
to	I-DISEASE
develop	0
diagnostic	I-DISEASE
tools	0
for	0
shift	0
work	0
disorder	0
,	0
to	I-DISEASE
determine	0
the	0
prevalence	I-DISEASE
of	B-DISEASE
shift	I-DISEASE
work	0
disorder	0
using	0
diagnostic	0
criteria	0
,	0
to	0
elucidate	0
the	0
burden	I-DISEASE
of	0
shift	I-DISEASE
work	I-DISEASE
disorder	0
over	0
and	I-DISEASE
above	I-DISEASE
that	I-DISEASE
which	0
may	I-DISEASE
be	0
due	I-DISEASE
to	I-DISEASE
shift	B-DISEASE
work	0
in	0
general	0
,	I-DISEASE
to	0
investigate	0
mechanisms	I-DISEASE
underlying	0
the	I-DISEASE
health	I-DISEASE
and	0
safety	I-DISEASE
consequences	I-DISEASE
of	0
shift	I-DISEASE
work	I-DISEASE
disorder	0
,	0
and	I-DISEASE
to	I-DISEASE
determine	I-DISEASE
which	0
shift	0
workers	I-DISEASE
are	I-DISEASE
at	I-DISEASE
greatest	I-DISEASE
risk	I-DISEASE
of	0
shift	I-DISEASE
work	0
disorder	I-DISEASE
.	0

Furthermore	0
,	0
there	0
is	I-DISEASE
limited	0
information	I-DISEASE
on	I-DISEASE
the	0
role	I-DISEASE
of	0
age	0
,	0
sex	0
,	0
and	I-DISEASE
circadian	I-DISEASE
chronotype	0
on	I-DISEASE
the	0
vulnerability	0
to	0
shift	0
work	I-DISEASE
disorder	0
.	I-DISEASE

Bibliography	0
Akerstedt	0
T.	0
Shift	0
work	0
and	0
disturbed	0
sleep	0
/	I-DISEASE
wakefulness	0
.	0

Occup	0
Med	0
2003;53:89–94	0
.	0

Ancoli	0
-	0
Israel	0
S	0
,	0
Cole	0
R	I-DISEASE
,	0
Alessi	I-DISEASE
C	0
,	0
Chambers	0
M	0
,	0
Moorcroft	I-DISEASE
W	0
,	0
Pollak	I-DISEASE
C.	0

The	0
role	0
of	0
actigraphy	0
in	0
the	I-DISEASE
study	I-DISEASE
of	0
sleep	I-DISEASE
and	0
circadian	0
rhythms	I-DISEASE
.	0

Sleep	0
2003;26:342–92	0
.	0

Boggild	0
H	0
,	0
Knutsson	0
A.	0
Shift	0
work	I-DISEASE
,	0
risk	I-DISEASE
factors	0
and	0
cardiovascular	0
disease	0
.	0

Scand	0
J	0
Work	0
Environ	0
Health	0
1999;25:85–99	0
.	0

Costa	0
G.	0
Shift	I-DISEASE
work	0
and	0
occupational	0
medicine	I-DISEASE
:	0
an	I-DISEASE
overview	0
.	0

Occup	0
Med	0
2003;53:83–8	0
.	0

Drake	0
CL	0
,	I-DISEASE
Roehrs	0
T	0
,	I-DISEASE
Richardson	I-DISEASE
G	0
,	I-DISEASE
Walsh	0
JK	0
,	I-DISEASE
Roth	0
T.	0
Shift	0
work	0
sleep	0
disorder	I-DISEASE
:	0
prevalence	0
and	0
consequences	0
beyond	0
that	I-DISEASE
of	I-DISEASE
symptomatic	0
day	I-DISEASE
workers	I-DISEASE
.	I-DISEASE

Sleep	0
2004;27:1453–62	0
.	0

Drake	0
CL	0
,	0
Wright	0
KP	0
Jr.	0
Shift	0
work	0
,	I-DISEASE
shift	0
work	0
disorder	0
,	0
and	0
jet	I-DISEASE
lag	0
.	0

In	0
:	0
Kryger	0
MH	0
,	I-DISEASE
Roth	0
T	I-DISEASE
,	0
Dement	I-DISEASE
WC	0
,	0
eds	0
.	0

Principles	0
and	I-DISEASE
practice	0
of	I-DISEASE
sleep	0
medicine	I-DISEASE
,	I-DISEASE
5th	0
ed	I-DISEASE
.	0

Philadelphia	0
:	I-DISEASE
Elsevier	0
Saunders	0
,	0
2011:784–98	0
.	I-DISEASE

Flo	0
E	0
,	0
Pallesen	0
S	0
,	0
Magerøy	0
N	0
,	0
et	0
al	0
.	0

Shift	0
work	0
disorder	0
in	0
nurses	0
--	0
assessment	I-DISEASE
,	0
prevalence	I-DISEASE
and	0
related	0
health	I-DISEASE
problems	0
.	0

PLoS	0
One	0
2012;7	0
:	0
e33981	0
.	0

Folkard	0
S	0
,	0
Tucker	0
P.	0
Shift	0
work	I-DISEASE
,	0
safety	0
and	0
productivity	0
.	0

Occup	0
Med	0
2003;53:95–101	0
.	0

Horne	0
J	0
,	0
Reyner	0
L.	0
Vehicle	I-DISEASE
accidents	I-DISEASE
related	0
to	0
sleep	0
:	0
a	0
review	I-DISEASE
.	0

Occup	0
Environ	0
Med	0
1999;56:289–94	0
.	0

Knutsson	0
A.	0
Health	0
disorders	0
of	0
shift	0
workers	0
.	0

Occup	0
Environ	0
Med	0
2003;53:103–8	0
.	0

Swanson	0
LM	0
,	0
Arnedt	I-DISEASE
JT	0
,	0
Rosekind	I-DISEASE
MR	I-DISEASE
,	I-DISEASE
Belenky	0
G	0
,	0
Balkin	I-DISEASE
TJ	I-DISEASE
,	I-DISEASE
Drake	I-DISEASE
C.	0
Sleep	I-DISEASE
disorders	0
and	I-DISEASE
work	0
performance	0
:	0
findings	I-DISEASE
from	I-DISEASE
the	0
2008	0
National	I-DISEASE
Sleep	I-DISEASE
Foundation	0
Sleep	I-DISEASE
in	0
America	0
poll	0
.	0

J	0
Sleep	0
Res	0
2011;20:487–94	B-DISEASE
.	0

Waage	0
S	I-DISEASE
,	I-DISEASE
Moen	0
BE	0
,	0
Pallesen	0
S	0
,	I-DISEASE
et	0
al	0
.	0

Shift	0
work	0
disorder	0
among	0
oil	0
rig	0
workers	0
in	0
the	I-DISEASE
North	0
Sea	0
.	0

Sleep	0
2009;32:558–65	0
.	0

Wright	0
KP	0
Jr	0
,	0
Bogan	0
RK	0
,	I-DISEASE
Wyatt	0
JK	I-DISEASE
.	0

Shift	0
work	0
and	0
the	0
assessment	0
and	I-DISEASE
management	0
of	0
shift	0
work	0
disorder	0
(	0
SWD	0
)	0
.	I-DISEASE

Sleep	0
Med	0
Rev	I-DISEASE
2013;17:41–54	0
.	0

Circadian	0
Rhythm	I-DISEASE
Sleep	0
-	0
Wake	0
Disorders	0
Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	0
Wake	0
Disorders	0
Jet	I-DISEASE
Lag	0
Disorder	I-DISEASE
Jet	0
lag	0
,	I-DISEASE
time	0
zone	0
change	0
syndrome	0
,	0
jet	0
lag	I-DISEASE
syndrome	0
,	0
jet	I-DISEASE
lag	0
type	I-DISEASE
.	0

ICD-9	0
-	0
CM	0
code	0
:	0
327.35	0
ICD-10	I-DISEASE
-	0
CM	0
code	0
:	0

G47.25	0
Alternate	0
Names	0
Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
C	I-DISEASE
must	0
be	0
met	I-DISEASE
A.	0

There	0
is	0
a	0
complaint	0
of	0
insomnia	I-DISEASE
or	0
excessive	0
daytime	I-DISEASE
sleepiness	0
,	0
accompanied	0
by	I-DISEASE
a	0
reduction	I-DISEASE
of	I-DISEASE
total	0
sleep	I-DISEASE
time	0
,	0
associated	0
with	0
transmeridian	0
jet	0
travel	0
across	0
at	0
least	0
two	0
time	0
zones	0
.	0

B.	0
There	0
is	0
associated	0
impairment	0
of	0
daytime	I-DISEASE
function	0
,	I-DISEASE
general	0
malaise	0
,	I-DISEASE
or	0
somatic	0
symptoms	I-DISEASE
(	0
e.g.	0
,	I-DISEASE
gastrointestinal	0
disturbance	0
)	0
within	0
one	0
to	0
two	0
days	I-DISEASE
after	0
travel	I-DISEASE
.	0

C.	0

The	0
sleep	0
disturbance	I-DISEASE
is	0
not	0
better	I-DISEASE
explained	I-DISEASE
by	0
another	I-DISEASE
current	0
sleep	0
disorder	I-DISEASE
,	I-DISEASE
medical	0
or	0
neurological	0
disorder	0
,	I-DISEASE
mental	0
disorder	0
,	0
medication	0
use	I-DISEASE
,	0
or	I-DISEASE
substance	0
use	0
disorder	0
.	0

Essential	0
Features	0
Jet	0
lag	I-DISEASE
disorder	0
is	I-DISEASE
characterized	I-DISEASE
by	0
a	I-DISEASE
temporary	0
mismatch	0
between	0
the	I-DISEASE
timing	0
of	I-DISEASE
the	0
sleep	I-DISEASE
and	I-DISEASE
wake	0
cycle	I-DISEASE
generated	0
by	0
the	I-DISEASE
endogenous	0
circadian	I-DISEASE
clock	0
and	I-DISEASE
that	I-DISEASE
of	0
the	I-DISEASE
sleep	0
and	I-DISEASE
wake	0
pattern	0
required	0
by	I-DISEASE
a	I-DISEASE
change	I-DISEASE
in	I-DISEASE
time	I-DISEASE
zone	0
.	0

Individuals	0
complain	0
of	0
disturbed	I-DISEASE
sleep	0
,	I-DISEASE
sleepiness	I-DISEASE
and	I-DISEASE
fatigue	I-DISEASE
,	0
and	0
impaired	0
daytime	0
function	0
.	I-DISEASE

The	0
severity	0
and	0
duration	0
of	0
symptoms	I-DISEASE
is	B-DISEASE
dependent	0
on	I-DISEASE
the	0
number	I-DISEASE
of	0
time	0
zones	0
traveled	I-DISEASE
,	I-DISEASE
the	0
ability	I-DISEASE
to	I-DISEASE
sleep	0
while	0
traveling	0
,	0
exposure	0
to	I-DISEASE
appropriate	0
circadian	0
times	0
cues	B-DISEASE
in	0
the	0
new	0
environment	I-DISEASE
,	0
tolerance	0
to	0
circadian	0
misalignment	0
when	0
awake	I-DISEASE
during	I-DISEASE
the	0
bio-	0
logical	0
night	I-DISEASE
,	I-DISEASE
and	I-DISEASE
the	0
direction	0
of	I-DISEASE
the	I-DISEASE
travel	0
.	I-DISEASE

Eastward	0
travel	0
(	0
requiring	0
advancing	0
circadian	0
rhythms	I-DISEASE
and	0
sleep	I-DISEASE
-	0
wake	0
hours	I-DISEASE
)	0
is	I-DISEASE
usually	I-DISEASE
more	I-DISEASE
difficult	0
to	I-DISEASE
adjust	0
to	0
than	0
westward	0
travel	0
.	0

Associated	0
Features	0

In	0
addition	0
to	0
sleep	I-DISEASE
disturbance	I-DISEASE
and	0
decreased	I-DISEASE
daytime	0
alertness	I-DISEASE
,	0
associated	0
features	0
may	0
include	0
general	I-DISEASE
malaise	0
and	0
gastrointestinal	I-DISEASE
symptoms	0
.	0

Numerous	0
other	0
variables	0
related	0
to	I-DISEASE
travel	0
,	0
such	0
as	I-DISEASE
sleep	0
loss	I-DISEASE
,	0
decreased	0
mobility	0
,	0
and	0
alcohol	0
and/or	0
caffeine	0
intake	0
,	0
contribute	0
to	0
the	0
overall	0
fatigue	0
.	0

Daytime	0
sleepiness	0
can	0
lead	I-DISEASE
to	0
memory	0
diffi-	I-DISEASE
culties	0
,	I-DISEASE
problems	0
concentrating	0
,	0
driving	I-DISEASE
and	0
flying	I-DISEASE
,	0
and	0
to	I-DISEASE
impaired	0
decision	0
-	0
making	0
.	0

Sleepiness	0
,	0
sleep	0
disturbance	0
and	0
circadian	0
misalignment	I-DISEASE
associated	0
with	I-DISEASE
jet	I-DISEASE
lag	0
may	0
also	0
impair	0
athletic	0
performance	0
.	0

Effects	0
of	0
jet	0
lag	0
not	0
only	0
affect	I-DISEASE
travelers	0
,	0
but	0
also	0
can	0
have	0
significant	0
consequences	0
for	0
airline	I-DISEASE
pilots	0
and	0
flight	0
attendants	0
.	0

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
There	I-DISEASE
are	I-DISEASE
individual	I-DISEASE
differences	I-DISEASE
in	I-DISEASE
the	0
ability	I-DISEASE
to	0
adjust	0
to	0
rapid	I-DISEASE
shifts	0
in	I-DISEASE
time	I-DISEASE
zones	0
;	0
however	0
,	0
specific	0
clinical	0
subtypes	I-DISEASE
have	0
not	0
been	I-DISEASE
identified	0
.	0

Demographics	0
Jet	0
lag	0
affects	0
all	0
age	0
,	0
sex	0
,	I-DISEASE
and	0
racial	0
groups	0
.	0

Limited	0
available	I-DISEASE
data	0
suggest	0
that	0
older	I-DISEASE
individuals	0
may	I-DISEASE
experience	I-DISEASE
fewer	0
jet	0
lag	0
symptoms	0
compared	0
with	0
younger	I-DISEASE
individu-	0
als	I-DISEASE
.	0

However	0
,	I-DISEASE
the	0
data	I-DISEASE
have	0
limitations	0
and	I-DISEASE
further	I-DISEASE
research	I-DISEASE
is	0
needed	0
to	0
better	0
define	0
the	I-DISEASE
relationship	I-DISEASE
between	0
age	I-DISEASE
and	0
the	I-DISEASE
development	0
of	0
jet	0
lag	0
disorder	0
.	0

There	0
are	0
no	0
studies	0
on	0
the	0
prevalence	I-DISEASE
of	I-DISEASE
jet	I-DISEASE
lag	0
disorder	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
Disturbed	0
sleep	I-DISEASE
and/or	I-DISEASE
shortened	0
sleep	I-DISEASE
duration	0
before	0
and	0
during	0
travel	I-DISEASE
contribute	I-DISEASE
to	I-DISEASE
jet	I-DISEASE
lag	I-DISEASE
symptoms	0
.	0

Prolonged	0
uncomfortable	0
sitting	0
positions	0
,	0
air	0
quality	I-DISEASE
and	0
pressure	0
,	I-DISEASE
stress	I-DISEASE
,	I-DISEASE
and	0
excessive	0
caffeine	I-DISEASE
and	I-DISEASE
alcohol	I-DISEASE
consumption	I-DISEASE
may	0
increase	0
the	0
severity	0
of	0
insomnia	0
and	0
impaired	I-DISEASE
alertness	0
and	I-DISEASE
function	0
associated	0
with	I-DISEASE
transmeridian	I-DISEASE
travel	0
.	0

Eastward	0
travel	0
often	0
leads	0
to	0
difficulties	0
with	I-DISEASE
sleep	0
onset	I-DISEASE
as	I-DISEASE
attempts	0
to	0
sleep	0
are	0
made	I-DISEASE
at	0
an	0
earlier	I-DISEASE
internal	0
circadian	0
time	0
when	0
the	0
travelers	0
’	I-DISEASE
biological	I-DISEASE
clock	I-DISEASE
is	0
pro-	0
moting	I-DISEASE
alertness	0
(	0
i.e.	0
,	0
biological	0
day	0
)	0
.	I-DISEASE

Difficulty	0
awakening	0
and	0
daytime	0
sleepiness	0
and	0
fatigue	I-DISEASE
occur	0
because	I-DISEASE
wake	0
time	0
also	0
occurs	0
at	0
an	0
earlier	I-DISEASE
biological	I-DISEASE
time	I-DISEASE
when	0
the	0
circadian	0
clock	0
is	0
still	0
promoting	I-DISEASE
sleep	0
(	I-DISEASE
i.e.	0
,	B-DISEASE
during	I-DISEASE
the	0
travelers	0
’	0
biological	0
night	0
)	0
.	0

Westward	0
jet	0
travel	0
often	0
leads	0
to	I-DISEASE
sleepiness	0
and	0
fatigue	I-DISEASE
in	0
the	0
evening	0
hours	0
of	0
the	0
new	I-DISEASE
time	0
zone	I-DISEASE
as	0
the	0
internal	0
circadian	0
clock	I-DISEASE
of	I-DISEASE
the	0
traveler	0
is	0
promoting	I-DISEASE
sleep	I-DISEASE
(	0
i.e.	0
,	0
biological	0
night	0
)	0
.	0

Sleep	0
disturbance	0
in	0
the	0
new	I-DISEASE
time	I-DISEASE
zone	0
is	0
typically	I-DISEASE
manifest	0
as	0
a	0
sleep	0
maintenance	0
issue	I-DISEASE
with	I-DISEASE
early	0
morning	I-DISEASE
awakenings	I-DISEASE
and	0
difficulty	0
returning	0
to	0
sleep	I-DISEASE
because	0
the	0
internal	I-DISEASE
circadian	I-DISEASE
clock	I-DISEASE
of	0
the	0
traveler	0
is	0
promoting	0
wakefulness	I-DISEASE
during	0
the	0
sleep	I-DISEASE
episode	0
(	I-DISEASE
i.e.	0
,	I-DISEASE
biological	I-DISEASE
day	I-DISEASE
)	0
.	0

Basic	0
circadian	0
science	0
principles	B-DISEASE
suggest	0
that	0
inappropriately	0
timed	0
exposure	I-DISEASE
to	0
light	0
and	0
darkness	0
during	0
and	I-DISEASE
immediately	0
after	I-DISEASE
jet	I-DISEASE
travel	0
can	0
shift	0
the	0
circadian	0
clock	0
in	I-DISEASE
the	0
wrong	0
direction	I-DISEASE
,	0
thereby	I-DISEASE
increasing	0
the	0
duration	0
of	0
jet	0
lag	I-DISEASE
symptoms	0
.	I-DISEASE

Time	0
at	0
destina-	I-DISEASE
tion	0
upon	0
arrival	0
may	0
also	0
influence	I-DISEASE
jet	0
lag	0
symptoms	0
with	0
fewer	0
symptoms	0
reported	0
following	0
midday	0
arrivals	0
after	0
eastward	0
travel	0
.	0

An	0
individual	0
’s	0
innate	0
circadian	0
preference	0
may	0
also	0
confer	I-DISEASE
a	0
greater	0
or	0
lesser	I-DISEASE
ability	0
to	I-DISEASE
adjust	0
to	0
a	I-DISEASE
particular	I-DISEASE
time	0
shift	0
,	0
but	0
this	0
finding	I-DISEASE
has	0
not	0
been	0
systematically	0
assessed	0
.	0

Circadian	0
Rhythm	I-DISEASE
Sleep	0
-	0
Wake	0
Disorders	0
Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	0
Wake	0
Disorders	0
Jet	I-DISEASE
lag	0
is	I-DISEASE
often	0
reported	0
to	I-DISEASE
be	0
worse	0
after	0
eastward	0
than	0
westward	0
travel	0
.	0

Westward	0
travel	0
may	0
generally	0
be	0
easier	I-DISEASE
because	I-DISEASE
the	0
genetically	I-DISEASE
determined	I-DISEASE
period	0
of	0
the	0
cir-	0
cadian	I-DISEASE
clock	I-DISEASE
in	0
humans	I-DISEASE
is	0
on	0
average	0
longer	0
than	0
24	0
hours	0
.	0

A	0
circadian	0
period	0
longer	B-DISEASE
than	0
24	I-DISEASE
hours	I-DISEASE
is	I-DISEASE
associated	I-DISEASE
with	0
a	0
circadian	0
drive	0
or	0
physiological	I-DISEASE
tendency	0
for	0
bed	0
and	0
wake	0
times	0
to	0
be	I-DISEASE
later	0
,	I-DISEASE
thus	I-DISEASE
making	0
it	I-DISEASE
easier	0
to	I-DISEASE
shift	0
the	0
circadian	0
clock	0
during	I-DISEASE
west-	0
ward	0
travel	I-DISEASE
to	I-DISEASE
more	I-DISEASE
delayed	I-DISEASE
sleep	I-DISEASE
and	0
wake	0
times	0
.	0

However	0
,	I-DISEASE
20	0
%	0
to	0
25	0
%	I-DISEASE
of	0
humans	I-DISEASE
have	0
circadian	0
periods	0
that	I-DISEASE
are	0
near	I-DISEASE
to	0
,	0
or	I-DISEASE
shorter	0
than	0
,	0
24	0
hours	0
,	I-DISEASE
and	I-DISEASE
these	0
individuals	I-DISEASE
may	0
find	0
it	0
easier	0
to	0
adapt	0
to	0
eastward	I-DISEASE
travel	0
.	0

Familial	0
Patterns	0
Not	0
applicable	0
or	0
known	0
.	I-DISEASE

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Jet	I-DISEASE
lag	0
is	0
usually	0
a	0
temporary	0
condition	0
.	0

Symptoms	0
begin	0
approximately	0
one	0
to	0
two	0
days	I-DISEASE
after	0
air	I-DISEASE
travel	0
across	0
at	0
least	0
two	0
time	I-DISEASE
zones	I-DISEASE
and	I-DISEASE
are	I-DISEASE
self	0
-	0
limited	0
.	0

The	0
severity	0
and	0
duration	0
of	0
symptoms	I-DISEASE
are	0
usually	0
in	I-DISEASE
proportion	0
to	0
the	0
number	I-DISEASE
of	0
time	I-DISEASE
zones	0
trav-	0
eled	I-DISEASE
and	0
the	I-DISEASE
direction	0
of	0
travel	0
.	0

It	0
is	0
estimated	0
that	0
it	0
takes	0
one	I-DISEASE
day	0
per	I-DISEASE
time	0
zone	0
for	I-DISEASE
circadian	0
rhythms	0
to	I-DISEASE
adjust	I-DISEASE
to	0
the	I-DISEASE
local	0
time	I-DISEASE
.	0

However	0
,	I-DISEASE
if	0
traveling	0
more	0
than	0
six	I-DISEASE
time	0
zones	I-DISEASE
,	0
circadian	0
rhythms	0
may	I-DISEASE
shift	0
in	I-DISEASE
the	0
opposite	0
direction	I-DISEASE
,	0
resulting	0
in	0
a	0
prolonged	0
period	0
of	I-DISEASE
adjustment	0
that	0
may	I-DISEASE
last	I-DISEASE
up	0
to	0
several	0
weeks	0
and	0
increased	0
severity	0
of	I-DISEASE
jet	I-DISEASE
-	0
lag	0
symptoms	I-DISEASE
.	0

Exposure	0
to	0
light	0
at	0
inappropriate	I-DISEASE
times	I-DISEASE
may	0
prolong	0
the	I-DISEASE
time	0
of	0
adjust-	I-DISEASE
ment	0
by	0
shifting	I-DISEASE
the	I-DISEASE
circadian	0
rhythms	I-DISEASE
in	0
the	0
opposite	0
direction	0
.	0

Menstrual	0
and	0
repro-	I-DISEASE
ductive	0
problems	0
have	I-DISEASE
been	I-DISEASE
associated	I-DISEASE
with	I-DISEASE
frequent	0
transmeridian	0
travel	I-DISEASE
in	0
female	0
airline	0
personnel	0
.	0

Poor	0
sleep	0
hygiene	I-DISEASE
practices	I-DISEASE
may	0
perpetuate	0
sleep	B-DISEASE
/	0
wake	I-DISEASE
complaints	0
,	0
and	0
repetitive	I-DISEASE
failed	0
attempts	I-DISEASE
to	I-DISEASE
initiate	0
or	I-DISEASE
maintain	0
sleep	0
at	0
desired	0
times	0
may	I-DISEASE
predis-	I-DISEASE
pose	0
to	0
the	B-DISEASE
development	0
of	0
insomnia	0
disorder	I-DISEASE
.	0

Developmental	0
Issues	0

The	0
effect	0
of	0
age	0
on	0
the	0
development	I-DISEASE
or	0
severity	0
of	0
jet	0
lag	0
disorder	0
symptoms	0
is	I-DISEASE
unknown	0
.	0

Pathology	0
and	0
Pathophysiology	0
The	I-DISEASE
symptoms	0
of	I-DISEASE
jet	I-DISEASE
lag	0
disorder	I-DISEASE
are	0
due	0
to	0
both	0
desynchronization	0
of	I-DISEASE
endogenous	0
circadian	0
rhythms	I-DISEASE
with	0
local	0
time	0
and	0
sleep	I-DISEASE
disturbance	0
.	I-DISEASE

The	0
severity	0
of	0
symptoms	0
can	0
be	0
influenced	I-DISEASE
by	0
the	0
environment	I-DISEASE
and	0
behaviors	0
of	0
the	0
traveler	I-DISEASE
.	0

Factors	0
inherent	0
to	I-DISEASE
jet	I-DISEASE
travel	0
,	0
including	0
prolonged	0
time	I-DISEASE
spent	0
sitting	0
in	0
a	0
confined	0
space	I-DISEASE
,	I-DISEASE
ability	0
to	I-DISEASE
sleep	I-DISEASE
on	0
long	0
-	0
haul	0
flights	I-DISEASE
,	I-DISEASE
decreased	0
physical	0
activity	I-DISEASE
,	0
and	0
a	0
low	I-DISEASE
oxygen	0
environment	0
,	0
may	0
influence	0
severity	0
.	I-DISEASE

Objective	0
Findings	0
Objective	0
laboratory	I-DISEASE
testing	0
usually	I-DISEASE
is	0
not	0
indicated	I-DISEASE
.	0

When	0
performed	0
,	0
polysomnogra-	0
phy	0
or	I-DISEASE
actigraphy	I-DISEASE
shows	0
disturbed	I-DISEASE
sleep	0
and	0
a	0
loss	I-DISEASE
of	0
a	I-DISEASE
normal	I-DISEASE
sleep	0
-	0
wake	0
pattern	I-DISEASE
or	0
a	0
mismatch	0
between	I-DISEASE
the	I-DISEASE
timing	0
of	I-DISEASE
sleep	I-DISEASE
and	I-DISEASE
wakefulness	0
with	0
the	I-DISEASE
desired	I-DISEASE
sleep	0
-	0
wake	0
pattern	I-DISEASE
of	I-DISEASE
the	0
local	I-DISEASE
time	I-DISEASE
.	I-DISEASE

Differential	0
Diagnosis	0
A	0
thorough	0
history	0
and	I-DISEASE
physical	I-DISEASE
examination	0
should	I-DISEASE
be	0
performed	0
to	0
exclude	0
other	0
mental	I-DISEASE
,	0
physical	0
,	I-DISEASE
or	0
sleep	0
disorders	0
.	0

Somatic	0
complaints	0
of	0
gastrointestinal	0
symptoms	0
may	0
indicate	I-DISEASE
an	0
underlying	I-DISEASE
medical	I-DISEASE
condition	0
.	0

When	0
jet	0
lag	0
symptoms	0
persist	0
,	0
increas-	I-DISEASE
ing	0
frustration	I-DISEASE
,	0
negative	0
expectations	0
,	0
and	0
poor	I-DISEASE
sleep	0
hygiene	0
may	I-DISEASE
predispose	0
the	I-DISEASE
indi-	0
vidual	I-DISEASE
to	0
the	0
development	B-DISEASE
of	0
chronic	0
insomnia	0
disorder	I-DISEASE
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE
Understanding	I-DISEASE
mechanisms	I-DISEASE
of	0
individual	I-DISEASE
differences	0
in	0
vulnerability	0
and	I-DISEASE
tolerance	0
to	I-DISEASE
disturbed	0
sleep	0
and	I-DISEASE
wakefulness	0
during	0
jet	0
lag	I-DISEASE
is	I-DISEASE
necessary	I-DISEASE
.	0

Development	0
of	0
effective	0
and	0
practical	0
strategies	0
to	I-DISEASE
combat	0
jet	0
-	0
lag	0
symptoms	0
and	0
improve	0
sleep	I-DISEASE
,	0
performance	I-DISEASE
and	I-DISEASE
safety	0
are	I-DISEASE
needed	0
.	0

It	0
is	0
unknown	0
how	I-DISEASE
expression	0
of	0
the	I-DISEASE
disorder	I-DISEASE
varies	I-DISEASE
across	0
the	0
life	0
span	0
.	0

Bibliography	0
Auger	0
RR	0
,	0
Morgenthaler	I-DISEASE
TI	0
.	I-DISEASE

Jet	0
lag	0
and	0
other	0
sleep	0
disorders	I-DISEASE
relevant	I-DISEASE
to	0
the	0
traveler	0
.	0

Travel	0
Med	0
Infect	I-DISEASE
Dis	0
2009;7:60–8	0
.	I-DISEASE

Burgess	0
HJ	0
,	0
Crowley	0
SJ	0
,	0
Gazda	0
CJ	0
,	0
Fogg	0
LF	0
.	0

Eastman	0
CI	0
.	I-DISEASE

Preflight	0
adjustment	0
to	0
eastward	0
travel	0
:	0
3	I-DISEASE
days	0
of	I-DISEASE
advancing	0
sleep	0
with	0
and	0
without	0
morning	0
bright	0
light	I-DISEASE
.	I-DISEASE

J	0
Biol	0
Rhythms	I-DISEASE
2003;18:318–28	0
.	0

Daan	0
S	0
,	0
Lewy	0
AJ	0
.	I-DISEASE

Scheduled	0
exposure	0
to	0
daylight	0
:	0
a	0
potential	0
strategy	0
to	I-DISEASE
reduce	I-DISEASE
“	0
jet	0
lag	0
”	0
following	0
transmeridian	0
flight	0
.	0

Psychopharmacol	0
Bull	0
1984;20:566–8	0
.	0

Dawson	0
D	0
,	I-DISEASE
Campbell	0
SS	I-DISEASE
.	I-DISEASE

Timed	0
exposure	0
to	0
bright	0
light	0
improves	0
sleep	I-DISEASE
and	0
alertness	I-DISEASE
during	0
simulated	0
night	0
shifts	0
.	0

Sleep	0
1991;14:511–6	0
.	0

Drake	0
CL	0
,	0
Wright	0
KP	0
Jr.	0
Shift	0
work	0
,	I-DISEASE
shift	0
work	0
disorder	0
,	0
and	0
jet	I-DISEASE
lag	0
.	0

In	0
:	0
Kryger	0
MH	0
,	I-DISEASE
Roth	0
T	I-DISEASE
,	0
Dement	I-DISEASE
WC	0
,	0
eds	0
.	0

Principles	0
and	I-DISEASE
practice	0
of	I-DISEASE
sleep	0
medicine	I-DISEASE
,	I-DISEASE
5th	0
ed	I-DISEASE
.	0

Philadelphia	0
:	I-DISEASE
Elsevier	0
Saunders	0
,	0
2011	0
;	I-DISEASE
784–98	0
.	I-DISEASE

Eastman	0
CI	0
,	I-DISEASE
Gazda	0
CJ	0
,	I-DISEASE
Burgess	0
HJ	0
,	I-DISEASE
Crowley	0
SJ	0
,	0
Fogg	0
LF	0
.	I-DISEASE

Advancing	0
circadian	0
rhythms	0
before	0
eastward	0
flight	0
:	I-DISEASE
a	0
strategy	I-DISEASE
to	0
prevent	0
or	0
reduce	I-DISEASE
jet	0
lag	I-DISEASE
.	0

Sleep	0
2005;28:33–44	0
.	0

Moline	0
ML	0
,	0
Pollak	0
CP	0
,	0
Monk	0
TH	0
,	I-DISEASE
et	0
al	0
.	0

Age	0
-	0
related	0
differences	0
in	0
recovery	0
from	I-DISEASE
simulated	0
jet	0
lag	0
.	0

Sleep	0
1992;15:28–40	0
.	0

Muhm	0
,	0
JM	0
,	0
Rock	0
PB	I-DISEASE
,	I-DISEASE
McMullin	0
DL	I-DISEASE
,	0
et	0
al	0
.	0

Effect	0
of	0
aircraft	0
-	0
cabin	0
altitude	0
on	I-DISEASE
passenger	0
discomfort	0
.	0

N	0
Engl	0
J	0
Med	0
2007;357:18–27	0
.	0

Sack	0
R	0
,	0
Auckley	0
D	0
,	0
Auger	0
RR	0
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Circadian	0
rhythm	I-DISEASE
sleep	0
disorders	0
:	0
part	0
i	I-DISEASE
,	0
basic	I-DISEASE
principles	0
,	0
shift	0
work	0
and	0
jet	I-DISEASE
lag	0
:	0
An	I-DISEASE
American	0
Academy	0
of	0
Sleep	0
Medicine	0
Review	I-DISEASE
.	I-DISEASE

Sleep	0
2007;30:1456–79	0
.	0

Suhner	0
A	0
,	0
Schlagenhauf	B-DISEASE
P	0
,	0
Höfer	0
I	I-DISEASE
,	I-DISEASE
Johnson	0
R	0
,	0
Tschopp	0
A	0
,	I-DISEASE
Steffen	0
R.	0
Effectiveness	I-DISEASE
and	0
tolerability	0
of	0
melatonin	0
and	I-DISEASE
zolpidem	I-DISEASE
for	I-DISEASE
the	0
alleviation	I-DISEASE
of	0
jet	0
lag	0
.	0

Aviat	0
Space	0
Environ	0
Med	0
2001;72:638–46	0
.	0

Circadian	0
Rhythm	I-DISEASE
Sleep	0
-	I-DISEASE
Wake	0
Disorders	0
Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	0
Wake	0
Disorders	0
Tresguerres	I-DISEASE
JA	0
,	I-DISEASE
Ariznavarreta	0
C	0
,	I-DISEASE
Granados	0
B	0
,	0
et	0
al	0
.	0

Circadian	0
urinary	I-DISEASE
6	0
-	0
sulphatoxymelatonin	0
,	0
cortisol	I-DISEASE
excretion	I-DISEASE
and	I-DISEASE
locomotor	0
activity	0
in	0
airline	0
pilots	0
during	I-DISEASE
transmeridian	0
flights	0
.	I-DISEASE

J	0
Pineal	0
Res	0
2001;31:16–22	0
.	0

Waterhouse	0
J	0
,	0
Edwards	0
B	0
,	0
Nevill	I-DISEASE
A	0
,	I-DISEASE
et	0
al	0
.	0

Identifying	0
some	0
determinants	0
of	0
“	0
jet	I-DISEASE
lag	I-DISEASE
”	0
and	0
its	0
symptoms	0
:	0
a	0
study	0
of	I-DISEASE
athletes	I-DISEASE
and	0
other	0
travellers	0
.	0

Br	0
J	0
Sports	0
Med	0
2002;36:54–60	0
.	I-DISEASE

Circadian	0
Sleep	I-DISEASE
-	0
Wake	0
Disorder	0
Not	I-DISEASE
Otherwise	I-DISEASE
Specified	0
(	0
NOS	0
)	0
ICD-9	0
-	0
CM	0
code	I-DISEASE
:	0
327.30	0
ICD-10	I-DISEASE
-	0
CM	0
code	0
:	0
G47.20	0
Patients	0
who	I-DISEASE
meet	I-DISEASE
all	0
of	0
the	0
general	0
diagnostic	I-DISEASE
criteria	0
for	0
a	0
CRSWD	0
but	0
do	0
not	I-DISEASE
meet	I-DISEASE
criteria	0
for	0
one	0
of	0
the	0
specific	0
types	0
of	I-DISEASE
circadian	B-DISEASE
rhythm	0
sleep	0
-	0
wake	0
disorders	I-DISEASE
are	0
clas-	0
sified	0
here	0
.	0

This	0
diagnosis	0
is	0
intended	0
primarily	0
for	0
patients	0
with	0
alterations	I-DISEASE
in	0
circa-	0
dian	0
sleep	0
-	0
wake	0
patterns	I-DISEASE
due	0
to	I-DISEASE
underlying	0
medical	0
,	0
neurologic	0
,	0
and	0
psychiatric	I-DISEASE
dis-	0
orders	0
.	0

The	0
underlying	0
neurological	0
,	0
psychiatric	0
,	I-DISEASE
or	I-DISEASE
medical	0
condition	I-DISEASE
is	0
typically	0
the	0
precipitating	0
factor	0
.	I-DISEASE

Patients	0
may	0
present	0
with	0
a	0
variety	0
of	I-DISEASE
symptoms	0
,	I-DISEASE
including	0
dis-	0
turbed	0
nocturnal	0
sleep	0
and	I-DISEASE
excessive	0
sleepiness	0
.	I-DISEASE

The	0
sleep	0
-	0
wake	I-DISEASE
pattern	0
may	0
range	B-DISEASE
from	0
alterations	0
in	0
the	0
phase	I-DISEASE
of	0
the	0
sleep	I-DISEASE
-	I-DISEASE
wake	0
cycle	I-DISEASE
to	0
irregular	0
sleep	0
-	I-DISEASE
wake	I-DISEASE
pattern	I-DISEASE
.	0

Recordings	0
of	0
sleep	0
logs	I-DISEASE
and	0
actigraphy	I-DISEASE
over	I-DISEASE
a	I-DISEASE
period	I-DISEASE
of	0
at	0
least	0
seven	I-DISEASE
days	I-DISEASE
,	I-DISEASE
preferably	0
for	0
14	I-DISEASE
days	0
or	I-DISEASE
longer	0
,	0
demonstrate	0
sleep	0
onsets	I-DISEASE
and	0
sleep	I-DISEASE
offsets	I-DISEASE
that	0
may	I-DISEASE
be	I-DISEASE
delayed	I-DISEASE
or	0
advanced	0
relative	0
to	0
conventional	I-DISEASE
times	0
,	0
irregular	I-DISEASE
or	0
non-24	0
-	0
hour	0
.	I-DISEASE

Sleep	0
-	0
wake	0
disturbances	I-DISEASE
are	0
common	I-DISEASE
in	I-DISEASE
patients	0
with	0
neurodegenerative	I-DISEASE
disorders	0
(	0
Alzheimer	I-DISEASE
disease	0
,	I-DISEASE
Parkinson	0
disease	0
,	I-DISEASE
Huntington	0
disease	0
)	0
,	0
as	0
well	0
as	I-DISEASE
neurodevelop-	0
mental	I-DISEASE
disorders	I-DISEASE
.	0

Sleep	0
-	0
wake	0
disturbances	I-DISEASE
associated	0
with	I-DISEASE
these	I-DISEASE
disorders	0
may	0
exhibit	0
some	0
features	0
of	0
irregular	0
sleep	I-DISEASE
-	0
wake	I-DISEASE
patterns	I-DISEASE
,	I-DISEASE
but	0
do	0
not	0
have	0
a	I-DISEASE
consistent	0
pattern	0
of	0
at	0
least	0
three	I-DISEASE
sleep	I-DISEASE
periods	0
per	0
day	0
.	0

The	0
particular	0
features	0
of	0
this	0
disorder	0
vary	I-DISEASE
with	0
the	0
type	I-DISEASE
of	0
underlying	0
medical	0
,	0
psychiatric	0
,	0
or	0
neurological	0
condition	0
.	0

The	0
disruption	0
of	0
the	0
sleep	I-DISEASE
-	I-DISEASE
wake	I-DISEASE
cycle	I-DISEASE
has	0
been	0
implicated	0
in	0
the	0
etiology	0
of	I-DISEASE
sundowning	0
and	0
noc-	I-DISEASE
turnal	0
wandering	I-DISEASE
in	0
older	0
adults	0
with	0
dementia	I-DISEASE
.	0

Patients	0
with	0
Parkinson	B-DISEASE
disease	0
may	0
exhibit	0
various	0
types	0
of	I-DISEASE
circadian	I-DISEASE
-	0
rhythm	0
alterations	0
.	0

In	0
addition	0
,	0
motor	0
fluctuations	0
can	0
exhibit	I-DISEASE
marked	0
diurnal	0
fluctuation	0
in	0
patients	0
with	0
Parkinson	0
disease	0
.	I-DISEASE

Parasomnias	0
NREM	0
-	0
Related	0
Parasomnias	0
Disorders	I-DISEASE
of	0
Arousal	0
(	I-DISEASE
From	0
NREM	0
Sleep)228	0

Confusional	0
Arousals229	0
Sleepwalking	0
229	0
Sleep	0
Terrors	I-DISEASE
230	0
Sleep	0
Related	0
Eating	0
Disorder	0
240	0
REM	I-DISEASE
-	0
Related	0
Parasomnias	I-DISEASE
REM	0
Sleep	I-DISEASE
Behavior	I-DISEASE
Disorder246	0

Recurrent	0
Isolated	0
Sleep	0
Paralysis	0
254	0
Nightmare	0
Disorder	I-DISEASE
257	0
Other	I-DISEASE
Parasomnias	0
Exploding	0
Head	0
Syndrome264	0
Sleep	0
Related	I-DISEASE
Hallucinations267	I-DISEASE
Sleep	0
Enuresis	I-DISEASE
270	0
Parasomnia	0
Due	0
to	0
a	I-DISEASE
Medical	I-DISEASE
Disorder276	0
Parasomnia	0

Due	0
to	0
a	0
Medication	0
or	I-DISEASE
Substance	0
276	0
Parasomnia	0
,	I-DISEASE
Unspecified	0
278	0
Isolated	0
Symptoms	0
and	0
Normal	I-DISEASE
Variants	0
Sleep	0
Talking	I-DISEASE
279	0
Parasomnias	0
are	I-DISEASE
undesirable	0
physical	0
events	0
or	I-DISEASE
experiences	0
that	0
occur	0
during	0
entry	0
into	I-DISEASE
sleep	0
,	0
within	0
sleep	0
,	0
or	0
during	0
arousal	0
from	0
sleep	0
.	I-DISEASE

Parasomnias	0
may	0
occur	0
during	0
non	0
-	I-DISEASE
rapid	0
eye	0
movement	I-DISEASE
sleep	0
(	0
NREM	0
)	0
,	0
rapid	I-DISEASE
eye	I-DISEASE
movement	0
sleep	0
(	0
REM	I-DISEASE
)	0
,	0
or	0
during	0
transitions	I-DISEASE
to	0
and	0
from	0
sleep	I-DISEASE
.	0

Parasomnias	0
encompass	0
abnormal	0
sleep	0
related	0
complex	0
movements	0
,	0
behaviors	0
,	0
emo-	0
tions	I-DISEASE
,	0
perceptions	0
,	I-DISEASE
dreams	0
,	0
and	0
autonomic	0
nervous	0
system	0
activity	0
.	0

Parasomnias	0
are	0
clinical	0
disorders	0
because	0
of	I-DISEASE
the	I-DISEASE
resulting	0
injuries	I-DISEASE
,	0
sleep	0
disruption	I-DISEASE
,	0
adverse	0
health	I-DISEASE
effects	I-DISEASE
,	0
and	I-DISEASE
untoward	0
psychosocial	0
effects	0
.	0

The	0
clinical	0
consequences	0
of	0
the	0
parasom-	I-DISEASE
nias	0
can	0
affect	0
the	0
patient	0
,	0
the	0
bed	0
partner	I-DISEASE
,	0
or	0
both	I-DISEASE
.	0

Human	0
consciousness	0
consists	0
of	0
three	0
essential	0
states	0
:	0
Wake	I-DISEASE
,	0
NREM	0
sleep	0
,	0
and	0
REM	I-DISEASE
sleep	0
.	0

The	0
three	0
states	0
are	I-DISEASE
modulated	0
by	0
a	I-DISEASE
host	0
of	I-DISEASE
influences	0
including	0
the	0
degree	0
of	0
ami-	I-DISEASE
nergic	I-DISEASE
and	0
cholinergic	B-DISEASE
neurochemical	0
bias	0
,	0
central	0
nervous	0
system	0
(	I-DISEASE
CNS	0
)	0
activation	I-DISEASE
,	0
Parasomnias	0
and	I-DISEASE
the	0
degree	0
of	0
endogenous	0
versus	0
exogenous	I-DISEASE
input	0
.	I-DISEASE

Under	0
normal	0
physiologic	0
conditions	0
,	I-DISEASE
which	I-DISEASE
include	I-DISEASE
homeostatic	0
drive	I-DISEASE
and	0
circadian	I-DISEASE
rhythmicity	0
,	0
the	0
process	I-DISEASE
of	0
state	0
declaration	I-DISEASE
is	B-DISEASE
maintained	0
in	0
a	0
stable	I-DISEASE
and	0
predictable	I-DISEASE
fashion	0
throughout	0
a	I-DISEASE
24	0
-	0
hour	0
period	0
.	0

However	0
,	I-DISEASE
as	0
the	0
sleep	I-DISEASE
-	I-DISEASE
wake	I-DISEASE
cycle	I-DISEASE
oscillates	0
,	0
the	I-DISEASE
normally	I-DISEASE
distinct	0
states	0
of	I-DISEASE
con-	0
sciousness	0
may	I-DISEASE
be	0
rendered	I-DISEASE
into	0
a	0
state	0
that	0
is	I-DISEASE
not	0
fully	0
declared	0
,	0
resulting	0
in	I-DISEASE
a	0
tempo-	0
rary	0
unstable	0
state	0
of	0
dissociation	0
.	0

Thus	0
,	0
sleep	0
and	I-DISEASE
wake	0
can	I-DISEASE
be	0
viewed	0
as	0
occurring	0
on	0
a	0
spectrum	0
rather	0
than	I-DISEASE
being	0
entirely	0
dichotomous	I-DISEASE
states	0
.	0

Parasomnias	0
are	0
the	0
result	0
of	0
such	0
state	0
dissociation	0
.	I-DISEASE

Recent	0
research	0
has	0
shown	0
that	0
com-	I-DISEASE
binations	0
of	0
one	I-DISEASE
or	I-DISEASE
more	0
of	0
these	0
states	0
do	I-DISEASE
occur	0
and	I-DISEASE
may	B-DISEASE
result	0
in	I-DISEASE
unstable	0
states	0
of	0
altered	0
consciousness	I-DISEASE
manifesting	0
as	I-DISEASE
parasomnias	0
.	0

Disorders	0
of	0
arousal	0
,	0
such	0
as	I-DISEASE
sleepwalking	I-DISEASE
,	0
sleep	I-DISEASE
terrors	0
,	0
and	0
confusional	0
arousals	0
are	0
an	I-DISEASE
admixture	0
of	I-DISEASE
wakefulness	0
and	0
NREM	0
sleep	0
.	0

Higher	0
cognitive	0
function	0
is	0
severely	0
impaired	I-DISEASE
,	0
if	0
not	0
absent	I-DISEASE
,	0
while	0
the	0
potential	0
for	I-DISEASE
motor	0
capacity	I-DISEASE
has	I-DISEASE
,	0
for	0
the	0
most	0
part	0
,	0
been	I-DISEASE
retained	0
.	0

REM	0
sleep	0
behavior	0
disorder	I-DISEASE
(	0
RBD	I-DISEASE
)	I-DISEASE
is	0
an	0
admixture	I-DISEASE
of	0
REM	0
sleep	0
coupled	I-DISEASE
with	I-DISEASE
waking	0
or	0
NREM	I-DISEASE
sleep	0
levels	I-DISEASE
of	0
tonic	0
EMG	0
activity	0
.	0

All	0
three	0
states	0
may	0
be	0
present	0
in	0
the	0
same	I-DISEASE
individual	0
as	0
an	0
overlap	I-DISEASE
of	0
disorders	I-DISEASE
.	0

The	0
comingling	0
of	0
basic	0
states	0
of	0
consciousness	I-DISEASE
is	0
the	0
result	0
of	0
different	0
forms	0
of	0
pathophysiology	I-DISEASE
.	0

In	0
disorders	0
of	0
arousal	I-DISEASE
,	0
no	0
identifiable	I-DISEASE
neuropathology	0
is	I-DISEASE
present	0
,	0
but	0
functional	0
changes	0
in	I-DISEASE
cerebral	I-DISEASE
activity	0
during	I-DISEASE
NREM	0
sleep	0
are	0
present	0
,	0
essentially	I-DISEASE
resulting	I-DISEASE
in	0
a	I-DISEASE
brain	I-DISEASE
in	0
which	I-DISEASE
certain	0
areas	I-DISEASE
are	0
deactivated	0
(	0
asleep	0
)	0
and	I-DISEASE
others	0
remain	I-DISEASE
activated	I-DISEASE
(	I-DISEASE
awake	0
)	0
.	I-DISEASE

This	0
CNS	0
activation	I-DISEASE
,	0
with	0
concomitant	0
skeletal	I-DISEASE
muscle	I-DISEASE
and	I-DISEASE
auto-	0
nomic	0
nervous	0
system	I-DISEASE
activation	0
,	I-DISEASE
is	I-DISEASE
believed	I-DISEASE
to	I-DISEASE
reflect	0
a	I-DISEASE
functional	0
disabling	0
of	0
,	0
or	I-DISEASE
damage	I-DISEASE
to	0
,	I-DISEASE
brain	0
areas	0
usually	I-DISEASE
responsible	I-DISEASE
for	0
the	0
inhibition	0
of	0
these	0
activities	0
during	I-DISEASE
sleep	0
.	0

Additionally	0
,	0
sleep	0
inertia	I-DISEASE
,	0
sleep	I-DISEASE
state	0
instability	0
,	I-DISEASE
and	0
locomotor	I-DISEASE
/	0
central	I-DISEASE
pattern	I-DISEASE
generators	0
are	0
thought	0
to	0
contribute	B-DISEASE
to	0
the	0
occurrence	0
of	0
NREM	0
parasomnias	I-DISEASE
.	0

NREM	0
disorders	0
of	0
arousal	I-DISEASE
frequently	0
appear	I-DISEASE
to	I-DISEASE
involve	0
the	I-DISEASE
disinhibition	0
of	0
“	I-DISEASE
basic	0
drive	0
states	0
”	0
such	0
as	I-DISEASE
feeding	0
,	0
sex	0
,	0
and	0
aggression	0
.	I-DISEASE

Here	0
,	I-DISEASE
it	0
has	0
been	0
postulated	0
that	I-DISEASE
central	0
pattern	I-DISEASE
generators	0
elicit	0
primal	0
fixed	0
action	0
patterns	I-DISEASE
that	0
would	0
otherwise	I-DISEASE
have	0
been	0
inhibited	0
by	0
the	0
prefrontal	0
cortex	0
during	I-DISEASE
wake	0
.	I-DISEASE

In	0
this	0
regard	0
,	0
aggression	0
is	0
typ-	I-DISEASE
ically	0
abrupt	0
in	I-DISEASE
onset	0
and	0
characterized	0
by	0
apparent	0
instinctual	0
defensive	0
posturing	I-DISEASE
as	0
opposed	0
to	0
behaviors	0
that	0
are	0
complex	I-DISEASE
and	0
procedural	0
.	I-DISEASE

These	0
can	0
emerge	0
in	0
pathologic	0
forms	0
with	0
the	0
parasomnias	I-DISEASE
,	0
as	0
seen	0
with	0
sleep	0
related	I-DISEASE
aggression	I-DISEASE
and	0
locomotion	I-DISEASE
,	0
sleep	0
related	0
eating	I-DISEASE
disorder	0
(	0
SRED	I-DISEASE
)	0
,	0
and	I-DISEASE
abnormal	I-DISEASE
sleep	I-DISEASE
related	0
sexual	I-DISEASE
behaviors	0
.	0

In	0
contrast	0
,	0
RBD	0
often	0
results	0
from	I-DISEASE
serious	0
neuropathology	0
.	0

Initially	0
,	0
this	0
neuropathology	0
affects	0
the	0
area	I-DISEASE
of	0
the	I-DISEASE
brain	I-DISEASE
responsible	0
for	0
inhibiting	I-DISEASE
muscle	0
tone	0
during	0
REM	0
sleep	I-DISEASE
.	0

As	0
a	0
result	0
,	0
dreams	0
may	I-DISEASE
be	0
enacted	0
.	I-DISEASE

In	0
the	0
case	I-DISEASE
of	0
REM	0
-	0
related	0
behaviors	0
,	I-DISEASE
the	0
experience	0
and	I-DISEASE
activity	0
reflect	0
the	I-DISEASE
actual	0
,	I-DISEASE
often	I-DISEASE
aggressive	0
content	0
of	0
a	0
dream	0
.	0

It	0
is	0
frequently	0
pos-	0
sible	0
to	0
correlate	I-DISEASE
observed	0
movements	0
with	0
later	0
descriptions	0
of	0
the	0
dream	I-DISEASE
.	0

The	0
initial	0
appearance	0
of	0
RBD	0
symptoms	I-DISEASE
is	0
often	0
followed	I-DISEASE
years	I-DISEASE
later	0
by	I-DISEASE
the	0
development	0
of	I-DISEASE
neu-	0
rodegenerative	0
disorders	I-DISEASE
,	0
particularly	0
Parkinson	0
disease	0
and	0
related	0
synucleinopathies	I-DISEASE
.	I-DISEASE

Abnormal	0
sleep	0
related	0
movements	I-DISEASE
comprise	0
a	I-DISEASE
separate	I-DISEASE
category	0
of	I-DISEASE
disorders	0
,	0
which	0
is	0
detailed	0
in	I-DISEASE
the	I-DISEASE
sleep	0
related	I-DISEASE
movement	0
disorders	I-DISEASE
section	0
.	I-DISEASE

Unlike	0
the	0
parasomnias	I-DISEASE
,	0
which	0
typ-	0
ically	I-DISEASE
entail	0
more	I-DISEASE
complex	0
movements	0
and	0
behavior	I-DISEASE
,	0
the	I-DISEASE
movement	0
disorders	0
encompass	0
a	0
broad	0
range	0
of	0
predominantly	0
simple	0
motoric	I-DISEASE
activities	I-DISEASE
:	0
myoclonic	I-DISEASE
,	0
repetitive	0
,	0
rocking	I-DISEASE
,	0
rhythmic	0
,	0
grinding	0
,	0
cramping	I-DISEASE
,	0
fragmentary	0
,	0
dystonic	I-DISEASE
,	0
or	0
dyskinetic	0
movements	0
or	I-DISEASE
tremors	0
,	0
which	I-DISEASE
are	0
not	0
usually	I-DISEASE
associated	0
with	0
dream	I-DISEASE
mentation	0
or	I-DISEASE
experiential	0
concomitants	0
.	I-DISEASE

Parasomnias	0
involve	0
sleep	0
related	0
behaviors	0
and	0
experiences	0
over	0
which	I-DISEASE
there	0
is	0
no	0
conscious	0
deliberate	0
control	I-DISEASE
.	0

There	0
are	0
ten	0
core	0
categories	0
of	0
parasomnias	I-DISEASE
listed	0
in	I-DISEASE
the	0
International	0
Classification	0
of	0
Sleep	0
Disorders	I-DISEASE
,	0
3rd	0
Edition	I-DISEASE
.	0

Only	0
one	0
of	0
the	0
core	I-DISEASE
cat-	I-DISEASE
egories	I-DISEASE
,	0
RBD	I-DISEASE
,	0
requires	0
video	0
-	0
polysomnographic	0
documentation	I-DISEASE
as	0
one	0
of	I-DISEASE
the	0
essen-	0
tial	0
diagnostic	0
criteria	0
.	0

However	0
,	I-DISEASE
for	0
most	0
of	0
the	I-DISEASE
other	I-DISEASE
parasomnias	0
,	0
polysomnographic	0
monitoring	0
can	0
provide	0
corroborative	0
documentation	I-DISEASE
in	I-DISEASE
support	0
of	0
the	0
clinical	0
diagnosis	0
.	0

Considerable	0
advances	0
have	0
taken	0
place	0
in	0
understanding	0
the	0
neurophysiologic	I-DISEASE
aspects	I-DISEASE
of	0
abnormal	0
arousals	I-DISEASE
from	0
slow	0
wave	0
sleep	0
associated	I-DISEASE
with	0
the	0
disorders	0
of	0
arousal	I-DISEASE
.	0

Advances	0
in	0
the	0
clinical	I-DISEASE
understanding	0
of	I-DISEASE
these	I-DISEASE
NREM	0
sleep	0
parasomnias	0
have	0
occurred	I-DISEASE
as	0
well	0
,	0
particularly	0
in	I-DISEASE
regard	0
to	0
their	0
prevalence	0
and	0
severity	I-DISEASE
in	0
adults	I-DISEASE
.	0

In	0
regard	0
to	0
RBD	0
,	0
long	0
-	I-DISEASE
term	0
delayed	I-DISEASE
emergence	0
of	0
neurodegeneration	I-DISEASE
has	0
frequently	0
been	I-DISEASE
found	0
in	0
middle	0
-	0
aged	0
and	0
older	0
adults	0
following	0
onset	I-DISEASE
of	0
RBD	I-DISEASE
.	0

When	0
combined	0
with	0
thorough	0
clinical	0
interviews	0
,	I-DISEASE
video	0
-	I-DISEASE
polysomnography	0
a	0
powerful	0
discriminating	0
tool	0
for	I-DISEASE
identifying	I-DISEASE
the	0
cause	I-DISEASE
of	0
sleep	I-DISEASE
related	0
injury	0
in	0
adults	0
.	I-DISEASE

Bibliography	0
Cramer	0
Bornemann	0
MA	0
,	I-DISEASE
Mahowald	I-DISEASE
MW	I-DISEASE
.	0

Sleep	0
forensics	I-DISEASE
.	0

In	0
:	0
Kryger	0
MH	0
,	I-DISEASE
Roth	0
T	I-DISEASE
,	0
Dement	I-DISEASE
WC	0
,	0
eds	0
.	0

Principles	0
and	I-DISEASE
practice	0
of	I-DISEASE
sleep	0
medicine	I-DISEASE
,	I-DISEASE
5th	0
ed	I-DISEASE
.	0

Philadelphia	0
:	0
Elsevier	0
Saunders	0
,	0
2010	0
.	I-DISEASE

Hobson	0
JA	0
.	0

REM	0
sleep	0
and	0
dreaming	I-DISEASE
:	0
towards	I-DISEASE
a	I-DISEASE
theory	0
of	I-DISEASE
protoconsciousness	0
.	0

Nat	0
Rev	0
Neurosci	0
2009;10:803–13	0
.	0

Ohayon	0
M	0
,	0
Caulet	0
M	0
,	0
Priest	I-DISEASE
R.	0
Violent	I-DISEASE
behavior	0
during	0
sleep	0
.	0

J	0
Clin	0
Psychiatry	I-DISEASE
1997;58:369–76	0
.	0

Ohayon	0
M	I-DISEASE
,	0
Mahowald	0
M	0
,	0
Dauvilliers	I-DISEASE
Y	0
,	I-DISEASE
Krystal	0
A	0
,	I-DISEASE
Leger	0
D.	0
Prevalence	I-DISEASE
and	0
comorbidity	0
of	I-DISEASE
nocturnal	0
wandering	0
in	0
the	0
US	I-DISEASE
adult	0
general	I-DISEASE
population	0
.	I-DISEASE

Neurology	0
2012;78:1583–9	0
.	0

Schenck	0
C	0
,	I-DISEASE
Milner	0
D	I-DISEASE
,	I-DISEASE
Hurwitz	I-DISEASE
T	0
,	I-DISEASE
Bundlie	0
S	0
,	0
Mahowald	0
M.	0
A	I-DISEASE
polysomnographic	I-DISEASE
and	I-DISEASE
clinical	I-DISEASE
report	0
on	0
sleep	0
related	0
injury	0
in	I-DISEASE
100	0
adult	0
patients	I-DISEASE
.	I-DISEASE

Am	0
J	0
Psychiatry	0
1989;146:1166–73	0
.	0

Siclari	0
F	0
,	0
Khatami	0
R	0
,	0
Urbaniok	I-DISEASE
F	0
,	I-DISEASE
et	0
al	0
.	0

Violence	0
in	0
sleep	0
.	I-DISEASE

Brain	0
2010;133:3494–509	0
.	0

Tassinari	0
C	0
,	0
Rubboli	0
G	I-DISEASE
,	0
Gardella	0
E	0
,	0
et	0
al	0
.	0

Central	0
pattern	0
generators	0
for	0
a	0
common	I-DISEASE
semiology	0
in	I-DISEASE
fronto-	I-DISEASE
limbic	0
seizures	0
and	0
in	I-DISEASE
parasomnias	0
.	0

A	0
neuroethologic	0
approach	0
.	0

Neurol	0
Sci	0
2005;26	0
:	0
s225–32	0
.	0

Parasomnias	0
Parasomnias	0
NREM	0
-	0
Related	0
Parasomnias	I-DISEASE
Disorders	0
of	0
Arousal	0
(	0
From	0
NREM	0
Sleep	0
)	0

This	0
group	0
of	0
NREM	I-DISEASE
-	0
related	0
disorders	I-DISEASE
,	0
which	I-DISEASE
includes	0
confusional	0
arousals	I-DISEASE
,	0
sleep-	I-DISEASE
walking	I-DISEASE
,	0
and	I-DISEASE
sleep	I-DISEASE
terrors	I-DISEASE
,	0
arise	0
as	0
a	0
result	I-DISEASE
of	0
incomplete	I-DISEASE
arousals	0
from	I-DISEASE
deep	0
sleep	0
.	0

The	0
conditions	0
share	0
:	0
(	0
1	I-DISEASE
)	0
similar	I-DISEASE
genetic	I-DISEASE
and	0
familial	0
patterns	0
;	I-DISEASE
(	0
2	I-DISEASE
)	I-DISEASE
similar	0
pathophysiology	I-DISEASE
of	I-DISEASE
partial	I-DISEASE
arousals	0
from	I-DISEASE
deep	I-DISEASE
sleep	0
;	I-DISEASE
and	0
(	I-DISEASE
3	I-DISEASE
)	0
similar	0
priming	0
by	I-DISEASE
sleep	0
deprivation	0
and	0
biopsychosocial	0
stressors	I-DISEASE
.	I-DISEASE

Disorders	0
of	0
arousal	0
are	0
:	0
(	I-DISEASE
1	I-DISEASE
)	0
not	I-DISEASE
secondary	0
to	I-DISEASE
psychiatric	I-DISEASE
disorders	0
;	0
(	0
2	0
)	0
not	I-DISEASE
generally	0
secondary	I-DISEASE
to	0
neuropathology	0
or	0
head	0
injury	I-DISEASE
;	0
(	0
3	I-DISEASE
)	0
associated	0
with	0
absent	0
or	0
minimal	0
cognitive	0
functioning	0
;	0
(	0
4	0
)	0
associated	0
with	I-DISEASE
amnesia	0
for	0
the	0
prior	I-DISEASE
episode	0
;	0
and	0
(	0
5	0
)	I-DISEASE
may	0
be	0
triggered	0
by	0
sound	0
,	I-DISEASE
touch	I-DISEASE
,	0
or	I-DISEASE
other	0
stimuli	0
.	0

General	0
Diagnostic	0
Criteria	0
for	I-DISEASE
Disorders	0
of	0
Arousal	I-DISEASE
Criteria	0
A	I-DISEASE
-	0
E	0
must	0
be	0
met	0
A.	I-DISEASE
Recurrent	I-DISEASE
episodes	0
of	I-DISEASE
incomplete	0
awakening	I-DISEASE
from	0
sleep.1	0
B.	0
Inappropriate	0
or	I-DISEASE
absent	0
responsiveness	0
to	0
efforts	B-DISEASE
of	0
others	0
to	I-DISEASE
intervene	0
or	0
redirect	0
the	0
person	I-DISEASE
during	0
the	0
episode	I-DISEASE
.	0

C.	0
Limited	I-DISEASE
(	0
e.g.	I-DISEASE
,	0
a	0
single	0
visual	0
scene	0
)	0
or	0
no	0
associated	0
cognition	0
or	I-DISEASE
dream	0
imagery	0
.	0

D.	0
Partial	0
or	0
complete	I-DISEASE
amnesia	0
for	0
the	I-DISEASE
episode	0
.	0

E.	0

The	0
disturbance	0
is	0
not	0
better	I-DISEASE
explained	I-DISEASE
by	I-DISEASE
another	0
sleep	I-DISEASE
disorder	I-DISEASE
,	0
mental	0
disorder	I-DISEASE
,	0
medical	I-DISEASE
condition	0
,	I-DISEASE
medication	I-DISEASE
,	0
or	0
substance	0
use	0
.	0

Notes	0
.	0

The	0
events	0
usually	0
occur	0
during	0
the	0
first	I-DISEASE
third	0
of	I-DISEASE
the	0
major	0
sleep	0
episode	I-DISEASE
.	0
.	0

The	0
individual	0
may	0
continue	0
to	0
appear	0
confused	0
and	0
disoriented	I-DISEASE
for	0
several	0
minutes	0
or	0
longer	0
following	I-DISEASE
the	0
episode	0
.	I-DISEASE

Confusional	0
Arousals	0
ICD-9	0
-	0
CM	0
code	I-DISEASE
:	0
327.41	0
Alternate	0
Names	0
Elpenor	0
syndrome	0
.	I-DISEASE

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
C	I-DISEASE
must	0
be	0
met	I-DISEASE
ICD-10	0
-	0
CM	0
code	0
:	0

G47.51	0
Sleepwalking	0
ICD-9	0
-	0
CM	0
code	I-DISEASE
:	I-DISEASE
307.46	0
Alternate	0
Names	0
Somnambulism	0
.	0

Diagnostic	0
Criteria	0
Criteria	0
A	0
and	0
B	I-DISEASE
must	I-DISEASE
be	0
met	I-DISEASE
ICD-10	0
-	0
CM	0
code	0
:	0
F51.3	0
Parasomnias	I-DISEASE
A.	0
The	0
disorder	0
meets	0
general	0
criteria	0
for	I-DISEASE
NREM	0
disorders	0
of	0
arousal	0
.	0

B.	0
The	0
episodes	0
are	0
characterized	0
by	0
mental	0
confusion	0
or	I-DISEASE
confused	0
behavior	0
that	0
occurs	0
while	0
the	I-DISEASE
patient	0
is	I-DISEASE
in	I-DISEASE
bed	0
.	0

C.	0
There	I-DISEASE
is	0
an	0
absence	0
of	I-DISEASE
terror	0
or	0
ambulation	0
outside	0
of	0
the	0
bed	0
.	0

Notes	0
.	0

There	0
is	0
typically	0
a	0
lack	0
of	0
autonomic	I-DISEASE
arousal	0
such	I-DISEASE
as	0
mydriasis	0
,	0
tachycardia	0
,	0
tachypnea	I-DISEASE
,	0
and	0
diaphoresis	I-DISEASE
during	0
an	0
episode	0
.	0

A.	0

The	0
disorder	0
meets	0
general	0
criteria	0
for	0
NREM	0
disorders	0
of	0
arousal	0
.	0

B.	0
The	0
arousals	0
are	0
associated	0
with	0
ambulation	0
and	0
other	I-DISEASE
complex	0
behaviors	0
out	0
of	0
bed	0
.	0

Parasomnias	0
Sleep	0
Terrors	0
ICD-9	0
-	0
CM	0
code	I-DISEASE
:	0
307.46	I-DISEASE
Alternate	0
Names	0
Night	0
terrors	0
,	0
pavor	I-DISEASE
nocturnus	I-DISEASE
.	0

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
C	I-DISEASE
must	0
be	0
met	I-DISEASE
ICD-10	0
-	0
CM	0
code	0
:	0

F51.4	0
A.	0
The	0
disorder	0
meets	0
general	I-DISEASE
criteria	0
for	0
NREM	I-DISEASE
disorders	0
of	0
arousal	0
.	0

B.	0
The	0
arousals	0
are	0
characterized	0
by	0
episodes	I-DISEASE
of	0
abrupt	I-DISEASE
terror	0
,	0
typically	0
beginning	0
with	0
an	I-DISEASE
alarming	0
vocalization	0
such	I-DISEASE
as	0
a	I-DISEASE
frightening	0
scream	0
.	0

C.	0
There	I-DISEASE
is	0
intense	0
fear	0
and	0
signs	I-DISEASE
of	0
autonomic	I-DISEASE
arousal	0
,	0
including	0
mydriasis	I-DISEASE
,	0
tachycardia	I-DISEASE
,	0
tachypnea	0
,	I-DISEASE
and	0
diaphoresis	0
during	0
an	0
episode	0
.	I-DISEASE

Essential	0
Features	0
Disorders	0
of	0
arousal	0
consist	0
of	I-DISEASE
complex	I-DISEASE
behaviors	I-DISEASE
that	0
are	0
usually	0
initiated	0
during	0
partial	0
arousals	I-DISEASE
from	0
slow	I-DISEASE
wave	I-DISEASE
(	0
N3	0
)	0
sleep	0
.	I-DISEASE

Most	0
episodes	0
are	0
brief	0
,	0
but	0
they	0
may	0
last	I-DISEASE
as	0
long	0
as	0
30	0
to	0
40	0
minutes	0
in	0
some	0
children	0
.	0

Sleep	0
talking	I-DISEASE
and	0
shouting	I-DISEASE
may	0
accompany	I-DISEASE
these	I-DISEASE
events	0
.	I-DISEASE

The	0
eyes	0
are	0
usually	0
open	0
during	0
an	I-DISEASE
episode	I-DISEASE
and	0
,	0
not	0
uncom-	I-DISEASE
monly	0
,	0
are	I-DISEASE
wide	I-DISEASE
open	0
with	I-DISEASE
a	0
confused	0
“	0
glassy	0
”	0
stare	I-DISEASE
.	0

The	0
patient	0
with	0
a	0
disorder	0
of	I-DISEASE
arousal	I-DISEASE
may	I-DISEASE
be	I-DISEASE
very	I-DISEASE
difficult	I-DISEASE
to	0
awaken	0
and	0
,	I-DISEASE
when	I-DISEASE
awakened	0
,	I-DISEASE
is	0
often	0
confused	0
.	0

There	0
is	0
usually	0
amnesia	0
for	0
these	0
episodes	0
,	0
although	I-DISEASE
adults	0
may	0
remember	0
fragments	0
of	0
episodes	I-DISEASE
.	0

Dream	0
-	0
like	0
mentation	0
is	0
sometimes	I-DISEASE
reported	I-DISEASE
in	0
adults	0
.	0

Other	0
high	0
-	0
level	I-DISEASE
cog-	0
nitive	I-DISEASE
functions	I-DISEASE
such	0
as	I-DISEASE
attention	0
,	0
planning	0
,	0
social	0
interaction	I-DISEASE
,	0
and	0
intent	I-DISEASE
are	0
absent	0
.	0

Because	0
disorders	0
of	0
arousal	0
usually	0
originate	0
from	0
slow	0
wave	I-DISEASE
sleep	0
,	0
they	0
most	0
often	0
emerge	I-DISEASE
in	0
the	0
first	I-DISEASE
third	0
or	0
first	0
half	0
of	0
the	0
typical	I-DISEASE
sleep	I-DISEASE
period	I-DISEASE
.	0

They	0
may	0
occur	0
during	0
other	0
times	0
of	0
increased	0
slow	I-DISEASE
wave	0
sleep	0
,	0
such	0
as	0
during	0
recovery	0
sleep	0
following	I-DISEASE
sleep	0
deprivation	0
.	0

They	0
rarely	0
arise	I-DISEASE
from	I-DISEASE
a	0
daytime	I-DISEASE
nap	I-DISEASE
.	0

Disorders	0
of	0
arousal	0
are	0
encountered	0
most	I-DISEASE
commonly	I-DISEASE
in	0
children	0
and	0
typically	0
resolve	I-DISEASE
by	I-DISEASE
puberty	0
but	I-DISEASE
may	0
persist	0
(	I-DISEASE
or	0
,	0
infrequently	0
,	0
arise	0
de	0
novo	I-DISEASE
)	0
in	0
adolescence	0
or	0
adulthood	0
.	0

Confusional	0
Arousals	0
:	0
Confusional	0
arousals	0
,	I-DISEASE
unlike	0
sleepwalking	0
,	0
occur	0
with	0
the	0
patient	0
in	0
bed	0
.	I-DISEASE

When	0
the	0
patient	I-DISEASE
leaves	I-DISEASE
the	0
bed	I-DISEASE
,	0
sleepwalking	0
has	I-DISEASE
been	0
initiated	0
.	0

Confusional	0
arousals	0
often	0
start	0
with	0
the	I-DISEASE
individual	I-DISEASE
sitting	0
up	I-DISEASE
in	I-DISEASE
bed	0
and	0
looking	0
about	0
in	0
a	I-DISEASE
confused	I-DISEASE
manner	0
.	0

Sleepwalking	0
:	0
Sleepwalking	0
episodes	0
typically	0
begin	I-DISEASE
as	I-DISEASE
confusional	0
arousals	I-DISEASE
.	0

Sleepwalking	0
episodes	0
can	0
also	I-DISEASE
begin	0
with	0
the	I-DISEASE
individual	0
immediately	I-DISEASE
leaving	I-DISEASE
the	0
bed	0
and	0
walking	I-DISEASE
or	0
even	I-DISEASE
“	0
bolting	0
”	I-DISEASE
from	0
the	0
bed	I-DISEASE
and	0
running	0
.	I-DISEASE

Highly	0
inappropriate	0
,	0
agitated	0
,	0
resistive	0
,	I-DISEASE
belligerent	0
,	I-DISEASE
or	0
violent	0
behavior	0
can	0
also	0
occur	0
.	0

Behaviors	0
can	0
be	0
simple	0
and	0
non	0
–	I-DISEASE
goal	0
-	I-DISEASE
directed	0
,	0
or	0
complex	I-DISEASE
and	0
protracted	I-DISEASE
,	0
and	0
may	I-DISEASE
involve	0
inappro-	I-DISEASE
priate	0
sexual	0
activity	0
with	0
oneself	0
or	0
an	I-DISEASE
individual	I-DISEASE
in	0
close	0
proximity	I-DISEASE
such	0
as	0
a	0
bed	0
partner	0
.	I-DISEASE

The	0
ambulation	0
may	0
terminate	0
spontaneously	0
,	0
at	I-DISEASE
times	0
in	0
inappropriate	0
places	0
,	0
or	0
the	0
sleepwalker	I-DISEASE
may	0
return	0
to	I-DISEASE
bed	I-DISEASE
,	0
lie	0
down	0
,	0
and	0
continue	0
to	0
sleep	0
without	I-DISEASE
reach-	0
ing	0
conscious	0
awareness	0
at	0
any	0
point	0
.	0

The	0
sleepwalking	0
individual	0
is	0
disoriented	0
in	I-DISEASE
time	I-DISEASE
and	0
place	I-DISEASE
,	0
with	0
slow	0
speech	0
,	0
with	0
severely	0
diminished	0
mentation	I-DISEASE
,	0
and	0
blunted	0
response	0
to	0
questions	0
or	I-DISEASE
requests	0
.	0

There	0
is	0
often	0
prominent	I-DISEASE
anterograde	0
and	0
retrograde	0
memory	0
impairment	I-DISEASE
.	0

Despite	0
diminished	0
external	0
perception	0
as	0
a	0
result	I-DISEASE
of	0
blockade	I-DISEASE
of	0
sensory	0
input	0
,	I-DISEASE
the	0
individual	I-DISEASE
may	0
appear	0
to	I-DISEASE
be	0
awake	I-DISEASE
during	0
some	0
or	0
most	0
of	0
a	0
disorder	0
of	I-DISEASE
arousal	0
with	I-DISEASE
reduced	0
vigilance	I-DISEASE
and	0
impaired	0
cognitive	0
response	0
.	0

Sleep	0
Terrors	I-DISEASE
:	0
Sleep	I-DISEASE
terrors	0
differ	I-DISEASE
from	I-DISEASE
other	0
disorders	I-DISEASE
of	0
arousal	I-DISEASE
in	0
that	I-DISEASE
the	0
events	0
are	I-DISEASE
often	I-DISEASE
accompanied	I-DISEASE
by	0
a	I-DISEASE
cry	I-DISEASE
or	0
piercing	0
scream	0
,	0
accompanied	0
by	0
autonomic	I-DISEASE
nervous	I-DISEASE
system	0
and	I-DISEASE
behavioral	I-DISEASE
manifestations	0
of	0
intense	0
fear	0
.	0

There	0
is	0
often	0
intense	I-DISEASE
autonomic	0
discharge	0
,	I-DISEASE
with	0
tachycardia	0
,	0
tachypnea	0
,	0
flushing	0
of	0
the	0
skin	0
,	0
diaphoresis	I-DISEASE
,	I-DISEASE
mydriasis	0
,	0
and	0
increased	0
muscle	0
tone	I-DISEASE
.	0

The	0
person	0
usually	0
sits	0
up	0
in	0
bed	0
;	0
is	I-DISEASE
unresponsive	0
to	0
exter-	0
nal	0
stimuli	0
;	I-DISEASE
and	0
,	0
if	I-DISEASE
awakened	0
,	0
is	0
confused	0
and	0
disoriented	0
.	I-DISEASE

However	0
,	I-DISEASE
bolting	0
out	0
of	0
bed	0
and	I-DISEASE
running	0
is	I-DISEASE
not	I-DISEASE
uncommon	0
in	I-DISEASE
adults	0
and	0
also	I-DISEASE
can	I-DISEASE
be	0
associated	I-DISEASE
with	0
violent	0
behav-	0
iors	0
,	I-DISEASE
particularly	0
if	I-DISEASE
attempts	I-DISEASE
are	I-DISEASE
made	I-DISEASE
to	0
block	I-DISEASE
or	0
restrain	I-DISEASE
the	0
individual	0
.	0

The	0
sleep	0
terror	0
episode	0
may	0
be	0
accompanied	I-DISEASE
by	0
incoherent	0
vocalizations	0
.	0

Sometimes	0
there	0
is	0
prolonged	0
inconsolability	0
associated	0
with	0
a	0
sleep	0
terror	0
in	0
children	0
or	I-DISEASE
adults	0
.	0

Associated	0
Features	0
Disorders	0
of	0
arousal	0
are	0
devoid	I-DISEASE
of	I-DISEASE
higher	I-DISEASE
cognitive	0
functions	0
such	0
as	0
planning	0
,	I-DISEASE
memory	0
from	0
before	I-DISEASE
an	0
incident	0
,	I-DISEASE
formation	0
of	0
a	0
memory	I-DISEASE
during	0
an	0
incident	I-DISEASE
,	0
true	I-DISEASE
social	0
inter-	0
action	0
,	0
or	0
recognition	I-DISEASE
of	I-DISEASE
others	I-DISEASE
.	0

Patients	0
exhibiting	0
disorders	0
of	I-DISEASE
arousal	0
are	I-DISEASE
not	I-DISEASE
con-	0
sciously	I-DISEASE
aware	0
and	0
behaviors	0
are	0
often	0
thought	I-DISEASE
to	I-DISEASE
be	0
“	I-DISEASE
automatic	0
”	0
in	0
nature	0
.	0

Self	0
-	0
injury	0
may	0
occur	0
as	0
well	0
as	0
injury	I-DISEASE
to	0
others	0
in	0
close	0
proximity	0
.	I-DISEASE

Disorders	0
of	0
arousal	0
,	0
in	0
particular	I-DISEASE
sleepwalking	I-DISEASE
,	0
can	I-DISEASE
involve	I-DISEASE
normal	0
,	0
routine	0
behav-	0
iors	0
that	0
are	0
inappropriate	I-DISEASE
only	0
in	0
regard	0
to	0
their	0
timing	0
.	I-DISEASE

More	0
often	0
,	0
however	0
,	0
sleep-	0
walking	I-DISEASE
involves	0
inappropriate	I-DISEASE
behaviors	0
,	0
such	0
as	0
urinating	0
in	I-DISEASE
a	0
wastebasket	0
,	I-DISEASE
moving	0
furniture	0
around	0
haphazardly	0
,	0
or	0
climbing	0
out	0
a	0
window	0
.	0

Sleepwalkers	0
are	0
sometimes	0
able	0
to	0
navigate	0
in	I-DISEASE
familiar	0
surroundings	I-DISEASE
,	0
but	0
are	0
prone	0
to	0
bumping	I-DISEASE
into	0
objects	0
or	0
falling	0
down	0
.	0

A	0
sudden	0
arousal	0
consistent	I-DISEASE
with	0
sleep	0
terrors	I-DISEASE
may	0
segue	I-DISEASE
rapidly	0
into	0
agitated	0
sleepwalking	0
and	0
panicky	0
running	I-DISEASE
and	0
other	I-DISEASE
potentially	0
dangerous	I-DISEASE
behav-	0
iors	0
.	I-DISEASE

Self	0
-	0
injury	0
is	0
not	0
unusual	I-DISEASE
and	0
when	0
resulting	I-DISEASE
in	0
death	0
has	0
been	0
given	0
the	I-DISEASE
term	I-DISEASE
of	0
Parasomnias	I-DISEASE
Parasomnias	0
“	0
parasomnia	0
pseudosuicide	0
.	0
”	0

Cuts	0
,	0
bruises	0
,	0
and	0
other	0
injuries	I-DISEASE
may	0
occur	I-DISEASE
—	0
often	0
to	0
the	I-DISEASE
surprise	0
of	I-DISEASE
the	0
sleepwalker	0
once	I-DISEASE
awake	I-DISEASE
.	0

Sleepwalkers	0
are	0
reported	0
to	0
have	0
a	0
high	0
tol-	0
erance	I-DISEASE
for	0
pain	0
.	0

Knife	0
cuts	0
,	I-DISEASE
burns	0
,	0
and	0
other	I-DISEASE
self	0
-	I-DISEASE
injury	0
sustained	0
during	0
sleepwalking	0
may	0
not	I-DISEASE
awaken	0
them	0
.	I-DISEASE

Violence	0
to	0
others	0
also	0
can	0
occur	0
with	0
adult	0
sleepwalking	I-DISEASE
,	0
especially	0
in	0
men	0
.	0

The	0
sleepwalker	0
does	0
not	0
generally	0
seek	0
out	I-DISEASE
the	I-DISEASE
eventual	0
victim	0
of	0
violence	0
.	I-DISEASE

More	0
typi-	0

cally	0
,	0
a	0
person	0
attempting	0
to	0
block	I-DISEASE
,	0
grab	0
,	0
restrain	0
,	0
redirect	0
or	0
awaken	I-DISEASE
a	0
sleepwalker	0
during	I-DISEASE
an	0
episode	0
may	0
be	0
violently	I-DISEASE
attacked	0
,	I-DISEASE
even	0
if	0
they	B-DISEASE
are	B-DISEASE
family	I-DISEASE
members	0
or	I-DISEASE
friends	0
.	0

This	0
may	0
result	0
in	0
a	0
form	0
of	0
primitive	0
defensive	0
aggression	0
including	0
pushing	0
,	0
hitting	0
,	I-DISEASE
kicking	0
,	0
or	0
throwing	0
objects	0
.	0

This	0
pattern	0
also	0
has	B-DISEASE
been	0
reported	0
in	0
the	0
sleep	I-DISEASE
laboratory	0
when	0
technical	0
personnel	I-DISEASE
have	0
attempted	0
to	0
return	0
sleepwalking	I-DISEASE
patients	I-DISEASE
to	0
bed	0
.	0

In	0
extreme	0
cases	I-DISEASE
,	B-DISEASE
victims	0
have	0
been	0
stabbed	0
with	I-DISEASE
knives	0
or	0
blunt	0
objects	I-DISEASE
.	0

Such	0
inappropriate	0
and	0
antisocial	0
behaviors	0
have	0
legal	I-DISEASE
and	0
forensic	0
implications	0
,	0
as	0
sleep-	I-DISEASE
walkers	0
have	I-DISEASE
been	I-DISEASE
arrested	0
and	I-DISEASE
charged	0
with	0
assault	0
and	0
battery	I-DISEASE
,	0
attempted	I-DISEASE
homicide	0
,	I-DISEASE
homicide	0
,	0
and	0
sexual	0
assault	0
with	0
indecency	0
.	0

The	0
child	0
with	0
calm	0
sleepwalking	0
may	I-DISEASE
quietly	I-DISEASE
walk	0
toward	I-DISEASE
a	0
light	0
or	0
to	0
the	0
parents	0
’	0
bedroom	I-DISEASE
.	0

Occasionally	0
,	0
children	0
will	I-DISEASE
walk	0
toward	0
a	0
window	0
or	0
door	0
or	0
even	0
go	0
outside	0
,	0
with	0
obvious	0
attendant	0
risk	0
.	0

Clinical	0
or	0
Pathophysiological	0
Subtypes	I-DISEASE
Sleep	I-DISEASE
related	I-DISEASE
abnormal	I-DISEASE
sexual	I-DISEASE
behaviors	I-DISEASE
are	0
primarily	I-DISEASE
classified	I-DISEASE
as	I-DISEASE
confusional	0
arous-	0
als	0
in	0
that	I-DISEASE
they	0
typically	0
occur	0
without	0
any	0
behaviors	I-DISEASE
outside	I-DISEASE
of	I-DISEASE
the	0
bed	0
(	I-DISEASE
or	0
chosen	I-DISEASE
sleep-	0
ing	I-DISEASE
accommodation	0
)	0
,	0
but	I-DISEASE
have	I-DISEASE
also	0
been	I-DISEASE
less	0
commonly	I-DISEASE
associated	I-DISEASE
with	0
sleepwalking	I-DISEASE
.	B-DISEASE

Other	0
terms	0
for	0
this	0
condition	0
include	I-DISEASE
“	I-DISEASE
atypical	0
sexual	I-DISEASE
behavior	0
during	0
sleep	0
,	0
”	0
“	I-DISEASE
sexsom-	0
nia	0
,	0
”	0
and	0
“	0
sleep	0
sex	0
.	0
”	I-DISEASE

Sleep	0
related	0
abnormal	I-DISEASE
sexual	0
behaviors	0
often	0
have	I-DISEASE
major	0
inter-	I-DISEASE
personal	0
,	0
clinical	0
,	0
and	0
occasional	I-DISEASE
criminal	0
consequences	0
.	I-DISEASE

The	0
set	0
of	I-DISEASE
abnormal	0
sexual	0
behaviors	0
during	0
disordered	0
arousals	I-DISEASE
includes	0
prolonged	0
or	0
violent	0
masturbation	0
,	I-DISEASE
sexual	0
molestation	0
and	I-DISEASE
assaults	0
(	0
of	0
minors	0
and	0
adults	I-DISEASE
)	I-DISEASE
,	0
initiation	I-DISEASE
of	I-DISEASE
sexual	0
intercourse	0
irre-	0
spective	I-DISEASE
of	0
the	0
menstrual	0
status	0
of	0
the	I-DISEASE
bed	0
partner	0
(	0
in	0
contrast	I-DISEASE
to	0
waking	I-DISEASE
intercourse	0
for	I-DISEASE
those	0
individuals	0
)	I-DISEASE
,	0
and	I-DISEASE
loud	0
(	0
sexual	0
)	0
vocalizations	0
during	0
sleep	0
—	0
followed	0
by	0
morning	I-DISEASE
amnesia	I-DISEASE
.	0

The	0
preponderance	0
of	0
patients	0
have	0
also	I-DISEASE
been	I-DISEASE
diagnosed	I-DISEASE
with	0
a	0
NREM	0
sleep	0
parasomnia	0
,	0
most	0
often	0
confusional	0
arousals	I-DISEASE
alone	0
but	0
on	0
occasion	0
with	0
sleepwalking	0
,	I-DISEASE
sleep	I-DISEASE
related	0
driving	I-DISEASE
,	0
or	0
sleep	0
related	0
eating	0
disorder	0
.	0

Obstructive	0
sleep	0
apnea	0
(	0
OSA	0
)	I-DISEASE
is	I-DISEASE
another	I-DISEASE
recognized	0
precipitant	0
of	0
sleep	0
related	I-DISEASE
abnormal	0
sexual	I-DISEASE
behaviors	0
.	0

The	0
presence	0
of	0
an	I-DISEASE
overlap	0
disorder	I-DISEASE
,	I-DISEASE
in	0
which	0
RBD	I-DISEASE
and	0
a	0
partial	I-DISEASE
arousal	0
disorder	I-DISEASE
(	I-DISEASE
sleepwalking	0
or	I-DISEASE
sleep	I-DISEASE
terrors	0
)	0
are	0
comorbid	I-DISEASE
in	0
a	I-DISEASE
patient	I-DISEASE
,	0
may	0
complicate	0
diagnosis	I-DISEASE
of	0
each	I-DISEASE
condition	0
.	0

Careful	0
review	0
of	0
history	0
and	0
use	0
of	I-DISEASE
polysomnography	0
may	I-DISEASE
facilitate	0
identification	0
of	0
this	0
presentation	0
.	I-DISEASE

Demographics	0
There	0
is	0
no	0
sex	0
difference	0
with	I-DISEASE
disorders	0
of	I-DISEASE
arousals	0
.	0

They	0
are	0
especially	0
prevalent	0
among	0
children	0
and	I-DISEASE
adults	0
younger	I-DISEASE
than	0
35	0
years	0
.	I-DISEASE

The	0
prevalence	0
rate	0
of	0
confusional	0
arousals	I-DISEASE
and	0
sleepwalking	0
are	I-DISEASE
similar	0
.	0

The	0
prevalence	0
of	0
confusional	0
arousals	0
in	0
children	I-DISEASE
three	0
to	0
13	I-DISEASE
years	0
of	0
age	0
in	0
a	I-DISEASE
large	0
population	0
-	0
based	0
study	0
was	0
17.3	0
%	0
.	0

Lifetime	0
prevalence	0
of	0
confusional	0
arousals	0
has	0
recently	I-DISEASE
been	0
reported	0
as	0
18.5	0
%	0
(	0
16.1	I-DISEASE
-	0
20.9	0
confidence	0
interval	I-DISEASE
)	0
.	0

The	0
prevalence	0
among	0
adults	0
older	0
than	0
15	0
years	0
is	I-DISEASE
2.9	0
%	0
to	0
4.2	0
%	0
.	0

The	0
lifetime	0
prevalence	0
of	I-DISEASE
sleepwalking	0
is	I-DISEASE
as	I-DISEASE
high	0
as	I-DISEASE
18.3	0
%	0
.	0

A	0
recent	0
study	I-DISEASE
of	I-DISEASE
“	0
noctur-	0
nal	I-DISEASE
wandering	0
”	I-DISEASE
that	0
likely	0
included	0
a	0
large	0
percentage	I-DISEASE
of	0
sleepwalkers	I-DISEASE
reported	I-DISEASE
a	0
life-	I-DISEASE
time	0
prevalence	I-DISEASE
of	0
29.2	I-DISEASE
%	0
.	0

A	0
Swedish	0
study	0
of	0
children	0
aged	I-DISEASE
6	0
-	0
16	I-DISEASE
years	0
found	0
the	0
inci-	I-DISEASE
dence	0
of	I-DISEASE
sleepwalking	0
to	0
be	I-DISEASE
40	0
%	I-DISEASE
.	0

Up	0
to	0
4.3	0
%	0
of	0
adults	0
sleepwalk	0
.	0

In	0
one	0
series	0
,	0
one	0
third	0
of	0
54	0
adult	I-DISEASE
patients	0
with	0
injurious	0
sleepwalking	0
(	0
with	0
or	I-DISEASE
without	0
night	I-DISEASE
terrors	0
)	0
began	0
sleepwalking	0
after	I-DISEASE
16	0
years	I-DISEASE
of	0
age	0
.	I-DISEASE

The	0
prevalence	0
of	0
sleep	0
terrors	0
has	0
not	I-DISEASE
been	0
studied	I-DISEASE
as	0
thoroughly	0
.	0

Prevalence	0
rates	0
of	0
1	0
%	0
to	0
6.5	0
%	0
in	0
children	0
and	0
2.2	0
%	0
in	I-DISEASE
adults	I-DISEASE
have	I-DISEASE
been	0
reported	I-DISEASE
,	0
with	0
a	0
virtually	0
constant	0
prevalence	0
rate	I-DISEASE
of	0
2.3	0
%	I-DISEASE
to	0
2.6	I-DISEASE
%	0
in	I-DISEASE
the	0
15	0
-	0
year	0
-	0
old	I-DISEASE
to	0
64	0
-	0
year	0
-	I-DISEASE
old	0
age	I-DISEASE
group	0
,	I-DISEASE
before	0
falling	0
to	I-DISEASE
1	0
%	0
in	I-DISEASE
the	0
older	0
than	0
65	0
years	I-DISEASE
age	0
group	0
.	0

Other	0
studies	0
have	0
reported	0
the	0
intermittent	I-DISEASE
appearance	0
of	0
sleep	I-DISEASE
terrors	0
in	0
25	0
%	0
of	0
children	0
younger	0
than	0
five	I-DISEASE
years	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
Disorders	0
of	I-DISEASE
arousal	I-DISEASE
are	0
most	I-DISEASE
often	0
evaluated	0
in	I-DISEASE
terms	0
of	0
predisposing	0
,	I-DISEASE
priming	I-DISEASE
,	I-DISEASE
and	0
precipitating	I-DISEASE
(	0
triggering	0
)	0
factors	I-DISEASE
.	I-DISEASE

Most	0
often	0
a	0
simultaneous	0
co	I-DISEASE
-	I-DISEASE
occurrence	I-DISEASE
of	0
these	I-DISEASE
factors	0
is	0
thought	0
necessary	0
in	0
order	0
for	0
a	0
disorder	0
of	0
arousal	0
occur	0
.	0

However	0
,	0
the	0
reason	0
a	0
disorder	0
of	I-DISEASE
arousal	0
occurs	I-DISEASE
on	0
one	0
night	0
and	I-DISEASE
not	0
others	I-DISEASE
is	0
not	0
fully	I-DISEASE
understood	0
.	0

A	0
genetic	0
predisposition	0
has	0
been	0
hypothesized	I-DISEASE
and	0
several	0
studies	I-DISEASE
have	0
identified	0
dif-	0
ferent	0
genetic	0
loci	I-DISEASE
and	0
modes	0
of	0
inheritance	0
(	0
see	0
Familial	0
Pattern	0
,	I-DISEASE
below	0
)	I-DISEASE
.	0

In	0
childhood	0
,	0
disorder	0
of	0
arousal	I-DISEASE
can	I-DISEASE
usually	0
be	I-DISEASE
considered	I-DISEASE
an	0
expected	0
and	0
normal	0
developmental	I-DISEASE
sleep	0
phenomenon	I-DISEASE
,	I-DISEASE
apart	0
from	0
those	0
cases	0
with	I-DISEASE
clinical	0
consequences	I-DISEASE
.	I-DISEASE

However	0
,	I-DISEASE
dis-	0
orders	0
of	0
arousal	0
that	I-DISEASE
persist	0
beyond	I-DISEASE
adolescence	0
or	0
begin	0
in	0
adulthood	0
can	I-DISEASE
often	0
be	0
problematic	0
and	0
may	I-DISEASE
require	0
clinical	0
attention	0
.	0

Parasomnias	0
Parasomnias	0
Many	0
priming	0
factors	0
for	I-DISEASE
disorders	I-DISEASE
of	0
arousal	0
,	0
in	I-DISEASE
particular	0
sleepwalking	0
,	0
have	I-DISEASE
been	0
identified	0
.	I-DISEASE

Sleep	0
deprivation	0
and	I-DISEASE
situational	I-DISEASE
stress	0
are	0
the	I-DISEASE
most	0
potent	I-DISEASE
factors	0
.	0

Hyperthyroidism	0
,	0
migraines	0
,	0
head	0
injury	0
,	I-DISEASE
encephalitis	I-DISEASE
,	I-DISEASE
stroke	0
,	0
and	0
other	0
conditions	0
have	0
also	0
been	0
reported	I-DISEASE
much	0
more	0
rarely	0
as	0
potential	I-DISEASE
priming	0
factors	0
.	0

OSA	0
and	0
other	0
sleep	0
related	0
respiratory	I-DISEASE
events	I-DISEASE
are	0
increasingly	I-DISEASE
recognized	0
precipitants	0
of	0
disorders	I-DISEASE
of	0
arousal	I-DISEASE
in	0
both	0
children	I-DISEASE
and	0
adults	I-DISEASE
.	0

Treatment	0
of	0
these	0
comorbid	0
con-	0
ditions	0
may	I-DISEASE
reduce	0
or	I-DISEASE
eliminate	0
the	0
occurrence	0
of	0
disorders	0
of	0
arousal	I-DISEASE
.	0

Disorders	0
of	0
arousal	0
may	0
also	0
be	I-DISEASE
triggered	B-DISEASE
by	0
environmental	I-DISEASE
stimuli	0
such	0
as	0
telephone	0
calls	0
,	I-DISEASE
pagers	0
,	0
messaging	I-DISEASE
from	0
electronic	0
devices	0
,	0
and	0
a	0
host	B-DISEASE
of	0
other	0
stimuli	I-DISEASE
.	0

It	0
is	0
clinically	0
important	0
to	0
note	I-DISEASE
that	I-DISEASE
first	0
responders	I-DISEASE
,	0
physicians	0
,	0
and	0
others	0
on	I-DISEASE
call	I-DISEASE
may	0
be	0
vulnerable	0
to	0
such	0
stimuli	0
,	0
increasing	0
the	0
potential	0
for	0
inappropriate	I-DISEASE
responses	B-DISEASE
and	0
behavior	0
.	0

Travel	0
,	0
sleeping	0
in	0
unfamiliar	0
surroundings	0
,	I-DISEASE
febrile	0
states	I-DISEASE
in	0
children	0
,	0
physical	0
or	0
emo-	I-DISEASE
tional	0
stress	0
in	0
adults	0
,	0
the	0
premenstrual	0
period	I-DISEASE
in	I-DISEASE
women	0
,	0
as	0
well	I-DISEASE
as	0
the	I-DISEASE
use	I-DISEASE
of	I-DISEASE
psycho-	0
tropic	0
medications	0
such	0
as	0
lithium	0
carbonate	0
,	0
phenothiazines	I-DISEASE
,	0
anticholinergic	0
agents	0
,	I-DISEASE
and	0
sedative	I-DISEASE
/	I-DISEASE
hypnotic	0
agents	0
have	0
been	0
associated	I-DISEASE
with	I-DISEASE
the	0
onset	0
of	0
sleepwalking	I-DISEASE
,	I-DISEASE
but	0
a	0
causal	0
relationship	I-DISEASE
has	I-DISEASE
yet	0
to	0
be	0
established	0
.	0

Alcohol	0
has	0
been	0
identified	0
in	0
previous	0
reports	0
as	0
a	I-DISEASE
potential	0
sleepwalking	0
trigger	0
.	0

However	0
,	0
the	0
amnesia	0
associated	0
with	0
dis-	0
orders	0
of	0
arousal	0
makes	0
these	0
reports	0
unreliable	0
.	I-DISEASE

More	0
recent	0
evidence	0
-	0
based	0
reviews	0
have	I-DISEASE
found	0
no	I-DISEASE
compelling	0
relationship	0
between	0
alcohol	0
and	0
disorders	I-DISEASE
of	0
arousal	0
.	I-DISEASE

Internal	0
stimuli	0
,	0
such	0
as	0
a	0
distended	I-DISEASE
bladder	0
,	0
or	0
external	0
stimuli	0
,	0
such	0
as	0
noise	0
or	0
light	I-DISEASE
,	0
can	0
also	0
precipitate	0
episodes	0
.	0

There	0
is	0
no	0
significant	0
association	0
between	0
childhood	I-DISEASE
disorders	0
of	I-DISEASE
arousal	0
and	0
psycho-	0
pathology	0
.	0

In	0
adult	0
sleepwalking	0
,	I-DISEASE
although	0
a	I-DISEASE
considerable	I-DISEASE
number	0
of	I-DISEASE
patients	0
may	0
have	0
a	I-DISEASE
past	0
or	0
current	I-DISEASE
history	0
of	I-DISEASE
nonpsychotic	0
depressive	0
and	0
anxiety	0
disorders	0
,	0
it	I-DISEASE
does	I-DISEASE
not	0
appear	I-DISEASE
that	0
the	0
psychiatric	0
disorder	0
and	0
sleepwalking	0
,	0
in	I-DISEASE
particular	I-DISEASE
,	0
are	0
tightly	I-DISEASE
linked	I-DISEASE
.	0

In	0
addition	0
,	0
when	0
the	0
two	I-DISEASE
conditions	I-DISEASE
emerge	0
in	I-DISEASE
close	0
temporal	0
proximity	0
,	I-DISEASE
control	0
of	I-DISEASE
the	0
psychiatric	I-DISEASE
disorder	0
often	0
does	0
not	0
control	0
the	0
parasomnia	I-DISEASE
,	0
for	0
which	0
separate	I-DISEASE
treatment	0
is	0
required	I-DISEASE
.	0

Familial	0
Pattern	0
Genetic	0
factors	0
appear	0
to	0
play	0
an	0
important	I-DISEASE
role	0
in	0
all	0
of	0
the	0
disorders	I-DISEASE
of	0
arousal	0
.	I-DISEASE

However	0
,	I-DISEASE
published	0
research	0
data	0
exist	0
primarily	I-DISEASE
for	0
patients	0
who	0
sleepwalk	0
.	0

Sleepwalking	0
has	0
a	0
familial	I-DISEASE
pattern	0
.	I-DISEASE

The	0
rate	0
of	0
childhood	I-DISEASE
sleepwalking	0
increases	I-DISEASE
in	I-DISEASE
relation	I-DISEASE
to	I-DISEASE
the	0
number	I-DISEASE
of	0
affected	I-DISEASE
parents	0
:	I-DISEASE
22	0
%	0
when	I-DISEASE
neither	0
parent	0
has	0
the	0
disor-	I-DISEASE
der	0
,	I-DISEASE
45	0
%	0
if	I-DISEASE
one	0
parent	I-DISEASE
is	0
affected	0
,	0
and	0
60	0
%	0
when	0
both	I-DISEASE
are	I-DISEASE
affected	0
.	0

Population	0
-	0
based	0
studies	0
of	0
monozygotic	I-DISEASE
and	I-DISEASE
dizygotic	0
twins	0
suggest	0
that	0
genetic	0
factors	0
play	0
a	I-DISEASE
role	0
in	I-DISEASE
65	0
%	0
of	0
cases	0
of	0
sleepwalking	0
.	I-DISEASE

Different	0
models	0
of	0
modes	0
of	I-DISEASE
inheritance	I-DISEASE
includ-	I-DISEASE
ing	0
multifactorial	I-DISEASE
,	0
recessive	0
with	0
incomplete	I-DISEASE
penetrance	0
,	I-DISEASE
and	0
autosomal	0
dominant	I-DISEASE
trait	0
with	0
reduced	0
penetrance	0
have	0
been	0
proposed	I-DISEASE
,	0
based	0
primarily	I-DISEASE
on	0
analysis	0
of	0
family	0
histories	0
.	0

However	0
,	I-DISEASE
these	0
finding	0
are	0
not	0
sufficiently	I-DISEASE
specific	0
to	I-DISEASE
be	0
used	0
for	I-DISEASE
diagnostic	0
testing	0
.	0

Further	0
,	0
the	0
mechanisms	I-DISEASE
by	0
which	0
a	I-DISEASE
genetic	0
predisposition	0
for	0
confusional	0
arousal	0
or	0
other	0
related	0
disorders	0
contributes	0
to	I-DISEASE
their	0
occurrence	0
are	0
not	0
known	0
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Confusional	I-DISEASE
arousals	0
most	0
often	0
appear	0
in	0
early	0
childhood	0
around	I-DISEASE
the	I-DISEASE
age	0
of	I-DISEASE
two	0
years	0
.	0

This	0
childhood	0
form	0
of	0
confusional	0
arousals	I-DISEASE
is	0
typically	0
benign	I-DISEASE
,	0
but	0
may	0
cause	0
concern	0
in	0
parents	0
.	0

Confusional	0
arousals	0
of	0
early	0
childhood	0
diminish	0
in	I-DISEASE
occurrence	0
after	0
the	0
age	0
of	0
five	0
years	0
.	0

Sleepwalking	0
can	0
begin	0
as	I-DISEASE
soon	0
as	0
a	I-DISEASE
child	0
is	I-DISEASE
able	0
to	0
walk	0
but	0
may	0
begin	0
at	0
almost	0
any	0
time	0
in	0
the	0
life	0
cycle	0
,	I-DISEASE
including	I-DISEASE
as	0
late	0
as	I-DISEASE
the	0
seventh	0
decade	0
.	I-DISEASE

Sleepwalking	0
is	0
often	0
preceded	0
by	0
confusional	I-DISEASE
arousals	0
.	0

Childhood	0
sleepwalking	0
usually	0
disappears	I-DISEASE
sponta-	0
neously	I-DISEASE
around	0
puberty	0
but	0
may	0
persist	0
into	0
adolescence	0
.	0

Episodes	0
can	0
occur	0
sporad-	0
ically	0
or	0
with	I-DISEASE
high	0
frequency	I-DISEASE
,	0
such	0
as	0
multiple	0
times	0
nightly	I-DISEASE
for	0
several	0
consecutive	I-DISEASE
nights	0
.	0

Sleepwalking	0
may	0
occur	0
for	I-DISEASE
the	0
first	0
time	I-DISEASE
in	I-DISEASE
adulthood	I-DISEASE
or	0
may	0
recur	I-DISEASE
in	0
adult-	0
hood	I-DISEASE
during	0
periods	0
of	I-DISEASE
sleep	0
deprivation	0
or	0
stress	0
.	0

Sleep	0
terrors	0
usually	0
emerge	I-DISEASE
in	0
children	0
aged	0
four	I-DISEASE
to	0
12	0
years	0
(	0
but	I-DISEASE
can	0
also	0
emerge	0
in	0
adulthood	0
)	0
and	I-DISEASE
tend	0
to	0
resolve	0
spontaneously	0
by	I-DISEASE
early	0
adolescence	0
,	I-DISEASE
as	0
does	0
sleep-	0
walking	0
.	0

Social	0
embarrassment	0
over	0
the	0
sleep	I-DISEASE
terrors	I-DISEASE
can	0
impair	0
social	I-DISEASE
relationships	0
in	0
children	0
and	0
adults	0
.	I-DISEASE

Serious	0
or	0
even	0
lethal	0
injuries	0
can	0
occur	I-DISEASE
.	0

Developmental	0
Issues	0
As	0
noted	0
above	0
,	0
disorders	I-DISEASE
of	0
arousal	I-DISEASE
most	0
often	0
occur	0
initially	I-DISEASE
in	0
childhood	I-DISEASE
and	0
decrease	0
in	I-DISEASE
occurrence	0
steadily	0
until	0
young	0
adulthood	I-DISEASE
.	0

However	0
,	I-DISEASE
they	0
may	0
occur	0
for	0
the	I-DISEASE
first	I-DISEASE
time	I-DISEASE
in	0
adulthood	0
or	I-DISEASE
reappear	0
after	0
many	0
asymptomatic	0
years	I-DISEASE
,	0
often	0
related	I-DISEASE
to	0
stress	0
,	I-DISEASE
sleep	I-DISEASE
deprivation	I-DISEASE
,	I-DISEASE
or	I-DISEASE
development	I-DISEASE
of	I-DISEASE
another	0
sleep	I-DISEASE
disorder	I-DISEASE
.	I-DISEASE

Pathology	0
and	0
Pathophysiology	0
The	0
overwhelming	0
majority	I-DISEASE
of	I-DISEASE
individuals	0
with	I-DISEASE
disorders	0
of	0
arousal	I-DISEASE
do	0
not	0
have	I-DISEASE
neuro-	0
logical	0
or	I-DISEASE
psychological	0
pathology	I-DISEASE
.	0

There	0
are	0
rare	0
reported	I-DISEASE
cases	0
of	I-DISEASE
confusional	I-DISEASE
arous-	0
als	I-DISEASE
associated	0
with	I-DISEASE
brain	I-DISEASE
lesions	0
in	0
areas	I-DISEASE
subserving	0
arousal	0
,	I-DISEASE
such	0
as	I-DISEASE
the	0
posterior	0
hypothalamus	0
,	I-DISEASE
midbrain	I-DISEASE
reticular	0
area	0
,	I-DISEASE
and	0
periventricular	0
gray	0
matter	0
.	0

However	0
,	I-DISEASE
data	0
from	0
a	0
single	I-DISEASE
patient	0
with	0
confusional	I-DISEASE
arousals	0
suggest	0
that	0
they	0
may	0
be	I-DISEASE
due	0
to	0
a	I-DISEASE
func-	0
tional	0
abnormality	0
in	0
the	0
brain	I-DISEASE
that	I-DISEASE
leaves	0
some	0
regions	I-DISEASE
,	0
such	I-DISEASE
as	0
hippocampus	I-DISEASE
and	0
Parasomnias	0
Parasomnias	0
frontal	0
associative	0
cortices	I-DISEASE
,	0
asleep	0
,	0
while	0
other	0
parts	0
of	0
the	0
brain	I-DISEASE
such	I-DISEASE
as	0
motor	I-DISEASE
,	0
cingu-	I-DISEASE
late	I-DISEASE
,	0
insular	0
,	0
amygdala	0
,	0
and	0
temporopolar	I-DISEASE
cortices	I-DISEASE
,	0
are	I-DISEASE
active	I-DISEASE
or	I-DISEASE
awake	I-DISEASE
.	I-DISEASE

It	0
is	0
generally	0
considered	I-DISEASE
that	0
disorders	I-DISEASE
of	I-DISEASE
arousal	0
represent	I-DISEASE
a	0
dissociation	0
of	0
different	0
regions	0
of	I-DISEASE
the	0
brain	I-DISEASE
in	I-DISEASE
addition	I-DISEASE
to	0
activation	0
of	0
locomotor	0
centers	0
/	I-DISEASE
central	I-DISEASE
pattern	0

gen-	0
erators	0
,	0
accompanied	I-DISEASE
by	0
sleep	0
inertia	I-DISEASE
and	0
sleep	I-DISEASE
state	0
instability	0
.	0

Objective	0
Findings	0

Although	0
not	0
routinely	I-DISEASE
indicated	0
for	0
the	0
evaluation	I-DISEASE
of	0
typical	I-DISEASE
,	0
uncomplicated	0
,	0
and	0
non-	0
injurious	0
parasomnias	0
,	0
polysomnographic	0
studies	0
demonstrate	0
that	0
disorders	0
of	0
arousal	0
typically	0
begin	0
after	0
an	I-DISEASE
arousal	0
from	I-DISEASE
slow	0
wave	0
sleep	0
,	0
most	0
commonly	0
toward	I-DISEASE
the	I-DISEASE
end	0
of	I-DISEASE
the	I-DISEASE
first	0
or	0
second	0
episode	I-DISEASE
of	0
slow	I-DISEASE
wave	I-DISEASE
sleep	I-DISEASE
.	I-DISEASE

Occasionally	0
,	0
disorders	0
of	0
arousal	0
can	I-DISEASE
emerge	0
from	0
stage	0
N2	0
sleep	0
.	I-DISEASE

Heart	0
rate	0
acceleration	0
,	I-DISEASE
increased	0
muscle	I-DISEASE
tone	I-DISEASE
,	0
and	I-DISEASE
muscle	0
twitching	0
may	0
rarely	0
be	0
observed	I-DISEASE
before	I-DISEASE
a	0
slow	I-DISEASE
wave	0
sleep	0
arousal	0
.	0

Diagnostic	0
polysomnography	0
may	0
note	0
high	0
-	I-DISEASE
amplitude	I-DISEASE
hypersynchronous	0
delta	0
waves	0
and	0
frequent	0
arousals	I-DISEASE
from	0
slow	I-DISEASE
wave	0
sleep	0
.	I-DISEASE

However	0
,	I-DISEASE
these	0
findings	0
have	0
a	0
low	I-DISEASE
spec-	0
ificity	0
and	I-DISEASE
have	0
been	0
reported	0
to	0
occur	I-DISEASE
in	0
other	0
disorders	0
such	0
as	0
OSA	0
and	0
in	0
asymp-	0
tomatic	0
individuals	0
.	0

On	0
rare	0
occasions	I-DISEASE
,	I-DISEASE
polysomnography	0
can	0
provide	I-DISEASE
support	0
for	0
the	0
clinical	0
diagnosis	0
by	0
documenting	0
arousals	0
from	I-DISEASE
slow	0
wave	0
sleep	0
accompanied	0
by	0
behaviors	0
typical	0
of	I-DISEASE
confusional	I-DISEASE
arousals	I-DISEASE
.	0

Out	0
-	0
of	0
-	0
bed	0
behaviors	0
are	0
very	0
rare	I-DISEASE
in	0
the	0
sleep	0
laboratory	I-DISEASE
.	0

Changes	0
between	0
the	0
home	I-DISEASE
and	0
sleep	I-DISEASE
laboratory	I-DISEASE
environment	0
,	I-DISEASE
timing	0
,	I-DISEASE
habits	0
,	I-DISEASE
and	0
other	I-DISEASE
factors	0
may	0
serve	I-DISEASE
to	0
decrease	0
the	0
likelihood	0
of	0
sleepwalking	0
in	I-DISEASE
the	0
laboratory	I-DISEASE
.	0

Time	0
-	0
synchronized	0
video	0
-	0
polysomnographic	I-DISEASE
(	I-DISEASE
vPSG	0
)	I-DISEASE
recording	0
is	0
essen-	0
tial	0
if	0
polysomnography	0
(	I-DISEASE
PSG	0
)	0
is	0
to	I-DISEASE
be	I-DISEASE
used	0
as	0
support	0
for	I-DISEASE
the	0
diagnosis	0
.	0

However	0
,	I-DISEASE
a	0
normal	0
PSG	0
does	I-DISEASE
not	I-DISEASE
rule	0
out	I-DISEASE
the	0
diagnosis	0
of	I-DISEASE
a	0
disorder	0
of	I-DISEASE
arousal	0
.	0

In	0
adults	0
in	0
whom	0
there	0
are	I-DISEASE
only	I-DISEASE
one	0
or	0
two	0
episodes	0
per	0
year	0
,	0
there	I-DISEASE
is	I-DISEASE
a	0
very	0
low	0
likelihood	0
of	0
occurrence	0
in	0
the	0
sleep	I-DISEASE
laboratory	I-DISEASE
.	0

However	0
,	I-DISEASE
the	0
sleep	I-DISEASE
study	0
may	I-DISEASE
assist	0
in	0
ruling	0
out	0
disorders	0
with	0
similar	0
presentations	0
,	I-DISEASE
such	0
as	0
RBD	0
or	0
nocturnal	0
epilepsy	0
.	0

PSG	0
may	0
further	0
be	B-DISEASE
useful	0
by	I-DISEASE
identifying	I-DISEASE
potential	0
triggers	I-DISEASE
,	0
such	0
as	0
sleep	0
related	0
breathing	I-DISEASE
disorder	I-DISEASE
or	I-DISEASE
peri-	I-DISEASE
odic	0
leg	0
movements	0
that	0
are	I-DISEASE
currently	0
present	0
.	0

Provocative	0
sleep	0
studies	0
using	I-DISEASE
sleep	0
deprivation	I-DISEASE
and	I-DISEASE
acoustic	0
stimuli	I-DISEASE
have	0
been	0
used	0
for	0
research	0
purposes	0
,	0
with	I-DISEASE
success	I-DISEASE
.	0

However	0
,	I-DISEASE
the	0
sensitivity	I-DISEASE
and	0
specificity	I-DISEASE
of	I-DISEASE
these	0
techniques	I-DISEASE
for	0
clinical	0
purposes	0
are	0
unknown	0
.	I-DISEASE

Postarousal	0
EEG	0
recordings	0
in	0
children	0
and	0
adults	I-DISEASE
with	0
sleepwalking	I-DISEASE
often	0
demon-	0

strate	0
a	0
partial	0
or	0
virtually	0
complete	0
persistence	I-DISEASE
of	0
sleep	I-DISEASE
,	0
with	0
diffuse	I-DISEASE
,	0
rhythmic	0
delta	I-DISEASE
activity	I-DISEASE
;	0
diffuse	I-DISEASE
delta	0
and	0
theta	0
activity	0
;	0
mixed	0
delta	0
,	0
theta	I-DISEASE
,	I-DISEASE
alpha	I-DISEASE
,	0
and	I-DISEASE
beta	I-DISEASE
activity	0
;	0
or	I-DISEASE
at	I-DISEASE
times	0
alpha	0
and	0
beta	0
activity	I-DISEASE
.	0

PSG	0
also	0
may	0
be	B-DISEASE
helpful	0
in	0
excluding	I-DISEASE
the	0
diagnosis	I-DISEASE
of	I-DISEASE
RBD	0
by	0
demonstration	0
of	0
normal	I-DISEASE
muscle	0
atonia	0
in	I-DISEASE
REM	0
sleep	I-DISEASE
(	0
assuming	0
adequate	0
amounts	0
of	I-DISEASE
REM	I-DISEASE
sleep	0
are	I-DISEASE
observed	0
)	I-DISEASE
.	0

Although	0
the	0
“	I-DISEASE
macrostructure	0
”	0
of	0
sleep	0
(	0
i.e.	I-DISEASE
,	0
the	I-DISEASE
cycling	0
of	0
various	0
NREM	0
and	0
REM	0
sleep	I-DISEASE
stages	0
and	0
the	0
relative	0
distributions	0
of	0
these	I-DISEASE
sleep	0
stages	0
)	I-DISEASE
is	0
generally	I-DISEASE
preserved	I-DISEASE
with	0
sleepwalking	0
,	0
the	0
“	I-DISEASE
microstructure	0
”	I-DISEASE
of	0
sleep	I-DISEASE
can	0
be	0
perturbed	I-DISEASE
.	0

Power	0
spectral	0
analyses	0
of	0
slow	0
wave	I-DISEASE
activity	I-DISEASE
in	0
adult	0
sleepwalkers	0
have	0
revealed	0
several	0
forms	0
of	0
slow	I-DISEASE
wave	0
sleep	I-DISEASE
dysregulation	0
,	0
including	0
high	0
amounts	0
of	0
slow	I-DISEASE
wave	0
sleep	0
fragmentation	I-DISEASE
(	0
particularly	0
during	0
the	0
first	0
NREM	0
-	0
REM	I-DISEASE
sleep	0
cycle	I-DISEASE
)	0
,	I-DISEASE
a	0
significant	0
increase	0
in	0
delta	0
power	0
just	I-DISEASE
prior	I-DISEASE
to	0
an	I-DISEASE
arousal	0
,	0
and	I-DISEASE
increased	0
slow	0
wave	0
activity	0
across	I-DISEASE
all	0
NREM	0
sleep	I-DISEASE
cycles	0
.	0

Differential	0
Diagnosis	0
Disorders	0
of	0
arousal	0
should	I-DISEASE
be	I-DISEASE
carefully	0
distinguished	I-DISEASE
from	0
other	0
disorders	0
with	I-DISEASE
similar	0
presentations	I-DISEASE
,	0
but	I-DISEASE
different	I-DISEASE
pathophysiologies	0
,	I-DISEASE
courses	0
,	0
and	0
treatments	0
.	0

Other	0
disorders	0
to	0
be	0
considered	0
include	0
RBD	I-DISEASE
,	0
sleep	0
related	0
epilepsy	0
,	I-DISEASE
sleep	0
related	0
dissocia-	I-DISEASE
tive	0
disorders	I-DISEASE
,	I-DISEASE
alcohol	0
and	0
drug	0
related	0
behaviors	0
,	I-DISEASE
and	I-DISEASE
OSA	0
.	0

RBD	0
typically	0
presents	0
as	0
dream	0
-	0
enacting	0
behaviors	0
during	0
the	0
second	0
half	0
of	I-DISEASE
the	I-DISEASE
night	I-DISEASE
and	I-DISEASE
usually	0
affects	I-DISEASE
middle	0
-	I-DISEASE
aged	0
men	0
,	0
but	I-DISEASE
also	0
can	0
affect	0
women	0
and	B-DISEASE
virtually	0
any	0
age	0
group	0
.	0

Because	0
sleepwalking	0
in	I-DISEASE
adults	0
can	0
also	0
present	0
as	0
dream	I-DISEASE
-	0
enacting	0
behaviors	0
that	I-DISEASE
emerge	0
during	0
any	I-DISEASE
time	0
of	I-DISEASE
the	0
night	I-DISEASE
,	0
vPSG	0
may	0
be	I-DISEASE
necessary	I-DISEASE
to	0
distinguish	0
sleep-	0
walking	0
from	0
RBD	I-DISEASE
.	0

In	0
contrast	0
to	0
disorders	0
of	0
arousal	I-DISEASE
,	I-DISEASE
signs	0
of	I-DISEASE
RBD	0
,	0
particularly	0
tonic	0
/	I-DISEASE
phasic	I-DISEASE
EMG	0
activity	0
during	I-DISEASE
REM	0
sleep	0
,	0
are	0
almost	0
always	0
present	I-DISEASE
during	0
sleep	I-DISEASE
studies	I-DISEASE
.	0

If	0
sleepwalking	0
(	0
or	0
sleep	0
terrors	I-DISEASE
)	0
occurs	0
with	0
RBD	0
in	0
the	0
same	0
patient	0
,	0
both	0
should	I-DISEASE
be	0
diagnosed	0
.	0

This	0
has	0
been	0
referred	0
to	0
as	0
a	0
parasomnia	0
overlap	0
disorder	0
.	0

Other	0
sleep	0
disorders	0
,	0
such	0
as	0
OSA	0
,	0
can	0
precipitate	0
disorders	0
of	0
arousal	0
.	0

Therefore	0
,	0
a	0
careful	0
history	0
must	0
be	0
obtained	0
to	0
identify	0
other	0
sleep	0
disorders	I-DISEASE
.	0

Sleep	0
related	0
epilepsy	I-DISEASE
can	0
manifest	0
with	0
wandering	0
behavior	0
or	0
with	0
frenzied	0
walking	0
or	0
running	0
.	I-DISEASE

In	0
adults	0
,	0
a	0
diagnosis	0
of	0
malingering	I-DISEASE
also	I-DISEASE
should	0
be	I-DISEASE
considered	0
.	0

If	0
a	0
neurologic	0
or	0
medical	0
disor-	0
der	0
is	0
identified	I-DISEASE
as	0
the	0
precipitant	0
of	0
a	0
disorder	0
of	0
arousal	I-DISEASE
,	I-DISEASE
then	0
the	0
sleepwalking	0
should	0
be	0
diagnosed	0
as	I-DISEASE
parasomnia	0
due	0
to	I-DISEASE
a	I-DISEASE
medical	I-DISEASE
disorder	0
.	I-DISEASE

Disorders	0
of	0
arousal	0
should	0
not	0
be	I-DISEASE
diagnosed	0
in	0
the	I-DISEASE
presence	0
of	0
alcohol	0
intoxication	0
.	0

The	0
behavior	0
of	0
the	0
alcohol	0
-	0
intoxicated	I-DISEASE
individual	0
may	0
superficially	0
resemble	0
that	0
of	I-DISEASE
the	0
sleepwalker	0
.	0

However	0
,	I-DISEASE
the	0
sleepwalker	I-DISEASE
is	0
typically	0
severely	I-DISEASE
cognitively	0
impaired	I-DISEASE
,	0
but	0
with	0
only	0
limited	0
motor	0
impairment	0
.	0

The	0
alcohol	0
-	0
intoxicated	I-DISEASE
individual	0
’s	0
level	I-DISEASE
of	0
cognitive	0
functioning	0
may	0
be	0
reduced	0
,	0
but	I-DISEASE
not	I-DISEASE
absent	I-DISEASE
,	I-DISEASE
whereas	0
motor	I-DISEASE
behavior	0
is	0
often	0
severely	I-DISEASE
impaired	0
.	0

In	0
alcoholic	0
blackouts	0
,	0
where	0
anterograde	0
amnesia	I-DISEASE
is	0
,	I-DISEASE
by	0
definition	0
,	0
Parasomnias	I-DISEASE
Parasomnias	0
the	I-DISEASE
cardinal	I-DISEASE
manifestation	0
,	I-DISEASE
it	0
is	0
important	0
to	0
note	0
that	0
outward	0
motor	0
behavior	0
and	I-DISEASE
cog-	0
nitive	0
function	I-DISEASE
may	0
not	0
be	0
impaired	I-DISEASE
and	0
may	0
be	I-DISEASE
perceived	0
as	I-DISEASE
normal	0
.	I-DISEASE

Thus	0
,	0
the	0
impor-	I-DISEASE
tance	0
of	0
appreciating	I-DISEASE
the	0
neuroscience	I-DISEASE
of	0
alcoholic	0
blackouts	0
and	0
its	I-DISEASE
potential	I-DISEASE
role	0
in	0
the	I-DISEASE
explanation	0
of	0
unusual	0
and	0
bizarre	0
nocturnal	0
behaviors	I-DISEASE
can	0
not	I-DISEASE
be	I-DISEASE
understated	0
because	0
these	I-DISEASE
can	0
mimic	0
parasomnias	0
.	0

The	0
former	0
are	0
exponentially	0
more	0
prevalent	I-DISEASE
and	I-DISEASE
thus	I-DISEASE
should	0
be	0
given	0
appropriate	0
weight	0
when	0
attributing	I-DISEASE
likely	0
causation	I-DISEASE
in	I-DISEASE
cases	I-DISEASE
with	0
criminal	0
allegations	I-DISEASE
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE
With	I-DISEASE
the	I-DISEASE
development	0
of	I-DISEASE
sophisticated	0
genetic	0
testing	I-DISEASE
and	0
neuroimaging	0
,	I-DISEASE
direct	0
research	0
into	I-DISEASE
the	0
causes	0
and	0
mechanisms	0
of	0
disorders	0
or	I-DISEASE
arousals	0
is	I-DISEASE
anticipated	I-DISEASE
.	0

Further	0
investigations	0
that	0
aid	0
in	0
the	0
characterization	I-DISEASE
of	0
the	I-DISEASE
pathophysiology	I-DISEASE
are	0
necessary	0
.	I-DISEASE

Further	0
development	0
of	0
sleep	0
laboratory	0
-	0
based	I-DISEASE
techniques	0
for	0
provoking	0
episodes	0
of	0
sleepwalking	0
would	0
improve	I-DISEASE
diagnostic	0
accuracy	0
.	0

Bibliography	0
Achermann	0
P	0
,	0
Werth	0
E	0
,	I-DISEASE
Dijk	0
DJ	I-DISEASE
,	0
Borbély	0
AA	0
.	0

Time	0
course	0
of	0
sleep	I-DISEASE
inertia	I-DISEASE
after	0
nighttime	I-DISEASE
and	0
daytime	I-DISEASE
sleep	I-DISEASE
episodes	0
.	0

Arch	0
Ital	0
Biol	0
1995;134:109–19	0
.	0

Broughton	0
RJ	0
.	0

Sleep	0
disorders	0
:	0
disorders	0
of	0
arousal	I-DISEASE
?	I-DISEASE

Science	0
1968;159:1070–8	I-DISEASE
.	0

Fisher	0
C	0
,	I-DISEASE
Kahn	0
E	0
,	0
Edwards	I-DISEASE
A	0
,	I-DISEASE
Davis	0
D	0
,	0
Fine	0
J.	0
A	0
psychophysiological	0
study	0
of	I-DISEASE
nightmares	0
and	I-DISEASE
night	0
terrors	0
.	0

III	0
.	0

Mental	0
content	0
and	0
recall	0
of	0
stage	I-DISEASE
4	I-DISEASE
night	0
terrors	I-DISEASE
.	0

J	0
Nerv	0
Ment	0
Dis	0
1974;158:174–88	0
.	0

Fisher	0
C	0
,	I-DISEASE
Kahn	0
E	0
,	0
Edwards	I-DISEASE
D	0
,	I-DISEASE
Davis	0
D.	0
A	0
psychophysiological	0
study	0
of	0
nightmares	0
and	I-DISEASE
night	I-DISEASE
terrors	0
:	I-DISEASE
physiological	0
aspects	0
of	0
the	0
stage	I-DISEASE
4	0
night	0
terror	0
.	0

J	0
Nerv	0
Ment	0
Dis	0
1973;157:75–98	0
.	0

Gastaut	0
H	0
,	0
Broughton	0
R.	0
A	0
clinical	I-DISEASE
and	0
polygraphic	I-DISEASE
study	0
of	0
episodic	0
phenomena	0
during	0
sleep	I-DISEASE
.	0

In	0
:	0
Wortis	0
J	I-DISEASE
,	0
ed	0
.	0

Recent	0
advances	0
in	0
biological	0
psychiatry	0
,	0
Volume	I-DISEASE
7	0
.	I-DISEASE

New	0
York	0
:	0
Plenum	0
Press	0
,	0
1965:197–223	0
.	0

Guilleminault	0
C	0
,	I-DISEASE
Moscovitch	0
A	0
,	0
Yuen	I-DISEASE
K	0
,	I-DISEASE
Poyares	0
D.	0
Atypical	0
sexual	0
behavior	0
during	0
sleep	0
.	0

Psychosom	0
Med	0
2002;64:328–36	I-DISEASE
.	0

Guilleminault	0
C	0
,	I-DISEASE
Silvestri	0
JM	0
.	0

Disorders	0
of	0
arousal	0
and	0
epilepsy	0
during	I-DISEASE
sleep	I-DISEASE
.	0

In	0
:	0
Sterman	0
M	0
,	0
Shouse	0
M	I-DISEASE
,	0
Passouant	0
P	0
,	0
eds	0
.	I-DISEASE

Sleep	0
and	0
epilepsy	0
.	0

New	0
York	0
:	0
Academic	0
Press	0
,	0
1983:513–31	I-DISEASE
.	0

Hublin	0
C	0
,	I-DISEASE
Kaprio	I-DISEASE
J	0
,	0
Partinen	I-DISEASE
M	0
,	I-DISEASE
Heikkila	0
K	I-DISEASE
,	0
Koskenvuo	I-DISEASE
M.	0
Parasomnias	I-DISEASE
:	0
co	0
-	I-DISEASE
occurrence	0
and	0
genetics	0
.	0

Psychiatr	0
Genet	0
2001;11:65–70	0
.	0

Hublin	0
C	0
,	I-DISEASE
Kaprio	I-DISEASE
J	0
,	0
Partinen	I-DISEASE
M	0
,	I-DISEASE
Heikkila	0
K	I-DISEASE
,	0
Koskenvuo	I-DISEASE
M.	0
Prevalence	I-DISEASE
and	0
genetics	0
of	I-DISEASE
sleepwalking	0
:	0
a	0
population	0
-	0
based	0
twin	I-DISEASE
study	0
.	0

Neurology	0
1997;48:177–81	0
.	0

Iranzo	0
A	0
,	0
Santamaria	0
J.	0
Severe	I-DISEASE
obstructive	I-DISEASE
sleep	0
apnea	0
/	0
hypopnea	0
mimicking	0
REM	0
sleep	0
behavior	0
disorder	I-DISEASE
.	I-DISEASE

Sleep	0
2005;28:203–6	0
.	0

Kales	0
A	0
,	0
Soldatos	0
C	0
,	0
Bixler	0
E	0
,	I-DISEASE
et	0
al	0
.	0

Hereditary	0
factors	I-DISEASE
in	0
sleepwalking	0
and	0
night	0
terrors	I-DISEASE
.	0

Br	0
J	0
Psychiatry	0
1980;137:111–8	0
.	0

Klackenberg	0
G.	0
Somnambulism	I-DISEASE
in	0
childhood	0
—	I-DISEASE
prevalence	0
,	0
course	0
and	0
behavioral	0
correlations	0
:	0
a	0
prospective	0
longitudinal	I-DISEASE
study	0
(	I-DISEASE
3	0
-	0
16	0
years	0
)	0
.	I-DISEASE

Acta	0
Paediatr	0
Scand	0
1982;71:495–9	0
.	0

Mahowald	0
M	0
,	0
Schenck	0
C	0
,	0
Goldner	0
M	I-DISEASE
,	I-DISEASE
Bachelder	I-DISEASE
V	0
,	0
Cramer	I-DISEASE
Bornemann	0
M.	I-DISEASE
Parasomnia	0
pseudo	0
-	I-DISEASE
suicide	0
.	0

J	0
Forensic	0
Sci	0
2003;48:1158–62	0
.	0

Nino	0
-	0
Murcia	I-DISEASE
G	I-DISEASE
,	0
Dement	0
W.	I-DISEASE
Psychophysiological	0
and	I-DISEASE
pharmacological	0
aspects	0
of	0
somnambulism	I-DISEASE
and	0
night	0
terrors	I-DISEASE
in	0
children	I-DISEASE

.	0

In	0
:	0
Meltzer	0
H	I-DISEASE
,	0
ed	0
.	0

Psychopharmacology	0
:	0
the	0
third	0
generation	0
of	0
progress	0
.	0

New	0
York	0
:	0
Raven	0
Press	0
,	0
1987:873–9	I-DISEASE
.	0

Ohayon	0
M	I-DISEASE
,	0
Guilleminault	B-DISEASE
C	0
,	0
Priest	I-DISEASE
R.	I-DISEASE
Night	I-DISEASE
terrors	0
,	0
sleepwalking	I-DISEASE
,	0
and	0
confusional	I-DISEASE
arousals	0
in	I-DISEASE
the	I-DISEASE
general	0
population	0
:	0
their	0
frequency	I-DISEASE
and	0
relationship	I-DISEASE
to	I-DISEASE
other	0
sleep	I-DISEASE
and	0
mental	0
disorders	I-DISEASE
.	0

J	0
Clin	0
Psychiatry	I-DISEASE
1999;60:268–76	0
.	0

Ohayon	0
M	0
,	0
Priest	0
R	0
,	0
Zulley	0
J	0
,	I-DISEASE
Smirne	0
S.	0

The	0
place	0
of	0
confusional	I-DISEASE
arousals	I-DISEASE
in	0
sleep	I-DISEASE
and	0
mental	0
disorders	I-DISEASE
:	0
findings	0
in	0
a	0
general	0
population	0
sample	0
of	0
13,057	0
subjects	0
.	0

J	0
Nerv	0
Ment	0
Dis	0
2000;188:340–8	0
.	0

Pilon	0
M	0
,	0
Zadra	0
A	0
,	0
Joncas	I-DISEASE
S	0
,	I-DISEASE
Montplaisir	0
J.	0
Hypersynchronous	0
delta	0
waves	0
and	0
somnambulism	I-DISEASE
:	0
brain	I-DISEASE
topography	0
and	0
effect	0
of	0
sleep	I-DISEASE
deprivation	I-DISEASE
.	0

Sleep	0
2006;29:77–84	0
.	0

Pressman	0
M	0
,	0
Mahowald	0
M	0
,	0
Schenck	I-DISEASE
C	0
,	I-DISEASE
Cramer	0
Bornemann	0
M.	I-DISEASE
Alcohol	0
-	I-DISEASE
induced	I-DISEASE
sleepwalking	I-DISEASE
or	0
confusional	I-DISEASE
arousal	0
as	0
a	0
defense	0
to	0
criminal	I-DISEASE
behavior	I-DISEASE
:	I-DISEASE
a	0
review	I-DISEASE
of	0
scientific	I-DISEASE
evidence	0
,	I-DISEASE
methods	0
and	0
forensic	0
considerations	0
.	0

J	0
Sleep	0
Rev	0
2007;16:198–212	B-DISEASE
.	0

Pressman	0
M.	0
Factors	0
that	0
predispose	0
,	I-DISEASE
prime	I-DISEASE
and	I-DISEASE
precipitate	I-DISEASE
NREM	0
parasomnias	0
in	0
adults	I-DISEASE
:	0
clinical	I-DISEASE
and	I-DISEASE
forensic	0
implications	0
.	0

Sleep	0
Med	0
Rev	I-DISEASE
2007;11:5–30	0
.	B-DISEASE

Pressman	0
MR	0
.	0

Hypersynchronous	0
delta	0
sleep	0
EEG	0
activity	I-DISEASE
and	0
sudden	I-DISEASE
arousals	0
from	I-DISEASE
slow	0
wave	0
sleep	0
in	0
adults	0
without	I-DISEASE
a	I-DISEASE
history	0
of	I-DISEASE
parasomnias	0
:	I-DISEASE
clinical	0
and	0
forensic	I-DISEASE
implications	0
.	0

Sleep	0
2004	0
;	0
27:706–10	0
.	0

Schenck	0
C	0
,	0
Arnulf	0
I	I-DISEASE
,	0
Mahowald	0
M.	0
Sleep	I-DISEASE
and	0
sex	0
:	0
what	0
can	0
go	I-DISEASE
wrong	0
?	0

A	0
review	0
of	0
the	0
literature	I-DISEASE
on	I-DISEASE
sleep	0
related	I-DISEASE
disorders	I-DISEASE
and	0
abnormal	0
sexual	0
behaviors	0
and	0
experiences	I-DISEASE
.	0

Sleep	0
2007;30:683–702	0
.	0

Schenck	0
C	0
,	I-DISEASE
Boyd	0
J	I-DISEASE
,	0
Mahowald	I-DISEASE
M.	0
A	I-DISEASE
parasomnia	0
overlap	0
disorder	0
involving	I-DISEASE
sleepwalking	0
,	I-DISEASE
sleep	0
terrors	0
,	0
and	0
REM	0
sleep	0
behavior	0
disorder	I-DISEASE
in	0
33	I-DISEASE
polysomnographically	0
confirmed	I-DISEASE
cases	0
.	0

Sleep	0
1997;20:972–81	0
.	0

Schenck	0
C	0
,	0
Mahowald	0
M.	0

On	0
the	0
reported	I-DISEASE
association	0
of	0
psychopathology	I-DISEASE
with	0
sleep	0
terrors	I-DISEASE
in	0
adults	0
.	0

Sleep	0
2000;23:448–9	0
.	0

Simonds	0
J	0
,	0
Parraga	0
H.	0
Prevalence	0
of	0
sleep	I-DISEASE
disorders	0
and	0
sleep	0
behaviors	0
in	0
children	0
and	I-DISEASE
adolescents	0
.	I-DISEASE

J	0
Am	0
Acad	0
Child	0
Adolesc	0
Psychiatry	0
1982;21:383–8	0
.	0

Zadra	0
A	0
,	0
Desautels	0
A	0
,	0
Petit	0
D	I-DISEASE
,	0
Montplaisir	0
J.	0
Somnambulism	0
:	I-DISEASE
clinical	0
aspects	0
and	I-DISEASE
pathophysiological	0
hypotheses	I-DISEASE
.	0

Lancet	0
Neurol	0
2013;12:285–94	0
.	0

Parasomnias	0
Parasomnias	0
Sleep	0
Related	0
Eating	0
Disorder	I-DISEASE
ICD-9	0
-	0
CM	0
code	0
:	0
327.40	0
Alternate	I-DISEASE
Names	0
Sleep	I-DISEASE
eating	0
Diagnostic	0
Criteria	I-DISEASE
Criteria	0

A	0
-	0
D	0
must	I-DISEASE
be	0
met	0
ICD-10	I-DISEASE
-	0
CM	0
code	0
:	0
G47.59	0
A.	I-DISEASE
Recurrent	0
episodes	0
of	0
dysfunctional	I-DISEASE
eating	I-DISEASE
that	0
occur	0
after	0
an	0
arousal	I-DISEASE
during	0
the	0
main	0
sleep	0
period	0
.	0

B.	0
The	0
presence	0
of	0
at	0
least	I-DISEASE
one	I-DISEASE
of	I-DISEASE
the	I-DISEASE
following	0
in	0
association	0
with	0
the	0
recurrent	0
episodes	I-DISEASE
of	0
involuntary	I-DISEASE
eating	0
:	0
.	0

Consumption	0
of	0
peculiar	0
forms	0
or	0
combinations	0
of	0
food	0
or	I-DISEASE
inedible	0
or	0
toxic	0
substances	0
.	0
.	0

Sleep	0
related	0
injurious	I-DISEASE
or	0
potentially	0
injurious	0
behaviors	0
performed	0
while	0
in	0
pursuit	0
of	0
food	0
or	0
while	0
cooking	0
food	0
.	0
.	0

Adverse	0
health	0
consequences	0
from	0
recurrent	0
nocturnal	0
eating	0
.	0

C.	0

There	0
is	0
partial	0
or	0
complete	0
loss	0
of	I-DISEASE
conscious	0
awareness	I-DISEASE
during	0
the	0
eating	0
episode	0
,	0
with	I-DISEASE
subsequent	0
impaired	0
recall	0
.	0

D.	0

The	0
disturbance	0
is	0
not	0
better	I-DISEASE
explained	I-DISEASE
by	I-DISEASE
another	0
sleep	I-DISEASE
disorder	I-DISEASE
,	0
mental	0
disorder	I-DISEASE
,	0
medical	I-DISEASE
disorder	0
,	0
medication	I-DISEASE
,	0
or	0
substance	0
use	0
.	0

Essential	0
Features	I-DISEASE
SRED	0
consists	0
of	0
recurrent	0
episodes	I-DISEASE
of	0
involuntary	I-DISEASE
eating	0
and	0
drinking	0
during	0
arous-	0
als	I-DISEASE
from	0
sleep	0
,	I-DISEASE
associated	0
with	0
diminished	0
levels	0
of	I-DISEASE
consciousness	I-DISEASE
and	0
subsequent	I-DISEASE
recall	0
,	I-DISEASE
with	0
problematic	I-DISEASE
consequences	0
.	I-DISEASE

The	0
episodes	0
of	0
eating	I-DISEASE
always	0
occur	0
in	0
an	0
involuntary	I-DISEASE
or	0
“	0
out	0
of	0
control	0
”	I-DISEASE
manner	0
after	0
an	I-DISEASE
interval	0
of	0
sleep	0
.	0

Typically	0
,	0
they	0
occur	0
during	0
partial	I-DISEASE
arousals	I-DISEASE
from	I-DISEASE
sleep	I-DISEASE
with	0
subsequent	0
partial	0
recall	0
.	0

On	0
the	0
one	I-DISEASE
hand	0
,	0
some	0
patients	0
can	I-DISEASE
not	I-DISEASE
be	I-DISEASE
easily	0
brought	0
to	0
full	0
consciousness	I-DISEASE
during	0
an	I-DISEASE
episode	I-DISEASE
of	0
eating	0
,	0
as	0
is	0
the	0
case	I-DISEASE
with	0
sleepwalking	0
,	I-DISEASE
and	0
may	I-DISEASE
have	0
no	I-DISEASE
recall	0
of	0
having	0
eaten	0
during	I-DISEASE
the	0
night	0
.	I-DISEASE

On	0
the	0
other	I-DISEASE
hand	0
,	0
some	0
patients	0
seemingly	I-DISEASE
have	I-DISEASE
considerable	0
alertness	0
during	0
an	0
episode	0
and	I-DISEASE
have	0
substantial	0
recall	0
in	0
the	0
morning	0
.	0

There	0
may	0
be	0
variability	I-DISEASE
of	I-DISEASE
awareness	0
and	I-DISEASE
subsequent	0
recall	I-DISEASE
within	0
one	0
night	I-DISEASE
,	0
and	I-DISEASE
across	I-DISEASE
the	I-DISEASE
evolution	0
of	I-DISEASE
the	0
disorder	0
in	I-DISEASE
individual	0
patients	0
.	I-DISEASE

The	0
recurrent	0
episodes	0
of	I-DISEASE
involuntary	0
eating	I-DISEASE
and	0
drinking	0
during	I-DISEASE
the	0
main	0
sleep	0
period	I-DISEASE
are	0
typically	I-DISEASE
associated	0
with	I-DISEASE
a	0
feeling	0
of	I-DISEASE
lack	0
of	0
control	0
over	0
eating	I-DISEASE
.	I-DISEASE

Problematic	0
features	0
of	0
the	0
recurrent	0
sleep	I-DISEASE
related	I-DISEASE
eating	0
include	I-DISEASE
the	I-DISEASE
following	0
:	0
con-	I-DISEASE
sumption	0
of	I-DISEASE
peculiar	I-DISEASE
forms	0
or	I-DISEASE
combinations	0
of	0
food	0
,	0
or	0
of	0
inedible	I-DISEASE
or	0
toxic	0
substances	0
(	0
e.g.	0
,	0
frozen	0
pizzas	0
,	0
raw	I-DISEASE
bacon	0
,	0
buttered	0
cigarettes	0
,	0
cat	I-DISEASE
food	0
and	I-DISEASE
salt	0
sandwiches	0
,	I-DISEASE
coffee	I-DISEASE
grounds	0
,	0
ammonia	0
cleaning	0
solutions	0
)	I-DISEASE
;	0
sleep	0
related	0
injury	0
(	I-DISEASE
e.g.	0
,	I-DISEASE
lacerations	I-DISEASE
from	0
care-	I-DISEASE
less	I-DISEASE
manipulation	0
of	I-DISEASE
kitchen	0
utensils	I-DISEASE
;	I-DISEASE
internal	I-DISEASE
or	0
external	0
burns	0
from	I-DISEASE
consuming	0
or	0
spilling	0
hot	I-DISEASE
foods	0
or	0
beverages	I-DISEASE
;	0
or	0
poisoning	0
and	0
internal	0
injuries	0
from	0
ingesting	I-DISEASE
toxic	I-DISEASE
substances	0
)	0
;	0
adverse	0
health	I-DISEASE
consequences	0
(	0
e.g.	0
,	0
dental	0
caries	0
and	0
tooth	0
chipping	0
from	0
biting	I-DISEASE
frozen	0
foods	0
)	I-DISEASE
;	0
weight	I-DISEASE
gain	0
;	I-DISEASE
obesity	I-DISEASE
(	0
including	0
morbid	0
obesity	0
resulting	0
in	0
bar-	0
iatric	I-DISEASE
surgery	0
)	0
;	I-DISEASE
various	I-DISEASE
metabolic	0
problems	I-DISEASE
,	I-DISEASE
such	0
as	0
destabilization	0
or	I-DISEASE
precipitation	0
of	0
diabetes	I-DISEASE
mellitus	I-DISEASE
,	I-DISEASE
hypertriglyceridemia	I-DISEASE
,	I-DISEASE
and	I-DISEASE
hypercholesterolemia	0
;	I-DISEASE
nonrestorative	0
sleep	0
from	0
sleep	I-DISEASE
disruption	I-DISEASE
;	0
morning	0
anorexia	0
and	0
abdominal	0
distention	0
.	I-DISEASE

SRED	0
carries	0
the	0
risk	0
of	I-DISEASE
consuming	0
foods	I-DISEASE
to	0
which	I-DISEASE
one	0
is	0
allergic	0
.	0

Also	0
,	0
overnight	0
fasting	0
prior	0
to	I-DISEASE
next	0
-	0
day	I-DISEASE
surgery	0
or	0
testing	0
can	0
be	0
compromised	0
.	I-DISEASE

Secondary	0
depressive	0
disorders	I-DISEASE
may	0
emerge	0
from	0
longstanding	I-DISEASE
personal	0
dejection	0
and	0
a	0
sense	I-DISEASE
of	0
failure	0
over	I-DISEASE
the	0
inability	0
to	I-DISEASE
control	0
the	I-DISEASE
nocturnal	0
eating	0
.	0

Secondary	0
food	0
restriction	0
,	0
prompted	0
by	0
despair	I-DISEASE
over	0
not	I-DISEASE
being	I-DISEASE
able	0
to	0
stop	0
the	0
nocturnal	I-DISEASE
eating	I-DISEASE
,	0
often	B-DISEASE
occurs	0
at	0
some	0
point	0
during	0
the	0
course	I-DISEASE
of	I-DISEASE
the	0
disorder	I-DISEASE
.	I-DISEASE

Patients	0
may	0
engage	0
in	0
potentially	0
hazardous	0
(	0
and	0
expensive	I-DISEASE
)	0
weight	0
-	I-DISEASE
loss	I-DISEASE
regimens	0
.	I-DISEASE

Insomnia	0
can	0
also	0
be	0
a	0
complication	0
.	B-DISEASE

Associated	0
Features	0
Nightly	0
eating	0
,	0
including	0
multiple	I-DISEASE
episodes	0
nightly	0
,	0
is	0
reported	0
by	0
a	0
majority	0
of	0
affected	0
individuals	I-DISEASE
.	0

The	0
episodes	0
of	0
eating	I-DISEASE
occur	0
during	0
any	I-DISEASE
time	0
in	I-DISEASE
the	0
sleep	I-DISEASE
cycle	I-DISEASE
.	0

High	0
-	0
caloric	0
foods	0
are	0
typically	0
preferred	0
.	0

The	0
foods	0
preferentially	0
consumed	0
during	0
sleep	0
related	I-DISEASE
eating	0
are	I-DISEASE
not	I-DISEASE
typically	0
consumed	0
with	I-DISEASE
preference	0
during	I-DISEASE
the	0
daytime	0
.	I-DISEASE

Paradoxically	0
,	0
to	0
the	I-DISEASE
extent	0
that	0
there	I-DISEASE
is	0
recall	I-DISEASE
,	I-DISEASE
hunger	0
and	0
thirst	0
are	0
notably	I-DISEASE
absent	I-DISEASE
during	0
episodes	0
of	0
compulsive	I-DISEASE
eating	0
with	0
SRED	0
.	0

The	0
episodes	0
of	0
eating	0
are	0
some-	0
times	0
experienced	0
as	I-DISEASE
food	0
-	0
related	0
enactment	0
of	0
a	0
dream	0
.	0

Simple	0
foods	0
or	0
entire	0
hot	0
or	0
cold	0
meals	0
may	0
be	0
prepared	0
and	I-DISEASE
consumed	0
.	0

Careless	0
food	0
handling	0
often	0
occurs	0
.	0

Alcoholic	0
beverages	0
are	0
almost	0
never	0
consumed	0
.	0

The	0
usual	0
response	0
to	0
interference	0
during	0
an	I-DISEASE
eating	I-DISEASE
episode	I-DISEASE
is	0
irritability	0
and	0
agitation	I-DISEASE
.	0

Clinical	0
or	0
Pathophysiological	0
Subtypes	0
None	I-DISEASE
known	I-DISEASE
.	0

Demographics	0
The	0
following	0
rates	0
of	0
SRED	0
,	I-DISEASE
as	0
determined	I-DISEASE
by	0
self	0
-	0
administered	0
questionnaire	0
,	I-DISEASE
have	I-DISEASE
been	I-DISEASE
reported	I-DISEASE
:	0
16.7	0
%	0
in	0
an	0
inpatient	0
eating	I-DISEASE
disorders	I-DISEASE
group	0
;	I-DISEASE
8.7	0
%	0
in	I-DISEASE
an	0
outpatient	0
eating	0
disorders	0
group	0
;	0
and	I-DISEASE
4.6	0
%	I-DISEASE
in	0
an	0
unselected	0
university	0
student	0
group	I-DISEASE
.	I-DISEASE

This	0
study	0
would	I-DISEASE
indicate	0
a	0
high	I-DISEASE
prevalence	I-DISEASE
of	I-DISEASE
SRED	I-DISEASE
,	0
although	0
confirmatory	0
studies	0
across	0
Parasomnias	I-DISEASE
Parasomnias	0
different	0
clinical	0
and	0
nonclinical	0
population	0
groups	0
are	0
needed	0
.	0

Females	0
comprise	I-DISEASE
60	0
%	0
to	0
83	0
%	I-DISEASE
of	0
patients	I-DISEASE
in	0
reported	0
series	0
.	0

Mean	0
age	0
of	0
onset	0
of	0
SRED	I-DISEASE
is	0
reported	0
to	I-DISEASE
be	0
22	0
-	0
39	0
years	0
.	0

In	0
the	0
reported	I-DISEASE
series	0
,	0
the	0
mean	I-DISEASE
duration	0
of	I-DISEASE
SRED	0
prior	0
to	0
clinical	0
presen-	0
tation	I-DISEASE
ranged	I-DISEASE
from	0
four	I-DISEASE
to	0
15	0
years	0
,	0
suggesting	0
that	0
SRED	I-DISEASE
often	I-DISEASE
is	0
a	I-DISEASE
chronic	I-DISEASE
disorder	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
SRED	0
can	I-DISEASE
be	I-DISEASE
idiopathic	0
,	I-DISEASE
but	0
it	0
appears	I-DISEASE
to	0
be	0
most	I-DISEASE
commonly	I-DISEASE
associated	0
with	I-DISEASE
a	0
primary	0
sleep	0
disorder	0
,	0
another	0
clinical	I-DISEASE
condition	0
,	0
or	I-DISEASE
use	0
of	0
a	0
sedative	I-DISEASE
-	0
hypnotic	0
medication	0
.	0

Sleepwalking	0
is	0
the	0
most	I-DISEASE
common	0
sleep	I-DISEASE
disorder	0
associated	0
with	I-DISEASE
sleep	0
related	0
eating	0
,	I-DISEASE
although	I-DISEASE
once	I-DISEASE
eating	0
becomes	0
part	I-DISEASE
of	0
the	0
behavioral	0
repertoire	0
,	I-DISEASE
it	0
quickly	0
becomes	0
the	0
predominant	I-DISEASE
,	0
if	I-DISEASE
not	0
the	0
exclusive	0
,	0
nocturnal	I-DISEASE
“	0
sleepwalking	0
”	I-DISEASE
behavior	0
.	0

This	0
would	0
indi-	0
cate	0
that	0
SRED	0
is	I-DISEASE
most	0
often	I-DISEASE
a	0
“	0
sleepwalking	0
variant	0
disorder	0
.	I-DISEASE
”	0

A	0
history	0
of	0
sleepwalk-	0
ing	0
during	0
childhood	I-DISEASE
appears	0
to	I-DISEASE
be	0
a	0
predisposing	0
factor	I-DISEASE
in	0
many	I-DISEASE
cases	0
.	0

A	0
recent	0
retro-	I-DISEASE
spective	0
controlled	0
study	I-DISEASE
of	B-DISEASE
SRED	0
patients	I-DISEASE
,	0
sleepwalking	0
patients	0
,	0
and	0
controls	I-DISEASE
found	I-DISEASE
that	I-DISEASE
SRED	I-DISEASE
patients	0
were	I-DISEASE
mainly	0
women	0
with	0
onset	0
of	I-DISEASE
the	0
disturbance	0
in	I-DISEASE
adulthood	0
.	I-DISEASE

They	0
typically	0
experienced	I-DISEASE
nightly	0
episodes	I-DISEASE
and	0
had	I-DISEASE
more	I-DISEASE
frequent	I-DISEASE
eating	0
problems	0
in	0
childhood	0
and	0
higher	0
current	I-DISEASE
anorexia	0
scores	0
than	0
sleepwalking	0
patients	0
or	0
controls	0
.	I-DISEASE

They	0
also	0
shared	0
commonalities	0
with	0
sleepwalking	I-DISEASE
patients	I-DISEASE
,	0
including	I-DISEASE
a	0
high	0
(	I-DISEASE
66	0
%	0
)	I-DISEASE
frequency	I-DISEASE
of	0
past	I-DISEASE
or	0
current	I-DISEASE
sleepwalking	0
,	0
a	0
similar	0
timing	0
of	I-DISEASE
parasomnia	0
episodes	I-DISEASE
(	0
in	0
the	I-DISEASE
first	I-DISEASE
half	0
of	0
the	0
night	0
)	0
,	0
and	I-DISEASE
numerous	0
arousals	I-DISEASE
from	0
stage	0
N3	0
.	I-DISEASE

On	0
video	0
-	0
polysom-	I-DISEASE
nography	0
,	I-DISEASE
eating	I-DISEASE
episodes	0
occurred	I-DISEASE
mostly	0
within	0
one	0
minute	0
after	0
awakening	I-DISEASE
from	0
stage	I-DISEASE
N2	I-DISEASE
or	0
N3	0
.	0

The	0
frequencies	0
of	0
RLS	0
,	0
PLMs	I-DISEASE
,	I-DISEASE
and	0
sleep	I-DISEASE
apnea	0
were	0
similar	0
across	I-DISEASE
the	0
three	I-DISEASE
groups	0
.	0

Other	0
sleep	0
disorders	I-DISEASE
that	0
can	0
be	0
closely	I-DISEASE
associated	0
with	I-DISEASE
SRED	0
include	0
:	0
RLS	0
,	0
PLMD	I-DISEASE
,	I-DISEASE
OSA	0
,	I-DISEASE
and	0
circadian	0
rhythm	0
sleep	0
-	0
wake	0
disorders	I-DISEASE
,	0
particularly	I-DISEASE
irregular	0
sleep/	I-DISEASE
wake	0
pattern	I-DISEASE
.	0

Multiple	0
sleep	0
disorders	0
in	0
the	0
same	I-DISEASE
patient	0
have	0
been	0
reported	0
with	0
SRED	0
,	0
including	0
sexsomnia	I-DISEASE
and	0
a	0
variant	0
of	0
confusional	0
arousals	0
and	0
sleepwalking	0
.	0

Medication	0
-	I-DISEASE
induced	0
SRED	I-DISEASE
has	0
been	0
reported	0
with	0
zolpidem	I-DISEASE
,	0
in	0
particular	0
,	I-DISEASE
but	0
also	0
with	0
a	0
broad	I-DISEASE
range	0
of	0
sedative	0
hypnotics	0
,	0
including	0
benzodiazepines	I-DISEASE
,	0
benzodiazepine	0
receptor	I-DISEASE
agonists	0
,	0
mirtazapine	0
,	I-DISEASE
risperidone	0
,	0
quetiapine	0
,	0
lithium	0
carbonate	0
,	0
anticholin-	0
ergics	I-DISEASE
,	I-DISEASE
and	0
various	0
other	0
psychotropic	0
agents	I-DISEASE
.	I-DISEASE

Onset	0
of	0
SRED	0
also	I-DISEASE
has	0
been	0
reported	I-DISEASE
with	0
cessation	I-DISEASE
of	0
cigarette	0
smoking	I-DISEASE
,	0
cessation	0
of	I-DISEASE
alcohol	0
and	I-DISEASE
substance	I-DISEASE
abuse	0
,	0
acute	0
stress	0
(	0
usually	0
involving	I-DISEASE
major	0
separation	0
reactions	0
)	I-DISEASE
,	I-DISEASE
after	0
daytime	0
dieting	0
,	0
and	0
with	I-DISEASE
onset	0
of	I-DISEASE
narcolepsy	0
,	0
autoimmune	I-DISEASE
hepatitis	0
,	0
encephalitis	0
,	0
and	I-DISEASE
other	I-DISEASE
conditions	I-DISEASE
.	0

SRED	0
can	0
also	0
be	0
associated	0
with	0
daytime	I-DISEASE
eating	0
disorders	I-DISEASE
,	0
and	0
with	0
nocturnal	I-DISEASE
dissocia-	0
tive	I-DISEASE
disorder	0
.	0

In	0
a	0
controlled	0
study	0
of	I-DISEASE
65	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
narcolepsy	I-DISEASE
-	0
cataplexy	0
,	0
32	0
%	0
of	I-DISEASE
patients	0
had	0
SRED	0
vs.	0
2	0
%	0
of	0
controls	I-DISEASE
.	I-DISEASE

Nocturnal	0
smoking	0
was	0
present	I-DISEASE
in	0
33	I-DISEASE
%	0
of	0
SRED	0
-	0
narcolepsy	0
-	0
cataplexy	0
patients	0
and	0
in	0
16	0
%	I-DISEASE
of	0
narcolepsy	0
-	0
cataplexy	0
patients	I-DISEASE
without	0
SRED	0
.	0

(	0
A	0
link	0
between	0
SRED	0
and	0
nocturnal	0
smoking	0
had	I-DISEASE
previously	0
been	0
identified	0
when	0
nocturnal	0
smoking	0
was	I-DISEASE
first	I-DISEASE
reported	0
in	0
2008	I-DISEASE
)	0
.	0

A	0
study	0
of	I-DISEASE
88	I-DISEASE
patients	0
with	I-DISEASE
RLS	0
and	0
42	I-DISEASE
patients	0
with	0
insomnia	I-DISEASE
who	0
were	0
systematically	I-DISEASE
questioned	I-DISEASE
for	0
the	0
presence	0
of	0
SRED	0
or	0
other	0
nocturnal	0
eating	0
demonstrated	0
that	0
36	I-DISEASE
%	0
of	0
patients	0
with	0
RLS	0
versus	0
zero	0
patients	0
with	I-DISEASE
insomnia	0
had	0
SRED	I-DISEASE
,	0
and	I-DISEASE
the	I-DISEASE
very	0
significant	0
difference	0
was	I-DISEASE
not	I-DISEASE
related	0
to	0
arousal	0
frequency	I-DISEASE
.	I-DISEASE

In	0
that	0
study	I-DISEASE
,	I-DISEASE
patients	0
with	I-DISEASE
RLS	0
who	0
were	I-DISEASE
taking	0
hypnotic	0
medications	0
were	I-DISEASE
at	0
additional	I-DISEASE
risk	I-DISEASE
for	0
SRED	0
.	0

Familial	0
Pattern	0
A	0
familial	0
basis	0
for	0
SRED	I-DISEASE
is	0
not	I-DISEASE
uncommon	0
,	0
including	0
co	0
-	0
occurrence	I-DISEASE
in	I-DISEASE
fraternal	0
twins	I-DISEASE
,	0
although	0
detailed	0
genetic	0
studies	0
have	0
not	0
been	0
carried	I-DISEASE
out	I-DISEASE
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
The	I-DISEASE
onset	0
of	I-DISEASE
SRED	0
can	I-DISEASE
be	0
insidious	0
and	0
sporadic	0
,	0
or	0
it	I-DISEASE
can	0
be	0
precipitous	0
and	0
fulmi-	0
nant	0
with	I-DISEASE
rapid	0
development	0
of	0
nightly	I-DISEASE
episodes	I-DISEASE
of	0
eating	0
,	0
related	0
or	0
unrelated	0
to	0
the	I-DISEASE
start	0
of	0
hypnotic	0
medication	I-DISEASE
therapy	0
of	0
insomnia	I-DISEASE
.	0

The	0
course	0
is	0
usually	0
unremitting	0
.	0

Fires	0
can	0
occur	0
when	0
the	0
individual	0
with	I-DISEASE
SRED	0
begins	I-DISEASE
to	0
cook	0
foods	0
on	0
the	0
stove	I-DISEASE
or	0
in	I-DISEASE
the	0
oven	0
,	0
and	0
then	0
abandons	0
them	0
.	I-DISEASE

A	0
variety	0
of	0
other	0
complications	0
have	0
been	0
described	0
previously	I-DISEASE
.	0

Developmental	0
Issues	0
SRED	0
can	0
emerge	0
in	0
childhood	I-DISEASE
,	0
either	0
associated	0
or	0
unassociated	0
with	0
a	0
family	0
history	0
of	0
SRED	I-DISEASE
.	0

Pathology	0
and	0
Pathophysiology	0
The	0
underlying	0
pathophysiology	I-DISEASE
of	I-DISEASE
SRED	0
is	I-DISEASE
unclear	0
.	0

Despite	0
the	0
broad	I-DISEASE
range	I-DISEASE
of	I-DISEASE
pre-	I-DISEASE
disposing	I-DISEASE
and	0
precipitating	I-DISEASE
factors	0
in	0
SRED	0
,	I-DISEASE
the	0
relatively	I-DISEASE
homogeneous	0
set	0
of	I-DISEASE
clinical	0
features	0
suggests	0
the	0
presence	I-DISEASE
of	0
a	I-DISEASE
“	I-DISEASE
final	I-DISEASE
common	I-DISEASE
pathway	0
”	I-DISEASE
that	0
can	I-DISEASE
be	0
accessed	0
by	0
a	0
variety	0
of	0
factors	0
.	I-DISEASE

Although	0
SRED	0
has	0
prominent	0
features	0
of	0
both	I-DISEASE
a	0
sleep	0
disorder	0
and	I-DISEASE
an	I-DISEASE
eating	I-DISEASE
disorder	I-DISEASE
,	I-DISEASE
its	0
relatively	0
homogeneous	I-DISEASE
presentation	0
supports	0
its	0
classification	0
as	0
a	I-DISEASE
separate	0
diagnostic	0
entity	0
.	I-DISEASE

More	0
than	0
half	0
of	I-DISEASE
patients	0
with	I-DISEASE
SRED	I-DISEASE
have	0
a	I-DISEASE
history	0
of	0
another	0
parasomnia	I-DISEASE
that	0
preceded	I-DISEASE
the	0
onset	0
of	I-DISEASE
nocturnal	0
eating	0
,	I-DISEASE
suggesting	0
that	0
the	I-DISEASE
presence	I-DISEASE
of	0
another	0
parasomnia	I-DISEASE
is	I-DISEASE
a	I-DISEASE
major	0
risk	I-DISEASE
factor	0
for	0
SRED	0
.	0

However	0
,	I-DISEASE
the	0
female	I-DISEASE
predominance	0
in	0
SRED	I-DISEASE
is	0
more	I-DISEASE
consistent	0
with	0
eating	0
disorders	0
,	0
which	I-DISEASE
are	0
female	0
pre-	I-DISEASE
dominant	0
,	I-DISEASE
than	0
with	0
sleepwalking	0
or	I-DISEASE
movement	0
disorders	0
(	0
RLS	I-DISEASE
/	I-DISEASE
PLMD	0
)	0
which	0
have	0
slight	0
to	0
no	0
female	I-DISEASE
bias	0
.	I-DISEASE

Thus	0
it	0
appears	0
that	0
two	0
basic	0
drive	0
states	0
—	I-DISEASE
sleeping	0
and	0
eating	I-DISEASE
—	0
are	0
pathologically	I-DISEASE
intertwined	0
in	0
SRED	I-DISEASE
.	0

Parasomnias	0
Parasomnias	0
Objective	0
Findings	0
Although	0
not	I-DISEASE
routinely	0
indicated	0
in	0
the	0
assessment	I-DISEASE
of	0
SRED	0
,	0
vPSG	0
evaluations	I-DISEASE
have	0
often	I-DISEASE
reported	0
positive	0
findings	0
.	0

The	0
most	0
common	0
finding	0
consists	0
of	0
multiple	I-DISEASE
confu-	0
sional	I-DISEASE
arousals	0
,	0
with	0
or	I-DISEASE
without	0
eating	I-DISEASE
,	0
arising	0
from	0
slow	I-DISEASE
wave	0
sleep	0
.	0

However	0
,	I-DISEASE
abnor-	0
mal	0
arousals	0
have	I-DISEASE
been	I-DISEASE
documented	0
from	I-DISEASE
all	0
stages	I-DISEASE
of	0
NREM	0
sleep	0
and	0
also	0
occasion-	0
ally	I-DISEASE
from	0
REM	0
sleep	0
.	I-DISEASE

The	0
level	0
of	0
consciousness	I-DISEASE
has	0
typically	0
spanned	I-DISEASE
the	0
range	I-DISEASE
from	0
virtual	0
unconsciousness	0
to	I-DISEASE
various	0
levels	I-DISEASE
of	0
partial	0
consciousness	I-DISEASE
despite	0
a	0
concurrent	0
EEG	0
pattern	0
that	I-DISEASE
is	I-DISEASE
often	0
predominantly	0
awake	I-DISEASE
,	I-DISEASE
suggesting	0
dissociation	0
between	0
the	0
EEG	0
and	0
the	0
level	0
of	I-DISEASE
consciousness	0
.	I-DISEASE

This	0
dissociation	0
also	0
can	0
be	0
found	0
in	0
adult	0
sleep-	I-DISEASE
walking	0
without	0
associated	I-DISEASE
eating	0
.	0

In	0
contrast	0
,	0
classic	0
sleepwalking	0
in	I-DISEASE
childhood	I-DISEASE
is	0
usually	0
associated	0
with	0
the	0
persistence	0
of	0
high	I-DISEASE
-	0
voltage	0
delta	I-DISEASE
waves	0
or	0
the	0
admixture	0
of	0
delta	0
,	I-DISEASE
theta	0
,	0
and	0
alpha	0
activity	I-DISEASE
.	0

A	0
predominant	0
wake	0
pattern	I-DISEASE
is	0
rare	0
in	I-DISEASE
childhood	0
sleep-	0
walking	0
.	0

PLMs	0
and	0
OSA	0
may	I-DISEASE
be	0
observed	I-DISEASE
in	I-DISEASE
polysomnographic	0
monitoring	I-DISEASE
of	0
SRED	0
patients	0
.	I-DISEASE

In	0
one	0
recent	0
study	I-DISEASE
that	I-DISEASE
addressed	I-DISEASE
the	I-DISEASE
boundaries	I-DISEASE
between	I-DISEASE
SRED	0
and	0
fully	0
conscious	I-DISEASE
abnormal	0
nocturnal	I-DISEASE
eating	I-DISEASE
,	I-DISEASE
22	0
of	0
35	0
patients	0
had	I-DISEASE
PLMs	I-DISEASE
,	I-DISEASE
5	I-DISEASE
of	I-DISEASE
35	0
had	I-DISEASE
RLS	0
,	I-DISEASE
and	I-DISEASE
29	I-DISEASE
of	0
35	0
had	0
recurring	0
chewing	0
and	I-DISEASE
swallowing	0
movements	I-DISEASE
during	I-DISEASE
sleep	0
that	0
were	0
associated	I-DISEASE
with	I-DISEASE
nearly	I-DISEASE
half	I-DISEASE
of	I-DISEASE
the	0
total	0
number	0
of	I-DISEASE
EEG	I-DISEASE
arousals	0
.	I-DISEASE

Differential	0
Diagnosis	0
SRED	0
must	0
be	0
distinguished	I-DISEASE
primarily	0
from	0
night	0
eating	I-DISEASE
syndrome	0
(	I-DISEASE
NES	0
)	I-DISEASE
,	I-DISEASE
which	I-DISEASE
is	I-DISEASE
characterized	I-DISEASE
by	0
excessive	I-DISEASE
eating	0
between	I-DISEASE
dinner	0
and	0
bedtime	I-DISEASE
and	I-DISEASE
during	0
full	I-DISEASE
awaken-	0
ings	I-DISEASE
during	0
the	I-DISEASE
sleep	0
period	0
.	0

In	0
contrast	0
to	0
daytime	0
eating	0
disorders	0
(	I-DISEASE
bulimia	0
nervosa	I-DISEASE
,	0
anorexia	0
nervosa	0
)	0
,	0
inappropriate	I-DISEASE
compensatory	0
behavior	I-DISEASE
,	I-DISEASE
such	0
as	0
self	0
-	0
induced	0
vom-	I-DISEASE
iting	I-DISEASE
,	0
enemas	0
,	0
misuse	0
of	0
laxatives	0
,	0
diuretics	0
,	0
or	0
other	0
medications	0
,	0
or	0
other	0
purging	0
activity	I-DISEASE
,	0
are	0
not	0
present	I-DISEASE
in	I-DISEASE
SRED	I-DISEASE
,	0
although	I-DISEASE
the	0
two	0
conditions	I-DISEASE
may	0
be	0
comorbid	0
.	0

A	0
person	0
with	0
a	0
daytime	0
eating	0
disorder	I-DISEASE
may	0
also	I-DISEASE
have	0
a	0
coexisting	0
SRED	I-DISEASE
that	0
is	I-DISEASE
asso-	I-DISEASE
ciated	0
with	0
confusional	0
arousals	0
but	0
not	0
associated	I-DISEASE
with	I-DISEASE
purging	I-DISEASE
behaviors	0
during	I-DISEASE
the	0
night	0
or	I-DISEASE
upon	0
arising	I-DISEASE
in	0
the	0
morning	0
.	0

Patients	0
with	0
longstanding	B-DISEASE
SRED	0
and	0
excessive	I-DISEASE
weight	0
gain	0
may	I-DISEASE
eventually	0
fast	0
during	I-DISEASE
the	0
daytime	0
and/or	I-DISEASE
engage	I-DISEASE
in	I-DISEASE
excessive	0
exer-	0
cise	0
to	0
prevent	I-DISEASE
obesity	0
from	I-DISEASE
the	0
SRED	0
.	0

Likewise	0
,	0
patients	0
who	I-DISEASE
otherwise	0
fulfill	0
crite-	I-DISEASE
ria	0
for	I-DISEASE
SRED	0
may	0
consciously	0
eat	0
during	0
the	0
prebedtime	0
period	0
in	I-DISEASE
a	0
futile	I-DISEASE
attempt	0
to	0
suppress	0
the	0
compulsion	0
to	0
eat	0
after	0
subsequently	0
falling	0
asleep	0
.	I-DISEASE

SRED	0
appears	0
to	0
be	0
considerably	0
more	I-DISEASE
female	I-DISEASE
predominant	0
that	I-DISEASE
NES	0
(	I-DISEASE
which	0
has	0
<	0
60	I-DISEASE
%	0
female	I-DISEASE
prevalence	I-DISEASE
)	0
,	0
and	0
mood	I-DISEASE
disorders	0
are	0
more	0
common	0
with	0
NES	0
than	0
with	0
SRED	0
.	I-DISEASE

Nevertheless	0
,	0
SRED	0
and	0
NES	0
share	I-DISEASE
a	I-DISEASE
considerable	0
number	I-DISEASE
of	0
overlapping	0
features	0
and	I-DISEASE
may	0
exist	I-DISEASE
along	I-DISEASE
a	0
common	I-DISEASE
spectrum	0
of	0
pathophysiology	0
.	0

SRED	0
should	0
also	0
be	0
distinguished	0
from	0
nocturnal	I-DISEASE
(	0
sleep	I-DISEASE
related	0
)	0
extensions	I-DISEASE
of	I-DISEASE
bulimia	I-DISEASE
nervosa	0
,	0
binge	0
-	I-DISEASE
eating	0
disorder	0
,	0
and	0
anorexia	0
nervosa	0
,	I-DISEASE
binge	0
/	0
purge	I-DISEASE
type	0
.	0

The	0
nocturnal	0
eating	I-DISEASE
(	0
drinking	0
)	I-DISEASE
syndrome	I-DISEASE
described	I-DISEASE
in	I-DISEASE
the	0
original	0
International	I-DISEASE
Classification	0
of	0
Sleep	0
Disorders	I-DISEASE
is	I-DISEASE
primarily	I-DISEASE
a	0
disorder	0
of	0
infancy	0
that	0
is	I-DISEASE
characterized	I-DISEASE
by	I-DISEASE
recurrent	I-DISEASE
awakenings	I-DISEASE
with	0
the	0
inability	I-DISEASE
to	I-DISEASE
resume	0
sleep	0
without	0
eating	0
or	I-DISEASE
drinking	0
.	0

Kleine	0
-	0
Levin	0
syndrome	I-DISEASE
(	0
periodic	I-DISEASE
hypersomnia	I-DISEASE
)	0
can	I-DISEASE
present	0
with	0
inappropriate	0
noctur-	0
nal	I-DISEASE
eating	I-DISEASE
,	I-DISEASE
but	0
its	I-DISEASE
predominance	I-DISEASE
in	I-DISEASE
adolescent	0
males	0
and	0
its	0
hallmark	I-DISEASE
symptom	0
complex	0
of	I-DISEASE
periodic	0
hypersomnia	0
,	0
hypersexuality	0
,	0
and	0
hyperphagia	0
lasting	0
days	I-DISEASE
to	0
weeks	I-DISEASE
should	0
easily	I-DISEASE
distinguish	I-DISEASE
it	0
from	0
SRED	0
.	I-DISEASE

Medical	0
and	0
neurologic	0
disorders	I-DISEASE
that	0
could	0
be	0
asso-	0
ciated	I-DISEASE
with	0
abnormal	0
recurrent	0
eating	0
during	0
the	I-DISEASE
main	0
sleep	0
period	I-DISEASE
(	0
usually	I-DISEASE
with	0
full	0
or	I-DISEASE
almost	0
full	I-DISEASE
alertness	0
)	I-DISEASE
should	I-DISEASE
also	0
be	I-DISEASE
excluded	0
.	0

These	0
include	0
:	0
hypoglycemic	0
states	0
,	0
peptic	I-DISEASE
ulcer	0
disease	I-DISEASE
,	0
reflux	0
esophagitis	0
,	0
and	0
Kluver	0
-	I-DISEASE
Bucy	0
syndrome	I-DISEASE
.	0

Unresolved	0
Issues	0
and	0
Future	0
Directions	I-DISEASE

The	0
extent	0
of	0
overlap	0
and	0
divergence	I-DISEASE
between	I-DISEASE
SRED	0
and	0
NES	0
needs	0
to	0
be	0
further	0
elucidated	0
.	0

Bibliography	0
Brion	0
A	I-DISEASE
,	0
Flamand	I-DISEASE
M	0
,	I-DISEASE
Oudiette	0
D	I-DISEASE
,	0
Voillery	0
D	0
,	0
Golmard	0
JL	I-DISEASE
,	0
Arnulf	I-DISEASE
I.	I-DISEASE
Sleep	0
related	I-DISEASE
eating	0
disorder	0
versus	I-DISEASE
sleepwalking	0
:	I-DISEASE
a	0
controlled	I-DISEASE
study	0
.	0

Sleep	0
Med	0
2012	0
;	0
3:1094–101	0
.	0

Howell	0
MJ	0
,	0
Schenck	0
CH	0
,	0
Crow	I-DISEASE
SJ	0
.	I-DISEASE

A	0
review	0
of	0
nighttime	0
eating	I-DISEASE
disorders	I-DISEASE
.	I-DISEASE

Sleep	0
Med	0
Rev	I-DISEASE
2009;13:23–-34	0
.	B-DISEASE

Howell	0
MJ	0
,	0
Schenck	0
CH	0
.	0

Restless	0
nocturnal	0
eating	0
:	I-DISEASE
a	0
common	0
feature	I-DISEASE
of	0
Willis	0
-	0
Ekbom	0
syndrome	0
(	0
RLS	0
)	0
.	0

J	0
Clin	0
Sleep	I-DISEASE
Med	0
2012;8:413–9	0
.	I-DISEASE

Palaia	0
V	0
,	0
Poli	0
F	0
,	0
Pizz	0
F	0
,	0
et	0
al	0
.	0

Narcolepsy	0
with	0
cataplexy	0
associated	0
with	0
nocturnal	0
compulsive	I-DISEASE
behaviors	0
:	0
a	0
case	0
-	0
control	I-DISEASE
study	0
.	0

Sleep	0
2011;34:1365–71	0
.	0

Schenck	0
CH	0
,	0
Hurwitz	0
TD	0
,	0
Bundlie	I-DISEASE
SR	0
,	0
Mahowald	0
MW	0
.	0

Sleep	0
-	I-DISEASE
related	I-DISEASE
eating	I-DISEASE
disorders	0
:	I-DISEASE
polysomnographic	I-DISEASE
correlates	0
of	I-DISEASE
a	0
heterogeneous	0
syndrome	I-DISEASE
distinct	0
from	0
daytime	I-DISEASE
eating	0
disorders	I-DISEASE
.	I-DISEASE

Sleep	0
1991;14:419–31	0
.	0

Schenck	0
CH	0
,	0
Hurwitz	0
TD	0
,	0
O’Connor	I-DISEASE
KA	0
,	0
Mahowald	0
MW	0
.	0

Additional	0
categories	0
of	0
sleep	0
-	0
related	0
eating	I-DISEASE
disorders	0
and	I-DISEASE
the	0
current	0
status	0
of	0
treatment	0
.	I-DISEASE

Sleep	0
1993;16:457–66	0
.	0

Vetrugno	0
R	0
,	0
Manconi	0
M	0
,	I-DISEASE
Ferini	I-DISEASE
-	I-DISEASE
Strambi	I-DISEASE
L	0
,	0
Provini	0
F	0
,	0
Plazzi	I-DISEASE
G	I-DISEASE
,	0
Montagna	0
P.	I-DISEASE
Nocturnal	0
eating	0
:	0
sleep	0
-	0
related	I-DISEASE
eating	I-DISEASE
disorder	I-DISEASE
or	I-DISEASE
night	I-DISEASE
eating	0
syndrome	0
?	0

A	0
videopolysomnographic	0
study	0
.	0

Sleep	0
2006;29:949–54	0
.	0

Vinai	0
P	0
,	0
Ferri	0
R	0
,	0
Ferini	I-DISEASE
-	0
Strambi	I-DISEASE
L	0
,	0
et	0
al	0
.	0

Defining	0
the	0
borders	0
between	I-DISEASE
sleep	0
-	0
related	I-DISEASE
eating	0
disorder	I-DISEASE
and	0
night	0
eating	0
syndrome	I-DISEASE
.	0

Sleep	0
Med	0
2012;13:686–90	0
.	0

Winkelman	0
JW	0
.	0

Clinical	0
and	0
polysomnographic	0
features	0
of	0
sleep	0
-	0
related	0
eating	I-DISEASE
disorder	0
.	0

J	0
Clin	0
Psychiatry	I-DISEASE
1998;59:14–9	0
.	0

Winkelman	0
JW	0
,	0
Herzog	0
DB	0
,	I-DISEASE
Fava	I-DISEASE
M.	0

The	0
prevalence	0
of	I-DISEASE
sleep	I-DISEASE
-	0
related	0
eating	I-DISEASE
disorder	0
in	I-DISEASE
psychiatric	0
and	0
non	0
-	0
psychiatric	0
populations	0
.	I-DISEASE

Psychol	0
Med	0
1999;29:1461–6	I-DISEASE
.	0

Winkelman	0
JW	0
.	0

Sleep	0
-	I-DISEASE
related	0
eating	I-DISEASE
disorder	0
and	I-DISEASE
night	I-DISEASE
eating	0
syndrome	I-DISEASE
:	I-DISEASE
sleep	0
disorders	I-DISEASE
,	0
eating	0
disorders	I-DISEASE
,	0
or	0
both	0
?	0

Sleep	0
2006;29:876–7	0
.	0

Parasomnias	0
Parasomnias	0
REM	0
-	0
Related	0
Parasomnias	I-DISEASE
REM	0
Sleep	0
Behavior	0
Disorder	0
ICD-9	0
-	0
CM	0
code	0
:	I-DISEASE
327.42	0
Alternate	0
Names	0
None	0
.	0

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
D	I-DISEASE
must	I-DISEASE
be	0
met	I-DISEASE
ICD-10	0
-	0
CM	0
code	I-DISEASE
:	0
G47.52	0
A.	I-DISEASE
Repeated	0
episodes	0
of	0
sleep	0
related	0
vocalization	0
and/or	I-DISEASE
complex	0
motor	0

behaviors.1,2	0
B.	0

These	0
behaviors	0
are	0
documented	0
by	0
polysomnography	0
to	I-DISEASE
occur	0
during	I-DISEASE
REM	0
sleep	0
or	I-DISEASE
,	0
based	0
on	I-DISEASE
clinical	I-DISEASE
history	0
of	I-DISEASE
dream	0
enactment	0
,	0
are	0
presumed	0
to	0
occur	I-DISEASE
during	0
REM	0
sleep	0
.	0

C.	0
Polysomnographic	I-DISEASE
recording	0
demonstrates	0
REM	0
sleep	0
without	I-DISEASE
atonia	0
(	I-DISEASE
RWA)3	0
D.	0

The	0
disturbance	0
is	0
not	0
better	I-DISEASE
explained	I-DISEASE
by	I-DISEASE
another	0
sleep	I-DISEASE
disorder	0
,	0
mental	0
disorder	I-DISEASE
,	0
medication	I-DISEASE
,	0
or	0
substance	I-DISEASE
use	0
.	0

Notes	0
.	0

This	0
criterion	0
can	0
be	0
fulfilled	I-DISEASE
by	I-DISEASE
observation	I-DISEASE
of	0
repetitive	I-DISEASE
episodes	0
during	0
a	I-DISEASE
single	0
night	0
of	I-DISEASE
video	0
polysomnography	0
.	I-DISEASE
.	0

The	0
observed	0
vocalizations	0
or	0
behaviors	0
often	0
correlate	0
with	0
simultaneously	I-DISEASE
occurring	0
dream	0
mentation	0
,	0
leading	0
to	0
the	0
frequent	I-DISEASE
report	I-DISEASE
of	0
“	0
acting	0
out	0
one	0
’s	0
dreams	0
.	0
”	0
.	0

As	0
defined	0
by	0
the	0
guidelines	I-DISEASE
for	0
scoring	0
PSG	0
features	I-DISEASE
of	0
RBD	0
in	0
the	0
most	0
recent	0
version	I-DISEASE
of	0
the	0
American	0
Academy	0
of	0
Sleep	0
Medicine	0
(	0
AASM	I-DISEASE
)	0
Manual	0
for	0
the	0
Scoring	I-DISEASE
of	0
Sleep	0
and	0
Associated	0
Events	0
.	0
.	I-DISEASE

Upon	0
awakening	0
,	0
the	0
individual	0
is	I-DISEASE
typically	I-DISEASE
awake	0
,	I-DISEASE
alert	0
,	0
coherent	0
,	0
and	0
oriented	I-DISEASE
.	0
.	0

On	0
occasion	0
,	0
there	0
may	I-DISEASE
be	0
patients	I-DISEASE
with	I-DISEASE
a	I-DISEASE
typical	0
clinical	0
history	0
of	0
RBD	0
with	0
dream	0
-	0
enacting	0
behaviors	0
,	0
who	0
also	0
exhibit	0
typical	0
RBD	0
behaviors	0
during	0
vPSG	I-DISEASE
,	0
but	0
do	0
not	I-DISEASE
demonstrate	0
sufficient	0
RWA	0
,	0
based	0
on	0
the	I-DISEASE
current	0
evidence	0
-	0
based	0
data	0
,	0
to	0
satisfy	I-DISEASE
the	0
PSG	0
criteria	I-DISEASE
for	0
diagnosing	0
RBD	I-DISEASE
.	0

In	0
such	0
patients	0
,	I-DISEASE
RBD	0
may	0
be	0
provisionally	0
diagnosed	I-DISEASE
,	0
based	0
on	0
clinical	0
judgment	0
.	0

The	0
same	0
rule	0
applies	0
when	0
vPSG	0
is	0
not	0
readily	0
available	0
.	0

6	0
.	0

Medications	0
may	I-DISEASE
unmask	0
latent	I-DISEASE
RBD	0
with	0
preexisting	0
RWA	0
,	0
according	0
to	0
current	0
expert	0
opinion	0
.	I-DISEASE

Therefore	0
,	0
medication	0
-	0
induced	0
RBD	0
can	0
be	0
diagnosed	0
as	0
RBD	0
,	0
using	0
clinical	0
judgment	I-DISEASE
,	0
pending	0
future	I-DISEASE
longitudinal	0
studies	0
.	0

Essential	0
Features	0
RBD	0
is	0
characterized	0
by	0
abnormal	0
behaviors	0
emerging	0
during	0
REM	0
sleep	0
that	0
may	0
cause	I-DISEASE
injury	0
or	0
sleep	I-DISEASE
disruption	0
.	0

RBD	0
is	0
also	0
associated	0
with	0
EMG	0
abnormalities	0
during	0
REM	I-DISEASE
sleep	0
.	0

The	0
EMG	0
demonstrates	0
an	0
excess	0
of	I-DISEASE
muscle	0
tone	0
during	I-DISEASE
REM	0
sleep	0
,	0
and/or	0
an	I-DISEASE
excess	I-DISEASE
of	I-DISEASE
phasic	0
EMG	0
twitch	0
activity	0
during	0
REM	0
sleep	0
.	0

A	0
complaint	0
of	I-DISEASE
sleep	I-DISEASE
related	0
injury	I-DISEASE
is	I-DISEASE
common	0
with	0
RBD	0
,	0
which	0
usually	0
manifests	0
as	I-DISEASE
an	0
attempted	I-DISEASE
enactment	I-DISEASE
of	0
unpleasant	0
,	0
action	0
-	0
filled	0
,	I-DISEASE
and	0
violent	0
dreams	I-DISEASE
in	0
which	0
the	I-DISEASE
individual	I-DISEASE
is	0
being	0
confronted	I-DISEASE
,	I-DISEASE
attacked	0
,	I-DISEASE
or	0
chased	0
by	I-DISEASE
unfamiliar	I-DISEASE
people	0
or	0
animals	I-DISEASE
.	I-DISEASE

Typically	0
,	0
at	0
the	I-DISEASE
end	I-DISEASE
of	0
an	I-DISEASE
episode	I-DISEASE
,	0
the	0
individual	I-DISEASE
awakens	0
quickly	0
,	0
becomes	I-DISEASE
rapidly	0
alert	0
,	0
and	0
reports	0
a	0
dream	0
with	0
a	0
coherent	I-DISEASE
story	0
.	0

The	0
dream	0
action	0
corresponds	B-DISEASE
closely	0
to	0
the	I-DISEASE
observed	I-DISEASE
sleep	I-DISEASE
behaviors	I-DISEASE
.	0

Sleep	0
and	0
dream	0
-	0
related	0
behaviors	I-DISEASE
reported	I-DISEASE
by	0
history	I-DISEASE
and	0
documented	0
during	0
vPSG	I-DISEASE
include	0
both	0
violent	0
and	0
(	0
less	B-DISEASE
commonly	I-DISEASE
)	0
nonviolent	0
behaviors	0
:	I-DISEASE
talking	0
(	0
including	I-DISEASE
giving	I-DISEASE
speeches	0
)	B-DISEASE
,	0
smiling	0
,	0
laughing	0
,	0
singing	0
,	0
whistling	I-DISEASE
,	I-DISEASE
shouting	0
,	0
swearing	0
profan-	0
ities	0
,	0
crying	I-DISEASE
,	I-DISEASE
chewing	0
,	0
gesturing	I-DISEASE
,	0
reaching	I-DISEASE
,	I-DISEASE
grabbing	0
,	0
arm	0
flailing	0
,	0
clapping	0
,	I-DISEASE
slap-	I-DISEASE
ping	0
,	0
punching	0
,	0
kicking	I-DISEASE
,	0
sitting	0
up	0
,	I-DISEASE
leaping	0
from	0
bed	I-DISEASE
,	I-DISEASE
crawling	0
,	I-DISEASE
running	0
,	I-DISEASE
or	I-DISEASE
dancing	0
.	I-DISEASE

Walking	0
,	I-DISEASE
however	0
,	0
is	0
quite	0
uncommon	I-DISEASE
with	0
RBD	I-DISEASE
,	0
and	0
leaving	0
the	0
room	0
is	I-DISEASE
especially	0
rare	0
,	0
because	0
the	0
eyes	0
are	0
usually	0
closed	0
,	0
precluding	0
attention	0
to	B-DISEASE
the	0
environment	0
.	0

There	0
can	0
be	0
rare	I-DISEASE
occurrences	I-DISEASE
of	0
smoking	I-DISEASE
a	0
fictive	I-DISEASE
cigarette	0
,	0
masturbation	0
-	0
like	0
behav-	I-DISEASE
ior	0
,	0
pelvic	I-DISEASE
thrusting	0
,	I-DISEASE
and	0
mimics	I-DISEASE
of	I-DISEASE
eating	I-DISEASE
,	I-DISEASE
drinking	0
,	I-DISEASE
urinating	I-DISEASE
,	I-DISEASE
and	I-DISEASE
defecating	0
.	I-DISEASE

The	0
eyes	0
usually	0
remain	0
closed	0
during	0
an	I-DISEASE
RBD	0
episode	0
,	0
with	0
the	0
person	0
attending	0
to	I-DISEASE
the	0
dream	0
action	I-DISEASE
and	0
not	0
to	0
the	0
actual	0
environment	I-DISEASE
.	I-DISEASE

Medical	0
attention	0
is	0
usually	0
sought	0
after	I-DISEASE
sleep	I-DISEASE
related	I-DISEASE
injury	I-DISEASE
has	0
occurred	0
to	0
either	0
the	0
person	I-DISEASE
or	0
the	0
bed	I-DISEASE
partner	0
,	0
and	0
rarely	0
because	0
of	0
sleep	I-DISEASE
disruption	I-DISEASE
.	0

Because	0
RBD	0
occurs	0
during	0
REM	0
sleep	I-DISEASE
,	I-DISEASE
it	0
usually	I-DISEASE
appears	0
at	0
least	0
90	0
minutes	0
after	I-DISEASE
sleep	0
onset	0
,	I-DISEASE
unless	I-DISEASE
there	0
is	0
coexisting	0
narcolepsy	I-DISEASE
,	0
in	I-DISEASE
which	0
case	I-DISEASE
RBD	I-DISEASE
can	0
emerge	0
shortly	0
after	0
sleep	0
onset	0
during	I-DISEASE
a	0
sleep	0
onset	0
rapid	0
eye	0
movement	I-DISEASE
period	0
(	I-DISEASE
SOREMP	0
)	I-DISEASE
.	0

There	0
is	0
an	0
acute	I-DISEASE
form	0
of	I-DISEASE
RBD	I-DISEASE
that	0
emerges	0
during	0
intense	0
REM	I-DISEASE
sleep	0
rebound	0
states	I-DISEASE
,	I-DISEASE
such	0
as	I-DISEASE
during	0
withdrawal	0
from	0
alcohol	0
and	I-DISEASE
sedative	I-DISEASE
-	0
hypnotic	0
agents	I-DISEASE
,	I-DISEASE
or	0
in	0
association	0
with	I-DISEASE
certain	0
medication	0
use	0
,	0
drug	0
intoxication	I-DISEASE
,	0
or	0
relapsing	0
multiple	0
sclerosis	0
.	0

Parasomnias	0
Parasomnias	0
Associated	0
Features	0
PLMs	0
during	I-DISEASE
NREM	0
sleep	0
are	0
very	0
common	0
with	0
RBD	0
and	0
may	0
disturb	I-DISEASE
the	0
sleep	0
of	0
the	I-DISEASE
bed	0
partner	0
.	0

Daytime	0
tiredness	0
or	0
sleepiness	0
is	0
uncommon	0
,	I-DISEASE
unless	0
narcolepsy	I-DISEASE
is	0
also	0
present	0
.	0

There	0
is	0
typically	0
no	0
history	0
of	0
irritable	I-DISEASE
,	0
aggressive	I-DISEASE
,	0
or	0
violent	0
behav-	0
ior	0
during	I-DISEASE
the	I-DISEASE
day	0
.	I-DISEASE

There	0
may	0
be	0
a	I-DISEASE
longstanding	0
prodromal	0
history	I-DISEASE
of	0
sleep	I-DISEASE
talking	0
,	0
yelling	0
,	I-DISEASE
limb	I-DISEASE
twitching	I-DISEASE
,	I-DISEASE
and	0
jerking	I-DISEASE
during	0
sleep	I-DISEASE
that	0
may	0
or	I-DISEASE
may	0
not	I-DISEASE
be	I-DISEASE
dream	0
related	B-DISEASE
.	0

Clinical	0
or	0
Pathophysiological	0
Subtypes	I-DISEASE
Parasomnia	I-DISEASE
overlap	I-DISEASE
disorder	I-DISEASE
is	I-DISEASE
a	I-DISEASE
condition	0
in	I-DISEASE
which	0
patients	0
have	0
both	I-DISEASE
RBD	0
and	I-DISEASE
either	I-DISEASE
a	0
disorder	I-DISEASE
of	0
arousal	I-DISEASE
,	I-DISEASE
sleep	0
related	0
eating	0
disorder	0
,	I-DISEASE
sexsomnia	0
,	0
or	I-DISEASE
rhythmic	I-DISEASE
movement	0
disorder	0
.	0

This	0
condition	0
is	0
male	0
predominant	0
,	0
but	I-DISEASE
less	0
so	0
than	0
isolated	0
RBD	0
.	0

Most	0
cases	0
begin	0
during	0
childhood	0
or	0
adolescence	0
.	0

Virtually	0
all	0
age	0
groups	0
can	0
be	0
affected	0
.	0

It	0
can	0
be	0
idiopathic	I-DISEASE
or	0
symptomatic	I-DISEASE
of	I-DISEASE
a	0
broad	I-DISEASE
set	0
of	0
disorders	0
,	I-DISEASE
including	0
narcolepsy	I-DISEASE
,	I-DISEASE
mul-	I-DISEASE
tiple	I-DISEASE
sclerosis	0
,	0
brain	0
tumor	0
(	0
and	0
therapy	I-DISEASE
)	0
,	0
rhombencephalitis	0
(	0
right	I-DISEASE
pontine	0
tegmen-	0
tum	0
/	0
medulla	0
lesion	0
)	0
,	I-DISEASE
brain	I-DISEASE
trauma	0
,	I-DISEASE
congenital	0
Moebius	0
syndrome	0
,	I-DISEASE
agrypnia	0
excitata	I-DISEASE
,	I-DISEASE
Machado	0
-	I-DISEASE
Joseph	0
disease	I-DISEASE
,	I-DISEASE
various	0
psychiatric	0
disorders	0
and	I-DISEASE
their	I-DISEASE
pharmacotherapies	0
,	0
and	0
substance	0
abuse	I-DISEASE
disorders	I-DISEASE
and	0
withdrawal	0
states	I-DISEASE
.	0

Status	0
dissociatus	0
can	0
be	0
classified	0
as	0
a	I-DISEASE
subtype	I-DISEASE
of	I-DISEASE
RBD	0
that	0
manifests	0
as	0
an	0
extreme	0
form	0
of	0
state	I-DISEASE
dissociation	0
without	0
identifiable	0
sleep	0
stages	0
,	0
but	I-DISEASE
with	0
sleep	0
and	I-DISEASE
dream	I-DISEASE
-	0
related	0
behaviors	I-DISEASE
that	0
closely	0
resemble	0
RBD	0
.	0

Status	0
dissociatus	0
represents	0
a	0
major	0
breakdown	0
of	0
the	0
polysomnographic	I-DISEASE
markers	0
for	0
REM	I-DISEASE
sleep	0
,	0
NREM	I-DISEASE
sleep	0
,	0
and	I-DISEASE
wakefulness	0
,	0
with	0
admixtures	0
of	I-DISEASE
these	0
states	I-DISEASE
being	0
present	I-DISEASE
,	I-DISEASE
but	0
with	I-DISEASE
conventional	I-DISEASE
sleep	0
stages	0
not	0
being	0
identifiable	0
during	I-DISEASE
polysomnographic	0
monitoring	0
.	0

There	0
is	0
abnormal	0
behavioral	0
release	0
that	0
can	I-DISEASE
be	0
associated	I-DISEASE
with	0
disturbed	0
dreaming	0
,	I-DISEASE
strongly	0
suggestive	I-DISEASE
of	0
dream	0
-	I-DISEASE
enacting	0
behaviors	0
that	0
closely	0
resemble	I-DISEASE
RBD	0
.	I-DISEASE

Not	0
uncommonly	0
,	0
the	0
indi-	0
vidual	I-DISEASE
thinks	0
he	0
is	I-DISEASE
awake	0
when	0
observers	0
presume	0
he	0
is	I-DISEASE
asleep	I-DISEASE
and	0
attempting	0
to	0
act	0
out	0
a	0
dream	I-DISEASE
,	I-DISEASE
or	0
vice	0
versa	I-DISEASE
.	I-DISEASE

An	0
underlying	0
neurologic	0
or	0
medical	0
condition	0
,	0
spanning	0
a	I-DISEASE
broad	0
range	0
of	I-DISEASE
pathology	0
,	0
is	I-DISEASE
virtually	0
always	0
present	I-DISEASE
.	0

Dream	0
enactment	0
(	0
“	0
oneirism	0
”	I-DISEASE
)	0
that	0
is	0
REM	0
sleep	0
related	I-DISEASE
or	0
related	0
to	I-DISEASE
a	0
dissociated	I-DISEASE
REM	I-DISEASE
sleep	0
-	I-DISEASE
wakefulness	0
state	0
can	0
be	0
a	I-DISEASE
core	0
feature	0
of	0
a	I-DISEASE
pathologic	0
condition	I-DISEASE
called	0
agrypnia	0
excitata	0
that	0
is	0
characterized	0
by	0
generalized	0
motor	0
overactivity	0
,	0
impaired	0
ability	0
to	I-DISEASE
initiate	0
and	I-DISEASE
maintain	I-DISEASE
sleep	I-DISEASE
(	0
with	0
“	0
wakeful	I-DISEASE
dreaming	I-DISEASE
”	0
)	0
,	0
loss	I-DISEASE
of	0
slow	I-DISEASE
wave	0
sleep	0
,	0
and	I-DISEASE
marked	I-DISEASE
motor	I-DISEASE
and	0
autonomic	I-DISEASE
sympathetic	0
activation	I-DISEASE
.	0

Agrypnia	0
excitata	0
is	0
found	0
with	I-DISEASE
such	I-DISEASE
diverse	0
conditions	0
as	I-DISEASE
delirium	0
tremens	0
,	0
Morvan	0
syndrome	0
,	0
and	0
fatal	0
familial	I-DISEASE
insomnia	0
.	0

Thus	0
,	0
agrypnia	0
excitata	0
manifests	0
as	I-DISEASE
both	I-DISEASE
a	0
severe	0
parasomnia	0
and	0
a	0
severe	0
insomnia	0
.	0

Demographics	0
RBD	0
is	0
a	0
male	0
predominant	0
disorder	0
that	0
usually	I-DISEASE
emerges	0
after	0
age	0
50	0
years	0
.	0

Cases	0
of	0
RBD	0
from	0
early	0
childhood	0
up	0
to	0
age	0
88	0
years	0
have	0
been	0
reported	0
.	0

RBD	0
emerging	0
in	0
adults	0
before	0
age	0
50	I-DISEASE
years	0
tends	I-DISEASE
to	I-DISEASE
have	0
different	0
demographics	0
and	0
associated	I-DISEASE
features	I-DISEASE
,	0
including	0
greater	0
sex	0
parity	0
and	0
increased	0
rates	0
of	0
idiopathic	0
RBD	0
and	I-DISEASE
para-	0
somnia	I-DISEASE
overlap	I-DISEASE
disorder	0
(	0
POD	0
)	0
,	0
comorbid	I-DISEASE
narcolepsy	I-DISEASE
,	0
antidepressant	I-DISEASE
medication	I-DISEASE
use	I-DISEASE
,	0
and	0
possibly	0
autoimmune	I-DISEASE
diseases	I-DISEASE
.	0

In	0
addition	0
,	0
the	0
clinical	I-DISEASE
presentation	0
of	I-DISEASE
RBD	0
in	I-DISEASE
younger	0
adults	0
differs	0
from	0
that	0
in	0
older	0
adults	0
in	0
being	0
less	0
aggressive	0
and	0
violent	0
,	0
presumably	I-DISEASE
due	0
to	0
greater	0
female	0
representation	I-DISEASE
and	0
higher	0
rates	0
of	0
comorbid	0
narco-	I-DISEASE
lepsy	0
(	I-DISEASE
which	I-DISEASE
manifests	0
with	0
milder	I-DISEASE
RBD	0
behaviors	0
)	0
.	I-DISEASE

RBD	0
associated	0
with	0
neurologic	0
disorders	0
and	0
other	I-DISEASE
symptomatic	0
forms	0
of	0
RBD	0
are	0
as	0
male	0
predominant	0
as	0
idiopathic	0
RBD	I-DISEASE
,	0
with	0
the	0
exception	0
of	0
narcolepsy	I-DISEASE
(	0
as	0
described	I-DISEASE
below	B-DISEASE
)	0
and	0
multiple	0
system	0
atrophy	0
.	0

Of	0
note	0
,	0
RBD	0
may	0
not	0
be	0
the	0
presenting	I-DISEASE
com-	I-DISEASE
plaint	0
to	0
a	0
sleep	0
disorders	0
center	0
.	0

Therefore	0
,	0
systematic	0
questioning	0
for	0
RBD	0
should	0
be	0
included	0
for	0
all	0
newly	0
evaluated	0
patients	0
at	I-DISEASE
a	0
sleep	0
center	0
.	0

RBD	0
in	0
children	0
is	0
virtually	I-DISEASE
never	0
idiopathic	0
and	0
is	I-DISEASE
usually	0
associated	0
with	0
narcolepsy	0
(	0
at	I-DISEASE
times	0
emerging	0
months	I-DISEASE
before	0
the	0
emergence	0
of	0
narcoleptic	0
symptoms	0
)	0
,	I-DISEASE
brainstem	I-DISEASE
tumors	I-DISEASE
,	0
antidepressant	0
medications	0
,	0
neurodevelopmental	0
disorders	0
,	0
and	0
various	I-DISEASE
rare	I-DISEASE
conditions	0
.	0

The	0
prevalence	0
is	I-DISEASE
not	0
known	I-DISEASE
with	0
much	I-DISEASE
certainty	0
,	I-DISEASE
although	0
a	0
prevalence	0
of	I-DISEASE
0.38	0
%	I-DISEASE
to	0
0.5	0
%	0
is	0
reported	I-DISEASE
in	0
the	0
elderly	0
and	0
the	0
general	0
population	I-DISEASE
.	I-DISEASE

A	0
2.1	0
%	0
prevalence	0
of	0
current	0
sleep	I-DISEASE
related	0
violence	0
has	I-DISEASE
been	I-DISEASE
reported	0
;	0
38	0
%	0
of	I-DISEASE
these	0
events	0
have	0
associated	0
dream	0
enactment	0
,	0
suggesting	0
a	0
prevalence	0
of	0
RBD	I-DISEASE
as	0
high	0
as	I-DISEASE
0.8	I-DISEASE
%	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0

The	0
major	0
predisposing	0
factors	0
are	0
male	I-DISEASE
sex	0
,	0
age	0
50	0
years	0
or	0
older	0
,	0
and	I-DISEASE
an	0
under-	0
lying	I-DISEASE
neurological	0
disorder	0
,	0
particularly	0
Parkinson	0
disease	0
,	I-DISEASE
multiple	0
system	0
atrophy	I-DISEASE
,	I-DISEASE
dementia	0
with	0
Lewy	0
bodies	0
,	0
narcolepsy	0
,	0
or	I-DISEASE
stroke	0
.	0

A	0
recent	0
multicenter	I-DISEASE
case	I-DISEASE
-	0
control	0
study	I-DISEASE
of	0
environmental	I-DISEASE
risk	0
factors	0
of	0
RBD	0
found	0
that	I-DISEASE
smoking	0
,	0
head	I-DISEASE
injury	0
,	0
pesticide	0
exposure	0
,	0
and	0
farming	I-DISEASE
were	0
significant	0
risk	I-DISEASE
factors	0
.	I-DISEASE

Medications	0
,	I-DISEASE
particularly	0
the	I-DISEASE
anti-	0
depressants	I-DISEASE
venlafaxine	I-DISEASE
,	0
serotonin	I-DISEASE
-	I-DISEASE
specific	0
reuptake	0
inhibitors	I-DISEASE
(	0
SSRIs	I-DISEASE
)	0
,	I-DISEASE
mirtazapine	I-DISEASE
,	0
and	I-DISEASE
other	0
antidepressant	0
agents	0
(	I-DISEASE
but	I-DISEASE
not	I-DISEASE
bupropion	I-DISEASE
)	I-DISEASE
are	0
an	I-DISEASE
increasingly	I-DISEASE
recognized	0
precipitating	0
factor	0
.	0

Beta	0
-	0
blockers	0
(	0
bisoprolol	0
,	I-DISEASE
atenolol	I-DISEASE
)	0
,	I-DISEASE
anticholinesterase	0
inhibitors	0
,	0
and	0
selegiline	0
can	I-DISEASE
also	0
trigger	I-DISEASE
RBD	I-DISEASE
.	0

Psychiatric	0
disorders	0
involving	I-DISEASE
depression	0
(	0
that	I-DISEASE
require	0
antidepressant	0
pharmacotherapy	I-DISEASE
)	0
may	0
comprise	0
a	0
predisposing	0
factor	I-DISEASE
,	0
particu-	0
larly	0
in	0
adults	0
younger	0
than	0
50	I-DISEASE
years	0
.	0

RBD	0
may	0
also	0
be	B-DISEASE
associated	0
with	0
posttraumatic	0
stress	0
disorder	I-DISEASE
.	0

Parasomnias	0
Parasomnias	0
Familial	0
Pattern	0
A	0
recent	I-DISEASE
multicenter	I-DISEASE
controlled	0
study	0
revealed	0
a	I-DISEASE
significantly	0
increased	I-DISEASE
positive	0
family	I-DISEASE
history	0
of	0
dream	I-DISEASE
enactment	0
,	0
raising	0
the	0
possibility	I-DISEASE
of	0
a	I-DISEASE
genetic	I-DISEASE
contribution	0
to	I-DISEASE
RBD	B-DISEASE
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Onset	I-DISEASE
of	0
chronic	0
RBD	0
can	0
be	0
gradual	0
or	0
rapid	0
,	0
and	0
the	0
course	0
is	0
often	0
progressive	0
.	0

Complications	0
include	0
sleep	0
related	0
injuries	0
to	I-DISEASE
self	I-DISEASE
and/or	I-DISEASE
bed	I-DISEASE
partner	0
that	0
at	0
times	0
are	0
life	0
threatening	0
,	0
and	I-DISEASE
disruption	0
of	0
the	0
bed	0
partner	0
’s	0
sleep	0
that	0
can	I-DISEASE
be	0
severe	0
.	0

Marital	0
discord	0
due	0
to	0
the	I-DISEASE
RBD	0
is	0
uncommon	0
but	0
can	0
be	0
severe	0
when	0
present	0
,	I-DISEASE
due	0
to	0
repeated	I-DISEASE
injury	0
and/or	0
disruption	0
of	0
the	0
bed	0
partner	0
’s	0
sleep	0
.	0

Delayed	0
emergence	0
of	0
a	0
neurodegenerative	0
disorder	I-DISEASE
,	I-DISEASE
often	0
more	I-DISEASE
than	0
a	0
decade	0
after	I-DISEASE
the	0
onset	I-DISEASE
of	0
idiopathic	0
RBD	I-DISEASE
,	0
is	0
very	0
common	0
in	0
men	0
50	I-DISEASE
years	0
of	0
age	0
and	0
older	0
.	0

These	0
dis-	0
orders	0
include	I-DISEASE
Parkinson	0
disease	0
(	I-DISEASE
PD	0
)	I-DISEASE
,	0
multiple	0
system	0
atrophy	0
(	0
MSA	I-DISEASE
)	I-DISEASE
,	0
and	I-DISEASE
dementia	0
with	0
Lewy	0
bodies	0
(	0
DLB	0
)	I-DISEASE
.	0

Two	0
recently	0
reported	0
series	0
found	0
81	0
%	I-DISEASE
and	0
82	I-DISEASE
%	0
eventual	0
conversion	0
rates	0
from	0
idiopathic	0
RBD	I-DISEASE
to	0
parkinsonism	I-DISEASE
/	0
dementia	0
(	0
and	0
also	0
mild	0
cog-	I-DISEASE
nitive	0
impairment	0
in	0
the	0
latter	I-DISEASE
study	I-DISEASE
)	I-DISEASE
.	0

Conversely	0
,	0
RBD	0
is	0
present	0
in	0
>	I-DISEASE
90	0
%	I-DISEASE
of	0
reported	0
cases	0
of	0
MSA	0
,	I-DISEASE
in	0
approximately	I-DISEASE
50	I-DISEASE
%	0
of	0
reported	0
cases	0
of	0
DLB	0
,	I-DISEASE
and	0
in	0
up	0
to	0
46	I-DISEASE
%	0
of	0
reported	0
patients	0
with	0
PD	I-DISEASE
.	0

Developmental	0
Issues	0
As	0
stated	0
previously	0
,	I-DISEASE
RBD	I-DISEASE
can	0
emerge	0
in	0
children	0
,	0
usually	0
in	I-DISEASE
association	I-DISEASE
with	0
narco-	0
lepsy	0
-	0
cataplexy	0
,	0
brainstem	0
tumors	0
,	0
or	0
antidepressant	0
medications	I-DISEASE
.	0

Pathology	0
and	0
Pathophysiology	0
Current	I-DISEASE
evidence	0
suggests	I-DISEASE
a	I-DISEASE
selective	0
association	I-DISEASE
between	I-DISEASE
RBD	0
and	0
neurodegenera-	0
tive	I-DISEASE
disorders	0
.	0

The	0
synucleinopathies	0
comprise	0
a	0
set	I-DISEASE
of	0
neurodegenerative	I-DISEASE
disorders	0
that	I-DISEASE
share	0
a	0
common	I-DISEASE
pathologic	I-DISEASE
lesion	0
composed	I-DISEASE
of	0
aggregates	0
of	0
insoluble	0
α	I-DISEASE
-	0
synu-	0
clein	0
protein	0
in	0
selectively	0
vulnerable	0
populations	0
of	0
neurons	I-DISEASE
and	0
glial	I-DISEASE
cells	0
.	0

These	0
pathologic	0
aggregates	0
appear	0
to	0
be	0
closely	I-DISEASE
linked	0
to	I-DISEASE
the	I-DISEASE
onset	0
and	0
progression	0
of	I-DISEASE
clin-	I-DISEASE
ical	I-DISEASE
symptoms	0
and	I-DISEASE
the	I-DISEASE
degeneration	0
of	0
affected	0
brain	0
regions	0
in	I-DISEASE
neurodegenerative	I-DISEASE
disorders	I-DISEASE
.	I-DISEASE

The	0
major	0
synucleinopathies	0
include	0
PD	0
,	I-DISEASE
DLB	I-DISEASE
,	0
and	0
MSA	0
.	0

RBD	0
can	0
be	0
strongly	0
linked	I-DISEASE
with	0
narcolepsy	I-DISEASE
(	0
almost	I-DISEASE
always	0
narcolepsy	0
type	0
1	0
)	0
,	I-DISEASE
rep-	0
resenting	0
another	0
form	0
of	0
REM	0
sleep	I-DISEASE
motor	0
-	0
behavioral	I-DISEASE
dyscontrol	0
.	0

The	0
RBD	0
may	0
be	0
precipitated	0
or	0
worsened	I-DISEASE
by	0
the	0
pharmacologic	0
treatment	0
of	0
cataplexy	I-DISEASE
.	0

RBD	0
associ-	0
ated	0
with	0
narcolepsy	0
is	0
now	I-DISEASE
considered	0
to	0
be	0
a	0
distinct	0
phenotype	0
of	0
RBD	I-DISEASE
,	0
character-	0
ized	I-DISEASE
by	0
lack	0
of	0
sex	0
predominance	I-DISEASE
,	0
less	I-DISEASE
complex	0
and	0
more	I-DISEASE
elementary	0
movements	0
in	I-DISEASE
REM	0
sleep	0
,	0
less	0
violent	0
behavior	0
in	I-DISEASE
REM	0
sleep	0
,	I-DISEASE
earlier	I-DISEASE
age	0
of	0
onset	0
,	I-DISEASE
and	I-DISEASE
hypocretin	0
deficiency	0
(	0
that	I-DISEASE
is	0
characteristic	I-DISEASE
of	I-DISEASE
narcolepsy	0
type	0
1	0
)	0
.	0

The	0
presence	0
of	0
RBD	0
in	0
pediat-	0
ric	0
patients	0
may	0
be	0
an	0
initial	0
manifestation	0
of	0
narcolepsy	I-DISEASE
type	I-DISEASE
1	I-DISEASE
.	I-DISEASE

Other	0
reported	0
etiologic	0
associations	0
of	0
RBD	0
with	0
neurologic	I-DISEASE
disorders	I-DISEASE
include	0
isch-	0
emic	0
or	0
hemorrhagic	0
cerebrovascular	0
disease	0
,	0
multiple	I-DISEASE
sclerosis	0
,	I-DISEASE
progressive	0
supranu-	0
clear	0
palsy	0
,	I-DISEASE
Guillain	0
-	0
Barré	I-DISEASE
syndrome	0
,	I-DISEASE
brainstem	0
neoplasms	0
(	0
including	0
cerebellopon-	0
tine	0
angle	0
tumors	0
)	I-DISEASE
,	I-DISEASE
Machado	I-DISEASE
-	0
Joseph	0
disease	0
(	I-DISEASE
spinocerebellar	I-DISEASE
ataxia	I-DISEASE
type	I-DISEASE
3	0
)	0
,	0
mitochon-	I-DISEASE
drial	I-DISEASE
encephalomyopathy	I-DISEASE
,	0
normal	0
pressure	0
hydrocephalus	I-DISEASE
,	0
Tourette	0
syndrome	I-DISEASE
,	0
group	0
A	I-DISEASE
xeroderma	I-DISEASE
,	I-DISEASE
and	0
autism	0
.	I-DISEASE

The	0
pathophysiology	0
of	0
human	I-DISEASE
RBD	0
is	I-DISEASE
presumed	I-DISEASE
to	0
correspond	I-DISEASE
to	0
the	0
findings	0
from	0
an	0
animal	I-DISEASE
model	0
of	I-DISEASE
RBD	I-DISEASE
with	0
respect	I-DISEASE
to	0
interruption	0
of	0
the	0
REM	0
atonia	0
pathway	0
and/	I-DISEASE
or	0
disinhibition	0
of	0
brainstem	I-DISEASE
motor	0
pattern	0
generators	0
.	I-DISEASE

Objective	0
Findings	0
Polysomnography	0
demonstrates	I-DISEASE
an	0
excessive	I-DISEASE
amount	0
of	0
sustained	I-DISEASE
or	0
intermittent	0
loss	0
of	I-DISEASE
REM	0
atonia	I-DISEASE
and/or	I-DISEASE
excessive	0
phasic	I-DISEASE
muscle	0
twitch	I-DISEASE
activity	0
of	0
the	0
submental	I-DISEASE
and/or	I-DISEASE
limb	I-DISEASE
EMGs	0
during	0
REM	I-DISEASE
sleep	0
.	0

Some	0
patients	0
have	I-DISEASE
almost	0
exclusively	0
arm	I-DISEASE
and	I-DISEASE
hand	0
behaviors	I-DISEASE
during	0
REM	0
sleep	0
,	0
indicating	I-DISEASE
the	I-DISEASE
need	0
for	I-DISEASE
both	I-DISEASE
upper	0
and	0
lower	0
extremity	0
EMG	0
monitoring	0
in	I-DISEASE
fully	0
evaluating	0
for	I-DISEASE
RBD	0
.	0

Some	0
patients	0
preserve	I-DISEASE
most	0
of	0
their	I-DISEASE
REM	0
atonia	0
but	I-DISEASE
have	I-DISEASE
excessive	0
EMG	0
twitching	0
during	0
REM	I-DISEASE
sleep	0
.	0

The	0
most	0
current	0
evidence	0
-	0
based	I-DISEASE
data	I-DISEASE
for	0
detecting	I-DISEASE
RWA	0
in	0
the	0
evaluation	I-DISEASE
of	0
RBD	I-DISEASE
indicate	0
that	0
any	I-DISEASE
(	0
tonic	0
/	0
phasic	0
)	0
chin	I-DISEASE
EMG	0
activity	0
combined	0
with	0
bilateral	0
phasic	I-DISEASE
activity	I-DISEASE
of	I-DISEASE
the	0
flexor	0
digitorum	0
superficialis	0
muscles	0
in	I-DISEASE
>	0
27	0
%	I-DISEASE
of	I-DISEASE
REM	I-DISEASE
sleep	0
(	I-DISEASE
scored	0
in	I-DISEASE
30	0
-	I-DISEASE
second	I-DISEASE
epochs	0
)	0
reliably	I-DISEASE
distinguishes	0
RBD	0
patients	I-DISEASE
from	0
controls	0
.	I-DISEASE

Autonomic	0
nervous	0
system	0
activa-	0
tion	0
(	I-DISEASE
such	I-DISEASE
as	0
tachycardia	I-DISEASE
)	0
is	0
uncommon	0
during	0
REM	0
sleep	I-DISEASE
motor	0
activation	0
in	I-DISEASE
RBD	0
,	0
in	0
contrast	0
to	0
the	0
disorders	I-DISEASE
of	0
arousal	0
.	0

Approximately	0
75	0
%	0
of	0
patients	0
have	I-DISEASE
PLMs	0
during	0
NREM	I-DISEASE
sleep	0
;	0
a	0
low	0
percentage	0
of	I-DISEASE
these	I-DISEASE
movements	0
is	I-DISEASE
associated	0
with	0
EEG	0
signs	0
of	0
arousal	0
.	I-DISEASE

Increased	0
percentages	0
of	0
slow	I-DISEASE
wave	0
sleep	I-DISEASE
and	I-DISEASE
increased	0
delta	I-DISEASE
power	0
in	0
RBD	0
have	0
been	0
found	0
in	0
controlled	0
and	0
uncontrolled	0
studies	0
,	0
but	0
this	0
can	0
be	I-DISEASE
a	0
highly	0
vari-	I-DISEASE
able	0
finding	0
in	0
RBD	I-DISEASE
,	0
depending	0
on	0
the	0
clinical	I-DISEASE
population	0
.	0

Sleep	0
architecture	I-DISEASE
and	0
the	0
customary	I-DISEASE
cycling	0
among	I-DISEASE
REM	0
and	I-DISEASE
NREM	0
sleep	0
stages	0
are	0
usually	0
preserved	I-DISEASE
in	0
RBD	0
,	I-DISEASE
although	0
some	0
patients	0
show	0
a	0
shift	0
toward	I-DISEASE
N1	I-DISEASE
sleep	0
.	I-DISEASE

Validated	0
RBD	0
screening	0
questionnaires	0
that	0
can	0
assist	I-DISEASE
in	0
the	I-DISEASE
process	0
of	0
diagnosing	0
RBD	0
are	0
currently	I-DISEASE
available	0
.	0

Parasomnias	0
Parasomnias	0
Differential	0
Diagnosis	0
RBD	0
is	I-DISEASE
one	0
of	0
several	0
disorders	0
that	I-DISEASE
can	0
manifest	0
as	0
complex	I-DISEASE
,	I-DISEASE
injurious	0
,	0
and	0
violent	0
sleep	0
related	0
and	0
dream	0
-	0
related	0
behaviors	0
in	0
adults	0
.	0

Other	0
disorders	0
that	0
can	I-DISEASE
mimic	0
RBD	0
in	I-DISEASE
adults	0
and/or	0
children	0
include	0
sleepwalking	0
,	0
sleep	I-DISEASE
terrors	I-DISEASE
,	I-DISEASE
OSA	0
,	I-DISEASE
nocturnal	0
seizures	I-DISEASE
(	0
nocturnal	0
frontal	0
lobe	0
epilepsy	I-DISEASE
;	0
nocturnal	0
complex	0
partial	0
seizures	I-DISEASE
)	0
;	I-DISEASE
rhyth-	0
mic	0
movement	0
disorders	0
;	0
sleep	I-DISEASE
related	0
dissociative	I-DISEASE
disorders	0
,	0
frightening	I-DISEASE
hypnopom-	0
pic	0
hallucinations	I-DISEASE
,	I-DISEASE
and	I-DISEASE
posttraumatic	I-DISEASE
stress	I-DISEASE
disorder	0
;	I-DISEASE
a	I-DISEASE
diagnosis	I-DISEASE
of	0
malingering	0
also	0
should	I-DISEASE
be	0
considered	0
.	I-DISEASE

In	0
general	0
,	0
RBD	0
involves	0
attempted	0
enactment	0
of	0
unpleasant	0
,	0
aggressive	0
dreams	0
that	0
usually	0
occurs	I-DISEASE
two	I-DISEASE
or	0
more	I-DISEASE
hours	0
after	0
sleep	0
onset	0
,	I-DISEASE
with	0
rapid	I-DISEASE
awakening	0
from	0
an	0
episode	0
.	0

In	0
contrast	0
,	0
sleepwalking	0
and	0
sleep	0
terror	I-DISEASE
episodes	0
often	I-DISEASE
emerge	0
within	0
two	0
hours	0
after	0
sleep	I-DISEASE
onset	I-DISEASE
,	0
are	I-DISEASE
not	0
usually	0
associated	0
with	0
rapid	0
alertness	0
,	0
and	0
are	0
rarely	0
associated	0
with	0
dreaming	0
in	I-DISEASE
children	0
.	0

Adults	0
can	0
have	0
dreams	0
associated	0
with	0
disor-	0
ders	0
of	I-DISEASE
arousal	0
,	0
but	0
they	0
are	0
usually	I-DISEASE
more	0
fragmentary	0
and	I-DISEASE
limited	0
than	0
RBD	0
dreams	0
.	0

Sleep	0
related	0
seizures	I-DISEASE
usually	0
present	0
with	0
repetitive	0
,	0
stereotypical	I-DISEASE
behaviors	0
.	0

Parasomnia	0
overlap	0
disorder	0
can	0
be	0
distinguished	I-DISEASE
from	I-DISEASE
status	0
dissociatus	I-DISEASE
in	0
several	0
ways	0
:	0
if	0
there	I-DISEASE
is	0
an	0
awakening	I-DISEASE
after	0
an	0
episode	0
of	0
RBD	0
,	0
sleepwalking	I-DISEASE
,	0
or	0
sleep	I-DISEASE
terror	0
,	I-DISEASE
there	0
is	0
the	0
realization	0
of	0
having	0
just	0
been	0
asleep	I-DISEASE
;	0
status	I-DISEASE
dissociatus	I-DISEASE
,	0
however	I-DISEASE
,	0
is	I-DISEASE
more	0
likely	I-DISEASE
to	0
manifest	I-DISEASE
with	0
confusion	I-DISEASE
over	I-DISEASE
whether	0
one	0
is	0
asleep	0
,	0
awake	0
,	0
or	0
dreaming	0
.	I-DISEASE

vPSG	0
in	0
overlap	0
conditions	0
shows	0
the	I-DISEASE
typical	0
findings	0
for	I-DISEASE
both	0
RBD	0
and	0
disorders	0
of	0
arousal	0
,	I-DISEASE
whereas	0
with	I-DISEASE
status	0
dissociatus	0
,	0
there	0
is	0
an	0
inability	0
to	0
discern	0
sleep	I-DISEASE
stages	I-DISEASE
.	0

Also	0
,	0
patients	0
with	I-DISEASE
status	0
dissociatus	0
do	I-DISEASE
not	0
walk	I-DISEASE
far	0
during	0
an	0
episode	0
,	0
and	I-DISEASE
their	I-DISEASE
behavioral	0
repertoire	0
more	0
closely	0
resembles	0
that	0
of	0
RBD	0
than	0
that	0
of	0
the	0
disorders	0
of	0
arousal	I-DISEASE
.	I-DISEASE

Unresolved	0
Issues	0
and	0
Future	0
Directions	I-DISEASE
Numerous	I-DISEASE
questions	I-DISEASE
related	0
to	0
the	0
vPSG	0
evaluation	0
of	I-DISEASE
RBD	0
remain	I-DISEASE
unresolved	0
.	0

These	0
include	0
issues	I-DISEASE
of	0
defining	0
and	I-DISEASE
quantifying	I-DISEASE
RWA	I-DISEASE
and	I-DISEASE
RBD	0
activity	0
such	I-DISEASE
as	I-DISEASE
:	0
(	0
1	0
)	0
What	I-DISEASE
is	0
the	I-DISEASE
minimum	0
REM	I-DISEASE
sleep	I-DISEASE
percentage	I-DISEASE
of	I-DISEASE
total	I-DISEASE
sleep	0
time	I-DISEASE
(	I-DISEASE
and	I-DISEASE
minimum	I-DISEASE
absolute	I-DISEASE
REM	0
sleep	0
time	0
)	I-DISEASE
needed	I-DISEASE
to	I-DISEASE
diagnose	0
RWA	0
or	I-DISEASE
rule	I-DISEASE
out	I-DISEASE
RWA	0
?	0

(	0
2	0
)	I-DISEASE
What	I-DISEASE
is	I-DISEASE
the	0
minimum	I-DISEASE
number	I-DISEASE
of	I-DISEASE
REM	0
sleep	0
epochs	0
and	I-DISEASE
minimum	0
duration	I-DISEASE
of	0
REM	0
sleep	I-DISEASE
epochs	0
necessary	I-DISEASE
to	0
diagnose	0
RWA	I-DISEASE
or	0
rule	I-DISEASE
out	0
RWA	0
?	I-DISEASE

(	0
3	0
)	0
What	I-DISEASE
guidelines	I-DISEASE
can	I-DISEASE
be	I-DISEASE
developed	I-DISEASE
for	I-DISEASE
diag-	0
nosing	0
or	I-DISEASE
ruling	I-DISEASE
out	0
RWA	0
in	0
the	0
setting	I-DISEASE
of	0
disrupted	I-DISEASE
REM	0
sleep	0
continuity	0
associated	I-DISEASE
with	0
conditions	I-DISEASE
such	0
as	I-DISEASE
obstructive	0
sleep	0
apnea	I-DISEASE
and	0
with	0
medications	0
?	0

(	0
4	0
)	0
What	I-DISEASE
are	I-DISEASE
the	0
minimal	I-DISEASE
amounts	0
of	I-DISEASE
true	0
RBD	0
behaviors	0
documented	0
by	0
vPSG	I-DISEASE
needed	0
to	0
identify	0
RBD	0
in	0
patients	0
without	0
sufficient	0
RWA	0
?	0

It	0
is	0
unclear	0
why	0
there	0
is	I-DISEASE
a	I-DISEASE
male	0
predominance	I-DISEASE
of	0
this	0
disorder	0
in	0
middle	0
-	0
aged	0
and	0
older	I-DISEASE
adults	0
.	0

It	0
is	0
unknown	0
if	I-DISEASE
RBD	0
subgroups	0
other	0
than	0
men	I-DISEASE
age	0
50	0
years	0
or	0
older	0
demon-	I-DISEASE
strate	0
increased	0
risk	I-DISEASE
for	0
development	0
of	0
parkinsonism	0
or	0
dementia	0
.	0

One	0
such	I-DISEASE
subgroup	0
comprises	0
patients	I-DISEASE
with	I-DISEASE
antidepressant	0
-	0
triggered	I-DISEASE
RBD	0
for	0
whom	0
the	0
potential	0
risk	0
for	0
future	0
parkinsonism	I-DISEASE
and	B-DISEASE
dementia	0
is	0
unclear	0
.	0

New	0
antidepressant	0
or	0
other	0
psychotro-	0
pic	0
agents	0
being	0
developed	I-DISEASE
for	0
clinical	0
use	I-DISEASE
should	I-DISEASE
be	0
assessed	0
for	0
their	0
immediate	I-DISEASE
and	0
long	0
-	0
term	0
effects	I-DISEASE
on	0
REM	0
atonia	0
,	0
REM	I-DISEASE
phasic	0
activity	0
,	0
REM	0
sleep	0
behavioral	0
release	0
,	I-DISEASE
and	I-DISEASE
proclivity	I-DISEASE
to	0
precipitate	0
dream	I-DISEASE
-	0
enacting	0
behaviors	0
.	I-DISEASE

Bibliography	0
Boeve	0
BF	0
.	0

REM	0
sleep	0
behavior	0
disorder	I-DISEASE
:	0
Updated	I-DISEASE
review	I-DISEASE
of	0
the	I-DISEASE
core	0
features	I-DISEASE
,	0
the	0
REM	0
sleep	I-DISEASE
behavior	0
disorder	0
-	I-DISEASE
neurodegenerative	0
disease	0
association	0
,	0
evolving	0
concepts	0
,	I-DISEASE
controversies	0
,	0
and	0
future	0
directions	0
.	I-DISEASE

Ann	0
N	0
Y	0
Acad	0
Sci	0
2010;1184:15–54	0
.	0

Dauvilliers	0
Y	I-DISEASE
,	0
Jennum	0
P	0
,	0
Plazzi	I-DISEASE
G.	0
REM	I-DISEASE
sleep	0
behaviour	0
disorder	0
and	I-DISEASE
REM	0
sleep	I-DISEASE
without	0
atonia	0
in	I-DISEASE
narcolepsy	I-DISEASE
.	0

Sleep	0
Med	0
2013;14:775–81	I-DISEASE
.	0

Frauscher	0
B	0
,	0
Gschliesser	0
V	0
,	0
Brandauer	I-DISEASE
E	0
,	I-DISEASE
et	0
al	0
.	0

REM	0
sleep	0
behavior	0
disorder	I-DISEASE
in	0
703	I-DISEASE
sleep	0
-	0
disorder	I-DISEASE
patients	I-DISEASE
:	0
the	0
importance	I-DISEASE
of	0
eliciting	I-DISEASE
a	0
comprehensive	0
sleep	I-DISEASE
history	0
.	I-DISEASE

Sleep	0
Med	0
2010;11:167–71	0
.	0

Frauscher	0
B	0
,	0
Iranzo	0
A	0
,	0
Gaig	I-DISEASE
C	0
,	I-DISEASE
et	0
al	0
.	0

Normative	0
EMG	0
values	0
during	I-DISEASE
REM	0
sleep	I-DISEASE
for	I-DISEASE
the	0
diagnosis	I-DISEASE
of	I-DISEASE
REM	0
sleep	I-DISEASE
behavior	0
disorder	0
.	I-DISEASE

Sleep	0
2012;35:835–47	0
.	0

Iranzo	0
A	0
,	0
Santamaria	0
J.	0
Severe	I-DISEASE
obstructive	I-DISEASE
sleep	0
apnea	0
/	0
hypopnea	0
mimicking	0
REM	0
sleep	0
behavior	0
disorder	I-DISEASE
.	I-DISEASE

Sleep	0
2005;28:203–6	0
.	0

Iranzo	0
A	0
,	0
Santamaria	0
J	0
,	I-DISEASE
Tolosa	I-DISEASE
E.	0

The	0
clinical	0
and	0
pathophysiological	I-DISEASE
relevance	0
of	I-DISEASE
REM	I-DISEASE
sleep	0
behavior	I-DISEASE
disorder	0
in	0
neurodegenerative	0
diseases	0
.	I-DISEASE

Sleep	0
Med	0
Rev	0
2009;13:385–401	0
.	B-DISEASE

Iranzo	0
A	0
,	0
Tolosa	0
E	0
,	I-DISEASE
Gelpi	0
E	0
,	I-DISEASE
et	0
al	0
.	0

Neurodegenerative	0
disease	0
status	0
and	0
post	0
-	0
mortem	I-DISEASE
pathology	0
in	I-DISEASE
isolated	0
rapid	0
-	0
eye	I-DISEASE
-	0
movement	0
sleep	0
behaviour	0
disorder	0
:	0
an	0
observational	0
cohort	0
study	0
.	I-DISEASE

Lancet	0
Neurol	0
2013;12:443–53	0
.	0

Ju	0
YE	0
.	0

Rapid	0
eye	0
movement	0
sleep	0
behavior	0
disorder	0
in	I-DISEASE
adults	0
younger	I-DISEASE
than	0
50	0
years	0
of	I-DISEASE
age	0
.	0

Sleep	0
Med	0
2013;14:768–74	0
.	0

Lloyd	0
R	0
,	0
Tippman	0
-	0
Peikert	0
M	I-DISEASE
,	0
Slocumb	I-DISEASE
N	0
,	0
Kotagal	0
S.	0
Characteristics	0
of	I-DISEASE
REM	0
sleep	0
behavior	0
disorder	0
in	0
childhood	0
.	I-DISEASE

J	0
Clin	0
Sleep	I-DISEASE
Med	0
2012:15:127–31	0
.	I-DISEASE

Olson	0
E	0
,	0
Boeve	0
B	0
,	0
Silber	I-DISEASE
M.	0
Rapid	I-DISEASE
eye	0
movement	0
sleep	0
behavior	0
disorder	0
:	I-DISEASE
demographic	0
,	I-DISEASE
clinical	I-DISEASE
,	0
and	0
laboratory	0
findings	0
in	0
93	0
cases	I-DISEASE
.	0

Brain	0
2000;123:331–9	0
.	0

Oudiette	0
D	0
,	0
De	0
Cock	I-DISEASE
VC	I-DISEASE
,	I-DISEASE
Lavault	0
S	I-DISEASE
,	0
Leu	0
S	I-DISEASE
,	I-DISEASE
Vidailhet	0
M	I-DISEASE
,	I-DISEASE
Arnulf	I-DISEASE
I.	I-DISEASE
Non	0
-	0
violent	0
elaborate	0
behaviors	0
may	0
also	0
occur	0
in	0
REM	I-DISEASE
sleep	0
behavior	I-DISEASE
disorder	0
.	0

Neurology	0
2009;72:551–7	0
.	0

Postuma	0
RB	0
,	0
Gagnon	0
JF	0
,	I-DISEASE
Vendette	I-DISEASE
M	0
,	0
Fantini	0
ML	0
,	0
Massicotte	0
-	0
Marquez	I-DISEASE
J	0
,	0
Montplaisir	I-DISEASE
J.	0
Quantifying	0
the	0
risk	0
of	0
neurodegenerative	I-DISEASE
disease	I-DISEASE
in	I-DISEASE
idiopathic	0
REM	0
sleep	0
behavior	0
disorder	0
.	I-DISEASE

Neurology	0
2009;72:1296–300	0
.	0

Schenck	0
CH	0
,	0
Mahowald	0
MW	0
.	0

REM	0
sleep	0
behavior	0
disorder	I-DISEASE
:	0
clinical	I-DISEASE
,	I-DISEASE
developmental	0
,	I-DISEASE
and	0
neuroscience	0
perspectives	0
16	0
years	0
after	0
its	0
formal	I-DISEASE
identification	I-DISEASE
in	0
SLEEP	I-DISEASE
.	0

Sleep	0
2002;25:120–38	0
.	0

Schenck	0
CH	0
,	0
Boeve	0
BF	I-DISEASE
,	0
Mahowald	I-DISEASE
MW	0
.	I-DISEASE

Delayed	0
emergence	0
of	0
a	0
parkinsonian	0
disorder	I-DISEASE
or	I-DISEASE
dementia	I-DISEASE
in	I-DISEASE
81	0
%	0
of	0
older	0
males	0
initially	0
diagnosed	0
with	0
idiopathic	I-DISEASE
REM	0
sleep	0
behavior	0
disorder	0
(	I-DISEASE
RBD	0
):	I-DISEASE
16	0
year	0
update	0
on	0
a	0
previously	I-DISEASE
reported	0
series	0
.	0

Sleep	0
Med	0
2013;14:744–8	0
.	0

Schenck	0
CH	0
,	0
Howell	0
MJ	0
.	0

Spectrum	0
of	0
RBD	0
(	0
overlap	0
between	I-DISEASE
RBD	0
and	0
other	0
parasomnias	0
)	0
.	0

Sleep	0
and	0
Biological	0
Rhythms	0
2013;11(Supplement	0
1):27–34	0
.	0

Parasomnias	0
Parasomnias	0
Recurrent	0
Isolated	0
Sleep	0
Paralysis	I-DISEASE
ICD-9	0
-	0
CM	0
code	0
:	0
327.43	I-DISEASE
ICD-10	0
-	0
CM	0
code	0
:	0
G47.53	0
Alternate	0
Names	0
Hypnagogic	0
and	0
hypnopompic	0
paralysis	0
,	I-DISEASE
predormital	0
and	0
postdormital	I-DISEASE
paralysis	0
,	0
kanashibari	0
(	0
Japan	0
)	0
.	0

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
D	I-DISEASE
must	I-DISEASE
be	0
met	I-DISEASE
A.	0
A	0
recurrent	0
inability	0
to	0
move	0
the	I-DISEASE
trunk	0
and	I-DISEASE
all	0
of	0
the	0
limbs	0
at	0
sleep	0
onset	0
or	I-DISEASE
upon	I-DISEASE
awakening	I-DISEASE
from	0
sleep	I-DISEASE
.	I-DISEASE

B.	0
Each	0
episode	0
lasts	0
seconds	0
to	I-DISEASE
a	0
few	0
minutes	I-DISEASE
.	0

C.	0

The	0
episodes	0
cause	0
clinically	I-DISEASE
significant	0
distress	0
including	I-DISEASE
bedtime	0
anxiety	I-DISEASE
or	0
fear	0
of	0
sleep	0
.	0

D.	0
The	0
disturbance	0
is	0
not	0
better	0
explained	I-DISEASE
by	0
another	I-DISEASE
sleep	0
disorder	0
(	I-DISEASE
especially	I-DISEASE
narcolepsy	0
)	0
,	0
mental	0
disorder	I-DISEASE
,	0
medical	I-DISEASE
condition	0
,	0
medication	0
,	0
or	I-DISEASE
substance	I-DISEASE
use	0
.	0

Essential	0
Features	0
Recurrent	0
isolated	I-DISEASE
sleep	0
paralysis	0
is	I-DISEASE
characterized	0
by	I-DISEASE
an	0
inability	0
to	0
perform	0
voluntary	0
movements	0
at	0
sleep	I-DISEASE
onset	I-DISEASE
(	0
hypnagogic	I-DISEASE
or	0
predormital	0
form	0
)	0
or	I-DISEASE
on	0
waking	0
from	0
sleep	0
(	0
hypnopompic	0
or	I-DISEASE
postdormital	0
form	0
)	0
in	0
the	0
absence	I-DISEASE
of	0
a	I-DISEASE
diagnosis	0
of	0
narcolepsy	0
.	0

The	0
event	0
consists	0
of	0
an	0
inability	I-DISEASE
to	0
speak	0
or	I-DISEASE
to	0
move	0
the	0
limbs	I-DISEASE
,	0
trunk	0
,	0
and	0
head	I-DISEASE
.	0

Respiration	0
is	0
usually	0
unaffected	0
.	0

Consciousness	0
is	0
preserved	0
,	0
and	0
full	0
recall	0
is	0
present	I-DISEASE
.	0

An	0
episode	0
of	0
sleep	0
paralysis	0
lasts	0
seconds	I-DISEASE
to	0
minutes	I-DISEASE
.	0

It	0
usually	0
resolves	0
spontaneously	0
but	0
can	I-DISEASE
be	0
aborted	0
by	0
sensory	0
stimulation	0
,	0
such	0
as	0
being	0
touched	0
or	0
spoken	I-DISEASE
to	0
,	0
or	0
by	0
the	0
patient	0
making	I-DISEASE
intense	0
efforts	0
to	I-DISEASE
move	0
.	0

Associated	0
Features	0
At	0
least	I-DISEASE
during	I-DISEASE
the	0
initial	I-DISEASE
episodes	0
,	I-DISEASE
intense	0
anxiety	0
is	0
usually	0
present	0
.	0

Hallucinatory	0
experiences	0
accompany	I-DISEASE
the	0
paralysis	0
in	0
about	I-DISEASE
25	0
%	0
to	0
75	0
%	0
of	0
patients	0
.	0

These	0
may	0
include	0
auditory	I-DISEASE
,	0
visual	0
,	I-DISEASE
or	0
tactile	I-DISEASE
hallucinations	0
,	0
or	0
the	0
sense	0
of	I-DISEASE
a	0
presence	I-DISEASE
in	I-DISEASE
the	0
room	I-DISEASE
.	0

Some	0
patients	0
experience	I-DISEASE
predormital	0
or	0
postdormital	0
hallucinations	I-DISEASE
at	0
separate	I-DISEASE
times	0
from	0
episodes	0
of	0
sleep	0
paralysis	I-DISEASE
.	0

Clinical	0
or	0
Pathophysiological	0
Subtypes	I-DISEASE
A	I-DISEASE
familial	I-DISEASE
form	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
paralysis	0
has	I-DISEASE
been	0
described	0
(	0
see	I-DISEASE
below	0
)	0
.	I-DISEASE

Demographics	0
Estimates	0
of	0
the	0
prevalence	0
of	0
sleep	I-DISEASE
paralysis	I-DISEASE
vary	I-DISEASE
widely	0
due	I-DISEASE
to	I-DISEASE
differences	0
in	I-DISEASE
the	0
definition	0
used	I-DISEASE
,	0
the	0
age	0
of	0
the	0
population	I-DISEASE
sampled	I-DISEASE
,	I-DISEASE
and	0
possibly	I-DISEASE
cultural	0
and	0
ethnic	I-DISEASE
factors	I-DISEASE
.	0

Most	0
prevalence	0
studies	0
of	0
sleep	0
paralysis	I-DISEASE
(	0
usually	0
of	I-DISEASE
students	0
younger	0
than	0
30	0
years	0
)	0
have	I-DISEASE
investigated	I-DISEASE
the	0
occurrence	0
of	I-DISEASE
one	0
or	0
more	0
episodes	0
without	0
require-	0
ment	I-DISEASE
of	0
recurrence	0
or	0
distress	0
.	I-DISEASE

These	0
suggest	0
a	0
15	0
%	0
to	0
40	0
%	0
prevalence	0
of	0
at	0
least	I-DISEASE
one	I-DISEASE
episode	0
of	0
sleep	0
paralysis	I-DISEASE
.	0

Two	0
notable	0
exceptions	0
are	0
a	0
1962	I-DISEASE
study	I-DISEASE
of	0
mostly	I-DISEASE
college	0
students	0
that	0
reported	0
a	0
prevalence	I-DISEASE
of	I-DISEASE
5	0
%	I-DISEASE
,	0
and	0
a	0
1999	0
study	I-DISEASE
of	I-DISEASE
all	I-DISEASE
adult	0
ages	0
that	0
found	I-DISEASE
a	0
prevalence	0
of	I-DISEASE
6	0
%	0
.	0

No	0
consistent	0
sex	0
differences	0
have	0
emerged	0
from	0
multiple	0
studies	0
.	0

The	0
mean	0
age	0
of	0
onset	0
is	0
14	I-DISEASE
to	0
17	I-DISEASE
years	0
,	0
although	0
onset	0
earlier	0
and	0
later	0
in	0
life	0
has	0
been	0
reported	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
Sleep	0
deprivation	I-DISEASE
and	I-DISEASE
irregular	0
sleep	I-DISEASE
-	0
wake	0
schedules	0
have	I-DISEASE
been	0
identified	I-DISEASE
as	0
predis-	0
posing	I-DISEASE
factors	0
to	I-DISEASE
episodes	0
of	I-DISEASE
sleep	0
paralysis	0
.	0

Mental	0
stress	0
has	0
been	0
reported	0
as	0
a	0
precipitating	0
factor	0
in	0
some	0
but	0
not	0
other	0
studies	0
.	0

Sleep	0
paralysis	0
appears	0
to	0
be	0
more	0
common	I-DISEASE
with	0
sleep	0
in	0
the	0
supine	0
position	I-DISEASE
.	0

Personality	0
factors	0
have	0
not	0
been	0
shown	I-DISEASE
to	I-DISEASE
play	0
a	I-DISEASE
major	0
role	0
,	0
although	I-DISEASE
one	0
study	0
found	0
a	I-DISEASE
higher	I-DISEASE
score	0
on	I-DISEASE
the	0
paranoia	0
scale	I-DISEASE
of	0
the	I-DISEASE
Minnesota	0
Multiphasic	0
Personality	I-DISEASE
Inventory	I-DISEASE
in	0
patients	I-DISEASE
with	0
sleep	0
paralysis	0
com-	0
pared	0
to	0
controls	0
.	0

Other	0
factors	0
that	0
have	I-DISEASE
been	0
noted	0
on	I-DISEASE
regression	0
analysis	I-DISEASE
include	0
an	0
association	0
with	0
bipolar	0
disorder	0
,	0
the	0
use	I-DISEASE
of	0
anxiolytic	0
medication	0
,	0
and	0
sleep	0
related	0
leg	0
cramps	0
.	0

Familial	0
Pattern	0
Two	0
families	0
with	0
apparent	0
familial	0
sleep	I-DISEASE
paralysis	I-DISEASE
occurring	0
over	0
three	0
and	0
four	0
gen-	0
erations	0
have	0
been	I-DISEASE
reported	0
.	I-DISEASE

A	0
maternal	0
form	0
of	0
transmission	0
has	0
been	0
postulated	0
.	I-DISEASE

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Onset	I-DISEASE
is	0
usually	0
in	0
adolescence	0
.	0

Most	0
events	0
appear	0
to	0
occur	0
in	0
the	0
second	0
and	I-DISEASE
third	0
decades	0
,	0
but	0
may	0
continue	0
later	0
in	0
life	0
.	0

There	0
are	0
no	0
known	0
complications	0
,	0
apart	I-DISEASE
from	0
anxiety	0
over	0
the	0
episodes	0
.	0

Developmental	0
Issues	0
Though	0
sleep	I-DISEASE
paralysis	0
may	I-DISEASE
be	0
present	0
as	I-DISEASE
part	I-DISEASE
of	0
the	0
narcolepsy	0
tetrad	0
in	I-DISEASE
children	0
,	0
there	I-DISEASE
is	0
no	0
information	0
currently	0
available	0
about	I-DISEASE
childhood	I-DISEASE
presentation	I-DISEASE
of	0
recurrent	I-DISEASE
isolated	0
sleep	0
paralysis	I-DISEASE
.	0

Parasomnias	0
Parasomnias	0
Pathology	0
and	0
Pathophysiology	0
Episodes	I-DISEASE
of	I-DISEASE
sleep	0
paralysis	0
elicited	0
by	I-DISEASE
awakening	0
patients	0
from	0
nocturnal	I-DISEASE
sleep	I-DISEASE
appear	I-DISEASE
to	I-DISEASE
arise	0
from	0
REM	0
sleep	0
.	I-DISEASE

Sleep	0
paralysis	0
is	0
an	0
example	0
of	I-DISEASE
state	0
dissociation	0
with	I-DISEASE
ele-	0
ments	0
of	0
REM	0
sleep	0
persisting	I-DISEASE
into	I-DISEASE
wakefulness	0
.	I-DISEASE

Early	0
-	0
onset	0
REM	0
sleep	0
after	0
forced	I-DISEASE
awakenings	0
has	0
been	0
shown	0
to	0
predispose	0
an	0
individual	0
to	0
having	0
sleep	0
paralysis	0
.	I-DISEASE

It	0
may	0
be	0
that	0
subjects	0
with	I-DISEASE
less	0
tolerance	0
to	0
sleep	0
disruption	0
are	0
more	0
likely	0
to	0
experi-	0
ence	0
the	I-DISEASE
phenomenon	0
.	0

Objective	0
Findings	0
Analysis	0
of	I-DISEASE
sleep	0
paralysis	I-DISEASE
after	I-DISEASE
forced	0
awakenings	I-DISEASE
during	0
PSG	0
studies	0
reveals	0
the	0
event	I-DISEASE
to	I-DISEASE
be	I-DISEASE
a	I-DISEASE
dissociated	0
state	0
with	I-DISEASE
the	0
persistence	0
of	0
REM	I-DISEASE
-	0
related	0
electromyographic	0
atonia	0
into	0
conscious	0
wakefulness	0
.	I-DISEASE

Hallucinatory	0
experiences	0
may	0
be	0
present	0
but	0
are	B-DISEASE
not	0
essential	0
for	0
the	0
diagnosis	0
.	0

Differential	0
Diagnosis	0
Cataplexy	0
produces	0
similar	0
generalized	I-DISEASE
paralysis	I-DISEASE
of	0
skeletal	0
muscles	0
but	0
occurs	0
during	I-DISEASE
wakefulness	0
and	0
is	0
precipitated	0
by	I-DISEASE
emotion	0
.	0

Atonic	0
seizures	0
occur	0
during	0
wakefulness	0
.	0

Nocturnal	0
panic	0
attacks	0
are	0
not	0
usually	0
associated	I-DISEASE
with	0
paralysis	I-DISEASE
.	0

Familial	0
periodic	0
paralysis	0
syndromes	0
,	0
especially	0
hypokalemic	I-DISEASE
periodic	I-DISEASE
paralysis	I-DISEASE
,	0
may	0
occur	I-DISEASE
at	0
rest	0
and	I-DISEASE
on	0
awakening	0
.	I-DISEASE

However	0
,	I-DISEASE
the	0
episodes	I-DISEASE
usually	0
last	0
hours	I-DISEASE
,	I-DISEASE
may	I-DISEASE
be	0
associated	0
with	0
car-	0
bohydrate	I-DISEASE
intake	I-DISEASE
,	I-DISEASE
and	0
are	I-DISEASE
usually	0
accompanied	0
by	0
hypokalemia	0
.	0

There	0
are	0
also	0
hyper-	0
kalemic	0
and	0
normokalemic	I-DISEASE
periodic	0
paralysis	I-DISEASE
syndromes	0
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE
Not	I-DISEASE
applicable	I-DISEASE
or	0
known	0
.	0

Bibliography	0
Fukuda	0
K.	0
Sleep	0
paralysis	0
and	0
sleep	0
-	0
onset	0
REM	0
period	0
in	0
normal	0
individuals	0
.	I-DISEASE

In	0
:	0
Olgilvie	0
R	0
,	0
Harsh	0
J	0
,	0
eds	0
.	0

Sleep	0
onset	0
:	0
normal	0
and	0
abnormal	I-DISEASE
processes	I-DISEASE
.	0

Washington	0
:	0
American	0
Psychological	I-DISEASE
Association	0
,	0
1994:161–81	I-DISEASE
.	0

Goode	0
G.	0
Sleep	0
paralysis	I-DISEASE
.	0

Arch	0
Neurol	0
1962;6:228–34	0
.	0

Hishikawa	0
Y.	0
Sleep	0
paralysis	0
.	0

In	0
:	0
Guilleminault	0
C	I-DISEASE
,	0
Dement	I-DISEASE
W	0
,	0
Passouant	I-DISEASE
P	0
,	0
eds	0
.	I-DISEASE

Narcolepsy	0
.	0

New	0
York	0
:	0
Spectrum	0
,	0
1976:97–124	0
.	0

Ohayon	0
M	I-DISEASE
,	0
Zulley	B-DISEASE
J	0
,	0
Guilleminault	0
C	I-DISEASE
,	I-DISEASE
Smirne	0
S.	0
Prevalence	I-DISEASE
and	I-DISEASE
pathologic	0
associations	0
of	0
sleep	I-DISEASE
paralysis	I-DISEASE
in	0
the	0
general	0
population	0
.	0

Neurology	0
1999;52:1194–200	0
.	0

Takeuchi	0
T	0
,	0
Fukuda	0
K	0
,	0
Sasaki	0
Y	0
,	I-DISEASE
Inugami	0
M	0
,	0
Murphy	0
T.	0
Factors	0
related	0
to	0
the	I-DISEASE
occurrence	0
of	0
isolated	0
sleep	0
paralysis	0
elicited	0
during	I-DISEASE
a	0
multi	I-DISEASE
-	I-DISEASE
phasic	0
sleep	0
-	I-DISEASE
wake	0
schedule	0
.	0

Sleep	0
2002;25:89–96	0
.	0

Takeuchi	0
T	0
,	0
Miyasita	0
A	0
,	I-DISEASE
Sasaki	0
Y	0
,	I-DISEASE
Inugami	0
M	0
,	0
Fukuda	0
K.	0
Isolated	0
sleep	0
paralysis	0
elicited	I-DISEASE
by	0
sleep	0
interruption	0
.	0

Sleep	0
1992;15:217–25	0
.	0

Nightmare	0
Disorder	0
ICD-9	0
-	0
CM	0
code	0
:	0
307.47	0
ICD-10	0
-	0
CM	I-DISEASE
code	0
:	0

F51.5	0
Alternate	0
Names	0
Nightmares	0
,	0
REM	0
nightmares	I-DISEASE
,	0
recurrent	I-DISEASE
nightmares	0
,	0
dream	0
anxiety	0
disorder	0
,	I-DISEASE
anxiety	0
dreams	0
.	I-DISEASE

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
C	I-DISEASE
must	I-DISEASE
be	0
met	I-DISEASE
A.	0
Repeated	0
occurrences	0
of	I-DISEASE
extended	I-DISEASE
,	0
extremely	I-DISEASE
dysphoric	0
,	I-DISEASE
and	0
well-	0
remembered	0
dreams	0
that	0
usually	0
involve	I-DISEASE
threats	0
to	0
survival	I-DISEASE
,	0
security	0
,	0
or	0
physical	0
integrity	0
.	0

B.	0
On	0
awakening	0
from	0
the	0
dysphoric	0
dreams	0
,	I-DISEASE
the	0
person	0
rapidly	0
becomes	0
oriented	0
and	0
alert	I-DISEASE
.	I-DISEASE

C.	0
The	I-DISEASE
dream	0
experience	0
,	0
or	0
the	I-DISEASE
sleep	0
disturbance	I-DISEASE
produced	I-DISEASE
by	0
awakening	0
from	0
it	0
,	I-DISEASE
causes	0
clinically	0
significant	I-DISEASE
distress	0
or	0
impairment	0
in	0
social	0
,	0
occupational	I-DISEASE
,	0
or	0
other	0
important	0
areas	0
of	I-DISEASE
functioning	0
as	0
indicated	0
by	I-DISEASE
the	0
report	I-DISEASE
of	I-DISEASE
at	0
least	0
one	0
of	I-DISEASE
the	0
following	0
:	I-DISEASE
.	I-DISEASE

Mood	0
disturbance	0
(	0
e.g.	0
,	0
persistence	0
of	0
nightmare	0
affect	0
,	0
anxiety	0
,	0
dysphoria	0
)	0
.	0
.	0

Sleep	0
resistance	0
(	0
e.g.	0
,	0
bedtime	0
anxiety	I-DISEASE
,	0
fear	0
of	0
sleep	0
/	0
subsequent	0
nightmares	0
)	I-DISEASE
.	I-DISEASE
.	0

Cognitive	0
impairments	0
(	0
e.g.	0
,	0
intrusive	0
nightmare	0
imagery	0
,	0
impaired	0
concentration	0
,	0
or	0
memory	0
)	0
.	0
.	I-DISEASE

Negative	0
impact	0
on	0
caregiver	0
or	0
family	0
functioning	0
(	0
e.g.	0
,	0
nighttime	0
disruption	0
)	0
.	0
.	0

Behavioral	0
problems	0
(	0
e.g.	0
,	0
bedtime	0
avoidance	I-DISEASE
,	0
fear	0
of	0
the	0
dark	0
)	0
.	0
.	0

Daytime	0
sleepiness	0
.	0
.	I-DISEASE

Fatigue	0
or	0
low	I-DISEASE
energy	0
.	0
.	0

Impaired	0
occupational	0
or	0
educational	0
function	0
.	0
.	0

Impaired	0
interpersonal	0
/	0
social	0
function	0
Notes	0
.	I-DISEASE

Nightmare	0
disorder	0
in	0
children	0
is	0
most	0
likely	0
to	0
occur	I-DISEASE
in	0
those	0
exposed	0
to	0
severe	0
psychosocial	I-DISEASE
stressors	0
.	0

Because	0
childhood	0
nightmares	0
often	0
resolve	0
spontaneously	0
,	I-DISEASE
the	0
diagnosis	I-DISEASE
should	I-DISEASE
be	0
given	0
only	I-DISEASE
if	0
there	0
is	0
persistent	0
distress	I-DISEASE
or	0
impairment	0
.	0

Parasomnias	0
Parasomnias	0
Essential	0
Features	0
Nightmare	0
disorder	I-DISEASE
is	I-DISEASE
characterized	0
by	0
recurrent	0
,	I-DISEASE
highly	0
dysphoric	0
dreams	I-DISEASE
,	I-DISEASE
which	I-DISEASE
are	0
disturbing	I-DISEASE
mental	0
experiences	I-DISEASE
that	0
generally	0
occur	0
during	0
REM	0
sleep	0
and	0
that	I-DISEASE
often	0
result	I-DISEASE
in	0
awakening	I-DISEASE
.	0

Given	0
that	I-DISEASE
these	I-DISEASE
experiences	0
are	0
most	0
often	0
associated	I-DISEASE
with	I-DISEASE
REM	0
sleep	0
,	0
the	I-DISEASE
episodes	0
have	I-DISEASE
a	0
greater	0
tendency	I-DISEASE
to	0
occur	I-DISEASE
during	0
the	0
second	I-DISEASE
half	I-DISEASE
of	I-DISEASE
the	I-DISEASE
major	0
sleep	I-DISEASE
episode	0
when	I-DISEASE
the	0
REM	0
pressure	I-DISEASE
is	0
most	0
pronounced	I-DISEASE
.	0

Nightmares	0
involve	I-DISEASE
an	0
internally	0
generated	0
conscious	0
experience	I-DISEASE
or	0
dream	0
sequence	0
that	0
seems	0
vivid	0
and	0
real	I-DISEASE
.	I-DISEASE

They	0
have	0
a	0
tendency	I-DISEASE
to	I-DISEASE
become	0
increasingly	0
more	0
disturbing	0
as	0
they	0
unfold	0
.	0

Emotions	0
are	0
characteristically	0
negative	I-DISEASE
and	0
most	0
frequently	0
involve	0
anxiety	I-DISEASE
,	0
fear	0
,	0
or	0
terror	0
but	I-DISEASE
may	0
also	0
involve	0
anger	0
,	0
rage	0
,	0
embarrassment	I-DISEASE
,	0
and	0
disgust	0
.	0

Nightmare	0
content	0
most	0
often	0
focuses	0
on	0
imminent	0
physical	0
danger	0
to	0
the	0
individual	0
but	0
may	0
also	0
involve	0
other	0
distressing	I-DISEASE
themes	0
.	0

Ability	0
to	0
detail	0
the	0
nightmare	I-DISEASE
’s	I-DISEASE
contents	I-DISEASE
upon	0
awakening	0
is	0
common	0
in	0
nightmare	0
disorder	0
.	0

Multiple	0
nightmares	0
within	0
a	I-DISEASE
single	0
sleep	0
episode	I-DISEASE
may	0
occur	I-DISEASE
and	0
may	0
bear	0
similar	0
themes	0
.	0

Because	0
nightmares	0
typically	0
arise	I-DISEASE
during	I-DISEASE
REM	I-DISEASE
sleep	I-DISEASE
,	0
they	I-DISEASE
may	0
occur	0
at	0
any	0
moment	0
that	I-DISEASE
REM	I-DISEASE
pressure	0
is	I-DISEASE
high	0
.	I-DISEASE

Nightmares	0
are	0
very	0
common	0
in	0
children	0
.	0

They	0
typically	0
occur	0
in	0
the	0
last	I-DISEASE
third	0
of	0
the	I-DISEASE
night	I-DISEASE
and	I-DISEASE
result	0
in	0
a	0
complete	0
awakening	0
,	0
after	I-DISEASE
which	0
the	0
child	0
can	0
often	0
provide	0
a	I-DISEASE
detailed	0
description	0
of	I-DISEASE
the	0
frightening	0
scenario	I-DISEASE
.	0

However	0
,	I-DISEASE
clear	0
distinction	0
from	0
con-	0
fusional	I-DISEASE
arousals	0
and	I-DISEASE
sleep	0
terrors	0
in	0
young	0
children	0
is	0
often	I-DISEASE
not	0
possible	I-DISEASE
.	I-DISEASE

Associated	0
Features	0
Postawakening	0
anxiety	0
and	0
difficulty	0
returning	I-DISEASE
to	0
sleep	I-DISEASE
may	0
be	0
present	I-DISEASE
.	0

Nightmares	0
are	I-DISEASE
more	I-DISEASE
common	0
in	0
those	0
with	0
higher	0
levels	I-DISEASE
of	0
anxiety	0
.	0

Additionally	0
,	0
nightmares	0
are	0
commonly	0
seen	0
in	0
those	0
who	0
have	0
been	0
physically	0
or	0
sexually	0
abused	I-DISEASE
and	0
in	0
those	I-DISEASE
suf-	0
fering	0
from	0
posttraumatic	0
stress	0
disorder	I-DISEASE
.	0

Nightmares	0
arising	I-DISEASE
either	I-DISEASE
immediately	0
following	0
a	0
trauma	I-DISEASE
(	0
acute	0
stress	0
disorder	0
[	0
ASD	I-DISEASE
]	0
)	I-DISEASE
or	0
one	0
month	I-DISEASE
or	0
more	0
after	0
a	0
trauma	0
(	0
posttraumatic	I-DISEASE
stress	0
disorder	I-DISEASE
[	I-DISEASE
PTSD	0
]	0
)	I-DISEASE
have	I-DISEASE
been	0
described	0
during	0
NREM	0
sleep	I-DISEASE
,	0
especially	0
N2	0
,	I-DISEASE
as	0
well	0
as	0
during	I-DISEASE
REM	0
sleep	I-DISEASE
and	0
at	I-DISEASE
sleep	I-DISEASE
onset	0
.	0

Posttraumatic	0
nightmares	0
may	0
take	0
the	0
form	0
of	I-DISEASE
a	I-DISEASE
realistic	I-DISEASE
reliving	0
of	0
a	0
traumatic	0
event	0
or	I-DISEASE
may	0
depict	0
only	I-DISEASE
some	0
of	0
its	0
elements	0
or	0
emotional	0
content	I-DISEASE
.	I-DISEASE

Clinical	0
or	0
Pathophysiological	0
Subtypes	0
None	I-DISEASE
known	I-DISEASE
.	0

Demographics	0
Occasional	0
nightmares	0
are	0
very	0
common	0
in	0
children	0
,	0
occurring	0
in	0
60	0
%	0
to	I-DISEASE
75	I-DISEASE
%	0
of	0
chil-	0
dren	0
,	0
beginning	0
as	0
young	0
as	0
2.5	I-DISEASE
years	0
of	0
age	I-DISEASE
.	0

The	0
occurrence	0
of	0
occasional	0
nightmares	0
in	0
children	0
does	I-DISEASE
not	0
constitute	I-DISEASE
a	0
nightmare	0
disorder	0
.	0

However	0
,	I-DISEASE
frequent	0
nightmares	0
are	0
uncommon	0
,	0
occurring	0
in	0
1	0
%	0
to	0
5	0
%	0
of	0
preadolescent	0
children	0
.	I-DISEASE

It	0
is	0
estimated	0
that	0
10	0
%	I-DISEASE
to	0
50	0
%	I-DISEASE
of	0
children	0
aged	I-DISEASE
three	0
to	0
five	0
years	I-DISEASE
have	I-DISEASE
at	0
least	0
occasional	I-DISEASE
nightmares	0
severe	0
enough	0
to	0
disturb	0
their	0
parents	0
.	0

Nightmares	0
appear	0
to	0
be	0
a	0
trait	0
-	I-DISEASE
like	0
characteristic	I-DISEASE
that	0
persists	0
over	0
time	0
during	0
childhood	I-DISEASE
.	0

The	0
best	0
predictor	0
of	0
recurrent	0
nightmares	I-DISEASE
at	0
an	0
older	0
age	0
is	0
recurrent	0
nightmares	0
in	0
childhood	0
.	0

Approximately	0
2	0
%	0
to	0
8	0
%	0
of	0
the	0
general	I-DISEASE
population	0
has	0
a	0
current	0
problem	0
with	I-DISEASE
nightmares	0
,	0
and	I-DISEASE
this	0
frequency	0
is	0
higher	0
in	0
clini-	0
cal	I-DISEASE
populations	0
.	0

Trauma	0
-	0
related	0
nightmares	0
are	0
the	I-DISEASE
most	0
consistent	0
problem	I-DISEASE
reported	0
by	0
patients	I-DISEASE
with	0
PTSD	0
.	I-DISEASE

Nightmares	0
beginning	I-DISEASE
within	0
three	0
months	0
of	0
a	0
trauma	0
are	I-DISEASE
present	0
in	0
up	0
to	0
80	0
%	0
of	0
patients	0
with	I-DISEASE
PTSD	0
.	0

Although	0
approximately	0
50	0
%	0
of	0
PTSD	I-DISEASE
cases	I-DISEASE
resolve	0
within	I-DISEASE
three	0
months	0
,	0
posttraumatic	0
nightmares	0
may	I-DISEASE
persist	0
throughout	0
life	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
Frequent	0
nightmares	I-DISEASE
are	I-DISEASE
associated	0
with	I-DISEASE
enduring	0
personality	0
characteristics	0
and	0
psy-	0
chopathologies	I-DISEASE
;	0
they	0
are	I-DISEASE
inversely	0
correlated	0
with	0
measures	0
of	I-DISEASE
well	0
-	0
being	I-DISEASE
.	0

Associations	0
with	0
psychopathology	0
have	0
been	0
identified	0
for	I-DISEASE
adults	0
and	I-DISEASE
adolescents	0
,	0
but	0
research	0
on	0
children	I-DISEASE
is	0
largely	I-DISEASE
absent	I-DISEASE
other	0
than	0
for	0
assessments	I-DISEASE
of	0
PTSD	0
.	0

Measures	0
of	I-DISEASE
nightmare	0
distress	I-DISEASE
are	0
much	0
more	I-DISEASE
robustly	0
associated	0
with	0
psychopathology	0
than	0
are	0
measures	0
of	I-DISEASE
nightmare	I-DISEASE
frequency	0
.	I-DISEASE

The	0
clinical	0
use	0
of	0
pharmacologic	0
agents	I-DISEASE
affecting	I-DISEASE
the	0
neurotransmitters	I-DISEASE
norepinephrine	0
,	0
serotonin	0
,	0
and	I-DISEASE
dopamine	I-DISEASE
is	0
associated	0
with	I-DISEASE
the	0
complaint	I-DISEASE
of	0
night-	0
mares	0
.	0

A	0
majority	0
of	0
these	I-DISEASE
agents	0
are	0
antidepressants	I-DISEASE
,	0
antihypertensives	I-DISEASE
,	0
and	0
dopa-	0
mine	0
-	I-DISEASE
receptor	0
agonists	I-DISEASE
.	0

Agents	0
affecting	0
the	0
neurotransmitters	I-DISEASE
gamma	0
-	I-DISEASE
aminobutyric	I-DISEASE
acid	I-DISEASE
(	I-DISEASE
GABA	I-DISEASE
)	0
,	I-DISEASE
acetylcholine	0
,	0
and	0
histamine	I-DISEASE
,	0
and	I-DISEASE
the	0
withdrawal	I-DISEASE
of	0
REM	0
sleep	0
sup-	0
pressive	0
agents	0
also	0
can	I-DISEASE
be	0
associated	0
with	0
the	I-DISEASE
complaint	I-DISEASE
of	0
nightmares	0
.	0

Of	0
note	0
,	0
nightmares	0
are	0
a	0
common	I-DISEASE
reaction	0
in	I-DISEASE
varenicline	0
,	0
which	0
is	0
an	0
agent	I-DISEASE
that	I-DISEASE
blocks	I-DISEASE
α-4	I-DISEASE
-	0
β-2	0
nicotinic	0
acetylcholine	0
receptors	0
.	I-DISEASE

Familial	0
Pattern	0
Twin	0
-	0
based	0
studies	0
have	I-DISEASE
identified	0
persistent	I-DISEASE
genetic	0
predisposition	0
to	0
nightmares	0
in	0
childhood	I-DISEASE
(	0
reported	0
retrospectively	I-DISEASE
by	0
adults	0
)	0
and	0
adulthood	0
as	0
well	0
as	0
genetic	0
influ-	I-DISEASE
ences	0
on	I-DISEASE
the	0
co	0
-	0
occurrence	0
of	0
nightmares	0
and	0
some	I-DISEASE
other	0
parasomnias	I-DISEASE
,	0
such	I-DISEASE
as	0
sleep	0
talking	0
(	I-DISEASE
somniloquy	0
)	I-DISEASE
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Nightmares	I-DISEASE
usually	0
start	0
between	0
ages	0
three	0
years	0
and	0
six	0
years	0
.	0

The	0
proportion	0
of	0
children	0
reporting	0
nightmares	0
reaches	0
a	0
peak	I-DISEASE
between	0
six	0
and	0
ten	0
years	0
of	I-DISEASE
age	0
and	0
decreases	I-DISEASE
thereafter	0
.	0

A	0
subgroup	0
of	0
children	I-DISEASE
continue	I-DISEASE
to	0
have	I-DISEASE
nightmares	0
into	0
Parasomnias	0
Parasomnias	0
adolescence	0
or	0
adulthood	0
and	I-DISEASE
may	0
become	0
lifelong	0
nightmare	0
sufferers	0
.	0

Nightmares	0
generally	0
diminish	0
in	I-DISEASE
frequency	0
and	0
intensity	I-DISEASE
over	0
the	0
course	0
of	0
decades	0
,	I-DISEASE
but	0
some	I-DISEASE
patients	0
still	0
describe	0
frequent	0
episodes	I-DISEASE
at	0
the	0
age	0
of	0
60	I-DISEASE
or	I-DISEASE
70	0
years	0
.	0

Nightmare	0
dis-	I-DISEASE
order	0
can	I-DISEASE
lead	0
to	I-DISEASE
sleep	I-DISEASE
avoidance	0
and	I-DISEASE
deprivation	I-DISEASE
,	0
and	I-DISEASE
thereby	I-DISEASE
to	0
more	I-DISEASE
intense	0
night-	0
mares	I-DISEASE
,	0
which	0
can	0
produce	0
insomnia	0
.	I-DISEASE

ASD	0
and	0
PTSD	0
associated	0
nightmares	0
can	I-DISEASE
develop	0
at	0
any	0
age	0
after	0
physical	0
or	0
emo-	0
tional	I-DISEASE
trauma	0
.	0

Individuals	0
with	0
PTSD	0
are	0
at	0
risk	0
for	I-DISEASE
developing	0
mood	I-DISEASE
disorders	I-DISEASE
and	0
depression	0
,	I-DISEASE
social	0
and	I-DISEASE
employment	0
consequences	0
,	I-DISEASE
self	0
-	0
destructive	0
and	0
impulsive	I-DISEASE
behavior	0
,	I-DISEASE
and	0
substance	0
abuse	0
;	0
it	I-DISEASE
is	0
not	0
known	0
to	0
what	0
extent	I-DISEASE
the	0
nightmares	0
symp-	I-DISEASE
tomatic	0
of	I-DISEASE
PTSD	0
contribute	0
to	0
these	I-DISEASE
complications	I-DISEASE
.	I-DISEASE

Developmental	0
Issues	0
As	0
stated	0
above	0
,	I-DISEASE
nightmares	I-DISEASE
are	0
very	0
common	0
in	0
children	0
but	0
the	I-DISEASE
occurrence	0
of	I-DISEASE
occa-	0
sional	I-DISEASE
nightmares	0
does	0
not	0
constitute	0
nightmare	I-DISEASE
disorder	0
.	0

Population	0
studies	0
have	0
revealed	0
that	0
the	I-DISEASE
prevalence	I-DISEASE
and	I-DISEASE
frequency	I-DISEASE
of	0
nightmares	0
increases	0
through	0
childhood	0
into	0
adolescence	0
.	0

For	0
example	0
,	0
preschoolers	0
seldom	0
report	0
“	I-DISEASE
bad	0
dreams	I-DISEASE
.	0
”	0

Furthermore	0
,	0
in	0
regard	0
to	0
the	0
prevalence	I-DISEASE
of	I-DISEASE
nightmares	I-DISEASE
,	0
children	0
appear	I-DISEASE
to	0
exhibit	0
a	I-DISEASE
sex	0
divergence	0
over	I-DISEASE
time	0
,	0
with	0
girls	0
demonstrating	0
higher	0
prevalence	I-DISEASE
by	0
late	I-DISEASE
adolescence	I-DISEASE
.	0

Pathology	0
and	0
Pathophysiology	0
Not	0
applicable	0
or	I-DISEASE
known	I-DISEASE
.	0

Objective	0
Findings	0
PSG	0
recordings	I-DISEASE
during	0
actual	I-DISEASE
nightmares	I-DISEASE
are	0
few	I-DISEASE
in	0
number	0
and	0
,	0
in	0
some	0
instances	I-DISEASE
,	0
have	I-DISEASE
shown	0
abrupt	0
awakenings	0
from	0
REM	0
sleep	0
preceded	0
by	0
accelerated	0
heart	I-DISEASE
and	0
respiratory	0
rates	0
.	I-DISEASE

Highly	0
disturbing	0
dream	0
content	0
frequently	0
contrasts	0
strikingly	I-DISEASE
with	0
relatively	I-DISEASE
minor	0
autonomic	0
changes	0
.	0

Distinctive	0
anomalies	0
in	I-DISEASE
nightly	0
sleep	0
architec-	I-DISEASE
ture	0
have	0
not	0
been	0
demonstrated	0
;	0
brainstem	0
and	0
auditory	0
-	0
evoked	0
potentials	I-DISEASE
appear	0
normal	I-DISEASE
.	0

Recordings	0
during	0
posttraumatic	0
nightmares	0
are	0
few	0
but	0
have	0
been	0
recorded	0
from	0
both	0
REM	0
and	0
NREM	0
sleep	0
.	0

PSG	0
recordings	0
of	0
sleep	0
in	0
patients	I-DISEASE
with	0
PTSD	I-DISEASE
have	I-DISEASE
provided	0
widely	0
variable	0
results	0
.	0

PSG	0
evaluation	0
is	0
not	0
routinely	0
performed	I-DISEASE
but	0
may	0
be	0
indicated	0
in	0
some	0
circumstances	0
to	0
exclude	I-DISEASE
other	0
parasomnias	0
such	I-DISEASE
as	0
disorders	0
of	0
arousal	0
and	0
sleep	0
-	0
associated	0
sei-	0
zures	I-DISEASE
.	0

A	0
PSG	0
is	0
particularly	0
appropriate	0
if	I-DISEASE
patients	I-DISEASE
report	0
nightmares	I-DISEASE
in	0
conjunction	0
with	0
sleep	0
behaviors	0
that	I-DISEASE
are	0
repetitive	0
or	I-DISEASE
stereotyped	0
or	0
are	0
injurious	0
to	0
self	0
or	0
others	0
.	0

Differential	0
Diagnosis	0
Nightmare	0
disorder	0
must	0
be	I-DISEASE
distinguished	I-DISEASE
from	0
dream	0
disturbances	I-DISEASE
associated	0
with	0
certain	0
other	0
neurological	I-DISEASE
and	0
sleep	0
disorders	I-DISEASE
.	0

Rare	0
cases	0
of	I-DISEASE
seizures	I-DISEASE
presenting	0
only	I-DISEASE
as	I-DISEASE
“	0
nightmares	I-DISEASE
”	0
have	0
been	0
reported	0
and	0
should	0
be	I-DISEASE
considered	0
in	I-DISEASE
the	0
differential	0
diagno-	I-DISEASE
sis	0
,	0
particularly	I-DISEASE
in	I-DISEASE
those	I-DISEASE
patients	0
who	I-DISEASE
present	0
with	I-DISEASE
a	0
history	0
of	0
central	0
nervous	0
system	0
disease	0
.	I-DISEASE

PSG	0
or	0
continuous	0
video	0
EEG	0
may	0
be	I-DISEASE
necessary	0
to	I-DISEASE
identify	I-DISEASE
nightmares	0
asso-	0
ciated	I-DISEASE
with	0
nocturnal	I-DISEASE
seizures	0
.	0

Nightmares	0
differ	I-DISEASE
from	I-DISEASE
sleep	0
terrors	0
in	I-DISEASE
having	I-DISEASE
detailed	0
recollection	I-DISEASE
of	0
dreaming	0
in	0
contrast	0
to	0
fragments	0
of	I-DISEASE
dreams	I-DISEASE
or	I-DISEASE
no	0
dream	0
recall	0
,	0
pre-	I-DISEASE
senting	0
no	I-DISEASE
or	0
minimal	0
overt	I-DISEASE
movement	I-DISEASE
or	I-DISEASE
autonomic	0
activity	I-DISEASE
,	0
occurring	0
late	0
in	0
the	0
night	I-DISEASE
,	0
being	I-DISEASE
followed	I-DISEASE
by	I-DISEASE
rapid	0
awakening	0
and	0
difficulty	0
returning	0
to	I-DISEASE
sleep	I-DISEASE
,	I-DISEASE
and	0
most	0
often	I-DISEASE
arising	I-DISEASE
from	0
REM	0
sleep	0
.	I-DISEASE

RBD	0
occurs	0
more	0
often	0
in	0
late	I-DISEASE
middle	0
-	0
aged	I-DISEASE
men	0
and	0
is	0
more	I-DISEASE
often	0
associated	0
with	I-DISEASE
violent	0
explosive	I-DISEASE
movements	0
and	0
a	0
history	0
of	0
nocturnal	0
injuries	I-DISEASE
.	0

The	0
dream	0
disturbance	0
of	0
RBD	0
usually	I-DISEASE
involves	0
being	0
threatened	0
or	0
attacked	0
by	0
unfamiliar	I-DISEASE
people	0
or	I-DISEASE
animals	I-DISEASE
and	0
is	I-DISEASE
controlled	0
in	0
tandem	0
with	0
the	0
sleep	0
behavioral	I-DISEASE
disturbance	I-DISEASE
by	0
appropriate	0
medication	0
.	0

Nightmares	0
occur	I-DISEASE
at	0
any	0
age	0
and	0
are	0
not	0
typ-	0
ically	I-DISEASE
associated	0
with	0
movements	I-DISEASE
,	0
overt	I-DISEASE
behaviors	0
,	0
or	0
injuries	0
.	0

Anxiety	0
may	0
accom-	0
pany	I-DISEASE
episodes	0
of	I-DISEASE
sleep	I-DISEASE
paralysis	0
occurring	I-DISEASE
either	0
at	0
sleep	0
onset	0
(	I-DISEASE
hypnagogic	0
)	0
or	0
offset	I-DISEASE
(	I-DISEASE
hypnopompic	I-DISEASE
)	0
,	0
when	I-DISEASE
the	0
individual	I-DISEASE
feels	0
conscious	0
but	0
unable	I-DISEASE
to	0
move	0
,	I-DISEASE
speak	0
,	0
and	I-DISEASE
,	0
at	I-DISEASE
times	0
,	0
breathe	I-DISEASE
properly	I-DISEASE
.	0

Anxiety	0
may	0
be	0
further	0
worsened	0
if	0
disturbing	0
hypnago-	0
gic	I-DISEASE
hallucinations	0
or	0
dream	0
sequences	0
accompany	I-DISEASE
the	I-DISEASE
paralysis	I-DISEASE
.	0

Nightmares	0
,	I-DISEASE
although	I-DISEASE
they	0
may	0
involve	0
some	B-DISEASE
degree	0
of	I-DISEASE
movement	0
inhibition	0
or	I-DISEASE
some	0
degree	0
of	I-DISEASE
apparent	0
wakefulness	0
,	I-DISEASE
are	0
usually	I-DISEASE
not	0
accompanied	0
by	0
feelings	0
of	I-DISEASE
either	I-DISEASE
total	0
paralysis	0
or	0
com-	I-DISEASE
plete	I-DISEASE
waking	0
consciousness	0
.	0

Patients	0
with	0
narcolepsy	0
often	0
report	0
nightmares	0
;	0
these	0
may	I-DISEASE
occur	0
at	0
sleep	0
onset	0
.	0

However	0
,	I-DISEASE
narcolepsy	0
and	0
nightmare	0
disorder	0
are	0
clearly	0
distinguishable	I-DISEASE
by	0
other	0
clinical	0
symptoms	0
.	0

Nocturnal	0
panic	0
attacks	0
occur	0
either	0
during	0
or	I-DISEASE
immediately	I-DISEASE
after	I-DISEASE
nocturnal	0
awakenings	0
from	0
NREM	0
sleep	0
,	I-DISEASE
usually	I-DISEASE
in	0
the	I-DISEASE
first	0
four	I-DISEASE
hours	0
of	0
the	0
sleep	0
episode	I-DISEASE
.	0

Although	0
frequency	0
of	0
panic	I-DISEASE
attacks	I-DISEASE
is	I-DISEASE
correlated	I-DISEASE
with	0
frequency	I-DISEASE
of	0
night-	0
mares	I-DISEASE
and	I-DISEASE
many	I-DISEASE
patients	I-DISEASE
report	I-DISEASE
that	0
dysphoric	I-DISEASE
dreams	0
precede	I-DISEASE
their	0
attacks	0
,	0
there	0
may	I-DISEASE
be	I-DISEASE
no	0
dream	I-DISEASE
recall	0
reported	I-DISEASE
on	0
awakening	I-DISEASE
with	0
a	0
panic	0
attack	0
.	0

Sleep	0
related	I-DISEASE
dissociative	I-DISEASE
disorders	0
comprise	0
a	0
sleep	I-DISEASE
related	0
variant	I-DISEASE
of	0
the	0
dissociative	I-DISEASE
disorders	0
as	0
defined	I-DISEASE
by	0
the	0
Diagnostic	I-DISEASE
and	0
Statistical	0
Manual	0
of	B-DISEASE
Mental	0
Disorders	I-DISEASE
,	I-DISEASE
Fifth	I-DISEASE
Edition	0
(	I-DISEASE
DSM	0
-	I-DISEASE
V	0
)	I-DISEASE
.	0

These	0
include	0
dissociative	0
identity	0
disorder	0
(	I-DISEASE
formerly	I-DISEASE
called	0
multi-	I-DISEASE
ple	0
personality	0
disorder	0
)	I-DISEASE
and	0
dissociative	I-DISEASE
fugue	0
,	0
in	I-DISEASE
which	I-DISEASE
individuals	I-DISEASE
meeting	0
waking	0
criteria	0
for	0
these	I-DISEASE
diagnoses	0
may	I-DISEASE
at	I-DISEASE
times	0
experience	I-DISEASE
the	I-DISEASE
recall	I-DISEASE
of	0
actual	0
physical	0
or	0
emotional	0
trauma	I-DISEASE
as	I-DISEASE
a	I-DISEASE
“	0
dream	I-DISEASE
”	0
during	0
periods	I-DISEASE
of	I-DISEASE
EEG	I-DISEASE
-	I-DISEASE
documented	0
nocturnal	I-DISEASE
waking	0
.	0

Parasomnias	0
Parasomnias	0
Nightmares	0
that	0
occur	0
intermittently	I-DISEASE
during	I-DISEASE
the	0
course	0
of	0
ASD	I-DISEASE
or	I-DISEASE
PTSD	0
are	0
an	0
expected	0
symptom	0
of	I-DISEASE
those	I-DISEASE
mental	0
disorders	0
and	0
do	0
not	0
always	I-DISEASE
require	I-DISEASE
independent	0
coding	I-DISEASE
as	0
nightmare	0
disorder	I-DISEASE
.	I-DISEASE

However	0
,	I-DISEASE
as	0
is	0
often	0
the	I-DISEASE
case	I-DISEASE
,	0
when	I-DISEASE
the	0
frequency	I-DISEASE
and/or	0
severity	I-DISEASE
of	0
posttraumatic	I-DISEASE
nightmares	0
is	0
such	0
that	0
they	0
require	0
independent	0
clinical	0
attention	I-DISEASE
,	I-DISEASE
then	0
a	0
diagnosis	0
of	0
nightmare	0
disorder	I-DISEASE
should	I-DISEASE
be	0
applied	0
.	0

In	0
some	0
cases	0
,	B-DISEASE
other	0
symp-	0
toms	B-DISEASE
of	0
PTSD	I-DISEASE
may	0
have	0
largely	I-DISEASE
resolved	0
while	0
the	I-DISEASE
nightmares	0
persist	0
.	0

Nightmare	0
disorder	I-DISEASE
should	0
be	0
coded	I-DISEASE
in	I-DISEASE
these	0
cases	0
as	I-DISEASE
well	0
.	0

It	0
is	0
clinically	0
important	0
to	0
establish	I-DISEASE
whether	0
nightmares	0
are	0
associated	0
with	0
PTSD	0
or	0
ASD	0
because	I-DISEASE
the	0
evaluation	0
,	0
course	0
,	I-DISEASE
complications	0
,	0
and	0
treatment	0
differ	I-DISEASE
significantly	0
for	I-DISEASE
these	I-DISEASE
groups	0
.	I-DISEASE

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE

Basic	0
pathophysiologic	0
studies	0
are	I-DISEASE
still	I-DISEASE
needed	I-DISEASE
,	I-DISEASE
especially	0
studies	I-DISEASE
contrasting	0
“	0
idio-	0
pathic	0
”	0
nightmare	0
disorder	0
and	0
nightmares	I-DISEASE
associated	0
with	0
PTSD	0
.	0

In	0
particular	0
,	0
deter-	0
mining	0
whether	I-DISEASE
posttraumatic	I-DISEASE
nightmares	0
arise	0
from	0
sleep	0
or	0
primarily	0
from	I-DISEASE
wakeful-	0
ness	I-DISEASE
would	0
be	I-DISEASE
an	0
important	I-DISEASE
distinguishing	0
feature	0
particularly	0
when	0
determining	0
effec-	I-DISEASE
tive	0
clinical	I-DISEASE
interventions	0
.	0

The	0
PSG	0
correlates	0
of	0
nightmare	0
disorder	0
and	I-DISEASE
posttraumatic	0
nightmares	I-DISEASE
as	0
well	0
as	0
the	0
variables	0
affecting	0
dream	0
mentation	0
and	I-DISEASE
recall	I-DISEASE
require	0
further	0
definition	0
and	0
delineation	I-DISEASE
.	I-DISEASE

The	0
distinction	0
between	0
nightmares	0
and	0
sleep	I-DISEASE
terrors	I-DISEASE
is	0
difficult	I-DISEASE
when	0
assessed	0
only	0
by	0
questionnaires	0
.	I-DISEASE

It	0
still	0
remains	0
unclear	0
to	I-DISEASE
what	0
degree	I-DISEASE
and	0
level	I-DISEASE
of	0
complexity	0
sleep	0
mentation	I-DISEASE
is	0
associated	I-DISEASE
with	I-DISEASE
sleep	0
terrors	0
.	I-DISEASE

The	0
topic	0
of	0
NREM	I-DISEASE
sleep	0
dream	0
distur-	I-DISEASE
bances	I-DISEASE
(	I-DISEASE
other	0
than	I-DISEASE
disturbed	0
mentation	I-DISEASE
that	0
may	I-DISEASE
occur	I-DISEASE
with	I-DISEASE
sleep	I-DISEASE
terrors	0
)	0
also	0
needs	0
formal	0
investigation	0
,	I-DISEASE
including	I-DISEASE
whether	0
or	I-DISEASE
not	I-DISEASE
the	0
term	0
NREM	0
sleep	0
nightmare	0
should	0
be	0
utilized	0
.	I-DISEASE

The	0
optimal	0
methods	0
for	I-DISEASE
assessing	0
nightmare	I-DISEASE
frequency	I-DISEASE
and	0
nightmare	I-DISEASE
distress	0
are	0
still	0
unclear	0
.	0

Standardized	0
scales	0
assessing	0
nightmare	0
distress	0
should	I-DISEASE
be	0
developed	0
and	I-DISEASE
utilized	0
.	0

Retrospective	0
questionnaire	0
-	0
based	0
evaluations	0
of	0
nightmares	I-DISEASE
are	0
problematic	I-DISEASE
inasmuch	0
as	0
they	0
underestimate	0
nightmare	0
frequencies	0
relative	0
to	0
home	I-DISEASE
logs	0
,	0
whereas	0
home	0
logs	I-DISEASE
may	I-DISEASE
selectively	I-DISEASE
increase	0
recall	0
of	0
nightmares	0
.	0

Bibliography	0
Germain	0
A	0
,	0
Nielsen	0
T.	I-DISEASE
Sleep	I-DISEASE
pathophysiology	0
in	I-DISEASE
posttraumatic	0
stress	0
disorder	0
and	I-DISEASE
idiopathic	I-DISEASE
nightmare	I-DISEASE
sufferers	I-DISEASE
.	0

Biol	0
Psychiatry	0
2003;54:1092–8	0
.	0

Hobson	0
J.	0
REM	0
sleep	0
and	0
dreaming	0
:	0
towards	0
a	I-DISEASE
theory	0
of	0
protoconsciousness	0
.	0

Nat	0
Rev	0
Neurosci	0
2009;10:803–13	0
.	0

Hublin	0
C	0
,	I-DISEASE
Kaprio	I-DISEASE
J	0
,	0
Partinen	I-DISEASE
M	I-DISEASE
,	I-DISEASE
Koskenvuo	0
M.	I-DISEASE
Nightmares	I-DISEASE
:	I-DISEASE
familial	0
aggregation	0
and	0
association	0
with	I-DISEASE
psychiatric	0
disorders	I-DISEASE
in	0
a	0
nationwide	I-DISEASE
twin	I-DISEASE
cohort	I-DISEASE
.	0

Am	0
J	0
Med	0
Genet	I-DISEASE
1999;88:329–36	0
.	0

Lavie	0
P.	0
Sleep	0
disturbances	0
in	0
the	I-DISEASE
wake	0
of	0
traumatic	0
events	I-DISEASE
.	I-DISEASE

N	0
Engl	0
J	0
Med	0
2001;345:1825–32	0
.	0

Levin	0
R	0
,	0
Fireman	0
G.	0
Nightmare	0
prevalence	I-DISEASE
,	0
nightmare	I-DISEASE
distress	0
,	0
and	0
self	0
-	0
reported	I-DISEASE
psychological	0
disturbance	0
.	0

Sleep	0
2002;25:205–12	0
.	0

Muzur	0
A	0
,	0
Pace	0
-	0
Schott	0
EF	I-DISEASE
,	0
Hobson	0
J.	0
The	0
prefrontal	0
cortex	0
in	0
sleep	0
.	I-DISEASE

Trends	0
Cogn	0
Sci	I-DISEASE
2002;6:475–81	0
.	0

Nielsen	0
T	0
,	0
Zadra	0
A.	0
Idiopathic	0
nightmares	I-DISEASE
and	0
dream	0
disturbances	0
associated	0
with	0
sleep	0
-	0
wake	0
transitions	0
.	I-DISEASE

In	0
:	0
Kryger	0
MH	0
,	I-DISEASE
Roth	0
T	I-DISEASE
,	0
Dement	I-DISEASE
WC	0
,	0
eds	0
.	0

Principles	0
and	I-DISEASE
practice	0
of	I-DISEASE
sleep	0
medicine	I-DISEASE
,	I-DISEASE
5th	0
ed	I-DISEASE
.	0

Philadelphia	0
:	I-DISEASE
Elsevier	0
Saunders	0
,	0
2010:1106–15	0
.	I-DISEASE

Pagel	0
J	0
,	0
Helfter	0
P.	0
Drug	0
induced	0
nightmares	0
—	0
an	0
etiology	0
based	0
review	0
.	0

Hum	0
Psychopharmacol	0
2003;18:59–67	0
.	0

Zadra	0
A	0
,	0
Donderi	0
D.	0
Nightmares	0
and	0
bad	0
dreams	I-DISEASE
:	0
their	0
prevalence	0
and	0
relationship	0
to	0
well	I-DISEASE
-	0
being	0
.	B-DISEASE

J	0
Abnorm	0
Psychol	0
2000;109:273–81	0
.	I-DISEASE

Parasomnias	0
Parasomnias	0
Other	0
Parasomnias	0
Exploding	0
Head	0
Syndrome	0
ICD-9	0
-	0
CM	0
code	0
:	0
327.49	0
Alternate	0
Names	0
Sensory	0
sleep	0
starts	0
,	I-DISEASE
sensory	I-DISEASE
sleep	0
shocks	0
.	0

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
C	I-DISEASE
must	0
be	0
met	I-DISEASE
ICD-10	0
-	0
CM	0
code	0
:	0

G47.59	0
A.	0
There	0
is	0
a	0
complaint	I-DISEASE
of	0
a	0
sudden	I-DISEASE
loud	0
noise	0
or	0
sense	0
of	0
explosion	I-DISEASE
in	0
the	0
head	I-DISEASE
either	0
at	0
the	0
wake	0
-	0
sleep	0
transition	I-DISEASE
or	I-DISEASE
upon	I-DISEASE
waking	I-DISEASE
during	I-DISEASE
the	0
night	0
.	0

B.	0
The	0
individual	0
experiences	0
abrupt	0
arousal	0
following	0
the	0
event	I-DISEASE
,	I-DISEASE
often	0
with	0
a	I-DISEASE
sense	0
of	0
fright	0
.	0

C.	0

The	0
experience	0
is	0
not	0
associated	I-DISEASE
with	0
significant	0
complaints	0
of	I-DISEASE
pain	0
.	0

Essential	0
Features	0
Exploding	0
head	0
syndrome	I-DISEASE
is	I-DISEASE
characterized	0
by	0
a	I-DISEASE
sudden	0
,	0
loud	0
imagined	0
noise	0
or	I-DISEASE
sense	0
of	0
a	I-DISEASE
violent	0
explosion	0
in	0
the	0
head	0
occurring	0
as	0
the	I-DISEASE
patient	0
is	0
falling	0
asleep	I-DISEASE
or	0
waking	0
during	0
the	0
night	0
.	0

The	0
event	0
is	0
variously	0
described	0
as	0
a	I-DISEASE
painless	0
loud	I-DISEASE
bang	0
,	0
an	0
explosion	0
,	0
a	I-DISEASE
clash	I-DISEASE
of	0
cymbals	I-DISEASE
,	0
or	I-DISEASE
a	0
bomb	0
exploding	0
,	0
but	0
occasionally	0
may	0
be	I-DISEASE
a	0
less	0
alarming	0
sound	0
.	0

It	0
is	0
usually	0
associated	0
with	0
a	0
sense	I-DISEASE
of	0
fright	I-DISEASE
,	0
and	0
many	0
patients	0
believe	0
they	I-DISEASE
are	0
having	0
a	I-DISEASE
stroke	0
.	0

In	0
a	0
minority	0
of	I-DISEASE
cases	0
a	I-DISEASE
flash	I-DISEASE
of	I-DISEASE
light	I-DISEASE
or	0
myoclonic	0
jerk	0
may	0
accompany	0
the	0
event	I-DISEASE
.	0

The	0
abnormal	0
sensation	0
lasts	0
a	I-DISEASE
few	I-DISEASE
seconds	0
and	0
may	I-DISEASE
recur	0
during	0
further	0
attempts	0
at	0
sleeping	0
.	0

The	0
number	0
of	0
attacks	I-DISEASE
varies	0
—	0
from	0
many	0
on	I-DISEASE
a	0
single	0
night	0
to	I-DISEASE
infrequent	0
—	0
with	0
some	0
patients	I-DISEASE
reporting	0
clustering	0
of	0
attacks	I-DISEASE
over	0
several	I-DISEASE
nights	I-DISEASE
fol-	0
lowed	0
by	I-DISEASE
a	I-DISEASE
gap	0
of	0
weeks	0
to	0
months	0
.	0

A	0
high	0
level	0
of	0
clinical	0
distress	0
can	0
be	0
associated	I-DISEASE
with	0
recurrent	0
attacks	0
,	0
with	0
concern	I-DISEASE
about	0
their	0
underlying	0
cause	0
.	0

Associated	0
Features	0
A	0
flash	0
of	I-DISEASE
light	I-DISEASE
may	I-DISEASE
accompany	0
the	I-DISEASE
sound	I-DISEASE
,	0
and	0
a	I-DISEASE
myoclonic	0
jerk	I-DISEASE
may	0
sometimes	0
occur	0
.	I-DISEASE

Although	0
the	0
event	I-DISEASE
is	0
typically	0
painless	0
,	I-DISEASE
a	0
simultaneous	I-DISEASE
stab	0
of	I-DISEASE
pain	0
in	0
the	0
head	0
has	I-DISEASE
occasionally	0
been	0
reported	0
.	0

An	0
insomnia	0
complaint	0
may	0
develop	0
as	I-DISEASE
a	0
result	0
of	I-DISEASE
the	0
recurring	0
arousals	0
and	I-DISEASE
anxiety	0
regarding	I-DISEASE
the	I-DISEASE
events	0
.	I-DISEASE

Clinical	0
or	0
Pathophysiological	0
Subtypes	0
None	I-DISEASE
known	I-DISEASE
.	0

Demographics	0
The	0
prevalence	0
is	0
unknown	0
.	0

Exploding	0
head	0
syndrome	I-DISEASE
is	I-DISEASE
reported	0
to	0
be	I-DISEASE
more	0
common	0
in	0
women	0
than	0
in	0
men	0
.	I-DISEASE

The	0
median	0
age	0
of	0
onset	0
is	0
58	I-DISEASE
years	0
,	I-DISEASE
but	0
onset	0
at	0
all	I-DISEASE
ages	0
has	0
been	0
reported	0
,	0
including	0
the	0
first	0
and	0
eighth	0
decades	0
.	I-DISEASE

Predisposing	0
and	0
Precipitating	0
Factors	0
Most	0
patients	I-DISEASE
do	I-DISEASE
not	0
detect	I-DISEASE
precipitating	0
factors	0
,	I-DISEASE
but	I-DISEASE
some	I-DISEASE
report	I-DISEASE
increased	I-DISEASE
numbers	0
of	I-DISEASE
attacks	0
when	0
under	0
personal	0
stress	0
or	0
overtired	I-DISEASE
.	0

Familial	0
Pattern	0
Occasional	0
cases	0
of	0
exploding	0
head	0
syndrome	0
occurring	I-DISEASE
in	0
the	0
same	0
family	0
have	0
been	0
reported	0
,	I-DISEASE
although	0
it	0
is	0
not	0
clear	0
whether	0
this	0
represents	0
a	0
true	I-DISEASE
familial	0
pattern	0
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complication	0
The	I-DISEASE
course	0
is	I-DISEASE
benign	0
with	0
no	0
reported	0
neurologic	0
sequelae	0
.	0

Frequent	0
events	0
on	0
a	0
single	0
night	0
can	I-DISEASE
result	0
in	I-DISEASE
insomnia	0
.	0

Clinical	0
levels	0
of	0
anxiety	0
may	0
result	0
from	0
patient	0
concern	I-DISEASE
about	0
a	0
serious	0
medical	0
basis	0
for	0
the	0
exploding	I-DISEASE
head	I-DISEASE
syndrome	0
.	0

The	0
condition	0
may	I-DISEASE
also	B-DISEASE
exacerbate	0
a	0
comorbid	I-DISEASE
migraine	0
disorder	0
.	0

In	0
many	0
patients	0
,	I-DISEASE
the	0
symptoms	I-DISEASE
appear	0
to	0
remit	I-DISEASE
spontaneously	0
over	0
some	0
years	0
.	0

Developmental	0
Issues	0
Not	0
known	0
or	0
applicable	0
.	0

Pathology	0
and	0
Pathophysiology	0
The	0
events	0
occur	I-DISEASE
most	I-DISEASE
frequently	0
during	I-DISEASE
a	0
period	0
of	0
drowsiness	0
preceding	0
sleep	I-DISEASE
.	0

Some	0
events	0
are	0
reported	0
to	0
occur	0
upon	0
waking	0
during	I-DISEASE
the	0
night	0
,	I-DISEASE
but	0
may	0
actually	I-DISEASE
be	0
occur-	0
ring	0
during	0
reinitiating	0
sleep	0
.	0

The	0
condition	0
appears	0
to	0
be	0
a	0
sensory	I-DISEASE
variant	0
of	I-DISEASE
the	0
better	0
-	0
known	0
transient	0
motor	I-DISEASE
phenomenon	0
of	0
sleep	I-DISEASE
starts	0
or	I-DISEASE
hypnic	0
jerks	0
occurring	0
at	0
wake	I-DISEASE
-	0
sleep	I-DISEASE
transition	0
.	0

The	0
neurophysiologic	0
mechanisms	0
underlying	0
these	0
hypnago-	0
gic	0
phenomena	0
are	I-DISEASE
unknown	0
.	0

Objective	0
Findings	0
VPSG	0
in	0
a	0
small	I-DISEASE
sample	I-DISEASE
of	0
patients	I-DISEASE
found	0
that	0
events	0
arose	0
from	0
early	I-DISEASE
drowsiness	0
with	0
predominant	I-DISEASE
alpha	0
rhythm	0
interspersed	0
with	0
some	0
theta	0
activity	0
.	0

In	0
one	0
patient	0
,	I-DISEASE
events	0
arose	0
during	I-DISEASE
transition	0
from	I-DISEASE
N1	0
sleep	0
,	0
in	I-DISEASE
another	0
patient	0
from	0
N1	0
sleep	0
to	0
wakeful-	0
ness	0
,	0
and	I-DISEASE
in	0
a	I-DISEASE
third	0
patient	0
from	I-DISEASE
N2	0
sleep	0
to	0
wakefulness	0
.	0

Events	0
occurring	0
in	0
the	0
N1/	I-DISEASE
Parasomnias	0
Parasomnias	0
N2	0
to	0
wake	0
transition	0
have	0
been	0
recorded	0
during	0
both	0
nocturnal	0
vPSG	I-DISEASE
and	0
MSLTs	I-DISEASE
.	0

Slow	0
eye	0
movements	0
were	0
present	0
in	0
the	0
only	0
tracing	I-DISEASE
reproduced	0
in	0
the	0
report	I-DISEASE
of	0
a	I-DISEASE
patient	0
with	0
exploding	0
head	0
syndrome	0
emerging	0
during	0
wake	0
to	I-DISEASE
N1	0
sleep	0
transition	0
.	I-DISEASE

Arousals	0
occurred	0
immediately	0
following	0
the	0
episodes	0
.	0

No	0
epileptiform	0
discharges	0
accompany	0
the	0
event	I-DISEASE
.	0

Differential	0
Diagnosis	0
Exploding	0
head	0
syndrome	0
should	I-DISEASE
be	0
distinguished	I-DISEASE
from	I-DISEASE
sudden	0
onset	0
-	0
headache	0
syn-	0
dromes	I-DISEASE
.	0

“	0
Idiopathic	0
stabbing	0
headache	0
”	0
(	0
ice	I-DISEASE
-	0
pick	I-DISEASE
headache	0
)	0
is	0
a	I-DISEASE
benign	I-DISEASE
syndrome	I-DISEASE
of	0
brief	0
stabs	0
of	0
pain	0
on	0
the	0
side	0
of	I-DISEASE
the	I-DISEASE
head	0
.	I-DISEASE

Although	0
they	0
can	0
occur	0
at	0
sleep	I-DISEASE
onset	I-DISEASE
,	0
they	I-DISEASE
are	0
more	0
common	0
during	0
wakefulness	0
.	I-DISEASE

“	0
Thunderclap	0
headache	0
”	0
is	0
a	I-DISEASE
very	I-DISEASE
severe	0
sudden	I-DISEASE
onset	I-DISEASE
headache	0
characteristic	0
of	0
subarachnoid	I-DISEASE
hemorrhage	0
but	I-DISEASE
also	0
resulting	I-DISEASE
from	0
other	0
causes	0
and	0
occasionally	0
occurring	0
as	0
a	0
benign	0
symptom	0
.	0

It	0
does	0
not	0
usually	I-DISEASE
occur	0
at	0
sleep	I-DISEASE
onset	0
.	0

“	0
Hypnic	0
headache	0
syndrome	0
”	I-DISEASE
affects	0
older	I-DISEASE
people	0
who	I-DISEASE
regularly	0
awaken	0
4	0
-	0
6	0
hours	I-DISEASE
after	0
sleep	0
onset	I-DISEASE
,	0
with	I-DISEASE
a	0
diffuse	I-DISEASE
headache	0
that	0
lasts	I-DISEASE
30	I-DISEASE
-	0
60	I-DISEASE
minutes	0
and	I-DISEASE
is	I-DISEASE
often	I-DISEASE
associated	0
with	0
nausea	0
but	0
no	0
autonomic	I-DISEASE
symptoms	I-DISEASE
.	0

Other	0
conditions	0
to	0
be	I-DISEASE
con-	I-DISEASE
sidered	I-DISEASE
include	I-DISEASE
sleep	0
related	I-DISEASE
migraines	0
,	I-DISEASE
cluster	I-DISEASE
headaches	I-DISEASE
,	0
and	I-DISEASE
nocturnal	I-DISEASE
paroxysmal	I-DISEASE
hemicrania	I-DISEASE
.	0

In	0
contrast	0
to	0
headache	I-DISEASE
syndromes	I-DISEASE
,	I-DISEASE
exploding	I-DISEASE
head	0
syndrome	I-DISEASE
is	0
usually	I-DISEASE
painless	0
.	0

Simple	0
partial	0
seizures	0
can	0
present	0
with	0
sensory	0
phenomena	0
but	0
do	0
not	0
usually	0
occur	0
predominantly	0
at	0
sleep	0
onset	0
.	I-DISEASE

Nocturnal	0
panic	0
attacks	0
can	0
waken	0
a	0
person	I-DISEASE
from	0
sleep	I-DISEASE
,	0
but	0
are	0
not	0
usually	0
associated	0
with	I-DISEASE
a	0
sense	0
of	0
noise	0
or	0
explosion	0
.	0

Recurrent	0
night-	0
mares	0
are	0
characterized	0
by	I-DISEASE
recall	I-DISEASE
of	0
more	0
complex	0
and	0
longer	0
-	0
lasting	0
visual	I-DISEASE
imagery	0
.	0

Sleep	0
starts	0
occur	0
at	0
wake	0
-	I-DISEASE
sleep	I-DISEASE
transition	I-DISEASE
but	I-DISEASE
are	0
predominantly	0
a	0
motor	0
phenomenon	0
with	I-DISEASE
sudden	0
myoclonic	0
jerks	I-DISEASE
rather	0
than	0
an	0
emphasis	0
on	0
sensory	0
symptoms	0
.	0

Unresolved	0
Issues	0
and	0
Future	0
Directions	I-DISEASE

The	0
neurophysiologic	0
basis	0
of	0
these	0
events	I-DISEASE
requires	I-DISEASE
further	0
study	I-DISEASE
.	0

Bibliography	0
Chakravarty	0
A.	0
Exploding	0
head	0
syndrome	0
:	0
report	0
of	I-DISEASE
two	0
new	0
cases	I-DISEASE
.	0

Cephalalgia	0
2008;28:399–400	0
.	0

Evans	0
RW	0
.	0

Exploding	0
head	0
syndrome	I-DISEASE
followed	I-DISEASE
by	0
sleep	0
paralysis	I-DISEASE
:	0
a	0
rare	0
migraine	0
aura	0
.	0

Headache	0
2006;46:682–3	0
.	0

Kallweit	0
U	0
,	0
Khatami	0
R	0
,	I-DISEASE
Bassetti	I-DISEASE
CL	0
.	I-DISEASE

Exploding	0
head	0
syndrome	I-DISEASE
-	I-DISEASE
more	0
than	0
“	I-DISEASE
snapping	0
of	0
the	0
brain	0
”	0
?	0

Sleep	0
Med	0
2008;9:589	0
.	0

Palikh	0
GM	0
,	0
Vaughn	0
BV	0
.	0

Topiramate	0
responsive	0
exploding	0
head	0
syndrome	0
.	0

J	0
Clin	0
Sleep	I-DISEASE
Med	0
2010;6:382–3	0
.	I-DISEASE

Pearce	0
JM	0
.	0

Clinical	0
features	0
of	0
the	0
exploding	0
head	0
syndrome	0
.	0

J	0
Neurol	0
Neurosurg	0
Psychiatry	0
1989;52:907–10	0
.	0

Sachs	0
C	0
,	0
Svanborg	0
E.	0

The	0
exploding	0
head	0
syndrome	0
:	0
polysomnographic	0
recordings	I-DISEASE
and	0
therapeutic	I-DISEASE
suggestions	0
.	0

Sleep	0
1991;14:263–6	0
.	0

Sleep	0
Related	0
Hallucinations	I-DISEASE
ICD-9	0
-	0
CM	I-DISEASE
code	0
:	0
368.16	0
ICD-10	0
-	0
CM	0
code	0
:	I-DISEASE

H53.16	0
Alternate	0
Names	0
Hypnagogic	0
hallucinations	0
,	0
hypnopompic	I-DISEASE
hallucinations	0
,	0
complex	I-DISEASE
nocturnal	0
visual	0
hallucinations	0
.	0

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
C	I-DISEASE
must	0
be	0
met	I-DISEASE
A.	0

There	0
is	0
a	0
complaint	0
of	0
recurrent	I-DISEASE
hallucinations	0
that	0
are	I-DISEASE
experienced	I-DISEASE
just	0
prior	0
to	0
sleep	0
onset	I-DISEASE
or	I-DISEASE
upon	0
awakening	I-DISEASE
during	I-DISEASE
the	0
night	0
or	0
in	0
the	0
morning	I-DISEASE
.	I-DISEASE

B.	0
The	0
hallucinations	0
are	0
predominantly	0
visual	I-DISEASE
.	I-DISEASE

C.	0

The	0
disturbance	0
is	0
not	0
better	I-DISEASE
explained	I-DISEASE
by	I-DISEASE
another	0
sleep	I-DISEASE
disorder	I-DISEASE
(	0
especially	0
narcolepsy	0
)	0
,	I-DISEASE
mental	I-DISEASE
disorder	0
,	I-DISEASE
medical	0
disorder	0
,	0
medication	0
,	0
or	0
substance	I-DISEASE
use	0
.	0

Essential	0
Features	0
Sleep	0
related	0
hallucinations	I-DISEASE
are	0
hallucinatory	I-DISEASE
experiences	0
that	I-DISEASE
occur	0
at	0
sleep	I-DISEASE
onset	0
or	0
on	0
awakening	0
from	0
sleep	I-DISEASE
.	I-DISEASE

Sleep	0
related	0
hallucinations	I-DISEASE
are	0
predominantly	0
visual	0
but	I-DISEASE
may	0
include	I-DISEASE
auditory	0
,	0
tactile	0
,	0
or	0
kinetic	0
phenomena	0
.	0

Hallucinations	0
at	0
sleep	I-DISEASE
onset	0
(	0
hypnagogic	I-DISEASE
hallucinations	I-DISEASE
)	0
may	I-DISEASE
be	0
difficult	0
to	I-DISEASE
differentiate	I-DISEASE
from	0
sleep	I-DISEASE
onset	0
dream-	I-DISEASE
ing	I-DISEASE
.	0

Hallucinations	0
on	0
waking	I-DISEASE
in	I-DISEASE
the	I-DISEASE
morning	0
(	I-DISEASE
hypnopompic	0
hallucinations	I-DISEASE
)	I-DISEASE
may	0
arise	I-DISEASE
out	0
of	I-DISEASE
a	I-DISEASE
period	I-DISEASE
of	0
REM	0
sleep	0
,	I-DISEASE
and	0
patients	I-DISEASE
also	I-DISEASE
may	0
be	I-DISEASE
uncertain	0
whether	0
they	I-DISEASE
rep-	0
resent	I-DISEASE
waking	0
or	0
dream	0
-	0
related	0
experiences	I-DISEASE
.	0

Complex	0
nocturnal	0
visual	0
hallucinations	0
may	0
represent	0
a	I-DISEASE
distinct	0
form	I-DISEASE
of	0
sleep	0
related	0
hallucinations	0
.	0

They	0
typically	0
occur	0
fol-	0
lowing	0
a	0
sudden	I-DISEASE
awakening	0
,	I-DISEASE
without	0
recall	0
of	0
a	0
preceding	0
dream	I-DISEASE
.	0

They	0
usually	0
take	0
the	0
form	0
of	0
complex	I-DISEASE
,	0
vivid	I-DISEASE
,	0
relatively	0
immobile	0
images	0
of	0
people	I-DISEASE
or	0
animals	0
,	0
sometimes	0
distorted	0
in	0
shape	0
or	0
size	0
.	0

These	0
hallucinations	0
may	0
remain	I-DISEASE
present	0
for	I-DISEASE
many	0
minutes	0
but	I-DISEASE
usually	0
disappear	0
if	0
ambient	0
illumination	0
is	0
increased	0
.	0

Patients	0
are	0
clearly	0
awake	0
but	0
often	0
initially	0
perceive	0
the	I-DISEASE
hallucinations	0
as	0
real	0
and	I-DISEASE
frightening	0
.	I-DISEASE

Associated	0
Features	0
Sleep	0
related	0
hallucinations	I-DISEASE
may	0
be	I-DISEASE
associated	0
with	I-DISEASE
episodes	0
of	0
sleep	0
paralysis	0
,	0
either	I-DISEASE
at	I-DISEASE
the	0
same	0
time	0
or	I-DISEASE
on	0
different	0
nights	0
.	0

Patients	0
with	0
complex	B-DISEASE
nocturnal	0
visual	0
hal-	0
lucinations	0
may	0
jump	0
out	0
of	0
the	0
bed	I-DISEASE
in	0
terror	I-DISEASE
,	0
sometimes	0
injuring	I-DISEASE
themselves	0
.	I-DISEASE

Some	0
patients	0
may	I-DISEASE
experience	B-DISEASE
other	0
parasomnias	I-DISEASE
,	0
such	0
as	0
sleep	0
talking	I-DISEASE
or	0
sleepwalking	0
,	0
sep-	I-DISEASE
arate	0
from	0
the	I-DISEASE
hallucinations	0
;	I-DISEASE
some	0
patients	0
may	I-DISEASE
also	I-DISEASE
experience	I-DISEASE
similar	0
complex	0
hal-	I-DISEASE
lucinations	0
during	I-DISEASE
the	0
day	I-DISEASE
,	0
unassociated	0
with	0
sleep	0
.	0

Parasomnias	0
Parasomnias	0
Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Dream	I-DISEASE
-	0
like	0
hypnagogic	0
and	I-DISEASE
hypnopompic	0
hallucinations	I-DISEASE
appear	0
to	I-DISEASE
differ	I-DISEASE
in	0
clini-	I-DISEASE
cal	0
features	0
and	0
pathogenesis	0
from	I-DISEASE
complex	0
nocturnal	I-DISEASE
visual	0
hallucinations	I-DISEASE
arising	I-DISEASE
in	0
wakefulness	0
after	I-DISEASE
sudden	I-DISEASE
arousals	0
during	0
the	0
night	0
.	0

Sleep	0
related	I-DISEASE
hallucinations	I-DISEASE
are	0
common	I-DISEASE
in	0
narcolepsy	I-DISEASE
and	0
also	0
occur	0
as	0
occasional	0
phenomena	0
in	0
a	I-DISEASE
high	0
per-	0
centage	I-DISEASE
of	0
the	0
general	0
population	0
.	I-DISEASE

In	0
contrast	0
,	0
complex	0
nocturnal	0
visual	I-DISEASE
hallucina-	0
tions	0
appear	I-DISEASE
to	I-DISEASE
be	0
rare	0
and	0
occur	0
in	I-DISEASE
the	0
setting	0
of	I-DISEASE
a	0
range	0
of	0
neurologic	0
and	0
visual	0
disorders	I-DISEASE
(	I-DISEASE
see	0
Differential	I-DISEASE
Diagnosis	0
)	0
as	0
well	I-DISEASE
as	0
in	0
an	0
idiopathic	0
form	0
.	0

However	0
,	I-DISEASE
further	0
work	0
is	0
needed	0
to	I-DISEASE
establish	0
whether	I-DISEASE
or	0
not	0
these	0
forms	0
of	0
hallucinations	I-DISEASE
represent	0
different	I-DISEASE
entities	I-DISEASE
.	0

Demographics	0
In	0
large	0
European	0
population	0
studies	0
,	I-DISEASE
sleep	0
related	I-DISEASE
hallucinations	0
have	0
been	I-DISEASE
reported	I-DISEASE
to	0
occur	I-DISEASE
with	0
a	I-DISEASE
prevalence	0
of	0
25	0
%	0
to	0
37	0
%	I-DISEASE
for	I-DISEASE
hypnagogic	0
hallucinations	I-DISEASE
,	0
whereas	0
the	I-DISEASE
equivalent	0
reported	0
prevalence	0
for	0
hypnopompic	I-DISEASE
hallucinations	0
is	0
7	I-DISEASE
%	0
to	I-DISEASE
13	0
%	I-DISEASE
.	0

Both	0
hypnagogic	0
and	0
hypnopompic	0
hallucinations	I-DISEASE
are	I-DISEASE
more	I-DISEASE
common	0
in	I-DISEASE
younger	0
persons	0
and	I-DISEASE
occur	I-DISEASE
slightly	0
more	I-DISEASE
frequently	0
in	0
women	I-DISEASE
than	0
in	I-DISEASE
men	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
Multivariate	0
analyses	I-DISEASE
in	I-DISEASE
large	0
population	I-DISEASE
studies	0
have	0
suggested	0
that	0
sleep	0
related	I-DISEASE
hal-	0
lucinations	0
are	I-DISEASE
associated	0
with	0
younger	0
age	0
,	I-DISEASE
current	I-DISEASE
drug	I-DISEASE
use	0
,	0
past	I-DISEASE
alcohol	0
use	I-DISEASE
,	0
anxiety	I-DISEASE
,	0
mood	0
disorder	0
,	0
sleep	0
onset	I-DISEASE
insomnia	0
,	I-DISEASE
and	0
perceived	0
insufficient	0
sleep	0
.	0

Familial	0
Pattern	0
Not	0
applicable	0
or	0
known	0
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Sleep	I-DISEASE
related	0
hallucinations	I-DISEASE
appear	0
to	I-DISEASE
be	I-DISEASE
more	I-DISEASE
common	0
in	I-DISEASE
adolescence	0
and	I-DISEASE
early	I-DISEASE
adult-	0
hood	I-DISEASE
.	0

In	0
many	0
patients	0
,	I-DISEASE
the	0
frequency	I-DISEASE
appears	0
to	0
decrease	I-DISEASE
with	0
age	0
.	0

The	0
natural	0
history	0
of	0
complex	0
nocturnal	0
visual	I-DISEASE
hallucinations	0
depends	I-DISEASE
on	0
the	I-DISEASE
underlying	0
cause	0
.	0

Developmental	0
Issues	0
Not	0
known	0
or	0
applicable	0
.	0

Pathology	0
and	0
Pathophysiology	0
It	0
is	0
presumed	I-DISEASE
that	I-DISEASE
most	0
sleep	I-DISEASE
related	0
hallucinations	0
are	0
due	0
to	0
dream	I-DISEASE
ideation	I-DISEASE
of	0
REM	I-DISEASE
sleep	0
intruding	0
into	0
wakefulness	0
,	0
but	0
this	I-DISEASE
has	0
not	0
been	I-DISEASE
firmly	0
established	I-DISEASE
.	0

Infrequent	0
hallucinations	0
of	0
this	0
type	0
may	0
be	I-DISEASE
within	0
the	I-DISEASE
limits	0
of	0
normal	0
sleep	0
-	0
wake	I-DISEASE
transition	I-DISEASE
.	0

Complex	0
nocturnal	0
visual	I-DISEASE
hallucinations	0
may	0
in	0
some	I-DISEASE
cases	0
be	I-DISEASE
release	0
phenomena	0
in	0
which	I-DISEASE
loss	0
of	I-DISEASE
visual	0
input	0
or	I-DISEASE
decreased	0
reticular	I-DISEASE
activating	0
system	I-DISEASE
activity	0
results	I-DISEASE
in	I-DISEASE
the	I-DISEASE
visual	0
cortex	I-DISEASE
generating	I-DISEASE
aberrant	I-DISEASE
images	I-DISEASE
.	0

Objective	0
Findings	0
Hypnagogic	0
hallucinations	I-DISEASE
appear	0
to	I-DISEASE
arise	0
predominantly	0
from	I-DISEASE
sleep	0
onset	0
REM	0
periods	0
.	I-DISEASE

However	0
,	I-DISEASE
the	0
very	I-DISEASE
few	0
reports	0
of	0
polysomnography	0
in	I-DISEASE
complex	0
nocturnal	0
visual	0
hallucinations	I-DISEASE
suggest	0
an	0
onset	0
from	I-DISEASE
NREM	0
sleep	0
.	0

MRI	0
scans	0
of	0
the	I-DISEASE
brain	0
,	I-DISEASE
PSG	I-DISEASE
,	0
EEG	I-DISEASE
,	0
and	0
neuropsychological	0
testing	0
may	0
help	I-DISEASE
in	I-DISEASE
the	0
differential	I-DISEASE
diagnosis	0
and	0
in	0
identifying	0
underlying	0
disorders	0
.	0

Differential	0
Diagnosis	0
Nightmares	0
are	0
frightening	0
dreams	I-DISEASE
awakening	I-DISEASE
the	0
patient	0
from	0
sleep	0
.	0

They	0
are	0
clearly	0
recognized	0
as	0
dreams	0
and	I-DISEASE
do	0
not	I-DISEASE
persist	0
into	0
wakefulness	0
.	0

Exploding	0
head	0
syndrome	I-DISEASE
consists	I-DISEASE
of	0
a	0
sudden	I-DISEASE
sensation	0
of	I-DISEASE
an	0
explosion	0
in	0
the	0
head	0
,	I-DISEASE
usually	0
at	I-DISEASE
sleep	I-DISEASE
onset	0
and	0
sometimes	0
accompanied	0
by	0
a	0
noise	I-DISEASE
or	0
flash	0
of	I-DISEASE
light	0
.	0

It	0
does	0
not	0
involve	I-DISEASE
complex	0
visual	0
imagery	I-DISEASE
and	0
lasts	I-DISEASE
only	0
seconds	0
.	0

In	0
RBD	0
,	0
the	0
patient	0
acts	I-DISEASE
out	I-DISEASE
dreams	0
during	I-DISEASE
REM	0
sleep	0
.	0

If	0
not	0
awakened	I-DISEASE
by	0
an	0
observer	I-DISEASE
,	0
the	0
person	I-DISEASE
usually	0
has	0
little	0
recollection	0
of	0
dream	0
content	0
.	0

Sleepwalking	0
may	0
occasionally	0
be	I-DISEASE
associated	0
with	0
dream	I-DISEASE
ideation	0
,	I-DISEASE
but	0
the	0
patient	0
recognizes	0
that	0
the	I-DISEASE
dream	0
occurred	0
during	I-DISEASE
sleep	I-DISEASE
.	0

Visual	0
hallucinations	0
can	0
be	I-DISEASE
due	0
to	0
epileptic	0
seizures	0
but	0
are	0
usually	0
brief	0
,	0
stereotyped	0
,	I-DISEASE
and	0
fragmentary	0
in	0
such	0
cases	0
.	0

Occasionally	0
,	0
complex	0
visual	0
hallucinations	0
may	0
be	I-DISEASE
associated	0
with	I-DISEASE
migraine	0
but	0
are	0
usually	0
followed	I-DISEASE
by	I-DISEASE
a	0
headache	0
.	I-DISEASE

Complex	0
nocturnal	0
visual	I-DISEASE
hallucinations	0
may	0
be	0
seen	I-DISEASE
in	0
patients	I-DISEASE
with	0
narcolepsy	0
,	0
PD	0
,	I-DISEASE
DLB	I-DISEASE
,	0
visual	0
loss	0
(	0
Charles	0
Bonnet	0
hallucinations	0
)	0
,	0
and	I-DISEASE
midbrain	I-DISEASE
and	0
diencephalic	I-DISEASE
pathology	0
(	0
peduncular	0
hallucinosis	0
)	0
,	0
as	0
well	I-DISEASE
as	0
with	I-DISEASE
the	0
use	0
of	I-DISEASE
β	I-DISEASE
-	0
adrenergic	0
receptor-	0
blocking	B-DISEASE
medications	I-DISEASE
.	I-DISEASE

Anxiety	0
disorders	0
have	0
been	I-DISEASE
noted	0
in	0
some	I-DISEASE
patients	0
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE

In	0
contrast	0
to	0
the	0
extensive	I-DISEASE
study	0
of	I-DISEASE
sleep	0
paralysis	I-DISEASE
,	0
little	0
work	0
has	0
been	0
reported	0
on	0
sleep	0
related	0
hallucinations	0
.	I-DISEASE

It	0
is	0
uncertain	0
whether	0
they	0
represent	0
normal	I-DISEASE
variants	0
or	I-DISEASE
pathologic	0
entities	0
.	0

It	0
is	0
unclear	0
whether	0
they	0
are	0
always	0
associated	0
with	I-DISEASE
REM	0
sleep	0
intruding	0
into	I-DISEASE
wakefulness	0
.	0

It	0
is	0
uncertain	0
how	0
frequently	0
complex	0
nocturnal	0
visual	I-DISEASE
hallucinations	I-DISEASE
are	0
an	0
independent	I-DISEASE
entity	0
,	0
as	I-DISEASE
opposed	I-DISEASE
to	0
representing	I-DISEASE
a	0
final	0
common	0
pathway	0
of	I-DISEASE
a	I-DISEASE
range	0
of	0
other	0
disorders	I-DISEASE
.	0

Further	0
work	0
is	0
needed	0
to	0
determine	0
from	0
which	0
stages	I-DISEASE
of	0
sleep	0
they	I-DISEASE
arise	0
.	0

Parasomnias	0
Parasomnias	0
Bibliography	0
Barnes	0
J	0
,	0
David	0
AS	0
.	0

Visual	0
hallucinations	0
in	0
Parkinson	I-DISEASE
’s	0
disease	I-DISEASE
:	0
a	0
review	0
and	0
phenomenological	0
survey	0
.	0

J	0
Neurol	0
Neurosurg	0
Psychiatry	0
2001;70:727–33	0
.	0

Kavey	0
N	0
,	0
Whyte	0
J.	0
Somnambulism	0
associated	B-DISEASE
with	0
hallucinations	0
.	0

Psychosomatics	0
1993;34:86–90	0
.	0

Mahowald	0
M	0
,	0
Woods	0
S	0
,	0
Schenck	I-DISEASE
C.	0
Sleeping	I-DISEASE
dreams	0
,	I-DISEASE
waking	0
hallucinations	I-DISEASE
,	0
and	0
the	I-DISEASE
central	0
nervous	I-DISEASE
system	0
.	I-DISEASE

Dreaming	0
1998;8:89–102	0
.	0

Manford	0
M	I-DISEASE
,	0
Andermann	0
F.	0
Complex	0
visual	0
hallucinations	0
.	0

Clinical	0
and	0
neurobiological	0
insights	0
.	0

Brain	0
1998;121:1819–40	0
.	0

Ohayon	0
M.	0
Prevalence	0
of	0
hallucinations	0
and	0
their	I-DISEASE
pathological	0
associations	I-DISEASE
in	0
the	I-DISEASE
general	0
population	0
.	0

Psychiatry	0
Res	0
2000;97:153–64	I-DISEASE
.	0

Ohayon	0
M	0
,	0
Priest	0
R	0
,	0
Caulet	0
M	0
,	I-DISEASE
Guilleminault	I-DISEASE
C.	0
Hypnagogic	0
and	I-DISEASE
hypnopompic	0
hallucinations	I-DISEASE
:	I-DISEASE
pathological	0
phenomena	I-DISEASE
?	0

Br	0
J	0
Psychiatry	0
1996;169:459–67	0
.	0

Silber	0
MH	0
,	0
Hansen	I-DISEASE
M	0
,	0
Girish	I-DISEASE
M.	0
Complex	I-DISEASE
nocturnal	0
visual	I-DISEASE
hallucinations	0
.	I-DISEASE

Sleep	0
Med	I-DISEASE
2005;6:363–6	I-DISEASE
.	0

Sleep	0
Enuresis	0
ICD-9	0
-	0
CM	0
code	0
:	0
788.36	0
ICD-10	I-DISEASE
-	0
CM	I-DISEASE
code	0
:	0

N39.44	0
Alternate	0
Names	0
Enuresis	0
nocturna	0
;	0
nocturnal	I-DISEASE
bedwetting	0
;	0
primary	0
,	0
familial	0
,	0
functional	0
,	I-DISEASE
idiopathic	0
,	0
monosymptomatic	0
,	0
or	0
essential	0
enuresis	0
;	0
night	0
wetting	I-DISEASE
;	0
sleep	0
related	I-DISEASE
enuresis	0
.	0

Diagnostic	0
Criteria	0
Primary	0
Sleep	0
Enuresis	0
–	I-DISEASE
Criteria	0
A	0
-	I-DISEASE
D	0
must	0
be	0
met	0
A.	0

The	0
patient	0
is	0
older	0
than	0
five	0
years	0
.	I-DISEASE

B.	0
The	0
patient	0
exhibits	0
recurrent	0
involuntary	I-DISEASE
voiding	0
during	0
sleep	0
,	0
occurring	0
at	0
least	I-DISEASE
twice	0
a	I-DISEASE
week	I-DISEASE
.	0

C.	0

The	0
condition	0
has	0
been	0
present	0
for	0
at	0
least	I-DISEASE
three	I-DISEASE
months	0
.	0

D.	0

The	0
patient	0
has	0
never	0
been	0
consistently	0
dry	0
during	0
sleep	I-DISEASE
.	0

Secondary	0
Sleep	0
Enuresis	0
–	0
Criteria	0
A	0
-	0
D	I-DISEASE
must	I-DISEASE
be	0
met	0
A.	0

The	0
patient	0
is	0
older	0
than	0
five	0
years	0
.	I-DISEASE

B.	0
The	0
patient	0
exhibits	0
recurrent	0
involuntary	I-DISEASE
voiding	0
during	0
sleep	0
,	0
occurring	0
at	0
least	I-DISEASE
twice	0
a	I-DISEASE
week	I-DISEASE
.	0

C.	0

The	0
condition	0
has	0
been	0
present	0
for	0
at	0
least	I-DISEASE
three	I-DISEASE
months	0
.	0

D.	0

The	0
patient	0
has	0
previously	0
been	0
consistently	0
dry	0
during	0
sleep	I-DISEASE
for	0
at	0
least	I-DISEASE
six	I-DISEASE
months	0
.	0

Essential	0
Features	0
Sleep	0
enuresis	0
(	0
SE	0
)	0
is	0
characterized	I-DISEASE
by	0
recurrent	0
involuntary	0
voiding	0
that	0
occurs	I-DISEASE
during	0
sleep	0
.	I-DISEASE

In	0
primary	0
SE	0
,	0
recurrent	0
involuntary	0
voiding	I-DISEASE
occurs	0
at	0
least	0
twice	0
a	0
week	0
during	0
sleep	I-DISEASE
after	I-DISEASE
five	0
years	0
of	0
age	I-DISEASE
in	0
a	0
patient	0
who	I-DISEASE
has	I-DISEASE
never	0
been	0
consistently	I-DISEASE
dry	0
during	0
sleep	0
for	0
six	0
consecutive	0
months	0
.	0

SE	0
is	0
considered	0
secondary	0
in	0
a	0
child	I-DISEASE
or	0
adult	0
who	0
had	0
previously	0
been	0
dry	0
for	0
six	0
consecutive	0
months	I-DISEASE
and	0
then	I-DISEASE
began	0
wetting	0
at	I-DISEASE
least	0
twice	I-DISEASE
a	I-DISEASE
week	0
.	I-DISEASE

Both	0
primary	0
and	0
secondary	0
enuresis	0
must	0
be	0
present	0
for	0
a	0
period	0
of	0
at	0
least	0
three	I-DISEASE
months	I-DISEASE
.	I-DISEASE

Though	0
primary	0
and	0
secondary	0
enuresis	0
share	0
the	0
common	0
symptom	I-DISEASE
of	I-DISEASE
voiding	0
during	0
sleep	0
,	0
they	I-DISEASE
are	0
understood	0
as	I-DISEASE
distinct	0
phenomena	I-DISEASE
with	0
different	0
etiologies	0
.	0

SE	0
is	0
associated	0
with	0
difficulty	0
arousing	I-DISEASE
from	I-DISEASE
sleep	I-DISEASE
in	I-DISEASE
response	0
to	0
an	0
urge	0
to	0
urinate	I-DISEASE
and	0
may	0
occur	I-DISEASE
during	0
any	0
sleep	0
stage	0
.	0

Sleep	0
disorders	I-DISEASE
that	0
fragment	I-DISEASE
sleep	0
such	I-DISEASE
as	I-DISEASE
sleep	0
apnea	I-DISEASE
are	0
associated	I-DISEASE
with	0
SE	0
,	0
and	I-DISEASE
treatment	I-DISEASE
of	0
these	I-DISEASE
disorders	0
may	I-DISEASE
cure	0
or	0
reduce	0
their	0
incidence	0
.	0

Associated	0
Features	0
Involuntary	0
voiding	0
during	0
wakefulness	I-DISEASE
may	I-DISEASE
be	0
associated	I-DISEASE
with	0
SE	I-DISEASE
and	0
,	0
if	0
present	I-DISEASE
,	0
generally	0
points	I-DISEASE
toward	0
a	0
physiological	0
etiology	0
.	0

Psychosocial	0
problems	0
are	I-DISEASE
consid-	0
ered	0
a	I-DISEASE
relatively	0
rare	0
cause	I-DISEASE
in	0
primary	0
SE	0
,	I-DISEASE
though	0
it	I-DISEASE
does	0
occur	I-DISEASE
more	I-DISEASE
commonly	0
in	0
children	0
with	0
attention	I-DISEASE
deficit	0
hyperactivity	I-DISEASE
disorder	0
and	0
in	0
children	0
living	I-DISEASE
in	I-DISEASE
disorga-	0
nized	0
families	0
.	0

Secondary	0
SE	0
is	0
seen	0
more	0
commonly	0
in	0
children	0
who	I-DISEASE
have	0
recently	0
experienced	0
a	0
significant	0
psychosocial	I-DISEASE
stress	0
,	0
such	0
as	0
parental	0
divorce	0
,	0
physical	0
or	0
sexual	B-DISEASE
abuse	0
,	0
or	0
neglect	0
.	0

Chronic	0
constipation	0
and	0
encopresis	I-DISEASE
(	I-DISEASE
fecal	0
soiling	I-DISEASE
)	I-DISEASE
often	0
occur	0
in	I-DISEASE
children	0
with	0
secondary	0
SE	I-DISEASE
.	0

SE	0
can	0
occur	0
in	0
association	0
with	0
diabetes	0
and	0
urinary	I-DISEASE
tract	0
infection	0
.	I-DISEASE

It	0
may	0
occur	0
in	0
individuals	0
with	0
nocturnal	0
epilepsy	0
.	0

Among	0
older	0
adults	0
,	0
SE	0
may	I-DISEASE
be	B-DISEASE
associated	I-DISEASE
with	I-DISEASE
symptoms	0
of	0
congestive	0
heart	I-DISEASE
failure	0
,	0
OSA	0
,	0
depression	I-DISEASE
,	0
and	0
dementia	0
.	0

SRBD	0
is	0
reported	0
in	0
8	0
%	0
to	0
47	0
%	0
of	0
children	0
with	0
enuresis	0
,	I-DISEASE
compared	I-DISEASE
to	0
an	0
overall	I-DISEASE
prev-	0
alence	0
of	0
1	0
%	0
to	0
2	I-DISEASE
%	0
.	0

PLMS	0
have	0
been	0
reported	0
in	0
patients	0
with	0
refractory	0
SE	I-DISEASE
.	0

A	0
large	0
epidemiology	0
study	0
of	0
children	0
aged	0
6	I-DISEASE
-	I-DISEASE
10	I-DISEASE
years	0
found	0
that	I-DISEASE
a	0
current	I-DISEASE
complaint	0
of	I-DISEASE
SE	I-DISEASE
was	0
significantly	I-DISEASE
associated	0
with	0
increased	0
ORs	I-DISEASE
(	0
2.7	0
-	0
3.4	0
)	0
for	I-DISEASE
subjectively	I-DISEASE
high	0
arousal	0
threshold	0
,	0
night	0
terrors	0
,	I-DISEASE
nocturia	0
,	0
and	0
confusion	I-DISEASE
when	0
awakened	0
from	0
sleep	I-DISEASE
.	0

Other	0
studies	0
have	0
found	0
mouth	0
breathing	I-DISEASE
,	0
nasal	0
congestion	0
,	0
snoring	0
,	0
and	I-DISEASE
restless	0
sleep	I-DISEASE
to	I-DISEASE
be	0
highly	I-DISEASE
related	0
to	I-DISEASE
enuresis	0
in	I-DISEASE
children	0
.	0

Parasomnias	0
Parasomnias	0
Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
The	I-DISEASE
most	0
important	0
distinction	0
is	I-DISEASE
between	0
primary	I-DISEASE
and	0
secondary	I-DISEASE
SE	I-DISEASE
.	0

Demographics	0
SE	0
occurs	0
in	0
15	0
%	0
to	0
20	0
%	I-DISEASE
of	0
5	0
-	0
year	0
-	0
olds	0
.	0

It	0
is	0
three	0
times	0
more	0
common	0
in	0
boys	0
than	0
in	0
girls	0
.	0

SE	0
is	0
reported	0
by	0
2.1	0
%	I-DISEASE
of	0
community	0
-	I-DISEASE
dwelling	0
older	0
adults	0
and	0
is	0
more	I-DISEASE
common	I-DISEASE
among	0
women	0
than	0
men	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
The	0
etiology	I-DISEASE
of	I-DISEASE
SE	0
is	0
complex	0
.	0

The	0
factors	0
that	0
precipitate	0
SE	0
on	0
a	0
particular	0
night	I-DISEASE
and	0
at	0
a	0
particular	I-DISEASE
time	0
remain	I-DISEASE
unknown	0
.	0

One	0
popular	I-DISEASE
model	I-DISEASE
hypothesizes	0
that	0
SE	0
consists	0
of	0
three	I-DISEASE
interrelated	0
factors	0
:	0
large	0
nocturnal	0
urine	I-DISEASE
volume	0
production	I-DISEASE
,	I-DISEASE
noc-	0
turnal	0
bladder	0
overactivity	0
,	0
and	0
difficulty	I-DISEASE
arousing	0
from	0
sleep	0
.	0

Several	0
studies	0
suggest	0
difficulty	0
arousing	I-DISEASE
from	I-DISEASE
sleep	I-DISEASE
is	0
most	0
important	0
in	0
primary	0
enuresis	I-DISEASE
,	0
whereas	0
bladder	0
instability	0
/	I-DISEASE
overactivity	0
is	0
more	0
important	I-DISEASE
in	0
secondary	0
enuresis	0
.	0

Children	0
with	0
enuresis	0
are	0
often	0
described	0
by	I-DISEASE
their	0
families	I-DISEASE
as	0
“	0
deep	I-DISEASE
sleepers	0
”	0
and	0
very	I-DISEASE
difficult	I-DISEASE
to	I-DISEASE
arouse	0
.	I-DISEASE

A	0
high	0
arousal	0
threshold	0
has	0
been	0
objectively	0
confirmed	0
in	0
these	0
children	0
.	0

It	0
has	0
been	0
reported	0
that	0
fragmentation	I-DISEASE
of	0
sleep	0
by	I-DISEASE
disorders	0
such	0
as	0
sleep	0
apnea	0
is	I-DISEASE
highly	0
correlated	I-DISEASE
with	0
SE	0
.	0

Sleep	0
fragmenting	0
disorders	0
such	I-DISEASE
as	0
sleep	0
apnea	0
and	I-DISEASE
PLMS	I-DISEASE
have	I-DISEASE
been	0
previously	0
reported	0
to	0
be	I-DISEASE
proximal	0
triggers	0
for	I-DISEASE
the	0
occurrence	0
of	0
disorders	0
of	0
arousal	I-DISEASE
—	I-DISEASE
sleepwalking	0
,	I-DISEASE
confusional	0
arousals	0
,	0
and	0
night	I-DISEASE
terrors	0
.	0

Successful	0
treatment	0
of	0
sleep	0
apnea	0
in	I-DISEASE
these	I-DISEASE
disorders	I-DISEASE
has	0
been	0
reported	0
to	0
result	0
in	0
reduction	0
or	0
elimination	0
of	0
disorders	0
of	0
arousal	0
.	0

Similarly	0
,	0
surgical	0
treatment	0
of	0
sleep	I-DISEASE
apneas	I-DISEASE
by	0
adenotonsillec-	I-DISEASE
tomy	0
has	I-DISEASE
been	0
reported	0
to	0
cure	I-DISEASE
nocturnal	0
enuresis	0
in	I-DISEASE
60	0
%	0
or	0
more	0
of	0
patients	0
,	I-DISEASE
although	I-DISEASE
this	0
is	0
not	0
a	0
consistent	0
result	0
.	0

Several	0
studies	0
have	0
noted	0
the	0
presence	I-DISEASE
of	0
sleep	0
related	I-DISEASE
breathing	I-DISEASE
disorder	0
in	0
>	0
40	0
%	I-DISEASE
of	0
enuresis	0
patients	0
studied	0
.	0

However	0
,	0
not	0
all	0
sleep	0
studies	I-DISEASE
have	0
noted	0
SRBD	0
in	0
patients	0
with	0
enuresis	0
.	0

Those	0
without	0
SRBD	I-DISEASE
were	0
still	0
found	0
to	0
have	0
high	I-DISEASE
arousal	0
threshold	0
from	0
sleep	0
.	0

Primary	0
SE	0
is	0
a	0
disorder	0
that	I-DISEASE
occurs	I-DISEASE
when	0
an	I-DISEASE
individual	0
fails	0
to	0
arouse	0
from	0
sleep	0
in	0
response	I-DISEASE
to	I-DISEASE
bladder	0
sensations	0
or	0
fails	0
to	0
inhibit	0
a	I-DISEASE
bladder	0
contraction	0
.	I-DISEASE

These	0
are	0
devel-	0
opmentally	I-DISEASE
acquired	0
skills	0
,	I-DISEASE
and	0
,	0
as	0
such	0
,	0
there	0
is	0
a	I-DISEASE
range	0
in	0
the	I-DISEASE
ages	0
of	0
their	0
acquisition	0
.	I-DISEASE

A	0
small	0
proportion	0
of	I-DISEASE
children	0
with	I-DISEASE
primary	0
SE	0
lack	I-DISEASE
the	0
normal	0
increase	0
in	0
vasopressin	0
release	I-DISEASE
during	0
sleep	I-DISEASE
,	I-DISEASE
leading	0
to	0
a	0
high	0
urinary	0
volume	0
that	I-DISEASE
exceeds	0
the	0
bladder	0
capac-	0
ity	I-DISEASE
.	0

If	0
these	0
children	0
do	I-DISEASE
not	0
arouse	I-DISEASE
to	0
the	0
sensation	0
of	I-DISEASE
a	0
full	0
bladder	0
,	0
primary	0
SE	0
is	0
the	I-DISEASE
result	0
.	I-DISEASE

Secondary	0
SE	0
can	0
be	0
caused	0
by	0
,	I-DISEASE
or	0
be	0
associated	0
with	0
,	0
any	0
one	0
of	I-DISEASE
the	0
following	I-DISEASE
identifiable	I-DISEASE
problems	0
:	0
(	0
1	0
)	0
an	I-DISEASE
inability	0
to	I-DISEASE
concentrate	0
urine	0
due	0
to	0
diabetes	0
mellitus	0
,	0
diabetes	0
insipidus	0
,	I-DISEASE
nephrogenic	0
diabetes	0
insipidus	0
(	0
idiopathic	0
or	0
pharmacologic	0

[	0
e.g.	0
,	0
secondary	0
to	I-DISEASE
the	0
use	I-DISEASE
of	0
lithium	I-DISEASE
carbonate	I-DISEASE
]	0
)	0
,	0
or	I-DISEASE
sickle	I-DISEASE
cell	0
disease	0
;	I-DISEASE
(	0
2	0
)	0
increased	0
urine	0
production	0
secondary	I-DISEASE
to	0
the	I-DISEASE
ingestion	I-DISEASE
of	0
caffeine	0
,	I-DISEASE
diuretics	0
,	0
or	0
other	0
agents	0
;	0
(	I-DISEASE
3	0
)	0
urinary	0
tract	0
pathology	0
,	0
such	0
as	0
urinary	I-DISEASE
tract	I-DISEASE
infections	0
,	I-DISEASE
irritable	0
bladder	0
,	I-DISEASE
malformations	0
of	0
the	I-DISEASE
genitourinary	0
tract	I-DISEASE
(	0
e.g.	0
,	I-DISEASE
ectopic	0
ureter	0
)	0
;	I-DISEASE
(	0
4	0
)	0
chronic	I-DISEASE
constipation	I-DISEASE
and	0
encopresis	0
;	I-DISEASE
(	I-DISEASE
5	I-DISEASE
)	0
neurologic	I-DISEASE
pathology	I-DISEASE
,	I-DISEASE
such	I-DISEASE
as	0
seizures	0
or	0
neurogenic	0
bladder	0
;	I-DISEASE
or	0
(	0
6	I-DISEASE
)	0
psychosocial	I-DISEASE
stressors	0
,	I-DISEASE
such	I-DISEASE
as	0
parental	0
divorce	0
,	0
neglect	0
,	I-DISEASE
physical	I-DISEASE
or	0
sexual	0
abuse	0
,	0
and	I-DISEASE
institution-	0
alization	I-DISEASE
.	I-DISEASE

The	0
mechanisms	0
by	0
which	0
secondary	I-DISEASE
SE	0
is	I-DISEASE
associated	0
with	I-DISEASE
these	0
problems	0
are	0
often	0
not	0
understood	I-DISEASE
.	0

Familial	0
Patterns	0
Hereditary	0
factors	0
are	0
suspected	0
in	I-DISEASE
children	I-DISEASE
with	0
primary	0
enuresis	0
.	0

There	0
is	0
often	0
a	0
high	0
prevalence	0
of	I-DISEASE
enuresis	0
among	0
the	0
parents	0
,	0
siblings	I-DISEASE
,	0
and	I-DISEASE
other	0
relatives	0
of	I-DISEASE
the	0
child	0
with	0
primary	0
enuresis	0
.	0

The	0
reported	0
prevalence	0
is	I-DISEASE
77	0
%	0
when	I-DISEASE
both	0
parents	0
were	0
enuretic	0
as	0
children	I-DISEASE
and	0
44	I-DISEASE
%	I-DISEASE
when	0
one	I-DISEASE
parent	0
has	0
a	0
history	0
of	0
enuresis	I-DISEASE
.	I-DISEASE

Recent	0
linkage	0
studies	0
support	0
the	0
hypothesis	0
of	I-DISEASE
genetic	0
and	I-DISEASE
phenotypic	0
heterogeneity	0
of	0
SE	I-DISEASE
.	0

A	0
putative	0
linkage	0
of	0
SE	0
to	0
a	I-DISEASE
region	0
on	I-DISEASE
chromosomes	0
22q	0
,	0
13q	0
,	0
and	I-DISEASE
12q	I-DISEASE
across	0
different	I-DISEASE
families	I-DISEASE
has	0
been	0
reported	0
.	I-DISEASE

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Voiding	I-DISEASE
is	0
a	I-DISEASE
spinal	0
reflex	I-DISEASE
during	0
wakefulness	0
and	0
sleep	I-DISEASE
during	0
infancy	0
,	0
until	0
about	I-DISEASE
18	0
months	0
of	I-DISEASE
age	I-DISEASE
.	I-DISEASE

Between	0
18	0
months	I-DISEASE
and	0
three	0
years	0
of	I-DISEASE
age	0
,	0
the	0
child	0
is	0
able	0
to	0
delay	0
voiding	0
with	0
a	I-DISEASE
full	0
bladder	0
,	0
first	0
during	0
wakefulness	0
and	I-DISEASE
at	I-DISEASE
a	0
later	I-DISEASE
age	I-DISEASE
during	0
sleep	0
.	0

The	0
primary	0
determinant	0
of	I-DISEASE
the	0
age	0
at	I-DISEASE
which	0
this	I-DISEASE
skill	0
is	0
acquired	I-DISEASE
is	0
developmental	0
matura-	I-DISEASE
tion	0
.	0

Somewhat	0
arbitrarily	0
,	0
primary	I-DISEASE
SE	0
is	0
defined	I-DISEASE
as	0
a	I-DISEASE
problem	0
if	0
it	0
persists	0
beyond	0
five	I-DISEASE
years	0
of	I-DISEASE
age	0
.	0

The	0
spontaneous	0
cure	0
rate	0
is	0
15	0
%	0
per	0
year	0
.	0

The	0
primary	0
complication	0
of	0
SE	0
is	I-DISEASE
to	I-DISEASE
the	0
child	I-DISEASE
’s	I-DISEASE
self	0
-	0
esteem	0
.	0

How	0
well	0
the	0
child	I-DISEASE
’s	0
family	0
deals	0
with	0
the	I-DISEASE
symptom	0
is	0
an	0
important	0
determinant	0
of	I-DISEASE
whether	0
complications	I-DISEASE
develop	I-DISEASE
.	0

Secondary	0
SE	0
can	0
occur	0
at	0
any	I-DISEASE
age	0
.	0

Complications	0
of	0
secondary	0
SE	0
are	0
determined	I-DISEASE
by	0
the	0
problem	0
leading	0
to	0
the	0
enuresis	I-DISEASE
.	0

Developmental	0
Issues	0
The	0
developmental	I-DISEASE
pattern	0
of	0
enuresis	0
is	0
similar	0
to	0
NREM	0
parasomnias	0
,	0
although	0
its	0
first	0
occurrence	0
in	B-DISEASE
adulthood	0
is	0
uncommon	0
.	0

Pathology	0
and	0
Pathophysiology	0
SE	0
is	0
a	I-DISEASE
heterogeneous	I-DISEASE
disorder	0
with	I-DISEASE
various	0
underlying	0
pathophysiological	0
mecha-	0
nisms	0
,	I-DISEASE
resulting	I-DISEASE
in	0
a	0
mismatch	0
between	0
nocturnal	0
bladder	I-DISEASE
capacity	I-DISEASE
and	0
the	I-DISEASE
amount	0
of	0
Parasomnias	I-DISEASE
Parasomnias	0
urine	0
produced	I-DISEASE
during	0
sleep	0
,	0
in	0
association	I-DISEASE
with	0
a	I-DISEASE
simultaneous	0
failure	I-DISEASE
of	0
arousal	0
from	0
sleep	0
in	I-DISEASE
response	I-DISEASE
to	I-DISEASE
the	I-DISEASE
sensation	0
of	0
bladder	0
fullness	0
.	I-DISEASE

SE	0
can	0
be	0
seen	I-DISEASE
in	0
association	0
with	0
sleep	0
fragmentation	I-DISEASE
disorders	0
including	0
SRBD	0
,	0
which	0
in	0
children	0
is	0
most	I-DISEASE
often	0
secondary	I-DISEASE
to	0
adenotonsillar	0
hypertrophy	I-DISEASE
.	0

Objective	0
Findings	0
In	0
primary	0
and	0
secondary	I-DISEASE
SE	0
,	0
enuretic	I-DISEASE
episodes	0
can	0
occur	0
in	0
all	0
sleep	I-DISEASE
stages	0
,	0
during	0
nocturnal	0
wakefulness	0
,	0
and	0
in	0
association	0
with	I-DISEASE
transient	0
arousals	I-DISEASE
.	0

Sleep	0
stages	0
have	0
not	0
been	0
found	0
to	0
be	0
different	I-DISEASE
on	0
nights	0
when	0
enuresis	0
occurs	0
versus	0
nights	0
on	0
which	I-DISEASE
it	0
does	0
not	0
occur	0
.	0

The	0
results	0
of	0
polysomnographic	0
studies	0
of	I-DISEASE
children	I-DISEASE
with	0
enuresis	I-DISEASE
com-	0
pared	0
to	0
normal	I-DISEASE
controls	0
have	0
been	0
inconsistent	0
.	0

A	0
computerized	0
power	0
analysis	0
of	0
sleep	I-DISEASE
data	I-DISEASE
suggested	I-DISEASE
an	I-DISEASE
increase	0
in	0
delta	0
power	0
,	0
whereas	0
the	0
majority	0
of	I-DISEASE
other	0
studies	0
have	0
reported	0
no	0
differences	0
.	I-DISEASE

However	0
,	I-DISEASE
a	0
recent	0
study	0
found	I-DISEASE
those	0
age	0
6	0
-	0
14	0
years	0
had	I-DISEASE
elevated	0
light	I-DISEASE
stage	I-DISEASE
N1	0
sleep	I-DISEASE
and	0
reduced	I-DISEASE
N3	0
sleep	I-DISEASE
and	0
REM	0
sleep	I-DISEASE
compared	0
to	0
normal	0
controls	I-DISEASE
.	0

The	0
population	0
with	0
enuresis	0
had	0
a	0
significantly	0
elevated	0
arousal	I-DISEASE
index	0
.	0

SRBD	0
has	0
been	0
reported	0
in	0
8	0
%	0
to	0
47	0
%	0
of	0
children	0
with	0
SE	0
.	I-DISEASE

SE	0
and	0
sleep	0
apnea	I-DISEASE
are	0
highly	I-DISEASE
correlated	0
with	0
an	I-DISEASE
increasing	0
prevalence	0
of	0
enuresis	0
as	0
the	I-DISEASE
respiratory	0
distur-	0
bance	0
index	0
(	I-DISEASE
RDI	0
)	0
increases	I-DISEASE
.	0

In	0
addition	0
to	0
SRBD	0
,	0
PLMS	0
(	0
range	0
of	I-DISEASE
3.9	0
to	0
38.6	0
per	I-DISEASE
hour	0
of	I-DISEASE
sleep	0
)	0
have	I-DISEASE
been	0
reported	0
in	0
a	0
group	0
of	0
children	I-DISEASE
with	I-DISEASE
treatment	0
-	I-DISEASE
resistant	0
SE	0
.	0

Recent	0
studies	0
have	0
demonstrated	0
that	0
patients	I-DISEASE
with	I-DISEASE
enuresis	0
are	0
subjectively	0
sleepier	0
than	0
normal	0
controls	0
.	I-DISEASE

This	0
has	0
been	0
hypothesized	0
to	0
result	0
from	0
fragmented	0
nocturnal	I-DISEASE
sleep	0
and	0
is	0
consistent	0
with	0
a	I-DISEASE
large	0
body	I-DISEASE
of	I-DISEASE
sleep	0
research	0
in	0
other	0
areas	0
.	0

Differential	0
Diagnosis	0
Enuresis	0
may	0
be	0
caused	I-DISEASE
by	0
a	0
variety	I-DISEASE
of	0
medical	0
or	0
neurological	0
disorders	0
such	I-DISEASE
as	0
diabetes	0
mellitus	0
,	0
diabetes	0
insipidus	0
,	0
epilepsy	0
,	I-DISEASE
sickle	0
cell	0
disease	0
,	I-DISEASE
bowel	0
or	0
bladder	0
dysfunction	0
,	0
anatomical	0
abnormalities	0
or	0
infection	0
of	I-DISEASE
the	0
urinary	0
tract	0
,	0
neurological/	0
developmental	0
disorders	I-DISEASE
or	0
other	0
sleep	0
disorders	0
,	I-DISEASE
especially	0
OSA	0
.	I-DISEASE

Organic	0
pathology	0
of	0
the	0
urinary	0
tract	I-DISEASE
is	0
more	0
prevalent	I-DISEASE
in	0
children	0
who	0
,	0
in	0
addition	I-DISEASE
to	0
sleep	0
enuresis	I-DISEASE
,	0
also	0
exhibit	0
daytime	0
enuresis	0
,	0
abnormalities	I-DISEASE
in	0
the	0
initiation	0
of	0
micturition	0
,	0
or	0
abnormal	0
urinary	0
flow	0
.	I-DISEASE

Evaluation	0
of	0
sleep	0
enuresis	I-DISEASE
should	0
include	0
complete	0
enuresis	0
history	I-DISEASE
,	0
sleep	0
history	0
,	0
physical	0
examination	I-DISEASE
and	I-DISEASE
laboratory	0
studies	I-DISEASE
(	0
as	0
indicated	0
)	0
to	0
exclude	I-DISEASE
these	I-DISEASE
etiol-	0
ogies	I-DISEASE
.	I-DISEASE

When	0
signs	0
and	0
symptoms	I-DISEASE
of	0
sleep	I-DISEASE
apnea	I-DISEASE
are	0
present	I-DISEASE
—	0
mouth	0
breathing	I-DISEASE
,	0
snoring	0
,	I-DISEASE
adenotonsillar	I-DISEASE
hypertrophy	0
,	I-DISEASE
daytime	0
sleepiness	0
,	0
hyperactivity	0
—	I-DISEASE
a	0
sleep	0
study	I-DISEASE
should	0
be	I-DISEASE
conducted	I-DISEASE
.	I-DISEASE

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE
Recent	I-DISEASE
advances	I-DISEASE
suggest	0
that	0
the	0
terms	0
primary	0
and	0
secondary	0
enuresis	I-DISEASE
may	0
be	0
overly	I-DISEASE
simplistic	0
.	0

Further	0
work	0
is	0
necessary	0
to	0
understand	0
the	I-DISEASE
genetic	I-DISEASE
and	0
clinical	0
aspects	0
of	0
SE	0
.	0

Other	0
sleep	0
disorders	0
are	0
common	0
in	0
children	0
with	I-DISEASE
SE	I-DISEASE
.	0

Though	0
it	0
may	0
be	0
possible	0
that	0
the	I-DISEASE
apneas	I-DISEASE
,	I-DISEASE
hypopneas	I-DISEASE
,	0
and	0
snoring	0
-	0
related	0
arousals	0
in	0
children	I-DISEASE
with	0
SRBD	I-DISEASE
could	0
be	0
the	0
trigger	I-DISEASE
of	I-DISEASE
SE	0
,	0
many	0
children	I-DISEASE
with	0
SE	0
do	0
not	0
have	0
a	0
sleep	I-DISEASE
disorder	0
.	I-DISEASE

In	0
such	0
cases	0
,	B-DISEASE
the	0
underlying	I-DISEASE
bladder	I-DISEASE
overactivity	0
may	I-DISEASE
be	0
the	0
stimulus	0
for	I-DISEASE
arousal	0
.	0

Studies	0
of	0
the	0
relationship	I-DISEASE
of	0
sleep	I-DISEASE
,	I-DISEASE
sleep	0
disorders	I-DISEASE
,	0
and	0
sleep	0
fragmentation	I-DISEASE
to	0
SE	I-DISEASE
performed	0
to	0
date	I-DISEASE
have	0
been	0
inconsistent	0
.	0

This	0
is	0
likely	0
due	0
to	0
differing	0
definitions	0
of	0
enuresis	I-DISEASE
and	0
varying	0
research	0
methodologies	0
.	0

Further	0
sophisticated	0
sleep	0
laboratory	I-DISEASE
studies	0
are	0
necessary	I-DISEASE
to	0
elucidate	I-DISEASE
the	0
relationship	I-DISEASE
.	0

In	0
particular	0
,	0
the	0
proximal	I-DISEASE
trigger	0
for	I-DISEASE
episodes	0
of	0
SE	0
has	0
not	0
been	0
determined	0
.	0

Some	0
studies	0
suggest	0
enuresis	0
is	0
sponta-	0
neous	0
,	0
whereas	0
others	0
suggest	0
a	0
relationship	0
to	0
sleep	I-DISEASE
disorders	0
that	0
result	0
in	0
arousals	0
—	0
similar	I-DISEASE
to	0
findings	I-DISEASE
in	0
disorders	0
of	I-DISEASE
arousal	I-DISEASE
.	0

Bibliography	0
Burgio	0
K	I-DISEASE
,	0
Locher	I-DISEASE
J	0
,	I-DISEASE
Ives	0
D	I-DISEASE
,	0
Hardin	0
J	0
,	0
Newman	0
A	I-DISEASE
,	I-DISEASE
Kuller	0
L.	I-DISEASE
Nocturnal	0
enuresis	0
in	0
community	0
-	0
dwelling	0
older	0
adults	I-DISEASE
.	0

J	0
Am	0
Geriatr	0
Soc	I-DISEASE
1996;44:139–43	0
.	0

Brooks	0
LJ	0
,	0
Topol	0
HI	0
.	0

Enuresis	0
in	0
children	0
with	0
sleep	0
apnea	I-DISEASE
.	0

J	0
Pediatr	0
2003;142:515–8	0
.	0

Chandra	0
M	0
,	0
Saharia	0
R	0
,	0
Hill	I-DISEASE
V	0
,	I-DISEASE
Shi	0
QH	0
.	0

Prevalence	0
of	0
diurnal	0
voiding	0
symptoms	0
and	0
difficult	0
arousal	0
from	I-DISEASE
sleep	0
in	0
children	0
with	I-DISEASE
nocturnal	0
enuresis	I-DISEASE
.	0

J	0
Urol	0
2004;172:311–6	0
.	0

Cohen	0
-	0
Zrubavel	0
V	0
,	0
Kushnir	I-DISEASE
B	I-DISEASE
,	0
Kushnir	I-DISEASE
J	0
,	I-DISEASE
Sadeh	0
A.	0
Sleep	0
and	I-DISEASE
sleepiness	I-DISEASE
in	0
children	I-DISEASE
with	0
nocturnal	0
enuresis	0
.	0

Sleep	0
2011;34:191–4	0
.	0

Dhondt	0
K	0
,	0
Raes	0
A	0
,	0
Hoebeke	0
P	0
,	I-DISEASE
Van	0
Laecke	0
E	0
,	0
Van	0
Herzeele	I-DISEASE
C	0
,	0
Vande	I-DISEASE
Walle	0
J.	0
Abnormal	0
sleep	0
architecture	0
and	I-DISEASE
refractory	I-DISEASE
nocturnal	0
enuresis	I-DISEASE
.	I-DISEASE

J	0
Urol	0
2009;182:1961–5	0
.	0

Jeyakumar	0
A	I-DISEASE
,	0
Rahman	0
SI	0
,	0
Armbrecht	I-DISEASE
ES	0
,	I-DISEASE
Mitchell	0
R.	0
The	0
association	0
between	0
sleep	I-DISEASE
-	0
disordered	0
breathing	0
and	0
enuresis	0
in	0
children	I-DISEASE
.	I-DISEASE

Laryngoscope	0
2012	0
Aug;122:1873–7	0
.	0

Neveus	0
T.	0
The	0
role	0
of	0
sleep	0
and	I-DISEASE
arousal	0
in	I-DISEASE
nocturnal	0
enuresis	0
.	0

Acta	0
Paediatr	0
2003;92:1118–23	0
.	0

Kalorin	0
CM	0
,	0
Mouzakes	0
J	0
,	0
Gavin	0
JP	0
,	I-DISEASE
et	0
al	0
.	0

Tonsillectomy	0
does	0
not	I-DISEASE
improve	0
bedwetting	0
:	I-DISEASE
results	I-DISEASE
of	I-DISEASE
a	0
prospective	0
controlled	0
trial	0
.	I-DISEASE

J	0
Urol	0
2010;184:2527	0
.	0

Neveus	0
T	0
,	0
Stenberg	0
A	0
,	0
Lackgren	I-DISEASE
G	I-DISEASE
,	I-DISEASE
Tuvemo	0
T	0
,	0
Hetta	I-DISEASE
J.	0
Sleep	I-DISEASE
of	I-DISEASE
children	0
with	I-DISEASE
enuresis	0
:	0
A	0
polysomnographic	0
study	0
.	0

Pediatrics	0
1999;103:1193–7	0
.	0

Norgaard	0
JP	0
,	0
Hansen	0
JH	0
,	I-DISEASE
Nielsen	0
JB	0
,	I-DISEASE
Petersen	0
BS	0
,	0
Knudsen	0
N	0
,	I-DISEASE
Djurhuus	0
JC	0
.	I-DISEASE

Simultaneous	0
registration	0
of	0
sleep	0
-	0
stages	I-DISEASE
and	I-DISEASE
bladder	0
activity	I-DISEASE
in	0
enuresis	0
.	0

Urology	0
1985;26:316–9	0
.	0

Sakellaropoulou	0
AV	0
,	I-DISEASE
Hatzistilianou	0
MN	0
,	0
Emporiadou	I-DISEASE
MN	0
,	I-DISEASE
et	0
al	0
.	0
Association	I-DISEASE
between	0
primary	I-DISEASE
nocturnal	0
enuresis	0
and	I-DISEASE
habitual	0
snoring	0
in	0
children	0
with	0
obstructive	I-DISEASE
sleep	0
apnoea	0
-	0
hypopnoea	I-DISEASE
syndrome	0
.	0

Arch	0
Med	0
Sci	0
2012;8:521–7	0
.	0

Stone	0
J	0
,	0
Malone	0
PS	0
,	I-DISEASE
Atwill	I-DISEASE
D	0
,	0
et	0
al	0
.	0

Symptoms	0
of	0
sleep	0
-	0
disordered	0
breathing	I-DISEASE
in	I-DISEASE
children	0
with	I-DISEASE
nocturnal	0
enuresis	0
.	0

J	0
Pediatr	0
Urol	0
2008;4:197	0
.	0

Parasomnias	0
Parasomnias	0
Weissbach	0
A	0
,	0
Leiberman	I-DISEASE
A	I-DISEASE
,	0
Tarasiuk	0
A	0
,	I-DISEASE
Goldbart	0
A	I-DISEASE
,	0
Tal	I-DISEASE
A.	I-DISEASE
Adenotonsillectomy	0
improves	I-DISEASE
enuresis	0
in	0
children	0
with	0
obstructive	0
sleep	I-DISEASE
apnea	I-DISEASE
syndrome	0
.	0

Int	0
J	0
Pediatr	0
Otorhinolaryngol	0
2006;70:1351–6	0
.	0

Wolfish	0
N.	0
Sleep	0
arousal	0
function	0
in	I-DISEASE
enuretic	I-DISEASE
males	0
.	0

Scand	0
J	0
Urol	0
Nephrol	0
Suppl	0
1999;202:24–6	0
.	0

Wolfish	0
NM	0
,	0
Pivik	0
RT	0
,	0
Busby	0
KA	0
.	0

Elevated	0
sleep	0
arousal	I-DISEASE
thresholds	0
in	0
enuretic	I-DISEASE
boys	I-DISEASE
:	0
clinical	0
implications	0
.	0

Acta	0
Paediatr	0
1997;86:381–4	0
.	0

Yeung	0
CK	0
,	0
Chiu	I-DISEASE
HN	0
,	0
Sit	0
FK	0
.	0

Sleep	0
disturbance	0
and	0
bladder	0
dysfunction	0
in	0
enuretic	0
children	0
with	0
treatment	0
failure	0
:	0
fact	I-DISEASE
or	0
fiction	0
?	0

Scand	0
J	0
Urol	0
Nephrol	0
Suppl	0
1999;202:20–3	0
.	0

Yeung	0
CK	0
,	0
Diao	I-DISEASE
M	0
,	0
Sreedhar	I-DISEASE
B.	0
Cortical	I-DISEASE
arousal	0
in	0
children	0
with	0
severe	0
enuresis	0
.	0

N	0
Engl	0
J	0
Med	0
2008;359;22–4	0
.	0

Parasomnia	0
Due	0
to	0
a	0
Medical	0
Disorder	I-DISEASE
ICD-9	0
-	0
CM	I-DISEASE
code	0
:	0
327.44	0
ICD-10	0
-	0
CM	I-DISEASE
code	0
:	0
G47.54	I-DISEASE
The	0
essential	0
feature	0
of	0
this	0
diagnosis	0
is	B-DISEASE
the	0
presence	0
of	I-DISEASE
a	0
parasomnia	0
that	I-DISEASE
is	I-DISEASE
attrib-	0
utable	0
to	I-DISEASE
an	0
underlying	0
neurological	0
or	0
medical	0
condition	0
.	I-DISEASE

RBD	0
is	0
the	0
parasomnia	0
most	I-DISEASE
commonly	0
associated	I-DISEASE
with	0
an	I-DISEASE
underlying	0
neurological	0
condition	0
(	0
“	0
symptomatic	I-DISEASE
RBD	0
”	0
)	I-DISEASE
.	0

However	0
,	I-DISEASE
when	0
diagnostic	I-DISEASE
criteria	0
for	I-DISEASE
RBD	I-DISEASE
are	0
met	0
,	0
the	0
more	0
specific	I-DISEASE
diagno-	0
sis	I-DISEASE
of	0
REM	0
sleep	I-DISEASE
behavior	0
disorder	0
should	0
be	0
made	0
.	0

Complex	0
nocturnal	0
sleep	0
related	0
(	0
hypnagogic	I-DISEASE
and	I-DISEASE
hypnopompic	0
)	0
visual	I-DISEASE
hallucina-	0
tions	0
can	0
occur	0
with	I-DISEASE
neurological	0
disorders	I-DISEASE
such	I-DISEASE
as	0
narcolepsy	0
,	0
PD	0
,	0
DLB	0
,	I-DISEASE
visual	0
loss	0
(	I-DISEASE
Charles	0
Bonnet	0
hallucinations	0
)	0
,	0
and	0
midbrain	0
and	0
diencephalic	0
pathology	0
(	0
pedun-	0
cular	0
hallucinosis	0
)	0
.	0

Dreaming	0
and	0
sleep	I-DISEASE
paralysis	0
may	0
or	0
may	I-DISEASE
not	0
be	I-DISEASE
associated	0
with	I-DISEASE
these	0
hallucinations	0
.	0

Parasomnia	0
Due	0
to	0
a	0
Medication	0
or	I-DISEASE
Substance	0
ICD-9	0
-	I-DISEASE
CM	0
code	0
:	0
292.85	0
(	0
drug	0
-	I-DISEASE
induced	0
)	I-DISEASE
;	I-DISEASE
291.82	I-DISEASE
(	0
alcohol	0
-	I-DISEASE
induced	I-DISEASE
)	0
ICD-10	0
-	0
CM	0
code	0
:	0
F11	I-DISEASE
-	0
F19	0
(	0
see	0
table	0
in	0
Appendix	0
B	0
for	0
detailed	I-DISEASE
coding	0
instructions	0
)	0

The	0
essential	0
feature	0
of	0
this	0
diagnosis	0
is	I-DISEASE
the	0
close	I-DISEASE
temporal	0
relationship	0
between	0
expo-	0
sure	0
to	I-DISEASE
a	I-DISEASE
drug	0
,	I-DISEASE
medication	0
,	0
or	0
biological	0
substance	0
and	0
the	I-DISEASE
onset	0
of	I-DISEASE
the	I-DISEASE
signs	0
and	I-DISEASE
symp-	I-DISEASE
toms	I-DISEASE
of	0
that	0
disorder	0
.	I-DISEASE

A	0
likely	0
causal	0
relationship	0
can	0
be	0
inferred	I-DISEASE
if	I-DISEASE
signs	0
and	0
symp-	0
toms	0
of	I-DISEASE
the	0
parasomnia	I-DISEASE
disappear	I-DISEASE
when	0
the	I-DISEASE
drug	I-DISEASE
or	0
substance	0
is	0
withdrawn	0
.	0

The	0
emergent	0
parasomnia	0
can	0
be	0
a	0
de	0
novo	0
parasomnia	I-DISEASE
,	I-DISEASE
the	0
aggravation	I-DISEASE
of	I-DISEASE
a	0
chronic	0
intermittent	0
parasomnia	0
,	I-DISEASE
or	0
the	I-DISEASE
reactivation	0
of	0
a	0
previous	0
parasomnia	I-DISEASE
.	0

As	0
discussed	0
previously	0
,	0
a	0
variety	I-DISEASE
of	I-DISEASE
medications	0
and	I-DISEASE
biological	0
substances	0
,	I-DISEASE
including	0
selective	0
serotonin	I-DISEASE
reuptake	0
inhibitors	0
,	0
venlafaxine	0
,	I-DISEASE
tricyclic	0
antidepressants	0
,	0
mono-	0
amine	I-DISEASE
oxidase	0
inhibitors	0
,	I-DISEASE
mirtazapine	0
,	I-DISEASE
bisoprolol	0
,	0
selegiline	0
,	0
or	0
cholinergic	0
treatment	0
for	I-DISEASE
Alzheimer	0
disease	0
,	I-DISEASE
have	I-DISEASE
been	0
reported	0
to	0
be	I-DISEASE
associated	I-DISEASE
with	I-DISEASE
acute	0
or	0
chronic	0
RBD	0
.	I-DISEASE

Acute	0
RBD	0
can	0
also	0
be	0
seen	0
during	0
states	0
of	0
withdrawal	0
from	0
cocaine	0
,	I-DISEASE
amphetamine	0
,	0
alcohol	0
,	0
barbiturate	0
,	0
and	0
meprobamate	0
abuse	0
.	0

Caffeine	0
and	I-DISEASE
chocolate	0
abuse	0
have	0
been	I-DISEASE
implicated	I-DISEASE
in	0
causing	0
or	0
unmasking	0
RBD	0
.	I-DISEASE

However	0
,	I-DISEASE
when	0
diagnostic	0
criteria	0
for	I-DISEASE
RBD	0
are	0
met	0
,	0
the	0
more	0
specific	I-DISEASE
diagnosis	0
of	I-DISEASE
REM	0
sleep	0
behavior	I-DISEASE
disorder	0
should	I-DISEASE
be	0
made	0
.	0

The	0
use	0
of	0
medications	0
such	0
as	0
β	I-DISEASE
-	0
adrenergic	I-DISEASE
receptor	0
-	0
blocking	0
agents	0
can	0
be	I-DISEASE
associ-	0
ated	0
with	I-DISEASE
sleep	0
related	0
hallucinations	0
.	0

When	0
the	0
clinical	I-DISEASE
presentation	0
suggests	0
a	I-DISEASE
direct	I-DISEASE
relationship	0
between	I-DISEASE
a	0
drug	0
or	0
substance	0
and	0
sleep	I-DISEASE
related	I-DISEASE
hallucinations	I-DISEASE
,	I-DISEASE
a	I-DISEASE
diagnosis	I-DISEASE
of	0
parasomnia	0
due	0
to	0
a	I-DISEASE
medication	0
or	0
substance	0
should	0
be	0
employed	I-DISEASE
.	I-DISEASE

Sedative	0
-	0
hypnotics	0
such	0
as	0
zolpidem	0
and	0
zopiclone	I-DISEASE
have	I-DISEASE
been	0
associated	0
with	0
apparent	0
NREM	0
parasomnias	I-DISEASE
including	0
SRED	0
and	0
sleep	I-DISEASE
driving	0
.	0

It	0
has	0
been	0
suggested	0
that	0
sleep	I-DISEASE
driving	I-DISEASE
is	0
an	I-DISEASE
overlap	0
behavior	0
in	0
which	0
the	0
sedative	I-DISEASE
-	0
hypnotic	0
increases	I-DISEASE
the	0
arousal	0
threshold	0
during	0
sleep	I-DISEASE
at	0
the	I-DISEASE
beginning	I-DISEASE
of	I-DISEASE
the	I-DISEASE
behavior	0
,	I-DISEASE
while	I-DISEASE
later	I-DISEASE
behavior	0
is	0
due	I-DISEASE
to	0
the	0
CNS	I-DISEASE
depressing	0
effects	0
of	0
the	0
drug	0
while	I-DISEASE
awake	I-DISEASE
.	0

It	0
has	0
not	0
been	I-DISEASE
determined	0
if	I-DISEASE
drug	0
-	0
re-	I-DISEASE
lated	0
NREM	0
parasomnias	0
are	0
associated	0
with	0
the	I-DISEASE
same	0
genetic	I-DISEASE
predisposition	0
,	0
priming	0
factors	0
,	0
and	0
triggers	I-DISEASE
observed	0
in	0
disorders	B-DISEASE
of	0
arousal	I-DISEASE
.	0

When	0
clinical	0
presentation	0
sug-	0
gests	0
a	I-DISEASE
direct	I-DISEASE
relationship	I-DISEASE
between	I-DISEASE
disorders	0
of	0
arousal	0
and	0
use	0
of	I-DISEASE
a	I-DISEASE
drug	I-DISEASE
or	I-DISEASE
substance	0
,	I-DISEASE
a	0
diagnosis	0
of	0
parasomnia	I-DISEASE
due	I-DISEASE
to	0
a	0
medication	0
or	0
substance	0
should	I-DISEASE
be	0
employed	0
.	0

Alcohol	0
has	0
often	0
appeared	0
on	0
lists	I-DISEASE
of	0
potential	0
sleepwalking	0
triggers	0
without	0
a	I-DISEASE
basis	0
in	0
reliable	I-DISEASE
empirical	I-DISEASE
scientific	I-DISEASE
research	I-DISEASE
.	0

Recent	0
evidence	0
-	0
based	I-DISEASE
reviews	0
have	0
found	0
no	0
relationship	I-DISEASE
between	0
alcohol	0
and	0
sleepwalking	0
.	0

The	0
behavior	0
of	0
the	0
alcohol	I-DISEASE
-	0
in-	I-DISEASE
toxicated	0
individual	I-DISEASE
may	I-DISEASE
superficially	0
resemble	0
that	0
of	0
the	0
sleepwalker	0
.	0

However	0
,	I-DISEASE
the	0
sleepwalker	I-DISEASE
is	0
typically	0
severely	I-DISEASE
cognitively	0
impaired	I-DISEASE
,	0
but	0
with	0
only	0
limited	0
motor	0
impairment	0
.	0

The	0
alcohol	0
-	0
intoxicated	I-DISEASE
individual	0
’s	0
level	I-DISEASE
of	0
cognitive	0
functioning	0
may	0
be	0
reduced	0
,	0
but	I-DISEASE
not	I-DISEASE
absent	I-DISEASE
,	I-DISEASE
whereas	0
motor	I-DISEASE
behavior	0
is	0
severely	0
impaired	I-DISEASE
.	0

Proponents	0
of	0
the	0
theory	0
of	I-DISEASE
alcohol	I-DISEASE
related	I-DISEASE
sleepwalking	0
suggest	I-DISEASE
that	I-DISEASE
the	0
effects	0
of	0
alcohol	0
are	I-DISEASE
similar	0
to	0
that	0
of	0
sleep	I-DISEASE
deprivation	0
—	0
that	0
is	I-DISEASE
,	I-DISEASE
alcohol	I-DISEASE
increases	0
deep	0
sleep	0
.	I-DISEASE

However	0
,	I-DISEASE
this	0
claim	0
in	0
not	0
substantiated	I-DISEASE
by	0
sleep	I-DISEASE
laboratory	0
-	0
based	0
studies	0
in	0
normal	0
controls	0
,	0
and	I-DISEASE
no	0
empirical	0
sleep	0
studies	0
of	0
alcohol	I-DISEASE
and	0
sleepwalking	0
have	0
ever	I-DISEASE
been	I-DISEASE
conducted	0
.	0

There	0
is	0
no	0
scientific	I-DISEASE
evidence	0
that	0
complex	I-DISEASE
behaviors	0
occurring	I-DISEASE
during	0
the	0
sleep	I-DISEASE
period	I-DISEASE
following	0
alcohol	I-DISEASE
ingestion	0
are	0
anything	I-DISEASE
other	0
than	0
the	0
nocturnal	0
wandering	0
of	I-DISEASE
Parasomnias	I-DISEASE
Parasomnias	0
an	0
alcohol	I-DISEASE
-	0
intoxicated	0
individual	0
.	0

Unconsciousness	0
,	0
intoxication	0
,	0
and	0
sleep	0
are	0
very	0
different	I-DISEASE
states	0
of	0
consciousness	0
.	I-DISEASE

Parasomnias	0
should	0
be	0
easily	0
distinguished	0
from	I-DISEASE
alcohol	I-DISEASE
intoxication	I-DISEASE
by	0
the	0
presence	0
of	0
significant	0
alcohol	0
ingestion	0
prior	0
to	I-DISEASE
bedtime	0
.	0

The	0
association	0
of	0
therapeutic	I-DISEASE
doses	0
of	0
sedative	I-DISEASE
hypnotic	I-DISEASE
drugs	I-DISEASE
and	0
apparent	0
para-	0
somnias	I-DISEASE
should	0
be	0
carefully	I-DISEASE
distinguished	0
from	I-DISEASE
the	0
expected	0
effects	0
of	0
drug	0
abuse	0
or	0
misuse	I-DISEASE
that	0
result	I-DISEASE
in	0
CNS	I-DISEASE
depression	0
.	0

Investigations	0
of	0
drivers	I-DISEASE
who	0
had	0
accidents	0
attributed	I-DISEASE
to	0
drug	I-DISEASE
-	0
related	0
sleep	0
driving	I-DISEASE
are	I-DISEASE
reported	0
to	0
show	0
that	I-DISEASE
(	0
1	0
)	0
blood	0
levels	I-DISEASE
of	0
prescribed	0
sedative	0
hypnotics	0
exceeded	I-DISEASE
therapeutic	0
ranges	0
;	0
(	0
2	0
)	0
the	0
individuals	0
failed	0
to	0
take	0
the	I-DISEASE
medication	I-DISEASE
at	I-DISEASE
the	I-DISEASE
correct	0
time	I-DISEASE
or	0
remain	I-DISEASE
in	I-DISEASE
bed	0
for	I-DISEASE
sufficient	I-DISEASE
time	0
follow-	I-DISEASE
ing	0
ingestion	0
;	0
and/or	0
(	0
3	0
)	0
the	I-DISEASE
individuals	0
combined	I-DISEASE
sedative	I-DISEASE
-	0
hypnotics	0
with	0
other	I-DISEASE
CNS	0
depressants	I-DISEASE
and/or	0
alcohol	0
.	I-DISEASE

Driving	0
with	0
a	0
high	0
blood	0
level	0
of	I-DISEASE
a	0
sedative	I-DISEASE
-	0
hypnotic	0
can	0
result	I-DISEASE
in	0
significant	0
cognitive	I-DISEASE
and	0
motor	0
impairment	0
.	0

Serious	0
accidents	0
can	0
result	0
.	0

Sleep	0
driving	I-DISEASE
and	0
other	0
complex	0
behaviors	0
in	I-DISEASE
this	0
population	0
are	0
more	0
likely	0
to	0
have	0
resulted	0
from	0
drug	0
misuse	I-DISEASE
and	I-DISEASE
abuse	0
rather	0
than	0
true	0
parasomnias	0
.	I-DISEASE

Parasomnia	0
,	0
Unspecified	0
ICD-9	0
-	0
CM	0
code	I-DISEASE
:	0
327.40	I-DISEASE
ICD-10	0
-	0
CM	0
code	I-DISEASE
:	0
G47.50	I-DISEASE
This	I-DISEASE
diagnosis	0
is	0
intended	0
for	0
parasomnias	0
that	0
can	0
not	0
be	0
classified	0
elsewhere	0
or	I-DISEASE
for	I-DISEASE
cases	0
in	0
which	0
the	0
physician	0
has	0
a	0
clinical	0
suspicion	0
of	0
a	0
parasomnia	0
but	0
is	0
unable	0
to	0
establish	I-DISEASE
a	I-DISEASE
specific	0
diagnosis	I-DISEASE
.	I-DISEASE

In	0
many	0
cases	0
,	B-DISEASE
“	0
parasomnia	0
,	0
unspecified	0
”	0
will	0
be	0
a	0
tem-	0
porary	0
diagnosis	0
.	0

However	0
,	I-DISEASE
in	0
other	0
patients	0
,	I-DISEASE
an	I-DISEASE
underlying	I-DISEASE
condition	I-DISEASE
may	0
not	0
ever	I-DISEASE
be	I-DISEASE
established	0
,	I-DISEASE
and	0
in	0
those	I-DISEASE
patients	0
,	I-DISEASE
“	0
parasomnia	0
,	0
unspecified	0
”	0
should	0
remain	0
an	0
ongoing	0
diagnosis	0
.	0

Isolated	0
Symptoms	0
and	0
Normal	0
Variants	0
Sleep	I-DISEASE
Talking	I-DISEASE
Alternate	0
Names	I-DISEASE
Somniloquy	0
.	0

The	0
essential	0
feature	0
is	0
talking	0
,	0
with	I-DISEASE
varying	0
degrees	I-DISEASE
of	0
comprehensibility	0
,	0
during	I-DISEASE
sleep	0
.	I-DISEASE

Sleep	0
talking	I-DISEASE
may	0
occur	B-DISEASE
during	0
REM	I-DISEASE
or	I-DISEASE
NREM	0
sleep	I-DISEASE
.	0

Sleep	0
talking	0
can	0
be	0
idiopathic	0
or	I-DISEASE
associated	I-DISEASE
with	0
parasomnias	0
such	0
as	0
RBD	0
or	0
disorders	0
of	I-DISEASE
arousal	I-DISEASE
such	0
as	I-DISEASE
confusional	0
arousal	0
.	0

Sleep	0
talking	I-DISEASE
may	0
follow	0
arousals	0
from	I-DISEASE
sleep	I-DISEASE
or	0
more	I-DISEASE
rarely	0
cause	0
them	0
.	I-DISEASE

Sleep	0
talking	I-DISEASE
is	B-DISEASE
highly	0
prevalent	0
.	0

A	0
recent	0
cross	I-DISEASE
-	I-DISEASE
sectional	0
epidemiologic	I-DISEASE
study	I-DISEASE
found	0
the	I-DISEASE
life-	0
time	0
prevalence	0
of	0
sleep	I-DISEASE
talking	I-DISEASE
to	I-DISEASE
be	0
66	I-DISEASE
%	0
and	I-DISEASE
current	0
prevalence	I-DISEASE
—	0
in	0
the	I-DISEASE
past	I-DISEASE
three	0
months	I-DISEASE
—	0
to	I-DISEASE
be	0
17	0
%	I-DISEASE
.	0

There	0
is	0
no	0
apparent	0
sex	0
difference	0
.	I-DISEASE

Onset	0
and	0
course	0
are	0
unknown	0
.	0

Complications	0
usually	0
arise	0
when	0
sleep	0
talking	0
is	I-DISEASE
very	0
frequent	I-DISEASE
or	0
loud	0
or	I-DISEASE
if	0
the	0
content	I-DISEASE
is	0
objectionable	0
to	I-DISEASE
others	0
.	0

Sleep	0
talking	0
is	0
usually	0
reported	0
by	0
the	I-DISEASE
bed	I-DISEASE
partner	0
or	0
someone	0
sleeping	0
in	0
the	0
same	I-DISEASE
room	0
or	0
sleeping	0
area	0
as	0
the	0
affected	0
individual	0
.	0

Sleep	0
talking	I-DISEASE
can	0
disrupt	0
the	0
sleep	I-DISEASE
of	I-DISEASE
a	0
bed	I-DISEASE
partner	0
,	0
roommate	0
,	0
or	0
others	I-DISEASE
in	0
a	0
group	I-DISEASE
-	0
sleeping	0
situation	0
(	I-DISEASE
such	0
as	0
college	I-DISEASE
dormitories	0
,	0
military	0
barracks	0
,	0
fire	0
stations	0
,	0
or	0
a	0
tent	0
while	0
camping	I-DISEASE
)	0
.	I-DISEASE

The	0
content	0
of	0
sleep	0
talking	0
has	0
not	0
been	0
shown	I-DISEASE
to	0
reflect	0
actual	0
prior	I-DISEASE
waking	0
behavior	I-DISEASE
or	0
memories	0
.	I-DISEASE

The	0
sleep	0
talker	I-DISEASE
is	I-DISEASE
rarely	0
aware	0
of	I-DISEASE
his	0
or	I-DISEASE
her	0
sleep	0
talking	0
.	I-DISEASE

Nocturnal	0
vocalization	0
,	0
including	0
frank	0
sleep	0
talking	I-DISEASE
,	0
is	I-DISEASE
often	0
seen	0
in	0
patients	0
with	0
RBD	0
and	0
subclinical	I-DISEASE
RBD	0
.	0

A	0
recent	0
report	I-DISEASE
notes	0
that	0
sleep	I-DISEASE
talking	I-DISEASE
may	0
be	I-DISEASE
a	I-DISEASE
useful	0
diagnostic	0
marker	0
for	0
differentiating	I-DISEASE
DLB	0
from	0
Alzheimer	I-DISEASE
disease	0
and	0
other	0
types	0
of	I-DISEASE
dementia	I-DISEASE
.	I-DISEASE

The	0
vocalizations	0
of	0
RBD	0
may	0
be	I-DISEASE
loud	0
,	0
emotional	I-DISEASE
,	0
profane	0
,	0
and	0
associated	0
with	I-DISEASE
behav-	I-DISEASE
iors	0
that	I-DISEASE
correlate	0
with	0
remembered	0
dream	0
mentation	0
.	I-DISEASE

Nocturnal	0
seizures	0
may	0
be	0
asso-	0
ciated	0
with	I-DISEASE
vocalization	0
that	I-DISEASE
tends	0
to	0
be	0
stereotypic	0
.	0

The	0
vocalizations	0
associated	0
with	0
sleep	0
terrors	0
are	I-DISEASE
emotionally	0
laden	I-DISEASE
and	0
associated	0
with	0
behaviors	0
of	0
intense	0
arousal	0
and	0
agitation	0
.	0

In	0
PTSD	0
,	0
increased	0
vocalizations	0
during	I-DISEASE
sleep	I-DISEASE
have	0
been	I-DISEASE
described	0
.	0

Bibliography	0
Arkin	0
AM	0
,	0
Toth	0
MF	0
,	I-DISEASE
Baker	0
J	I-DISEASE
,	0
Hastey	0
JM	0
.	0

The	0
frequency	0
of	0
sleep	0
talking	0
in	0
the	0
laboratory	0
among	I-DISEASE
chronic	0
sleep	0
talkers	I-DISEASE
and	0
good	0
dream	I-DISEASE
recallers	I-DISEASE
.	0

J	0
Nerv	0
Ment	0
Dis	0
1970;151:369–74	0
.	0

Bjorvatn	0
B	0
,	0
Grønli	I-DISEASE
J	0
,	0
Pallesen	I-DISEASE
S.	0
Prevalence	I-DISEASE
of	0
different	0
parasomnias	0
in	0
the	0
general	I-DISEASE
population	0
.	I-DISEASE

Sleep	0
Med	0
2010;11:1031–4	0
.	0

Parasomnias	0
Parasomnias	0
Honda	0
K	0
,	0
Hashimoto	I-DISEASE
M	0
,	0
Yatabe	0
Y	0
,	I-DISEASE
et	0
al	0
.	0

The	0
usefulness	0
of	0
monitoring	0
sleep	0
talking	0
for	I-DISEASE
the	0
diagnosis	0
of	I-DISEASE
Dementia	0
with	0
Lewy	0
bodies	0
.	0

Int	0
Psychogeriatr	0
2013;25:851–8	0
.	0

Hublin	0
C	0
,	I-DISEASE
Kaprio	I-DISEASE
J	0
,	0
Partinen	I-DISEASE
M	0
,	I-DISEASE
Koskenvuo	0
M.	I-DISEASE
Sleeptalking	0
in	I-DISEASE
twins	0
:	0
epidemiology	0
and	0
psychiatric	I-DISEASE
comorbidity	0
.	0

Behav	0
Genet	0
1998;28:289–98	0
.	0

Reimao	0
RN	0
,	0
Lefevre	0
AB	0
.	0

Prevalence	0
of	0
sleep	0
-	0
talking	0
in	0
childhood	B-DISEASE
.	0

Brain	0
Dev	0
1980;2:353–7	0
.	0

Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
Restless	0
Legs	0
Syndrome282	I-DISEASE
Periodic	0
Limb	I-DISEASE
Movement	0
Disorder	I-DISEASE
292	0
Sleep	0
Related	0
Leg	I-DISEASE
Cramps	0

299	0
Sleep	0
Related	0
Bruxism303	0
Sleep	0
Related	0
Rhythmic	I-DISEASE
Movement	0
Disorder312	I-DISEASE
Benign	0
Sleep	0
Myoclonus	0
of	I-DISEASE
Infancy	0
317	0
Propriospinal	0
Myoclonus	0
at	I-DISEASE
Sleep	0
Onset321	0
Sleep	0
Related	0
Movement	I-DISEASE
Disorder	0
Due	0
to	0
a	I-DISEASE
Medical	I-DISEASE
Disorder325	0
Sleep	0
Related	0
Movement	0
Disorder	0
Due	0
to	0
a	0
Medication	0
or	I-DISEASE
Substance	I-DISEASE
.....	0
326	I-DISEASE
Sleep	I-DISEASE
Related	0
Movement	0
Disorder	0
,	I-DISEASE
Unspecified327	I-DISEASE
Isolated	0
Symptoms	0
and	0
Normal	0
Variants	I-DISEASE
Excessive	I-DISEASE
Fragmentary	0
Myoclonus	0
328	0
Hypnagogic	0
Foot	I-DISEASE
Tremor	0
and	0
Alternating	I-DISEASE
Leg	0
Muscle	I-DISEASE
Activation	I-DISEASE
330	I-DISEASE
Sleep	0
Starts	0
(	0
Hypnic	I-DISEASE
Jerks)335	0

Sleep	0
related	0
movement	I-DISEASE
disorders	0
are	0
primarily	0
characterized	I-DISEASE
by	0
relatively	0
simple	0
,	0
usually	0
stereotyped	0
,	0
movements	I-DISEASE
that	0
disturb	0
sleep	0
or	0
its	0
onset	0
.	0

Restless	0
legs	0
syndrome	0
(	0
RLS	0
)	I-DISEASE
is	I-DISEASE
an	I-DISEASE
exception	I-DISEASE
in	0
that	0
patients	0
typically	0
engage	0
in	I-DISEASE
walking	I-DISEASE
or	I-DISEASE
nonstereotypic	0
limb	0
movement	0
to	0
reduce	0
leg	0
discomfort	0
.	I-DISEASE

However	0
,	I-DISEASE
RLS	0
is	0
closely	0
associated	0
with	0
periodic	0
limb	I-DISEASE
movements	0
(	0
PLMs	0
)	I-DISEASE
,	0
which	0
are	I-DISEASE
usually	I-DISEASE
simple	I-DISEASE
and	0
stereotyped	0
within	0
a	0
series	0
.	0

Nocturnal	0
sleep	0
disturbance	0
or	I-DISEASE
complaints	0
of	0
daytime	I-DISEASE
sleepiness	0
or	I-DISEASE
fatigue	I-DISEASE
are	0
a	0
prerequisite	0
for	0
a	I-DISEASE
diagnosis	I-DISEASE
of	0
a	I-DISEASE
sleep	0
related	0
movement	0
disorder	0
.	0

For	0
example	0
,	0
many	0
normal	0
sleepers	I-DISEASE
exhibit	I-DISEASE
episodes	0
of	I-DISEASE
periodic	0
limb	0
movements	0
of	0
sleep	0
(	I-DISEASE
PLMS	I-DISEASE
)	0
but	I-DISEASE
have	0
no	0
complaint	0
of	0
a	0
sleep	I-DISEASE
disturbance	I-DISEASE
,	0
nor	0
do	I-DISEASE
they	0
show	0
a	0
significant	0
objective	0
dis-	0
turbance	0
of	0
their	I-DISEASE
sleep	0
as	I-DISEASE
a	I-DISEASE
result	I-DISEASE
of	I-DISEASE
the	0
movements	0
.	0

Such	0
persons	0
should	0
not	0
be	0
classi-	0
fied	0
as	0
having	I-DISEASE
periodic	0
limb	0
movement	0
disorder	0
(	0
PLMD	0
)	0
,	0
but	I-DISEASE
instead	0
,	0
the	0
presence	0
of	0
PLMS	0
should	I-DISEASE
simply	0
be	I-DISEASE
noted	0
.	0

Similar	0
considerations	0
relate	0
to	I-DISEASE
the	0
distinction	I-DISEASE
between	I-DISEASE
rhythmic	0
movement	0
disorder	0
and	0
the	0
presence	I-DISEASE
of	0
rhythmic	I-DISEASE
movements	0
.	0

Body	0
movements	0
that	0
disturb	0
sleep	0
also	I-DISEASE
are	0
seen	0
in	0
many	0
other	0
sleep	0
disorder	I-DISEASE
categories	0
(	0
e.g.	I-DISEASE
,	0
in	0
parasomnias	0
such	0
as	0
sleepwalking	0
,	0
sleep	0
terrors	0
,	0
and	0
rapid	I-DISEASE
eye	0
movement	I-DISEASE
(	0
REM	I-DISEASE
)	0
sleep	0
behavior	0
disorder	0
(	0
RBD	I-DISEASE
)	0
)	0
.	0

However	0
,	I-DISEASE
these	0
parasomnias	0
differ	0
from	0
the	0
simple	0
ste-	I-DISEASE
reotyped	0
movements	0
categorized	I-DISEASE
as	0
sleep	0
related	0
movement	I-DISEASE
disorders	0
in	0
that	0
they	0
involve	0
complex	0
behaviors	I-DISEASE
during	I-DISEASE
the	0
sleep	0
period	0
.	I-DISEASE

Parasomnia	0
-	0
related	0
movements	0
may	0
appear	I-DISEASE
Sleep	I-DISEASE
Related	0
Movement	I-DISEASE
Disorders	0
purposeful	0
and	I-DISEASE
goal	0
directed	0
,	I-DISEASE
but	0
are	0
outside	0
the	0
conscious	I-DISEASE
awareness	0
of	0
the	0
individual	0
.	0

Parasomnias	0
are	0
listed	0
in	0
a	0
separate	I-DISEASE
section	I-DISEASE
from	0
the	0
sleep	0
related	0
movement	0
disorders	0
.	0

Although	0
the	0
history	I-DISEASE
may	0
be	0
diagnostic	I-DISEASE
,	I-DISEASE
polysomnography	0
is	I-DISEASE
sometimes	0
necessary	0
to	0
make	I-DISEASE
a	0
firm	I-DISEASE
diagnosis	I-DISEASE
of	0
sleep	I-DISEASE
related	0
movement	0
disorders	0
and	0
distinguish	0
them	I-DISEASE
from	I-DISEASE
parasomnias	I-DISEASE
.	I-DISEASE

In	0
these	0
cases	0
,	B-DISEASE
it	0
is	0
necessary	I-DISEASE
to	0
add	I-DISEASE
all	0
-	0
night	0
video	I-DISEASE
recording	0
to	I-DISEASE
the	0
poly-	I-DISEASE
somnographic	I-DISEASE
recording	0
and	0
to	0
correlate	0
the	0
documented	0
movements	I-DISEASE
with	0
the	0
techni-	I-DISEASE
cian	0
’s	0
description	I-DISEASE
of	0
the	0
patient	0
’s	I-DISEASE
behavior	0
and	0
level	I-DISEASE
of	I-DISEASE
consciousness	0
in	0
order	0
to	0
estab-	0
lish	I-DISEASE
a	I-DISEASE
diagnosis	0
.	0

There	0
are	0
some	0
movement	0
disorders	0
that	I-DISEASE
may	I-DISEASE
occur	0
during	0
both	0
sleep	0
and	I-DISEASE
wakefulness	I-DISEASE
.	I-DISEASE

If	0
the	0
presentation	I-DISEASE
during	0
sleep	0
is	I-DISEASE
significantly	I-DISEASE
different	0
from	0
that	0
during	0
wakefulness	0
,	I-DISEASE
or	0
if	I-DISEASE
the	0
movement	0
is	I-DISEASE
entirely	0
confined	0
to	0
sleep	0
,	0
then	I-DISEASE
the	I-DISEASE
move-	0
ment	I-DISEASE
disorder	0
is	0
classified	0
here	0
(	I-DISEASE
e.g.	0
,	0
the	0
occurrence	0
of	0
bruxism	0
exclusively	0
in	0
sleep	I-DISEASE
)	I-DISEASE
.	0

Restless	0
Legs	0
Syndrome	0
ICD-9	I-DISEASE
-	0
CM	0
code	0
:	0
333.94	0
Alternate	0
Names	0
Willis	0
-	0
Ekbom	I-DISEASE
disease	I-DISEASE
.	0

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
C	I-DISEASE
must	0
be	0
met	I-DISEASE
ICD-10	0
-	0
CM	0
code	0
:	0

G25.81	0
A.	0
An	0
urge	0
to	0
move	I-DISEASE
the	0
legs	0
,	I-DISEASE
usually	0
accompanied	0
by	I-DISEASE
or	0
thought	0
to	I-DISEASE
be	I-DISEASE
caused	0
by	0
uncomfortable	0
and	0
unpleasant	0
sensations	0
in	0
the	0
legs.1,2	I-DISEASE
These	0
symptoms	0
must	0
:	I-DISEASE
.	0

Begin	0
or	0
worsen	0
during	0
periods	0
of	0
rest	I-DISEASE
or	0
inactivity	I-DISEASE
such	0
as	0
lying	0
down	0
or	0
sitting	0
;	0
.	0

Be	0
partially	0
or	I-DISEASE
totally	0
relieved	0
by	0
movement	I-DISEASE
,	0
such	I-DISEASE
as	0
walking	0
or	0
stretching	0
,	0
at	I-DISEASE
least	I-DISEASE
as	I-DISEASE
long	0
as	0
the	0
activity	0
continues;3	0
and	I-DISEASE
.	0

Occur	0
exclusively	0
or	0
predominantly	0
in	0
the	0
evening	I-DISEASE
or	0
night	I-DISEASE
rather	0
than	0
during	I-DISEASE
the	0
day.4	0
B.	I-DISEASE
The	I-DISEASE
above	0
features	0
are	0
not	0
solely	0
accounted	0
for	0
as	0
symptoms	0
of	I-DISEASE
another	I-DISEASE
medical	I-DISEASE
or	0
a	I-DISEASE
behavioral	0
condition	I-DISEASE
(	0
e.g.	0
,	0
leg	0
cramps	0
,	I-DISEASE
positional	I-DISEASE
discomfort	0
,	0
myalgia	I-DISEASE
,	0
venous	0
stasis	0
,	I-DISEASE
leg	I-DISEASE
edema	I-DISEASE
,	0
arthritis	0
,	0
habitual	I-DISEASE
foot	I-DISEASE
tapping	I-DISEASE
)	0
.	0

C.	0

The	0
symptoms	0
of	0
RLS	0
cause	0
concern	I-DISEASE
,	I-DISEASE
distress	0
,	I-DISEASE
sleep	0
disturbance	0
,	I-DISEASE
or	0
impairment	0
in	I-DISEASE
mental	I-DISEASE
,	0
physical	I-DISEASE
,	0
social	0
,	0
occupational	0
,	0
educational	0
,	I-DISEASE
behavioral	I-DISEASE
,	0
or	B-DISEASE
other	0
important	I-DISEASE
areas	0
of	0
functioning.5	0
Notes	0
.	0

Sometimes	0
the	0
urge	I-DISEASE
to	0
move	0
the	0
legs	I-DISEASE
is	0
present	I-DISEASE
without	0
the	I-DISEASE
uncomfortable	0
sensations	0
,	0
and	0
sometimes	0
the	0
arms	I-DISEASE
or	0
other	0
parts	0
of	0
the	0
body	I-DISEASE
are	0
involved	0
in	0
addition	0
to	0
the	0
legs	I-DISEASE
.	0
.	0

For	0
children	0
,	0
the	0
description	0
of	0
these	I-DISEASE
symptoms	0
should	0
be	0
in	0
the	0
child	I-DISEASE
’s	0
own	0
words	0
.	0
.	I-DISEASE

When	0
symptoms	0
are	0
very	0
severe	0
,	0
relief	I-DISEASE
by	0
activity	0
may	0
not	0
be	0
noticeable	0
but	0
must	0
have	0
been	0
previously	0
present	0
.	0
.	0

As	0
a	0
result	0
of	0
severity	0
,	0
treatment	I-DISEASE
intervention	0
,	I-DISEASE
or	0
treatment	0
-	0
induced	0
augmentation	0
,	I-DISEASE
the	I-DISEASE
worsening	0
in	0
the	0
evening	0
or	0
night	0
may	I-DISEASE
not	0
be	0
noticeable	I-DISEASE
but	0
must	I-DISEASE
have	0
been	0
previously	0
present	0
.	0
.	0

For	0
certain	0
research	0
applications	0
,	0
such	0
as	I-DISEASE
genetic	0
or	0
epidemiological	0
studies	0
,	0
it	0
may	0
be	I-DISEASE
appropriate	0
to	0
omit	0
criterion	0
C.	I-DISEASE

If	0
so	0
,	0
this	0
should	0
be	0
clearly	I-DISEASE
stated	0
in	I-DISEASE
the	0
research	0
report	0
.	0

Essential	0
Features	0
RLS	0
is	0
a	0
sensorimotor	0
disorder	I-DISEASE
characterized	0
by	I-DISEASE
a	0
complaint	0
of	0
a	0
strong	0
,	I-DISEASE
nearly	0
irresist-	0
ible	I-DISEASE
urge	0
to	0
move	0
the	0
limbs	0
.	I-DISEASE

This	0
urge	0
to	0
move	0
is	0
often	0
but	I-DISEASE
not	0
always	I-DISEASE
accompanied	0
by	0
other	0
uncomfortable	I-DISEASE
sensations	0
felt	I-DISEASE
deep	0
inside	0
the	0
limbs	I-DISEASE
or	0
by	0
a	0
feeling	0
that	0
is	I-DISEASE
simply	0
difficult	I-DISEASE
or	0
impossible	0
to	I-DISEASE
describe	0
.	0

Although	0
the	0
legs	I-DISEASE
are	0
most	0
prominently	0
affected	I-DISEASE
,	0
“	I-DISEASE
restless	0
legs	0
”	0
is	0
a	0
misnomer	I-DISEASE
,	I-DISEASE
in	I-DISEASE
that	I-DISEASE
21	0
%	0
to	0
57	0
%	0
of	0
individuals	I-DISEASE
with	0
RLS	0
describe	I-DISEASE
some	0
arm	0
sensations	0
.	I-DISEASE

The	0
most	0
common	0
adult	0
RLS	I-DISEASE
descriptors	I-DISEASE
in	I-DISEASE
English	0
are	I-DISEASE
“	0
rest-	0
less	0
,	0
”	0
“	I-DISEASE
uncomfortable	I-DISEASE
,	0
”	I-DISEASE
“	0
twitchy	0
,	0
”	0
“	0
need	0
to	I-DISEASE
stretch	0
,	0
”	I-DISEASE
“	0
urge	0
to	I-DISEASE
move	0
,	0
”	0
and	0
“	0
legs	0
want	0
to	0
move	I-DISEASE
on	I-DISEASE
their	0
own	0
.	0
”	0

About	0
half	0
express	I-DISEASE
their	0
RLS	0
sensations	0
as	I-DISEASE
painful	0
.	I-DISEASE

“	0
Numb	0
”	0
and	0
“	0
cold	0
”	I-DISEASE
are	0
very	0
uncommon	0
descriptors	0
for	0
RLS	0
.	0

Criteria	0
A1	I-DISEASE
-	0
3	0
specify	0
the	0
necessary	I-DISEASE
characteristics	0
of	I-DISEASE
the	0
RLS	0
sensations	0
:	I-DISEASE
worse	0
at	I-DISEASE
rest	0
,	0
better	I-DISEASE
with	0
movement	0
,	0
and	0
predominant	0
occurrence	0
in	0
the	0
evening	0
or	0
night	0
.	I-DISEASE

The	0
separation	0
of	0
worsening	0
at	0
rest	0
(	I-DISEASE
criterion	0
A1	I-DISEASE
)	0
from	0
worsening	I-DISEASE
in	0
the	0
evening/	I-DISEASE
night	0
(	I-DISEASE
criterion	0
A3	0
)	I-DISEASE
is	0
based	0
on	0
circadian	0
rhythm	I-DISEASE
studies	0
that	0
show	I-DISEASE
an	0
increase	0
at	0
night	0
,	0
independent	0
of	0
activity	0
level	I-DISEASE
.	I-DISEASE

RLS	0
must	0
be	0
differentiated	0
from	0
other	0
condi-	0
tions	0
that	I-DISEASE
can	0
mimic	0
RLS	0
(	0
criterion	0
B	0
)	0
.	0

Clinically	0
significant	0
RLS	0
is	0
defined	0
by	I-DISEASE
RLS	I-DISEASE
symptoms	0
causing	I-DISEASE
substantial	0
distress	0
,	0
sleep	I-DISEASE
disturbance	0
,	I-DISEASE
or	0
impairment	I-DISEASE
of	0
function	0
(	0
criterion	0
C	0
)	I-DISEASE
.	I-DISEASE

Associated	0
Features	0
Disturbed	0
sleep	0
is	I-DISEASE
a	0
common	I-DISEASE
,	I-DISEASE
prominent	I-DISEASE
,	0
and	0
distressing	0
aspect	0
of	0
RLS	I-DISEASE
.	0

Sleep	0
onset	I-DISEASE
and	0
maintenance	0
complaints	0
in	I-DISEASE
individuals	0
with	I-DISEASE
RLS	I-DISEASE
are	0
notably	0
higher	0
than	0
in	0
con-	I-DISEASE
trols	0
,	I-DISEASE
with	I-DISEASE
odds	0
ratios	0
(	0
OR	0
)	0
between	I-DISEASE
1.7	I-DISEASE
and	I-DISEASE
3.5	0
.	I-DISEASE

In	0
clinical	0
populations	0
,	I-DISEASE
disturbed	0
Sleep	I-DISEASE
Related	I-DISEASE
Movement	I-DISEASE
Disorders	0
Sleep	0
Related	0
Movement	0
Disorders	0
sleep	0
is	I-DISEASE
reported	0
in	0
60	I-DISEASE
%	0
to	0
90	0
%	0
of	0
individuals	0
with	I-DISEASE
RLS	0
,	0
is	I-DISEASE
typically	0
the	I-DISEASE
most	I-DISEASE
trou-	0
bling	0
symptom	0
,	0
and	0
is	I-DISEASE
often	I-DISEASE
the	0
primary	0
reason	I-DISEASE
for	I-DISEASE
seeking	0
medical	0
care	0
.	B-DISEASE

The	0
Medical	0
Outcomes	0
Study	0
Sleep	I-DISEASE
Questionnaire	I-DISEASE
scores	I-DISEASE
for	I-DISEASE
sleep	0
quantity	0
,	0
sleep	0
disturbance	I-DISEASE
,	I-DISEASE
sleep	I-DISEASE
adequacy	I-DISEASE
,	0
and	I-DISEASE
sleep	I-DISEASE
problems	0
are	0
significantly	I-DISEASE
worse	0
for	0
RLS	I-DISEASE
patients	I-DISEASE
than	0
con-	I-DISEASE
trols	I-DISEASE
.	0

Daytime	0
fatigue	0
and	0
daytime	0
sleepiness	0
are	0
also	I-DISEASE
common	0
complaints	I-DISEASE
;	0
however	0
,	0
the	I-DISEASE
sleepiness	0
is	I-DISEASE
not	I-DISEASE
as	I-DISEASE
severe	I-DISEASE
as	0
expected	I-DISEASE
for	0
the	0
degree	0
of	0
sleep	0
disruption	I-DISEASE
,	0
implying	I-DISEASE
hyperarousal	I-DISEASE
in	0
RLS	0
.	I-DISEASE

In	0
contrast	0
to	0
obstructive	I-DISEASE
sleep	0
apnea	0
,	0
Epworth	I-DISEASE
Sleepiness	I-DISEASE
Scale	0
scores	I-DISEASE
in	0
RLS	0
are	0
typically	I-DISEASE
in	0
the	I-DISEASE
normal	I-DISEASE
range	0
,	0
and	0
either	0
no	I-DISEASE
different	0
or	I-DISEASE
marginally	0
elevated	I-DISEASE
when	I-DISEASE
compared	I-DISEASE
to	I-DISEASE
normal	I-DISEASE
controls	I-DISEASE
.	0

Clinical	0
sleep	0
disturbance	I-DISEASE
correlates	0
with	0
both	0
severity	0
of	0
RLS	0
and	0
health	0
impact	0
of	0
RLS	0
.	0

Some	0
individuals	0
with	0
RLS	0
may	0
choose	I-DISEASE
to	0
work	0
at	I-DISEASE
night	0
,	0
thereby	I-DISEASE
shifting	0
quiet	0
activities	I-DISEASE
and	0
their	0
sleep	I-DISEASE
schedule	0
away	I-DISEASE
from	0
the	0
circadian	0
peak	I-DISEASE
of	0
their	0
RLS	0
symptoms	0
.	0

PLMs	0
,	0
a	0
family	I-DISEASE
history	0
of	I-DISEASE
RLS	0
,	0
and	I-DISEASE
response	0
to	0
dopaminergic	0
therapy	I-DISEASE
are	0
supportive	I-DISEASE
of	0
the	0
diagnosis	I-DISEASE
.	0

Periodic	0
limb	0
movements	0
can	0
occur	0
in	0
sleep	0
(	0
PLMS	I-DISEASE
)	0
or	0
wakeful-	0
ness	0
(	0
PLMW	0
)	I-DISEASE
.	0

PLMW	0
occur	0
during	0
quiet	0
rest	0
and	I-DISEASE
frequently	I-DISEASE
at	0
the	I-DISEASE
transition	0
between	0
waking	I-DISEASE
and	0
sleep	0
,	I-DISEASE
disrupting	I-DISEASE
sleep	I-DISEASE
onset	I-DISEASE
or	0
the	I-DISEASE
return	0
to	0
sleep	0
.	I-DISEASE

PLMS	0
are	0
frequently	0
associated	0
with	0
arousal	0
from	0
sleep	0
.	I-DISEASE

RLS	0
sensory	0
and	0
motor	0
features	0
respond	0
initially	I-DISEASE
to	I-DISEASE
treatment	I-DISEASE
with	0
dopaminergic	0
therapy	0
in	0
almost	0
all	0
cases	0
.	0

Multiple	0
clinic	0
-	0
based	0
and	0
population	I-DISEASE
-	I-DISEASE
based	0
studies	I-DISEASE
have	0
shown	0
an	0
increased	0
preva-	0
lence	I-DISEASE
of	I-DISEASE
mood	0
and	I-DISEASE
anxiety	0
disorders	0
in	0
individuals	0
with	0
RLS	0
.	0

Most	0
controlled	0
studies	0
using	0
validated	0
assessments	0
have	I-DISEASE
shown	0
significantly	I-DISEASE
increased	0
ORs	I-DISEASE
for	I-DISEASE
moderately	0
or	0
highly	I-DISEASE
elevated	0
depressive	0
symptoms	I-DISEASE
(	0
OR	I-DISEASE
1.95	0
and	0
3.67	0
)	0
,	0
major	0
depression	0
(	I-DISEASE
OR	0
2.6	0
)	0
,	I-DISEASE
major	0
depressive	0
disorder	0
(	0
OR	0
2.57	I-DISEASE
and	0
4.7	0
)	I-DISEASE
,	0
generalized	0
anxiety	0
disorder	I-DISEASE
(	I-DISEASE
OR	I-DISEASE
3.5	0
)	I-DISEASE
,	0
panic	0
disorder	I-DISEASE
(	I-DISEASE
OR	0
4.7	0
,	I-DISEASE
12.9	0
,	I-DISEASE
and	0
18.9	I-DISEASE
)	I-DISEASE
,	0
and	I-DISEASE
posttraumatic	0
stress	0
disorder	I-DISEASE
(	0
OR	I-DISEASE
3.76	I-DISEASE
)	I-DISEASE
.	0

In	0
addition	0
,	0
a	0
positive	0
correlation	I-DISEASE
has	0
been	0
found	I-DISEASE
between	0
the	0
severity	0
of	0
RLS	0
and	0
depression	0
/	0
anxiety	0
symptoms	0
.	0

Relevant	0
to	0
the	0
RLS	0
-	0
depression	I-DISEASE
relationship	0
is	I-DISEASE
the	I-DISEASE
emerging	0
evidence	0
that	0
treatment	I-DISEASE
of	0
RLS	0
improves	0
depressive	0
symptoms	I-DISEASE
.	0

Similarly	0
,	0
increased	0
rates	I-DISEASE
of	0
attention	I-DISEASE
deficit	I-DISEASE
hyperactivity	0
disorder	I-DISEASE
(	0
ADHD	0
)	0
have	I-DISEASE
been	0
found	I-DISEASE
in	I-DISEASE
RLS	I-DISEASE
,	0
both	0
in	0
pediatric	0
and	0
adult	I-DISEASE
studies	0
.	0

Emerging	0
data	0
indicate	0
that	0
about	0
one	I-DISEASE
fourth	0
of	0
individuals	I-DISEASE
with	0
RLS	0
have	0
ADHD	0
symptoms	I-DISEASE
,	0
and	0
conversely	0
,	I-DISEASE
that	0
12	I-DISEASE
%	0
to	0
35	0
%	0
of	I-DISEASE
those	0
with	0
ADHD	I-DISEASE
meet	0
criteria	0
for	0
RLS	0
.	0

Other	0
medical	0
condi-	0
tions	I-DISEASE
for	0
which	I-DISEASE
there	0
is	0
some	I-DISEASE
evidence	0
for	I-DISEASE
greater	0
-	0
than	0
-	0
chance	0
association	I-DISEASE
include	I-DISEASE
narcolepsy	0
,	0
migraine	0
,	0
chronic	0
obstructive	0
pulmonary	I-DISEASE
disease	0
,	0
Parkinson	I-DISEASE
disease	B-DISEASE
,	0
multiple	0
sclerosis	0
,	0
peripheral	0
neuropathy	0
,	I-DISEASE
obstructive	I-DISEASE
sleep	I-DISEASE
apnea	0
,	0
diabetes	I-DISEASE
melli-	0
tus	0
,	0
fibromyalgia	I-DISEASE
,	I-DISEASE
rheumatoid	I-DISEASE
arthritis	0
,	0
nocturnal	I-DISEASE
eating	0
,	0
obesity	I-DISEASE
,	0
thyroid	0
disease	I-DISEASE
,	0
and	0
heart	I-DISEASE
disease	0
.	I-DISEASE

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Evidence	I-DISEASE
in	I-DISEASE
the	I-DISEASE
literature	I-DISEASE
is	I-DISEASE
not	0
sufficient	I-DISEASE
to	0
support	0
well	I-DISEASE
-	I-DISEASE
defined	I-DISEASE
subtypes	I-DISEASE
of	I-DISEASE
RLS	0
.	0

Early	0
-	0
onset	0
RLS	0
(	0
prior	I-DISEASE
to	I-DISEASE
age	0
45	I-DISEASE
years	0
)	0
is	I-DISEASE
more	I-DISEASE
familial	0
and	0
associated	0
with	0
slower	I-DISEASE
progression	0
than	0
late	0
-	0
onset	0
RLS	0
.	0

In	0
addition	0
,	0
the	0
classification	I-DISEASE
of	0
“	I-DISEASE
secondary	0
”	I-DISEASE
RLS	0
has	0
been	0
suggested	0
when	0
the	I-DISEASE
condition	0
occurs	I-DISEASE
in	I-DISEASE
association	0
with	0
iron	0
deficiency	0
,	0
preg-	I-DISEASE
nancy	I-DISEASE
,	0
and	0
chronic	I-DISEASE
renal	0
failure	0
,	0
but	I-DISEASE
this	0
construct	0
has	0
been	0
challenged	0
based	0
on	0
patho-	0
physiological	0
,	0
family	0
history	0
,	0
genetic	0
,	I-DISEASE
and	I-DISEASE
clinical	0
course	I-DISEASE
data	0
.	0

Demographics	0
The	0
overall	0
prevalence	0
of	0
RLS	I-DISEASE
has	I-DISEASE
been	I-DISEASE
estimated	I-DISEASE
at	0
5	0
%	0
to	0
10	0
%	I-DISEASE
in	0
European	0
and	I-DISEASE
North	0
American	0
population	0
-	0
based	I-DISEASE
studies	0
.	I-DISEASE

However	0
,	I-DISEASE
in	0
Asian	0
countries	0
,	0
studies	I-DISEASE
thus	0
far	I-DISEASE
indicate	0
a	0
lower	0
prevalence	0
.	0

Prevalence	0
is	0
about	0
twice	0
as	0
high	0
in	I-DISEASE
women	0
than	0
in	0
men	0
.	0

In	0
most	0
studies	0
,	0
prevalence	0
increases	I-DISEASE
with	I-DISEASE
age	0
up	0
to	0
60	0
-	0
70	0
years	0
,	I-DISEASE
except	0
in	0
Asian	0
populations	0
where	I-DISEASE
an	0
age	0
-	0
related	0
increase	I-DISEASE
has	0
not	0
been	I-DISEASE
found	0
.	0

Various	0
measures	0
of	0
clinical	0
significance	0
such	0
as	I-DISEASE
frequency	0
(	0
1	0
-	0
2	0
times	I-DISEASE
/	0
week	0
)	I-DISEASE
,	I-DISEASE
severity	I-DISEASE
(	0
moderate	I-DISEASE
to	0
severe	0
distress	0
)	0
,	I-DISEASE
differential	0
diagnosis	0
,	0
and	0
impact	0
have	0
been	0
applied	0
to	0
population	0
-	0
based	0
studies	0
.	0

These	0
analyses	0
indicate	0
the	0
prevalence	I-DISEASE
of	I-DISEASE
clinically	I-DISEASE
significant	0
RLS	I-DISEASE
to	0
be	0
2	0
%	0
to	0
3	I-DISEASE
%	0
in	0
Europe	I-DISEASE
and	0
North	0
America	0
,	0
but	0
lower	0
in	I-DISEASE
Asia	0
.	0

Annual	0
incidence	0
rates	0
have	0
been	0
reported	0
as	I-DISEASE
0.8	0
%	I-DISEASE
to	0
2.2	0
%	0
.	0

Pediatric	0
prevalence	0
rates	0
are	I-DISEASE
2	0
%	0
to	I-DISEASE
4	0
%	I-DISEASE
in	0
UK	0
/	0
US	0
and	0
Turkish	0
studies	I-DISEASE
,	0
with	I-DISEASE
moderate	0
to	0
severe	0
RLS	0
in	0
about	0
0.5	I-DISEASE
%	0
to	0
1	I-DISEASE
%	0
.	0

Adolescents	0
are	0
more	0
likely	0
to	0
have	0
moderate	0
to	0
severe	I-DISEASE
RLS	0
symptoms	0
than	0
younger	I-DISEASE
children	0
—	I-DISEASE
one	0
half	0
of	I-DISEASE
12-	I-DISEASE
to	0
17	0
-	I-DISEASE
year	0
-	0
olds	I-DISEASE
com-	0
pared	0
to	I-DISEASE
one	0
fourth	0
of	I-DISEASE
8-	0
to	0
11	0
-	0
year	0
-	0
olds	I-DISEASE
with	0
RLS	0
.	I-DISEASE

Boys	0
are	0
affected	0
as	0
often	0
as	0
girls	0
,	0
with	0
the	0
sex	0
difference	0
not	0
emerging	0
until	0
the	0
late	I-DISEASE
teens	0
or	0
twenties	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
A	0
positive	I-DISEASE
family	I-DISEASE
history	0
of	I-DISEASE
RLS	0
,	0
the	I-DISEASE
genetic	0
variants	I-DISEASE
noted	I-DISEASE
below	0
,	I-DISEASE
and	I-DISEASE
female	I-DISEASE
sex	0
confer	I-DISEASE
increased	0
risk	0
for	I-DISEASE
RLS	I-DISEASE
.	0

The	0
best	0
characterized	0
precipitating	0
factors	0
are	0
iron	0
deficiency	0
,	I-DISEASE
certain	0
medications	0
,	0
pregnancy	0
,	0
chronic	0
renal	0
failure	0
,	I-DISEASE
and	0
prolonged	0
immo-	0
bility	0
.	0

Mild	0
iron	0
deficiency	0
,	0
characterized	0
by	0
serum	I-DISEASE
ferritin	0
below	I-DISEASE
50	0
μg	0
/	I-DISEASE
L	I-DISEASE
,	0
has	I-DISEASE
been	0
associated	0
with	I-DISEASE
increased	I-DISEASE
severity	0
of	0
RLS	0
,	0
and	0
repletion	I-DISEASE
of	0
iron	0
stores	I-DISEASE
from	0
below	0
50	I-DISEASE
-	0
75	0
μg	0
/	0
L	0
has	0
been	0
found	0
to	0
diminish	I-DISEASE
RLS	I-DISEASE
symptoms	0
.	0

Medications	0
that	I-DISEASE
may	0
precip-	I-DISEASE
itate	0
or	0
aggravate	I-DISEASE
RLS	0
and/or	I-DISEASE
PLMS	0
include	0
sedating	0
antihistamines	0
,	0
some	0
centrally	I-DISEASE
active	I-DISEASE
dopamine	I-DISEASE
receptor	I-DISEASE
antagonists	I-DISEASE
,	0
and	0
most	I-DISEASE
antidepressants	0
.	0

An	0
exception	0
is	0
the	0
antidepressant	I-DISEASE
bupropion	0
,	I-DISEASE
with	0
its	0
dopamine	0
-	0
promoting	0
activity	0
.	0

The	0
prevalence	0
of	I-DISEASE
RLS	0
during	0
pregnancy	I-DISEASE
is	I-DISEASE
two	0
to	I-DISEASE
three	0
times	0
greater	0
than	0
in	0
the	0
general	0
population	I-DISEASE
.	0

There	0
is	0
a	0
peak	0
in	0
the	0
number	I-DISEASE
of	I-DISEASE
women	I-DISEASE
affected	0
by	0
RLS	0
in	0
the	0
Sleep	0
Related	I-DISEASE
Movement	I-DISEASE
Disorders	I-DISEASE
Sleep	0
Related	0
Movement	0
Disorders	0
third	0
trimester	I-DISEASE
,	I-DISEASE
with	0
resolution	0
of	0
symptoms	0
for	0
most	0
,	0
but	0
not	0
all	0
,	0
by	I-DISEASE
one	0
month	0
after	0
delivery	I-DISEASE
.	0

Independent	0
predictors	0
of	0
RLS	0
during	0
pregnancy	I-DISEASE
are	I-DISEASE
a	0
family	I-DISEASE
history	0
of	0
RLS	0
(	0
OR	0
8.43	I-DISEASE
)	I-DISEASE
,	I-DISEASE
a	0
history	0
of	0
RLS	0
in	I-DISEASE
prior	0
pregnancy	I-DISEASE
(	I-DISEASE
OR	0
53.74	0
)	I-DISEASE
,	0
a	0
history	0
of	I-DISEASE
RLS	0
in	0
the	0
past	0
(	I-DISEASE
OR	I-DISEASE
12.91	I-DISEASE
)	0
,	I-DISEASE
and	0
hemoglobin	0
≤11	0
g	I-DISEASE
/	I-DISEASE
dL	I-DISEASE
(	0
OR	0
2.05	0
)	0
.	I-DISEASE

Parity	0
,	0
the	0
number	0
of	I-DISEASE
previous	I-DISEASE
pregnancies	I-DISEASE
,	0
appears	I-DISEASE
to	0
account	0
for	0
the	0
2:1	0
sex	I-DISEASE
difference	0
between	I-DISEASE
women	I-DISEASE
and	0
men	0
in	0
the	0
general	0
population	I-DISEASE
prevalence	I-DISEASE
of	0
RLS	0
.	I-DISEASE

In	0
chronic	0
renal	0
failure	0
patients	0
,	0
the	I-DISEASE
prevalence	0
of	I-DISEASE
RLS	0
is	0
two	0
to	0
five	0
times	I-DISEASE
greater	0
than	0
in	I-DISEASE
the	0
general	0
population	0
.	0

This	0
represents	0
prevalence	0
rates	I-DISEASE
of	0
11	I-DISEASE
%	I-DISEASE
to	0
58	I-DISEASE
%	0
in	0
US	0
and	0
European	0
chronic	I-DISEASE
renal	0
failure	0
clinics	I-DISEASE
.	0

Compared	0
to	0
patients	0
with	I-DISEASE
chronic	0
renal	0
failure	I-DISEASE
without	0
RLS	I-DISEASE
,	I-DISEASE
those	0
with	0
RLS	0
have	0
greater	I-DISEASE
sleep	0
disturbance	I-DISEASE
,	0
report	0
poorer	I-DISEASE
quality	0
of	0
life	0
,	0
and	I-DISEASE
more	I-DISEASE
frequently	0
discontinue	I-DISEASE
dialysis	0
prematurely	I-DISEASE
.	0

Typically	0
,	0
RLS	0
symptoms	0
improve	0
dramatically	0
within	0
one	0
month	I-DISEASE
after	0
kidney	0
transplantation	0
but	0
become	0
severe	I-DISEASE
again	0
with	0
transplant	I-DISEASE
failure	0
.	0

There	0
is	0
limited	0
or	I-DISEASE
contradictory	0
evidence	I-DISEASE
for	I-DISEASE
sleep	0
deprivation	0
,	0
peripheral	0
neuropathy	I-DISEASE
,	I-DISEASE
radiculopathy	I-DISEASE
,	I-DISEASE
pain	0
,	0
caffeine	0
,	0
tobacco	I-DISEASE
,	0
or	0
alcohol	I-DISEASE
as	0
exacerbating	I-DISEASE
factors	I-DISEASE
for	0
RLS	I-DISEASE
.	I-DISEASE

Familial	0
Patterns	0
Early	0
-	0
onset	0
RLS	0
is	I-DISEASE
highly	0
familial	I-DISEASE
,	0
with	0
40	I-DISEASE
%	I-DISEASE
to	0
92	I-DISEASE
%	I-DISEASE
of	0
cases	I-DISEASE
reporting	0
affected	I-DISEASE
family	0
members	0
.	0

High	0
concordance	0
rates	I-DISEASE
are	0
observed	0
in	I-DISEASE
monozygotic	I-DISEASE
twins	I-DISEASE
.	0

The	0
risk	0
of	0
RLS	I-DISEASE
is	0
two	I-DISEASE
to	I-DISEASE
six	0
times	I-DISEASE
greater	0
for	0
first	0
-	0
degree	0
relatives	I-DISEASE
of	I-DISEASE
patients	0
with	I-DISEASE
RLS	0
than	0
for	0
those	I-DISEASE
from	0
the	0
general	0
population	0
.	I-DISEASE

Although	0
an	0
autosomal	0
dominant	0
model	0
of	0
RLS	I-DISEASE
is	0
sug-	I-DISEASE
gested	0
by	0
many	0
family	0
studies	0
,	I-DISEASE
recent	I-DISEASE
genomewide	0
linkage	I-DISEASE
and	0
association	0
studies	0
suggest	0
a	I-DISEASE
more	0
complex	I-DISEASE
gene	0
-	0
environment	I-DISEASE
pattern	0
.	0

Linkage	0
analyses	I-DISEASE
have	0
reported	0
several	0
different	0
gene	I-DISEASE
loci	0
associated	0
with	I-DISEASE
RLS	0
but	0
,	0
to	0
date	I-DISEASE
,	0
no	0
single	I-DISEASE
causative	0
gene	0
.	0

However	0
,	I-DISEASE
genomewide	0
association	0
studies	I-DISEASE
have	0
identified	I-DISEASE
single	0
nucleotide	0
poly-	0
morphisms	0
in	I-DISEASE
RLS	0
,	0
four	I-DISEASE
of	I-DISEASE
which	I-DISEASE
have	I-DISEASE
been	0
replicated	0
:	0
BTBD9	0
,	0
MEIS1	I-DISEASE
,	I-DISEASE
MAP2K5/	I-DISEASE
LBXCOR	0
,	I-DISEASE
and	0
PTPRD	0
.	0

Nonetheless	0
,	0
the	0
relationship	I-DISEASE
between	0
familial	0
RLS	0
and	0
these	0
findings	0
remains	0
to	0
be	0
determined	0
.	I-DISEASE

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Onset	I-DISEASE
of	0
RLS	0
symptoms	0
occurs	0
at	0
all	0
ages	0
,	I-DISEASE
from	I-DISEASE
childhood	0
to	I-DISEASE
late	0
adult	0
life	0
.	0

Mean	0
age	0
of	0
onset	0
for	0
familial	0
RLS	I-DISEASE
is	0
in	0
the	0
third	0
or	0
fourth	0
decade	0
,	0
with	0
onset	0
prior	I-DISEASE
to	0
age	0
21	0
years	0
in	0
about	0
one	I-DISEASE
third	I-DISEASE
of	0
cases	0
.	0

The	0
clinical	0
course	0
of	0
RLS	0
differs	0
based	I-DISEASE
on	0
age	0
of	0
onset	0
.	0

In	0
early	0
-	0
onset	I-DISEASE
RLS	0
(	0
before	I-DISEASE
age	0
45	I-DISEASE
years	0
)	0
,	I-DISEASE
slow	I-DISEASE
progression	0
of	I-DISEASE
symptoms	0
is	0
found	0
in	0
about	0
two	0
thirds	0
of	0
cases	0
.	I-DISEASE

Most	0
of	0
the	0
remaining	I-DISEASE
one	0
third	0
report	0
stable	0
symp-	0
toms	0
over	0
time	I-DISEASE
,	0
although	0
remission	I-DISEASE
has	0
been	0
described	0
.	0

In	0
late	0
-	0
onset	I-DISEASE
RLS	0
,	0
rapid	I-DISEASE
pro-	0
gression	I-DISEASE
is	0
typical	0
and	0
aggravating	I-DISEASE
factors	0
are	I-DISEASE
common	I-DISEASE
.	0

Significant	0
impairment	0
of	0
health	I-DISEASE
-	0
related	I-DISEASE
quality	I-DISEASE
of	0
life	I-DISEASE
(	I-DISEASE
HRQoL	0
)	0
has	I-DISEASE
been	0
found	0
in	0
moderate	0
to	I-DISEASE
severe	0
RLS	I-DISEASE
.	0

Both	0
physical	0
health	0
and	0
mental	0
health	0
scores	0
have	0
consis-	0
tently	I-DISEASE
been	I-DISEASE
found	0
to	0
be	0
lower	0
for	0
individuals	0
with	I-DISEASE
RLS	0
,	0
using	0
standard	0
QoL	0
assess-	I-DISEASE
ment	I-DISEASE
tools	0
.	0

The	0
HRQoL	0
impairments	0
are	0
strongly	0
associated	0
with	0
severity	I-DISEASE
of	I-DISEASE
RLS	0
and	0
remain	0
after	0
controlling	0
for	I-DISEASE
age	0
,	0
sex	I-DISEASE
,	0
and	0
disease	0
comorbidity	I-DISEASE
.	0

In	0
addition	0
,	0
patients	0
with	0
cancer	0
,	I-DISEASE
type	0
2	I-DISEASE
diabetes	0
,	0
or	0
renal	0
failure	0
who	I-DISEASE
also	0
have	0
RLS	I-DISEASE
have	0
been	I-DISEASE
shown	0
to	0
have	0
poorer	0
quality	I-DISEASE
of	0
life	0
than	I-DISEASE
those	I-DISEASE
without	I-DISEASE
RLS	0
.	0

Overall	0
,	0
RLS	0
accounts	0
for	0
a	0
major	0
disease	0
burden	I-DISEASE
on	0
those	0
who	0
suffer	0
from	0
it	I-DISEASE
,	0
demonstrated	0
to	I-DISEASE
be	0
similar	0
to	0
or	0
worse	0
than	0
that	I-DISEASE
associated	0
with	0
osteoarthritis	I-DISEASE
,	0
congestive	0
heart	I-DISEASE
failure	I-DISEASE
,	0
depression	0
,	0
Parkinson	0
disease	I-DISEASE
,	0
or	0
stroke	I-DISEASE
.	0

Large	0
population	0
-	0
based	I-DISEASE
studies	0
have	0
found	0
positive	0
associations	I-DISEASE
between	I-DISEASE
RLS	0
and	0
cardiovascular	0
disease	0
,	0
including	0
coronary	0
heart	I-DISEASE
disease	0
and	0
stroke	0
.	0

Repetitive	0
surges	I-DISEASE
in	I-DISEASE
heart	0
rate	0
and	I-DISEASE
blood	0
pressure	0
associated	I-DISEASE
with	0
PLMS	0
are	I-DISEASE
a	0
potential	0
mediator	I-DISEASE
in	0
the	0
physiology	I-DISEASE
of	0
these	I-DISEASE
relationships	0
.	0

Only	0
limited	0
mortality	0
data	I-DISEASE
are	0
available	0
,	I-DISEASE
suggesting	0
increased	I-DISEASE
risk	0
of	0
mortality	0
in	I-DISEASE
women	0
and	I-DISEASE
in	I-DISEASE
chronic	0
renal	I-DISEASE
failure	0
patients	0
with	0
RLS	0
.	0

Developmental	0
Issues	0
The	0
accurate	0
diagnosis	0
of	0
RLS	0
in	0
children	0
and	0
adolescents	0
requires	I-DISEASE
understanding	0
of	0
developmental	I-DISEASE
language	I-DISEASE
and	I-DISEASE
cognitive	I-DISEASE
skills	0
.	0

Adequate	0
verbal	0
skills	0
are	I-DISEASE
needed	0
for	0
children	0
to	0
communicate	I-DISEASE
the	0
sensory	I-DISEASE
component	0
of	0
RLS	I-DISEASE
and	0
description	0
must	0
be	I-DISEASE
in	I-DISEASE
“	I-DISEASE
the	0
child	0
’s	0
own	0
words	0
,	I-DISEASE
”	0
rather	0
than	0
by	0
a	0
parent	0
or	0
caretaker	0
.	0

For	0
criterion	0
A	0
,	0
children	0
rarely	I-DISEASE
use	I-DISEASE
or	0
understand	0
the	0
word	0
“	0
urge	0
.	0
”	0

Instead	0
they	0
describe	0
that	0
their	0
legs	0
“	0
need	0
to	I-DISEASE
”	0
“	0
have	0
to	0
”	0
or	I-DISEASE
“	0
got	0
to	0
”	0
move	0
.	0

Descriptors	0
for	0
the	0
discomfort	0
include	0
:	I-DISEASE
bugs	I-DISEASE
,	0
ants	I-DISEASE
,	0
weird/	0
funny	0
feelings	0
,	0
tingle	0
,	0
wiggly	0
,	I-DISEASE
and	0
shaky	0
.	0

Younger	0
children	0
often	I-DISEASE
use	0
the	0
word	I-DISEASE
“	0
kick	0
”	I-DISEASE
rather	0
than	0
“	0
move	0
,	0
”	0
e.g.	0
,	0
“	0
my	0
legs	0
want	0
to	0
kick	0
.	0
”	0

Similar	0
to	0
adults	0
,	0
children	0
report	I-DISEASE
arm	0
involvement	0
in	0
almost	0
half	0
of	I-DISEASE
cases	I-DISEASE
.	0

Sitting	0
in	0
class	0
,	0
lying	0
in	0
bed	0
,	0
reading	I-DISEASE
a	0
book	0
,	0
and	0
riding	0
in	I-DISEASE
a	0
car	0
are	I-DISEASE
situations	0
where	0
children	0
report	I-DISEASE
onset	0
or	0
worsening	0
of	0
their	0
symp-	I-DISEASE
toms	0
.	0

Relief	0
is	0
typically	0
achieved	0
by	0
moving	0
around	0
,	0
walking	I-DISEASE
,	0
rubbing	0
,	0
kicking	0
,	0
or	I-DISEASE
distraction	0
.	0

Perhaps	0
as	0
a	0
result	0
of	0
prolonged	I-DISEASE
periods	I-DISEASE
of	0
sitting	I-DISEASE
in	0
class	0
,	0
two	0
thirds	0
of	I-DISEASE
children	I-DISEASE
and	I-DISEASE
adolescents	I-DISEASE
with	0
RLS	0
report	0
daytime	0
leg	I-DISEASE
sensations	0
.	0

Because	0
of	0
this	0
,	0
for	0
diagnostic	0
criterion	I-DISEASE
A3	0
(	I-DISEASE
worse	0
in	0
the	0
evening	0
/	0
night	0
)	0
,	I-DISEASE
it	I-DISEASE
is	0
important	0
to	0
compare	I-DISEASE
equal	0
duration	0
of	I-DISEASE
sitting	0
or	0
lying	I-DISEASE
down	0
in	0
the	I-DISEASE
day	0
to	0
sitting	0
or	0
lying	0
down	0
in	I-DISEASE
the	0
evening/	0
night	I-DISEASE
.	0

However	0
,	I-DISEASE
even	0
with	0
such	0
comparisons	0
,	0
a	0
significant	I-DISEASE
subset	0
of	0
children	0
do	I-DISEASE
not	0
report	I-DISEASE
worsening	0
at	0
evening	I-DISEASE
/	0
night	0
,	0
yet	0
meet	0
all	0
other	I-DISEASE
diagnostic	0
criteria	0
and	0
have	0
sup-	0
portive	0
features	0
for	0
RLS	0
,	0
including	I-DISEASE
a	0
positive	0
family	0
history	I-DISEASE
.	I-DISEASE

Children	0
who	0
are	0
age	0
six	0
years	0
or	I-DISEASE
older	0
and	I-DISEASE
developmentally	0
normal	0
have	0
been	0
shown	0
to	0
report	0
detailed	0
,	0
ade-	0
quate	0
descriptors	0
for	0
RLS	I-DISEASE
symptoms	0
.	0

For	0
children	0
who	I-DISEASE
are	0
too	0
young	0
to	I-DISEASE
adequately	0
describe	I-DISEASE
RLS	0
sensations	0
or	0
are	0
developmentally	0
delayed	I-DISEASE
,	0
a	0
PLMD	0
diagnosis	0
may	0
be	0
Sleep	0
Related	0
Movement	0
Disorders	I-DISEASE
Sleep	I-DISEASE
Related	I-DISEASE
Movement	I-DISEASE
Disorders	0
the	0
initial	0
diagnosis	0
,	0
with	0
full	0
RLS	0
symptomatology	0
evident	I-DISEASE
over	0
time	0
.	I-DISEASE

Diagnosis	0
by	0
observational	0
techniques	I-DISEASE
has	0
been	0
suggested	0
but	0
not	0
yet	0
validated	0
.	0

The	0
differential	0
diagnosis	0
of	0
pediatric	0
RLS	I-DISEASE
includes	0
positional	0
discomfort	I-DISEASE
,	0
sore	0
leg	0
muscles	0
,	0
joint	I-DISEASE
/	0
tendon	0
injury	I-DISEASE
,	0
and	0
bruises	0
,	0
all	0
of	0
which	I-DISEASE
are	0
common	0
mimics	0
.	0

In	0
child-	0
hood	0
,	I-DISEASE
RLS	0
is	0
frequently	0
misdiagnosed	I-DISEASE
as	I-DISEASE
“	0
growing	I-DISEASE
pains	0
.	0
”	0

Four	0
specific	0
domains	0
that	0
are	0
affected	0
in	0
pediatric	0
RLS	I-DISEASE
are	0
sleep	0
,	0
daily	0
activities	0
,	I-DISEASE
mood	0
,	0
and	I-DISEASE
energy	0
/	0
vital-	0
ity	0
.	0

Difficulties	0
with	0
sleep	0
onset	0
,	0
sleep	0
maintenance	0
,	I-DISEASE
and	I-DISEASE
sleep	0
quality	0
are	0
common	0
.	0

Negative	0
influence	0
of	0
RLS	0
on	0
waking	I-DISEASE
activities	I-DISEASE
includes	I-DISEASE
academic	I-DISEASE
impact	0
due	0
to	0
dis-	0
ruption	0
of	0
schoolwork	0
,	0
homework	I-DISEASE
,	0
and	0
ability	0
to	0
concentrate	0
.	0

Severity	0
assessment	0
of	0
pediatric	0
RLS	0
has	I-DISEASE
thus	I-DISEASE
far	0
been	0
limited	0
to	0
simple	0
measures	I-DISEASE
of	0
self	I-DISEASE
-	0
reported	0
frequency	0
and	0
intensity	0
.	0

Because	0
pediatric	0
RLS	0
is	0
highly	0
familial	I-DISEASE
,	I-DISEASE
the	0
presence	I-DISEASE
of	0
RLS	0
in	0
a	I-DISEASE
first	0
-	I-DISEASE
degree	I-DISEASE
rela-	I-DISEASE
tive	I-DISEASE
helps	0
to	0
increase	0
diagnostic	0
certainty	0
in	I-DISEASE
childhood	I-DISEASE
RLS	0
.	I-DISEASE

Similarly	0
,	0
the	0
presence	I-DISEASE
of	0
PLMS	I-DISEASE
or	I-DISEASE
a	0
history	I-DISEASE
of	0
PLMD	0
is	0
quite	0
helpful	0
in	0
supporting	0
an	0
RLS	I-DISEASE
diagnosis	0
in	0
chil-	0
dren	0
.	0

As	0
in	0
adults	0
,	0
approximately	0
70	0
%	0
of	0
children	I-DISEASE
with	I-DISEASE
RLS	0
demonstrate	0
PLMS	I-DISEASE
≥	0
5/	I-DISEASE
hour	0
on	0
a	0
single	0
night	0
and	0
nearly	0
90	0
%	0
when	I-DISEASE
multiple	0
nights	0
are	I-DISEASE
sampled	0
.	0

PLMS	0
≥	0
5/	0
hour	0
are	0
uncommon	0
in	0
pediatric	0
normative	0
samples	0
.	0

As	0
noted	0
above	0
,	0
pediatric	0
RLS	I-DISEASE
is	0
comorbid	0
with	I-DISEASE
ADHD	0
in	0
about	0
one	0
fourth	0
of	I-DISEASE
cases	I-DISEASE
,	0
and	0
,	0
as	0
in	0
adults	B-DISEASE
,	0
higher	0
rates	I-DISEASE
of	0
anxiety	0
and	I-DISEASE
depressive	0
symptoms	I-DISEASE
are	I-DISEASE
found	I-DISEASE
.	0

RLS	0
is	0
common	0
in	0
pediatric	0
chronic	0
kidney	I-DISEASE
disease	0
.	0

Prevalence	0
rates	0
of	0
RLS	0
increase	0
with	0
age	I-DISEASE
until	0
late	I-DISEASE
adulthood	0
then	0
stabilize	0
or	I-DISEASE
decrease	0
slightly	0
in	0
the	0
elderly	I-DISEASE
.	0

However	0
,	I-DISEASE
strong	0
associations	0
with	0
anxiety	0
,	I-DISEASE
mood	0
disorders	I-DISEASE
,	0
and	0
decreased	0
QoL	0
measures	0
remain	0
in	0
the	0
elderly	0
.	0

Diagnostic	0
criteria	0
for	0
RLS	0
in	0
the	0
cog-	0
nitive	0
-	I-DISEASE
impaired	0
elderly	0
have	0
been	0
suggested	0
but	0
not	0
validated	0
.	0

Pathology	0
and	0
Pathophysiology	0
Brain	0
iron	0
deficiency	I-DISEASE
,	I-DISEASE
central	0
nervous	I-DISEASE
system	0
dopamine	0
regulation	I-DISEASE
,	0
and	0
genetics	I-DISEASE
appear	0
to	0
be	I-DISEASE
primary	0
factors	0
in	0
the	0
pathophysiology	0
of	0
RLS	I-DISEASE
.	I-DISEASE

Iron	0
is	0
important	0
in	I-DISEASE
brain	0
dopa-	0
mine	I-DISEASE
production	0
and	I-DISEASE
synaptic	0
density	0
,	0
as	0
well	0
as	I-DISEASE
in	0
myelin	0
synthesis	I-DISEASE
and	0
energy	0
pro-	0
duction	0
.	0

A	0
connection	0
between	I-DISEASE
RLS	0
and	0
low	I-DISEASE
brain	I-DISEASE
iron	0
is	I-DISEASE
supported	0
by	0
autopsy	0
data	0
,	0
MRI	I-DISEASE
,	0
brain	0
sonography	I-DISEASE
,	0
and	0
cerebrospinal	0
fluid	0
analysis	I-DISEASE
.	0

Evidence	0
for	I-DISEASE
central	0
nervous	0
system	0
dopaminergic	I-DISEASE
system	I-DISEASE
involvement	0
comes	I-DISEASE
mainly	0
from	0
multiple	0
randomized	0
clinical	0
trials	I-DISEASE
that	0
have	0
clearly	I-DISEASE
demonstrated	0
the	0
effect	0
of	0
dopaminergic	0
drugs	0
for	I-DISEASE
RLS	I-DISEASE
and	0
PLMS	I-DISEASE
.	0

In	0
addition	0
,	0
an	0
altered	0
dopaminergic	I-DISEASE
profile	I-DISEASE
in	0
RLS	I-DISEASE
is	0
supported	0
by	0
func-	0
tional	0
MRI	I-DISEASE
,	I-DISEASE
positron	0
emission	I-DISEASE
tomography	0
,	0
and	0
autopsy	0
data	I-DISEASE
.	I-DISEASE

Association	0
of	0
gene	0
vari-	0
ants	0
BTBD9	0
,	I-DISEASE
MEIS1	0
,	I-DISEASE
MAP2K5	0
/	0
LBXCOR	0
,	0
and	0
PTPRD	I-DISEASE
with	0
RLS	0
has	I-DISEASE
been	0
replicated	I-DISEASE
,	0
indicating	0
a	0
genetic	I-DISEASE
substrate	0
upon	0
which	0
environmental	0
factors	0
might	0
act	I-DISEASE
.	0

BTBD9	0
is	0
estimated	0
to	0
confer	0
a	0
population	I-DISEASE
attributable	0
risk	I-DISEASE
(	0
PAR	0
)	0
of	I-DISEASE
50	0
%	0
for	0
RLS	0
.	I-DISEASE

Together	0
,	0
BTBD9	0
,	0
MEIS1	0
,	0
and	0
MAP2K5	0
/	I-DISEASE
LBXCOR	0
account	0
for	0
70	0
%	0
of	I-DISEASE
the	I-DISEASE
PAR	0
for	0
RLS	0
in	I-DISEASE
indi-	0
viduals	0
with	I-DISEASE
European	0
ancestry	I-DISEASE
.	0

Thus	0
far	0
,	0
two	0
of	0
the	I-DISEASE
variants	I-DISEASE
,	0
BTBD9	I-DISEASE
and	0
MEIS1	0
,	0
appear	0
to	0
influence	I-DISEASE
expression	0
of	0
PLMS	I-DISEASE
,	0
as	0
well	0
as	0
iron	0
homeostasis	I-DISEASE
.	0

However	0
,	I-DISEASE
the	0
full	B-DISEASE
role	0
of	I-DISEASE
RLS	I-DISEASE
gene	0
variants	I-DISEASE
has	0
not	0
been	0
adequately	I-DISEASE
defined	0
.	0

Objective	0
Findings	0

Although	0
polysomnography	0
is	0
not	0
routinely	0
indicated	0
in	I-DISEASE
the	0
evaluation	I-DISEASE
of	I-DISEASE
RLS	0
,	0
poly-	0
somnographic	I-DISEASE
studies	I-DISEASE
demonstrate	I-DISEASE
significant	0
objective	I-DISEASE
sleep	0
abnormalities	I-DISEASE
in	0
RLS	0
,	0
with	0
increased	I-DISEASE
latency	0
to	0
persistent	I-DISEASE
sleep	0
and	I-DISEASE
higher	I-DISEASE
arousal	0
index	0
as	0
the	0
most	I-DISEASE
consis-	0
tent	0
differences	I-DISEASE
in	0
sleep	I-DISEASE
architecture	0
.	0

PLMS	0
≥5	0
/	0
hour	0
occur	0
in	0
70	I-DISEASE
%	0
to	0
80	0
%	0
of	0
adults	0
with	0
RLS	0
on	0
single	0
-	0
night	0
testing	0
but	0
in	0
>	I-DISEASE
90	I-DISEASE
%	0
when	0
multiple	0
nights	B-DISEASE
are	0
sampled	0
.	0

In	0
adult	0
RLS	0
,	0
PLMS	0
are	0
more	I-DISEASE
prominent	0
during	I-DISEASE
the	0
first	0
half	0
of	I-DISEASE
the	I-DISEASE
night	0
and	I-DISEASE
vary	0
in	I-DISEASE
frequency	0
from	I-DISEASE
night	I-DISEASE
to	0
night	0
.	0

About	0
one	0
third	0
of	0
PLMS	0
are	I-DISEASE
associated	0
with	0
cortical	I-DISEASE
arousals	0
,	0
and	0
most	I-DISEASE
have	0
associated	I-DISEASE
autonomic	I-DISEASE
arousals	0
.	I-DISEASE

PLMS	0
are	0
not	0
influenced	0
by	0
placebo	I-DISEASE
effect	0
.	0

PLMS	0
arousals	0
contribute	0
to	0
the	0
primary	I-DISEASE
RLS	I-DISEASE
morbidity	0
of	I-DISEASE
sleep	0
dis-	0
turbance	0
.	0

Furthermore	0
,	0
RLS	0
sensory	0
symptoms	0
impair	0
return	0
to	0
sleep	0
,	0
and	0
thereby	I-DISEASE
result	0
in	0
more	0
prolonged	0
awakening	0
.	0

The	0
Suggested	0
Immobilization	0
Test	0
(	0
SIT	0
)	B-DISEASE
evaluates	0
PLMW	I-DISEASE
and	I-DISEASE
related	0
sensory	0
com-	0
ponents	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
during	0
resting	I-DISEASE
wakefulness	0
.	I-DISEASE

A	0
standard	0
polysomnogram	0
recording	0
without	0
respiratory	0
measures	0
is	0
used	I-DISEASE
for	I-DISEASE
one	I-DISEASE
hour	0
before	0
the	0
usual	I-DISEASE
bedtime	0
while	0
the	I-DISEASE
subject	I-DISEASE
sits	I-DISEASE
comfortably	0
awake	0
and	0
upright	I-DISEASE
in	I-DISEASE
bed	0
with	0
the	I-DISEASE
legs	0
outstretched	I-DISEASE
.	0

RLS	0
diagnosis	0
is	0
supported	0
by	0
a	0
finding	I-DISEASE
of	0
more	I-DISEASE
than	0
40	0
PLMW	0
/	0
hour	0
.	0

Activity	0
monitors	0
with	0
high	0
-	0
frequency	0
sampling	I-DISEASE
and	0
body	I-DISEASE
-	0
position	0
monitoring	0
may	0
be	0
attached	I-DISEASE
to	I-DISEASE
the	0
ankle	I-DISEASE
or	I-DISEASE
foot	0
to	0
provide	I-DISEASE
an	0
alternate	0
measure	I-DISEASE
of	0
PLMs	0
.	I-DISEASE

Recordings	0
assess	0
the	0
frequency	I-DISEASE
and	0
variability	I-DISEASE
of	I-DISEASE
PLMs	0
from	I-DISEASE
night	0
to	0
night	0
,	0
typically	0
over	0
three	I-DISEASE
to	0
five	I-DISEASE
nights	0
.	0

Differential	0
Diagnosis	0

The	0
differentiation	0
of	0
RLS	I-DISEASE
from	0
other	I-DISEASE
conditions	0
that	0
may	I-DISEASE
have	0
characteristics	0
of	0
RLS	0
is	0
essential	I-DISEASE
,	I-DISEASE
because	0
approximately	I-DISEASE
40	0
%	0
of	0
individuals	0
without	0
RLS	0
will	I-DISEASE
report	I-DISEASE
some	0
urge	I-DISEASE
or	0
need	0
to	0
move	0
the	0
legs	0
while	0
at	0
rest	I-DISEASE
.	0

Fulfilling	0
diagnostic	0
criteria	0
A2	0
(	0
better	0
with	I-DISEASE
movement	0
)	I-DISEASE
and	0
A3	0
(	0
worse	I-DISEASE
in	0
the	I-DISEASE
evening	0
/	0
night	I-DISEASE
)	0
improves	I-DISEASE
specificity	0
for	0
an	I-DISEASE
RLS	I-DISEASE
diagnosis	0
to	I-DISEASE
only	0
about	I-DISEASE
70	0
%	I-DISEASE
,	0
based	I-DISEASE
on	0
studies	0
that	0
have	0
used	0
structured	0
diagnostic	0
interviews	0
.	0

However	0
,	I-DISEASE
differentiating	0
RLS	0
from	0
leg	I-DISEASE
cramps	I-DISEASE
and	0
positional	0
discomfort	0
improves	I-DISEASE
specificity	0
to	I-DISEASE
94	0
%	I-DISEASE
,	I-DISEASE
emphasizing	0
the	I-DISEASE
importance	0
of	0
differential	0
diagnosis	I-DISEASE
.	0

The	0
Sleep	0
Related	I-DISEASE
Movement	I-DISEASE
Disorders	0
Sleep	0
Related	I-DISEASE
Movement	0
Disorders	I-DISEASE
most	0
important	I-DISEASE
“	0
mimics	0
”	0
of	I-DISEASE
RLS	0
are	0
leg	I-DISEASE
cramps	0
,	0
positional	0
discomfort	0
,	0
arthralgias/	0
arthritis	I-DISEASE
,	0
myalgias	0
,	I-DISEASE
leg	I-DISEASE
edema	0
,	0
peripheral	0
neuropathy	0
,	0
radiculopathy	0
,	I-DISEASE
and	0
habitual	0
foot	0
tapping	0
.	0

Not	0
characteristic	0
of	0
RLS	0
are	0
:	I-DISEASE
“	I-DISEASE
knotting	0
”	I-DISEASE
of	0
the	0
muscle	0
(	0
cramps	I-DISEASE
)	I-DISEASE
,	I-DISEASE
relief	I-DISEASE
with	I-DISEASE
a	0
single	I-DISEASE
postural	0
shift	0
(	0
positional	0
discomfort	0
)	0
,	I-DISEASE
limitation	0
to	0
joints	0
(	0
arthritis	0
)	0
,	0
sore-	0
ness	0
to	0
palpation	I-DISEASE
(	0
myalgias	I-DISEASE
)	0
,	I-DISEASE
and	0
other	0
abnormalities	I-DISEASE
on	0
physical	0
examination	I-DISEASE
.	0

Less	0
common	0
conditions	0
to	0
be	0
differentiated	0
from	0
RLS	0
include	0
neuroleptic	0
-	0
induced	0
akathi-	0

sia	0
,	0
myelopathy	0
,	0
symptomatic	0
venous	I-DISEASE
insufficiency	I-DISEASE
,	0
peripheral	0
artery	0
disease	0
,	0
eczema	I-DISEASE
,	0
orthopedic	I-DISEASE
problems	0
,	0
painful	I-DISEASE
legs	0
and	0
moving	0
toes	0
,	0
and	0
anxiety	I-DISEASE
-	0
induced	0
restlessness	0
.	0

Neuroleptic	0
-	0
induced	0
akathisia	0
differs	0
from	I-DISEASE
RLS	I-DISEASE
in	0
that	0
akathisia	0
is	0
associated	0
with	0
the	0
need	0
to	I-DISEASE
move	0
the	0
entire	0
body	0
and	0
occurs	0
in	I-DISEASE
association	0
with	I-DISEASE
use	0
of	I-DISEASE
dopamine	I-DISEASE
-	0
receptor	I-DISEASE
antagonists	0
.	0

Painful	0
legs	0
and	0
moving	0
toes	0
have	0
neither	0
a	0
clear	0
circadian	0
pattern	0
nor	0
the	0
sense	0
of	0
an	I-DISEASE
urge	0
to	I-DISEASE
move	0
.	0

Pain	0
involving	0
the	0
legs	I-DISEASE
occurs	0
with	0
numerous	0
conditions	0
,	0
including	0
arthritis	0
,	0
vascular	0
problems	0
,	I-DISEASE
sports	0
/	0
orthopedic	I-DISEASE
injuries	0
,	0
and	0
neuropathy	0
.	0

These	0
pains	0
can	0
have	0
a	0
nocturnal	0
presentation	I-DISEASE
and	0
may	I-DISEASE
be	0
worse	0
at	0
rest	I-DISEASE
,	0
but	I-DISEASE
improvement	0
with	0
movement	I-DISEASE
either	0
does	0
not	0
occur	0
or	0
entails	0
more	0
exercise	0
than	0
simple	0
movement	0
of	0
the	I-DISEASE
leg	0
.	0

The	0
urge	0
to	0
move	0
,	0
if	0
present	0
at	0
all	I-DISEASE
,	0
usually	0
stems	0
from	0
awareness	0
that	0
movement	0
produces	0
relief	0
rather	0
than	0
the	0
strong	0
primary	I-DISEASE
urgency	0
of	0
movement	0
felt	0
with	0
RLS	0
.	0

The	0
presence	0
of	0
pain	I-DISEASE
,	0
however	0
,	I-DISEASE
does	0
not	0
exclude	I-DISEASE
a	0
diagnosis	0
of	0
RLS	0
,	I-DISEASE
because	I-DISEASE
about	0
50	I-DISEASE
%	0
of	0
patients	0
with	0
RLS	I-DISEASE
report	0
their	I-DISEASE
RLS	I-DISEASE
symptoms	0
as	0
painful	0
.	I-DISEASE

Although	0
it	0
is	0
important	0
that	I-DISEASE
RLS	I-DISEASE
symptoms	I-DISEASE
not	I-DISEASE
be	I-DISEASE
attributable	I-DISEASE
solely	0
to	I-DISEASE
another	I-DISEASE
medical	0
or	I-DISEASE
behavioral	I-DISEASE
condition	0
,	I-DISEASE
it	0
should	0
also	0
be	I-DISEASE
appreciated	0
that	0
any	I-DISEASE
of	0
these	I-DISEASE
mimics	0
can	I-DISEASE
occur	0
in	0
an	0
individual	0
who	0
also	0
has	0
RLS	0
.	I-DISEASE

For	0
example	0
,	0
some	0
subjects	0
may	I-DISEASE
have	0
both	0
RLS	0
and	0
leg	0
cramps	0
.	0

When	0
the	0
diagnosis	I-DISEASE
of	0
RLS	0
is	0
not	I-DISEASE
certain	0
,	I-DISEASE
evaluation	0
for	0
the	0
supportive	0
features	0
such	I-DISEASE
as	0
the	0
presence	I-DISEASE
of	I-DISEASE
PLMS	0
or	0
a	0
family	0
history	0
of	0
RLS	0
may	0
be	I-DISEASE
helpful	0
.	0

Diagnostic	0
interviews	0
that	0
include	0
differential	0
diagnosis	0
have	I-DISEASE
been	0
validated	0
for	0
RLS	0
.	0

These	0
demonstrate	0
sensitivity	0
and	B-DISEASE
specificity	0
of	I-DISEASE
>	I-DISEASE
90	I-DISEASE
%	I-DISEASE
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE

The	0
diagnosis	0
of	0
RLS	0
relies	0
on	I-DISEASE
the	I-DISEASE
subjective	0
report	I-DISEASE
of	0
sensory	0
symptoms	0
that	0
lie	0
outside	I-DISEASE
the	0
range	0
of	I-DISEASE
common	0
sensory	0
experience	0
.	0

Many	0
patients	0
have	I-DISEASE
difficulty	0
describing	0
the	0
sensations	I-DISEASE
.	0

Further	0
studies	0
of	0
the	I-DISEASE
biological	I-DISEASE
bases	I-DISEASE
for	I-DISEASE
RLS	0
may	I-DISEASE
lead	0
to	0
better	0
classification	0
of	0
RLS	0
and	0
possibly	0
to	I-DISEASE
objective	0
tests	0
for	0
diagnosis	0
.	0

Iron	0
,	0
dopa-	0
mine	0
,	0
and	0
genetic	I-DISEASE
research	0
hold	I-DISEASE
particular	0
promise	0
.	0

Additional	0
epidemiological	0
and	0
genetic	I-DISEASE
studies	0
outside	0
the	I-DISEASE
US	0
and	0
Europe	0
are	0
needed	I-DISEASE
to	0
explore	0
apparent	0
population	0
differences	0
.	I-DISEASE

The	0
diagnostic	0
standards	0
and	I-DISEASE
severity	0
assessment	I-DISEASE
for	0
children	0
and	I-DISEASE
cogni-	0
tively	0
impaired	0
adults	0
require	0
further	I-DISEASE
development	0
.	0

Clarification	0
of	0
the	0
natural	0
course	0
and	I-DISEASE
potential	I-DISEASE
exacerbating	0
factors	I-DISEASE
is	0
needed	0
.	0

Better	0
understanding	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
with	0
comor-	I-DISEASE
bidities	I-DISEASE
such	0
as	I-DISEASE
mood	0
disorders	0
and	0
attention	0
deficit	0
hyperactivity	I-DISEASE
disorder	0
might	0
lead	I-DISEASE
to	0
improved	I-DISEASE
outcomes	0
in	0
those	0
disorders	I-DISEASE
.	0

Further	0
evaluation	0
of	0
long	I-DISEASE
-	0
term	I-DISEASE
complica-	0
tions	0
is	I-DISEASE
important	I-DISEASE
,	0
including	0
clarification	0
of	0
associations	I-DISEASE
with	0
hypertension	0
,	I-DISEASE
cardiovas-	0
cular	0
disease	0
,	0
and	0
stroke	I-DISEASE
.	0

Bibliography	0
Allen	0
R	0
,	0
Picchietti	0
D	0
,	I-DISEASE
Hening	0
W	0
,	0
et	0
al	0
.	0

Restless	0
legs	0
syndrome	0
:	0
diagnostic	0
criteria	0
,	B-DISEASE
special	0
considerations	I-DISEASE
,	0
and	0
epidemiology	0
.	0

A	0
report	0
from	0
the	0
restless	0
legs	0
syndrome	0
diagnosis	0
and	0
epidemiology	0
workshop	0
at	0
the	0
National	0
Institutes	0
of	I-DISEASE
Health	I-DISEASE
.	I-DISEASE

Sleep	0
Med	0
2003;4:101–19	I-DISEASE
.	0

Allen	0
RP	0
,	0
Stillman	0
P	0
,	0
Myers	0
AJ	0
.	I-DISEASE

Physician	0
-	0
diagnosed	0
restless	0
legs	0
syndrome	0
in	0
a	0
large	0
sample	I-DISEASE
of	0
primary	0
medical	0
care	0
patients	I-DISEASE
in	0
western	0
Europe	0
:	0
Prevalence	0
and	0
characteristics	0
.	0

Sleep	0
Med	0
2010;11:31–7	I-DISEASE
.	0

Dauvilliers	0
Y	I-DISEASE
,	0
Winkelmann	0
J.	0
Restless	0
legs	I-DISEASE
syndrome	0
:	I-DISEASE
update	I-DISEASE
on	0
pathogenesis	0
.	0

Curr	0
Opin	0
Pulm	0
med	0
2013;19:594	0
-	0
600	0
.	0

Earley	0
CJ	0
,	0
Silber	I-DISEASE
MH	0
.	0

Restless	0
legs	0
syndrome	0
:	0
Understanding	0
its	0
consequences	I-DISEASE
and	0
the	I-DISEASE
need	0
for	I-DISEASE
better	0
treatment	0
.	0

Sleep	0
Med	0
2010;11:807–15	I-DISEASE
.	0

Ekbom	0
K.	0
Restless	0
legs	0
:	0
a	I-DISEASE
clinical	0
study	0
.	0

Acta	0
Med	0
Scand	0
1945;158:1–122	I-DISEASE
.	0

Ferini	0
-	0
Strambi	0
L	I-DISEASE
,	I-DISEASE
Walters	I-DISEASE
AS	I-DISEASE
,	I-DISEASE
Sica	I-DISEASE
D.	0

The	0
relationship	0
among	0
restless	0
legs	0
syndrome	0
(	I-DISEASE
Willis	0
-	I-DISEASE
Ekbom	0
Disease	0
)	0
,	0
hypertension	0
,	I-DISEASE
cardiovascular	I-DISEASE
disease	0
,	I-DISEASE
and	0
cerebrovascular	I-DISEASE
disease	0
.	0

J	0
Neurol	0
2013	0

Aug	0
21	I-DISEASE
.	0

[	0
Epub	0
ahead	0
of	I-DISEASE
print	0
]	0
Hening	I-DISEASE
WA	I-DISEASE
,	0
Allen	0
RP	0
,	0
Washburn	0
M	0
,	I-DISEASE
Lesage	0
SR	0
,	0
Earley	0
CJ	0
.	0

The	0
four	0
diagnostic	0
criteria	0
for	0
Restless	0
Legs	I-DISEASE
Syndrome	0
are	I-DISEASE
unable	0
to	0
exclude	0
confounding	0
conditions	0
(	I-DISEASE
“	0
mimics	0
”	I-DISEASE
)	0
.	I-DISEASE

Sleep	0
Med	0
2009;10:976–81	0
.	0

Ohayon	0
MM	0
,	0
O’Hara	0
R	0
,	0
Vitiello	I-DISEASE
MV	0
.	0

Epidemiology	0
of	0
restless	0
legs	0
syndrome	0
:	I-DISEASE
A	0
synthesis	0
of	I-DISEASE
the	0
literature	0
.	0

Sleep	0
Med	0
Rev	0
2012;16:283–95	0
.	0

Picchietti	0
DL	0
,	0
Arbuckle	0
RA	0
,	0
Abetz	0
L	0
,	0
et	0
al	0
.	0

Pediatric	0
restless	0
legs	0
syndrome	0
:	0
analysis	I-DISEASE
of	I-DISEASE
symptom	0
descriptions	I-DISEASE
and	0
drawings	0
.	0

J	0
Child	0
Neurol	0
2011;26:1365–76	0
.	0

Picchietti	0
DL	0
,	0
Bruni	0
O	0
,	0
de	I-DISEASE
Weerd	0
A	I-DISEASE
,	0
et	0
al	I-DISEASE
.	0

Pediatric	0
restless	0
legs	0
syndrome	0
diagnostic	0
criteria	0
:	0
An	0
update	I-DISEASE
by	0
the	0
International	0
Restless	I-DISEASE
Legs	0
Syndrome	0
Study	0
Group	I-DISEASE
.	I-DISEASE

Sleep	0
Med	0
2013;14:1253	I-DISEASE
-	0
9	0
.	I-DISEASE

Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
Periodic	I-DISEASE
Limb	I-DISEASE
Movement	0
Disorder	0
ICD-9	0
-	0
CM	0
code	0
:	0
327.51	I-DISEASE
ICD-10	0
-	0
CM	0
code	0
:	0
G47.61	0
Alternate	0
Names	0

Periodic	0
movement	0
disorder	0
of	0
sleep	0
,	I-DISEASE
sleep	I-DISEASE
myoclonus	0
syndrome	I-DISEASE
,	0
nocturnal	0
myoclo-	0
nus	0
syndrome	0
.	I-DISEASE

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
D	I-DISEASE
must	I-DISEASE
be	0
met	I-DISEASE
A.	0
Polysomnography	0
demonstrates	0
PLMS	I-DISEASE
,	0
as	0
defined	I-DISEASE
in	0
the	I-DISEASE
most	0
recent	0
version	0
of	0
the	0
American	I-DISEASE
Academy	I-DISEASE
of	0
Sleep	0
Medicine	0
(	0
AASM	I-DISEASE
)	B-DISEASE

Manual	0
for	0
the	0
Scoring	I-DISEASE
of	0
Sleep	0
and	I-DISEASE
Associated	I-DISEASE
Events	I-DISEASE
.	0

B.	0
The	0
frequency	0
is	0
>	0
5	0
/	0
hour	0
in	0
children	0
or	0
>	I-DISEASE
15	0
/	0
hour	I-DISEASE
in	0
adults.1	0

C.	0
The	I-DISEASE
PLMS	0
cause	0
clinically	0
significant	0
sleep	I-DISEASE
disturbance	0
or	I-DISEASE
impairment	0
in	0
mental	I-DISEASE
,	0
physical	0
,	I-DISEASE
social	0
,	0
occupational	I-DISEASE
,	0
educational	0
,	0
behavioral	0
,	0
or	0
other	I-DISEASE
important	0
areas	0
of	I-DISEASE
functioning.2,3	0
D.	0
The	0
PLMS	I-DISEASE
and	0
the	0
symptoms	0
are	I-DISEASE
not	0
better	I-DISEASE
explained	0
by	0
another	I-DISEASE
current	0
sleep	0
disorder	0
,	0
medical	0
or	I-DISEASE
neurological	I-DISEASE
disorder	0
,	0
or	I-DISEASE
mental	I-DISEASE
disorder	I-DISEASE
(	0
e.g.	0
,	0
PLMS	0
occurring	I-DISEASE
with	0
apneas	I-DISEASE
or	0
hypopneas	0
should	I-DISEASE
not	I-DISEASE
be	0
scored).4,5	I-DISEASE
Notes	0
.	0

The	0
PLMS	0
Index	0
must	0
be	0
interpreted	0
in	0
the	0
context	I-DISEASE
of	0
a	0
patient	0
’s	0
sleep	0
related	I-DISEASE
complaint	0
.	0

In	0
adults	0
,	0
normative	0
values	0
greater	0
than	I-DISEASE
five	0
per	I-DISEASE
hour	0
have	0
been	0
found	0
in	0
studies	I-DISEASE
that	0
did	0
not	I-DISEASE
exclude	0
respiratory	I-DISEASE
event	0
-	0
related	0
arousals	I-DISEASE
(	I-DISEASE
using	0
sensitive	I-DISEASE
respiratory	I-DISEASE
monitoring	0
)	0
and	0
other	0
causes	0
for	0
PLMS	0
.	I-DISEASE

Data	0
suggest	0
a	0
partial	I-DISEASE
overlap	0
of	I-DISEASE
PLMS	I-DISEASE
Index	0
values	I-DISEASE
between	0
symptomatic	0
and	I-DISEASE
asymptomatic	0
individuals	0
,	I-DISEASE
emphasizing	I-DISEASE
the	0
importance	I-DISEASE
of	0
clinical	0
context	0
over	0
an	0
absolute	0
cutoff	I-DISEASE
value	0
.	0
.	I-DISEASE

If	0
PLMS	0
are	0
present	0
without	0
clinical	0
sleep	0
disturbance	I-DISEASE
or	I-DISEASE
daytime	0
impairment	0
,	0
the	0
PLMS	I-DISEASE
can	0
be	0
noted	0
as	I-DISEASE
a	0
polysomnographic	0
finding	0
,	0
but	I-DISEASE
criteria	I-DISEASE
are	I-DISEASE
not	0
met	0
for	I-DISEASE
a	0
diagnosis	0
of	0
PLMD	0
.	0
.	0

The	0
presence	0
of	0
insomnia	0
or	0
hypersomnia	0
with	0
PLMS	0
is	I-DISEASE
not	0
sufficient	0
to	0
establish	0
the	0
diagnosis	I-DISEASE
of	0
PLMD	0
.	I-DISEASE

Studies	0
have	0
shown	0
that	0
in	0
most	0
cases	0
the	0
cause	I-DISEASE
of	0
the	0
accompanying	0
insomnia	0
or	0
hypersomnia	I-DISEASE
is	0
something	0
other	I-DISEASE
than	0
the	0
PLMS	0
.	0

To	0
establish	0
the	0
diagnosis	I-DISEASE
of	0
PLMD	I-DISEASE
,	I-DISEASE
it	0
is	0
essential	0
to	0
establish	0
a	0
reasonable	0
cause	I-DISEASE
-	0
and	0
-	I-DISEASE
effect	0
relationship	I-DISEASE
between	0
the	0
insomnia	0
or	0
hypersomnia	I-DISEASE
and	0
the	0
PLMS	I-DISEASE
.	0

This	0
requires	0
that	I-DISEASE
other	0
causes	0
of	I-DISEASE
insomnia	I-DISEASE
such	0
as	I-DISEASE
anxiety	0
or	0
other	0
causes	0
of	0
hypersomnia	I-DISEASE
such	I-DISEASE
as	0
obstructive	I-DISEASE
sleep	0
apnea	0
or	0
narcolepsy	0
are	0
ruled	0
out	0
.	0

PLMS	0
are	0
common	0
,	0
but	0
PLMD	0
is	0
thought	0
to	I-DISEASE
be	0
rare	0
in	0
adults	0
.	0
.	I-DISEASE

PLMD	0
can	0
not	0
be	0
diagnosed	0
in	I-DISEASE
the	I-DISEASE
context	0
of	0
RLS	I-DISEASE
,	0
narcolepsy	0
,	0
untreated	0
obstructive	I-DISEASE
sleep	0
apnea	0
,	0
or	0
REM	0
sleep	0
behavior	0
disorder	I-DISEASE
;	I-DISEASE
PLMS	I-DISEASE
occur	0
commonly	I-DISEASE
in	I-DISEASE
these	0
conditions	I-DISEASE
but	0
the	0
sleep	0
complaint	0
is	0
more	I-DISEASE
readily	0
ascribed	I-DISEASE
to	0
the	0
accompanying	0
disorder	0
.	0

The	0
diagnosis	0
of	0
RLS	0
takes	0
precedence	I-DISEASE
over	I-DISEASE
that	0
of	I-DISEASE
PLMD	0
when	0
potentially	0
sleep-	0
disrupting	0
PLMS	I-DISEASE
occur	0
in	I-DISEASE
the	I-DISEASE
context	0
of	I-DISEASE
RLS	0
.	0

In	0
such	0
cases	0
,	B-DISEASE
the	0
diagnosis	I-DISEASE
of	0
RLS	0
is	0
made	0
and	0
the	0
PLMS	0
are	0
noted	I-DISEASE
.	0
.	0

When	0
it	0
is	0
reasonably	0
certain	0
that	I-DISEASE
the	I-DISEASE
PLMS	I-DISEASE
have	I-DISEASE
been	0
induced	0
by	0
medication	0
,	0
and	I-DISEASE
full	0
criteria	0
for	I-DISEASE
PLMD	0
are	0
met	0
,	0
it	0
is	0
preferred	0
that	0
the	0
more	0
specific	0
diagnosis	0
of	I-DISEASE
PLMD	I-DISEASE
be	0
used	0
,	0
rather	I-DISEASE
than	0
“	0
Sleep	0
related	I-DISEASE
movement	I-DISEASE
disorder	0
due	0
to	0
a	0
medication	I-DISEASE
or	I-DISEASE
substance	I-DISEASE
.	I-DISEASE
”	0

Essential	0
Features	0
PLMD	0
is	0
characterized	0
by	0
periodic	I-DISEASE
episodes	0
of	I-DISEASE
repetitive	0
,	0
highly	0
stereotyped	0
limb	0
movements	I-DISEASE
that	0
occur	0
during	0
sleep	0
(	0
PLMS	0
)	0
,	0
in	I-DISEASE
conjunction	I-DISEASE
with	0
clinical	0
sleep	0
dis-	0
turbance	0
or	0
fatigue	0
that	0
can	0
not	0
be	0
accounted	I-DISEASE
for	I-DISEASE
by	0
another	0
primary	I-DISEASE
sleep	0
disorder	0
or	0
other	I-DISEASE
etiology	0
.	I-DISEASE

PLMS	0
occur	0
most	0
frequently	0
in	0
the	0
lower	0
extremities	0
.	I-DISEASE

They	0
typically	0
involve	0
exten-	0
sion	0
of	0
the	I-DISEASE
big	0
toe	I-DISEASE
,	0
often	0
in	0
combination	0
with	0
partial	I-DISEASE
flexion	0
of	0
the	0
ankle	0
,	0
the	0
knee	0
,	0
and	I-DISEASE
sometimes	0
,	0
the	I-DISEASE
hip	0
.	0

Similar	0
movements	0
can	0
occur	0
in	0
the	0
upper	I-DISEASE
limbs	0
.	0

Individual	0
movements	0
may	0
be	0
associated	0
with	0
an	I-DISEASE
autonomic	I-DISEASE
arousal	I-DISEASE
,	0
a	0
cortical	0
arousal	0
,	0
or	I-DISEASE
an	I-DISEASE
awakening	0
.	I-DISEASE

Typically	0
,	0
the	0
patient	B-DISEASE
is	0
unaware	0
of	0
the	0
limb	I-DISEASE
movements	0
or	0
the	0
frequent	I-DISEASE
sleep	0
disruption	I-DISEASE
.	0

An	0
arousal	0
may	0
precede	B-DISEASE
,	0
coincide	I-DISEASE
with	I-DISEASE
,	0
or	I-DISEASE
follow	0
the	0
limb	0
movement	I-DISEASE
,	0
suggesting	I-DISEASE
that	0
a	0
central	I-DISEASE
generator	0
may	0
give	0
rise	0
to	0
both	I-DISEASE
the	I-DISEASE
periodic	0
movements	I-DISEASE
and	I-DISEASE
the	0
related	I-DISEASE
sleep	I-DISEASE
disturbance	I-DISEASE
.	0

A	0
clinical	0
history	0
of	0
sleep	0
onset	I-DISEASE
problems	0
,	0
sleep	I-DISEASE
maintenance	I-DISEASE
problems	0
,	0
or	0
unrefresh-	0
ing	0
sleep	0
attributable	0
to	I-DISEASE
the	0
PLMS	0
is	0
needed	0
for	0
a	0
diagnosis	I-DISEASE
of	0
PLMD	I-DISEASE
.	I-DISEASE

These	0
symp-	0
toms	0
have	B-DISEASE
most	I-DISEASE
consistently	I-DISEASE
been	0
associated	I-DISEASE
with	0
PLMS	0
,	0
and	0
the	0
presence	0
of	I-DISEASE
these	0
clinical	0
symptoms	I-DISEASE
differentiates	0
PLMD	I-DISEASE
from	0
asymptomatic	0
PLMS	0
.	0

Although	0
exces-	0
sive	0
daytime	0
sleepiness	0
has	I-DISEASE
been	0
reported	0
with	I-DISEASE
PLMD	0
in	0
the	0
past	0
,	0
newer	I-DISEASE
data	0
do	0
not	0
find	I-DISEASE
significantly	0
elevated	0
Epworth	B-DISEASE
Sleepiness	0
Scale	0
scores	I-DISEASE
or	0
Multiple	I-DISEASE
Sleep	0
Latency	0
Test	I-DISEASE
(	0
MSLT	I-DISEASE
)	0
values	0
in	0
subjects	0
with	0
PLMS	I-DISEASE
.	0

If	0
the	0
only	I-DISEASE
complaint	0
is	0
sleep	0
disruption	I-DISEASE
for	0
the	0
bed	I-DISEASE
partner	0
,	0
then	0
PLMD	0
should	I-DISEASE
not	0
be	0
diagnosed	0
but	0
the	I-DISEASE
sleep	0
disturbance	0
of	I-DISEASE
the	I-DISEASE
bed	0
partner	0
can	I-DISEASE
be	0
noted	0
.	0

Sleep	0
Related	I-DISEASE
Movement	I-DISEASE
Disorders	0
Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
The	I-DISEASE
PLMS	I-DISEASE
index	0
should	0
exceed	0
five	0
per	0
hour	0
in	I-DISEASE
children	I-DISEASE
and	0
15	0
per	0
hour	I-DISEASE
in	0
adult	I-DISEASE
cases	I-DISEASE
for	0
a	I-DISEASE
diagnosis	I-DISEASE
of	0
PLMD	0
.	0

This	0
is	0
based	0
on	0
substantial	0
normative	0
data	I-DISEASE
in	0
children	I-DISEASE
.	0

In	0
adults	0
,	0
there	0
is	I-DISEASE
a	0
significant	I-DISEASE
increase	0
in	0
sleep	0
disturbance	0
symptoms	0
with	0
PLMS	0
>	I-DISEASE
15	0
/	0
hour	0
.	0

The	0
PLMS	0
and	0
the	0
symptoms	0
of	I-DISEASE
sleep	I-DISEASE
disturbance	0
or	I-DISEASE
nonrestorative	I-DISEASE
sleep	0
should	0
not	0
be	0
better	I-DISEASE
explained	0
by	I-DISEASE
another	I-DISEASE
etiology	I-DISEASE
.	I-DISEASE

Most	0
important	0
in	I-DISEASE
the	0
differential	I-DISEASE
diagnosis	0
are	0
RLS	0
,	0
REM	0
sleep	0
behavior	0
disorder	0
(	0
RBD	0
)	0
,	0
and	I-DISEASE
narcolepsy	0
.	I-DISEASE

Research	0
studies	0
indicate	0
that	0
five	0
or	I-DISEASE
more	0
PLMS	0
per	I-DISEASE
hour	0
occur	0
in	0
80	0
%	0
to	0
90	0
%	0
of	I-DISEASE
patients	0
with	0
RLS	0
,	I-DISEASE
in	0
about	I-DISEASE
70	I-DISEASE
%	0
with	0
RBD	0
,	0
and	0
in	I-DISEASE
45	I-DISEASE
%	0
to	0
65	0
%	0
with	0
narcolepsy	I-DISEASE
.	0

In	0
RBD	0
,	0
PLMS	0
are	0
often	I-DISEASE
present	0
without	0
arousals	0
during	0
nonrapid	0
eye	I-DISEASE
movement	I-DISEASE
sleep	0
(	I-DISEASE
NREM	0
)	0
sleep	I-DISEASE
but	0
can	0
also	0
con-	0
tinue	0
into	0
REM	I-DISEASE
sleep	I-DISEASE
,	I-DISEASE
which	0
is	0
unusual	0
in	I-DISEASE
all	I-DISEASE
other	0
settings	0
.	0

If	0
significant	0
daytime	0
sleep-	0
iness	0
and	I-DISEASE
PLMS	0
are	0
present	I-DISEASE
,	0
a	0
diagnosis	0
of	0
narcolepsy	0
should	I-DISEASE
be	0
considered	0
.	I-DISEASE

PLMD	0
should	0
not	0
be	0
diagnosed	0
when	I-DISEASE
criteria	I-DISEASE
for	0
one	0
of	0
these	0
three	0
disorders	0
is	0
met	0
.	0

However	0
,	I-DISEASE
the	0
primary	I-DISEASE
disorder	0
“	I-DISEASE
with	0
PLMS	0
”	I-DISEASE
can	0
be	0
specified	0
(	0
e.g.	0
,	I-DISEASE
“	0
RLS	0
with	0
PLMS	0
”	0
)	0
.	0

A	0
sensitive	0
technique	0
,	0
such	0
as	0
pressure	I-DISEASE
transducer	0
airflow	I-DISEASE
monitoring	0
or	0
esophageal	0
manometry	I-DISEASE
,	0
should	I-DISEASE
be	0
used	I-DISEASE
to	0
monitor	0
breathing	0
during	0
polysomnography	0
to	0
rea-	0
sonably	I-DISEASE
exclude	I-DISEASE
sleep	0
related	I-DISEASE
breathing	0
disorders	I-DISEASE
(	I-DISEASE
SRBDs	0
)	0
as	0
the	0
direct	I-DISEASE
cause	0
of	I-DISEASE
the	0
PLMS	I-DISEASE
.	I-DISEASE

When	0
independent	0
PLMS	0
are	0
present	0
in	0
patients	0
with	0
SRBDs	0
,	0
a	0
separate	0
diag-	0
nosis	0
of	I-DISEASE
PLMD	0
may	0
be	I-DISEASE
considered	0
if	0
the	0
PLMS	0
persist	0
despite	I-DISEASE
adequate	I-DISEASE
treatment	0
of	0
the	I-DISEASE
SRBD	0
and	0
otherwise	I-DISEASE
unexplained	0
sleep	0
disturbance	0
remains	0
.	0

Ideally	0
,	0
polysom-	0
nography	0
for	0
the	0
diagnosis	I-DISEASE
of	0
PLMD	0
should	0
be	0
performed	0
after	0
the	0
biologic	I-DISEASE
effect	0
of	0
a	I-DISEASE
medication	0
or	0
substance	0
,	0
such	0
as	I-DISEASE
an	0
antidepressant	0
known	0
to	0
induce	0
or	0
aggravate	0
PLMS	0
,	0
has	0
ended	0
.	0

Associated	0
Features	0
Higher	0
rates	0
of	0
mood	I-DISEASE
disorders	0
,	0
anxiety	I-DISEASE
,	0
attention	0
deficits	0
,	0
oppositional	0
behaviors	I-DISEASE
,	I-DISEASE
and	0
parasomnias	I-DISEASE
have	0
been	I-DISEASE
reported	0
in	0
some	0
studies	0
of	I-DISEASE
patients	0
with	0
PLMD	0
.	0

In	0
children	0
with	I-DISEASE
PLMD	0
,	0
a	0
family	0
history	0
of	I-DISEASE
RLS	0
is	0
common	0
.	0

A	0
sustained	0
clinical	0
response	0
to	0
dopa-	0
minergic	0
therapy	0
is	I-DISEASE
supportive	0
of	0
the	0
diagnosis	0
of	0
PLMD	0
.	0

Although	0
PLMD	0
symptoms	0
may	0
be	0
responsive	0
to	0
benzodiazepines	I-DISEASE
,	I-DISEASE
benzodiazepine	0
responsiveness	0
is	I-DISEASE
not	0
support-	0
i	I-DISEASE
ve	0
of	0
the	I-DISEASE
diagnosis	0
due	0
to	0
the	0
nonspecific	0
effect	0
of	I-DISEASE
benzodiazepines	0
on	0
sleep	I-DISEASE
.	0

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Not	I-DISEASE
applicable	I-DISEASE
or	I-DISEASE
known	I-DISEASE
.	I-DISEASE

Demographics	0
Although	0
PLMD	0
is	0
thought	0
to	0
be	0
rare	0
,	0
the	0
exact	0
prevalence	0
is	0
not	0
known	0
.	0

PLMD	0
has	0
been	0
reported	0
in	0
both	0
children	0
and	0
adults	0
.	I-DISEASE

PLMS	0
>	0
5	0
/	0
hour	0
are	0
very	0
uncommon	0
in	0
children	0
and	0
adults	0
younger	I-DISEASE
than	0
the	I-DISEASE
age	0
of	0
40	I-DISEASE
years	0
,	0
but	0
then	0
increase	0
markedly	0
with	I-DISEASE
advancing	0
age	I-DISEASE
,	0
occurring	0
in	0
over	0
45	0
%	0
of	0
the	0
elderly	0
.	0

The	0
population	0
prevalence	I-DISEASE
of	I-DISEASE
PLMS	0
>	I-DISEASE
15	0
/	0
hour	I-DISEASE
has	0
been	0
estimated	0
at	0
7.6	0
%	I-DISEASE
of	I-DISEASE
18-	I-DISEASE
to	0
65	0
-	0
year	0
-	I-DISEASE
olds	I-DISEASE
,	0
with	I-DISEASE
4.5	I-DISEASE
%	0
of	I-DISEASE
the	0
total	0
population	0
also	0
reporting	0
sleep	0
disturbance	0
or	0
excessive	I-DISEASE
sleepiness	I-DISEASE
.	I-DISEASE

However	0
,	I-DISEASE
RLS	0
and	0
medication	0
-	I-DISEASE
induced	0
PLMS	0
were	I-DISEASE
not	0
exclusionary	0
criteria	0
in	0
this	0
popula-	I-DISEASE
tion	0
,	0
suggesting	0
much	0
lower	0
rates	0
for	0
PLMD	0
.	0

The	0
increase	0
in	0
PLMS	0
with	0
age	0
may	I-DISEASE
occur	0
as	0
a	0
partial	0
expression	0
of	0
familial	0
or	I-DISEASE
genetic	0
factors	0
associated	I-DISEASE
with	0
RLS	0
,	0
based	0
on	0
data	0
that	I-DISEASE
show	I-DISEASE
very	0
little	0
increase	0
in	0
PLMS	I-DISEASE
with	0
age	0
when	0
individuals	0
who	0
have	0
RLS	0
or	0
first	0
-	0
degree	0
relatives	0
with	0
RLS	0
are	0
excluded	I-DISEASE
.	0

PLMS	0
are	0
less	0
common	0
in	0
black	0
adults	0
and	0
children	0
than	0
in	0
whites	I-DISEASE
.	0

No	0
sex	0
difference	0
has	0
been	0
described	0
for	I-DISEASE
PLMS	0
or	I-DISEASE
PLMD	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
A	0
positive	I-DISEASE
family	I-DISEASE
history	0
of	I-DISEASE
RLS	0
confers	0
increased	0
risk	0
for	I-DISEASE
PLMS	I-DISEASE
and	0
PLMD	0
.	I-DISEASE

The	0
genetic	0
variants	0
noted	0
below	0
may	I-DISEASE
be	I-DISEASE
a	I-DISEASE
mediator	I-DISEASE
of	0
this	0
risk	0
.	0

Precipitation	0
or	0
aggrava-	0
tion	0
of	0
PLMS	0
has	I-DISEASE
been	0
reported	I-DISEASE
with	0
the	0
use	0
of	0
several	0
medications	I-DISEASE
.	0

Selective	0
sero-	I-DISEASE
tonin	I-DISEASE
reuptake	I-DISEASE
inhibitor	0
antidepressants	I-DISEASE
,	I-DISEASE
tricyclic	0
antidepressants	I-DISEASE
,	0
lithium	0
,	0
and	0
dopa-	0
mine	I-DISEASE
receptor	0
antagonists	0
have	I-DISEASE
most	0
often	0
been	0
associated	0
with	0
this	0
effect	I-DISEASE
.	0

Low	0
brain	0
iron	0
,	0
as	0
reflected	0
by	I-DISEASE
serum	0
ferritin	I-DISEASE
level	0
,	0
may	I-DISEASE
worsen	I-DISEASE
PLMS	0
via	I-DISEASE
the	0
role	0
of	0
iron	0
in	0
dopamine	0
function	0
.	I-DISEASE

Less	0
evidence	0
is	0
available	0
for	0
obstructive	0
sleep	I-DISEASE
apnea	0
(	0
OSA	0
)	0
,	0
alcohol	I-DISEASE
,	0
pain	I-DISEASE
,	0
and	0
sleep	I-DISEASE
deprivation	0
as	0
factors	0
that	0
worsen	0
PLMS	0
.	I-DISEASE

Familial	0
Patterns	0

The	0
familial	0
pattern	0
of	0
PLMD	0
has	0
not	I-DISEASE
been	0
studied	0
in	0
detail	0
.	0

Families	0
with	0
RLS	0
have	0
been	0
found	0
to	I-DISEASE
include	0
first	I-DISEASE
-	0
degree	0
relatives	0
without	I-DISEASE
RLS	0
but	I-DISEASE
with	I-DISEASE
increased	I-DISEASE
rates	I-DISEASE
of	0
PLMS	0
or	0
PLMD	0
,	I-DISEASE
raising	0
the	0
possibility	0
that	0
PLMD	I-DISEASE
is	0
an	0
attenuated	I-DISEASE
manifestation	I-DISEASE
or	0
a	0
precursor	0
to	0
RLS	0
.	I-DISEASE

The	0
gene	0
variants	0
BTBD9	0
and	0
MEIS1	0
,	0
which	0
were	I-DISEASE
found	0
in	0
genome-	0
wide	0
studies	0
of	0
RLS	0
,	0
appear	I-DISEASE
to	0
influence	0
the	0
expression	0
of	0
PLMS	0
.	I-DISEASE

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Although	I-DISEASE
the	0
typical	0
age	0
of	0
onset	0
is	I-DISEASE
not	0
known	0
,	0
PLMD	0
occurs	I-DISEASE
in	0
both	0
children	0
and	0
adults	0
,	0
with	I-DISEASE
onset	0
as	0
early	I-DISEASE
as	0
infancy	0
.	0

The	0
natural	0
history	0
has	0
not	0
been	I-DISEASE
described	0
in	0
detail	0
,	0
but	0
some	0
pediatric	0
cases	0
of	0
PLMD	I-DISEASE
progress	0
to	I-DISEASE
RLS	0
.	0

Incidence	0
and	0
remission	0
rates	0
are	0
unknown	0
.	I-DISEASE

Impaired	0
performance	0
in	0
a	0
simulated	0
driving	0
task	0
has	0
been	0
found	0
in	0
patients	0
with	0
PLMD	0
.	0

Increased	0
PLMS	0
have	0
been	0
associated	0
with	0
a	0
higher	0
risk	I-DISEASE
of	0
cardiovascular	0
disease	0
,	0
stroke	0
,	I-DISEASE
and	0
mortality	0
in	I-DISEASE
some	B-DISEASE
studies	0
.	0

PLMS	0
-	0
related	0
overac-	0
tivity	0
of	I-DISEASE
the	I-DISEASE
sympathetic	0
nervous	I-DISEASE
system	0
is	0
postulated	0
to	I-DISEASE
be	0
a	I-DISEASE
potential	0
mechanism	0
for	0
these	0
associations	0
.	0

Sleep	0
Related	I-DISEASE
Movement	I-DISEASE
Disorders	0
Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
Developmental	I-DISEASE
Issues	I-DISEASE
Given	0
the	0
low	0
background	0
rates	0
of	0
PLMS	0
in	I-DISEASE
children	I-DISEASE
,	I-DISEASE
PLMD	0
has	0
emerged	0
as	0
a	I-DISEASE
useful	0
diagnostic	0
category	0
in	I-DISEASE
pediatric	0
sleep	0
medicine	0
.	0

Pediatric	0
PLMD	0
has	0
important	0

clini-	0

cal	0

and	0
polysomnographic	0
correlates	0
that	0
are	0
comparable	0
in	I-DISEASE
severity	0
to	I-DISEASE
pediatric	0
OSA	0
.	0

However	0
,	0
PLMS	0
and	0
PLMD	0
normative	0
data	I-DISEASE
remain	0
sparse	0
for	0
children	0
younger	0
than	0
two	0
years	I-DISEASE
.	0

In	0
the	0
elderly	I-DISEASE
,	I-DISEASE
frequent	0
occurrence	0
of	I-DISEASE
other	0
conditions	I-DISEASE
that	0
can	0
account	0
for	0
sleep	0
dis-	I-DISEASE

turbance	0
and	0
fatigue	0
makes	0
application	0
of	I-DISEASE
PLMD	0
criteria	0
difficult	I-DISEASE
,	0
even	0
though	0
PLMS	0
are	0
common	0
.	0

Pathology	0
and	0
Pathophysiology	0
Dopaminergic	0
impairment	0
has	I-DISEASE
been	I-DISEASE
implicated	0
in	I-DISEASE
the	0
pathophysiology	0
of	0
PLMS	0
and	0
PLMD	I-DISEASE
.	0

The	0
study	0
of	I-DISEASE
PLMS	I-DISEASE
in	0
RLS	0
and	I-DISEASE
in	0
children	0
also	0
suggests	0
genetic	0
diathesis	I-DISEASE
and	0
iron	I-DISEASE
status	0
as	0
factors	I-DISEASE
.	0

Cyclic	0
alternating	0
pattern	0
,	0
a	0
marker	0
of	I-DISEASE
nonrestorative	0
sleep	I-DISEASE
,	0
is	0
increased	0
in	I-DISEASE
individuals	0
with	I-DISEASE
PLMS	0
and	0
may	I-DISEASE
influence	0
the	0
periodicity	0
of	0
PLMS	0
.	0

Cortical	0
arousals	0
can	0
precede	0
,	0
coincide	I-DISEASE
with	0
,	0
or	I-DISEASE
follow	0
PLMS	0
,	0
indicating	0
that	0
PLMS	I-DISEASE
do	0
not	0
cause	I-DISEASE
the	0
arousals	0
.	0

In	0
addition	0
,	0
PLMS	0
can	0
be	0
dissociated	I-DISEASE
from	0
arousals	I-DISEASE
pharma-	0
cologically	0
,	0
suggesting	0
an	0
indirect	I-DISEASE
relation	I-DISEASE
,	0
possibly	I-DISEASE
mediated	0
by	0
a	0
central	I-DISEASE
generator	0
.	0

The	0
autonomic	0
arousals	0
associated	0
with	I-DISEASE
PLMS	I-DISEASE
are	I-DISEASE
characterized	0
by	I-DISEASE
significant	0
heart	0
rate	0
and	0
blood	0
pressure	I-DISEASE
surges	0
,	0
a	I-DISEASE
mechanism	0
for	0
possible	0
increased	0
cardiovascular	I-DISEASE
and	0
cerebrovascular	I-DISEASE
disease	0
risk	0
.	I-DISEASE

Objective	0
Findings	0
PLMS	0
can	I-DISEASE
appear	0
immediately	I-DISEASE
with	I-DISEASE
the	0
onset	I-DISEASE
of	0
stage	0
N1	0
sleep	0
,	I-DISEASE
are	I-DISEASE
frequent	0
during	0
stage	I-DISEASE
N2	0
sleep	I-DISEASE
,	0
decrease	0
in	0
frequency	I-DISEASE
in	I-DISEASE
stage	0
N3	I-DISEASE
,	I-DISEASE
and	0
are	I-DISEASE
usually	0
absent	0
during	0
stage	0
R	0
sleep	0
.	0

PLMS	0
typically	0
occur	0
in	0
discrete	0
episodes	0
that	0
last	I-DISEASE
from	I-DISEASE
a	0
few	0
minutes	0
to	0
an	0
hour	0
.	0

Both	0
lower	0
limbs	0
should	0
be	0
monitored	0
for	0
the	0
presence	I-DISEASE
of	0
limb	0
movements	0
.	0

Movements	0
of	0
the	0
upper	0
limbs	I-DISEASE
may	0
be	I-DISEASE
sampled	0
if	I-DISEASE
clinically	0
indicated	0
.	0

The	0
anterior	0
tibialis	0
electro-	0
myogram	0
(	0
EMG	I-DISEASE
)	0
shows	I-DISEASE
repetitive	0
contractions	0
,	0
each	0
lasting	I-DISEASE
0.5	0
to	0
10	0
seconds	I-DISEASE
.	0

The	0
movements	0
may	0
affect	B-DISEASE
one	0
or	0
,	0
more	0
typically	0
,	0
both	0
of	0
the	0
lower	0
limbs	I-DISEASE
,	0
but	0
not	0
neces-	0
sarily	0
in	0
a	0
symmetric	0
or	0
simultaneous	0
pattern	0
.	0

Specific	0
scoring	0
criteria	0
for	0
PLMS	0
are	0
described	I-DISEASE
in	0
the	I-DISEASE
AASM	0
Manual	0
for	0
the	I-DISEASE
Scoring	0
of	0
Sleep	0
and	0
Associated	I-DISEASE
Events	0
.	0

Self	0
-	0
reports	0
,	0
bed	0
partner	0
observations	0
,	0
or	I-DISEASE
parental	0
reports	0
for	0
children	0
have	I-DISEASE
not	0
been	I-DISEASE
found	0
to	I-DISEASE
have	0
sufficient	0
specificity	0
or	0
sensitivity	0
to	0
replace	0
objective	0
testing	0
for	I-DISEASE
PLMS	0
.	0

Care	0
must	0
be	0
taken	I-DISEASE
to	0
discriminate	0
PLMS	I-DISEASE
from	0
other	I-DISEASE
movements	0
such	0
as	0
a	0
simple	0
change	I-DISEASE
in	0
body	0
position	I-DISEASE
,	0
stretching	0
of	0
a	0
limb	0
,	0
or	0
a	0
muscle	0
cramp	I-DISEASE
.	0

PLMS	0
are	0
longer	0
in	0
duration	0
than	I-DISEASE
myoclonic	0
jerks	0
,	I-DISEASE
which	0
,	0
by	0
definition	0
,	0
are	I-DISEASE
typically	0
50	I-DISEASE
to	I-DISEASE
150	0
millisec-	0
onds	0
long	0
.	0

Movements	0
associated	0
with	0
respiratory	0
events	0
,	0
hypnagogic	I-DISEASE
foot	0
tremor	I-DISEASE
,	0
or	0
alternating	0
leg	0
muscle	0
activation	I-DISEASE
during	0
sleep	0
(	0
ALMA	0
)	0
should	0
not	0
be	0
included	0
in	I-DISEASE
the	0
PLMS	0
index	I-DISEASE
.	0

PLMS	0
may	0
be	0
associated	0
with	0
electroencephalographic	0
(	I-DISEASE
cortical	0
)	I-DISEASE
arousals	0
or	0
with	0
awakenings	I-DISEASE
.	0

Autonomic	0
arousals	0
—	I-DISEASE
measured	I-DISEASE
by	0
a	I-DISEASE
change	0
in	I-DISEASE
heart	I-DISEASE
rate	0
,	0
blood	0
pressure	0
,	0
or	I-DISEASE
pulse	0
transit	0
time	I-DISEASE
—	0
have	0
been	0
shown	0
to	0
be	0
more	0
frequent	0
than	0
cortical	I-DISEASE
arousals	0
.	0

In	0
some	0
cases	0
,	0
periodic	0
arousals	0
may	I-DISEASE
persist	0
even	0
though	0
the	0
PLMS	0
have	0
subsided	0
.	I-DISEASE

The	0
arousals	0
are	0
typically	I-DISEASE
more	0
difficult	I-DISEASE
to	0
measure	0
than	I-DISEASE
are	0
the	0
PLMS	0
,	I-DISEASE
and	0
their	I-DISEASE
clinical	0
significance	0
is	I-DISEASE
a	0
topic	0
of	0
ongoing	0
debate	0
.	0

As	0
with	0
obstructive	0
sleep	0
apnea	0
,	0
the	I-DISEASE
associated	I-DISEASE
cortical	I-DISEASE
arousal	I-DISEASE
index	0
has	0
not	I-DISEASE
proven	0
more	I-DISEASE
useful	I-DISEASE
than	0
the	I-DISEASE
PLMS	0
index	0
in	0
making	0
clini-	0
cal	0
decisions	0
.	I-DISEASE

Although	0
a	0
subjective	0
report	0
of	0
excessive	I-DISEASE
daytime	I-DISEASE
sleepiness	0
is	I-DISEASE
present	0
in	0
some	0
patients	0
with	0
PLMD	I-DISEASE
,	0
mean	0
sleep	I-DISEASE
latency	0
measured	0
by	0
MSLT	0
has	0
not	0
been	I-DISEASE
found	0
to	0
be	0
consistently	0
abnormal	I-DISEASE
or	0
to	0
correlate	0
with	0
the	0
PLMS	0
cortical	0
arousal	0
index	0
.	0

The	0
movements	0
should	0
be	0
reported	0
as	0
an	0
index	0
of	0
total	0
sleep	0
time	0
,	0
called	0
the	0
PLMS	I-DISEASE
index	0
.	0

The	0
PLMS	0
index	0
is	0
the	0
number	0
of	I-DISEASE
periodic	I-DISEASE
limb	I-DISEASE
movements	0
per	0
hour	0
of	0
total	0
sleep	I-DISEASE
time	0
,	0
as	I-DISEASE
determined	0
by	0
polysomnography	0
.	0

The	0
PLMS	0
arousal	0
index	0
is	0
the	I-DISEASE
number	I-DISEASE
of	0
PLMS	I-DISEASE
associated	0
with	0
a	0
cortical	0
arousal	0
,	I-DISEASE
expressed	0
per	0
hour	0
of	0
total	0
sleep	0
time	0
.	0

Other	0
parameters	0
for	0
the	0
description	I-DISEASE
of	0
PLMS	I-DISEASE
include	0
periodicity	I-DISEASE
index	0
,	0
intermove-	I-DISEASE
ment	0
interval	0
distribution	I-DISEASE
,	0
and	0
time	I-DISEASE
of	0
night	0
distribution	0
.	0

These	0
features	0
have	0
been	0
shown	0
to	0
help	I-DISEASE
differentiate	0
PLMS	0
patterns	0
in	0
different	0
conditions	I-DISEASE
(	0
e.g.	0
,	0
a	0
finding	0
of	0
the	I-DISEASE
highest	0
periodicity	0
indices	0
in	0
adult	I-DISEASE
RLS	I-DISEASE
and	I-DISEASE
PLMD	I-DISEASE
)	0
.	0

Leg	0
actigraphy	I-DISEASE
has	0
been	0
validated	0
against	0
PSG	0
for	0
the	I-DISEASE
measurement	0
of	0
PLMS	0
and	0
provides	0
a	I-DISEASE
methodology	0
to	0
assess	I-DISEASE
PLMS	0
in	0
large	0
populations	0
,	0
as	0
well	I-DISEASE
as	0
night	0
-	I-DISEASE
to	0
-	0
night	0
variability	I-DISEASE
.	0

Differential	0
Diagnosis	0
As	0
described	0
in	0
the	I-DISEASE
essential	0
features	0
section	0
,	I-DISEASE
PLMD	0
is	0
a	0
diagnosis	0
of	I-DISEASE
exclusion	0
and	0
it	I-DISEASE
is	0
important	0
to	0
differentiate	0
it	0
from	0
other	I-DISEASE
conditions	I-DISEASE
in	0
which	0
PLMS	0
occur	0
,	I-DISEASE
particularly	0
RLS	0
,	0
RBD	0
,	0
narcolepsy	0
,	0
and	0
SRBDs	I-DISEASE
.	I-DISEASE

Increased	0
rates	0
of	0
PLMS	0
have	0
also	I-DISEASE
been	0
reported	0
in	0
multiple	0
system	0
atrophy	0
,	0
dopa	0
-	I-DISEASE
responsive	I-DISEASE
dystonia	0
,	I-DISEASE
sleep	0
related	0
eating	0
disorder	0
,	0
spinal	0
cord	I-DISEASE
injury	I-DISEASE
,	0
end	0
-	0
stage	0
renal	0
disease	I-DISEASE
,	0
congestive	0
heart	0
failure	0
,	0
Parkinson	I-DISEASE
disease	0
,	0
sickle	0
cell	I-DISEASE
disease	0
,	0
posttraumatic	I-DISEASE
stress	0
disorder	I-DISEASE
,	I-DISEASE
Asperger	0
syndrome	0
,	0
Williams	0
syn-	I-DISEASE
drome	I-DISEASE
,	0
and	0
multiple	0
sclerosis	0
.	0

Dopaminergic	0
impairment	0
and/or	0
diminished	0
inhibition	0
of	0
the	I-DISEASE
central	0
pattern	I-DISEASE
generator	0
for	0
PLMS	0
have	0
been	0
proposed	0
as	I-DISEASE
common	I-DISEASE
factors	I-DISEASE
linking	0
various	0
disorders	0
and	0
PLMS	0
.	0

Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
Sleep	0
Related	0
Movement	0
Disorders	0
Sleep	I-DISEASE
starts	I-DISEASE
(	0
hypnic	0
jerks	0
)	0
need	0
to	0
be	0
differentiated	I-DISEASE
from	0
PLMS	0
.	I-DISEASE

Sleep	0
starts	0
typically	0
are	0
limited	0
to	I-DISEASE
the	0
transition	0
from	I-DISEASE
wakefulness	0
to	I-DISEASE
sleep	0
,	0
are	0
not	0
periodic	0
,	I-DISEASE
and	I-DISEASE
are	0
briefer	0
(	0
20	0
to	0
100	0
milliseconds	I-DISEASE
)	0
than	0
PLMS	0
.	0

Normal	0
phasic	0
REM	0
activity	0
is	0
limited	I-DISEASE
to	I-DISEASE
REM	0
sleep	I-DISEASE
,	I-DISEASE
typically	0
occurs	0
in	0
5-	I-DISEASE
to	I-DISEASE
15	I-DISEASE
-	0
second	I-DISEASE
clusters	0
,	0
and	0
is	0
usually	I-DISEASE
associated	0
with	I-DISEASE
bursts	0
of	I-DISEASE
REMs	I-DISEASE
.	0

Phasic	0
REM	0
EMG	0
twitches	0
are	0
more	0
variable	0
in	0
duration	I-DISEASE
and	0
do	0
not	0
have	I-DISEASE
the	0
periodicity	I-DISEASE
of	I-DISEASE
PLMS	0
.	I-DISEASE

Fragmentary	0
myoclonus	0
is	0
characterized	0
by	0
EMG	0
activity	0
that	0
is	I-DISEASE
briefer	0
(	0
75	0
to	0
150	0
milliseconds	I-DISEASE
)	I-DISEASE
,	I-DISEASE
more	I-DISEASE
variable	0
in	0
duration	0
,	0
less	0
periodic	0
than	0
PLMS	0
,	I-DISEASE
and	I-DISEASE
has	0
little	0
or	0
no	I-DISEASE
associated	0
visible	0
movement	0
.	0

Also	0
,	0
PLMS	0
must	0
be	0
differentiated	0
from	0
movements	I-DISEASE
associated	I-DISEASE
with	0
nocturnal	0
epileptic	0
seizures	0
and	0
myoclonic	0
epilepsy	0
and	0
from	I-DISEASE
a	0
number	0
of	0
forms	0
of	0
myoclonus	0
seen	0
while	0
awake	0
,	I-DISEASE
such	0
as	0
in	0
Alzheimer	I-DISEASE
disease	0
,	0
Creutzfeldt	0
-	0
Jakob	0
disease	0
,	0
and	0
other	0
neuropathologic	0
conditions	0
.	0

However	0
,	I-DISEASE
in	0
these	0
disorders	0
,	I-DISEASE
the	I-DISEASE
involuntary	I-DISEASE
movements	0
are	0
prominent	0
during	0
the	0
daytime	0
,	0
often	I-DISEASE
do	I-DISEASE
not	0
disappear	0
with	0
activity	0
,	0
are	0
prominent	0
in	I-DISEASE
the	0
arms	0
and	0
other	0
body	I-DISEASE
parts	0
in	I-DISEASE
addition	0
to	0
the	0
legs	0
,	0
and	0
do	I-DISEASE
not	0
display	I-DISEASE
the	I-DISEASE
periodicity	0
seen	0
with	0
PLMS	I-DISEASE
.	I-DISEASE

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE

There	0
has	0
been	0
controversy	0
over	0
the	0
clinical	I-DISEASE
significance	0
of	I-DISEASE
PLMS	0
.	0

To	0
date	0
,	0
the	0
inter-	I-DISEASE
pretation	0
of	I-DISEASE
most	I-DISEASE
studies	I-DISEASE
has	0
been	0
confounded	0
by	0
multiple	0
factors	I-DISEASE
that	0
include	0
:	I-DISEASE
impre-	0
cise	I-DISEASE
diagnostic	0
criteria	0
;	I-DISEASE
confusion	0
between	I-DISEASE
PLMS	I-DISEASE
and	0
PLMD	I-DISEASE
;	0
inadequate	I-DISEASE
monitoring	I-DISEASE
for	0
subtle	0
SRBDs	0
;	0
a	I-DISEASE
lack	0
of	0
consideration	0
of	I-DISEASE
medications	0
known	I-DISEASE
to	0
induce	0
,	0
worsen	0
,	0
or	I-DISEASE
suppress	0
PLMS	I-DISEASE
;	I-DISEASE
and	0
inadequate	I-DISEASE
measurement	0
of	0
the	0
known	0
night	I-DISEASE
-	0
to	0
-	I-DISEASE
night	0
vari-	0
ability	I-DISEASE
of	0
PLMS	I-DISEASE
.	0

Newer	0
respiratory	0
monitoring	0
techniques	0
for	0
polysomnography	0
and	I-DISEASE
the	0
use	I-DISEASE
of	0
actigraphy	0
monitors	0
over	I-DISEASE
several	0
nights	I-DISEASE
should	0
help	0
address	I-DISEASE
a	I-DISEASE
number	I-DISEASE
of	0
these	0
issues	I-DISEASE
.	0

The	0
role	0
of	0
associated	0
arousals	0
in	I-DISEASE
relation	I-DISEASE
to	0
clinical	I-DISEASE
symptoms	0
is	0
yet	0
to	0
be	0
determined	I-DISEASE
,	I-DISEASE
but	0
the	I-DISEASE
appreciation	0
of	I-DISEASE
autonomic	0
arousals	0
as	0
well	I-DISEASE
as	I-DISEASE
cortical	I-DISEASE
arousals	0
might	I-DISEASE
be	0
critical	I-DISEASE
.	I-DISEASE

It	0
is	0
possible	0
that	0
PLMS	0
are	I-DISEASE
a	0
measurable	0
marker	I-DISEASE
of	0
unstable	0
sleep	0
,	0
related	0
to	I-DISEASE
genetic	0
diathesis	I-DISEASE
and	I-DISEASE
dopaminergic	I-DISEASE
impairment	0
.	0

Bibliography	0
Ferri	0
R.	I-DISEASE
The	0
time	0
structure	I-DISEASE
of	I-DISEASE
leg	0
movement	I-DISEASE
activity	0
during	I-DISEASE
sleep	0
:	0
The	0
theory	I-DISEASE
behind	I-DISEASE
the	I-DISEASE
practice	I-DISEASE
.	0

Sleep	0
Med	0
2012;13:433–41	0
.	0

Gingras	0
JL	0
,	0
Gaultney	0
JF	0
,	0
Picchietti	I-DISEASE
DL	0
.	0

Pediatric	0
periodic	0
limb	0
movement	I-DISEASE
disorder	0
:	I-DISEASE
sleep	I-DISEASE
symptom	0
and	I-DISEASE
polysomnographic	0
correlates	0
compared	0
to	I-DISEASE
obstructive	0
sleep	I-DISEASE
apnea	I-DISEASE
.	0

J	0
Clin	0
Sleep	I-DISEASE
Med	0
2011;7:603–9	0
.	I-DISEASE

Hornyak	0
M	I-DISEASE
,	0
Feige	0
B	0
,	0
Riemann	I-DISEASE
D	0
,	I-DISEASE
Voderholzer	0
U.	0
Periodic	0
leg	I-DISEASE
movements	0
in	I-DISEASE
sleep	0
and	0
periodic	0
limb	0
movement	0
disorder	0
:	0
prevalence	0
,	0
clinical	I-DISEASE
significance	0
and	0
treatment	I-DISEASE
.	0

Sleep	0
Med	0
Rev	I-DISEASE
2006;10:169–77	0
.	B-DISEASE

Koo	0
BB	0
,	0
Blackwell	I-DISEASE
T	0
,	0
Ancoli	0
-	0
Israel	I-DISEASE
S	0
,	0
Stone	0
KL	I-DISEASE
,	0
Stefanick	I-DISEASE
ML	I-DISEASE
,	I-DISEASE
Redline	I-DISEASE
S.	0
Association	0
of	0
incident	I-DISEASE
cardiovascular	0
disease	0
with	I-DISEASE
periodic	0
limb	0
movements	I-DISEASE
during	0
sleep	0
in	0
older	0
men	0
:	0
Outcomes	0
of	0
Sleep	I-DISEASE
Disorders	I-DISEASE
in	0
Older	I-DISEASE
Men	I-DISEASE
(	0
MrOS	0
)	0
Study	I-DISEASE
.	0

Circulation	0
2011;124:1223–31	0
.	0

Pennestri	0
MH	I-DISEASE
,	0
Whittom	I-DISEASE
S	0
,	0
Adam	I-DISEASE
B	I-DISEASE
,	I-DISEASE
Petit	I-DISEASE
D	0
,	0
Carrier	I-DISEASE
J	I-DISEASE
,	I-DISEASE
Montplaisir	I-DISEASE
J.	I-DISEASE
PLMS	I-DISEASE
and	0
PLMW	0
in	0
healthy	0
subjects	I-DISEASE
as	0
a	I-DISEASE
function	0
of	0
age	I-DISEASE
:	0
prevalence	I-DISEASE
and	I-DISEASE
interval	I-DISEASE
distribution	0
.	0

Sleep	0
2006;29:1183–7	0
.	0

Picchietti	0
DL	0
,	0
Rajendran	0
RR	0
,	0
Wilson	I-DISEASE
MP	0
,	0
Picchietti	0
MA	0
.	0

Pediatric	0
restless	0
legs	0
syndrome	0
and	0
periodic	0
limb	I-DISEASE
movement	0
disorder	I-DISEASE
:	0
parent	0
-	0
child	0
pairs	0
.	I-DISEASE

Sleep	0
Med	0
2009;10:925–31	0
.	0

Picchietti	0
D.	0
Periodic	0
limb	0
movements	I-DISEASE
in	0
sleep	I-DISEASE
:	0
irrelevant	I-DISEASE
epiphenomenon	0
,	0
marker	I-DISEASE
for	I-DISEASE
a	0
potential	0
problem	0
,	0
or	I-DISEASE
a	0
disorder	0
?	0

J	0
Clin	0
Sleep	I-DISEASE
Med	0
2006;2:446–7	0
.	I-DISEASE

Scofield	0
H	0
,	0
Roth	0
T	0
,	0
Drake	I-DISEASE
C.	0
Periodic	I-DISEASE
limb	0
movements	I-DISEASE
during	0
sleep	0
:	0
population	I-DISEASE
prevalence	0
,	I-DISEASE
clinical	I-DISEASE
correlates	0
,	I-DISEASE
and	0
racial	0
differences	0
.	I-DISEASE

Sleep	0
2008;31:1221–7	0
.	0

Stefansson	0
H	0
,	0
Rye	0
DB	0
,	I-DISEASE
Hicks	0
A	0
,	I-DISEASE
et	0
al	0
.	0

A	0
genetic	0
risk	0
factor	0
for	0
periodic	0
limb	I-DISEASE
movements	0
in	I-DISEASE
sleep	0
.	0

N	0
Engl	0
J	0
Med	0
2007;357:639–47	0
.	0

Walters	0
AS	0
,	0
Rye	0
DB	0
.	0

Review	0
of	0
the	0
relationship	I-DISEASE
of	0
restless	I-DISEASE
legs	0
syndrome	0
and	I-DISEASE
periodic	0
limb	0
movements	0
in	0
sleep	0
to	I-DISEASE
hypertension	0
,	0
heart	0
disease	0
,	0
and	0
stroke	0
.	0

Sleep	0
2009;32:589–97	0
.	0

Sleep	0
Related	0
Leg	I-DISEASE
Cramps	0
ICD-9	0
-	0
CM	I-DISEASE
code	0
:	I-DISEASE
327.52	0
Alternate	0
names	0
Leg	0
cramps	0
,	I-DISEASE
“	I-DISEASE
charley	0
horse	I-DISEASE
,	0
”	0
nocturnal	0
leg	0
cramps	0
.	I-DISEASE

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
C	I-DISEASE
must	0
be	0
met	I-DISEASE
ICD-10	0
-	0
CM	0
code	0
:	0
G47.62	0
Sleep	I-DISEASE
Related	0
Movement	0

Disorders	0
A.	0

A	0
painful	0
sensation	0
in	0
the	0
leg	I-DISEASE
or	0
foot	0
associated	I-DISEASE
with	0
sudden	0
,	0
involuntary	0
muscle	0
hardness	0
or	0
tightness	0
,	I-DISEASE
indicating	0
a	0
strong	0
muscle	0
contraction	0
.	0

B.	0
The	0
painful	0
muscle	0
contractions	0
occur	I-DISEASE
during	I-DISEASE
the	0
time	0
in	0
bed	I-DISEASE
,	0
although	0
they	0
may	I-DISEASE
arise	0
from	0
either	I-DISEASE
wakefulness	0
or	0
sleep	0
.	I-DISEASE

C.	0

The	0
pain	0
is	0
relieved	0
by	0
forceful	0
stretching	0
of	0
the	0
affected	0
muscles	0
,	0
thus	0
releasing	0
the	I-DISEASE
contraction	0
.	I-DISEASE

Essential	0
Features	0
Sleep	0
related	0
leg	I-DISEASE
cramps	0
are	I-DISEASE
painful	0
sensations	I-DISEASE
caused	0
by	0
sudden	0
and	0
intense	0
involun-	0
tary	I-DISEASE
contractions	0
of	I-DISEASE
muscles	0
or	0
muscle	0
groups	0
during	0
which	I-DISEASE
there	0
is	I-DISEASE
muscle	0
spasm	I-DISEASE
and	0
hardness	0
for	I-DISEASE
several	I-DISEASE
seconds	0
.	0

These	0
painful	0
sensations	0
are	0
usually	0
in	0
the	0
calf	I-DISEASE
or	0
small	0
muscle	0
of	0
the	0
foot	I-DISEASE
.	I-DISEASE

Occurring	0
during	0
the	0
time	0
in	0
bed	I-DISEASE
,	I-DISEASE
sleep	0
related	0
leg	0
cramps	0
may	I-DISEASE
arise	I-DISEASE
from	0
either	I-DISEASE
wakefulness	I-DISEASE
or	0
sleep	I-DISEASE
.	0

Sleep	0
related	0
leg	I-DISEASE
cramps	0
usually	I-DISEASE
start	I-DISEASE
abruptly	I-DISEASE
but	0
may	0
in	0
some	0
cases	0
be	0
preceded	0
by	I-DISEASE
a	I-DISEASE
less	0
painful	I-DISEASE
warning	0
sensation	0
.	0

The	0
muscle	0
contractions	0
last	0
for	0
a	0
few	0
seconds	0
up	0
to	0
several	0
minutes	0
and	I-DISEASE
then	0
remit	I-DISEASE
spontaneously	I-DISEASE
.	0

The	0
frequency	0
of	0
sleep	0
related	0
leg	I-DISEASE
cramps	0
varies	0
considerably	I-DISEASE
from	0
less	0
than	0
yearly	0
to	0
multiple	0
episodes	0
every	0
night	0
.	0

Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0

The	0
cramps	0
can	I-DISEASE
be	I-DISEASE
relieved	0
by	0
strongly	I-DISEASE
stretching	0
the	I-DISEASE
affected	0
muscle	0
and	I-DISEASE
sometimes	0
also	0
by	I-DISEASE
local	0
massage	0
,	I-DISEASE
application	0
of	0
heat	0
,	0
or	0
movement	0
of	I-DISEASE
the	0
affected	0
limb	I-DISEASE
.	I-DISEASE

Leg	0
cramps	0
can	0
be	B-DISEASE
present	0
primarily	0
during	0
the	0
daytime	0
.	0

Associated	0
Features	0
The	0
muscle	0
cramp	0
affects	I-DISEASE
sleep	I-DISEASE
.	I-DISEASE

The	0
pain	0
from	0
the	0
cramp	I-DISEASE
itself	I-DISEASE
and	I-DISEASE
from	I-DISEASE
the	I-DISEASE
activities	0
used	0
to	I-DISEASE
relieve	0
it	I-DISEASE
commonly	I-DISEASE
disturb	0
sleep	0
onset	0
or	0
cause	I-DISEASE
an	0
awakening	0
from	I-DISEASE
sleep	0
.	I-DISEASE

Often	0
the	0
presenting	0
complaint	0
is	0
insomnia	0
,	0
at	0
times	0
severe	0
.	0

Tenderness	0
and	0
discomfort	0
in	0
the	0
muscle	0
may	0
persist	0
for	I-DISEASE
several	0
hours	0
after	0
the	0
cramp-	0
ing	I-DISEASE
.	0

Persisting	0
discomfort	0
after	0
the	0
cramping	0
episode	0
often	I-DISEASE
delays	0
subsequent	I-DISEASE
return	0
to	0
sleep	0
.	0

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Sleep	I-DISEASE
related	I-DISEASE
leg	I-DISEASE
cramps	I-DISEASE
are	I-DISEASE
known	0
to	I-DISEASE
be	I-DISEASE
either	I-DISEASE
idiopathic	0
or	I-DISEASE
secondary	I-DISEASE
to	0
other	I-DISEASE
medical	0
conditions	0
,	0
but	0
there	0
have	I-DISEASE
been	0
no	0
indications	0
of	I-DISEASE
significant	0
differences	0
in	0
the	0
clinical	0
features	0
of	0
the	0
disorder	0
related	0
to	I-DISEASE
the	0
cause	I-DISEASE
.	I-DISEASE

Demographics	0
Sleep	0
related	0
leg	0
cramps	0
are	I-DISEASE
common	I-DISEASE
.	0

It	0
has	0
been	0
suggested	0
that	0
nearly	I-DISEASE
every	0
adult	0
older	I-DISEASE
than	0
50	0
years	0
has	0
experienced	0
sleep	0
related	I-DISEASE
leg	I-DISEASE
cramps	0
at	0
least	0
once	0
.	0

Both	0
the	0
prevalence	I-DISEASE
and	I-DISEASE
the	0
frequency	I-DISEASE
of	0
the	0
events	I-DISEASE
increase	0
with	0
age	0
.	0

Sleep	0
related	I-DISEASE
leg	I-DISEASE
cramps	0
have	I-DISEASE
been	I-DISEASE
reported	I-DISEASE
to	0
occur	I-DISEASE
at	0
least	0
occasionally	0
in	I-DISEASE
about	0
7	I-DISEASE
%	0
of	0
children	I-DISEASE
and	0
adoles-	0
cents	0
,	0
33	0
%	0
in	I-DISEASE
adults	I-DISEASE
older	0
than	I-DISEASE
60	0
years	0
,	0
and	0
50	0
%	0
in	0
adults	I-DISEASE
older	0
than	I-DISEASE
80	0
years	0
,	0
with	I-DISEASE
both	0
older	0
groups	0
reporting	I-DISEASE
a	I-DISEASE
symptom	0
frequency	0
of	0
at	0
least	0
once	I-DISEASE
every	0
two	0
months	0
.	0

Nightly	0
leg	0
cramps	0
have	0
been	0
reported	0
in	0
6	0
%	0
of	0
adults	0
older	0
than	0
60	0
years	0
.	0

No	0
defin-	0
itive	0
sex	I-DISEASE
information	0
has	0
been	I-DISEASE
reported	0
,	I-DISEASE
though	0
a	0
single	0
study	0
reported	0
a	I-DISEASE
higher	0
prev-	I-DISEASE
alence	0
in	0
women	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
Predisposing	0
factors	I-DISEASE
include	I-DISEASE
diabetes	0
mellitus	I-DISEASE
,	0
amyotrophic	0
lateral	0
sclerosis	0
,	0
cramp	I-DISEASE
fasciculation	0
syndrome	0
,	I-DISEASE
peripheral	0
vascular	0
disease	0
,	0
hypokalemia	0
,	0
hypocalcemia	B-DISEASE
,	0
hypomagnesemia	0
,	0
and	0
metabolic	I-DISEASE
disorders	0
.	0

The	0
disorder	0
can	I-DISEASE
be	0
associated	I-DISEASE
with	0
prior	I-DISEASE
vigorous	0
exercise	I-DISEASE
,	0
prolonged	0
standing	I-DISEASE
at	0
work	I-DISEASE
,	I-DISEASE
dehydration	0
,	I-DISEASE
fluid	I-DISEASE
and	0
electrolyte	0
distur-	0
bances	0
,	I-DISEASE
endocrine	I-DISEASE
disorders	0
,	0
neuromuscular	0
disorders	I-DISEASE
,	0
disorders	0
of	0
reduced	I-DISEASE
mobility	0
,	0
vascular	0
disease	0
,	0
cirrhosis	I-DISEASE
,	0
and	I-DISEASE
hemodialysis	0
.	I-DISEASE

Medications	0
that	I-DISEASE
have	0
been	I-DISEASE
associated	0
with	0
sleep	I-DISEASE
related	0
leg	I-DISEASE
cramps	I-DISEASE
include	I-DISEASE
oral	0
contraceptives	I-DISEASE
,	0
intravenous	I-DISEASE
iron	I-DISEASE
sucrose	0
,	I-DISEASE
teriparatide	0
,	0
raloxifene	0
,	0
diuretics	0
,	0
long	I-DISEASE
-	I-DISEASE
acting	0
β	0
-	0
agonists	I-DISEASE
,	0
and	0
statins	0
.	0

Sleep	0
related	0
leg	I-DISEASE
cramps	0
occur	0
in	I-DISEASE
about	0
40	0
%	0
of	0
pregnant	0
women	0
and	0
generally	0
resolve	I-DISEASE
after	0
delivery	0
.	0

Familial	0
Pattern	0
Not	0
known	0
.	0

Onset	0
,	0
Course	0
and	0
Complications	0
Sleep	I-DISEASE
related	0
leg	0
cramps	I-DISEASE
have	0
not	0
been	I-DISEASE
reported	0
in	0
infancy	I-DISEASE
,	0
nor	0
in	I-DISEASE
children	0
younger	0
than	0
eight	0
years	0
.	0

The	0
peak	0
onset	0
is	0
usually	0
in	0
adulthood	0
,	0
but	I-DISEASE
the	0
condition	0
may	I-DISEASE
be	0
seen	0
for	0
the	0
first	I-DISEASE
time	0
in	0
old	0
age	0
.	0

The	0
natural	0
history	0
of	0
leg	0
cramps	0
is	I-DISEASE
not	0
well	0
under-	0
stood	0
.	0

Many	0
patients	0
describe	I-DISEASE
a	0
waxing	0
and	I-DISEASE
waning	I-DISEASE
course	0
of	I-DISEASE
many	0
years	0
’	0
duration	0
.	0

Complications	0
include	0
muscle	0
tenderness	0
,	0
insomnia	I-DISEASE
,	I-DISEASE
and	0
occasional	I-DISEASE
daytime	0
fatigue	0
due	0
to	0
interrupted	0
sleep	I-DISEASE
.	0

No	0
marked	0
mental	0
or	0
social	0
dysfunction	0
has	0
been	0
described	0
due	0
to	0
sleep	0
related	0
leg	0
cramps	I-DISEASE
alone	I-DISEASE
.	0

Pathology	0
and	0
Pathophysiology	0
Many	0
sleep	0
related	I-DISEASE
leg	I-DISEASE
cramps	0
appear	I-DISEASE
to	0
be	0
idiopathic	I-DISEASE
.	0

Although	0
leg	0
cramps	0
involve	B-DISEASE
abnormal	0
muscle	I-DISEASE
tone	0
,	0
they	I-DISEASE
are	0
generally	0
considered	0
not	0
to	I-DISEASE
involve	I-DISEASE
agonist	I-DISEASE
-	0
antagonist	0
co	I-DISEASE
-	0
contractions	0
and	0
,	0
thus	0
,	0
are	I-DISEASE
not	0
classified	I-DISEASE
as	0
dystonias	0
.	0

Some	0
nocturnal	0
leg	0
cramps	0
,	0
particularly	I-DISEASE
those	I-DISEASE
in	0
the	I-DISEASE
feet	I-DISEASE
,	0
may	0
resemble	I-DISEASE
dystonias	0
but	I-DISEASE
,	0
unlike	0
classic	I-DISEASE
dystonias	0
,	I-DISEASE
sleep	0
related	0
leg	0
and	0
foot	I-DISEASE
cramps	0
are	0
relieved	I-DISEASE
by	0
stretching	0
the	I-DISEASE
affected	I-DISEASE
muscle	0
or	0
muscles	0
.	I-DISEASE

Electrophysiologic	0
recordings	0
show	0
that	I-DISEASE
the	0
cramps	I-DISEASE
typically	I-DISEASE
start	0
with	I-DISEASE
spontaneous	0
firing	I-DISEASE
of	I-DISEASE
anterior	I-DISEASE
horn	0
cells	I-DISEASE
followed	I-DISEASE
by	0
motor	I-DISEASE
unit	0
discharges	0
for	0
contractions	0
at	I-DISEASE
rates	0
up	I-DISEASE
to	0
300	0
Hz	I-DISEASE
(	0
considerably	I-DISEASE
more	0
than	0
with	0
voluntary	0
muscle	0
contractions	0
)	0
.	I-DISEASE

The	0
pain	0
may	0
result	B-DISEASE
from	0
local	0
metabolite	I-DISEASE
accumulations	0
or	0
from	0
local	0
ischemia	0
.	0

Muscle	0
and	0
tendon	I-DISEASE
shortening	I-DISEASE
due	0
to	I-DISEASE
age	0
or	0
lack	I-DISEASE
of	0
stretching	0
exercise	0
is	0
thought	0
to	I-DISEASE
contribute	0
to	0
the	I-DISEASE
development	0
of	0
sleep	0
related	0
leg	I-DISEASE
cramps	0
.	I-DISEASE

Exercise	0
involving	0
stretch-	0
ing	0
the	0
affected	0
muscles	I-DISEASE
is	0
thought	I-DISEASE
to	0
help	0
prevent	0
or	0
reduce	0
the	0
occurrence	I-DISEASE
of	0
sleep	0
related	0
leg	0
cramps	0
.	0

Objective	0
Findings	0
Polysomnographic	0
studies	I-DISEASE
of	0
patients	I-DISEASE
with	0
chronic	0
sleep	I-DISEASE
related	0
leg	0
cramps	0
reveal	0
non-	I-DISEASE
periodic	0
bursts	0
of	I-DISEASE
gastrocnemius	I-DISEASE
EMG	0
activity	I-DISEASE
.	0

Episodes	0
arise	0
from	I-DISEASE
sleep	I-DISEASE
without	0
any	I-DISEASE
specific	I-DISEASE
preceding	0
physiologic	I-DISEASE
changes	0
during	0
sleep	I-DISEASE
.	0

Differential	0
Diagnosis	0
Sleep	0
related	0
leg	0
cramps	I-DISEASE
are	I-DISEASE
common	I-DISEASE
in	0
chronic	0
myelopathy	I-DISEASE
,	0
peripheral	0
neuropathy	0
,	0
muscular	0
pain	0
fasciculation	I-DISEASE
syndrome	0
,	0
and	0
disorders	0
of	0
calcium	0
metabolism	I-DISEASE
.	0

These	0
causes	0
should	I-DISEASE
be	0
differentiated	I-DISEASE
by	0
clinical	I-DISEASE
history	0
and	0
physical	0
examination	0
.	0

RLS	0
is	0
Sleep	I-DISEASE
Related	0
Movement	0
Disorders	I-DISEASE
Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
sometimes	0
confused	I-DISEASE
with	I-DISEASE
sleep	0
related	I-DISEASE
leg	0
cramps	0
because	I-DISEASE
both	0
can	I-DISEASE
present	0
with	I-DISEASE
leg	I-DISEASE
discomfort	0
during	I-DISEASE
the	0
sleep	I-DISEASE
period	I-DISEASE
and	0
RLS	0
patients	0
sometimes	0
complain	0
of	0
a	0
cramping	I-DISEASE
sensation	I-DISEASE
.	0

However	0
,	I-DISEASE
if	0
patients	0
meet	0
the	0
diagnostic	I-DISEASE
criteria	0
for	I-DISEASE
RLS	0
and	0
do	0
not	0
describe	0
an	I-DISEASE
actual	0
cramp	I-DISEASE
or	I-DISEASE
hardening	0
of	I-DISEASE
the	0
muscle	0
,	0
the	0
diagnosis	I-DISEASE
should	I-DISEASE
be	0
RLS	I-DISEASE
.	I-DISEASE

Because	0
leg	0
cramps	0
can	I-DISEASE
mimic	0
RLS	I-DISEASE
and	0
meet	0
all	I-DISEASE
the	0
criteria	0
for	0
RLS	0
,	0
the	I-DISEASE
description	0
of	0
an	I-DISEASE
actual	0
spasm	I-DISEASE
or	0
hardening	0
of	0
the	I-DISEASE
muscle	0
is	0
a	0
critical	0
differentiating	0
factor	I-DISEASE
.	I-DISEASE

A	0
leg	0
cramp	0
is	I-DISEASE
also	I-DISEASE
a	I-DISEASE
much	I-DISEASE
briefer	0
event	I-DISEASE
than	0
the	0
typical	0
symptoms	0
of	0
RLS	I-DISEASE
,	0
which	0
can	I-DISEASE
persist	0
for	0
hours	0
.	I-DISEASE

However	0
,	I-DISEASE
RLS	0
and	0
leg	0
cramps	I-DISEASE
may	0
sometimes	0
be	I-DISEASE
seen	0
in	0
the	0
same	I-DISEASE
individual	0
.	0

Dystonia	0
is	0
ongoing	0
daily	I-DISEASE
spasm	0
of	0
muscles	0
and	0
is	0
distinguished	0
electrophysiologi-	0
cally	0
from	I-DISEASE
leg	0
cramps	I-DISEASE
by	I-DISEASE
ongoing	I-DISEASE
co	I-DISEASE
-	0
contraction	0
of	0
agonist	0
and	0
antagonist	0
muscles	0
.	I-DISEASE

Dystonia	0
can	0
be	0
focal	I-DISEASE
,	0
as	0
in	I-DISEASE
the	I-DISEASE
case	I-DISEASE
of	0
muscles	0
of	I-DISEASE
the	0
neck	0
(	I-DISEASE
torticollis	0
)	I-DISEASE
or	I-DISEASE
hand	0
(	0
writer	0
’s	0
cramp	0
)	I-DISEASE
,	0
or	0
generalized	I-DISEASE
as	0
in	0
the	0
case	I-DISEASE
of	I-DISEASE
torsion	0
dystonia	0
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE
Sleep	I-DISEASE
related	I-DISEASE
leg	0
cramps	0
are	0
common	0
and	I-DISEASE
can	0
affect	0
sleep	I-DISEASE
.	0

Their	0
association	0
with	0
other	0
disorders	0
and	I-DISEASE
different	I-DISEASE
medications	0
hinder	I-DISEASE
accurate	0
epidemiological	0
data	0
and	0
under-	0
estimate	0
their	0
effect	0
on	I-DISEASE
sleep	0
and	I-DISEASE
on	0
quality	0
of	0
life	0
.	I-DISEASE

Instruments	0
to	0
quantify	0
the	0
sever-	0
ity	B-DISEASE
of	I-DISEASE
the	0
disorder	0
and	0
its	0
impact	0
are	0
needed	0
to	I-DISEASE
adequately	I-DISEASE
address	0
clinical	0
relevance	0
,	0
treatment	0
,	0
and	0
the	0
potential	I-DISEASE
occupational	0
hazards	0
.	I-DISEASE

Effective	0
treatments	0
for	I-DISEASE
sleep	0
related	0
leg	I-DISEASE
cramps	I-DISEASE
have	0
yet	I-DISEASE
to	0
be	0
developed	0
.	0

The	0
prophylactic	0
benefits	0
of	0
stretching	0
exercises	0
remain	I-DISEASE
to	0
be	I-DISEASE
adequately	0
validated	0
.	0

Bibliography	0
Allen	0
RE	0
,	0
Kirby	0
KA	0
.	I-DISEASE

Nocturnal	0
leg	0
cramps	0
.	0

Am	0
Fam	0
Physician	0
2012;86:350–5	0
.	0

Bahk	0
JW	0
,	I-DISEASE
Kim	0
H	0
,	I-DISEASE
Jung	I-DISEASE
-	0
Choi	0
K	0
,	0
Jung	I-DISEASE
MC	I-DISEASE
,	0
Lee	I-DISEASE
I.	0
Relationship	0
between	I-DISEASE
prolonged	0
standing	0
and	0
symptoms	0
of	0
varicose	0
veins	I-DISEASE
and	0
nocturnal	I-DISEASE
leg	0
cramps	0
among	I-DISEASE
women	0
and	I-DISEASE
men	0
.	0

Ergonomics	0
2012;55:133–9	0
.	0

Butler	0
J	0
,	0
Mulkerrin	0
E	0
,	0
O’Keeffe	I-DISEASE
S.	0
Nocturnal	I-DISEASE
leg	0
cramps	0
in	0
older	0
people	0
.	I-DISEASE

Postgrad	0
Med	0
J	0
2002;78:596–8	0
.	0

Garrison	0
SR	0
,	0
Dormuth	0
CR	0
,	0
Morrow	I-DISEASE
RL	0
,	I-DISEASE
Carney	0
GA	0
,	0
Khan	0
KM	0
.	0

Nocturnal	0
leg	0
cramps	0
and	0
prescription	0
use	I-DISEASE
that	I-DISEASE
precedes	0
them	I-DISEASE
:	0
a	0
sequence	0
symmetry	0
analysis	0
.	I-DISEASE

Arch	0
Intern	0
Med	0
2012;172:120–6	0
.	I-DISEASE

Hawke	0
F	0
,	0
Chuter	0
V	0
,	I-DISEASE
Burns	I-DISEASE
J.	0
Factors	I-DISEASE
associated	0
with	0
night	0
-	0
time	0
calf	I-DISEASE
muscle	I-DISEASE
cramps	0
;	I-DISEASE
a	0
case	0
control	0
study	0
.	0

Muscle	0
Nerve	0
2013;47:339–43	0
.	I-DISEASE

Hawke	0
F	0
,	0
Chuter	0
V	0
,	I-DISEASE
Burns	I-DISEASE
J.	0
Impact	I-DISEASE
of	0
nocturnal	0
calf	0
cramping	0
on	0
quality	0
of	0
sleep	I-DISEASE
and	I-DISEASE
health	0
-	0
related	0
quality	0
of	I-DISEASE
life	0
.	0

Qual	0
Life	0
Res	0
2013;22:1281–6	0
.	0

Heimisdottir	0
F	0
,	0
Guddnason	0
V	0
,	I-DISEASE
Sigurdsson	0
G	0
,	I-DISEASE
Benediktsson	I-DISEASE
R.	0
[	0
Foot	0
disease	0
in	I-DISEASE
Icelandic	0
patients	I-DISEASE
with	I-DISEASE
established	0
type	I-DISEASE
2	0
diabetes	0
]	0
.	0

Laeknabladid	0
2008;94:109–14	0
.	0

Hudson	0
AJ	0
,	0
Brown	0
WF	0
,	I-DISEASE
Gilbert	0
JJ	0
.	I-DISEASE

The	0
muscular	0
pain	0
-	0
fasciculation	0
syndrome	0
.	0

Neurology	0
1978;28:1105–9	0
.	0

Jacobsen	0
J	I-DISEASE
,	0
Rosenberg	0
R	0
,	0
Huttenlocher	I-DISEASE
P	0
,	I-DISEASE
Spire	0
J.	0
Familial	0
nocturnal	0
cramping	0
.	I-DISEASE

Sleep	0
1986;9:54–60	0
.	0

Kleopa	0
KA	0
,	0
Zamba	0
-	0
Papanicolaou	I-DISEASE
E	I-DISEASE
,	0
Kyriakides	0
T.	0
Compressive	0
lumbar	0
myelopathy	0
presenting	I-DISEASE
as	I-DISEASE
segmental	0
motor	0
neuron	I-DISEASE
disease	0
.	0

Muscle	0
Nerve	0
2003;28:69–73	0
.	I-DISEASE

Leung	0
AK	I-DISEASE
,	0
Wong	0
BE	0
,	0
Chan	I-DISEASE
PY	0
,	I-DISEASE
Cho	0
HY	0
.	0

Nocturnal	0
leg	0
cramps	0
in	0
children	I-DISEASE
:	I-DISEASE
incidence	I-DISEASE
and	0
clinical	I-DISEASE
characteristics	0
.	0

J	0
Natl	0
Med	0
Assoc	0
1999;91:329–32	0
.	0

Matsumoto	0
M	0
,	0
Watanabe	I-DISEASE
K	0
,	0
Tsuji	I-DISEASE
T	0
,	I-DISEASE
et	0
al	0
.	0

Nocturnal	0
leg	0
cramps	0
:	0
a	I-DISEASE
common	I-DISEASE
complaint	0
in	0
patients	I-DISEASE
with	0
lumbar	0
spinal	0
canal	I-DISEASE
stenosis	0
.	0

Spine	0
(	0
Phila	0
Pa	0
1976	0
)	0
2009;34	0
:	0
E189–94	I-DISEASE
.	0

Norris	0
FJ	0
,	0
Gasteiger	0
E	0
,	0
Chatfield	0
P.	0

An	0
electromyographic	0
study	0
of	0
induced	0
and	I-DISEASE
spontaneous	I-DISEASE
muscle	0
cramps	I-DISEASE
.	0

Electroencephalogr	0
Clin	0
Neurophysiol	0
1957;9:139–47	0
.	0

Parisi	0
L	0
,	0
Serrao	I-DISEASE
M	0
,	0
Rossi	I-DISEASE
P	0
,	I-DISEASE
et	0
al	0
.	0

Afterdischarge	0
activity	0
in	0
neuropathic	0
patients	0
with	0
frequent	0
muscle	0
cramps	0
.	0

Acta	0
Neurol	0
Scand	0
2000;102:359–62	0
.	0

Pitkin	0
RM	0
.	0

Endocrine	0
regulation	0
of	0
calcium	0
homeostasis	0
during	I-DISEASE
pregnancy	0
.	0

Clin	0
Perinatol	I-DISEASE
1983;10:575–92	0
.	0

Saskin	0
P	0
,	0
Whelton	0
C	0
,	I-DISEASE
Moldofsky	I-DISEASE
H	0
,	I-DISEASE
Akin	0
F.	0
Sleep	0
and	0
nocturnal	0
leg	0
cramps	0
.	0

Sleep	0
1988;11:307–8	0
.	0

Weiner	0
I	0
,	0
Weiner	0
H.	0
Nocturnal	0
leg	I-DISEASE
muscle	0
cramps	0
.	0

JAMA	0
1980;244:2332–3	0
.	0

Sleep	0
Related	0
Bruxism	I-DISEASE
ICD-9	0
-	0
CM	0
code	0
:	0
327.53	0
ICD-10	0
-	0
CM	0
code	0
:	I-DISEASE
G47.63	I-DISEASE
Alternate	0
Names	0
Nocturnal	0
bruxism	0
,	0
nocturnal	0
tooth	0
grinding	0
,	0
tooth	I-DISEASE
clenching	0
.	I-DISEASE

Diagnostic	0
Criteria	0
Criteria	0
A	0
and	0
B	I-DISEASE
must	0
be	0
met	I-DISEASE
A.	0

The	0
presence	0
of	0
regular	0
or	0
frequent	0
tooth	0
grinding	0
sounds	I-DISEASE
occurring	0
during	0
sleep	0
.	I-DISEASE

B.	0
The	0
presence	0
of	0
one	0
or	I-DISEASE
more	I-DISEASE
of	0
the	0
following	0
clinical	0
signs	0
:	0
.	0

Abnormal	0
tooth	0
wear	0
consistent	I-DISEASE
with	0
above	I-DISEASE
reports	0
of	0
tooth	I-DISEASE
grinding	0
during	0
sleep	0
.	I-DISEASE
.	0

Transient	0
morning	0
jaw	0
muscle	I-DISEASE
pain	0
or	0
fatigue	I-DISEASE
;	0
and/or	0
temporal	0
headache	0
;	0
and/or	0
jaw	0
locking	I-DISEASE
upon	0
awakening	0
consistent	0
with	0
above	I-DISEASE
reports	I-DISEASE
of	0
tooth	0
grinding	0
during	0
sleep	0
.	0

Notes	0
.	0

Although	0
polysomnography	0
is	0
not	0
required	0
for	0
the	I-DISEASE
diagnosis	0
,	I-DISEASE
sleep	I-DISEASE
bruxism	0
,	0
as	I-DISEASE
described	0
in	I-DISEASE
the	I-DISEASE
most	I-DISEASE
recent	0
version	0
of	0
the	0
AASM	0
Manual	0
for	I-DISEASE
the	0
Scoring	I-DISEASE
of	0
Sleep	I-DISEASE
and	I-DISEASE
Associated	0
Events	0
,	0
is	0
ideally	0
recorded	0
with	0
masseter	I-DISEASE
muscle	I-DISEASE
activity	I-DISEASE
with	0
audio	0
-	0
video	0
signal	0
to	0
increase	I-DISEASE
diagnostic	I-DISEASE
reliability	I-DISEASE
.	0

Essential	0
Features	0
Bruxism	0
is	0
defined	0
as	0
a	I-DISEASE
repetitive	0
jaw	I-DISEASE
-	0
muscle	0
activity	0
characterized	I-DISEASE
by	0
clenching	I-DISEASE
or	0
grinding	0
of	I-DISEASE
the	0
teeth	0
and/or	0
by	0
bracing	0
or	I-DISEASE
thrusting	I-DISEASE
of	0
the	0
mandible	0
.	0

Bruxism	0
Sleep	0
Related	I-DISEASE
Movement	0
Disorders	0
Sleep	I-DISEASE
Related	I-DISEASE
Movement	0
Disorders	I-DISEASE
has	0
been	0
divided	0
into	I-DISEASE
its	I-DISEASE
two	0
distinct	0
circadian	0
manifestations	I-DISEASE
:	0
sleep	0
bruxism	0
and	0
awake	0
bruxism	I-DISEASE
.	I-DISEASE

In	0
sleep	0
,	0
jaw	0
muscle	0
contractions	0
are	0
frequently	0
repeated	0
over	0
time	0
and	0
are	0
termed	0
rhythmic	0
masticatory	0
muscle	0
activity	0
(	0
RMMA	0
)	0
.	0

These	0
contractions	0
can	0
take	I-DISEASE
two	0
forms	I-DISEASE
on	I-DISEASE
electromyographic	0
traces	0
:	0
a	0
series	0
of	0
repetitive	0
activity	I-DISEASE
(	0
phasic	0
muscle	I-DISEASE
contractions	0
)	I-DISEASE
or	0
isolated	0
sustained	0
jaw	0
clenching	0
(	I-DISEASE
tonic	I-DISEASE
contractions	0
)	0
.	0

These	0
contractions	0
during	0
sleep	I-DISEASE
produce	0
tooth	I-DISEASE
-	0
grinding	I-DISEASE
sounds	I-DISEASE
and	0
are	0
referred	0
to	0
as	0
sleep	I-DISEASE
related	0
bruxism	I-DISEASE
.	I-DISEASE

Sleep	0
related	0
bruxism	I-DISEASE
can	I-DISEASE
lead	0
to	0
abnormal	I-DISEASE
tooth	0
wear	I-DISEASE
,	0
tooth	I-DISEASE
pain	0
,	0
jaw	0
muscle	I-DISEASE
pain	0
,	I-DISEASE
and	I-DISEASE
temporal	0
headache	0
.	0

Severe	0
sleep	0
related	0
bruxism	I-DISEASE
may	I-DISEASE
also	0
result	0
in	0
sleep	I-DISEASE
dis-	0
ruption	0
.	0

This	0
may	0
involve	0
not	0
only	I-DISEASE
the	0
individual	I-DISEASE
affected	0
,	I-DISEASE
but	0
also	0
the	0
bed	I-DISEASE
partner	0
,	0
because	0
the	0
sounds	I-DISEASE
made	0
by	0
the	0
friction	0
of	0
the	I-DISEASE
teeth	I-DISEASE
are	I-DISEASE
usually	0
perceived	I-DISEASE
as	0
being	I-DISEASE
unpleasant	0
and	0
can	0
be	0
quite	0
loud	I-DISEASE
and	0
disturbing	I-DISEASE
to	I-DISEASE
those	0
nearby	0
.	I-DISEASE

The	0
disorder	0
is	0
typically	0
brought	0
to	0
dental	I-DISEASE
or	0
medical	0
attention	0
because	0
of	0
the	0
tooth	I-DISEASE
damage	I-DISEASE
,	I-DISEASE
pain	0
,	I-DISEASE
or	0
disturbing	0
sounds	0
.	0

Less	0
commonly	0
,	0
it	0
may	0
present	0
as	0
a	0
cause	I-DISEASE
of	0
dis-	0
turbed	0
sleep	0
.	0

Young	0
and	I-DISEASE
otherwise	0
healthy	0
individuals	0
with	I-DISEASE
sleep	0
related	I-DISEASE
bruxism	I-DISEASE
appear	0
to	0
have	0
normal	0
sleep	0
structure	0
and	0
homeostasis	I-DISEASE
.	I-DISEASE

The	0
majority	0
of	0
RMMA	0
epi-	0
sodes	0
during	I-DISEASE
sleep	0
occur	I-DISEASE
in	0
association	0
with	0
sleep	0
arousal	0
.	0

Jaw	0
muscle	0
pain	0
,	0
tenderness	0
in	0
the	I-DISEASE
masseter	0
and	0
temporalis	I-DISEASE
muscle	0
regions	0
,	I-DISEASE
morning	0
headache	I-DISEASE
,	0
or	I-DISEASE
fatigue	I-DISEASE
can	I-DISEASE
arise	I-DISEASE
due	0
to	0
sleep	0
related	0
bruxism	I-DISEASE
.	0

Associated	0
Features	0
Additional	0
symptoms	0
include	0
a	I-DISEASE
variety	I-DISEASE
of	I-DISEASE
unpleasant	I-DISEASE
muscle	0
and	0
tooth	0
sensations	I-DISEASE
,	0
lim-	I-DISEASE
itation	0
of	0
jaw	I-DISEASE
movements	0
,	0
orofacial	0
pain	0
,	I-DISEASE
and	0
temporal	0
/	0
tension	0
headaches	0
.	I-DISEASE

Tooth	0
wear	0
,	0
fractured	0
teeth	0
,	0
and	I-DISEASE
buccal	0
lacerations	I-DISEASE
also	0
can	I-DISEASE
occur	0
.	0

These	0
symptoms	0
may	0
be	0
induced	0
by	0
sleep	I-DISEASE
related	I-DISEASE
bruxism	I-DISEASE
,	0
but	0
the	0
connection	0
may	0
not	I-DISEASE
be	I-DISEASE
apparent	0
to	I-DISEASE
the	0
affected	0
indi-	0
vidual	0
and	0
diagnostic	0
discrimination	I-DISEASE
is	I-DISEASE
weak	0
.	I-DISEASE

Headaches	0
are	0
frequently	0
reported	I-DISEASE
by	0
both	0
adults	0
and	0
children	0
with	0
sleep	0
related	I-DISEASE
bruxism	0
.	0

The	0
headache	0
usually	I-DISEASE
involves	0
the	0
temporal	I-DISEASE
regions	I-DISEASE
and	0
it	I-DISEASE
has	0
the	0
charac-	I-DISEASE
teristics	0
of	0
a	I-DISEASE
tension	I-DISEASE
headache	0
.	I-DISEASE

It	0
is	0
reported	0
either	0
in	0
the	0
morning	I-DISEASE
(	I-DISEASE
more	I-DISEASE
frequently	0
)	0
or	I-DISEASE
during	0
the	0
day	I-DISEASE
(	0
with	0
wake	0
bruxism	I-DISEASE
)	0
.	0

The	0
estimated	0
OR	0
for	0
headache	0
in	I-DISEASE
individuals	0
with	0
sleep	I-DISEASE
related	I-DISEASE
bruxism	I-DISEASE
is	0
>	0
4	0
compared	I-DISEASE
to	0
controls	0
.	I-DISEASE

There	0
is	0
high	0
individual	I-DISEASE
variability	0
in	I-DISEASE
the	I-DISEASE
intensity	0
and	I-DISEASE
duration	0
of	0
sleep	0
related	0
bruxism	I-DISEASE
,	I-DISEASE
but	I-DISEASE
in	0
the	I-DISEASE
most	0
severe	0
cases	0
,	0
hundreds	0
of	0
events	I-DISEASE
can	0
occur	0
during	I-DISEASE
a	0
night	0
of	0
sleep	I-DISEASE
.	0

However	0
,	I-DISEASE
no	0
direct	I-DISEASE
relationship	0
has	0
been	0
observed	0
between	I-DISEASE
the	0
severity	I-DISEASE
of	0
sleep	I-DISEASE
related	I-DISEASE
bruxism	I-DISEASE
and	I-DISEASE
the	0
appearance	I-DISEASE
of	0
clinical	I-DISEASE
signs	0
and	0
symptoms	0
.	I-DISEASE

Indeed	0
,	0
indi-	0
viduals	0
with	0
a	I-DISEASE
mild	I-DISEASE
to	0
moderate	I-DISEASE
index	0
of	0
sleep	0
bruxism	I-DISEASE
(	0
2	I-DISEASE
to	0
4	0
RMMA	I-DISEASE
episodes	0
/	0
hour	0
of	0
sleep	I-DISEASE
)	0
have	0
a	0
higher	0
risk	I-DISEASE
of	0
reporting	0
painful	0
jaw	I-DISEASE
upon	0
awakening	0
(	0
OR	0
3.9	I-DISEASE
)	I-DISEASE
,	0
and	0
masticatory	0
muscle	I-DISEASE
fatigue	0
(	0
OR	0
5.1	I-DISEASE
)	0
compared	I-DISEASE
to	0
individuals	I-DISEASE
with	I-DISEASE
severe	0
sleep	I-DISEASE
related	0
bruxism	0
(	I-DISEASE
>	0
4	I-DISEASE
RMMA	0
episodes	0
/	I-DISEASE
hour	0
of	0
sleep	I-DISEASE
)	0
.	I-DISEASE

Psychosocial	0
components	0
may	I-DISEASE
also	0
be	0
linked	0
to	I-DISEASE
sleep	0
related	I-DISEASE
bruxism	0
.	0

The	0
psycholog-	0
ical	0
assessment	0
of	0
otherwise	I-DISEASE
healthy	I-DISEASE
adults	I-DISEASE
with	0
sleep	0
related	0
bruxism	0
suggests	0
a	0
cor-	I-DISEASE
relation	I-DISEASE
(	I-DISEASE
not	I-DISEASE
yet	0
proven	0
as	0
a	0
causality	0
)	0
between	I-DISEASE
bruxism	I-DISEASE
and	I-DISEASE
stress	I-DISEASE
/	0
anxiety	0
.	0

Moreover	0
,	0
both	0
children	0
and	I-DISEASE
adults	I-DISEASE
with	0
sleep	0
related	I-DISEASE
bruxism	I-DISEASE
seem	0
to	0
have	0
higher	0
scores	I-DISEASE
in	0
stress	0
,	I-DISEASE
anxiety	0
,	0
and	0
psychiatric	0
scales	0
compared	0
to	0
control	0
individuals	0
.	I-DISEASE

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Sleep	I-DISEASE
related	I-DISEASE
bruxism	I-DISEASE
without	I-DISEASE
clear	I-DISEASE
cause	0
is	I-DISEASE
termed	0
primary	I-DISEASE
or	0
idiopathic	0
.	0

Forms	0
of	I-DISEASE
sleep	0
related	0
bruxism	0
associated	I-DISEASE
with	I-DISEASE
the	0
use	I-DISEASE
of	0
psychoactive	0
medications	I-DISEASE
,	0
recreational	0
drugs	0
,	0
or	0
a	I-DISEASE
variety	0
of	0
medical	0
disorders	0
(	0
e.g.	0
,	I-DISEASE
Parkinson	0
disease	0
,	0
RBD	0
,	I-DISEASE
Down	0
syndrome	0
)	0
are	0
defined	0
as	0
secondary	0
sleep	I-DISEASE
related	0
bruxism	0
.	I-DISEASE

Treatment	0
-	0
induced	0
sleep	0
related	0
bruxism	I-DISEASE
is	I-DISEASE
also	0
termed	I-DISEASE
iatrogenic	0
.	0

Although	0
the	0
primary	I-DISEASE
form	0
of	0
sleep	I-DISEASE
related	I-DISEASE
bruxism	I-DISEASE
is	I-DISEASE
most	0
often	0
reported	0
in	0
healthy	0
children	0
and	0
adults	0
,	I-DISEASE
secondary	0
sleep	0
related	0
bruxism	0
is	I-DISEASE
observed	I-DISEASE
in	I-DISEASE
children	0
with	0
cere-	I-DISEASE
bral	B-DISEASE
palsy	0
and	I-DISEASE
mental	0
retardation	0
and	0
in	0
adult	0
patients	0
with	I-DISEASE
abnormal	0
movements	0
such	I-DISEASE
as	0
in	0
oromandibular	0
myoclonus	I-DISEASE
/	I-DISEASE
facio	0
-	I-DISEASE
mandibular	I-DISEASE
myoclonus	0
or	0
with	0
sleep	I-DISEASE
related	I-DISEASE
breathing	0
disorders	0
.	0

OSA	0
and	0
sleep	0
related	0
bruxism	0
commonly	I-DISEASE
co	I-DISEASE
-	0
occur	I-DISEASE
.	0

Tooth	0
grinding	0
and	0
clenching	0
also	0
can	I-DISEASE
occur	I-DISEASE
during	0
wakefulness	0
,	0
as	0
an	I-DISEASE
oral	0
parafunc-	0
tional	I-DISEASE
activity	I-DISEASE
known	0
as	0
awake	0
bruxism	0
.	0

Awake	0
bruxism	0
is	0
considered	0
a	I-DISEASE
different	0
dis-	I-DISEASE
order	0
,	I-DISEASE
probably	0
with	0
different	0
diagnostic	0
criteria	0
and	I-DISEASE
pathophysiology	I-DISEASE
;	0
its	I-DISEASE
association	0
with	0
sleep	0
bruxism	0
is	0
still	I-DISEASE
under	I-DISEASE
debate	I-DISEASE
.	0

However	0
,	I-DISEASE
the	0
two	I-DISEASE
oral	0
activities	0
may	0
coexist	0
in	I-DISEASE
the	0
same	0
individual	0
.	I-DISEASE

Demographics	0
The	0
prevalence	0
of	0
sleep	0
related	0
bruxism	I-DISEASE
,	0
based	I-DISEASE
on	I-DISEASE
reports	0
from	0
parents	0
or	0
sleep	0
partner	0
,	0
is	0
highest	0
in	0
childhood	0
(	0
approximately	0
14	0
%	I-DISEASE
to	0
17	0
%	I-DISEASE
)	0
and	0
then	0
decreases	0
over	0
the	0
life	0
span	0
.	0

In	0
teenagers	0
to	0
young	0
adults	0
,	0
prevalence	I-DISEASE
is	I-DISEASE
in	I-DISEASE
the	0
12	0
%	0
range	0
.	0

In	0
young	0
to	0
middle	0
-	0
aged	0
adults	0
,	0
it	I-DISEASE
is	0
approximately	0
8	0
%	0
but	0
as	0
little	0
as	0
3	I-DISEASE
%	0
in	0
older	0
persons	0
.	0

The	0
reported	0
reduction	0
in	0
tooth	0
grinding	I-DISEASE
in	I-DISEASE
the	0
elderly	I-DISEASE
probably	0
overestimates	0
the	0
actual	0
Sleep	0
Related	I-DISEASE
Movement	I-DISEASE
Disorders	I-DISEASE
Sleep	I-DISEASE
Related	I-DISEASE
Movement	0
Disorders	0
reduction	0
,	0
because	0
edentulism	I-DISEASE
,	I-DISEASE
use	0
of	I-DISEASE
dentures	0
,	0
and	0
changes	0
in	0
sleeping	0
behaviors	0
(	0
i.e.	0
,	I-DISEASE
in	0
isolation	0
)	I-DISEASE
may	0
influence	0
reporting	0
.	0

There	0
is	0
no	0
reported	0
sex	0
difference	I-DISEASE
for	I-DISEASE
the	0
prev-	I-DISEASE
alence	0
of	0
sleep	0
related	0
bruxism	0
.	I-DISEASE

Predisposing	0
and	0
Precipitating	0
Factors	0
Predisposing	0
factors	I-DISEASE
include	I-DISEASE
personality	0
types	I-DISEASE
;	0
for	0
example	0
,	0
individuals	0
who	I-DISEASE
are	0
highly	0
motivated	I-DISEASE
or	0
characteristically	I-DISEASE
maintain	0
high	0
vigilance	0
may	0
have	I-DISEASE
an	0
increased	0
preva-	I-DISEASE
lence	0
of	0
sleep	0
related	0
bruxism	0
.	0

Genetic	0
predisposition	0
is	0
plausible	0
but	0
still	0
under	I-DISEASE
investigation	0
.	0

As	0
described	0
below	0
,	0
there	0
is	I-DISEASE
some	0
familial	0
predisposition	0
due	0
to	0
environmental	0
or	0
shared	0
genetic	0
factors	0
.	0

Recently	0
,	0
a	0
serotonin	0
gene	0
was	0
described	I-DISEASE
in	0
bruxism	0
patients	0
but	0
the	0
absence	0
of	0
distinction	I-DISEASE
between	I-DISEASE
the	0
wake	I-DISEASE
and	0
sleep	0
forms	0
in	0
this	I-DISEASE
report	I-DISEASE
preclude	I-DISEASE
firm	I-DISEASE
conclusions	0
.	0

Precipitating	0
factors	0
can	0
include	0
anxiety	0
related	0
to	0
current	0
life	I-DISEASE
events	I-DISEASE
,	0
tasks	0
requir-	I-DISEASE
ing	0
high	I-DISEASE
levels	0
of	0
performance	I-DISEASE
,	0
and	0
repetitive	0
tasks	0
with	0
short	0
deadlines	0
.	0

The	0
use	0
of	0
cigarettes	0
or	0
caffeine	0
in	I-DISEASE
the	0
hours	0
before	0
sleep	0
also	I-DISEASE
can	I-DISEASE
contribute	I-DISEASE
to	I-DISEASE
the	0
occur-	0
rence	I-DISEASE
of	I-DISEASE
sleep	0
related	0
bruxism	0
(	0
probably	0
due	I-DISEASE
to	I-DISEASE
the	I-DISEASE
increased	0
arousals	0
and	I-DISEASE
sleep	0
instability	0
)	0
.	0

The	0
role	0
of	0
dental	0
morphologic	0
“	0
defects	0
”	0
(	I-DISEASE
occlusal	0
interferences	0
)	0
remains	0
controver-	0
sial	I-DISEASE
in	0
the	0
etiology	I-DISEASE
of	0
sleep	0
related	0
bruxism	0
.	I-DISEASE

Tooth	0
contacts	0
do	0
not	0
usually	0
set	I-DISEASE
in	I-DISEASE
motion	I-DISEASE
a	0
bruxism	0
episode	0
;	0
they	0
are	0
usually	0
late	0
in	0
the	I-DISEASE
series	0
of	0
events	0
occurring	0
during	0
sleep	0
related	I-DISEASE
bruxism	0
/	0

tooth	0
grinding	B-DISEASE
.	0

Hence	0
,	0
the	0
causality	I-DISEASE
link	0
between	0
tooth	0
contact	0
and	0
sleep	0
related	0
bruxism	0
is	I-DISEASE
not	I-DISEASE
supported	I-DISEASE
by	0
the	0
temporal	I-DISEASE
sequence	0
.	0

Familial	0
Patterns	0
Sleep	0
related	0
bruxism	0
tends	0
to	I-DISEASE
occur	I-DISEASE
in	I-DISEASE
families	0
;	0
approximately	0
20	I-DISEASE
%	0
to	I-DISEASE
50	0
%	I-DISEASE
of	I-DISEASE
affected	0
individuals	0
have	0
at	0
least	0
one	0
direct	I-DISEASE
family	0
member	I-DISEASE
with	0
a	I-DISEASE
history	I-DISEASE
of	0
tooth	0
grinding	0
,	0
and	0
childhood	0
sleep	0
related	I-DISEASE
bruxism	I-DISEASE
appears	I-DISEASE
to	I-DISEASE
persist	I-DISEASE
into	0
adulthood	I-DISEASE
in	I-DISEASE
two	I-DISEASE
thirds	0
of	I-DISEASE
reported	0
cases	I-DISEASE
.	0

However	0
,	I-DISEASE
no	0
genetic	0
variants	0
or	0
genetic	0
inheritance	0
patterns	I-DISEASE
so	0
far	0
have	0
been	0
associated	0
with	0
sleep	0
related	I-DISEASE
bruxism	I-DISEASE
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
The	I-DISEASE
onset	0
of	I-DISEASE
sleep	0
related	I-DISEASE
bruxism	0
may	0
occur	0
during	I-DISEASE
childhood	I-DISEASE
,	0
adolescence	B-DISEASE
,	0
or	0
adulthood	0
.	0

It	0
is	0
difficult	0
to	0
establish	0
the	0
time	I-DISEASE
of	0
onset	I-DISEASE
with	0
precision	0
because	0
it	0
is	0
mainly	I-DISEASE
based	0
on	0
the	0
awareness	0
of	0
the	0
individual	0
or	0

his	0
/	0
her	0
family	0
members	0
who	0
report	0
the	0
disorder	I-DISEASE
.	0

Sleep	0
related	0
bruxism	I-DISEASE
in	I-DISEASE
childhood	0
has	0
been	0
reported	0
by	0
parents	0
to	0
begin	0
as	0
soon	0
as	I-DISEASE
both	0
upper	0
and	I-DISEASE
lower	0
teeth	0
have	0
erupted	0
.	0

Secondary	0
sleep	0
related	I-DISEASE
bruxism	I-DISEASE
may	0
occur	0
at	I-DISEASE
any	0
age	0
,	I-DISEASE
but	0
is	0
more	0
common	0
in	I-DISEASE
younger	0
and	0
middle	I-DISEASE
-	0
aged	I-DISEASE
adults	0
.	0

Even	0
without	0
a	I-DISEASE
tooth	0
grinding	I-DISEASE
history	I-DISEASE
or	I-DISEASE
complaints	0
,	I-DISEASE
RMMA	0
may	0
be	0
observed	0
in	0
most	I-DISEASE
normal	I-DISEASE
sleepers	0
(	0
on	0
average	I-DISEASE
,	0
one	0
episode	0
per	0
hour	I-DISEASE
of	I-DISEASE
sleep	0
)	I-DISEASE
across	0
the	I-DISEASE
life	I-DISEASE
span	I-DISEASE
.	0

However	0
,	I-DISEASE
in	0
individuals	0
with	0
sleep	0
related	I-DISEASE
bruxism	I-DISEASE
,	I-DISEASE
jaw	0
-	0
muscle	0
contractions	I-DISEASE
are	0
more	I-DISEASE
frequent	0
and	I-DISEASE
more	I-DISEASE
intense	0
.	0

This	0
may	0
explain	0
the	0
secondary	I-DISEASE
tooth	0
damage	I-DISEASE
and	0
the	I-DISEASE
occurrence	I-DISEASE
of	0
pain	0
and	I-DISEASE
other	0
symptoms	I-DISEASE
.	0

The	0
night	0
-	I-DISEASE
to	I-DISEASE
-	0
night	0
variability	I-DISEASE
in	0
episodes	I-DISEASE
of	0
audible	0
tooth	0
grinding	0
sounds	0
is	I-DISEASE
large	0
(	0
greater	I-DISEASE
than	0
50	0
%	0
coefficient	0
of	0
variation	0
)	I-DISEASE
.	0

In	0
-	0
laboratory	0
polysomnographic	0
record-	0
ings	I-DISEASE
indicate	I-DISEASE
that	0
the	I-DISEASE
corresponding	0
variability	0
in	0
frequency	I-DISEASE
of	0
RMMA	I-DISEASE
is	0
smaller	I-DISEASE
(	I-DISEASE
approximately	0
25	0
%	0
)	0
,	0
although	0
ambulatory	0
recording	I-DISEASE
has	0
suggested	I-DISEASE
somewhat	I-DISEASE
higher	0
RMMA	I-DISEASE
variability	0
.	0

First	0
-	0
night	0
effect	0
on	0
RMMA	0
index	0
is	0
minimal	0
.	0

Dental	0
damage	0
and	0
abnormal	0
tooth	0
wear	I-DISEASE
are	0
the	0
most	I-DISEASE
frequent	0
signs	0
of	0
the	I-DISEASE
disorder	I-DISEASE
.	I-DISEASE

However	0
,	I-DISEASE
they	0
are	0
not	0
a	I-DISEASE
direct	I-DISEASE
proof	0
of	I-DISEASE
current	0
sleep	0
related	I-DISEASE
bruxism	I-DISEASE
and	0
many	0
contrib-	0
uting	0
factors	0
have	I-DISEASE
to	0
be	0
ruled	0
out	0
(	I-DISEASE
e.g.	I-DISEASE
,	0
type	0
of	I-DISEASE
diet	B-DISEASE
in	0
the	0
occurrence	0
of	0
abnormal	0
tooth	0
wear	0
)	0
.	I-DISEASE

Diagnostic	0
discriminative	0
strength	0
of	0
these	0
dental	0
findings	I-DISEASE
is	0
weak	I-DISEASE
;	0
severity	0
of	0
wear	0
can	0
not	I-DISEASE
account	0
for	0
the	I-DISEASE
index	0
(	0
i.e.	0
,	0
frequency	0
of	0
RMMA	I-DISEASE
)	0
.	0

Sleep	0
related	0
bruxism	I-DISEASE
could	I-DISEASE
lead	0
to	0
temporomandibular	0
joint	0
disorders	I-DISEASE
(	0
e.g.	0
,	0
pain	0
,	0
joint	I-DISEASE
sound	0
[	0
click	0
]	0
,	I-DISEASE
or	0
jaw	0
movement	0
limitations	0
)	I-DISEASE
,	0
although	0
recent	I-DISEASE
evidence	0
does	0
not	0
support	I-DISEASE
this	0
association	0
.	0

Transient	0
morning	0
orofacial	0
pain	I-DISEASE
,	0
including	0
temporal	I-DISEASE
headaches	0
,	I-DISEASE
is	0
not	0
uncommon	0
,	I-DISEASE
as	0
described	I-DISEASE
above	I-DISEASE
.	I-DISEASE

Hypertrophy	0
of	0
the	0
masseter	0
and	0
temporalis	I-DISEASE
muscles	I-DISEASE
can	0
occur	I-DISEASE
,	0
but	0
the	0
diagnostic	0
specificity	0
of	0
this	0
finding	0
for	I-DISEASE
sleep	0
related	0
bruxism	0
is	0
also	0
weak	0
.	0

The	0
natural	0
course	0
of	0
this	0
sleep	0
disorder	I-DISEASE
is	0
usually	I-DISEASE
benign	0
.	0

Many	0
individuals	0
with	0
sleep	0
related	0
bruxism	I-DISEASE
remain	I-DISEASE
asymptomatic	0
for	I-DISEASE
most	0
of	0
their	0
lives	0
.	0

Others	0
can	0
experi-	0
ence	0
associated	0
symptoms	0
(	I-DISEASE
i.e.	0
,	I-DISEASE
pain	0
)	0
that	0
may	0
interfere	0
with	0
their	0
quality	0
of	I-DISEASE
life	0
and/	0
or	0
sleep	0
and	0
may	0
require	I-DISEASE
treatments	0
.	0

Further	0
diagnostic	0
investigations	0
and	I-DISEASE
assessment	0
are	0
recommended	I-DISEASE
if	0
sleep	0
related	0
bruxism	I-DISEASE
is	0
associated	0
with	0
other	I-DISEASE
more	0
severe	0
sleep	I-DISEASE
or	0
medical	0
disorders	0
(	0
e.g.	0
,	0
SRBD	I-DISEASE
,	0
RBD	0
,	I-DISEASE
epilepsy	0
)	0
.	0

Developmental	0
Issues	0
Sleep	0
related	0
bruxism	0
is	I-DISEASE
frequently	I-DISEASE
reported	0
in	I-DISEASE
childhood	0
but	0
decreases	0
with	0
age	0
.	0

However	0
,	I-DISEASE
some	0
individuals	0
may	0
experience	I-DISEASE
it	0
every	0
night	I-DISEASE
for	I-DISEASE
most	0
of	0
their	I-DISEASE
lives	0
.	I-DISEASE

Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
Sleep	0
Related	0
Movement	0
Disorders	0
Conceptualizations	I-DISEASE
of	I-DISEASE
sleep	0
related	0
bruxism	0
in	0
children	0
vary	0
.	0

Some	0
consider	0
this	0
a	0
physiological	0
oral	0
parafunction	I-DISEASE
while	0
teeth	I-DISEASE
are	0
erupting	0
or	0
exfoliating	0
,	0
whereas	I-DISEASE
others	0
view	0
this	I-DISEASE
as	0
a	0
sleep	0
disorder	0
with	0
many	0
associated	I-DISEASE
signs	0
and	I-DISEASE
symptoms	I-DISEASE
.	0

Sleep	0
related	I-DISEASE
bruxism	I-DISEASE
,	I-DISEASE
especially	0
in	0
children	I-DISEASE
,	0
has	0
been	I-DISEASE
associated	0
with	0
attention	0
deficit	0
hyperactivity	I-DISEASE
disorder	I-DISEASE
,	0
parasomnias	I-DISEASE
,	0
SRBD	0
,	0
snoring	0
,	0
and	0
many	0
psychological	0
and	0
medical	I-DISEASE
conditions	0
.	0

In	0
the	0
elderly	I-DISEASE
,	I-DISEASE
sleep	0
related	I-DISEASE
bruxism	I-DISEASE
has	I-DISEASE
been	0
observed	0
in	0
association	0
with	I-DISEASE
movement	0
disorders	0
(	0
e.g.	0
,	I-DISEASE
Parkinson	0
disease	0
or	0
oral	0
tardive	0
dyskinesia	0
persisting	I-DISEASE
during	0
sleep	0
)	I-DISEASE
,	0
RBD	I-DISEASE
,	0
and	0
dementia	0
.	0

Pathology	0
and	0
Pathophysiology	0
The	0
majority	0
of	I-DISEASE
RMMA	I-DISEASE
episodes	0
during	I-DISEASE
sleep	0
(	0
up	0
to	0
80	0
%	I-DISEASE
)	0
occur	I-DISEASE
in	I-DISEASE
association	0
with	I-DISEASE
sleep	0
arousals	0
.	0

Sleep	0
related	I-DISEASE
bruxism	I-DISEASE
episodes	I-DISEASE
typically	0
follow	0
a	I-DISEASE
clear	I-DISEASE
arousal	I-DISEASE
sequence	0
,	0
starting	0
with	0
increased	0
sympathetic	I-DISEASE
-	0
cardiac	0
activity	0
and	0
fast	I-DISEASE
electroenceph-	0
alographic	0
(	0
EEG	I-DISEASE
)	0
waves	0
in	0
the	I-DISEASE
minutes	I-DISEASE
to	I-DISEASE
seconds	0
preceding	0
the	0
onset	0
of	0
an	I-DISEASE
RMMA	0
episode	0
.	0

The	0
jaw	0
muscle	I-DISEASE
contractions	0
are	0
then	I-DISEASE
followed	I-DISEASE
by	I-DISEASE
,	I-DISEASE
or	0
are	0
concomitant	0
with	0
,	0
an	0
increase	0
in	0
blood	0
pressure	0
and	0
ventilation	0
.	0

RMMA	0
episodes	0
sometimes	0
conclude	0
with	0
swallowing	0
.	0

Other	0
causes	0
of	I-DISEASE
sleep	I-DISEASE
bruxism	0
onset	I-DISEASE
are	0
unknown	0
,	I-DISEASE
although	0
potential	I-DISEASE
candidates	0
include	0
airway	0
resistance	0
and	0
oropharyngeal	0
dryness	I-DISEASE
.	0

In	0
the	0
majority	I-DISEASE
of	0
individuals	0
with	0
sleep	0
related	I-DISEASE
bruxism	I-DISEASE
,	0
the	0
frequency	0
of	0
sleep	0
arous-	0
als	0
is	I-DISEASE
within	0
the	0
normal	0
range	0
.	0

However	0
,	I-DISEASE
they	0
may	0
have	0
an	0
exaggerated	I-DISEASE
responsiveness	0
to	I-DISEASE
ongoing	0
sleep	0
arousals	I-DISEASE
or	0
an	0
increased	I-DISEASE
magnitude	I-DISEASE
of	I-DISEASE
arousal	I-DISEASE
.	0

Individuals	0
with	0
sleep	0
related	I-DISEASE
bruxism	I-DISEASE
show	I-DISEASE
more	0
CAP	0
phase	0
A3	0
(	0
as	I-DISEASE
described	0
by	0
the	I-DISEASE
scoring	I-DISEASE
and	0
analysis	I-DISEASE
of	0
cyclic	I-DISEASE
alternating	0
pattern	0
(	I-DISEASE
CAP	I-DISEASE
)	I-DISEASE
during	0
sleep	0
)	0
than	0
controls	0
,	I-DISEASE
an	I-DISEASE
expression	0
of	0
increased	0
arousal	0
pressure	0
and	I-DISEASE
increased	I-DISEASE
sleep	0
instability	I-DISEASE
.	I-DISEASE

This	0
increased	0
sleep	0
instability	I-DISEASE
seems	0
to	0
be	0
the	0
“	I-DISEASE
permissive	0
window	0
”	0
for	0
occurrence	0
of	I-DISEASE
RMMA	0
during	0
sleep	I-DISEASE
.	0

Objective	0
Findings	0
Polysomnographic	0
(	I-DISEASE
PSG	0
)	I-DISEASE
monitoring	0
of	0
individuals	I-DISEASE
with	0
sleep	0
related	0
bruxism	I-DISEASE
demonstrates	0
increased	I-DISEASE
masseter	0
and	0
temporalis	I-DISEASE
muscle	0
activity	I-DISEASE
during	I-DISEASE
sleep	I-DISEASE
,	0
along	0
with	I-DISEASE
grinding	0
sounds	0
.	I-DISEASE

RMMA	0
episodes	0
can	0
occur	0
during	0
all	0
sleep	I-DISEASE
stages	0
,	0
but	I-DISEASE
are	0
most	0
common	0
in	0
sleep	0
stages	0
N1	0
and	I-DISEASE
N2	0
(	0
more	0
than	0
80	0
%	I-DISEASE
of	I-DISEASE
episodes	0
)	0
,	B-DISEASE
whereas	0
fewer	I-DISEASE
than	0
10	I-DISEASE
%	0
of	0
RMMA	0
episodes	0
occur	I-DISEASE
during	0
REM	0
sleep	0
.	0

However	0
,	I-DISEASE
in	0
some	0
individuals	0
,	0
sleep	I-DISEASE
related	0
bruxism	I-DISEASE
occurs	0
predominantly	0
in	0
REM	0
sleep	0
.	0

As	0
described	0
above	0
,	0
the	0
majority	I-DISEASE
of	I-DISEASE
sleep	0
related	I-DISEASE
bruxism	I-DISEASE
episodes	0
are	0
temporally	0
associated	0
with	I-DISEASE
sleep	0
arousal	0
and	0
are	0
preceded	I-DISEASE
by	0
signs	0
of	0
autonomic	0
/	I-DISEASE
cardiac	I-DISEASE
activa-	0
tion	0
(	0
e.g.	I-DISEASE
,	0
increased	I-DISEASE
heart	0
rate	0
and	0
blood	0
pressure	0
)	I-DISEASE
.	0

Three	0
subtypes	0
of	0
the	0
EMG	0
pattern	I-DISEASE
of	I-DISEASE
sleep	0
related	I-DISEASE
bruxism	0
have	0
been	I-DISEASE
described	I-DISEASE
:	0
phasic	0
activity	0
at	0
1	0
Hz	0
frequency	0
with	0
EMG	0
bursts	0
lasting	0
0.25	I-DISEASE
to	0
2	0
seconds	0
;	0
sustained	0
tonic	I-DISEASE
activity	I-DISEASE
lasting	0
longer	0
than	0
2	0
seconds	0
;	I-DISEASE
or	0
a	I-DISEASE
mixed	0
pattern	0
.	0

An	0
episode	0
begins	0
after	0
at	0
least	I-DISEASE
a	I-DISEASE
three	0
-	0
second	0
interval	0
with	0
no	0
muscle	0
activity	I-DISEASE
.	0

Polysomnography	0
is	0
not	0
usually	0
performed	0
in	I-DISEASE
otherwise	I-DISEASE
healthy	0
individuals	I-DISEASE
with	0
sleep	0
related	0
bruxism	0
in	0
routine	I-DISEASE
clinical	I-DISEASE
settings	I-DISEASE
.	I-DISEASE

However	0
,	I-DISEASE
PSG	0
may	I-DISEASE
be	0
indicated	0
to	I-DISEASE
demon-	0
strate	I-DISEASE
the	0
disorder	0
and	0
to	0
rule	I-DISEASE
out	I-DISEASE
associated	I-DISEASE
respiratory	0
disturbances	I-DISEASE
,	0
gastroesophageal	0
reflux	0
,	0
RBD	0
,	0
night	0
terrors	0
,	0
faciomandibular	I-DISEASE
myoclonus	0
,	0
or	0
epilepsy	0
.	0

The	0
sensitivity	0
of	0
polysomnographic	I-DISEASE
study	0
in	I-DISEASE
detecting	I-DISEASE
sleep	0
related	I-DISEASE
bruxism	0
in	0
severe	0
cases	0
is	0
moderate	I-DISEASE
to	I-DISEASE
high	I-DISEASE
;	0
in	0
milder	0
cases	0
,	B-DISEASE
however	0
,	0
it	I-DISEASE
may	I-DISEASE
be	0
low	0
due	I-DISEASE
to	0
the	I-DISEASE
night	0
-	0
to	0
-	0
night	0
variability	I-DISEASE
in	I-DISEASE
RMMA	0
and	0
tooth	I-DISEASE
grinding	I-DISEASE
.	0

Ambulatory	0
home	0
monitoring	I-DISEASE
may	0
be	0
used	0
for	0
screening	I-DISEASE
,	I-DISEASE
diagnosis	0
,	0
and	0
treatment	0
outcome	0
assessment	I-DISEASE
by	0
studying	0
the	I-DISEASE
individual	0
in	0
his	0
/	0
her	0
usual	0
environment	0
,	0
but	0
it	I-DISEASE
is	0
characterized	0
by	0
lower	0
diagnostic	0
specificity	0
due	0
to	0
the	0
absence	0
of	0
audiovisual	0
record-	I-DISEASE
ings	I-DISEASE
(	0
i.e.	0
,	0
20	I-DISEASE
%	0
overestimation	I-DISEASE
in	0
RMMA	I-DISEASE
frequency	0
is	I-DISEASE
expected	0
due	0
to	0
poor	0
capacity	0
to	0
exclude	0
concomitant	0
nonspecific	I-DISEASE
activities	0
)	I-DISEASE
.	0

To	0
record	0
and	0
score	0
sleep	0
related	I-DISEASE
bruxism	I-DISEASE
activity	0
(	0
i.e.	0
,	0
RMMA	0
)	0

,	0
there	0
must	I-DISEASE
be	0
a	I-DISEASE
minimum	I-DISEASE
of	I-DISEASE
one	0
masseter	I-DISEASE
muscle	0
monitor	0
,	0
ideally	I-DISEASE
with	0
audiovisual	0
recording	0
,	0
to	I-DISEASE
associate	0
muscular	0
activity	0
with	0
grinding	0
sound	0
production	I-DISEASE
.	0

Video	0
monitoring	0
helps	0
distinguish	0
bruxism	0
from	I-DISEASE
other	0
orofacial	0
and	I-DISEASE
masticatory	0
movements	0
that	0
normally	I-DISEASE
occur	0
during	I-DISEASE
sleep	0
(	0
e.g.	I-DISEASE
,	0
swallowing	I-DISEASE
,	0
coughing	0
)	I-DISEASE
and	I-DISEASE
from	I-DISEASE
specific	0
movement	0
disorders	I-DISEASE
(	0
RBD	0
,	I-DISEASE
epilepsy	0
and	0
tooth	0
tapping	0
,	0
oromandibular	0
myoclonus	I-DISEASE
)	0
.	I-DISEASE

For	0
the	0
best	I-DISEASE
level	0
of	0
diagnostic	I-DISEASE
specificity	I-DISEASE
and	0
sensitivity	I-DISEASE
,	0
bilateral	0
masseter	0
and	0
tem-	0
poralis	I-DISEASE
muscle	I-DISEASE
EMG	0
recordings	0
,	0
referenced	0
to	0
ear	0
,	0
mastoid	I-DISEASE
,	I-DISEASE
or	0
zygomatic	0
bone	I-DISEASE
,	0
are	I-DISEASE
advisable	0
.	0

Differential	0
Diagnosis	0

The	0
disorder	0
seldom	0
poses	0
diagnostic	0
problems	0
.	0

Evaluation	0
for	0
temporomandibular	0
disorders	0
and	0
damage	0
to	I-DISEASE
dentition	0
is	I-DISEASE
indicated	0
.	0

Sleep	0
related	0
bruxism	I-DISEASE
needs	I-DISEASE
to	0
be	0
differentiated	0
from	0
other	I-DISEASE
faciomandibular	0
activities	0
occurring	0
during	0
sleep	0
,	I-DISEASE
such	0
as	I-DISEASE
faciomandibular	I-DISEASE
myoclonus	0
,	0
SRBD	0
,	0
RBD	0
,	0
abnormal	I-DISEASE
swallowing	0
,	0
gastro	B-DISEASE
-	0
esophageal	I-DISEASE
reflux	0
,	0
night	0
terrors	0
,	0
confusional	0
arousals	0
,	0
dyskinetic	0
jaw	0
movements	0
persisting	0
in	0
sleep	0
(	I-DISEASE
dystonia	0
,	I-DISEASE
tremor	I-DISEASE
,	0
chorea	0
,	I-DISEASE
dyskinesia	0
)	I-DISEASE
,	I-DISEASE
and	0
,	0
rarely	0
,	I-DISEASE
sleep	0
related	I-DISEASE
epilepsy	I-DISEASE
.	I-DISEASE

Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
Oromandibular	I-DISEASE
or	I-DISEASE
faciomandibular	0
myoclonus	0
has	0
been	0
observed	0
in	0
approximately	0
10	I-DISEASE
%	0
of	0
individuals	0
with	0
severe	0
sleep	I-DISEASE
related	I-DISEASE
bruxism	0
,	I-DISEASE
but	I-DISEASE
it	0
can	0
also	0
occur	0
in	0
indi-	0
viduals	0
without	I-DISEASE
abnormally	0
increased	I-DISEASE
RMMA	0
events	0
.	I-DISEASE

As	0
opposed	0
to	0
sleep	0
related	0
bruxism	I-DISEASE
,	I-DISEASE
faciomandibular	0
myoclonus	I-DISEASE
consists	0
of	0
EMG	0
bursts	0
of	0
brief	I-DISEASE
duration	0
(	0
less	I-DISEASE
than	0
250	0
milliseconds	0
in	0
length	0
)	0
in	0
the	0
facial	I-DISEASE
muscles	I-DISEASE
;	0
these	0
can	0
occur	I-DISEASE
either	0
as	0
isolated	0
bursts	0
or	0
as	0
a	I-DISEASE
cluster	0
of	I-DISEASE
regularly	0
or	0
irregularly	0
occurring	0
brief	0
bursts	0
.	I-DISEASE

A	0
high	0
index	0
of	0
oromandibular	0
myoclonus	0
in	I-DISEASE
sleep	0
has	I-DISEASE
been	0
observed	0
in	0
idiopathic	0
RBD	0
patients	0
.	I-DISEASE

Rhythmic	0
jaw	0
movements	0
also	I-DISEASE
have	0
been	0
observed	0
in	0
association	I-DISEASE
with	0
partial	0
complex	0
or	0
generalized	0
seizure	0
disorders	0
.	0

Epilepsy	0
needs	0
to	0
be	0
considered	0
in	0
the	I-DISEASE
differential	0
diagnosis	0
,	I-DISEASE
although	0
the	0
presentation	0
of	0
epilepsy	I-DISEASE
as	0
relatively	0
isolated	0
sleep	0
related	0
bruxism	0
is	0
very	0
rare	I-DISEASE
.	I-DISEASE

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE

An	0
expert	0
bruxism	0
international	I-DISEASE
group	0
has	I-DISEASE
proposed	0
a	0
diagnostic	I-DISEASE
grading	0
system	0
of	0
“	I-DISEASE
possible	0
,	I-DISEASE
”	I-DISEASE
“	0
probable	I-DISEASE
,	0
”	I-DISEASE
and	0
“	0
definite	0
”	0
for	I-DISEASE
both	0
sleep	0
and	I-DISEASE
awake	0
bruxism	0
.	I-DISEASE

Such	0
a	0
clinical	0
tool	0
will	0
help	I-DISEASE
to	I-DISEASE
discriminate	0
sleep	I-DISEASE
bruxism	I-DISEASE
from	0
awake	I-DISEASE
bruxism	I-DISEASE
,	0
although	I-DISEASE
further	0
validation	0
is	I-DISEASE
required	0
for	0
clinical	0
and	0
research	0
purposes	0
in	I-DISEASE
all	0
relevant	0
dental	0
and	0
medical	I-DISEASE
domains	0
.	0

In	0
summary	0
,	0
this	0
group	0
suggests	0
that	I-DISEASE
a	0
rating	I-DISEASE
of	0
:	0
(	0
1	I-DISEASE
)	0
“	I-DISEASE
possible	0
”	0
is	I-DISEASE
given	0
if	0
based	0
on	0
self	0
-	0
report	I-DISEASE
,	0
by	0
means	I-DISEASE
of	0
questionnaires	I-DISEASE
,	0
and/or	0
the	0
anamnestic	0
part	0
of	0
a	0
clinical	I-DISEASE
examination	I-DISEASE
;	0
(	0
2	I-DISEASE
)	0
“	0
probable	I-DISEASE
”	I-DISEASE
sleep	I-DISEASE
or	I-DISEASE
awake	0
bruxism	I-DISEASE
is	I-DISEASE
given	0
if	I-DISEASE
based	0
on	0
self	0
-	0
report	I-DISEASE
and	0
supportive	I-DISEASE
physical	I-DISEASE
findings	0
;	0
(	I-DISEASE
3	0
)	I-DISEASE
“	I-DISEASE
definite	0
”	I-DISEASE
sleep	I-DISEASE
bruxism	0
if	0
based	I-DISEASE
on	I-DISEASE
self	0
-	I-DISEASE
report	0
,	0
physical	I-DISEASE
findings	I-DISEASE
,	I-DISEASE
and	0
a	0
polysomnographic	0
recording	0
,	0
preferably	0
with	0
audiovisual	I-DISEASE
recordings	I-DISEASE
.	I-DISEASE

The	0
clinical	0
relevance	0
of	0
sleep	0
related	I-DISEASE
bruxism	I-DISEASE
in	I-DISEASE
cases	0
of	0
comorbidity	0
with	I-DISEASE
other	I-DISEASE
medical	0
problems	I-DISEASE
such	I-DISEASE
as	0
snoring	I-DISEASE
,	0
sleep	0
related	0
breathing	0
disorder	0
,	0
RBD	I-DISEASE
,	I-DISEASE
attention	0
deficit	I-DISEASE
hyperactivity	I-DISEASE
disorder	0
,	I-DISEASE
headache	0
,	0
and	0
orofacial	0
pain	0
needs	0
to	I-DISEASE
be	0
assessed	0
in	0
order	I-DISEASE
to	0
distinguish	I-DISEASE
primary	I-DISEASE
benign	I-DISEASE
forms	I-DISEASE
of	0
sleep	I-DISEASE
related	0
bruxism	I-DISEASE
from	0
those	I-DISEASE
that	I-DISEASE
rep-	0
resent	0
an	0
epiphenomenon	I-DISEASE
of	0
other	0
more	I-DISEASE
severe	0
sleep	I-DISEASE
and	I-DISEASE
medical	I-DISEASE
disorders	I-DISEASE
.	I-DISEASE

Sleep	0
related	I-DISEASE
bruxism	I-DISEASE
may	I-DISEASE
be	0
concomitant	0
to	I-DISEASE
breathing	I-DISEASE
disorders	I-DISEASE
,	0
including	0
any	0
level	0
of	0
severity	I-DISEASE
of	I-DISEASE
OSA	0
;	I-DISEASE
further	0
research	0
is	0
in	0
progress	0
to	I-DISEASE
assess	I-DISEASE
the	0
specificity	0
and	I-DISEASE
validity	0
of	I-DISEASE
this	I-DISEASE
association	0
.	I-DISEASE

There	0
is	0
currently	0
no	0
evidence	0
supporting	0
the	I-DISEASE
possibility	I-DISEASE
that	0
patients	0
with	I-DISEASE
sleep	0
related	I-DISEASE
bruxism	I-DISEASE
,	I-DISEASE
in	0
its	0
primary	I-DISEASE
form	0
,	I-DISEASE
are	0
at	0
increased	0
risk	0
of	I-DISEASE
neurological	0
disorders	0
;	I-DISEASE
such	0
a	0
risk	I-DISEASE
factor	0
assessment	0
needs	0
long-	0
term	0
study	0
before	I-DISEASE
any	0
conclusion	0
can	0
be	0
drawn	0
.	0

Investigation	0
of	I-DISEASE
genetic	0
associations	0
to	0
sleep	0
related	I-DISEASE
bruxism	I-DISEASE
require	I-DISEASE
large	0
sample	0
sizes	0
,	0
using	0
valid	I-DISEASE
tools	I-DISEASE
to	I-DISEASE
assess	I-DISEASE
the	0
specificity	0
of	0
RMMA	0
versus	0
other	0
oromandibular	I-DISEASE
activities	0
and	0
to	I-DISEASE
discriminate	0
gene	I-DISEASE
candidates	0
specific	0
for	0
bruxism	0
from	0
those	0
related	0
to	0
its	I-DISEASE
comorbidities	I-DISEASE
such	I-DISEASE
as	0
stress	0
or	0
other	0
related	I-DISEASE
triggers	0
of	I-DISEASE
RMMA	0
.	0

Bibliography	0
Abe	0
S	I-DISEASE
,	0
Yamaguchi	0
T	0
,	I-DISEASE
Rompré	0
PH	0
,	0
De	0
Grandmont	0
P	0
,	0
Chen	I-DISEASE
YJ	0
,	0
Lavigne	I-DISEASE
GJ	0
.	0

Tooth	0
wear	0
in	0
young	0
subjects	0
:	0
a	I-DISEASE
discriminator	0
between	I-DISEASE
sleep	0
bruxers	0
and	0
controls	0
?	0

Int	0
J	0
Prosthodont	0
2009;22:342–50	0
.	0

Carra	0
MC	0
,	0
Macaluso	0
GM	0
,	0
Rompre	0
PH	0
,	I-DISEASE
et	0
al	0
.	0

Clonidine	0
has	I-DISEASE
a	0
paradoxical	0
effect	0
on	0
cyclic	I-DISEASE
arousal	0
and	I-DISEASE
sleep	0
bruxism	0
during	0
NREM	0
sleep	0
.	I-DISEASE

Sleep	0
2010;33:1711–6	0
.	0

Hublin	0
C	0
,	I-DISEASE
Kaprio	I-DISEASE
J	0
,	0
Partinen	I-DISEASE
M	0
,	I-DISEASE
Koskenvuo	0
M.	I-DISEASE
Sleep	0
bruxism	I-DISEASE
based	0
on	0
self	0
-	0
report	I-DISEASE
in	0
a	0
nationwide	0
twin	0
cohort	0
.	0

J	0
Sleep	0
Res	0
1998;7:61–7	B-DISEASE
.	0

Lavigne	0
G	0
,	0
Guitard	0
F	0
,	0
Rompre	0
P	0
,	0
Montplaisir	0
J.	0
Variability	0
in	I-DISEASE
sleep	0
bruxism	I-DISEASE
activity	0
over	0
time	I-DISEASE
.	0

J	0
Sleep	0
Res	0
2001;10:237–44	B-DISEASE
.	0

Lavigne	0
G	0
,	0
Manzini	0
C	0
,	0
Huynh	I-DISEASE
NT	0
.	I-DISEASE

Sleep	0
bruxism	0
.	0

In	0
:	0
Kryger	0
MH	0
,	I-DISEASE
Roth	0
T	I-DISEASE
,	0
Dement	I-DISEASE
WC	0
,	0
eds	0
.	0

Principles	0
and	I-DISEASE
practice	0
of	I-DISEASE
sleep	0
medicine	I-DISEASE
,	I-DISEASE
5th	0
ed	I-DISEASE
.	0

St.	0
Louis	0
:	0
Elsevier	0
Saunders	0
,	0
2011:1129–39	I-DISEASE
.	0

Lobbezoo	0
F	0
,	0
Ahlberg	0
J	0
,	0
Glaros	I-DISEASE
AG	0
,	0
et	0
al	0
.	0

Bruxism	0
defined	0
and	0
graded	0
:	0
An	0
international	I-DISEASE
consensus	0
.	I-DISEASE

J	0
Oral	0
Rehab	0
2013;40:2–4	0
.	0

Ohayon	0
M	I-DISEASE
,	0
Li	0
K	0
,	0
Guilleminault	I-DISEASE
C.	0
Risk	I-DISEASE
factors	I-DISEASE
for	0
sleep	0
bruxism	0
in	0
the	I-DISEASE
general	0
population	0
.	I-DISEASE

Chest	0
2001;119:53–61	0
.	0

Rompre	0
PH	0
,	0
Daigle	I-DISEASE
-	0
Landry	0
D	0
,	0
Guitard	I-DISEASE
F	0
,	0
Montplaisir	0
JY	I-DISEASE
,	0
Lavigne	I-DISEASE
GJ	0
.	0

Identification	0
of	0
a	0
sleep	0
bruxism	0
subgroup	I-DISEASE
with	I-DISEASE
a	I-DISEASE
higher	0
risk	0
of	0
pain	0
.	0

J	0
Dent	0
Res	0
2007;86:837–42	0
.	0

Vetrugno	0
R	0
,	0
Provini	0
F	0
,	0
Plazzi	I-DISEASE
G	0
,	I-DISEASE
et	0
al	0
.	0

Familial	0
nocturnal	0
facio	0
-	0
mandibular	0
myoclonus	0
mimicking	I-DISEASE
sleep	0
bruxism	I-DISEASE
.	0

Neurology	0
2002;58:644–7	0
.	0

Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
Sleep	I-DISEASE
Related	I-DISEASE
Rhythmic	0
Movement	0
Disorder	0
ICD-9	0
-	0
CM	0
code	I-DISEASE
:	0
327.59	0
ICD-10	0
-	0
CM	0
code	0
:	0
G47.69	0
Alternate	0
Names	0
Body	I-DISEASE
rocking	0
,	I-DISEASE
head	0
banging	0
,	0
head	0
rolling	0
,	0
body	0
rolling	0
,	0
jactatio	0
capitis	B-DISEASE
nocturna	I-DISEASE
,	I-DISEASE
jac-	0
tatio	0
corporis	I-DISEASE
nocturna	I-DISEASE
,	0
rhythmie	0
du	0
sommeil	0
.	0

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
D	I-DISEASE
must	0
be	0
met	I-DISEASE
A.	0

The	0
patient	0
exhibits	0
repetitive	B-DISEASE
,	0
stereotyped	0
,	I-DISEASE
and	0
rhythmic	0
motor	0
behaviors	0
involving	0
large	0
muscle	0
groups	0
.	0

B.	0
The	0
movements	0
are	0
predominantly	0
sleep	0
related	I-DISEASE
,	I-DISEASE
occurring	I-DISEASE
near	0
nap	0
or	0
bedtime	0
,	0
or	0
when	0
the	0
individual	I-DISEASE
appears	0
drowsy	I-DISEASE
or	0
asleep	0
.	0

C.	0

The	0
behaviors	0
result	0
in	0
a	0
significant	0
complaint	0
as	0
manifest	I-DISEASE
by	0
at	0
least	I-DISEASE
one	I-DISEASE
of	0
the	I-DISEASE
following:1	I-DISEASE
.	0

Interference	0
with	0
normal	0
sleep	0
.	0
.	I-DISEASE

Significant	0
impairment	0
in	I-DISEASE
daytime	I-DISEASE
function	0
.	I-DISEASE
.	0

Self	0
-	0
inflicted	0
bodily	0
injury	0
or	0
likelihood	0
of	0
injury	I-DISEASE
if	0
preventive	0
measures	0
are	I-DISEASE
not	0
used	0
.	I-DISEASE

D.	0

The	0
rhythmic	0
movements	0
are	0
not	0
better	I-DISEASE
explained	I-DISEASE
by	0
another	I-DISEASE
movement	0
disorder	0
or	0
epilepsy	0
.	0

Notes	0
.	0

When	0
there	0
are	0
no	0
clinical	0
consequences	0
of	I-DISEASE
the	0
rhythmic	I-DISEASE
movements	0
,	0
the	0
rhythmic	I-DISEASE
movements	0
are	I-DISEASE
simply	0
noted	0
but	0
the	0
term	I-DISEASE
rhythmic	0
movement	0
disorder	0
is	0
not	I-DISEASE
employed	0
.	0

Essential	0
Features	0
Sleep	0
related	0
rhythmic	I-DISEASE
movement	0
disorder	I-DISEASE
(	0
RMD	I-DISEASE
)	0
is	0
characterized	I-DISEASE
by	0
repetitive	0
,	I-DISEASE
ste-	0
reotyped	0
,	0
and	0
rhythmic	0
motor	0
behaviors	0
(	0
not	0
tremors	I-DISEASE
)	0
that	0
occur	0
predominantly	0
during	I-DISEASE
drowsiness	0
or	0
sleep	0
and	0
involve	0
large	0
muscle	0
groups	I-DISEASE
.	0

The	0
occurrence	0
of	0
significant	0
clinical	0
consequences	0
differentiates	I-DISEASE
RMD	0
from	I-DISEASE
developmentally	0
normal	0
sleep	0
related	0
movements	0
.	0

Typically	0
seen	0
in	0
infants	0
and	0
children	I-DISEASE
,	I-DISEASE
but	0
also	0
in	0
adults	0
,	0
RMD	0
comprises	0
several	0
sub-	0
types	0
.	0

Body	0
rocking	0
may	0
involve	0
the	0
entire	I-DISEASE
body	I-DISEASE
,	0
with	I-DISEASE
the	0
individual	I-DISEASE
on	0
hands	0
and	0
knees	I-DISEASE
,	0
or	0
it	0
may	0
be	0
limited	0
to	0
the	0
torso	I-DISEASE
,	0
with	0
the	0
individual	I-DISEASE
sitting	0
.	0

Head	0
banging	0
often	I-DISEASE
occurs	I-DISEASE
with	0
the	0
person	I-DISEASE
prone	0
,	I-DISEASE
repeatedly	0
lifting	0
the	0
head	I-DISEASE
or	0
entire	0
upper	0
torso	0
,	I-DISEASE
and	0
forc-	I-DISEASE
ibly	0
banging	0
the	0
head	0
back	I-DISEASE
down	I-DISEASE
into	I-DISEASE
the	I-DISEASE
pillow	0
or	0
mattress	0
.	I-DISEASE

Alternately	0
,	0
the	0
individual	0
may	I-DISEASE
sit	I-DISEASE
with	B-DISEASE
the	0
back	I-DISEASE
of	I-DISEASE
the	0
head	0
against	I-DISEASE
the	0
headboard	0
or	I-DISEASE
wall	0
,	B-DISEASE
repeatedly	0
banging	0
the	0
occiput	0
.	I-DISEASE

Combining	0
head	0
banging	0
and	I-DISEASE
body	0
rocking	I-DISEASE
,	I-DISEASE
they	0
may	I-DISEASE
rock	0
on	0
hands	0
and	0
knees	0
,	I-DISEASE
banging	I-DISEASE
the	0
vertex	I-DISEASE
or	I-DISEASE
frontal	I-DISEASE
region	0
of	0
the	0
head	0
into	I-DISEASE
the	I-DISEASE
headboard	0
or	I-DISEASE
wall	I-DISEASE
.	0

Head	0
rolling	0
consists	0
of	0
side	0
-	0
to	I-DISEASE
-	0
side	I-DISEASE
head	0
movements	0
,	0
usually	0
with	0
the	I-DISEASE
child	I-DISEASE
(	0
or	I-DISEASE
adult	0
)	0
in	0
the	0
supine	I-DISEASE
position	0
.	I-DISEASE

Less	0
common	0
rhythmic	0
movement	0
forms	0
include	0
body	I-DISEASE
rolling	0
,	0
leg	0
banging	0
,	I-DISEASE
or	0
leg	0
rolling	I-DISEASE
.	0

Rhythmic	0
humming	0
or	0
inarticulate	0
sounds	0
often	0
accompany	0
the	0
body	I-DISEASE
,	I-DISEASE
head	0
,	I-DISEASE
or	0
limb	0
movements	I-DISEASE
and	0
may	0
be	I-DISEASE
quite	0
loud	I-DISEASE
.	0

Episodes	0
often	0
occur	I-DISEASE
near	I-DISEASE
sleep	0
onset	0
,	I-DISEASE
although	0
they	I-DISEASE
also	0
may	0
occur	0
at	0
any	0
time	I-DISEASE
during	0
the	0
night	I-DISEASE
and	I-DISEASE
even	I-DISEASE
during	0
quiet	0
wakeful	0
activities	I-DISEASE
,	I-DISEASE
such	0
as	0
listening	I-DISEASE
to	0
music	I-DISEASE
or	0
trav-	0
eling	0
in	0
vehicles	0
.	0

The	0
movement	0
frequency	0
can	0
vary	0
,	I-DISEASE
but	I-DISEASE
the	0
rate	I-DISEASE
is	0
usually	0
between	0
0.5	0
per	0
second	0
and	0
two	0
per	I-DISEASE
second	0
.	0

Duration	0
of	0
the	0
individual	0
movement	0
clusters	0
also	I-DISEASE
varies	0
but	0
generally	0
is	0
less	I-DISEASE
than	0
15	0
minutes	0
.	0

Cessation	0
of	0
movements	0
may	0
occur	0
fol-	0
lowing	0
environmental	0
disturbance	0
or	0
being	0
spoken	0
to	0
.	0

Children	0
who	0
have	0
sufficient	0
language	0
development	0
to	0
be	0
asked	I-DISEASE
about	0
event	0
recall	0
in	0
the	0
morning	I-DISEASE
are	I-DISEASE
typically	0
amnestic	I-DISEASE
for	0
the	0
episodes	0
.	0

Rarely	0
,	0
adults	0
will	0
report	0
a	I-DISEASE
volitional	0
component	0
.	0

Sleep	0
related	0
rhythmic	I-DISEASE
movements	0
are	0
common	0
in	0
normal	0
infants	I-DISEASE
and	0
children	0
.	0

Without	0
evidence	B-DISEASE
for	0
significant	0
consequences	0
,	I-DISEASE
the	I-DISEASE
movements	I-DISEASE
alone	I-DISEASE
should	0
not	0
be	I-DISEASE
considered	I-DISEASE
a	0
disorder	I-DISEASE
.	0

Sleep	0
related	I-DISEASE
rhythmic	I-DISEASE
movements	0
should	0
be	0
considered	I-DISEASE
a	0
disorder	I-DISEASE
only	0
if	0
the	0
behaviors	I-DISEASE
significantly	0
interfere	I-DISEASE
with	0
normal	0
sleep	I-DISEASE
,	I-DISEASE
cause	0
significant	0
impairment	0
in	I-DISEASE
daytime	0
function	I-DISEASE
,	0
or	0
result	I-DISEASE
in	0
self	0
-	0
inflicted	0
bodily	0
injury	0
(	0
or	0
would	0
result	I-DISEASE
in	0
injury	0
if	0
preventive	0
measures	0
are	0
not	I-DISEASE
used	I-DISEASE
)	0
.	0

Associated	0
Features	0
The	0
vast	0
majority	0
of	I-DISEASE
infants	I-DISEASE
and	0
children	I-DISEASE
with	I-DISEASE
sleep	0
related	I-DISEASE
rhythmic	I-DISEASE
movements	0
are	I-DISEASE
otherwise	0
developmentally	0
and	0
intellectually	0
normal	I-DISEASE
,	0
as	0
are	0
most	0
adolescents	I-DISEASE
and	0
adults	0
.	I-DISEASE

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Body	I-DISEASE
Rocking	I-DISEASE
:	I-DISEASE
The	I-DISEASE
whole	I-DISEASE
body	0
is	I-DISEASE
rocked	0
while	I-DISEASE
on	0
the	I-DISEASE
hands	0
and	0
knees	I-DISEASE
.	0

Head	0
Banging	0
:	0
The	0
head	0
is	0
forcibly	I-DISEASE
moved	0
,	0
striking	0
an	0
object	0
.	0

Head	0
Rolling	0
:	0
The	0
head	0
is	0
moved	I-DISEASE
laterally	0
,	I-DISEASE
typically	0
while	0
in	0
a	0
supine	0
position	I-DISEASE
.	0

Other	0
:	0
Includes	0
body	0
rolling	0
,	0
leg	I-DISEASE
rolling	0
,	0
and	0
leg	I-DISEASE
banging	0
.	I-DISEASE

Combined	0
:	0
Involves	0
two	0
or	0
more	0
of	I-DISEASE
the	0
individual	0
types	0
.	I-DISEASE

Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
Sleep	0
Related	0
Movement	0
Disorders	0
Demographics	I-DISEASE

At	0
nine	I-DISEASE
months	0
of	0
age	0
,	0
59	I-DISEASE
%	0
of	0
all	0
infants	0
have	0
been	0
reported	0
to	0
exhibit	0
one	0
or	I-DISEASE
more	0
of	0
the	0
following	0
sleep	0
related	I-DISEASE
rhythmic	I-DISEASE
movements	0
:	0
body	I-DISEASE
rocking	0
(	0
43	0
%	0
)	0
,	0
head	0
banging	0
(	I-DISEASE
22	I-DISEASE
%	0
)	0
,	I-DISEASE
or	0
head	0
rolling	0
(	0
24	0
%	I-DISEASE
)	0
.	I-DISEASE

At	0
18	I-DISEASE
months	I-DISEASE
,	0
the	0
overall	I-DISEASE
prevalence	I-DISEASE
has	I-DISEASE
been	0
reported	0
to	0
decline	0
to	0
33	0
%	I-DISEASE
,	0
and	0
by	I-DISEASE
five	0
years	I-DISEASE
,	0
to	0
only	0
5	0
%	I-DISEASE
.	0

Most	0
pediatric	0
studies	0
have	0
found	0
no	0
sex	0
difference	0
.	I-DISEASE

Over	0
50	0
cases	0
of	I-DISEASE
RMD	0
have	I-DISEASE
been	I-DISEASE
reported	0
in	I-DISEASE
adolescents	0
and	0
adults	0
,	0
with	0
a	I-DISEASE
male	I-DISEASE
pre-	0
ponderance	I-DISEASE
found	I-DISEASE
in	0
adults	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
The	0
soothing	I-DISEASE
effect	I-DISEASE
of	0
vestibular	I-DISEASE
stimulation	0
has	0
been	0
proposed	0
as	0
the	0
initiating	0
factor	I-DISEASE
in	I-DISEASE
infants	0
and	0
toddlers	0
.	0

Environmental	0
stress	0
and	0
lack	0
of	0
environmental	I-DISEASE
stimulation	0
have	0
also	0
been	0
proposed	0
as	0
factors	0
.	0

One	0
study	I-DISEASE
found	0
higher	0
anxiety	0
scores	0
in	0
children	0
with	I-DISEASE
body	0
rocking	0
than	0
in	0
controls	0
.	I-DISEASE

Self	0
-	0
stimulation	0
has	0
been	0
suggested	0
as	0
a	0
factor	I-DISEASE
,	0
particularly	0
in	I-DISEASE
intellectually	0
disabled	0
,	0
autistic	0
,	0
and	I-DISEASE
emotionally	0
disturbed	0
children	0
.	0

Rhythmic	0
movements	0
have	0
been	0
postulated	0
to	0
be	I-DISEASE
a	0
calming	I-DISEASE
technique	0
employed	0
by	0
children	0
to	0
combat	0
insomnia	I-DISEASE
.	0

Rhythmic	0
movements	0
have	0
been	0
reported	0
in	0
association	I-DISEASE
with	0
RLS	0
,	0
OSA	0
,	0
narcolepsy	0
,	0
RBD	I-DISEASE
,	0
and	0
ADHD	I-DISEASE
.	0

Rhythmic	0
movements	0
may	0
be	0
used	0
as	0
a	I-DISEASE
conscious	0
strategy	I-DISEASE
to	0
relieve	0
the	0
urge	0
to	I-DISEASE
move	0
or	0
the	0
uncomfortable	0
sensations	I-DISEASE
associated	0
with	0
RLS	0
.	0
OSA-	0

associated	0
RMD	0
often	0
improves	0
with	0
positive	0
airway	I-DISEASE
pressure	0
.	I-DISEASE

Individuals	0
with	0
narco-	0
lepsy	0
may	0
initiate	0
rhythmic	I-DISEASE
movements	0
to	I-DISEASE
terminate	0
episodes	0
of	0
sleep	0
paralysis	0
.	I-DISEASE

In	0
older	0
children	0
or	I-DISEASE
adults	0
,	0
stereotypic	I-DISEASE
movements	0
may	0
be	0
associated	0
with	0
intellectual	0
disability	0
or	0
autism	0
spectrum	0
disorder	0
.	0

However	0
,	I-DISEASE
in	0
most	0
of	0
these	I-DISEASE
cases	0
,	I-DISEASE
the	I-DISEASE
movements	I-DISEASE
are	0
not	0
predominantly	I-DISEASE
sleep	0
related	I-DISEASE
,	I-DISEASE
and	0
an	I-DISEASE
additional	0
diagnosis	I-DISEASE
of	0
RMD	0
is	0
not	I-DISEASE
indicated	I-DISEASE
.	0

Familial	0
Patterns	0

A	0
familial	0
pattern	0
has	0
been	0
reported	0
rarely	0
,	0
as	0
has	0
occurrence	0
in	0
identical	0
twins	0
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
The	I-DISEASE
onset	0
of	0
sleep	0
related	0
rhythmic	0
movements	0
is	0
typically	I-DISEASE
in	I-DISEASE
early	0
childhood	I-DISEASE
.	0

Body	0
rocking	0
has	0
a	0
mean	0
age	0
of	0
onset	0
of	I-DISEASE
six	0
months	0
,	0
head	0
banging	0
of	I-DISEASE
nine	0
months	0
,	0
and	0
head	I-DISEASE
rolling	0
of	0
ten	0
months	I-DISEASE
.	0

The	0
condition	0
may	0
rarely	0
present	0
at	0
an	I-DISEASE
older	0
age	0
following	0
central	0
nervous	0
system	0
trauma	0
.	0

Sleep	0
related	0
rhythmic	I-DISEASE
movements	0
commonly	0
resolve	0
in	I-DISEASE
the	0
second	I-DISEASE
or	0
third	0
year	0
of	0
life	0
.	I-DISEASE

Persistence	0
at	0
five	0
years	I-DISEASE
of	0
age	I-DISEASE
occurs	I-DISEASE
in	0
about	I-DISEASE
5	0
%	0
of	0
children	0
.	0

Sleep	0
related	0
movements	I-DISEASE
rarely	0
continue	0
into	0
adolescence	0
and	0
adulthood	0
.	0

Worsening	0
or	0
spontaneous	0
onset	0
in	0
adults	0
is	0
very	0
rare	I-DISEASE
.	0

In	0
some	0
adult	0
cases	0
the	0
chief	I-DISEASE
concern	I-DISEASE
is	0
disturbance	I-DISEASE
of	0
the	0
bed	0
partner	0
’s	0
sleep	0
.	0

Most	0
adolescents	0
and	0
adults	I-DISEASE
have	0
one	0
form	0
of	0
RMD	I-DISEASE
,	0
although	0
some	0
have	0
two	0
or	I-DISEASE
more	0
.	0

Head	0
banging	0
is	I-DISEASE
the	0
most	I-DISEASE
disturbing	0
form	I-DISEASE
of	0
the	I-DISEASE
problem	I-DISEASE
.	0

Typical	0
cases	0
in	I-DISEASE
infants	0
and	0
toddlers	I-DISEASE
pose	I-DISEASE
little	0
risk	I-DISEASE
of	I-DISEASE
serious	0
injury	0
.	I-DISEASE

Vigorous	0
rhythmic	0
movements	0
can	I-DISEASE
produce	0
loud	I-DISEASE
noises	I-DISEASE
when	0
the	I-DISEASE
patient	0
hits	0
the	I-DISEASE
bed	I-DISEASE
frame	0
or	I-DISEASE
when	0
the	0
bed	0
bangs	0
against	I-DISEASE
the	0
wall	0
or	0
floor	0
.	I-DISEASE

The	0
noises	0
can	0
be	0
very	0
disturbing	I-DISEASE
to	I-DISEASE
other	0
family	I-DISEASE
members	0
.	0

Parental	0
concern	0
is	0
common	0
,	0
and	0
psychosocial	0
consequences	0
in	I-DISEASE
the	0
older	0
individual	0
can	0
be	0
distressing	0
.	I-DISEASE

It	0
is	0
important	0
to	I-DISEASE
discuss	0
appropriate	I-DISEASE
safety	I-DISEASE
precautions	0
with	I-DISEASE
the	0
patient	0
’s	0
caretak-	0
ers	I-DISEASE
.	I-DISEASE

Under	0
extraordinary	0
circumstances	0
,	0
particularly	0
in	I-DISEASE
the	0
developmentally	0
disabled	0
,	0
injury	0
to	0
soft	0
tissues	0
or	I-DISEASE
bone	I-DISEASE
has	0
been	I-DISEASE
reported	0
.	0

Developmental	0
Issues	0
Because	0
age	I-DISEASE
-	0
related	0
factors	I-DISEASE
are	I-DISEASE
a	I-DISEASE
critical	0
dimension	0
for	0
RMD	0
,	0
developmental	I-DISEASE
issues	0
are	0
discussed	0
under	0
Essential	0
Features	0
and	0
other	I-DISEASE
sections	0
.	I-DISEASE

Pathology	0
and	0
Pathophysiology	0
In	0
infants	0
and	I-DISEASE
young	I-DISEASE
children	0
,	I-DISEASE
rhythmic	0
movements	0
have	0
been	0
hypothesized	I-DISEASE
to	I-DISEASE
promote	0
motor	0
development	0
by	0
stimulation	0
of	0
the	0
vestibular	0
system	I-DISEASE
.	I-DISEASE

More	0
recently	0
,	0
the	0
role	I-DISEASE
of	I-DISEASE
inhibitory	I-DISEASE
control	0
on	I-DISEASE
the	0
central	0
motor	I-DISEASE
pattern	0
generator	0
has	0
been	I-DISEASE
sug-	0
gested	I-DISEASE
as	0
a	0
physiologic	0
mechanism	0
to	0
explain	I-DISEASE
both	I-DISEASE
pediatric	0
and	I-DISEASE
adult	I-DISEASE
forms	0
of	0
sleep	0
related	0
rhythmic	0
movements	0
.	0

Objective	0
Findings	0
Polysomnographic	0
scoring	I-DISEASE
rules	0
for	I-DISEASE
RMD	0
are	0
defined	I-DISEASE
in	0
the	0
AASM	0
Manual	0
for	0
the	I-DISEASE
Scoring	0
of	0
Sleep	I-DISEASE
and	0
Associated	I-DISEASE
Events	0
.	0

Video	0
-	0
polysomnographic	I-DISEASE
studies	0
have	0
shown	0
rhythmic	I-DISEASE
movements	0
to	I-DISEASE
occur	0
most	0
often	0
in	0
association	0
with	I-DISEASE
stages	0
N1	0
and	I-DISEASE
N2	0
sleep	0
;	0
46	0
%	0
occur	0
while	I-DISEASE
falling	0
asleep	I-DISEASE
or	I-DISEASE
during	0
NREM	0
sleep	0
;	0
30	0
%	0
during	0
both	0
NREM	0
and	I-DISEASE
REM	0
sleep	I-DISEASE
;	I-DISEASE
and	I-DISEASE
24	0
%	0
only	I-DISEASE
during	0
REM	0
sleep	0
.	I-DISEASE

The	0
exclusively	0
REM	0
-	0
related	0
rhythmic	0
movements	I-DISEASE
occur	0
more	I-DISEASE
frequently	0
in	0
adults	0
.	0

Although	0
an	0
epileptic	0
etiology	0
has	0
been	0
reported	0
in	0
one	0
individual	0
,	0
most	0
EEG	0
studies	0
have	I-DISEASE
shown	0
normal	0
activity	I-DISEASE
between	0
epi-	0
sodes	0
of	0
rhythmic	0
behavior	0
.	0

Differential	0
Diagnosis	0
RMD	0
must	0
be	0
distinguished	I-DISEASE
from	I-DISEASE
other	0
repetitive	0
movements	I-DISEASE
involving	0
restricted	0
small	I-DISEASE
muscle	0
groups	I-DISEASE
,	0
such	0
as	I-DISEASE
sleep	0
related	I-DISEASE
bruxism	0
,	0
thumb	0
sucking	I-DISEASE
,	I-DISEASE
and	I-DISEASE
rhythmic	0
sucking	I-DISEASE
of	0
a	0
pacifier	I-DISEASE
or	0
the	0
lips	0
,	0
as	0
well	0
as	I-DISEASE
other	I-DISEASE
specifically	0
defined	0
rhythmic	I-DISEASE
movements	0
of	0
sleep	0
,	0
such	I-DISEASE
as	I-DISEASE
hypnagogic	0
foot	I-DISEASE
tremor	0
.	0

Sleep	0
Related	I-DISEASE
Movement	I-DISEASE
Disorders	0
Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
In	I-DISEASE
adults	I-DISEASE
,	0
RMD	0
can	0
be	0
misdiagnosed	0
as	0
RBD	0
or	I-DISEASE
be	0
comorbid	0
with	0
RBD	0
.	I-DISEASE

Video	0
poly-	0
somnography	0
is	0
particularly	0
helpful	I-DISEASE
in	0
these	0
cases	I-DISEASE
.	0

Rhythmic	0
movements	0
may	0
occur	0
as	0
a	0
conscious	I-DISEASE
or	0
unconscious	I-DISEASE
strategy	0
to	I-DISEASE
relieve	I-DISEASE
RLS	0
symptoms	0
.	I-DISEASE

If	0
the	0
rhythmic	I-DISEASE
move-	0
ments	0
are	0
clearly	0
in	0
response	0
to	0
RLS	0
sensations	0
,	0
then	0
a	I-DISEASE
separate	0
diagnosis	0
of	I-DISEASE
RMD	0
is	0
not	0
needed	0
.	0

However	0
,	I-DISEASE
RMD	0
may	0
be	0
diagnosed	0
if	I-DISEASE
RMD	0
criteria	0
are	0
met	0
and	0
RLS	0
does	0
not	I-DISEASE
adequately	0
explain	I-DISEASE
the	0
presence	I-DISEASE
or	0
extent	0
of	0
rhythmic	0
movements	0
.	I-DISEASE

Children	0
with	0
autism	0
spectrum	0
disorder	0
often	I-DISEASE
exhibit	I-DISEASE
repetitive	0
behaviors	I-DISEASE
,	0
but	0
these	0
movements	0
typically	0
occur	I-DISEASE
during	0
wakefulness	0
and	I-DISEASE
are	0
not	0
predominantly	0
sleep	0
related	0
.	I-DISEASE

Stereotypic	0
movement	0
disorder	0
is	I-DISEASE
a	0
Diagnostic	I-DISEASE
and	I-DISEASE
Statistical	0
Manual	I-DISEASE
of	0
Mental	0
Disorders	0
(	I-DISEASE
DSM	0
)	I-DISEASE
diagnosis	I-DISEASE
that	0
is	I-DISEASE
typically	0
seen	0
with	0
intellectual	0
disability	I-DISEASE
and	I-DISEASE
is	I-DISEASE
not	0
predominantly	0
sleep	I-DISEASE
related	0
.	0

In	0
children	0
with	I-DISEASE
autism	0
spectrum	0
disorder	0
or	I-DISEASE
intellectual	0
disability	I-DISEASE
,	0
an	0
additional	I-DISEASE
diagnosis	I-DISEASE
of	0
RMD	I-DISEASE
should	0
be	0
made	I-DISEASE
only	0
if	0
the	0
movements	0
are	I-DISEASE
predominantly	I-DISEASE
sleep	0
related	0
.	I-DISEASE

Akathisia	0
is	0
seen	0
as	I-DISEASE
a	0
complication	0
of	0
neuroleptic	0
medi-	I-DISEASE
cation	0
and	0
is	0
not	0
predominantly	0
sleep	I-DISEASE
related	0
.	0

Autoerotic	0
or	0
masturbatory	0
behaviors	0
may	0
involve	0
body	0
rocking	0
or	0
other	0
repetitive	0
body	0
movements	0
,	0
but	0
the	0
primary	0
focus	0
is	0
genital	0
stimulation	0
as	0
is	0
evident	0
by	I-DISEASE
direct	I-DISEASE
genital	0
contact	I-DISEASE
.	0

Rarely	0
,	0
RMD	0
needs	0
to	0
be	I-DISEASE
differentiated	I-DISEASE
from	0
epilepsy	I-DISEASE
,	0
tic	0
disorders	0
,	0
or	0
involuntary	I-DISEASE
movements	0
associated	0
with	I-DISEASE
other	0
neurological	0
conditions	0
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE

There	0
is	0
controversy	0
about	0
the	0
classification	I-DISEASE
of	0
hypnagogic	0
foot	I-DISEASE
tremor	0
as	I-DISEASE
a	0
separate	I-DISEASE
entity	0
or	I-DISEASE
as	0
a	0
subtype	0
of	0
sleep	0
related	0
rhythmic	0
movements	0
.	I-DISEASE

Many	0
aspects	0
of	0
sleep	0
related	0
rhythmic	I-DISEASE
movements	0
deserve	0
further	I-DISEASE
study	0
,	0
including	0
the	0
relationship	0
of	0
the	0
typical	I-DISEASE
form	I-DISEASE
seen	0
in	0
otherwise	0
normal	0
infants	0
and	0
young	I-DISEASE
children	0
to	I-DISEASE
the	I-DISEASE
rhythmic	I-DISEASE
movements	0
seen	0
in	0
children	0
with	0
intellectual	0
disability	0
and	0
autism	I-DISEASE
spectrum	0
disorder	0
.	0

The	0
pathophysiology	0
of	0
persistent	I-DISEASE
RMD	0
is	I-DISEASE
poorly	I-DISEASE
understood	0
,	0
as	0
is	0
the	0
association	0
with	0
other	I-DISEASE
sleep	0
disorders	0
in	I-DISEASE
adults	0
.	0

Bibliography	0
Dyken	0
M	I-DISEASE
,	0
Lin	0
-	0
Dyken	I-DISEASE
D	0
,	I-DISEASE
Yamada	0
T.	0
Diagnosing	0
rhythmic	I-DISEASE
movement	0
disorder	I-DISEASE
with	0
video	0
-	0
polysomnography	0
.	0

Pediatr	0
Neurol	0
1997;16:37–41	0
.	0

Kohyama	0
J	0
,	0
Matsukura	0
F	0
,	0
Kimura	I-DISEASE
K	0
,	0
Tachibana	0
N.	0
Rhythmic	0
movement	0
disorder	0
:	I-DISEASE
polysomnographic	0
study	0
and	0
summary	0
of	0
reported	0
cases	0
.	0

Brain	0
Dev	0
2002;24:33–8	0
.	0

Laberge	0
L	0
,	0
Tremblay	0
R	I-DISEASE
,	0
Vitaro	I-DISEASE
F	0
,	I-DISEASE
Montplaisir	0
J.	0
Development	0
of	0
parasomnias	0
from	0
childhood	0
to	0
early	I-DISEASE
adolescence	0
.	0

Pediatrics	0
2000;106:67–74	0
.	0

Manni	0
R	I-DISEASE
,	0
Terzaghi	0
M.	0
Rhythmic	0
movements	0
during	0
sleep	I-DISEASE
:	0
a	0
physiological	0
and	0
pathological	0
profile	I-DISEASE
.	I-DISEASE

Neurol	0
Sci	0
2005;26	0
:	0
s181–5	0
.	0

Mayer	0
G	0
,	I-DISEASE
Wilde	0
-	0
Frenz	0
J	I-DISEASE
,	0
Kurella	0
B.	0
Sleep	0
related	0
rhythmic	0
movement	0
disorder	0
revisited	0
.	I-DISEASE

J	0
Sleep	0
Res	0
2007;16:110–6	I-DISEASE
.	0

Benign	0
Sleep	0
Myoclonus	0
of	0
Infancy	0
ICD-9	0
-	0
CM	0
code	I-DISEASE
:	0
327.59	0
Alternate	0
Names	0
Benign	0
neonatal	I-DISEASE
sleep	0
myoclonus	0
.	I-DISEASE

Diagnostic	0
Criteria	0
Criteria	0

A	0
-	0
E	0
must	I-DISEASE
be	0
met	0
ICD-10	I-DISEASE
-	0
CM	0
code	0
:	0
G47.69	0
Sleep	I-DISEASE
Related	0
Movement	0
Disorders	I-DISEASE
A.	I-DISEASE
Observation	I-DISEASE
of	0
repetitive	0
myoclonic	0
jerks	B-DISEASE
that	0
involve	0
the	I-DISEASE
limbs	0
,	0
trunk	I-DISEASE
,	0
or	0
whole	0
body	0
.	0

B.	0
The	0
movements	0
occur	0
in	0
early	0
infancy	0
,	0
typically	I-DISEASE
from	0
birth	0
to	0
six	0
months	0
of	0
age	0
.	0

C.	0

The	0
movements	0
occur	0
only	0
during	0
sleep	0
.	I-DISEASE

D.	0

The	0
movements	0
stop	0
abruptly	0
and	0
consistently	I-DISEASE
when	0
the	0
infant	I-DISEASE
is	0
aroused	0
.	0

E.	0

The	0
disorder	0
is	0
not	0
better	I-DISEASE
explained	I-DISEASE
by	0
another	0
sleep	I-DISEASE
disorder	I-DISEASE
,	0
medical	0
or	0
neurological	0
disorder	I-DISEASE
,	0
or	0
medication	I-DISEASE
use	0
.	0

Essential	0
Features	0
Benign	0
sleep	0
myoclonus	0
of	I-DISEASE
infancy	I-DISEASE
(	0
BSMI	0
)	0
is	0
characterized	0
by	0
repetitive	0
myoclonic	I-DISEASE
jerks	I-DISEASE
that	0
occur	I-DISEASE
during	0
sleep	0
in	0
neonates	0
and	0
infants	0
.	I-DISEASE

Although	0
BSMI	0
is	0
benign	0
and	0
relatively	0
rare	0
,	0
it	I-DISEASE
is	I-DISEASE
included	0
in	0
the	0
sleep	0
related	0
movement	I-DISEASE
disorders	I-DISEASE
section	I-DISEASE
because	0
it	0
is	0
commonly	0
confused	0
with	0
epilepsy	0
.	0

However	0
,	I-DISEASE
unlike	0
the	0
jerks	I-DISEASE
of	I-DISEASE
myoclonic	I-DISEASE
seizures	0
and	I-DISEASE
myoclonic	0
encephalopathy	0
,	0
the	0
jerks	0
of	I-DISEASE
BSMI	I-DISEASE
occur	0
exclusively	0
during	0
sleep	0
.	0

The	0
jerks	0
are	I-DISEASE
often	I-DISEASE
bilateral	0
and	I-DISEASE
massive	0
,	0
typically	I-DISEASE
involving	0
large	0
muscle	0
groups	0
.	0

The	0
movements	0
can	0
occur	0
in	0
the	0
whole	I-DISEASE
body	0
or	0
exclusively	0
in	0
the	0
limbs	I-DISEASE
,	0
the	0
trunk	I-DISEASE
,	I-DISEASE
or	0
rarely	0
,	0
the	0
face	0
.	0

Associated	0
Features	0
Not	0
applicable	0
or	0
known	0
.	0

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Most	I-DISEASE
infants	I-DISEASE
with	I-DISEASE
BSMI	I-DISEASE
are	I-DISEASE
neurologically	0
normal	I-DISEASE
,	0
born	0
to	0
mothers	I-DISEASE
with	0
no	0
history	I-DISEASE
of	0
illicit	I-DISEASE
drug	0
use	0
.	0

However	0
,	I-DISEASE
BSMI	0
has	0
been	0
described	0
in	0
more	0
than	0
half	0
of	0
infants	0
with	0
neonatal	0
opioid	0
withdrawal	0
syndrome	0
,	0
suggesting	0
a	0
subtype	0
with	0
this	0
specific	0
etiology	I-DISEASE
.	0

It	0
must	0
be	0
stressed	I-DISEASE
,	0
however	0
,	I-DISEASE
that	0
some	I-DISEASE
cases	0
of	0
neonatal	0
abstinence	0
syndrome	0
do	0
not	0
follow	0
a	I-DISEASE
benign	0
clinical	0
course	0
.	0

Whether	0
such	0
cases	0
should	0
be	0
included	0
with	I-DISEASE
those	0
of	0
BSMI	0
is	0
an	0
unresolved	0
matter	0
.	0

Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
Demographics	0

The	0
prevalence	0
is	0
unknown	0
.	I-DISEASE

The	0
incidence	0
has	0
been	0
estimated	0
at	0
3.7	I-DISEASE
per	0
10,000	0
live	0
births	0
.	0

More	0
than	0
200	0
cases	0
have	0
been	0
described	0
in	0
the	0
literature	I-DISEASE
.	0

Males	0
are	0
affected	0
more	0
than	0
females	0
by	I-DISEASE
a	0
ratio	I-DISEASE
of	0
about	0
2:1	0
.	I-DISEASE

The	0
typical	0
age	0
range	0
is	0
birth	0
to	0
six	0
months	I-DISEASE
of	0
age	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
Predisposing	0
factors	I-DISEASE
have	I-DISEASE
not	0
been	0
delineated	0
.	0

Rocking	0
or	0
repetitive	I-DISEASE
noises	0
may	0
pre-	0
cipitate	I-DISEASE
individual	I-DISEASE
episodes	I-DISEASE
of	I-DISEASE
BSMI	0
.	I-DISEASE

Familial	0
Patterns	0
Familial	0
occurrence	0
has	0
been	0
described	I-DISEASE
.	0

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Onset	I-DISEASE
is	0
usually	I-DISEASE
noted	0
between	I-DISEASE
birth	0
and	0
one	0
month	I-DISEASE
of	0
age	0
in	0
a	0
neurologically	0
normal	0
infant	0
.	0

The	0
course	0
is	0
self	0
-	0
limited	0
and	I-DISEASE
benign	0
.	I-DISEASE

The	0
disorder	0
may	I-DISEASE
be	B-DISEASE
present	I-DISEASE
for	I-DISEASE
only	I-DISEASE
a	0
few	I-DISEASE
days	0
or	0
may	0
last	I-DISEASE
for	0
several	I-DISEASE
months	I-DISEASE
.	0

Maximum	0
expression	0
is	0
typically	0
between	0
15	0
and	I-DISEASE
35	0
days	I-DISEASE
of	0
age	0
.	0

BSMI	0
resolves	0
by	0
three	0
months	0
of	0
age	I-DISEASE
in	0
64	I-DISEASE
%	0
of	0
affected	0
infants	0
,	0
by	I-DISEASE
six	0
months	0
in	I-DISEASE
95	0
%	0
,	0
and	0
by	0
12	0
months	I-DISEASE
in	0
97	0
%	0
with	0
persistence	0
rarely	0
into	0
the	0
second	0
year	0
of	0
life	I-DISEASE
or	I-DISEASE
later	0
.	I-DISEASE

There	0
are	0
no	0
known	0
complications	0
.	0

Long	0
-	0
term	0
follow	0
-	0
up	I-DISEASE
in	I-DISEASE
a	0
limited	I-DISEASE
number	I-DISEASE
of	0
children	0
has	I-DISEASE
shown	0
normal	0
psychomotor	0
development	0
and	I-DISEASE
normal	0
cognitive	I-DISEASE
function	0
at	0
five	0
to	0
10	I-DISEASE
years	I-DISEASE
of	0
age	I-DISEASE
.	0

There	0
is	0
no	0
evidence	I-DISEASE
for	0
an	0
increased	I-DISEASE
risk	0
of	I-DISEASE
seizures	0
.	0

Developmental	0
Issues	0
Because	0
age	0
-	0
related	0
factors	I-DISEASE
are	I-DISEASE
a	I-DISEASE
critical	0
dimension	0
for	0
BSMI	0
,	0
developmental	I-DISEASE
issues	0
are	0
discussed	0
throughout	0
this	0
section	0
.	0

Pathology	0
and	0
Pathophysiology	0
The	I-DISEASE
presence	0
of	I-DISEASE
a	I-DISEASE
generator	0
in	I-DISEASE
the	0
cervical	0
spinal	0
cord	0
that	0
is	0
not	I-DISEASE
adequately	I-DISEASE
inhibited	I-DISEASE
due	I-DISEASE
to	0
immature	0
myelination	I-DISEASE
of	I-DISEASE
descending	0
pathways	I-DISEASE
has	0
been	0
hypothesized	I-DISEASE
.	0

Objective	0
Findings	0
Video	0
-	I-DISEASE
polysomnographic	0
EEG	I-DISEASE
and	I-DISEASE
EMG	0
monitoring	I-DISEASE
has	0
demonstrated	0
paroxysmal	0
muscle	I-DISEASE
activity	0
,	I-DISEASE
without	0
ictal	0
or	I-DISEASE
interictal	0
EEG	0
abnormalities	0
.	0

BSMI	0
occurs	0
predom-	0
inantly	0
during	0
quiet	0
sleep	I-DISEASE
but	0
also	I-DISEASE
may	0
be	0
present	0
during	0
active	0
sleep	0
.	0

The	0
muscle	0
jerks	0
are	I-DISEASE
usually	0
seen	0
in	0
clusters	0
of	0
four	0
or	0
five	0
jerks	0
per	0
second	I-DISEASE
,	I-DISEASE
each	0
jerk	I-DISEASE
lasting	0
40	I-DISEASE
to	0
300	0
milliseconds	0
.	0

BSMI	0
clusters	0
typically	0
repeat	0
in	0
irregular	0
series	0
for	0
one	I-DISEASE
to	0
15	0
minutes	0
,	I-DISEASE
but	0
,	I-DISEASE
in	0
some	0
cases	I-DISEASE
,	0
the	I-DISEASE
clusters	0
may	0
recur	I-DISEASE
for	0
up	I-DISEASE
to	0
60	0
minutes	0
or	0
longer	I-DISEASE
and	0
be	0
mistaken	0
for	0
status	0
epilepticus	I-DISEASE
.	0

One	0
study	I-DISEASE
showed	0
30	0
%	0
of	0
the	I-DISEASE
jerks	I-DISEASE
to	I-DISEASE
involve	0
the	0
whole	0
body	I-DISEASE
,	0
20	I-DISEASE
%	0
to	0
involve	0
the	0
abdominal	0
or	0
proximal	0
muscles	0
,	0
and	0
50	0
%	0
to	I-DISEASE
involve	0
only	0
the	0
arms	0
or	0
the	0
legs	0
.	0

The	0
arms	0
are	0
usually	0
more	0
involved	0
than	I-DISEASE
the	0
legs	I-DISEASE
.	0

Activity	0
is	0
symmetrical	0
in	0
over	0
90	0
%	I-DISEASE
of	0
cases	0
but	0
can	0
be	0
lateralized	0
.	0

The	0
myoclonus	0
is	0
not	I-DISEASE
associ-	0
ated	0
with	I-DISEASE
arousals	I-DISEASE
,	I-DISEASE
awakenings	0
,	0
or	0
sleep	0
stage	0
transitions	I-DISEASE
.	0

Spontaneous	0
or	0
provoked	0
awakening	0
of	0
the	0
infant	I-DISEASE
leads	0
to	I-DISEASE
prompt	I-DISEASE
,	0
abrupt	0
,	0
and	0
consis-	I-DISEASE
tent	I-DISEASE
cessation	0
of	I-DISEASE
the	0
movements	I-DISEASE
.	0

Gentle	0
rocking	0
of	0
the	0
infant	0
or	I-DISEASE
the	I-DISEASE
infant	0
’s	I-DISEASE
crib	0
has	0
been	0
shown	0
to	0
provoke	I-DISEASE
the	0
myoclonus	0
.	0

This	0
may	0
be	0
a	I-DISEASE
useful	0
maneuver	0
during	I-DISEASE
EEG	0
monitoring	I-DISEASE
when	0
differentiation	0
from	0
seizures	0
is	0
of	0
concern	I-DISEASE
.	0

In	0
contrast	0
to	0
jitteriness	0
and	0
other	0
nonepileptic	0
etiologies	0
,	I-DISEASE
BSMI	0
will	0
often	0
increase	0
rather	0
than	I-DISEASE
be	0
suppressed	0
by	I-DISEASE
gentle	0
restraint	0
.	0

Neuroimaging	0
studies	0
are	0
normal	0
.	0

Differential	0
Diagnosis	0
BSMI	0
should	0
be	0
distinguished	I-DISEASE
from	I-DISEASE
myoclonic	0
seizures	I-DISEASE
;	I-DISEASE
misdiagnosis	0
may	0
lead	0
to	0
unnecessary	0
diagnostic	0
testing	0
or	I-DISEASE
medication	0
use	I-DISEASE
.	0

The	0
absence	0
of	0
episodes	0
while	0
awake	0
in	I-DISEASE
infants	0
with	I-DISEASE
BSMI	0
is	0
the	0
single	0
most	0
helpful	0
clinical	0
feature	0
.	I-DISEASE

In	0
addition	0
,	0
BSMI	0
will	0
stop	0
abruptly	I-DISEASE
and	0
consistently	I-DISEASE
when	0
the	0
infant	0
is	I-DISEASE
aroused	0
.	I-DISEASE

Neonatal	0
sei-	I-DISEASE
zures	0
are	0
often	0
seen	0
in	I-DISEASE
the	I-DISEASE
context	I-DISEASE
of	0
perinatal	0
disorders	0
such	0
as	I-DISEASE
hypoxic	0
-	0
ischemic	0
encephalopathy	I-DISEASE
,	0
infection	0
,	0
or	0
metabolic	0
abnormalities	0
,	I-DISEASE
whereas	0
BSMI	0
is	I-DISEASE
typically	0
present	I-DISEASE
in	0
neurologically	0
normal	0
infants	0
.	0

Infantile	0
spasms	0
(	0
West	0
syndrome	0
)	0
are	I-DISEASE
most	0
often	0
seen	I-DISEASE
after	I-DISEASE
the	0
first	0
month	0
of	0
life	0
but	I-DISEASE
sometimes	0
occur	0
earlier	0
.	0

Infantile	0
spasms	0
are	0
usually	0
manifest	0
by	0
sudden	I-DISEASE
head	0
flexion	I-DISEASE
with	0
arm	0
extension	0
and	0
lower	0
extremity	I-DISEASE
flexion	0
.	0

They	0
are	0
usually	0
associated	0
with	0
a	0
hypsarrhythmic	I-DISEASE
EEG	0
pattern	0
.	0

Pyridoxine-	0
dependency	0
seizures	0
are	I-DISEASE
responsive	0
to	0
treatment	I-DISEASE
with	0
vitamin	0
B6	0
.	0

In	0
cases	0
that	0
are	0
dif-	0
ficult	0
to	0
differentiate	0
,	0
an	0
EEG	0
obtained	0
during	0
sleep	0
will	I-DISEASE
show	0
normal	0
patterns	0
when	0
BSMI	I-DISEASE
is	0
elicited	0
by	0
gentle	I-DISEASE
rocking	I-DISEASE
.	0

Anticonvulsant	0
medications	0
are	0
ineffective	0
and	0
unnecessary	0
in	0
BSMI	0
.	I-DISEASE

BSMI	0
also	0
should	0
be	B-DISEASE
distinguished	0
from	0
other	I-DISEASE
disorders	0
that	I-DISEASE
occur	0
during	I-DISEASE
wakeful-	0
ness	I-DISEASE
,	I-DISEASE
including	I-DISEASE
myoclonic	I-DISEASE
encephalopathies	0
,	B-DISEASE
hyperekplexia	0
(	0
startle	0
disease	0
)	0
,	0
drug	0
withdrawal	0
,	0
and	I-DISEASE
jitteriness	0
.	0

Benign	0
myoclonus	0
of	0
early	0
infancy	0
usually	0
occurs	0
after	0
the	0
third	0
month	0
of	0
life	0
and	0
only	0
occurs	0
during	0
wakefulness	I-DISEASE
.	0

PLMD	0
can	0
occur	0
in	0
infants	0
but	0
typically	0
has	0
a	0
distinctly	0
different	0
duration	0
and	I-DISEASE
fre-	0
quency	I-DISEASE
.	0

The	0
muscle	0
activity	0
is	0
of	0
longer	I-DISEASE
duration	I-DISEASE
(	0
0.5	I-DISEASE
to	I-DISEASE
10	0
seconds	0
)	0
and	0
recurs	I-DISEASE
at	I-DISEASE
a	0
more	I-DISEASE
regular	0
and	0
longer	0
interval	0
(	0
typically	0
20	I-DISEASE
to	0
40	0
seconds	I-DISEASE
)	0
.	I-DISEASE

PLMD	0
can	0
be	0
associated	0
with	0
EEG	0
arousals	0
,	0
whereas	I-DISEASE
BSMI	0
is	0
not	0
.	0

BSMI	0
is	0
more	0
often	0
seen	0
in	0
the	0
arms	0
than	I-DISEASE
the	0
legs	0
,	0
whereas	0
PLMD	0
predominantly	I-DISEASE
occurs	0
in	0
the	0
lower	0
limbs	0
.	0

Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
Phasic	I-DISEASE
-	I-DISEASE
REM	0
muscle	0
activity	0
typically	0
involves	0
smaller	0
muscle	0
groups	I-DISEASE
and	0
can	0
be	0
linked	0
to	0
observable	I-DISEASE
eye	0
movements	0
.	0

Sleep	0
starts	0
occur	0
at	0
the	0
wake	I-DISEASE
-	I-DISEASE
sleep	0
transition	I-DISEASE
and	0
typ-	0
ically	0
are	0
not	0
repetitive	0
.	0

Propriospinal	0
myoclonus	0
at	I-DISEASE
sleep	0
onset	0
is	I-DISEASE
a	I-DISEASE
rare	0
disorder	0
that	0
has	0
not	I-DISEASE
been	0
reported	0
in	I-DISEASE
children	I-DISEASE
and	0
is	I-DISEASE
characterized	0
by	I-DISEASE
jerks	0
involving	0
the	0
abdominal	I-DISEASE
and	I-DISEASE
truncal	0
muscles	0
at	I-DISEASE
the	I-DISEASE
transition	I-DISEASE
from	0
wakefulness	I-DISEASE
to	0
sleep	0
.	0

Fragmentary	0
myoclo-	0
nus	0
has	0
been	0
described	0
in	I-DISEASE
adults	0
and	I-DISEASE
is	0
primarily	0
a	0
nonspecific	I-DISEASE
EMG	0
finding	I-DISEASE
with	I-DISEASE
little	0
or	I-DISEASE
no	0
visible	0
movement	0
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE

The	0
prevalence	0
,	0
incidence	0
,	0
and	0
pathophysiology	I-DISEASE
of	0
BSMI	I-DISEASE
warrant	I-DISEASE
further	0
study	0
.	0

Bibliography	0
Alfonso	0
I	0
,	0
Papazian	0
O	0
,	0
Aicardi	0
J	0
,	0
Jeffries	0
HE	0
.	0

A	0
simple	0
maneuver	0
to	0
provoke	0
benign	0
neonatal	0
sleep	0
myoclonus	I-DISEASE
.	0

Pediatrics	0
1995;96:1161–3	0
.	0

Di	0
Capua	0
M	0
,	0
Fusco	0
L	0
,	0
Ricci	0
S	I-DISEASE
,	0
Vigevano	0
F.	0
Benign	I-DISEASE
neonatal	0
sleep	I-DISEASE
myoclonus	0
:	0
clinical	0
features	0
and	0
video-	0
polygraphic	0
recordings	0
.	0

Mov	0
Disord	0
1993;8:191–4	0
.	0

Held	0
-	0
Egli	0
K	0
,	0
Rüegger	0
C	I-DISEASE
,	0
Das	I-DISEASE
-	0
Kundu	0
S	0
,	0
Schmitt	0
B	0
,	0
Bucher	0
HU	0
.	0

Benign	0
neonatal	0
sleep	0
myoclonus	0
in	0
newborn	0
infants	I-DISEASE
of	0
opioid	I-DISEASE
dependent	0
mothers	0
.	0

Acta	0
Paediatrica	0
2009;98:69–73	0
.	0

Hrastovec	0
A	0
,	0
Hostnik	0
T	0
,	I-DISEASE
Neubauer	I-DISEASE
D.	0
Benign	I-DISEASE
convulsions	0
in	0
newborns	0
and	0
infants	0
:	I-DISEASE
Occurrence	I-DISEASE
,	0
clinical	0
course	0
and	I-DISEASE
prognosis	0
.	0

Eur	0
J	0
Paediatr	0
Neurol	0
2012;16:64–73	0
.	0

Maurer	0
VO	0
,	0
Rizzi	0
M	0
,	0
Bianchetti	0
MG	0
,	0
Ramelli	0
GP	0
.	0

Benign	0
neonatal	0
sleep	0
myoclonus	0
:	0
a	0
review	I-DISEASE
of	0
the	I-DISEASE
literature	0
.	0

Pediatrics	0
2010;125	0
:	0
e919–24	0
.	0

Propriospinal	0
Myoclonus	0
at	I-DISEASE
Sleep	0
Onset	0
ICD-9	I-DISEASE
-	I-DISEASE
CM	0
code	0
:	0
327.59	0
ICD-10	0
-	0
CM	0
code	0
:	0
G47.69	0
Alternate	I-DISEASE
Names	0

Spinal	0
myoclonus	0
,	0
plurisegmental	0
myoclonus	0
,	0
intersegmental	0
myoclonus	0
,	I-DISEASE
axial	0
myoclonus	0
.	I-DISEASE

Diagnostic	0
Criteria	0
Criteria	0

A	0
-	0
E	0
must	0
be	0
met	0
A.	I-DISEASE

The	0
patient	0
complains	0
of	0
sudden	0
jerks	I-DISEASE
,	0
mainly	0
of	I-DISEASE
the	0
abdomen	0
,	0
trunk	I-DISEASE
,	0
and	I-DISEASE
neck	0
.	0

B.	0
The	0
jerks	0
appear	0
during	0
relaxed	I-DISEASE
wakefulness	0
and	0
drowsiness	0
,	I-DISEASE
as	0
the	0
patient	0
attempts	0
to	0
fall	0
asleep	0
.	I-DISEASE

C.	0

The	0
jerks	0
disappear	I-DISEASE
upon	I-DISEASE
mental	0
activation	0
and	I-DISEASE
with	0
onset	I-DISEASE
of	0
a	0
stable	0
sleep	0
stage	0
.	I-DISEASE

D.	0
The	0
jerks	0
result	0
in	I-DISEASE
difficulty	I-DISEASE
initiating	0
sleep	0
.	I-DISEASE

E.	0

The	0
disorder	0
is	I-DISEASE
not	I-DISEASE
better	I-DISEASE
explained	I-DISEASE
by	I-DISEASE
another	0
sleep	I-DISEASE
disorder	I-DISEASE
,	0
medical	0
or	0
neurological	0
disorder	I-DISEASE
,	0
mental	0
disorder	I-DISEASE
,	0
medication	0
use	0
,	0
or	0
substance	0
use	I-DISEASE
disorder	0
.	0

Notes	0
.	0

Although	0
there	0
is	I-DISEASE
no	0
current	0
definitive	0
evidence	I-DISEASE
that	0
propriospinal	I-DISEASE
myoclonus	0
confined	I-DISEASE
to	0
sleep	I-DISEASE
onset	0
is	I-DISEASE
associated	0
with	0
significant	I-DISEASE
structural	0
lesions	I-DISEASE
of	0
the	0
spinal	0
cord	0
,	I-DISEASE
propriospinal	0
myoclonus	0
that	I-DISEASE
is	I-DISEASE
persistent	0
during	I-DISEASE
the	0
day	0
has	0
been	0
linked	I-DISEASE
to	0
structural	I-DISEASE
spinal	0
cord	0
pathology	I-DISEASE
in	I-DISEASE
16	0
%	0
to	I-DISEASE
20	0
%	I-DISEASE
of	I-DISEASE
cases	0
.	0

Essential	0
Features	0
Propriospinal	0
myoclonus	0
at	I-DISEASE
sleep	I-DISEASE
onset	0
(	0
PSM	I-DISEASE
)	0
consists	0
of	0
sudden	I-DISEASE
myoclonic	0
jerks	I-DISEASE
occurring	I-DISEASE
in	0
the	I-DISEASE
transition	I-DISEASE
from	0
wakefulness	0
to	0
sleep	0
and	0
,	0
rarely	0
,	I-DISEASE
during	I-DISEASE
intrasleep	0
wakefulness	0
and	I-DISEASE
upon	I-DISEASE
awakening	0
in	0
the	0
morning	0
.	I-DISEASE

The	0
jerks	0
arise	I-DISEASE
mainly	I-DISEASE
in	I-DISEASE
the	I-DISEASE
axial	0
muscles	I-DISEASE
and	I-DISEASE
spread	I-DISEASE
rostrally	0
and	I-DISEASE
caudally	0
according	0
to	0
propriospinal	I-DISEASE
propagation	0
.	I-DISEASE

The	0
jerks	0
may	I-DISEASE
be	I-DISEASE
of	0
variable	I-DISEASE
intensity	I-DISEASE
;	0
they	I-DISEASE
are	0
isolated	0
,	0
recurring	0
in	0
quasi	I-DISEASE
-	0
periodic	I-DISEASE
fashion	I-DISEASE
for	0
variable	0
durations	0
,	0
or	0
may	I-DISEASE
be	I-DISEASE
repeated	0
in	0
brief	I-DISEASE
clusters	0
of	0
a	I-DISEASE
few	I-DISEASE
movements	0
,	0
sepa-	0
rated	0
by	0
longer	I-DISEASE
intervals	0
.	I-DISEASE

Jerks	0
involve	I-DISEASE
the	0
abdominal	0
and	I-DISEASE
truncal	I-DISEASE
muscles	I-DISEASE
first	0
and	0
are	0
then	0
propagated	0
to	I-DISEASE
proximal	0
muscles	I-DISEASE
of	0
the	I-DISEASE
limbs	I-DISEASE
and	0
the	0
neck	0
.	0

The	0
pattern	0
of	0
move-	0
ment	0
is	0
usually	0
flexor	0
but	I-DISEASE
may	0
be	0
an	0
extension	0
of	0
the	I-DISEASE
trunk	I-DISEASE
.	0

Vocalization	0
rarely	0
occurs	0
.	0

The	0
jerks	0
are	0
most	I-DISEASE
often	0
spontaneous	0
but	I-DISEASE
,	0
in	0
some	0
cases	0
,	0
can	I-DISEASE
be	0
evoked	0
by	I-DISEASE
external	0
stimulations	I-DISEASE
.	0

The	0
jerks	0
appear	I-DISEASE
to	I-DISEASE
be	0
related	0
to	I-DISEASE
the	I-DISEASE
recumbent	I-DISEASE
position	I-DISEASE
and	0
a	I-DISEASE
state	I-DISEASE
of	0
Sleep	I-DISEASE
Related	0
Movement	0
Disorders	I-DISEASE
Sleep	0
Related	I-DISEASE
Movement	0
Disorders	0
relaxed	0
wakefulness	0
,	I-DISEASE
particularly	I-DISEASE
when	I-DISEASE
the	0
patient	0
tries	0
to	0
fall	0
asleep	0
.	0

Any	0
mental	0
acti-	0
vation	0
makes	0
the	0
jerks	0
disappear	0
.	I-DISEASE

The	0
jerks	0
eventually	I-DISEASE
disappear	I-DISEASE
at	0
sleep	0
onset	I-DISEASE
and	I-DISEASE
remain	I-DISEASE
absent	0
throughout	0
all	0
stages	0
of	0
sleep	I-DISEASE
,	0
even	I-DISEASE
though	I-DISEASE
they	0
sometimes	I-DISEASE
reappear	0
during	0
intrasleep	0
wakefulness	0
.	0

Associated	0
Features	0
PSM	0
often	0
is	0
associated	I-DISEASE
with	I-DISEASE
severe	0
sleep	I-DISEASE
-	0
onset	0
insomnia	0
due	0
to	0
the	I-DISEASE
inability	0
of	0
the	I-DISEASE
patient	I-DISEASE
to	0
fall	0
asleep	0
because	0
of	0
the	0
recurrent	0
disturbing	0
muscular	0
activity	I-DISEASE
.	0

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
PSM	I-DISEASE
may	I-DISEASE
be	I-DISEASE
considered	I-DISEASE
a	I-DISEASE
variant	0
of	I-DISEASE
the	0
more	I-DISEASE
generally	0
described	I-DISEASE
propriospinal	0
myoc-	0
lonus	I-DISEASE
seen	0
during	I-DISEASE
the	0
daytime	I-DISEASE
.	0

In	0
daytime	0
PSM	0
,	I-DISEASE
myoclonic	I-DISEASE
jerks	0
involve	I-DISEASE
the	0
thoracoab-	0
dominal	0
/	I-DISEASE
paraspinal	I-DISEASE
or	0
cervical	I-DISEASE
muscles	I-DISEASE
and	I-DISEASE
spread	I-DISEASE
caudally	I-DISEASE
or	0
rostrally	0
to	0
the	0
other	0
myotomes	0
.	0

The	0
jerks	0
are	0
provoked	0
or	0
worsened	0
by	0
the	0
recumbent	I-DISEASE
position	0
and	0
can	0
not	0
be	0
voluntarily	0
suppressed	0
.	0

They	0
are	0
often	0
preceded	I-DISEASE
by	0
premonitory	0
sensations	I-DISEASE
,	0
are	0
stable	0
over	0
time	0
,	0
and	0
respond	0
unpredictably	0
to	0
drug	I-DISEASE
treatment	0
.	0

The	0
frequent	0
presleep	0
worsening	0
of	0
daytime	0
PSM	I-DISEASE
(	0
around	I-DISEASE
50	0
%	0
of	I-DISEASE
the	I-DISEASE
cases	0
)	I-DISEASE
suggests	0
that	0
patients	I-DISEASE
with	B-DISEASE
PSM	I-DISEASE
may	0
have	0
a	I-DISEASE
milder	0
or	I-DISEASE
variant	I-DISEASE
form	0
of	0
a	0
single	I-DISEASE
clinical	I-DISEASE
and	0
neurophysiologic	0
entity	0
.	0

Demographics	0
Epidemiologic	0
data	0
are	0
lacking	0
.	0

PSM	0
is	0
probably	0
a	0
rare	0
condition	0
.	I-DISEASE

A	0
higher	0
prevalence	0
in	I-DISEASE
men	0
is	0
reported	I-DISEASE
.	0

The	0
disorder	0
affects	0
adults	0
and	0
has	I-DISEASE
not	0
been	0
reported	I-DISEASE
in	0
children	0
.	I-DISEASE

Predisposing	0
and	0
Precipitating	0
Factors	0
Not	0
applicable	I-DISEASE
or	I-DISEASE
known	0
.	0

Familial	0
Patterns	0
Not	0
applicable	0
or	0
known	0
.	I-DISEASE

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
PSM	I-DISEASE
arises	0
in	I-DISEASE
adulthood	0
and	I-DISEASE
is	0
usually	I-DISEASE
a	0
chronic	0
,	I-DISEASE
unremitting	0
condition	I-DISEASE
.	0

Patients	0
may	0
develop	B-DISEASE
a	B-DISEASE
fear	0
of	0
falling	I-DISEASE
asleep	0
,	I-DISEASE
anxiety	0
,	0
and	0
depression	0
.	0

Intense	0
myoclonic	0
jerks	I-DISEASE
may	0
cause	0
injury	0
to	0
the	0
patient	I-DISEASE
or	0
the	0
bed	0
partner	0
.	0

Pathology	0
and	0
Pathophysiology	0
The	0
pathophysiology	0
of	I-DISEASE
PSM	I-DISEASE
is	0
unknown	I-DISEASE
.	0

PSM	0
is	0
thought	I-DISEASE
to	0
originate	0
from	0
a	0
focal	0
spinal	I-DISEASE
pattern	I-DISEASE
generator	0
,	0
set	0
into	0
motion	I-DISEASE
by	I-DISEASE
supraspinal	I-DISEASE
dysfacilitatory	I-DISEASE
influences	0
typical	0
of	0
the	0
state	0
of	0
relaxed	I-DISEASE
wakefulness	0
and	0
drowsiness	I-DISEASE
.	0

PSM	0
is	0
presumed	0
to	0
propagate	0
up	0
and	0
down	I-DISEASE
the	I-DISEASE
spinal	0
cord	0
via	0
slowly	I-DISEASE
conducting	0
,	I-DISEASE
long	0
propriospinal	0
(	I-DISEASE
intersegmental	0
)	0
pathways	0
.	0

A	0
focal	0
spinal	I-DISEASE
generator	0
thus	0
is	I-DISEASE
able	I-DISEASE
to	0
recruit	I-DISEASE
muscles	0
from	0
multiple	0
segments	0
.	0

Objective	0
Findings	0
Polysomnography	0
demonstrates	I-DISEASE
brief	0
myoclonic	I-DISEASE
EMG	0
bursts	0
recurring	I-DISEASE
nonperiodi-	0
cally	0
with	0
alpha	I-DISEASE
activity	0
present	I-DISEASE
on	0
the	0
EEG	I-DISEASE
and	0
,	I-DISEASE
in	0
particular	0
,	0
when	I-DISEASE
alpha	I-DISEASE
activity	I-DISEASE
spreads	0
from	0
the	0
posterior	0
to	0
the	I-DISEASE
anterior	0
brain	0
regions	0
.	0

Epileptic	0
EEG	0
discharges	0
are	I-DISEASE
not	0
observed	0
in	0
PSM	0
.	0

Jerks	0
disappear	I-DISEASE
either	0
with	I-DISEASE
EEG	0
desynchronization	0
,	I-DISEASE
due	0
to	I-DISEASE
mental	0
activation	0
,	0
or	0
with	0
appearance	0
of	0
sleep	I-DISEASE
spindles	I-DISEASE
and	0
K	0
-	0
complexes	0
.	0

Jerks	0
remain	0
absent	0
throughout	0
sleep	0
but	0
may	I-DISEASE
occasionally	0
reappear	I-DISEASE
upon	0
awakening	0
and	0
during	0
intrasleep	0
wakefulness	I-DISEASE
.	0

Polysomnography	0
with	0
extended	0
EMG	I-DISEASE
recording	0
demonstrates	I-DISEASE
that	I-DISEASE
the	0
jerks	I-DISEASE
arise	0
first	I-DISEASE
in	0
spinal	I-DISEASE
innervated	I-DISEASE
muscles	I-DISEASE
and	I-DISEASE
then	I-DISEASE
propagate	I-DISEASE
to	0
more	0
caudal	0
and	0
rostral	0
muscles	I-DISEASE
according	I-DISEASE
to	0
a	I-DISEASE
propriospinal	I-DISEASE
pattern	0
of	0
propagation	0
.	0

Detailed	0
analysis	0
of	0
the	I-DISEASE
jerks	0
shows	I-DISEASE
that	I-DISEASE
the	0
EMG	0
activity	0
originates	I-DISEASE
in	I-DISEASE
muscles	0
innervated	0
by	I-DISEASE
thoracic	0
or	0
cervical	0
spinal	0
segments	0
(	0
sternocleidomastoid	0
,	0
paraspinalis	0
,	0
rectus	I-DISEASE
abdominis	0
)	I-DISEASE
and	0
then	0
spreads	0
to	I-DISEASE
more	0
rostrally	0
and	0
caudally	I-DISEASE
innervated	0
muscles	0
at	0
a	0
slow	0
velocity	0
(	0
2	0
to	0
16	I-DISEASE
milliseconds	0
;	I-DISEASE
around	0
5	I-DISEASE
milliseconds	0
on	0
average	I-DISEASE
)	I-DISEASE
.	0

Back	0
-	0
averaging	0
of	0
the	0
EEG	I-DISEASE
does	0
not	0
show	0
any	I-DISEASE
jerk	0
-	0
locked	I-DISEASE
cortical	0
activity	I-DISEASE
.	0

MRI	0
of	0
the	0
brain	0
is	0
normal	0
.	I-DISEASE

In	0
a	0
recent	0
review	I-DISEASE
of	0
PSM	I-DISEASE
,	I-DISEASE
only	I-DISEASE
one	I-DISEASE
patient	0
with	0
exacerbation	I-DISEASE
at	0
sleep	0
onset	I-DISEASE
had	0
a	0
hypersignal	I-DISEASE
at	I-DISEASE
T10	0
-	0
T11	0
and	I-DISEASE
a	0
nonspecific	I-DISEASE
medullary	0
cone	I-DISEASE
lesion	I-DISEASE
.	0

The	0
remaining	0
patients	I-DISEASE
had	I-DISEASE
no	0
signs	I-DISEASE
on	I-DISEASE
spinal	0
cord	I-DISEASE
MRI	I-DISEASE
at	0
sleep	0
onset	I-DISEASE
.	I-DISEASE

MRI	0
of	0
the	0
spine	0
is	I-DISEASE
usually	0
normal	I-DISEASE
but	0
demonstrates	I-DISEASE
a	0
focal	0
lesion	0
in	I-DISEASE
around	0
20	0
%	0
of	0
the	I-DISEASE
cases	0
.	0

The	0
causal	0
relationship	0
of	0
PSM	0
with	I-DISEASE
these	I-DISEASE
spinal	I-DISEASE
lesions	I-DISEASE
is	0
unclear	0
,	0
although	0
magnetic	0
resonance	I-DISEASE
diffusion	0
tensor	0
imaging	I-DISEASE
with	0
fiber	0
tracking	0
may	0
demonstrate	I-DISEASE
spinal	0
tract	B-DISEASE
disorganization	I-DISEASE
.	0

Differential	0
Diagnosis	0
PSM	0
shows	0
features	0
similar	I-DISEASE
to	I-DISEASE
those	0
of	0
the	0
syndrome	0
of	0
intensified	0
sleep	0
starts	I-DISEASE
.	0

However	0
,	I-DISEASE
sleep	0
starts	I-DISEASE
(	0
hypnic	I-DISEASE
jerks	I-DISEASE
)	0
usually	I-DISEASE
appear	0
during	0
the	0
transition	I-DISEASE
between	0
wakefulness	I-DISEASE
and	I-DISEASE
sleep	I-DISEASE
and	I-DISEASE
during	0
light	I-DISEASE
NREM	0
sleep	0
,	I-DISEASE
whereas	0
PSM	I-DISEASE
may	I-DISEASE
sometimes	0
be	0
present	0
during	I-DISEASE
relaxed	0
wakefulness	0
.	0

Unlike	0
PSM	0
,	0
sleep	I-DISEASE
starts	0
(	I-DISEASE
hypnic	I-DISEASE
jerks	0
)	I-DISEASE
some-	0
times	I-DISEASE
affect	0
only	I-DISEASE
one	0
or	I-DISEASE
a	0
few	0
body	I-DISEASE
segments	0
;	0
propriospinal	0
propagation	0
is	0
not	0
present	0
in	0
neurophysiological	0
studies	0
of	0
sleep	0
starts	I-DISEASE
.	0

Phasic	0
REM	0
twitches	0
,	0
which	0
are	0
a	I-DISEASE
normal	0
phenomenon	I-DISEASE
during	0
REM	0
sleep	0
,	0
involve	0
the	I-DISEASE
distal	0
muscles	0
of	I-DISEASE
the	0
hands	0
and	0
face	0
,	0
often	I-DISEASE
without	I-DISEASE
displacement	I-DISEASE
of	0
the	I-DISEASE
body	0
segment	0
.	I-DISEASE

Fragmentary	0
myoclonus	0
resembles	0
physiological	0
hypnic	0
myoclonus	0
,	0
but	0
in	0
an	0
enhanced	0
form	0
,	I-DISEASE
and	0
persists	I-DISEASE
throughout	0
all	0
stages	0
of	0
NREM	0
and	0
REM	0
sleep	0
.	0

Both	0
physiological	0
hypnic	0
myoclonus	I-DISEASE
and	0
frag-	I-DISEASE
mentary	I-DISEASE
myoclonus	0
are	I-DISEASE
EMG	0
findings	0
not	0
associated	0
with	0
overt	I-DISEASE
muscular	0
activity	0
and	I-DISEASE
Sleep	0
Related	0
Movement	0
Disorders	0
Sleep	0
Related	0
Movement	0
Disorders	0
do	0
not	0
involve	0
muscles	0
acting	0
across	0
large	0
joints	0
.	0

Epileptic	0
myoclonus	0
is	0
not	0
confined	0
to	0
relaxed	0
wakefulness	0
and	I-DISEASE
may	I-DISEASE
be	0
associated	0
with	0
epileptic	I-DISEASE
discharges	0
on	I-DISEASE
the	0
EEG	I-DISEASE
.	0

PLMS	0
are	0
longer	0
in	0
duration	0
,	I-DISEASE
involve	0
mainly	0
the	I-DISEASE
lower	0
limbs	0
,	I-DISEASE
and	0
usually	0
spare	I-DISEASE
truncal	0
and	0
abdominal	I-DISEASE
muscles	0
.	0

PLMs	0
may	0
begin	0
during	0
presleep	0
wakefulness	0
but	I-DISEASE
generally	0
occur	I-DISEASE
during	0
NREM	0
sleep	0
.	0

Some	0
patients	0
with	0
RLS	0
may	0
have	0
prominent	0
PLMs	0
in	0
wakefulness	0
while	0
sitting	0
or	0
lying	0
down	0
.	0

However	0
,	I-DISEASE
prominent	0
leg	0
discomfort	0
is	0
usually	I-DISEASE
present	0
in	I-DISEASE
these	0
patients	0
.	I-DISEASE

Occasionally	0
PSM	0
may	0
be	I-DISEASE
present	0
in	0
RLS	0
/	0
PLMS	0
patients	0
in	0
wake	0
before	0
sleep	0
,	I-DISEASE
but	0
the	I-DISEASE
EMG	I-DISEASE
morphology	0
is	0
different	0
.	0

In	0
addition	0
,	0
when	0
myoclonic	0
jerks	0
involving	0
leg	0
muscles	0
appear	0
,	0
the	0
PSM	0
disappears	0
.	0

Psychogenic	0
myoclonus	0
may	I-DISEASE
simulate	0
PSM	0
but	I-DISEASE
the	I-DISEASE
muscle	0
recruitment	0
pattern	0
,	0
the	0
spread	I-DISEASE
velocity	0
,	I-DISEASE
and	0
the	I-DISEASE
record-	I-DISEASE
ing	0
of	0
cortical	0
premovement	0
activity	0
observed	I-DISEASE
before	I-DISEASE
voluntary	I-DISEASE
movements	I-DISEASE
may	0
be	0
useful	0
to	0
differentiate	I-DISEASE
the	0
two	0
types	0
of	0
jerks	0
.	I-DISEASE

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE
Future	I-DISEASE
studies	I-DISEASE
are	0
needed	0
to	0
better	0
define	0
the	0
distinctions	0
between	0
PSM	0
and	I-DISEASE
related	I-DISEASE
conditions	0
such	0
as	0
sleep	0
starts	I-DISEASE
(	0
hypnic	I-DISEASE
jerks	0
)	0
and	I-DISEASE
,	I-DISEASE
in	I-DISEASE
particular	0
,	I-DISEASE
the	0
syndrome	0
of	0
inten-	I-DISEASE
sified	I-DISEASE
sleep	I-DISEASE
starts	I-DISEASE
.	0

Also	0
,	0
neuroimaging	0
and	0
possibly	0
postmortem	0
studies	0
may	0
detect	I-DISEASE
the	0
neural	0
structures	0
responsible	0
for	0
the	I-DISEASE
initiation	I-DISEASE
of	I-DISEASE
the	I-DISEASE
myoclonic	0
jerks	0
.	0

Bibliography	0
Montagna	0
P	I-DISEASE
,	0
Provini	0
F	0
,	I-DISEASE
Plazzi	0
G	I-DISEASE
,	0
Liguori	0
R	0
,	0
Lugaresi	0
E.	I-DISEASE
Propriospinal	I-DISEASE
myoclonus	0
upon	I-DISEASE
relaxation	0
and	0
drowsiness	0
:	0
a	0
cause	0
of	0
severe	I-DISEASE
insomnia	0
.	I-DISEASE

Mov	0
Disord	0
1997;12:66–72	0
.	0

Montagna	0
P	0
,	0
Provini	0
F	0
,	0
Vetrugno	I-DISEASE
R.	0
Propriospinal	I-DISEASE
myoclonus	0
at	0
sleep	0
onset	0
.	0

Neurophysiologique	0
clinique	0
2006;36:351–5	0
.	I-DISEASE

Roze	0
E	0
,	0
Bounolleau	0
P	0
,	0
Ducreux	I-DISEASE
D	I-DISEASE
,	I-DISEASE
et	0
al	0
.	0

Propriospinal	0
myclonusmyoclonus	0
revisited	I-DISEASE
.	0

Clinical	0
,	0
neurophysiologic	0
,	0
and	0
neuroradiologic	I-DISEASE
findings	0
.	0

Neurology	0
2009;72:1301–9	0
.	0

Tison	0
F	0
,	0
Arne	0
P	0
,	I-DISEASE
Dousset	0
V	0
,	I-DISEASE
Paty	0
J	0
,	0
Henry	0
P.	0
Propriospinal	I-DISEASE
myoclonus	0
induced	0
by	I-DISEASE
relaxation	0
and	0
drowsiness	0
.	0

Rev	0
Neurol	0
(	0
Paris	0
)	0
1998;154:423–5	I-DISEASE
.	I-DISEASE

Vetrugno	0
R	0
,	0
Provini	0
F	0
,	0
Meletti	I-DISEASE
S	0
,	I-DISEASE
et	0
al	0
.	0

Propriospinal	0
myoclonus	0
at	I-DISEASE
the	0
sleep	0
-	I-DISEASE
wake	I-DISEASE
transition	0
:	0
a	0
new	0
type	I-DISEASE
of	I-DISEASE
parasomnia	0
.	I-DISEASE

Sleep	0
2001;24:835–43	0
.	0

Sleep	0
Related	0
Movement	I-DISEASE
Disorder	0
Due	0
to	0
a	I-DISEASE
Medical	0
Disorder	I-DISEASE
ICD-9	0
-	0
CM	0
code	0
:	0
327.59	I-DISEASE
ICD-10	0
-	0
CM	I-DISEASE
code	0
:	0
G47.69	I-DISEASE
Diagnostic	0
Criteria	0

Criteria	0
A	0
-	0
C	0
must	0
be	0
met	I-DISEASE
A.	0

The	0
patient	0
manifests	0
sleep	0
related	0
movements	I-DISEASE
that	I-DISEASE
disturb	0
sleep	I-DISEASE
or	0
its	0
onset	0
.	0

B.	0
The	0
movement	0
disorder	0
occurs	0
as	I-DISEASE
a	0
consequence	0
of	I-DISEASE
a	0
significant	0
underlying	0
medical	0
or	0
neurological	0
condition	0
.	0

C.	0

The	0
symptoms	0
are	0
not	0
better	I-DISEASE
explained	I-DISEASE
by	I-DISEASE
another	0
sleep	I-DISEASE
related	I-DISEASE
movement	I-DISEASE
disorder	0
,	I-DISEASE
other	0
untreated	I-DISEASE
sleep	0
disorder	0
,	I-DISEASE
substance	I-DISEASE
use	0
,	0
or	0
mental	0
disorder	0
.	0

This	0
diagnosis	0
is	0
intended	0
for	0
sleep	0
related	I-DISEASE
movement	I-DISEASE
disorders	I-DISEASE
due	0
to	0
an	0
underlying	I-DISEASE
medical	0
or	0
neurologic	0
condition	0
that	I-DISEASE
do	0
not	0
meet	I-DISEASE
criteria	0
for	0
another	I-DISEASE
specific	I-DISEASE
movement	0
disorder	0
.	I-DISEASE

Many	0
neurological	0
conditions	0
may	0
be	0
associated	0
with	0
movement	0
abnormali-	I-DISEASE
ties	0
that	0
are	0
evident	0
in	0
wake	0
and	0
sleep	0
.	I-DISEASE

In	0
some	0
cases	0
,	I-DISEASE
the	0
nocturnal	I-DISEASE
manifestations	I-DISEASE
of	0
the	I-DISEASE
movement	I-DISEASE
abnormalities	0
may	I-DISEASE
be	I-DISEASE
apparent	0
before	0
establishment	0
of	0
a	I-DISEASE
firm	0
neurolog-	0
ical	0
diagnosis	0
.	0

Thus	0
,	0
in	0
some	0
cases	0
,	I-DISEASE
“	I-DISEASE
sleep	0
related	I-DISEASE
movement	I-DISEASE
disorder	0
due	0
to	0
a	0
medical	I-DISEASE
disorder	0
”	0
is	I-DISEASE
a	0
temporary	0
diagnosis	0
,	0
given	0
when	0
a	I-DISEASE
sleep	0
diagnosis	I-DISEASE
is	0
required	0
before	0
the	I-DISEASE
underlying	I-DISEASE
medical	0
or	0
neurological	0
condition	0
can	0
be	I-DISEASE
fully	I-DISEASE
diagnosed	0
.	I-DISEASE

Once	0
the	0
pres-	I-DISEASE
ence	0
of	0
a	0
medical	0
or	0
neurological	I-DISEASE
condition	0
is	0
clearly	0
established	0
,	0
that	I-DISEASE
becomes	I-DISEASE
the	0
sole	0
diagnosis	0
unless	0
the	0
sleep	0
complaint	I-DISEASE
is	0
the	0
focus	0
of	I-DISEASE
independent	I-DISEASE
clinical	B-DISEASE
attention	0
.	I-DISEASE

When	0
a	0
movement	0
disorder	0
that	0
is	I-DISEASE
listed	I-DISEASE
elsewhere	0
in	I-DISEASE
the	0
sleep	I-DISEASE
related	I-DISEASE
movement	I-DISEASE
disorder	0
section	I-DISEASE
of	I-DISEASE
the	0
International	I-DISEASE
Classification	0
of	0
Sleep	0
Disorders	0
,	0
3rd	0
Edition	I-DISEASE
is	0
caused	I-DISEASE
or	0
exacerbated	0
by	0
a	0
medical	0
or	0
neurological	0
condition	0
(	0
e.g.	0
,	I-DISEASE
restless	0
legs	0
syn-	0
drome	I-DISEASE
)	0
,	0
it	0
is	0
preferred	I-DISEASE
that	0
the	0
more	0
specific	0
diagnosis	0
(	0
e.g.	I-DISEASE
,	0
RLS	I-DISEASE
)	0
be	I-DISEASE
used	0
rather	0
than	0
“	0
sleep	I-DISEASE
related	0
movement	0
due	I-DISEASE
to	0
a	0
medical	0
disorder	I-DISEASE
,	0
”	0
with	I-DISEASE
annotation	I-DISEASE
of	I-DISEASE
the	I-DISEASE
relation-	0
ship	I-DISEASE
to	0
the	0
medical	I-DISEASE
or	I-DISEASE
neurological	I-DISEASE
disorder	0
.	0

Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
Sleep	I-DISEASE
Related	I-DISEASE
Movement	0
Disorder	0
Due	0
to	0
a	0
Medication	0
or	I-DISEASE
Substance	0
ICD-9	0
-	0
CM	0
code	0
:	0
292.85	0
(	I-DISEASE
drug	I-DISEASE
-	0
induced	0
)	0
;	0
291.82	0
(	0
alcohol	0
-	0
induced	0
)	I-DISEASE
ICD-10	0
-	0
CM	0
code	I-DISEASE
:	I-DISEASE
F11	0
-	0
F19	0
(	0
see	I-DISEASE
table	I-DISEASE
in	I-DISEASE
Appendix	0
B	I-DISEASE
for	0
detailed	0
coding	0
instructions	I-DISEASE
)	0

Diagnostic	0
Criteria	0
Criteria	0
A	0
-	0
C	I-DISEASE
must	0
be	0
met	I-DISEASE
A.	0

The	0
patient	0
manifests	0
sleep	0
related	0
movements	I-DISEASE
that	I-DISEASE
disturb	0
sleep	I-DISEASE
or	0
its	0
onset	0
.	0

B.	0
The	0
movement	0
disorder	0
occurs	I-DISEASE
as	I-DISEASE
a	I-DISEASE
consequence	0
of	I-DISEASE
current	0
medication	0
or	0
substance	0
use	0
or	I-DISEASE
withdrawal	0
from	0
a	I-DISEASE
wake	0
-	0
promoting	I-DISEASE
medication	0
or	0
substance	0
.	I-DISEASE

C.	0

The	0
symptoms	0
are	0
not	0
better	I-DISEASE
explained	0
by	0
another	0
sleep	I-DISEASE
related	0
movement	I-DISEASE
disorder	0
,	I-DISEASE
other	0
untreated	I-DISEASE
sleep	0
disorder	0
,	I-DISEASE
or	I-DISEASE
medical	0
,	0
neurological	0
,	0
or	0
mental	I-DISEASE
disorder	0
.	I-DISEASE

This	0
diagnosis	0
is	0
intended	0
for	0
sleep	0
related	I-DISEASE
movement	I-DISEASE
disorders	I-DISEASE
due	0
to	0
a	0
medication	0
or	0
substance	I-DISEASE
(	0
toxin	0
or	I-DISEASE
other	0
bioactive	0
substance	0
)	0
that	I-DISEASE
do	0
not	I-DISEASE
meet	0
criteria	0
for	I-DISEASE
another	0
spe-	0
cific	0
movement	0
disorder	0
.	0

Many	0
substances	0
may	0
be	0
associated	0
with	0
movement	0
abnor-	0
malities	I-DISEASE
that	0
are	0
evident	0
in	I-DISEASE
wake	0
and	I-DISEASE
sleep	0
.	0

To	0
the	0
extent	I-DISEASE
that	0
the	0
movement	I-DISEASE
abnormal-	I-DISEASE
ity	0
is	I-DISEASE
an	0
expected	0
complication	0
of	0
the	0
substance(s	0
)	0
involved	0
(	I-DISEASE
e.g.	0
,	I-DISEASE
tardive	0
dyskinesia	I-DISEASE
or	0
akathisia	I-DISEASE
associated	0
with	0
neuroleptic	0
usage	0
)	0
,	0
this	0
diagnosis	0
is	0
unnecessary	0
unless	0
the	0
sleep	0
related	0
aspects	0
of	0
the	0
movement	0
abnormality	0
or	0
its	0
sequelae	0
,	I-DISEASE
are	I-DISEASE
the	I-DISEASE
focus	I-DISEASE
of	0
independent	0
clinical	I-DISEASE
attention	0
.	0

When	0
a	0
movement	0
disorder	0
that	0
is	I-DISEASE
listed	I-DISEASE
elsewhere	0
in	I-DISEASE
the	0
sleep	I-DISEASE
related	I-DISEASE
movement	I-DISEASE
disorder	0
section	I-DISEASE
of	I-DISEASE
the	0
International	I-DISEASE
Classification	0
of	0
Sleep	0
Disorders	0
,	0
3rd	0
Edition	I-DISEASE
is	0
caused	I-DISEASE
or	0
exacerbated	0
by	I-DISEASE
drugs	0
or	0
substances	0
(	0
e.g.	0
,	0
restless	0
legs	0
syndrome	I-DISEASE
)	I-DISEASE
,	0
it	0
is	0
pre-	0
ferred	0
that	0
the	0
more	I-DISEASE
specific	I-DISEASE
diagnosis	I-DISEASE
(	0
e.g.	0
,	I-DISEASE
RLS	I-DISEASE
)	0
be	0
used	0
rather	I-DISEASE
than	I-DISEASE
“	0
Sleep	I-DISEASE
related	0
movement	I-DISEASE
disorder	0
due	0
to	I-DISEASE
a	0
medication	0
or	0
substance	I-DISEASE
,	0
”	0
with	I-DISEASE
annotation	I-DISEASE
of	0
the	0
relation-	0
ship	I-DISEASE
to	I-DISEASE
drug	I-DISEASE
or	0
substance	0
.	0

Sleep	0
Related	0
Movement	I-DISEASE
Disorder	0
,	0
Unspecified	0
ICD-9	I-DISEASE
-	0
CM	I-DISEASE
code	0
:	0
327.59	0
ICD-10	0
-	0
CM	0
code	I-DISEASE
:	0
G47.69	I-DISEASE
This	I-DISEASE
diagnosis	I-DISEASE
is	0
assigned	0
when	0
patients	I-DISEASE
have	0
a	0
sleep	0
related	0
movement	0
disorder	0
that	0
can	I-DISEASE
not	0
be	0
classified	0
elsewhere	I-DISEASE
or	0
is	0
suspected	0
to	0
be	0
associated	I-DISEASE
with	0
an	0
underlying	I-DISEASE
psy-	0
chiatric	I-DISEASE
condition	I-DISEASE
.	I-DISEASE

In	0
some	0
cases	0
,	B-DISEASE
“	0
sleep	0
related	I-DISEASE
movement	I-DISEASE
disorder	I-DISEASE
,	0
unspecified	0
”	0
is	0
a	0
temporary	0
diagnosis	0
prior	0
to	I-DISEASE
establishment	0
of	0
an	0
underlying	0
psychiatric	0
condition	0
that	I-DISEASE
may	0
explain	0
the	I-DISEASE
sleep	I-DISEASE
related	0
movement	0
(	I-DISEASE
e.g.	0
,	0
movements	0
associated	0
with	0
posttrau-	0
matic	0
stress	0
disorder	I-DISEASE
nightmares	0
prior	0
to	0
firm	0
establishment	0
of	0
the	I-DISEASE
psychiatric	0
diag-	0
nosis	0
)	I-DISEASE
.	0

Once	0
the	0
psychiatric	I-DISEASE
diagnosis	0
is	0
established	0
,	I-DISEASE
that	0
becomes	I-DISEASE
the	0
sole	0
diagnosis	0
unless	0
the	0
sleep	I-DISEASE
complaint	I-DISEASE
is	I-DISEASE
the	I-DISEASE
focus	I-DISEASE
of	0
independent	0
clinical	0
attention	0
.	0

Sleep	0
Related	I-DISEASE
Movement	I-DISEASE
Disorders	0
Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
Isolated	I-DISEASE
Symptoms	I-DISEASE
and	0
Normal	0
Variants	I-DISEASE
Excessive	0
Fragmentary	0
Myoclonus	0
Excessive	0
fragmentary	0
myoclonus	0
(	0
EFM	0
)	0
is	I-DISEASE
a	0
largely	I-DISEASE
incidental	0
polysomnographic	0
finding	0
on	0
EMG	I-DISEASE
,	0
characterized	0
by	0
small	0
movements	0
of	0
the	0
corners	0
of	0
the	I-DISEASE
mouth	0
,	0
fingers	0
,	0
or	0
toes	0
,	I-DISEASE
or	I-DISEASE
by	I-DISEASE
no	I-DISEASE
visible	0
movement	0
at	0
all	0
.	0

The	0
finding	0
is	0
associated	0
with	0
no	0
known	I-DISEASE
clinical	0
consequence	I-DISEASE
.	0

Large	0
limb	0
movements	0
across	0
large	0
joint	0
spaces	I-DISEASE
are	I-DISEASE
not	0
characteristic	I-DISEASE
of	0
EFM	0
and	0
,	I-DISEASE
if	I-DISEASE
present	0
,	0
should	I-DISEASE
exclude	0
the	0
diagnosis	0
of	0
EFM	0
.	0

Scoring	0
of	0
EFM	0
is	0
described	0
in	I-DISEASE
the	I-DISEASE
most	0
recent	0
version	I-DISEASE
of	0
the	I-DISEASE
AASM	0
Manual	0
for	I-DISEASE
the	0
Scoring	0
of	I-DISEASE
Sleep	0
and	I-DISEASE
Associated	0
Events	0
.	0

The	0
condition	0
is	I-DISEASE
a	0
NREM	0
phenomenon	0
and	0
the	I-DISEASE
move-	I-DISEASE
ments	0
resemble	I-DISEASE
the	0
phasic	I-DISEASE
twitches	0
seen	I-DISEASE
in	0
normal	I-DISEASE
REM	I-DISEASE
sleep	0
except	0
that	0
they	0
are	0
more	0
universally	I-DISEASE
dispersed	0
throughout	0
a	I-DISEASE
sleep	0
epoch	I-DISEASE
than	0
phasic	0
REM	0
twitches	0
,	0
which	0
are	0
generally	I-DISEASE
clustered	0
within	0
small	I-DISEASE
groups	0
in	0
a	0
sleep	0
epoch	0
.	I-DISEASE

Its	0
importance	0
lies	0
in	0
that	0
it	I-DISEASE
is	0
within	0
the	I-DISEASE
differential	I-DISEASE
diagnosis	0
of	0
other	0
sleep	0
related	I-DISEASE
movement	I-DISEASE
disorders	0
.	I-DISEASE

Patients	0
usually	0
are	B-DISEASE
not	0
aware	0
of	I-DISEASE
the	0
twitch	0
-	I-DISEASE
like	0
movements	0
.	0

Patients	0
may	0
have	0
other	0
coexistent	0
sleep	I-DISEASE
disorders	I-DISEASE
,	0
but	I-DISEASE
EFM	0
does	0
not	0
appear	0
to	0
contribute	I-DISEASE
to	I-DISEASE
the	0
symptoms	I-DISEASE
of	0
these	0
sleep	0
disorders	0
.	I-DISEASE

EFM	0
,	0
a	I-DISEASE
NREM	0
phenomenon	0
,	0
is	0
less	I-DISEASE
common	I-DISEASE
than	0
phasic	0
REM	0
twitches	0
,	0
which	I-DISEASE
occur	0
in	0
REM	I-DISEASE
sleep	0
in	I-DISEASE
normal	0
individuals	0
without	I-DISEASE
sleep	0
complaints	0
.	0

Most	0
cases	0
have	0
been	0
reported	0
in	0
adults	0
.	0

EFM	0
is	0
predominantly	I-DISEASE
found	0
in	0
males	0
.	0

A	0
recent	0
study	I-DISEASE
found	I-DISEASE
EFM	0
in	0
100	I-DISEASE
%	0
of	I-DISEASE
62	0
patients	0
with	I-DISEASE
a	I-DISEASE
variety	0
of	I-DISEASE
sleep	I-DISEASE
disorders	I-DISEASE
,	I-DISEASE
bringing	0
into	0
question	0
the	0
specificity	0
of	I-DISEASE
EFM	I-DISEASE
.	0

Numerous	0
causes	0
of	I-DISEASE
chronic	0
sleep	0
fragmentation	I-DISEASE
may	I-DISEASE
be	0
associated	I-DISEASE
with	I-DISEASE
EFM	0
.	0

The	0
condition	0
has	I-DISEASE
been	0
described	0
with	0
obstructive	0
sleep	0
apnea	I-DISEASE
and	0
primary	0
central	I-DISEASE
sleep	0
apnea	I-DISEASE
,	0
sleep	I-DISEASE
related	0
hypoxemic	0
/	I-DISEASE
hypoventilation	0
syndromes	I-DISEASE
,	0
narcolepsy	0
,	I-DISEASE
PLMD	I-DISEASE
,	I-DISEASE
and	0
various	I-DISEASE
causes	0
of	0
insomnia	0
.	I-DISEASE

In	0
apneic	0
patients	0
,	I-DISEASE
the	0
twitching	0
intensifies	I-DISEASE
during	0
periods	I-DISEASE
of	0
increased	0
hypoxemia	0
.	I-DISEASE

One	0
report	I-DISEASE
has	0
found	0
excessive	0
fragmentary	I-DISEASE
myoclonus	0
to	0
be	I-DISEASE
very	0
common	0
in	0
children	0
with	0
Niemann	I-DISEASE
-	0
Pick	0
disease	I-DISEASE
,	0
type	0
C.	0
No	0
specific	0
precipitating	0
factors	0
have	0
been	I-DISEASE
reported	0
.	0

The	0
contribution	0
of	0
EFM	I-DISEASE
to	0
the	I-DISEASE
symptomatology	I-DISEASE
of	I-DISEASE
any	0
of	0
these	0
disorders	0
is	0
unknown	0
.	0

The	0
course	0
is	0
not	0
well	0
studied	0
but	0
appears	0
to	I-DISEASE
be	0
benign	0
and	0
non	0
-	0
progressive	0
.	0

The	0
dis-	0
order	0
may	I-DISEASE
be	0
the	I-DISEASE
sole	B-DISEASE
abnormality	I-DISEASE
in	I-DISEASE
some	0
cases	0
of	0
excessive	0
daytime	0
sleepiness	I-DISEASE
,	0
but	0
causality	0
is	I-DISEASE
questionable	0
.	0

No	0
other	0
serious	0
consequences	B-DISEASE
of	0
the	I-DISEASE
disorder	I-DISEASE
have	0
been	0
described	0
when	0
it	0
occurs	0
in	0
isolation	0
.	0

In	0
some	0
cases	0
,	B-DISEASE
EFM	0
is	0
present	I-DISEASE
in	0
normal	I-DISEASE
individuals	0
.	0

Its	0
relatively	0
benign	0
course	0
sug-	0
gests	0
that	0
it	0
is	I-DISEASE
not	0
associated	0
with	0
a	0
neurodegenerative	0
process	I-DISEASE
.	0

In	0
most	0
reported	0
cases	0
,	0
there	0
have	I-DISEASE
been	0
associated	I-DISEASE
sleep	0
abnormalities	I-DISEASE
and	0
sleep	0
disruption	0
,	I-DISEASE
suggesting	0
that	0
EFM	I-DISEASE
may	0
be	0
due	I-DISEASE
to	0
disruptions	I-DISEASE
of	0
normal	I-DISEASE
motor	0
-	0
control	I-DISEASE
mechanisms	0
during	I-DISEASE
sleep	0
.	0

Whether	0
there	0
is	I-DISEASE
a	0
genetic	0
or	0
other	0
basis	0
predisposing	0
individuals	0
to	0
develop	0
the	0
condi-	0
tion	0
is	0
unknown	I-DISEASE
.	I-DISEASE

In	0
any	0
case	0
,	0
it	0
would	0
appear	0
to	0
result	I-DISEASE
from	0
intensification	0
of	0
an	I-DISEASE
other-	0
wise	I-DISEASE
normal	I-DISEASE
motor	I-DISEASE
phenomenon	I-DISEASE
.	0

The	0
predominant	0
topographic	0
distribution	0
of	0
EFM	0
in	I-DISEASE
distal	0
and	I-DISEASE
facial	0
muscles	0
suggests	0
that	I-DISEASE
cortical	0
motor	I-DISEASE
centers	0
participate	I-DISEASE
in	I-DISEASE
its	I-DISEASE
generation	0
.	0

EFM	0
is	0
detected	I-DISEASE
as	0
isolated	0
,	0
very	0
brief	0
(	I-DISEASE
usually	I-DISEASE
75	0
to	0
150	0
milliseconds	0
)	I-DISEASE
,	0
asymmetrical	0
,	0
asynchronous	0
EMG	I-DISEASE
potentials	0
in	0
various	0
muscles	0
of	I-DISEASE
the	0
face	0
,	I-DISEASE
trunk	0
,	0
arms	0
,	0
and	0
legs	0
.	0

The	0
amplitude	0
varies	0
from	0
approximately	0
50	0
to	0
several	0
hundred	I-DISEASE
microvolts	0
;	0
the	0
taller	0
amplitudes	0
are	I-DISEASE
often	0
associated	0
with	I-DISEASE
visible	0
movement	0
of	0
the	0
fingers	0
,	0
toes	I-DISEASE
,	I-DISEASE
or	I-DISEASE
corners	I-DISEASE
of	0
the	0
mouth	0
,	0
whereas	0
the	0
smaller	0
ones	0
may	I-DISEASE
resemble	I-DISEASE
fasciculation	0
potentials	0
and	0
be	0
without	0
overt	0
movement	0
.	0

Large	0
movements	0
across	0
large	0
joint	0
spaces	0
preclude	I-DISEASE
a	0
diag-	I-DISEASE
nosis	0
of	0
EFM	0
.	0

Small	0
twitch	0
-	0
like	I-DISEASE
movements	0
may	I-DISEASE
be	0
observed	0
on	I-DISEASE
video	0
recording	0
.	I-DISEASE

Episodes	0
of	0
these	0
myoclonic	0
potentials	0
typically	I-DISEASE
last	I-DISEASE
from	0
10	0
minutes	0
to	0
several	0
hours	0
.	0

They	0
often	0
appear	0
at	0
sleep	0
onset	I-DISEASE
and	0
continue	0
through	0
the	0
NREM	0
sleep	0
stages	0
,	0
includ-	I-DISEASE
ing	0
slow	0
wave	0
sleep	0
.	0

The	0
presence	0
of	0
EFM	I-DISEASE
in	0
REM	I-DISEASE
is	0
difficult	0
to	I-DISEASE
determine	0
because	0
it	0
is	0
superimposed	0
on	0
the	I-DISEASE
normal	0
phasic	0
clusters	0
of	0
physiological	0
phasic	0
REM	0
twitches	0
.	0

EFM	0
is	0
electromyographically	I-DISEASE
similar	0
to	0
the	0
latter	I-DISEASE
.	0

Occasionally	0
,	0
the	0
EMG	I-DISEASE
activity	0
also	0
persists	I-DISEASE
during	0
EEG	0
periods	0
of	0
wakefulness	0
within	0
the	0
sleep	0
period	0
or	I-DISEASE
is	0
present	0
in	I-DISEASE
drowsiness	0
prior	0
to	0
sleep	0
onset	0
.	0

The	0
EEG	0
usually	0
shows	I-DISEASE
no	0
changes	0
at	I-DISEASE
the	0
time	I-DISEASE
of	I-DISEASE
the	0
movements	0
,	I-DISEASE
although	0
high	I-DISEASE
-	0
amplitude	0
EMG	I-DISEASE
potentials	0
may	0
be	0
associated	0
with	0
a	0
K	I-DISEASE
complex	0
or	0
even	I-DISEASE
with	0
transient	0
EEG	0
arousal	I-DISEASE
.	0

There	0
are	0
no	0
ocular	I-DISEASE
or	0
autonomic	I-DISEASE
accom-	0
paniments	0
.	I-DISEASE

It	0
seems	0
possible	0
that	0
,	0
depending	0
on	I-DISEASE
the	0
digitalization	I-DISEASE
rates	0
,	0
digital	0
systems	0
may	0
record	I-DISEASE
less	0
fragmentary	0
myoclonus	0
than	0
earlier	0
paper	0
records	0
.	0

No	0
laboratory	0
tests	0
other	I-DISEASE
than	0
polysomnography	0
(	I-DISEASE
optimally	0
with	I-DISEASE
multiple	0
EMG	0
leads	I-DISEASE
)	I-DISEASE
have	0
been	0
reported	0
to	0
be	I-DISEASE
helpful	0
in	0
assessing	0
EFM	0
.	0

EFM	0
generally	0
has	I-DISEASE
a	I-DISEASE
maximum	0
burst	I-DISEASE
duration	I-DISEASE
of	0
only	I-DISEASE
150	0
milliseconds	0
and	0
does	0
not	0
recur	I-DISEASE
periodically	I-DISEASE
.	0

It	0
can	0
be	0
distinguished	I-DISEASE
from	0
PLMS	0
because	I-DISEASE
PLMS	0
are	I-DISEASE
character-	0
ized	0
by	0
a	0
longer	0
burst	I-DISEASE
duration	I-DISEASE
(	0
typically	0
0.5	0
to	0
10	0
seconds	0
)	0
and	I-DISEASE
a	I-DISEASE
long	I-DISEASE
period	0
between	0
bursts	0
(	I-DISEASE
5	0
-	I-DISEASE
90	0
seconds	0
)	0
.	0

EFM	0
,	0
which	I-DISEASE
occurs	0
in	I-DISEASE
NREM	0
,	0
must	0
also	0
be	I-DISEASE
differentiated	0
from	0
normal	0
physiological	0
phasic	I-DISEASE
REM	0
twitches	0
,	0
which	0
have	0
a	0
similar	0
burst	0
duration	I-DISEASE
but	0
are	0
limited	I-DISEASE
to	0
the	0
REM	I-DISEASE
state	0
and	I-DISEASE
tend	0
to	0
occur	0
in	0
clusters	I-DISEASE
within	I-DISEASE
an	0
epoch	0
,	I-DISEASE
as	I-DISEASE
opposed	0
to	0
EFM	0
in	I-DISEASE
which	I-DISEASE
bursts	I-DISEASE
tend	0
not	I-DISEASE
to	0
cluster	0
within	I-DISEASE
a	0
particular	0
epoch	0
.	0

Larger	0
body	0
move-	0

ments	0
across	0
the	0
large	0
joints	I-DISEASE
are	0
not	I-DISEASE
a	0
feature	I-DISEASE
of	0
excessive	0
fragmentary	0
myoclonus	I-DISEASE
.	0

The	0
presence	0
of	0
such	0
movements	0
suggests	I-DISEASE
other	0
disorders	0
.	I-DISEASE

Sleep	0
Related	I-DISEASE
Movement	I-DISEASE
Disorders	0
Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
Further	I-DISEASE
investigation	I-DISEASE
is	0
necessary	0
to	I-DISEASE
determine	0
whether	I-DISEASE
EFM	0
occurs	I-DISEASE
as	I-DISEASE
a	0
consequence	0
of	0
sleep	0
disruption	0
or	I-DISEASE
whether	I-DISEASE
it	0
is	0
an	I-DISEASE
independent	0
cause	I-DISEASE
of	0
sleep	0
disruption	0
and	0
daytime	0
symptoms	I-DISEASE
in	0
its	I-DISEASE
own	0
right	I-DISEASE
.	0

It	0
must	0
also	0
be	B-DISEASE
determined	0
whether	0
there	0
are	I-DISEASE
any	I-DISEASE
physiolog-	0
ical	0
differences	I-DISEASE
that	0
distinguish	0
fragmentary	I-DISEASE
myoclonus	I-DISEASE
seen	0
in	I-DISEASE
many	0
normal	0
individu-	0
als	0
from	0
EFM	0
.	0

It	0
is	0
not	0
known	I-DISEASE
whether	0
some	0
additional	0
pathophysiological	0
element	I-DISEASE
is	I-DISEASE
required	0
to	0
increase	0
fragmentary	0
myoclonus	I-DISEASE
into	0
an	0
abnormal	0
range	0
.	0

The	0
current	0
thresh-	0
old	0
for	0
the	I-DISEASE
diagnosis	0
of	0
EFM	I-DISEASE
should	0
be	0
further	I-DISEASE
investigated	I-DISEASE
because	0
the	I-DISEASE
scoring	0
criteria	I-DISEASE
lack	I-DISEASE
specificity	I-DISEASE
.	0

The	0
apparent	0
strong	0
predominance	0
in	0
males	0
also	0
remains	0
unexplained	0
.	0

Bibliography	0
Broughton	0
R.	0
Pathological	0
fragmentary	0
myoclonus	0
,	I-DISEASE
intensified	0
sleep	0
starts	0
and	0
hypnagogic	0
foot	0
tremor	0
:	I-DISEASE
three	0
unusual	0
sleep	I-DISEASE
-	0
related	I-DISEASE
disorders	0
.	0

In	0
:	0
Koella	0
WP	0
,	0
Schulz	I-DISEASE
OF	I-DISEASE
,	0
Visser	0
P	0
,	0
eds	0
.	0

Sleep	0
1986	0
.	0

Stuttgart	0
:	0

Fischer	0
-	0
Verlag	0
,	0
1988:240–3	0
.	B-DISEASE

Broughton	0
R	0
,	0
Tolentino	0
MA	0
.	0

Fragmentary	0
pathological	0
myoclonus	0
in	0
NREM	0
sleep	0
.	I-DISEASE

Electroencephalogr	0
Clin	0
Neurophysiol	0
1984;57:303–9	0
.	0

Broughton	0
R	0
,	0
Tolentino	I-DISEASE
MA	0
,	0
Krelina	I-DISEASE
M.	I-DISEASE
Excessive	I-DISEASE
fragmentary	0
myoclonus	0
in	0
NREM	0
sleep	0
:	I-DISEASE
a	0
report	0
of	I-DISEASE
38	0
cases	0
.	0

Electroencephalogr	0
Clin	0
Neurophysiol	0
1985;61:123–33	0
.	0

Frauscher	0
B	0
,	I-DISEASE
Kunz	0
A	I-DISEASE
,	0
Brandauer	0
E	0
,	I-DISEASE
Ulmer	0
H	0
,	0
Poewe	0
W	0
,	I-DISEASE
Hogl	I-DISEASE
B.	0
Fragmentary	I-DISEASE
myoclonus	0
in	0
sleep	I-DISEASE
revisited	0
:	0
A	0
polysomnographic	0
study	I-DISEASE
in	0
62	I-DISEASE
patients	I-DISEASE
.	I-DISEASE

Sleep	0
Med	0
2011;12:410–5	0
.	0

Goyal	0
MK	0
,	0
Kumar	0
G	0
,	0
Sivaraman	0
M.	0
Sahota	I-DISEASE
P.	0
Teaching	0
neuroimages	0
:	0
excessive	0
fragmentary	0
hypnic	0
myoclonus	0
.	I-DISEASE

Neurology	0
2011;77	0
:	0
e59	0
–	I-DISEASE
e60	0
.	I-DISEASE

Lins	0
O	0
,	I-DISEASE
Castonguay	0
M	0
,	I-DISEASE
Dunham	0
W	I-DISEASE
,	I-DISEASE
Nevsimalova	0
S	I-DISEASE
,	I-DISEASE
Broughton	I-DISEASE
R.	0
Excessive	0
fragmentary	0
myoclonus	0
:	0
time	0
of	0
night	0
and	0
sleep	0
stage	I-DISEASE
distributions	I-DISEASE
.	0

Can	0
J	0
Neurol	0
Sci	0
1993;20:142–6	0
.	0

Vankova	0
J	0
,	0
Stepanova	0
I	0
,	0
Jech	I-DISEASE
R	0
,	0
et	0
al	0
.	0

Sleep	0
disturbances	0
and	0
hypocretin	I-DISEASE
deficiency	0
in	0
Niemann	0
-	0
Pick	I-DISEASE
disease	0
type	0
C.	0
Sleep	0
2003;26:427–30	0
.	I-DISEASE

Vetrugno	0
R	0
,	0
Plazzi	0
G	0
,	I-DISEASE
Provini	I-DISEASE
F	0
,	I-DISEASE
Liguori	0
R	I-DISEASE
,	0
Lugaresi	0
E	0
,	I-DISEASE
Montagna	0
P.	0
Excessive	I-DISEASE
fragmentary	0
hypnic	0
myoclonus	0
:	0
clinical	0
and	I-DISEASE
neurophysiological	0
findings	0
.	0

Sleep	0
Med	0
2002;3:73–6	0
.	0

Montagna	0
P	0
,	0
Liguori	0
R	0

et	0
al	0
.	0

Physiological	0
hypnic	0
myoclonus	0
Electroencephalogr	0
Clin	0
Neurophysiol	0
1988;70:172–6	0
.	I-DISEASE

Hypnagogic	0
Foot	0
Tremor	0
and	I-DISEASE
Alternating	0
Leg	I-DISEASE
Muscle	I-DISEASE
Activation	0
Hypnagogic	I-DISEASE
foot	0
tremor	0
(	0
HFT	I-DISEASE
)	0
is	I-DISEASE
rhythmic	I-DISEASE
movement	0
of	I-DISEASE
the	0
feet	I-DISEASE
or	0
toes	0
that	0
occurs	0
at	I-DISEASE
the	0
transition	0
between	0
wake	I-DISEASE
and	0
sleep	0
or	0
during	0
light	0
NREM	0
sleep	I-DISEASE
(	0
stages	0
N1	0
and	I-DISEASE
N2	I-DISEASE
)	I-DISEASE
.	0

Alternating	0
leg	0
muscle	0
activation	0
(	0
ALMA	0
)	I-DISEASE
consists	0
of	I-DISEASE
brief	0
activation	I-DISEASE
of	0
the	0
ante-	0
rior	I-DISEASE
tibialis	0
in	I-DISEASE
one	I-DISEASE
leg	0
in	0
alternation	0
with	0
similar	0
activation	0
in	0
the	0
other	0
leg	0
during	0
sleep	0
or	0
arousals	0
from	0
sleep	0
.	0

HFT	0
may	0
be	0
a	0
relatively	0
common	0
and	0
normal	0
finding	I-DISEASE
.	0

Affected	0
individuals	0
move	0
the	B-DISEASE
feet	0
or	0
the	I-DISEASE
toes	0
rhythmically	0
for	I-DISEASE
seconds	0
to	0
minutes	0
during	0
drowsy	I-DISEASE
wakefulness	0
or	0
lighter	I-DISEASE
stages	0
of	0
sleep	0
.	I-DISEASE

It	0
can	0
be	0
pathologically	0
exagger-	0
ated	0
in	0
some	0
patients	I-DISEASE
.	0

ALMA	0
is	0
defined	0
by	0
a	0
polysomnographic	0
pattern	I-DISEASE
with	0
unknown	I-DISEASE
clinical	0
manifestations	0
,	0
but	0
frequency	0
of	I-DISEASE
muscle	I-DISEASE
activations	0
,	I-DISEASE
length	I-DISEASE
of	0
activations	0
,	0
and	0
occurrence	0
primarily	I-DISEASE
with	I-DISEASE
arousals	0
suggest	0
that	0
ALMA	I-DISEASE
may	I-DISEASE
be	0
similar	0
to	0
HFT	0
or	0
rep-	I-DISEASE
resent	I-DISEASE
an	0
EMG	I-DISEASE
manifestation	0
of	I-DISEASE
some	0
episodes	0
of	0
HFT	I-DISEASE
.	0

The	0
original	0
case	0
series	0
that	0
described	I-DISEASE
ALMA	I-DISEASE
did	0
not	I-DISEASE
link	0
it	0
with	0
movement	0
of	0
the	I-DISEASE
lower	0
extremity	I-DISEASE
,	I-DISEASE
but	0
a	0
subse-	0
quent	0
report	0
did	0
.	0

HFT	0
and	0
ALMA	I-DISEASE
are	0
considered	0
together	I-DISEASE
because	I-DISEASE
the	0
relationship	I-DISEASE
between	0
them	I-DISEASE
remains	0
to	0
be	0
clarified	I-DISEASE
,	0
and	0
the	0
similarity	0
in	I-DISEASE
a	0
number	0
of	0
their	I-DISEASE
features	I-DISEASE
suggests	0
they	0
may	I-DISEASE
not	0
be	0
fully	0
independent	I-DISEASE
entities	0
.	0

Associated	0
features	0
of	0
HFT	0
and	0
ALMA	I-DISEASE
are	I-DISEASE
similar	0
.	I-DISEASE

Most	0
cases	0
of	0
HFT	0
have	0
been	I-DISEASE
reported	0
in	0
persons	0
with	0
other	0
sleep	0
disorders	0
,	0
such	I-DISEASE
as	0
RLS	0
or	I-DISEASE
SRBDs	0
.	0

ALMA	0
has	0
been	0
identified	0
mainly	0
in	0
patients	I-DISEASE
with	0
SRBD	I-DISEASE
or	0
PLMs	0
.	0

Seventy	0
-	0
five	0
percent	0
of	0
patients	0
with	I-DISEASE
ALMA	0
in	I-DISEASE
the	0
original	0
series	0
used	I-DISEASE
antidepressant	0
medication	I-DISEASE
.	0

In	0
that	0
study	0
,	I-DISEASE
patients	0
with	I-DISEASE
ALMA	0
complained	0
of	I-DISEASE
sleepiness	0
,	0
insomnia	I-DISEASE
,	0
or	0
restless	I-DISEASE
of	0
the	0
legs	I-DISEASE
,	0
but	0
only	0
one	0
reported	0
patient	0
had	0
more	0
specific	0
complaints	0
of	0
sudden	0
nocturnal	0
muscle	I-DISEASE
contractions	0
in	0
his	0
legs	0
and	0
a	I-DISEASE
sensation	0
that	0
his	0
legs	0
were	0
vibrating	0
.	0

A	0
separately	0
reported	0
case	0
of	0
a	I-DISEASE
patient	I-DISEASE
with	0
ALMA	I-DISEASE
documented	0
absence	0
of	0
any	0
SRBD	0
,	I-DISEASE
PLMs	0
,	0
or	I-DISEASE
use	0
of	0
antidepressant	0
medication	0
.	0

This	0
patient	0
complained	0
of	0
frequent	0
and	0
easily	I-DISEASE
provoked	0
awakenings	0
,	0
as	0
well	0
as	0
excessive	0
daytime	0
sleepiness	0
.	0

The	0
ALMA	0
and	0
symptoms	I-DISEASE
responded	0
to	0
treat-	0
ment	0
with	0
pramipexole	0
.	0

The	0
single	0
series	0
in	0
which	0
HFT	I-DISEASE
was	0
studied	I-DISEASE
found	I-DISEASE
that	0
it	0
occurs	0
in	0
7.5	0
%	0
of	I-DISEASE
patients	0
in	I-DISEASE
whom	0
a	0
polysomnogram	0
was	0
performed	0
for	0
other	I-DISEASE
reasons	0
.	0

Affected	0
individuals	0
range	0
in	0
age	0
from	I-DISEASE
14	0
to	0
72	0
years	0
,	0
with	0
a	I-DISEASE
majority	0
in	0
the	0
middle	0
-	0
age	I-DISEASE
range	0
(	0
40	0
to	I-DISEASE
65	I-DISEASE
years	I-DISEASE
)	0
.	0

Men	0
and	0
women	0
are	I-DISEASE
equally	0
affected	I-DISEASE
.	I-DISEASE

It	0
is	0
possible	0
that	0
the	0
frequency	I-DISEASE
of	I-DISEASE
these	0
move-	0
ments	0
may	0
be	0
increased	0
in	0
individuals	I-DISEASE
with	I-DISEASE
disorders	0
such	I-DISEASE
as	0
RLS	0
or	0
SRBD	0
,	0
but	0
it	0
can	0
occur	0
in	0
individuals	0
with	0
otherwise	0
normal	0
sleep	0
.	0

The	0
prevalence	0
of	I-DISEASE
the	0
condition	0
in	I-DISEASE
the	0
general	0
population	0
and	0
its	0
frequency	0
in	0
affected	0
individuals	0
remains	0
uncertain	0
.	I-DISEASE

The	0
initial	0
series	0
reporting	I-DISEASE
ALMA	0
found	0
that	I-DISEASE
it	0
occurs	I-DISEASE
in	0
1.1	0
%	0
of	0
unselected	0
studies	0
from	0
a	0
sleep	0
disorder	0
center	0
.	0

Patients	0
with	0
ALMA	0
were	0
mostly	0
male	0
(	0
11:5	0
)	I-DISEASE
and	0
ranged	0
in	0
age	0
from	I-DISEASE
12	I-DISEASE
to	I-DISEASE
70	0
years	0
,	0
with	0
most	0
aged	0
35	I-DISEASE
to	0
55	0
years	0
(	0
mean	I-DISEASE
age	0
41	0
years	I-DISEASE
)	I-DISEASE
.	0

Therefore	0
,	0
the	0
age	I-DISEASE
ranges	0
of	0
both	I-DISEASE
conditions	0
are	I-DISEASE
similar	0
,	0
with	0
both	0
males	0
and	0
females	I-DISEASE
affected	0
.	I-DISEASE

These	0
distributions	0
may	0
be	0
due	0
to	0
the	0
incidental	I-DISEASE
discovery	0
of	0
both	0
entities	0
during	0
routine	I-DISEASE
sleep	I-DISEASE
studies	0
for	I-DISEASE
other	I-DISEASE
sleep	0
complaints	0
.	0

No	0
predisposing	0
factors	0
are	0
known	0
for	0
HFT	0
.	0

The	0
use	0
of	0
antidepressant	0
medication	0
may	0
increase	I-DISEASE
risk	0
for	0
ALMA	0
.	0

No	0
longitudinal	0
studies	0
have	0
been	0
performed	0
for	0
either	0
entity	I-DISEASE
.	0

In	0
some	0
individuals	0
,	0
HFT	0
is	0
an	I-DISEASE
occasional	0
finding	I-DISEASE
,	0
but	0
others	0
appear	0
to	0
manifest	I-DISEASE
the	0
rhythmic	0
movements	I-DISEASE
Sleep	0
Related	0
Movement	0
Disorders	0
Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
on	0
many	I-DISEASE
nights	B-DISEASE
and	0
over	0
a	0
span	0
of	0
at	0
least	0
months	0
.	I-DISEASE

ALMA	0
showed	0
some	0
tendency	0
to	0
persist	I-DISEASE
between	0
two	0
different	I-DISEASE
recordings	0
in	0
the	0
originally	0
reported	0
series	I-DISEASE
.	0

Because	0
most	0
individuals	0
are	0
unaware	0
of	0
the	I-DISEASE
presence	I-DISEASE
of	0
the	0
HFT	0
movements	0
,	I-DISEASE
and	0
patients	I-DISEASE
with	I-DISEASE
ALMA	I-DISEASE
may	0
have	0
no	I-DISEASE
associated	0
complaint	0
or	0
awareness	0
of	I-DISEASE
the	0
phenomenon	0
,	I-DISEASE
the	I-DISEASE
evo-	0
lution	0
of	I-DISEASE
HFT	0
and	0
ALMA	0
may	0
be	0
difficult	I-DISEASE
to	0
follow	I-DISEASE
except	I-DISEASE
in	0
the	0
sleep	0
laboratory	I-DISEASE
or	0
with	I-DISEASE
home	I-DISEASE
monitoring	0
.	0

Although	0
usually	0
an	0
incidental	I-DISEASE
and	0
benign	0
finding	I-DISEASE
,	0
HFT	I-DISEASE
may	0
cause	0
sleep	0
disruption	I-DISEASE
and	0
sleep	I-DISEASE
-	I-DISEASE
onset	0
insomnia	I-DISEASE
if	0
sufficiently	0
prolonged	0
or	0
severe	0
.	0

In	0
HFT	0
,	0
the	I-DISEASE
patient	0
typically	I-DISEASE
reports	I-DISEASE
foot	I-DISEASE
movements	0
(	I-DISEASE
directly	0
experienced	0
or	0
observed	0
by	0
others	I-DISEASE
)	0
that	I-DISEASE
occur	0
at	0
the	0
transition	0
between	I-DISEASE
wake	0
and	0
sleep	I-DISEASE
or	0
during	I-DISEASE
light	0
sleep	0
.	I-DISEASE

On	0
occasion	0
,	0
movement	0
has	0
not	0
been	I-DISEASE
observed	0
but	I-DISEASE
HFT	0
is	0
seen	0
as	0
an	0
incidental	I-DISEASE
finding	I-DISEASE
on	0
sleep	I-DISEASE
study	0
conducted	0
for	0
other	0
indications	0
.	0

Polysomnography	0
demonstrates	0
a	0
pattern	0
of	0
brief	I-DISEASE
,	I-DISEASE
repeated	0
activation	0
of	0
the	0
anterior	0
tibialis	0
in	0
one	I-DISEASE
leg	I-DISEASE
.	0

The	0
minimum	0
frequency	0
is	0
0.3	0
Hz	I-DISEASE
;	0
the	0
maximum	I-DISEASE
4.0	0
Hz	0
.	0

Multiple	0
leg	0
activations	0
in	I-DISEASE
a	0
single	0
leg	I-DISEASE
occur	0
in	0
a	0
train	0
of	0
at	0
least	0
four	I-DISEASE
movements	I-DISEASE
.	0

EMG	0
recordings	0
of	0
the	0
foot	0
or	I-DISEASE
leg	I-DISEASE
muscles	0
or	I-DISEASE
video	0
record-	0
ings	0
of	0
movement	0
may	I-DISEASE
show	I-DISEASE
trains	0
of	I-DISEASE
recurrent	0
1	0
-	0
Hz	0
to	0
2	I-DISEASE
-	0
Hz	I-DISEASE
EMG	0
potentials	I-DISEASE
or	I-DISEASE
move-	0
ments	0
.	I-DISEASE

Typical	0
associated	0
EMG	0
bursts	I-DISEASE
are	0
300	I-DISEASE
to	I-DISEASE
700	0
milliseconds	I-DISEASE
in	0
duration	0
,	0
and	0
the	0
typical	0
duration	0
of	0
trains	I-DISEASE
is	I-DISEASE
10	I-DISEASE
to	0
15	0
seconds	0
,	0
although	I-DISEASE
longer	0
bursts	I-DISEASE
and	0
trains	0
have	0
been	I-DISEASE
reported	I-DISEASE
.	0

In	0
morbid	0
conditions	0
,	0
trains	0
may	0
persist	I-DISEASE
much	0
longer	I-DISEASE
.	0

Events	0
are	0
recorded	0
at	0
the	0
transition	I-DISEASE
into	I-DISEASE
sleep	0
and	I-DISEASE
during	0
stages	0
N1	0
and	0
N2	0
sleep	I-DISEASE
.	0

Distribution	0
over	0
the	0
night	B-DISEASE
has	0
not	0
been	I-DISEASE
fully	0
investigated	0
.	0

Persistent	0
HFT	0
has	0
been	0
found	0
in	I-DISEASE
about	0
half	0
of	I-DISEASE
the	0
indi-	0
viduals	I-DISEASE
who	0
have	I-DISEASE
had	0
multiple	I-DISEASE
studies	0
.	I-DISEASE

Alternation	0
between	0
legs	0
has	0
not	0
been	0
described	0
,	0
but	0
its	0
potential	0
occurrence	0
is	0
suggested	0
in	I-DISEASE
two	0
published	0
studies	0
of	0
HFT	0
.	0

In	0
ALMA	0
,	0
polysomnography	I-DISEASE
demonstrates	0
a	I-DISEASE
pattern	I-DISEASE
of	0
brief	0
,	0
repeated	0
activation	0
of	0
the	0
anterior	I-DISEASE
tibialis	I-DISEASE
in	0
one	I-DISEASE
leg	0
alternating	0
with	0
similar	0
activation	0
in	0
the	0
other	0
leg	0
.	0

At	0
a	I-DISEASE
minimum	0
,	0
a	0
single	I-DISEASE
leg	0
muscle	0
activation	I-DISEASE
in	0
one	0
leg	0
is	0
followed	0
sequentially	0
by	0
a	0
similar	I-DISEASE
single	0
activation	0
in	0
the	0
other	I-DISEASE
leg	0
,	I-DISEASE
reactivation	0
in	0
the	I-DISEASE
original	0
leg	0
,	0
and	I-DISEASE
then	0
reactivation	0
in	0
the	0
alternate	0
leg	0
,	0
with	0
some	I-DISEASE
continued	0
alternation	0
beyond	0
this	0
minimal	0
sequence	0
in	I-DISEASE
most	0
instances	0
.	0

The	0
minimum	0
frequency	0
of	0
alternating	0
EMG	0
bursts	0
is	0
0.5	I-DISEASE
Hz	0
,	I-DISEASE
and	0
the	0
maximum	0
frequency	I-DISEASE
is	I-DISEASE
3.0	I-DISEASE
Hz	I-DISEASE
.	0

The	0
patient	0
may	0
report	0
foot	0
movements	I-DISEASE
(	I-DISEASE
directly	0
experi-	I-DISEASE
enced	0
or	0
observed	0
by	0
others	0
)	I-DISEASE
that	0
occur	I-DISEASE
at	I-DISEASE
the	0
transition	I-DISEASE
between	0
wake	0
and	I-DISEASE
sleep	I-DISEASE
or	I-DISEASE
during	0
light	I-DISEASE
sleep	I-DISEASE
.	I-DISEASE

As	0
noted	0
above	0
,	0
there	0
is	I-DISEASE
frequently	I-DISEASE
no	0
observation	I-DISEASE
of	0
movement	0
reported	0
but	0
alternating	0
leg	I-DISEASE
muscle	0
activation	0
is	I-DISEASE
recorded	0
as	0
an	0
incidental	0
finding	0
on	0
polysomnography	I-DISEASE
.	0

ALMA	0
can	0
be	0
demonstrated	0
by	I-DISEASE
polysomnography	0
if	I-DISEASE
the	0
surface	I-DISEASE
EMG	0
is	0
recorded	0
inde-	I-DISEASE
pendently	0
from	I-DISEASE
both	I-DISEASE
right	0
and	I-DISEASE
left	0
anterior	0
tibialis	0
muscles	0
.	I-DISEASE

A	0
sequence	0
of	0
ALMA	0
may	0
begin	0
with	0
one	0
to	I-DISEASE
several	0
lengthy	0
activations	I-DISEASE
(	I-DISEASE
one	0
to	I-DISEASE
two	I-DISEASE
seconds	0
)	I-DISEASE
in	0
one	0
or	0
both	0
legs	0
.	0

Some	0
patients	0
show	I-DISEASE
unilateral	0
activity	0
at	0
times	I-DISEASE
.	0

ALMA	0
usually	0
closely	0
precedes	0
or	0
follows	I-DISEASE
an	I-DISEASE
arousal	0
or	0
awakening	0
and	0
gradually	0
diminishes	0
as	0
sleep	I-DISEASE
returns	I-DISEASE
.	0

However	0
,	I-DISEASE
ALMA	0
can	0
also	0
emerge	0
without	0
arousals	0
from	I-DISEASE
any	0
sleep	0
stage	0
.	0

Proclivity	0
for	0
any	0
spe-	0
cific	0
portion	0
of	0
the	0
nocturnal	0
sleep	0
cycle	0
has	0
not	0
been	0
identified	I-DISEASE
.	I-DISEASE

Leg	0
muscle	I-DISEASE
activa-	0
tions	0
during	0
REM	0
sleep	I-DISEASE
,	0
in	I-DISEASE
comparison	0
to	0
NREM	0
sleep	I-DISEASE
,	0
are	0
often	I-DISEASE
briefer	0
and	I-DISEASE
some-	0

what	0
less	0
regular	0
.	0

Sequences	0
of	0
ALMA	0
sometimes	I-DISEASE
recur	0
at	0
intervals	I-DISEASE
similar	0
to	I-DISEASE
those	0
of	0
PLMs	I-DISEASE
.	0

Extensor	0
forearm	0
EMG	I-DISEASE
study	0
may	0
suggest	0
alternating	I-DISEASE
muscle	0
activity	I-DISEASE
in	0
the	0
upper	0
extremities	0
,	0
though	I-DISEASE
it	0
is	0
less	I-DISEASE
prominent	0
than	0
activation	0
in	0
the	0
legs	0
.	0

ALMA	0
shows	0
some	0
night	0
-	0
to	I-DISEASE
-	I-DISEASE
night	0
consistency	I-DISEASE
.	0

Repeat	0
studies	0
are	0
likely	0
to	0
show	0
persistent	0
ALMA	0
.	0

The	0
number	0
of	0
sequences	0
recorded	0
,	0
on	I-DISEASE
average	0
,	0
and	0
the	0
timing	0
of	I-DISEASE
ALMA	0
with	0
respect	0
to	0
arousals	0
tends	0
to	0
remain	0
constant	0
.	0

The	0
specific	0
polysomnographic	I-DISEASE
criteria	0
for	0
HFT	0
during	0
sleep	0
and	I-DISEASE
ALMA	0
are	0
defined	0
in	I-DISEASE
the	0
most	I-DISEASE
recent	I-DISEASE
version	0
of	I-DISEASE
the	0
AASM	0
Manual	0
for	0
the	0
Scoring	I-DISEASE
of	0
Sleep	0
and	I-DISEASE
Associated	0
Events	0
.	0

Presentation	0
of	0
HFT	0
or	0
ALMA	0
with	I-DISEASE
other	0
concurrent	0
sleep	I-DISEASE
disorders	0
is	0
common	0
.	I-DISEASE

Because	0
of	0
the	0
similar	I-DISEASE
frequency	I-DISEASE
,	0
duration	I-DISEASE
,	0
and	I-DISEASE
body	0
part	0
involvement	0
of	0
the	0
move-	I-DISEASE
ments	0
,	0
HFT	0
and	0
ALMA	0
may	0
represent	0
variants	0
of	0
the	I-DISEASE
same	0
disorder	0
.	I-DISEASE

Insufficient	0
sci-	0

entific	0
evidence	0
has	0
accumulated	0
to	0
make	0
this	I-DISEASE
a	0
certainty	0
.	0

Thus	0
,	0
these	0
entities	0
are	I-DISEASE
listed	0
sequentially	I-DISEASE
but	I-DISEASE
separately	0
.	0

Of	0
note	0
,	0
some	0
have	0
questioned	0
whether	I-DISEASE
HFT	0
and	0
ALMA	0
might	0
represent	0
a	0
variant	0
of	0
rhythmic	0
movement	0
disorder	I-DISEASE
in	0
which	0
movements	0
are	0
confined	I-DISEASE
to	0
the	0
legs	0
and	0
an	I-DISEASE
older	0
population	0
is	0
affected	0
.	0

HFT	0
and	0
ALMA	0
should	0
be	0
distinguished	0
from	0
other	I-DISEASE
sleep	I-DISEASE
-	0
onset	0
movements	I-DISEASE
:	I-DISEASE
PLMD	0
(	I-DISEASE
especially	I-DISEASE
the	0
polyclonic	I-DISEASE
form	0
)	I-DISEASE
,	0
PSM	0
,	0
and	I-DISEASE
sleep	I-DISEASE
related	0
RMD	0
.	I-DISEASE

Movement	0
disorders	0
that	0
should	I-DISEASE
be	0
distinguished	0
from	I-DISEASE
HFT	0
and	0
ALMA	0
include	0
dyskinetic	0
movements	0
of	0
the	0
foot	0
,	0
such	0
as	0
painful	0
legs	0
and	I-DISEASE
moving	0
toes	0
;	I-DISEASE
tremors	0
or	0
rhythmic	I-DISEASE
movements	0
of	0
other	I-DISEASE
cause	0
(	0
Parkinson	0
disease	0
,	0
clonus	0
)	I-DISEASE
;	0
and	I-DISEASE
neuroleptic	I-DISEASE
-	0
induced	0
akathisia	0
.	I-DISEASE

None	0
of	I-DISEASE
these	0
conditions	0
involves	0
regular	0
alternation	I-DISEASE
between	0
sides	I-DISEASE
,	0
as	0
seen	0
in	0
ALMA	0
,	0
or	0
an	0
associ-	I-DISEASE
ation	0
with	0
the	0
use	0
of	0
antidepressant	I-DISEASE
medication	I-DISEASE
.	0

Whether	0
HFT	0
should	0
be	I-DISEASE
distinguished	0
from	0
ALMA	I-DISEASE
is	0
not	0
known	0
.	0

Potential	0
differences	0
based	0
on	0
existing	0
reports	0
include	0
the	0
presence	0
of	0
clear	I-DISEASE
movement	0
in	0
HFT	0
as	I-DISEASE
opposed	0
to	0
some	I-DISEASE
uncertainty	0
whether	0
ALMA	0
must	0
involve	I-DISEASE
movement	0
.	I-DISEASE

ALMA	0
,	0
in	0
contrast	0
to	0
HFT	0
,	I-DISEASE
alternates	0
between	I-DISEASE
sides	0
,	0
occurs	0
in	0
any	0
sleep	I-DISEASE
stage	0
,	0
can	I-DISEASE
occur	I-DISEASE
without	0
arousal	0
,	0
and	0
is	I-DISEASE
associated	I-DISEASE
with	0
the	I-DISEASE
use	I-DISEASE
of	0
antidepressants	0
.	I-DISEASE

Sleep	0
Related	I-DISEASE
Movement	I-DISEASE
Disorders	0
Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
High	I-DISEASE
-	I-DISEASE
frequency	0
leg	0
movements	0
(	0
HFLM	0
)	I-DISEASE
also	0
have	I-DISEASE
been	0
described	0
as	0
a	0
repetitive	0
ante-	0
rior	I-DISEASE
tibialis	0
,	0
polysomnographic	I-DISEASE
activation	0
phenomenon	I-DISEASE
,	0
possibly	I-DISEASE
showing	0
some	0
asso-	0
ciation	0
with	0
RLS	0
,	0
and	0
with	I-DISEASE
potential	0
overlap	I-DISEASE
with	0
HFT	0
and	I-DISEASE
ALMA	I-DISEASE
.	I-DISEASE

In	0
contrast	0
to	0
HFT	0
,	0
however	I-DISEASE
,	I-DISEASE
HFLM	0
occur	I-DISEASE
in	0
all	0
sleep	0
stages	0
,	0
and	0
are	I-DISEASE
mostly	0
unilateral	I-DISEASE
rather	0
than	0
bilateral	0
.	0

In	0
contrast	0
to	0
ALMA	0
,	0
HFLM	0
are	I-DISEASE
mostly	0
unilateral	I-DISEASE
rather	0
than	0
alternating	0
,	0
and	0
often	I-DISEASE
show	0
sequences	0
that	I-DISEASE
last	0
longer	0
than	0
those	0
reported	0
for	0
ALMA	I-DISEASE
.	0

The	0
reported	0
HFLM	0
may	0
be	I-DISEASE
more	I-DISEASE
common	0
than	I-DISEASE
ALMA	0
,	0
and	0
the	0
possibility	0
exists	0
that	I-DISEASE
ALMA	I-DISEASE
rep-	0
resents	0
a	0
subtype	0
of	0
HFLM	0
in	I-DISEASE
which	I-DISEASE
leg	0
alternation	0
occurs	0
.	I-DISEASE

The	0
degree	0
to	0
which	0
these	I-DISEASE
movements	0
are	I-DISEASE
quasi	0
-	I-DISEASE
voluntary	0
remains	0
to	0
be	0
determined	0
because	I-DISEASE
some	0
are	0
suppressible	I-DISEASE
.	0

Whether	0
HFT	0
and	0
ALMA	I-DISEASE
are	0
merely	0
alternate	I-DISEASE
forms	0
of	I-DISEASE
the	0
same	0
underlying	0
motor	I-DISEASE
mechanism	0
is	I-DISEASE
also	0
unclear	0
.	I-DISEASE

As	0
reports	0
of	0
these	0
move-	0
ments	0
have	I-DISEASE
arisen	0
from	I-DISEASE
reviews	0
of	I-DISEASE
sleep	0
center	0
records	0
,	I-DISEASE
nothing	I-DISEASE
is	0
known	0
about	0
their	I-DISEASE
manifestation	0
in	0
the	0
general	0
population	I-DISEASE
.	0

The	0
associations	0
noted	I-DISEASE
may	I-DISEASE
be	0
due	I-DISEASE
to	0
biased	0
sampling	I-DISEASE
caused	0
by	I-DISEASE
a	0
skewing	0
of	0
the	0
population	0
toward	I-DISEASE
those	I-DISEASE
with	I-DISEASE
sleep	I-DISEASE
disorders	0
,	0
especially	0
respiratory	I-DISEASE
disorders	I-DISEASE
.	0

The	0
degree	0
to	0
which	I-DISEASE
HFT	I-DISEASE
and	0
ALMA	I-DISEASE
have	0
clinical	I-DISEASE
significance	0
remains	0
uncertain	0
.	0

Bibliography	0
Berry	0
RB	I-DISEASE
.	0

A	0
woman	0
with	0
rhythmic	0
foot	0
movements	I-DISEASE
.	0

J	0
Clin	0
Sleep	I-DISEASE
Med	0
2007;3:749–51	0
.	I-DISEASE

Broughton	0
R.	0
Pathological	0
fragmentary	I-DISEASE
myoclonus	0
,	0
intensified	I-DISEASE
sleep	0
starts	I-DISEASE
and	0
hypnagogic	0
foot	0
tremor	0
:	0
three	I-DISEASE
unusual	I-DISEASE
sleep	I-DISEASE
-	I-DISEASE
related	0
disorders	0
.	0

In	0
:	0
Koella	0
WP	0
,	0
Schulz	I-DISEASE
OF	I-DISEASE
,	0
Visser	0
P	0
,	0
eds	0
.	0

Sleep	0
1986	0
.	0

Stuttgart	0
:	0

Fischer	0
-	0
Verlag	0
,	0
1988:240–3	0
.	B-DISEASE

Chervin	0
RD	0
,	0
Consens	0
FB	0
,	0
Kutluay	I-DISEASE
E.	0
Alternating	I-DISEASE
leg	0
muscle	0
activation	0
during	0
sleep	0
and	0
arousals	0
:	0
a	0
new	0
sleep	0
-	0
related	0
motor	0
phenomenon	0
?	I-DISEASE

Mov	0
Disord	0
2003;18:551–9	0
.	0

Consentino	0
FI	0
,	0
Iero	0
I	0
,	0
Lanuzza	I-DISEASE
B	0
,	0
Tripodi	0
M	0
,	0
Ferri	0
R.	0
The	I-DISEASE
neurophysiology	0
of	0
the	I-DISEASE
alternating	0
leg	0
muscle	0
activation	0
(	I-DISEASE
ALMA	0
)	0
during	0
sleep	0
:	B-DISEASE
Study	I-DISEASE
of	0
one	0
patient	I-DISEASE
before	I-DISEASE
and	0
after	0
treatment	0
with	0
pramipexole	I-DISEASE
.	0

Sleep	0
Med	0
2006;7:63–71	I-DISEASE
.	0

Cunningham	0
SL	0
,	0
Winkelman	0
JW	0
,	I-DISEASE
Dorsey	0
CM	0
,	I-DISEASE
et	0
al	0
.	0

An	0
electromyographic	0
marker	0
for	0
neuroleptic	0
-	0
induced	0
akathisia	0
:	I-DISEASE
preliminary	0
measures	0
of	0
sensitivity	0
and	0
specificity	0
.	0

Clin	0
Neuropharmacol	0
1996;19:321–32	0
.	0

Wichniak	0
A	I-DISEASE
,	0
Tracik	I-DISEASE
F	0
,	I-DISEASE
Geisler	I-DISEASE
P	0
,	I-DISEASE
Ebersbach	0
G	0
,	0
Morrissey	I-DISEASE
SP	0
,	I-DISEASE
Zulley	0
J.	0
Rhythmic	I-DISEASE
feet	0
movements	I-DISEASE
while	0
falling	0
asleep	0
.	0

Mov	0
Disord	0
2001;16:1164–70	0
.	0

Yang	0
C	0
,	I-DISEASE
Winkelman	0
JW	0
,	I-DISEASE
White	0
DP	0
.	I-DISEASE

The	0
effects	0
of	0
antidepressants	0
on	0
leg	0
movements	I-DISEASE
(	0
abstract	I-DISEASE
)	0
Sleep	0
2004;27(Abst	0
Suppl):A311–2	0
.	I-DISEASE

Yang	0
C	0
,	I-DISEASE
Winkelman	0
JW	0
.	0

Clinical	0
and	0
polysomnographic	0
characteristics	0
of	0
high	0
frequency	0
leg	0
movements	I-DISEASE
.	0

J	0
Clin	0
Sleep	I-DISEASE
Med	0
2010;6:431–8	0
.	I-DISEASE

Sleep	0
Starts	0
(	0
Hypnic	0
Jerks	0
)	0

Sleep	0
starts	0
,	0
also	0
known	0
as	0
hypnic	0
jerks	0
,	0
are	I-DISEASE
sudden	0
,	I-DISEASE
brief	0
,	0
simultaneous	I-DISEASE
contractions	0
of	0
the	I-DISEASE
body	0
or	I-DISEASE
one	0
or	0
more	0
body	I-DISEASE
segments	0
occurring	0
at	0
sleep	0
onset	0
.	0

Sleep	0
starts	0
(	0
or	0
hypnic	0
jerks	0
)	0
usually	I-DISEASE
consist	I-DISEASE
of	I-DISEASE
a	0
single	I-DISEASE
contraction	0
that	0
often	I-DISEASE
affects	0
the	0
body	0
asymmetrically	0
.	0

The	0
jerks	0
may	I-DISEASE
be	I-DISEASE
either	0
spontaneous	I-DISEASE
or	I-DISEASE
induced	I-DISEASE
by	I-DISEASE
stimuli	0
.	0

The	0
motor	0
activity	0
is	0
often	0
associated	I-DISEASE
with	0
a	0
sensory	I-DISEASE
component	0
,	0
which	0
may	I-DISEASE
be	0
somesthetic	I-DISEASE
,	0
often	I-DISEASE
an	I-DISEASE
impression	0
of	0
falling	0
or	0
less	0
commonly	0
pain	0
or	0
tingling	0
;	I-DISEASE
auditory	0
,	I-DISEASE
such	I-DISEASE
as	I-DISEASE
banging	0
,	0
snapping	0
or	0
crackling	I-DISEASE
noises	0
;	0
or	0
visual	0
,	I-DISEASE
including	0
flashing	0
lights	0
,	0
hypnagogic	I-DISEASE
dreams	I-DISEASE
,	0
or	0
hallucina-	0
tions	I-DISEASE
.	0

A	0
sharp	0
cry	0
may	0
occur	0
.	0

The	0
patient	0
may	0
not	0
recall	I-DISEASE
a	I-DISEASE
jerk	I-DISEASE
that	I-DISEASE
was	I-DISEASE
noted	0
by	0
a	0
bed	0
partner	0
if	0
the	0
sleep	I-DISEASE
start	I-DISEASE
does	0
not	0
cause	0
awakening	0
.	0

Multiple	0
jerks	0
occasionally	I-DISEASE
occur	I-DISEASE
in	0
succession	0
,	0
usually	0
early	I-DISEASE
in	0
the	0
sleep	0
period	I-DISEASE
.	0

When	0
sleep	0
starts	I-DISEASE
or	0
hypnic	0
jerks	0
are	0
frequent	I-DISEASE
,	I-DISEASE
intense	I-DISEASE
,	I-DISEASE
or	0
repetitive	0
,	0
they	I-DISEASE
may	0
lead	0
to	I-DISEASE
sleep	0
-	0
onset	0
insomnia	0
.	0

Purely	0
sensory	0
sleep	0
starts	0
are	0
subjective	I-DISEASE
,	0
localized	0
,	I-DISEASE
sensory	0
impressions	0
that	0
occur	I-DISEASE
at	0
sleep	0
onset	I-DISEASE
and	I-DISEASE
are	0
not	0
associated	0
with	0
motor	0
activity	0
.	0

The	0
term	0
“	0
Intensified	0
sleep	0
starts	I-DISEASE
”	0
has	I-DISEASE
been	I-DISEASE
applied	0
to	0
both	0
the	0
motor	0
and	0
purely	I-DISEASE
sensory	I-DISEASE
forms	I-DISEASE
when	0
a	0
complaint	0
of	0
difficulty	0
falling	I-DISEASE
asleep	I-DISEASE
as	I-DISEASE
a	0
result	I-DISEASE
of	0
the	0
starts	0
is	I-DISEASE
present	I-DISEASE
.	0

A	0
prevalence	0
of	0
60	0
%	0
to	0
70	0
%	0
has	0
been	0
reported	0
,	0
but	0
with	0
a	0
highly	0
sporadic	0
occurrence	0
.	0

Sleep	0
starts	0
affect	0
all	0
ages	0
and	0
both	I-DISEASE
sexes	0
.	I-DISEASE

Excessive	0
caffeine	0
or	0
other	I-DISEASE
stimulant	0
intake	I-DISEASE
,	0
prior	0
intense	I-DISEASE
physical	0
work	0
or	0
exercise	0
,	0
sleep	I-DISEASE
deprivation	0
,	0
and	I-DISEASE
emotional	0
stress	0
can	0
increase	0
the	I-DISEASE
frequency	I-DISEASE
and	I-DISEASE
severity	0
of	0
sleep	I-DISEASE
starts	0
.	0

Sleep	0
starts	0
are	0
an	0
essentially	0
universal	I-DISEASE
component	0
of	0
the	I-DISEASE
sleep	I-DISEASE
-	0
onset	0
process	0
,	0
although	I-DISEASE
they	0
are	0
often	I-DISEASE
not	0
recalled	I-DISEASE
.	0

Hypnic	0
jerks	0
may	0
occur	I-DISEASE
at	0
any	I-DISEASE
age	I-DISEASE
,	0
as	0
a	I-DISEASE
subjective	0
com-	0
plaint	0
;	0
however	I-DISEASE
,	0
they	0
are	I-DISEASE
usually	0
encountered	0
in	0
adulthood	0
.	0

The	0
course	0
is	0
usually	0
benign	0
.	0

Intensified	0
sleep	0
starts	I-DISEASE
may	0
lead	I-DISEASE
to	I-DISEASE
avoidance	B-DISEASE
/	0
delay	I-DISEASE
of	0
sleep	I-DISEASE
,	0
a	0
fear	0
of	I-DISEASE
falling	0
asleep	0
and	I-DISEASE
chronic	0
anxiety	0
.	0

As	0
a	0
result	0
,	0
acute	0
and	0
chronic	I-DISEASE
sleep	0
deprivation	I-DISEASE
may	0
occur	0
.	0

Sleep	0
-	0
onset	0
insomnia	0
may	0
result	0
either	I-DISEASE
from	0
repeated	I-DISEASE
awakenings	0
induced	0
by	0
the	0
starts	0
or	I-DISEASE
from	0
anxiety	0
about	I-DISEASE
falling	0
asleep	0
.	0

Injury	0
,	0
such	0
as	0
bruising	0
a	0
foot	I-DISEASE
against	0
a	0
bedstead	0
or	0
kicking	I-DISEASE
a	0
sleeping	0
companion	I-DISEASE
,	0
may	0
occasionally	0
occur	0
.	0

The	0
physiological	0
mechanisms	0
underlying	0
sleep	0
starts	I-DISEASE
are	0
uncertain	0
.	0

No	0
pathologic	0
finding	0
has	0
been	0
described	0
except	0
for	0
a	I-DISEASE
single	0
case	0
of	0
auditory	0
sleep	0
starts	I-DISEASE
associated	0
with	0
a	I-DISEASE
brainstem	0
lesion	0
.	0

Hypnic	0
jerks	0
are	0
hypothetically	I-DISEASE
caused	0
by	I-DISEASE
sudden	I-DISEASE
descending	0
volleys	I-DISEASE
originating	0
in	0
the	0
brainstem	0
reticular	0
formation	I-DISEASE
activated	0
by	0
the	0
system	B-DISEASE
insta-	0
bility	0
at	0
the	I-DISEASE
transition	0
between	0
wake	0
and	0
sleep	B-DISEASE
.	I-DISEASE

However	0
,	I-DISEASE
the	0
similarity	I-DISEASE
between	0
sleep	0
starts	I-DISEASE
and	0
the	I-DISEASE
startle	I-DISEASE
response	0
has	0
led	0
some	0
to	I-DISEASE
postulate	0
that	0
abnormalities	0
of	0
sensory	I-DISEASE
Sleep	0
Related	0
Movement	0
Disorders	0
Sleep	I-DISEASE
Related	I-DISEASE
Movement	0
Disorders	I-DISEASE
processing	0
are	0
primary	0
,	I-DISEASE
with	0
secondary	0
motor	0
manifestations	0
involving	0
the	0
reticulo-	I-DISEASE
spinal	0
tract	0
.	0

Sleep	0
starts	0
are	0
a	0
prominent	0
symptom	0
in	B-DISEASE
hereditary	0
hyperekplexia	I-DISEASE
,	0
some	0
cases	0
of	I-DISEASE
which	0
are	0
caused	0
by	0
mutations	I-DISEASE
in	0
the	I-DISEASE
glycine	0
receptor	I-DISEASE
.	0

It	0
has	0
also	0
been	B-DISEASE
postu-	0
lated	0
that	0
sleep	0
starts	0
are	0
a	0
response	0
to	0
hypnagogic	0
imagery	0
.	0

Polysomnographic	0
monitoring	0
shows	0
that	0
hypnic	0
jerks	0
occur	I-DISEASE
during	0
transitions	I-DISEASE
from	0
wakefulness	0
to	I-DISEASE
sleep	0
,	0
mainly	I-DISEASE
at	0
the	0
beginning	I-DISEASE
of	0
the	I-DISEASE
sleep	0
episode	0
.	I-DISEASE

Superficial	0
EMG	0
recordings	0
of	0
the	0
involved	0
muscles	I-DISEASE
show	0
brief	I-DISEASE
(	0
generally	0
75	0
-	I-DISEASE
millisecond	0
to	I-DISEASE
250	0
-	0
mil-	0
lisecond	0
)	0
high	0
-	0
amplitude	I-DISEASE
potentials	0
,	I-DISEASE
either	0
singly	0
or	0
in	0
succession	0
.	0

The	0
EEG	0
typically	0
shows	I-DISEASE
drowsiness	0
or	0
stage	0
N1	0
sleep	I-DISEASE
patterns	0
,	0
sometimes	0
with	0
a	I-DISEASE
negative	I-DISEASE
-	0
vertex	0
sharp	0
wave	0
occurring	0
at	0
the	0
time	0
of	0
the	I-DISEASE
jerk	I-DISEASE
.	I-DISEASE

Autonomic	0
activation	0
,	0
including	0
tachycardia	0
,	0
tachypnea	I-DISEASE
or	0
irregular	I-DISEASE
breathing	I-DISEASE
,	0
and	0
sudomotor	0
activation	0
may	I-DISEASE
follow	0
an	0
intense	0
jerk	0
.	0

After	0
the	0
jerk	I-DISEASE
,	I-DISEASE
a	0
brief	0
arousal	I-DISEASE
or	0
a	0
return	0
to	0
sustained	0
wakefulness	0
may	0
occur	0
.	0

Physical	0
and	0
neurological	0
examinations	0
and	0
routine	I-DISEASE
laboratory	0
tests	0
are	0
otherwise	0
normal	0
.	0

Although	0
polysomnography	0
is	0
not	0
necessary	0
for	0
diagnosis	I-DISEASE
in	0
most	I-DISEASE
individuals	I-DISEASE
,	0
it	0
may	0
be	0
indicated	0
in	I-DISEASE
occasional	0
cases	0
with	0
complaints	I-DISEASE
of	0
insomnia	0
and	0
frequent	I-DISEASE
movements	I-DISEASE
.	I-DISEASE

Hypnic	0
jerks	0
must	0
be	I-DISEASE
differentiated	0
from	I-DISEASE
a	I-DISEASE
number	0
of	I-DISEASE
physiological	0
or	0
pathologic	0
movements	0
that	0
occur	0
at	0
sleep	0
onset	0
or	0
during	0
sleep	0
.	0

Physiological	0
partial	0
hypnic	0
myoclonus	0
consists	0
of	I-DISEASE
small	I-DISEASE
,	0
isolated	I-DISEASE
contractions	0
of	0
a	0
muscle	0
or	0
part	0
thereof	0
,	0
occur-	I-DISEASE
ring	0
sporadically	0
in	0
distal	0
muscles	0
and	0
resembling	0
fasciculation	0
potentials	0
.	I-DISEASE

The	0
con-	0
tractions	I-DISEASE
are	I-DISEASE
particularly	0
evident	I-DISEASE
during	I-DISEASE
stage	I-DISEASE
N1	I-DISEASE
and	0
REM	0
sleep	0
.	0

Fragmentary	0
myoclonus	0
consists	0
of	0
profuse	0
,	0
brief	0
,	0
small	I-DISEASE
-	0
amplitude	0
muscle	I-DISEASE
twitches	0
that	0
occur	I-DISEASE
in	0
an	0
asynchronous	0
,	0
symmetrical	0
,	0
and	0
bilateral	0
manner	0
,	I-DISEASE
especially	0
in	0
distal	I-DISEASE
muscles	0
.	0

Fragmentary	0
myoclonus	0
occurs	0
at	0
sleep	0
onset	0
as	0
well	0
as	0
within	0
all	0
sleep	0
stages	0
.	0

Contrary	0
to	0
the	0
massive	0
jerks	0
of	I-DISEASE
the	I-DISEASE
sleep	I-DISEASE
starts	I-DISEASE
or	0
hypnic	I-DISEASE
jerks	I-DISEASE
,	0
the	0
small	I-DISEASE
muscle	0
twitches	I-DISEASE
of	I-DISEASE
physiological	0
partial	0
hypnic	0
myoclonus	0
and	0
of	0
fragmentary	I-DISEASE
myoclonus	0
often	0
represent	0
only	0
an	0
EMG	0
finding	I-DISEASE
and	0
are	0
not	0
associated	0
with	0
overt	I-DISEASE
movements	0
at	0
the	0
joints	I-DISEASE
.	0

Normal	0
body	0
movements	0
are	0
complex	0
,	0
with	I-DISEASE
body	0
postural	0
shifts	0
usually	0
at	0
the	0
transition	0
between	I-DISEASE
one	0
sleep	0
stage	0
and	0
another	0
.	0

Benign	0
sleep	0
myoclonus	0
of	I-DISEASE
infancy	0
consists	0
of	0
myoclonic	0
jerks	I-DISEASE
at	0
the	0
elbow	0
,	0
fingers	0
,	0
toes	0
,	I-DISEASE
and	I-DISEASE
face	0
during	I-DISEASE
sleep	0
in	0
infants	I-DISEASE
.	0

PSM	0
is	0
characterized	I-DISEASE
by	0
jerks	0
,	0
usually	I-DISEASE
spontaneous	0
,	I-DISEASE
but	0
sometimes	0
also	0
evoked	0
,	0
arising	I-DISEASE
first	0
in	0
spinal	I-DISEASE
innervated	0
axial	0
muscles	0
of	0
the	0
trunk	0
,	I-DISEASE
neck	I-DISEASE
,	0
or	I-DISEASE
abdomen	I-DISEASE
and	I-DISEASE
then	0
prop-	0
agated	0
at	0
slow	0
velocity	0
to	I-DISEASE
more	0
rostral	I-DISEASE
and	0
caudal	0
muscles	I-DISEASE
.	0

PSM	0
is	0
present	0
during	0
relaxed	0
wakefulness	0
,	0
characterized	I-DISEASE
by	0
diffuse	0
EEG	0
alpha	0
activity	0
,	0
and	0
disappears	0
with	0
sleep	0
onset	0
or	0
mental	0
activation	0
.	0

PSM	0
is	0
usually	0
a	0
chronic	0
condition	0
associated	0
with	0
sleep	I-DISEASE
-	0
onset	0
insomnia	0
.	0

Excessive	0
startling	0
and	0
hypnic	I-DISEASE
jerks	I-DISEASE
may	I-DISEASE
occur	I-DISEASE
as	0
part	I-DISEASE
of	0
the	0
hyperekplexia	0
syndrome	0
,	0
in	I-DISEASE
which	0
generalized	0
myoclonus	I-DISEASE
is	0
readily	0
elicited	0
by	0
stimuli	0
during	0
either	I-DISEASE
wakeful-	0
ness	I-DISEASE
or	I-DISEASE
sleep	0
.	0

The	0
major	0
form	0
of	0
this	0
condition	0
is	I-DISEASE
also	0
characterized	I-DISEASE
by	0
stiffness	0
and	0
falls	0
.	0

Brief	0
epileptic	0
myoclonus	0
can	0
be	0
differentiated	0
by	I-DISEASE
coexistent	0
EEG	0
discharge	0
,	0
the	0
presence	0
of	0
other	I-DISEASE
features	0
of	0
epileptic	I-DISEASE
seizures	0
,	0
and	0
the	0
occurrence	I-DISEASE
of	0
the	I-DISEASE
myoclonus	0
in	0
both	I-DISEASE
wakefulness	0
and	I-DISEASE
during	0
sleep	0
rather	0
than	0
only	0
at	I-DISEASE
sleep	0
onset	I-DISEASE
.	I-DISEASE

The	0
muscle	0
contractions	0
of	0
PLMD	0
are	I-DISEASE
much	I-DISEASE
longer	0
in	0
duration	0
,	0
involve	0
mainly	0
the	0
feet	I-DISEASE
and	0
lower	0
legs	I-DISEASE
,	0
show	I-DISEASE
periodicity	0
,	0
and	0
occur	0
within	I-DISEASE
sleep	0
.	0

RLS	0
consists	0
of	I-DISEASE
slower	0
and	0
repetitive	I-DISEASE
semivoluntary	I-DISEASE
movements	0
at	I-DISEASE
sleep	0
onset	0
that	0
are	0
associated	0
with	I-DISEASE
deep	0
,	0
unpleasant	I-DISEASE
,	0
and	0
sometimes	0
unbearable	0
sensations	0
,	0
which	I-DISEASE
are	0
temporarily	0
relieved	I-DISEASE
by	0
getting	0
up	I-DISEASE
and	0
exercising	0
.	0

Bibliography	0
Broughton	0
R.	0
Pathological	0
fragmentary	0
myoclonus	0
,	I-DISEASE
intensified	0
sleep	0
starts	0
and	0
hypnagogic	0
foot	0
tremor	0
:	I-DISEASE
three	0
unusual	0
sleep	I-DISEASE
-	0
related	I-DISEASE
disorders	0
.	0

In	0
:	0
Koella	0
WP	0
,	0
Schulz	I-DISEASE
OF	I-DISEASE
,	0
Visser	0
P	0
,	0
eds	0
.	0

Sleep	0
1986	0
.	0

Stuttgart	0
:	0
Fisher	0
Verlag	I-DISEASE
;	0
1988:240–3	0
.	B-DISEASE

Kennard	0
MA	0
,	0
Schwartzman	0
AE	0
,	0
Millar	0
TP	0
.	I-DISEASE

Sleep	0
,	0
consciousness	0
,	0
and	0
the	I-DISEASE
alpha	I-DISEASE
electroencephalographic	0
rhythm	I-DISEASE
.	0

Arch	0
Neurol	0
Psychiatry	0
1958;79:328–35	0
.	0

Montagna	0
P	0
,	0
Liguori	0
R	0
,	0
Zucconi	B-DISEASE
M	0
,	0
et	0
al	0
.	0

Physiological	0
hypnic	0
myoclonus	0
.	0

Electroencephalgr	0
Clin	0
Neurophysiol	0
1988;70:172–6	0
.	0

Oswald	0
I.	0
Sudden	0
bodily	0
jerks	0
on	0
falling	0
asleep	0
.	I-DISEASE

Brain	0
1959;82:92–103	0
.	0

Salih	0
F	0
,	0
Klingebiel	0
R	0
,	0
Zschenderlein	I-DISEASE
R	0
,	I-DISEASE
et	0
al	0
.	0

Acoustic	0
sleep	0
starts	0
with	0
sleep	0
-	I-DISEASE
onset	I-DISEASE
insomnia	0
related	0
to	0
a	0
brainstem	I-DISEASE
lesion	0
.	0

Neurology	0
2008;70:1935–7	0
.	0

Sander	0
HW	0
,	0
Geisse	0
H	0
,	0
Quinto	I-DISEASE
C	0
,	0
Sachdeo	0
R	0
,	0
Chokroverty	0
S.	0
Sensory	I-DISEASE
sleep	0
starts	0
.	I-DISEASE

J	0
Neurol	0
Neurosurg	0
Psychiatry	0
1998;64:690	0
.	0

Vetrugno	0
R	0
,	0
Montagna	0
P.	0
Sleep	0
-	0
to	0
-	I-DISEASE
wake	0
transition	0
movement	0
disorders	I-DISEASE
.	0

Sleep	0
Med	0
2011;12	I-DISEASE
:	0
S11–6	I-DISEASE
.	0

Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
Other	0
Sleep	0
Disorder	0
ICD-9	0
-	I-DISEASE
CM	0
code	0
:	0
327.8	0
ICD-10	0
-	0
CM	0
code	0
:	I-DISEASE

G47.8	0
Sleep	0
disorders	0
that	0
can	0
not	I-DISEASE
be	I-DISEASE
classified	0
elsewhere	0
in	I-DISEASE
the	0
International	0
Classification	0
of	0
Sleep	I-DISEASE
Disorders	0
,	0
3rd	I-DISEASE
Edition	0
are	0
listed	0
here	0
.	0

This	0
may	0
be	0
due	I-DISEASE
to	0
the	0
fact	I-DISEASE
that	0
the	I-DISEASE
sleep	I-DISEASE
disorder	I-DISEASE
overlaps	0
more	0
than	0
one	0
category	0
or	0
,	I-DISEASE
more	0
often	0
,	0
when	0
insufficient	0
data	0
have	0
been	0
collected	0
to	I-DISEASE
firmly	0
establish	0
another	0
diagnosis	0
.	0

It	0
is	0
also	0
possible	B-DISEASE
that	0
new	I-DISEASE
sleep	I-DISEASE
disorders	I-DISEASE
that	I-DISEASE
do	0
not	0
fall	I-DISEASE
within	0
any	0
of	0
the	0
current	I-DISEASE
major	0
categories	0
will	0
be	0
dis-	0
covered	0
during	0
the	I-DISEASE
lifetime	I-DISEASE
of	0
the	I-DISEASE
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	0
Disorders	0
,	0
3rd	0
Edition	0
.	0

When	0
a	0
specific	0
diagnosis	0
can	0
not	0
yet	I-DISEASE
be	0
determined	I-DISEASE
but	0
the	0
presenting	I-DISEASE
problem	0
clearly	0
falls	0
into	0
a	0
specific	0
category	0
(	0
e.g.	0
,	0
a	0
circadian	I-DISEASE
rhythm	0
sleep	0
-	0
wake	0
dis-	B-DISEASE
order	0
)	I-DISEASE
,	0
the	0
“	0
unspecified	0
”	0
diagnosis	0
within	I-DISEASE
that	0
category	I-DISEASE
(	0
e.g.	0
,	0
circadian	0
rhythm	0
sleep-	0
wake	0
disorder	I-DISEASE
,	0
unspecified	0
)	0
is	0
preferred	0
.	I-DISEASE

The	0
International	0
Classification	0
of	0
Sleep	0
Disorders	I-DISEASE
,	I-DISEASE
2nd	0
Edition	I-DISEASE
included	0
a	I-DISEASE
specific	0
diagnosis	I-DISEASE
of	0
environmental	I-DISEASE
sleep	0
disorder	0
within	0
this	I-DISEASE
section	0
.	0

This	0
diagnosis	0
is	0
infre-	0
quently	0
employed	0
in	I-DISEASE
the	0
clinical	I-DISEASE
setting	0
and	0
significant	0
controversy	I-DISEASE
exists	0
regarding	0
whether	I-DISEASE
environmentally	0
induced	I-DISEASE
sleep	0
disturbance	0
represents	0
a	0
clinical	0
disorder	0
per	I-DISEASE
se	0
.	0

The	0
condition	0
is	0
typically	0
characterized	0
by	0
complaints	I-DISEASE
of	0
sleep	I-DISEASE
initiation	0
and/or	0
maintenance	0
that	0
are	0
the	I-DISEASE
direct	0
result	0
of	I-DISEASE
an	0
environmental	0
factor	0
.	0

Associated	0
daytime	0
symptoms	0
such	0
as	0
sleepiness	0
,	I-DISEASE
fatigue	0
,	I-DISEASE
or	0
cognitive	0
or	0
emotional	0
disturbance	0
may	I-DISEASE
be	0
present	0
.	I-DISEASE

The	0
environmental	0
disturbance	0
may	0
be	0
a	0
physical	I-DISEASE
stimulus	0
such	0
as	0
noise	0
(	0
e.g.	0
,	0
vehicular	0
traffic	0
,	0
aircraft	0
,	0
bed	0
partner	0
snoring	0
)	0
,	0
light	0
,	0
temperature	0
,	B-DISEASE
movement	0
(	0
e.g.	I-DISEASE
,	0
bed	0
partner	0
movement	0
disorder	0
or	I-DISEASE
parasomnia	I-DISEASE
)	0
,	0
an	I-DISEASE
emotional	0
stimulus	0
such	0
as	0
environ-	I-DISEASE
mental	I-DISEASE
danger	0
(	0
e.g.	0
,	0
combat	0
setting	I-DISEASE
or	0
disaster	0
area	0
)	0
,	0
or	0
an	0
environmental	0
requirement	0
(	0
such	0
as	I-DISEASE
caring	I-DISEASE
for	0
an	0
infant	I-DISEASE
or	0
elderly	0
family	0
member	I-DISEASE
)	0
.	0

Hospitalization	0
is	0
often	0
cited	0
as	0
a	I-DISEASE
precipitant	I-DISEASE
of	0
environmental	I-DISEASE
sleep	0
disturbance	0
although	0
many	0
additional	0
factors	I-DISEASE
(	0
e.g.	0
,	0
anxiety	0
or	0
pain	0
)	0
may	0
also	I-DISEASE
contribute	0
to	0
sleep	0
disturbance	0
in	I-DISEASE
this	I-DISEASE
setting	0
.	0

If	0
the	0
clinician	I-DISEASE
determines	0
that	0
an	0
environmental	I-DISEASE
factor	0
is	I-DISEASE
the	0
primary	0
cause	I-DISEASE
of	0
a	0
sleep	I-DISEASE
distur-	0
bance	I-DISEASE
,	I-DISEASE
a	I-DISEASE
diagnosis	0
of	0
Other	0
Sleep	0
Disorder	0
may	I-DISEASE
be	0
employed	0
.	I-DISEASE

It	0
is	0
the	0
physical	0
aspects	0
of	0
the	I-DISEASE
environment	0
,	I-DISEASE
rather	0
than	0
their	0
psychological	0
meaning	0
,	0
which	0
account	I-DISEASE
for	I-DISEASE
the	0
sleep	I-DISEASE
complaint	0
.	0

Unlike	0
insomnia	0
disorder	0
,	0
the	0
sleep	0
disturbance	0
is	0
dependent	I-DISEASE
on	0
the	0
presence	0
of	0
the	0
environmental	0
factor	0
.	I-DISEASE

In	0
the	0
absence	I-DISEASE
of	0
the	0
stimu-	I-DISEASE
lus	B-DISEASE
,	0
sleep	0
is	0
normal	0
.	0

The	0
prevalence	0
of	I-DISEASE
environmentally	0
induced	0
sleep	0
disturbances	I-DISEASE
is	I-DISEASE
not	0
known	0
although	0
,	0
as	0
noted	0
,	I-DISEASE
the	0
diagnosis	I-DISEASE
is	I-DISEASE
not	I-DISEASE
commonly	0
reported	0
in	0
sleep	0
centers	0
.	0

Some	0
individuals	0
Other	0
Sleep	0
Disorder	0
may	0
be	I-DISEASE
more	0
susceptible	I-DISEASE
to	0
environmental	0
disturbances	0
but	0
little	0
is	0
known	I-DISEASE
about	0
spe-	0
cific	0
characteristics	0
that	0
might	0
predispose	0
to	I-DISEASE
this	I-DISEASE
condition	0
.	0

Although	0
environmental	0
factors	0
may	0
play	0
a	I-DISEASE
contributing	I-DISEASE
role	0
in	I-DISEASE
some	0
cases	0
of	I-DISEASE
chronic	I-DISEASE
insomnia	0
disorder	I-DISEASE
,	0
multiple	0
other	I-DISEASE
factors	0
account	0
for	0
that	0
condition	0
,	0
which	I-DISEASE
is	I-DISEASE
typically	0
evident	I-DISEASE
even	0
in	I-DISEASE
the	0
absence	I-DISEASE
of	0
the	0
offending	0
environmental	0
stimulus	I-DISEASE
.	0

Distinguishing	0
an	0
insomnia	I-DISEASE
disorder	0
from	0
an	I-DISEASE
environmentally	0
induced	0
sleep	I-DISEASE
disturbance	0
may	0
pose	I-DISEASE
a	I-DISEASE
challenge	0
in	I-DISEASE
certain	I-DISEASE
clinical	0
encounters	I-DISEASE
and	I-DISEASE
providers	0
must	0
use	0
clinical	0
judgment	0
in	I-DISEASE
establishing	0
the	0
diagnosis	0
.	0

In	0
behavioral	0
insomnia	0
of	0
childhood	0
,	I-DISEASE
the	I-DISEASE
child	0
may	I-DISEASE
require	I-DISEASE
certain	0
environmental	0
cir-	0
cumstances	0
in	I-DISEASE
order	I-DISEASE
to	0
sleep	I-DISEASE
(	0
e.g.	0
,	0
a	0
pacifier	I-DISEASE
,	0
music	I-DISEASE
,	0
lights	0
,	0
television	0
,	0
or	0
a	I-DISEASE
parent	0
)	0
.	0

It	0
is	0
the	0
absence	I-DISEASE
of	0
these	I-DISEASE
circumstances	0
that	0
results	I-DISEASE
in	0
sleep	0
initiation	0
or	0
maintenance	0
prob-	I-DISEASE
lems	0
.	0

In	0
such	0
cases	0
,	0
a	0
diagnosis	0
of	0
chronic	0
insomnia	0
disorder	0
(	0
behavioral	0
insomnia	0
of	0
childhood	I-DISEASE
–	0
sleep	0
-	I-DISEASE
onset	0
association	0
type	0
)	0
is	0
indicated	0
.	0

Bibliography	0
Basner	0
M	0
,	0
Griefahn	0
B	I-DISEASE
,	I-DISEASE
Berg	0
MV	I-DISEASE
.	0

Aircraft	0
noise	B-DISEASE
effects	0
on	0
sleep	0
:	I-DISEASE
mechanisms	I-DISEASE
,	0
mitigation	I-DISEASE
and	0
research	0
needs	0
.	0

Noise	0
Health	0
2010;12:95–109	0
.	0

Hume	0
KI	0
,	0
Brink	0
M	0
,	I-DISEASE
Basner	0
M.	0
Effects	I-DISEASE
of	0
environmental	0
noise	I-DISEASE
on	0
sleep	0
.	0

Noise	0
Health	0
.	0

2012;14:297–302	0
.	0

Thiessen	0
G	0
,	0
Lapointe	0
A.	0
Effect	I-DISEASE
of	I-DISEASE
continuous	0
traffic	I-DISEASE
noise	0
on	0
percentage	0
of	0
deep	0
sleep	I-DISEASE
,	0
waking	0
,	0
and	0
sleep	I-DISEASE
latency	0
.	I-DISEASE

J	0
Acoust	0
Soc	0
Amer	I-DISEASE
1983;73:225–9	I-DISEASE
.	0

Yilmaz	0
M	0
,	0
Sayin	0
Y	0
,	0
Gurler	I-DISEASE
H.	0
Sleep	0
quality	0
of	I-DISEASE
hospitalized	0
patients	0
in	0
surgical	0
units	0
.	I-DISEASE

Nurs	0
Forum	0
2012;47:183–92	0
.	0

Appendix	0
A	0
:	0
Sleep	0
Related	0
Medical	I-DISEASE
and	I-DISEASE
Neurological	I-DISEASE
Disorders	I-DISEASE
Fatal	0
Familial	0
Insomnia342	0
Sleep	0
Related	0
Epilepsy	I-DISEASE
345	0
Sleep	0
Related	I-DISEASE
Headaches350	0
Sleep	0
Related	0
Laryngospasm	0
355	0
Sleep	0
Related	0
Gastroesophageal	0
Reflux	0
358	I-DISEASE
Sleep	I-DISEASE
Related	I-DISEASE
Myocardial	I-DISEASE
Ischemia	0
363	0
The	0
disorders	0
presented	I-DISEASE
in	I-DISEASE
this	I-DISEASE
section	0
may	0
have	0
a	I-DISEASE
unique	0
presentation	0
during	I-DISEASE
the	B-DISEASE
sleep	0
period	I-DISEASE
or	I-DISEASE
may	I-DISEASE
present	0
exclusively	0
in	I-DISEASE
association	0
with	0
sleep	I-DISEASE
.	0

Some	0
of	0
these	0
disorders	0
(	0
e.g.	I-DISEASE
,	0
sleep	0
related	I-DISEASE
epilepsy	0
and	0
sleep	I-DISEASE
related	I-DISEASE
headache	0
)	I-DISEASE
may	0
be	0
encountered	I-DISEASE
during	I-DISEASE
evaluation	I-DISEASE
for	0
other	0
sleep	I-DISEASE
disorders	I-DISEASE
.	I-DISEASE

In	0
addition	0
,	0
some	0
of	0
these	I-DISEASE
disorders	0
are	0
in	0
the	0
dif-	0
ferential	0
diagnosis	0
of	0
other	I-DISEASE
sleep	0
-	I-DISEASE
wake	0
disorders	0
.	0

Sleep	0
related	I-DISEASE
epilepsy	I-DISEASE
must	0
be	0
con-	0
sidered	0
in	I-DISEASE
the	I-DISEASE
differential	0
diagnosis	0
of	0
certain	0
movement	I-DISEASE
disorders	I-DISEASE
and	0
parasomnias	0
.	I-DISEASE

Sleep	0
related	0
headaches	I-DISEASE
may	I-DISEASE
be	0
a	0
clue	I-DISEASE
to	0
the	I-DISEASE
presence	0
of	I-DISEASE
sleep	0
apnea	0
.	I-DISEASE

Sleep	0
related	I-DISEASE
gastroesophageal	I-DISEASE
reflux	0
may	0
either	0
be	I-DISEASE
a	0
precipitant	I-DISEASE
of	0
a	0
sleep	0
apnea	I-DISEASE
episode	0
or	I-DISEASE
be	I-DISEASE
trig-	0
gered	I-DISEASE
by	0
sleep	0
apnea	0
with	0
aspiration	I-DISEASE
pneumonia	I-DISEASE
as	I-DISEASE
its	0
most	0
serious	0
consequence	I-DISEASE
.	I-DISEASE

Sleep	0
related	I-DISEASE
myocardial	I-DISEASE
ischemia	0
is	0
an	I-DISEASE
important	0
consideration	0
because	0
myocardial	0
infarc-	0
tion	I-DISEASE
has	I-DISEASE
a	0
predilection	I-DISEASE
for	I-DISEASE
the	0
early	I-DISEASE
morning	0
hours	0
during	0
the	0
latter	I-DISEASE
phase	0
of	0
the	0
sleep	0
period	B-DISEASE
and	0
may	0
be	0
precipitated	0
by	I-DISEASE
episodes	0
of	I-DISEASE
sleep	I-DISEASE
apnea	0
.	I-DISEASE

It	0
is	0
important	0
to	I-DISEASE
be	0
aware	0
of	I-DISEASE
sleep	0
related	I-DISEASE
laryngospasm	I-DISEASE
as	0
a	0
potentially	0
life	0
-	0
threatening	0
consequence	0
of	I-DISEASE
neurode-	0
generative	0
diseases	0
such	0
as	0
multiple	0
system	I-DISEASE
atrophy	0
.	0

Fatal	0
familial	0
insomnia	0
,	0
although	0
rare	0
,	0
presents	0
with	0
severe	0
insomnia	0
and	I-DISEASE
has	0
a	0
well	0
-	0
understood	0
neuropathology	I-DISEASE
.	0

Appendix	0
A	0
:	0
Sleep	0
Related	0
Medical	I-DISEASE
and	I-DISEASE
Neurological	I-DISEASE
Disorders	I-DISEASE
Fatal	0
Familial	0
Insomnia	0
Alternate	0
Names	0
Fatal	I-DISEASE
progressive	0
insomnia	0
with	I-DISEASE
dysautonomia	0
,	0
familial	0
thalamic	0
degeneration	0
of	0
the	0
anterior	0
and	0
dorsomedial	I-DISEASE
thalamic	0
nuclei	0
,	0
thalamic	0
insomnia	0
.	0

Essential	0
Features	0
Fatal	0
familial	0
insomnia	0
is	0
a	I-DISEASE
very	0
rare	0
,	0
progressive	0
disorder	0
characterized	0
by	0
initial	I-DISEASE
dif-	0
ficulties	0
in	I-DISEASE
falling	0
asleep	0
and	0
maintaining	0
sleep	0
,	0
spontaneous	0
lapses	0
from	I-DISEASE
quiet	I-DISEASE
wake-	0
fulness	0
into	I-DISEASE
a	0
sleep	0
state	0
with	0
enacted	0
dreams	0
(	0
oneiric	0
stupor	0
)	I-DISEASE
,	I-DISEASE
and	0
loss	0
of	0
slow	0
wave	I-DISEASE
sleep	I-DISEASE
features	0
.	0

In	0
later	0
stages	0
of	0
the	0
disease	I-DISEASE
,	I-DISEASE
it	0
may	0
not	0
be	I-DISEASE
possible	0
to	0
identify	0
any	I-DISEASE
dis-	0
tinct	0
sleep	I-DISEASE
stages	0
.	0

Although	0
loss	0
of	0
temporal	0
and	0
spatial	I-DISEASE
orientation	0
develops	0
,	I-DISEASE
cognitive	0
function	0
is	0
retained	0
until	0
impaired	0
alertness	0
makes	0
testing	I-DISEASE
impossible	0
.	0

The	0
disorder	0
progresses	I-DISEASE
to	B-DISEASE
unarousable	0
coma	0
,	0
and	0
finally	I-DISEASE
,	0
death	0
.	0

Associated	0
Features	0
Bronchopulmonary	0
and	I-DISEASE
other	0
infections	0
may	I-DISEASE
also	0
be	I-DISEASE
present	0
.	0

There	0
is	0
a	0
loss	0
of	0
the	I-DISEASE
circadian	I-DISEASE
rhythmicity	0
of	I-DISEASE
endocrine	0
rhythms	0
.	0

Autonomic	0
hyperactivity	0
(	0
e.g.	0
,	0
pyrexia	0
,	0
salivation	0
,	I-DISEASE
hyperhidrosis	0
,	0
tachycardia	0
,	0
tachypnea	0
,	I-DISEASE
and	0
dyspnea	0
)	I-DISEASE
is	0
present	0
.	0

The	0
disor-	0
der	0
includes	0
somatomotor	0
disturbances	0
,	I-DISEASE
with	0
dysarthria	I-DISEASE
,	0
dysphagia	0
,	0
tremor	0
,	0
sponta-	I-DISEASE
neous	0
and	0
reflex	0
myoclonus	0
,	0
dystonic	0
posturing	0
,	0
ataxia	0
,	0
and	0
a	0
positive	0
Babinski	0
sign	0
.	0

Hallucinations	0
may	0
be	I-DISEASE
present	0
.	0

Clinical	0
and	0
Pathologic	0
Subtypes	I-DISEASE
None	0
.	0

Demographics	0
Age	0
of	0
onset	0
is	0
usually	I-DISEASE
in	I-DISEASE
adulthood	0
,	I-DISEASE
between	0
36	0
and	I-DISEASE
62	0
years	0
of	0
age	0
.	I-DISEASE

The	0
disorder	0
is	0
rare	0
.	I-DISEASE

There	0
are	0
no	0
sex	I-DISEASE
differences	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
Not	0
known	I-DISEASE
or	I-DISEASE
applicable	0
.	0

Familial	0
Patterns	0
Fatal	0
familial	0
insomnia	0
(	0
FFI	I-DISEASE
)	0
is	I-DISEASE
transmitted	0
according	0
to	0
an	0
autosomal	0
dominant	I-DISEASE
pattern	I-DISEASE
.	I-DISEASE

Patients	0
harbor	0
a	B-DISEASE
missense	0
GAC	0
to	I-DISEASE
AAC	I-DISEASE
mutation	0
at	I-DISEASE
codon	0
178	0
of	0
the	0
prion	0
protein	I-DISEASE
gene	0
PRNP	I-DISEASE
located	I-DISEASE
on	I-DISEASE
chromosome	0
20	0
,	0
cosegregating	0
with	0
the	0
methionine	0
Appendix	0
A	0
:	0
Sleep	0
Related	0
Medical	0
and	0
Neurological	0
Disorders	0
polymorphism	0
at	I-DISEASE
codon	I-DISEASE
129	0
of	0
the	0
same	I-DISEASE
gene	0
on	0
the	I-DISEASE
mutated	0
allele	I-DISEASE
(	I-DISEASE
D178N	I-DISEASE
129	0
M	0
)	I-DISEASE
.	I-DISEASE

The	0
clinical	0
syndrome	0
varies	0
by	0
the	0
M129V	I-DISEASE
genotype	0
.	I-DISEASE

Patients	0
who	0
are	B-DISEASE
methionine	0
homozygous	0
at	0
the	0
129	0
codon	0
are	0
younger	0
and	0
display	I-DISEASE
a	0
shorter	I-DISEASE
disease	I-DISEASE
course	0
than	0
do	0
patients	0
who	0
are	0
methionine	0
-	0
valine	0
heterozygous	0
at	0
codon	I-DISEASE
129	0
.	I-DISEASE

Onset	0
,	0
Course	0
,	0
and	0
Complications	0

The	0
disorder	0
is	0
always	0
fatal	0
,	B-DISEASE
usually	I-DISEASE
within	0
eight	I-DISEASE
to	0
72	0
months	0
.	0

The	0
course	0
is	0
one	0
of	0
relentless	I-DISEASE
worsening	0
of	0
symptoms	I-DISEASE
.	0

Patients	0
may	0
die	0
after	0
a	0
short	0
(	0
less	0
than	I-DISEASE
12	0
months	0
)	0
or	0
long	0
(	0
12	0
to	0
72	I-DISEASE
months	0
)	0
disease	0
course	0
.	0

The	0
younger	0
age	0
at	0
disease	I-DISEASE
onset	0
and	I-DISEASE
,	0
conse-	I-DISEASE
quently	I-DISEASE
,	0
a	0
lower	0
rate	0
of	I-DISEASE
comorbidity	0
,	0
may	I-DISEASE
explain	0
the	0
generally	0
more	0
prolonged	0
disease	0
course	I-DISEASE
in	I-DISEASE
FFI	I-DISEASE
in	I-DISEASE
comparison	0
to	I-DISEASE
other	0
prion	I-DISEASE
diseases	0
.	0

Complications	0
include	0
infections	0
(	0
in	0
particular	I-DISEASE
of	0
the	0
lungs	0
and	0
bladder	0
)	I-DISEASE
that	I-DISEASE
develop	0
during	I-DISEASE
the	I-DISEASE
course	I-DISEASE
of	I-DISEASE
the	0
disease	I-DISEASE
,	0
especially	0
in	I-DISEASE
the	0
late	I-DISEASE
stages	0
,	0
and	I-DISEASE
represent	0
the	0
usual	0
cause	I-DISEASE
of	0
death	0
.	0

Other	0
frequent	0
com-	0
plications	0
include	0
skin	I-DISEASE
ulcers	I-DISEASE
when	0
patients	I-DISEASE
become	0
bedridden	I-DISEASE
and	0
aspiration	0
of	0
food	I-DISEASE
due	0
to	0
the	I-DISEASE
severe	0
dysphagia	I-DISEASE
;	0
the	0
latter	0
may	0
require	0
nasogastric	0
or	I-DISEASE
gastrostomy	I-DISEASE
feeding	0
.	0

Pathology	0
and	0
Pathophysiology	0
Severe	0
bilateral	0
loss	I-DISEASE
of	I-DISEASE
neurons	0
,	I-DISEASE
with	0
reactive	0
gliosis	0
of	0
the	0
anterior	0
and	I-DISEASE
dorsomedial	0
thalamic	I-DISEASE
nuclei	0
and	0
severe	0
neuronal	0
loss	I-DISEASE
and	0
reactive	I-DISEASE
astrogliosis	0
in	0
the	I-DISEASE
inferior	I-DISEASE
olives	I-DISEASE
,	I-DISEASE
are	I-DISEASE
found	0
.	0

Spongiform	0
changes	0
in	0
cortical	0
layers	0
in	0
cases	0
with	0
a	I-DISEASE
prolonged	0
course	0
have	0
been	I-DISEASE
described	0
.	0

Deposition	0
of	0
proteinase	0
K	0
-	0
resistant	0
prion	I-DISEASE
protein	0
type	I-DISEASE
2	0
in	0
the	0
grey	I-DISEASE
matter	0
but	0
not	I-DISEASE
the	0
white	B-DISEASE
matter	0
occurs	I-DISEASE
in	0
both	0
familial	0
and	0
sporadic	0
fatal	0
insomnia	0
.	0

Both	0
familial	0
and	0
sporadic	0
fatal	0
insomnia	I-DISEASE
have	B-DISEASE
been	0
transmitted	I-DISEASE
to	0
transgenic	0
animals	0
by	0
intracerebral	0
inoculum	I-DISEASE
of	0
brain	0
homogenates	I-DISEASE
.	0

Objective	0
Findings	0

In	0
early	0
stages	0
of	0
FFI	0
,	I-DISEASE
periods	I-DISEASE
of	0
relaxed	0
wakefulness	0
alternate	0
with	I-DISEASE
episodes	0
of	0
elec-	I-DISEASE
troencephalographic	0
(	0
EEG	I-DISEASE
)	0
desynchronization	0
,	0
rapid	0
eye	0
movement	0
(	0
REM	0
)	I-DISEASE
bursts	I-DISEASE
,	0
loss	I-DISEASE
of	0
antigravity	0
muscle	0
tone	0
,	0
and	0
irregular	0
myoclonic	0
and	0
tremor	I-DISEASE
-	0
like	0
limb	0
-	0
muscle	0
activities	0
associated	I-DISEASE
with	I-DISEASE
vivid	0
dreams	I-DISEASE
(	0
oneiric	I-DISEASE
stupor	I-DISEASE
)	I-DISEASE
.	0

Sleep	0
spindles	0
and	0
features	0
of	0
slow	0
wave	I-DISEASE
sleep	0
are	0
absent	0
or	0
progressively	0
lost	0
throughout	0
the	0
course	0
of	I-DISEASE
the	0
illness	0
.	I-DISEASE

In	0
the	0
final	I-DISEASE
stages	I-DISEASE
of	0
the	I-DISEASE
disorder	I-DISEASE
,	0
the	I-DISEASE
EEG	I-DISEASE
becomes	0
unreactive	0
and	0
progressively	0
flattens	I-DISEASE
until	0
death	0
occurs	I-DISEASE
;	0
it	I-DISEASE
may	0
display	0
periodic	0
spike	I-DISEASE
discharges	I-DISEASE
.	0

Positron	0
emission	0
tomography	0
(	I-DISEASE
PET	0
)	0
with	I-DISEASE
(	0
18F)-2	I-DISEASE
-	0
fluorodeoxy	0
-	I-DISEASE
d	0
-	0
glucose	I-DISEASE
shows	0
tha-	I-DISEASE
lamic	I-DISEASE
hypometabolism	0
.	0

Magnetic	0
resonance	0
spectroscopy	0
with	0
multisequences	0
can	0
detect	0
prion	0
-	I-DISEASE
induced	0
gliosis	0
in	0
vivo	0
.	0

Circadian	0
rhythms	I-DISEASE
of	0
body	I-DISEASE
temperature	0
,	I-DISEASE
systemic	I-DISEASE
blood	0
pressure	I-DISEASE
,	0
and	0
heart	0
and	I-DISEASE
respiratory	0
rate	I-DISEASE
and	0
endocrine	0
rhythms	I-DISEASE
of	0
growth	I-DISEASE
hormone	0
,	0
prolactin	0
,	I-DISEASE
luteinizing	I-DISEASE
hormone	I-DISEASE
,	0
follicle	I-DISEASE
-	0
stimulating	I-DISEASE
hormone	0
,	I-DISEASE
and	0
adrenocorticotropic	0
Appendix	0
A	0
:	I-DISEASE
Sleep	0
Related	0
Medical	0
and	I-DISEASE
Neurological	0
Disorders	0
hormone	0
may	0
be	I-DISEASE
lost	0
.	I-DISEASE

Serum	0
catecholamine	0
and	0
cortisol	I-DISEASE
values	0
are	I-DISEASE
elevated	I-DISEASE
,	0
with	I-DISEASE
low	I-DISEASE
or	0
undetectable	0
adrenocorticotropic	I-DISEASE
hormone	0
levels	I-DISEASE
.	I-DISEASE

Pathologic	0
examination	0
demon-	0
strates	0
degeneration	0
of	I-DISEASE
the	I-DISEASE
anterior	0
and	0
dorsomedial	0
thalamic	I-DISEASE
nuclei	0
and	0
atrophy	0
of	I-DISEASE
the	0
inferior	0
olivary	B-DISEASE
nucleus	0
.	0

Deposition	0
of	0
proteinase	0
K	0
-	0
resistant	0
prion	0
protein	0
type	I-DISEASE
2	0
is	0
found	0
in	0
the	0
brain	0
.	0

Differential	0
Diagnosis	0

This	0
disorder	0
must	0
be	0
differentiated	0
from	0
REM	0
sleep	0
behavior	I-DISEASE
disorder	I-DISEASE
(	0
RBD	0
)	0
,	0
which	0
is	I-DISEASE
not	0
associated	I-DISEASE
with	0
autonomic	I-DISEASE
hyperactivity	0
or	0
a	0
familial	I-DISEASE
pattern	I-DISEASE
.	0

The	0
differential	0
diagnosis	0
includes	0
dementia	0
,	0
familial	0
Creutzfeldt	0
-	I-DISEASE
Jakob	0
disease	0
with	0
the	I-DISEASE
178	0
codon	0
mutation	0
in	0
the	I-DISEASE
PRNP	0
cosegregating	0
with	0
the	0
valine	0
polymorphism	I-DISEASE
at	I-DISEASE
codon	0
129	0
on	I-DISEASE
the	0
mutated	0
allele	0
,	0
Morvan	0
fibrillary	0
chorea	0
,	0
delirium	I-DISEASE
tremens	0
,	0
or	0
even	I-DISEASE
schizophrenia	I-DISEASE
.	0

A	0
sporadic	0
form	0
of	0
fatal	0
insomnia	I-DISEASE
has	I-DISEASE
also	0
been	I-DISEASE
reported	0
.	0

Unresolved	0
Issues	0
and	0
Future	0
Directions	I-DISEASE
Not	I-DISEASE
applicable	I-DISEASE
or	0
known	0
.	0

Bibliography	0
Cortelli	0
P	0
,	0
Perani	0
D	0
,	I-DISEASE
Parchi	0
P	I-DISEASE
,	0
et	0
al	0
.	0

Cerebral	0
metabolism	0
in	0
fatal	0
familial	0
insomnia	I-DISEASE
:	0
relation	0
to	0
duration	0
,	0
neuropathology	0
,	0
and	0
distribution	I-DISEASE
of	I-DISEASE
protease	0
-	I-DISEASE
resistant	0
prion	0
protein	0
.	0

Neurology	0
1997;49:126–33	0
.	0

Goldfarb	0
L	0
,	0
Petersen	0
R	I-DISEASE
,	0
Tabaton	0
M	0
,	I-DISEASE
et	0
al	0
.	0

Fatal	0
familial	0
insomnia	0
and	0
familial	0
Creutzfeldt	I-DISEASE
-	0
Jakob	0
disease	I-DISEASE
:	0
disease	0
phenotype	0
determined	0
by	I-DISEASE
a	I-DISEASE
DNA	0
polymorphism	0
.	I-DISEASE

Science	0
1992;258:806–8	0
.	0

Haik	0
S	0
,	0
Galanaud	0
D	0
,	0
Linguraru	I-DISEASE
MG	0
,	I-DISEASE
et	0
al	0
.	0

In	0
vivo	0
detection	0
of	0
thalamic	0
gliosis	I-DISEASE
.	0

A	0
pathoradiologic	0
demonstration	0
in	0
familial	0
fatal	0
insomnia	0
.	0

Arch	0
Neurol	0
2008;65:545–9	0
.	0

Krasnianski	0
A	0
,	0
Bartl	0
M	0
,	I-DISEASE
Sanchez	I-DISEASE
Juan	0
PJ	I-DISEASE
,	0
et	0
al	0
.	0

Fatal	0
familial	0
insomnia	0
:	0
clinical	0
features	0
and	0
early	0
identification	I-DISEASE
.	0

Ann	0
Neurol	0
2008;63:658–61	0
.	0

Lugaresi	0
E	0
,	0
Medori	0
R	0
,	0
Montagna	I-DISEASE
P	0
,	I-DISEASE
et	0
al	0
.	0

Fatal	0
familial	0
insomnia	0
and	0
dysautonomia	0
with	0
selective	0
degeneration	0
of	I-DISEASE
thalamic	0
nuclei	0
.	0

N	0
Engl	0
J	0
Med	0
1986;315:997–1003	0
.	0

Monari	0
L	0
,	0
Chen	I-DISEASE
S	0
,	0
Brown	I-DISEASE
P	0
,	0
et	0
al	0
.	0

Fatal	0
familial	0
insomnia	0
and	0
familial	0
Creutzfeldt	I-DISEASE
-	0
Jakob	0
disease	I-DISEASE
:	0
different	0
prion	0
proteins	0
determined	I-DISEASE
by	I-DISEASE
a	0
DNA	0
polymorphism	I-DISEASE
.	0

Proc	0
Natl	0
Acad	0
Sci	0
U	0
S	0
A	0
1994;91:2839–42	0
.	0

Montagna	0
P	0
,	0
Cortelli	0
P	0
,	0
Gambetti	0
P	0
,	I-DISEASE
Lugaresi	0
E.	0
Fatal	I-DISEASE
familial	0
insomnia	0
:	0
sleep	0
,	0
neuroendocrine	0
and	I-DISEASE
vegetative	0
alterations	0
.	0

Adv	0
Neuroimmunol	0
1995;5:13–21	0
.	0

Montagna	0
P	0
,	0
Gambetti	0
P	0
,	0
Cortelli	I-DISEASE
P	0
,	I-DISEASE
Lugaresi	0
E.	0
Familial	0
and	0
sporadic	0
fatal	I-DISEASE
insomnia	0
.	0

Lancet	0
Neurol	0
2003;2:167–76	0
.	0

Sforza	0
E	0
,	I-DISEASE
Montagna	0
P	0
,	0
Tinuper	I-DISEASE
P	0
,	I-DISEASE
et	0
al	0
.	0

Sleep	0
-	0
wake	0
cycle	I-DISEASE
abnormalities	0
in	0
fatal	0
familial	0
insomnia	I-DISEASE
.	0

Evidence	0
of	0
the	0
role	B-DISEASE
of	0
the	I-DISEASE
thalamus	I-DISEASE
in	0
sleep	I-DISEASE
regulation	0
.	0

Electroencephalogr	0
Clin	0
Neurophysiol	0
1995;94:398–405	0
.	0

Telling	0
G	0
,	0
Parchi	I-DISEASE
P	0
,	0
DeArmond	I-DISEASE
S	0
,	I-DISEASE
et	0
al	0
.	0

Evidence	0
for	I-DISEASE
the	0
conformation	I-DISEASE
of	0
the	I-DISEASE
pathologic	I-DISEASE
isoform	I-DISEASE
of	I-DISEASE
the	0
prion	0
protein	0
enciphering	0
and	0
propagating	I-DISEASE
prion	I-DISEASE
diversity	0
.	0

Science	0
1996;274:2079–82	0
.	0

Appendix	0
A	0
:	0
Sleep	0
Related	0
Medical	I-DISEASE
and	I-DISEASE
Neurological	0
Disorders	I-DISEASE
Sleep	0
Related	0
Epilepsy	0
Alternate	0
Names	0
Sleep	0
epilepsy	0
,	0
nocturnal	I-DISEASE
seizure	0
,	I-DISEASE
sleep	0
related	0
seizures	0
.	0

Essential	0
Features	0
A	0
seizure	0
is	0
a	0
paroxysmal	I-DISEASE
event	0
resulting	I-DISEASE
from	0
a	0
sudden	0
excessive	0
discharge	0
of	I-DISEASE
the	0
neurons	0
of	0
the	0
cerebral	I-DISEASE
cortex	0
,	0
whereas	I-DISEASE
epilepsy	0
is	I-DISEASE
a	0
condition	0
of	0
recurrent	0
unpro-	0
voked	0
seizures	I-DISEASE
.	0

Sleep	0
facilitates	0
epileptic	0
activity	I-DISEASE
and	0
seizures	0
.	I-DISEASE

The	0
characteristics	0
of	0
specific	0
subtypes	0
of	0
sleep	0
related	0
epilepsy	I-DISEASE
are	0
discussed	I-DISEASE
in	0
the	0
Clinical	0
and	0
Pathologic	0
Subtypes	0
section	I-DISEASE
below	0
.	0

Associated	0
Features	0
The	0
different	0
types	0
of	I-DISEASE
nocturnal	I-DISEASE
frontal	I-DISEASE
lobe	I-DISEASE
epilepsy	0
(	0
NFLE	0
)	I-DISEASE
may	0
cause	I-DISEASE
severe	I-DISEASE
sleep	0
disruption	I-DISEASE
,	0
affecting	I-DISEASE
both	0
macrostructure	I-DISEASE
and	0
microstructure	0
of	0
sleep	0
,	0
resulting	0
in	0
poor	I-DISEASE
sleep	I-DISEASE
quality	I-DISEASE
,	0
daytime	0
fatigue	0
,	0
and	0
sleepiness	0
in	0
some	I-DISEASE
patients	I-DISEASE
.	0

The	0
movements	0
also	0
may	B-DISEASE
be	0
so	0
severe	0
that	0
injuries	I-DISEASE
can	0
occur	0
.	0

From	0
one	0
third	0
to	0
one	0
half	0
of	I-DISEASE
patients	0
with	I-DISEASE
sleep	0
related	0
epilepsy	I-DISEASE
also	0
have	0
occasional	I-DISEASE
attacks	0
during	0
the	0
day	0
,	I-DISEASE
although	0
these	0
are	0
not	0
necessarily	0
of	0
the	0
same	I-DISEASE
type	0
as	I-DISEASE
those	0
occurring	I-DISEASE
at	0
night	0
.	0

Neurocognitive	0
impairment	0
is	0
typically	I-DISEASE
diagnosed	0
in	0
almost	I-DISEASE
all	I-DISEASE
cases	I-DISEASE
of	0
continuous	0
spike	0
waves	0
during	0
NREM	0
sleep	0
(	I-DISEASE
CSWS	I-DISEASE
)	0
.	I-DISEASE

Motor	0
impairment	0
in	I-DISEASE
the	0
form	0
of	0
a	I-DISEASE
unilat-	0
eral	I-DISEASE
deficit	0
is	0
sometimes	0
seen	0
as	0
an	0
associated	0
feature	0
of	I-DISEASE
CSWS	0
.	0

Clinical	0
and	0
Pathologic	0
Subtypes	0
Clinical	0
and	0
EEG	0
criteria	0
are	I-DISEASE
used	0
to	0
define	0
a	0
variety	0
of	I-DISEASE
sleep	0
related	0
epilepsy	I-DISEASE
subtypes	0
.	0

Several	0
types	0
of	I-DISEASE
epileptic	I-DISEASE
syndromes	0
have	I-DISEASE
a	I-DISEASE
marked	0
tendency	I-DISEASE
to	0
manifest	0
only	I-DISEASE
or	I-DISEASE
pre-	0
dominantly	I-DISEASE
during	0
sleep	0
,	I-DISEASE
or	0
after	0
arousal	0
from	0
sleep	I-DISEASE
.	0

These	0
include	0
NFLE	0
,	0
benign	0
epilepsy	0
of	I-DISEASE
childhood	0
with	0
centrotemporal	0
spikes	0
(	0
BECT	0
)	0
,	0
benign	0
epilepsy	I-DISEASE
with	I-DISEASE
occip-	0
ital	I-DISEASE
paroxysms	0
(	0
BEOP	0
)	I-DISEASE
,	I-DISEASE
early	0
-	0
onset	0
or	0
late	0
-	0
onset	I-DISEASE
childhood	0
occipital	0
epilepsy	0
,	0
juvenile	0
myoclonic	I-DISEASE
epilepsy	I-DISEASE
(	0
JME	I-DISEASE
)	I-DISEASE
,	0
generalized	0
tonic	0
-	I-DISEASE
clonic	I-DISEASE
seizures	I-DISEASE
on	0
awakening	0
,	0
certain	0
forms	I-DISEASE
of	0
temporal	0
lobe	0
epilepsy	0
,	0
tonic	0
seizure	0
(	I-DISEASE
as	0
a	0
component	0
of	0
Lennox	I-DISEASE
-	0
Gastaut	0
syndrome	0
)	I-DISEASE
,	0
Landau	0
-	I-DISEASE
Kleffner	I-DISEASE
syndrome	I-DISEASE
,	0
and	I-DISEASE
continuous	I-DISEASE
spike	0
waves	I-DISEASE
during	I-DISEASE
NREM	0
sleep	0
(	0
CSWS	I-DISEASE
)	0
.	0

NFLE	0
may	0
present	0
in	0
three	0
distinct	0
ways	I-DISEASE
:	0
(	I-DISEASE
1	0
)	0
nocturnal	0
paroxysmal	I-DISEASE
arousal	0
,	0
(	0
2	0
)	I-DISEASE
noc-	0
turnal	I-DISEASE
paroxysmal	0
dystonia	0
,	I-DISEASE
or	I-DISEASE
(	I-DISEASE
3	0
)	I-DISEASE
episodic	I-DISEASE
nocturnal	0
wanderings	0
.	I-DISEASE

Appendix	0
A	0
:	0
Sleep	0
Related	0
Medical	I-DISEASE
and	I-DISEASE
Neurological	I-DISEASE
Disorders	I-DISEASE
BECT	0
can	0
present	0
with	0
focal	0
clonic	I-DISEASE
facial	0
twitching	0
that	I-DISEASE
is	0
often	I-DISEASE
preceded	0
by	0
perioral	0
numbness	0
.	I-DISEASE

These	0
seizures	0
are	0
more	I-DISEASE
often	0
seen	0
in	I-DISEASE
drowsiness	0
and	0
sleep	0
than	0
wakeful-	0
ness	0
.	0

The	0
clinical	0
course	0
is	0
often	0
benign	I-DISEASE
with	I-DISEASE
disappearance	0
of	I-DISEASE
the	0
seizures	0
in	0
adulthood	0
.	0

BEOP	0
is	0
characterized	0
by	0
focal	0
seizures	0
marked	I-DISEASE
by	I-DISEASE
deviation	I-DISEASE
of	0
the	I-DISEASE
eyes	0
and	I-DISEASE
vom-	0
iting	I-DISEASE
.	I-DISEASE

Sleep	0
is	0
the	0
main	I-DISEASE
precipitating	0
factor	0
,	I-DISEASE
with	0
most	I-DISEASE
of	0
the	0
seizures	0
occurring	0
soon	0
after	I-DISEASE
sleep	0
onset	I-DISEASE
or	0
in	0
the	0
early	0
hours	0
of	0
the	0
morning	I-DISEASE
.	0

There	0
is	0
frequent	0
evolution	0
to	0
secondary	0
generalized	0
attacks	0
.	I-DISEASE

The	0
clinical	0
evolution	0
of	I-DISEASE
the	0
early	I-DISEASE
-	I-DISEASE
onset	0
type	I-DISEASE
is	0
benign	0
,	0
whereas	0
in	0
the	I-DISEASE
late	0
-	I-DISEASE
onset	0
type	0
with	0
visual	0
seizures	0
,	0
the	0
prognosis	I-DISEASE
is	0
uncertain	I-DISEASE
.	0

JME	0
is	0
characterized	0
by	0
massive	0
bilaterally	0
synchronous	I-DISEASE
myoclonic	0
jerks	I-DISEASE
,	0
which	0
are	0
most	I-DISEASE
frequently	0
noted	I-DISEASE
on	0
awakening	0
.	0

CSWS	0
(	I-DISEASE
formerly	0
known	0
as	0
electrical	I-DISEASE
status	I-DISEASE
epilepticus	0
of	I-DISEASE
sleep	0
[	0
ESES	0
]	0
)	0
is	I-DISEASE
charac-	0
terized	0
by	I-DISEASE
continuous	0
and	0
diffuse	0
slow	0
spike	0
-	I-DISEASE
and	I-DISEASE
-	I-DISEASE
wave	0
complexes	I-DISEASE
persisting	0
through	0
NREM	I-DISEASE
sleep	I-DISEASE
(	0
at	0
least	0
85	I-DISEASE
%	I-DISEASE
of	I-DISEASE
the	I-DISEASE
duration	0
)	I-DISEASE
,	0
as	0
well	0
as	I-DISEASE
neuropsychological	0
and	0
motor	0
impairment	0
.	I-DISEASE

Despite	0
the	0
continuous	I-DISEASE
presence	I-DISEASE
of	0
epileptic	I-DISEASE
spike	0
-	0
wave	I-DISEASE
activity	0
on	0
EEG	0
in	0
sleep	0
,	I-DISEASE
there	0
may	0
be	I-DISEASE
no	0
associated	I-DISEASE
visible	0
sleep	0
related	0
movement	0
.	I-DISEASE

However	0
,	I-DISEASE
clinical	0
epileptic	0
seizures	0
are	I-DISEASE
sometimes	I-DISEASE
seen	0
in	I-DISEASE
the	0
daytime	0
.	0

Demographics	0
There	0
is	0
no	0
significant	0
sex	0
predominance	I-DISEASE
.	0

Predisposing	0
and	0
Participating	0
Factors	0
Stress	0
,	I-DISEASE
sleep	I-DISEASE
deprivation	0
,	I-DISEASE
irregularities	0
of	I-DISEASE
the	I-DISEASE
sleep	0
-	0
wake	I-DISEASE
rhythm	I-DISEASE
,	I-DISEASE
other	I-DISEASE
sleep	0
patholo-	0
gies	0
,	0
and	0
the	I-DISEASE
use	I-DISEASE
of	I-DISEASE
stimulant	I-DISEASE
drugs	0
or	0
other	I-DISEASE
drugs	I-DISEASE
that	0
modify	0
sleep	0
architecture	0
may	0
predispose	0
an	I-DISEASE
individual	I-DISEASE
to	I-DISEASE
having	I-DISEASE
seizures	0
.	0

Perinatal	0
or	0
prenatal	0
problems	0
,	0
congenital	I-DISEASE
hemiparesis	I-DISEASE
,	0
and	I-DISEASE
prior	0
encephalopathy	I-DISEASE
may	0
be	0
considered	0
antecedents	I-DISEASE
of	I-DISEASE
the	0
syndrome	I-DISEASE
of	0
CSWS	0
.	0

OSA	0
may	0
exacerbate	0
sleep	B-DISEASE
related	0
seizures	I-DISEASE
and	0
complicate	0
their	I-DISEASE
treatment	I-DISEASE
.	0

Familial	0
Patterns	0

The	0
idiopathic	0
generalized	0
epilepsies	B-DISEASE
form	0
the	I-DISEASE
largest	0
category	0
of	0
epilepsies	0
that	0
appear	I-DISEASE
to	0
be	0
heritable	I-DISEASE
but	0
show	0
no	I-DISEASE
clear	0
mendelian	0
mode	0
of	0
transmission	0
.	0

Juvenile	0
myoclonic	0
epilepsy	0
and	0
idiopathic	0
generalized	0
epilepsy	0
with	0
adolescent	0
onset	0
appear	0
to	0
be	0
genet-	0
ically	0
heterogeneous	0
.	0

Among	0
the	0
partial	I-DISEASE
epilepsies	I-DISEASE
,	0
BECT	0
shows	I-DISEASE
a	0
familial	I-DISEASE
pattern	0
.	0

A	0
form	0
of	0
autosomal	0
dominant	0
NFLE	0
with	0
70	0
%	I-DISEASE
to	0
80	0
%	0
penetrance	0
has	0
been	0
reported	0
in	I-DISEASE
many	I-DISEASE
countries	0
,	0
and	0
a	0
genetic	0
heterogeneity	0
also	I-DISEASE
has	0
been	I-DISEASE
reported	I-DISEASE
.	0

Genetic	0
factors	0
have	0
not	0
been	0
established	I-DISEASE
in	0
CSWS	0
and	0
seem	0
to	0
play	0
a	0
minor	0
role	0
.	0

Familial	0
anteced-	0
ents	0
of	0
epilepsy	0
(	0
including	0
febrile	0
convulsions	0
)	0
have	0
been	0
found	0
in	0
15	I-DISEASE
%	0
of	0
cases	I-DISEASE
.	0

Appendix	0
A	0
:	0
Sleep	0
Related	0
Medical	I-DISEASE
and	I-DISEASE
Neurological	I-DISEASE
Disorders	I-DISEASE
Onset	0
,	0
Course	0
,	0
and	0
Complications	I-DISEASE
Idiopathic	0
generalized	0
epilepsies	I-DISEASE
and	0
partial	0
epilepsy	0
may	0
start	0
at	0
any	0
age	0
.	0

The	0
onset	0
of	0
benign	I-DISEASE
epilepsies	0
of	0
childhood	0
with	0
centrotemporal	I-DISEASE
or	0
occipital	0
spikes	0
is	0
between	0
4	0
and	I-DISEASE
12	0
years	0
of	0
age	0
.	0

The	0
onset	0
of	0
NFLE	0
is	0
generally	0
from	0
age	0
10	0
to	0
16	0
years	0
,	I-DISEASE
mostly	0
before	I-DISEASE
the	0
age	0
of	I-DISEASE
20	0
years	0
.	0

The	0
average	0
age	0
of	0
recognition	0
of	I-DISEASE
CSWS	I-DISEASE
is	I-DISEASE
between	I-DISEASE
4	0
and	0
14	0
years	0
,	0
but	I-DISEASE
the	0
appearance	0
of	I-DISEASE
the	0
first	0
seizure	0
is	0
early	0
,	0
typically	I-DISEASE
between	0
two	0
months	0
and	0
12	0
years	I-DISEASE
of	0
age	0
.	0

Most	0
patients	0
with	0
recurrent	0
sleep	0
related	0
epilepsy	I-DISEASE
continue	0
to	0
have	0
seizures	0
restricted	0
to	0
sleep	0
.	0

In	0
some	0
cases	0
,	B-DISEASE
they	0
may	0
have	0
seizures	0
during	I-DISEASE
both	0
sleep	0
and	0
wakefulness	I-DISEASE
.	0

For	0
focal	0
epilepsies	I-DISEASE
(	0
excluding	0
BECT	I-DISEASE
and	I-DISEASE
the	0
early	I-DISEASE
-	0
onset	0
type	0
of	0
BEOP	0
)	I-DISEASE
,	0
the	0
prognosis	I-DISEASE
is	0
less	0
favorable	0
compared	0
to	0
generalized	0
epilepsies	I-DISEASE
.	0

At	0
least	I-DISEASE
35	I-DISEASE
%	0
of	0
the	I-DISEASE
focal	I-DISEASE
seizures	I-DISEASE
confined	0
to	0
sleep	0
are	0
resistant	I-DISEASE
to	0
antiepileptic	I-DISEASE
drugs	0
.	0

Definitive	0
data	0
on	0
the	0
natural	0
history	0
of	I-DISEASE
NFLE	0
are	I-DISEASE
not	0
available	0
,	0
although	0
a	I-DISEASE
high	I-DISEASE
prev-	0
alence	0
of	I-DISEASE
parasomnias	0
has	0
been	0
documented	0
in	0
NFLE	0
patients	I-DISEASE
.	0

CSWS	0
resolves	I-DISEASE
in	0
many	0
cases	0
within	0
three	0
years	0
after	I-DISEASE
onset	0
,	0
and	0
in	0
almost	0
all	I-DISEASE
cases	0
by	0
the	0
mid	0
-	0
teen	0
years	0
.	0

Despite	0
normalization	0
of	0
the	0
EEG	0
and	I-DISEASE
elimination	I-DISEASE
of	0
seizures	I-DISEASE
,	0
neuropsychological	0
impairment	0
may	0
persist	0
.	I-DISEASE

Interictal	0
paroxysmal	I-DISEASE
activity	I-DISEASE
may	0
induce	0
prolonged	I-DISEASE
cognitive	I-DISEASE
and	0
motor	I-DISEASE
impairment	0
.	0

Hyperkinesias	0
,	0
aggressiveness	0
,	0
and	0
psy-	0
chotic	I-DISEASE
states	0
may	0
appear	0
.	0

OSA	0
may	0
exacerbate	0
sleep	B-DISEASE
related	0
seizures	I-DISEASE
and	0
complicate	0
their	I-DISEASE
treatment	I-DISEASE
.	0

Pathology	0
and	0
Pathophysiology	0
In	0
idiopathic	0
generalized	I-DISEASE
epilepsy	I-DISEASE
,	0
genetic	I-DISEASE
factors	0
are	0
contributory	0
.	0

Pathogenic	0
markers	0
,	0
associated	0
neurologic	0
deficits	0
,	0
or	0
characteristic	0
brain	0
imaging	0
findings	0
have	0
not	0
been	0
identified	0
.	0

However	0
,	0
microdysgenesis	0
has	0
been	0
described	0
in	I-DISEASE
some	0
forms	0
of	0
idiopathic	0
generalized	0
epilepsy	0
.	0

EEG	0
recordings	0
with	0
sphenoidal	0
or	0
zygomatic	0
leads	0
may	0
show	I-DISEASE
epileptic	0
activity	0
over	0
the	I-DISEASE
mesiotemporal	0
regions	0
in	0
partial	0
complex	0
seizures	0
.	0

Video	0
-	0
polysomnographic	0
(	0
vPSG	0
)	0
analysis	0
confirms	0
that	I-DISEASE
the	0
motor	0
pattern	0
of	0
NFLE	I-DISEASE
resembles	I-DISEASE
that	0
noted	0
in	I-DISEASE
orbital	0
and	0
mesial	0
frontal	0
seizures	0
.	0

Nocturnal	0
frontal	0
lobe	0
sei-	0

zures	0
involve	I-DISEASE
a	0
large	0
neuronal	0
network	0
,	I-DISEASE
and	0
some	I-DISEASE
of	0
their	0
clinical	0
expressions	0
are	0
pos-	0
sible	0
consequences	0
of	I-DISEASE
disinhibition	0
of	0
innate	0
motor	0
patterns	0
produced	I-DISEASE
by	I-DISEASE
the	0
central	0
pattern	0
generator	0
.	0

Recent	0
reports	0
derived	0
from	0
stereo	0
-	0
EEG	I-DISEASE
studies	0
seem	I-DISEASE
to	0
show	0
that	0
in	0
some	0
cases	0
,	0
the	I-DISEASE
seizures	I-DISEASE
(	I-DISEASE
in	0
particular	0
nocturnal	0
wanderings	0
)	I-DISEASE
may	I-DISEASE
arise	0
from	0
temporal	I-DISEASE
or	I-DISEASE
insular	0
regions	I-DISEASE
(	0
rather	0
than	0
frontal	0
regions	B-DISEASE
)	I-DISEASE
with	I-DISEASE
a	0
secondary	0
spread	0
to	I-DISEASE
the	I-DISEASE
cingulate	0
regions	I-DISEASE
.	0

They	0
may	0
sometimes	0
mimic	0
parasomnias	0
.	0

Appendix	0
A	0
:	0
Sleep	0
Related	0
Medical	I-DISEASE
and	I-DISEASE
Neurological	I-DISEASE
Disorders	I-DISEASE
Secondary	0
bilateral	0
synchrony	0
is	0
the	0
mechanism	0
generating	0
CSWS	0
.	I-DISEASE

This	0
hypothesis	0
is	0
supported	0
by	0
EEG	0
,	I-DISEASE
intracranial	0
recordings	I-DISEASE
,	0
EEG	0
with	0
coherence	0
computer	0
-	I-DISEASE
assisted	0
analysis	0
,	I-DISEASE
and	0
metabolic	0
(	0
positron	0
emission	I-DISEASE
tomography	0

[	0
PET	0
]	0
and	0
single	0
-	I-DISEASE
photon	0
emis-	0
sion	0
computed	0
tomography	0
[	0
SPECT	0
]	0
)	0
studies	0
.	0

CSWS	0
associated	I-DISEASE
with	0
Landau	0
-	0
Kleffner	0
syndrome	0
(	0
an	I-DISEASE
acquired	0
epileptic	0
aphasia	I-DISEASE
)	I-DISEASE
is	0
probably	I-DISEASE
secondary	0
to	0
an	I-DISEASE
alteration	0
of	0
function	0
over	0
the	I-DISEASE
temporal	0
area	0
.	0

Objective	0
Findings	0
Patients	0
with	0
suspected	0
sleep	I-DISEASE
related	I-DISEASE
epilepsy	I-DISEASE
often	I-DISEASE
need	0
to	0
be	I-DISEASE
evaluated	0
in	0
the	I-DISEASE
sleep	I-DISEASE
laboratory	0
with	I-DISEASE
video	0
and	0
full	0
-	0
head	I-DISEASE
EEG	0
monitoring	I-DISEASE
in	0
order	I-DISEASE
to	I-DISEASE
obtain	0
the	0
correct	0
diagnosis	0
.	0

The	0
characteristic	0
interictal	0
epileptiform	0
activity	I-DISEASE
in	0
idiopathic	0
general-	0
ized	I-DISEASE
epilepsies	0
usually	0
increases	0
during	I-DISEASE
NREM	0
sleep	I-DISEASE
,	0
whereas	0
it	I-DISEASE
decreases	0
during	0
REM	0
sleep	0
and	0
wakefulness	0
.	I-DISEASE

Interictal	0
epileptiform	0
activity	I-DISEASE
may	0
be	0
associated	I-DISEASE
with	I-DISEASE
phasic	I-DISEASE
arousals	I-DISEASE
.	0

In	0
partial	0
epilepsies	I-DISEASE
,	0
the	0
interictal	I-DISEASE
epileptiform	I-DISEASE
activity	0
occurs	I-DISEASE
in	0
a	I-DISEASE
localized	0
distribu-	0
tion	0
with	I-DISEASE
an	I-DISEASE
increase	0
in	I-DISEASE
spike	0
frequency	0
in	0
stages	0
N2	I-DISEASE
and	I-DISEASE
N3	I-DISEASE
compared	0
to	0
REM	0
sleep	0
.	I-DISEASE

Most	0
of	0
the	0
seizures	I-DISEASE
are	0
activated	I-DISEASE
in	I-DISEASE
stage	0
N2	0
sleep	0
.	0

Monitoring	0
may	0
also	I-DISEASE
detect	B-DISEASE
tran-	0
sient	I-DISEASE
autonomic	I-DISEASE
alterations	0
in	I-DISEASE
cardiac	0
rhythm	0
,	0
blood	I-DISEASE
pressure	0
,	0
and	0
respiration	I-DISEASE
during	0
seizures	0
.	0

If	0
epilepsy	0
is	0
suspected	0
,	0
a	0
standard	I-DISEASE
daytime	0
16	I-DISEASE
-	0
channel	0
to	I-DISEASE
20	0
-	0
channel	0
EEG	0
(	0
with	0
partial	0
or	0
total	0
sleep	0
deprivation	0
the	0
night	I-DISEASE
before	I-DISEASE
,	I-DISEASE
as	I-DISEASE
indicated	0
)	0
should	I-DISEASE
be	I-DISEASE
per-	0
formed	0
.	0

Ambulatory	0
24	0
-	I-DISEASE
hour	0
EEG	I-DISEASE
recordings	0
may	I-DISEASE
be	0
useful	I-DISEASE
to	0
detect	0
distribution	0
of	0
interictal	0
epileptiform	I-DISEASE
activity	0
during	0
the	I-DISEASE
sleep	I-DISEASE
-	0
wake	0
cycle	0
.	0

Nocturnal	0
vPSG	0
is	0
the	0
gold	0
standard	0
test	I-DISEASE
for	I-DISEASE
NFLE	I-DISEASE
.	0

Most	0
of	0
the	0
seizures	I-DISEASE
appear	0
during	I-DISEASE
NREM	I-DISEASE
sleep	0
,	I-DISEASE
with	0
preponderance	0
in	I-DISEASE
NREM	0
stages	0
N1	I-DISEASE
and	0
N2	0
(	I-DISEASE
greater	0
than	0
60	0
%	0
)	0
.	0

Rarely	0
do	0
they	0
emerge	0
from	0
REM	0
sleep	0
.	0

In	0
some	0
cases	0
,	I-DISEASE
particularly	0
in	I-DISEASE
paroxysmal	0
arousals	0
,	I-DISEASE
the	0
motor	0
attacks	0
may	0
show	0
a	I-DISEASE
periodicity	0
(	0
every	I-DISEASE
20	0
seconds	0
to	0
two	0
minutes	0
)	0
.	I-DISEASE

Due	0
to	0
the	0
fact	I-DISEASE
that	0
the	I-DISEASE
discharges	I-DISEASE
originate	0
deep	I-DISEASE
in	0
the	0
frontal	0
lobe	I-DISEASE
and	0
are	I-DISEASE
not	I-DISEASE
visible	0
using	I-DISEASE
scalp	0
EEG	0
,	0
the	0
EEG	I-DISEASE
during	0
the	I-DISEASE
attacks	0
is	0
uninformative	I-DISEASE
in	I-DISEASE
almost	0
half	0
of	0
the	0
cases	0
.	0

In	0
a	0
few	0
cases	0
,	0
recording	0
using	I-DISEASE
intracranial	0
or	0
depth	0
electrodes	0
confirms	0
the	0
paroxysms	0
during	I-DISEASE
or	I-DISEASE
preceding	0
the	0
motor	I-DISEASE
components	I-DISEASE
.	0

The	0
interictal	0
sleep	0
EEG	I-DISEASE
is	0
generally	I-DISEASE
normal	0
,	0
but	I-DISEASE
in	I-DISEASE
30	0
%	0
to	0
40	0
%	0
of	0
subjects	0
,	I-DISEASE
focal	0
epileptic	0
abnormalities	0
are	0
seen	I-DISEASE
,	0
predominantly	0
in	0
the	0
anterior	0
regions	0
.	0

The	0
video	0
recording	0
of	I-DISEASE
the	0
different	I-DISEASE
types	0
of	I-DISEASE
attacks	I-DISEASE
in	0
NFLE	0
permits	0
categorization	0
of	0
the	I-DISEASE
seizures	I-DISEASE
and	0
characterization	I-DISEASE
of	0
the	I-DISEASE
main	0
features	0
.	I-DISEASE

During	0
CSWS	0
,	I-DISEASE
diffuse	0
spike	0
waves	0
at	I-DISEASE
two	0
to	I-DISEASE
2.5	0
Hz	0
occur	0
in	0
bursts	0
,	0
with	0
or	0
without	0
clinical	0
manifestations	I-DISEASE
.	0

The	0
discharges	0
are	0
continuous	I-DISEASE
and	0
occupy	I-DISEASE
from	I-DISEASE
85	0
%	I-DISEASE
to	0
100	0
%	0
Appendix	0
A	0
:	I-DISEASE
Sleep	0
Related	0
Medical	I-DISEASE
and	0
Neurological	0
Disorders	0
of	I-DISEASE
NREM	0
sleep	0
stages	I-DISEASE
.	0

Abnormalities	0
arise	0
as	0
soon	I-DISEASE
as	0
the	0
patients	I-DISEASE
fall	0
asleep	I-DISEASE
and	0
dis-	0
appear	I-DISEASE
abruptly	0
on	0
awakening	I-DISEASE
.	0

REM	0
sleep	0
is	0
typically	I-DISEASE
preserved	0
,	I-DISEASE
and	0
the	0
frequency	I-DISEASE
of	I-DISEASE
spike	0
-	0
wave	I-DISEASE
discharges	0
significantly	I-DISEASE
decreases	0
but	I-DISEASE
the	I-DISEASE
frontal	0
predominance	0
of	0
the	0
infrequent	0
bursts	0
may	0
become	0
more	0
prominent	I-DISEASE
.	0

In	0
general	0
,	0
EEG	0
patterns	0
during	0
REM	I-DISEASE
sleep	0
are	0
similar	0
to	0
those	0
in	0
the	0
awake	0
records	0
.	I-DISEASE

The	0
sleep	0
structure	I-DISEASE
is	I-DISEASE
normal	0
,	I-DISEASE
but	I-DISEASE
the	0
presence	I-DISEASE
of	0
almost	0
continuous	0
spike	I-DISEASE
-	I-DISEASE
wave	I-DISEASE
discharges	0
makes	0
the	I-DISEASE
recognition	I-DISEASE
of	I-DISEASE
normal	0
NREM	0
sleep	0
EEG	0
elements	0
(	I-DISEASE
such	I-DISEASE
as	I-DISEASE
K	0
complexes	0
,	I-DISEASE
spindles	0
,	0
or	0
vertex	0
sharp	0
transients	I-DISEASE
)	I-DISEASE
difficult	0
.	0

Differential	0
Diagnosis	0
NFLE	0
may	0
be	0
mistaken	I-DISEASE
for	I-DISEASE
a	0
disorder	I-DISEASE
of	I-DISEASE
arousal	0
from	0
NREM	0
such	0
as	I-DISEASE
sleepwalking	0
,	0
confusional	I-DISEASE
arousal	0
,	I-DISEASE
or	0
sleep	0
terror	I-DISEASE
.	0

Ictal	0
and	0
interictal	0
EEGs	0
are	0
often	0
normal	I-DISEASE
because	0
the	I-DISEASE
focus	0
for	I-DISEASE
the	0
epileptic	I-DISEASE
discharge	0
may	I-DISEASE
be	I-DISEASE
deep	0
in	I-DISEASE
the	I-DISEASE
brain	0
.	0

Disorders	0
of	0
arousal	0
show	0
a	0
different	I-DISEASE
pattern	0
of	0
episodes	0
in	0
that	0
they	0
occur	0
out	0
of	I-DISEASE
stage	0
N3	0
sleep	I-DISEASE
,	0
are	0
not	0
ste-	I-DISEASE
reotyped	0
,	0
often	I-DISEASE
have	0
a	0
sustained	I-DISEASE
autonomic	B-DISEASE
component	0
,	0
and	0
are	0
frequently	0
seen	0
during	0
the	0
first	I-DISEASE
part	0
of	0
the	I-DISEASE
night	I-DISEASE
.	0

Partial	0
arousal	0
disorders	0
tend	0
to	0
disappear	0
or	0
decrease	0
in	0
fre-	I-DISEASE
quency	0
after	0
adolescence	0
.	0

VPSG	0
is	0
often	0
useful	0
.	0

Sleep	0
talking	I-DISEASE
,	0
bruxism	0
,	0
and	0
rhythmic	I-DISEASE
movement	0
disorders	I-DISEASE
can	0
be	0
differentiated	0
from	0
nocturnal	0
seizures	0
by	0
history	I-DISEASE
and	0
vPSG	0
recordings	0
.	0

Benign	0
neonatal	0
sleep	0
myoclonus	0
may	0
be	0
confused	I-DISEASE
with	0
clonic	I-DISEASE
or	0
myoc-	0
lonic	0
seizures	I-DISEASE
during	0
sleep	I-DISEASE
.	I-DISEASE

In	0
the	0
elderly	0
(	0
older	0
than	0
60	0
years	0
)	I-DISEASE
,	0
the	0
main	0
differentiation	0
from	0
RBD	0
is	0
by	0
vPSG	I-DISEASE
recording	0
.	0

PLMD	0
,	0
sleep	0
starts	0
,	0
and	I-DISEASE
propriospinal	I-DISEASE
myoclonus	0
at	I-DISEASE
sleep	0
onset	I-DISEASE
do	0
not	I-DISEASE
show	0
EEG	I-DISEASE
epileptiform	0
activity	0
and	I-DISEASE
belong	I-DISEASE
in	0
the	0
category	I-DISEASE
of	0
move-	I-DISEASE
ment	I-DISEASE
disorders	0
during	0
sleep	I-DISEASE
.	0

Jerks	0
,	I-DISEASE
dyskinesias	0
,	0
or	0
arousal	0
on	I-DISEASE
resumption	0
of	0
breathing	0
in	0
patients	0
with	0
OSA	0
also	0
enter	0
into	0
the	0
differential	0
diagnosis	0
of	0
sleep	0
related	0
epilepsy	0
.	0

Rare	0
cases	0
of	0
anoxic	0
syncope	0
with	I-DISEASE
some	0
clonic	0
jerks	I-DISEASE
at	0
the	0
end	0
of	I-DISEASE
a	0
prolonged	0
(	I-DISEASE
longer	I-DISEASE
than	I-DISEASE
two	I-DISEASE
minutes	0
)	0
obstructive	0
event	I-DISEASE
have	I-DISEASE
been	I-DISEASE
described	0
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE
Not	I-DISEASE
applicable	I-DISEASE
or	0
known	0
.	0

Bilbliography	0
Bazil	0
C	0
,	0
Malow	0
B	0
,	I-DISEASE
Sammaritano	0
M.	I-DISEASE
Sleep	0
and	0
epilepsy	0
:	0
the	0
clinical	0
spectrum	I-DISEASE
.	I-DISEASE

Amsterdam	0
:	0
Elsevier	0
Science	0
;	0
2002	0
.	I-DISEASE

Dinner	0
D	0
,	0
Luders	0
H.	0
Relationship	0
of	0
epilepsy	0
and	0
sleep	0
:	0
an	0
overview	0
.	0

In	0
:	0
Dinner	0
D	0
,	0
Luders	0
H	0
,	0
eds	0
.	0

Epilepsy	0
and	0
sleep	0
:	0
physiological	0
and	I-DISEASE
clinical	I-DISEASE
relationships	0
.	I-DISEASE

San	0
Diego	0
:	0
Academic	0
Press	0
,	0
2001:2–18	I-DISEASE
.	0

Malow	0
B.	0
Paroxysmal	0
events	0
in	0
sleep	I-DISEASE
.	I-DISEASE

J	0
Clin	0
Neurophysiol	0
2002;19:522–34	0
.	0

Nobili	0
L	0
,	0
Cossu	0
M	I-DISEASE
,	0
Mai	0
R.	0
Sleep	I-DISEASE
-	0
related	0
hyperkinetic	0
seizures	0
of	0
temporal	I-DISEASE
lobe	0
origin	I-DISEASE
.	I-DISEASE

Neurology	0
2004;62:482–5	0
.	0

Oldani	0
A	0
,	0
Zucconi	0
M	0
,	0
Ferini	I-DISEASE
-	0
Strambi	I-DISEASE
L	0
,	0
Bizzozero	0
D	0
,	0
Smirne	I-DISEASE
S.	I-DISEASE
Autosomal	0
dominant	I-DISEASE
nocturnal	0
frontal	0
lobe	0
epilepsy	0
:	0
electroclinical	0
picture	I-DISEASE
.	0

Epilepsia	0
1996;37:964–76	0
.	0

Appendix	0
A	0
:	0
Sleep	0
Related	0
Medical	I-DISEASE
and	I-DISEASE
Neurological	I-DISEASE
Disorders	I-DISEASE
Provini	0
F	0
,	0
Plazzi	0
G	0
,	0
Tinuper	0
P	0
,	I-DISEASE
Vandi	0
S	0
,	0
Lugaresi	0
E	0
,	I-DISEASE
Montagna	I-DISEASE
P.	0
Nocturnal	I-DISEASE
frontal	I-DISEASE
lobe	0
epilepsy	0
.	0

A	0
clinical	0
and	0
polygraphic	0
overview	0
of	I-DISEASE
100	0
consecutive	0
cases	I-DISEASE
.	0

Brain	0
1999;122:1017–31	0
.	0

Scheffer	0
I	0
,	0
Bhatia	0
K	0
,	0
Lopes	I-DISEASE
-	0
Cendes	0
I	0
,	0
et	0
al	0
.	0

Autosomal	0
dominant	0
nocturnal	0
frontal	0
lobe	0
epilepsy	0
.	0

A	0
distinctive	0
clinical	0
disorder	0
.	0

Brain	0
1995;118:61–73	0
.	0

Shouse	0
M	0
,	0
Martins	0
da	0
Silva	0
A	I-DISEASE
,	0
Sammaritano	I-DISEASE
M.	0
Circadian	0
rhythm	I-DISEASE
,	I-DISEASE
sleep	0
,	I-DISEASE
and	0
epilepsy	I-DISEASE
.	I-DISEASE

J	0
Clin	0
Neurophysiol	0
1996;13:32–50	0
.	0

Tassinari	0
C	0
,	0
Dravet	0
C	I-DISEASE
,	0
Roger	0
J.	0
CSWS	0
:	I-DISEASE

Encephalography	0
related	0
to	0
electrical	0
status	0
epilepticus	0
during	I-DISEASE
slow	0
sleep	I-DISEASE
.	0

Electroencephalogr	0
Clin	0
Neurophysiol	0
1977;43:529–30	0
.	0

Tinuper	0
P	0
,	0
Provini	0
F	0
,	0
Bisulli	0
F	0
,	I-DISEASE
et	0
al	0
.	0

Movements	0
disorders	0
in	0
sleep	0
:	0
guideline	I-DISEASE
for	I-DISEASE
differentiating	0
epileptic	I-DISEASE
from	0
non	0
-	0
epileptic	0
motor	0
phenomena	I-DISEASE
arising	0
from	0
sleep	I-DISEASE
.	0

Sleep	0
Med	0
Rev	I-DISEASE
2007;11:255–67	0
.	B-DISEASE

Zucconi	0
M.	0
Sleep	0
-	0
related	0
epilepsy	0
.	0

Handb	0
Clin	I-DISEASE
Neurol	0
2011;99:1109–37	I-DISEASE
.	0

Sleep	0
Related	0
Headaches	0
Alternate	0
Names	0
Various	0
(	I-DISEASE
see	0
Clinical	0
and	0
Pathologic	0
Subtypes	0
)	0
.	0

Essential	0
Features	0
Sleep	0
related	0
headaches	I-DISEASE
are	I-DISEASE
a	I-DISEASE
group	0
of	I-DISEASE
unilateral	0
or	0
bilateral	0
cephalalgias	I-DISEASE
of	I-DISEASE
varying	I-DISEASE
severity	0
and	I-DISEASE
duration	0
that	0
occur	0
during	0
sleep	0
or	0
upon	0
awakening	I-DISEASE
from	0
sleep	0
.	I-DISEASE

It	0
is	0
a	0
heterogenous	0
group	0
of	I-DISEASE
different	I-DISEASE
headache	I-DISEASE
entities	0
with	0
the	0
common	I-DISEASE
feature	I-DISEASE
of	0
occur-	I-DISEASE
rence	0
during	0
sleep	I-DISEASE
or	0
upon	0
awakening	0
.	0

The	0
characteristics	0
of	0
specific	0
subtypes	0
of	0
sleep	I-DISEASE
related	0
headache	I-DISEASE
are	I-DISEASE
discussed	I-DISEASE
in	I-DISEASE
the	0
Clinical	0
and	0
Pathologic	I-DISEASE
Subtypes	0
section	I-DISEASE
below	0
.	0

Associated	0
Features	0
Individual	0
features	I-DISEASE
associated	0
with	0
specific	0
sleep	0
related	I-DISEASE
headache	I-DISEASE
types	I-DISEASE
are	I-DISEASE
discussed	0
in	0
the	0
following	I-DISEASE
section	0
.	I-DISEASE

Clinical	0
and	0
Pathologic	0
Subtypes	I-DISEASE
Most	0
sleep	0
related	0
headaches	0
are	I-DISEASE
daytime	0
headache	I-DISEASE
conditions	I-DISEASE
that	I-DISEASE
also	0
may	I-DISEASE
occur	0
during	I-DISEASE
sleep	I-DISEASE
.	0

These	0
include	0
the	0
primary	I-DISEASE
headaches	0
such	I-DISEASE
as	I-DISEASE
migraine	0
,	I-DISEASE
cluster	I-DISEASE
head-	0
ache	0
,	0
and	0
chronic	I-DISEASE
paroxysmal	I-DISEASE
hemicrania	0
.	I-DISEASE

There	0
are	0
other	0
primary	0
headaches	0
that	I-DISEASE
occur	I-DISEASE
solely	0
with	0
sleep	0
;	0
for	0
example	0
,	0
hypnic	0
headaches	0
.	0

In	0
addition	0
,	0
secondary	0
head-	0
aches	0
related	I-DISEASE
to	0
medical	I-DISEASE
,	I-DISEASE
neurological	0
,	0
psychiatric	0
,	0
and	I-DISEASE
sleep	I-DISEASE
disorders	0
can	0
cause	0
sleep	I-DISEASE
related	0
headaches	0
.	0

Migraines	0
are	0
common	0
recurrent	0
headaches	0
of	0
moderate	0
to	0
severe	I-DISEASE
intensity	0
that	0
last	0
between	0
four	0
and	I-DISEASE
72	0
hours	0
.	I-DISEASE

Pain	0
is	0
typically	0
unilateral	0
and	0
pulsating	0
,	I-DISEASE
aggra-	0
vated	0
by	0
routine	0
physical	0
activity	0
and	0
associated	I-DISEASE
with	I-DISEASE
nausea	0
,	I-DISEASE
and/or	0
photophobia	0
Appendix	0
A	0
:	0
Sleep	0
Related	I-DISEASE
Medical	0
and	0
Neurological	I-DISEASE
Disorders	0
or	0
phonophobia	0
.	0

They	0
occur	0
during	0
the	0
day	I-DISEASE
or	0
during	0
sleep	0
;	I-DISEASE
approximately	0
50	0
%	0
of	0
migraine	0
attacks	I-DISEASE
occur	0
between	0
4:00	I-DISEASE
a.m.	0
and	0
9:00	0
a.m.	0

Migraine	0
headaches	0
do	0
not	0
have	I-DISEASE
a	I-DISEASE
fixed	0
association	I-DISEASE
with	0
a	0
particular	0
sleep	0
stage	0
.	0

The	0
patient	0
may	0
awaken	I-DISEASE
with	I-DISEASE
a	0
migraine	I-DISEASE
out	I-DISEASE
of	I-DISEASE
REM	0
sleep	0
,	0
or	I-DISEASE
the	0
headaches	I-DISEASE
may	I-DISEASE
occur	0
in	I-DISEASE
relationship	I-DISEASE
to	I-DISEASE
stage	0
N3	0
sleep	0
.	0

A	0
“	0
classic	0
migraine	0
”	I-DISEASE
headache	0
is	0
preceded	0
by	I-DISEASE
an	0
aura	0
(	0
if	I-DISEASE
the	I-DISEASE
patient	I-DISEASE
is	0
awake	I-DISEASE
)	I-DISEASE
,	0
which	0
usually	I-DISEASE
lasts	0
four	I-DISEASE
to	0
60	I-DISEASE
minutes	I-DISEASE
and	0
typically	I-DISEASE
consists	0
of	I-DISEASE
homonymous	I-DISEASE
visual	I-DISEASE
field	0
defects	0
and	0
scintillating	0
scotomas	I-DISEASE
.	0

In	0
some	0
patients	0
,	I-DISEASE
the	0
aura	I-DISEASE
may	I-DISEASE
continue	0
or	0
even	0
begin	0
during	0
the	I-DISEASE
headache	0
phase	I-DISEASE
.	0

In	0
contrast	0
,	0
“	0
common	0
migraine	0
”	I-DISEASE
does	0
not	0
start	0
with	0
an	I-DISEASE
aura	0
.	0

Other	0
signs	0
of	0
neurological	I-DISEASE
dysfunction	0
may	0
include	I-DISEASE
unilateral	0
paresthesias	I-DISEASE
,	0
weakness	0
,	0
and	0
aphasia	0
.	I-DISEASE

Features	0
of	0
brainstem	0
involvement	I-DISEASE
may	0
include	0
vertigo	B-DISEASE
,	0
tinni-	I-DISEASE
tus	I-DISEASE
,	0
dysarthria	0
,	0
decreased	0
hearing	I-DISEASE
,	0
diplopia	0
,	I-DISEASE
ataxia	0
,	0
bilateral	0
paresthesias	0
,	0
and	0
impaired	I-DISEASE
level	0
of	0
consciousness	0
.	I-DISEASE

A	0
familial	0
syndrome	0
with	0
hemiplegia	0
is	I-DISEASE
well	I-DISEASE
described	0
.	0

The	0
hemiplegia	0
is	0
ipsilateral	0
or	I-DISEASE
contralateral	0
to	I-DISEASE
the	0
side	I-DISEASE
of	0
the	0
headache	0
.	I-DISEASE

Cluster	0
headaches	I-DISEASE
are	0
severe	I-DISEASE
,	0
unilateral	0
,	I-DISEASE
periorbital	0
or	0
temporal	0
headaches	0
that	0
start	0
quickly	0
and	0
peak	0
within	0
10	I-DISEASE
to	I-DISEASE
15	0
minutes	0
.	0

They	0
have	0
a	0
relatively	0
shorter	0
duration	0
,	I-DISEASE
usually	0
lasting	I-DISEASE
15	0
minutes	0
to	0
three	0
hours	0
(	I-DISEASE
mean	0
,	0
60	0
minutes	0
)	0
.	0

The	0
headaches	0
occur	I-DISEASE
daily	I-DISEASE
during	0
cluster	0
periods	I-DISEASE
—	I-DISEASE
usually	I-DISEASE
one	0
to	0
three	0
attacks	0
per	0
day	I-DISEASE
over	0
a	0
period	I-DISEASE
of	0
one	0
to	0
two	0
months	0
.	0

Most	0
patients	0
have	0
one	0
cluster	0
period	I-DISEASE
per	0
year	0
,	I-DISEASE
though	0
this	0
can	0
vary	0
from	0
patient	0
to	0
patient	0
.	I-DISEASE

The	0
headaches	0
tend	I-DISEASE
to	I-DISEASE
occur	0
at	0
the	I-DISEASE
same	I-DISEASE
hour	I-DISEASE
each	0
day	0
,	0
with	0
75	0
%	I-DISEASE
of	I-DISEASE
cluster	0
episodes	I-DISEASE
reported	I-DISEASE
to	0
occur	0
between	0
9:00	0
p.m.	0
and	I-DISEASE
10:00	I-DISEASE
a.m.	I-DISEASE

One	0
or	I-DISEASE
more	0
cranial	0
autonomic	I-DISEASE
features	0
(	I-DISEASE
e.g.	0
,	I-DISEASE
ipsilateral	0
conjunctival	0
injection	0
,	0
lacrimation	0
,	I-DISEASE
nasal	0
congestion	0
,	I-DISEASE
rhinorrhea	0
,	0
forehead	I-DISEASE
and	0
facial	0
sweating	0
,	I-DISEASE
miosis	0
,	0
ptosis	0
,	0
or	I-DISEASE
eyelid	0
edema	0
)	0
invariably	0
accompany	0
attacks	0
of	0
cluster	0
headaches	0
.	I-DISEASE

A	0
strong	0
predilection	I-DISEASE
for	I-DISEASE
attacks	0
to	0
occur	I-DISEASE
during	0
sleep	I-DISEASE
is	0
well	0
recognized	I-DISEASE
,	I-DISEASE
and	0
these	I-DISEASE
attacks	0
are	0
strongly	I-DISEASE
related	0
to	0
REM	0
sleep	0
.	I-DISEASE

Chronic	0
paroxysmal	0
hemicrania	0
closely	0
resembles	I-DISEASE
cluster	0
headaches	0
and	0
consists	0
of	0
severe	0
unilateral	0
orbital	0
,	I-DISEASE
supraorbital	I-DISEASE
,	I-DISEASE
or	I-DISEASE
temporal	I-DISEASE
pain	0
associated	I-DISEASE
with	0
one	0
or	I-DISEASE
more	I-DISEASE
cranial	I-DISEASE
autonomic	0
features	I-DISEASE
.	I-DISEASE

However	0
,	I-DISEASE
the	0
attacks	I-DISEASE
are	0
usually	0
of	I-DISEASE
shorter	0
duration	I-DISEASE
(	0
lasting	0
two	0
to	0
30	0
minutes	0
)	0
and	I-DISEASE
occur	I-DISEASE
more	0
frequently	0
,	0
most	0
often	0
at	I-DISEASE
a	I-DISEASE
frequency	0
of	0
more	I-DISEASE
than	0
five	0
per	I-DISEASE
day	0
.	0

In	0
contrast	0
to	0
cluster	I-DISEASE
headaches	I-DISEASE
,	I-DISEASE
chronic	I-DISEASE
paroxysmal	0
hemicrania	I-DISEASE
is	0
exqui-	I-DISEASE
sitely	0
sensitive	0
to	0
indomethacin	0
.	0

Attacks	0
are	0
also	0
strongly	0
associated	0
with	0
REM	0
sleep	0
.	I-DISEASE

Hypnic	0
headaches	0
are	0
an	I-DISEASE
uncommon	0
type	I-DISEASE
of	I-DISEASE
headache	0
that	I-DISEASE
awakens	0
the	0
patient	0
from	I-DISEASE
sleep	0
with	I-DISEASE
a	I-DISEASE
generalized	I-DISEASE
or	I-DISEASE
lateralized	0
headache	I-DISEASE
that	0
lasts	0
at	I-DISEASE
least	0
15	I-DISEASE
minutes	0
(	I-DISEASE
range	I-DISEASE
,	B-DISEASE
one	I-DISEASE
to	I-DISEASE
180	I-DISEASE
minutes	0
)	0
with	0
a	0
frequency	0
of	0
at	0
least	0
15	I-DISEASE
times	0
per	0
month	0
.	0

Onset	0
is	0
typically	0
after	0
the	0
age	0
of	I-DISEASE
50	0
,	I-DISEASE
although	0
similar	0
headaches	0
are	0
described	I-DISEASE
rarely	I-DISEASE
in	0
younger	0
indi-	I-DISEASE
viduals	0
,	0
including	0
children	0
.	0

In	0
comparison	0
to	0
cluster	I-DISEASE
headaches	I-DISEASE
,	I-DISEASE
hypnic	I-DISEASE
headaches	0
are	I-DISEASE
Appendix	0
A	I-DISEASE
:	0
Sleep	I-DISEASE
Related	0
Medical	I-DISEASE
and	0
Neurological	0
Disorders	0
less	0
severe	0
,	0
often	0
bilateral	I-DISEASE
and	0
not	I-DISEASE
associated	0
with	0
cranial	0
autonomic	0
features	0
.	0

Isolated	0
nausea	0
,	0
photophobia	0
,	0
or	0
phonophobia	I-DISEASE
may	0
be	I-DISEASE
present	0
.	0

They	0
may	0
occur	0
one	0
to	0
three	0
times	I-DISEASE
during	0
the	I-DISEASE
night	I-DISEASE
,	I-DISEASE
with	0
many	0
patients	0
reporting	I-DISEASE
that	I-DISEASE
the	0
headaches	I-DISEASE
occur	I-DISEASE
at	0
the	0
same	0
time	I-DISEASE
of	0
the	I-DISEASE
night	0
.	I-DISEASE

The	0
headaches	0
tend	I-DISEASE
to	I-DISEASE
occur	0
during	0
REM	I-DISEASE
sleep	I-DISEASE
.	I-DISEASE

However	0
,	I-DISEASE
they	0
also	0
have	0
been	0
reported	0
to	0
occur	I-DISEASE
during	0
stage	0
N3	0
sleep	0
.	0

A	0
positive	0
therapeutic	I-DISEASE
response	0
to	0
lithium	0
,	I-DISEASE
indomethacin	0
,	I-DISEASE
and	0
caffeine	0
has	0
been	I-DISEASE
reported	0
in	I-DISEASE
many	I-DISEASE
patients	0
.	I-DISEASE

Other	0
medical	0
(	0
e.g.	0
,	0
hypertension	0
)	I-DISEASE
,	0
neurologic	I-DISEASE
(	0
e.g.	0
,	I-DISEASE
brain	0
tumors	I-DISEASE
,	I-DISEASE
arteriovenous	0
mal-	0
formations	0
,	0
cerebral	I-DISEASE
venous	0
thrombosis	0
and	0
trauma	0
)	I-DISEASE
,	0
psychiatric	0
(	I-DISEASE
e.g.	0
,	0
depression	0
)	I-DISEASE
,	0
and	0
sleep	0
disorders	I-DISEASE
(	0
e.g.	0
,	0
snoring	I-DISEASE
and	I-DISEASE
OSA	I-DISEASE
)	0
also	0
can	0
give	0
rise	I-DISEASE
to	0
headaches	0
that	I-DISEASE
may	0
occur	0
during	I-DISEASE
sleep	0
or	0
upon	0
awakening	0
from	I-DISEASE
sleep	0
.	I-DISEASE

Patients	0
with	0
increased	B-DISEASE
intracranial	0
pressure	0
(	0
due	I-DISEASE
,	0
for	0
example	0
,	0
to	0
brain	0
tumor	0
,	0
hematoma	0
,	0
arteriovenous	I-DISEASE
malformations	0
,	0
or	0
cerebral	0
venous	0
thrombosis	0
)	I-DISEASE
may	0
complain	0
of	I-DISEASE
headache	I-DISEASE
in	I-DISEASE
the	0
morning	0
or	0
head-	0
ache	0
that	0
starts	0
after	I-DISEASE
recumbence	0
and	I-DISEASE
improves	0
after	I-DISEASE
the	I-DISEASE
patient	0
is	0
up	I-DISEASE
for	I-DISEASE
30	0
to	I-DISEASE
60	I-DISEASE
minutes	0
.	0

Nausea	0
,	0
vomiting	0
,	0
signs	0
of	I-DISEASE
focal	I-DISEASE
neurological	0
deficits	I-DISEASE
,	0
and	I-DISEASE
papilledema	0
may	0
be	0
present	0
.	I-DISEASE

The	0
headache	0
may	I-DISEASE
worsen	0
with	0
bending	0
down	I-DISEASE
or	0
sneezing	I-DISEASE
or	0
with	0
other	0
activities	I-DISEASE
that	0
may	I-DISEASE
cause	0
further	0
increase	I-DISEASE
in	0
intracranial	I-DISEASE
pressure	0
.	0

Sleep	0
related	0
headaches	I-DISEASE
can	I-DISEASE
disrupt	0
nocturnal	0
sleep	I-DISEASE
,	0
although	0
the	0
exact	0
prevalence	0
of	I-DISEASE
this	0
complication	I-DISEASE
is	0
unknown	0
.	0

Demographics	0
The	0
exact	0
prevalence	0
of	0
sleep	0
related	I-DISEASE
headaches	I-DISEASE
is	I-DISEASE
not	0
known	I-DISEASE
.	I-DISEASE

One	0
study	I-DISEASE
from	I-DISEASE
a	0
head-	0
ache	0
clinic	I-DISEASE
suggested	0
that	I-DISEASE
17	0
%	I-DISEASE
of	0
all	0
headache	0
patients	0
complain	I-DISEASE
of	I-DISEASE
nocturnal	0
or	0
early	I-DISEASE
morning	0
headaches	0
,	0
and	I-DISEASE
roughly	I-DISEASE
half	I-DISEASE
of	0
these	I-DISEASE
were	0
related	I-DISEASE
to	0
an	0
identifiable	0
sleep	I-DISEASE
disorder	0
.	I-DISEASE

However	0
,	I-DISEASE
many	0
primary	0
headache	0
disorders	I-DISEASE
can	I-DISEASE
occur	0
during	0
sleep	0
as	0
well	0
.	0

Sleep	0
related	0
migraines	I-DISEASE
have	I-DISEASE
been	0
reported	0
to	0
increase	0
in	0
frequency	0
with	0
age	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
Migraine	0
headaches	I-DISEASE
have	I-DISEASE
several	0
predisposing	I-DISEASE
factors	0
that	0
vary	0
from	0
patient	0
to	0
patient	I-DISEASE
.	I-DISEASE

However	0
,	I-DISEASE
stress	0
,	0
relaxation	0
,	0
changes	I-DISEASE
in	0
weather	0
and	0
barometric	0
pressure	0
,	0
changes	0
in	I-DISEASE
sleep	0
pattern	0
,	I-DISEASE
hypoglycemia	0
,	0
and	0
specific	0
foods	0
(	0
e.g.	0
,	0
chocolate	0
,	I-DISEASE
Chinese	0
food	0
,	0
alcohol	0
)	0
have	0
been	0
known	0
to	0
trigger	I-DISEASE
migraine	0
headaches	0
.	I-DISEASE

Alcohol	0
can	0
also	0
predispose	0
an	0
indi-	0
vidual	I-DISEASE
to	0
having	I-DISEASE
cluster	0
headache	0
and	0
chronic	0
paroxysmal	0
hemicrania	0
.	0

OSA	0
and	0
atten-	0
dant	0
hypoxia	0
have	I-DISEASE
been	I-DISEASE
reported	0
to	I-DISEASE
be	0
a	0
trigger	I-DISEASE
for	0
cluster	0
headache	0
.	0

However	0
,	I-DISEASE
sleep	0
apnea	I-DISEASE
may	0
also	I-DISEASE
predispose	I-DISEASE
a	0
person	I-DISEASE
to	0
having	0
other	0
types	0
of	0
headache	I-DISEASE
and	0
may	I-DISEASE
inde-	I-DISEASE
pendently	0
lead	I-DISEASE
to	0
morning	0
headaches	0
.	I-DISEASE

Change	0
of	0
sleep	0
pattern	I-DISEASE
and	0
insomnia	I-DISEASE
can	0
pre-	0
dispose	0
the	0
patient	0
to	0
developing	0
headaches	0
.	I-DISEASE

Appendix	0
A	0
:	0
Sleep	0
Related	0
Medical	I-DISEASE
and	I-DISEASE
Neurological	I-DISEASE
Disorders	I-DISEASE
Familial	0
Patterns	0
There	0
is	0
a	0
positive	I-DISEASE
family	0
history	0
for	I-DISEASE
migraine	0
in	0
up	0
to	0
80	0
%	0
of	0
patients	0
with	0
this	I-DISEASE
disor-	0
der	0
.	0

Familial	0
hemiplegic	0
migraine	0
is	0
inherited	0
in	0
an	I-DISEASE
autosomal	0
dominant	I-DISEASE
pattern	0
with	0
a	0
variety	I-DISEASE
of	0
genetic	I-DISEASE
mutations	0
identified	0
on	0
chromosomes	0
1	0
and	0
19	0
.	0

Cluster	0
headache	I-DISEASE
does	0
not	I-DISEASE
have	0
as	I-DISEASE
strong	0
of	0
a	I-DISEASE
familial	0
disposition	0
as	0
migraine	I-DISEASE
headache	0
,	0
but	I-DISEASE
first	I-DISEASE
-	I-DISEASE
degree	0
relatives	I-DISEASE
of	0
probands	0
with	0
cluster	I-DISEASE
headache	I-DISEASE
are	I-DISEASE
seven	I-DISEASE
times	0
more	0
likely	I-DISEASE
to	I-DISEASE
develop	I-DISEASE
cluster	I-DISEASE
headaches	0
,	0
and	0
the	0
concordance	0
rates	0
in	0
monozygotic	I-DISEASE
twins	I-DISEASE
is	I-DISEASE
100	0
%	I-DISEASE
.	I-DISEASE

The	0
inheritance	0
patterns	0
of	0
hypnic	0
headache	0
are	0
not	0
known	I-DISEASE
.	I-DISEASE

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Migraine	I-DISEASE
headache	0
usually	I-DISEASE
starts	0
in	0
the	0
second	0
or	0
third	I-DISEASE
decade	0
of	0
life	0
,	I-DISEASE
with	0
a	0
slightly	0
earlier	I-DISEASE
onset	0
in	I-DISEASE
men	0
than	0
in	I-DISEASE
women	I-DISEASE
.	0

The	0
mean	0
age	0
of	0
onset	0
of	0
cluster	I-DISEASE
headache	0
is	I-DISEASE
28	0
years	0
.	0

Chronic	0
paroxysmal	0
hemicrania	0
has	0
a	I-DISEASE
wide	0
range	0
of	0
onset	0
,	0
from	0
childhood	0
to	0
old	0
age	I-DISEASE
.	0

Most	0
patients	0
with	0
hypnic	0
headache	0
are	0
elderly	I-DISEASE
,	0
with	I-DISEASE
the	0
age	0
of	0
onset	0
from	0
40	0
to	0
82	0
years	0
.	0

Brain	0
tumors	0
are	0
more	0
prevalent	0
in	0
the	0
elderly	0
,	I-DISEASE
most	0
occurring	0
from	0
the	0
fifth	0
decade	I-DISEASE
to	I-DISEASE
late	0
life	0
.	0

Most	0
sleep	0
related	I-DISEASE
headaches	I-DISEASE
are	I-DISEASE
benign	I-DISEASE
and	I-DISEASE
tend	0
to	I-DISEASE
decrease	0
in	0
frequency	0
with	0
age	0
.	0

There	0
may	0
be	0
spontaneous	I-DISEASE
remissions	I-DISEASE
that	0
last	I-DISEASE
from	0
months	I-DISEASE
to	0
years	0
.	0

Pregnancy	0
has	0
a	0
variable	0
effect	0
on	I-DISEASE
these	I-DISEASE
headaches	0
.	I-DISEASE

Migraines	0
tend	0
to	0
decrease	0
with	0
age	0
and	I-DISEASE
,	0
in	0
women	0
,	0
may	0
stop	0
after	0
menopause	I-DISEASE
.	0

Cluster	0
headaches	I-DISEASE
,	0
as	I-DISEASE
the	0
name	0
suggests	I-DISEASE
,	I-DISEASE
occur	I-DISEASE
in	0
clusters	0
and	0
are	0
accompanied	0
by	I-DISEASE
pain	0
-	I-DISEASE
free	I-DISEASE
intervals	0
lasting	0
months	0
to	0
a	0
couple	0
of	I-DISEASE
years	0
.	I-DISEASE

They	0
also	0
tend	0
to	0
decrease	0
with	I-DISEASE
age	0
.	0

Hypnic	0
headache	0
occurs	0
infrequently	0
.	0

Headaches	0
in	0
patients	0
with	I-DISEASE
brain	0
tumors	I-DISEASE
are	I-DISEASE
related	0
to	I-DISEASE
an	0
increase	I-DISEASE
in	0
intracranial	I-DISEASE
pressure	0
and	0
tend	0
to	0
improve	I-DISEASE
with	0
treatment	0
of	0
the	0
primary	0
lesion	0
and	0
a	0
decrease	0
in	I-DISEASE
intracranial	I-DISEASE
pres-	0
sure	I-DISEASE
.	0

Some	0
patients	0
with	I-DISEASE
OSA	0
report	0
improvement	0
of	0
the	0
headache	I-DISEASE
after	I-DISEASE
treatment	I-DISEASE
of	0
the	0
apnea	0
.	I-DISEASE

The	0
sleep	0
related	0
headaches	I-DISEASE
can	I-DISEASE
cause	I-DISEASE
sleep	0
disruption	0
and	I-DISEASE
insomnia	0
with	0
decreased	0
sleep	0
efficiency	0
.	0

Cluster	0
headaches	I-DISEASE
occurring	0
regularly	I-DISEASE
in	0
sleep	0
can	I-DISEASE
also	0
lead	I-DISEASE
to	0
tran-	0
sient	0
situational	0
insomnia	0
that	0
may	I-DISEASE
resolve	0
after	0
the	I-DISEASE
remission	0
or	0
the	0
treatment	0
of	I-DISEASE
the	B-DISEASE
cluster	0
headache	0
.	I-DISEASE

Depending	0
on	0
the	0
etiology	I-DISEASE
of	0
the	0
sleep	I-DISEASE
related	0
headache	I-DISEASE
(	I-DISEASE
e.g.	I-DISEASE
,	0
brain	0
tumor	0
)	I-DISEASE
,	0
other	0
complications	0
may	0
occur	0
.	0

Developmental	0
Issues	0
Not	0
applicable	0
or	0
known	0
.	0

Appendix	0
A	0
:	0
Sleep	0
Related	0
Medical	I-DISEASE
and	I-DISEASE
Neurological	I-DISEASE
Disorders	I-DISEASE
Pathology	0
and	0
Pathophysiology	I-DISEASE
Several	0
anatomic	0
areas	I-DISEASE
are	0
common	0
to	I-DISEASE
the	0
physiology	0
of	0
both	0
sleep	I-DISEASE
and	I-DISEASE
headaches	I-DISEASE
;	0
these	0
include	I-DISEASE
the	0
brainstem	I-DISEASE
and	I-DISEASE
diencephalon	0
,	0
specifically	0
the	I-DISEASE
ventrolateral	0
periaque-	I-DISEASE
ductal	0
gray	I-DISEASE
and	I-DISEASE
the	I-DISEASE
posterior	I-DISEASE
hypothalamus	0
.	0

From	0
a	0
neurochemical	0
perspective	I-DISEASE
,	0
ade-	0
nosine	I-DISEASE
,	0
melatonin	I-DISEASE
,	0
and	0
orexin	0
also	0
are	0
involved	I-DISEASE
in	0
both	0
the	0
regulation	0
of	0
sleep	0
and	0
the	0
evolution	0
of	I-DISEASE
headaches	0
.	0

Dysfunction	0
of	0
REM	0
sleep	0
and	0
arousal	I-DISEASE
mechanisms	I-DISEASE
are	I-DISEASE
common	I-DISEASE
to	0
many	0
headache	0
disorders	0
.	0

Data	0
from	0
transgenic	0
models	I-DISEASE
indicate	0
that	0
dis-	I-DISEASE
ruption	0
of	I-DISEASE
sleep	0
occurs	0
in	0
two	0
forms	0
of	I-DISEASE
familial	I-DISEASE
migraine	0
.	0

However	0
,	I-DISEASE
current	0
mechanis-	0
tic	0
explanations	0
of	0
the	0
relationship	I-DISEASE
between	0
sleep	0
and	0
headache	I-DISEASE
are	0
speculative	0
.	I-DISEASE

Objective	0
Findings	0
Polysomnographic	0
aspects	I-DISEASE
of	0
sleep	I-DISEASE
related	0
headaches	0
need	I-DISEASE
to	0
be	0
better	0
defined	0
.	I-DISEASE

Migraine	0
headache	0
is	0
reported	0
to	I-DISEASE
occur	0
in	0
association	0
with	0
REM	0
sleep	0
or	0
stage	0
N3	0
sleep	I-DISEASE
.	0

An	0
excess	0
of	0
stage	0
N3	0
sleep	0
also	I-DISEASE
has	I-DISEASE
been	I-DISEASE
reported	0
in	0
patients	0
with	0
migraine	0
.	I-DISEASE

However	0
,	0
large	0
controlled	0
studies	0
are	0
not	0
available	0
.	I-DISEASE

Fifty	0
percent	0
of	0
cluster	I-DISEASE
headaches	I-DISEASE
and	I-DISEASE
a	I-DISEASE
majority	0
of	I-DISEASE
chronic	0
paroxysmal	0
hemicrania	0
are	I-DISEASE
associated	0
with	I-DISEASE
REM	0
sleep	0
.	0

OSA	0
and	0
hypoxia	0
during	0
sleep	0
may	0
aggravate	I-DISEASE
other	0
sleep	I-DISEASE
related	0
headaches	0
or	0
may	0
be	0
an	I-DISEASE
independent	0
cause	I-DISEASE
of	I-DISEASE
headache	I-DISEASE
.	0

Hypnic	0
headache	0
occurs	0
during	I-DISEASE
sleep	0
,	I-DISEASE
with	I-DISEASE
recent	0
reports	I-DISEASE
of	0
headache	0
during	0
REM	0
sleep	0
and	I-DISEASE
uncommonly	I-DISEASE
during	0
stage	I-DISEASE
N3	0
sleep	I-DISEASE
.	0

Thus	0
,	0
the	0
majority	I-DISEASE
of	0
sleep	I-DISEASE
related	I-DISEASE
headaches	I-DISEASE
seem	I-DISEASE
to	0
have	0
some	0
relationship	0
with	0
REM	I-DISEASE
sleep	0
,	0
but	I-DISEASE
there	I-DISEASE
are	0
no	0
defining	I-DISEASE
or	0
pathognomonic	I-DISEASE
polysomnographic	I-DISEASE
aspects	0
of	0
indi-	I-DISEASE
vidual	0
headache	0
syndromes	0
.	0

Neuroimaging	0
studies	0
(	0
computed	0
tomography	0
or	0
magnetic	I-DISEASE
resonance	0
imaging	I-DISEASE
head	0
scans	0
or	I-DISEASE
angiography	0
)	0
may	I-DISEASE
be	I-DISEASE
performed	0
to	I-DISEASE
rule	0
out	0
structural	0
,	I-DISEASE
vascular	I-DISEASE
,	I-DISEASE
or	I-DISEASE
infectious	I-DISEASE
disease	0
processes	I-DISEASE
that	0
may	0
cause	0
headaches	0
.	0

Differential	0
Diagnosis	0
Sleep	0
related	0
headaches	0
are	I-DISEASE
a	I-DISEASE
heterogeneous	I-DISEASE
group	I-DISEASE
of	0
different	0
headache	0
entities	0
with	0
a	I-DISEASE
common	I-DISEASE
expression	0
of	I-DISEASE
occurrence	0
during	I-DISEASE
sleep	I-DISEASE
.	0

They	0
need	0
to	0
be	0
differentiated	0
from	0
other	0
headache	0
conditions	I-DISEASE
that	0
are	0
not	0
sleep	I-DISEASE
related	0
.	I-DISEASE

These	0
include	0
tension	I-DISEASE
-	0
type	0
head-	I-DISEASE
aches	I-DISEASE
and	0
headaches	I-DISEASE
associated	0
with	I-DISEASE
paranasal	I-DISEASE
sinus	0
inflammation	0
,	I-DISEASE
tooth	0
infection	0
,	I-DISEASE
ear	0
infection	0
,	I-DISEASE
febrile	0
illness	I-DISEASE
,	I-DISEASE
benign	I-DISEASE
intracranial	0
hypertension	I-DISEASE
,	I-DISEASE
intracranial	0
hypoten-	I-DISEASE
sion	I-DISEASE
,	I-DISEASE
vasculitis	0
,	0
head	0
trauma	0
,	0
alcohol	0
intoxication	0
,	0
or	0
bruxism	I-DISEASE
.	0

Although	0
the	0
initial	I-DISEASE
presentation	0
may	0
be	0
one	I-DISEASE
of	0
headache	I-DISEASE
,	I-DISEASE
detailed	0
history	0
and	0
examination	0
will	I-DISEASE
identify	I-DISEASE
one	0
of	I-DISEASE
these	0
contributing	0
conditions	0
.	0

Tension	0
-	0
type	0
headaches	I-DISEASE
are	I-DISEASE
bilateral	I-DISEASE
headaches	I-DISEASE
with	0
a	I-DISEASE
feeling	I-DISEASE
of	I-DISEASE
a	0
band	0
-	0
like	I-DISEASE
tighten-	0
ing	0
sensation	I-DISEASE
around	0
the	0
head	0
.	0

In	0
patients	0
older	I-DISEASE
than	0
50	0
years	0
,	I-DISEASE
giant	0
cell	I-DISEASE
arteritis	0
may	0
Appendix	0
A	0
:	0
Sleep	I-DISEASE
Related	0
Medical	0
and	I-DISEASE
Neurological	0
Disorders	0
present	0
with	0
lateralized	0
or	0
bilateral	I-DISEASE
headache	0
with	0
tenderness	I-DISEASE
over	0
the	0
temporal	0
area	I-DISEASE
,	0
accompanied	0
by	0
polymyalgia	0
rheumatica	0
and	I-DISEASE
visual	0
problems	I-DISEASE
,	0
including	0
loss	I-DISEASE
of	0
vision	0
.	0

Exploding	0
head	0
syndrome	I-DISEASE
is	I-DISEASE
in	0
the	0
differential	I-DISEASE
diagnosis	0
of	0
headache	I-DISEASE
because	0
it	0
may	0
occur	I-DISEASE
in	I-DISEASE
association	0
with	0
the	0
sleep	0
period	0
.	0

Patients	0
report	0
hearing	0
an	0
explosion	0
in	I-DISEASE
the	I-DISEASE
head	0
which	I-DISEASE
is	0
unaccompanied	0
by	0
pain	0
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE
Not	I-DISEASE
applicable	I-DISEASE
or	0
known	0
.	0

Bibliography	0
Brennan	0
KC	0
,	0
Charles	0
A.	0
Sleep	I-DISEASE
and	0
headache	I-DISEASE
.	0

Semin	0
Neurol	0
2009;29:406–17	0
.	0

Sleep	0
Related	0
Laryngospasm	0
Alternate	0
Names	0
Stridor	0
,	0
laryngeal	0
dysfunction	0
.	0

Essential	0
Features	0
Sleep	0
related	0
laryngospasm	I-DISEASE
is	0
a	I-DISEASE
disorder	0
in	I-DISEASE
which	0
tracheal	0
muscle	0
dysfunction	I-DISEASE
or	0
para-	I-DISEASE
tracheal	0
soft	0
-	I-DISEASE
tissue	0
swelling	0
causes	0
stridor	0
or	0
interruption	0
of	0
airflow	I-DISEASE
,	0
with	I-DISEASE
associated	0
awakening	0
from	0
sleep	I-DISEASE
.	0

Patients	0
may	0
have	B-DISEASE
total	B-DISEASE
or	0
near	0
-	0
total	0
cessation	I-DISEASE
of	0
airflow	0
while	0
asleep	I-DISEASE
,	0
and	0
suddenly	0
arouse	0
.	I-DISEASE

This	0
brief	0
respiratory	I-DISEASE
blockage	0
(	0
lasting	0
an	I-DISEASE
estimated	0
five	I-DISEASE
to	0
45	0
seconds	0
)	0
is	0
often	I-DISEASE
followed	I-DISEASE
by	I-DISEASE
a	0
period	0
of	0
stridor	0
that	0
lasts	0
several	0
minutes	I-DISEASE
and	0
gradually	I-DISEASE
evolves	I-DISEASE
to	0
normal	0
breathing	I-DISEASE
.	0

Episodes	0
are	0
associated	0
with	0
panic	0
and	0
fear	I-DISEASE
of	0
suffocation	I-DISEASE
;	0
cyanosis	0
may	0
be	0
observed	0
.	I-DISEASE

In	0
some	0
cases	0
of	B-DISEASE
laryngospasm	0
during	0
sleep	I-DISEASE
,	0
patients	I-DISEASE
may	0
have	0
frequent	I-DISEASE
laryngeal	0
stridor	I-DISEASE
(	I-DISEASE
which	0
may	0
be	0
difficult	0
for	0
families	0
to	0
dif-	0
ferentiate	0
from	I-DISEASE
snoring	I-DISEASE
)	0
,	I-DISEASE
associated	0
tachypnea	0
,	I-DISEASE
and	0
intermittent	0
upper	0
airway	0
blockage	0
.	0

Associated	0
Features	0
Fear	0
and	0
panic	0
upon	I-DISEASE
awakening	I-DISEASE
often	0
accompany	I-DISEASE
events	I-DISEASE
and	0
may	0
,	0
at	0
times	I-DISEASE
,	I-DISEASE
lead	0
to	I-DISEASE
insomnia	0
.	0

In	0
some	0
cases	0
of	B-DISEASE
sleep	0
related	I-DISEASE
laryngospasm	I-DISEASE
,	0
gastroesophageal	I-DISEASE
reflux	0
has	0
been	0
identified	0
.	0

Less	0
commonly	0
,	0
sleep	0
related	0
laryngospasm	I-DISEASE
has	0
been	0
related	0
to	0
underlying	0
OSA	0
.	0

Clinical	0
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Sleep	I-DISEASE
related	I-DISEASE
laryngospasm	I-DISEASE
may	I-DISEASE
be	I-DISEASE
associated	0
with	I-DISEASE
multisystem	I-DISEASE
atrophy	I-DISEASE
,	0
a	I-DISEASE
neurode-	0
generative	0
disorder	0
.	0

Appendix	0
A	0
:	0
Sleep	0
Related	0
Medical	I-DISEASE
and	I-DISEASE
Neurological	I-DISEASE
Disorders	I-DISEASE
Demographics	0
Prevalence	0
data	0
do	0
not	0
exist	0
.	0

Typical	0
age	0
of	0
onset	0
is	0
unknown	0
,	I-DISEASE
although	0
when	0
the	0
con-	0
dition	0
is	I-DISEASE
due	0
to	I-DISEASE
multisystem	I-DISEASE
atrophy	0
,	I-DISEASE
affected	0
individuals	0
are	0
typically	0
older	I-DISEASE
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
Sleep	0
related	I-DISEASE
laryngospasm	I-DISEASE
may	0
be	I-DISEASE
associated	0
with	0
gastroesophageal	0
reflux	I-DISEASE
.	I-DISEASE

Laryngeal	0
dysfunction	0
seen	0
in	0
other	0
disorders	0
,	0
including	0
laryngeal	0
tumors	0
and	0
multisystem	0
atrophy	0
,	0
may	0
cause	0
sleep	0
related	I-DISEASE
stridor	0
and	0
intermittent	0
laryngospasm	0
.	0

Precipitating	0
factors	0
include	0
use	0
of	0
hypnotic	0
or	I-DISEASE
other	0
central	I-DISEASE
nervous	0
system	0
depressant	I-DISEASE
medications	0
.	0

Tonic	0
-	0
clonic	0
seizures	0
may	0
be	0
a	0
rare	0
cause	I-DISEASE
of	0
sleep	0
related	0
laryngospasm	I-DISEASE
in	0
children	I-DISEASE
.	I-DISEASE

Familial	0
Patterns	0
Not	0
applicable	0
or	0
known	0
.	I-DISEASE

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
Laryngospasm	I-DISEASE
is	0
a	0
common	0
cause	0
of	0
death	0
in	0
multiple	0
system	0
atrophy	0
.	0

Developmental	0
Issues	0
Not	0
known	0
.	0

Pathology	0
and	0
Pathophysiology	0
When	0
not	0
associated	I-DISEASE
with	I-DISEASE
neurodegenerative	0
disorders	I-DISEASE
of	0
known	I-DISEASE
pathology	0
(	0
e.g.	0
,	I-DISEASE
mul-	0
tisystem	0
atrophy	0
)	0
,	0
the	0
pathology	0
and	0
pathophysiology	I-DISEASE
is	0
uncertain	0
.	0

Sleep	0
related	0
laryn-	I-DISEASE
gospasm	0
can	0
be	0
related	0
to	0
tracheal	0
muscle	0
dysfunction	0
,	0
postnasal	I-DISEASE
drip	0
,	I-DISEASE
or	0
reflux	0
of	0
gas-	0
troesophageal	0
contents	0
causing	0
irritation	0
of	0
soft	0
tissue	0
in	0
the	0
upper	0
airway	0
.	0

Laryngeal	0
tumors	0
and	0
multisystem	0
atrophy	0
can	0
cause	I-DISEASE
laryngeal	0
dysfunction	I-DISEASE
,	0
resulting	0
in	I-DISEASE
sleep	0
related	0
laryngospasm	0
.	I-DISEASE

Objective	0
Findings	0
Sleep	0
related	I-DISEASE
laryngospasm	0
may	I-DISEASE
be	I-DISEASE
observed	I-DISEASE
on	0
PSG	0
with	0
accompanying	0
audio	0
record-	0
ing	I-DISEASE
.	I-DISEASE

It	0
is	0
seen	0
in	0
all	0
stages	0
of	I-DISEASE
sleep	0
but	I-DISEASE
is	0
most	0
severe	0
in	0
REM	0
sleep	I-DISEASE
.	0

Laryngospasm	0
can	0
appear	0
to	0
be	0
similar	0
to	0
snoring	0
on	I-DISEASE
the	0
polysomnographic	0
snoring	0
channel	0
,	0
but	I-DISEASE
the	0
audio	I-DISEASE
recording	I-DISEASE
will	0
confirm	0
the	0
high	0
-	0
pitched	0
inspiratory	I-DISEASE
sound	I-DISEASE
as	0
laryngospasm	I-DISEASE
.	0

OSA	0
has	0
also	0
been	0
detected	0
in	0
some	0
cases	0
.	I-DISEASE

Patients	0
or	0
family	0
members	0
may	0
mistake	0
laryngospasm	0
for	0
snoring	0
or	0
sleep	0
apnea	0
.	0

PSG	0
evaluation	0
may	0
be	B-DISEASE
necessary	0
to	I-DISEASE
distin-	0
guish	0
these	I-DISEASE
disorders	I-DISEASE
.	0

In	0
children	0
,	I-DISEASE
PSG	0
or	0
sleep	0
-	0
deprived	I-DISEASE
EEG	I-DISEASE
may	0
demonstrate	0
sei-	0
zures	0
that	0
manifest	I-DISEASE
solely	0
as	0
nocturnal	I-DISEASE
laryngospasm	0
.	0

Endoscopy	0
of	0
the	0
upper	I-DISEASE
airway	0
is	I-DISEASE
necessary	0
to	0
examine	I-DISEASE
vocal	0
cord	0
function	0
and	0
to	0
exclude	I-DISEASE
upper	0
airway	0
pathology	I-DISEASE
.	0

Gastroesophageal	0
studies	0
may	0
reveal	0
evidence	I-DISEASE
of	0
reflux	0
.	0

Appendix	0
A	0
:	0
Sleep	0
Related	0
Medical	I-DISEASE
and	I-DISEASE
Neurological	I-DISEASE
Disorders	I-DISEASE
Differential	0
Diagnosis	0
OSA	0
may	0
cause	0
awakenings	I-DISEASE
,	0
with	0
choking	I-DISEASE
or	0
gasping	0
for	0
air	0
,	I-DISEASE
excessive	I-DISEASE
daytime	I-DISEASE
som-	0
nolence	I-DISEASE
,	I-DISEASE
restlessness	0
,	I-DISEASE
or	0
insomnia	0
.	0

If	0
OSA	0
is	0
a	0
diagnostic	0
consideration	0
,	0
sleep	0
study	I-DISEASE
is	0
warranted	0
.	0

Sleep	0
related	0
gastroesophageal	I-DISEASE
reflux	0
may	0
result	0
in	I-DISEASE
coughing	0
or	I-DISEASE
choking	0
episodes	0
during	0
the	0
night	0
without	0
true	I-DISEASE
laryngospasm	0
.	I-DISEASE

However	0
,	I-DISEASE
these	0
episodes	0
usually	0
are	0
described	I-DISEASE
in	0
the	0
setting	I-DISEASE
of	0
chest	0
pain	0
or	0
“	0
heartburn	0
.	0
”	0

One	0
possible	I-DISEASE
cause	0
of	I-DISEASE
sleep	0
related	I-DISEASE
laryngospasm	I-DISEASE
may	0
be	I-DISEASE
occult	0
acid	0
reflux	0
into	0
the	0
upper	I-DISEASE
airway	0
,	0
causing	I-DISEASE
irritation	0
or	0
swelling	0
.	0

Sleep	0
terrors	0
may	0
be	I-DISEASE
associated	0
with	0
sensations	0
of	0
impaired	0
breathing	0
or	0
choking	0
,	0
rapid	0
heartbeat	I-DISEASE
,	I-DISEASE
and	0
agitation	I-DISEASE
.	0

However	0
,	I-DISEASE
sleep	0
terrors	I-DISEASE
are	0
most	I-DISEASE
common	I-DISEASE
in	0
children	0
,	0
and	I-DISEASE
most	0
patients	0
do	0
not	I-DISEASE
focus	0
on	I-DISEASE
upper	0
airway	0
choking	0
.	0

Panic	0
disorder	0
can	0
involve	0
abrupt	0
awakening	0
with	I-DISEASE
respiratory	0
distress	I-DISEASE
,	0
signs	0
of	0
sympathetic	0
activity	0
,	0
and	0
fear	0
of	I-DISEASE
dying	0
.	0

However	0
,	I-DISEASE
most	0
patients	0
also	0
have	0
daytime	0
episodes	0
of	I-DISEASE
panic	0
.	0

Nocturnal	0
asthma	0
can	0
result	0
in	0
sleep	0
related	0
coughing	0
,	0
wheezing	0
,	I-DISEASE
or	0
shortness	0
of	0
breath	0
.	0

REM	0
sleep	0
behavior	0
disorder	I-DISEASE
(	0
RBD	I-DISEASE
)	I-DISEASE
may	0
be	0
in	I-DISEASE
the	0
differential	I-DISEASE
diagnosis	0
of	I-DISEASE
laryngospasm	I-DISEASE
,	0
but	0
is	I-DISEASE
generally	0
recognizable	0
by	0
polysomnographic	0
features	0
of	0
RBD	I-DISEASE
and	I-DISEASE
a	0
history	I-DISEASE
of	0
dream	I-DISEASE
enactment	0
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE
Published	I-DISEASE
reports	I-DISEASE
generally	0
have	0
been	0
limited	0
to	0
case	I-DISEASE
series	0
.	0

Clarification	0
of	I-DISEASE
the	0
rela-	0
tionship	0
between	I-DISEASE
laryngospasm	0
,	0
sleep	I-DISEASE
related	0
breathing	0
disorders	0
,	0
and	0
gastroesopha-	I-DISEASE
geal	0
reflux	0
is	0
needed	0
.	I-DISEASE

Bibliography	0
Aloe	0
F	0
,	0
Thorpy	0
M.	0
Sleep	0
-	0
related	I-DISEASE
laryngospasm	0
.	0

Arq	0
Neuropsiquiatr	0
1995;53:46–52	0
.	I-DISEASE

Campbell	0
A	0
,	0
Pierce	0
R.	0
Brief	I-DISEASE
upper	0
airway	0
dysfunction	0
.	0

Respir	0
Med	0
1994;88:125–9	0
.	B-DISEASE

Guilleminault	0
C	0
,	I-DISEASE
Eldridge	0
F	0
,	0
Phillips	I-DISEASE
J	0
,	I-DISEASE
Dement	0
W.	0
Two	0
occult	0
causes	0
of	I-DISEASE
insomnia	0
and	0
their	I-DISEASE
therapeutic	0
problems	0
.	0

Arch	0
Gen	0
Psychiatry	0
1976;33:1241–5	0
.	0

Iriarte	0
J	0
,	0
Urrestarazu	0
E	0
,	0
Alegre	I-DISEASE
M	0
,	I-DISEASE
Goni	0
C	0
,	0
Viteri	0
C	0
,	I-DISEASE
Artieda	0
J.	0
Sleep	I-DISEASE
-	0
related	0
laryngospasm	I-DISEASE
:	0
A	0
video	I-DISEASE
polysomnographic	I-DISEASE
recording	I-DISEASE
.	0

Epileptic	0
Disord	0
2006;8:70–2	0
.	0

Kavey	0
N	0
,	0
Whyte	0
J	0
,	0
Blitzer	I-DISEASE
A	0
,	I-DISEASE
Gidro	0
-	0
Frank	0
S.	0
Sleep	0
-	I-DISEASE
related	0
laryngeal	0
obstruction	I-DISEASE
presenting	0
as	0
snoring	0
or	0
sleep	I-DISEASE
apnea	I-DISEASE
.	0

Laryngoscope	0
1989;99:851–4	0
.	0

Roland	0
MM	0
,	0
Baran	I-DISEASE
AS	0
,	I-DISEASE
Richert	0
AC	0
.	I-DISEASE

Sleep	0
related	0
laryngospasm	I-DISEASE
caused	0
by	0
gastroesophageal	0
reflux	0
.	0

Sleep	0
Med	0
2008;9:451–3	I-DISEASE
.	0

Thorpy	0
M	0
,	0
Aloe	0
F.	0
Choking	0
during	I-DISEASE
sleep	0
.	0

Sleep	0
Res	0
1989;18:314	I-DISEASE
.	B-DISEASE

Thorpy	0
M	0
,	0
Aloe	0
F.	0
Sleep	0
related	I-DISEASE
laryngospasm	0
.	0

Sleep	0
Res	0
1989;18:313	0
.	B-DISEASE

Thurnheer	0
R	0
,	0
Henz	0
S	0
,	0
Knoblauch	I-DISEASE
A.	0
Sleep	0
-	0
related	0
laryngospasm	0
.	0

Eur	0
Respir	0
J	0
1997;10:2084–6	I-DISEASE
.	0

Appendix	0
A	0
:	0
Sleep	0
Related	0
Medical	I-DISEASE
and	I-DISEASE
Neurological	I-DISEASE
Disorders	I-DISEASE
Sleep	0
Related	0
Gastroesophageal	0
Reflux	0
Alternative	0
Names	0
Gastroesophageal	0
reflux	0
,	I-DISEASE
nocturnal	0
gastroesophageal	I-DISEASE
reflux	0
,	0
supine	0
gastroesophageal	0
reflux	I-DISEASE
,	0
nocturnal	0
heartburn	I-DISEASE
,	0
reflux	0
esophagitis	0
,	0
esophagitis	0
,	0
heartburn	0
.	I-DISEASE

Essential	0
Features	0
Sleep	0
related	0
gastroesophageal	I-DISEASE
reflux	0
(	I-DISEASE
GER	0
)	I-DISEASE
occurs	0
when	0
gastric	0
contents	0
cross	0
the	I-DISEASE
lower	0
esophageal	0
sphincter	I-DISEASE
(	0
LES	0
)	0
into	0
the	0
esophagus	0
and	I-DISEASE
,	0
potentially	0
,	I-DISEASE
into	0
more	0
prox-	0
imal	0
sites	0
during	0
sleep	0
time	I-DISEASE
.	0

Symptoms	0
are	0
usually	0
noticed	0
during	0
arousals	0
or	0
awak-	0
enings	I-DISEASE
.	0

Symptoms	0
may	0
include	0
heartburn	0
,	0
substernal	I-DISEASE
burning	I-DISEASE
,	0
chest	I-DISEASE
discomfort	0
,	0
a	0
sour	I-DISEASE
or	0
bitter	I-DISEASE
taste	I-DISEASE
in	0
the	I-DISEASE
mouth	0
,	0
regurgitation	0
,	0
water	0
brash	0
,	I-DISEASE
coughing	0
,	0
choking	I-DISEASE
,	0
or	0
unex-	0
plained	0
excessive	0
daytime	0
sleepiness	0
,	0
even	I-DISEASE
in	I-DISEASE
the	0
absence	0
of	0
typical	0
reflux	0
symptoms	0
.	I-DISEASE

Sleep	0
related	I-DISEASE
GER	I-DISEASE
is	B-DISEASE
associated	0
with	0
sleep	I-DISEASE
onset	0
and	I-DISEASE
sleep	0
maintenance	0
insomnia	I-DISEASE
,	0
early	0
morning	I-DISEASE
awakenings	I-DISEASE
,	0
sleep	I-DISEASE
disturbances	I-DISEASE
,	0
arousals	0
,	0
unrefreshing	0
sleep	I-DISEASE
,	I-DISEASE
daytime	I-DISEASE
functioning	0
difficulties	I-DISEASE
,	0
and	0
excessive	0
daytime	0
sleepiness	0
.	0

GER	0
is	0
a	0
potential	0
asthma	0
trigger	I-DISEASE
,	I-DISEASE
predisposes	0
to	0
aspiration	0
,	0
and	0
is	0
a	0
cause	I-DISEASE
of	0
cough	0
.	0

GER	0
commonly	0
coexists	0
in	0
patients	0
with	I-DISEASE
chronic	I-DISEASE
obstructive	0
pulmonary	I-DISEASE
disease	0
,	0
cystic	0
fibrosis	0
,	0
idiopathic	I-DISEASE
pulmo-	I-DISEASE
nary	0
fibrosis	I-DISEASE
,	0
and	0
bronchiolitis	0
obliterans	0
syndrome	0
in	I-DISEASE
lung	I-DISEASE
transplant	0
recipients	0
.	0

Sleep	0
related	0
GER	I-DISEASE
is	0
associated	0
with	0
sleep	0
related	0
laryngospasm	I-DISEASE
and	I-DISEASE
is	0
prevalent	0
in	0
patients	0
with	0
OSA	0
.	0

Associated	0
Features	0
Associated	0
features	I-DISEASE
of	0
this	I-DISEASE
disorder	0
include	0
dysphagia	I-DISEASE
,	0
odynophagia	0
,	0
laryngopharyn-	0
gitis	0
,	I-DISEASE
laryngospasm	0
,	0
epigastric	I-DISEASE
burning	0
,	0
chronic	0
cough	0
,	0
wheezing	0
,	I-DISEASE
or	I-DISEASE
chest	0
pain	0
that	0
may	0
mimic	I-DISEASE
angina	0
.	0

Other	0
associated	0
features	0
of	0
sleep	0
related	I-DISEASE
GER	I-DISEASE
include	0
sleep	0
onset	0
and	0
sleep	0
maintenance	0
insomnia	0
,	I-DISEASE
excessive	0
daytime	0
sleepiness	I-DISEASE
,	0
daytime	I-DISEASE
fatigue	0
,	I-DISEASE
poor	0
daytime	0
functioning	0
,	0
and	0
reduced	0
work	0
productivity	I-DISEASE
.	0

Patients	0
with	0
sleep	0
related	0
GER	0
also	I-DISEASE
have	I-DISEASE
a	0
decrease	I-DISEASE
in	0
health	0
-	0
related	0
quality	0
of	I-DISEASE
life	I-DISEASE
and	0
more	I-DISEASE
health	0
care	0
visits	0
.	0

Clinical	0
and	0
Pathological	0
Subtypes	0
Not	0
applicable	0
or	0
known	0
.	I-DISEASE

Demographics	0
GER	0
symptoms	0
affect	0
up	0
to	0
44	0
%	0
of	0
adults	0
in	0
the	0
United	0
States	0
monthly	I-DISEASE
,	0
and	I-DISEASE
20	0
%	0
weekly	I-DISEASE
.	0

Among	0
patients	0
with	I-DISEASE
weekly	0
heartburn	I-DISEASE
,	0
79	I-DISEASE
%	0
report	I-DISEASE
GER	0
symptoms	0
during	0
sleep	0
time	0
,	I-DISEASE
57	I-DISEASE
%	0
report	I-DISEASE
waking	0
up	0
during	0
sleep	0
,	0
and	I-DISEASE
40	I-DISEASE
%	0
report	I-DISEASE
that	I-DISEASE
GER	0
during	0
sleep	I-DISEASE
time	0
affected	0
their	0
ability	0
to	0
work	0
the	0
next	I-DISEASE
day	0
.	I-DISEASE

Among	0
the	0
15,315	0
subjects	0
of	0
the	I-DISEASE
Sleep	I-DISEASE
Heart	0
Health	I-DISEASE
Study	0
,	0
25	0
%	0
reported	0
heartburn	0
during	0
sleep	0
.	0

In	0
a	0
review	0
of	0
5	0
large	0
Appendix	0
A	0
:	I-DISEASE
Sleep	0
Related	0
Medical	0
and	0
Neurological	0
Disorders	I-DISEASE
population	0
studies	0
,	I-DISEASE
the	0
mean	0
prevalence	0
of	0
heartburn	0
during	0
sleep	I-DISEASE
time	0
was	0
54	I-DISEASE
%	0
±	I-DISEASE
22	0
%	0
(	0
standard	0
deviation	0
)	0
.	0

In	0
patients	0
with	0
OSA	0
,	0
sleep	I-DISEASE
related	I-DISEASE
reflux	0
symptoms	I-DISEASE
are	0
present	0
in	0
up	0
to	0
62	0
%	0
.	0

Furthermore	0
,	0
in	0
a	0
trial	0
examining	0
consecutive	0
asthmatics	I-DISEASE
,	I-DISEASE
50	0
%	0
had	0
awakenings	0
from	0
sleep	0
because	I-DISEASE
of	0
heartburn	I-DISEASE
.	0

Thus	0
,	0
GER	0
symptoms	B-DISEASE
during	0
sleep	0
time	I-DISEASE
are	I-DISEASE
common	I-DISEASE
.	0

There	0
is	0
no	0
known	I-DISEASE
predilection	0
for	I-DISEASE
men	I-DISEASE
or	0
women	0
.	0

However	0
,	I-DISEASE
men	0
are	0
more	0
likely	0
than	I-DISEASE
women	0
to	I-DISEASE
develop	0
Barrett	0
esophagus	0
.	0

Predisposing	0
and	0
Precipitating	0
Factors	I-DISEASE
Predisposing	0
factors	I-DISEASE
for	I-DISEASE
sleep	0
related	I-DISEASE
GER	0
include	0
eating	I-DISEASE
within	I-DISEASE
two	0
hours	I-DISEASE
of	0
bedtime	0
,	I-DISEASE
an	I-DISEASE
elevated	I-DISEASE
body	0
mass	0
index	I-DISEASE
,	I-DISEASE
erosive	I-DISEASE
esophagitis	I-DISEASE
,	I-DISEASE
and	I-DISEASE
hiatal	0
hernia	I-DISEASE
.	I-DISEASE

Predictors	0
of	0
heart-	0
burn	0
during	0
sleep	0
include	I-DISEASE
consumption	0
of	I-DISEASE
alcohol	0
or	0
carbonated	I-DISEASE
beverages	0
,	0
or	0
the	I-DISEASE
use	I-DISEASE
of	I-DISEASE
benzodiazepines	0
before	0
sleep	0
time	0
.	0

Other	0
predictors	0
of	0
heartburn	0
during	0
sleep	0
include	0
the	0
presence	I-DISEASE
of	0
insomnia	0
,	0
hypertension	0
,	0
asthma	I-DISEASE
,	0
snoring	0
,	I-DISEASE
or	0
daytime	I-DISEASE
sleepiness	0
.	0

The	0
relationship	0
between	0
GER	0
and	0
sleep	0
disturbance	I-DISEASE
is	I-DISEASE
bidirectional	0
.	0

Sleep	0
related	0
GER	I-DISEASE
is	0
associated	0
with	0
short	0
sleep	0
duration	I-DISEASE
,	0
difficulty	0
falling	0
asleep	I-DISEASE
,	0
arousals	I-DISEASE
,	0
poor	0
sleep	I-DISEASE
quality	0
,	0
and	0
early	0
morning	0
awakenings	0
.	I-DISEASE

Conversely	0
,	0
sleep	0
deprivation	I-DISEASE
induces	0
a	I-DISEASE
state	I-DISEASE
of	0
esophageal	I-DISEASE
hyperalgesia	0
to	0
acid	0
,	I-DISEASE
thus	0
worsening	I-DISEASE
heartburn	0
symptoms	0
.	I-DISEASE

Familial	0
Patterns	0
Not	0
applicable	0
or	0
known	0
.	I-DISEASE

Onset	0
,	0
Course	0
,	0
and	0
Complications	0
GER	I-DISEASE
occurs	0
in	0
all	0
age	0
groups	0
,	0
including	0
infants	0
and	0
children	0
.	I-DISEASE

Sleep	0
disruption	0
occurs	0
more	0
frequently	0
in	0
infants	0
and	0
children	I-DISEASE
with	0
GER	0
,	0
compared	0
to	0
infants	I-DISEASE
and	0
children	0
without	I-DISEASE
GER	I-DISEASE
.	I-DISEASE

The	0
incidence	0
of	0
GER	0
increases	0
with	0
age	I-DISEASE
.	0

GER	0
may	0
be	0
more	0
severe	I-DISEASE
and	0
is	I-DISEASE
associated	0
with	I-DISEASE
more	0
complications	0
in	0
older	0
adults	0
.	0

GER	0
is	0
a	0
chronic	0
disease	0
which	0
is	I-DISEASE
rarely	I-DISEASE
cured	I-DISEASE
,	0
but	0
it	0
may	0
be	0
controlled	I-DISEASE
with	I-DISEASE
lifestyle	0
,	0
and	0
medical	0
and/or	0
surgical	0
therapies	0
.	0

In	0
patients	0
with	I-DISEASE
sleep	0
related	I-DISEASE
GER	I-DISEASE
,	I-DISEASE
medical	0
GER	I-DISEASE
therapy	0
improved	0
sleep	0
disturbances	0
and	0
daytime	I-DISEASE
functioning	0
in	I-DISEASE
placebo	I-DISEASE
-	0
con-	I-DISEASE
trolled	0
trials	0
.	0

Long	0
-	0
term	0
outcome	0
data	0
are	0
currently	I-DISEASE
lacking	0
.	I-DISEASE

If	0
GER	0
is	0
left	0
untreated	0
,	I-DISEASE
the	0
disease	0
generally	I-DISEASE
progresses	0
and	0
can	0
be	I-DISEASE
associated	0
with	I-DISEASE
many	0
complications	0
.	0

Esophageal	0
complications	I-DISEASE
include	0
esophagitis	I-DISEASE
,	0
esophageal	0
erosions	I-DISEASE
,	0
esophageal	I-DISEASE
stric-	I-DISEASE
ture	0
,	0
ulcerations	0
with	0
stricture	I-DISEASE
,	I-DISEASE
and	0
Barrett	I-DISEASE
esophagus	I-DISEASE
,	I-DISEASE
which	0
is	0
thought	I-DISEASE
to	0
be	I-DISEASE
a	0
precur-	0
sor	I-DISEASE
to	0
esophageal	I-DISEASE
adenocarcinoma	0
.	I-DISEASE

Reflux	0
can	0
also	0
result	0
in	0
dysphagia	0
,	0
weight	0
loss	0
,	0
and	0
upper	0
gastrointestinal	0
bleeding	0
.	I-DISEASE

Sleep	0
related	I-DISEASE
GER	I-DISEASE
is	B-DISEASE
more	0
commonly	0
associated	0
with	0
erosive	I-DISEASE
esophagitis	0
,	0
stricture	0
,	I-DISEASE
Barrett	0
esophagitis	I-DISEASE
,	0
and	0
esophageal	I-DISEASE
adenocarci-	0
noma	I-DISEASE
,	0
compared	0
to	0
diurnal	0
reflux	I-DISEASE
.	0

Extraesophageal	0
complications	0
include	0
pulmonary	I-DISEASE
complications	0
previously	0
discussed	0
in	0
the	I-DISEASE
Essential	0
Features	0
section	0
.	0

Appendix	0
A	0
:	0
Sleep	0
Related	0
Medical	I-DISEASE
and	I-DISEASE
Neurological	I-DISEASE
Disorders	I-DISEASE
Pathology	0
and	0
Pathophysiology	0
Two	0
major	0
pathophysiologic	I-DISEASE
mechanisms	0
cause	0
individual	I-DISEASE
reflux	0
episodes	0
.	0

Transient	0
LES	0
relaxations	0
(	I-DISEASE
LES	0
relaxations	0
occurring	I-DISEASE
without	I-DISEASE
esophageal	I-DISEASE
contractions	0
)	0
account	0
for	0
53	I-DISEASE
%	I-DISEASE
to	I-DISEASE
74	0
%	I-DISEASE
of	0
GER	I-DISEASE
episodes	I-DISEASE
.	0

Transient	0
LES	0
relaxations	0
decrease	I-DISEASE
the	0
LES	0
pres-	I-DISEASE
sure	0
to	I-DISEASE
the	I-DISEASE
gastric	0
pressure	0
gradient	0
,	0
facilitating	0
the	0
retrograde	I-DISEASE
flow	0
of	0
gastric	I-DISEASE
contents	0
.	0

An	0
LES	0
pressure	I-DISEASE
of	0
10	I-DISEASE
mm	I-DISEASE
Hg	I-DISEASE
or	I-DISEASE
less	0
is	0
the	0
second	0
mechanism	I-DISEASE
by	I-DISEASE
which	I-DISEASE
intra	I-DISEASE
-	0
abdom-	I-DISEASE
inal	0
pressure	0
overcomes	0
the	0
LES	0
pressure	0
,	I-DISEASE
resulting	0
in	0
the	I-DISEASE
retrograde	0
flow	I-DISEASE
of	I-DISEASE
gastric	I-DISEASE
contents	0
into	0
the	0
esophagus	0
.	0

Pathophysiology	0
of	0
sleep	I-DISEASE
related	I-DISEASE
GER	0
is	I-DISEASE
similar	I-DISEASE
to	I-DISEASE
diurnal	I-DISEASE
GER	0
(	0
i.e.	0
,	0
transient	0
LES	0
relaxations	0
and	0
a	I-DISEASE
low	0
LES	I-DISEASE
pressure	0
)	0
.	0

However	0
,	I-DISEASE
sleep	0
impacts	I-DISEASE
esophageal	I-DISEASE
physiology	0
through	I-DISEASE
the	0
impairment	I-DISEASE
of	0
esophageal	0
acid	I-DISEASE
clearance	I-DISEASE
mechanisms	0
when	I-DISEASE
GER	0
events	0
occur	I-DISEASE
.	0

With	0
sleep	0
onset	I-DISEASE
,	0
the	0
upper	I-DISEASE
esophageal	0
sphincter	0
(	I-DISEASE
UES	0
)	0
pressure	0
decreases	0
and	0
is	I-DISEASE
lowest	I-DISEASE
during	0
N3	I-DISEASE
sleep	0
,	I-DISEASE
thus	0
predisposing	0
to	0
aspiration	I-DISEASE
.	I-DISEASE

The	0
UES	0
contractile	0
reflex	0
remains	0
intact	0
during	0
sleep	0
,	I-DISEASE
including	0
REM	0
sleep	0
.	0

Lower	0
esophageal	0
sphincter	0
(	I-DISEASE
LES	0
)	0
pressure	0
remains	0
unchanged	I-DISEASE
during	0
sleep	0
.	0

Sleep	0
increases	0
the	I-DISEASE
vagal	I-DISEASE
threshold	0
for	I-DISEASE
trig-	0
gering	0
transient	0
LES	0
relaxations	0
,	0
so	I-DISEASE
they	I-DISEASE
usually	I-DISEASE
do	0
not	I-DISEASE
occur	I-DISEASE
during	0
stable	0
sleep	0
and	0
are	0
usually	0
confined	0
to	0
arousals	0
.	I-DISEASE

When	0
GER	0
events	0
occur	0
during	0
sleep	0
,	I-DISEASE
esophageal	I-DISEASE
refluxate	I-DISEASE
clearance	0
is	I-DISEASE
prolonged	0
and	0
an	0
arousal	I-DISEASE
is	0
required	0
.	0

Sleep	0
facilitates	0
proxi-	I-DISEASE
mal	I-DISEASE
refluxate	0
migration	0
toward	I-DISEASE
the	0
UES	I-DISEASE
.	0

Saliva	0
secretion	0
,	0
with	0
its	0
acid	0
-	0
neutralizing	0
bicarbonate	I-DISEASE
,	0
ceases	0
during	0
sleep	0
.	0

Swallowing	0
,	0
required	0
for	I-DISEASE
esophageal	0
peristalsis	0
and	0
refluxate	0
clearance	I-DISEASE
,	0
does	0
not	0
occur	I-DISEASE
during	0
sleep	I-DISEASE
and	I-DISEASE
is	0
dependent	I-DISEASE
on	0
an	0
arousal	0
.	0

Sleep	0
also	0
delays	0
gastric	I-DISEASE
emptying	0
by	0
disrupting	0
gastromyoelectric	0
function	I-DISEASE
.	I-DISEASE

Events	0
causing	0
arousals	0
,	I-DISEASE
including	0
periodic	0
limb	I-DISEASE
movements	0
and	I-DISEASE
apneas	0
,	0
could	0
trigger	I-DISEASE
transient	0
LES	I-DISEASE
relaxations	0
and	0
thus	I-DISEASE
GER	0
events	0
.	0

Because	0
refluxate	0
clearance	0
requires	0
an	0
arousal	0
,	I-DISEASE
medications	I-DISEASE
decreasing	I-DISEASE
the	0
arousal	0
response	0
(	0
including	I-DISEASE
benzodiazepines	I-DISEASE
and	0
zolp-	0
idem	I-DISEASE
)	0
may	0
prolong	0
refluxate	0
clearance	0
and	0
increase	I-DISEASE
the	0
risk	0
of	I-DISEASE
aspiration	0
during	0
sleep	0
.	I-DISEASE

The	0
pathology	0
of	0
GER	0
includes	0
abnormal	I-DISEASE
esophageal	0
manometry	0
,	I-DISEASE
endoscopy	0
,	I-DISEASE
and	0
esophageal	0
biopsy	0
findings	I-DISEASE
.	I-DISEASE

Esophageal	0
manometry	I-DISEASE
findings	0
include	I-DISEASE
an	0
increased	0
frequency	I-DISEASE
of	0
transient	I-DISEASE
LES	0
relaxations	0
,	I-DISEASE
altered	I-DISEASE
or	0
decreased	I-DISEASE
esophageal	I-DISEASE
peristaltic	0
contraction	I-DISEASE
amplitude	0
,	0
and	0
a	0
decrease	I-DISEASE
in	0
LES	I-DISEASE
pressure	0
.	I-DISEASE

Endoscopic	0
findings	0
include	0
changes	0
ranging	0
from	I-DISEASE
mild	I-DISEASE
erythema	0
,	I-DISEASE
erosions	0
,	0
and	0
ulcerations	0
to	0
severe	I-DISEASE
erosions	I-DISEASE
with	I-DISEASE
stricture	I-DISEASE
.	0

Barrett	0
esophagus	0
is	0
identified	I-DISEASE
when	0
columnar	0
tissue	I-DISEASE
replaces	0
the	I-DISEASE
normal	0
squamous	0
epithelium	0
of	0
the	I-DISEASE
distal	I-DISEASE
esophagus	0
.	0

Objective	0
Findings	0
Diagnostic	0
testing	0
is	0
not	I-DISEASE
required	I-DISEASE
for	0
sleep	I-DISEASE
related	0
GER	0
.	0

The	0
diagnosis	0
can	0
be	0
made	0
if	0
typical	0
symptoms	0
of	0
heartburn	0
and/or	0
regurgitation	0
are	0
present	0
during	0
sleep	0
time	0
.	0

Appendix	0
A	0
:	0
Sleep	0
Related	0
Medical	I-DISEASE
and	0
Neurological	0
Disorders	I-DISEASE
PSG	0
is	0
not	0
indicated	0
.	0

Esophageal	0
pH	0
monitoring	0
,	0
which	0
may	0
be	0
combined	0
with	I-DISEASE
esophageal	0
impedance	0
,	0
objectively	0
measures	0
individual	0
GER	I-DISEASE
events	0
.	I-DISEASE

Esophageal	0
monitoring	0
is	0
recommended	0
in	0
difficult	0
,	I-DISEASE
refractory	0
cases	0
,	0
or	0
when	0
symptoms	0
continue	0
despite	I-DISEASE
therapy	0
.	0

Sleep	0
related	0
GER	I-DISEASE
is	0
more	0
likely	0
to	0
occur	0
during	I-DISEASE
the	0
first	0
two	0
hours	0
of	0
sleep	I-DISEASE
time	0
.	I-DISEASE

Furthermore	0
,	0
in	0
studies	0
using	0
combined	0
esophageal	0
pH	0
monitoring	I-DISEASE
with	0
actigraphy	0
,	0
acid	0
reflux	0
events	I-DISEASE
occurred	I-DISEASE
primarily	0
during	I-DISEASE
the	I-DISEASE
recumbent	0
-	0
awake	0
period	0
,	I-DISEASE
versus	0
the	0
recumbent	I-DISEASE
-	0
asleep	0
period	I-DISEASE
.	0

Reflux	0
events	0
are	0
more	0
likely	0
to	0
occur	0
in	0
the	I-DISEASE
right	0
side	0
down	I-DISEASE
and	I-DISEASE
supine	0
positions	I-DISEASE
than	I-DISEASE
in	0
the	I-DISEASE
left	0
side	0
down	0
position	0
.	I-DISEASE

PSG	0
without	0
esophageal	0
pH	I-DISEASE
or	0
impedance	I-DISEASE
monitoring	0
reveals	0
arousals	0
that	0
are	I-DISEASE
often	0
associated	0
with	0
swallows	I-DISEASE
and	0
a	I-DISEASE
notable	I-DISEASE
increase	0
in	0
chin	0
EMG	0
tone	0
.	0

Esophageal	0
pH	0
monitoring	0
detects	0
acid	0
reflux	0
events	0
and	0
can	I-DISEASE
be	0
integrated	0
with	0
PSG	0
.	0

Esophageal	0
pH	0
monitoring	0
should	0
be	0
performed	0
over	0
a	0
24	I-DISEASE
-	I-DISEASE
hour	0
period	0
to	0
improve	I-DISEASE
the	I-DISEASE
test	I-DISEASE
’s	0
sensitiv-	I-DISEASE
ity	0
and	I-DISEASE
specificity	0
,	0
which	0
approximate	0
90	I-DISEASE
%	0
.	0

The	0
distal	0
pH	0
probe	0
is	0
placed	I-DISEASE
5	I-DISEASE
cm	0
above	I-DISEASE
the	0
LES	0
.	I-DISEASE

A	0
proximal	0
pH	0
probe	0
is	0
often	I-DISEASE
placed	I-DISEASE
near	0
the	I-DISEASE
UES	0
.	0

An	0
acid	0
reflux	I-DISEASE
event	0
is	0
defined	0
when	I-DISEASE
the	0
pH	I-DISEASE
drops	0
to	I-DISEASE
less	0
than	I-DISEASE
4.0	0
,	0
and	0
this	0
variable	0
is	I-DISEASE
reported	0
as	0
time	0
(	0
%	0
)	0
where	0
pH	0
is	I-DISEASE
less	0
than	I-DISEASE
4.0	I-DISEASE
.	0

The	0
percent	0
time	0
where	0
pH	0
is	0
less	I-DISEASE
than	0
4	I-DISEASE
is	0
reported	0
over	0
the	I-DISEASE
total	I-DISEASE
recording	I-DISEASE
time	I-DISEASE
,	0
upright	I-DISEASE
time	0
and	0
supine	0
time	0
.	0

Note	0
that	0
supine	0
(	0
in	0
this	I-DISEASE
testing	0
)	0
is	0
defined	I-DISEASE
as	0
the	0
period	0
of	0
time	0
that	0
the	0
patient	I-DISEASE
is	I-DISEASE
in	0
bed	0
.	0

Symptom	0
correlation	0
is	0
also	0
helpful	0
using	0
the	I-DISEASE
event	0
marker	I-DISEASE
on	0
the	0
device	0
or	0
diaries	0
.	I-DISEASE

Normal	0
esophageal	0
pH	0
times	I-DISEASE
during	0
the	0
“	I-DISEASE
supine	0
”	I-DISEASE
or	I-DISEASE
sleep	0
period	0
are	I-DISEASE
:	0
1	I-DISEASE
)	I-DISEASE
distal	0
pH	I-DISEASE
<	0
4	0
-	0
less	0
than	0
3.5	0
%	I-DISEASE
of	0
the	I-DISEASE
time	I-DISEASE
;	0
and	0
2	0
)	0
proximal	0
pH	0
<	I-DISEASE
4	0
-	0
less	I-DISEASE
than	0
0.6	I-DISEASE
%	0
of	0
the	0
time	0
.	0

If	0
esophageal	0
pH	0
monitoring	I-DISEASE
is	0
integrated	0
with	I-DISEASE
polysomnography	0
,	I-DISEASE
esophageal	0
acid	0
events	0
can	I-DISEASE
be	0
cor-	0
related	0
with	I-DISEASE
sleep	I-DISEASE
events	0
,	I-DISEASE
including	0
arousals	0
,	I-DISEASE
apneas	0
,	0
laryngospasm	I-DISEASE
,	0
and	0
increased	0
chin	I-DISEASE
EMG	0
tone	I-DISEASE
.	0

Esophageal	0
pH	0
monitoring	0
also	0
can	0
be	0
performed	0
simultaneously	0
with	I-DISEASE
actigraphy	0
to	0
correlate	0
acid	0
reflux	0
events	I-DISEASE
with	I-DISEASE
sleep	0
and	I-DISEASE
wake	0
periods	0
.	0

Catheter-	0
free	0
wireless	0
pH	I-DISEASE
systems	0
are	I-DISEASE
also	I-DISEASE
available	0
and	I-DISEASE
are	0
deployed	0
into	I-DISEASE
the	I-DISEASE
esophagus	0
,	I-DISEASE
usually	I-DISEASE
by	I-DISEASE
endoscopy	I-DISEASE
.	I-DISEASE

Esophageal	0
impedance	0
monitoring	0
can	I-DISEASE
be	0
combined	0
with	I-DISEASE
pH	0
probes	I-DISEASE
detecting	0
liquid	0
,	I-DISEASE
gas	0
,	0
or	I-DISEASE
liquid	I-DISEASE
gas	I-DISEASE
in	I-DISEASE
the	0
esophagus	0
,	0
and	0
can	0
assess	0
both	I-DISEASE
acid	0
and	0
nonacid	I-DISEASE
reflux	0
events	I-DISEASE
.	0

Use	0
of	0
esophageal	I-DISEASE
impedance	0
monitoring	I-DISEASE
is	0
often	I-DISEASE
performed	I-DISEASE
in	I-DISEASE
esophageal	0
centers	0
,	0
and	I-DISEASE
this	0
technique	0
would	0
be	I-DISEASE
difficult	0
to	0
integrate	0
with	0
polysomnography	0
.	0

Other	0
objective	0
measures	0
include	0
esophageal	0
endoscopy	0
with	I-DISEASE
or	0
without	I-DISEASE
biopsy	0
in	0
order	0
to	0
evaluate	0
for	I-DISEASE
esophagitis	0
and	0
other	I-DISEASE
esophageal	0
complications	0
.	0

A	0
histologic	0
evaluation	0
is	0
required	0
to	0
establish	I-DISEASE
a	0
diagnosis	0
of	0
Barrett	0
esophagus	0
.	0

Appendix	0
A	0
:	0
Sleep	0
Related	0
Medical	I-DISEASE
and	I-DISEASE
Neurological	I-DISEASE
Disorders	I-DISEASE
Differential	0
Diagnosis	0
The	0
differential	0
diagnosis	0
is	0
primarily	0
with	0
peptic	I-DISEASE
ulcer	0
disease	0
and	0
angina	0
.	I-DISEASE

The	0
chest	0
pain	0
associated	0
with	0
GER	0
is	I-DISEASE
sometimes	0
indistinguishable	I-DISEASE
from	0
that	0
of	0
angina	0
.	0

Duodenal	0
ulcer	0
disease	0
is	0
commonly	0
associated	0
with	I-DISEASE
a	0
burning	0
epigastric	0
pain	0
,	0
and	0
this	0
can	I-DISEASE
sometimes	I-DISEASE
be	0
similar	I-DISEASE
to	0
the	I-DISEASE
pain	0
experienced	0
by	0
patients	I-DISEASE
with	I-DISEASE
GER	0
.	I-DISEASE

Other	0
conditions	0
that	0
may	0
be	0
associated	0
with	0
GER	0
include	0
OSA	0
,	0
sleep	0
related	0
abnormal	0
swallowing	I-DISEASE
,	I-DISEASE
and	0
sleep	I-DISEASE
related	0
laryngospasm	0
.	0

PSG	0
evaluation	0
with	0
respiratory	0
and	0
pH	0
monitoring	I-DISEASE
can	0
differentiate	I-DISEASE
these	0
disorders	0
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE
Not	I-DISEASE
applicable	I-DISEASE
or	0
known	0
.	0

Bibliography	0
Allen	0
L	0
,	0
Poh	0
CH	I-DISEASE
,	I-DISEASE
Gasiorowska	0
A	I-DISEASE
,	0
et	0
al	0
.	0

Increased	0
oesophageal	0
acid	0
exposure	0
at	0
the	I-DISEASE
beginning	0
of	0
the	I-DISEASE
recumbent	0
period	0
is	0
primarily	0
a	0
recumbent	I-DISEASE
-	0
awake	0
phenomenon	I-DISEASE
.	0

Aliment	0
Pharmacol	0
Ther	0
2010;32:787–94	0
.	0

Bajaj	0
JS	0
,	0
Bajaj	0
S	0
,	0
Dua	0
KS	0
,	0
et	0
al	0
.	0

Influence	0
of	0
sleep	0
stages	I-DISEASE
on	0
esophago	I-DISEASE
-	I-DISEASE
upper	0
esophageal	I-DISEASE
sphincter	0
contractile	I-DISEASE
reflex	0
and	I-DISEASE
secondary	0
esophageal	0
peristalsis	0
.	I-DISEASE

Gastroenterology	0
2006;130:17–25	0
.	0

Fass	0
R	0
,	0
Johnson	0
DA	0
,	I-DISEASE
Orr	I-DISEASE
WC	0
,	I-DISEASE
et	I-DISEASE
al	0
.	0

The	0
effect	0
of	0
dexlansoprazole	0
MR	0
on	I-DISEASE
nocturnal	0
heartburn	0
and	I-DISEASE
GERD-	0
related	0
sleep	0
disturbances	0
in	0
patients	0
with	0
symptomatic	0
GERD	I-DISEASE
.	0

Am	0
J	0
Gastroenterol	0
2011;106:421–31	0
.	0

Fass	0
R	0
,	0
Quan	0
SF	0
,	0
O’Connor	0
GT	0
,	I-DISEASE
et	0
al	0
.	0

Predictors	0
of	0
heartburn	0
during	0
sleep	0
in	0
a	I-DISEASE
large	0
prospective	I-DISEASE
cohort	0
study	0
.	0

Chest	0
2005;127:1654–66	0
.	0

Fujiwara	0
Y	0
,	0
Arakawa	0
T	0
,	I-DISEASE
Fass	0
R.	0
Gastroesophageal	I-DISEASE
reflux	0
disease	0
and	0
sleep	0
disturbances	0
.	I-DISEASE

J	0
Gastroenterol	0
2012;47:760–9	0
.	0

Gagliardi	0
GS	I-DISEASE
,	0
Shah	0
AP	0
,	I-DISEASE
Goldstein	I-DISEASE
M	0
,	I-DISEASE
et	0
al	0
.	0

Effect	0
of	0
zolpidem	0
on	0
the	0
sleep	I-DISEASE
arousal	I-DISEASE
response	0
to	I-DISEASE
nocturnal	0
esophageal	0
acid	0
exposure	0
.	0

Clin	0
Gastroenterol	I-DISEASE
Hepatol	0
2009;7:948–52	0
.	0

Gerson	0
LB	0
,	0
Fass	I-DISEASE
R.	0
A	0
systematic	0
review	0
of	0
definitions	0
,	0
prevalence	0
,	0
and	0
response	0
to	0
treatment	I-DISEASE
of	I-DISEASE
nocturnal	0
gastroesophageal	0
reflux	0
disease	0
.	0

Clin	0
Gastroenterol	I-DISEASE
Hepatol	0
2009;7:372–8	0
.	0

Ghaem	0
M	I-DISEASE
,	0
Armstrong	0
KL	0
,	I-DISEASE
Trocki	0
O	0
,	I-DISEASE
et	0
al	0
.	0

The	0
sleep	0
patterns	0
of	0
infants	0
and	0
young	I-DISEASE
children	0
with	I-DISEASE
gastro-	0
oesophageal	0
reflux	0
.	0

J	0
Paediatr	0
Child	0
Health	0
1998;34:160–3	0
.	0

Green	0
BT	0
,	0
Broughton	0
WA	0
,	0
O’Connor	I-DISEASE
JB	0
.	I-DISEASE

Marked	0
improvement	I-DISEASE
in	0
nocturnal	I-DISEASE
gastroesophageal	0
reflux	I-DISEASE
in	0
a	0
large	I-DISEASE
cohort	0
of	I-DISEASE
patients	0
with	0
obstructive	0
sleep	I-DISEASE
apnea	0
treated	0
with	I-DISEASE
continuous	0
positive	0
airway	0
pressure	0
.	0

Arch	0
Intern	0
Med	0
2003;163:41–5	0
.	I-DISEASE

Harding	0
SM	0
,	0
Richter	0
JE	0
,	0
Guzzo	I-DISEASE
MR	0
,	I-DISEASE
et	0
al	0
.	0

Asthma	0
and	0
gastroesophageal	0
reflux	0
:	0
acid	0
suppressive	I-DISEASE
therapy	0
improves	I-DISEASE
asthma	0
outcome	0
.	0

Am	0
J	0
Med	0
1996;100:395–405	I-DISEASE
.	0

Harding	0
SM	0
.	0

Gastroesophageal	0
reflux	0
during	0
sleep	0
.	0

Sleep	0
Med	0
Clin	I-DISEASE
2007;2:41–50	0
.	I-DISEASE

Locke	0
GR	0
3rd	I-DISEASE
,	0
Talley	0
NJ	0
,	0
Fett	0
SL	I-DISEASE
,	0
et	0
al	0
.	0

Prevalence	0
and	0
clinical	0
spectrum	0
of	0
gastroesophageal	0
reflux	I-DISEASE
:	0
a	I-DISEASE
population	0
-	I-DISEASE
based	0
study	0
in	0
Olmstead	I-DISEASE
County	0
,	0
Minnesota	I-DISEASE
.	0

Gastroenterology	0
1997;112:1448–56	0
.	0

Mainie	0
I	0
,	0
Tutuian	0
R	0
,	I-DISEASE
Shay	I-DISEASE
S	0
,	0
et	0
al	0
.	0

Acid	0
and	0
non	0
-	0
acid	0
reflux	0
in	I-DISEASE
patients	0
with	I-DISEASE
persistent	0
symptoms	0
despite	I-DISEASE
acid	0
suppressive	0
therapy	0
:	0
a	I-DISEASE
multicentre	0
study	0
using	0
combined	0
ambulatory	0
impedance	0
pH	0
monitoring	0
.	0

Gut	0
2006;55:1398–402	0
.	0

Appendix	0
A	0
:	0
Sleep	0
Related	0
Medical	I-DISEASE
and	I-DISEASE
Neurological	I-DISEASE
Disorders	I-DISEASE
Schey	0
R	0
,	0
Dickman	0
R	0
,	0
Parthasarathy	0
S	0
,	I-DISEASE
et	0
al	0
.	0

Sleep	0
deprivation	0
is	I-DISEASE
hyperalgesic	I-DISEASE
in	0
patients	0
with	I-DISEASE
gastroesophageal	0
reflux	I-DISEASE
disease	0
.	0

Gastroenterology	0
2007;133:1787–95	0
.	0

Shaheen	0
NJ	0
,	0
Weinberg	0
DS	0
,	I-DISEASE
Denberg	0
TD	0
,	I-DISEASE
et	0
al	0
.	0

Upper	0
endoscopy	0
for	0
gastroesophageal	0
reflux	0
disease	0
:	0
Best	0
Practice	I-DISEASE
Advice	I-DISEASE
from	0
the	0
Clinical	0
Guidelines	0
Committee	0
of	0
the	0
American	I-DISEASE
College	0
of	0
Physicians	0
.	0

Ann	0
Intern	0
Med	0
2012;157:808–16	0
.	0

Shaker	0
R.	0
Castell	0
DO	0
,	0
Schoenfeld	0
PS	0
,	0
et	0
al	0
.	0

Nighttime	0
heartburn	I-DISEASE
is	0
an	0
under	0
-	0
appreciated	I-DISEASE
clinical	0
problem	I-DISEASE
that	0
impacts	0
sleep	I-DISEASE
and	0
daytime	I-DISEASE
function	I-DISEASE
:	I-DISEASE
the	0
results	I-DISEASE
of	0
a	I-DISEASE
Gallup	0
survey	0
conducted	0
on	I-DISEASE
behalf	0
of	0
the	0
American	I-DISEASE
Gastroenterological	0
Association	0
.	0

Am	0
J	0
Gastroenterol	0
2003;98:1487–93	0
.	0

Sontag	0
SJ	0
,	0
O’Connell	0
S	0
,	0
Miller	0
TQ	0
,	I-DISEASE
et	0
al	0
.	I-DISEASE

Asthmatics	0
have	0
more	0
nocturnal	I-DISEASE
gasping	I-DISEASE
and	0
reflux	0
symptoms	I-DISEASE
than	I-DISEASE
nonasthmatics	0
,	I-DISEASE
and	0
they	0
are	0
related	I-DISEASE
to	0
bedtime	0
eating	I-DISEASE
.	0

Am	0
J	0
Gastroenterol	0
2004;99:789–96	0
.	0

Sleep	0
Related	0
Myocardial	I-DISEASE
Ischemia	0
Alternate	0
Names	0
Unstable	I-DISEASE
angina	0
,	I-DISEASE
coronary	0
insufficiency	0
-	0
acute	0
,	0
nocturnal	0
angina	0
,	0
angina	I-DISEASE
decubitus	0
,	0
variant	0
angina	0
,	0
Prinzmetal	0
angina	0
,	0
vasospastic	0
angina	I-DISEASE
,	0
angina	0
pectoris	0
,	0
atherosclerotic	0
heart	0
disease	0
,	0
asymptomatic	0
cardiac	I-DISEASE
ischemia	0
,	0
silent	0
ischemia	0
.	0

Essential	0
Features	0
Sleep	0
related	0
myocardial	I-DISEASE
ischemia	0
is	0
characterized	0
by	0
nocturnal	0
reduction	0
of	0
blood	0
flow	0
to	I-DISEASE
the	I-DISEASE
myocardium	0
,	B-DISEASE
typically	0
during	0
sleep	0
.	0

The	0
symptoms	0
of	0
sleep	0
related	0
myo-	I-DISEASE
cardial	I-DISEASE
ischemia	0
are	I-DISEASE
very	0
similar	0
to	0
those	0
that	0
characterize	I-DISEASE
episodes	I-DISEASE
of	0
cardiac	I-DISEASE
isch-	0
emia	I-DISEASE
during	0
the	I-DISEASE
daytime	0
.	0

Classically	0
,	0
there	0
is	0
a	I-DISEASE
feeling	0
of	I-DISEASE
chest	0
pressure	I-DISEASE
or	0
pain	0
that	0
awakens	I-DISEASE
the	0
patient	I-DISEASE
from	I-DISEASE
sleep	I-DISEASE
and	I-DISEASE
may	0
be	I-DISEASE
described	0
as	0
a	I-DISEASE
“	I-DISEASE
viselike	I-DISEASE
”	I-DISEASE
discomfort	0
.	0

The	0
discomfort	0
may	0
radiate	0
to	0
the	I-DISEASE
chin	B-DISEASE
and	0
jaw	I-DISEASE
and	0
to	0
the	I-DISEASE
arm	0
,	0
especially	I-DISEASE
the	0
left	0
arm	0
.	0

Associated	0
Features	0
Acute	0
episodes	0
of	0
sleep	0
related	I-DISEASE
myocardial	I-DISEASE
ischemia	I-DISEASE
sometimes	0
elicit	0
atrial	0
or	0
ventric-	0
ular	0
arrhythmias	0
.	0

Other	0
associated	0
presentations	0
include	I-DISEASE
acute	I-DISEASE
onset	0
of	I-DISEASE
shortness	0
of	I-DISEASE
breath	0
that	0
wakes	0
the	0
patient	0
from	I-DISEASE
sleep	I-DISEASE
and	0
that	I-DISEASE
may	0
be	I-DISEASE
secondary	0
to	0
left	0
ventricular	0
diastolic	I-DISEASE
dysfunction	0
or	0
ischemic	B-DISEASE
mitral	0
regurgitation	I-DISEASE
.	I-DISEASE

Other	0
related	0
features	I-DISEASE
depend	0
on	0
the	0
trigger	I-DISEASE
for	0
the	0
cardiac	I-DISEASE
ischemia	0
.	0

Ischemic	0
events	0
related	0
to	0
OSA	0
may	I-DISEASE
present	I-DISEASE
during	0
those	I-DISEASE
times	0
of	0
sleep	0
when	0
nocturnal	0
desaturation	I-DISEASE
is	I-DISEASE
most	0
severe	I-DISEASE
.	0

Cardiac	0
isch-	0
emia	0
related	0
to	I-DISEASE
hemodynamic	I-DISEASE
changes	I-DISEASE
or	0
vasospasm	I-DISEASE
occurring	0
during	0
REM	0
sleep	0
may	0
present	I-DISEASE
in	0
the	0
early	I-DISEASE
hours	0
of	0
the	0
morning	0
,	I-DISEASE
around	0
the	0
time	I-DISEASE
of	0
waking	0
,	0
when	I-DISEASE
REM	I-DISEASE
sleep	I-DISEASE
is	0
most	0
likely	I-DISEASE
to	0
occur	I-DISEASE
.	I-DISEASE

Ischemia	0
associated	0
with	0
nocturnal	0
hypotension	0
is	0
most	I-DISEASE
likely	0
to	I-DISEASE
occur	0
during	0
slow	0
wave	0
(	0
N3	0
)	0
sleep	0
,	0
when	0
blood	I-DISEASE
pressure	0
is	0
lowest	0
.	0

Clinical	0
and	0
Pathophysiologic	0
Subtypes	I-DISEASE
None	I-DISEASE
known	I-DISEASE
.	I-DISEASE

Appendix	0
A	0
:	0
Sleep	0
Related	0
Medical	I-DISEASE
and	I-DISEASE
Neurological	0
Disorders	I-DISEASE
Demographics	0

The	0
specifics	0
of	0
prevalence	0
,	0
sex	I-DISEASE
ratios	I-DISEASE
,	0
and	0
age	0
ranges	0
have	0
not	0
been	0
comprehensively	I-DISEASE
evaluated	0
.	0

Some	0
insights	0
into	0
demographics	0
can	0
be	0
extrapolated	0
,	0
depending	I-DISEASE
on	0
the	0
cause	0
of	0
nocturnal	0
angina	I-DISEASE
.	I-DISEASE

For	0
sleep	0
related	I-DISEASE
myocardial	I-DISEASE
ischemia	0
triggered	0
by	I-DISEASE
OSA	0
,	I-DISEASE
the	0
preponderance	0
of	0
OSA	0
in	0
men	I-DISEASE
suggests	I-DISEASE
that	I-DISEASE
middle	I-DISEASE
-	0
aged	0
men	0
with	0
severe	0
OSA	I-DISEASE
are	0
more	0
likely	0
to	I-DISEASE
experience	0
nocturnal	0
angina	0
,	0
particularly	0
if	0
they	0
have	I-DISEASE
more	0
severe	0
coronary	0
artery	0
disease	0
.	I-DISEASE

Variant	0
angina	0
(	0
also	0
referred	0
to	0
as	I-DISEASE
vasospastic	I-DISEASE
or	I-DISEASE
Prinzmetal	0
angina	0
)	0
more	0
commonly	0
affects	0
younger	0
populations	I-DISEASE
,	0
particularly	0
women	0
and	0
those	0
of	0
Asian	I-DISEASE
descent	0
.	0

Cardiac	0
ischemia	0
secondary	0
to	0
nocturnal	0
hypotension	I-DISEASE
is	0
more	0
com-	I-DISEASE
monly	0
manifested	0
in	0
older	0
individuals	0
,	0
particularly	I-DISEASE
those	0
with	0
severe	0
vasculopathy	I-DISEASE
who	0
are	0
taking	0
multiple	0
antihypertensive	0
medications	I-DISEASE
,	0
and	I-DISEASE
especially	0
those	0
in	I-DISEASE
whom	0
autonomic	0
dysfunction	0
(	I-DISEASE
related	0
to	0
either	I-DISEASE
age	0
or	0
diabetes	0
)	I-DISEASE
may	0
impair	0
blood	I-DISEASE
pressure	0
homeostatic	I-DISEASE
mechanisms	I-DISEASE
.	0

Predisposing	0
and	0
Precipitating	0
Factors	0
Predisposing	0
factors	I-DISEASE
include	I-DISEASE
established	0
coronary	I-DISEASE
artery	0
disease	0
or	0
valvular	0
disease	0
such	I-DISEASE
as	0
aortic	0
stenosis	I-DISEASE
.	0

Because	0
coronary	0
filling	0
occurs	0
during	0
diastole	0
,	I-DISEASE
conditions	0
associated	I-DISEASE
with	0
reduced	0
diastolic	0
blood	0
pressure	0
,	0
such	I-DISEASE
as	0
severe	I-DISEASE
aortic	0
regurgita-	0
tion	0
,	0
may	0
elicit	0
nocturnal	I-DISEASE
angina	0
,	0
particularly	0
in	B-DISEASE
the	0
presence	0
of	I-DISEASE
preexisting	0
coro-	0

nary	0
artery	0
disease	0
.	0

Similarly	0
,	0
any	0
predisposition	0
to	0
hypotension	0
,	I-DISEASE
which	0
is	I-DISEASE
most	0
likely	0
to	0
occur	0
during	0
slow	I-DISEASE
wave	I-DISEASE
(	0
N3	0
)	0
sleep	0
,	0
may	0
heighten	0
risk	I-DISEASE
.	0

Usual	0
risk	I-DISEASE
factors	0
for	0
coronary	0
artery	0
disease	I-DISEASE
that	0
predispose	I-DISEASE
an	0
individual	0
to	0
the	0
development	0
of	I-DISEASE
sleep	I-DISEASE
related	I-DISEASE
myocardial	I-DISEASE
ischemia	I-DISEASE
include	0
hypertension	0
,	I-DISEASE
diabetes	I-DISEASE
mellitus	0
,	I-DISEASE
cigarette	I-DISEASE
smoking	0
,	I-DISEASE
and	0
hyperlipidemia	0
.	I-DISEASE

Retrospective	0
and	I-DISEASE
prospective	I-DISEASE
studies	0
suggest	0
that	I-DISEASE
OSA	I-DISEASE
may	0
be	I-DISEASE
a	0
trigger	0
for	0
myo-	I-DISEASE
cardial	0
infarction	I-DISEASE
and	0
sudden	I-DISEASE
death	I-DISEASE
that	0
occurs	0
at	0
night	0
.	0

Deeper	0
oxyhemoglobin	0
desaturations	0
,	I-DISEASE
which	I-DISEASE
may	I-DISEASE
be	I-DISEASE
encountered	I-DISEASE
in	I-DISEASE
REM	0
,	I-DISEASE
particularly	0
with	0
coexisting	0
pulmonary	I-DISEASE
disease	0
or	I-DISEASE
truncal	I-DISEASE
-	0
abdominal	I-DISEASE
obesity	0
,	0
are	I-DISEASE
more	0
likely	I-DISEASE
to	I-DISEASE
trigger	I-DISEASE
cardiac	I-DISEASE
ischemia	0
.	0

In	0
patients	0
with	I-DISEASE
vasospastic	0
angina	0
,	0
use	0
of	0
nonselective	I-DISEASE
β	0
-	0
adrenergic	0
receptor	0
-	0
blocking	I-DISEASE
agents	0
may	0
theoretically	I-DISEASE
increase	0
the	0
likelihood	0
of	0
vasospasm	0
.	0

In	0
patients	0
with	I-DISEASE
nocturnal	0
angina	0
secondary	0
to	I-DISEASE
hypotension	0
,	I-DISEASE
an	0
excess	0
of	0
antihy-	0
pertensive	0
medications	I-DISEASE
,	0
as	0
well	I-DISEASE
as	0
long	0
-	0
acting	I-DISEASE
nitroglycerin	I-DISEASE
administered	I-DISEASE
prior	0
to	0
sleep	0
,	I-DISEASE
may	0
contribute	I-DISEASE
.	0

Finally	0
,	0
in	0
the	0
proper	I-DISEASE
clinical	I-DISEASE
context	I-DISEASE
,	0
abuse	I-DISEASE
of	0
drugs	0
such	0
as	0
amphetamine	0
,	0
cocaine	0
,	0
and	I-DISEASE
other	0
stimulants	0
,	0
needs	0
to	0
be	0
considered	I-DISEASE
in	0
the	0
evaluation	0
of	0
myocardial	I-DISEASE
ischemia	0
.	0

Familial	0
Patterns	0
Familial	0
patterns	0
reflect	0
those	0
of	I-DISEASE
the	0
underlying	I-DISEASE
disease	0
process	0
.	0

Appendix	0
A	0
:	0
Sleep	0
Related	0
Medical	I-DISEASE
and	I-DISEASE
Neurological	I-DISEASE
Disorders	I-DISEASE
Onset	0
,	0
Course	0
,	0
and	0
Complications	I-DISEASE
For	0
angina	0
related	I-DISEASE
to	0
OSA	0
,	0
the	0
first	0
presentation	0
of	0
nocturnal	0
angina	0
may	I-DISEASE
occur	0
only	I-DISEASE
when	0
the	0
severity	I-DISEASE
of	0
both	0
the	I-DISEASE
sleep	0
apnea	I-DISEASE
and	0
the	0
coronary	I-DISEASE
artery	I-DISEASE
disease	0
are	0
suffi-	0
cient	0
to	I-DISEASE
elicit	0
sleep	0
related	I-DISEASE
myocardial	I-DISEASE
ischemia	I-DISEASE
.	I-DISEASE

This	0
is	0
likely	0
to	0
be	0
most	0
common	0
in	0
middle	0
-	0
aged	0
to	0
older	0
men	0
,	0
particularly	0
those	I-DISEASE
who	0
are	0
overweight	0
,	0
although	0
several	0
studies	0
have	I-DISEASE
documented	0
life	0
-	I-DISEASE
threatening	0
OSA	0
related	0
cardiac	0
ischemia	0
in	0
women	0
.	0

It	0
is	0
notable	0
that	0
several	0
studies	I-DISEASE
have	I-DISEASE
reported	0
cardiac	0
ischemia	I-DISEASE
in	0
patients	0
with	0
OSA	0
even	I-DISEASE
in	0
the	0
absence	I-DISEASE
of	0
severe	0
coronary	0
artery	0
stenosis	0
.	0

ST	0
segment	0
changes	0
occur-	0
ring	0
as	0
a	I-DISEASE
result	0
of	I-DISEASE
OSA	0
would	0
be	0
expected	0
to	0
resolve	I-DISEASE
with	0
treatment	0
of	0
the	0
OSA	0
.	0

Regardless	0
of	0
the	0
underlying	I-DISEASE
etiology	0
,	0
potential	0
complications	0
of	I-DISEASE
sleep	0
related	0
myo-	I-DISEASE
cardial	I-DISEASE
ischemia	0
include	I-DISEASE
acute	I-DISEASE
left	0
ventricular	0
dysfunction	0
,	0
ischemic	0
mitral	0
regur-	0
gitation	I-DISEASE
and	I-DISEASE
pulmonary	I-DISEASE
edema	0
,	0
arrhythmias	0
,	0
and	0
even	0
progression	0
to	0
myocardial	0
infarction	I-DISEASE
and	0
death	I-DISEASE
.	0

Pathology	0
and	0
Pathophysiology	0
For	0
sleep	0
related	I-DISEASE
myocardial	I-DISEASE
ischemia	0
related	I-DISEASE
to	0
OSA	I-DISEASE
,	I-DISEASE
the	0
apnea	0
-	I-DISEASE
related	0
hypoxemia	0
and	I-DISEASE
surges	0
in	I-DISEASE
blood	0
pressure	0
and	0
heart	0
rate	I-DISEASE
at	0
termination	I-DISEASE
of	0
apnea	0
may	I-DISEASE
all	0
result	0
in	0
rel-	0
ative	0
myocardial	0
oxygen	I-DISEASE
deficiency	0
.	0

A	0
substrate	0
of	0
preexisting	0
severe	0
coronary	I-DISEASE
artery	I-DISEASE
disease	0
is	I-DISEASE
expected	0
to	0
exacerbate	I-DISEASE
this	0
problem	0
.	I-DISEASE

Variant	0
angina	0
may	0
be	0
more	0
likely	0
to	I-DISEASE
occur	0
during	I-DISEASE
sleep	0
because	0
of	0
the	0
significant	0
and	I-DISEASE
abrupt	I-DISEASE
fluctuations	0
in	I-DISEASE
cardiovascular	0
neural	I-DISEASE
control	0
during	0
REM	0
sleep	0
.	0

For	0
nocturnal	0
angina	0
related	0
to	0
hypotension	0
,	I-DISEASE
perfu-	I-DISEASE
sion	I-DISEASE
of	0
the	0
coronary	0
arteries	0
during	0
diastole	I-DISEASE
makes	0
maintenance	0
of	I-DISEASE
diastolic	0
pressures	0
during	0
sleep	0
important	0
for	0
adequate	I-DISEASE
myocardial	0
perfusion	0
.	I-DISEASE

Autonomic	0
insufficiency	0
due	0
to	0
old	0
age	0
,	I-DISEASE
diabetes	0
,	I-DISEASE
and	0
medication	0
effects	0
blunts	0
the	0
ability	I-DISEASE
of	0
the	0
cardiovascular	I-DISEASE
system	0
to	I-DISEASE
maintain	I-DISEASE
adequate	0
blood	I-DISEASE
pressure	0
.	I-DISEASE

Objective	0
Findings	0
Electrocardiographic	0
monitoring	I-DISEASE
during	0
sleep	I-DISEASE
reveals	I-DISEASE
horizontal	0
or	I-DISEASE
downsloping	I-DISEASE
ST	0
segment	0
depression	0
of	0
greater	I-DISEASE
than	I-DISEASE
or	I-DISEASE
equal	I-DISEASE
to	0
1	0
mm	0
,	0
or	0
ST	0
segment	I-DISEASE
elevation	I-DISEASE
of	0
1	0
mm	0
or	I-DISEASE
more	0
.	I-DISEASE

The	0
electrocardiographic	0
evidence	I-DISEASE
of	I-DISEASE
sleep	0
related	0
coronary	0
artery	0
ischemia	I-DISEASE
is	I-DISEASE
sometimes	0
unaccompanied	0
by	I-DISEASE
chest	0
discomfort	I-DISEASE
or	0
other	0
symptoms	I-DISEASE
(	0
silent	0
ischemia	0
)	0
and	0
may	0
be	I-DISEASE
incidentally	0
noted	0
on	0
either	0
Holter	0
monitoring	I-DISEASE
or	I-DISEASE
telemetry	0
.	0

In	0
general	0
,	0
ST	0
segment	0
abnormalities	I-DISEASE
indicative	I-DISEASE
of	0
myocardial	0
ischemia	0
are	0
1	0
mm	0
or	0
more	0
horizontal	I-DISEASE
or	0
down	I-DISEASE
-	0
sloping	0
depression	0
or	0
ST	0
segment	I-DISEASE
elevation	0
,	I-DISEASE
which	I-DISEASE
may	B-DISEASE
be	0
detected	0
on	0
the	I-DISEASE
single	0
lead	0
electrocardiogram	0
(	I-DISEASE
ECG	0
)	I-DISEASE
employed	0
in	0
most	I-DISEASE
sleep	0
labo-	0
ratories	0
.	I-DISEASE

However	0
,	I-DISEASE
because	0
the	0
sensitivity	I-DISEASE
of	I-DISEASE
single	I-DISEASE
-	0
lead	I-DISEASE
ECG	0
in	0
detecting	0
ischemic	0
changes	0
is	I-DISEASE
poor	I-DISEASE
,	0
the	I-DISEASE
patient	0
with	0
symptoms	0
compatible	0
with	I-DISEASE
angina	I-DISEASE
with	I-DISEASE
a	0
normal	0
-	I-DISEASE
ap-	0
pearing	0
single	0
ECG	0
channel	0
should	0
be	0
further	0
evaluated	I-DISEASE
with	I-DISEASE
multichannel	0
ECG	I-DISEASE
.	I-DISEASE

Appendix	0
A	0
:	0
Sleep	0
Related	0
Medical	I-DISEASE
and	I-DISEASE
Neurological	I-DISEASE
Disorders	I-DISEASE
Sleep	0
related	0
myocardial	I-DISEASE
ischemia	0
in	0
patients	I-DISEASE
without	0
sleep	0
related	I-DISEASE
breathing	0
disor-	I-DISEASE
ders	0
may	0
be	0
associated	0
with	I-DISEASE
REM	0
sleep	0
.	0

Slow	0
wave	0
sleep	0
with	I-DISEASE
a	0
fall	0
in	0
blood	0
pressure	0
and	0
heart	0
rate	0
can	0
be	0
associated	I-DISEASE
with	0
ischemia	0
.	I-DISEASE

Sleep	0
related	0
breathing	I-DISEASE
disorders	0
,	0
par-	0
ticularly	I-DISEASE
OSA	0
,	I-DISEASE
may	0
elicit	0
oxygen	0
desaturation	0
and	0
consequent	I-DISEASE
sleep	0
related	0
myocar-	0
dial	0
ischemia	0
.	0

The	0
presence	0
of	0
cardiac	0
arrhythmias	0
should	0
prompt	0
an	I-DISEASE
evaluation	0
for	0
nocturnal	0
ischemia	0
.	0

Differential	0
Diagnosis	0
Sleep	0
related	0
myocardial	0
ischemia	I-DISEASE
must	I-DISEASE
be	I-DISEASE
differentiated	I-DISEASE
from	0
gastroesophageal	0
reflux	0
,	0
which	0
may	I-DISEASE
also	0
be	0
associated	0
with	0
chest	0
discomfort	0
.	0

The	0
nature	0
of	0
the	I-DISEASE
pain	I-DISEASE
,	I-DISEASE
associated	I-DISEASE
symptoms	0
and	I-DISEASE
prior	0
history	0
are	0
helpful	0
in	0
making	0
a	0
distinction	0
,	I-DISEASE
although	0
12	0
-	0
lead	0
ECG	0
may	0
be	I-DISEASE
necessary	0
in	I-DISEASE
some	0
cases	0
.	0

Nocturnal	0
panic	0
attacks	0
may	I-DISEASE
be	0
asso-	0
ciated	I-DISEASE
with	0
chest	I-DISEASE
wall	0
pain	0
and	0
respiratory	0
distress	0
.	I-DISEASE

Although	0
the	0
majority	I-DISEASE
of	0
patients	0
with	I-DISEASE
nocturnal	I-DISEASE
panic	I-DISEASE
will	I-DISEASE
have	I-DISEASE
a	I-DISEASE
history	0
of	0
daytime	0
panic	I-DISEASE
attacks	0
,	I-DISEASE
a	I-DISEASE
small	0
percentage	0
have	0
only	0
nocturnal	0
events	0
.	I-DISEASE

Nocturnal	0
panic	0
attacks	0
typically	0
occur	0
during	I-DISEASE
transition	0
from	0
N2	I-DISEASE
to	0
N3	0
sleep	I-DISEASE
.	0

Other	0
causes	0
of	I-DISEASE
nocturnal	I-DISEASE
respiratory	0
distress	0
,	I-DISEASE
including	0
heart	I-DISEASE
failure	0
and	0
pulmonary	0
disease	I-DISEASE
,	0
may	I-DISEASE
be	I-DISEASE
confused	0
with	I-DISEASE
myocardial	B-DISEASE
ischemic	0
episodes	0
,	0
although	0
typical	0
anginal	I-DISEASE
chest	0
pain	0
is	I-DISEASE
not	0
evident	0
in	I-DISEASE
these	I-DISEASE
cases	0
.	0

Chest	0
pain	0
due	0
to	I-DISEASE
thoracic	0
mass	0
,	I-DISEASE
pleuritic	0
pain	I-DISEASE
,	0
aortic	0
aneurysm	0
,	0
or	0
other	0
thoracic	0
disease	0
should	I-DISEASE
be	0
considered	0
in	0
the	0
differential	0
diagnosis	0
.	0

Chest	0
wall	0
pain	0
may	0
be	0
sec-	0
ondary	I-DISEASE
to	0
a	I-DISEASE
variety	0
of	0
causes	0
such	0
as	0
trauma	I-DISEASE
,	0
muscle	0
spasm	I-DISEASE
,	0
or	0
immobility	0
.	0

Unresolved	0
Issues	0
and	0
Further	0
Directions	I-DISEASE

More	0
comprehensive	0
data	0
are	0
needed	0
to	I-DISEASE
identify	I-DISEASE
the	0
prevalence	I-DISEASE
and	0
demographics	0
of	0
the	0
various	0
causes	I-DISEASE
of	0
sleep	I-DISEASE
related	I-DISEASE
myocardial	I-DISEASE
ischemia	I-DISEASE
.	0

Further	0
information	0
is	0
also	0
needed	0
to	I-DISEASE
explore	I-DISEASE
the	0
relationship	I-DISEASE
between	0
sleep	0
related	I-DISEASE
myocardial	I-DISEASE
ischemia	0
and	I-DISEASE
the	0
circadian	0
variation	I-DISEASE
in	0
myocardial	0
infarction	0
and	0
sudden	0
death	I-DISEASE
,	0
particularly	0
the	I-DISEASE
role	I-DISEASE
of	0
treatment	0
on	0
outcomes	0
.	0

Bibliography	0
Caples	0
S	I-DISEASE
,	0
Rosen	0
C	0
,	I-DISEASE
Shen	0
W	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	I-DISEASE

The	0
scoring	0
of	0
cardiac	0
events	0
during	0
sleep	I-DISEASE
.	I-DISEASE

J	0
Clin	0
Sleep	I-DISEASE
Med	0
2007;15:147–54	0
.	I-DISEASE

Franklin	0
K	0
,	0
Nilsson	0
J	0
,	I-DISEASE
Sahlin	0
C	0
,	0
Naslund	0
U.	0
Sleep	I-DISEASE
apnoea	0
and	0
nocturnal	I-DISEASE
angina	0
.	0

Lancet	0
1995;345:1085–7	0
.	0

Gami	0
A	I-DISEASE
,	0
Howard	0
D	0
,	0
Olson	I-DISEASE
E	0
,	I-DISEASE
Somers	0
V.	0
Day	0
-	0
night	0
pattern	0
of	0
sudden	I-DISEASE
death	I-DISEASE
in	0
obstructive	I-DISEASE
sleep	0
apnea	0
.	0

New	0
Engl	0
J	0
Med	0
2005;352:1206–14	0
.	0

Appendix	0
A	0
:	0
Sleep	0
Related	0
Medical	I-DISEASE
and	I-DISEASE
Neurological	I-DISEASE
Disorders	I-DISEASE
Muller	0
J	0
,	0
Ludmer	0
P	0
,	I-DISEASE
Willich	0
S	0
,	I-DISEASE
et	0
al	0
.	0

Circadian	0
variation	I-DISEASE
and	0
the	0
frequency	0
of	0
sudden	I-DISEASE
cardiac	I-DISEASE
death	0
.	0

Circulation	0
1987;75:131–8	0
.	0

Nowlin	0
J	0
,	0
Troyer	0
WJ	0
,	I-DISEASE
Collins	I-DISEASE
W	I-DISEASE
,	I-DISEASE
et	0
al	0
.	I-DISEASE

The	0
association	0
of	0
nocturnal	0
angina	0
pectoris	0
with	I-DISEASE
dreaming	0
.	I-DISEASE

Ann	0
Intern	0
Med	0
1965;63:1040–6	0
.	I-DISEASE

Schroeder	0
J	0
,	0
Motta	0
J	0
,	0
Guilleminault	I-DISEASE
C.	0
Hemodynamic	0
studies	0
in	0
sleep	I-DISEASE
apnea	I-DISEASE
.	0

In	0
:	0
Guilleminault	0
C	I-DISEASE
,	I-DISEASE
Dement	I-DISEASE
W	I-DISEASE
,	0
eds	I-DISEASE
.	0

Sleep	0
Apnea	0
Syndromes	0
.	I-DISEASE

New	0
York	0
:	0

Alan	0
R.	0
Liss	0
,	0
1978:177–96	0
.	0

Sert	0
Kuniyoshi	0
F	0
,	0
Garcia	0
-	0
Touchard	0
A	0
,	I-DISEASE
Gami	0
A	0
,	0
et	0
al	0
.	I-DISEASE

Day	0
-	0
night	0
variation	I-DISEASE
of	0
acute	I-DISEASE
myocardial	0
infarction	0
in	I-DISEASE
obstructive	0
sleep	0
apnea	0
.	0

J	0
Amer	0
Coll	0
Cardiol	B-DISEASE
2008;52:343–6	0
.	0

Verrier	0
R	0
,	0
Muller	I-DISEASE
J	0
,	0
Hobson	I-DISEASE
J.	0
Sleep	I-DISEASE
,	0
dreams	0
,	0
and	0
sudden	0
death	I-DISEASE
:	I-DISEASE
the	0
case	I-DISEASE
for	0
sleep	0
as	0
an	0
autonomic	0
stress	0
test	I-DISEASE
for	0
the	0
heart	0
.	0

Cardiovasc	0
Res	0
1996;31:181	0
-	0
211	0
.	I-DISEASE

Appendix	0
B	0
:	0
ICD-10	0
-	0
CM	I-DISEASE
Coding	I-DISEASE
for	0
Substance-	0
Induced	0
Sleep	0
Disorders	0
ICD-10	I-DISEASE
-	0
CM	0
coding	0
for	0
substance	0
-	0
induced	0
disorders	0
is	0
more	0
complex	0
than	I-DISEASE
ICD-9	0
-	0
CM	0
coding	0
.	I-DISEASE

The	0
series	0
F10.xxx-F19.xxx	0
(	0
which	0
is	0
the	I-DISEASE
general	0
section	I-DISEASE
for	0
substance	0
-	0
in-	0
duced	0
mental	I-DISEASE
and	0
behavioral	0
disorders	I-DISEASE
in	0
ICD-10	I-DISEASE
-	0
CM	0
)	0
contains	0
the	I-DISEASE
pertinent	0
codes	0
for	I-DISEASE
substance	0
-	0
induced	I-DISEASE
sleep	0
disorders	0
.	0

There	0
are	0
specific	0
codes	0
for	0
sleep	0
disorders	I-DISEASE
induced	0
by	I-DISEASE
alcohol	0
,	0
opioids	0
,	0
sedatives	0
,	I-DISEASE
cocaine	0
,	0
other	I-DISEASE
stimulants	0
and	0
other	0
psychoactive	0
sub-	0
stances	0
.	0

However	0
,	I-DISEASE
in	0
the	0
case	I-DISEASE
of	I-DISEASE
cannabis	I-DISEASE
,	0
hallucinogens	I-DISEASE
,	0
nicotine	I-DISEASE
and	0
inhalants	0
,	0
there	0
are	0
no	0
sleep	I-DISEASE
-	0
specific	0
codes	0
.	0

In	0
these	0
instances	0
,	0
the	0
coder	I-DISEASE
must	0
use	0
an	0
“	0
unspecified	0
”	0
or	0
“	0
other	0
”	0
code	0
.	0

A	0
detailed	0
list	0
of	I-DISEASE
the	0
appropriate	I-DISEASE
codes	0
for	0
substance	0
-	0
induced	0
sleep	0
dis-	I-DISEASE
orders	0
is	I-DISEASE
included	0
in	0
the	I-DISEASE
table	0
below	0
.	0

Substance	0
Relevant	0
ICD-10	0
-	I-DISEASE
CM	0
Codes	0
Alcohol	I-DISEASE
F10.182	0
Alcohol	I-DISEASE
abuse	0
with	0
alcohol	I-DISEASE
-	I-DISEASE
induced	0
sleep	I-DISEASE
disorder	0
F10.282	0
Alcohol	I-DISEASE
dependence	0
with	0
alcohol	0
-	0
induced	0
sleep	I-DISEASE
disorder	I-DISEASE
F10.982	0
Alcohol	0
use	0
,	0
unspecified	I-DISEASE
with	I-DISEASE
alcohol	I-DISEASE
-	0
induced	0
sleep	0
disorder	0
Opioid	I-DISEASE
F11.182	I-DISEASE
Opioid	0
abuse	0
with	I-DISEASE
opioid	0
-	0
induced	0
sleep	0
disorder	I-DISEASE
F11.282	I-DISEASE
Opioid	0
dependence	0
with	0
opioid	0
-	I-DISEASE
induced	I-DISEASE
sleep	I-DISEASE
disorder	0
F11.982	0
Opioid	0
use	0
,	0
unspecified	I-DISEASE
with	I-DISEASE
opioid	0
-	I-DISEASE
induced	I-DISEASE
sleep	I-DISEASE
disorder	I-DISEASE
Cannabis	I-DISEASE
F12.188	0
Cannabis	I-DISEASE
abuse	I-DISEASE
with	0
other	0
cannabis	0
-	I-DISEASE
induced	I-DISEASE
disorder	I-DISEASE
F12.288	0
Cannabis	I-DISEASE
dependence	I-DISEASE
with	I-DISEASE
other	I-DISEASE
cannabis	I-DISEASE
-	I-DISEASE
induced	0
disorder	I-DISEASE
F12.988	I-DISEASE
Cannabis	0
use	0
,	0
unspecified	I-DISEASE
with	I-DISEASE
other	I-DISEASE
cannabis	I-DISEASE
-	I-DISEASE
induced	I-DISEASE
disorder	0
Sedative	0
,	0
Hypnotic	0
or	I-DISEASE
Anxiolytic	0
F13.182	I-DISEASE
Sedative	0
,	0
hypnotic	0
or	0
anxiolytic	0
abuse	I-DISEASE
with	I-DISEASE
sedative	0
,	I-DISEASE
hypnotic	0
or	0
anxiolytic	0
-	0
induced	0
sleep	0
disorder	0
F13.282	0
Sedative	0
,	0
hypnotic	I-DISEASE
or	0
anxiolytic	I-DISEASE
dependence	I-DISEASE
with	0
sedative	I-DISEASE
,	I-DISEASE
hypnotic	0
or	I-DISEASE
anxiolytic	0
-	0
induced	I-DISEASE
sleep	0
disorder	0
F13.982	I-DISEASE
Sedative	0
,	0
hypnotic	I-DISEASE
or	I-DISEASE
anxiolytic	I-DISEASE
use	0
,	0
unspecified	I-DISEASE
with	0
sedative	I-DISEASE
,	I-DISEASE
hypnotic	I-DISEASE
or	I-DISEASE
anxiolytic	I-DISEASE
-	0
induced	I-DISEASE
sleep	0
disorder	0
Appendix	I-DISEASE
B	I-DISEASE
:	0
ICD-10	I-DISEASE
-	0
CM	I-DISEASE
Coding	0
for	0
Substance	I-DISEASE
-	0
Induced	0
Sleep	0
Disorders	0
Substance	0

Relevant	0
ICD-10	0
-	I-DISEASE
CM	0
Codes	0
Cocaine	0
F14.182	I-DISEASE
Cocaine	0
abuse	I-DISEASE
with	I-DISEASE
cocaine	0
-	0
induced	0
sleep	0
disorder	0
F14.282	0
Cocaine	I-DISEASE
dependence	0
with	0
cocaine	I-DISEASE
-	0
induced	0
sleep	0
disorder	0
F14.982	I-DISEASE
Cocaine	0
use	I-DISEASE
,	I-DISEASE
unspecified	0
with	I-DISEASE
cocaine	0
-	0
induced	0
sleep	0
disorder	0
Other	0
Stimulant	0
(	0
includes	I-DISEASE
amphetamine	0
and	I-DISEASE
caffeine	I-DISEASE
)	0

F15.182	0
Other	0
stimulant	0
abuse	0
with	0
stimulant	I-DISEASE
-	B-DISEASE
induced	0
sleep	I-DISEASE
disorder	0
F15.282	0
Other	0
stimulant	0
dependence	0
with	I-DISEASE
stimulant	0
-	0
induced	I-DISEASE
sleep	I-DISEASE
disorder	0
F15.982	0
Other	0
stimulant	0
use	0
,	I-DISEASE
unspecified	0
with	0
stimulant	0
-	0
induced	0
sleep	0
disorder	0
Hallucinogen	0
(	0
includes	0
ecstasy	0
,	I-DISEASE
PCP	I-DISEASE
,	I-DISEASE
phencyclidine	I-DISEASE
)	0

F16.188	0
Hallucinogen	0
abuse	I-DISEASE
with	0
other	0
hallucinogen	I-DISEASE
-	I-DISEASE
induced	0
disorder	I-DISEASE
F16.288	0
Hallucinogen	0
dependence	0
with	0
other	I-DISEASE
hallucinogen	I-DISEASE
-	I-DISEASE
induced	0
disorder	I-DISEASE
F16.988	0
Hallucinogen	0
use	0
,	0
unspecified	0
with	I-DISEASE
other	I-DISEASE
hallucinogen-	0
induced	0
disorder	I-DISEASE
Nicotine	0
F17.208	I-DISEASE
Nicotine	0
dependence	I-DISEASE
,	0
unspecified	0
,	0
with	0
other	0
nicotine-	0
induced	I-DISEASE
disorders	0
F17.218	I-DISEASE
Nicotine	0
dependence	0
,	I-DISEASE
cigarettes	0
,	I-DISEASE
with	I-DISEASE
other	0
nicotine	0
-	0
induced	0
disorders	0
F17.228	I-DISEASE
Nicotine	I-DISEASE
dependence	0
,	I-DISEASE
chewing	0
tobacco	I-DISEASE
,	0
with	I-DISEASE
other	I-DISEASE
nicotine-	0
induced	I-DISEASE
disorders	0
F17.298	I-DISEASE
Nicotine	0
dependence	0
,	I-DISEASE
other	0
tobacco	I-DISEASE
product	0
,	0
with	I-DISEASE
other	I-DISEASE
nicotine	0
-	0
induced	0
disorders	I-DISEASE
Inhalant	I-DISEASE
(	I-DISEASE
includes	0
volatile	I-DISEASE
solvents	0
)	B-DISEASE

F18.188	0
Inhalant	0
abuse	0
with	0
other	0
inhalant	0
-	0
induced	0
disorder	I-DISEASE
F18.288	0
Inhalant	0
dependence	0
with	0
other	0
inhalant	I-DISEASE
-	0
induced	I-DISEASE
disorder	0
F18.988	0
Inhalant	0
use	0
,	0
unspecified	0
with	I-DISEASE
other	I-DISEASE
inhalant	0
-	0
induced	0
disorder	0
Other	I-DISEASE
Psychoactive	0
Substance	I-DISEASE
(	0
includes	0
polysubstance	0
drug	0
use	0
)	0

F19.182	0
Other	0
psychoactive	0
substance	0
abuse	0
with	I-DISEASE
psychoactive	I-DISEASE
substance	0
-	I-DISEASE
induced	0
sleep	0
disorder	0
F19.282	0
Other	0
psychoactive	I-DISEASE
substance	0
dependence	0
with	I-DISEASE
psychoactive	0
substance	0
-	0
induced	0
sleep	0
disorder	0
F19.982	0
Other	0
psychoactive	I-DISEASE
substance	I-DISEASE
use	0
,	I-DISEASE
unspecified	0
with	0
psychoactive	0
substance	0
-	0
induced	0
sleep	I-DISEASE
disorder	0
Glossary	0
Actigraphy	0
:	0
A	I-DISEASE
measurement	I-DISEASE
of	0
physical	0
activity	B-DISEASE
,	0
typically	I-DISEASE
via	I-DISEASE
a	I-DISEASE
wrist	0
-	I-DISEASE
worn	I-DISEASE
movement	I-DISEASE
sensor	0
,	0
employed	0
to	0
estimate	0
sleep	I-DISEASE
and	0
wakefulness	0
based	I-DISEASE
on	I-DISEASE
relative	0
levels	I-DISEASE
of	0
physical	I-DISEASE
inactivity	0
and	I-DISEASE
activity	0
.	0

Alveolar	0
Hypoventilation	0
:	0
A	I-DISEASE
condition	0
in	0
which	I-DISEASE
ventilation	0
of	I-DISEASE
the	0
lung	0
gas	I-DISEASE
exchanging	0
units	0
is	0
decreased	0
relative	I-DISEASE
to	I-DISEASE
the	0
carbon	0
dioxide	I-DISEASE
production	0
(	0
excretion	0
)	0
such	0
that	I-DISEASE
the	I-DISEASE
arterial	0
partial	I-DISEASE
pressure	0
of	0
carbon	0
dioxide	0
is	0
increased	0
.	0

Alveolar	0
ventilation	0
is	0
equal	0
to	0
the	0
minute	0
ventilation	0
(	I-DISEASE
tidal	0
volume	0
×	0
respiratory	0
rate	0
)	I-DISEASE
minus	0
the	0
dead	I-DISEASE
space	0
ventilation	I-DISEASE
.	0

Apneic	0
Threshold	0
:	I-DISEASE

The	0
value	0
of	0
PaCO2	0
below	0
which	0
central	I-DISEASE
apnea	0
occurs	I-DISEASE
during	0
NREM	0
sleep	I-DISEASE
.	0

Ataxic	0
Breathing	I-DISEASE
:	0
A	0
breathing	I-DISEASE
pattern	I-DISEASE
consisting	I-DISEASE
of	0
irregular	I-DISEASE
variation	0
in	0
tidal	I-DISEASE
volume	I-DISEASE
and	0
respiratory	I-DISEASE
rate	0
,	I-DISEASE
characteristic	0
of	0
the	0
effects	0
of	0
opioids	0
on	I-DISEASE
breathing	I-DISEASE
.	0

Autonomic	0
Arousal	0
:	0
An	0
abrupt	0
shift	I-DISEASE
in	0
autonomic	0
nervous	0
system	0
activity	0
during	0
sleep	0
characterized	0
by	I-DISEASE
an	0
increase	0
in	I-DISEASE
sympathetic	0
activity	I-DISEASE
,	0
including	0
heart	0
rate	0
and	0
blood	0
pressure	0
.	I-DISEASE

Biological	0
Day	0
/	0
Night	0
:	0
In	0
humans	0
,	0
biological	I-DISEASE
day	0
refers	0
to	0
the	0
internal	I-DISEASE
circadian	I-DISEASE
time	0
when	0
wakefulness	I-DISEASE
and	0
associated	I-DISEASE
functions	0
are	0
promoted	0
(	0
e.g.	0
,	0
when	I-DISEASE
endogenous	0
melatonin	0
levels	I-DISEASE
are	0
low	0
)	0
.	0

Biological	0
night	0
refers	I-DISEASE
to	0
the	0
internal	I-DISEASE
circadian	I-DISEASE
time	0
when	I-DISEASE
sleep	0
and	0
associated	I-DISEASE
functions	0
are	0
promoted	0
(	0
e.g.	0
,	I-DISEASE
when	0
endogenous	0
melatonin	0
levels	0
are	0
high	0
)	I-DISEASE
.	0

Cataplexy	0
:	0

More	0
than	0
one	0
episode	0
of	0
generally	I-DISEASE
brief	I-DISEASE
(	I-DISEASE
<	I-DISEASE
2	0
minutes	0
)	0
,	I-DISEASE
usually	0
bilaterally	0
symmetrical	0
sudden	0
loss	I-DISEASE
of	0
muscle	0
tone	0
with	0
retained	0
consciousness	0
.	0

The	0
episodes	0
are	0
precipitated	0
by	0
strong	I-DISEASE
emotions	I-DISEASE
,	0
usually	I-DISEASE
positive	0
,	0
with	0
almost	0
all	I-DISEASE
patients	I-DISEASE
reporting	0
some	0
episodes	I-DISEASE
precipitated	0
by	0
emotions	0
associated	0
with	0
laughter	0
.	I-DISEASE

Chemosensitivity	0
:	0
The	0
sensitivity	0
of	0
the	0
chemoreceptors	I-DISEASE
to	0
increases	I-DISEASE
in	0
PCO2	0
or	I-DISEASE
decreases	0
in	0
PO2	I-DISEASE
.	0

In	0
humans	0
this	0
is	0
measured	0
by	0
increases	I-DISEASE
in	0
ventilation	0
associated	0
with	0
these	0
stimuli	0
.	0

Chronotype	0
:	0
Individual	0
timing	0
preference	0
for	I-DISEASE
various	I-DISEASE
physical	0
and	0
mental	0
activities	0
,	0
and	0
sleep	0
and	I-DISEASE
wakefulness	I-DISEASE
,	I-DISEASE
over	I-DISEASE
the	I-DISEASE
course	0
of	0
a	0
day	I-DISEASE
.	0

“	0
Morningness	0
”	0
refers	0
to	0
preference	0
for	0
earlier	0
timing	0
of	0
activities	I-DISEASE
and	0
sleep	0
initiation	0
;	I-DISEASE
“	0
eveningness	0
”	0
refers	0
to	0
preference	0
for	0
later	0
timing	0
of	0
activities	0
and	I-DISEASE
sleep	0
initiation	0
.	0

Glossary	0
Circadian	I-DISEASE
Misalignment	0
:	0

Incorrect	0
or	0
inappropriate	0
timing	0
of	0
sleep	0
and	0
wakefulness	I-DISEASE
with	I-DISEASE
respect	0
to	0
internal	I-DISEASE
circadian	0
timing	0
(	0
e.g.	0
,	0
the	0
wake	B-DISEASE
episode	I-DISEASE
occurring	0
entirely	0
or	0
partially	I-DISEASE
during	0
the	0
biological	I-DISEASE
night	I-DISEASE
and/or	0
the	0
major	I-DISEASE
sleep	0
episode	0
occurring	0
entirely	I-DISEASE
or	0
partially	I-DISEASE
during	I-DISEASE
the	0
biological	0
day	I-DISEASE
)	0
.	I-DISEASE

Circadian	0
Period	I-DISEASE
(	0
tau	0
):	0
The	0
time	I-DISEASE
it	0
takes	I-DISEASE
to	0
complete	0
one	0
circadian	0
cycle	0
(	I-DISEASE
e.g.	0
,	0
time	I-DISEASE
from	0
one	0
circadian	0
phase	0
on	0
day	0
1	I-DISEASE
to	0
the	0
same	0
circadian	0
phase	0
on	0
day	0
2	0
)	0
.	0

Circadian	0
Phase	I-DISEASE
:	0
The	0
time	0
at	I-DISEASE
which	I-DISEASE
a	0
particular	I-DISEASE
event	0
occurs	0
within	0
the	0
circadian	0
cycle	I-DISEASE
(	I-DISEASE
e.g.	I-DISEASE
,	0
onset	B-DISEASE
,	0
offset	0
,	0
trough	0
,	I-DISEASE
peak	0
)	0
.	0

Circadian	0
Rhythm	I-DISEASE
:	0
Biological	0
oscillation	0
,	0
with	I-DISEASE
a	0
periodicity	I-DISEASE
near	0
24	I-DISEASE
hours	I-DISEASE
,	0
which	0
is	I-DISEASE
clock-	I-DISEASE
driven	0
(	I-DISEASE
i.e.	0
,	I-DISEASE
not	0
caused	I-DISEASE
by	0
external	0
or	I-DISEASE
non	0
-	I-DISEASE
circadian	I-DISEASE
clock	0
factors	0
)	0
.	0

Comorbid	0
Insomnia	0
:	0
An	I-DISEASE
insomnia	0
syndrome	0
thought	0
to	0
have	I-DISEASE
partial	0
or	0
total	0
independence	0
from	0
a	0
co	0
-	0
occurring	I-DISEASE
sleep	0
disorder	0
or	0
sleep	0
-	0
disruptive	I-DISEASE
medical	I-DISEASE
,	0
psychiatric	I-DISEASE
,	I-DISEASE
substance	0
dependence	I-DISEASE
/	0
abuse	I-DISEASE
disorder	0
.	0

Conditioned	0
Arousal	0
:	0
An	0
arousal	0
response	I-DISEASE
developed	0
by	0
the	0
repeated	0
association	0
of	0
a	0
specific	0
setting	0
such	0
as	0
the	0
bedroom	0
with	0
unsuccessful	0
sleep	0
attempts	I-DISEASE
.	I-DISEASE

Cortical	0
Arousal	0
:	I-DISEASE
An	0
abrupt	0
shift	I-DISEASE
of	0
EEG	0
frequency	0
to	0
a	0
faster	0
frequency	0
lasting	0
at	0
least	0
3	0
seconds	0
,	0
indicating	0
cortical	0
activation	0
.	0

Cyclic	0
Alternating	0
Pattern	0
(	0
CAP	0
):	I-DISEASE
The	I-DISEASE
occurrence	0
in	0
NREM	0
sleep	0
of	0
transient	I-DISEASE
EEG	0
events	0
(	0
phase	0
A	0
,	0
subtypes	I-DISEASE
A1	0
,	0
A2	0
and	0
A3	0
)	0
interrupting	0
the	I-DISEASE
background	0
activity	0
(	0
phase	0
B	0
)	0
.	0

CAP	0
is	0
a	0
sensitive	0
marker	0
of	I-DISEASE
sleep	I-DISEASE
instability	0
,	I-DISEASE
usually	I-DISEASE
increased	0
in	0
sleep	I-DISEASE
disorders	0
that	I-DISEASE
adversely	0
affect	0
sleep	I-DISEASE
continuity	0
.	0

Dim	0
Light	0
Melatonin	0
Onset	I-DISEASE
(	0
DLMO	I-DISEASE
):	I-DISEASE
A	0
marker	I-DISEASE
of	0
internal	0
circadian	0
phase	I-DISEASE
designated	0
by	I-DISEASE
the	0
rise	0
in	I-DISEASE
melatonin	0
above	0
low	0
daytime	0
levels	0
,	I-DISEASE
typically	I-DISEASE
assessed	0
via	0
blood	0
or	0
salivary	0
melatonin	I-DISEASE
levels	I-DISEASE
.	0

Melatonin	0
levels	0
are	0
reduced	0
by	0
exposure	0
to	I-DISEASE
light	0
and	I-DISEASE
thus	0
need	0
to	0
be	0
assessed	0
in	I-DISEASE
dim	I-DISEASE
light	0
to	I-DISEASE
be	0
accurate	I-DISEASE
.	0

Dopaminergic	0
:	0

Related	0
to	0
the	0
neurotransmitter	0
dopamine	0
.	0

Dystonia	0
:	0
Involuntary	0
muscle	0
contractions	0
that	0
result	0
in	0
slow	I-DISEASE
repetitive	0
movements	0
or	0
abnormal	0
postures	0
.	0

Early	0
Morning	0
Awakening	0
:	0
The	0
termination	I-DISEASE
of	I-DISEASE
sleep	0
at	I-DISEASE
least	0
30	I-DISEASE
minutes	I-DISEASE
before	I-DISEASE
the	0
desired	0
rising	I-DISEASE
time	I-DISEASE
with	I-DISEASE
a	0
concomitant	0
reduced	0
total	0
sleep	I-DISEASE
time	0
compared	I-DISEASE
to	0
the	I-DISEASE
usual	I-DISEASE
premorbid	I-DISEASE
sleep	0
pattern	0
.	0

Electromyogram	0
(	0
EMG	0
):	0
Physiological	0
recording	0
of	I-DISEASE
muscle	0
activity	I-DISEASE
,	I-DISEASE
based	0
on	0
electrical	0
activity	0
that	I-DISEASE
accompanies	I-DISEASE
muscle	0
contraction	I-DISEASE
.	0

For	0
sleep	0
monitoring	0
purposes	0
,	0
EMG	0
is	0
typically	0
recorded	I-DISEASE
from	0
skin	0
surface	0
rather	0
than	0
intramuscular	I-DISEASE
electrodes	0
.	0

Entrained	0
/	0
Entrainment	0
:	0
The	0
successful	0
end	I-DISEASE
result	0
(	I-DISEASE
entrained	0
)	0
or	0
process	0
of	0
(	I-DISEASE
entrainment	0
)	0
synchronization	I-DISEASE
of	I-DISEASE
an	0
internal	0
circadian	0
clock	0
to	0
the	0
environment	0
(	0
e.g.	I-DISEASE
,	0
light	0
dark	0
cycle	0
)	0
,	0
producing	0
a	0
stable	0
phase	I-DISEASE
relationship	I-DISEASE
between	0
the	I-DISEASE
circadian	0
clock	0
and	0
environmental	0
time	I-DISEASE
.	0

Fatigue	0
:	0
A	I-DISEASE
lack	0
of	0
energy	I-DISEASE
,	I-DISEASE
accompanied	0
by	I-DISEASE
a	0
desire	0
to	0
reduce	0
or	0
limit	I-DISEASE
activity	0
levels	0
.	0

This	0
symptom	0
should	0
be	B-DISEASE
differentiated	0
from	0
reports	0
of	I-DISEASE
subjective	I-DISEASE
sleepiness	0
as	0
well	0
as	0
from	0
unintended	0
sleep	0
episodes	0
.	I-DISEASE

Homeostasis	0
:	0

The	0
tendency	0
of	0
a	0
living	0
organism	0
to	0
maintain	0
internal	0
equilibrium	0
by	0
adjusting	0
and	0
regulating	0
its	I-DISEASE
physiological	0
processes	0
.	I-DISEASE

Hypercapnia	0
:	0
Elevation	0
of	0
the	0
arterial	0
partial	I-DISEASE
pressure	I-DISEASE
of	I-DISEASE
carbon	0
dioxide	0
(	0
PaCO2	I-DISEASE
)	0
to	I-DISEASE
a	0
level	0
>	I-DISEASE
45	0
mm	0

Hg	0
during	0
wakefulness	0
.	0

Hypersomnolence	0
:	0
Excessive	0
sleepiness	0
during	0
the	0
normal	0
wake	0
period	I-DISEASE
.	0

Hypersomnia	0
:	0
A	0
disorder	0
characterized	0
by	I-DISEASE
excessive	0
sleepiness	0
(	I-DISEASE
e.g.	0
idiopathic	0
hypersomnia	0
)	I-DISEASE
.	0

Hypnagogic	0
Hallucinations	0
:	0

Vivid	0
dreamlike	0
experiences	I-DISEASE
occurring	0
at	0
the	0
transition	0
from	0
wake	I-DISEASE
to	0
sleep	0
.	0

Hypnopompic	0
Hallucinations	0
:	0

Vivid	0
dreamlike	0
experiences	I-DISEASE
occurring	0
at	0
the	0
transition	0
from	0
sleep	I-DISEASE
to	0
wake	0
.	0

Myalgia	0
:	0
Muscle	0
pain	0
.	0

Nonrestorative	0
Sleep	0
:	0
Sleep	0
that	0
is	I-DISEASE
perceived	I-DISEASE
to	0
be	I-DISEASE
poor	0
in	0
quality	0
and	I-DISEASE
unrefreshing	0
,	0
resulting	I-DISEASE
in	0
a	0
sense	0
of	0
feeling	0
unrested	0
upon	0
awakening	0
.	I-DISEASE

Glossary	0
Glossary	0
Odds	0
Ratio	0
:	0

A	0
statistical	0
term	0
that	0
provides	0
a	I-DISEASE
measure	I-DISEASE
of	0
the	I-DISEASE
strength	I-DISEASE
of	0
relationship	0
between	0
two	0
variables	I-DISEASE
;	0
the	0
odds	I-DISEASE
of	0
an	0
event	0
occurring	0
in	0
one	0
group	I-DISEASE
compared	0
to	0
the	I-DISEASE
odds	I-DISEASE
of	I-DISEASE
it	0
occurring	0
in	0
another	0
group	0
.	0

Oneirism	0
:	I-DISEASE
Acting	0
-	0
out	0
of	0
dreams	I-DISEASE
,	0
usually	I-DISEASE
from	0
REM	0
sleep	0
.	0

Out	0
of	0
Center	0
Sleep	0
Testing	0
:	0
A	I-DISEASE
sleep	0
study	I-DISEASE
performed	0
outside	0
of	0
the	0
sleep	0
center	I-DISEASE
,	0
usually	0
at	I-DISEASE
a	0
patient	0
’s	0
home	0
and	0
with	0
limited	I-DISEASE
(	0
typically	I-DISEASE
respiratory	I-DISEASE
related	0
)	0
channels	I-DISEASE
(	I-DISEASE
parameters	0
)	0
recorded	0
.	I-DISEASE

Parasomnia	0
Pseudo	0
-	0
Suicide	0
:	0
A	I-DISEASE
death	I-DISEASE
,	0
erroneously	I-DISEASE
attributed	I-DISEASE
by	0
authorities	0
to	0
suicide	0
,	I-DISEASE
which	I-DISEASE
results	0
from	I-DISEASE
complex	0
parasomnia	0
,	0
usually	0
from	0
NREM	I-DISEASE
sleep	0
.	0

Parkinson	0
Disease	0
:	0
A	0
neurodegenerative	0
movement	I-DISEASE
disorder	I-DISEASE
which	0
may	I-DISEASE
result	0
in	0
bradykinesia	I-DISEASE
,	I-DISEASE
rigidity	0
,	I-DISEASE
tremor	0
,	0
and/or	I-DISEASE
postural	0
instability	0
,	0
and	0
eventually	0
cognitive	0
decline	I-DISEASE
.	0

Phase	0
Advance	0
/	0
Delay	0
:	0
A	0
shift	I-DISEASE
in	0
the	I-DISEASE
timing	0
of	I-DISEASE
the	I-DISEASE
internal	0
circadian	I-DISEASE
clock	I-DISEASE
in	0
which	0
circadian	I-DISEASE
phase	0
is	I-DISEASE
moved	0
earlier	0
(	0
advance	0
,	0
such	0
as	0
required	0
for	0
eastward	0
jet	0
travel	0
or	0
to	0
assume	0
an	0
earlier	0
sleep	0
schedule	0
)	0
or	0
later	I-DISEASE
(	0
delay	0
,	0
such	0
as	I-DISEASE
required	0
for	0
westward	0
jet	0
travel	0
or	I-DISEASE
to	I-DISEASE
assume	0
a	0
later	0
sleep	0
schedule	0
)	I-DISEASE
.	I-DISEASE

Phase	0
Response	0
Curve	I-DISEASE
:	I-DISEASE
Graphic	0
representation	0
that	I-DISEASE
describes	0
the	0
circadian	0
phase	0
shifting	I-DISEASE
response	0
to	0
a	I-DISEASE
time	0
cue	0
(	I-DISEASE
e.g.	0
,	0
light	0
)	0
as	0
a	0
function	I-DISEASE
of	0
the	0
internal	I-DISEASE
circadian	I-DISEASE
time	I-DISEASE
at	0
which	I-DISEASE
the	0
cue	0
is	0
presented	0
.	0

Phase	0
Tolerance	0
:	0

The	0
ability	0
to	I-DISEASE
be	0
awake	0
or	0
asleep	0
at	0
an	I-DISEASE
inappropriate	0
internal	0
circadian	0
time	0
.	0

Physiological	0
Hyperarousal	0
:	0
A	0
state	0
of	0
chronic	0
physiologic	0
arousal	0
as	0
reflected	0
by	0
measures	0
such	0
as	I-DISEASE
increased	I-DISEASE
mean	0
latency	0
on	0
MSLT	0
,	0
increased	0
metabolic	0
rate	0
and	I-DISEASE
glucose	0
metabolism	0
in	0
the	0
CNS	0
(	0
PET	0
scan	0
)	0
,	0
decreased	0
heart	0
rate	I-DISEASE
variability	0
and	I-DISEASE
increased	0
heart	I-DISEASE
rate	I-DISEASE
.	0

PHOX2B	0
:	0

A	0
paired	0
-	0
like	I-DISEASE
homobox	0
gene	0
,	I-DISEASE
mutation	0
of	I-DISEASE
which	0
is	0
the	0
defining	I-DISEASE
abnormality	0
of	I-DISEASE
Congenital	0
Central	0
Hypoventilation	I-DISEASE
Syndrome	0
.	0

Prevalence	0
:	0

The	0
proportion	0
of	0
the	I-DISEASE
population	I-DISEASE
affected	I-DISEASE
by	I-DISEASE
a	0
disease	I-DISEASE
or	0
condition	0
at	I-DISEASE
a	I-DISEASE
given	0
time	I-DISEASE
;	0
prevalence	I-DISEASE
indicates	I-DISEASE
how	0
widespread	0
a	0
disease	0
or	0
condition	0
is	I-DISEASE
,	0
thereby	0
serving	0
as	B-DISEASE
a	I-DISEASE
measure	0
of	0
its	0
burden	0
on	0
society	0
.	0

REM	0
Sleep	0
without	0
Atonia	I-DISEASE
,	I-DISEASE
REM	I-DISEASE
-	I-DISEASE
without	0
Atonia	I-DISEASE
:	0
The	0
intermittent	I-DISEASE
or	I-DISEASE
continuous	I-DISEASE
loss	I-DISEASE
of	0
the	0
normal	I-DISEASE
muscle	0
atonia	I-DISEASE
of	0
REM	0
sleep	0
.	0

Reverse	0
First	0
Night	0
Effect	0
:	0
A	0
propensity	I-DISEASE
to	0
sleep	0
better	0
than	0
usual	0
on	I-DISEASE
the	0
first	I-DISEASE
night	0
in	0
the	I-DISEASE
sleep	0
laboratory	I-DISEASE
.	0

Sleep	0
Attacks	0
:	0
Inappropriate	I-DISEASE
falling	0
asleep	0
with	0
few	I-DISEASE
or	I-DISEASE
no	0
prodromal	0
symptoms	0
of	0
sleepiness	0
.	0

Sleep	0
Diary	0
(	I-DISEASE
sleep	0
log	0
):	0
An	I-DISEASE
instrument	0
used	0
by	0
individuals	I-DISEASE
to	0
keep	0
records	0
of	0
their	0
nightly	0
sleep	0
duration	0
and	0
quality	0
over	0
a	I-DISEASE
period	I-DISEASE
of	I-DISEASE
days	0
to	0
weeks	I-DISEASE
.	0

Sleep	0
Drunkenness	0
(	0
prolonged	0
sleep	0
inertia	0
):	I-DISEASE
Prolonged	0
difficulty	I-DISEASE
waking	0
up	0
after	0
a	I-DISEASE
night	0
’s	I-DISEASE
sleep	I-DISEASE
or	0
a	I-DISEASE
nap	0
with	0
repeated	0
returns	0
to	I-DISEASE
sleep	0
,	0
irritability	I-DISEASE
,	0
automatic	I-DISEASE
behavior	0
and	0
confusion	0
.	I-DISEASE

Sleep	0
Homeostasis	I-DISEASE
:	0
A	0
process	I-DISEASE
which	0
describes	I-DISEASE
the	0
propensity	I-DISEASE
for	0
sleep	I-DISEASE
driven	0
by	0
duration	0
of	I-DISEASE
prior	I-DISEASE
time	0
awake	I-DISEASE
and	0
sleep	I-DISEASE
history	0
.	0

Sleep	0
Hygiene	0
:	0
A	0
set	0
of	I-DISEASE
rules	I-DISEASE
/	0
instructions	I-DISEASE
about	0
lifestyle	0
(	0
caffeine	0
intake	0
,	0
alcohol	I-DISEASE
and	0
tobacco	0
use	0
,	0
diet	0
,	0
etc	0
.	0
)	0

and	0
environmental	0
factors	0
(	0
light	0
,	I-DISEASE
noise	I-DISEASE
,	0
temperature	I-DISEASE
)	0
that	I-DISEASE
affect	0
overall	0
sleep	0
duration	I-DISEASE
and	0
quality	0
.	I-DISEASE

Sleep	0
Onset	I-DISEASE
REM	0
Period	0
(	0
SOREMP	I-DISEASE
):	I-DISEASE
REM	I-DISEASE
sleep	I-DISEASE
occurring	0
within	0
15	I-DISEASE
minutes	I-DISEASE
of	0
sleep	I-DISEASE
onset	0
on	I-DISEASE
a	I-DISEASE
multiple	I-DISEASE
sleep	I-DISEASE
latency	0
test	0
or	I-DISEASE
overnight	0
polysomnogram	I-DISEASE
.	I-DISEASE

Sleep	0
Related	I-DISEASE
Abnormal	I-DISEASE
Sexual	0
Behaviors	0
:	0
Any	I-DISEASE
of	0
a	I-DISEASE
spectrum	0
of	0
sexualized	0
behaviors	0
which	0
arise	I-DISEASE
from	I-DISEASE
sleep	0
,	0
typically	0
NREM	0
sleep	0
.	0

Sleep	0
Related	I-DISEASE
Violence	I-DISEASE
:	0
Violent	0
behavior	0
which	I-DISEASE
is	0
associated	I-DISEASE
with	0
a	I-DISEASE
NREM	0
parasomnia	0
when	0
the	I-DISEASE
affected	0
individual	0
is	I-DISEASE
accidentally	0
provoked	0
by	0
another	0
person	0
in	I-DISEASE
close	0
proximity	I-DISEASE
–	0
usually	I-DISEASE
a	0
family	0
member	0
.	I-DISEASE

Suggested	0
Immobilization	0
Test	0
:	0
A	0
procedure	0
for	0
evaluation	0
of	I-DISEASE
periodic	0
leg	0
movements	0
and	0
related	0
sensory	I-DISEASE
components	0
of	0
RLS	I-DISEASE
during	0
resting	I-DISEASE
wakefulness	0
.	0

A	0
standard	0
polysomnogram	0
recording	0
without	0
respiratory	0
measures	0
is	0
used	I-DISEASE
for	I-DISEASE
one	I-DISEASE
hour	0
while	0
the	0
subject	I-DISEASE
sits	0
quietly	0
awake	I-DISEASE
and	0
upright	I-DISEASE
in	0
bed	0
with	0
the	0
legs	I-DISEASE
outstretched	I-DISEASE
.	0

Glossary	0
Index	I-DISEASE
A	0
Actigraphy	0
35	0
,	I-DISEASE
144	I-DISEASE
,	I-DISEASE
152	I-DISEASE
,	0
159	0
,	0
161–163	0
,	0
165	I-DISEASE
,	0
182	0
,	I-DISEASE
185	0
,	0
187	0
,	0
189	0
,	0
191	I-DISEASE
,	0
196	0
,	I-DISEASE
199	0
,	0
204	0
,	0
207	0
,	0
209	0
,	0
213	0
,	I-DISEASE
215	0
,	0
218	I-DISEASE
,	I-DISEASE
223	0
,	0
224	0
,	0
297	I-DISEASE
,	0
298	0
,	I-DISEASE
361	0
Adenotonsillar	0
hypertrophy	I-DISEASE
65	I-DISEASE
,	0
66	0
,	I-DISEASE
139	0
,	0
274	0
Advanced	0
sleep	0
-	I-DISEASE
wake	I-DISEASE
phase	0
disorder	0
198–203	I-DISEASE
Agrypnia	0
excitata	0
248	I-DISEASE
Akathisia	0
290	0
,	I-DISEASE
316	I-DISEASE
,	0
326	0
,	0
333	I-DISEASE
Alcohol	I-DISEASE
27	I-DISEASE
,	I-DISEASE
31	I-DISEASE
,	0
43	0
,	I-DISEASE
54	0
,	0
57	0
,	0
110	I-DISEASE
,	I-DISEASE
122	I-DISEASE
,	I-DISEASE
125	I-DISEASE
,	I-DISEASE
,	I-DISEASE
139	0
,	0
167	0
,	I-DISEASE
168	0
,	0
175	I-DISEASE
,	0
176	0
,	I-DISEASE
192	0
,	I-DISEASE
194	I-DISEASE
,	0
200	I-DISEASE
,	0
212	0
,	0
217	0
,	0
219	0
,	0
220	0
,	0
221	0
,	0
234	0
,	I-DISEASE
237	I-DISEASE
,	0
238	0
,	0
241	I-DISEASE
,	0
242	I-DISEASE
,	0
247	0
,	0
268	0
,	I-DISEASE
276–278	0
,	0
286	I-DISEASE
,	I-DISEASE
295	0
,	0
326	I-DISEASE
,	I-DISEASE
352	0
,	0
354	I-DISEASE
,	I-DISEASE
359	0
,	0
369	I-DISEASE
Alpha-1	I-DISEASE
antitrypsin	0
129	0
,	0
130	0
,	I-DISEASE
136	I-DISEASE
Alternating	0
leg	0
muscle	0
activation	0
330–334	0
Alzheimer	0
disease	I-DISEASE
204	0
,	0
205	0
,	I-DISEASE
224	0
,	I-DISEASE
277	0
,	I-DISEASE
279	0
,	0
Amyotrophic	0
lateral	0
sclerosis	0
300	0
Angina	I-DISEASE
61	I-DISEASE
,	I-DISEASE
358	I-DISEASE
,	0
362–366	I-DISEASE
Antidepressant	I-DISEASE
148	0
,	0
153	0
,	0
176	0
,	0
249	0
,	I-DISEASE
250	0
,	I-DISEASE
,	I-DISEASE
259	I-DISEASE
,	0
277	B-DISEASE
,	0
285	I-DISEASE
,	0
294	I-DISEASE
,	I-DISEASE
295	0
,	0
331	0
,	I-DISEASE
333	I-DISEASE
Anxiety	0
disorder	0
26	I-DISEASE
,	I-DISEASE
28	0
,	I-DISEASE
31	I-DISEASE
,	I-DISEASE
38	I-DISEASE
,	0
148	0
,	I-DISEASE
192	0
,	I-DISEASE
,	I-DISEASE
257	I-DISEASE
,	0
269	0
,	0
284	0
Anxiolytic	0
110	I-DISEASE
,	I-DISEASE
122	0
,	I-DISEASE
130	I-DISEASE
,	0
255	0
,	I-DISEASE
369	0
Apneic	0
threshold	0
72	0
,	0
73	0
,	I-DISEASE
82	0
,	0
91	B-DISEASE
,	I-DISEASE
92	0
Apparent	0
life	0
-	0
threatening	0
event	I-DISEASE
(	I-DISEASE
ALTE	I-DISEASE
)	I-DISEASE
94	0
,	0
,	0
97	0
,	I-DISEASE
114	0
,	0
117	I-DISEASE
Arrhythmia	0
58	0
,	I-DISEASE
65	0
,	0
101	I-DISEASE
,	I-DISEASE
110	0
,	0
122	I-DISEASE
,	I-DISEASE
126	0
,	I-DISEASE
,	0
136	0
,	0
363	I-DISEASE
,	0
365	0
,	0
366	0
Asperger	0
syndrome	I-DISEASE
206	I-DISEASE
,	0
297	I-DISEASE
Asthma	0
61	I-DISEASE
,	I-DISEASE
357–359	I-DISEASE
Ataxic	I-DISEASE
breathing	I-DISEASE
74	0
,	0
76	0
,	0
85	0
,	I-DISEASE
87	0
,	0
88	I-DISEASE
,	I-DISEASE
105	0
,	I-DISEASE
,	0
125	0
,	0
127	0
,	0
128	I-DISEASE
Atrial	0
fibrillation	0
53	0
,	I-DISEASE
55	0
,	0
58	I-DISEASE
,	0
69	0
,	I-DISEASE
71	0
,	0
139	0
Attention	0
deficit	0
hyperactivity	0
disorder	I-DISEASE
66	0
,	I-DISEASE
192	0
,	0
193	0
,	0
195	I-DISEASE
,	0
271	0
,	0
284	I-DISEASE
,	0
288	0
,	0
291	I-DISEASE
,	I-DISEASE
308	0
,	0
310	I-DISEASE
,	0
314	I-DISEASE
Augmentation	0
59	0
,	I-DISEASE
283	I-DISEASE
Autism	0
(	0
see	B-DISEASE
also	I-DISEASE
pervasive	0
developmental	0
disorder	I-DISEASE
)	0
119	0
,	0
195	0
,	I-DISEASE
200	0
,	0
206	0
,	I-DISEASE
211	0
,	0
251	0
,	0
314	0
,	0
316	0
B	I-DISEASE
Barrett	0
esophagus	I-DISEASE
359–361	I-DISEASE
Behavioral	I-DISEASE
insomnia	0
of	I-DISEASE
childhood	0
(	0
see	0
also	I-DISEASE
limit	I-DISEASE
-	I-DISEASE
setting	0
sleep	I-DISEASE
disorder	I-DISEASE
and	0
sleep-	0
onset	0
association	0
disorder	I-DISEASE
)	0
21	I-DISEASE
,	0
27	0
,	I-DISEASE
29	0
,	0
340	I-DISEASE
Benign	I-DISEASE
epilepsy	0
of	0
childhood	0
with	I-DISEASE
centrotemporal	I-DISEASE
spikes	0
(	I-DISEASE
BECT	I-DISEASE
)	0
345–347	0
Benign	0
epilepsy	I-DISEASE
with	0
occipital	0
paroxysms	0
(	0
BEOP	I-DISEASE
)	B-DISEASE
345–347	0
Benign	I-DISEASE
sleep	0
myoclonus	I-DISEASE
of	I-DISEASE
infancy	0
317–320	I-DISEASE
Biot	0
breathing	0
87	0
Blindness	I-DISEASE
202	0
,	0
209–213	0
Body	0
rocking	0
312–314	0
,	I-DISEASE
316	0
Breathing	0
disorders	0
(	I-DISEASE
see	0
sleep	0
related	0
breathing	I-DISEASE
disorders	0
)	I-DISEASE
Bruxism	0
(	0
see	0
sleep	I-DISEASE
related	0
bruxism	0
)	0
C	0
Cataplexy	0
141	I-DISEASE
,	0
145–162	I-DISEASE
,	I-DISEASE
171	0
,	0
242	0
,	0
250	0
,	0
256	0
Catathrenia	I-DISEASE
141	I-DISEASE
Central	0
disorders	0
of	I-DISEASE
hypersomnolence	0
–	I-DISEASE
188	I-DISEASE
Central	0
sleep	I-DISEASE
apnea	0
due	I-DISEASE
to	I-DISEASE
a	I-DISEASE
medical	0
disorder	0
without	0
Cheyne	0
-	0
Stokes	I-DISEASE
breathing	0
75–79	0
Index	0
Central	I-DISEASE
sleep	I-DISEASE
apnea	0
due	0
to	I-DISEASE
a	0
medication	0
or	I-DISEASE
substance	0
85–89	0
Central	0

69–107	0
Central	0
sleep	0
apnea	0
with	0
Cheyne	I-DISEASE
-	I-DISEASE
Stokes	I-DISEASE
breathing	0
69–75	0
Cerebrovascular	0
accident	I-DISEASE
(	0
see	0
also	0
stroke	0
)	0
,	I-DISEASE
78	0
,	0
93	0
Charley	0
horse	0
299	0
Chemoresponsiveness	0
80	0
,	0
81	B-DISEASE
,	B-DISEASE
91	I-DISEASE
,	0
92	0
,	0
121	0
,	0
,	0
129	I-DISEASE
Chemosensitivity	0
111	0
,	0
123	I-DISEASE
,	0
126	I-DISEASE
,	0
130	0
,	B-DISEASE
131	I-DISEASE
,	I-DISEASE
Chiari	0
malformation	I-DISEASE
76–78	0
,	0
93	I-DISEASE
,	B-DISEASE
116	0
Children	0
’s	0
Chronotype	0
Questionnaire	0
196	I-DISEASE
Choking	I-DISEASE
(	0
see	I-DISEASE
also	I-DISEASE
sleep	0
related	I-DISEASE
laryngospasm	0
)	0
53	0
,	I-DISEASE
54	0
,	0
96	I-DISEASE
,	I-DISEASE
357	0
,	I-DISEASE
358	0
Chronic	0
bronchitis	I-DISEASE
129	I-DISEASE
Chronic	I-DISEASE
fatigue	0
syndrome	0
39	0
,	0
154	0
,	0
160	0
,	0
,	I-DISEASE
181	0
,	0
206	0
Chronic	I-DISEASE
insomnia	0
disorder	0
21–41	0
Chronic	0
obstructive	0
pulmonary	I-DISEASE
disease	I-DISEASE
(	I-DISEASE
see	0
also	I-DISEASE
lower	0
airway	0
)	0
55	I-DISEASE
,	0
56	0
,	I-DISEASE
129	0
,	0
131	0
,	0
,	0
138	0
,	I-DISEASE
284	0
,	0
358	0
Chronic	I-DISEASE
pain	0
22	0
,	I-DISEASE
31	B-DISEASE
,	0
86	0
,	I-DISEASE
87	0
Chronic	0
renal	0
failure	I-DISEASE
285	0
,	0
286	I-DISEASE
,	0
287	0
Chronotype	I-DISEASE
184	0
,	I-DISEASE
189–193	0
,	I-DISEASE
195–197	B-DISEASE
,	0
199	I-DISEASE
,	I-DISEASE
,	0
219	0
Circadian	0
period	I-DISEASE
195	I-DISEASE
,	0
197	0
,	I-DISEASE
201	I-DISEASE
,	0
209	I-DISEASE
,	0
212	B-DISEASE
,	0
,	0
222	I-DISEASE
Circadian	I-DISEASE
phase	0
191–196	0
,	0
199	0
,	0
200	0
Circadian	I-DISEASE
rhythm	0
sleep	I-DISEASE
-	0
wake	I-DISEASE
disorders	0
–	I-DISEASE
224	0
Circadian	0
sleep	0
-	I-DISEASE
wake	0
disorder	I-DISEASE
not	I-DISEASE
otherwise	I-DISEASE
specified	I-DISEASE
224	0
Cluster	0
headache	0
266	0
,	0
350–354	0
Comorbid	0
insomnia	0
21	0
Complex	0
nocturnal	I-DISEASE
visual	0
hallucinations	0
–	I-DISEASE
269	0
Complex	I-DISEASE
sleep	0
apnea	0
(	0
see	0
also	0
treatment-	B-DISEASE
emergent	0
central	I-DISEASE
sleep	0
apnea	I-DISEASE
)	I-DISEASE

102	0
Conditioned	0
arousal	0
20	0
,	0
23	0
,	0
26	0
,	0
28	0
Confusional	0
arousal	0

228–239	0
Congenital	0
central	0
alveolar	0
hypoventilation	0
syndrome	0
113–117	I-DISEASE
Congestive	0
heart	I-DISEASE
failure	0
50	0
,	0
53	0
,	0
55	0
,	I-DISEASE
58	0
,	I-DISEASE
61	0
,	0
,	0
71	0
,	0
72	0
,	I-DISEASE
93	0
,	0
271	0
,	0
287	0
,	0
297	I-DISEASE
Continuous	0
spike	0
and	0
wave	0
in	0
sleep	I-DISEASE
(	0
CSWS	0
)	I-DISEASE
,	0
346	0
,	0
347	0
,	I-DISEASE
348	I-DISEASE
Coronary	I-DISEASE
artery	I-DISEASE
disease	0
(	0
see	0
also	I-DISEASE
angina	I-DISEASE
)	0
,	0
55	0
,	I-DISEASE
58	I-DISEASE
,	I-DISEASE
61	I-DISEASE
,	0
139	0
,	I-DISEASE
364	0
,	I-DISEASE
365	0
Cor	0
pulmonale	0
55	0
,	0
66	0
,	I-DISEASE
77	0
,	0
91	I-DISEASE
,	0
109	I-DISEASE
,	I-DISEASE
110	0
,	I-DISEASE
,	I-DISEASE
115	0
,	0
117	0
,	I-DISEASE
119	0
,	0
122	I-DISEASE
,	I-DISEASE
125	0
,	0
129	I-DISEASE
,	I-DISEASE
135	I-DISEASE
Cyclic	0
alternating	0
pattern	0
296	I-DISEASE
,	I-DISEASE
308	0
Cystic	0
fibrosis	0
129	0
,	0
130	0
,	0
136	I-DISEASE
,	I-DISEASE
358	0
D	0
Delayed	0
sleep	0
-	0
wake	I-DISEASE
phase	0
disorder	0
191–198	0
Dementia	0
with	0
Lewy	I-DISEASE
bodies	0
249	0
,	0
250	B-DISEASE
Diabetes	0
53	0
,	0
55	I-DISEASE
,	0
58	I-DISEASE
,	0
62	I-DISEASE
,	0
118	0
,	I-DISEASE
119	0
,	0
187	0
,	I-DISEASE
241	I-DISEASE
,	0
,	I-DISEASE
273	B-DISEASE
,	0
274	I-DISEASE
,	I-DISEASE
284	I-DISEASE
,	0
287	I-DISEASE
,	0
300	I-DISEASE
,	0
364	I-DISEASE
,	0
365	I-DISEASE
Diagnostic	I-DISEASE
and	I-DISEASE
statistical	0
manual	0
26	0
,	0
28	I-DISEASE
,	0
,	B-DISEASE
261	I-DISEASE
,	0
316	0
Dim	0
-	0
light	I-DISEASE
melatonin	0
onset	I-DISEASE
196	0
,	0
199	0
,	0
209	0
Disorders	B-DISEASE
of	I-DISEASE
arousal	I-DISEASE
(	0
from	0
NREM	0
sleep	I-DISEASE
)	I-DISEASE
–	0
239	0
Dopamine	0
172	0
,	0
176	0
,	I-DISEASE
259	0
,	0
284	I-DISEASE
,	I-DISEASE
285	I-DISEASE
,	0
288	I-DISEASE
,	I-DISEASE
,	I-DISEASE
294–298	0
Down	0
syndrome	0
57	I-DISEASE
,	0
65	0
,	0
305	I-DISEASE
Dystonia	0
297	I-DISEASE
,	I-DISEASE
301	0
,	0
302	I-DISEASE
,	I-DISEASE
309	I-DISEASE
,	I-DISEASE
345	0
E	I-DISEASE
Early	I-DISEASE
morning	I-DISEASE
awakening	I-DISEASE
24	I-DISEASE
,	I-DISEASE
33	0
,	0
37	B-DISEASE
,	0
45	0
,	I-DISEASE
195	0
,	I-DISEASE
202	0
,	0
221	0
,	I-DISEASE
358	I-DISEASE
,	0
359	0
Electromyogram	I-DISEASE
(	I-DISEASE
EMG	0
)	0
60	0
,	I-DISEASE
226	I-DISEASE
,	I-DISEASE
237	0
,	0
247	0
,	0
251	0
,	0
296	0
,	I-DISEASE
298	I-DISEASE
,	I-DISEASE
301	0
,	0
309	0
,	I-DISEASE
310	I-DISEASE
,	0
318	I-DISEASE
,	I-DISEASE
320	0
,	0
323	I-DISEASE
,	I-DISEASE
324	0
,	I-DISEASE
328	0
,	I-DISEASE
329	I-DISEASE
,	B-DISEASE
331–333	0
,	0
336	I-DISEASE
,	0
361	I-DISEASE
Emphysema	0
(	I-DISEASE
see	0
also	0
chronic	0
obstructive	0
pulmonary	0
disease	I-DISEASE
)	0
129	0
,	0
130	0
,	I-DISEASE
136	I-DISEASE
Entrainment	I-DISEASE
189	B-DISEASE
,	I-DISEASE
197	0
,	0
206	I-DISEASE
,	0
210–213	0
Environmental	0
sleep	I-DISEASE
disorder	I-DISEASE
339	0
Epilepsy	I-DISEASE
(	0
see	I-DISEASE
also	0
sleep	0
related	I-DISEASE
epilepsy	0
and	0
seizure	0
)	0
68	0
,	0
236	I-DISEASE
,	0
237	0
,	0
252	0
,	B-DISEASE
271	0
,	0
274	I-DISEASE
,	0
298	0
,	0
307	0
,	I-DISEASE
309	I-DISEASE
,	I-DISEASE
310	0
,	0
312	0
,	I-DISEASE
316	I-DISEASE
,	0
317	I-DISEASE
,	0
341	0
,	0
345–349	0
Epworth	0
Sleepiness	0
Scale	0
55	0
,	0
86	I-DISEASE
,	0
144	0
,	0
163	0
,	0
173	B-DISEASE
,	I-DISEASE
181	0
,	I-DISEASE
196	I-DISEASE
,	0
284	0
,	0
293	0
Esophageal	0
manometry	0
60	0
,	0
294	0
,	0
360	0
Esophageal	I-DISEASE
pH	0
361	0
Excessive	0
fragmentary	0
myoclonus	0
328–330	I-DISEASE
Excessive	0
time	0
in	B-DISEASE
bed	I-DISEASE
47	I-DISEASE

Exploding	0
head	0
syndrome	I-DISEASE
264–266	I-DISEASE
F	0
Fatal	0
familial	I-DISEASE
insomnia	0
342–344	0
Ferritin	0
285	0
,	0
295	0
Fibromyalgia	0
39	I-DISEASE
,	0
284	0
Free	0
-	0
running	0
(	0
see	I-DISEASE
non-24	0
-	0
hour	I-DISEASE
sleep	0
-	I-DISEASE
wake	I-DISEASE
rhythm	0
disorder	0
)	0

G	0
Gastroesophageal	I-DISEASE
reflux	0
(	0
see	0
also	I-DISEASE
sleep	0
related	0
gastroesophageal	I-DISEASE
reflux	0
)	0
22	0
,	0
23	0
,	I-DISEASE
31	I-DISEASE
,	0
33	I-DISEASE
,	0
38	I-DISEASE
,	0
55	0
,	0
61	0
,	0
99	I-DISEASE
,	0
101	I-DISEASE
,	0
117	0
,	0
309	0
,	0
341	0
,	0
355–358	0
,	0
362	I-DISEASE
,	0
363	0
,	I-DISEASE
366	0
H	0
Hcrt	0
149	0
,	0
156–160	0
,	0
171	0
Headaches	0
(	0
see	0
sleep	I-DISEASE
related	0
headaches	0
)	I-DISEASE
Head	0
banging	I-DISEASE
312–315	0
Head	I-DISEASE
trauma	I-DISEASE
149	0
,	I-DISEASE
156	I-DISEASE
,	0
157	I-DISEASE
,	0
168	0
,	0
170	I-DISEASE
,	0
172	0
,	I-DISEASE
High	0
-	I-DISEASE
altitude	0
periodic	0
breathing	I-DISEASE
79–84	I-DISEASE
hPer2	I-DISEASE
(	I-DISEASE
clock	0
gene	I-DISEASE
)	I-DISEASE
201	I-DISEASE
hPer3	I-DISEASE
(	0
clock	0
gene	I-DISEASE
)	0
193	0
,	I-DISEASE
194	0
Human	0
leukocyte	I-DISEASE
antigen	I-DISEASE
149	0
,	0
150	0
,	I-DISEASE
152	0
,	0
153	0
,	0
157–160	0
,	0
164	0
,	I-DISEASE
168	I-DISEASE
,	0
169	I-DISEASE
,	0
194	0
Huntington	0
disease	0
205	0
,	B-DISEASE
224	I-DISEASE
Hypernychthemeral	0
209	0
Hypersomnia	0
associated	I-DISEASE
with	0
psychiatric	I-DISEASE
disorders	I-DISEASE
179–182	0
Hypersomnia	0
due	B-DISEASE
to	I-DISEASE
a	0
medical	I-DISEASE
disorder	B-DISEASE
–	I-DISEASE
175	0
Hypersomnia	0
due	I-DISEASE
to	0
a	0
medication	I-DISEASE
or	I-DISEASE
substance	I-DISEASE
175–178	0
Hypertension	I-DISEASE
32	I-DISEASE
,	0
53	0
,	I-DISEASE
55	I-DISEASE
,	0
56	0
,	0
58	I-DISEASE
,	0
60	0
,	0
61	0
,	I-DISEASE
66	0
,	0
,	0
91	0
,	0
110	B-DISEASE
,	0
112	B-DISEASE
,	0
116	0
,	0
120	I-DISEASE
,	0
122–126	I-DISEASE
,	0
128–132	0
,	0
134–137	I-DISEASE
,	0
139	0
,	0
140	0
,	0
291	I-DISEASE
,	0
352	0
,	I-DISEASE
354	0
,	0
359	0
,	0
364	0
Hyperthyroidism	0
234	0
Hypnagogic	0
foot	0
tremor	I-DISEASE
330–334	0
Hypnagogic	0
hallucination	0
148	0
,	0
150	I-DISEASE
,	I-DISEASE
151	0
,	0
,	I-DISEASE
158	0
,	0
163	0
,	0
171	0
,	I-DISEASE
183	0
,	0
261	I-DISEASE
,	0
267–269	0
,	I-DISEASE
Hypnic	0
headache	I-DISEASE
266	0
,	0
350	0
,	I-DISEASE
351	B-DISEASE
,	0
353	I-DISEASE
,	I-DISEASE
354	0
Hypnic	0
jerks	I-DISEASE
(	0
see	0
also	I-DISEASE
sleep	I-DISEASE
starts	I-DISEASE
)	0
335–337	0
Hypnopompic	0
hallucination	0
148	I-DISEASE
,	0
252	0
,	I-DISEASE
267	0
,	0
,	I-DISEASE
276	0
Hypnotic	0
22	I-DISEASE
,	0
33	I-DISEASE
,	0
110	0
,	0
122	0
,	0
130	I-DISEASE
,	I-DISEASE
176	I-DISEASE
,	0
178	0
,	I-DISEASE
,	I-DISEASE
194	0
,	I-DISEASE
212	I-DISEASE
,	I-DISEASE
234	I-DISEASE
,	0
242	0
,	I-DISEASE
243	I-DISEASE
,	0
247	0
,	0
277	0
,	0
,	0
356	0
,	0
369	I-DISEASE
Hypocretin	0
145	I-DISEASE
,	0
146	I-DISEASE
,	0
149–156	0
,	0
158–160	I-DISEASE
,	0
,	I-DISEASE
169	I-DISEASE
,	0
172	0
,	I-DISEASE
250	I-DISEASE
Hypothyroidism	I-DISEASE
57	B-DISEASE
,	0
112	I-DISEASE
,	0
118	0
,	0
123	0
,	0
127	0
,	0
173	I-DISEASE
Hypoventilation	I-DISEASE
(	I-DISEASE
see	0
sleep	I-DISEASE
related	0
hypoventilation	0
disorders	0
)	0

I	0
Idiopathic	0
central	0
alveolar	0
hypoventilation	0

121–124	0
Idiopathic	0
hypersomnia	0
161–166	I-DISEASE
Idiopathic	0
insomnia	I-DISEASE
20	I-DISEASE
,	0
27	I-DISEASE
Inadequate	0
sleep	0
hygiene	0
20	0
,	0
27	0
,	0
197	I-DISEASE
Insomnia	0
19–48	0
Index	0
Index	0
Insomnia	0
due	0
to	0
(	0
a	0
)	I-DISEASE
medical	B-DISEASE
condition	I-DISEASE
28	0
Insomnia	0
due	I-DISEASE
to	0
(	0
another	0
)	0
mental	0
disorder	0
Insomnia	0
due	I-DISEASE
to	0
drug	0
or	0
substance	0
28	0
Insomnia	0
with	I-DISEASE
objectively	0
short	0
sleep	0
duration	0
29	0

Insufficient	0
sleep	0
syndrome	0
182–186	0
Iron	0
deficiency	I-DISEASE
285	I-DISEASE
,	0
288	0
Irregular	0
sleep	0
-	0
wake	0
rhythm	0
disorder	I-DISEASE
–	0
208	0
J	I-DISEASE
Jet	0
lag	I-DISEASE
disorder	0
220–224	I-DISEASE
Juvenile	0
myoclonic	0
epilepsy	0
(	0
JME	0
)	I-DISEASE
345	0
,	0
K	I-DISEASE
Kleine	I-DISEASE
-	0
Levin	0
syndrome	0
166–170	0
L	0
Laryngospasm	I-DISEASE
(	0
see	0
sleep	0
related	0
laryngospasm	0
)	0

Late	0
-	0
onset	0
central	0
hypoventilation	0
with	0
hypothalamic	0
dysfunction	0
118–120	0
Leg	0
cramps	0
(	0
see	0
sleep	0
related	0
leg	0
cramps	0
)	I-DISEASE

Limit	0
-	I-DISEASE
setting	0
sleep	I-DISEASE
disorder	0
21	I-DISEASE
Long	I-DISEASE
sleeper	0
187–188	I-DISEASE
Lower	I-DISEASE
airway	0
(	I-DISEASE
lung	0
disease	0
)	I-DISEASE
(	0
see	I-DISEASE
also	I-DISEASE
chronic	0
obstructive	0
pulmonary	0
disease	0
,	0
emphysema	0
and	0
chronic	0
bronchitis	0
)	0
52	0
,	0
129	0
,	0
135	0
M	0
Major	0
depression	0
(	0
see	0
also	I-DISEASE
mood	0
disorder	0
)	0

180	0
,	0
193	0
,	0
284	0
Melatonin	0
(	I-DISEASE
see	0
also	I-DISEASE
dim	0
-	0
light	0
melatonin	0
onset	0
)	0

173	0
,	0
176	0
,	0
189	0
,	0
191	I-DISEASE
,	0
195	I-DISEASE
,	0
196	0
,	0
200	0
,	0
201	I-DISEASE
,	0
206	0
,	I-DISEASE
207	0
,	0
209	0
,	0
213	0
,	0
218	I-DISEASE
,	0
354	0
Menopause	I-DISEASE
57	I-DISEASE
,	0
353	I-DISEASE
Menstrual	I-DISEASE
-	0
related	0
Kleine	0
-	0
Levin	0
syndrome	I-DISEASE
167	I-DISEASE
Methadone	0
(	0
see	I-DISEASE
also	I-DISEASE
opioid	0
)	0
86	I-DISEASE
,	I-DISEASE
87	I-DISEASE
,	0
105	I-DISEASE
,	0
126	0
Migraine	I-DISEASE
170	I-DISEASE
,	0
234	0
,	0
265	I-DISEASE
,	I-DISEASE
266	0
,	I-DISEASE
269	0
,	I-DISEASE
284	I-DISEASE
,	0
350–354	0
Mood	I-DISEASE
disorder	0
(	0
see	I-DISEASE
also	0
major	0
depression	I-DISEASE
)	I-DISEASE
28	0
,	0
53	0
,	I-DISEASE
168	I-DISEASE
,	0
179	I-DISEASE
,	I-DISEASE
192	I-DISEASE
,	0
193	B-DISEASE
,	0
212	0
,	I-DISEASE
244	I-DISEASE
,	I-DISEASE
260	I-DISEASE
,	I-DISEASE
268	I-DISEASE
,	B-DISEASE
288	I-DISEASE
,	0
291	I-DISEASE
,	0
294	0
Morningness	0
-	0
eveningness	0
questionnaire	0
189	0
,	0
190	0
,	0
196	B-DISEASE
Movement	I-DISEASE
disorders	0
(	0
see	0
sleep	0
related	0
movement	0
disorders	0
)	0

Multiple	0
sclerosis	0
34	0
,	I-DISEASE
156	0
,	0
170	I-DISEASE
,	0
247	I-DISEASE
,	0
248	0
,	0
251	0
,	0
284	I-DISEASE
,	0
297	0
Multiple	I-DISEASE
sleep	0
latency	0
test	I-DISEASE
35	0
,	0
55	I-DISEASE
,	0
61	0
,	0
144	I-DISEASE
,	0
146	0
,	0
151–165	0
,	0
169	0
,	0
171–174	0
,	0
177	0
,	0
179	0
,	I-DISEASE
181	0
,	0
185	0
,	0
188	I-DISEASE
,	I-DISEASE
218	I-DISEASE
,	0
266	0
,	0
293	0
,	I-DISEASE
297	I-DISEASE
Multisystem	0
atrophy	0
355	0
,	0
356	0
Munich	0
Chronotype	I-DISEASE
Questionnaire	0
190	I-DISEASE
,	I-DISEASE
196	0
Muscular	I-DISEASE
dystrophy	0
67	0
,	I-DISEASE
117	I-DISEASE
Myocardial	0
ischemia	0
(	I-DISEASE
see	I-DISEASE
sleep	I-DISEASE
related	0
myocardial	0
ischemia	I-DISEASE
)	I-DISEASE

Myotonic	0
dystrophy	0
57	0
,	0
156	0
,	0
172	I-DISEASE
,	I-DISEASE
175	I-DISEASE
N	0
Narcolepsy	0
type	0
1	0
146–155	0
Narcolepsy	0
type	0
2	0
155–161	I-DISEASE
Negative	0
expectations	0
23	0
,	0
219	0
,	0
223	I-DISEASE
Neuromuscular	0
(	0
disease	I-DISEASE
/	0
disorder	I-DISEASE
)	I-DISEASE
52	I-DISEASE
,	0
64	0
,	0
,	0
66	0
,	I-DISEASE
67	0
,	0
93	I-DISEASE
,	0
112	0
,	0
121	0
,	0
123	0
,	I-DISEASE
126–131	0
,	I-DISEASE
–	0
137	I-DISEASE
,	I-DISEASE
153	0
,	0
300	0
Night	0
eating	I-DISEASE
syndrome	0
244	0
,	0
245	0
Nightmare	I-DISEASE
disorder	I-DISEASE
257–263	0
Nocturnal	I-DISEASE
frontal	0
lobe	0
epilepsy	0
(	I-DISEASE
NFLE	0
)	0
,	I-DISEASE
345–349	I-DISEASE
Nocturnal	0
paroxysmal	0
hemicrania	0
266	I-DISEASE
Non-24	I-DISEASE
-	I-DISEASE
hour	I-DISEASE
sleep	B-DISEASE
-	I-DISEASE
wake	0
rhythm	0
disorder	0
–	0
214	0
Nonrestorative	0
sleep	0
23	0
,	0
33	0
,	0
39	0
,	I-DISEASE
43	0
,	0
53	0
,	I-DISEASE
69	0
,	0
75	0
,	0
79	0
,	0
85	0
,	0
89	I-DISEASE
,	0
241	I-DISEASE
,	0
294	0
,	0
296	0

O	0

Obesity	0
51	0
,	0
53	0
,	0
55	0
,	I-DISEASE
57	0
,	I-DISEASE
58	0
,	0
61	0
,	0
65	0
,	I-DISEASE
66	0
,	0
68	I-DISEASE
,	0
108–111	0
,	0
116	0
,	0
118–121	0
,	I-DISEASE
123	0
,	0
124	0
,	0
126	I-DISEASE
,	0
128	0
,	0
139	0
,	0
148	0
,	0
151	I-DISEASE
,	0
173	0
,	I-DISEASE
241	0
,	0
244	0
,	0
284	0
,	I-DISEASE
364	0
Obesity	0
hypoventilation	0
syndrome	0
108–113	0
Obstructive	I-DISEASE
sleep	0
apnea	0
,	I-DISEASE
adult	0
53–62	I-DISEASE
Obstructive	0
sleep	0
apnea	I-DISEASE
disorders	0
53–68	I-DISEASE
Obstructive	I-DISEASE
sleep	0
apnea	I-DISEASE
,	0
pediatric	0
63–68	0
Oneirism	0
248	0
Opioid	0
(	I-DISEASE
see	I-DISEASE
also	0
methadone	0
)	0
51	0
,	0
69	I-DISEASE
,	0
74	0
,	0
85–88	0
,	I-DISEASE
93	I-DISEASE
,	I-DISEASE
103	0
,	I-DISEASE
126	I-DISEASE
,	0
176	0
,	0
317	I-DISEASE
,	0
369	I-DISEASE
Opioid	I-DISEASE
withdrawal	0
88	I-DISEASE
,	I-DISEASE
317	0
Other	0
insomnia	0
disorder	0
46	0
Other	0
parasomnias	0
264–278	I-DISEASE
Other	I-DISEASE
sleep	0
disorder	I-DISEASE
339–340	0
Out	0
-	0
of	0
-	0
center	0
sleep	0
testing	0
(	I-DISEASE
OCST	0
)	0
50	0
,	0
53	I-DISEASE
,	0
,	0
60	0
,	0
61	0
,	0
134	0
,	I-DISEASE
137	0
,	0
139	I-DISEASE
P	0
Paradoxical	0
insomnia	I-DISEASE
20	I-DISEASE
,	I-DISEASE
27	0
,	0
35	I-DISEASE
Parasomnia	0
due	I-DISEASE
to	I-DISEASE
a	0
medical	0
disorder	0
276	I-DISEASE
Parasomnia	I-DISEASE
due	0
to	0
a	0
medication	I-DISEASE
or	0
substance	I-DISEASE
–	0
278	B-DISEASE
Parasomnia	0
overlap	0
disorder	0
237	0
,	0
248	B-DISEASE
,	I-DISEASE
249	I-DISEASE
,	I-DISEASE
Parasomnias	I-DISEASE
225–280	0
Parasomnia	0
,	I-DISEASE
unspecified	0
278	I-DISEASE
Parenchymal	I-DISEASE
(	I-DISEASE
lung	I-DISEASE
disease	I-DISEASE
)	0
52	I-DISEASE
,	0
93	0
,	0
109	I-DISEASE
,	I-DISEASE
,	0
121	0
,	0
123	0
,	0
124	I-DISEASE
,	0
127–131	0
,	0
134–137	I-DISEASE
Parkinson	0
disease	0
156	0
,	I-DISEASE
172	0
,	I-DISEASE
205	0
,	0
224	0
,	0
227	0
,	0
249	0
,	0
250	0
,	0
284	I-DISEASE
,	0
287	0
,	0
297	0
,	I-DISEASE
305	0
,	0
308	0
,	I-DISEASE
333	0
Performance	0
anxiety	I-DISEASE
26	I-DISEASE
Periodic	0
breathing	0
50	0
,	0
74	0
,	I-DISEASE
78–83	0
,	I-DISEASE
87	0
,	0
92	0
,	0
,	I-DISEASE
95	0
,	0
98	0
,	I-DISEASE
101	0
Periodic	0
limb	0
movement	0
disorder	0
292–299	0
Periodic	I-DISEASE
limb	0
movements	0
of	0
sleep	0
148	0
,	I-DISEASE
271	0
,	0
272	I-DISEASE
,	0
274	0
,	0
281	0
,	I-DISEASE
284	0
,	0
285	I-DISEASE
,	0
287–290	0
,	I-DISEASE
292–298	0
,	0
324	0
,	0
329	0
Periodic	0
limb	I-DISEASE
movements	0
of	0
wake	I-DISEASE
284	0
,	0
289	0
Pervasive	I-DISEASE
developmental	0
disorder	0
(	0
see	I-DISEASE
also	0
autism	I-DISEASE
)	0
206	0
Phase	I-DISEASE
response	0
curve	I-DISEASE
193	I-DISEASE
,	0
201	I-DISEASE
PHOX2B	I-DISEASE
113	0
,	0
114	0
,	0
116	0
,	0
118–120	0
,	I-DISEASE
123	I-DISEASE
Physiological	I-DISEASE
hyperarousal	0
33	I-DISEASE
,	0
35	0
Posttraumatic	I-DISEASE
stress	0
disorder	0
249	I-DISEASE
,	0
252	0
,	0
258	0
,	0
,	0
260	0
,	0
262	0
,	0
279	0
,	I-DISEASE
284	0
,	0
297	0
,	0
327	I-DISEASE
Prader	I-DISEASE
-	I-DISEASE
Willi	0
syndrome	0
120	0
,	I-DISEASE
156	0
,	0
172	0
Pramipexole	0
176	0
,	I-DISEASE
331	0
Pregnancy	0
139	I-DISEASE
,	0
140	I-DISEASE
,	I-DISEASE
285	0
,	I-DISEASE
286	0
,	I-DISEASE
353	0
Prematurity	I-DISEASE
91	I-DISEASE
,	I-DISEASE
98–101	I-DISEASE
Primary	0
central	I-DISEASE
sleep	0
apnea	0
89–94	0
Primary	0
central	0
sleep	0
apnea	0
of	0
infancy	0
–	0
98	0
Primary	I-DISEASE
central	0
sleep	0
apnea	I-DISEASE
of	0
prematurity	0
–	0
102	0
Primary	I-DISEASE
insomnia	I-DISEASE
20	0
,	I-DISEASE
21	0
,	0
26	0
,	I-DISEASE
28	I-DISEASE
,	0
29	0
Prion	0
protein	I-DISEASE
342–344	0
Propriospinal	I-DISEASE
myoclonus	I-DISEASE
at	0
sleep	0
onset	I-DISEASE
–	0
324	I-DISEASE
Psychophysiological	0
insomnia	0
20	I-DISEASE
,	0
26	0
Pulmonary	0
hypertension	0
55	0
,	0
56	I-DISEASE
,	0
66	0
,	I-DISEASE
77	0
,	0
91	0
,	0
110	0
,	0
112	I-DISEASE
,	I-DISEASE
113	0
,	0
116	0
,	0
120	I-DISEASE
,	0
122–124	0
,	0
126	0
,	0
128	I-DISEASE
,	0
130–132	0
,	0
134	0
,	0
136	I-DISEASE
,	0
137	0
R	0
Recurrent	I-DISEASE
hypersomnia	0
145	I-DISEASE
,	I-DISEASE
166	0
Recurrent	0
isolated	0
sleep	I-DISEASE
paralysis	0
254–256	0
REM	0
-	I-DISEASE
related	0
parasomnias	0
246–263	0
REM	0
sleep	0
behavior	0
disorder	0
246–253	0

REM	0
sleep	0
without	0
atonia	I-DISEASE
151	I-DISEASE
,	I-DISEASE
152	I-DISEASE
,	0
159	I-DISEASE
,	0
,	0
247	0
,	0
251	0
,	I-DISEASE
252	0
Renal	0
failure	I-DISEASE
70–74	I-DISEASE
,	0
285–287	0
Residual	0
hypersomnia	0
173	0
Index	0
Index	0
Respiratory	0
depressant	0
51	I-DISEASE
,	I-DISEASE
85	0
,	0
121	0
,	0
125–127	0
Respiratory	B-DISEASE
effort	0
related	I-DISEASE
arousal	0
(	0
RERA	0
)	I-DISEASE
53	0
,	0
54	I-DISEASE
,	I-DISEASE
56	I-DISEASE
,	0
60	0
,	I-DISEASE
61	0
,	0
65	I-DISEASE
,	0
102	0
,	0
139	0
,	I-DISEASE
164	0
Restless	0
legs	I-DISEASE
syndrome	0
282–291	I-DISEASE
Reverse	I-DISEASE
first	0
-	I-DISEASE
night	I-DISEASE
effect	I-DISEASE
34	I-DISEASE
Rhythmic	0
masticatory	0
muscle	0
activity	I-DISEASE
304	I-DISEASE
,	0
,	I-DISEASE
307–311	0
S	0
Secondary	I-DISEASE
insomnia	I-DISEASE
20	I-DISEASE
,	I-DISEASE
21	0
,	0
28	0
,	I-DISEASE
29	0
Sedating	0
medication	0
54	I-DISEASE
,	0
57	I-DISEASE
,	0
165	I-DISEASE
,	0
176	B-DISEASE
,	0
177	0
Sedative	0
86	I-DISEASE
,	0
125	0
,	0
175–178	0
,	0
192	0
,	0
194	I-DISEASE
,	I-DISEASE
200	0
,	0
,	0
234	0
,	0
242	0
,	0
247	0
,	0
277	0
,	0
278	0
,	0
369	0
Seizures	0
(	I-DISEASE
see	0
also	I-DISEASE
epilepsy	0
)	I-DISEASE
55	0
,	I-DISEASE
66	0
,	B-DISEASE
68	0
,	0
,	I-DISEASE
101	0
,	0
115	I-DISEASE
,	0
153	I-DISEASE
,	0
170	I-DISEASE
,	I-DISEASE
176	0
,	0
252	0
,	0
256	0
,	0
260	I-DISEASE
,	I-DISEASE
261	0
,	0
266	0
,	0
269	I-DISEASE
,	0
273	0
,	0
279	I-DISEASE
,	0
298	0
,	0
310	B-DISEASE
,	0
317–319	B-DISEASE
,	0
337	0
,	0
345–349	0
,	0
356	0
Sexsomnia	0
232	I-DISEASE
,	0
242	0
,	I-DISEASE
248	0
Shift	I-DISEASE
work	I-DISEASE
disorder	0
215–219	I-DISEASE
Short	0
sleeper	I-DISEASE
47–48	I-DISEASE
Short	0
-	0
term	0
insomnia	I-DISEASE
disorder	0
41–45	I-DISEASE
Sleep	0
attack	B-DISEASE
143	0
,	I-DISEASE
147	I-DISEASE
Sleep	I-DISEASE
drunkenness	0
154	I-DISEASE
,	0
160	0
,	0
162	0
,	0
163	0
Sleep	I-DISEASE
enuresis	0
270–276	0
Sleep	0
inertia	0
162	0
,	I-DISEASE
192	0
,	0
197	0
,	I-DISEASE
226	I-DISEASE
,	0
236	0
Sleep	I-DISEASE
log	I-DISEASE
144	0
,	I-DISEASE
152	0
,	I-DISEASE
159	0
,	0
162	I-DISEASE
,	0
182	0
,	I-DISEASE
187	0
,	0
189	B-DISEASE
,	0
,	0
196	I-DISEASE
,	I-DISEASE
199	0
,	0
204	0
,	I-DISEASE
207	0
,	0
209	0
,	I-DISEASE
213	0
,	0
215	I-DISEASE
,	0
,	0
224	0
Sleep	I-DISEASE
-	0
onset	I-DISEASE
association	I-DISEASE
disorder	0
21	0

Sleep	0
onset	0
REM	0
period	B-DISEASE
144	0
,	0
146	0
,	0
152	0
,	0
–	0
162	0
,	0
164	0
,	I-DISEASE
165	0
,	0
169	I-DISEASE
,	0
171	0
,	0
174	0
,	0
177	I-DISEASE
,	I-DISEASE
,	I-DISEASE
247	0
,	I-DISEASE
269	0
Sleep	0
paralysis	0
148	0
,	0
150	0
,	0
151	0
,	0
153	I-DISEASE
,	0
156	0
,	I-DISEASE
,	I-DISEASE
163	0
,	0
171	0
,	0
183	I-DISEASE
,	0
254–256	0
,	I-DISEASE
261	0
,	0
266	0
,	0
,	0
269	0
,	0
276	I-DISEASE
,	0
314	I-DISEASE
Sleep	I-DISEASE
related	0
abnormal	0
sexual	0
behaviors	0
Sleep	0
related	I-DISEASE
breathing	0
disorders	I-DISEASE
49–141	I-DISEASE
Sleep	0
related	0
Sleep	I-DISEASE
related	0
Sleep	0
related	I-DISEASE
Sleep	I-DISEASE
related	0
–	I-DISEASE
363	I-DISEASE
Sleep	I-DISEASE
related	I-DISEASE
Sleep	0
related	I-DISEASE
Sleep	I-DISEASE
related	I-DISEASE
–	0
133	I-DISEASE
Sleep	I-DISEASE
related	I-DISEASE
bruxism	0
303–311	0
eating	I-DISEASE
disorder	I-DISEASE
240–245	I-DISEASE
epilepsy	I-DISEASE
345–350	I-DISEASE
gastroesophageal	0
reflux	I-DISEASE
hallucinations	0
267–270	0
headaches	I-DISEASE
350–355	I-DISEASE
hypoventilation	I-DISEASE
disorders	0
hypoventilation	0
due	0
to	0
a	I-DISEASE
medical	0
disorder	I-DISEASE
128–133	0
Sleep	0
related	0
hypoventilation	0
due	0
to	0
a	0
medication	0
or	0
substance	0
124–128	0
Sleep	0
related	I-DISEASE
hypoxemia	0

134–138	0
Sleep	0
related	0
injury	I-DISEASE
227	0
,	I-DISEASE
241	I-DISEASE
,	0
247	I-DISEASE
,	0
250	0
Sleep	0
related	0
laryngospasm	0
355–357	I-DISEASE
Sleep	I-DISEASE
related	0
leg	I-DISEASE
cramps	0
299–303	0
Sleep	0
related	0
medical	0
and	0
neurological	I-DISEASE
disorders	0
341–367	I-DISEASE
Sleep	I-DISEASE
related	0
movement	I-DISEASE
disorder	I-DISEASE
due	0
to	0
a	0
medical	0
disorder	0
325	I-DISEASE
Sleep	I-DISEASE
related	0
movement	0
disorder	0
due	0
to	0
a	0
medication	0
or	0
substance	0
326	0
Sleep	0
related	I-DISEASE
movement	I-DISEASE
disorders	I-DISEASE
281–337	I-DISEASE
Sleep	0
related	0
movement	0
disorder	0
,	0
unspecified	0
327	I-DISEASE
Sleep	I-DISEASE
related	0
myocardial	I-DISEASE
ischemia	0
363–367	0
Sleep	I-DISEASE
related	0
rhythmic	0
movement	0
disorder	0
–	0
316	0
Sleep	I-DISEASE
starts	I-DISEASE
(	0
see	0
also	0
hypnic	I-DISEASE
jerks	I-DISEASE
)	I-DISEASE

335–337	0
Sleep	0
talking	0
279–280	0
Sleep	0
terrors	I-DISEASE
228–239	B-DISEASE
Sleepwalking	0
228–239	0
Smith	0
-	0
Magenis	0
syndrome	0
173	0
,	0
200	0
,	0
206	I-DISEASE
Snoring	0
139–140	I-DISEASE

Status	0
cataplecticus	0
148	0
Status	0
dissociatus	0
248	0
,	0
252	0
Stroke	I-DISEASE
(	0
see	0
also	0
cerebrovascular	0
accident	0
)	I-DISEASE
34	I-DISEASE
,	0
50	I-DISEASE
,	0
53	0
,	0
55	0
,	0
58	0
,	I-DISEASE
61	0
,	I-DISEASE
70–74	0
,	0
76	0
,	0
140	0
,	0
172	0
,	0
173	B-DISEASE
,	0
234	0
,	0
249	0
,	0
264	0
,	0
287	0
,	0
291	B-DISEASE
,	I-DISEASE
295	0
Sudden	0
infant	0
death	0
syndrome	0
(	I-DISEASE
SIDS	0
)	0
94	0
,	0
97	I-DISEASE
,	0
98	I-DISEASE
Suggested	0
immobilization	0
test	0
289	I-DISEASE
Synucleinopathies	0
(	I-DISEASE
see	0
also	I-DISEASE
Parkinson	I-DISEASE
disease	I-DISEASE
and	0
multisystem	0
atrophy	I-DISEASE
)	I-DISEASE
227	0
,	0
250	0
T	I-DISEASE
Treatment	I-DISEASE
-	0
emergent	I-DISEASE
central	0
sleep	0
apnea	0
102–107	0
V	0
Ventilatory	0
drive	0
50	I-DISEASE
,	I-DISEASE
59	I-DISEASE
,	I-DISEASE
66	I-DISEASE
,	0
72	I-DISEASE
,	0
74	0
,	0
87	0
,	I-DISEASE
90	0
,	I-DISEASE
92	0
,	0
122	0
,	I-DISEASE
124	0
,	I-DISEASE
125	I-DISEASE
Violence	0
(	0
in	I-DISEASE
sleep	0
)	0
232	0
,	0
249	0
W	0
Willis	I-DISEASE
-	0
Ekbom	I-DISEASE
disease	0
282	0
Index	0

